Citrus Sinensis ID: 036334
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 654 | 2.2.26 [Sep-21-2011] | |||||||
| O48788 | 658 | Probable inactive recepto | yes | no | 0.963 | 0.957 | 0.751 | 0.0 | |
| Q9LVM0 | 654 | Probable inactive recepto | no | no | 0.938 | 0.938 | 0.558 | 0.0 | |
| Q9C9Y8 | 640 | Probable inactive recepto | no | no | 0.902 | 0.921 | 0.537 | 1e-178 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.917 | 0.937 | 0.492 | 1e-158 | |
| Q9SUQ3 | 638 | Probable inactive recepto | no | no | 0.882 | 0.904 | 0.492 | 1e-157 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.883 | 0.882 | 0.496 | 1e-156 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.914 | 0.892 | 0.489 | 1e-150 | |
| Q9M8T0 | 627 | Probable inactive recepto | no | no | 0.900 | 0.939 | 0.489 | 1e-150 | |
| Q9LVI6 | 647 | Probable inactive recepto | no | no | 0.883 | 0.893 | 0.484 | 1e-146 | |
| Q9FMD7 | 625 | Probable inactive recepto | no | no | 0.917 | 0.96 | 0.452 | 1e-140 |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 942 bits (2435), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 481/640 (75%), Positives = 543/640 (84%), Gaps = 10/640 (1%)
Query: 23 VNSEPTQDKQALLAFLSRTPHKNRVQWNASDSACNWVGVECDANRSFVYSLRLPGVGLVG 82
VNSE T +KQALL FL + PH+NR+QWN SDSACNWVGVEC++N+S ++SLRLPG GLVG
Sbjct: 21 VNSESTAEKQALLTFLQQIPHENRLQWNESDSACNWVGVECNSNQSSIHSLRLPGTGLVG 80
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
IP +LG+L++LRVLSLRSNRLSG+IPSDFSNLT LRSLYLQ N+FSG FP S T++N
Sbjct: 81 QIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQLNN 140
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGS 202
L RLD+SSNNF+G IPF VNNLTHLTGLFL NN FSGNLPSI+ L DFNVSNNNLNGS
Sbjct: 141 LIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSIS-LGLVDFNVSNNNLNGS 199
Query: 203 IPATLSKFPQSSFTGNLDLCGGPLPPCNPFFPSPAPSPSLPPPVAPVHKKSNKLSTAAIV 262
IP++LS+F SFTGN+DLCGGPL PC FF SP+PSPSL P + K +KLS AAIV
Sbjct: 200 IPSSLSRFSAESFTGNVDLCGGPLKPCKSFFVSPSPSPSLINPSNRLSSKKSKLSKAAIV 259
Query: 263 GIAVGGAVFIVLLLLLLLFCLKKRRR---QRPGKAPKPPAAATARAVTMEAGTSSSKDDI 319
I V A+ +LLL LLLF ++RR + K PKP AT R V + G SSSK+++
Sbjct: 260 AIIVASALVALLLLALLLFLCLRKRRGSNEARTKQPKPAGVAT-RNVDLPPGASSSKEEV 318
Query: 320 TGGAA----EADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVV 375
TG ++ E +RNKLVF EGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVV
Sbjct: 319 TGTSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVV 378
Query: 376 KRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGS 435
KRLK+V K+EFE QMEV+GKIKH NV+PLRA+YYSKDEKLLV+D+MP GSLSALLHGS
Sbjct: 379 KRLKDVMASKKEFETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGS 438
Query: 436 RGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP 495
RGSGRTPLDWDNRMRIA++AARGLAHLHVS K+VHGNIKASNILL P+ D CVSD+GLN
Sbjct: 439 RGSGRTPLDWDNRMRIAITAARGLAHLHVSAKLVHGNIKASNILLHPNQDTCVSDYGLNQ 498
Query: 496 LFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLP 555
LF N++PP R+AGY APEV+ETRKVTFKSDVYSFGVLLLELLTGK+PNQASLGEEGIDLP
Sbjct: 499 LFSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLP 558
Query: 556 RWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615
RWV SVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAM CVSTVPDQRP MQEV+RMIE+
Sbjct: 559 RWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIED 618
Query: 616 MNRGE-TDDGLRQSSDDPSKGSDGHTPPPESRTPPTALTP 654
+NR E TDDGLRQSSDDPSKGS+G TPP ESRTPP ++TP
Sbjct: 619 VNRSETTDDGLRQSSDDPSKGSEGQTPPGESRTPPRSVTP 658
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 675 bits (1741), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/643 (55%), Positives = 463/643 (72%), Gaps = 29/643 (4%)
Query: 8 LICFLLLS---CGGGIGYVNSEPTQDKQALLAFLSRTPHKNRVQWNASDSAC-NWVGVEC 63
L+ FL ++ C I +NS D+QALLAF + PH R+ WN+++ C +WVGV C
Sbjct: 27 LVSFLFVTTTFCSYAIADLNS----DRQALLAFAASVPHLRRLNWNSTNHICKSWVGVTC 82
Query: 64 DANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLY 123
++ + V++LRLPG+GL+GPIPPNTLGKL LR+LSLRSN LSG +P D +L L +Y
Sbjct: 83 TSDGTSVHALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIY 142
Query: 124 LQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS 183
LQ N FSG P+ V+R +L LDLS N+F+GKIP NL LTGL L+NNK SG +P+
Sbjct: 143 LQHNNFSGEVPSFVSR--QLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPN 200
Query: 184 INPANLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDLCGGPLPPCNPFFPSPAPSPSLP 243
++ +LR N+SNN+LNGSIP+ L FP SSF+GN LCG PL PC P P+ +P +
Sbjct: 201 LDTVSLRRLNLSNNHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHIS 260
Query: 244 -PPVAPV-HKKSNK--LSTAAIVGIAVGGAVFIVLLLLLLLFCLKKRRRQRPGKAPKPPA 299
PP+ P HK+ +K L + I+ IA GGA ++L+ +++L C K++ +R
Sbjct: 261 TPPLPPFPHKEGSKRKLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKREDSI----- 315
Query: 300 AATARAVTMEAGTSSSKDDITGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSV 359
V ++ T +K + G E ++NKLVFF G Y+FDLEDLLRASAEVLGKGS
Sbjct: 316 ------VKVKTLTEKAKQEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSY 369
Query: 360 GTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLL 418
GT+YKAVLEE TTVVVKRLKEVA GKREFE QME++ ++ H +VVPLRA+YYSKDEKL+
Sbjct: 370 GTAYKAVLEESTTVVVKRLKEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLM 429
Query: 419 VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG--KIVHGNIKAS 476
V DY PAG+LS+LLHG+RGS +TPLDWD+R++I LSAA+G+AHLH +G K HGNIK+S
Sbjct: 430 VCDYYPAGNLSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSS 489
Query: 477 NILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLEL 536
N++++ + DAC+SDFGL PL P R AGYRAPEV+ETRK T KSDVYSFGVL+LE+
Sbjct: 490 NVIMKQESDACISDFGLTPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEM 549
Query: 537 LTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCV 596
LTGK+P Q+ ++ +DLPRWVQSVVREEWT+EVFD+ELMR+ NIEEEMVQ+LQIAM CV
Sbjct: 550 LTGKSPVQSPSRDDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACV 609
Query: 597 STVPDQRPAMQEVVRMIENMNRGETDDGLRQSSDDPSKGSDGH 639
+ VP+ RP M +VVRMIE + R + R SSDD SK D +
Sbjct: 610 AQVPEVRPTMDDVVRMIEEI-RVSDSETTRPSSDDNSKPKDSN 651
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 626 bits (1615), Expect = e-178, Method: Compositional matrix adjust.
Identities = 336/625 (53%), Positives = 424/625 (67%), Gaps = 35/625 (5%)
Query: 30 DKQALLAFLSRTPHKNRVQWNASDSAC-NWVGVECDANRSFVYSLRLPGVGLVGPIPPNT 88
DKQALL F S PH ++ WN++ C +W G+ C N + V +LRLPG GL GP+P T
Sbjct: 28 DKQALLEFASLVPHSRKLNWNSTIPICASWTGITCSKNNARVTALRLPGSGLYGPLPEKT 87
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
KL LR++SLRSN L G IPS +L +RSLY N FSG P ++ +RL LDL
Sbjct: 88 FEKLDALRIISLRSNHLQGNIPSVILSLPFIRSLYFHENNFSGTIPPVLS--HRLVNLDL 145
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLS 208
S+N+ SG IP + NLT LT L L+NN SG +P++ P L+ N+S NNLNGS+P+++
Sbjct: 146 SANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIPNL-PPRLKYLNLSFNNLNGSVPSSVK 204
Query: 209 KFPQSSFTGNLDLCGGPLPPCNPFFPSPAPSPSLPPPVAP---VHKKSNK--LSTAAIVG 263
FP SSF GN LCG PL PC +P+PSP+ P + + + K LST AIVG
Sbjct: 205 SFPASSFQGNSLLCGAPLTPCPENTTAPSPSPTTPTEGPGTTNIGRGTAKKVLSTGAIVG 264
Query: 264 IAVGGAVFIVLLLLLLLFCLKKRRRQRPGKAPKPPAAATARAVTMEAGTSSSK-DDITGG 322
IAVGG+V + ++L ++ C K+R P A + G S +K ++ G
Sbjct: 265 IAVGGSVLLFIILAIITLCCAKKRDGGQDSTAVPKA---------KPGRSDNKAEEFGSG 315
Query: 323 AAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVA 382
EA++NKLVFFEG Y+FDLEDLLRASAEVLGKGS GT+YKA+LEEGTTVVVKRLKEVA
Sbjct: 316 VQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVA 375
Query: 383 VGKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRT 441
GKREFE QME +G+I H NV PLRA+Y+SKDEKLLVYDY G+ S LLHG+ GR
Sbjct: 376 AGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQGGNFSMLLHGNNEGGRA 435
Query: 442 PLDWDNRMRIALSAARGLAHLHVS--GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499
LDW+ R+RI L AARG++H+H + K++HGNIK+ N+LL + CVSDFG+ PL +
Sbjct: 436 ALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELHVCVSDFGIAPLMSH 495
Query: 500 -TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWV 558
T P+R GYRAPE +ETRK T KSDVYSFGVLLLE+LTGKA + + EE +DLP+WV
Sbjct: 496 HTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAAGKTTGHEEVVDLPKWV 555
Query: 559 QSVVREEWTAEVFDVELMRY-HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM- 616
QSVVREEWT EVFDVEL++ HN+EEEMVQ+LQIAM CVS PD RP+M+EVV M+E +
Sbjct: 556 QSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRPSMEEVVNMMEEIR 615
Query: 617 ---------NRGETDDGLRQSSDDP 632
NR + + +R SSD P
Sbjct: 616 PSGSGPGSGNRASSPEMIR-SSDSP 639
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 560 bits (1442), Expect = e-158, Method: Compositional matrix adjust.
Identities = 311/632 (49%), Positives = 419/632 (66%), Gaps = 32/632 (5%)
Query: 11 FLLLSCGGGIGYVNSEPTQDKQALLAFLSRTPHKNRVQWNASDSACN-WVGVECDANR-- 67
FLLL+ + V+++ D+QALL F + PH ++ WN + S C+ W+G+ CD +
Sbjct: 15 FLLLAATAVL--VSADLASDEQALLNFAASVPHPPKLNWNKNLSLCSSWIGITCDESNPT 72
Query: 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSN 127
S V ++RLPGVGL G IPP TLGKL L+VLSLRSN L G +PSD +L L LYLQ N
Sbjct: 73 SRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYLYLQHN 132
Query: 128 QFSGVFPA----SVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS 183
FSG S+++ +L LDLS N+ SG IP + NL+ +T L+L+NN F G + S
Sbjct: 133 NFSGELTTNSLPSISK--QLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGPIDS 190
Query: 184 INPANLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDLCGGPLPPCNPFFPSPAPSPSLP 243
++ +++ N+S NNL+G IP L K P+ SF GN LCG PL C+ + +PS +LP
Sbjct: 191 LDLPSVKVVNLSYNNLSGPIPEHLKKSPEYSFIGNSLLCGPPLNACSG--GAISPSSNLP 248
Query: 244 PPVAP-VHKKSNKLSTAAIVGIAVGGAVFIVLLLLLLLFCLKKRRRQRPGKAPKPPAAAT 302
P+ +H + S A I+ I VG +V ++ L ++ L CL K+ ++ G
Sbjct: 249 RPLTENLHPVRRRQSKAYIIAIVVGCSVAVLFLGIVFLVCLVKKTKKEEGGG-------- 300
Query: 303 ARAVTMEAGTSSSK--DDITGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVG 360
V + G +SK D G + ++NKL FFE ++FDLEDLL+ASAEVLGKGS G
Sbjct: 301 -EGVRTQMGGVNSKKPQDFGSGVQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFG 359
Query: 361 TSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLV 419
T+YKAVLE+ T VVVKRL+EV K+EFE QME++GKI +H N VPL A+YYSKDEKLLV
Sbjct: 360 TAYKAVLEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLV 419
Query: 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNIL 479
Y YM GSL ++HG+RG +DW+ RM+IA ++ +++LH S K VHG+IK+SNIL
Sbjct: 420 YKYMTKGSLFGIMHGNRGD--RGVDWETRMKIATGTSKAISYLH-SLKFVHGDIKSSNIL 476
Query: 480 LRPDHDACVSDFGLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTG 539
L D + C+SD L LF T R GY APEV+ETR+V+ +SDVYSFGV++LE+LTG
Sbjct: 477 LTEDLEPCLSDTSLVTLFNLPTHTPRTIGYNAPEVIETRRVSQRSDVYSFGVVILEMLTG 536
Query: 540 KAP-NQASLGEEG--IDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCV 596
K P Q L +E IDLPRWV+SVVREEWTAEVFDVEL+++ NIEEEMVQ+LQ+A+ CV
Sbjct: 537 KTPLTQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACV 596
Query: 597 STVPDQRPAMQEVVRMIENMNRGETDDGLRQS 628
+ P+ RP M+EV RMIE++ R + L+Q+
Sbjct: 597 ARNPESRPKMEEVARMIEDVRRLDQSQQLQQN 628
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SUQ3|Y4374_ARATH Probable inactive receptor kinase At4g23740 OS=Arabidopsis thaliana GN=At4g23740 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 554 bits (1428), Expect = e-157, Method: Compositional matrix adjust.
Identities = 309/627 (49%), Positives = 409/627 (65%), Gaps = 50/627 (7%)
Query: 24 NSEPTQDKQALLAFLSRTPHKNRVQWNASDSACN-WVGVECDANRSFVYSLRLPGVGLVG 82
NS+P +DK+ALL FL+ + WN + CN W GV C+ + S + ++RLPGVGL G
Sbjct: 23 NSDPLEDKRALLEFLTIMQPTRSLNWNETSQVCNIWTGVTCNQDGSRIIAVRLPGVGLNG 82
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
IPPNT+ +LS LRVLSLRSN +SGE P DF L L LYLQ N SG P +
Sbjct: 83 QIPPNTISRLSALRVLSLRSNLISGEFPKDFVELKDLAFLYLQDNNLSGPLPLDFSVWKN 142
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINP-ANLRDFNVSNN-NLN 200
LT ++LS+N F+G IP ++ L + L L NN SG++P ++ ++L+ ++SNN +L
Sbjct: 143 LTSVNLSNNGFNGTIPSSLSRLKRIQSLNLANNTLSGDIPDLSVLSSLQHIDLSNNYDLA 202
Query: 201 GSIPATLSKFPQSSFTGNLDLCGGPLPPC-NPFFPSPAPSPSLPPPVAPVHKKSNKLSTA 259
G IP L +FP SS+TG +D+ +PP N +P PPP H+K +K A
Sbjct: 203 GPIPDWLRRFPFSSYTG-IDI----IPPGGNYTLVTP------PPPSEQTHQKPSK---A 248
Query: 260 AIVGIAVGGAVFIVL-----------LLLLLLFCLKKRRRQRPGKAPKPPAAATARAVTM 308
+G++ VF+++ L +L C +R+ +R + +
Sbjct: 249 RFLGLS--ETVFLLIVIAVSIVVITALAFVLTVCYVRRKLRRGD------GVISDNKLQK 300
Query: 309 EAGTSSSKDDITGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLE 368
+ G S K E N+L FFEG YSFDLEDLLRASAEVLGKG+ GT+YKAVLE
Sbjct: 301 KGGMSPEK---FVSRMEDVNNRLSFFEGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLE 357
Query: 369 EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428
+ T+V VKRLK+VA GKR+FE QME++G IKH+NVV L+A+YYSKDEKL+VYDY GS+
Sbjct: 358 DATSVAVKRLKDVAAGKRDFEQQMEIIGGIKHENVVELKAYYYSKDEKLMVYDYFSRGSV 417
Query: 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV--SGKIVHGNIKASNILLRPDHDA 486
++LLHG+RG R PLDW+ RM+IA+ AA+G+A +H +GK+VHGNIK+SNI L + +
Sbjct: 418 ASLLHGNRGENRIPLDWETRMKIAIGAAKGIARIHKENNGKLVHGNIKSSNIFLNSESNG 477
Query: 487 CVSDFGLNPLFGNTTPP-TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQA 545
CVSD GL + PP +R AGYRAPEV +TRK + SDVYSFGV+LLELLTGK+P
Sbjct: 478 CVSDLGLTAVMSPLAPPISRQAGYRAPEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHT 537
Query: 546 SLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPA 605
+ G+E I L RWV SVVREEWTAEVFD+EL+RY NIEEEMV++LQIAM CV DQRP
Sbjct: 538 TAGDEIIHLVRWVHSVVREEWTAEVFDIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPK 597
Query: 606 MQEVVRMIENMNRGETDDGLRQSSDDP 632
M ++VR+IEN+ G R++S +P
Sbjct: 598 MSDLVRLIENV-------GNRRTSIEP 617
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 553 bits (1426), Expect = e-156, Method: Compositional matrix adjust.
Identities = 306/616 (49%), Positives = 403/616 (65%), Gaps = 38/616 (6%)
Query: 30 DKQALLAFLSRTPHKNRVQWNASDSA-CNWVGVECDANRSFVYSLRLPGVGLVGPIPPNT 88
D+ ALL+ S + +WN ++ CNW GV+C++NR V +LRLPGV L G IP
Sbjct: 36 DRTALLSLRSAVGGRT-FRWNIKQTSPCNWAGVKCESNR--VTALRLPGVALSGDIPEGI 92
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
G L+QLR LSLR N LSG +P D S + LR LYLQ N+FSG P + ++ L RL+L
Sbjct: 93 FGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLVRLNL 152
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLS 208
+SN+F+G+I NLT L LFLENN+ SG++P ++ L FNVSNN+LNGSIP L
Sbjct: 153 ASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLDLP-LVQFNVSNNSLNGSIPKNLQ 211
Query: 209 KFPQSSFTGNLDLCGGPLPPCNPFFPSPAPSPSLP-------PPV---APVHKKSNKLST 258
+F SF LCG PL C P PS P PP + KK NKLS
Sbjct: 212 RFESDSFL-QTSLCGKPLKLC----PDEETVPSQPTSGGNRTPPSVEGSEEKKKKNKLSG 266
Query: 259 AAIVGIAVGGAV-FIVLLLLLLLFCLKKRRRQRPG------KAPKPPAAATARAV---TM 308
AI GI +G V F +++L+L++ C KK ++ K +P AV +
Sbjct: 267 GAIAGIVIGCVVGFALIVLILMVLCRKKSNKRSRAVDISTIKQQEPEIPGDKEAVDNGNV 326
Query: 309 EAGTSSSKDDITGGAAEADRN-----KLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSY 363
+ ++++ +TG ++ N KLVFF FDLEDLLRASAEVLGKG+ GT+Y
Sbjct: 327 YSVSAAAAAAMTGNGKASEGNGPATKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAY 386
Query: 364 KAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423
KAVL+ T V VKRLK+V + +EF+ ++E++G + H+N+VPLRA+Y+S+DEKLLVYD+M
Sbjct: 387 KAVLDAVTVVAVKRLKDVMMADKEFKEKIELVGAMDHENLVPLRAYYFSRDEKLLVYDFM 446
Query: 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG-KIVHGNIKASNILLRP 482
P GSLSALLHG+RG+GR+PL+WD R RIA+ AARGL +LH G HGNIK+SNILL
Sbjct: 447 PMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQGTSTSHGNIKSSNILLTK 506
Query: 483 DHDACVSDFGLNPLFGNT-TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKA 541
HDA VSDFGL L G++ T P R GYRAPEV + ++V+ K DVYSFGV+LLEL+TGKA
Sbjct: 507 SHDAKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLELITGKA 566
Query: 542 PNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMV-QLLQIAMGCVSTVP 600
P+ + + EEG+DLPRWV+SV R+EW EVFD EL+ EEEM+ +++Q+ + C S P
Sbjct: 567 PSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECTSQHP 626
Query: 601 DQRPAMQEVVRMIENM 616
DQRP M EVVR +EN+
Sbjct: 627 DQRPEMSEVVRKMENL 642
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 533 bits (1373), Expect = e-150, Method: Compositional matrix adjust.
Identities = 314/642 (48%), Positives = 408/642 (63%), Gaps = 44/642 (6%)
Query: 30 DKQALLAFLSRTPHKNRVQ-WNASDSACNWVGVECDANRSFVYSLRLPGVGLVGPIPPNT 88
D + LL F ++ WN + + C W GV C+ NR V L L + L G I T
Sbjct: 31 DSETLLNFKLTADSTGKLNSWNTTTNPCQWTGVSCNRNR--VTRLVLEDINLTGSISSLT 88
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L+ LRVLSL+ N LSG IP + SNLT L+ L+L +NQFSG FP S+T + RL RLDL
Sbjct: 89 --SLTSLRVLSLKHNNLSGPIP-NLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRLDL 145
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLS 208
S NNFSG+IP D+ +LTHL L LE+N+FSG +P+IN ++L+DFNVS NN NG IP +LS
Sbjct: 146 SFNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFNGQIPNSLS 205
Query: 209 KFPQSSFTGNLDLCGGPLPPCNPFFPSPA---------PSPSLPPPVAP-----VH--KK 252
+FP+S FT N LCG PL C P SP P P +H K
Sbjct: 206 QFPESVFTQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSIHGGDK 265
Query: 253 SN---KLSTAAIVGIAVGGAVFIVLLLLLLLFCLKKRRRQRPGKAPKPPAAATARAVTME 309
SN ++ST +++ I +G + + + LLL +C RQ K +
Sbjct: 266 SNNTSRISTISLIAIILGDFIILSFVSLLLYYCF---WRQYAVNKKKHSKILEGEKIVYS 322
Query: 310 AG--TSSSKDDITGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVL 367
+ +S++++ D+ K+VFFE G F+LEDLLRASAE+LGKG GT+YKAVL
Sbjct: 323 SNPYPTSTQNNNNQNQQVGDKGKMVFFE-GTRRFELEDLLRASAEMLGKGGFGTAYKAVL 381
Query: 368 EEGTTVVVKRLKE--VAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425
E+G V VKRLK+ GK+EFE QMEVLG+++H N+V L+A+Y++++EKLLVYDYMP
Sbjct: 382 EDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPN 441
Query: 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG---KIVHGNIKASNILLRP 482
GSL LLHG+RG GRTPLDW R++IA AARGLA +H S K+ HG+IK++N+LL
Sbjct: 442 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDR 501
Query: 483 DHDACVSDFGLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
+A VSDFGL+ +F + + GYRAPE+++ RK T KSDVYSFGVLLLE+LTGK P
Sbjct: 502 SGNARVSDFGLS-IFAPSQTVAKSNGYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKCP 560
Query: 543 NQASLGEEG--IDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVP 600
N G G +DLPRWVQSVVREEWTAEVFD+ELMRY +IEEEMV LLQIAM C +
Sbjct: 561 NMVETGHSGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAA 620
Query: 601 DQRPAMQEVVRMIENMNRGETD-----DGLRQSSDDPSKGSD 637
D RP M VV++IE++ G ++ DG+ + D P D
Sbjct: 621 DHRPKMGHVVKLIEDIRGGGSEASPCNDGINSAVDSPCLSED 662
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M8T0|Y3288_ARATH Probable inactive receptor kinase At3g02880 OS=Arabidopsis thaliana GN=At3g02880 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 532 bits (1371), Expect = e-150, Method: Compositional matrix adjust.
Identities = 298/609 (48%), Positives = 402/609 (66%), Gaps = 20/609 (3%)
Query: 20 IGYVNSEPTQDKQALLAFLSRTPHKNR-VQWNASDSA-CNWVGVECDANRSFVYSLRLPG 77
+ V S+ D++ALLA R + R + WN S S+ CNW GV CDA R V +LRLPG
Sbjct: 19 LAAVTSDLESDRRALLAV--RNSVRGRPLLWNMSASSPCNWHGVHCDAGR--VTALRLPG 74
Query: 78 VGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV 137
GL G +P +G L+QL+ LSLR N LSG IPSDFSNL LLR LYLQ N FSG P+ +
Sbjct: 75 SGLFGSLPIGGIGNLTQLKTLSLRFNSLSGPIPSDFSNLVLLRYLYLQGNAFSGEIPSLL 134
Query: 138 TRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNN 197
+ + R++L N FSG+IP +VN+ T L L+LE N+ SG +P I L+ FNVS+N
Sbjct: 135 FTLPSIIRINLGENKFSGRIPDNVNSATRLVTLYLERNQLSGPIPEIT-LPLQQFNVSSN 193
Query: 198 NLNGSIPATLSKFPQSSFTGNLDLCGGPLPPCNPFFPS--PAPSPSLPPPVAPVHKKSNK 255
LNGSIP++LS +P+++F GN LCG PL C P+ A P+ PP K S+K
Sbjct: 194 QLNGSIPSSLSSWPRTAFEGN-TLCGKPLDTCEAESPNGGDAGGPNTPPE----KKDSDK 248
Query: 256 LSTAAIVGIAVGGAVFIVLLLLLLLFCLKKRRRQR--PGKAPKPP--AAATARAVTMEAG 311
LS AIVGI +G V ++LLLL+L +KR+++ P + + P AA ++ A+ E
Sbjct: 249 LSAGAIVGIVIGCVVGLLLLLLILFCLCRKRKKEENVPSRNVEAPVAAATSSAAIPKETV 308
Query: 312 TSSSKDDITGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGT 371
TG + A L FF FDL+ LL+ASAEVLGKG+VG+SYKA E G
Sbjct: 309 VVVPPAKATGSESGAVNKDLTFFVKSFGEFDLDGLLKASAEVLGKGTVGSSYKASFEHGL 368
Query: 372 TVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSAL 431
V VKRL++V V ++EF ++ VLG + H N+V L A+Y+S+DEKLLV++YM GSLSA+
Sbjct: 369 VVAVKRLRDVVVPEKEFRERLHVLGSMSHANLVTLIAYYFSRDEKLLVFEYMSKGSLSAI 428
Query: 432 LHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV-SGKIVHGNIKASNILLRPDHDACVSD 490
LHG++G+GRTPL+W+ R IAL AAR +++LH G HGNIK+SNILL ++A VSD
Sbjct: 429 LHGNKGNGRTPLNWETRAGIALGAARAISYLHSRDGTTSHGNIKSSNILLSDSYEAKVSD 488
Query: 491 FGLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEE 550
+GL P+ +T+ P R+ GYRAPE+ + RK++ K+DVYSFGVL+LELLTGK+P L EE
Sbjct: 489 YGLAPIISSTSAPNRIDGYRAPEITDARKISQKADVYSFGVLILELLTGKSPTHQQLNEE 548
Query: 551 GIDLPRWVQSVVREEWTAEVFDVELMRYH-NIEEEMVQLLQIAMGCVSTVPDQRPAMQEV 609
G+DLPRWVQSV ++ ++V D EL RY E +++LL+I M C + PD RP+M EV
Sbjct: 549 GVDLPRWVQSVTEQQTPSDVLDPELTRYQPEGNENIIRLLKIGMSCTAQFPDSRPSMAEV 608
Query: 610 VRMIENMNR 618
R+IE ++
Sbjct: 609 TRLIEEVSH 617
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 518 bits (1335), Expect = e-146, Method: Compositional matrix adjust.
Identities = 303/626 (48%), Positives = 391/626 (62%), Gaps = 48/626 (7%)
Query: 30 DKQALLAFLSRTPHKNRVQWNASDSA-CNWVGVECDANRSFVYSLRLPGVGLVGPIPPNT 88
DK ALL+F S + + W+ ++ CNW GV CD R V +LRLPG L G IP
Sbjct: 34 DKSALLSFRSAVGGRT-LLWDVKQTSPCNWTGVLCDGGR--VTALRLPGETLSGHIPEGI 90
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
G L+QLR LSLR N L+G +P D + + LR LYLQ N+FSG P + ++ L RL+L
Sbjct: 91 FGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNRFSGEIPEVLFSLSNLVRLNL 150
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLS 208
+ N FSG+I NLT L L+LENNK SG+L ++ + + FNVSNN LNGSIP +L
Sbjct: 151 AENEFSGEISSGFKNLTRLKTLYLENNKLSGSLLDLDLSLDQ-FNVSNNLLNGSIPKSLQ 209
Query: 209 KFPQSSFTGNLDLCGGPLPPCNPFFPSPAPSPSLPPPVAPV---------HKKSNKLSTA 259
KF SF G LCG PL C+ + PS P V + KK KLS
Sbjct: 210 KFDSDSFVGT-SLCGKPLVVCS----NEGTVPSQPISVGNIPGTVEGSEEKKKRKKLSGG 264
Query: 260 AIVGIAVGGAVFIVLLLLLLLFCLKKRRRQRPG------------KAPKPPAAATA---R 304
AI GI +G V + L++++L+ +K+ +R + P AA A R
Sbjct: 265 AIAGIVIGCVVGLSLIVMILMVLFRKKGNERTRAIDLATIKHHEVEIPGEKAAVEAPENR 324
Query: 305 AVTMEAGTSSSKDDITGGAAEADRN---KLVFFEGGVYSFDLEDLLRASAEVLGKGSVGT 361
+ E S+ K A E + + KLVFF FDLEDLLRASAEVLGKG+ GT
Sbjct: 325 SYVNEYSPSAVK------AVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGT 378
Query: 362 SYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421
+YKAVL+ T V VKRLK+V + REF+ ++EV+G + H+N+VPLRA+YYS DEKLLVYD
Sbjct: 379 AYKAVLDAVTLVAVKRLKDVTMADREFKEKIEVVGAMDHENLVPLRAYYYSGDEKLLVYD 438
Query: 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI-VHGNIKASNILL 480
+MP GSLSALLHG++G+GR PL+W+ R IAL AARGL +LH + HGN+K+SNILL
Sbjct: 439 FMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQDPLSSHGNVKSSNILL 498
Query: 481 RPDHDACVSDFGLNPLF-GNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTG 539
HDA VSDFGL L ++T P R GYRAPEV + R+V+ K+DVYSFGV+LLELLTG
Sbjct: 499 TNSHDARVSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFGVVLLELLTG 558
Query: 540 KAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH---NIEEEMVQLLQIAMGCV 596
KAP+ + + EEG+DL RWV SV REEW EVFD ELM ++EEEM ++LQ+ + C
Sbjct: 559 KAPSNSVMNEEGMDLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCT 618
Query: 597 STVPDQRPAMQEVVRMIENMNRGETD 622
PD+RP M EVVR I+ + + D
Sbjct: 619 EQHPDKRPVMVEVVRRIQELRQSGAD 644
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FMD7|Y5659_ARATH Probable inactive receptor kinase At5g16590 OS=Arabidopsis thaliana GN=At5g16590 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 499 bits (1284), Expect = e-140, Method: Compositional matrix adjust.
Identities = 285/630 (45%), Positives = 398/630 (63%), Gaps = 30/630 (4%)
Query: 8 LICFLLLSCGGGIGYVNSEPTQDKQALLAFLSRTPHKNRVQWNASDSACNWVGVECDANR 67
L F C + V S+ D++AL+A L H + WN + C W GV+C++ R
Sbjct: 9 LSVFFFFIC---LVSVTSDLEADRRALIA-LRDGVHGRPLLWNLTAPPCTWGGVQCESGR 64
Query: 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSN 127
V +LRLPGVGL GP+P +G L++L LS R N L+G +P DF+NLTLLR LYLQ N
Sbjct: 65 --VTALRLPGVGLSGPLPI-AIGNLTKLETLSFRFNALNGPLPPDFANLTLLRYLYLQGN 121
Query: 128 QFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPA 187
FSG P+ + + + R++L+ NNF G+IP +VN+ T L L+L++N+ +G +P I
Sbjct: 122 AFSGEIPSFLFTLPNIIRINLAQNNFLGRIPDNVNSATRLATLYLQDNQLTGPIPEIK-I 180
Query: 188 NLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDLCGGPLPPCNPFFPSPAPSPSLPPPVA 247
L+ FNVS+N LNGSIP LS P+++F GNL LCG PL C P + + V
Sbjct: 181 KLQQFNVSSNQLNGSIPDPLSGMPKTAFLGNL-LCGKPLDAC-PVNGTGNGT------VT 232
Query: 248 PVHK-KSNKLSTAAIVGIAVG-GAVFIVLLLLLLLFCLKKRRRQ--RPGKAPKPPAAATA 303
P K KS+KLS AIVGI +G + +VL L++ C KK++ Q + P ++
Sbjct: 233 PGGKGKSDKLSAGAIVGIVIGCFVLLLVLFLIVFCLCRKKKKEQVVQSRSIEAAPVPTSS 292
Query: 304 RAVTMEA-------GTSSSKDDITGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGK 356
AV E+ +S++ ++ A ++ L FF FDL+ LL+ASAEVLGK
Sbjct: 293 AAVAKESNGPPAVVANGASENGVSKNPAAVSKD-LTFFVKSFGEFDLDGLLKASAEVLGK 351
Query: 357 GSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEK 416
G+ G+SYKA + G V VKRL++V V ++EF +++VLG I H N+V L A+Y+S+DEK
Sbjct: 352 GTFGSSYKASFDHGLVVAVKRLRDVVVPEKEFREKLQVLGSISHANLVTLIAYYFSRDEK 411
Query: 417 LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV-SGKIVHGNIKA 475
L+V++YM GSLSALLHG++GSGR+PL+W+ R IAL AAR +++LH HGNIK+
Sbjct: 412 LVVFEYMSRGSLSALLHGNKGSGRSPLNWETRANIALGAARAISYLHSRDATTSHGNIKS 471
Query: 476 SNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLE 535
SNILL +A VSD+ L P+ T+ P R+ GYRAPEV + RK++ K+DVYSFGVL+LE
Sbjct: 472 SNILLSESFEAKVSDYCLAPMISPTSTPNRIDGYRAPEVTDARKISQKADVYSFGVLILE 531
Query: 536 LLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH-NIEEEMVQLLQIAMG 594
LLTGK+P L EEG+DLPRWV S+ ++ ++VFD EL RY + E M++LL I +
Sbjct: 532 LLTGKSPTHQQLHEEGVDLPRWVSSITEQQSPSDVFDPELTRYQSDSNENMIRLLNIGIS 591
Query: 595 CVSTVPDQRPAMQEVVRMIENMNRGETDDG 624
C + PD RP M EV R+IE ++R G
Sbjct: 592 CTTQYPDSRPTMPEVTRLIEEVSRSPASPG 621
|
Might be involved in early recognition of growth promoting fungi. Appears to be specific for P.indica. Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 654 | ||||||
| 280967730 | 655 | protein kinase [Malus x domestica] | 0.980 | 0.978 | 0.823 | 0.0 | |
| 225445372 | 653 | PREDICTED: probable inactive receptor ki | 0.963 | 0.964 | 0.817 | 0.0 | |
| 255576916 | 657 | Nodulation receptor kinase precursor, pu | 0.966 | 0.961 | 0.816 | 0.0 | |
| 224143443 | 621 | predicted protein [Populus trichocarpa] | 0.932 | 0.982 | 0.772 | 0.0 | |
| 449520207 | 664 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.955 | 0.941 | 0.797 | 0.0 | |
| 449443127 | 653 | PREDICTED: probable inactive receptor ki | 0.980 | 0.981 | 0.760 | 0.0 | |
| 449464274 | 664 | PREDICTED: probable inactive receptor ki | 0.955 | 0.941 | 0.795 | 0.0 | |
| 357477837 | 655 | hypothetical protein MTR_4g113100 [Medic | 0.961 | 0.960 | 0.809 | 0.0 | |
| 449520357 | 653 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.980 | 0.981 | 0.759 | 0.0 | |
| 15225780 | 658 | putative inactive receptor kinase [Arabi | 0.963 | 0.957 | 0.751 | 0.0 |
| >gi|280967730|gb|ACZ98536.1| protein kinase [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 1026 bits (2654), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 533/647 (82%), Positives = 575/647 (88%), Gaps = 6/647 (0%)
Query: 8 LICFLLLSCGGGIGYVNSEPTQDKQALLAFLSRTPHKNRVQWNASDSACNWVGVECDANR 67
+ LLS G VNSEP QDKQALLAFLS+TPH NRVQWNAS SAC WVG++CD N+
Sbjct: 13 FVLITLLSLSGE--RVNSEPIQDKQALLAFLSQTPHANRVQWNASVSACTWVGIKCDDNQ 70
Query: 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSN 127
S+VYSLRLPGVGLVGP+PPNTLG+L+QLRVLSLRSNRLSG IP+DFSNLTLLRSLYLQ N
Sbjct: 71 SYVYSLRLPGVGLVGPVPPNTLGRLTQLRVLSLRSNRLSGPIPADFSNLTLLRSLYLQGN 130
Query: 128 QFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPA 187
Q SG FP +T++ RL RL LSSNNF+G IPF V+NLTHLT L+LENN FSG LP+I
Sbjct: 131 QLSGEFPTGLTQLERLNRLVLSSNNFTGPIPFAVSNLTHLTVLYLENNGFSGKLPNIQAP 190
Query: 188 NLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDLCGGPLPPCNPFFPSPAPSPSLPPPVA 247
NL +FNVSNN LNGSIP +LSKFP S+F+GNLDLCGGPL CNPFFP+PAPSP PP +
Sbjct: 191 NLTNFNVSNNQLNGSIPQSLSKFPASAFSGNLDLCGGPLKACNPFFPAPAPSPESPPIIP 250
Query: 248 PVHKKSNKLSTAAIVGIAVGGAVFIVLLLLLLLFCLKKRRRQRPGKAPKPPAAATARAVT 307
VHKKS KLSTAAIV IAVG A+ + LLLL+L CL+KRRRQ+P KAPKPP A R+V
Sbjct: 251 -VHKKSKKLSTAAIVAIAVGSALALFLLLLVLFLCLRKRRRQQPAKAPKPPVAT--RSVE 307
Query: 308 MEAGTSSSKDDITGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVL 367
EAGTSSSKDDITGG+ EA+RNKLVFF GGVYSFDLEDLLRASAEVLGKGSVGTSYKAVL
Sbjct: 308 TEAGTSSSKDDITGGSTEAERNKLVFFNGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVL 367
Query: 368 EEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427
EEGTTVVVKRLK+V V KREFEM MEVLGKIKHDNVVPLRAFY+SKDEKLLV DYM AGS
Sbjct: 368 EEGTTVVVKRLKDVVVTKREFEMTMEVLGKIKHDNVVPLRAFYFSKDEKLLVSDYMSAGS 427
Query: 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDAC 487
LSALLHGSRGSGRTPLDWDNRM+IALSAARG+AHLHVSGK+VHGNIK+SNILLRPD+DA
Sbjct: 428 LSALLHGSRGSGRTPLDWDNRMKIALSAARGIAHLHVSGKVVHGNIKSSNILLRPDNDAS 487
Query: 488 VSDFGLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASL 547
VSDFGLNPLFG +TPP RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASL
Sbjct: 488 VSDFGLNPLFGTSTPPNRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASL 547
Query: 548 GEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQ 607
GEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAM CVSTVPDQRPAMQ
Sbjct: 548 GEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPAMQ 607
Query: 608 EVVRMIENMNRGETDDGLRQSSDDPSKGSDGHTPPPESRTPPTALTP 654
EVVRMIE+MNR ETDDGLRQSSDDPSKGSDGHTPP SRTPP+ +TP
Sbjct: 608 EVVRMIEDMNRAETDDGLRQSSDDPSKGSDGHTPPGGSRTPPS-VTP 653
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225445372|ref|XP_002281635.1| PREDICTED: probable inactive receptor kinase At2g26730 [Vitis vinifera] gi|297738889|emb|CBI28134.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1018 bits (2633), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 518/634 (81%), Positives = 561/634 (88%), Gaps = 4/634 (0%)
Query: 21 GYVNSEPTQDKQALLAFLSRTPHKNRVQWNASDSACNWVGVECDANRSFVYSLRLPGVGL 80
G V+SEPTQDKQ LLAFLS+ PH+NR+QWNASDSACNWVGV CDANRS VY+LRLPGVGL
Sbjct: 24 GRVSSEPTQDKQTLLAFLSQIPHENRIQWNASDSACNWVGVGCDANRSNVYTLRLPGVGL 83
Query: 81 VGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRM 140
VG IP NT+G+LSQLRVLSLRSNRLSG+IP DF+NLTLLRSLYLQ N FSG FP S+T++
Sbjct: 84 VGQIPENTIGRLSQLRVLSLRSNRLSGDIPRDFANLTLLRSLYLQDNLFSGGFPGSITQL 143
Query: 141 NRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN 200
RL RLDLSSNNF+G++PF +NNL LTGLFL+NN FSG++PSIN L DFNVSNN LN
Sbjct: 144 TRLGRLDLSSNNFTGELPFSINNLNQLTGLFLQNNGFSGSIPSINSDGLDDFNVSNNRLN 203
Query: 201 GSIPATLSKFPQSSFTGNLDLCGGPLPPCNPFFPSPAPSPSLPPPVAPVHKKSNKLSTAA 260
GSIP TL KF SSF GNL LCGGPLPPCNPF P PV KKS KLSTAA
Sbjct: 204 GSIPQTLFKFGSSSFAGNLALCGGPLPPCNPF-FPSPTPSPSIVPSNPVQKKSKKLSTAA 262
Query: 261 IVGIAVGGAVFIVLLLLLLLFCLKKRRRQRPGKAPKPPAAATARAVTMEAGTSSSKDDIT 320
I+ I+VG A+ +L LLLLF L RR++ + PKPP T R++ E TSSSKDDIT
Sbjct: 263 IIAISVGSAL---ILCLLLLFLLLCLRRRQRRQPPKPPKPETTRSIVAETATSSSKDDIT 319
Query: 321 GGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKE 380
GG+AEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLK+
Sbjct: 320 GGSAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKD 379
Query: 381 VAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGR 440
V V K+EFEMQ++VLGKIKH+NVVPLRAFY+SKDEKLLVYD+M AGSLSALLHGSRGSGR
Sbjct: 380 VTVTKKEFEMQIDVLGKIKHENVVPLRAFYFSKDEKLLVYDFMAAGSLSALLHGSRGSGR 439
Query: 441 TPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500
TPLDWDNRMRIALSAARG+AHLHVSGK+VHGNIK+SNILLRPDHDACVSDFGLNPLFGN+
Sbjct: 440 TPLDWDNRMRIALSAARGIAHLHVSGKVVHGNIKSSNILLRPDHDACVSDFGLNPLFGNS 499
Query: 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQS 560
TPP RVAGYRAPEV+ETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQS
Sbjct: 500 TPPNRVAGYRAPEVMETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQS 559
Query: 561 VVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620
VVREEWTAEVFDVELMRYHNIEEEMVQLLQIAM CVSTVPDQRPAMQEVVRMIE+MNRGE
Sbjct: 560 VVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPAMQEVVRMIEDMNRGE 619
Query: 621 TDDGLRQSSDDPSKGSDGHTPPPESRTPPTALTP 654
TDDGLRQSSDDPSKGS GHTPPPESRTPP A+TP
Sbjct: 620 TDDGLRQSSDDPSKGSGGHTPPPESRTPPAAVTP 653
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255576916|ref|XP_002529343.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223531163|gb|EEF33010.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1012 bits (2616), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 521/638 (81%), Positives = 573/638 (89%), Gaps = 6/638 (0%)
Query: 21 GYVNSEPTQDKQALLAFLSRTPHKNRVQWNASDSACNWVGVECDANRSFVYSLRLPGVGL 80
G VNSEP QDKQALLAFLS+ PH NR+QWN SDSACNWVG+ CDAN S VY LRLPGV L
Sbjct: 22 GRVNSEPVQDKQALLAFLSQVPHANRLQWNQSDSACNWVGIVCDANLSSVYELRLPGVDL 81
Query: 81 VGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRM 140
VGPIP NTLG+LSQLRVLSLRSNRLSG+IPSDFSNLTLLRSLYLQ+N+FSG FP S+ +
Sbjct: 82 VGPIPSNTLGQLSQLRVLSLRSNRLSGQIPSDFSNLTLLRSLYLQNNEFSGEFPPSLVGL 141
Query: 141 NRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN 200
RL RLDLSSNNF+G IPF VNNLTHLT L+L+NN FSG LPSIN ++L DF+VSNN+LN
Sbjct: 142 TRLARLDLSSNNFTGSIPFGVNNLTHLTRLYLQNNNFSGTLPSINLSSLNDFDVSNNSLN 201
Query: 201 GSIPATLSKFPQSSFTGNLDLCGGPLPPCNPFFPSPAPSP---SLPPPVAPVHKKSNKLS 257
GSIP+ L++FP +SF GN++LCGGPLPPC+PFFPSP+P+P + PP + HKKS KLS
Sbjct: 202 GSIPSDLTRFPAASFVGNVNLCGGPLPPCSPFFPSPSPAPSENTSPPSLN--HKKSKKLS 259
Query: 258 TAAIVGIAVGGAVFIVLLLLLLLFCLKKRRRQRPGKAPKPPAAATA-RAVTMEAGTSSSK 316
T AIV I++G A+ +LLLLL+ CL++R+R +P K PKP A +TA RAV +EAGTSSSK
Sbjct: 260 TVAIVLISIGAAIIAFILLLLLVLCLRRRKRHQPPKQPKPAAVSTAARAVPVEAGTSSSK 319
Query: 317 DDITGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVK 376
DDITGG+ EA+RNKLVFFEGG+YSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVK
Sbjct: 320 DDITGGSTEAERNKLVFFEGGIYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVK 379
Query: 377 RLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSR 436
RLK+V V KREFE QME LGKIKHDNVVPLRAFYYSKDEKLLVYD+M AGSLSALLHGSR
Sbjct: 380 RLKDVVVSKREFETQMENLGKIKHDNVVPLRAFYYSKDEKLLVYDFMAAGSLSALLHGSR 439
Query: 437 GSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPL 496
GSGRTPLDWDNRMRIA+SAARGLAHLHV GK+VHGNIK+SNILLRPD DA +SDF LNPL
Sbjct: 440 GSGRTPLDWDNRMRIAMSAARGLAHLHVVGKVVHGNIKSSNILLRPDQDAAISDFALNPL 499
Query: 497 FGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPR 556
FG TPP+RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPR
Sbjct: 500 FGTATPPSRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPR 559
Query: 557 WVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
WVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAM CVSTVPDQRPAMQEVVRMIE++
Sbjct: 560 WVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPAMQEVVRMIEDI 619
Query: 617 NRGETDDGLRQSSDDPSKGSDGHTPPPESRTPPTALTP 654
NRGETDDGLRQSSDDPSKGSDGHTPP ESRTPP+ +TP
Sbjct: 620 NRGETDDGLRQSSDDPSKGSDGHTPPQESRTPPSGVTP 657
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224143443|ref|XP_002324958.1| predicted protein [Populus trichocarpa] gi|222866392|gb|EEF03523.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1010 bits (2611), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 500/647 (77%), Positives = 548/647 (84%), Gaps = 37/647 (5%)
Query: 8 LICFLLLSCGGGIGYVNSEPTQDKQALLAFLSRTPHKNRVQWNASDSACNWVGVECDANR 67
L+ FLLL G V+SEP QDKQALLAFLS+ PH+NR+QWNAS S C W G+ECDAN+
Sbjct: 12 LVSFLLLLSHG---RVDSEPVQDKQALLAFLSKVPHENRLQWNASASVCTWFGIECDANQ 68
Query: 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSN 127
SFVYSLRLPGVGL+G IPPNTLG++SQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQ+N
Sbjct: 69 SFVYSLRLPGVGLIGSIPPNTLGRMSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQNN 128
Query: 128 QFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPA 187
F+G FP S+TR+ RL+RLDLSSNNF+G IPF VNNLTHLTGL L+NN F+G+LPS+NP
Sbjct: 129 VFTGDFPPSLTRLTRLSRLDLSSNNFTGSIPFSVNNLTHLTGLLLQNNHFAGSLPSVNPL 188
Query: 188 NLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDLCGGPLPPCNPFFPSPAPSPSLPPPVA 247
NL DFNVSNN+LNGSIP L+KFP SSF+GNL LCG PL PP
Sbjct: 189 NLTDFNVSNNSLNGSIPQVLAKFPASSFSGNLQLCGRPL-----------------PPCN 231
Query: 248 PVHKKSNKLSTAAIVGIAVGGAVFIVLLLLLLLFCLKKRRRQRPGKAPKPPAAATARAVT 307
P + G KK++R RP K PKP ATARAV
Sbjct: 232 PFFPSPAPSPSEIPPGPPSSH---------------KKKQRSRPAKTPKP--TATARAVA 274
Query: 308 MEAGTSSSKDDITGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVL 367
+EAGTSSSKDDITGG+AEA+RNKLVFFEGG+YSFDLEDLLRASAEVLGKGSVGTSYKAVL
Sbjct: 275 VEAGTSSSKDDITGGSAEAERNKLVFFEGGIYSFDLEDLLRASAEVLGKGSVGTSYKAVL 334
Query: 368 EEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427
EEGTTVVVKRLK+V V KR+FE QMEVLGKIKHDNVVPLRA+YYSKDEKLLV D+MP GS
Sbjct: 335 EEGTTVVVKRLKDVVVTKRDFETQMEVLGKIKHDNVVPLRAYYYSKDEKLLVSDFMPVGS 394
Query: 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDAC 487
LSALLHGSRGSGRTPLDWDNRMRIA+S ARGLAHLH++GK++HGNIK+SNILLRPD+DAC
Sbjct: 395 LSALLHGSRGSGRTPLDWDNRMRIAMSTARGLAHLHIAGKVIHGNIKSSNILLRPDNDAC 454
Query: 488 VSDFGLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASL 547
VSD+GLNPLFG +TPP+RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASL
Sbjct: 455 VSDYGLNPLFGTSTPPSRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASL 514
Query: 548 GEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQ 607
GEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAM CVSTVPDQRPAMQ
Sbjct: 515 GEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPAMQ 574
Query: 608 EVVRMIENMNRGETDDGLRQSSDDPSKGSDGHTPPPESRTPPTALTP 654
EVVRMIE+MNRGETDDGLRQSSDDPSKGS+ HTPPPESRTPP+ +TP
Sbjct: 575 EVVRMIEDMNRGETDDGLRQSSDDPSKGSESHTPPPESRTPPSTVTP 621
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449520207|ref|XP_004167125.1| PREDICTED: LOW QUALITY PROTEIN: probable inactive receptor kinase At2g26730-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 964 bits (2491), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/631 (79%), Positives = 555/631 (87%), Gaps = 6/631 (0%)
Query: 23 VNSEPTQDKQALLAFLSRTPHKNRVQWNASDSACNWVGVECDANRSFVYSLRLPGVGLVG 82
V SEPT DK ALL FL++TPH++R+QWNASD+ACNWVGV CDA RSFV+SLRLPGVGLVG
Sbjct: 29 VQSEPTADKAALLDFLNKTPHESRLQWNASDTACNWVGVSCDATRSFVFSLRLPGVGLVG 88
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
PIP NT+G+L++LRVLSLRSNR+SGE+P+DFSNL LRSLYLQ N+ SG FPASVT++ R
Sbjct: 89 PIPANTIGRLNRLRVLSLRSNRISGELPADFSNLGFLRSLYLQDNELSGNFPASVTQLTR 148
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPA--NLRDFNVSNNNLN 200
LTRLDLSSNNFSG IPF VNNLTHL+GLFLENN FSG+LPSI A +L FNVSNN LN
Sbjct: 149 LTRLDLSSNNFSGPIPFSVNNLTHLSGLFLENNGFSGSLPSIPAAATSLTGFNVSNNKLN 208
Query: 201 GSIPATLSKFPQSSFTGNLDLCGGPLPPCNPFFPSPAP--SPSLPPPVAPVHKKSNKLST 258
GSIP TLSKF SSF GNL LCGGPLP C+PFFPSPAP + ++ PP PV KKS KLS
Sbjct: 209 GSIPETLSKFNASSFAGNLALCGGPLPSCSPFFPSPAPSPTSAVKPPQFPVEKKSKKLSI 268
Query: 259 AAIVGIAVGGAVFIVLLLLLLLFCLKKRRRQRPGKAPKPPAAATARAVTMEAGTSSSKDD 318
AAIVGI VG A +LL LLLFCL+KR R++P K P AA R+V EAGTSSSKDD
Sbjct: 269 AAIVGIVVGAAFVAFILLFLLLFCLRKRERRQPAKPPSTVVAA--RSVPAEAGTSSSKDD 326
Query: 319 ITGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRL 378
ITGG+ E ++N+LVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRL
Sbjct: 327 ITGGSVETEKNRLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRL 386
Query: 379 KEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGS 438
K+V + K+EFE QME LG +KH+NVVPLRAFY+S+DEKLLV DYM AGSLS+ LHGSRGS
Sbjct: 387 KDVVMTKKEFETQMEALGNVKHENVVPLRAFYFSRDEKLLVSDYMAAGSLSSSLHGSRGS 446
Query: 439 GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498
GRTPLDWDNRM+IALSAARGLAHLH+SGK+VHGNIK+SNILLRP+HDA VSDFGLNPLFG
Sbjct: 447 GRTPLDWDNRMKIALSAARGLAHLHLSGKLVHGNIKSSNILLRPNHDAAVSDFGLNPLFG 506
Query: 499 NTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWV 558
+TPP R+AGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGK+PNQASLGEEGIDLPRWV
Sbjct: 507 ASTPPNRIAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLPRWV 566
Query: 559 QSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
QSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAM CV+TVPDQRP+MQEVVRMIE +NR
Sbjct: 567 QSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVATVPDQRPSMQEVVRMIEELNR 626
Query: 619 GETDDGLRQSSDDPSKGSDGHTPPPESRTPP 649
ETDDGLRQSSDDPSKGSDG TPP ES T P
Sbjct: 627 VETDDGLRQSSDDPSKGSDGQTPPQESSTTP 657
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449443127|ref|XP_004139332.1| PREDICTED: probable inactive receptor kinase At2g26730-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 962 bits (2487), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/652 (76%), Positives = 558/652 (85%), Gaps = 11/652 (1%)
Query: 9 ICFLLLSCGGGIGYVNSEPTQDKQALLAFLSRTPHKNRVQWNASDSACNWVGVECDANRS 68
+C + L I +VNSEPTQD+QALL F S+TPH NRVQWN S+S CNWVGVECD+++S
Sbjct: 7 LCSVFLLLLLVIQWVNSEPTQDRQALLDFFSKTPHANRVQWNLSNSVCNWVGVECDSSKS 66
Query: 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQ 128
FVYSLRLPGVGLVG IP NT+GKL+QLRVLSLRSNRLSGEIPSDFSNL +LR+LYLQ N
Sbjct: 67 FVYSLRLPGVGLVGSIPANTVGKLTQLRVLSLRSNRLSGEIPSDFSNLVMLRNLYLQDNA 126
Query: 129 FSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPAN 188
FSG FP+S+ R+ RLTRLDLSSN FSG IP V+NLTHL+G+FL+NN FSG+LP+I+ N
Sbjct: 127 FSGEFPSSLIRLTRLTRLDLSSNEFSGPIPASVDNLTHLSGIFLQNNGFSGSLPNISALN 186
Query: 189 LRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDLCGGPLPPCNPFFPSPAPSPSLPPPVAP 248
L FNVSNN LNGSIP +L+KFP SSF GNLDLCGGP PPC+ PSPS P
Sbjct: 187 LTSFNVSNNKLNGSIPNSLAKFPASSFAGNLDLCGGPFPPCS----PLTPSPSPSQIPPP 242
Query: 249 VHKKSNKLSTAAIVGIAVGGAVFIVLLLLLLLFCLKKRRRQRPGKAPKPPAA--ATARAV 306
+KKS KLSTAAI+GI +G LLLL+L+ C+++R + K+PKPP A AR++
Sbjct: 243 SNKKSKKLSTAAIIGIVIGAVFAAFLLLLILILCIRRRSNKTQTKSPKPPTAVGTAARSI 302
Query: 307 -TMEAGTSSSKDDITGGAAEA-DRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYK 364
EAGTSSSKDDITGG+ EA +RNKLVFFEGG+Y+FDLEDLLRASAEVLGKGSVGTSYK
Sbjct: 303 PVAEAGTSSSKDDITGGSVEATERNKLVFFEGGIYNFDLEDLLRASAEVLGKGSVGTSYK 362
Query: 365 AVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424
AVLEEGTTVVVKRLK+V V K+EFE QME+LGKIKH+NVVPLRAFY+SKDEKLLVYDY+
Sbjct: 363 AVLEEGTTVVVKRLKDVVVTKKEFENQMEILGKIKHENVVPLRAFYFSKDEKLLVYDYIS 422
Query: 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH 484
GSLSA LHGSRGSGRTPLDWD+RMRIALSA RGLAHLH++GK+VHGNIK+SNILLRPDH
Sbjct: 423 TGSLSASLHGSRGSGRTPLDWDSRMRIALSAGRGLAHLHLTGKVVHGNIKSSNILLRPDH 482
Query: 485 DACVSDFGLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQ 544
DAC+SDFGLNPLFG TPP RVAGYRAPEVVETRKVTFKSDVYS+GVLLLELLTGKAPNQ
Sbjct: 483 DACISDFGLNPLFGTATPPNRVAGYRAPEVVETRKVTFKSDVYSYGVLLLELLTGKAPNQ 542
Query: 545 ASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRP 604
SLGE+GIDLPRWVQSVVREEWTAEVFD ELMR+HNIEEEMVQLLQIAM CVSTVPDQRP
Sbjct: 543 QSLGEDGIDLPRWVQSVVREEWTAEVFDAELMRFHNIEEEMVQLLQIAMSCVSTVPDQRP 602
Query: 605 AMQEVVRMIENM--NRGETDDGLRQSSDDPSKGSDGHTPPPESRTPPTALTP 654
AM EVVRMIE+M +R ETDDGLRQSSD+PSKGSD +TPP ESRTPP +TP
Sbjct: 603 AMPEVVRMIEDMSSHRSETDDGLRQSSDEPSKGSDVNTPPAESRTPP-GVTP 653
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449464274|ref|XP_004149854.1| PREDICTED: probable inactive receptor kinase At2g26730-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 961 bits (2484), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/631 (79%), Positives = 554/631 (87%), Gaps = 6/631 (0%)
Query: 23 VNSEPTQDKQALLAFLSRTPHKNRVQWNASDSACNWVGVECDANRSFVYSLRLPGVGLVG 82
V SEPT DK ALL FL++TPH++R+QWNASD+ACNWVGV CDA RSFV+SLRLPGVGLVG
Sbjct: 29 VQSEPTADKAALLDFLNKTPHESRLQWNASDTACNWVGVSCDATRSFVFSLRLPGVGLVG 88
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
PIP NT+G+L++LRVLSLRSNR+SGE+P+DFSNL LRSLYLQ N+ SG FPASVT++ R
Sbjct: 89 PIPANTIGRLNRLRVLSLRSNRISGELPADFSNLGFLRSLYLQDNELSGNFPASVTQLTR 148
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPA--NLRDFNVSNNNLN 200
LTRLDLSSNNFSG IPF NNLTHL+GLFLENN FSG+LPSI A +L FNVSNN LN
Sbjct: 149 LTRLDLSSNNFSGPIPFSENNLTHLSGLFLENNGFSGSLPSIPAAATSLTGFNVSNNKLN 208
Query: 201 GSIPATLSKFPQSSFTGNLDLCGGPLPPCNPFFPSPAP--SPSLPPPVAPVHKKSNKLST 258
GSIP TLSKF SSF GNL LCGGPLP C+PFFPSPAP + ++ PP PV KKS KLS
Sbjct: 209 GSIPETLSKFNASSFAGNLALCGGPLPSCSPFFPSPAPSPTSAVKPPQFPVEKKSKKLSI 268
Query: 259 AAIVGIAVGGAVFIVLLLLLLLFCLKKRRRQRPGKAPKPPAAATARAVTMEAGTSSSKDD 318
AAIVGI VG A +LL LLLFCL+KR R++P K P AA R+V EAGTSSSKDD
Sbjct: 269 AAIVGIVVGAAFVAFILLFLLLFCLRKRERRQPAKPPSTVVAA--RSVPAEAGTSSSKDD 326
Query: 319 ITGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRL 378
ITGG+ E ++N+LVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRL
Sbjct: 327 ITGGSVETEKNRLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRL 386
Query: 379 KEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGS 438
K+V + K+EFE QME LG +KH+NVVPLRAFY+S+DEKLLV DYM AGSLS+ LHGSRGS
Sbjct: 387 KDVVMTKKEFETQMEALGNVKHENVVPLRAFYFSRDEKLLVSDYMAAGSLSSSLHGSRGS 446
Query: 439 GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498
GRTPLDWDNRM+IALSAARGLAHLH+SGK+VHGNIK+SNILLRP+HDA VSDFGLNPLFG
Sbjct: 447 GRTPLDWDNRMKIALSAARGLAHLHLSGKLVHGNIKSSNILLRPNHDAAVSDFGLNPLFG 506
Query: 499 NTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWV 558
+TPP R+AGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGK+PNQASLGEEGIDLPRWV
Sbjct: 507 ASTPPNRIAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLPRWV 566
Query: 559 QSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
QSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAM CV+TVPDQRP+MQEVVRMIE +NR
Sbjct: 567 QSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVATVPDQRPSMQEVVRMIEELNR 626
Query: 619 GETDDGLRQSSDDPSKGSDGHTPPPESRTPP 649
ETDDGLRQSSDDPSKGSDG TPP ES T P
Sbjct: 627 VETDDGLRQSSDDPSKGSDGQTPPQESSTTP 657
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357477837|ref|XP_003609204.1| hypothetical protein MTR_4g113100 [Medicago truncatula] gi|355510259|gb|AES91401.1| hypothetical protein MTR_4g113100 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 957 bits (2475), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 515/636 (80%), Positives = 565/636 (88%), Gaps = 7/636 (1%)
Query: 23 VNSEPTQDKQALLAFLSRTPHKNRVQWNASDSACNWVGVECDANRSFVYSLRLPGVGLVG 82
VNSEP QDKQALLAF+S+TPH NRVQWNASDS CNWVGV+CDA S VYSLRLP V LVG
Sbjct: 23 VNSEPVQDKQALLAFISQTPHSNRVQWNASDSVCNWVGVQCDATNSSVYSLRLPAVDLVG 82
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
P+PPNT+G+L+ LRVLSLRSN L+GEIP+DFSNLT LRS+YLQ N+FSG FPAS+TR+ R
Sbjct: 83 PLPPNTIGRLTNLRVLSLRSNGLTGEIPTDFSNLTFLRSIYLQKNKFSGEFPASLTRLTR 142
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGS 202
LTRLDLSSNNF+G IPF +NNLTHL+GLFLENN FSG+LPSI ANL F+VSNNNLNGS
Sbjct: 143 LTRLDLSSNNFTGSIPFSINNLTHLSGLFLENNTFSGSLPSIT-ANLNGFDVSNNNLNGS 201
Query: 203 IPATLSKFPQSSFTGNLDLCGGPLP-PCNPFFPSPAPSPSLPPPVAPVHKKSNKLSTAAI 261
IP TLSKFP++SF GNLDLCG PL C+PFFP+PAPSP PP KKS KLST AI
Sbjct: 202 IPKTLSKFPEASFAGNLDLCGPPLKTSCSPFFPAPAPSPDNIPPADKPKKKSKKLSTGAI 261
Query: 262 VGIAVGGAVFIVLLLLLLLFCLKKRRRQRPGKAPKPPAAATARAVTMEAGTSSSKDDITG 321
V I VG +F+ +LLLLLL CL+KRRR+ P K PKP AA R+ EAGTSSSKDDITG
Sbjct: 262 VAIVVGSILFLAILLLLLLLCLRKRRRRTPAKPPKPVVAA--RSAPAEAGTSSSKDDITG 319
Query: 322 GAAEADR--NKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLK 379
G+AEA+R NKLVFF+GG+YSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLK
Sbjct: 320 GSAEAERERNKLVFFDGGIYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLK 379
Query: 380 EVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSG 439
+V V K+EFEMQME+LGKIKHDNVVPLRAFYYSKDEKLLVYDYM AGSLSALLHGSRGSG
Sbjct: 380 DVVVTKKEFEMQMEILGKIKHDNVVPLRAFYYSKDEKLLVYDYMAAGSLSALLHGSRGSG 439
Query: 440 RTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR-PDHDACVSDFGLNPLFG 498
RTPLDWDNRMRIAL A+RG+A LH SGK+VHGNIK+SNILL+ PD+DA VSDFGLNPLFG
Sbjct: 440 RTPLDWDNRMRIALGASRGVACLHASGKVVHGNIKSSNILLKGPDNDASVSDFGLNPLFG 499
Query: 499 NTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWV 558
N +P RVAGYRAPEV+ETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWV
Sbjct: 500 NGSPSNRVAGYRAPEVLETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWV 559
Query: 559 QSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
QSVVREEWTAEVFD ELMR+HNIEEEMVQLLQIAM CVS VPDQRP+MQ+VVRMIE+MNR
Sbjct: 560 QSVVREEWTAEVFDAELMRFHNIEEEMVQLLQIAMACVSIVPDQRPSMQDVVRMIEDMNR 619
Query: 619 GETDDGLRQSSDDPSKGSDGHTPPPESRTPPTALTP 654
GETD+GLRQSSDDPSKGS+GHTPPPESRTPP + TP
Sbjct: 620 GETDEGLRQSSDDPSKGSEGHTPPPESRTPPRSRTP 655
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449520357|ref|XP_004167200.1| PREDICTED: LOW QUALITY PROTEIN: probable inactive receptor kinase At2g26730-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2454), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/652 (75%), Positives = 557/652 (85%), Gaps = 11/652 (1%)
Query: 9 ICFLLLSCGGGIGYVNSEPTQDKQALLAFLSRTPHKNRVQWNASDSACNWVGVECDANRS 68
+C + L I +VNSEPTQD+QALL F S+TPH NRVQWN S+S CNWVGVECD+++S
Sbjct: 7 LCSVFLLLLLVIQWVNSEPTQDRQALLDFFSKTPHANRVQWNLSNSVCNWVGVECDSSKS 66
Query: 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQ 128
FVYSLRLPGVGLVG IP NT+GKL+QLRVLSLRSNRLSGEIPSDFSNL +LR+LYLQ N
Sbjct: 67 FVYSLRLPGVGLVGSIPANTVGKLTQLRVLSLRSNRLSGEIPSDFSNLVMLRNLYLQDNA 126
Query: 129 FSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPAN 188
FSG FP+S+ R+ RLTRLDLSSN FSG IP V+NLTHL+G+FL+NN FSG+LP+I+ N
Sbjct: 127 FSGEFPSSLIRLTRLTRLDLSSNEFSGPIPASVDNLTHLSGIFLQNNGFSGSLPNISALN 186
Query: 189 LRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDLCGGPLPPCNPFFPSPAPSPSLPPPVAP 248
L FNVSNN LNGSIP +L+KFP SSF GNLDLCGGP PPC+ PSPS P
Sbjct: 187 LTSFNVSNNKLNGSIPNSLAKFPASSFAGNLDLCGGPFPPCS----PLTPSPSPSXNPPP 242
Query: 249 VHKKSNKLSTAAIVGIAVGGAVFIVLLLLLLLFCLKKRRRQRPGKAPKPPAA--ATARAV 306
+KKS KLSTAAI+GI +G LLLL+L+ C+++R + K+PKPP A AR++
Sbjct: 243 SNKKSKKLSTAAIIGIVIGAVFAAFLLLLILILCIRRRSNKTQTKSPKPPTAVGTAARSI 302
Query: 307 -TMEAGTSSSKDDITGGAAEA-DRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYK 364
EAGTSSSKDDITGG+ EA +RNKLV FEGG+Y+FDLEDLLRASAEVLGKGSVGTSYK
Sbjct: 303 PVAEAGTSSSKDDITGGSVEATERNKLVXFEGGIYNFDLEDLLRASAEVLGKGSVGTSYK 362
Query: 365 AVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424
AVLEEGTTVVVKRLK+V V K+EFE QME+LGKIKH+NVVPLRAFY+SKDEKLLVYDY+
Sbjct: 363 AVLEEGTTVVVKRLKDVVVTKKEFENQMEILGKIKHENVVPLRAFYFSKDEKLLVYDYIS 422
Query: 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH 484
GSLSA LHGSRGSGRTPLDWD+RMRIALSA RGLAHLH++GK+VHGNIK+SNILLRPDH
Sbjct: 423 TGSLSASLHGSRGSGRTPLDWDSRMRIALSAGRGLAHLHLTGKVVHGNIKSSNILLRPDH 482
Query: 485 DACVSDFGLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQ 544
DAC+SDFGLNPLFG TPP RVAGYRAPEVVETRKVTFKSDVYS+GVLLLELLTGKAPNQ
Sbjct: 483 DACISDFGLNPLFGTATPPNRVAGYRAPEVVETRKVTFKSDVYSYGVLLLELLTGKAPNQ 542
Query: 545 ASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRP 604
SLGE+GIDLPRWVQSVVREEWTAEVFD ELMR+HNIEEEMVQLLQIAM CVSTVPDQRP
Sbjct: 543 QSLGEDGIDLPRWVQSVVREEWTAEVFDAELMRFHNIEEEMVQLLQIAMSCVSTVPDQRP 602
Query: 605 AMQEVVRMIENM--NRGETDDGLRQSSDDPSKGSDGHTPPPESRTPPTALTP 654
AM EVVRMIE+M +R ETDDGLRQSSD+PSKGSD +TPP ESRTPP +TP
Sbjct: 603 AMPEVVRMIEDMSSHRSETDDGLRQSSDEPSKGSDVNTPPAESRTPP-GVTP 653
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15225780|ref|NP_180241.1| putative inactive receptor kinase [Arabidopsis thaliana] gi|75219509|sp|O48788.1|Y2267_ARATH RecName: Full=Probable inactive receptor kinase At2g26730; Flags: Precursor gi|2760839|gb|AAB95307.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|60543329|gb|AAX22262.1| At2g26730 [Arabidopsis thaliana] gi|224589527|gb|ACN59297.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|330252786|gb|AEC07880.1| putative inactive receptor kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 942 bits (2435), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 481/640 (75%), Positives = 543/640 (84%), Gaps = 10/640 (1%)
Query: 23 VNSEPTQDKQALLAFLSRTPHKNRVQWNASDSACNWVGVECDANRSFVYSLRLPGVGLVG 82
VNSE T +KQALL FL + PH+NR+QWN SDSACNWVGVEC++N+S ++SLRLPG GLVG
Sbjct: 21 VNSESTAEKQALLTFLQQIPHENRLQWNESDSACNWVGVECNSNQSSIHSLRLPGTGLVG 80
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
IP +LG+L++LRVLSLRSNRLSG+IPSDFSNLT LRSLYLQ N+FSG FP S T++N
Sbjct: 81 QIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQLNN 140
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGS 202
L RLD+SSNNF+G IPF VNNLTHLTGLFL NN FSGNLPSI+ L DFNVSNNNLNGS
Sbjct: 141 LIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSIS-LGLVDFNVSNNNLNGS 199
Query: 203 IPATLSKFPQSSFTGNLDLCGGPLPPCNPFFPSPAPSPSLPPPVAPVHKKSNKLSTAAIV 262
IP++LS+F SFTGN+DLCGGPL PC FF SP+PSPSL P + K +KLS AAIV
Sbjct: 200 IPSSLSRFSAESFTGNVDLCGGPLKPCKSFFVSPSPSPSLINPSNRLSSKKSKLSKAAIV 259
Query: 263 GIAVGGAVFIVLLLLLLLFCLKKRRR---QRPGKAPKPPAAATARAVTMEAGTSSSKDDI 319
I V A+ +LLL LLLF ++RR + K PKP AT R V + G SSSK+++
Sbjct: 260 AIIVASALVALLLLALLLFLCLRKRRGSNEARTKQPKPAGVAT-RNVDLPPGASSSKEEV 318
Query: 320 TGGAA----EADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVV 375
TG ++ E +RNKLVF EGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVV
Sbjct: 319 TGTSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVV 378
Query: 376 KRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGS 435
KRLK+V K+EFE QMEV+GKIKH NV+PLRA+YYSKDEKLLV+D+MP GSLSALLHGS
Sbjct: 379 KRLKDVMASKKEFETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGS 438
Query: 436 RGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP 495
RGSGRTPLDWDNRMRIA++AARGLAHLHVS K+VHGNIKASNILL P+ D CVSD+GLN
Sbjct: 439 RGSGRTPLDWDNRMRIAITAARGLAHLHVSAKLVHGNIKASNILLHPNQDTCVSDYGLNQ 498
Query: 496 LFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLP 555
LF N++PP R+AGY APEV+ETRKVTFKSDVYSFGVLLLELLTGK+PNQASLGEEGIDLP
Sbjct: 499 LFSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLP 558
Query: 556 RWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615
RWV SVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAM CVSTVPDQRP MQEV+RMIE+
Sbjct: 559 RWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIED 618
Query: 616 MNRGE-TDDGLRQSSDDPSKGSDGHTPPPESRTPPTALTP 654
+NR E TDDGLRQSSDDPSKGS+G TPP ESRTPP ++TP
Sbjct: 619 VNRSETTDDGLRQSSDDPSKGSEGQTPPGESRTPPRSVTP 658
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 654 | ||||||
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.533 | 0.530 | 0.822 | 3.3e-219 | |
| TAIR|locus:2161308 | 654 | AT5G58300 [Arabidopsis thalian | 0.509 | 0.509 | 0.643 | 3.9e-155 | |
| TAIR|locus:2077898 | 640 | AT3G08680 [Arabidopsis thalian | 0.5 | 0.510 | 0.629 | 1.7e-141 | |
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.472 | 0.461 | 0.591 | 6e-133 | |
| TAIR|locus:2128414 | 638 | AT4G23740 [Arabidopsis thalian | 0.475 | 0.487 | 0.618 | 1.6e-130 | |
| TAIR|locus:2156784 | 640 | RUL1 "REDUCED IN LATERAL GROWT | 0.487 | 0.498 | 0.574 | 6.4e-125 | |
| TAIR|locus:2198090 | 655 | RKL1 "receptor-like kinase 1" | 0.470 | 0.470 | 0.576 | 2.4e-123 | |
| TAIR|locus:2088500 | 647 | RLK902 "receptor-like kinase 9 | 0.448 | 0.452 | 0.593 | 4.6e-120 | |
| TAIR|locus:2075502 | 627 | AT3G02880 [Arabidopsis thalian | 0.455 | 0.475 | 0.533 | 9.5e-120 | |
| TAIR|locus:2174190 | 625 | LRR1 [Arabidopsis thaliana (ta | 0.474 | 0.496 | 0.504 | 2.3e-114 |
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1507 (535.5 bits), Expect = 3.3e-219, Sum P(2) = 3.3e-219
Identities = 291/354 (82%), Positives = 321/354 (90%)
Query: 306 VTMEAGTSSSKDDITGGAA----EADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGT 361
V + G SSSK+++TG ++ E +RNKLVF EGGVYSFDLEDLLRASAEVLGKGSVGT
Sbjct: 305 VDLPPGASSSKEEVTGTSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGT 364
Query: 362 SYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421
SYKAVLEEGTTVVVKRLK+V K+EFE QMEV+GKIKH NV+PLRA+YYSKDEKLLV+D
Sbjct: 365 SYKAVLEEGTTVVVKRLKDVMASKKEFETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFD 424
Query: 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR 481
+MP GSLSALLHGSRGSGRTPLDWDNRMRIA++AARGLAHLHVS K+VHGNIKASNILL
Sbjct: 425 FMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLHVSAKLVHGNIKASNILLH 484
Query: 482 PDHDACVSDFGLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKA 541
P+ D CVSD+GLN LF N++PP R+AGY APEV+ETRKVTFKSDVYSFGVLLLELLTGK+
Sbjct: 485 PNQDTCVSDYGLNQLFSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKS 544
Query: 542 PNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPD 601
PNQASLGEEGIDLPRWV SVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAM CVSTVPD
Sbjct: 545 PNQASLGEEGIDLPRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPD 604
Query: 602 QRPAMQEVVRMIENMNRGET-DDGLRQSSDDPSKGSDGHTPPPESRTPPTALTP 654
QRP MQEV+RMIE++NR ET DDGLRQSSDDPSKGS+G TPP ESRTPP ++TP
Sbjct: 605 QRPVMQEVLRMIEDVNRSETTDDGLRQSSDDPSKGSEGQTPPGESRTPPRSVTP 658
|
|
| TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1122 (400.0 bits), Expect = 3.9e-155, Sum P(2) = 3.9e-155
Identities = 217/337 (64%), Positives = 269/337 (79%)
Query: 306 VTMEAGTSSSKDDITGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKA 365
V ++ T +K + G E ++NKLVFF G Y+FDLEDLLRASAEVLGKGS GT+YKA
Sbjct: 316 VKVKTLTEKAKQEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKA 375
Query: 366 VLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMP 424
VLEE TTVVVKRLKEVA GKREFE QME++ ++ H +VVPLRA+YYSKDEKL+V DY P
Sbjct: 376 VLEESTTVVVKRLKEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYP 435
Query: 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG--KIVHGNIKASNILLRP 482
AG+LS+LLHG+RGS +TPLDWD+R++I LSAA+G+AHLH +G K HGNIK+SN++++
Sbjct: 436 AGNLSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQ 495
Query: 483 DHDACVSDFGLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
+ DAC+SDFGL PL P R AGYRAPEV+ETRK T KSDVYSFGVL+LE+LTGK+P
Sbjct: 496 ESDACISDFGLTPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSP 555
Query: 543 NQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQ 602
Q+ ++ +DLPRWVQSVVREEWT+EVFD+ELMR+ NIEEEMVQ+LQIAM CV+ VP+
Sbjct: 556 VQSPSRDDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEV 615
Query: 603 RPAMQEVVRMIENMNRGETDDGLRQSSDDPSKGSDGH 639
RP M +VVRMIE + +++ R SSDD SK D +
Sbjct: 616 RPTMDDVVRMIEEIRVSDSET-TRPSSDDNSKPKDSN 651
|
|
| TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1042 (371.9 bits), Expect = 1.7e-141, Sum P(2) = 1.7e-141
Identities = 211/335 (62%), Positives = 255/335 (76%)
Query: 311 GTSSSK-DDITGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEE 369
G S +K ++ G EA++NKLVFFEG Y+FDLEDLLRASAEVLGKGS GT+YKA+LEE
Sbjct: 303 GRSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILEE 362
Query: 370 GTTVVVKRLKEVAVGKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428
GTTVVVKRLKEVA GKREFE QME +G+I H NV PLRA+Y+SKDEKLLVYDY G+
Sbjct: 363 GTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQGGNF 422
Query: 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH-VSG-KIVHGNIKASNILLRPDHDA 486
S LLHG+ GR LDW+ R+RI L AARG++H+H SG K++HGNIK+ N+LL +
Sbjct: 423 SMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELHV 482
Query: 487 CVSDFGLNPLFGN-TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQA 545
CVSDFG+ PL + T P+R GYRAPE +ETRK T KSDVYSFGVLLLE+LTGKA +
Sbjct: 483 CVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAAGKT 542
Query: 546 SLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY-HNIEEEMVQLLQIAMGCVSTVPDQRP 604
+ EE +DLP+WVQSVVREEWT EVFDVEL++ HN+EEEMVQ+LQIAM CVS PD RP
Sbjct: 543 TGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRP 602
Query: 605 AMQEVVRMIENMNRGETDDGL--RQSSDDPSKGSD 637
+M+EVV M+E + + G R SS + + SD
Sbjct: 603 SMEEVVNMMEEIRPSGSGPGSGNRASSPEMIRSSD 637
|
|
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 929 (332.1 bits), Expect = 6.0e-133, Sum P(2) = 6.0e-133
Identities = 191/323 (59%), Positives = 239/323 (73%)
Query: 327 DRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKE-VAV-G 384
D+ K+VFFEG F+LEDLLRASAE+LGKG GT+YKAVLE+G V VKRLK+ V V G
Sbjct: 342 DKGKMVFFEG-TRRFELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAG 400
Query: 385 KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLD 444
K+EFE QMEVLG+++H N+V L+A+Y++++EKLLVYDYMP GSL LLHG+RG GRTPLD
Sbjct: 401 KKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLD 460
Query: 445 WDNRMRIALSAARGLAHLHVSGK---IVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT 501
W R++IA AARGLA +H S K + HG+IK++N+LL +A VSDFGL+ +F +
Sbjct: 461 WTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLS-IFAPSQ 519
Query: 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEG--IDLPRWVQ 559
+ GYRAPE+++ RK T KSDVYSFGVLLLE+LTGK PN G G +DLPRWVQ
Sbjct: 520 TVAKSNGYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAVDLPRWVQ 579
Query: 560 SVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619
SVVREEWTAEVFD+ELMRY +IEEEMV LLQIAM C + D RP M VV++IE++ G
Sbjct: 580 SVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDIRGG 639
Query: 620 ETD-----DGLRQSSDDPSKGSD 637
++ DG+ + D P D
Sbjct: 640 GSEASPCNDGINSAVDSPCLSED 662
|
|
| TAIR|locus:2128414 AT4G23740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 993 (354.6 bits), Expect = 1.6e-130, Sum P(2) = 1.6e-130
Identities = 198/320 (61%), Positives = 248/320 (77%)
Query: 329 NKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREF 388
N+L FFEG YSFDLEDLLRASAEVLGKG+ GT+YKAVLE+ T+V VKRLK+VA GKR+F
Sbjct: 318 NRLSFFEGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKDVAAGKRDF 377
Query: 389 EMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNR 448
E QME++G IKH+NVV L+A+YYSKDEKL+VYDY GS+++LLHG+RG R PLDW+ R
Sbjct: 378 EQQMEIIGGIKHENVVELKAYYYSKDEKLMVYDYFSRGSVASLLHGNRGENRIPLDWETR 437
Query: 449 MRIALSAARGLAHLHV--SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPP-TR 505
M+IA+ AA+G+A +H +GK+VHGNIK+SNI L + + CVSD GL + PP +R
Sbjct: 438 MKIAIGAAKGIARIHKENNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMSPLAPPISR 497
Query: 506 VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREE 565
AGYRAPEV +TRK + SDVYSFGV+LLELLTGK+P + G+E I L RWV SVVREE
Sbjct: 498 QAGYRAPEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHTTAGDEIIHLVRWVHSVVREE 557
Query: 566 WTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM-NRG---ET 621
WTAEVFD+EL+RY NIEEEMV++LQIAM CV DQRP M ++VR+IEN+ NR E
Sbjct: 558 WTAEVFDIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENVGNRRTSIEP 617
Query: 622 DDGLRQSSDDPSKGSDGHTP 641
+ L+ S++ + S+ TP
Sbjct: 618 EPELKPKSENGA--SETSTP 635
|
|
| TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 925 (330.7 bits), Expect = 6.4e-125, Sum P(2) = 6.4e-125
Identities = 188/327 (57%), Positives = 241/327 (73%)
Query: 307 TMEAGTSSSK-DDITGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKA 365
T G +S K D G + ++NKL FFE ++FDLEDLL+ASAEVLGKGS GT+YKA
Sbjct: 305 TQMGGVNSKKPQDFGSGVQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKA 364
Query: 366 VLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMP 424
VLE+ T VVVKRL+EV K+EFE QME++GKI +H N VPL A+YYSKDEKLLVY YM
Sbjct: 365 VLEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVYKYMT 424
Query: 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH 484
GSL ++HG+RG +DW+ RM+IA ++ +++LH S K VHG+IK+SNILL D
Sbjct: 425 KGSLFGIMHGNRGD--RGVDWETRMKIATGTSKAISYLH-SLKFVHGDIKSSNILLTEDL 481
Query: 485 DACVSDFGLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP-N 543
+ C+SD L LF T R GY APEV+ETR+V+ +SDVYSFGV++LE+LTGK P
Sbjct: 482 EPCLSDTSLVTLFNLPTHTPRTIGYNAPEVIETRRVSQRSDVYSFGVVILEMLTGKTPLT 541
Query: 544 QASLGEEG--IDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPD 601
Q L +E IDLPRWV+SVVREEWTAEVFDVEL+++ NIEEEMVQ+LQ+A+ CV+ P+
Sbjct: 542 QPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNPE 601
Query: 602 QRPAMQEVVRMIENMNRGETDDGLRQS 628
RP M+EV RMIE++ R + L+Q+
Sbjct: 602 SRPKMEEVARMIEDVRRLDQSQQLQQN 628
|
|
| TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 908 (324.7 bits), Expect = 2.4e-123, Sum P(2) = 2.4e-123
Identities = 181/314 (57%), Positives = 234/314 (74%)
Query: 321 GGAAEAD---RNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKR 377
G A+E + KLVFF FDLEDLLRASAEVLGKG+ GT+YKAVL+ T V VKR
Sbjct: 341 GKASEGNGPATKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKR 400
Query: 378 LKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRG 437
LK+V + +EF+ ++E++G + H+N+VPLRA+Y+S+DEKLLVYD+MP GSLSALLHG+RG
Sbjct: 401 LKDVMMADKEFKEKIELVGAMDHENLVPLRAYYFSRDEKLLVYDFMPMGSLSALLHGNRG 460
Query: 438 SGRTPLDWDNRMRIALSAARGLAHLHVSGKIV-HGNIKASNILLRPDHDACVSDFGLNPL 496
+GR+PL+WD R RIA+ AARGL +LH G HGNIK+SNILL HDA VSDFGL L
Sbjct: 461 AGRSPLNWDVRSRIAIGAARGLDYLHSQGTSTSHGNIKSSNILLTKSHDAKVSDFGLAQL 520
Query: 497 FGNT-TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLP 555
G++ T P R GYRAPEV + ++V+ K DVYSFGV+LLEL+TGKAP+ + + EEG+DLP
Sbjct: 521 VGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLELITGKAPSNSVMNEEGVDLP 580
Query: 556 RWVQSVVREEWTAEVFDVELMRYHNIEEEMV-QLLQIAMGCVSTVPDQRPAMQEVVRMIE 614
RWV+SV R+EW EVFD EL+ EEEM+ +++Q+ + C S PDQRP M EVVR +E
Sbjct: 581 RWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKME 640
Query: 615 NMNRGETDDGLRQS 628
N+ D + ++
Sbjct: 641 NLRPYSGSDQVNEA 654
|
|
| TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 883 (315.9 bits), Expect = 4.6e-120, Sum P(2) = 4.6e-120
Identities = 177/298 (59%), Positives = 221/298 (74%)
Query: 330 KLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFE 389
KLVFF FDLEDLLRASAEVLGKG+ GT+YKAVL+ T V VKRLK+V + REF+
Sbjct: 347 KLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTLVAVKRLKDVTMADREFK 406
Query: 390 MQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRM 449
++EV+G + H+N+VPLRA+YYS DEKLLVYD+MP GSLSALLHG++G+GR PL+W+ R
Sbjct: 407 EKIEVVGAMDHENLVPLRAYYYSGDEKLLVYDFMPMGSLSALLHGNKGAGRPPLNWEVRS 466
Query: 450 RIALSAARGLAHLHVSGKIV-HGNIKASNILLRPDHDACVSDFGLNPLFG-NTTPPTRVA 507
IAL AARGL +LH + HGN+K+SNILL HDA VSDFGL L ++T P R
Sbjct: 467 GIALGAARGLDYLHSQDPLSSHGNVKSSNILLTNSHDARVSDFGLAQLVSASSTTPNRAT 526
Query: 508 GYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWT 567
GYRAPEV + R+V+ K+DVYSFGV+LLELLTGKAP+ + + EEG+DL RWV SV REEW
Sbjct: 527 GYRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAPSNSVMNEEGMDLARWVHSVAREEWR 586
Query: 568 AEVFDVELMRYH---NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETD 622
EVFD ELM ++EEEM ++LQ+ + C PD+RP M EVVR I+ + + D
Sbjct: 587 NEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHPDKRPVMVEVVRRIQELRQSGAD 644
|
|
| TAIR|locus:2075502 AT3G02880 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 831 (297.6 bits), Expect = 9.5e-120, Sum P(2) = 9.5e-120
Identities = 160/300 (53%), Positives = 216/300 (72%)
Query: 320 TGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLK 379
TG + A L FF FDL+ LL+ASAEVLGKG+VG+SYKA E G V VKRL+
Sbjct: 317 TGSESGAVNKDLTFFVKSFGEFDLDGLLKASAEVLGKGTVGSSYKASFEHGLVVAVKRLR 376
Query: 380 EVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSG 439
+V V ++EF ++ VLG + H N+V L A+Y+S+DEKLLV++YM GSLSA+LHG++G+G
Sbjct: 377 DVVVPEKEFRERLHVLGSMSHANLVTLIAYYFSRDEKLLVFEYMSKGSLSAILHGNKGNG 436
Query: 440 RTPLDWDNRMRIALSAARGLAHLHV-SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498
RTPL+W+ R IAL AAR +++LH G HGNIK+SNILL ++A VSD+GL P+
Sbjct: 437 RTPLNWETRAGIALGAARAISYLHSRDGTTSHGNIKSSNILLSDSYEAKVSDYGLAPIIS 496
Query: 499 NTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWV 558
+T+ P R+ GYRAPE+ + RK++ K+DVYSFGVL+LELLTGK+P L EEG+DLPRWV
Sbjct: 497 STSAPNRIDGYRAPEITDARKISQKADVYSFGVLILELLTGKSPTHQQLNEEGVDLPRWV 556
Query: 559 QSVVREEWTAEVFDVELMRYH-NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617
QSV ++ ++V D EL RY E +++LL+I M C + PD RP+M EV R+IE ++
Sbjct: 557 QSVTEQQTPSDVLDPELTRYQPEGNENIIRLLKIGMSCTAQFPDSRPSMAEVTRLIEEVS 616
|
|
| TAIR|locus:2174190 LRR1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 810 (290.2 bits), Expect = 2.3e-114, Sum P(2) = 2.3e-114
Identities = 158/313 (50%), Positives = 218/313 (69%)
Query: 314 SSKDDITGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTV 373
+S++ ++ A ++ L FF FDL+ LL+ASAEVLGKG+ G+SYKA + G V
Sbjct: 310 ASENGVSKNPAAVSKD-LTFFVKSFGEFDLDGLLKASAEVLGKGTFGSSYKASFDHGLVV 368
Query: 374 VVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLH 433
VKRL++V V ++EF +++VLG I H N+V L A+Y+S+DEKL+V++YM GSLSALLH
Sbjct: 369 AVKRLRDVVVPEKEFREKLQVLGSISHANLVTLIAYYFSRDEKLVVFEYMSRGSLSALLH 428
Query: 434 GSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV-HGNIKASNILLRPDHDACVSDFG 492
G++GSGR+PL+W+ R IAL AAR +++LH HGNIK+SNILL +A VSD+
Sbjct: 429 GNKGSGRSPLNWETRANIALGAARAISYLHSRDATTSHGNIKSSNILLSESFEAKVSDYC 488
Query: 493 LNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGI 552
L P+ T+ P R+ GYRAPEV + RK++ K+DVYSFGVL+LELLTGK+P L EEG+
Sbjct: 489 LAPMISPTSTPNRIDGYRAPEVTDARKISQKADVYSFGVLILELLTGKSPTHQQLHEEGV 548
Query: 553 DLPRWVQSVVREEWTAEVFDVELMRYHN-IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
DLPRWV S+ ++ ++VFD EL RY + E M++LL I + C + PD RP M EV R
Sbjct: 549 DLPRWVSSITEQQSPSDVFDPELTRYQSDSNENMIRLLNIGISCTTQYPDSRPTMPEVTR 608
Query: 612 MIENMNRGETDDG 624
+IE ++R G
Sbjct: 609 LIEEVSRSPASPG 621
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O48788 | Y2267_ARATH | No assigned EC number | 0.7515 | 0.9633 | 0.9574 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 654 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-40 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-36 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-26 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-24 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-07 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 7e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.001 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 7e-49
Identities = 164/559 (29%), Positives = 248/559 (44%), Gaps = 123/559 (22%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTR 145
P LG LS+L L L N+LSGEIP + S+ L SL L NQ SG PAS + M L++
Sbjct: 492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ 551
Query: 146 LDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPA 205
LDLS N SG+IP NL GN+ S L N+S+N+L+GS+P+
Sbjct: 552 LDLSQNQLSGEIP---KNL--------------GNVES-----LVQVNISHNHLHGSLPS 589
Query: 206 T--LSKFPQSSFTGNLDLCGGP----LPPCNPFFPSPAPSPSLPPPVAPVHKKSNKLSTA 259
T S+ GN+DLCGG LPPC +P S
Sbjct: 590 TGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTP----------------SWWFYIT 633
Query: 260 AIVGIAVGGAVFIVLLLLLLLFCLKKRRRQRPGKAPKPPAAATARAVTMEAGTSSSKDDI 319
+G F+VL L+ F + R + V E GT
Sbjct: 634 CTLG------AFLVLALVAFGFVFIRGRN-----------NLELKRVENEDGTW------ 670
Query: 320 TGGAAEADRNKLVFFEGGVY-SFDLEDLLRASAE--VLGKGSVGTSYKA-VLEEGTTVVV 375
+L FF+ V S + D+L + E V+ +G G SYK ++ G VV
Sbjct: 671 ----------ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVV 720
Query: 376 KRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGS 435
K + +V ++ +GK++H N+V L S+ L+++Y+ +LS +L
Sbjct: 721 KEINDV---NSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN- 776
Query: 436 RGSGRTPLDWDNRMRIALSAARGLAHLHV--SGKIVHGNIKASNILL--RPDHDACVSDF 491
L W+ R +IA+ A+ L LH S +V GN+ I++ + + +S
Sbjct: 777 -------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLS-- 827
Query: 492 GLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEG 551
L L T + Y APE ET+ +T KSD+Y FG++L+ELLTGK+P A G G
Sbjct: 828 -LPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886
Query: 552 ------------IDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTV 599
L W+ +R + + + E+V+++ +A+ C +T
Sbjct: 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVN------------QNEIVEVMNLALHCTATD 934
Query: 600 PDQRPAMQEVVRMIENMNR 618
P RP +V++ +E+ +R
Sbjct: 935 PTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 5e-42
Identities = 64/192 (33%), Positives = 96/192 (50%), Gaps = 14/192 (7%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRLK--EVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
LG+G GT Y A + G V +K +K + + E ++E+L K+ H N+V L +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 411 YSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVH 470
++ LV +Y GSL LL L D +RI L GL +LH S I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK----ENEGKLSEDEILRILLQILEGLEYLH-SNGIIH 115
Query: 471 GNIKASNILL-RPDHDACVSDFGL-NPLFGNTTPPTRVAG---YRAPEVVETR-KVTFKS 524
++K NILL + ++DFGL L + + + G Y APEV+ + + KS
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 525 DVYSFGVLLLEL 536
D++S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 85/268 (31%), Positives = 127/268 (47%), Gaps = 26/268 (9%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQ---MEVLGKIKHDNVVPLR 407
LG GS GT YKA G V VK LK+ + ++ + + +L ++ H N+V L
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
+ KD LV +Y G L L S PL D +IAL RGL +LH S
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILRGLEYLH-SNG 118
Query: 468 IVHGNIKASNILLRPDHDACVSDFGL-NPLFGNTTPPTRVAG---YRAPEVV-ETRKVTF 522
I+H ++K NILL + ++DFGL L +++ T G Y APEV+
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 523 KSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582
K DV+S GV+L ELLTGK P GE +D + ++ ++ + +
Sbjct: 179 KVDVWSLGVILYELLTGKPPFS---GENILDQLQLIRRILGPPLEFDEPKW-----SSGS 230
Query: 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVV 610
EE L++ C++ P +RP +E++
Sbjct: 231 EEAKDLIK---KCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 69/197 (35%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEV--LGKIKHDNVVPLRA 408
E LG+GS G Y A + G V +K +K+ + K + E+ L K+KH N+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
+ +D+ LV +Y G L LL RG L D L +LH S I
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLK-KRG----RLSEDEARFYLRQILSALEYLH-SKGI 118
Query: 469 VHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKVTFKSD 525
VH ++K NILL D ++DFGL T G Y APEV+ + D
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178
Query: 526 VYSFGVLLLELLTGKAP 542
++S GV+L ELLTGK P
Sbjct: 179 IWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 352 EVLGKGSVGTSYKAVL-----EEGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNVV 404
+ LG+G+ G YK L + V VK LKE A EF + ++ K+ H N+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
L ++ ++V +YMP G L L R + L + + AL ARG+ +L
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYL---RKNRPKELSLSDLLSFALQIARGMEYLE- 120
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLN-PLFGNTTPPTRVAG----YR--APEVVET 517
S +H ++ A N L+ + +SDFGL+ L+ + +V G R APE ++
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY--YKVKGGKLPIRWMAPESLKE 178
Query: 518 RKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576
K T KSDV+SFGVLL E+ T G+ P G ++ +++ R L
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYP---GMSNAEVLEYLKKGYR-----------LP 224
Query: 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613
+ N E+ +L+ C + P+ RP E+V ++
Sbjct: 225 KPPNCPPELYKLMLQ---CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 81/293 (27%), Positives = 124/293 (42%), Gaps = 61/293 (20%)
Query: 352 EVLGKGSVGTSYKAVLEEG----TTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVP 405
+ LG+G+ G YK L+ T V VK LKE A +++F + V+ K+ H NVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRG----SGRTPLDWDNRMRIALSAARGLAH 461
L ++ LV +YM G L L SR ++ L + + A+ A+G+ +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGL-----NPLFGNTTP----PTRVAGYRAP 512
L S K VH ++ A N L+ D +SDFGL + + P R + AP
Sbjct: 121 LA-SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR---WMAP 176
Query: 513 EVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571
E ++ T KSDV+SFGVLL E+ T G P +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY------------------------PGLS 212
Query: 572 DVELMRY----------HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614
+ E++ Y +E+ +L+ C P+ RP E+V +E
Sbjct: 213 NEEVLEYLRKGYRLPKPEYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 80/276 (28%), Positives = 126/276 (45%), Gaps = 37/276 (13%)
Query: 352 EVLGKGSVGTSYKAVLE-----EGTTVVVKRLKEVAVGK--REFEMQMEVLGKIKHDNVV 404
+ LG+G+ G YK L+ + V VK LKE A + EF + ++ K+ H NVV
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
L ++ +V +YM G L + L +R L + + AL ARG+ +L
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP----KLSLSDLLSFALQIARGMEYLE- 119
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG----YR--APEVVETR 518
S +H ++ A N L+ + +SDFGL+ R G R APE ++
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLS-RDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 519 KVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577
K T KSDV+SFGVLL E+ T G+ P G ++ ++++ R L +
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYP---GMSNEEVLEYLKNGYR-----------LPQ 224
Query: 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613
N E+ L+ C + P+ RP E+V ++
Sbjct: 225 PPNCPPELYDLMLQ---CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 79/281 (28%), Positives = 122/281 (43%), Gaps = 46/281 (16%)
Query: 352 EVLGKGSVGTSYKAVL-----EEGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNVV 404
+ LG+G+ G YK L T V VK LKE A + EF + ++ K+ H N+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
L + +V +YMP G L L L + +++AL A+G+ +L
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLE- 119
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-------YRAPEVVET 517
S VH ++ A N L+ + +SDFGL R G + APE ++
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGL-SRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178
Query: 518 RKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVR----EEWTAEVFD 572
K T KSDV+SFGVLL E+ T G+ P G ++ ++ R E E+++
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYP---GMSNEEVLELLEDGYRLPRPENCPDELYE 235
Query: 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613
+ M+Q C + P+ RP E+V +
Sbjct: 236 L-----------MLQ-------CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 65/196 (33%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 352 EVLGKGSVGTSYKA-VLEEGTTVVVKRLKEVAVGKREFEMQ-MEVLGKIKHDNVVPLRAF 409
E +GKG G YKA G V +K +K + K+E + +++L K KH N+V
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
Y KDE +V ++ GSL LL + L + +GL +LH S I+
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQ----TLTESQIAYVCKELLKGLEYLH-SNGII 120
Query: 470 HGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKVTFKSDV 526
H +IKA+NILL D + + DFGL+ +T + G + APEV+ + +K+D+
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADI 180
Query: 527 YSFGVLLLELLTGKAP 542
+S G+ +EL GK P
Sbjct: 181 WSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 63/274 (22%), Positives = 121/274 (44%), Gaps = 35/274 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKR--LKEVAVGKREFEMQ-MEVLGKIKHDNVVPLR 407
+ +GKGS G Y +G V+K L ++ +RE + +++L K+ H N++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
+ K + +V +Y G LS + + P + + + L +LH S K
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFVQLCLALKYLH-SRK 123
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR-VAG---YRAPEVVETRKVTFK 523
I+H +IK NI L + + DFG++ + +T + V G Y +PE+ + + +K
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYK 183
Query: 524 SDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583
SD++S G +L EL T K P + +L +++ + Y I
Sbjct: 184 SDIWSLGCVLYELCTLKHPFEGE------NLLELALKILKGQ------------YPPIPS 225
Query: 584 ----EMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613
E+ L+ + P++RP++ ++++
Sbjct: 226 QYSSELRNLVS---SLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 26/205 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGK---REFEMQMEVLGKIKHDNVVPLR 407
+++G+G+ G YK + LE G V +K++ + + + ++++L +KH N+V
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAA------RGLAH 461
+ D ++ +Y GSL ++ G P L A +GLA+
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKF---GPFPES--------LVAVYVYQVLQGLAY 114
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGL-NPLFGNTTPPTRVAG---YRAPEVVET 517
LH G ++H +IKA+NIL D ++DFG+ L + V G + APEV+E
Sbjct: 115 LHEQG-VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 518 RKVTFKSDVYSFGVLLLELLTGKAP 542
+ SD++S G ++ELLTG P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 4e-26
Identities = 75/316 (23%), Positives = 119/316 (37%), Gaps = 30/316 (9%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKRE----FEMQMEVLGKIKH-DNVVPL 406
LG+GS G Y A + V +K L + K + F ++++L + H N+V L
Sbjct: 6 RKLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
F+ + LV +Y+ GSL LL + + PL + I L +LH G
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLK--KIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 467 KIVHGNIKASNILLRPD-HDACVSDFGLNPLFGNTTPPTRV----------AGYRAPEVV 515
I+H +IK NILL D + DFGL L + + + GY APEV+
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 516 E---TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572
+ SD++S G+ L ELLTG P + ++ E T +
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ---TLKIILELPTPSLA- 236
Query: 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRP-AMQEVVRMIENMNRGETDDGLRQSSDD 631
+ N E + ++ P R + ++ + + + D D
Sbjct: 237 -SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD 295
Query: 632 PSKGSDGHTPPPESRT 647
S PP
Sbjct: 296 DSAPLRLSLPPSLEAL 311
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 30/209 (14%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFE-MQME--VLGKIKHDNVVPLR 407
E+LG+GS G+ Y A+ ++ G + VK ++ + E E ++ E +L ++H N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 408 AFYYSKDEK-LLVY-DYMPAGSLSALLHGSRGSGRTPLDWDNRMRI-ALSAARGLAHLHV 464
+++ L ++ +Y+ GSLS+LL + G+ P + +R GLA+LH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLP---EPVIRKYTRQILEGLAYLH- 118
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGL--------NPLFGNT---TPPTRVAGYRAPE 513
S IVH +IK +NIL+ D ++DFG + TP + APE
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY-----WMAPE 173
Query: 514 VVETRKVTFKSDVYSFGVLLLELLTGKAP 542
V+ + +D++S G ++E+ TGK P
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 69/274 (25%), Positives = 111/274 (40%), Gaps = 31/274 (11%)
Query: 344 EDLLRASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVGKREFEMQ----MEVLGKI 398
DL R VLG+GS G YK G +K++ G EF Q ++ L
Sbjct: 1 SDLERVK--VLGQGSSGVVYKVRHKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSC 56
Query: 399 KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARG 458
+ VV +Y + E +V +YM GSL+ LL L IA +G
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVL-----AYIARQILKG 111
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR----VAGYRAPEV 514
L +LH I+H +IK SN+L+ + ++DFG++ + NT Y +PE
Sbjct: 112 LDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPER 171
Query: 515 VETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574
++ ++ +D++S G+ LLE GK P +L +Q++
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL---MQAICDGP-------PP 221
Query: 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQE 608
+ E + C+ P +RP+ E
Sbjct: 222 SLPAEEFSPEFRDFIS---ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 60/197 (30%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYY 411
+GKG G G V VK LK+ + + F + V+ ++H N+V L
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
+ +V +YM GSL L R GR + ++ AL G+ +L VH
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLE-EKNFVHR 126
Query: 472 NIKASNILLRPDHDACVSDFGLNP-----LFGNTTPPTRVAGYRAPEVVETRKVTFKSDV 526
++ A N+L+ D A VSDFGL P + APE + +K + KSDV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP----VKWTAPEALREKKFSTKSDV 182
Query: 527 YSFGVLLLELLT-GKAP 542
+SFG+LL E+ + G+ P
Sbjct: 183 WSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 67/212 (31%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQME------VLGKIKHDNVVP 405
+GKGS G +K V + V +K++ + K + E VL K+ ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYA--MKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
+ K + +V +Y G L LL RG PL D R + GLAHLH S
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR---PLPEDQVWRFFIQILLGLAHLH-S 119
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGL------NPLFGNTTPPTRVAGYRAPEVVETRK 519
KI+H +IK+ N+ L + + D G+ N F NT T Y +PE+ E +
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPY--YLSPELCEDKP 177
Query: 520 VTFKSDVYSFGVLLLELLTGKAP----NQASL 547
KSDV++ GV+L E TGK P NQ +L
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGAL 209
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 41/286 (14%)
Query: 354 LGKGSVGTSYKAVLE-----EGTTVVVKRLKEVAVGK--REFEMQMEVLGKIKHDNVVPL 406
LG+G G + G V VK L + +FE ++E+L + H+N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 407 RAFYYSKDEK--LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
+ + L+ +Y+P+GSL L R ++ + + +G+ +L
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ----INLKRLLLFSSQICKGMDYLG- 126
Query: 465 SGKIVHGNIKASNILLRPDHDACV--SDFGLNPLFGNTTPPTRVAGYR------------ 510
S + +H ++ A NIL+ + + V SDFGL + P Y
Sbjct: 127 SQRYIHRDLAARNILV--ESEDLVKISDFGLAKV-----LPEDKDYYYVKEPGESPIFWY 179
Query: 511 APEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGE--EGIDLPRWVQSVVREEWTA 568
APE + T K + SDV+SFGV L EL T P+Q+ E I + + V R
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239
Query: 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614
+ L R + +E+ L+++ C P RP+ +++ +++
Sbjct: 240 KE-GERLPRPPSCPDEVYDLMKL---CWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-22
Identities = 55/134 (41%), Positives = 76/134 (56%), Gaps = 3/134 (2%)
Query: 73 LRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV 132
L L G LVG IP +L L+ L L+L SN+L G+IP + + L+ +YL N SG
Sbjct: 169 LDLGGNVLVGKIPN-SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227
Query: 133 FPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLP-SI-NPANLR 190
P + + L LDL NN +G IP + NL +L LFL NK SG +P SI + L
Sbjct: 228 IPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLI 287
Query: 191 DFNVSNNNLNGSIP 204
++S+N+L+G IP
Sbjct: 288 SLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 6e-21
Identities = 71/227 (31%), Positives = 97/227 (42%), Gaps = 38/227 (16%)
Query: 34 LLAFLS--RTPHKNRVQWNASDSACNWVGVECDANRSFVYSLRLPGVG------------ 79
LL+F S P K WN+S C W G+ C+ N S V S+ L G
Sbjct: 34 LLSFKSSINDPLKYLSNWNSSADVCLWQGITCN-NSSRVVSIDLSGKNISGKISSAIFRL 92
Query: 80 ------------LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSN 127
L GPIP + S LR L+L +N +G IP + L +L L +N
Sbjct: 93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGS--IPNLETLDLSNN 150
Query: 128 QFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--N 185
SG P + + L LDL N GKIP + NLT L L L +N+ G +P
Sbjct: 151 MLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ 210
Query: 186 PANLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDLC----GGPLPP 228
+L+ + NNL+G IP + + +LDL GP+P
Sbjct: 211 MKSLKWIYLGYNNLSGEIPYEIG---GLTSLNHLDLVYNNLTGPIPS 254
|
Length = 968 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 8e-21
Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNV 403
LG+G+ G + + V VK LKE A +++FE + E+L +H+N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALL--HG-------SRGSGRTPLDWDNRMRIALS 454
V D ++V++YM G L+ L HG S S L ++IA+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 455 AARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR---- 510
A G+ +L S VH ++ N L+ D + DFG++ TT RV G+
Sbjct: 131 IASGMVYL-ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV-YTTDYYRVGGHTMLPI 188
Query: 511 ---APEVVETRKVTFKSDVYSFGVLLLELLT-GKAP 542
PE + RK T +SDV+SFGV+L E+ T GK P
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 8e-21
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEV--LGKIKHDNVVPLRAF 409
E LG+GS G+ YKA+ +E VV +K V V + E+ E+ L + +V
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVA--IKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
Y+ + +V +Y AGS+S ++ + + +T L + I +GL +LH S K +
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIM---KITNKT-LTEEEIAAILYQTLKGLEYLH-SNKKI 121
Query: 470 HGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR-VAG---YRAPEVVETRKVTFKSD 525
H +IKA NILL + A ++DFG++ +T V G + APEV++ K+D
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKAD 181
Query: 526 VYSFGVLLLELLTGKAPN 543
++S G+ +E+ GK P
Sbjct: 182 IWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 1e-20
Identities = 66/204 (32%), Positives = 94/204 (46%), Gaps = 27/204 (13%)
Query: 354 LGKGSVGTSYKA-VLEEGTTVVVKRL-KEVAVGKREFEMQME---VLGKIKHDNVVPLRA 408
LGKGS G + G +K L K+ + ++E E + +L +I H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 409 FYYS--KDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR---GLAHL 462
+Y+ +EKL LV +Y P G L + L GR + R AA L +L
Sbjct: 59 -HYAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEE-----RARFYAAEIVLALEYL 109
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN----TTPPTRVAGYRAPEVVETR 518
H G I++ ++K NILL D ++DFGL + T Y APEV+ +
Sbjct: 110 HSLG-IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 519 KVTFKSDVYSFGVLLLELLTGKAP 542
D +S GVLL E+LTGK P
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 69/267 (25%), Positives = 114/267 (42%), Gaps = 35/267 (13%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG-----KREFEM-QMEVLGKIKHDNVVPLR 407
LGKGS G+ YK LKEV +G +RE + ++ +L + H N++ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYA--LKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
+ ++ +V +Y P G LS + R R + RI + RGL LH K
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAIS-KRKKKRKLIPEQEIWRIFIQLLRGLQALH-EQK 123
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG--YRAPEVVETRKVTFKSD 525
I+H ++K++NILL + + D G++ + T++ Y APEV + R ++KSD
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSD 183
Query: 526 VYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR--YHNIEE 583
++S G LL E+ T P +A + + ++ R Y I
Sbjct: 184 IWSLGCLLYEMATFAPPFEAR--------------------SMQDLRYKVQRGKYPPIPP 223
Query: 584 EMVQ-LLQIAMGCVSTVPDQRPAMQEV 609
Q L + P RP ++
Sbjct: 224 IYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 5e-19
Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK 413
+G G G + E V +K ++E A+ + +F + +V+ K+ H +V L +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 414 DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNI 473
LV+++M G LS L RG + + + L G+A+L S ++H ++
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAYLE-SSNVIHRDL 126
Query: 474 KASNILLRPDHDACVSDFG-----LNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYS 528
A N L+ + VSDFG L+ + ++T + +PEV K + KSDV+S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 529 FGVLLLELLT-GKAP 542
FGVL+ E+ + GK P
Sbjct: 187 FGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 62/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 352 EVLGKGSVGTSYKAVLEE--GTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAF 409
+ +GKG G +L + G V VK +K A + F + V+ +++H N+V L
Sbjct: 12 QTIGKGEFG---DVMLGDYRGNKVAVKCIKNDATAQ-AFLAEASVMTQLRHSNLVQLLGV 67
Query: 410 YYSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
+ L +V +YM GSL L R GR+ L D ++ +L + +L +
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE-ANNF 123
Query: 469 VHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV-AGYRAPEVVETRKVTFKSDVY 527
VH ++ A N+L+ D+ A VSDFGL +T ++ + APE + +K + KSDV+
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 528 SFGVLLLELLT-GKAP 542
SFG+LL E+ + G+ P
Sbjct: 184 SFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 68/257 (26%), Positives = 112/257 (43%), Gaps = 46/257 (17%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAVGK--REFEMQMEVLGKIKHDNV 403
E LG+G+ G YK L T+V +K LKE A K +EF + E++ ++H N+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALL-----------HGSRGSGRTPLDWDNRMRIA 452
V L + ++++Y+ G L L + ++ LD + + IA
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 453 LSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN---------PLFGNTTPP 503
+ A G+ +L S VH ++ A N L+ +SDFGL+ + + P
Sbjct: 131 IQIAAGMEYLS-SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGI---------- 552
R + PE + K T +SD++SFGV+L E+ + G P +E I
Sbjct: 190 VR---WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP 246
Query: 553 ---DLPRWVQSVVREEW 566
D P V +++ E W
Sbjct: 247 CPEDCPARVYALMIECW 263
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-18
Identities = 53/159 (33%), Positives = 85/159 (53%), Gaps = 11/159 (6%)
Query: 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSG 131
SL L L G IP + +L L +L L SN +G+IP ++L L+ L L SN+FSG
Sbjct: 288 SLDLSDNSLSGEIP-ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSG 346
Query: 132 VFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLP-SINPAN-L 189
P ++ + N LT LDLS+NN +G+IP + + +L L L +N G +P S+ L
Sbjct: 347 EIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSL 406
Query: 190 RDFNVSNNNLNGSIPATLSKFP--------QSSFTGNLD 220
R + +N+ +G +P+ +K P ++ G ++
Sbjct: 407 RRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRIN 445
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 62/196 (31%), Positives = 96/196 (48%), Gaps = 12/196 (6%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK 413
LG G G + T V VK LK + F + +++ K++HD +V L A +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 414 DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNI 473
+ +V +YM GSL L G G+ L + +A A G+A+L S +H ++
Sbjct: 74 EPIYIVTEYMSKGSLLDFLKS--GEGKK-LRLPQLVDMAAQIAEGMAYLE-SRNYIHRDL 129
Query: 474 KASNILLRPDHDAC-VSDFGLNPLFGNTTPPTRVAG-----YRAPEVVETRKVTFKSDVY 527
A NIL+ ++ C ++DFGL L + R + APE + T KSDV+
Sbjct: 130 AARNILV-GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVW 188
Query: 528 SFGVLLLELLT-GKAP 542
SFG+LL E++T G+ P
Sbjct: 189 SFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK 413
LG G G ++ + T V VK LK + ++F + +++ K++H ++ L A +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 414 DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNI 473
+ +V + M GSL L G G L + +A A G+A+L + +H ++
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAGRA---LKLPQLIDMAAQVASGMAYLE-AQNYIHRDL 129
Query: 474 KASNILLRPDHDAC-VSDFGLNPLFGNTTPPTRVAG-----YRAPEVVETRKVTFKSDVY 527
A N+L+ +++ C V+DFGL + R + APE + + KSDV+
Sbjct: 130 AARNVLVG-ENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 528 SFGVLLLELLT-GKAP 542
SFG+LL E++T G+ P
Sbjct: 189 SFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 38/213 (17%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLK-----EVAVGKREFEMQMEVLGKIKHDNVVP 405
+ +G G+ G YKA + G V +K +K + + ++E M L + +H N+V
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISM----LKECRHPNIV- 63
Query: 406 LRAFY--YSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
A++ Y + +KL +V +Y GSL + +RG PL + +GLA+L
Sbjct: 64 --AYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG----PLSELQIAYVCRETLKGLAYL 117
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---------TPPTRVAGYRAPE 513
H +GKI H +IK +NILL D D ++DFG++ T TP + APE
Sbjct: 118 HETGKI-HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPY-----WMAPE 171
Query: 514 VVETRKV---TFKSDVYSFGVLLLELLTGKAPN 543
V + K D+++ G+ +EL + P
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 30/206 (14%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM---------QMEVLGKIKHDNV 403
LG+G+ YKA E G V +K++K +G+R+ ++++L ++KH N+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIK---LGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGR-TPLDWDNRMRIALSAARGLAHL 462
+ L + K LV+++M L ++ S TP D + M + L RGL +L
Sbjct: 65 IGLLDVFGHKSNINLVFEFME-TDLEKVIK--DKSIVLTPADIKSYMLMTL---RGLEYL 118
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG------YRAPEVV- 515
H + I+H ++K +N+L+ D ++DFGL FG+ P ++ YRAPE++
Sbjct: 119 HSNW-ILHRDLKPNNLLIASDGVLKLADFGLARSFGS--PNRKMTHQVVTRWYRAPELLF 175
Query: 516 ETRKVTFKSDVYSFGVLLLELLTGKA 541
R D++S G + ELL
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 342 DLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFE-----MQMEVLG 396
DLE L LG G+ G K VL T ++ K + + E ++++L
Sbjct: 2 DLEYL-----GELGAGNSGVVSK-VLHRPTGKIMAV-KTIRLEINEAIQKQILRELDILH 54
Query: 397 KIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAA 456
K +V +Y+ + + +YM GSL +L GR P + IA++
Sbjct: 55 KCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGK--IAVAVL 110
Query: 457 RGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV--AGYRAPEV 514
+GL +LH KI+H ++K SNIL+ + DFG++ N+ T V + Y APE
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPER 170
Query: 515 VETRKVTFKSDVYSFGVLLLELLTGKAP 542
++ + KSD++S G+ L+EL TG+ P
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 5e-18
Identities = 48/134 (35%), Positives = 65/134 (48%), Gaps = 2/134 (1%)
Query: 80 LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTR 139
L G IP L L L L SN L GEIP LR + LQ N FSG P+ T+
Sbjct: 368 LTGEIP-EGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426
Query: 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLP-SINPANLRDFNVSNNN 198
+ + LD+S+NN G+I ++ L L L NKF G LP S L + ++S N
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQ 486
Query: 199 LNGSIPATLSKFPQ 212
+G++P L +
Sbjct: 487 FSGAVPRKLGSLSE 500
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 5e-18
Identities = 57/150 (38%), Positives = 78/150 (52%), Gaps = 11/150 (7%)
Query: 80 LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTR 139
L GPIPP+ L +L L L N LSGEIP L L L+L SN F+G P ++T
Sbjct: 272 LSGPIPPSIFS-LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS 330
Query: 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS--INPANLRDFNVSNN 197
+ RL L L SN FSG+IP ++ +LT L L N +G +P + NL + +N
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN 390
Query: 198 NLNGSIPATLS--------KFPQSSFTGNL 219
+L G IP +L + +SF+G L
Sbjct: 391 SLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420
|
Length = 968 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 67/199 (33%), Positives = 103/199 (51%), Gaps = 21/199 (10%)
Query: 352 EVLGKGSVGTSYKAVLE---EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRA 408
E++G+G G AVL+ G V VK +K V + F + V+ K+ H N+V L
Sbjct: 12 EIIGEGEFG----AVLQGEYTGQKVAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLG 66
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
+V + M G+L L R GR + ++ +L A G+ +L S K+
Sbjct: 67 VILHNG-LYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLE-SKKL 121
Query: 469 VHGNIKASNILLRPDHDACVSDFGL---NPL-FGNTTPPTRVAGYRAPEVVETRKVTFKS 524
VH ++ A NIL+ D A VSDFGL + N+ P + + APE ++ +K + KS
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK---WTAPEALKHKKFSSKS 178
Query: 525 DVYSFGVLLLELLT-GKAP 542
DV+S+GVLL E+ + G+AP
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 41/277 (14%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG-KREFEMQ----MEVLGKIKHDNVVPLRA 408
LG G+ G+ K V T V+ + K V +G K Q ++++ + + +V
Sbjct: 13 LGAGNGGSVSK-VKHIPTGTVMAK-KVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
+ +++ + ++M GSL + + G P+ + +IA++ GL +L+ +I
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIY---KKGG--PIPVEILGKIAVAVVEGLTYLYNVHRI 125
Query: 469 VHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV--AGYRAPEVVETRKVTFKSDV 526
+H +IK SNIL+ + DFG++ N+ T V + Y +PE ++ K T KSDV
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDV 185
Query: 527 YSFGVLLLELLTGKAP----NQASLGEEG----IDLPRWVQSVVREE---WTAEVFDVEL 575
+S G+ ++EL GK P N G++ +DL +Q +V+E + F +L
Sbjct: 186 WSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL---LQQIVQEPPPRLPSSDFPEDL 242
Query: 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612
+ V C+ P +RP Q++ M
Sbjct: 243 -------RDFVDA------CLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 6e-18
Identities = 55/144 (38%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 80 LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTR 139
L G IP +G L+ L L L N L+G IPS NL L+ L+L N+ SG P S+
Sbjct: 224 LSGEIP-YEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
Query: 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS--INPANLRDFNVSNN 197
+ +L LDLS N+ SG+IP V L +L L L +N F+G +P + L+ + +N
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342
Query: 198 NLNGSIPATLSKFPQSSFTGNLDL 221
+G IP L K ++ T LDL
Sbjct: 343 KFSGEIPKNLGK--HNNLT-VLDL 363
|
Length = 968 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 354 LGKGSVGTSYKAVL----EEGTTVVVKRLKEVAVGKREFE---MQMEVLGKIKHDNVVPL 406
+G+GS G KA+L E+G V+K + + +E E ++ VL +KH N+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRG---SGRTPLDWDNRMRIALSAARGLAHLH 463
+ + +V DY G L ++ RG LDW ++I L L H+H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW--FVQICL----ALKHVH 118
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA----GYRAPEVVETRK 519
KI+H +IK+ NI L D + DFG+ + +T R Y +PE+ E R
Sbjct: 119 -DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP 177
Query: 520 VTFKSDVYSFGVLLLELLTGK 540
KSD+++ G +L E+ T K
Sbjct: 178 YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM-----QMEVLGKIKHDNVVP 405
EV+G G+ Y A+ L V +KR+ + K + + +++ + + H NVV
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRID---LEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALL-HGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
+ DE LV Y+ GSL ++ G LD + +GL +LH
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG---LDEAIIATVLKEVLKGLEYLHS 120
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNP-LFGNTTPPTRV----AG---YRAPEVVE 516
+G+I H +IKA NILL D ++DFG++ L +V G + APEV+E
Sbjct: 121 NGQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 517 TRK-VTFKSDVYSFGVLLLELLTGKAP 542
FK+D++SFG+ +EL TG AP
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 77/271 (28%), Positives = 125/271 (46%), Gaps = 30/271 (11%)
Query: 354 LGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYS 412
LG G G Y+ V ++ TV VK LKE + EF + V+ +IKH N+V L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 413 KDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGN 472
+ ++ ++M G+L L R R ++ + +A + + +L +H +
Sbjct: 74 EPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRD 129
Query: 473 IKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG------YRAPEVVETRKVTFKSDV 526
+ A N L+ +H V+DFGL+ L T T AG + APE + K + KSDV
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDV 188
Query: 527 YSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585
++FGVLL E+ T G +P GIDL + V ++ + + E R ++
Sbjct: 189 WAFGVLLWEIATYGMSP------YPGIDLSQ-VYELLEKGYRME-------RPEGCPPKV 234
Query: 586 VQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
+L++ C P RP+ E+ + E M
Sbjct: 235 YELMR---ACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 33/228 (14%)
Query: 353 VLGKGSVGTSYKAV-LEEGTT----VVVKRLKEV--AVGKREFEMQMEVLGKIKHDNVVP 405
VLG G+ GT YK V + EG V +K L+E +E + V+ + H +VV
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGS--GRTPLDWDNRMRIALSAARGLAHLH 463
L S + L+ MP G L + + + + L+W + A+G+++L
Sbjct: 74 LLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLE 126
Query: 464 VSGKIVHGNIKASNILLR-PDHDACVSDFGLNPLFGNTTPPTRVAGYR------APEVVE 516
+VH ++ A N+L++ P H ++DFGL L G + A E +
Sbjct: 127 EKR-LVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 517 TRKVTFKSDVYSFGVLLLELLT-GKAPNQA-------SLGEEGIDLPR 556
R T KSDV+S+GV + EL+T G P + L E+G LP+
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-17
Identities = 55/142 (38%), Positives = 76/142 (53%), Gaps = 3/142 (2%)
Query: 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSN 127
+ +L L L G IP N +G S L+VL L N L G+IP+ +NLT L L L SN
Sbjct: 140 PNLETLDLSNNMLSGEIP-NDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASN 198
Query: 128 QFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--N 185
Q G P + +M L + L NN SG+IP+++ LT L L L N +G +PS N
Sbjct: 199 QLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN 258
Query: 186 PANLRDFNVSNNNLNGSIPATL 207
NL+ + N L+G IP ++
Sbjct: 259 LKNLQYLFLYQNKLSGPIPPSI 280
|
Length = 968 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVK--RLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAF 409
E +GKG+ G YK VL+ T V VK R KR+F + E+L + H N+V L
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
K +V + +P GSL L + ++++L AA G+ +L S +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV----KKLLQMSLDAAAGMEYLE-SKNCI 115
Query: 470 HGNIKASNILLRPDHDACVSDFGLN---------PLFGNTTPPTRVAGYRAPEVVETRKV 520
H ++ A N L+ ++ +SDFG++ G P + + APE + +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK---WTAPEALNYGRY 172
Query: 521 TFKSDVYSFGVLLLELLTG 539
T +SDV+S+G+LL E +
Sbjct: 173 TSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 11/206 (5%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK 413
LG+G G + T V +K LK + F + +V+ K++H+ +V L A S+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SE 72
Query: 414 DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNI 473
+ +V +YM GSL L G G L + +A A G+A++ VH ++
Sbjct: 73 EPIYIVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDL 128
Query: 474 KASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-----YRAPEVVETRKVTFKSDVYS 528
+A+NIL+ + V+DFGL L + R + APE + T KSDV+S
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 529 FGVLLLELLT-GKAPNQASLGEEGID 553
FG+LL EL T G+ P + E +D
Sbjct: 189 FGILLTELTTKGRVPYPGMVNREVLD 214
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 63/195 (32%), Positives = 96/195 (49%), Gaps = 11/195 (5%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK 413
LG G G + T V VK LK + F + +++ K++HD +V L A S+
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-SE 72
Query: 414 DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNI 473
+ +V +YM GSL L G GR L N + +A A G+A++ I H ++
Sbjct: 73 EPIYIVTEYMSKGSLLDFL--KDGEGRA-LKLPNLVDMAAQVAAGMAYIERMNYI-HRDL 128
Query: 474 KASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-----YRAPEVVETRKVTFKSDVYS 528
+++NIL+ ++DFGL L + R + APE + T KSDV+S
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 529 FGVLLLELLT-GKAP 542
FG+LL EL+T G+ P
Sbjct: 189 FGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 29/238 (12%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLK-EVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYS 412
LG G G ++ + + V +K LK + + +++F+ +++ L +++H +++ L A
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 413 KDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGN 472
+ ++ + M GSL A L G L + + +A A G+A+L +H +
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQV---LPVASLIDMACQVAEGMAYLE-EQNSIHRD 129
Query: 473 IKASNILLRPDHDACVSDFGLNPLF-------GNTTPPTRVAGYRAPEVVETRKVTFKSD 525
+ A NIL+ D V+DFGL L + P + + APE + KSD
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK---WTAPEAASHGTFSTKSD 186
Query: 526 VYSFGVLLLELLT-GKAPNQASLGEEGIDL-------------PRWVQSVVREEWTAE 569
V+SFG+LL E+ T G+ P E D P+ + ++ E W AE
Sbjct: 187 VWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAE 244
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 69/212 (32%), Positives = 96/212 (45%), Gaps = 37/212 (17%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVK-----RLKEVAVGKREFEMQMEVLGKIKHDNVVPLR 407
+G G+ G Y AV L+ G + VK + +E +M+VL +KH N+V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTI--KEIADEMKVLELLKHPNLVK-- 63
Query: 408 AFYYS---KDEKLLVY-DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
YY EK+ ++ +Y G+L LL R LD L GLA+LH
Sbjct: 64 --YYGVEVHREKVYIFMEYCSGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLH 116
Query: 464 VSGKIVHGNIKASNILLRPDHDACV--SDFGLNPLFGN--TTPPTRVAG------YRAPE 513
G IVH +IK +NI L DH+ + DFG N TT V Y APE
Sbjct: 117 SHG-IVHRDIKPANIFL--DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 514 VVETRKVTFK---SDVYSFGVLLLELLTGKAP 542
V+ K +D++S G ++LE+ TGK P
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 64/280 (22%), Positives = 116/280 (41%), Gaps = 39/280 (13%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVAVGK--REFEMQMEVLGKIKHDNVVP 405
+V+G G G + L ++ V +K LK + K +F + ++G+ H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
L +++ +YM GSL L + G + + A G+ +L
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYLSEM 125
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG------YRAPEVVETRK 519
VH ++ A NIL+ + VSDFGL+ ++ G + APE + RK
Sbjct: 126 N-YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 520 VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579
T SDV+SFG+++ E++ S GE P W + + + + +
Sbjct: 185 FTSASDVWSFGIVMWEVM--------SYGER----PYW-------DMSNQDVIKAVEDGY 225
Query: 580 NIEEEM---VQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
+ M L Q+ + C ++RP ++V ++ M
Sbjct: 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 73/283 (25%), Positives = 116/283 (40%), Gaps = 48/283 (16%)
Query: 354 LGKGSVGTSYKAVL------EEGTTVVVKRLKEVAVGKR-EFEMQMEVLGKIKHDNVVPL 406
LG+G+ G + A ++ V VK LKE + R +F+ + E+L ++H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 407 RAFYYSKDEKLLVYDYMPAGSL----------SALLHGSRGSGRTPLDWDNRMRIALSAA 456
L+V++YM G L + +L G L + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 457 RGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP---------LFGNTTPPTRVA 507
G+ +L S VH ++ N L+ + DFG++ + G T P R
Sbjct: 133 SGMVYL-ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR-- 189
Query: 508 GYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEW 566
+ PE + RK T +SD++SFGV+L E+ T GK P W Q E
Sbjct: 190 -WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP--------------WYQLSNTEAI 234
Query: 567 TAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEV 609
EL R E+ ++Q GC P QR ++++
Sbjct: 235 ECITQGRELERPRTCPPEVYAIMQ---GCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-16
Identities = 63/209 (30%), Positives = 83/209 (39%), Gaps = 46/209 (22%)
Query: 98 LSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKI 157
L L + L G IP+D S L L+S+ L N G P S+ + L LDLS N+F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 158 PFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQSSFTG 217
P + LT L L L N SG +P ++ L +FT
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP------------------AALGGRLLHRASFNFTD 524
Query: 218 NLDLCGGP-LPPCNPFFPSPAPSPSLPPPVAPVHKKSNKLSTAAIVGIAVGGAVFIVLLL 276
N LCG P L C P LS A +GIA G +V + L+
Sbjct: 525 NAGLCGIPGLRACGP-----------------------HLSVGAKIGIAFGVSVAFLFLV 561
Query: 277 LLLLFCLKKR----RRQRPGKAPKPPAAA 301
+ + K+R R QR P A A
Sbjct: 562 ICAMCWWKRRQNILRAQRIAAREAPYAKA 590
|
Length = 623 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREF------EMQMEVLGKIKHDNVVPL 406
+G+G+ G YKA + G V +K+++ K F E++ +L K++H N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIK--LLQKLRHPNIVRL 63
Query: 407 RAFYYSKDEK--LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
+ SK + +V++YM L+ LL S GL +LH
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDH-DLTGLLD----SPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPT---RVAG--YRAPEVV--ET 517
+G I+H +IK SNIL+ D ++DFGL + RV YR PE++ T
Sbjct: 119 NG-ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 518 RKVTFKSDVYSFGVLLLELLTGKAPNQAS 546
R + D++S G +L EL GK Q S
Sbjct: 178 R-YGPEVDMWSVGCILAELFLGKPIFQGS 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 11/203 (5%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK 413
LG+G G + T V +K LK + F + +++ K++HD +VPL A S+
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV-VSE 72
Query: 414 DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNI 473
+ +V ++M GSL L G G+ L + +A A G+A++ I H ++
Sbjct: 73 EPIYIVTEFMGKGSLLDFL--KEGDGKY-LKLPQLVDMAAQIADGMAYIERMNYI-HRDL 128
Query: 474 KASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-----YRAPEVVETRKVTFKSDVYS 528
+A+NIL+ + ++DFGL L + R + APE + T KSDV+S
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 529 FGVLLLELLT-GKAPNQASLGEE 550
FG+LL EL+T G+ P + E
Sbjct: 189 FGILLTELVTKGRVPYPGMVNRE 211
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 68/276 (24%), Positives = 125/276 (45%), Gaps = 45/276 (16%)
Query: 353 VLGKGSVGTSYKAVL----EEGTTVVVKR--LKEVAVGKREFEM-QMEVLGKIKHDNVVP 405
VLGKG+ G +A L E+ + VV K L ++ +R + ++ +L ++H N++
Sbjct: 7 VLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII- 62
Query: 406 LRAFY--YSKDEKLLV-YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIAL--SAARGLA 460
A+Y + D LL+ +Y G+L + + ++ M + ++
Sbjct: 63 --AYYNHFMDDNTLLIEMEYANGGTLYDKI-----VRQKGQLFEEEMVLWYLFQIVSAVS 115
Query: 461 HLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR-VAG---YRAPEVVE 516
++H +G I+H +IK NI L + DFG++ + G+ V G Y +PE+ +
Sbjct: 116 YIHKAG-ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQ 174
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576
K FKSD+++ G +L ELLT K A+ + V +V+ +T +
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDAT------NPLNLVVKIVQGNYT-----PVVS 223
Query: 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612
Y E++ L+ + P++RP EV+
Sbjct: 224 VY---SSELISLVH---SLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 22/199 (11%)
Query: 354 LGKGSVGTSYKA-VLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIK------HDNVVPL 406
+G+G+ G +KA E G TV +K+ VA+ + E + + L +IK H VV L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKK---VALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+ +LV +YMP LS +L PL +G+A++H +G
Sbjct: 65 LDVFPHGSGFVLVMEYMP-SDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 467 KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPT---RVAG--YRAPEVV-ETRKV 520
I+H ++K +N+L+ D ++DFGL LF P +VA YRAPE++ RK
Sbjct: 120 -IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 521 TFKSDVYSFGVLLLELLTG 539
D+++ G + ELL G
Sbjct: 179 DPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-16
Identities = 51/135 (37%), Positives = 69/135 (51%), Gaps = 3/135 (2%)
Query: 80 LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTR 139
LVG IP LG++ L+ + L N LSGEIP + LT L L L N +G P+S+
Sbjct: 200 LVGQIP-RELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN 258
Query: 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS--INPANLRDFNVSNN 197
+ L L L N SG IP + +L L L L +N SG +P I NL ++ +N
Sbjct: 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN 318
Query: 198 NLNGSIPATLSKFPQ 212
N G IP L+ P+
Sbjct: 319 NFTGKIPVALTSLPR 333
|
Length = 968 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 40/211 (18%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQ--------MEVLGKIKHDNV 403
E +G+G+ G YKA KEVA+ K Q + ++ KH N+
Sbjct: 25 EKIGEGASGEVYKAT-------DRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
V Y DE +V +YM GSL+ ++ + ++ + +GL +LH
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLH 133
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGL-----------NPLFGNTTPPTRVAGY-RA 511
S ++H +IK+ NILL D ++DFG N + G TP Y A
Sbjct: 134 -SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVG--TP------YWMA 184
Query: 512 PEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
PEV++ + K D++S G++ +E+ G+ P
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 37/223 (16%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM---QMEVLGKIKHDNVVPLR 407
E +GKGS GT K +G +V K + + ++E + ++ +L ++KH N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR-- 63
Query: 408 AFYYSKD---EKLLVYDYMP---AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
YY + +Y M G L+ L+ + R ++ + RI L
Sbjct: 64 --YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYE 120
Query: 462 LH----VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---------TPPTRVAG 508
H ++H ++K +NI L +++ + DFGL + G+ TP
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY----- 175
Query: 509 YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP----NQASL 547
Y +PE + KSD++S G L+ EL P NQ L
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 82/298 (27%), Positives = 127/298 (42%), Gaps = 52/298 (17%)
Query: 353 VLGKGSVGTSYKAVLEE------GTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVV 404
LG+G G KA TTV VK LKE A R+ + +L ++ H +V+
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSR-------GSGRT------------PLDW 445
L LL+ +Y GSL + L SR GS L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 446 DNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN-PLFGNTTPPT 504
+ + A +RG+ +L K+VH ++ A N+L+ +SDFGL+ ++ +
Sbjct: 127 GDLISFAWQISRGMQYL-AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 505 RVAG-----YRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWV 558
R G + A E + T +SDV+SFGVLL E++T G P GI P +
Sbjct: 186 RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP------YPGIA-PERL 238
Query: 559 QSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
++++ + E R N EEM L+ + C PD+RP ++ + +E M
Sbjct: 239 FNLLKTGYRME-------RPENCSEEMYNLM---LTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 8e-16
Identities = 72/268 (26%), Positives = 124/268 (46%), Gaps = 28/268 (10%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK 413
LG G G + A + T V VK +K ++ F + V+ ++HD +V L A +K
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TK 72
Query: 414 DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNI 473
+ ++ ++M GSL L GS + PL + + A G+A + I H ++
Sbjct: 73 EPIYIITEFMAKGSLLDFLKSDEGS-KQPLP--KLIDFSAQIAEGMAFIEQRNYI-HRDL 128
Query: 474 KASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-----YRAPEVVETRKVTFKSDVYS 528
+A+NIL+ ++DFGL + + R + APE + T KSDV+S
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 188
Query: 529 FGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQ 587
FG+LL+E++T G+ P G+ P ++++ R + R N EE
Sbjct: 189 FGILLMEIVTYGRIP------YPGMSNPEVIRALER--------GYRMPRPENCPEE--- 231
Query: 588 LLQIAMGCVSTVPDQRPAMQEVVRMIEN 615
L I M C P++RP + + ++++
Sbjct: 232 LYNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 9e-16
Identities = 69/270 (25%), Positives = 122/270 (45%), Gaps = 28/270 (10%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYY 411
+ LG G G + T V +K LK+ ++ F + ++ +++H +V L A
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV- 70
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
+++ ++ +YM GSL L G L + + +A A G+A + I H
Sbjct: 71 TQEPIYIITEYMENGSLVDFLKTPEGI---KLTINKLIDMAAQIAEGMAFIERKNYI-HR 126
Query: 472 NIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-----YRAPEVVETRKVTFKSDV 526
+++A+NIL+ ++DFGL L + R + APE + T KSDV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 527 YSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585
+SFG+LL E++T G+ P G+ P +Q++ R + R N EE
Sbjct: 187 WSFGILLTEIVTYGRIP------YPGMTNPEVIQNLER--------GYRMPRPDNCPEE- 231
Query: 586 VQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615
L ++ C P++RP + + ++E+
Sbjct: 232 --LYELMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 66/245 (26%), Positives = 107/245 (43%), Gaps = 25/245 (10%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK 413
LG G G + T V VK LK + + F + ++ ++HD +V L A +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 414 DEKLLVYDYMPAGSLSALLHGSRGSG-RTPLDWDNRMRIALSAARGLAHLHVSGKIVHGN 472
+ ++ +YM GSL L G P D +I A G+A++ I H +
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI----AEGMAYIERKNYI-HRD 128
Query: 473 IKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-----YRAPEVVETRKVTFKSDVY 527
++A+N+L+ ++DFGL + + R + APE + T KSDV+
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 528 SFGVLLLELLT-GKAP-------NQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579
SFG+LL E++T GK P + S + G +PR E E++D+ +
Sbjct: 189 SFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR------MENCPDELYDIMKTCWK 242
Query: 580 NIEEE 584
EE
Sbjct: 243 EKAEE 247
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 83/306 (27%), Positives = 131/306 (42%), Gaps = 47/306 (15%)
Query: 338 VYSFDLEDLLRASAEVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAVGK--REFE 389
+ + L + LG+G+ G KA E +TV VK LK+ A K +
Sbjct: 6 EWELPRDRL--TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLV 63
Query: 390 MQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSG--------- 439
+ME++ I KH N++ L + +V +Y G+L L R G
Sbjct: 64 SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123
Query: 440 --RTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---- 493
L + + A ARG+ L S K +H ++ A N+L+ DH ++DFGL
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFL-ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 494 --NPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEE 550
+ TT + APE + R T +SDV+SFGVLL E+ T G +P
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP------YP 236
Query: 551 GIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVV 610
GI + +++E + E + N +E+ L+ C VP QRP +++V
Sbjct: 237 GIPVEELF-KLLKEGYRME-------KPQNCTQELYHLM---RDCWHEVPSQRPTFKQLV 285
Query: 611 RMIENM 616
++ M
Sbjct: 286 EDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 73/291 (25%), Positives = 127/291 (43%), Gaps = 46/291 (15%)
Query: 354 LGKGSVGTSYKAVL------EEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPL 406
LG+G+ G + A ++ V VK LK+ + +++F + E+L ++H+++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALL--HG------SRGSGRTPLDWDNRMRIALSAARG 458
D ++V++YM G L+ L HG + G+ L + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN---------PLFGNTTPPTRVAGY 509
+ +L S VH ++ N L+ + + DFG++ + G+T P R +
Sbjct: 133 MVYL-ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR---W 188
Query: 510 RAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTA 568
PE + RK T +SDV+S GV+L E+ T GK P W Q E
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--------------WYQLSNNEVIEC 234
Query: 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619
L R +E+ L+ +GC P R ++E+ +++N+ +
Sbjct: 235 ITQGRVLQRPRTCPKEVYDLM---LGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 67/286 (23%), Positives = 129/286 (45%), Gaps = 51/286 (17%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM-----------QMEVLGKIKHD 401
+GKG YKA+ L +G V +K+++ FEM ++++L ++ H
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQI-------FEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 402 NVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRT---PLDWDNRMRIALSAARG 458
NV+ A + +E +V + AG LS ++ + R W +++
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SA 118
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN-TTPPTRVAG---YRAPEV 514
L H+H S +I+H +IK +N+ + + D GL F + TT + G Y +PE
Sbjct: 119 LEHMH-SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 515 VETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWT---AEVF 571
+ FKSD++S G LL E+ A Q+ + ++L + + + ++ A+ +
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHY 233
Query: 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617
EL ++V C++ P++RP + V+++ + M+
Sbjct: 234 SEEL-------RDLVS------RCINPDPEKRPDISYVLQVAKEMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 353 VLGKGSVGTSY----KAVLEEG--TTVVVKRLKEVAVGK--REFEMQMEVLGKIKHDNVV 404
LG+G G + K + EEG T V+VK L++ EF ++++ K+ H NVV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRT----PLDWDNRMRIALSAARGLA 460
L + ++ +Y G L L ++ PL ++ + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 461 HLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP--------LFGNTTPPTRVAGYRAP 512
HL + + VH ++ A N L+ + VS L+ N P R + AP
Sbjct: 132 HLS-NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR---WLAP 187
Query: 513 EVVETRKVTFKSDVYSFGVLLLELLT-GKAP 542
E V+ + KSDV+SFGVL+ E+ T G+ P
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 77/278 (27%), Positives = 116/278 (41%), Gaps = 42/278 (15%)
Query: 354 LGKGSVGTSYKAVLEEGT----TVVVKRLKE--VAVGKREFEMQMEVLGKIKHDNVVPLR 407
LG G+ G+ K V + V VK LK+ +A GK+EF + V+ ++ H +V R
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV--R 60
Query: 408 AFYYSKDEKL-LVYDYMPAGSLSALLHGSRG-SGRTPLDWDNRMRIALSAARGLAHLHVS 465
K E L LV + P G L L R + A A G+A+L S
Sbjct: 61 LIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE-S 113
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLNPL--FGNTTPPTRVAG-----YRAPEVVETR 518
VH ++ A N+LL H A +SDFG++ G+ AG + APE +
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 519 KVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577
K + KSDV+S+GV L E + G P +G ++ ++S R L R
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYG---EMKGAEVIAMLESGER-----------LPR 219
Query: 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615
+E+ ++ C P+ RP E+
Sbjct: 220 PEECPQEIYSIML---SCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 3e-15
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 61/222 (27%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLK--------------EVAVGKREFEMQMEVLG 396
E LG+G+ G YKA + G V +K+++ E+++ L
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISL-----------LK 53
Query: 397 KIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAA 456
++KH N+V L +++ + LV++Y L L + LS
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLD--------------KRPGPLSPN 98
Query: 457 ----------RGLAHLHVSGKIVHGNIKASNILLRPDHDACV--SDFGLNPLFGNTTPP- 503
RGLA+ H S +I+H ++K NIL+ + D + +DFGL FG
Sbjct: 99 LIKSIMYQLLRGLAYCH-SHRILHRDLKPQNILI--NRDGVLKLADFGLARAFGIPLRTY 155
Query: 504 -TRVAG--YRAPEV-VETRKVTFKSDVYSFGVLLLELLTGKA 541
V YRAPE+ + ++ + D++S G + E++TGK
Sbjct: 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGK------REFEMQMEVLGKIKHDNVV 404
E+LG GS G+ Y+ + L++G VK + G+ ++ E ++ +L K++H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 405 PLRAFYY---SKDEKLLVY-DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLA 460
Y +++ L ++ + +P GSL+ LL GS P+ R L GL
Sbjct: 66 Q----YLGTEREEDNLYIFLELVPGGSLAKLL-KKYGSFPEPV-IRLYTRQILL---GLE 116
Query: 461 HLHVSGKIVHGNIKASNILLRPDHDACV--SDFGLNP---LFGNTTPPTRVAGYRAPEVV 515
+LH VH +IK +NIL+ D + V +DFG+ F + APEV+
Sbjct: 117 YLH-DRNTVHRDIKGANILV--DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVI 173
Query: 516 -ETRKVTFKSDVYSFGVLLLELLTGKAP 542
+ +D++S G +LE+ TGK P
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 70/279 (25%), Positives = 112/279 (40%), Gaps = 33/279 (11%)
Query: 354 LGKGSVGTSYKAVLEEGTT---VVVKRLKEVAVGKRE--FEMQMEVLGKIKHDNVVPLRA 408
+G G G G + VVVK L+ A + F +++ ++ H NV+
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
LLV ++ P G L L +RG D R+A A GL LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QADF 121
Query: 469 VHGNIKASNILLRPDHDACVSDFGLN----PLFGNTTPPTRVAGYR--APEVVETR---- 518
+H ++ N L D + D+GL P T R APE+VE R
Sbjct: 122 IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDL 181
Query: 519 ---KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575
T KS+++S GV + EL T L +E + ++ VVRE+ D++L
Sbjct: 182 LPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-----LKQVVREQ------DIKL 230
Query: 576 MRYHNIEEEMV-QLLQIAMGCVSTVPDQRPAMQEVVRMI 613
+ ++ + + ++ C P+ RP +EV ++
Sbjct: 231 PK-PQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 71/270 (26%), Positives = 113/270 (41%), Gaps = 36/270 (13%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK 413
LG G G + V +K ++E A+ + +F + +V+ K+ H N+V L +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 414 DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNI 473
+V +YM G L L +G T D + + +L +G I H ++
Sbjct: 72 RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD----MCSDVCEAMEYLESNGFI-HRDL 126
Query: 474 KASNILLRPDHDACVSDFGLNPLF--------GNTTPPTRVAGYRAPEVVETRKVTFKSD 525
A N L+ D+ VSDFGL T P + A PEV + + + KSD
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA---PPEVFDYSRFSSKSD 183
Query: 526 VYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584
V+SFGVL+ E+ + GK P R+ S V E +A L R E
Sbjct: 184 VWSFGVLMWEVFSEGKMP-----------YERFSNSEVVESVSA---GYRLYRPKLAPTE 229
Query: 585 MVQLLQIAMG-CVSTVPDQRPAMQEVVRMI 613
+ + M C P+ RPA ++++ +
Sbjct: 230 VYTI----MYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 59/229 (25%), Positives = 91/229 (39%), Gaps = 52/229 (22%)
Query: 352 EVLGKGSVGTSYKAVL-EEGTTVVVKRL---------KEVAVGKREFEMQMEVLGKIK-H 400
+++G+GS T A E +K L K V K E EVL ++ H
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYV-KIE----KEVLTRLNGH 61
Query: 401 DNVVPLRAFYYS--KDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR 457
++ L YY+ +E L V +Y P G L + GS LD A
Sbjct: 62 PGIIKL---YYTFQDEENLYFVLEYAPNGELLQYIR-KYGS----LDEKCTRFYAAEILL 113
Query: 458 GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV----------- 506
L +LH G I+H ++K NILL D ++DFG + + P
Sbjct: 114 ALEYLHSKG-IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 507 -------------AGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
A Y +PE++ + SD+++ G ++ ++LTGK P
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLR-AF 409
LG+G+ G+ K L+ + + +++ ++E+ K +V AF
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 410 YYSKDEKL-LVYDYMPAGSLSALLHGSRG-SGRT---PLDWDNRMRIALSAARGLAHLHV 464
+ + +Y GSL ++ + GR L +IA S +GL++LH
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSYLH- 122
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG--YRAPEVVETRKVTF 522
S KI+H +IK SNILL + DFG++ N+ T Y APE ++ + +
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSI 182
Query: 523 KSDVYSFGVLLLELLTGKAP 542
SDV+S G+ LLE+ + P
Sbjct: 183 TSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 30/208 (14%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKRE----FEMQMEVLGKIKHDNVVPLRAF 409
LG G+ G YKA +E T + K + + E F +++++L + KH N+V L
Sbjct: 13 LGDGAFGKVYKAQHKE--TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
Y+ +++ ++ ++ G+L +++ L + L LH S K++
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLH-SHKVI 125
Query: 470 HGNIKASNILLRPDHDACVSDFGLNPLFGNT---------TPPTRVAGYRAPEVV--ETR 518
H ++KA NILL D D ++DFG++ +T TP + APEVV ET
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPY-----WMAPEVVACETF 180
Query: 519 KVT---FKSDVYSFGVLLLELLTGKAPN 543
K +K+D++S G+ L+EL + P+
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPPH 208
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 20/213 (9%)
Query: 342 DLEDLLRASAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEMQMEVLGKIKH 400
DL+DL +G+G+ GT K + + GT + VKR++ K + + M++ ++
Sbjct: 5 DLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS 59
Query: 401 DNVVPLRAFY---YSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR 457
+ + FY + + + + + M SL ++ + + +IA++ +
Sbjct: 60 SDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118
Query: 458 GLAHLHVSGKIVHGNIKASNILLRPDHDACVS--DFGLNPLFGNTTPPTRVAG---YRAP 512
L +L KI+H ++K SNILL D + + DFG++ ++ TR AG Y AP
Sbjct: 119 ALNYLKEELKIIHRDVKPSNILL--DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 176
Query: 513 EVVET---RKVTFKSDVYSFGVLLLELLTGKAP 542
E ++ +SDV+S G+ L E+ TGK P
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 70/280 (25%), Positives = 129/280 (46%), Gaps = 30/280 (10%)
Query: 352 EVLGKGSVGTSYKA-VLEEGTTVVVKRLK-EVAVG-KREFEMQMEVLGKIKHDNVVPLRA 408
E+LG G+ GT YKA L + VK + ++ V +++ ++E+L K ++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRM-RIALSAARGLAHLHVSGK 467
++ ++ + ++M GSL + P ++ + RIA++ +GL +L S K
Sbjct: 67 AFFVENRISICTEFMDGGSLDVY-------RKIP---EHVLGRIAVAVVKGLTYLW-SLK 115
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA--GYRAPEVVETRKVTFKSD 525
I+H ++K SN+L+ + DFG++ N+ T V Y APE + + SD
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSD 175
Query: 526 VYSFGVLLLELLTGKAPNQASLGEEGIDLP-RWVQSVVREEWTAEVFDVELMRYHNIEEE 584
V+S G+ +EL G+ P +G +P + +Q +V E D ++ E+
Sbjct: 176 VWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-------DPPVLPVGQFSEK 228
Query: 585 MVQLLQIAMGCVSTVPDQRPAMQEVVR--MIENMNRGETD 622
V + C+ P +RPA + ++ I N G +
Sbjct: 229 FVHFIT---QCMRKQPKERPAPENLMDHPFIVQYNDGNAE 265
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 23/201 (11%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRLK----EVAVGKREF-EMQMEVLGKIKHDNVVPLR 407
+G+G+ G YKA G V +K++K + K E+++ L ++ H N++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKL--LKELNHPNIIKLL 64
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
+ K + LV+++M + L + + L +GLA H G
Sbjct: 65 DVFRHKGDLYLVFEFM----DTDLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHG- 118
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPP------TRVAGYRAPEVVETRKV- 520
I+H ++K N+L+ + ++DFGL FG+ P TR YRAPE++ K
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR--WYRAPELLLGDKGY 176
Query: 521 TFKSDVYSFGVLLLELLTGKA 541
+ D++S G + ELL+ +
Sbjct: 177 STPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 46/286 (16%)
Query: 354 LGKGSVGTSYKAVL------EEGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVP 405
LG+GS G Y+ + E T V +K + E A + EF + V+ + +VV
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSR-----GSGRTPLDWDNRMRIALSAARGLA 460
L + L+V + M G L + L R G P +++A A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 461 HLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP---------PTRVAGYRA 511
+L + K VH ++ A N ++ D + DFG+ T P R + A
Sbjct: 134 YLA-AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WMA 189
Query: 512 PEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEV 570
PE ++ T KSDV+SFGV+L E+ T + P Q EE + V
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF---------------V 234
Query: 571 FDVELMRY-HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615
D + N +++++L+++ C P RP E+V +++
Sbjct: 235 IDGGHLDLPENCPDKLLELMRM---CWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 43/288 (14%)
Query: 352 EVLGKGSVGTSYKAVL--EEGTT--VVVKRLKEVAVGKREFEMQMEVLGKIK---HDNVV 404
++LG+G G+ + L ++G+ V VK +K E E + +K H NV+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 405 PLR--AFYYSKDEK----LLVYDYMPAGSLSALLHGSR-GSGRTPLDWDNRMRIALSAAR 457
L F S +K +++ +M G L + L SR G L ++ + A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 458 GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF--GNTTPPTRVA----GYRA 511
G+ +L + +H ++ A N +LR D CV+DFGL+ G+ R+A + A
Sbjct: 125 GMEYLS-NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 512 PEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEV 570
E + R T KSDV++FGV + E+ T G+ P G++ E+
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIATRGQTP------YPGVE-------------NHEI 224
Query: 571 FDVEL--MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
+D R E+ + +L + C P RP ++ ++EN+
Sbjct: 225 YDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 63/211 (29%), Positives = 109/211 (51%), Gaps = 27/211 (12%)
Query: 353 VLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVG----KREFEM------QMEVLGKIKHD 401
++G GS G+ Y + G + VK+++ +V R+ M ++ +L +++H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 402 NVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
N+V D + +Y+P GS++ALL+ + G+ L N +R L +GL +
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETL-VRNFVRQIL---KGLNY 121
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR----------A 511
LH + I+H +IK +NIL+ +SDFG++ + T+ G R A
Sbjct: 122 LH-NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 512 PEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
PEVV+ T K+D++S G L++E+LTGK P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 78/278 (28%), Positives = 118/278 (42%), Gaps = 47/278 (16%)
Query: 353 VLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLG---KIKHDNVVPLRA 408
VLGKG+ G Y A L + +K + E R + E + +KH N+V
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR---GLAHLHVS 465
+ + +P GSLSALL G PL DN I + GL +LH
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWG----PLK-DNEQTIIFYTKQILEGLKYLH-D 126
Query: 466 GKIVHGNIKASNILLRPDHDAC-VSDFG-------LNPLFGNTTPPTRVAGYRAPEVVE- 516
+IVH +IK N+L+ +SDFG +NP T T Y APEV++
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDK 183
Query: 517 -TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575
R +D++S G ++E+ TGK P LGE P+ A +F V +
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPFI-ELGE-----PQ-----------AAMFKVGM 226
Query: 576 MRYH-NIEEEM-VQLLQIAMGCVSTVPDQRPAMQEVVR 611
+ H I E + + + C PD+R + ++++
Sbjct: 227 FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 41/219 (18%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAF 409
EV+G+G+ G YKA ++ G V +K + + + E + + +L K H N+
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 410 YYSK------DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR------IALSAAR 457
+ K D+ LV + GS++ L+ G R G R++ I R
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-------KRLKEEWIAYILRETLR 124
Query: 458 GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---------TPPTRVAG 508
GLA+LH K++H +IK NILL + + + DFG++ +T TP
Sbjct: 125 GLAYLH-ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTP-----Y 178
Query: 509 YRAPEVV---ETRKVTF--KSDVYSFGVLLLELLTGKAP 542
+ APEV+ E ++ +SDV+S G+ +EL GK P
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKRE---FEMQME--VLGKIKHDNVVPL 406
E +GKGS G YKA+ ++ T VV +K + + + E ++Q E L + + +
Sbjct: 7 ECIGKGSFGEVYKAI-DKRTNQVVA-IKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK- 63
Query: 407 RAFYYS---KDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
YY K KL ++ +Y GS LL LD I GL +L
Sbjct: 64 ---YYGSFLKGSKLWIIMEYCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYL 114
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---------TPPTRVAGYRAPE 513
H GKI H +IKA+NILL + D ++DFG++ +T TP + APE
Sbjct: 115 HEEGKI-HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTP-----FWMAPE 168
Query: 514 VVETRKVTFKSDVYSFGVLLLELLTGKAPNQ 544
V++ K+D++S G+ +EL G+ P
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPPLS 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 65/203 (32%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 353 VLGKGSVGTSYKA-VLEEGTTVVVKRLKEVAVGKREFEM----QMEVLGKIKHDNVVPLR 407
VLGKG G V G K+L++ + KR+ E + ++L K+ VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR---GLAHLHV 464
Y +KD LV M G L ++ +G R AA GL LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF------EEGRAVFYAAEICCGLEDLHQ 120
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLN-PLFGNTTPPTRVA--GYRAPEVVETRKVT 521
+IV+ ++K NILL +SD GL + T RV GY APEVV+ + T
Sbjct: 121 E-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 179
Query: 522 FKSDVYSFGVLLLELLTGKAPNQ 544
F D ++ G LL E++ G++P Q
Sbjct: 180 FSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 53/194 (27%), Positives = 96/194 (49%), Gaps = 12/194 (6%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNVVPLRAF 409
E+LGKG+ G +K L++ T V VK KE K +F + +L + H N+V L
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
+ +V + +P G + L + +T ++ AL AA G+A+L S +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKT----KQLVKFALDAAAGMAYLE-SKNCI 115
Query: 470 HGNIKASNILLRPDHDACVSDFGL-----NPLFGNTTPPTRVAGYRAPEVVETRKVTFKS 524
H ++ A N L+ ++ +SDFG+ + ++ ++ + APE + + + +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 525 DVYSFGVLLLELLT 538
DV+S+G+LL E +
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 51/195 (26%), Positives = 97/195 (49%), Gaps = 13/195 (6%)
Query: 354 LGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEM-QMEVLGKIKHDNVVPLRAFYY 411
+G+GS G A + G V VK++ +RE ++ ++ H+NVV + Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
DE +V +++ G+L+ ++ +R ++ + + LS R L++LH G ++H
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLSVLRALSYLHNQG-VIHR 142
Query: 472 NIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR----VAGYRAPEVVETRKVTFKSDVY 527
+IK+ +ILL D +SDFG P + + APEV+ + D++
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 528 SFGVLLLELLTGKAP 542
S G++++E++ G+ P
Sbjct: 203 SLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 352 EVLGKGSVGTSYKAVLE----EGTTVVVKRLKE--VAVGKREFEMQMEVLGKIKHDNVVP 405
EV+G G G + L+ V +K LK +R+F + ++G+ H N++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
L +++ ++M G+L + L + G T + +R + + L+ ++
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ-FTVIQLVGMLRGIAAGMKYLSEMNY- 127
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLNP-LFGNTTPPTRVAG--------YRAPEVVE 516
VH ++ A NIL+ + VSDFGL+ L +T+ PT + + APE +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 517 TRKVTFKSDVYSFGVLLLELLT-GKAP 542
RK T SDV+S+G+++ E+++ G+ P
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 64/204 (31%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 353 VLGKGSVGTSYKA-VLEEGTTVVVKRLKEVAVGKREFEM----QMEVLGKIKHDNVVPLR 407
VLGKG G V G K+L++ + KR+ E + ++L K+ VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR---GLAHLHV 464
Y +KD LV M G L ++ G + R AA GL LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF------DEERAVFYAAEITCGLEDLH- 119
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLN-PLFGNTTPPTRVA--GYRAPEVVETRKVT 521
+IV+ ++K NILL +SD GL + T RV GY APEVV+ + T
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYT 179
Query: 522 FKSDVYSFGVLLLELLTGKAPNQA 545
F D + G L+ E++ GK+P +
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 74/297 (24%), Positives = 129/297 (43%), Gaps = 55/297 (18%)
Query: 354 LGKGSVGTSYKA------VLEEGTTVVVKRLKEVAVGKR-EFEMQMEVLGKIKHDNVVPL 406
LG+G+ G + A ++ V VK LK+ + R +F+ + E+L ++H+++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALL--HGSRG---------SGRTPLDWDNRMRIALSA 455
D ++V++YM G L+ L HG + L + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 456 ARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP---------LFGNTTPPTRV 506
A G+ +L S VH ++ N L+ + + DFG++ + G+T P R
Sbjct: 133 ASGMVYL-ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR- 190
Query: 507 AGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREE 565
+ PE + RK T +SDV+SFGV+L E+ T GK P W Q
Sbjct: 191 --WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--------------WFQLS---- 230
Query: 566 WTAEVFDVELMRYHNIEEEMV---QLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619
EV + + + +E V ++ I +GC P QR ++E+ +++ + +
Sbjct: 231 -NTEVIEC-ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 8e-14
Identities = 56/203 (27%), Positives = 85/203 (41%), Gaps = 18/203 (8%)
Query: 354 LGKGSVGTSYKA-VLEEGTTVVVKRLKEVAVGKREFE----MQMEVLGKIKHDNVVPLRA 408
LGKG G V G K+L + + KR+ E + ++L K+ +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 409 FYYSKDEKLLVYDYMPAGSLSALL--HGSRGSGRTPLDWDNRMRI-ALSAARGLAHLHVS 465
+ +KD+ LV M G L + G G + R A GL HLH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP------EARAIFYAAQIICGLEHLHQR 114
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKVTF 522
IV+ ++K N+LL + +SD GL AG Y APEV++ F
Sbjct: 115 R-IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 523 KSDVYSFGVLLLELLTGKAPNQA 545
D ++ G L E++ G++P +
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 61/269 (22%), Positives = 122/269 (45%), Gaps = 35/269 (13%)
Query: 353 VLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKRE---FEMQMEVLGKIKHDNVVPLRA 408
V+G+G+ G + + V++K++ + K E + + +VL + H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGS---GRTPLDWDNRMRIALSAARGLAHLHVS 465
+ ++V +Y P G+L+ + S T L + ++ +AL H+H +
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH------HVH-T 119
Query: 466 GKIVHGNIKASNILL-RPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKVT 521
I+H ++K NILL + + DFG++ + + + V G Y +PE+ E +
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 522 FKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581
KSD+++ G +L EL + K E +LP V ++ + A + D RY
Sbjct: 180 QKSDIWALGCVLYELASLKR------AFEAANLPALVLKIMSGTF-APISD----RYSP- 227
Query: 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVV 610
L Q+ + ++ P +RP + +++
Sbjct: 228 -----DLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFE-MQMEVLGKIKHDNVVPLRAF- 409
E +GKGS G YK + VV ++ ++ + E E +Q E+ + D+ R +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 410 YYSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
Y K KL ++ +Y+ GS LL PL+ I +GL +LH KI
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPG------PLEETYIATILREILKGLDYLHSERKI 123
Query: 469 VHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV----AGYRAPEVVETRKVTFKS 524
H +IKA+N+LL D ++DFG+ +T + APEV++ FK+
Sbjct: 124 -HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 525 DVYSFGVLLLELLTGKAPN 543
D++S G+ +EL G+ PN
Sbjct: 183 DIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 354 LGKGSVGT----SYKAVLEE-GTTVVVKRLKE-VAVGKREFEMQMEVLGKIKHDNVVPLR 407
LGKG+ G+ Y + + G V VK+L+ A R+FE ++E+L ++HDN+V +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 408 AFYYS--KDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
YS + LV +Y+P GSL L R LD + A +G+ +L S
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER----LDHRKLLLYASQICKGMEYLG-S 126
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-------YRAPEVVETR 518
+ VH ++ NIL+ ++ + DFGL + +V + APE +
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 519 KVTFKSDVYSFGVLLLELLT 538
K + SDV+SFGV+L EL T
Sbjct: 187 KFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEM-QMEV--LGKIKHDNVVPLR 407
+ +G+GS G Y A + + V+K + + +E E + EV L K+KH N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRG---SGRTPLDWDNRMRIALSAARGLAHLHV 464
A + +V +Y G L ++ RG S L W ++I+L GL H+H
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISL----GLKHIH- 118
Query: 465 SGKIVHGNIKASNILLRPDHD-ACVSDFGLNPLFGNTTPPTRV-AG---YRAPEVVETRK 519
KI+H +IK+ NI L + A + DFG+ ++ G Y +PE+ + R
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP 178
Query: 520 VTFKSDVYSFGVLLLELLTGKAP 542
K+D++S G +L EL T K P
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 72/267 (26%), Positives = 106/267 (39%), Gaps = 32/267 (11%)
Query: 353 VLGKGSVGTSYKA-VLEEGTTVVVKRLKEVAVGKREFEM----QMEVLGKIKHDNVVPLR 407
VLGKG G V G KRL++ + KR+ E + ++L K+ VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR---GLAHLHV 464
Y +KD LV M G L ++ G R AA GL LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF------EEERALFYAAEILCGLEDLHR 120
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLN---PLFGNTTPPTRVAGYRAPEVVETRKVT 521
V+ ++K NILL +SD GL P + GY APEV+ ++ T
Sbjct: 121 EN-TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYT 179
Query: 522 FKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581
D + G L+ E++ G++P + + V REE V + E +
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGR-----------KEKVKREEVDRRVLETEEVYSAKF 228
Query: 582 EEEMVQLLQIAMGCVSTVPDQRPAMQE 608
EE + ++ + + P QR QE
Sbjct: 229 SEEAKSICKMLL---TKDPKQRLGCQE 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM-QMEVLGKIKHDNVVPLRAF 409
E +G+G+ GT Y A+ + G V +K++ K+E + ++ V+ + KH N+V
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
Y DE +V +Y+ GSL+ ++ T +D + + L LH S +++
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLH-SNQVI 137
Query: 470 HGNIKASNILLRPDHDACVSDFG----LNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSD 525
H +IK+ NILL D ++DFG + P + + APEVV + K D
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 526 VYSFGVLLLELLTGKAP 542
++S G++ +E++ G+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 78/293 (26%), Positives = 123/293 (41%), Gaps = 49/293 (16%)
Query: 352 EVLGKGSVGTSYKAVL--------EEGTTVVVKRLK-EVAVGKRE-FEMQMEVLGKIKHD 401
VLG+G G K L G V VK LK E ++ ++ +L + H+
Sbjct: 10 RVLGEGHFG---KVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66
Query: 402 NVVPLRAFYYSKDEK--LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGL 459
N+V + + K L+ +Y+P GSL L + L+ + A G+
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL------PKHKLNLAQLLLFAQQICEGM 120
Query: 460 AHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR--------- 510
A+LH S +H ++ A N+LL D + DFGL P YR
Sbjct: 121 AYLH-SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-----PEGHEYYRVREDGDSPV 174
Query: 511 ---APEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLG--EEGIDLPRWVQSVVREE 565
A E ++ K ++ SDV+SFGV L ELLT Q+ EE I + +VVR
Sbjct: 175 FWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR-- 232
Query: 566 WTAEVFD--VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
E+ + + L N +E+ L++ C T RP + ++ +++ M
Sbjct: 233 -LIELLERGMRLPCPKNCPQEVYILMK---NCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 66/274 (24%), Positives = 128/274 (46%), Gaps = 27/274 (9%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRLKEV----AVGKREFEMQMEVLGKIKHDNVVPLRA 408
+G+G Y+A L +G V +K+++ A + + ++++L ++ H NV+ A
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 409 FYYSKDEKLLVYDYMPAGSLSALL-HGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
+ +E +V + AG LS ++ H + P + + L +A L H+H S +
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LEHMH-SRR 126
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFGN-TTPPTRVAG---YRAPEVVETRKVTFK 523
++H +IK +N+ + + D GL F + TT + G Y +PE + FK
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 524 SDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583
SD++S G LL E+ A Q+ + ++L + + E D + + E
Sbjct: 187 SDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKI-------EQCDYPPLPSDHYSE 235
Query: 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617
E+ QL+ + C++ P++RP + V + + M+
Sbjct: 236 ELRQLVNM---CINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 52/173 (30%), Positives = 77/173 (44%), Gaps = 24/173 (13%)
Query: 393 EVLGKIKHDNVVPLRAFYYS--KDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRM 449
++L + + VV YYS + L LV +Y+P G L++LL + GS LD D
Sbjct: 45 DILSQAQSPYVV---KLYYSFQGKKNLYLVMEYLPGGDLASLLE-NVGS----LDEDVAR 96
Query: 450 RIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---------NPLFGNT 500
L +LH S I+H ++K NIL+ + ++DFGL L +
Sbjct: 97 IYIAEIVLALEYLH-SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155
Query: 501 TPPTRVAG---YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEE 550
R+ G Y APEV+ + + D +S G +L E L G P EE
Sbjct: 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 65/273 (23%), Positives = 109/273 (39%), Gaps = 39/273 (14%)
Query: 354 LGKGSVGTSYKAVL-------EEGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNVV 404
LG G+ G Y+ V VK L++ A K+EF + ++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTP--LDWDNRMRIALSAARGLAHL 462
L + + ++ + M G L + L +R P L + I L A+G +L
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 463 HVSGKIVHGNIKASNILLRPDHDAC-----VSDFGL-NPLFGNTTPPTRVAG-----YRA 511
+H ++ A N L+ + DFGL ++ + G + A
Sbjct: 123 E-QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181
Query: 512 PEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571
PE + K T +SDV+SFGVL+ E+LT Q ++ + V + R
Sbjct: 182 PESLLDGKFTTQSDVWSFGVLMWEILT--LGQQPYPALNNQEVLQHVTAGGR-------- 231
Query: 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRP 604
L + N +++ QL+ C + P +RP
Sbjct: 232 ---LQKPENCPDKIYQLMTN---CWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 45/146 (30%), Positives = 75/146 (51%), Gaps = 15/146 (10%)
Query: 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
+YS E + ++M GSL +L + +GR P + ++ IA+ RGL +L KI+
Sbjct: 68 FYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAV--LRGLTYLREKHKIM 122
Query: 470 HGNIKASNILLRPDHDACVSDFG----LNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSD 525
H ++K SNIL+ + + DFG L N+ TR Y +PE ++ T +SD
Sbjct: 123 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR--SYMSPERLQGTHYTVQSD 180
Query: 526 VYSFGVLLLELLTGK----APNQASL 547
++S G+ L+E+ G+ P+ L
Sbjct: 181 IWSLGLSLVEMAIGRYPIPPPDAKEL 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 352 EVLGKGSVGTSYKAVLE----EGTTVVVKRLKEVAVGKR--EFEMQMEVLGKIKHDNVVP 405
+V+G G G ++ +L+ + V +K LK K+ +F + ++G+ H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
L +++ +YM G+L L G + +R + + L+ ++
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQLVGMLRGIAAGMKYLSDMNY- 128
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-------YRAPEVVETR 518
VH ++ A NIL+ + + VSDFGL+ + + T + APE + R
Sbjct: 129 ---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 519 KVTFKSDVYSFGVLLLELLT-GKAP 542
K T SDV+SFG+++ E+++ G+ P
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 36/216 (16%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEM--------------QMEVLGK 397
E++GKG+ G Y A+ TT + +K+V + ++E L
Sbjct: 7 ELIGKGTYGRVYLAL--NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 398 IKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAA- 456
+ H N+V F +++ + +Y+P GS+ + L RT ++ ++ +
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-------RTYGRFEEQLVRFFTEQV 117
Query: 457 -RGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP----LFGNTTPPTRVAG--- 508
GLA+LH G I+H ++KA N+L+ D +SDFG++ ++ N + G
Sbjct: 118 LEGLAYLHSKG-ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ-NMSMQGSVF 175
Query: 509 YRAPEVVETRKVTF--KSDVYSFGVLLLELLTGKAP 542
+ APEV+ + + K D++S G ++LE+ G+ P
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 352 EVLGKGSVGTSYKA-VLEEGTTVVVKRLKEV---AVGKREFEMQMEVLGKIKHDNVVPLR 407
V+G+G+ G K G V +K+ KE K+ +++VL +++H+N+V L+
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
+ K LV++Y+ +L LL S G L D + +A+ H S
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGG----LPPDAVRSYIWQLLQAIAYCH-SHN 120
Query: 468 IVHGNIKASNILLRPDHDACVSDFGL-NPLFGNTTPP------TRVAGYRAPEV-VETRK 519
I+H +IK NIL+ + DFG L P TR YRAPE+ V
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR--WYRAPELLVGDTN 178
Query: 520 VTFKSDVYSFGVLLLELLTGKA 541
DV++ G ++ ELL G+
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 7e-13
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 353 VLGKGSVGTSYKAV-LEEGTTVVVKRL----KEVAVGKREF-EMQMEVLGKIKHDNVVPL 406
+G G+ G AV G V +K++ ++ KR E+++ L ++H+N++ L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKL--LRHLRHENIIGL 64
Query: 407 RAFYYSKD----EKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
+ +V + M L ++ S + PL D+ RGL +
Sbjct: 65 LDILRPPSPEDFNDVYIVTELMET-DLHKVIK----SPQ-PLTDDHIQYFLYQILRGLKY 118
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGL----NPLFGNTTPPTR-VAG--YRAPEV 514
LH S ++H ++K SNIL+ + D + DFGL +P T V YRAPE+
Sbjct: 119 LH-SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPEL 177
Query: 515 V-ETRKVTFKSDVYSFGVLLLELLTGKA 541
+ + + T D++S G + ELLT K
Sbjct: 178 LLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 53/270 (19%), Positives = 112/270 (41%), Gaps = 47/270 (17%)
Query: 363 YKAVLEEGTTVVVKRLKEVAVGK----REFEMQMEVLGKIKHDNVVPLRAFYYSKDEKL- 417
YK + V+++ K+ G E +++ L +I +N++ + F + L
Sbjct: 37 YKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 418 ---LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIK 474
L+ +Y G L +L + L + ++ +A+ +GL +L+ + N+
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150
Query: 475 ASNILLRPDHDACVSDFGLNPLFGNTTPPTR---VAGYRAPEVVET--RKVTFKSDVYSF 529
+ + L+ ++ + GL + + PP + Y + +++ + T K D+YS
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSS--PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSL 208
Query: 530 GVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM---- 585
GV+L E+ TGK P E + T E++D L+ N ++
Sbjct: 209 GVVLWEIFTGKIPF------ENLT-------------TKEIYD--LIINKNNSLKLPLDC 247
Query: 586 VQLLQ-IAMGCVSTVPDQRPAMQEVVRMIE 614
++ I C S +RP ++E++ +
Sbjct: 248 PLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 77/272 (28%), Positives = 116/272 (42%), Gaps = 48/272 (17%)
Query: 371 TTVVVKRLKEVAVGK------REFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424
TV VK LK+ A K E EM M+++GK H N++ L ++ +Y
Sbjct: 45 VTVAVKMLKDDATDKDLSDLVSEMEM-MKMIGK--HKNIINLLGACTQDGPLYVLVEYAS 101
Query: 425 AGSLSALLHGSRGSG--------RTP---LDWDNRMRIALSAARGLAHLHVSGKIVHGNI 473
G+L L R G + P L + + + A ARG+ +L S K +H ++
Sbjct: 102 KGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL-ASQKCIHRDL 160
Query: 474 KASNILLRPDHDACVSDFGLN------PLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVY 527
A N+L+ D+ ++DFGL + TT + APE + R T +SDV+
Sbjct: 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 220
Query: 528 SFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMV 586
SFGVLL E+ T G +P EE L + E R
Sbjct: 221 SFGVLLWEIFTLGGSPYPGIPVEELFKLLK-----------------EGHRMDKPANCTH 263
Query: 587 QLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
+L I C VP QRP +++V E+++R
Sbjct: 264 ELYMIMRECWHAVPSQRPTFKQLV---EDLDR 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 8e-13
Identities = 54/197 (27%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM-QMEVLGKIKHDNVVPLRAF 409
E +G+G+ GT Y A+ + G V +K++ K+E + ++ V+ + K+ N+V
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
Y DE +V +Y+ GSL+ ++ T +D + + L LH S +++
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALDFLH-SNQVI 137
Query: 470 HGNIKASNILLRPDHDACVSDFG----LNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSD 525
H +IK+ NILL D ++DFG + P + + APEVV + K D
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 526 VYSFGVLLLELLTGKAP 542
++S G++ +E++ G+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 55/223 (24%), Positives = 88/223 (39%), Gaps = 42/223 (18%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM---------------QMEVLGK 397
LG+G+ G KA G V +K++K + + + +++++ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 398 IKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR 457
IKH+N++ L Y D LV D M A L ++ + L I L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV-----DRKIRLTESQVKCILLQILN 130
Query: 458 GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----------------- 500
GL LH +H ++ +NI + ++DFGL +G
Sbjct: 131 GLNVLHKW-YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 501 -TPPTRVAGYRAPEVV-ETRKVTFKSDVYSFGVLLLELLTGKA 541
T YRAPE++ K F D++S G + ELLTGK
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 53/197 (26%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM-QMEVLGKIKHDNVVPLRAF 409
E +G+G+ GT Y A+ + G V ++++ K+E + ++ V+ + K+ N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
Y DE +V +Y+ GSL+ ++ T +D + + L LH S +++
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLH-SNQVI 138
Query: 470 HGNIKASNILLRPDHDACVSDFG----LNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSD 525
H +IK+ NILL D ++DFG + P + + APEVV + K D
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 526 VYSFGVLLLELLTGKAP 542
++S G++ +E++ G+ P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 23/202 (11%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTV----VVKRLKEVAVGKREFEMQME--VLGKIKHDNVV 404
+VLG G+ GT YK + + EG TV +K L E K E E ++ + H ++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGS--GRTPLDWDNRMRIALSAARGLAHL 462
L S +L V MP G L +H + + + L+W + A+G+ +L
Sbjct: 73 RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 125
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYRAP------EVVE 516
++VH ++ A N+L++ + ++DFGL L G + P E +
Sbjct: 126 E-ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 517 TRKVTFKSDVYSFGVLLLELLT 538
RK T +SDV+S+GV + EL+T
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 342 DLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFE-MQMEVLGKIKH 400
D E+L E +GKGS G +K + VV ++ ++ + E E +Q E+ +
Sbjct: 1 DPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 401 DNVVPLRAFYYS---KDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAA 456
D+ P YY KD KL ++ +Y+ GS LL PLD I
Sbjct: 60 DS--PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREIL 111
Query: 457 RGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR----VAGYRAP 512
+GL +LH S K +H +IKA+N+LL + ++DFG+ +T + AP
Sbjct: 112 KGLDYLH-SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 513 EVVETRKVTFKSDVYSFGVLLLELLTGKAPN 543
EV++ K+D++S G+ +EL G+ P+
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPH 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 27/211 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
EV+G G+ G YK ++ G +K + + E ++++ +L K H + A Y
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNI---ATY 78
Query: 411 Y----------SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLA 460
Y D+ LV ++ AGS++ L+ ++G+ L D I RGLA
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA---LKEDWIAYICREILRGLA 135
Query: 461 HLHVSGKIVHGNIKASNILLRPDHDACVSDFG----LNPLFGNTTPPTRVAGYRAPEVV- 515
HLH K++H +IK N+LL + + + DFG L+ G + APEV+
Sbjct: 136 HLHAH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194
Query: 516 --ETRKVT--FKSDVYSFGVLLLELLTGKAP 542
E T ++SD++S G+ +E+ G P
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 48/210 (22%), Positives = 84/210 (40%), Gaps = 25/210 (11%)
Query: 353 VLGKGS----VGTSYKAVLEEGTTVVVKRLK-EVAVGKREFEMQMEVL--GKIKHDNVVP 405
++GK + K T V VK++ + + +Q E++ +++H N++P
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
+ E +V M GS LL G L ++ L+A L ++H
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNA---LDYIHSK 120
Query: 466 GKIVHGNIKASNILLRPDHDACVS-----------DFGLNPLFGNTTPPTRVAGYRAPEV 514
G +H ++KAS+ILL D +S + + + +PEV
Sbjct: 121 G-FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 515 VET--RKVTFKSDVYSFGVLLLELLTGKAP 542
++ + KSD+YS G+ EL G P
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 48/195 (24%), Positives = 98/195 (50%), Gaps = 13/195 (6%)
Query: 354 LGKGSVGTSYKA-VLEEGTTVVVKRLKEVAVGKREFEM-QMEVLGKIKHDNVVPLRAFYY 411
+G+GS G A G V VK++ +RE ++ ++ +H N+V + + Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
DE +V +++ G+L+ ++ +R ++ + + L+ + L+ LH + ++H
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLAVLKALSFLH-AQGVIHR 139
Query: 472 NIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR-VAG---YRAPEVVETRKVTFKSDVY 527
+IK+ +ILL D +SDFG P + + G + APEV+ + D++
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIW 199
Query: 528 SFGVLLLELLTGKAP 542
S G++++E++ G+ P
Sbjct: 200 SLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 61/234 (26%), Positives = 94/234 (40%), Gaps = 38/234 (16%)
Query: 356 KGSVGTSYKA------------VLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNV 403
KG+ G+ Y A VL++ + ++ V + +Q E V
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE------SPYV 59
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
L + SKD LV +Y+ G ++L+ + G P DW + IA G+ LH
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDW-AKQYIA-EVVLGVEDLH 114
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKV 520
G I+H +IK N+L+ ++DFGL+ N + G Y APE +
Sbjct: 115 QRG-IIHRDIKPENLLIDQTGHLKLTDFGLSR---NGLENKKFVGTPDYLAPETILGVGD 170
Query: 521 TFKSDVYSFGVLLLELLTGKAPNQASLGEEGID--LPRWVQSVVREEWTAEVFD 572
SD +S G ++ E L G P A + D L R + W EV +
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN------WPEEVKE 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRL----KEVAVGKREFE-MQMEV--LGKIKHDNVV 404
EVLGKG+ GT Y + +G + VK++ V ++E+E +Q EV L +KH N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
+ + +++P GS+S++L+ PL + G+A+LH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLH- 119
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFG---------LNPLFGNTTPPTRVAGY-RAPEV 514
+ +VH +IK +N++L P+ + DFG L+ N Y APEV
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 515 VETRKVTFKSDVYSFGVLLLELLTGKAP 542
+ KSD++S G + E+ TGK P
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLK------EVAVGKREFEMQMEVLGKIKHDNVV 404
E++G+G+ G Y+ + G V +K + +V+ +RE + +L +++
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQRE----VALLSQLRQSQPP 62
Query: 405 PLRAFY--YSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
+ +Y Y K +L ++ +Y GS+ L+ P+ I L +
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKY 116
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG-NTTPPTRVAG---YRAPEVV-E 516
+H G ++H +IKA+NIL+ + + DFG+ L N++ + G + APEV+ E
Sbjct: 117 IHKVG-VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE 175
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKAP 542
+ K+D++S G+ + E+ TG P
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAF 409
E +GKG+ G YK ++G+ VK L ++ E E + +L + H NVV
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 410 YYSKDEKL-----LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
+Y D+ + LV + GS++ L+ G G+ LD I A GL HLH
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-LDEAMISYILYGALLGLQHLH- 145
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNP------LFGNTTPPTRVAGYRAPEVVETR 518
+ +I+H ++K +NILL + + DFG++ L NT+ T + APEV+
Sbjct: 146 NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF--WMAPEVIACE 203
Query: 519 K-----VTFKSDVYSFGVLLLELLTGKAP 542
+ + DV+S G+ +EL G P
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 342 DLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFE---MQMEVLGKI 398
D E+L E +GKGS G +K + VV ++ ++ + E E ++ VL +
Sbjct: 1 DPEELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 399 KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARG 458
V Y + ++ +Y+ GS LL P D + +G
Sbjct: 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILKG 113
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV----AGYRAPEV 514
L +LH S K +H +IKA+N+LL D ++DFG+ +T + APEV
Sbjct: 114 LDYLH-SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 515 VETRKVTFKSDVYSFGVLLLELLTGKAPN 543
++ K+D++S G+ +EL G+ PN
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 75/285 (26%), Positives = 117/285 (41%), Gaps = 44/285 (15%)
Query: 354 LGKGSVGTSYKAVL------EEGTTVVVKRLKEVAVGKR--EFEMQMEVLGKIKHDNVVP 405
LG+GS G Y+ E T V VK + E A + EF + V+ +VV
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSR-----GSGRTPLDWDNRMRIALSAARGLA 460
L L+V + M G L + L R GR P +++A A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 461 HLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF---------GNTTPPTRVAGYRA 511
+L+ K VH ++ A N ++ D + DFG+ G P R + A
Sbjct: 134 YLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WMA 189
Query: 512 PEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571
PE ++ T SD++SFGV+L E+ SL E+ Q + E+ V
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEI--------TSLAEQP------YQGLSNEQVLKFVM 235
Query: 572 D-VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615
D L + N E + L+++ C P RP E+V ++++
Sbjct: 236 DGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 69/271 (25%), Positives = 120/271 (44%), Gaps = 45/271 (16%)
Query: 368 EEGTTVVVKRLKEVAVGK------REFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421
++ TV VK LK+ A K E E+ M+++GK H N++ L + ++ +
Sbjct: 42 DQTVTVAVKMLKDNATDKDLADLISEMEL-MKLIGK--HKNIINLLGVCTQEGPLYVIVE 98
Query: 422 YMPAGSLSALLHGSRGSG-----------RTPLDWDNRMRIALSAARGLAHLHVSGKIVH 470
Y G+L L R G L + + + A ARG+ +L S + +H
Sbjct: 99 YAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE-SRRCIH 157
Query: 471 GNIKASNILLRPDHDACVSDFGLN------PLFGNTTPPTRVAGYRAPEVVETRKVTFKS 524
++ A N+L+ D+ ++DFGL + T+ + APE + R T +S
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS 217
Query: 525 DVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583
DV+SFG+L+ E+ T G +P EE + ++RE + + N
Sbjct: 218 DVWSFGILMWEIFTLGGSPYPGIPVEE-------LFKLLREGHRMD-------KPSNCTH 263
Query: 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614
E+ L++ C VP QRP +++V ++
Sbjct: 264 ELYMLMR---ECWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 75/272 (27%), Positives = 118/272 (43%), Gaps = 48/272 (17%)
Query: 371 TTVVVKRLKEVAVGK------REFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424
T V VK LK A K E EM M+++GK H N++ L ++ +Y
Sbjct: 51 TKVAVKMLKSDATEKDLSDLISEMEM-MKMIGK--HKNIINLLGACTQDGPLYVIVEYAS 107
Query: 425 AGSLSALLHGSRGSG--------RTP---LDWDNRMRIALSAARGLAHLHVSGKIVHGNI 473
G+L L R G + P L + + + A ARG+ +L S K +H ++
Sbjct: 108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL-ASKKCIHRDL 166
Query: 474 KASNILLRPDHDACVSDFGLN------PLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVY 527
A N+L+ D+ ++DFGL + TT + APE + R T +SDV+
Sbjct: 167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 226
Query: 528 SFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMV 586
SFGVLL E+ T G +P EE L + + + N E+
Sbjct: 227 SFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS--------------NCTNELY 272
Query: 587 QLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
+++ C VP QRP +++V E+++R
Sbjct: 273 MMMR---DCWHAVPSQRPTFKQLV---EDLDR 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 36/212 (16%)
Query: 354 LGKGSVGTSYKA-VLEEGTTVVVKRLKEVAVGKREFEMQM----EVLGKIKHDNVVPLRA 408
LG G G V + T +K +K+ + + + + E+L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 409 FYYSKDEKLLVY---DYMPAGSLSALLHGSRGSGRTPLD-WDNRMRIALSAARGLAHLHV 464
+ KD+K +Y +Y G L +L RG D + R IA +LH
Sbjct: 61 TF--KDKKY-IYMLMEYCLGGELWTILR-DRGL----FDEYTARFYIA-CVVLAFEYLHN 111
Query: 465 SGKIVHGNIKASNILLRPDHDACVS--DFGLNPLFGNT--------TPPTRVAGYRAPEV 514
G I++ ++K N+LL D + V DFG + TP Y APE+
Sbjct: 112 RG-IIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTP-----EYVAPEI 163
Query: 515 VETRKVTFKSDVYSFGVLLLELLTGKAPNQAS 546
+ + F D +S G+LL ELLTG+ P
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 6e-12
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHD-NVVPLRAF 409
E++G G+ G YK ++ G +K + + E + ++ +L K H N+
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 410 YYSK------DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
+ K D+ LV ++ AGS++ L+ ++G+ L + I RGL+HLH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---TLKEEWIAYICREILRGLSHLH 128
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFG----LNPLFGNTTPPTRVAGYRAPEVV---E 516
K++H +IK N+LL + + + DFG L+ G + APEV+ E
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 517 TRKVT--FKSDVYSFGVLLLELLTGKAP 542
T FKSD++S G+ +E+ G P
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 48/275 (17%)
Query: 368 EEGTTVVVKRLKEVAVGK------REFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421
+E TV VK LK+ A K E EM M+++GK H N++ L ++ +
Sbjct: 45 KEAVTVAVKMLKDDATEKDLSDLVSEMEM-MKMIGK--HKNIINLLGACTQDGPLYVIVE 101
Query: 422 YMPAGSLSALLHGSRGSG-----------RTPLDWDNRMRIALSAARGLAHLHVSGKIVH 470
Y G+L L R G + + + + ARG+ +L S K +H
Sbjct: 102 YASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL-ASQKCIH 160
Query: 471 GNIKASNILLRPDHDACVSDFGLNPLFGN------TTPPTRVAGYRAPEVVETRKVTFKS 524
++ A N+L+ ++ ++DFGL N TT + APE + R T +S
Sbjct: 161 RDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 220
Query: 525 DVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583
DV+SFGVL+ E+ T G +P EE L + ++ R + A N
Sbjct: 221 DVWSFGVLMWEIFTLGGSPYPGIPVEE---LFKLLKEGHRMDKPA-----------NCTN 266
Query: 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
E+ +++ C +P RP +++V E+++R
Sbjct: 267 ELYMMMR---DCWHAIPSHRPTFKQLV---EDLDR 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFE-----MQMEVLGKIKHDNVVPLRA 408
LGKG+ G+ YK VL T V + +KE+ + E + M++++L K +V
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMA-MKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
++ + + +YM AGSL L G + P D RI + +GL L I
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIP--EDVLRRITYAVVKGLKFLKEEHNI 124
Query: 469 VHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA--GYRAPEVVETRKV------ 520
+H ++K +N+L+ + + DFG++ + T + Y APE +++
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTY 184
Query: 521 TFKSDVYSFGVLLLELLTGKAP 542
T +SDV+S G+ +LE+ G+ P
Sbjct: 185 TVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 7e-12
Identities = 50/197 (25%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM-QMEVLGKIKHDNVVPLRAF 409
E +G+G+ GT + A+ + G V +K++ K+E + ++ V+ ++K+ N+V
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
+ DE +V +Y+ GSL+ ++ T +D + + L LH + +++
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCRECLQALEFLH-ANQVI 137
Query: 470 HGNIKASNILLRPDHDACVSDFG----LNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSD 525
H +IK+ N+LL D ++DFG + P + + APEVV + K D
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 526 VYSFGVLLLELLTGKAP 542
++S G++ +E++ G+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 48/195 (24%), Positives = 98/195 (50%), Gaps = 13/195 (6%)
Query: 354 LGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEM-QMEVLGKIKHDNVVPLRAFYY 411
+G+GS G A ++ G V VK++ +RE ++ ++ +H+NVV + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
DE +V +++ G+L+ ++ +R ++ + + L+ + L+ LH G ++H
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLKALSVLHAQG-VIHR 140
Query: 472 NIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR----VAGYRAPEVVETRKVTFKSDVY 527
+IK+ +ILL D +SDFG P + + APE++ + D++
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 528 SFGVLLLELLTGKAP 542
S G++++E++ G+ P
Sbjct: 201 SLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 352 EVLGKGSVGTSY--KAVL--EEGTTVVVKRLKEVAVGKRE---FEMQMEVLGKIKHDNVV 404
+VLG+GS G + + + + G +K LK+ + R+ +M+ ++L ++ H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
L + ++ + L+ D++ G L L S+ T + D + +A A L HLH
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFT--EEDVKFYLA-ELALALDHLHS 116
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR----VAGYRAPEVVETRKV 520
G I++ ++K NILL + ++DFGL+ + Y APEVV R
Sbjct: 117 LG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 175
Query: 521 TFKSDVYSFGVLLLELLTGKAPNQ 544
T +D +SFGVL+ E+LTG P Q
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 66/267 (24%), Positives = 111/267 (41%), Gaps = 28/267 (10%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK 413
LG G G V +K +KE ++ + EF + +V+ K+ H+ +V L +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 414 DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNI 473
+V +YM G L L + + G+A+L S + +H ++
Sbjct: 72 RPIYIVTEYMSNGCLLNYLR----EHGKRFQPSQLLEMCKDVCEGMAYLE-SKQFIHRDL 126
Query: 474 KASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-----YRAPEVVETRKVTFKSDVYS 528
A N L+ VSDFGL+ + + V + PEV+ K + KSDV++
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186
Query: 529 FGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQ 587
FGVL+ E+ + GK P + E ++ V +R L R H E +
Sbjct: 187 FGVLMWEVYSLGKMPYERFNNSETVEK---VSQGLR-----------LYRPHLASE---K 229
Query: 588 LLQIAMGCVSTVPDQRPAMQEVVRMIE 614
+ I C ++RP Q+++ IE
Sbjct: 230 VYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 64/258 (24%), Positives = 109/258 (42%), Gaps = 46/258 (17%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNV 403
E LG+ G YK L E+ V +K LK+ A G + EF+ + + +++H N+
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALL-----HGSRGSG------RTPLDWDNRMRIA 452
V L + +++ Y L L H GS ++ L+ + + I
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 453 LSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---------NPLFGNTTPP 503
A G+ L S +VH ++ N+L+ + +SD GL L GN+ P
Sbjct: 131 TQIAAGMEFLS-SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGI---------- 552
R + +PE + K + SD++S+GV+L E+ + G P ++ I
Sbjct: 190 IR---WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP 246
Query: 553 ---DLPRWVQSVVREEWT 567
D P WV +++ E W
Sbjct: 247 CPDDCPAWVYTLMLECWN 264
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFE---MQMEVLGKIKHDNVVPLRAFY 410
LG G+ G YKA +E + ++ E + E E +++E+L H +V L +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 411 YSKDEKLLVYDYMPAGSLSA-LLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
Y + ++ ++ P G++ A +L RG L I L +LH S KI+
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRG-----LTEPQIQVICRQMLEALQYLH-SMKII 132
Query: 470 HGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGY------RAPEVV--ETRKVT 521
H ++KA N+LL D D ++DFG++ N R + APEVV ET K T
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 522 ---FKSDVYSFGVLLLELLTGKAPNQ 544
+K+D++S G+ L+E+ + P+
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHH 216
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 61/198 (30%), Positives = 86/198 (43%), Gaps = 12/198 (6%)
Query: 353 VLGKGSVGTSYKA-VLEEGTTVVVKRLKEVAVGKREFEM----QMEVLGKIKHDNVVPLR 407
VLGKG G V G K+L++ + KR+ E + +L K+ VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
Y +KD LV M G L ++ G D + A GL L +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG---FDEQRAIFYAAELCCGLEDLQRE-R 122
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLN-PLFGNTTPPTRVA--GYRAPEVVETRKVTFKS 524
IV+ ++K NILL +SD GL + T RV GY APEV+ K TF
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSP 182
Query: 525 DVYSFGVLLLELLTGKAP 542
D + G L+ E++ G++P
Sbjct: 183 DWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 70/229 (30%), Positives = 108/229 (47%), Gaps = 32/229 (13%)
Query: 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLK-EVAVGKREFEMQM---EVLGKIKHDN--VV 404
+VLGKGS G A L+ +G VK LK +V + + E M VL + +N +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLA-LAWENPFLT 59
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR---GLAH 461
L + +K+ V +++ G L + H + GR L R AA GL
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDL--MFH-IQDKGRFDL-----YRATFYAAEIVCGLQF 111
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGL--NPLFGNTTPPT--RVAGYRAPEVVET 517
LH G I++ ++K N++L D ++DFG+ +FG+ T Y APE+++
Sbjct: 112 LHSKG-IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170
Query: 518 RKVTFKSDVYSFGVLLLELLTGKAPNQA--------SLGEEGIDLPRWV 558
K TF D +SFGVLL E+L G++P S+ + PRW+
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKR--EFEMQMEVLGKIKHDNVVPL-RAFY 410
LG G+ G YKA +E + ++ + + ++ +++++L H N+V L AFY
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 411 YSKDEKLLVYDYMPAGSLSA-LLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
Y + +L+ ++ G++ A +L R PL + L +LH + KI+
Sbjct: 73 YENNLWILI-EFCAGGAVDAVMLELER-----PLTEPQIRVVCKQTLEALNYLHEN-KII 125
Query: 470 HGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGY------RAPEVV--ET---R 518
H ++KA NIL D D ++DFG++ NT R + APEVV ET R
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 519 KVTFKSDVYSFGVLLLELLTGKAPNQ 544
+K+DV+S G+ L+E+ + P+
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHH 209
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 28/203 (13%)
Query: 373 VVVKRLKEVAVGK--REFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSA 430
V +K LK K R+F + ++G+ H N++ L ++V +YM GSL A
Sbjct: 35 VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA 94
Query: 431 LLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSD 490
L G T + +R A G+ +L G VH ++ A NIL+ + VSD
Sbjct: 95 FLRKHDGQ-FTVIQLVGMLR---GIASGMKYLSDMG-YVHRDLAARNILVNSNLVCKVSD 149
Query: 491 FGL------NPLFGNTTP----PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-G 539
FGL +P TT P R + APE + RK T SDV+S+G+++ E+++ G
Sbjct: 150 FGLSRVLEDDPEAAYTTRGGKIPIR---WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 206
Query: 540 KAP-----NQASLG--EEGIDLP 555
+ P NQ + EEG LP
Sbjct: 207 ERPYWEMSNQDVIKAIEEGYRLP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 352 EVLGKGSVGTSYKAVLEEG---TTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVP 405
+V+G+G+ G +A++++ +K LKE A R+F ++EVL K+ H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSR------------GSGRTPLDWDNRMRIAL 453
L ++ + +Y P G+L L SR G+ T L ++ A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST-LTSQQLLQFAS 126
Query: 454 SAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN---PLFGNTTPPTRVAGYR 510
A G+ +L + +H ++ A N+L+ + + ++DFGL+ ++ T +
Sbjct: 127 DVATGMQYLS-EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWM 185
Query: 511 APEVVETRKVTFKSDVYSFGVLLLELLT-GKAP 542
A E + T KSDV+SFGVLL E+++ G P
Sbjct: 186 AIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 33/234 (14%)
Query: 352 EVLGKGSVGTSYKAVL-----EEGTTVVVKRLKEVAVGKR--EFEMQMEVLGKIKHDNVV 404
E LG+ + G YK L + V +K LK++ ++ EF+ + ++ ++ H N+V
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALL------------HGSRGSGRTPLDWDNRMRIA 452
L + ++++Y+ G L L G+ ++ LD + + IA
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 453 LSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP---------LFGNTTPP 503
+ A G+ +L S VH ++ A NIL+ +SD GL+ + + P
Sbjct: 131 IQIAAGMEYL-SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPR 556
R + PE + K + SD++SFGV+L E+ + G P +E I++ R
Sbjct: 190 IR---WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 64/210 (30%), Positives = 90/210 (42%), Gaps = 28/210 (13%)
Query: 352 EVLGKGSVGTSYKAVL--EEG--TTVVVKRL------KEVAVGKREFEMQMEVLGKIKHD 401
V+GKG G Y L +G VK L +EV +F + ++ H
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE----QFLKEGIIMKDFSHP 56
Query: 402 NVVPLRAFYYSKD-EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLA 460
NV+ L + L+V YM G L + R P D + L A+G+
Sbjct: 57 NVLSLLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNPTVKD-LIGFGLQVAKGME 112
Query: 461 HLHVSGKIVHGNIKASNILLRPDHDACVSDFGL--NPLFGNTTPPTRVAGYRAP------ 512
+L S K VH ++ A N +L V+DFGL + G + P
Sbjct: 113 YL-ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 513 EVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
E ++T+K T KSDV+SFGVLL EL+T AP
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTT----VVVKRLKEVAVGKREFEMQME--VLGKIKHDNVV 404
+VLG G+ GT YK + + EG V +K L+E K E+ E V+ + + +V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALL--HGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
L + +L + MP G L + H + L+W + A+G+ +L
Sbjct: 73 RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 125
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYRAP------EVVE 516
++VH ++ A N+L++ ++DFGL L G G + P E +
Sbjct: 126 E-ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 517 TRKVTFKSDVYSFGVLLLELLT-GKAPNQ-------ASLGEEGIDLPR 556
R T +SDV+S+GV + EL+T G P +S+ E+G LP+
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 49/194 (25%), Positives = 98/194 (50%), Gaps = 10/194 (5%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFY 410
LG G+ G K + ++ ++L + + + + +++VL + +V +
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 411 YSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVH 470
YS E + ++M GSL +L ++ R P + ++ IA+ RGLA+L +I+H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAV--LRGLAYLREKHQIMH 127
Query: 471 GNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA--GYRAPEVVETRKVTFKSDVYS 528
++K SNIL+ + + DFG++ ++ + V Y +PE ++ + +SD++S
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 187
Query: 529 FGVLLLELLTGKAP 542
G+ L+EL G+ P
Sbjct: 188 MGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 71/288 (24%), Positives = 129/288 (44%), Gaps = 43/288 (14%)
Query: 352 EVLGKGSVGTSYKAVLEEG---TTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVP 405
+V+G+G+ G KA +++ +KR+KE A R+F ++EVL K+ H N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRG---------SGRTPLDWDNRMRIALSA- 455
L + L +Y P G+L L SR + T ++ + +A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 456 -ARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN---PLFGNTTPPTRVAGYRA 511
ARG+ +L + +H ++ A NIL+ ++ A ++DFGL+ ++ T + A
Sbjct: 133 VARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 191
Query: 512 PEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEV 570
E + T SDV+S+GVLL E+++ G P + E +
Sbjct: 192 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--------------YCGMTCAELYEKLP 237
Query: 571 FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVV----RMIE 614
L + N ++E+ L++ C P +RP+ +++ RM+E
Sbjct: 238 QGYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-HDNVVPLRAF 409
E +GKG+ G +K + + G+ VK L + E E + +L + H NVV
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 410 YYSKDEK-----LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIAL---SAARGLAH 461
YY KD K LV + GS++ L+ G G + IA A GL H
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG----ERMEEPIIAYILHEALMGLQH 139
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPPTRVAGYRAPEVVET 517
LHV+ K +H ++K +NILL + + DFG++ +T + APEV+
Sbjct: 140 LHVN-KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 198
Query: 518 RK---VTF--KSDVYSFGVLLLELLTGKAP 542
+ T+ + DV+S G+ +EL G P
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQME-------VLGKIKHDNV 403
+ LG G+ + Y+A ++ GT + VK++ V E E +E ++ ++ H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
+ + L ++M GS+S LL + RGL++LH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLH 120
Query: 464 VSGKIVHGNIKASNILL-RPDHDACVSDFG-LNPLFGNTTPPTRVAG-------YRAPEV 514
+I+H ++K +N+L+ ++DFG L T G + APEV
Sbjct: 121 -ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 515 VETRKVTFKSDVYSFGVLLLELLTGKAP 542
+ + DV+S G +++E+ T K P
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 23/207 (11%)
Query: 352 EVLGKGSVGT----SYKAVLEEGTTVVVKRLKEVAVGK--REFEMQMEVLGKIKHDNVVP 405
+ LG GS G + + V VK LK + +F + ++ + H+N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLD--WDNRMRIALSAARGLAHLH 463
L + + V + P GSL L G + D ++IA G+ +L
Sbjct: 61 LYGVVLTHPLMM-VTELAPLGSLLDRLR-KDALGHFLISTLCDYAVQIA----NGMRYLE 114
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR-------APEVVE 516
S + +H ++ A NILL D + DFGL + + APE +
Sbjct: 115 -SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 517 TRKVTFKSDVYSFGVLLLELLT-GKAP 542
TR + SDV+ FGV L E+ T G+ P
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 74/229 (32%), Positives = 109/229 (47%), Gaps = 36/229 (15%)
Query: 353 VLGKGSVGTSYKAVLEE--GTTVV--VKRL-KEVAVGKREFEMQM---EVLGKI-KHDNV 403
VLGKGS G K +L E GT + VK L K+V + + E M VL KH +
Sbjct: 2 VLGKGSFG---KVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRI-ALSAARGLAHL 462
L + + +KD V +Y+ G L + H R SGR + R R A GL L
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQR-SGRFD---EPRARFYAAEIVLGLQFL 112
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGL---NPLFGNTTPPTRVAG---YRAPEVVE 516
H G I++ ++K N+LL + ++DFG+ L G TT + G Y APE++
Sbjct: 113 HERG-IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT--STFCGTPDYIAPEILS 169
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKAPNQA--------SLGEEGIDLPRW 557
+ D ++ GVLL E+L G++P + S+ E+ + PRW
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRW 218
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 53/195 (27%), Positives = 87/195 (44%), Gaps = 11/195 (5%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK 413
LG G G + V +K + E A+ + +F + +V+ K+ H +V L +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 414 DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNI 473
+V ++M G L L +G L D + + G+ +L + I H ++
Sbjct: 72 KPLYIVTEFMENGCLLNYLRQRQGK----LSKDMLLSMCQDVCEGMEYLERNSFI-HRDL 126
Query: 474 KASNILLRPDHDACVSDFG-----LNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYS 528
A N L+ VSDFG L+ + +++ + PEV K + KSDV+S
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 529 FGVLLLELLT-GKAP 542
FGVL+ E+ T GK P
Sbjct: 187 FGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-11
Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 34/221 (15%)
Query: 368 EEGTTVVVKRLKEVAV-GKRE---FEMQMEVLGKIKHDNVVPLRAFYYSKDEKLL-VYDY 422
G V +K L+ A + + F + + ++ H N+V L + L V++Y
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP 482
+P +L +L + L R+ L LA H G IVH ++K NI++
Sbjct: 61 VPGRTLREVL-----AADGALPAGETGRLMLQVLDALACAHNQG-IVHRDLKPQNIMVSQ 114
Query: 483 DHD---ACVSDFGLNPLFGNT--------TPPTRVAG---YRAPEVVETRKVTFKSDVYS 528
A V DFG+ L T T V G Y APE + VT SD+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 529 FGVLLLELLTGKAPNQAS---------LGEEGIDLPRWVQS 560
+G++ LE LTG+ Q + L + LP W+
Sbjct: 175 WGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAG 215
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTV---VVKRLKEVAVGKREFEM---QMEVLGKIKHDNVV 404
++LG G GT +K + + EG ++ V + + G++ F+ M +G + H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
L +L V P GSL + R S LD + + A+G+ +L
Sbjct: 73 RLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDS----LDPQRLLNWCVQIAKGMYYLEE 127
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPL---------FGNTTPPTRVAGYRAPEVV 515
+VH N+ A NILL+ D ++DFG+ L + P + + A E +
Sbjct: 128 HR-MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK---WMALESI 183
Query: 516 ETRKVTFKSDVYSFGVLLLELLTGKAPNQASL 547
+ T +SDV+S+GV + E+++ A A +
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 14/177 (7%)
Query: 370 GTTVVVKRL----KEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425
G V +K++ + KR + ++++L ++H+N++ L + S E + +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG 93
Query: 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD 485
L LL PL+ RGL ++H +G +VH ++K SNIL+ + D
Sbjct: 94 TDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAG-VVHRDLKPSNILINENCD 146
Query: 486 ACVSDFGL-NPLFGNTTPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGK 540
+ DFGL T YRAPE++ T +K + D++S G + E+L GK
Sbjct: 147 LKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 20/201 (9%)
Query: 353 VLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGK-------REFEMQMEVLGKIKHDNVVP 405
V+GKG+ G ++++ T + +K + K R + +L ++ H +V
Sbjct: 7 VIGKGAFGKVC--IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSA-ARGLAHLHV 464
L + ++ LV D + G L H S+ + + +++ + L +LH
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLR--YHLSQKVKFS----EEQVKFWICEIVLALEYLH- 117
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKVT 521
S I+H +IK NILL ++DF + T T +G Y APEV+ + +
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 522 FKSDVYSFGVLLLELLTGKAP 542
D +S GV E L GK P
Sbjct: 178 VAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 29/206 (14%)
Query: 353 VLGKGSVG-----TSYKAVLEEGT-TVVVKRLKEVA-VGKREFEMQ----MEVLGKIKHD 401
LG G+ G T+Y + V VK LK A +RE M M LG H+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN--HE 99
Query: 402 NVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
N+V L L++ +Y G L L R + L ++ + + A+G+A
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAF 156
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGL--------NPLF-GNTTPPTRVAGYRAP 512
L S +H ++ A N+LL + DFGL N + GN P + + AP
Sbjct: 157 L-ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK---WMAP 212
Query: 513 EVVETRKVTFKSDVYSFGVLLLELLT 538
E + TF+SDV+S+G+LL E+ +
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 7e-11
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 352 EVLGKGSVGTSYKAVLEEG---TTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVP 405
+V+G+G+ G KA +++ +KR+KE A R+F ++EVL K+ H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSR------------GSGRTPLDWDNRMRIAL 453
L + L +Y P G+L L SR + T L + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST-LSSQQLLHFAA 119
Query: 454 SAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN---PLFGNTTPPTRVAGYR 510
ARG+ +L + +H ++ A NIL+ ++ A ++DFGL+ ++ T +
Sbjct: 120 DVARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 178
Query: 511 APEVVETRKVTFKSDVYSFGVLLLELLT-GKAP 542
A E + T SDV+S+GVLL E+++ G P
Sbjct: 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 71/297 (23%), Positives = 123/297 (41%), Gaps = 58/297 (19%)
Query: 354 LGKGSVGTSYKAVL------EEGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNVVP 405
+G+G+ G ++A E T V VK LKE A + +F+ + ++ + H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALL------------HGSR-----GSGRTPLDWDNR 448
L L+++YM G L+ L H + G PL +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 449 MRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN---------PLFGN 499
+ IA A G+A+L K VH ++ N L+ + ++DFGL+ N
Sbjct: 133 LCIAKQVAAGMAYLS-ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191
Query: 500 TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWV 558
P R + PE + + T +SDV+++GV+L E+ + G P
Sbjct: 192 DAIPIR---WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP---------------Y 233
Query: 559 QSVVREEWTAEVFDVELMRY-HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614
+ EE V D ++ N E+ L+++ C S +P RP+ + R+++
Sbjct: 234 YGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRL---CWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 349 ASAEVLGKGSVGTSYKAVLEEGTT---VVVKRLKEVAVGKR----EFEMQMEVLGKIKHD 401
A + LG+G G+ + L + + V VK +K +A+ R +F + + + H
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMK-IAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 402 NVVPLRAFYYSKDEK------LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSA 455
NV+ L E +++ +M G L + L SR G P +M +
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR-LGDCPQYLPTQMLVKFMT 119
Query: 456 --ARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF--GNTTPPTRVA---- 507
A G+ +L S +H ++ A N +L + + CV+DFGL+ G+ R+A
Sbjct: 120 DIASGMEYLS-SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 508 GYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEW 566
+ A E + R T KSDV+SFGV + E+ T G+ P G E ++ +++ R +
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP---GVENSEIYDYLRQGNRLKQ 235
Query: 567 TAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615
+ D L + C P RP+ + + +E
Sbjct: 236 PPDCLD--------------GLYSLMSSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 49/195 (25%), Positives = 96/195 (49%), Gaps = 13/195 (6%)
Query: 354 LGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEM-QMEVLGKIKHDNVVPLRAFYY 411
+G+GS G A + G V VK + +RE ++ ++ +H NVV + Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
+E ++ +++ G+L+ ++ +R L+ + + S + L +LH G ++H
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR------LNEEQIATVCESVLQALCYLHSQG-VIHR 141
Query: 472 NIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR-VAG---YRAPEVVETRKVTFKSDVY 527
+IK+ +ILL D +SDFG P + + G + APEV+ + D++
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 528 SFGVLLLELLTGKAP 542
S G++++E++ G+ P
Sbjct: 202 SLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 64/274 (23%), Positives = 127/274 (46%), Gaps = 27/274 (9%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRLKEV----AVGKREFEMQMEVLGKIKHDNVVPLRA 408
+G+G Y+A L + V +K+++ A +++ ++++L ++ H NV+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGR-TPLDWDNRMRIALSAARGLAHLHVSGK 467
+ +E +V + AG LS ++ + R P + + L +A + H+H S +
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VEHMH-SRR 126
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFGN-TTPPTRVAG---YRAPEVVETRKVTFK 523
++H +IK +N+ + + D GL F + TT + G Y +PE + FK
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 524 SDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583
SD++S G LL E+ A Q+ + ++L Q + E D + + E
Sbjct: 187 SDIWSLGCLLYEM----AALQSPFYGDKMNLFSLCQKI-------EQCDYPPLPTEHYSE 235
Query: 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617
++ +L+ + C+ PDQRP + V ++ + M+
Sbjct: 236 KLRELVSM---CIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 48/194 (24%), Positives = 98/194 (50%), Gaps = 10/194 (5%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFY 410
LG G+ G +K + ++ ++L + + + + +++VL + +V +
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 411 YSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVH 470
YS E + ++M GSL +L + +GR P ++ IA+ +GL +L KI+H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IKGLTYLREKHKIMH 127
Query: 471 GNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA--GYRAPEVVETRKVTFKSDVYS 528
++K SNIL+ + + DFG++ ++ + V Y +PE ++ + +SD++S
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 187
Query: 529 FGVLLLELLTGKAP 542
G+ L+E+ G+ P
Sbjct: 188 MGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 37/209 (17%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFE-----MQM-EV--LGKIK-HD 401
+ LG G+ G+ Y A E G V +K++K ++F M + EV L K+ H
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMK------KKFYSWEECMNLREVKSLRKLNEHP 58
Query: 402 NVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR-IALSAARGLA 460
N+V L+ + DE V++YM G+L L+ + P ++ +R I +GLA
Sbjct: 59 NIVKLKEVFRENDELYFVFEYM-EGNLYQLM---KDRKGKPFS-ESVIRSIIYQILQGLA 113
Query: 461 HLHVSGKIVHGNIKASNILLRPDHDACVSDFGL------NPLFGNTTP--PTRVAGYRAP 512
H+H G H ++K N+L+ ++DFGL P + T TR YRAP
Sbjct: 114 HIHKHG-FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY---TDYVSTR--WYRAP 167
Query: 513 EVV-ETRKVTFKSDVYSFGVLLLELLTGK 540
E++ + + D+++ G ++ EL T +
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM----QMEVLGKIKHDNVVPLRA 408
LG+G+ G YKA ++ G V +K++ + K F + ++++L K+KH NVVPL
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKIL-MHNEKDGFPITALREIKILKKLKHPNVVPLID 74
Query: 409 FYY-----SKDEKLLVYDYMP--AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
SK ++ VY P LS LL T M L G+ +
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK-LTESQIKCYMLQLLE---GINY 130
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACV--SDFGL-NPLFGNTTPPTRVAG---------- 508
LH I+H +IKA+NIL+ D+ + +DFGL P G P G
Sbjct: 131 LH-ENHILHRDIKAANILI--DNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187
Query: 509 ----YRAPEVV-ETRKVTFKSDVYSFGVLLLELLTGK 540
YR PE++ R+ T D++ G + E+ T +
Sbjct: 188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 40/213 (18%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRL----------KEVAVGKREFEMQMEVLGKIKHDN 402
LG+G+ G Y ++ G + VK++ KEV E ++++L ++H+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEV----NALECEIQLLKNLQHER 65
Query: 403 VVPLRAFYY---SKDEKLLVY-DYMPAGSLSALL--HGSRGSGRTPLDWDNRMRIALSAA 456
+V YY DE L ++ +YMP GS+ L +G L +
Sbjct: 66 IVQ----YYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-------ALTETVTRKYTRQIL 114
Query: 457 RGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFG----LNPLFGNTTPPTRVAG---Y 509
G+ +LH S IVH +IK +NIL + + DFG L + + T V G +
Sbjct: 115 EGVEYLH-SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 510 RAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
+PEV+ K+DV+S G ++E+LT K P
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 70/230 (30%), Positives = 103/230 (44%), Gaps = 36/230 (15%)
Query: 353 VLGKGSVGTSYKAVLEE--GTT--VVVKRLK-EVAVGKREFEMQM---EVLG-KIKHDNV 403
VLGKGS G K +L E GT +K LK +V + + E M VL +H +
Sbjct: 2 VLGKGSFG---KVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR---GLA 460
L + +K+ V +Y+ G L + + SGR R AA GL
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEA-----RARFYAAEIICGLQ 110
Query: 461 HLHVSGKIVHGNIKASNILLRPDHDACVSDFGL--NPLFGNTTPPT--RVAGYRAPEVVE 516
LH G I++ ++K N+LL D ++DFG+ + G T Y APE+++
Sbjct: 111 FLHKKG-IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK 169
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGID--------LPRWV 558
+K D +SFGVLL E+L G++P +E D PRW+
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWI 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 27/209 (12%)
Query: 353 VLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQME-----VLGKIKHDNVVPLR 407
V+G+GS G + +KE+ + K ++ +L K+KH N+V +
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYA--MKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRG---SGRTPLDWDNRMRIALSAARGLAHLHV 464
+ + +V +Y G L + RG T L W +M + G+ H+H
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH- 117
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-------YRAPEVVET 517
+++H +IK+ NI L + + DFG L + P A Y PE+ E
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS---PGAYACTYVGTPYYVPPEIWEN 174
Query: 518 RKVTFKSDVYSFGVLLLELLTGKAPNQAS 546
KSD++S G +L EL T K P QA+
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 20/202 (9%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFE-----MQMEVLGKIKHDNVVPL 406
E LG+G+ T YK TT + LKE+ + E ++ ++ ++KH+N+V L
Sbjct: 6 EKLGEGTYATVYKG--RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL 63
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALL--HGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
+++++ +LV++YM L + HG RG LD + +G+A H
Sbjct: 64 HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRG----ALDPNTVKSFTYQLLKGIAFCH- 117
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG---NTTPPTRVA-GYRAPEVV-ETRK 519
+++H ++K N+L+ + ++DFGL FG NT V YRAP+V+ +R
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 520 VTFKSDVYSFGVLLLELLTGKA 541
+ D++S G ++ E++TG+
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 450 RIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG- 508
+IA+S + L +LH ++H ++K SN+L+ + + DFG++ ++ T AG
Sbjct: 107 KIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGC 166
Query: 509 --YRAPEVV----ETRKVTFKSDVYSFGVLLLELLTGKAP 542
Y APE + + KSDV+S G+ ++EL TG+ P
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 21/183 (11%)
Query: 373 VVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSA 430
V VK L+ A + +F ++++L ++ N+ L ++ +YM G L+
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 431 LLH------GSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH 484
L L + + +A A G+ +L S VH ++ N L+ ++
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE-SLNFVHRDLATRNCLVGKNY 167
Query: 485 DACVSDFGL-NPLF--------GNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLE 535
++DFG+ L+ G P R + A E V K T KSDV++FGV L E
Sbjct: 168 TIKIADFGMSRNLYSSDYYRVQGRAPLPIR---WMAWESVLLGKFTTKSDVWAFGVTLWE 224
Query: 536 LLT 538
+LT
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 69/285 (24%), Positives = 119/285 (41%), Gaps = 44/285 (15%)
Query: 354 LGKGSVGTSYKAVL------EEGTTVVVKRLKEVAVGKR--EFEMQMEVLGKIKHDNVVP 405
LG+GS G Y+ + E T V +K + E A + EF + V+ + +VV
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSR-----GSGRTPLDWDNRMRIALSAARGLA 460
L L++ + M G L + L R + P +++A A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 461 HLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF---------GNTTPPTRVAGYRA 511
+L+ + K VH ++ A N ++ D + DFG+ G P R + +
Sbjct: 134 YLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---WMS 189
Query: 512 PEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEV 570
PE ++ T SDV+SFGV+L E+ T + P Q E+ V+R +
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ----------VLRFVMEGGL 239
Query: 571 FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615
D + N + + +L+++ C P RP+ E++ I+
Sbjct: 240 LD----KPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 26/222 (11%)
Query: 336 GGVYSFDLEDLLRASAEVLGKGSVGTSYKA-VLEEGTTVVVKRLKEVAVG---KREFEMQ 391
G Y DL DL +G G+ G YK + G + VK+++ KR M
Sbjct: 7 GQKYPADLNDLENLGE--IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRIL-MD 63
Query: 392 MEVLGKIKHD--NVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRM 449
++V+ K HD +V ++ + + + + M + L LL +G P+ D
Sbjct: 64 LDVVLK-SHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQG----PIPEDILG 117
Query: 450 RIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVS--DFGLNPLFGNTTPPTRVA 507
++ ++ + L +L ++H ++K SNILL D V DFG++ ++ TR A
Sbjct: 118 KMTVAIVKALHYLKEKHGVIHRDVKPSNILL--DASGNVKLCDFGISGRLVDSKAKTRSA 175
Query: 508 G---YRAPEVVETRKVT----FKSDVYSFGVLLLELLTGKAP 542
G Y APE ++ ++DV+S G+ L+EL TG+ P
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 59/215 (27%), Positives = 89/215 (41%), Gaps = 30/215 (13%)
Query: 346 LLRASAEVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAVGKREFEMQMEVL--GK 397
LLRA LG G+ G Y+ + V VK L E + E + ME L K
Sbjct: 10 LLRA----LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 398 IKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRG--SGRTPLDWDNRMRIALSA 455
H N+V L + + + ++ + M G L + L +R + L + + A
Sbjct: 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 456 ARGLAHLHVSGKIVHGNIKASNILLR---PDHDACVSDFGLNPLF---------GNTTPP 503
A+G +L +H +I A N LL P A ++DFG+ G P
Sbjct: 126 AKGCKYLE-ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184
Query: 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT 538
+ + PE T K+DV+SFGVLL E+ +
Sbjct: 185 IK---WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 354 LGKGSVGTSYKAVLE---EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKH--DNVVPLRA 408
LG G+ G K V + + V +K LK EM E +I H DN +R
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMRE--AEIMHQLDNPYIVRM 60
Query: 409 FYYSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
+ E L LV + G L+ L G + + N + + + G+ +L
Sbjct: 61 IGVCEAEALMLVMEMASGGPLNKFLSGKKDE----ITVSNVVELMHQVSMGMKYLE-GKN 115
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFG--NTTPPTRVAG-----YRAPEVVETRKV 520
VH ++ A N+LL H A +SDFGL+ G ++ R AG + APE + RK
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 521 TFKSDVYSFGVLLLELLT-GKAPNQASLGEEGI 552
+ +SDV+S+G+ + E + G+ P + G E +
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM 208
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 65/289 (22%), Positives = 118/289 (40%), Gaps = 54/289 (18%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV-------GKREFEMQME--------VLG 396
E LG G+ G YK V ++ + LKE+ V KRE + + +
Sbjct: 6 EHLGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 397 KIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLD---WDNRMRIAL 453
+++H N+V + D +V D + L + + + + W+ +++ L
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 454 SAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YR 510
+ L +LH +IVH ++ +NI+L D ++DFGL + T V G Y
Sbjct: 125 A----LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180
Query: 511 APEVVETRKVTFKSDVYSFGVLLLELLTGKAP----NQASLGEEGIDLPRWVQSVVREEW 566
PE+V+ K+DV++FG +L ++ T + P N SL + ++
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE------------- 227
Query: 567 TAEVFDVELMRYHNIEEEMV--QLLQIAMGCVSTVPDQRPAMQEVVRMI 613
Y + E M + + C++ + RP + +V MI
Sbjct: 228 ---------AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 28/204 (13%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM------QMEVLGKIKHDNVVPL 406
+G GS G Y A + V +K++ GK+ E ++ L +++H N +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALL--HGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
+ Y + LV +Y GS S +L H + PL I A +GLA+LH
Sbjct: 81 KGCYLREHTAWLVMEYC-LGSASDILEVH------KKPLQEVEIAAICHGALQGLAYLHS 133
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVV---ETR 518
+I H +IKA NILL ++DFG L +P G + APEV+ +
Sbjct: 134 HERI-HRDIKAGNILLTEPGTVKLADFGSASL---VSPANSFVGTPYWMAPEVILAMDEG 189
Query: 519 KVTFKSDVYSFGVLLLELLTGKAP 542
+ K DV+S G+ +EL K P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 62/210 (29%), Positives = 91/210 (43%), Gaps = 35/210 (16%)
Query: 353 VLGKGSVGTSYKAVLEE----GTTVVVKRLK-EVAVGKREFEMQM------EVLGKIKHD 401
VLG+G G K +L E G +K LK + + E E M E +H
Sbjct: 6 VLGRGHFG---KVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 402 NVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR---G 458
+V L A + ++D V +Y G L +H S R AA G
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---------RAVFYAACVVLG 113
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---NPLFGNTTPPTRVAG---YRAP 512
L +LH KIV+ ++K N+LL + ++DFGL FG+ T + G + AP
Sbjct: 114 LQYLH-ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--STFCGTPEFLAP 170
Query: 513 EVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
EV+ T D + GVL+ E+L G++P
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 5e-10
Identities = 63/201 (31%), Positives = 91/201 (45%), Gaps = 22/201 (10%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEM------QMEVLGKIKHDNVVPLR 407
+G GS G Y A + T VV K GK+ E +++ L +IKH N + +
Sbjct: 33 IGHGSFGAVYFA-RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
Y + LV +Y GS S LL + PL I A +GLA+LH S
Sbjct: 92 GCYLREHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAITHGALQGLAYLH-SHN 145
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVV---ETRKVT 521
++H +IKA NILL ++DFG + +P G + APEV+ + +
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASI---ASPANSFVGTPYWMAPEVILAMDEGQYD 202
Query: 522 FKSDVYSFGVLLLELLTGKAP 542
K DV+S G+ +EL K P
Sbjct: 203 GKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 339 YSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVV-VKRL----KEVAVGKREFEMQME 393
Y D E++ E+ G GS G Y A VV VK++ K+ ++ +++
Sbjct: 15 YKDDPEEIFVGLHEI-GHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73
Query: 394 VLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIAL 453
L ++KH N + + Y + LV +Y GS S LL + PL I
Sbjct: 74 FLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAITH 128
Query: 454 SAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YR 510
A +GLA+LH S ++H +IKA NILL ++DFG ++P G +
Sbjct: 129 GALQGLAYLH-SHNMIHRDIKAGNILLTEPGQVKLADFGSASK---SSPANSFVGTPYWM 184
Query: 511 APEVV---ETRKVTFKSDVYSFGVLLLELLTGKAP 542
APEV+ + + K DV+S G+ +EL K P
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 370 GTTVVVKRLKEVAVGKR--EFEMQMEVLGKIKHDNVVPLRAFYYSKDEK--LLVYDYMPA 425
G V VK LK + G + + ++E+L + H+N+V + L+ +++P+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD 485
GSL L ++ ++ +++ A+ +G+ +L S + VH ++ A N+L+ +H
Sbjct: 93 GSLKEYLPRNKNK----INLKQQLKYAVQICKGMDYLG-SRQYVHRDLAARNVLVESEHQ 147
Query: 486 ACVSDFGLNPLFGNTTPPTRVAG-------YRAPEVVETRKVTFKSDVYSFGVLLLELLT 538
+ DFGL V + APE + K SDV+SFGV L ELLT
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 68/219 (31%), Positives = 103/219 (47%), Gaps = 53/219 (24%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKE-VAVGK---------------REFEMQMEVLGK 397
LGKG+ G +KA+ +R KE VA+ K RE M ++ LG
Sbjct: 15 LGKGAYGIVWKAI--------DRRTKEVVALKKIFDAFRNATDAQRTFREI-MFLQELGD 65
Query: 398 IKHDNVVPLRAFYYSKDEK--LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR-IALS 454
H N+V L ++++K LV++YM L A++ R + D R I
Sbjct: 66 --HPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI-------RANILEDVHKRYIMYQ 115
Query: 455 AARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL----NPLFGNTTPP------- 503
+ L ++H SG ++H ++K SNILL D ++DFGL + L N P
Sbjct: 116 LLKALKYIH-SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 504 TRVAGYRAPEV-VETRKVTFKSDVYSFGVLLLELLTGKA 541
TR YRAPE+ + + + T D++S G +L E+L GK
Sbjct: 175 TR--WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 67/287 (23%), Positives = 118/287 (41%), Gaps = 43/287 (14%)
Query: 353 VLGKGSVGTSYKAVL--EEGT--TVVVKRLKE---VAVGKREFEMQMEVLGKIKHDNVVP 405
+LGKG G+ +A L E+G+ V VK LK + EF + + + H NV+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 406 LRAFYYSKDEK------LLVYDYMPAGSLSALLHGSR-GSGRTPLDWDNRMRIALSAARG 458
L K +++ +M G L L SR G L +R + A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP------LFGNTTPPTRVAGYRAP 512
+ +L S +H ++ A N +L + CV+DFGL+ + + A
Sbjct: 126 MEYLS-SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL 184
Query: 513 EVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571
E + T SDV++FGV + E++T G+ P G++ +E++
Sbjct: 185 ESLADNVYTTHSDVWAFGVTMWEIMTRGQTP------YAGVE-------------NSEIY 225
Query: 572 D--VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
+ ++ R + + + ++ C S P RP+ Q + +E +
Sbjct: 226 NYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 14/204 (6%)
Query: 347 LRASAEVLGKGSVGTSYKAV-LEEGTTVVVKRL----KEVAVGKREFEMQMEVLGKIKHD 401
L + +G GS G Y A + V +K++ K+ ++ ++ L K++H
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 402 NVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
N + R Y + LV +Y GS S LL + PL + A +GLA+
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAY 130
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYRAPEVV---ETR 518
LH S ++H ++KA NILL + DFG + + APEV+ +
Sbjct: 131 LH-SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEG 189
Query: 519 KVTFKSDVYSFGVLLLELLTGKAP 542
+ K DV+S G+ +EL K P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 31/205 (15%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEV----AVGK---REFEMQMEVLGKIKHDNV 403
++G+GS G K +E G V +K+ E V K RE M L +++H+N+
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRM----LKQLRHENL 62
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
V L + K LV++++ L L G LD + RG+ H
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCH 117
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--------TPPTRVAGYRAPE-V 514
S I+H +IK NIL+ + DFG F T T YRAPE +
Sbjct: 118 -SHNIIHRDIKPENILVSQSGVVKLCDFG----FARTLAAPGEVYTDYVATRWYRAPELL 172
Query: 515 VETRKVTFKSDVYSFGVLLLELLTG 539
V K D+++ G L+ E+LTG
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 12/172 (6%)
Query: 376 KRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLH-- 433
KRLK+ + G++ ++ E+L K+ +V L + SK LV M G L ++
Sbjct: 29 KRLKKKS-GEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV 87
Query: 434 GSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL 493
G RG L+ + + + G+ HLH S IV+ ++K N+LL + +SD GL
Sbjct: 88 GERG-----LEMERVIHYSAQITCGILHLH-SMDIVYRDMKPENVLLDDQGNCRLSDLGL 141
Query: 494 NPLFGNTTPPTRVAG---YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
+ T+ AG Y APE+++ ++ D ++ G + E++ G+ P
Sbjct: 142 AVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 25/202 (12%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRLKEVAV-------GKREFEMQMEVLGKIKHDNVVP 405
+G+G+ G Y+A G V +K+++ RE + +L ++H N+V
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITLLLNLRHPNIVE 70
Query: 406 LRAFYYSK--DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
L+ K D LV +Y L++LL + TP + L RGL +LH
Sbjct: 71 LKEVVVGKHLDSIFLVMEYCEQ-DLASLLD----NMPTPFSESQVKCLMLQLLRGLQYLH 125
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN----TTPPTRVAGYRAPEVV-ETR 518
I+H ++K SN+LL ++DFGL +G TP YRAPE++
Sbjct: 126 -ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCT 184
Query: 519 KVTFKSDVYSFGVLLLELLTGK 540
T D+++ G +L ELL K
Sbjct: 185 TYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 32/203 (15%)
Query: 354 LGKGSVGTSY-----KAVLEEGTTVVVKRLKEVAVGKR------EFEMQMEVLGKIKHDN 402
LGKGS GT Y KAV EE +K LKE+ VG+ + + ++L K+ H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEER----LKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 403 VVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRT-----PLDWDNRMRIALSAAR 457
+V A + +D ++ +Y L L + +G+T +W ++ +
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------ 117
Query: 458 GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP-LFGNTTPPTRVAG---YRAPE 513
G+ ++H +I+H ++KA NI L+ ++ + DFG++ L G+ T G Y +PE
Sbjct: 118 GVHYMHQR-RILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175
Query: 514 VVETRKVTFKSDVYSFGVLLLEL 536
++ + KSD++S G +L E+
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 67/231 (29%), Positives = 102/231 (44%), Gaps = 33/231 (14%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLK-EVAVGKREFEMQM---EVLGKIKHDNV 403
++LGKG+ G K +L G +K LK EV + K E + VL +H +
Sbjct: 1 KLLGKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRI-ALSAARGLAHL 462
L+ + +KD V +Y+ G L H SR + ++R R L +L
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFS----EDRTRFYGAEIVSALDYL 111
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR-----VAGYRAPEVVET 517
H SGKIV+ ++K N++L D ++DFGL G T T Y APEV+E
Sbjct: 112 H-SGKIVYRDLKLENLMLDKDGHIKITDFGLCKE-GITDAATMKTFCGTPEYLAPEVLED 169
Query: 518 RKVTFKSDVYSFGVLLLELLTGKAP----NQASLGE----EGIDLPRWVQS 560
D + GV++ E++ G+ P + L E E I PR + +
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSA 220
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 24/231 (10%)
Query: 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLK-EVAVGKREFEMQM---EVLG-KIKHDNVVP 405
++LGKGS G + A L+ +K LK +V + + E M VL +H +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
L + +K+ V +Y+ G L + D A GL LH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSK 115
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGL--NPLFGNTTPPT--RVAGYRAPEVVETRKVT 521
G IV+ ++K NILL D ++DFG+ + G+ T Y APE++ +K
Sbjct: 116 G-IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174
Query: 522 FKSDVYSFGVLLLELLTGKAPNQASLGEEGID--------LPRWVQSVVRE 564
D +SFGVLL E+L G++P EE PRW+ ++
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKD 225
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 354 LGKGSVGTSYKAVLEEGTT-----VVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRA 408
+G G+ GT YK V+ T V+ E V +R+ ++E+L + H NVV
Sbjct: 82 IGSGAGGTVYK-VIHRPTGRLYALKVIYGNHEDTV-RRQICREIEILRDVNHPNVVKCHD 139
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
+ E ++ ++M GSL G D +A G+A+LH I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE---------GTHIADEQFLADVARQILSGIAYLH-RRHI 189
Query: 469 VHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA----GYRAPEVVET-----RK 519
VH +IK SN+L+ + ++DFG++ + T P + Y +PE + T
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAY 249
Query: 520 VTFKSDVYSFGVLLLELLTGKAP 542
+ D++S GV +LE G+ P
Sbjct: 250 DGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 40/213 (18%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQM---------EVLGKIKHD 401
+G+G+ G A G V +K++ FE Q ++L + KH+
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISP-------FEHQTFCQRTLREIKILRRFKHE 63
Query: 402 NVVPLRAF-----YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRT-PLDWDNRMRIALSA 455
N++ + + S ++ +V + M L L+ +T L D+
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLI-------KTQHLSNDHIQYFLYQI 115
Query: 456 ARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR-----VAG-- 508
RGL ++H S ++H ++K SN+LL + D + DFGL + T VA
Sbjct: 116 LRGLKYIH-SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 509 YRAPEVVETRKVTFKS-DVYSFGVLLLELLTGK 540
YRAPE++ K K+ D++S G +L E+L+ +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 51/190 (26%), Positives = 90/190 (47%), Gaps = 30/190 (15%)
Query: 440 RTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL------ 493
++PL ++ + + ARG+ L S K +H ++ A NILL ++ + DFGL
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL-ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 494 NPLF---GNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGE 549
+P + G+ P + + APE + + T +SDV+SFGVLL E+ + G +P
Sbjct: 227 DPDYVRKGSARLPLK---WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG---- 279
Query: 550 EGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEV 609
VQ + EE+ + D MR E ++ +I + C P +RP +
Sbjct: 280 --------VQ--INEEFCQRLKDGTRMRAP--ENATPEIYRIMLACWQGDPKERPTFSAL 327
Query: 610 VRMIENMNRG 619
V ++ ++ +
Sbjct: 328 VEILGDLLQE 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 17/189 (8%)
Query: 354 LGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG-KREFEMQMEVLGKIKHDNVVPLRAFYY 411
L GS G + A + VV+K +G K ++ +L + H +V+ ++
Sbjct: 74 LTPGSEGRVFVATKPGQPDPVVLK------IGQKGTTLIEAMLLQNVNHPSVIRMKDTLV 127
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
S +V + + + L SR PL D + I GL +LH + +I+H
Sbjct: 128 SGAITCMVLPHYSSDLYTYLTKRSR-----PLPIDQALIIEKQILEGLRYLH-AQRIIHR 181
Query: 472 NIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKVTFKSDVYS 528
++K NI + C+ D G +AG APEV+ K K+D++S
Sbjct: 182 DVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWS 241
Query: 529 FGVLLLELL 537
G++L E+L
Sbjct: 242 AGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 5e-09
Identities = 62/216 (28%), Positives = 94/216 (43%), Gaps = 50/216 (23%)
Query: 352 EVLGKGSVGTSYKAVLEEGTT--VVVK--------RLKEVAVGKREFEMQMEVLGKIKHD 401
+ LG GS G V +G+ +K +LK+V E +L I+H
Sbjct: 7 KTLGTGSFGR-VMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNE----KRILQSIRHP 61
Query: 402 NVVPLRAFYYSKDEKLL--VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR-- 457
+V L + +D+ L V +Y+P G L + L R SGR P AA+
Sbjct: 62 FLVNLYGSF--QDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPV-----ARFYAAQVV 111
Query: 458 -GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF-----GNT-----TPPTRV 506
L +LH S IV+ ++K N+LL D ++DFG F G T TP
Sbjct: 112 LALEYLH-SLDIVYRDLKPENLLLDSDGYIKITDFG----FAKRVKGRTYTLCGTPE--- 163
Query: 507 AGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
Y APE++ ++ D ++ G+L+ E+L G P
Sbjct: 164 --YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 352 EVLGKGSVGTSYKAVLEE--GTTVV--VKRL-KEVAVGKREFEMQM---EVLG-KIKHDN 402
+VLGKGS G K +L E GT V +K L K+V + + + M +L KH
Sbjct: 1 KVLGKGSFG---KVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 403 VVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRI-ALSAARGLAH 461
+ L + +KD V +Y+ G L + SR D + R R A L
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-----KFD-EPRSRFYAAEVTLALMF 111
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGL---NPLFGNTTPPTRVAG---YRAPEVV 515
LH G +++ ++K NILL + ++DFG+ L G TT T G Y APE++
Sbjct: 112 LHRHG-VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--TTFCGTPDYIAPEIL 168
Query: 516 ETRKVTFKSDVYSFGVLLLELLTGKAPNQA 545
+ + D ++ GVL+ E++ G+ P +A
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEV--LGKIKHDNVVPLRAFY 410
+G G+ G YKA L G VK +K + G +Q E+ + + KH N+V Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIK-LEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 411 YSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVH 470
S+++ + +Y GSL + H + PL + +GLA+LH GK+ H
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKGKM-H 129
Query: 471 GNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR----VAGYRAPEVVETRK---VTFK 523
+IK +NILL + D ++DFG+ T + + APEV K
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQL 189
Query: 524 SDVYSFGVLLLELLTGKAP 542
D+++ G+ +EL + P
Sbjct: 190 CDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 51/188 (27%), Positives = 88/188 (46%), Gaps = 30/188 (15%)
Query: 439 GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL----- 493
+ PL ++ + + ARG+ L S K +H ++ A NILL ++ + DFGL
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFL-ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 494 -NPLF---GNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLG 548
+P + G+ P + + APE + + T +SDV+SFGVLL E+ + G +P
Sbjct: 225 KDPDYVRKGDARLPLK---WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG--- 278
Query: 549 EEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQE 608
VQ + EE+ + + MR E ++ I + C P+ RP E
Sbjct: 279 ---------VQ--IDEEFCRRLKEGTRMR--APEYATPEIYSIMLDCWHNNPEDRPTFSE 325
Query: 609 VVRMIENM 616
+V ++ ++
Sbjct: 326 LVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 42/136 (30%), Positives = 67/136 (49%), Gaps = 18/136 (13%)
Query: 418 LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASN 477
LV DY AG L + + RT + + + + + + H+H S ++H +IK++N
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGL-LFIQVLLAVHHVH-SKHMIHRDIKSAN 173
Query: 478 ILLRPDHDACVSDFGLNPLFGNT-----------TPPTRVAGYRAPEVVETRKVTFKSDV 526
ILL + + DFG + ++ T TP Y APE+ + + K+D+
Sbjct: 174 ILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY-----YVAPEIWRRKPYSKKADM 228
Query: 527 YSFGVLLLELLTGKAP 542
+S GVLL ELLT K P
Sbjct: 229 FSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 37/220 (16%)
Query: 350 SAEVLGKGSVGTSYKAVLEEGTT-----VVVKRLKEVAVGKREFEMQMEVLGK------- 397
+++L +G+ G + +L + V VK +K+ A E+Q+ +L +
Sbjct: 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS-----EIQVTLLLQESCLLYG 64
Query: 398 IKHDNVVP-LRAFYYSKDEKLLVYDYMPAGSLSALL----HGSRGSGRTPLDWDNRMRIA 452
+ H N++P L + ++Y YM G+L L G + + L + +A
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA-LSTQQLVHMA 123
Query: 453 LSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---------NPLFGNTTPP 503
+ A G+++LH ++H +I A N ++ + ++D L + L N P
Sbjct: 124 IQIACGMSYLH-KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAP 542
+ + A E + ++ + SDV+SFGVLL EL+T G+ P
Sbjct: 183 VK---WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 47/185 (25%), Positives = 84/185 (45%), Gaps = 30/185 (16%)
Query: 442 PLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP------ 495
PLD D+ +R + A+G+ L S +H ++ A N+LL A + DFGL
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL-ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266
Query: 496 ---LFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEG 551
+ GN P + + APE + T +SDV+S+G+LL E+ + GK+P G
Sbjct: 267 NYVVKGNARLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP------YPG 317
Query: 552 IDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
I + +V+ + D E+ ++++ C + P +RP ++ +
Sbjct: 318 ILVNSKFYKMVKRGYQMSRPDFAPP-------EIYSIMKM---CWNLEPTERPTFSQISQ 367
Query: 612 MIENM 616
+I+
Sbjct: 368 LIQRQ 372
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 73/286 (25%), Positives = 119/286 (41%), Gaps = 49/286 (17%)
Query: 353 VLGKGSVGTSYKAV-LEEGTT----VVVKRLKEVAVGKREFEMQME--VLGKIKHDNVVP 405
VLG G+ GT YK + + +G V +K L+E K E+ E V+ + V
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALL--HGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
L + +L V MP G L + + R + L+W + A+G+++L
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE 126
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYRAP------EVVET 517
++VH ++ A N+L++ + ++DFGL L G + P E +
Sbjct: 127 -EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185
Query: 518 RKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDL----PRWVQSVVREEWTAEVFD 572
R+ T +SDV+S+GV + EL+T G P E DL R Q + T +V+
Sbjct: 186 RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPI---CTIDVYM 242
Query: 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
+ MV+ I + RP +E+V M R
Sbjct: 243 I-----------MVKCWMID-------SECRPRFRELVDEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 30/212 (14%)
Query: 351 AEVLGKGSVGTSYKAV-LEEGTTVVVKRL------KEVAVGKREFEMQMEVLGKIKHDNV 403
++LG+G+ G Y + G + VK++ +E + E ++++L ++HD +
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 404 VPLRAFYYS-----KDEKLLVY-DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR 457
V YY +++KL ++ +YMP GS+ L L + R +
Sbjct: 67 VQ----YYGCLRDPEEKKLSIFVEYMPGGSIKDQL-----KAYGALTENVTRRYTRQILQ 117
Query: 458 GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFG----LNPLFGNTTPPTRVAG---YR 510
G+++LH S IVH +IK +NIL + + DFG + + + T V G +
Sbjct: 118 GVSYLH-SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 511 APEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
+PEV+ K+DV+S ++E+LT K P
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 22/202 (10%)
Query: 353 VLGKGSVGTSYKAV-LEEGTTVVVKR-LKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
++G GS G Y+A+ ++ V +K+ L++ RE + ++ + H N++ L+ +Y
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRE----LLIMKNLNHINIIFLKDYY 128
Query: 411 YS----KDEKLL----VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
Y+ K+EK + V +++P + H +R + PL L R LA++
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAYI 186
Query: 463 HVSGKIVHGNIKASNILLRPD-HDACVSDFG-LNPLFGNTTPPTRVAG--YRAPEV-VET 517
H S I H ++K N+L+ P+ H + DFG L + + YRAPE+ +
Sbjct: 187 H-SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245
Query: 518 RKVTFKSDVYSFGVLLLELLTG 539
T D++S G ++ E++ G
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 60/220 (27%), Positives = 87/220 (39%), Gaps = 49/220 (22%)
Query: 353 VLGKGSVGTSYKAVL-------EEGTTVVVKRLKEVAVGKR----EFEM-QMEVLGKIKH 400
VLG G+ G K L + G +K LK+ + ++ E + +VL ++
Sbjct: 7 VLGTGAYG---KVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRR 63
Query: 401 DNVVPLRAFYYSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR-- 457
+ + + D KL L+ DY+ G L L+ R S R
Sbjct: 64 CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-------------QREHFTESEVRVY 110
Query: 458 ------GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA---- 507
L HLH G I++ +IK NILL + ++DFGL+ F A
Sbjct: 111 IAEIVLALDHLHQLG-IIYRDIKLENILLDSEGHVVLTDFGLSKEF--LAEEEERAYSFC 167
Query: 508 ---GYRAPEVVETRKVTFKS--DVYSFGVLLLELLTGKAP 542
Y APEV+ D +S GVL ELLTG +P
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 353 VLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG--KREFEM----QMEVLGKIKHDNVVPL 406
+G+G+ G YKA + T + LK+V + K F + ++++L ++ H N+V L
Sbjct: 14 QIGEGTYGQVYKAR--DKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 407 RAFYYSKDEKL----------LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAA 456
+ K + L LV++YM L LL SG D+
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLE----SGLVHFSEDHIKSFMKQLL 126
Query: 457 RGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF--GNTTPPT-RVAG--YRA 511
GL + H +H +IK SNILL ++DFGL L+ + P T +V YR
Sbjct: 127 EGLNYCHKKN-FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185
Query: 512 PEVV--ETRKVTFKSDVYSFGVLLLELLTGKAPNQAS 546
PE++ E R DV+S G +L EL T K QA+
Sbjct: 186 PELLLGEER-YGPAIDVWSCGCILGELFTKKPIFQAN 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 2e-08
Identities = 22/61 (36%), Positives = 31/61 (50%), Gaps = 2/61 (3%)
Query: 94 QLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNN 152
L+ L L +NRL+ IP F L L+ L L N + + P + + + L LDLS NN
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 153 F 153
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 50/209 (23%)
Query: 367 LEEGTTVVVKRLKE------VAVGKREFEMQME-----------VLGKIKHDNVVPLRAF 409
+EEGT VV R ++ VA+ K + E + E +L K++H N+V ++
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEV 72
Query: 410 YYSK--DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAA----------R 457
D+ +V +Y+ L +L+ M+ +
Sbjct: 73 VVGSNLDKIYMVMEYVEH-DLKSLM--------------ETMKQPFLQSEVKCLMLQLLS 117
Query: 458 GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG-NTTPPTRVA---GYRAPE 513
G+AHLH I+H ++K SN+LL + DFGL +G P T++ YRAPE
Sbjct: 118 GVAHLH-DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPE 176
Query: 514 VV-ETRKVTFKSDVYSFGVLLLELLTGKA 541
++ ++ + D++S G + ELLT K
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 351 AEVLGKGSVGTSYKAV-LEEGTTVVVKRLK------EVAVGKREFEMQMEVLGKIKHDNV 403
++LG+G+ G Y ++ G + K+++ E + E ++++L ++H+ +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 404 VPLRAFYYSKDEKLLV--YDYMPAGSLSALL--HGSRGSGRTPLDWDNRMRIALSAARGL 459
V + EK L +YMP GS+ L +G+ T + G+
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVT-------RKYTRQILEGM 119
Query: 460 AHLHVSGKIVHGNIKASNILLRPDHDACVSDFG----LNPLFGNTTPPTRVAG---YRAP 512
++LH S IVH +IK +NIL + + DFG L + + T V G + +P
Sbjct: 120 SYLH-SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 513 EVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
EV+ K+DV+S G ++E+LT K P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 20/199 (10%)
Query: 354 LGKGSVGTSYKA---VLEEGTTVVVKRLKEVAVGKREFEMQME--VLGKIKHDNVVPLRA 408
+G G+ G + + E + V + EV K+E + E VL ++ H ++ R
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFII--RL 66
Query: 409 FYYSKDEKLL--VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSA--ARGLAHLHV 464
F+ D++ L + +Y+P G L + L R SGR + N + ++ L +LH
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYL---RNSGR----FSNSTGLFYASEIVCALEYLH- 118
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGL-NPLFGNTTPPTRVAGYRAPEVVETRKVTFK 523
S +IV+ ++K NILL + ++DFG L T Y APEV++++
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKA 178
Query: 524 SDVYSFGVLLLELLTGKAP 542
D ++ G+L+ E+L G P
Sbjct: 179 VDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLK---------EVAVGKREFEMQMEVLGKIKHD 401
E +G+G+ G YKA G V +K+++ A+ RE + +L ++ H
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--RE----ISLLKELNHP 59
Query: 402 NVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
N+V L +++++ LV++++ L + S SG PL L +GLA
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSG-IPLPLIKSYLFQL--LQGLAF 115
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG----NTTPPTRVAGYRAPEV-VE 516
H S +++H ++K N+L+ + ++DFGL FG T YRAPE+ +
Sbjct: 116 CH-SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 174
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKA 541
+ + D++S G + E++T +A
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 31/209 (14%)
Query: 355 GKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFE-------MQMEVLGKIKHDNVVPLR 407
G+G+ G YKA + G +K+ K ++ ++ +L ++KH+NVV L
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 408 -AFYYSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRM--RIALSAARGLAHLH 463
F D+ + L++DY L ++ R + R + M + G+ +LH
Sbjct: 69 EVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSI--PPSMVKSLLWQILNGVHYLH 125
Query: 464 VSGKIVHGNIKASNILLRPDHDAC----VSDFGLNPLFGNTTPPTRVAG---------YR 510
S ++H ++K +NIL+ + + D GL LF P +A YR
Sbjct: 126 -SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA--PLKPLADLDPVVVTIWYR 182
Query: 511 APEVV-ETRKVTFKSDVYSFGVLLLELLT 538
APE++ R T D+++ G + ELLT
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 23/202 (11%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRLK-----EVAVGKREFEMQMEVLGKIKHDNVVPLR 407
+G G+ G YKA + G +K +K + AV ++E M + KH N+V
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC----KHSNIVAYF 72
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
Y +D+ + ++ GSL + H + PL ++ +GL +LH GK
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR----VAGYRAPEVVET-RKVTF 522
+ H +IK +NILL + ++DFG++ T + + APEV RK +
Sbjct: 128 M-HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186
Query: 523 KS--DVYSFGVLLLELLTGKAP 542
D+++ G+ +EL + P
Sbjct: 187 NQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 31/208 (14%)
Query: 354 LGKGSVG----TSYKAVLEEGTTVVVKRLKEVAVGKRE-FEMQM---EVLGKIKHDNVVP 405
LGKG G +A G K+L + + KR+ +E M +L K+ +V
Sbjct: 1 LGKGGFGEVSACQMRAT---GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS 57
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDN----RMRIALSAAR---G 458
L + +K + LV M G L ++ +D +N R A+ G
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYN--------VDEENPGFPEPRACFYTAQIISG 109
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR----VAGYRAPEV 514
L HLH +I++ ++K N+LL D + +SD GL + T+ G+ APE+
Sbjct: 110 LEHLH-QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPEL 168
Query: 515 VETRKVTFKSDVYSFGVLLLELLTGKAP 542
++ + F D ++ GV L E++ + P
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 458 GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA--GYRAPEVV 515
GL H+H +V+ ++K +NILL +SD GL F P V GY APEV+
Sbjct: 109 GLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL 167
Query: 516 ETRKVTFKS--DVYSFGVLLLELLTGKAPNQ 544
+ + V + S D +S G +L +LL G +P +
Sbjct: 168 Q-KGVAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 50/187 (26%), Positives = 86/187 (45%), Gaps = 30/187 (16%)
Query: 440 RTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL------ 493
+ L ++ + + A+G+ L S K +H ++ A NILL ++ + DFGL
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 494 NPLF---GNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGE 549
+P + G+ P + + APE + R T +SDV+SFGVLL E+ + G +P
Sbjct: 232 DPDYVRKGDARLPLK---WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP------Y 282
Query: 550 EGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEV 609
G+ + EE+ + + MR + ++ Q + C P QRP E+
Sbjct: 283 PGVK--------IDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSEL 332
Query: 610 VRMIENM 616
V + N+
Sbjct: 333 VEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 65/271 (23%), Positives = 120/271 (44%), Gaps = 36/271 (13%)
Query: 353 VLGKGSVG-TSYKAVLEEGTTVVVKRLKEVAVGKRE---FEMQMEVLGKIKHDNVVPLRA 408
V+GKGS G S +G V+K+L +RE E + ++L ++KH N+V R
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 409 FYYSKDEKL-LVYDYMPAGSLSALLHGSRGS---GRTPLDWDNRMRIALSAARGLAHLHV 464
+ +D L +V + G L L +G ++W ++IA++ L +LH
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW--FVQIAMA----LQYLH- 119
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP-PTRVAG---YRAPEVVETRKV 520
I+H ++K N+ L + V D G+ + N + + G Y +PE+ +
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPY 179
Query: 521 TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580
+KSDV++ G + E+ T K A D+ V ++ + D
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAK------DMNSLVYRIIEGKLPPMPKDY------- 226
Query: 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
E+ +L+ + S P++RP+++ ++R
Sbjct: 227 -SPELGELIATML---SKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 36/206 (17%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKR--------------LKEVAVGKREFEMQMEVLGKI 398
+G+G+ GT YKA L G V +K+ L+E+A+ K+ L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQ--------LESF 58
Query: 399 KHDNVVPLR---AFYYSKDEKL--LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIAL 453
+H N+V L + E LV++++ L+ L G P + MR L
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 454 SAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA---GYR 510
RG+ LH S +IVH ++K NIL+ D ++DFGL ++ T V YR
Sbjct: 118 ---RGVDFLH-SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYR 173
Query: 511 APEVVETRKVTFKSDVYSFGVLLLEL 536
APEV+ D++S G + EL
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 27/203 (13%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKR---------LKEVAVGKREFEMQMEVLGKIKHDNV 403
+G+GS G +K E G V +K+ +K++A+ RE M L ++KH N+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL--REIRM----LKQLKHPNL 62
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
V L + K + LV++Y L+ L RG + +I + + H
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-----VPEHLIKKIIWQTLQAVNFCH 117
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFG----LNPLFGNTTPPTRVAGYRAPE-VVETR 518
+H ++K NIL+ + DFG L + T YRAPE +V
Sbjct: 118 -KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 519 KVTFKSDVYSFGVLLLELLTGKA 541
+ DV++ G + ELLTG+
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 70/271 (25%), Positives = 114/271 (42%), Gaps = 40/271 (14%)
Query: 354 LGKGSVGTSYKAVLE---EGTTVVVKRLK---EVAVGKREFEMQMEVLGKIKHDNVVPLR 407
LG G+ GT K + + TV VK LK K E + V+ ++ DN +R
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL--DNPYIVR 60
Query: 408 AFYYSKDEK-LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+ E +LV + G L+ L ++ + N + + G+ +L +
Sbjct: 61 MIGICEAESWMLVMELAELGPLNKFLQKNKH-----VTEKNITELVHQVSMGMKYLEET- 114
Query: 467 KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-------YRAPEVVETRK 519
VH ++ A N+LL H A +SDFGL+ G + + APE + K
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 520 VTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578
+ KSDV+SFGVL+ E + G+ P G +G ++ + ++S R E
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKP---YKGMKGNEVTQMIESGERMECPQRC-------- 223
Query: 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEV 609
EM L+++ C + D+RP V
Sbjct: 224 ---PPEMYDLMKL---CWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 61/201 (30%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 353 VLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQM----EVLGK-IKHDNVVPL 406
V+GKGS G A +G VK L++ A+ K++ + + VL K +KH +V L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRI-ALSAARGLAHLHVS 465
+ + D+ V DY+ G L L R P + R R A A L +LH S
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRER---SFP---EPRARFYAAEIASALGYLH-S 114
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGL--NPLFGNTTPPTRVAG--YRAPEVVETRKVT 521
I++ ++K NILL ++DFGL + + T T Y APEV+ +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 522 FKSDVYSFGVLLLELLTGKAP 542
D + G +L E+L G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 351 AEVLGKGSVGTSYKAV-LEEGTTVVVKRLK------EVAVGKREFEMQMEVLGKIKHDNV 403
++LG+G+ G Y + G + VK+++ E + E ++++L + H+ +
Sbjct: 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 404 VPLRAFYYSKDEKLL--VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
V E+ L ++MP GS+ L S G+ L + + G+++
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK-SYGA----LTENVTRKYTRQILEGVSY 121
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFG----LNPLFGNTTPPTRVAG---YRAPEV 514
LH S IVH +IK +NIL + + DFG L + + T V G + +PEV
Sbjct: 122 LH-SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 515 VETRKVTFKSDVYSFGVLLLELLTGKAP 542
+ K+D++S G ++E+LT K P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKR--LKEVAVGKREFEM-QMEVLGKIKHDNVVPLR 407
E +G+G+ GT +KA E V +KR L + G + ++ +L ++KH N+V L
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
+S + LV++Y L G +D + +GLA H S
Sbjct: 66 DVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGD----IDPEIVKSFMFQLLKGLAFCH-SHN 119
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-------YRAPEVVETRKV 520
++H ++K N+L+ + + ++DFGL FG P R YR P+V+ K+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFG---IPVRCYSAEVVTLWYRPPDVLFGAKL 176
Query: 521 TFKS-DVYSFGVLLLELLTGKAP 542
S D++S G + EL P
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 355 GKGSVGTSYKAVLEEGTTVVVKRL----KEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
+G V ++ VL G V VK+L + KR + ++ +L + H N++ L +
Sbjct: 33 AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVF 89
Query: 411 YSK------DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
+ + LV + M A +L ++H LD + + G+ HLH
Sbjct: 90 TPQKSLEEFQDVYLVMELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLHS 141
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TPPTRVAGYRAPEVVETRKVT 521
+G I+H ++K SNI+++ D + DFGL TP YRAPEV+
Sbjct: 142 AG-IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYK 200
Query: 522 FKSDVYSFGVLLLELLTGKAPNQASLGEEGID 553
D++S G ++ EL+ G Q G + ID
Sbjct: 201 ENVDIWSVGCIMGELVKGSVIFQ---GTDHID 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 54/218 (24%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKE----VAVGKREFEMQMEVLGKIKHDNVVPL 406
+G G+ G A + G V +K+L KR + ++ +L + H+NV+ L
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGL 79
Query: 407 -------------RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR-IA 452
+ Y LV M A L+ ++ + S D+ ++ +
Sbjct: 80 LDVFTPASSLEDFQDVY-------LVTHLMGA-DLNNIVKCQKLS-------DDHIQFLV 124
Query: 453 LSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL-----NPLFGNTTPPTRVA 507
RGL ++H +G I+H ++K SNI + D + + DFGL + + G TR
Sbjct: 125 YQILRGLKYIHSAG-IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVA--TR-- 179
Query: 508 GYRAPEVV-----ETRKVTFKSDVYSFGVLLLELLTGK 540
YRAPE++ + V D++S G ++ ELLTGK
Sbjct: 180 WYRAPEIMLNWMHYNQTV----DIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRL-KEVAVGKREFEMQME----VLGKIKHDNVVP 405
+V+GKGS G A + +G VK L K++ + ++E + M +L +KH +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
L + + ++ V D++ G L H R R+ + R A A L +LH S
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGEL--FFHLQRE--RSFPEPRARFYAA-EIASALGYLH-S 114
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLN----PLFGNTTPPTRVAGYRAPEVVETRKVT 521
IV+ ++K NILL ++DFGL TT Y APEV+ +
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 522 FKSDVYSFGVLLLELLTGKAP 542
D + G +L E+L G P
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 26/223 (11%)
Query: 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNVVPLRA 408
E +G+G+ G + L + T V VK +E K +F + +L + H N+V L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLH--GSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
K +V + + G L G R L +++ +AA G+ +L S
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPR------LKVKELIQMVENAAAGMEYLE-SK 113
Query: 467 KIVHGNIKASNILLRPDHDACVSDFGL-----NPLFGNTTPPTRV-AGYRAPEVVETRKV 520
+H ++ A N L+ + +SDFG+ + ++ +T ++ + APE + +
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 521 TFKSDVYSFGVLLLELLT-GKAP-----NQAS--LGEEGIDLP 555
+ +SDV+SFG+LL E + G P NQ + E+G+ LP
Sbjct: 174 SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP 216
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 30/81 (37%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSG 131
S+ L G + G IPP +LG ++ L VL L N +G IP LT LR L L N SG
Sbjct: 446 SINLSGNSIRGNIPP-SLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG 504
Query: 132 VFPASV-TRMNRLTRLDLSSN 151
PA++ R+ + + N
Sbjct: 505 RVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 59/239 (24%), Positives = 104/239 (43%), Gaps = 38/239 (15%)
Query: 325 EADRNKLVFFE-------GGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKR 377
E R +L E G V+ + E L AE LG+G+ + VL V VK
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGL----AEFLGEGAPEFDGQPVL-----VAVKM 51
Query: 378 LKE--VAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHG- 434
L+ + +F +++++ ++K+ N++ L S D ++ +YM G L+ L
Sbjct: 52 LRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQR 111
Query: 435 ------SRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACV 488
+ + + N + +A+ A G+ +L S VH ++ N L+ + +
Sbjct: 112 EIESTFTHANNIPSVSIANLLYMAVQIASGMKYL-ASLNFVHRDLATRNCLVGNHYTIKI 170
Query: 489 SDFGLN---------PLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT 538
+DFG++ + G P R + A E + K T SDV++FGV L E+ T
Sbjct: 171 ADFGMSRNLYSGDYYRIQGRAVLPIR---WMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 32/205 (15%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRL----KEVAVGKREFEMQMEVLGKIKHDNVVPLRA 408
+G G+ GT A+ G V +K+L + KR + ++ +L +KH+NV+ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLD 81
Query: 409 FYYSKDEKL-------LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
+ + D L LV +M L L+ + L D + +GL +
Sbjct: 82 VF-TPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK------LSEDRIQFLVYQMLKGLKY 133
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGL-----NPLFGNTTPPTRVAGYRAPEVVE 516
+H +G I+H ++K N+ + D + + DFGL + + G TR YRAPEV+
Sbjct: 134 IHAAG-IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV--TR--WYRAPEVIL 188
Query: 517 T-RKVTFKSDVYSFGVLLLELLTGK 540
T D++S G ++ E+LTGK
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 26/162 (16%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L L L+ L L N LS ++P SNL+ L +L L N+ S P + ++ L LDL
Sbjct: 159 LRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDL 216
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFS------GNLPSI-----------------N 185
S+N+ ++ ++NL +L+GL L NNK GNL ++ +
Sbjct: 217 SNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISSLGS 275
Query: 186 PANLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDLCGGPLP 227
NLR+ ++S N+L+ ++P NL L L
Sbjct: 276 LTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALE 317
|
Length = 394 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 49/199 (24%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 355 GKGSVGTSYKAVLEEGTTVVVKRL----KEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
+G V +Y A+LE V +K+L + KR + ++ ++ + H N++ L +
Sbjct: 36 AQGIVCAAYDAILER--NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 92
Query: 411 YSK------DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
+ + +V + M A + + LD + + G+ HLH
Sbjct: 93 TPQKSLEEFQDVYIVMELMDANLCQVI--------QMELDHERMSYLLYQMLCGIKHLHS 144
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TPPTRVAGYRAPEVVETRKVT 521
+G I+H ++K SNI+++ D + DFGL G + TP YRAPEV+
Sbjct: 145 AG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 522 FKSDVYSFGVLLLELLTGK 540
D++S G ++ E++ G
Sbjct: 204 ENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 64/236 (27%), Positives = 102/236 (43%), Gaps = 31/236 (13%)
Query: 354 LGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGK----REFEMQMEVLGKIKHDNVVPLRA 408
+G+G G + A ++ G V +KR+K+ + K R + ++L K + +V L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL-- 66
Query: 409 FYYS--KDEKL-LVYDYMPAGSLSALLHGSR----GSGRTPLDWDNRMRIALSAARGLAH 461
Y+ DE L L +Y+P G LL+ R + M A+ A
Sbjct: 67 -LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM---AEMFEAVDA------ 116
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVVETR 518
LH G +H ++K N L+ ++DFGL+ G T V G Y APEV+ +
Sbjct: 117 LHELG-YIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTYANSVVGSPDYMAPEVLRGK 173
Query: 519 KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEG-IDLPRWVQSVVREEWTAEVFDV 573
F D +S G +L E L G P S E +L W +++ R + F++
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNL 229
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 352 EVLGKGSVGTSYKAVL-EEGTT---VVVKRL-KEVAVGKREFEMQM---EVLGKIKHDNV 403
++LGKG+ G K +L E T +K L KEV + K E + VL +H +
Sbjct: 1 KLLGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRI-ALSAARGLAHL 462
L+ + + D V +Y G L H SR + ++R R L +L
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFS----EDRARFYGAEIVSALGYL 111
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGL---NPLFGNTTPP-TRVAGYRAPEVVETR 518
H S +V+ ++K N++L D ++DFGL G T Y APEV+E
Sbjct: 112 H-SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 519 KVTFKSDVYSFGVLLLELLTGKAP 542
D + GV++ E++ G+ P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 341 FDLEDLLRASAEVLGKGSVGTSYKAV-LEEGTTVVVKRL----KEVAVGKREFEMQMEVL 395
FD+ + E +G G+ G A+ G V +K++ + KR ++++L
Sbjct: 1 FDVGSRYKPI-ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKIL 58
Query: 396 GKIKHDNVVPLRAFYYSKDEKL----LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRI 451
KHDN++ +R +V D M L ++H + PL + +R
Sbjct: 59 RHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQ-----PLT-EEHIRY 111
Query: 452 AL-SAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-- 508
L RGL ++H S ++H ++K SN+L+ D + + DFG+ G ++ PT
Sbjct: 112 FLYQLLRGLKYIH-SANVIHRDLKPSNLLVNEDCELRIGDFGMAR--GLSSSPTEHKYFM 168
Query: 509 --------YRAPEVV-----ETRKVTFKSDVYSFGVLLLELL 537
YRAPE++ T + D++S G + E+L
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAI----DMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 46/182 (25%), Positives = 83/182 (45%), Gaps = 30/182 (16%)
Query: 443 LDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP------- 495
LD ++ + + A+G++ L S +H ++ A NILL + DFGL
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL-ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269
Query: 496 --LFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGI 552
+ GN P + + APE + TF+SDV+S+G+LL E+ + G +P G+
Sbjct: 270 YVVKGNARLPVK---WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP------YPGM 320
Query: 553 DLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612
+ +++E + R + E ++ I C P +RP +++V++
Sbjct: 321 PVDSKFYKMIKEGY----------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370
Query: 613 IE 614
IE
Sbjct: 371 IE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 46/213 (21%)
Query: 353 VLGKGSVGT---SYKAVLEEGTTVVVKRLKEVAVGKREFEMQME--------VLGK-IKH 400
+G G+ G +Y V G V +K+L R F+ VL K + H
Sbjct: 23 PIGSGAQGIVCAAYDTVT--GQNVAIKKLS------RPFQNVTHAKRAYRELVLMKLVNH 74
Query: 401 DNVVP-LRAFYYSKDEKL-------LVYDYMPAGSLSALLHGSRGSGRTPLDWDN-RMRI 451
N++ L F + + L LV + M A +L ++ +D D+ RM
Sbjct: 75 KNIIGLLNVF--TPQKSLEEFQDVYLVMELMDA-NLCQVIQ---------MDLDHERMSY 122
Query: 452 ALSAAR-GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TPPTRVA 507
L G+ HLH +G I+H ++K SNI+++ D + DFGL G + TP
Sbjct: 123 LLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 181
Query: 508 GYRAPEVVETRKVTFKSDVYSFGVLLLELLTGK 540
YRAPEV+ D++S G ++ E++ G
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 65/282 (23%), Positives = 108/282 (38%), Gaps = 48/282 (17%)
Query: 353 VLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKR--EFEMQMEVLGKIKHDNVVPLRAFY 410
+L + T VVVK LK A K EF Q + ++H N++
Sbjct: 12 LLSEIYTDTG-------VARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQC 64
Query: 411 YSKDEKLLVYDYMPAGSLSALLHGS---RGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
LLV++Y G L + L R + + L R+A A G+ H+H
Sbjct: 65 VEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL----LQRMACEIAAGVTHMH-KHN 119
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFGN----TTPPTRVAGYR--APEVVETR--- 518
+H ++ N L D V D+G+ P T + R APE+V
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179
Query: 519 ----KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574
+ T S+V++ GV L EL A + L + + + V++++ V+
Sbjct: 180 LITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV-----LNHVIKDQ------QVK 228
Query: 575 LMRYH---NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613
L + E ++LQ P++R +EV R++
Sbjct: 229 LFKPQLELPYSERWYEVLQFCW----LSPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 50/199 (25%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 355 GKGSVGTSYKAVLEEGTTVVVKRL----KEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
+G V +Y AVL+ V +K+L + KR + ++ ++ + H N++ L +
Sbjct: 29 AQGIVCAAYDAVLDR--NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 85
Query: 411 YSK------DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
+ + LV + M A + + LD + + G+ HLH
Sbjct: 86 TPQKSLEEFQDVYLVMELMDANLCQVI--------QMELDHERMSYLLYQMLCGIKHLHS 137
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TPPTRVAGYRAPEVVETRKVT 521
+G I+H ++K SNI+++ D + DFGL G + TP YRAPEV+
Sbjct: 138 AG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 196
Query: 522 FKSDVYSFGVLLLELLTGK 540
D++S G ++ E++ K
Sbjct: 197 ENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVAVG-KREFEMQMEVLGK-IKHDNVVP 405
+G+G G Y+ V E V VK K RE +Q + + H ++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
L +++ +V + P G L + L ++ S LD + + + + LA+L S
Sbjct: 72 LIGVI-TENPVWIVMELAPLGELRSYLQVNKYS----LDLASLILYSYQLSTALAYLE-S 125
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-----YRAPEVVETRKV 520
+ VH +I A N+L+ + DFGL+ + + G + APE + R+
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 521 TFKSDVYSFGVLLLELLT-GKAPNQ 544
T SDV+ FGV + E+L G P Q
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKPFQ 210
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 66/304 (21%), Positives = 121/304 (39%), Gaps = 56/304 (18%)
Query: 354 LGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVG----KREFEMQMEVLGKIKHDNVVPLRA 408
+GKG +G Y A V +K+++E K+ F + ++ + H +VP+ +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 409 FYYSKDEKLLVYDYMP---AGSLSALLHGSRGSGRTPLDWDNR------MRIALSAARGL 459
D VY MP +L +LL + + + I +
Sbjct: 70 ICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 460 AHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL-------------------NPLFGNT 500
++H G ++H ++K NILL + + D+G N + +
Sbjct: 127 EYVHSKG-VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 501 TPPTRVAG---YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRW 557
T P ++ G Y APE + + +D+Y+ GV+L ++LT P + G + I
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK-ISYRDV 244
Query: 558 VQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQR-PAMQEVVRMIENM 616
+ S +E+ Y I L QIAM ++ P +R ++QE+ + +E
Sbjct: 245 ILS-----------PIEVAPYREIPP---FLSQIAMKALAVDPAERYSSVQELKQDLEPH 290
Query: 617 NRGE 620
+G
Sbjct: 291 LQGS 294
|
Length = 932 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 349 ASAEVLGKGSVGTSYKAV-LEEGTTVVVKRL----KEVAVGKREFEMQMEVLGKIKHDNV 403
S + +G G+ G+ A+ G V +K+L + KR + ++ +L ++H+NV
Sbjct: 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENV 76
Query: 404 VPLRAFYYSKDEKLLVYDY---MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLA 460
+ L + S D+ MP + L G PL D + GL
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMP--YMQTDLQKIMGH---PLSEDKVQYLVYQMLCGLK 131
Query: 461 HLHVSGKIVHGNIKASNILLRPDHDACVSDFGL-NPLFGNTTPPTRVAGYRAPEVVET-R 518
++H +G I+H ++K N+ + D + + DFGL T YRAPEV+
Sbjct: 132 YIHSAG-IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWM 190
Query: 519 KVTFKSDVYSFGVLLLELLTGK 540
D++S G ++ E+LTGK
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 65/271 (23%), Positives = 117/271 (43%), Gaps = 34/271 (12%)
Query: 391 QMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR 450
++ L H +V + S D+ LL+ +Y G L+ + R P
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIK-QRLKEHLPFQEYEVGL 173
Query: 451 IALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP---PTRVA 507
+ L +H S K++H ++K++NI L P + DFG + + ++ +
Sbjct: 174 LFYQIVLALDEVH-SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 508 G---YRAPEVVETRKVTFKSDVYSFGVLLLELLT----GKAPNQASLGEEGI-----DLP 555
G Y APE+ E ++ + K+D++S GV+L ELLT K P+Q + ++ + P
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP 292
Query: 556 RWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIA-MGCVSTVPDQRPAMQEVVRMIE 614
V S ++ + D L + + QLL + V+ + Q++VR E
Sbjct: 293 CPVSSGMK-----ALLDPLLSKNPALRPTTQQLLHTEFLKYVANL------FQDIVRHSE 341
Query: 615 NMNRGETDDGLRQSSDDPSKGSDGHTPPPES 645
++ + ++ LRQ + S PPP S
Sbjct: 342 TISPHDREEILRQ-----LQESGERAPPPSS 367
|
Length = 478 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 48/213 (22%), Positives = 86/213 (40%), Gaps = 32/213 (15%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQME-----------VLGKIKH 400
E +G+G+ G YKA + T +L VA+ K EM E +L +
Sbjct: 7 EKIGEGTYGKVYKA--RDKNT---GKL--VALKKTRLEMDEEGIPPTALREISLLQMLSE 59
Query: 401 DN-VVPLRAFYYSKDEK-----LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALS 454
+V L + +++ LV++Y+ + L + + PL
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 455 AARGLAHLHVSGKIVHGNIKASNILLRPDHDAC-VSDFGLNPLF----GNTTPPTRVAGY 509
+G+AH H G ++H ++K N+L+ ++D GL F + T Y
Sbjct: 119 LLKGVAHCHKHG-VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWY 177
Query: 510 RAPEV-VETRKVTFKSDVYSFGVLLLELLTGKA 541
RAPEV + + + D++S G + E+ +
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 61/202 (30%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQME-----VLGKIKHDNVVP 405
+V+GKGS G A + E VK L++ A+ K++ E + +L +KH +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRI-ALSAARGLAHLHV 464
L + + D+ V DY+ G L L R + R R A A L +LH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLH- 113
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGL--NPLFGNTTPPTRVAG--YRAPEVVETRKV 520
S IV+ ++K NILL ++DFGL + N T T Y APEV+ +
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 521 TFKSDVYSFGVLLLELLTGKAP 542
D + G +L E+L G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 7e-07
Identities = 18/40 (45%), Positives = 21/40 (52%), Gaps = 4/40 (10%)
Query: 29 QDKQALLAF---LSRTPHKNRVQWNASDSA-CNWVGVECD 64
D+ ALLAF L+ P WN S S C+W GV CD
Sbjct: 3 DDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 352 EVLGKGSVGTSYKAVLEE----GTTVVVKRLK-EVAVGKREFEMQM---EVLGKIKHDNV 403
++LGKG+ G K +L + G +K LK EV V K E + VL +H +
Sbjct: 1 KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 57
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRI-ALSAARGLAHL 462
L+ + + D V +Y G L H SR + ++R R L +L
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFS----EDRARFYGAEIVSALDYL 111
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGL--NPLFGNTTPPTRVAG--YRAPEVVETR 518
H +V+ ++K N++L D ++DFGL + T T Y APEV+E
Sbjct: 112 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 171
Query: 519 KVTFKSDVYSFGVLLLELLTGKAP 542
D + GV++ E++ G+ P
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 17/147 (11%)
Query: 403 VVPLRAFYYSKDEKLLVYDYMPAGSLSALL--HGSRGSGRTPLDWDNRMRI-ALSAARGL 459
+V + +++ D+ + D M G L L HG + MR A GL
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS--------EKEMRFYATEIILGL 110
Query: 460 AHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA--GYRAPEVVET 517
H+H + +V+ ++K +NILL +SD GL F P V GY APEV++
Sbjct: 111 EHMH-NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ- 168
Query: 518 RKVTFKS--DVYSFGVLLLELLTGKAP 542
+ + S D +S G +L +LL G +P
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 8e-07
Identities = 62/240 (25%), Positives = 90/240 (37%), Gaps = 64/240 (26%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVV--VKRLKEVAVGKR------EFEMQMEVLGKIKHDNV 403
++LGKG VG + V +GT + +K L + + KR E E+L + H +
Sbjct: 7 KLLGKGDVGRVF-LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQ--EILATLDHPFL 63
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR------ 457
L A + ++ LV DY P G L LL G ++ AR
Sbjct: 64 PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGK-----------CLSEEVARFYAAEV 112
Query: 458 --GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG------- 508
L +LH+ G IV+ ++K NILL +SDF L+ PP A
Sbjct: 113 LLALEYLHLLG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 509 --------------------------YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
Y APEV+ D ++ G+LL E+L G P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 354 LGKGSVGTSYKAVLEE-GTTVVVKRL-KEVAVGKREFEMQM---EVLGKIKHDN---VVP 405
+GKG+ G Y+ ++ +K L K+ V K+E + +L + D +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSA-ARGLAHLHV 464
L+ + + + LV DYM G L L + GR ++R + ++ L HLH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL---QKEGRFS---EDRAKFYIAELVLALEHLH- 113
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNP--LFGNTTPPT--RVAGYRAPEV-VETRK 519
IV+ ++K NILL + DFGL+ L N T T Y APEV ++ +
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 520 VTFKSDVYSFGVLLLELLTGKAP 542
T D +S GVL+ E+ G +P
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 25/205 (12%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRL-KEVAVGKREFE---MQMEVLGKIKHDNV 403
++LGKG+ G K +L G +K L KEV + K E + VL +H +
Sbjct: 1 KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRI-ALSAARGLAHL 462
L+ + + D V +Y G L H SR T + R R L +L
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFT----EERARFYGAEIVSALEYL 111
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR-----VAGYRAPEVVET 517
H S +V+ +IK N++L D ++DFGL G + T Y APEV+E
Sbjct: 112 H-SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEVLED 169
Query: 518 RKVTFKSDVYSFGVLLLELLTGKAP 542
D + GV++ E++ G+ P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-06
Identities = 19/46 (41%), Positives = 21/46 (45%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQF 129
IP L L+VL L N L+ P FS L LRSL L N
Sbjct: 15 IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLK-EVAVGKREFEMQM---EVLG-KIKHDNVVP 405
VLGKGS G A L+E G VK LK +V + + E M +L H +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
L + + D V +++ G L + SR D A L LH
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDK 115
Query: 466 GKIVHGNIKASNILLRPDHDA-C-VSDFGL--NPLFGNTTPPT--RVAGYRAPEVVETRK 519
G I++ ++K N+LL DH+ C ++DFG+ +F T T Y APE+++
Sbjct: 116 G-IIYRDLKLDNVLL--DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 520 VTFKSDVYSFGVLLLELLTGKAPNQA 545
D ++ GVLL E+L G AP +A
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 352 EVLGKGSVGTSY---KAV-LEEGTTVVVKRLKEVAVGKRE-----FEMQMEVLGKIKHDN 402
+VLG G+ G + K + G +K L++ A+ ++ + VL ++
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 403 VVPLRAFYYSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
+ + + + KL L+ DY+ G + L+ R D + L H
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEH 120
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF-----GNTTPPTRVAGYRAPEVVE 516
LH G IV+ +IK NILL + ++DFGL+ F T Y APE++
Sbjct: 121 LHKLG-IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR 179
Query: 517 TRKVTFKS-DVYSFGVLLLELLTGKAP 542
+ K+ D +S G+L+ ELLTG +P
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 353 VLGKGSVGTSYKAVLEE--GTTVV--VKRLK-EVAVGKREFEMQM---EVLG-KIKHDNV 403
VLGKGS G K +L E GT + +K LK +V + + E M VL K +
Sbjct: 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL 63
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSR-GSGRTPLDWDNRMRIALSAARGLAHL 462
L + + + D V +Y+ G L + H + G + P + + A A GL L
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEP----HAVFYAAEIAIGLFFL 117
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGL--NPLFGNTTPPT--RVAGYRAPEVVETR 518
H G I++ ++K N++L + ++DFG+ +FG T T Y APE++ +
Sbjct: 118 HSKG-IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQ 176
Query: 519 KVTFKSDVYSFGVLLLELLTGKAP 542
D ++FGVLL E+L G+ P
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 352 EVLGKGSVGTSY----KAVLEEGTTVVVKRLKEVAVGKR-----EFEMQMEVLGKIKHDN 402
+VLG G+ G + + + G +K LK+ + ++ + +VL I+
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 403 VVPLRAFYYSKDEKL-LVYDYMPAGSL-SALLHGSRGSGRTPLDWDNRMRIALSAARGLA 460
+ + + D KL L+ DY+ G L + L R + + + +AL
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE------ 119
Query: 461 HLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF--GNTTPPTRVAG---YRAPEVV 515
HLH G I++ +IK NILL + ++DFGL+ F G Y AP++V
Sbjct: 120 HLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 516 ETRKVTFKS--DVYSFGVLLLELLTGKAP 542
D +S GVL+ ELLTG +P
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKRE---FEM----QMEVLGKIKHDNVVPL 406
+G+G+ G YKA ++G K KE A+ + E M ++ +L ++KH NV+ L
Sbjct: 9 VGRGTYGHVYKAKRKDG-----KDEKEYALKQIEGTGISMSACREIALLRELKHPNVIAL 63
Query: 407 RAFYYSKDEK--LLVYDYMPAGSLSAL-LHGSRGSGRTPLDWDNRMRIAL--SAARGLAH 461
+ + S ++ L++DY + H + + + P+ M +L G+ +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 462 LHVSGKIVHGNIKASNILLR---PDHDAC-VSDFGLNPLFGNTTPP-------TRVAGYR 510
LH + ++H ++K +NIL+ P+ ++D G LF + P YR
Sbjct: 124 LHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 511 APE-VVETRKVTFKSDVYSFGVLLLELLTGK 540
APE ++ R T D+++ G + ELLT +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 353 VLGKGSVGTSYKAVLEE--GTT--VVVKRLK-EVAVGKREFEMQM---EVLG-KIKHDNV 403
VLGKGS G K +L E GT +K LK +V + + E M VL K +
Sbjct: 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFL 63
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
L + + + D V +Y+ G L + G + P + + A A GL LH
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEP----HAVFYAAEIAIGLFFLH 118
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGL---NPLFGNTTPP-TRVAGYRAPEVVETRK 519
G I++ ++K N++L + ++DFG+ N G TT Y APE++ +
Sbjct: 119 SKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 520 VTFKSDVYSFGVLLLELLTGKAP 542
D ++FGVLL E+L G+AP
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 33/208 (15%)
Query: 352 EVLGKGSVGTSYKA---VLEEGTTVVVK--RLKEVAVGKREFEM-QMEVLGKIKHDNVVP 405
E +G+G+ G YKA V E T+ +K RL++ G + ++ +L +++H N+V
Sbjct: 8 EKIGEGTYGVVYKARDRVTNE--TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVR 65
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALS----AARGLAH 461
L+ +S+ LV++Y+ L + +P D+ R+ + RG+A+
Sbjct: 66 LQDVVHSEKRLYLVFEYLD-------LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAY 117
Query: 462 LHVSGKIVHGNIKASNILL-RPDHDACVSDFGLNPLFGNTTPPTRVAG-------YRAPE 513
H S +++H ++K N+L+ R + ++DFGL FG P R YRAPE
Sbjct: 118 CH-SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG---IPVRTFTHEVVTLWYRAPE 173
Query: 514 V-VETRKVTFKSDVYSFGVLLLELLTGK 540
+ + +R + D++S G + E++ K
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 56/251 (22%), Positives = 99/251 (39%), Gaps = 35/251 (13%)
Query: 371 TTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSA 430
+VV+K L F ++ ++ H ++V L +DE ++V +Y+ G L
Sbjct: 31 VSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCV-RDENIMVEEYVKFGPLDV 89
Query: 431 LLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL-------RPD 483
LH + + L W ++ +A A L +L K+VHGN+ NIL+
Sbjct: 90 FLHREKNN--VSLHW--KLDVAKQLASALHYLE-DKKLVHGNVCGKNILVARYGLNEGYV 144
Query: 484 HDACVSDFGLNPLFGNTTPPTRVAGYRAPEVVE--TRKVTFKSDVYSFGVLLLELLT-GK 540
+SD G+ + + APE + +T +D +SFG LLE+ + G+
Sbjct: 145 PFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
Query: 541 APNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVP 600
P E + Q + AE+ L+ C + P
Sbjct: 205 EPLSTLSSSEKERFYQ-DQHRLPMPDCAELA--NLI----------------NQCWTYDP 245
Query: 601 DQRPAMQEVVR 611
+RP+ + ++R
Sbjct: 246 TKRPSFRAILR 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 50/198 (25%), Positives = 85/198 (42%), Gaps = 20/198 (10%)
Query: 373 VVVKRLKEVAVGK--REFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSA 430
V + L+ K R F + LG+ H N+V L + ++V +YM G+L +
Sbjct: 36 VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS 95
Query: 431 LLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSD 490
L G L M + A G+ +L G VH + A +L+ D +S
Sbjct: 96 FLRKHEGQ----LVAGQLMGMLPGLASGMKYLSEMG-YVHKGLAAHKVLVNSDLVCKISG 150
Query: 491 FGLNPLFGNTTPPTRVAG-----YRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAP-- 542
F + T ++G + APE ++ + SDV+SFG+++ E+++ G+ P
Sbjct: 151 FRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW 210
Query: 543 ---NQASLG--EEGIDLP 555
Q + E+G LP
Sbjct: 211 DMSGQDVIKAVEDGFRLP 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 59/203 (29%), Positives = 88/203 (43%), Gaps = 20/203 (9%)
Query: 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRL-KEVAVGKREFEMQME----VLGKIKHDNVVP 405
+V+GKGS G A + +G+ VK L K+ + K+E M +L +KH +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRI-ALSAARGLAHLHV 464
L + + ++ V DY+ G L L R P R R A A + +LH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRER-CFLEP-----RARFYAAEVASAIGYLH- 113
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGL-----NPLFGNTTPPTRVAGYRAPEVVETRK 519
S I++ ++K NILL ++DFGL P T+ Y APEV+
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEP 172
Query: 520 VTFKSDVYSFGVLLLELLTGKAP 542
D + G +L E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 10/91 (10%)
Query: 457 RGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL------NPLFGNTTPPTRVAGYR 510
RGL ++H S ++H ++K SN+LL + D + DFGL F TR YR
Sbjct: 119 RGLKYIH-SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR--WYR 175
Query: 511 APEVV-ETRKVTFKSDVYSFGVLLLELLTGK 540
APE++ + T DV+S G + ELL K
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 31/210 (14%)
Query: 352 EVLGKGSVGTSYKAVLEE--------GTTVVVKRLKEVAVGKRE-FEMQMEVLGKIKHDN 402
E LG+G+ +K + E T V++K L + E F ++ ++ H +
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 403 VVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
+V DE ++V +Y+ GSL L + + W ++ +A A L L
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISW--KLEVAKQLAWALHFL 116
Query: 463 HVSGKIVHGNIKASNILLRPDHDAC--------VSDFGLNPLFGNTTPPTRVAGYR---- 510
G + HGN+ A N+LL + D +SD G++ T P + R
Sbjct: 117 EDKG-LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI----TVLPKEILLERIPWV 171
Query: 511 APEVVE-TRKVTFKSDVYSFGVLLLELLTG 539
PE +E + ++ +D +SFG L E+ +G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 3e-06
Identities = 18/59 (30%), Positives = 27/59 (45%)
Query: 119 LRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKF 177
L+SL L +N+ + + + + L LDLS NN + P + L L L L N
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 21/196 (10%)
Query: 357 GSVGTSYKAVLEEGTTVVVKRLK---EVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK 413
GSV ++Y L + V VK+L + + R ++ +L +KH+NV+ L +
Sbjct: 29 GSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPA 86
Query: 414 ------DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
+E LV + M A L+ ++ + L ++ + RGL ++H +G
Sbjct: 87 TSIENFNEVYLVTNLMGA-DLNNIVKCQK------LSDEHVQFLIYQLLRGLKYIHSAG- 138
Query: 468 IVHGNIKASNILLRPDHDACVSDFGL-NPLFGNTTPPTRVAGYRAPEV-VETRKVTFKSD 525
I+H ++K SN+ + D + + DFGL T YRAPE+ + D
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVD 198
Query: 526 VYSFGVLLLELLTGKA 541
++S G ++ ELL GKA
Sbjct: 199 IWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 46/183 (25%), Positives = 87/183 (47%), Gaps = 21/183 (11%)
Query: 373 VVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSA 430
V VK L+E A + +F +++++ ++K N++ L A + D ++ +YM G L+
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 431 LL--HGSRGSG----RTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH 484
L H + + + + + +A A G+ +L S VH ++ N L+ ++
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS-SLNFVHRDLATRNCLVGKNY 167
Query: 485 DACVSDFGLNP---------LFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLE 535
++DFG++ + G P R + + E + K T SDV++FGV L E
Sbjct: 168 TIKIADFGMSRNLYSGDYYRIQGRAVLPIR---WMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 536 LLT 538
+LT
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 34/208 (16%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVK--RLKEVAVGK-----REFEMQMEVLGKIKHDNV 403
E +G+G+ G YKA G V +K RL+ G RE + +L ++ H N+
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE----ISLLKELNHPNI 60
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIA---LSAARGLA 460
V L +S+++ LV++++ L + +PL + I +G+A
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDL-DLKKYMD------SSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 461 HLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-------YRAPE 513
+ H S +++H ++K N+L+ + ++DFGL FG P R YRAPE
Sbjct: 114 YCH-SHRVLHRDLKPQNLLIDREGALKLADFGLARAFG---VPVRTYTHEVVTLWYRAPE 169
Query: 514 V-VETRKVTFKSDVYSFGVLLLELLTGK 540
+ + +R+ + D++S G + E++ +
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 51/207 (24%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 354 LGKGSVGTSYKAVLEEGTT---VVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
+G+G+ G YKA ++G +K+++ + ++ +L ++KH NV+ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQKVF 67
Query: 411 YSK-DEKL-LVYDYMPAGSLSAL-LHGSRGSGRTPLDWDNRMRIAL--SAARGLAHLHVS 465
S D K+ L++DY + H + + + P+ M +L G+ +LH +
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 466 GKIVHGNIKASNILLR---PDHDAC-VSDFGLNPLFGNTTPP-------TRVAGYRAPE- 513
++H ++K +NIL+ P+ ++D G LF + P YRAPE
Sbjct: 128 W-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186
Query: 514 VVETRKVTFKSDVYSFGVLLLELLTGK 540
++ R T D+++ G + ELLT +
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 39/132 (29%), Positives = 66/132 (50%), Gaps = 6/132 (4%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTL-LRSLYLQSNQFSGVFPASVTRMNRLT 144
+ L +L+ L L L +N ++ +IP L L+ L L N+ P+ + + L
Sbjct: 109 ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLK 166
Query: 145 RLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSIN-PANLRDFNVSNNNLNGSI 203
LDLS N+ S +P ++NL++L L L NK S P I + L + ++SNN++ +
Sbjct: 167 NLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-EL 224
Query: 204 PATLSKFPQSSF 215
++LS S
Sbjct: 225 LSSLSNLKNLSG 236
|
Length = 394 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 37/124 (29%), Positives = 53/124 (42%), Gaps = 4/124 (3%)
Query: 87 NTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRL 146
L L L L L NRL I LT L SL L +N + + P + L L
Sbjct: 87 ENLLNLLPLPSLDLNLNRLRSNISELL-ELTNLTSLDLDNNNITDIPPLIGLLKSNLKEL 145
Query: 147 DLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPA 205
DLS N +P + NL +L L L N S + N +NL + ++S N ++ +P
Sbjct: 146 DLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPP 203
Query: 206 TLSK 209
+
Sbjct: 204 EIEL 207
|
Length = 394 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 33/93 (35%), Positives = 47/93 (50%), Gaps = 10/93 (10%)
Query: 457 RGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPT-----RVAG--Y 509
R L ++H + + H ++K NIL D + DFGL + N TP VA Y
Sbjct: 114 RALKYIH-TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172
Query: 510 RAPEVVET--RKVTFKSDVYSFGVLLLELLTGK 540
RAPE+ + K T D++S G + E+LTGK
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 51/197 (25%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 357 GSVGTSYKAVLEEGTTVVVKRL----KEVAVGKREFEMQMEVLGKIKHDNVV-------P 405
GSV ++ + G V VK+L + + KR + ++ +L +KH+NV+ P
Sbjct: 31 GSVCAAFDT--KTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTP 87
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
R+ D L+ + + L+ ++ + L D+ + RGL ++H S
Sbjct: 88 ARSLEEFNDVYLVTH--LMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH-S 138
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN-TTPPTRVAGYRAPEV-VETRKVTFK 523
I+H ++K SN+ + D + + DFGL + T YRAPE+ +
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT 198
Query: 524 SDVYSFGVLLLELLTGK 540
D++S G ++ ELLTG+
Sbjct: 199 VDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 44/160 (27%), Positives = 68/160 (42%), Gaps = 25/160 (15%)
Query: 400 HDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALL--HGSRGSGRTPLDWDNRMRIALSAAR 457
H N+VP RA + + +E +V +M GS L+ H G + + I +
Sbjct: 58 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY-----ILQGVLK 112
Query: 458 GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR------------ 505
L ++H G VH ++KAS+IL+ D +S GL R
Sbjct: 113 ALDYIHHMG-YVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSV 169
Query: 506 -VAGYRAPEVVETRKVTF--KSDVYSFGVLLLELLTGKAP 542
V + +PEV++ + KSD+YS G+ EL G P
Sbjct: 170 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 7e-06
Identities = 41/163 (25%), Positives = 61/163 (37%), Gaps = 27/163 (16%)
Query: 399 KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARG 458
+ N + L + +L+ DY+ G L LL L +I
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEA 121
Query: 459 LAHLHVSGKIVHGNIKASNILL-RPDHDACVSDFGLNPLFGNTTPPTRVAG--------- 508
L LH I+H +IK N+L R + D+GL ++ G
Sbjct: 122 LNDLH-KHNIIHNDIKLENVLYDRAKDRIYLCDYGL----------CKIIGTPSCYDGTL 170
Query: 509 -YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEE 550
Y +PE ++ D ++ GVL ELLTGK P + EE
Sbjct: 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 7/104 (6%)
Query: 457 RGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG-----NTTPPTRVAGYRA 511
RGL +LH S I+H +IK N+L+ + + DFGL + + T YRA
Sbjct: 114 RGLKYLH-SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 512 PEV-VETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDL 554
PE+ + +R T D++S G + ELL + QA + +DL
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL 216
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 37/212 (17%)
Query: 354 LGKGSVGT---SYKAVLEEGTTVVVKRLKEVAVGK-------REFEMQMEVLGKIKHDNV 403
LG+G+ G + A E TV +K++ V K RE ++ G H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG---HKNI 64
Query: 404 VPLR----AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGL 459
L F + +E L + M A L ++ + PL + GL
Sbjct: 65 TCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQ-----PLTDAHFQSFIYQILCGL 118
Query: 460 AHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL----NPLFGNTTP------PTRVAGY 509
++H S ++H ++K N+L+ D + + DFGL + G TR Y
Sbjct: 119 KYIH-SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR--WY 175
Query: 510 RAPEVVETRKVTFKS-DVYSFGVLLLELLTGK 540
RAPE++ + + K+ DV+S G +L ELL K
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 40/146 (27%), Positives = 69/146 (47%), Gaps = 14/146 (9%)
Query: 403 VVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
+V L + + + LV +Y+ G L + H R + L ++ A L L
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQR---QRKLPEEHARFYAAEICIALNFL 112
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFG-----LNPLFGNTTPP-TRVAGYRAPEVVE 516
H G I++ ++K N+LL D ++D+G L P G+TT Y APE++
Sbjct: 113 HERG-IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILR 169
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKAP 542
+ F D ++ GVL+ E++ G++P
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 352 EVLGKGSVGTSYKAVLE-EGTTVVVK--RLKEVAVGKREFEMQMEVLGKIKHDNVVPLRA 408
E LG+GS T YK + G V +K RL+E + +L +KH N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
++K+ LV++Y+ L + G G P +N RGL+++H I
Sbjct: 71 IIHTKETLTLVFEYVHT-DLCQYMDKHPG-GLHP---ENVKLFLFQLLRGLSYIH-QRYI 124
Query: 469 VHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG------YRAPEV-VETRKVT 521
+H ++K N+L+ + ++DFGL + P + YR P+V + + + +
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 522 FKSDVYSFGVLLLELLTGKA 541
D++ G + +E++ G A
Sbjct: 183 TCLDMWGVGCIFVEMIQGVA 202
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 14/149 (9%)
Query: 400 HDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGL 459
H +V L + + ++ V +Y+ G L + H R + P + +S A L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR-QRKLPEEHARFYSAEISLA--L 109
Query: 460 AHLHVSGKIVHGNIKASNILLRPDHDACVSDFG-----LNPLFGNTTPP-TRVAGYRAPE 513
+LH G I++ ++K N+LL + ++D+G L P G+TT Y APE
Sbjct: 110 NYLHERG-IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPE 166
Query: 514 VVETRKVTFKSDVYSFGVLLLELLTGKAP 542
++ F D ++ GVL+ E++ G++P
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 44/156 (28%), Positives = 68/156 (43%), Gaps = 16/156 (10%)
Query: 394 VLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIAL 453
VL ++ +VPL+ + S ++ LV ++ G L H + GR + R
Sbjct: 46 VLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL---FHHLQREGRF-----DLSRARF 97
Query: 454 SAAR---GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPL-FGNTTPPTRVAG- 508
A L +LH +++ ++K NILL + DFGL L + G
Sbjct: 98 YTAELLCALENLH-KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGT 156
Query: 509 --YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
Y APE++ T D ++ GVLL E+LTG P
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 49/182 (26%), Positives = 74/182 (40%), Gaps = 16/182 (8%)
Query: 371 TTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428
VVVK L+ A + +F + + ++H N++ LLV ++ P G L
Sbjct: 23 AQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDL 82
Query: 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACV 488
L R + D R+A A GL HLH +H ++ N LL D +
Sbjct: 83 KGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-KNNFIHSDLALRNCLLTADLTVKI 141
Query: 489 SDFGLNPLFGN----TTPPTRVAGYR--APEVVE-------TRKVTFKSDVYSFGVLLLE 535
D+GL+ TP R APE+V+ T +S+V+S GV + E
Sbjct: 142 GDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWE 201
Query: 536 LL 537
L
Sbjct: 202 LF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 47/213 (22%), Positives = 88/213 (41%), Gaps = 19/213 (8%)
Query: 337 GVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLG 396
G + LRAS E S + ++ KR+K + + E ++ LG
Sbjct: 159 GAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALG 218
Query: 397 KIKHDNVVPLRAFYYSKDEKLLV---YDYMPAGSLSALLHGSRGSGRTPLDWDNR--MRI 451
++ H+N++ + S+ ++ YD+ S + + PL R M+
Sbjct: 219 RLNHENILKIEEILRSEANTYMITQKYDF---DLYSFMYDEAFDWKDRPLLKQTRAIMKQ 275
Query: 452 ALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGY-- 509
L A + ++H K++H +IK NI L D + DFG F G+
Sbjct: 276 LLCA---VEYIH-DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVG 330
Query: 510 ----RAPEVVETRKVTFKSDVYSFGVLLLELLT 538
+PE++ +D++S G++LL++L+
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 353 VLGKGSVGTSYKA---------------VLEEGTTVVVKRLKEVAVGKREFEMQMEVLGK 397
VLGKG G ++ VL++ T +V+ K+ A K E +L
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKAT--IVRNQKDTAHTKAE----RNILEA 56
Query: 398 IKHDNVVPLRAFYYSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSA- 455
+KH +V L + + KL L+ +Y+ G L L R + ++ LS
Sbjct: 57 VKHPFIVDL-IYAFQTGGKLYLILEYLSGGELFMHLE------REGIFMEDTACFYLSEI 109
Query: 456 ARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL--NPLFGNTTPPTRVAG--YRA 511
+ L HLH G I++ ++K NILL ++DFGL + T T Y A
Sbjct: 110 SLALEHLHQQG-IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMA 168
Query: 512 PEVVETRKVTFKS-DVYSFGVLLLELLTGKAPNQASLGEEGID 553
PE++ R K+ D +S G L+ ++LTG P A ++ ID
Sbjct: 169 PEIL-MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 353 VLGKGSVGTSYKAVLEEGTTVV--VKRLKEVAVGKRE----FEMQMEVLGKIKHDNVVPL 406
++G+G G + V E+ T + +K +K+ + +E FE + ++L + L
Sbjct: 8 LVGRGHFG-EVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH-LHVS 465
+ + KD LV +Y P G L +LL +R D ++ + L+ H +H
Sbjct: 67 QYAFQDKDNLYLVMEYQPGGDLLSLL--NRYED--QFD-EDMAQFYLAELVLAIHSVHQM 121
Query: 466 GKIVHGNIKASNILL-RPDHDACVSDFGLNPLFG-----NTTPPTRVAGYRAPEVVETRK 519
G VH +IK N+L+ R H DFG N+ P Y APEV+ T
Sbjct: 122 G-YVHRDIKPENVLIDRTGHIKLA-DFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 520 VTFKS------DVYSFGVLLLELLTGKAP 542
K D +S GV+ E++ G++P
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 29/173 (16%)
Query: 399 KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARG 458
+H N++ + + ++ +M GS ++LL G + N I A RG
Sbjct: 57 RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN---ILFGALRG 113
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF-----GNTTP--------PTR 505
L +LH +G I H NIKAS+IL+ D VS GL+ L+ G T
Sbjct: 114 LNYLHQNGYI-HRNIKASHILI--SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTS 170
Query: 506 VAGYRAPEVV--ETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPR 556
V + +PE++ + KSD+YS G+ EL TG+ P Q D+ R
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ--------DMLR 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 60/236 (25%), Positives = 96/236 (40%), Gaps = 38/236 (16%)
Query: 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLK--EVAVGKREFEMQME--VLGKIKHDNVVPL 406
E LG GS G A + G +K LK E+ K+ + E +L ++ H +V +
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLA--HLHV 464
+ ++ + +++ G L L R +GR P N + A LA +LH
Sbjct: 84 MCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFP----NDVAKFYHAELVLAFEYLH- 135
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNP--------LFGNTTPPTRVAGYRAPEVVE 516
S I++ ++K N+LL V+DFG L G TP Y APEV++
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCG--TPE-----YLAPEVIQ 188
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKAP--------NQASLGEEGIDLPRWVQSVVRE 564
++ D ++ GVLL E + G P + + P W R+
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARD 244
|
Length = 329 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 55/240 (22%), Positives = 104/240 (43%), Gaps = 25/240 (10%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFE-----MQMEVLGKIKHDNVVPLRA 408
LG+G+ T YK + +V LKE+ + E ++ +L +KH N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVA--LKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
+++ LV++Y+ L L S ++ N RGL + H K+
Sbjct: 72 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNS----INMHNVKLFLFQLLRGLNYCH-RRKV 125
Query: 469 VHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-------YRAPEV-VETRKV 520
+H ++K N+L+ + ++DFGL + PT+ YR P++ + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARA---KSIPTKTYSNEVVTLWYRPPDILLGSTDY 182
Query: 521 TFKSDVYSFGVLLLELLTGKAPNQASLGEEGID-LPRWVQSVVREEWTAEVFDVELMRYH 579
+ + D++ G + E+ TG+ S EE + + R + + E W + + E Y+
Sbjct: 183 STQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN 242
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 353 VLGKGSVGTSYKAVLEE----GTTVVVKRLK-EVAVGKREFEMQM---EVLGKI-KHDNV 403
VLGKGS G K +L E +K LK +V + + E M VL K +
Sbjct: 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFL 63
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSR-GSGRTPLDWDNRMRIALSAARGLAHL 462
L + + + D V +Y+ G L + H + G + P + A + GL L
Sbjct: 64 TQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEP----QAVFYAAEISVGLFFL 117
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGL---NPLFGNTTPP-TRVAGYRAPEVVETR 518
H G I++ ++K N++L + ++DFG+ + + G TT Y APE++ +
Sbjct: 118 HRRG-IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQ 176
Query: 519 KVTFKSDVYSFGVLLLELLTGKAP 542
D +++GVLL E+L G+ P
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 33/209 (15%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG--KREFEM----QMEVLGKIKHDNVVPLR 407
+G+G+ G +KA ++ +V LK+V + K F + ++++L +KH+NVV L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVA--LKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 408 AFYYSKDEK--------LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNR-MRIALSAARG 458
+K LV+++ L+ LL S + + L + M++ L+ G
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFC-EHDLAGLL--SNKNVKFTLSEIKKVMKMLLN---G 131
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG---NTTPP---TRVAG--YR 510
L ++H KI+H ++KA+NIL+ D ++DFGL F N+ P RV YR
Sbjct: 132 LYYIH-RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 511 APEV-VETRKVTFKSDVYSFGVLLLELLT 538
PE+ + R D++ G ++ E+ T
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 49/197 (24%), Positives = 86/197 (43%), Gaps = 15/197 (7%)
Query: 353 VLGKGSVGTSYKAVLEEGTTVV-VKRLKEVAVGKREFEM---QMEVLGKIKHDNVVPLRA 408
V+G+G+ G K +E +V +K+ K+ + E ++++L +K +N+V L+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
+ + + LV++Y+ L L G P + L A H I
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGV---PPEKVRSYIYQLIKAIHWCH---KNDI 121
Query: 469 VHGNIKASNILLRPDHDACVSDFGL--NPLFGNTTPPTRVAG---YRAPEVVETRKVTFK 523
VH +IK N+L+ + + DFG N G+ T YR+PE++
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 524 SDVYSFGVLLLELLTGK 540
D++S G +L EL G+
Sbjct: 182 VDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 44/214 (20%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRLK--------------EVAVGKR--EFEMQ----- 391
+G G+ GT YKA G V +K ++ EVA+ KR F+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 392 MEVLGKIKHDNVVPLRAFYYSKDEKLLVY-DYMPAGSLSALLHGSRGSGRTPLD-WDNRM 449
M+V + D + + D+ L Y D +P L P + + M
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGL-------------PAETIKDLM 114
Query: 450 RIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG---NTTPPTRV 506
R L RGL LH + IVH ++K NIL+ ++DFGL ++ TP
Sbjct: 115 RQFL---RGLDFLHAN-CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVT 170
Query: 507 AGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGK 540
YRAPEV+ D++S G + E+ K
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 41/153 (26%), Positives = 63/153 (41%), Gaps = 28/153 (18%)
Query: 406 LRAFYYSKDEKLL--VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
++ Y +D+K L V +YMP G L L+ + P W R A L +H
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKW-ARFYTA-EVVLALDAIH 159
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----------TPPTRVAGYRAPE 513
G +H ++K N+LL ++DFG TP Y +PE
Sbjct: 160 SMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTP-----DYISPE 213
Query: 514 VVETRKVT----FKSDVYSFGVLLLELLTGKAP 542
V++++ + D +S GV L E+L G P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 49/216 (22%), Positives = 88/216 (40%), Gaps = 41/216 (18%)
Query: 354 LGKGSVGTSYKAVLEE-GTTVVVKRL-----KEVAVGKREFEMQMEVLGKIKHDNVVPLR 407
LG GS G + AV + V VK++ + V RE ++++ ++ HDN+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALRE----IKIIRRLDHDNIVKVY 68
Query: 408 AFYYSKDEKL--------------LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIAL 453
L +V +YM + L G PL ++
Sbjct: 69 EVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQG-------PLSEEHARLFMY 121
Query: 454 SAARGLAHLHVSGKIVHGNIKASNILLRPDHDAC-VSDFGLNPLF-------GNTTPPTR 505
RGL ++H S ++H ++K +N+ + + + DFGL + G +
Sbjct: 122 QLLRGLKYIH-SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 506 VAGYRAPEVV-ETRKVTFKSDVYSFGVLLLELLTGK 540
YR+P ++ T D+++ G + E+LTGK
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 45/191 (23%), Positives = 81/191 (42%), Gaps = 31/191 (16%)
Query: 373 VVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSA 430
V VK L+ A + +F ++++L ++K N++ L +D ++ +YM G L+
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 431 LLH---------------GSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKA 475
L + + + +AL A G+ +L S VH ++
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAI-SYSSLLHVALQIASGMKYL-SSLNFVHRDLAT 166
Query: 476 SNILLRPDHDACVSDFGLN---------PLFGNTTPPTRVAGYRAPEVVETRKVTFKSDV 526
N L+ + ++DFG++ + G P R + A E + K T SDV
Sbjct: 167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR---WMAWECILMGKFTTASDV 223
Query: 527 YSFGVLLLELL 537
++FGV L E+L
Sbjct: 224 WAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 25/205 (12%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKI---------KHDNV 403
+G+G+ G +KA L+ G V LK V V E M + + ++ +H NV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 404 VPL----RAFYYSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARG 458
V L ++ KL LV++++ L+ L G + M RG
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM---FQLLRG 122
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA---GYRAPEVV 515
L LH S ++VH ++K NIL+ ++DFGL ++ T V YRAPEV+
Sbjct: 123 LDFLH-SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 181
Query: 516 ETRKVTFKSDVYSFGVLLLELLTGK 540
D++S G + E+ K
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 13/112 (11%)
Query: 449 MRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG 508
+ I S R + +LH +I+H +IKA NI + D C+ DFG F + G
Sbjct: 185 LAIERSVLRAIQYLH-ENRIIHRDIKAENIFINHPGDVCLGDFGA-ACFPVDINANKYYG 242
Query: 509 Y------RAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGE-EGID 553
+ APE++ D++S G++L E+ T SL E +G+D
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC----HDSLFEKDGLD 290
|
Length = 391 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 415 EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIK 474
E ++V +++ G L L + GR P+ W ++ +A A L++L +VHGN+
Sbjct: 90 ENIMVEEFVEHGPLDVCLR--KEKGRVPVAW--KITVAQQLASALSYLE-DKNLVHGNVC 144
Query: 475 ASNILL--RPDHDAC-----VSDFGLNPLFGNTTPPTRVA--GYRAPEVVET-RKVTFKS 524
A NILL + +SD G++ F + RV + APE V ++ +
Sbjct: 145 AKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERVERIPWIAPECVPGGNSLSTAA 202
Query: 525 DVYSFGVLLLEL-LTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583
D +SFG LLE+ G+ P + E E F + H + E
Sbjct: 203 DKWSFGTTLLEICFDGEVPLKERTPSE-----------------KERF---YEKKHRLPE 242
Query: 584 EMVQLLQIAMG-CVSTVPDQRPAMQEVVR 611
+ L + C++ P QRP+ + ++R
Sbjct: 243 PSCKELATLISQCLTYEPTQRPSFRTILR 271
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKRE---FEMQMEV--LGKIKHDNVVPL 406
+ LG+GS T YK + +V LKE+ + E F E L +KH N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVA--LKEIRLEHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIAL-SAARGLAHLHVS 465
++K LV++Y+ L + G G + + +R+ L RGLA+ H
Sbjct: 69 HDIIHTKKTLTLVFEYLDT-DLKQYMD-DCGGGLSM----HNVRLFLFQLLRGLAYCH-Q 121
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-------YRAPEVV-ET 517
+++H ++K N+L+ + ++DFGL + P++ YR P+V+ +
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLARA---KSVPSKTYSNEVVTLWYRPPDVLLGS 178
Query: 518 RKVTFKSDVYSFGVLLLELLTGKA 541
+ + D++ G + E+ TG+
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 53/229 (23%), Positives = 98/229 (42%), Gaps = 25/229 (10%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFE-----MQMEVLGKIKHDNVVPL 406
E LG+G+ T +K + +V LKE+ + E ++ +L +KH N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVA--LKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
++ LV++Y L L + N RGLA+ H
Sbjct: 70 HDIVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH-RR 123
Query: 467 KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-------YRAPEV-VETR 518
K++H ++K N+L+ + ++DFGL + PT+ YR P+V + +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARA---KSVPTKTYSNEVVTLWYRPPDVLLGSS 180
Query: 519 KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLP-RWVQSVVREEW 566
+ + + D++ G + E+ +G+ S E+ + L R + + E W
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 4e-04
Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 14/90 (15%)
Query: 457 RGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG-NTTPP------TRVAGY 509
+ L H+H +G I H +IK NIL++ D ++DFG G + PP TR Y
Sbjct: 111 KSLDHMHRNG-IFHRDIKPENILIKDDILK-LADFG--SCRGIYSKPPYTEYISTR--WY 164
Query: 510 RAPEVVETRKV-TFKSDVYSFGVLLLELLT 538
RAPE + T K D+++ G + E+L+
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFE-----MQMEVLGKIKHDNVVPLRA 408
LG+G+ T +K + +V LKE+ + E ++ +L +KH N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVA--LKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
+++ LV++Y+ S L G + N RGL++ H KI
Sbjct: 71 IIHTERCLTLVFEYLD----SDLKQYLDNCGNL-MSMHNVKIFMFQLLRGLSYCH-KRKI 124
Query: 469 VHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-------YRAPEV-VETRKV 520
+H ++K N+L+ + ++DFGL + PT+ YR P+V + + +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARA---KSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 521 TFKSDVYSFGVLLLELLTGK 540
+ D++ G +L E+ TG+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 56/180 (31%), Positives = 73/180 (40%), Gaps = 53/180 (29%)
Query: 403 VVPLRAFYYSKDEKLL--VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIA-LSAARGL 459
+V L +Y +DE+ L V +YMP G L LL R P + R IA L A L
Sbjct: 63 IVKL--YYSFQDEEHLYLVMEYMPGGDLMNLL--IR-KDVFPEET-ARFYIAELVLA--L 114
Query: 460 AHLHVSGKIVHGNIKASNILLRPDHDAC----VSDFGL------------------NPLF 497
+H G I H +IK NIL+ DA ++DFGL N LF
Sbjct: 115 DSVHKLGFI-HRDIKPDNILI----DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 498 GNTTPPTR------------VAG---YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
+ R G Y APEV+ + D +S GV+L E+L G P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 14/197 (7%)
Query: 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQME--VLGKIKHDNVVPLRA 408
E LG+GS T YK + G V +K + F E +L +KH N+V L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
++K+ V++YM ++ G L N RGLA++H I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRLFMFQLLRGLAYIH-GQHI 124
Query: 469 VHGNIKASNILLRPDHDACVSDFGL--NPLFGNTTPPTRVAG--YRAPEVV-ETRKVTFK 523
+H ++K N+L+ + ++DFGL + T + V YR P+V+ +
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA 184
Query: 524 SDVYSFGVLLLELLTGK 540
D++ G + +E+L G+
Sbjct: 185 LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 22/159 (13%)
Query: 397 KIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAA 456
++ H ++V L E ++V +++ G L +H TP W + ++A A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTP--W--KFKVAKQLA 115
Query: 457 RGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP--PTRVAG------ 508
L++L +VHGN+ NILL + + G P + P P V
Sbjct: 116 SALSYLE-DKDLVHGNVCTKNILLA--REGIDGECG--PFIKLSDPGIPITVLSRQECVE 170
Query: 509 ---YRAPEVVE-TRKVTFKSDVYSFGVLLLEL-LTGKAP 542
+ APE VE ++ ++ +D +SFG L E+ G+ P
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 9e-04
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTV-VVKRLKEVAVGKRE----FEMQMEVLGKIKHDNVVPL 406
+V+G+G+ G L+ V +K L + + KR F + +VL + + L
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLD----WDNRMRIALSAARGLAHL 462
+ ++ LV DY G L LL S+ R P D + M IA+ + L +
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLAEMVIAIDSVHQLHY- 123
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFG--LNPLFGNTTPPTRVAG---YRAPEVVET 517
VH +IK NIL+ + ++DFG L + T + G Y +PE+++
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 518 R-----KVTFKSDVYSFGVLLLELLTGKAP 542
K + D +S GV + E+L G+ P
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 9e-04
Identities = 51/207 (24%), Positives = 82/207 (39%), Gaps = 33/207 (15%)
Query: 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNIL 479
Y + LL G T LD + ARG+ L S VH ++ A N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDL---LSFTYQVARGMEFL-ASKNCVHRDLAARNVL 269
Query: 480 LRPDHDACVSDFGLNPLF---------GNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFG 530
L + DFGL G+T P + + APE + T SDV+S+G
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK---WMAPESIFDNLYTTLSDVWSYG 326
Query: 531 VLLLELLTGKAPNQASLGEEGIDLP-RWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLL 589
+LL E+ SLG G P V S + + R + ++
Sbjct: 327 ILLWEIF--------SLG--GTPYPGMIVDSTFYNKIKSG------YRMAKPDHATQEVY 370
Query: 590 QIAMGCVSTVPDQRPAMQEVVRMIENM 616
I + C ++ P++RP+ + ++E++
Sbjct: 371 DIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 9/90 (10%)
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFG-----LNPLFGNTTPP-TRVAGYRAP 512
L LH G I++ ++K N+LL + ++D+G + P G+TT Y AP
Sbjct: 109 LNFLHERG-IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCGTPNYIAP 165
Query: 513 EVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
E++ F D ++ GVL+ E++ G++P
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 42/181 (23%), Positives = 72/181 (39%), Gaps = 17/181 (9%)
Query: 368 EEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427
E+ V+VK G + ++++L I H ++ L Y K +V MP
Sbjct: 117 EQRKKVIVK----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYK 169
Query: 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDAC 487
+ R PL + + I LA+LH G I+H ++K NI L +A
Sbjct: 170 CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHGRG-IIHRDVKTENIFLDEPENAV 225
Query: 488 VSDFGLNPLFGNTTPPTRVAGY------RAPEVVETRKVTFKSDVYSFGVLLLELLTGKA 541
+ DFG + G+ +PE++ K+D++S G++L E+
Sbjct: 226 LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
Query: 542 P 542
Sbjct: 286 T 286
|
Length = 392 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 25/159 (15%)
Query: 403 VVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
VV + + +K +V +Y+ G + LL + G P+D RM A L +L
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLL---KNIGALPVDM-ARMYFA-ETVLALEYL 117
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGL----------NPLFGNTTPPTR------V 506
H G IVH ++K N+L+ ++DFGL N G+ TR V
Sbjct: 118 HNYG-IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 507 AG---YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
G Y APEV+ + D ++ G++L E L G P
Sbjct: 177 CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 47/181 (25%), Positives = 67/181 (37%), Gaps = 39/181 (21%)
Query: 402 NVVPLRAFYYSKDEKLLVYDYMPAGSL-SALLHGSRGSGRTPLDWDNRMRIALSAARGLA 460
N+V L + S+D LV + G L S + W M +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 461 HLHVSGKIVHGNIKASNILL--------------RPDHDACVSDFGLNPLFGNTTPPTRV 506
LH G IV ++ +NILL D+C + N
Sbjct: 101 -LHREG-IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----------- 147
Query: 507 AGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQ---ASLGEE-GIDLPRWVQSVV 562
Y APEV + T D +S G +L ELLTGK + + + +++P WV
Sbjct: 148 --YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEA 205
Query: 563 R 563
R
Sbjct: 206 R 206
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 36.3 bits (85), Expect = 0.001
Identities = 12/37 (32%), Positives = 21/37 (56%), Gaps = 2/37 (5%)
Query: 94 QLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFS 130
L L L +N+++ ++P SNL L +L L N+ +
Sbjct: 2 NLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 23/66 (34%), Positives = 30/66 (45%), Gaps = 14/66 (21%)
Query: 142 RLTRLDLSSNNFS--GKIPFDVNNLTHLTGLFLENNKFSGNLPSINP------ANLRDFN 193
L LDLS+N + F L +L L L N NL SI+P +LR +
Sbjct: 1 NLKSLDLSNNRLTVIPDGAF--KGLPNLKVLDLSGN----NLTSISPEAFSGLPSLRSLD 54
Query: 194 VSNNNL 199
+S NNL
Sbjct: 55 LSGNNL 60
|
Length = 60 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 35/220 (15%)
Query: 347 LRASAE------VLGKGSVGTSYKAVLEEGTTVV--VKRLKEVAVGKRE----FEMQMEV 394
LR AE V+G+G+ G + V + T V +K L + + KR F + ++
Sbjct: 38 LRMKAEDYEVVKVIGRGAFG-EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 395 LGKIKHDNVVPLRAFYYSKDEKLL--VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIA 452
+ VV L FY +D++ L V +YMP G L L+ + + + +A
Sbjct: 97 MAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA 154
Query: 453 LSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFG----LNPLFGNTTPPTRVA- 507
L A +H G +H ++K N+LL ++DFG +N G T V
Sbjct: 155 LDA------IHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGT 206
Query: 508 -GYRAPEVVETRK----VTFKSDVYSFGVLLLELLTGKAP 542
Y +PEV++++ + D +S GV L E+L G P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 30/122 (24%), Positives = 49/122 (40%), Gaps = 29/122 (23%)
Query: 442 PLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT 501
P + +I L + H ++H ++K NIL+ SD ++P+
Sbjct: 227 PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILME------TSDTVVDPVTNRAL 280
Query: 502 PP------------------TRVA-----GYRAPEVVETRKVTFKSDVYSFGVLLLELLT 538
PP +R A YR+PEVV + +D++S G ++ EL T
Sbjct: 281 PPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT 340
Query: 539 GK 540
GK
Sbjct: 341 GK 342
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 654 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.48 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.48 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.45 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.39 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.36 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.3 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.3 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.27 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.12 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.1 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.07 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.07 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.07 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.02 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.0 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.99 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.95 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.95 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.92 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.9 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.87 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.86 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.85 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.84 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.82 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.81 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.76 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.74 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.72 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.61 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.59 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.53 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.52 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.51 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.48 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.41 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.39 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.31 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.27 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.26 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.25 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.16 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.14 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-61 Score=570.96 Aligned_cols=491 Identities=30% Similarity=0.509 Sum_probs=342.7
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 149 (654)
++.|+|++|.+.|.+|. ...+++|+.|+|++|.+++.+|..|.++++|+.|+|++|++++.+|..+.++++|++|+|+
T Consensus 454 L~~L~L~~n~~~~~~p~--~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 531 (968)
T PLN00113 454 LQMLSLARNKFFGGLPD--SFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLS 531 (968)
T ss_pred CcEEECcCceeeeecCc--ccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECC
Confidence 55666666666665554 2345677788888888888888888888888888888888888888888888888888888
Q ss_pred cccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCccc--ccCCCCccccCCCCCCCCC
Q 036334 150 SNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPAT--LSKFPQSSFTGNLDLCGGP 225 (654)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~--~~~~~~l~~~~n~~~c~~~ 225 (654)
+|+++|.+|..+..+++|+.|+|++|++++.+|.. .+++|+.|++++|+++|.+|.. +..+....+.||+.+|+.+
T Consensus 532 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~ 611 (968)
T PLN00113 532 HNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGD 611 (968)
T ss_pred CCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCc
Confidence 88888888888888888888888888888877765 6778888888888888888843 5566666778888888743
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCccCCCCcccceeeeeehhhHHHHHHHHHHHHHHhhccccCCCCCCCCCCcchhhhh
Q 036334 226 LPPCNPFFPSPAPSPSLPPPVAPVHKKSNKLSTAAIVGIAVGGAVFIVLLLLLLLFCLKKRRRQRPGKAPKPPAAATARA 305 (654)
Q Consensus 226 ~~~C~~~~~s~~p~~~~~~~~~~~~~~~~~~~~~~ii~~~i~~~~~~~l~~~~~~~~~~~rr~~~~~~~~~~~~~~~~~~ 305 (654)
... ..++... . ......+++++++++++++++++++++++ +++|++.+..+....
T Consensus 612 ~~~------------~~~~c~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-------- 666 (968)
T PLN00113 612 TTS------------GLPPCKR---V-RKTPSWWFYITCTLGAFLVLALVAFGFVF-IRGRNNLELKRVENE-------- 666 (968)
T ss_pred ccc------------CCCCCcc---c-cccceeeeehhHHHHHHHHHHHHHHHHHH-HHhhhcccccccccc--------
Confidence 210 0000000 0 01112233333333333322222222222 222221111100000
Q ss_pred hhhccCCCCCCCcccCCcccccCCceeEee-CCccccCHHHHHHHh--hccccccCceeEEEEEe-cCCcEEEEEEeccc
Q 036334 306 VTMEAGTSSSKDDITGGAAEADRNKLVFFE-GGVYSFDLEDLLRAS--AEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEV 381 (654)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~--~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~ 381 (654)
.+. . +...+. .....+..+++.... .++||+|+||.||+|.. .+|..||||+++..
T Consensus 667 ----~~~---~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~ 726 (968)
T PLN00113 667 ----DGT---W-------------ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV 726 (968)
T ss_pred ----ccc---c-------------cccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCC
Confidence 000 0 000000 001123334433322 45799999999999996 56899999998654
Q ss_pred ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 036334 382 AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461 (654)
Q Consensus 382 ~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~ 461 (654)
... ...|++.+++++|||||+++++|.+++..++||||+++|+|.++++ .++|..+.+++.|+|+||+|
T Consensus 727 ~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~y 795 (968)
T PLN00113 727 NSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRF 795 (968)
T ss_pred ccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHH
Confidence 322 2346889999999999999999999999999999999999999996 27999999999999999999
Q ss_pred hhc---cCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh
Q 036334 462 LHV---SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT 538 (654)
Q Consensus 462 LH~---~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t 538 (654)
||. .+ |+||||||+||+++.++.+++. ||............++.+|||||++.+..++.++|||||||++|||+|
T Consensus 796 LH~~~~~~-iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~t 873 (968)
T PLN00113 796 LHCRCSPA-VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLT 873 (968)
T ss_pred hccCCCCC-eecCCCCHHhEEECCCCceEEE-eccccccccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHh
Confidence 994 45 9999999999999999888875 666544433334466788999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc-cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 539 GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR-YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 539 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
|+.||....+ .......|.............+|+.+.. .....++..++.+++.+||+.||++||||+|++++|+++.
T Consensus 874 g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 874 GKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 9999964333 2334566665444333333334433321 1223466778899999999999999999999999999997
Q ss_pred cCCC
Q 036334 618 RGET 621 (654)
Q Consensus 618 ~~~~ 621 (654)
+...
T Consensus 953 ~~~~ 956 (968)
T PLN00113 953 RSSS 956 (968)
T ss_pred cccc
Confidence 7543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-51 Score=426.11 Aligned_cols=279 Identities=42% Similarity=0.689 Sum_probs=245.3
Q ss_pred ccccCHHHHHHHh-----hccccccCceeEEEEEecCCcEEEEEEecccccC-HHHHHHHHHHHhccCCCccccccEEEE
Q 036334 338 VYSFDLEDLLRAS-----AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG-KREFEMQMEVLGKIKHDNVVPLRAFYY 411 (654)
Q Consensus 338 ~~~~~~~~~~~~~-----~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpniv~l~~~~~ 411 (654)
...|.++++..++ .++||+|+||.||+|.+.+|+.||||++...... .++|..|++++.+++|||+|+|+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 3467888888887 3689999999999999999999999998776554 677999999999999999999999999
Q ss_pred eCC-ceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC--CeecCCCCCCcEEECCCCCeEE
Q 036334 412 SKD-EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG--KIVHGNIKASNILLRPDHDACV 488 (654)
Q Consensus 412 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~ivHrDlk~~NIll~~~~~~kl 488 (654)
+.+ +.+||||||++|+|.++|+..... +++|..|++||.++|+||+|||... +|+||||||+|||+|+++++||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 998 599999999999999999965321 7999999999999999999999766 5999999999999999999999
Q ss_pred eccCCCCCcCC-CCCC----CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 036334 489 SDFGLNPLFGN-TTPP----TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR 563 (654)
Q Consensus 489 ~Dfgla~~~~~-~~~~----~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 563 (654)
+|||+|..... .... .+|.+|+|||++..+..++|+|||||||+|.||+||+.+.+.........+..|....+.
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99999976654 3221 688999999999999999999999999999999999998876655555669999999998
Q ss_pred hchhhhhhhHhhhccCChH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 564 EEWTAEVFDVELMRYHNIE-EEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
+....+++|+.+....... +++..+.+++.+|++.+|.+||+|.||+++|+.+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 8889999999886433333 7888899999999999999999999999999776654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=399.97 Aligned_cols=263 Identities=33% Similarity=0.471 Sum_probs=212.9
Q ss_pred ccCHHHHHHHhhccccccCceeEEEEEecCCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCC-c
Q 036334 340 SFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKD-E 415 (654)
Q Consensus 340 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-~ 415 (654)
.++.+++ .+.+.||+|+||+||+|.+.....||||++.....+ .++|.+|+.+|.+++|||||+++|+|.++. .
T Consensus 37 ~i~~~~l--~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 37 EIDPDEL--PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred ecChHHh--hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 3444444 234569999999999999984344999999875433 458999999999999999999999999887 7
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC-CeEEeccCCC
Q 036334 416 KLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH-DACVSDFGLN 494 (654)
Q Consensus 416 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~-~~kl~Dfgla 494 (654)
.++|||||++|+|.++++.. ....+++..+++++.|||+||+|||++++||||||||+|||++.++ ++||+|||++
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 99999999999999999853 2457999999999999999999999886699999999999999998 9999999999
Q ss_pred CCcCC----CCCCCccccccCccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 495 PLFGN----TTPPTRVAGYRAPEVVE--TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 495 ~~~~~----~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
+.... .+...||..|||||++. ...|+.|+|||||||+||||+||+.||..... ......+.....
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~-- 263 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGL-- 263 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCC--
Confidence 76553 23357888999999999 56999999999999999999999999986433 111111111111
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDD 623 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 623 (654)
++.....+...+..++.+||..||+.||+|.+++..|+.+.......
T Consensus 264 --------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 264 --------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred --------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 12222235567778888999999999999999999999998655443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=395.73 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=216.3
Q ss_pred HHHHHhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 345 DLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 345 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
.......+.||+|.||+||.|.+.....||+|.++......++|.+|+++|++++|+|||+++|+|..++.++||||||+
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 33345567899999999999999977899999999988888999999999999999999999999999889999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC--
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP-- 502 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-- 502 (654)
.|+|.++|+.. ....+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||+|+...+...
T Consensus 285 ~GsLl~yLr~~---~~~~l~~~~Ll~~a~qIaeGM~YLes~~-~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRTR---EGGLLNLPQLLDFAAQIAEGMAYLESKN-YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhhc---CCCccchHHHHHHHHHHHHHHHHHHhCC-ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 99999999863 3456899999999999999999999998 99999999999999999999999999996554322
Q ss_pred ---CCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 503 ---PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 503 ---~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
..-...|.|||.+..+.++.|+|||||||+||||+| |+.||...... +.+..+.+.. +.
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~------ev~~~le~Gy-----------Rl 423 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE------EVLELLERGY-----------RL 423 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH------HHHHHHhccC-----------cC
Confidence 122345999999999999999999999999999999 88888765432 2232222222 22
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
..+..+...+++||..||+.+|++||||+.+...|+++....
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 334456667888999999999999999999999999987654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=369.46 Aligned_cols=253 Identities=27% Similarity=0.407 Sum_probs=205.9
Q ss_pred cCHHHHHHHhhccccccCceeEEEEEec-CCcEEEEEEeccc--ccCHHHHHHHHHHHhccCCCccccccEEEEeCC-ce
Q 036334 341 FDLEDLLRASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV--AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD-EK 416 (654)
Q Consensus 341 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-~~ 416 (654)
+...++. ..+.||+|..|+|||+.++ +++.+|+|.+... ...++++.+|++++++++||+||.++|.|.+++ ..
T Consensus 76 i~~~dle--~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLE--RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhh--hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 3444542 3478999999999999976 4788999999543 344678899999999999999999999999998 49
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCC
Q 036334 417 LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPL 496 (654)
Q Consensus 417 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~ 496 (654)
.|+||||++|+|++++... +.+++....+|+.+|++||.|||+..+||||||||+|||++..|+|||||||.+..
T Consensus 154 sI~mEYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred EeehhhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence 9999999999999999843 55999999999999999999999644599999999999999999999999999887
Q ss_pred cCCC--CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 497 FGNT--TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 497 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
+.+. ....||..|||||.+.+..|+.++||||||++++|+.+|+.||....+ ...+....+..++.+.. +
T Consensus 229 lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~~Iv~~pp------P- 300 (364)
T KOG0581|consen 229 LVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLCAIVDEPP------P- 300 (364)
T ss_pred hhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHHHHhcCCC------C-
Confidence 7554 456788899999999999999999999999999999999999986511 11222222222222111 0
Q ss_pred hhccCChH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 575 LMRYHNIE-EEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 575 ~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
. .+. .+..++..++..|+++||.+||+++|+++.
T Consensus 301 --~--lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 --R--LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred --C--CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 111 355567777889999999999999999875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=398.57 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=211.1
Q ss_pred hccccccCceeEEEEEec------CCcEEEEEEecccccC--HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 351 AEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
.+.||+|+||+||+|+.. +...||||.++..... +.+|++|++++..++|||||+|+|+|..++.+++|+||
T Consensus 491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEY 570 (774)
T KOG1026|consen 491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEY 570 (774)
T ss_pred hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEe
Confidence 467999999999999832 3467999999987544 67899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCC---------CCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCC
Q 036334 423 MPAGSLSALLHGSRGSG---------RTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL 493 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgl 493 (654)
|..|||.++|....... ..+|+..+.+.||.|||.||+||.++. +|||||.++|+||+++..|||+|||+
T Consensus 571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~-FVHRDLATRNCLVge~l~VKIsDfGL 649 (774)
T KOG1026|consen 571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH-FVHRDLATRNCLVGENLVVKISDFGL 649 (774)
T ss_pred cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc-ccccchhhhhceeccceEEEeccccc
Confidence 99999999997543221 334899999999999999999999887 99999999999999999999999999
Q ss_pred CCCcCCC-C-----CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhch
Q 036334 494 NPLFGNT-T-----PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEW 566 (654)
Q Consensus 494 a~~~~~~-~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 566 (654)
++..-.. . ...-..+|||||.|..++|+.++|||||||+|||+++ |+.||.+...++ +...++.+.
T Consensus 650 sRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VIe~i~~g~ 722 (774)
T KOG1026|consen 650 SRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VIECIRAGQ 722 (774)
T ss_pred chhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HHHHHHcCC
Confidence 8754322 1 1222356999999999999999999999999999999 999998766544 222222222
Q ss_pred hhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 567 TAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
. ..-++.+..++++||..||+..|++||+|+||...|+..-..+
T Consensus 723 l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 723 L----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred c----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 1 2345667788999999999999999999999999999887654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=345.63 Aligned_cols=250 Identities=24% Similarity=0.397 Sum_probs=204.4
Q ss_pred HHhhccccccCceeEEEEE-ecCCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccE-EEEeCCc-eEEEEE
Q 036334 348 RASAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRA-FYYSKDE-KLLVYD 421 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~-~~~~~~~-~~lv~e 421 (654)
+.+.++||+|.||+||++. ..+|..||.|.++-...+ ..+...|+.+|++++|||||++++ -|.++.+ ++||||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 4566889999999999998 668999999999854433 345778999999999999999999 4544445 899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc---cCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV---SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~---~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
||..|+|...++..+. ++..+++..+|+++.|+++||.++|. ++.|+||||||.||+++.+|.|||+|||+++++.
T Consensus 101 ~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred hhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999986653 45679999999999999999999997 2359999999999999999999999999999987
Q ss_pred CC----CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 499 NT----TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 499 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
.. ....||+.||+||.+.+..|+.|+||||+||++|||+.-+.||.+. ++...-.++.+.++ .
T Consensus 180 s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qgd~-~------ 246 (375)
T KOG0591|consen 180 SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQGDY-P------ 246 (375)
T ss_pred chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcCCC-C------
Confidence 65 3468899999999999999999999999999999999999999864 23332223322221 1
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
....+-+..++.+|+..|+..||+.||+...+++.+.
T Consensus 247 ---~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 247 ---PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ---CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1122445667889999999999999998555554444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=358.38 Aligned_cols=190 Identities=28% Similarity=0.409 Sum_probs=170.3
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
+.||+|+||+||+|+++ ++..||||.+.+.. ...+-+..|+.+|+.++|||||++++++.+++..|+|||||++|+
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGD 95 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGD 95 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCC
Confidence 44999999999999965 58999999997653 234557899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC------CCeEEeccCCCCCcCCCC
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD------HDACVSDFGLNPLFGNTT 501 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~------~~~kl~Dfgla~~~~~~~ 501 (654)
|.++++. +..+++..+..++.|+|.||++||+++ ||||||||.|||++.. -.+||+|||+|+.+....
T Consensus 96 Ls~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~~~-IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~ 169 (429)
T KOG0595|consen 96 LSDYIRR-----RGRLPEATARHFMQQLASALQFLHENN-IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS 169 (429)
T ss_pred HHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh
Confidence 9999984 346999999999999999999999998 9999999999999875 358999999999987653
Q ss_pred ---CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 036334 502 ---PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASL 547 (654)
Q Consensus 502 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 547 (654)
...|++-|||||++....|+.|+|+||+|+|+|++++|+.||+...
T Consensus 170 ~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 170 MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 4567777999999999999999999999999999999999998643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=373.59 Aligned_cols=241 Identities=24% Similarity=0.412 Sum_probs=202.9
Q ss_pred HHhhccccccCceeEEEEEe-cCCcEEEEEEeccc----ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 348 RASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEV----AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
|..+++||+|+|+.||++.. ..|+.||+|++.+. ....+...+||++.++++|||||+++++|++.+..|||.|+
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLEL 99 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLEL 99 (592)
T ss_pred eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEe
Confidence 34568899999999999996 77999999999773 34456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 500 (654)
|+.++|.++++ .+.++++.++..++.||+.||.|||+.+ |+|||||..|+|++++.+|||+|||+|......
T Consensus 100 C~~~sL~el~K-----rrk~ltEpEary~l~QIv~GlkYLH~~~-IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 100 CHRGSLMELLK-----RRKPLTEPEARYFLRQIVEGLKYLHSLG-IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred cCCccHHHHHH-----hcCCCCcHHHHHHHHHHHHHHHHHHhcC-ceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 99999999998 2467999999999999999999999998 999999999999999999999999999987633
Q ss_pred --CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 501 --TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
....||+.|.|||++....++..+||||+|||||-|+.|++||+... +..-+..+...++. .
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vkety~~Ik~~~Y~---------~- 237 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VKETYNKIKLNEYS---------M- 237 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------HHHHHHHHHhcCcc---------c-
Confidence 45678899999999999999999999999999999999999997532 21222222222211 1
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
+.....+..+||.++|+.||.+|||+.+|+..
T Consensus 238 --P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 --PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred --ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11222334556779999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=359.51 Aligned_cols=245 Identities=24% Similarity=0.406 Sum_probs=196.4
Q ss_pred HhhccccccCceeEEEEE-ecCCcEEEEEEeccccc--------CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEE
Q 036334 349 ASAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAV--------GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~--------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 419 (654)
.+.+.||+|+||.|-+|. .++|+.||||++.+... .....++|+++|++++|||||+++++|...+..|+|
T Consensus 175 ii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmV 254 (475)
T KOG0615|consen 175 IISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMV 254 (475)
T ss_pred EeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEE
Confidence 346889999999999998 45699999999976522 123467999999999999999999999999999999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC---CCeEEeccCCCCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD---HDACVSDFGLNPL 496 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~---~~~kl~Dfgla~~ 496 (654)
|||++||+|.+.+-.+ ..+.+..-..++.|++.|+.|||+.| |+||||||+|||+..+ -.+||+|||+|+.
T Consensus 255 lE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH~~G-I~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 255 LEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLHSQG-IIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred EEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHHHcC-cccccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999999743 45777888999999999999999999 9999999999999876 6799999999999
Q ss_pred cCCC---CCCCccccccCccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhh
Q 036334 497 FGNT---TPPTRVAGYRAPEVVETRK---VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEV 570 (654)
Q Consensus 497 ~~~~---~~~~~~~~y~aPE~~~~~~---~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 570 (654)
.+.. ....||+.|.|||++.++. +..++|+||+||+||-+++|.+||....... ....++.+..+...
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-----sl~eQI~~G~y~f~- 402 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-----SLKEQILKGRYAFG- 402 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-----cHHHHHhcCccccc-
Confidence 8654 4567899999999997654 3348899999999999999999998654322 12223333332211
Q ss_pred hhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 571 FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 571 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
...+.... .+...+|.+|+..||++|||+.|+++.
T Consensus 403 ----p~~w~~Is---eea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 403 ----PLQWDRIS---EEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ----Chhhhhhh---HHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 01122223 345567779999999999999999763
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=382.72 Aligned_cols=250 Identities=24% Similarity=0.424 Sum_probs=213.4
Q ss_pred HhhccccccCceeEEEEEecC----CcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE----GTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
.+.++||.|.||+||+|.++- ...||||.+|... ..+.+|..|..+|.++.||||++|.|+....+..+||+||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 346899999999999999652 3579999999764 3457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT- 501 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 501 (654)
|++|+|+.+|+... ..+.+.+...++++||.||+||.+.+ +|||||.++|||++.+..+||+|||+++.+.+..
T Consensus 712 MENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLsdm~-YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 712 MENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLSDMN-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHhhcC-chhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 99999999998654 34899999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCcc------ccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 502 PPTRV------AGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 502 ~~~~~------~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
....| ..|.|||.|..+.++.++|||||||+|||.++ |.+||-.+.+.+ .+..+ .+++
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd------VIkaI-e~gy-------- 851 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD------VIKAI-EQGY-------- 851 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH------HHHHH-Hhcc--------
Confidence 22222 34999999999999999999999999999998 999988765433 12222 2221
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
+...+-++...|.+||+.||++|-.+||.|.+|+..|+++.++-
T Consensus 852 --RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 852 --RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred --CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 33445567788999999999999999999999999999998763
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=330.73 Aligned_cols=257 Identities=22% Similarity=0.305 Sum_probs=196.7
Q ss_pred HhhccccccCceeEEEEEecC-CcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+...++|+|+||.|||++.++ |+.||||++.....+ ++-..+||++|++++|+|+|.++++|......+||||||+
T Consensus 5 E~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~d 84 (396)
T KOG0593|consen 5 EKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCD 84 (396)
T ss_pred hhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecc
Confidence 444679999999999999765 999999999876543 4567899999999999999999999999999999999998
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
..-|.++-+. ...++...+.+++.|+++|+.|+|+++ ++||||||+|||++.+|.+||||||+|+.+....
T Consensus 85 hTvL~eLe~~-----p~G~~~~~vk~~l~Q~l~ai~~cHk~n-~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 85 HTVLHELERY-----PNGVPSELVKKYLYQLLKAIHFCHKNN-CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred hHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHhhhhhhcC-eecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 8555555442 334889999999999999999999887 9999999999999999999999999999887432
Q ss_pred -CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhH--------HHHHHhhhc-hhhhh
Q 036334 502 -PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPR--------WVQSVVREE-WTAEV 570 (654)
Q Consensus 502 -~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~--------~~~~~~~~~-~~~~~ 570 (654)
.-..|..|+|||.+.+ ..|...+||||+||++.||++|.+.|.+..+-+...... .-++++... ....+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 2345667999999877 789999999999999999999999998765544222111 111111111 11111
Q ss_pred hhHhhhccCChH----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 571 FDVELMRYHNIE----EEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 571 ~~~~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.-+........+ ....-++++++.|++.||++|++-+++++
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 101100111111 11224678899999999999999998864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=386.41 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=213.5
Q ss_pred hhccccccCceeEEEEEecC--Cc----EEEEEEeccc--ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLEE--GT----TVVVKRLKEV--AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~--g~----~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
..+.||+|+||.||+|...+ |. .||||.++.. .....+|.+|..+|++++|||||+++|+|.+.+..+|++|
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 35789999999999998653 43 4899998876 3446789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCC--CCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 422 YMPAGSLSALLHGSRGSG--RTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
||++|+|..+|++.+... ...+...+.+.++.|||+|++||++++ +|||||.++|+|+++...|||+|||+|+.+..
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~-fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~ 854 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH-FVHRDLAARNCLLDERRVVKIADFGLARDIYD 854 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC-CcCcchhhhheeecccCcEEEcccchhHhhhh
Confidence 999999999999775432 346899999999999999999999998 99999999999999999999999999984322
Q ss_pred -CCC----C-CccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhh
Q 036334 500 -TTP----P-TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 500 -~~~----~-~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 572 (654)
... . .-...|||||.+..+.++.|+|||||||+|||++| |..||......+- +....+++
T Consensus 855 ~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~~gg------- 921 (1025)
T KOG1095|consen 855 KDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVLEGG------- 921 (1025)
T ss_pred chheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHHhCC-------
Confidence 211 1 11245999999999999999999999999999999 8999986544321 11111222
Q ss_pred HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCCCCCCC
Q 036334 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDDGLRQ 627 (654)
Q Consensus 573 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~ 627 (654)
+...+..+...+++||.+||+.+|++||+|..+++++.++..........+
T Consensus 922 ----RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~ 972 (1025)
T KOG1095|consen 922 ----RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGP 972 (1025)
T ss_pred ----ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcccc
Confidence 334455667788899999999999999999999999999986665554443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=354.87 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=203.3
Q ss_pred HHHHhhccccccCceeEEEEEecCCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 346 LLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 346 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
....+.+.||+|.||+||+|.+. -.||||++...... .+.|+.|+.++++-+|.||+-+.|||..+.. .||+.+
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred HHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 34456789999999999999987 36999999866433 4679999999999999999999999988877 999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 500 (654)
|+|.+|+.++|.. ...++..+...||.|||+||.|||.++ |||||||+.|||+.+++.|||+|||++.....-
T Consensus 469 CeGsSLY~hlHv~----etkfdm~~~idIAqQiaqGM~YLHAK~-IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLHAKN-IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred ccCchhhhhccch----hhhhhHHHHHHHHHHHHHhhhhhhhhh-hhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 9999999999964 356999999999999999999999998 999999999999999999999999998654321
Q ss_pred ----CCCCccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 ----TPPTRVAGYRAPEVVE---TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 ----~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....+...|||||++. ..+|++.+|||||||++|||++|..||.....+..+- ++..++...
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif-------mVGrG~l~p---- 612 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF-------MVGRGYLMP---- 612 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE-------EecccccCc----
Confidence 2233445699999985 3579999999999999999999999998432221110 011111111
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
++ ......+.+++.+|+..||..++++||.|.+|+..|+++...
T Consensus 613 d~--s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 613 DL--SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cc--hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 10 112234555677777799999999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=348.47 Aligned_cols=259 Identities=22% Similarity=0.341 Sum_probs=204.6
Q ss_pred HHHHhhccccccCceeEEEEE-ecCCcEEEEEEecccccCHHH--HHHHHHHHhccC-CCccccccEEEEeCC-ceEEEE
Q 036334 346 LLRASAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKRE--FEMQMEVLGKIK-HDNVVPLRAFYYSKD-EKLLVY 420 (654)
Q Consensus 346 ~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~--~~~e~~~l~~l~-hpniv~l~~~~~~~~-~~~lv~ 420 (654)
..|.+.+.||.|+||.||+|+ ...|..||||+++.....-++ -.+|+..|++++ |||||++.+++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 356667889999999999999 556999999999887555444 358999999998 999999999999888 899999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
|||+ .+|++++++. ...+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+|+.....
T Consensus 90 E~Md-~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~G-fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 90 EFMD-CNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHG-FFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred Hhhh-hhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcC-cccccCChhheEecccceeEecccccccccccC
Confidence 9995 5999999853 457999999999999999999999998 999999999999999999999999999987644
Q ss_pred ---CCCCccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hchh-----
Q 036334 501 ---TPPTRVAGYRAPEVVE-TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR----EEWT----- 567 (654)
Q Consensus 501 ---~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~----- 567 (654)
+.-..|..|+|||++. .+.|+.+.||||+|||++|+.+-++.|.+..+.+.+ -.+..++. +.|.
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi---~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI---YKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH---HHHHHHhCCCccccchhHHHH
Confidence 3345677899999875 578999999999999999999999999876543321 11111111 1111
Q ss_pred hhhhhHhhhccC------ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 568 AEVFDVELMRYH------NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 568 ~~~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
...+...+.... -...+..+.++++.+|+++||.+|||++|++++=
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 111111111100 1123556788899999999999999999998753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=335.52 Aligned_cols=257 Identities=28% Similarity=0.404 Sum_probs=192.6
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHH--HhccCCCccccccEEEEeCC----ceEEEEEecC
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEV--LGKIKHDNVVPLRAFYYSKD----EKLLVYDYMP 424 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~--l~~l~hpniv~l~~~~~~~~----~~~lv~e~~~ 424 (654)
.++||+|+||.||||.+. ++.||||++.... ++.|+.|-++ +-.++|+||++++++-.... +++||+||.+
T Consensus 215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HHHhhcCccceeehhhcc-CceeEEEecCHHH--HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 367999999999999987 5999999997654 3445555444 55678999999999876554 7899999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC--------CeecCCCCCCcEEECCCCCeEEeccCCCCC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG--------KIVHGNIKASNILLRPDHDACVSDFGLNPL 496 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------~ivHrDlk~~NIll~~~~~~kl~Dfgla~~ 496 (654)
.|+|.++|.. ..++|....+|+..+++||+|||+.. .|+|||||++|||+.+|+.+.|+|||+|..
T Consensus 292 kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 292 KGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred CCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 9999999973 46999999999999999999999532 599999999999999999999999999987
Q ss_pred cCCC------CCCCccccccCccccCCCCC------CcchhHHHHHHHHHHHHhCCCCCCC-CCCCCCC----------C
Q 036334 497 FGNT------TPPTRVAGYRAPEVVETRKV------TFKSDVYSFGVLLLELLTGKAPNQA-SLGEEGI----------D 553 (654)
Q Consensus 497 ~~~~------~~~~~~~~y~aPE~~~~~~~------~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~----------~ 553 (654)
+... ....||.+|||||++++... -.+.||||+|.|||||+++-.-++. ..++-.. .
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 7533 34678888999999976432 2468999999999999996544321 1111100 0
Q ss_pred hhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 036334 554 LPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGET 621 (654)
Q Consensus 554 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 621 (654)
+.+.-..++++.. ++.+.........+..+.+.+..||..||+.|.|+.=+-+++.++..-..
T Consensus 446 ~e~mq~~VV~kK~-----RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 446 LEEMQELVVRKKQ-----RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHHHHHHHHhhcc-----CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 1111111111111 11111111222456678888899999999999999999999998876543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=336.09 Aligned_cols=232 Identities=27% Similarity=0.362 Sum_probs=192.0
Q ss_pred hhccccccCceeEEEEEecC-CcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.++||+|+||+||.++.++ ++.+|+|++++... ..+....|..+|.+++||+||.++-.|++++.+|+|+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 45889999999999998654 88999999987633 23456789999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
||.|..+|.. ...+++..+.-++..|+.||.|||+++ ||||||||+|||+|.+|+++|+|||+++..-..
T Consensus 109 GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~~g-IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t 182 (357)
T KOG0598|consen 109 GGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHSKG-IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDAT 182 (357)
T ss_pred CccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHhCC-eeeccCCHHHeeecCCCcEEEeccccchhcccCCCcc
Confidence 9999999983 456899999999999999999999998 999999999999999999999999999854322
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
....||+.|||||++.+..|+..+|.||+||++|||++|.+||... +...++..+.++.... ....
T Consensus 183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~------~~~~~~~~I~~~k~~~--------~p~~ 248 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE------DVKKMYDKILKGKLPL--------PPGY 248 (357)
T ss_pred ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc------cHHHHHHHHhcCcCCC--------CCcc
Confidence 2347788899999999999999999999999999999999999764 3344444444433100 1111
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCC
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRP 604 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RP 604 (654)
..++. .+++...+..||++|.
T Consensus 249 ls~~a---rdll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 249 LSEEA---RDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCHHH---HHHHHHHhccCHHHhc
Confidence 33334 4455589999999996
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=317.33 Aligned_cols=256 Identities=23% Similarity=0.384 Sum_probs=200.8
Q ss_pred HHhhccccccCceeEEEEE-ecCCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 348 RASAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
|...++||+|.||.||+|. .+.|+.||||+++..... .....+||+.|+.++|+||+.++++|...+...||+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 4556789999999999999 456999999999866332 456789999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC--
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-- 501 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-- 501 (654)
+. +|...+++. ...++..++..++.++++|++|||.+. |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 84 ~t-dLe~vIkd~----~i~l~pa~iK~y~~m~LkGl~y~H~~~-IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 84 PT-DLEVVIKDK----NIILSPADIKSYMLMTLKGLAYCHSKW-ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred cc-cHHHHhccc----ccccCHHHHHHHHHHHHHHHHHHHhhh-hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 65 999999853 456899999999999999999999998 9999999999999999999999999999887543
Q ss_pred --CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh----hhchh--hhhhh
Q 036334 502 --PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVV----REEWT--AEVFD 572 (654)
Q Consensus 502 --~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~----~~~~~--~~~~~ 572 (654)
....|..|+|||.+.+ +.|+..+||||.|||+.||+.|.+-|.+..+-+. +...+ ..+ .+.|. ....|
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ--L~~If-~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ--LSKIF-RALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH--HHHHH-HHcCCCCcccCcccccccc
Confidence 2345677999998765 6799999999999999999999888876543221 11111 111 11111 01111
Q ss_pred ---Hh----hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 573 ---VE----LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 573 ---~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.. .....-...+..+.++++..|+..||.+|+++.|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 10 00001123344556888899999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=343.46 Aligned_cols=256 Identities=25% Similarity=0.346 Sum_probs=194.5
Q ss_pred hhccccccCceeEEEEE-ecCCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeC--CceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e~~ 423 (654)
..+.||+|.||.||+|+ ..+|+.||+|++.... .......+||.+|++++||||++|.+...+. ..+|||||||
T Consensus 121 ki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM 200 (560)
T KOG0600|consen 121 KIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM 200 (560)
T ss_pred HHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc
Confidence 34779999999999999 5579999999987653 2334567999999999999999999998876 6899999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC--
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-- 501 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-- 501 (654)
+. ||..++... ...++..++..++.|++.||+|+|.++ |.|||||.+|||||.+|.+||+|||+|+++....
T Consensus 201 dh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~g-vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 201 DH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSRG-VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred cc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhcC-eeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 77 898888742 346999999999999999999999998 9999999999999999999999999999876543
Q ss_pred ---CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh-hhchhh------hh
Q 036334 502 ---PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVV-REEWTA------EV 570 (654)
Q Consensus 502 ---~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~------~~ 570 (654)
..+-|..|+|||.+.+ ..|+.++|+||.||||.||++|++.|++..+-+.+..+-.+.... .+.|.. ..
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~ 354 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATI 354 (560)
T ss_pred ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccc
Confidence 3344667999999876 479999999999999999999999998865433221111000000 111110 11
Q ss_pred hhHhhhccCChHHH----HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 571 FDVELMRYHNIEEE----MVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 571 ~~~~~~~~~~~~~~----~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
+.+.........+. ....++|+..+|..||.+|.|+.++++
T Consensus 355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11100000001111 123567777999999999999998864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=340.61 Aligned_cols=256 Identities=18% Similarity=0.319 Sum_probs=203.1
Q ss_pred ccCHHHHHHHhhccccccCceeEEEEEecCCcEEEEEEecccccC----HHHHHHHHHHHhccCCCccccccEEEEe---
Q 036334 340 SFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG----KREFEMQMEVLGKIKHDNVVPLRAFYYS--- 412 (654)
Q Consensus 340 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~l~~~~~~--- 412 (654)
.++.+++.......||+|++|.||+|.. +|+.||||+++..... .+.+.+|+.+|++++||||++++|++.+
T Consensus 14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 14 CIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92 (283)
T ss_pred ecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence 3455555444446799999999999998 4899999999765433 3567799999999999999999999877
Q ss_pred -CCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEecc
Q 036334 413 -KDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDF 491 (654)
Q Consensus 413 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Df 491 (654)
....++||||+++|+|.+++.. ...+++..+++++.|++.|+.|||+...++||||||+||++++++.+||+||
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~df 167 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICH 167 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEccc
Confidence 3467899999999999999974 2458999999999999999999997533889999999999999999999999
Q ss_pred CCCCCcCCC-CCCCccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 492 GLNPLFGNT-TPPTRVAGYRAPEVVET--RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 492 gla~~~~~~-~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
|++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+......
T Consensus 168 g~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------~~~~~~i~~~~~~- 240 (283)
T PHA02988 168 GLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------KEIYDLIINKNNS- 240 (283)
T ss_pred chHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCC-
Confidence 998765433 23456778999999976 6899999999999999999999999975321 1222222211110
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
..........+.+++.+||+.||++|||++|+++.|++++
T Consensus 241 ---------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 241 ---------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ---------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 0011123345777888999999999999999999999876
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=349.38 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=198.1
Q ss_pred HHhhccccccCceeEEEEEe------cCCcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccccccEEEEeCC-ceE
Q 036334 348 RASAEVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKD-EKL 417 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~-~~~ 417 (654)
+.+.++||+|+||.||+|.. ..++.||||+++.... ....+.+|+.++.++ +||||++++++|...+ ..+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (338)
T cd05102 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM 88 (338)
T ss_pred ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence 45568899999999999974 2356899999975432 235688899999999 8999999999887654 578
Q ss_pred EEEEecCCCchhhhhccCCCC---------------------------------------------------------CC
Q 036334 418 LVYDYMPAGSLSALLHGSRGS---------------------------------------------------------GR 440 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~---------------------------------------------------------~~ 440 (654)
+||||+++|+|.+++...+.. ..
T Consensus 89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd05102 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK 168 (338)
T ss_pred EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence 999999999999998743210 12
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC------CCCCccccccCccc
Q 036334 441 TPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT------TPPTRVAGYRAPEV 514 (654)
Q Consensus 441 ~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~------~~~~~~~~y~aPE~ 514 (654)
.++++..+.+++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... ....++..|+|||+
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 247 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC-EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence 35888999999999999999999998 999999999999999999999999998765322 11223456999999
Q ss_pred cCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHh
Q 036334 515 VETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAM 593 (654)
Q Consensus 515 ~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 593 (654)
+.+..++.++|||||||++|||++ |..||......+ . +......+... .........+.+++.
T Consensus 248 ~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~-~~~~~~~~~~~----------~~~~~~~~~l~~li~ 311 (338)
T cd05102 248 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----E-FCQRLKDGTRM----------RAPENATPEIYRIML 311 (338)
T ss_pred hhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----H-HHHHHhcCCCC----------CCCCCCCHHHHHHHH
Confidence 998999999999999999999997 999997532211 1 11111111100 011122345778888
Q ss_pred hccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 594 GCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 594 ~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
+||+.||++|||+.|+++.|+++.++
T Consensus 312 ~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 312 ACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=343.37 Aligned_cols=239 Identities=23% Similarity=0.326 Sum_probs=195.5
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccccC----HHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVG----KREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.++.||+|+|++||+|.. ..++.||||++.+...- .+.+.+|-++|.+| .||.|++|+-.|.+...+|+|+||+
T Consensus 77 Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A 156 (604)
T KOG0592|consen 77 FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYA 156 (604)
T ss_pred hhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEec
Confidence 457899999999999984 45899999999765322 23466777888888 8999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
++|+|.++|+. .+.+++.-...++.+|+.||+|||+.| ||||||||+|||+|+||++||.|||.|+.+...
T Consensus 157 ~nGdll~~i~K-----~Gsfde~caR~YAAeIldAleylH~~G-IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 157 PNGDLLDLIKK-----YGSFDETCARFYAAEILDALEYLHSNG-IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred CCCcHHHHHHH-----hCcchHHHHHHHHHHHHHHHHHHHhcC-ceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 99999999984 456999999999999999999999998 999999999999999999999999999876432
Q ss_pred --------------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhch
Q 036334 501 --------------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEW 566 (654)
Q Consensus 501 --------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 566 (654)
...+||+.|.+||++..+..++.+|+|+||||||+|+.|++||.+..+. ..++.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney------liFqk------ 298 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY------LIFQK------ 298 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH------HHHHH------
Confidence 1245778899999999999999999999999999999999999864321 11122
Q ss_pred hhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 567 TAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
+++..+.-.....+ ...+|+.+.+..||.+|++.++|.+.
T Consensus 299 ---I~~l~y~fp~~fp~---~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 ---IQALDYEFPEGFPE---DARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---HHHhcccCCCCCCH---HHHHHHHHHHccCccccccHHHHhhC
Confidence 22222222223333 44456669999999999999888654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=349.77 Aligned_cols=251 Identities=27% Similarity=0.425 Sum_probs=203.0
Q ss_pred hccccccCceeEEEEEecC--C--cE-EEEEEeccc----ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 351 AEVLGKGSVGTSYKAVLEE--G--TT-VVVKRLKEV----AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~--g--~~-vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
.++||+|+||.||+|.+.. + .. ||||..+.. .....+|.+|.++|+.++|||||+++|++.....+++|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 4789999999999999653 2 23 899998852 2345689999999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT 501 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 501 (654)
+|.||+|.++|+... ..++..++.+++.++|.||+|||+++ ++||||.++|+|++.++.+||+|||+++.-....
T Consensus 242 l~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh~k~-~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~ 316 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLHSKN-CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV 316 (474)
T ss_pred ecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHHHCC-CcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence 999999999998542 25999999999999999999999998 9999999999999999999999999987654221
Q ss_pred C----CCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhh
Q 036334 502 P----PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576 (654)
Q Consensus 502 ~----~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (654)
. ..-...|+|||.+....|++++|||||||++||+++ |..||.+... .+....+...++....
T Consensus 317 ~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~------~~v~~kI~~~~~r~~~------ 384 (474)
T KOG0194|consen 317 MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN------YEVKAKIVKNGYRMPI------ 384 (474)
T ss_pred eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH------HHHHHHHHhcCccCCC------
Confidence 1 112346999999999999999999999999999999 8889876432 2222223233332211
Q ss_pred ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 036334 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETD 622 (654)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 622 (654)
.......+..++.+||..+|++||+|.++.+.|+.+......
T Consensus 385 ----~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 385 ----PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ----CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 112334556666799999999999999999999999866544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=345.93 Aligned_cols=241 Identities=26% Similarity=0.397 Sum_probs=198.5
Q ss_pred hhccccccCceeEEEEE-ecCCcEEEEEEecccccCHHH-HHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 350 SAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKRE-FEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~-~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
..+.||+|+.|.||.|. ...++.||||++.......++ +..|+.+|+..+|+|||++++.|...+++|+|||||++|+
T Consensus 277 ~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggs 356 (550)
T KOG0578|consen 277 DFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGS 356 (550)
T ss_pred chhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCc
Confidence 34679999999999998 456889999999877655544 6689999999999999999999988899999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CCC
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPP 503 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~ 503 (654)
|.+++.. ..+++.++..|+.++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+... ...
T Consensus 357 LTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~~g-IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~Tm 429 (550)
T KOG0578|consen 357 LTDVVTK------TRMTEGQIAAICREILQGLKFLHARG-IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTM 429 (550)
T ss_pred hhhhhhc------ccccHHHHHHHHHHHHHHHHHHHhcc-eeeeccccceeEeccCCcEEEeeeeeeeccccccCccccc
Confidence 9999974 34999999999999999999999998 999999999999999999999999998776533 456
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.||+.|||||++....|++|+||||||++++||+-|++||-.... .+.+.-+-..+ .+++.. .+.
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrAlyLIa~ng------~P~lk~---~~k 494 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNG------TPKLKN---PEK 494 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HHHHHHHhhcC------CCCcCC---ccc
Confidence 889999999999999999999999999999999999999864221 11111111111 112222 233
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
....+-+++.+||..|+++|+++.|+++.
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 33445556669999999999999999864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.23 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=205.3
Q ss_pred HhhccccccCceeEEEEEecCCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.++++||+|.||.|..+....+..||||.++.... ..++|.+|+++|.+++|||||+++|+|..++.+++|+|||++|
T Consensus 541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 34789999999999999998789999999997743 4578999999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--CCC-
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--TPP- 503 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--~~~- 503 (654)
+|.+++..+.. ..+.-....+|+.||+.||+||.+-+ +|||||.++|||+|.++++||+|||+++-+-.. ...
T Consensus 621 DLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes~n-fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 621 DLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLESLN-FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred cHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHhhc-hhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 99999986532 22455667889999999999999887 999999999999999999999999998854322 222
Q ss_pred ---CccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 504 ---TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT--GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 504 ---~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
.-...|||||.+..++++.++|||+||+++||+++ ...||....++. ..+.....++.+-...+ .
T Consensus 697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~~-------l 766 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQVV-------L 766 (807)
T ss_pred cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCccee-------c
Confidence 22356999999999999999999999999999887 788887654432 11212222222211111 1
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
..+.-+...++++|.+||+.+.++||+|+++...|.+.
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 12334556788999999999999999999999988764
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=345.23 Aligned_cols=259 Identities=27% Similarity=0.413 Sum_probs=218.2
Q ss_pred cCHHHHHHHhhccccccCceeEEEEEecC-CcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEE
Q 036334 341 FDLEDLLRASAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 341 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 419 (654)
++.+.-......+||-|.||.||.|+|+. .-.||||.++......++|..|..+|+.++|||+|+++|+|..+..+|||
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 33333333457889999999999999875 56899999999988899999999999999999999999999999999999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
+|||.+|+|.++|++.. +..++.-..+.++.||+.||+||..++ +|||||.++|+|+.++..|||+|||+++++..
T Consensus 342 TEfM~yGNLLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEkkn-FIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECN---RSEVPAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EecccCccHHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 99999999999998763 556888889999999999999999887 99999999999999999999999999998865
Q ss_pred CCCC-----CccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 500 TTPP-----TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 500 ~~~~-----~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
.+.. .....|.|||.+....++.|+|||+|||+|||+.| |-.||.+ +++.. +...+..++
T Consensus 418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG------idlSq-VY~LLEkgy------- 483 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQ-VYGLLEKGY------- 483 (1157)
T ss_pred CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC------ccHHH-HHHHHhccc-------
Confidence 4322 22345999999999999999999999999999999 7777754 33333 223333333
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
+.+..+.|...+++||+.||++.|.+||+|+|+.+.+|.|-...
T Consensus 484 ---RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 484 ---RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred ---cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 23445667778999999999999999999999999999886444
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=333.75 Aligned_cols=251 Identities=28% Similarity=0.430 Sum_probs=197.3
Q ss_pred HhhccccccCceeEEEEEecC-CcEEEEEEecccccC-HHHHHHHHHHHhccCCCccccccEEEEeCC--ceEEEEEecC
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVG-KREFEMQMEVLGKIKHDNVVPLRAFYYSKD--EKLLVYDYMP 424 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpniv~l~~~~~~~~--~~~lv~e~~~ 424 (654)
...+.||+|+||.||++...+ |+..|||........ .+.+++|+.+|.+++|||||+++|.....+ .+++.|||++
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence 446889999999999999654 899999998655221 456899999999999999999999755544 5899999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC-CCCeEEeccCCCCCcCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP-DHDACVSDFGLNPLFGN---- 499 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~---- 499 (654)
+|+|.+++.... . .+++..+.+++.||++||+|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 100 ~GsL~~~~~~~g---~-~l~E~~v~~ytr~iL~GL~ylHs~g-~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 100 GGSLSDLIKRYG---G-KLPEPLVRRYTRQILEGLAYLHSKG-IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred CCcHHHHHHHcC---C-CCCHHHHHHHHHHHHHHHHHHHhCC-EeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 999999998553 1 5999999999999999999999998 999999999999999 79999999999886652
Q ss_pred ---CCCCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 500 ---TTPPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 500 ---~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
.....+|+.|||||++..+ ....++||||+||++.||+||+.||... .....++..+........
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~------ 243 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPE------ 243 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCC------
Confidence 2245678889999999853 3446999999999999999999999753 112222222222221111
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
.+....++ ..+++.+|+..+|++|||+.++++.-.-....
T Consensus 244 -ip~~ls~~---a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 244 -IPDSLSDE---AKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred -CCcccCHH---HHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 11122333 44566699999999999999999887654433
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=343.42 Aligned_cols=237 Identities=24% Similarity=0.400 Sum_probs=196.7
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchhhh
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSAL 431 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 431 (654)
+-||.|+.|.||+|+++ ++.||||+.+.. -+.+|+-|++++||||+.|.|+|....-+|||||||..|-|+.+
T Consensus 130 eWlGSGaQGAVF~Grl~-netVAVKKV~el------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH-NETVAVKKVREL------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhccCcccceeeeecc-CceehhHHHhhh------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 56999999999999988 789999987542 24568889999999999999999999999999999999999999
Q ss_pred hccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---CCCCcccc
Q 036334 432 LHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TPPTRVAG 508 (654)
Q Consensus 432 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~~~~~~~~ 508 (654)
|+. ..++.....+.+..+||.||+|||.+. |||||||+-||||..+..|||+|||-++...+. ....||..
T Consensus 203 Lka-----~~~itp~llv~Wsk~IA~GM~YLH~hK-IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVa 276 (904)
T KOG4721|consen 203 LKA-----GRPITPSLLVDWSKGIAGGMNYLHLHK-IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVA 276 (904)
T ss_pred Hhc-----cCccCHHHHHHHHHHhhhhhHHHHHhh-HhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHh
Confidence 984 456888889999999999999999886 999999999999999999999999988766544 23567788
Q ss_pred ccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHH
Q 036334 509 YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQL 588 (654)
Q Consensus 509 y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 588 (654)
|||||+|...++++|+||||||||||||+||..||..-+..-. ++ .+ -........+..+...+
T Consensus 277 WMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI------Iw---------GV-GsNsL~LpvPstcP~Gf 340 (904)
T KOG4721|consen 277 WMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI------IW---------GV-GSNSLHLPVPSTCPDGF 340 (904)
T ss_pred hhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee------EE---------ec-cCCcccccCcccCchHH
Confidence 9999999999999999999999999999999999975322110 00 00 00111222344555566
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 589 LQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 589 ~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
.-|+++||+..|.+||+|.+++..|+-..
T Consensus 341 klL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred HHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 77788999999999999999999998554
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=327.74 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=197.3
Q ss_pred HHhhccccccCceeEEEEE-ecCCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 348 RASAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
|++.++||.|..++||+|+ ...++.||||++.-.. .+-+.+++|+..|+.++||||++++..|..+..+|+||.||.
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa 107 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA 107 (516)
T ss_pred eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence 3456889999999999998 4458999999996543 335788999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+|++.++++.... ..+++..+..|++++++||.|||++| .||||||+.||||+.+|.|||+|||.+..+-..
T Consensus 108 ~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH~~G-~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 108 GGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLHQNG-HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred CCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHHhcC-ceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 9999999986643 23899999999999999999999998 899999999999999999999999975433221
Q ss_pred ----CCCCccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchh---hhhh
Q 036334 501 ----TPPTRVAGYRAPEVVET--RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWT---AEVF 571 (654)
Q Consensus 501 ----~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 571 (654)
....++++|||||++.. ..|+.|+|||||||+..||.+|..||...-+. +.+...++.... ....
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~pp~~~t~~~ 257 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQNDPPTLLTSGL 257 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCCCCCcccccC
Confidence 23467888999999643 57999999999999999999999999864321 111111111110 0011
Q ss_pred hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 572 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
+. +......+.+.+++..|+.+||++|||++++++
T Consensus 258 ~~-----d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 258 DK-----DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred Ch-----HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11 111122335778888999999999999999954
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=338.83 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=211.6
Q ss_pred ccCHHHHHHHhhccccccCceeEEEEEec---CCc--EEEEEEeccc--ccCHHHHHHHHHHHhccCCCccccccEEEEe
Q 036334 340 SFDLEDLLRASAEVLGKGSVGTSYKAVLE---EGT--TVVVKRLKEV--AVGKREFEMQMEVLGKIKHDNVVPLRAFYYS 412 (654)
Q Consensus 340 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~---~g~--~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~ 412 (654)
.+.+........+.||+|-||.||+|.+. .|+ .||||.-|.. ..+.+.|..|..+|+.++|||||+++|+|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 44555555566889999999999999843 243 5888887764 3446789999999999999999999999965
Q ss_pred CCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccC
Q 036334 413 KDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFG 492 (654)
Q Consensus 413 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfg 492 (654)
...|||||.++.|.|.++|+.. ...++......++.||+.||+|||++. +|||||..+|||+.+..-||++|||
T Consensus 463 -~P~WivmEL~~~GELr~yLq~n----k~sL~l~tL~ly~~Qi~talaYLeSkr-fVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQN----KDSLPLRTLTLYCYQICTALAYLESKR-FVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred -cceeEEEecccchhHHHHHHhc----cccchHHHHHHHHHHHHHHHHHHHhhc-hhhhhhhhhheeecCcceeeecccc
Confidence 5789999999999999999864 345899999999999999999999997 9999999999999999999999999
Q ss_pred CCCCcCCCCCCCc-----cccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhch
Q 036334 493 LNPLFGNTTPPTR-----VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEW 566 (654)
Q Consensus 493 la~~~~~~~~~~~-----~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 566 (654)
+++.+.+...-.. ...|||||.+.-++++.++|||.|||.+||++. |..||.+-.+.+-+.. +..+
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-------iEnG- 608 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-------IENG- 608 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-------ecCC-
Confidence 9998876532221 234999999999999999999999999999998 9999987654432110 0111
Q ss_pred hhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 567 TAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
.+...++.+...|+.|+-+||+.+|.+||.+.|+...|.++.+.+
T Consensus 609 ---------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 609 ---------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred ---------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 033345567778889999999999999999999999999887643
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=337.29 Aligned_cols=245 Identities=23% Similarity=0.347 Sum_probs=199.7
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEeccc----c--cCHHHHHHHHHHHhccC-CCccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEV----A--VGKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~----~--~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e 421 (654)
.++.||+|.||+|+.|.. ..|+.||+|++... . ...+.+.+|+.++++++ ||||+++++++......++|||
T Consensus 21 ~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmE 100 (370)
T KOG0583|consen 21 LGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVME 100 (370)
T ss_pred eeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEE
Confidence 457899999999999974 46899999977553 1 22456678999999999 9999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC-CCeEEeccCCCCCcC-C
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD-HDACVSDFGLNPLFG-N 499 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~-~~~kl~Dfgla~~~~-~ 499 (654)
|+.+|+|.+++.. ...+.+..+.+++.|++.|++|||+++ |+||||||+|||++.+ +++||+|||++.... .
T Consensus 101 y~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~~g-i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~ 174 (370)
T KOG0583|consen 101 YCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHSRG-IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGE 174 (370)
T ss_pred ecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhCC-EeeCCCCHHHEEecCCCCCEEEeccccccccCCC
Confidence 9999999999984 345888999999999999999999998 9999999999999999 999999999998772 2
Q ss_pred ---CCCCCccccccCccccCCCC-CC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 500 ---TTPPTRVAGYRAPEVVETRK-VT-FKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 500 ---~~~~~~~~~y~aPE~~~~~~-~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
.....|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||... +.......+.....
T Consensus 175 ~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~------~~~~l~~ki~~~~~-------- 240 (370)
T KOG0583|consen 175 DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS------NVPNLYRKIRKGEF-------- 240 (370)
T ss_pred CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc------cHHHHHHHHhcCCc--------
Confidence 34567888899999999877 86 7899999999999999999999862 22222222222111
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
..+.... ..++..++.+|+..||.+|+++.+|+ .-.-++.
T Consensus 241 -~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 241 -KIPSYLL--SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred -cCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 1111110 34566777799999999999999999 5565664
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=336.78 Aligned_cols=240 Identities=24% Similarity=0.373 Sum_probs=200.8
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEecccccCH---HHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGK---REFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
|.+.+.||+|+||.||||+.+ +.+.||+|.+.+..... +.+.+|++++++++|||||.++++|+...++++|+||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 344577999999999999855 47899999997765444 45788999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC--
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-- 501 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-- 501 (654)
.| +|..+|.. ...++++.+..++.|+..||.|||+.+ |.|||+||.|||++..+.+|+||||+|+.+...+
T Consensus 84 ~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs~r-ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 84 VG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHSNR-ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred hh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhcC-cccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 76 99999983 456999999999999999999999998 9999999999999999999999999999887653
Q ss_pred --CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 502 --PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 502 --~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
...||+-|||||++.++.|+..+|+||+|||+||+++|++||.... +...+..+..+. ..
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~------------v~ 218 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDP------------VK 218 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCC------------CC
Confidence 4578888999999999999999999999999999999999997521 222222222211 11
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.+......+..++...+.+||.+|.+..+++..
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 122444567777779999999999999998653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=313.97 Aligned_cols=288 Identities=21% Similarity=0.266 Sum_probs=211.2
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEe--CCceEEEEEe
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYS--KDEKLLVYDY 422 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~ 422 (654)
+..+.|++|+||.||+|+.+ +++.||+|+++..... .-.-.+||.+|.+++|||||.+..+... -+..|+||||
T Consensus 79 e~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~ 158 (419)
T KOG0663|consen 79 EKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY 158 (419)
T ss_pred HHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence 44678999999999999954 5889999999865421 2235789999999999999999998764 3568999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT- 501 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 501 (654)
|+. +|..++... .+++...++..++.|+++|++|||... |+|||||++|+|++..|.+||+|||+|+.++...
T Consensus 159 ~Eh-DLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH~~w-ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 159 VEH-DLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLHDNW-ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred HHh-hHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHhhce-eEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 977 999999865 357899999999999999999999988 9999999999999999999999999999987663
Q ss_pred ---CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH--hhhchhhhhhhH--
Q 036334 502 ---PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSV--VREEWTAEVFDV-- 573 (654)
Q Consensus 502 ---~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-- 573 (654)
...-|..|+|||.+.+ ..|++.+|+||+|||+.||+++++.|.+..+-+..+ ..++-. ..+.........
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~--~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD--KIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH--HHHHHhCCCccccCCCccccch
Confidence 3445678999999876 579999999999999999999999998755433211 111100 000000000000
Q ss_pred ----hhh---------ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCCCCCCCCCCCCCCCCCCCC
Q 036334 574 ----ELM---------RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDDGLRQSSDDPSKGSDGHT 640 (654)
Q Consensus 574 ----~~~---------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (654)
.+. .+.... -...-++++...+..||.+|.|+.|.++. ..-...+-...+..+++....+....
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~Pt~P~k~~~~~ 387 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMFPTWPAKSEQQR 387 (419)
T ss_pred hhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhhcCCCcccccccc
Confidence 000 000000 11234567779999999999999998763 33344455555666666665555555
Q ss_pred CCCCCCC
Q 036334 641 PPPESRT 647 (654)
Q Consensus 641 ~~~~~~~ 647 (654)
.++...+
T Consensus 388 ~~~~~~~ 394 (419)
T KOG0663|consen 388 VKRGTSP 394 (419)
T ss_pred CCCCCCC
Confidence 4444433
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=341.55 Aligned_cols=241 Identities=26% Similarity=0.362 Sum_probs=200.7
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEeccc----ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEV----AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
.++.||.|+.|.|..|++ ..|+.+|||++.+. ......+++||.+|+.+.||||++++++++++.++|+|.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 357799999999999984 56999999999765 2234678999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---C
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---T 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~ 501 (654)
+|.|++++. .++++++.++.+++.||+.|+.|+|..+ |+||||||+|+|+|..+++||+|||+|..-... .
T Consensus 96 gGELFdylv-----~kG~l~e~eaa~ff~QIi~gv~yCH~~~-icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 96 GGELFDYLV-----RKGPLPEREAAHFFRQILDGVSYCHAFN-ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLE 169 (786)
T ss_pred CchhHHHHH-----hhCCCCCHHHHHHHHHHHHHHHHHhhhc-ceeccCCchhhhhhcccCEeeeccceeecccCCcccc
Confidence 999999997 3567999999999999999999999888 999999999999999999999999999876554 3
Q ss_pred CCCccccccCccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 502 PPTRVAGYRAPEVVETRKVT-FKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
...|.+.|.|||++.+..|+ .++||||+|||||.|+||+.||++. ++...+..+-++.+ ..
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~LLlKV~~G~f------------~M 231 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRVLLLKVQRGVF------------EM 231 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHHHHHHHHcCcc------------cC
Confidence 45677789999999999886 7899999999999999999999842 22222222222221 11
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
+..-..+..+|+.+|+..||+.|.|++||++.--
T Consensus 232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred CCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 2222334556677999999999999999998754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=332.75 Aligned_cols=238 Identities=25% Similarity=0.369 Sum_probs=196.9
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccc--ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV--AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
.+.||+|.||.||+|... .++.||+|++.-. ....+++++|+.++..++++||.++++.+..+..++++||||.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 377999999999999954 5889999999755 3445789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CCC
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPP 503 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~ 503 (654)
+.+.+... ..+++..+.-++.+++.|+.|||.++ .+|||||+.|||+..+|.+|++|||.+...... ...
T Consensus 98 v~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH~~~-kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tf 171 (467)
T KOG0201|consen 98 VLDLLKSG-----NILDEFEIAVILREVLKGLDYLHSEK-KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTF 171 (467)
T ss_pred hhhhhccC-----CCCccceeeeehHHHHHHhhhhhhcc-eecccccccceeEeccCcEEEEecceeeeeechhhccccc
Confidence 99999732 34577888889999999999999998 999999999999999999999999998766533 456
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+..-..+ +.....+.. ...
T Consensus 172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl---------------Ipk~~PP~L--~~~ 234 (467)
T KOG0201|consen 172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL---------------IPKSAPPRL--DGD 234 (467)
T ss_pred cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe---------------ccCCCCCcc--ccc
Confidence 788999999999999999999999999999999999999987544221110 000000011 113
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
+...+.+++..|+.+||+.||++.++++
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 3445667777999999999999999865
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=332.00 Aligned_cols=239 Identities=22% Similarity=0.367 Sum_probs=187.3
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
..+.||+|+||.||+|... +|+.||||++..... ....+.+|++++++++|+||+++++++..++..++||||+++|
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 4578999999999999865 589999999865432 2456889999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TP 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~ 502 (654)
+|.+.. ..++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...... ..
T Consensus 158 ~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 227 (353)
T PLN00034 158 SLEGTH---------IADEQFLADVARQILSGIAYLHRRH-IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNS 227 (353)
T ss_pred cccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC-EeecCCCHHHEEEcCCCCEEEcccccceecccccccccc
Confidence 986532 2567788899999999999999998 999999999999999999999999998765432 23
Q ss_pred CCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 503 PTRVAGYRAPEVVET-----RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
..++..|+|||++.. ...+.++|||||||++|||++|+.||......+ ............ .
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~-----------~ 293 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAICMSQ-----------P 293 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhccC-----------C
Confidence 456778999998743 234568999999999999999999997322211 111111110000 0
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.........++.+++.+||+.||++||++.|+++.
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111223457788889999999999999999874
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=336.74 Aligned_cols=240 Identities=20% Similarity=0.253 Sum_probs=193.8
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+.+.||+|+||.||+|... +|+.||+|+++... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 100 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence 34578999999999999965 58899999997542 22356788999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-CC
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-TP 502 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-~~ 502 (654)
++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 101 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 174 (329)
T PTZ00263 101 VGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHSKD-IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT 174 (329)
T ss_pred CCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHEEECCCCCEEEeeccCceEcCCCcce
Confidence 99999999973 345889999999999999999999998 999999999999999999999999998866443 23
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... . .....
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~~-------~--~p~~~- 238 (329)
T PTZ00263 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKILAGRL-------K--FPNWF- 238 (329)
T ss_pred ecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHHHhcCCc-------C--CCCCC-
Confidence 4567889999999999999999999999999999999999964321 111122111110 0 01111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPA-----MQEVVRM 612 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 612 (654)
...+.+++.+||+.||++||+ ++++++.
T Consensus 239 --~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 239 --DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 124567888999999999997 6777643
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=335.81 Aligned_cols=236 Identities=22% Similarity=0.271 Sum_probs=190.6
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
++||+|+||.||++... +|+.||+|+++... .....+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999854 68999999997642 12345678999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TP 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~ 502 (654)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~-ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCD-VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 99999873 345899999999999999999999998 999999999999999999999999998753221 22
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... . ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~~~~~~~-------~-----~p~ 216 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEEI-------R-----FPR 216 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCCC-------C-----CCC
Confidence 3467889999999999999999999999999999999999964321 111111111110 0 011
Q ss_pred HHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRP-----AMQEVVR 611 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 611 (654)
....++.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1233566788899999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=346.68 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=202.1
Q ss_pred HhhccccccCceeEEEEEecCC-cEEEEEEeccc-ccCHHHHHHHHHHHhccC-CCccccccEE-EEe------CCceEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEG-TTVVVKRLKEV-AVGKREFEMQMEVLGKIK-HDNVVPLRAF-YYS------KDEKLL 418 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g-~~vavK~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~l~~~-~~~------~~~~~l 418 (654)
.+.++|.+|||+.||.|....+ ..||+|++-.. ...-+...+||++|++|+ |+|||.+++. ... ..+++|
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 3458899999999999997765 99999998655 334567889999999997 9999999993 221 136789
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC-CeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 419 VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG-KIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
.||||++|.|-+++.... ...|++.++++|+.|+++|+++||... +|||||||-+||||+.+++.||||||.|.-.
T Consensus 120 LmEyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred ehhhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 999999999999997432 234999999999999999999999765 7999999999999999999999999998643
Q ss_pred CCC-------------CCCCccccccCcccc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH
Q 036334 498 GNT-------------TPPTRVAGYRAPEVV---ETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSV 561 (654)
Q Consensus 498 ~~~-------------~~~~~~~~y~aPE~~---~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~ 561 (654)
-.. ....+|+.|+|||++ .+...++|+|||||||+||-|+....||+....
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------------- 263 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------------- 263 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------------
Confidence 211 234567889999987 577899999999999999999999999975321
Q ss_pred hhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 562 VREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
..+++..+ .+.....+...|..||+.||+.||++||++-+|++.+.++....
T Consensus 264 ------laIlng~Y-~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 ------LAILNGNY-SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ------eeEEeccc-cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 11222222 22233566778888999999999999999999999999887544
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=329.97 Aligned_cols=255 Identities=22% Similarity=0.318 Sum_probs=194.5
Q ss_pred hhccccccCceeEEEEEecC-----------------CcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLEE-----------------GTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFY 410 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~ 410 (654)
+.+.||+|+||.||++.+.+ +..||+|.++... ....++.+|++++.+++||||+++++++
T Consensus 9 ~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 88 (304)
T cd05096 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVC 88 (304)
T ss_pred eeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 45789999999999997532 3369999987643 2345788999999999999999999999
Q ss_pred EeCCceEEEEEecCCCchhhhhccCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCC
Q 036334 411 YSKDEKLLVYDYMPAGSLSALLHGSRG--------------SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKAS 476 (654)
Q Consensus 411 ~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~ 476 (654)
.+.+..++||||+++|+|.+++..... .....+++..+++++.|++.||+|||+.+ |+||||||+
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-ivH~dlkp~ 167 (304)
T cd05096 89 VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-FVHRDLATR 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC-ccccCcchh
Confidence 999999999999999999998864321 11235788999999999999999999998 999999999
Q ss_pred cEEECCCCCeEEeccCCCCCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCC
Q 036334 477 NILLRPDHDACVSDFGLNPLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT--GKAPNQASLG 548 (654)
Q Consensus 477 NIll~~~~~~kl~Dfgla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t--g~~pf~~~~~ 548 (654)
|||++.++.+||+|||++....... ...++..|+|||++.++.++.++|||||||++|||++ +..||.....
T Consensus 168 Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 247 (304)
T cd05096 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD 247 (304)
T ss_pred heEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCH
Confidence 9999999999999999987653321 1223557999999988899999999999999999987 5567664322
Q ss_pred CCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 549 EEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
. .....+......... .. .......+...+.+++.+||+.||++|||+++|.+.|++
T Consensus 248 ~---~~~~~~~~~~~~~~~-~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 248 E---QVIENAGEFFRDQGR-QV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred H---HHHHHHHHHhhhccc-cc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 1 111111111111100 00 000111233467888899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=323.76 Aligned_cols=247 Identities=22% Similarity=0.362 Sum_probs=197.2
Q ss_pred HHhhccccccCceeEEEEEec----CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 348 RASAEVLGKGSVGTSYKAVLE----EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
+.+.+.||+|+||.||+|.+. .+..||+|.++.... ....+.+|+.++++++||||+++++++..++..++|||
T Consensus 7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 86 (266)
T cd05064 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTE 86 (266)
T ss_pred eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEE
Confidence 345678999999999999753 356899999876532 23568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT 501 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 501 (654)
|+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+.......
T Consensus 87 ~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~~-iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 87 YMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEMG-YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred eCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC-EeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 99999999999743 235899999999999999999999988 9999999999999999999999999876543221
Q ss_pred -----CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 502 -----PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 502 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
...++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ..+..+ .....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------~~~~~~-~~~~~-------- 226 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------DVIKAV-EDGFR-------- 226 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHH-HCCCC--------
Confidence 1223456999999999999999999999999999875 99999754221 111111 11110
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
..........+.+++.+||+.+|++||+++++.+.|+++
T Consensus 227 --~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 --LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011122344677888899999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=324.22 Aligned_cols=249 Identities=23% Similarity=0.314 Sum_probs=194.5
Q ss_pred HHhhccccccCceeEEEEEe-cCCcEEEEEEeccccc---------------CHHHHHHHHHHHhccCCCccccccEEEE
Q 036334 348 RASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAV---------------GKREFEMQMEVLGKIKHDNVVPLRAFYY 411 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---------------~~~~~~~e~~~l~~l~hpniv~l~~~~~ 411 (654)
|.+.+.||+|.||.|-+|+. .+++.||+|++.+... ..+...+||.+|++++|||||+|+++..
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 34556799999999999995 4689999999965321 1246889999999999999999999988
Q ss_pred eC--CceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEe
Q 036334 412 SK--DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVS 489 (654)
Q Consensus 412 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~ 489 (654)
+. +.+|||+|||..|.+...-. ....+++.++++++.++..||+|||.++ |+||||||+|+|++++|+|||+
T Consensus 179 DP~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Qg-iiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQG-IIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred CcccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhcC-eeccccchhheEEcCCCcEEee
Confidence 75 46899999999988765432 2233999999999999999999999998 9999999999999999999999
Q ss_pred ccCCCCCcCCC---------CCCCccccccCccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhH
Q 036334 490 DFGLNPLFGNT---------TPPTRVAGYRAPEVVETRK----VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPR 556 (654)
Q Consensus 490 Dfgla~~~~~~---------~~~~~~~~y~aPE~~~~~~----~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~ 556 (654)
|||.+..+... ....||+.|+|||...++. .+.+.||||+||+||.|+.|+.||.+... ..
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~------~~ 326 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE------LE 326 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH------HH
Confidence 99998766211 2467889999999987632 35788999999999999999999975322 11
Q ss_pred HHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 557 WVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
....+ +...+ .+...++...++-+|+.++|++||+.|.+..+|.....--..
T Consensus 327 l~~KI---------vn~pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 327 LFDKI---------VNDPL-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHH---------hcCcc-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 11122 11122 122222344566678889999999999999999877654443
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=340.21 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=197.1
Q ss_pred HHhhccccccCceeEEEEEe------cCCcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEE
Q 036334 348 RASAEVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLL 418 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~l 418 (654)
+.+.+.||+|+||.||+|.. ..+..||||+++.... ..+.+.+|+++++.+ +||||++++++|...+..++
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 45578999999999999963 2356899999975432 345678899999999 89999999999999999999
Q ss_pred EEEecCCCchhhhhccCCCC------------------------------------------------------------
Q 036334 419 VYDYMPAGSLSALLHGSRGS------------------------------------------------------------ 438 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~------------------------------------------------------------ 438 (654)
||||+++|+|.+++...+..
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 99999999999998643210
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC------
Q 036334 439 ----------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP------ 502 (654)
Q Consensus 439 ----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~------ 502 (654)
....+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 275 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN-CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCC
Confidence 1125889999999999999999999988 99999999999999999999999999876543211
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...+..|+|||++.+..++.++|||||||++|||++ |..||....... . ....+..+.... . .
T Consensus 276 ~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~----~~~~~~~~~~~~-------~---~ 339 (375)
T cd05104 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--K----FYKMIKEGYRML-------S---P 339 (375)
T ss_pred CCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--H----HHHHHHhCccCC-------C---C
Confidence 122346999999999999999999999999999998 888886532211 1 111111111100 0 0
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
.....++.+++.+||+.||++||++.||++.|++.
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11123577888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=319.37 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=196.7
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCC----ceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD----EKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~----~~~lv~e~~~~g 426 (654)
.+.||+|.||+||+|.++ |+.||||++.........-+.||..-..++|+||+.+++.-..+. +++||++|.+.|
T Consensus 216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~G 294 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHG 294 (513)
T ss_pred EEEecCccccceeecccc-CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCC
Confidence 478999999999999998 999999999765433333344555555679999999999865443 579999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-----cC--CeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV-----SG--KIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-----~~--~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
||+|+|. ...++....++++..+|.||+|||. +| .|.|||||+.|||+..++.+.|+|+|+|.....
T Consensus 295 SL~DyL~------r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~ 368 (513)
T KOG2052|consen 295 SLYDYLN------RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 368 (513)
T ss_pred cHHHHHh------hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecc
Confidence 9999997 3569999999999999999999993 22 599999999999999999999999999876543
Q ss_pred C--------CCCCccccccCccccCCCC----C--CcchhHHHHHHHHHHHHhC----------CCCCCCCCCCCCCChh
Q 036334 500 T--------TPPTRVAGYRAPEVVETRK----V--TFKSDVYSFGVLLLELLTG----------KAPNQASLGEEGIDLP 555 (654)
Q Consensus 500 ~--------~~~~~~~~y~aPE~~~~~~----~--~~~~DvwslGvil~el~tg----------~~pf~~~~~~~~~~~~ 555 (654)
. ....||.+|||||++.... + -..+||||||+|+||+..+ +.||.+..+.+.. ..
T Consensus 369 ~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs-~e 447 (513)
T KOG2052|consen 369 DTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS-FE 447 (513)
T ss_pred cCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC-HH
Confidence 3 3467888899999996532 1 2458999999999998863 2455443322211 00
Q ss_pred HHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 556 RWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
+ .++-.....+.+.........+.+..+.++|+.||..+|..|-|+-.+-+.|.++.+
T Consensus 448 e-----MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 448 E-----MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred H-----HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 0 011111222334444555677899999999999999999999999999999999875
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=324.24 Aligned_cols=242 Identities=33% Similarity=0.553 Sum_probs=188.7
Q ss_pred hccccccCceeEEEEEec-----CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 351 AEVLGKGSVGTSYKAVLE-----EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+.||+|.||.||+|.+. .+..|+||.++.... ..+++.+|++.+++++||||++++|++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999976 256899999966432 3578899999999999999999999999888899999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
++|+|.+++... ....+++..+++++.||++||+|||+++ ++|+||+++||++++++.+||+|||++......
T Consensus 84 ~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~-iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 84 PGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNN-IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTT-EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccc---cccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccc
Confidence 999999999854 2356899999999999999999999987 999999999999999999999999998766221
Q ss_pred ---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhh
Q 036334 501 ---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576 (654)
Q Consensus 501 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (654)
........|+|||.+....++.++||||||+++||+++ |+.||... +........ .+...
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~~~~~~~~-~~~~~--------- 223 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DNEEIIEKL-KQGQR--------- 223 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CHHHHHHHH-HTTEE---------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccc-ccccc---------
Confidence 22334456999999988889999999999999999999 67887543 122222222 11111
Q ss_pred ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
..........+.+++.+||+.+|++||||+++++.|
T Consensus 224 -~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 -LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111122334677888899999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.16 Aligned_cols=254 Identities=25% Similarity=0.375 Sum_probs=197.7
Q ss_pred HHHhhccccccCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccccccEEEEeCCceE
Q 036334 347 LRASAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKL 417 (654)
Q Consensus 347 ~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~ 417 (654)
.+.+.+.||+|+||.||+|... ++..||+|+++.... ....+.+|+++++.+ +|+||++++++|...+..+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 4456788999999999998742 235799999976432 234678899999999 8999999999999999999
Q ss_pred EEEEecCCCchhhhhccCCC------------------------------------------------------------
Q 036334 418 LVYDYMPAGSLSALLHGSRG------------------------------------------------------------ 437 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~------------------------------------------------------------ 437 (654)
+||||+++|+|.+++.....
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 99999999999998854210
Q ss_pred -----CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC------CCCcc
Q 036334 438 -----SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT------PPTRV 506 (654)
Q Consensus 438 -----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~------~~~~~ 506 (654)
.....+++..+++++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++....... ...++
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN-CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 01135789999999999999999999998 9999999999999999999999999987653321 11223
Q ss_pred ccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHH
Q 036334 507 AGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585 (654)
Q Consensus 507 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (654)
..|||||++.+..++.++|||||||++|||++ |+.||....... ............ . ... ...
T Consensus 278 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~~~~-----~--~~~---~~~ 341 (374)
T cd05106 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRGYQM-----S--RPD---FAP 341 (374)
T ss_pred cceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHcccCc-----c--CCC---CCC
Confidence 46999999988899999999999999999997 999997532211 011111111100 0 000 112
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 586 VQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 586 ~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
.++.+++.+||+.||++|||+.++++.|+++.
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 46778888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=320.39 Aligned_cols=247 Identities=23% Similarity=0.408 Sum_probs=201.0
Q ss_pred HhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.+.+.||+|+||.||+|...++..||+|.+.......+.+.+|+.++++++|+||+++++++.+.+..++||||+++|+|
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (261)
T cd05072 9 KLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL 88 (261)
T ss_pred EEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcH
Confidence 44578999999999999988888999999876655667889999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-----CC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-----PP 503 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-----~~ 503 (654)
.++++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 89 ~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~-i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (261)
T cd05072 89 LDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKN-YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 164 (261)
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccchhhEEecCCCcEEECCCccceecCCCceeccCCC
Confidence 99997432 345889999999999999999999987 9999999999999999999999999997664322 11
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
.++..|+|||++....++.++|||||||++|||++ |+.||...... ..... ....+.. ....
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~------~~~~~-~~~~~~~----------~~~~ 227 (261)
T cd05072 165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS------DVMSA-LQRGYRM----------PRME 227 (261)
T ss_pred ccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH------HHHHH-HHcCCCC----------CCCC
Confidence 23446999999988889999999999999999998 99998643211 11111 1111100 0111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
....++.+++.+||..+|++||+++++.+.|+++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1234577888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=319.78 Aligned_cols=246 Identities=27% Similarity=0.386 Sum_probs=200.4
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
..+.||+|+||.||+|... .++.||+|+++.......++.+|++++++++||||+++++++..++..++||||+++++|
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (263)
T cd05052 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 89 (263)
T ss_pred EeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcH
Confidence 3577999999999999965 488999999887655567889999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC-----C
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP-----P 503 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----~ 503 (654)
.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++........ .
T Consensus 90 ~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~-i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 165 (263)
T cd05052 90 LDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 165 (263)
T ss_pred HHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-EeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCC
Confidence 99986432 345899999999999999999999988 99999999999999999999999999877654321 1
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..+..|+|||.+.+..++.++|||||||++|||++ |..||..... ....... ..... .....
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~~~-~~~~~----------~~~~~ 228 (263)
T cd05052 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELL-EKGYR----------MERPE 228 (263)
T ss_pred CCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHH-HCCCC----------CCCCC
Confidence 22346999999998899999999999999999998 8899864321 1111111 11110 01111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
....++.+++.+||+.+|++||++.+++++|+++
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2234677788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=319.12 Aligned_cols=247 Identities=26% Similarity=0.425 Sum_probs=201.6
Q ss_pred HhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.+.+.||+|+||.||+|...+++.||+|.++......+++.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (261)
T cd05068 9 QLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSL 88 (261)
T ss_pred eeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcH
Confidence 34578999999999999987788999999987666677899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC--CCc-
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP--PTR- 505 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~--~~~- 505 (654)
.+++.... ...+++..+..++.|++.|+.|||+++ |+||||||+||++++++.+||+|||++........ ..+
T Consensus 89 ~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (261)
T cd05068 89 LEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN-YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA 164 (261)
T ss_pred HHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCC
Confidence 99997432 235899999999999999999999998 99999999999999999999999999876643211 111
Q ss_pred --cccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 506 --VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 506 --~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
...|+|||++.+..++.++||||||+++|||++ |+.||..... ......+ ..... .....
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~-~~~~~----------~~~~~ 227 (261)
T cd05068 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN------AEVLQQV-DQGYR----------MPCPP 227 (261)
T ss_pred cCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHH-HcCCC----------CCCCC
Confidence 236999999998899999999999999999999 9999864321 1111111 11110 01112
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
.....+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 2335678888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=316.63 Aligned_cols=241 Identities=24% Similarity=0.370 Sum_probs=197.9
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchhh
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSA 430 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~ 430 (654)
.+.||+|+||.||++.++++..+|+|.++.......++.+|++++++++||||+++++++..++..++||||+++|+|.+
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 88 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHH
Confidence 46799999999999998888899999988666667789999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC-----CCc
Q 036334 431 LLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP-----PTR 505 (654)
Q Consensus 431 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----~~~ 505 (654)
+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+........ ..+
T Consensus 89 ~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~ 163 (256)
T cd05114 89 YLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS-FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF 163 (256)
T ss_pred HHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC-ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCC
Confidence 987432 35899999999999999999999998 99999999999999999999999999876533211 122
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 506 VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 506 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
+..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...+..+...... ......
T Consensus 164 ~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~i~~~~~~-----------~~~~~~ 226 (256)
T cd05114 164 PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEMISRGFRL-----------YRPKLA 226 (256)
T ss_pred chhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHCCCCC-----------CCCCCC
Confidence 346999999988889999999999999999999 8999865321 1222222111110 001112
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 585 MVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
...+.+++.+||+.+|++||+++++++.|
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 24678889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=324.40 Aligned_cols=243 Identities=26% Similarity=0.322 Sum_probs=193.2
Q ss_pred hccccccCceeEEEEEe-cCCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.+.||+|+||+||++.. .+|+.||+|.+.... .....+.+|++++++++|+||+++++++.+++..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 46799999999999985 468999999986542 2234577899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---CC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TP 502 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~~ 502 (654)
|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...... ..
T Consensus 85 g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 85 GDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRER-IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred CcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 99998886432 235899999999999999999999998 999999999999999999999999998765432 23
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..++..|+|||++.+..++.++|||||||++|||++|+.||....... ....+....... . .....
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~--------~---~~~~~ 226 (285)
T cd05631 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---KREEVDRRVKED--------Q---EEYSE 226 (285)
T ss_pred CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch---hHHHHHHHhhcc--------c---ccCCc
Confidence 456788999999999999999999999999999999999998643221 111111111100 0 00111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPA-----MQEVVR 611 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 611 (654)
....++.+++.+||+.||++||+ ++++++
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 22335677888999999999997 777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=328.77 Aligned_cols=239 Identities=18% Similarity=0.221 Sum_probs=193.3
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 84 (291)
T cd05612 5 RIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVP 84 (291)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCC
Confidence 3577999999999999965 58899999986532 223567889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-CCC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-TPP 503 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-~~~ 503 (654)
+|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 85 ~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (291)
T cd05612 85 GGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHSKE-IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL 158 (291)
T ss_pred CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHeEECCCCCEEEEecCcchhccCCcccc
Confidence 9999999973 345899999999999999999999998 999999999999999999999999998866443 234
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... .+ ...
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~-------~~-----~~~ 220 (291)
T cd05612 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIYEKILAGKL-------EF-----PRH 220 (291)
T ss_pred cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCc-------CC-----Ccc
Confidence 567889999999988999999999999999999999999975321 111222211110 00 011
Q ss_pred HHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPA-----MQEVVRM 612 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 612 (654)
....+.+++.+||+.||.+||+ ++|+++.
T Consensus 221 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 221 LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1234667888999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=329.84 Aligned_cols=236 Identities=22% Similarity=0.278 Sum_probs=189.8
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
++||+|+||.||++... +|..||+|+++... .....+.+|++++++++||||++++++|...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999854 68999999997642 12345678999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TP 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~ 502 (654)
+|..++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 99988863 235899999999999999999999998 999999999999999999999999998753221 22
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..++..|+|||++.+..++.++|||||||++|||++|+.||...... .....+..... . . ..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~~~~~~~-------~--~---p~ 216 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEEI-------R--F---PR 216 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCCC-------C--C---CC
Confidence 34677899999999999999999999999999999999999653221 11111111110 0 0 11
Q ss_pred HHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRP-----AMQEVVR 611 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 611 (654)
....++.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1223566778899999999998 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=329.96 Aligned_cols=193 Identities=23% Similarity=0.364 Sum_probs=168.6
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
...+.||+|+||.||++... +|..||+|.+.... .....+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (331)
T cd06649 8 ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 87 (331)
T ss_pred eEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCC
Confidence 34577999999999999965 57889999987542 2245788999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--CCC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--TPP 503 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--~~~ 503 (654)
|+|.+++.. ...+++..+..++.|++.||.|||+++.|+||||||+|||++.++.+||+|||++...... ...
T Consensus 88 ~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (331)
T cd06649 88 GSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (331)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccccC
Confidence 999999974 2358999999999999999999998655999999999999999999999999998765432 233
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQAS 546 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 546 (654)
.++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 5677899999999989999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=296.47 Aligned_cols=254 Identities=22% Similarity=0.293 Sum_probs=202.9
Q ss_pred HhhccccccCceeEEEEE-ecCCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCC-----ceEEEEE
Q 036334 349 ASAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD-----EKLLVYD 421 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-----~~~lv~e 421 (654)
.+.+.||+|+|+.||.++ ..++..+|+|++.... .+.+..++|++.-++++||||++++++...+. +.|++++
T Consensus 24 ri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~P 103 (302)
T KOG2345|consen 24 RIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLP 103 (302)
T ss_pred EEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEee
Confidence 345789999999999998 6678899999997764 56678899999999999999999999875433 4899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC-CeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG-KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
|+..|+|.+.+...+. +...+++.+.++|+.+|++||++||+.. +++||||||.||++.+++.+++.|||.++...-.
T Consensus 104 yy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~ 182 (302)
T KOG2345|consen 104 YYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQ 182 (302)
T ss_pred hhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceE
Confidence 9999999999976543 3457999999999999999999999775 6999999999999999999999999998765322
Q ss_pred C-------------CCCccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh
Q 036334 501 T-------------PPTRVAGYRAPEVVET---RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE 564 (654)
Q Consensus 501 ~-------------~~~~~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 564 (654)
. ...-+..|+|||.+.- ...++++|||||||+||+|+.|..||+.... .+..+.
T Consensus 183 i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSla--------- 252 (302)
T KOG2345|consen 183 IEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLA--------- 252 (302)
T ss_pred eechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEE---------
Confidence 1 1233556999999853 4578999999999999999999999975332 221111
Q ss_pred chhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 565 EWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
..+....+ ..+........+.++++.|++.||.+||++.+++..++++.
T Consensus 253 ---LAv~n~q~-s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 ---LAVQNAQI-SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---Eeeecccc-ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11112122 12222335667888999999999999999999999998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.64 Aligned_cols=192 Identities=23% Similarity=0.330 Sum_probs=172.9
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC----HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG----KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||.|+||+|..++.+ +|..+|+|++.+...- .+....|..+|+.+.||+++++++.|.+...+++||||++
T Consensus 48 ~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~ 127 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVP 127 (355)
T ss_pred heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccC
Confidence 4578999999999999955 5889999999876322 2335678899999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-CCC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-TPP 503 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-~~~ 503 (654)
||.|..+++.. +.+++..+..+|.||+.|++|||+.+ |++|||||+|||+|.+|.+||.|||+|+..... ...
T Consensus 128 GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH~~~-iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~Tl 201 (355)
T KOG0616|consen 128 GGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLHSLD-IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTWTL 201 (355)
T ss_pred CccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHHhcC-eeeccCChHHeeeccCCcEEEEeccceEEecCcEEEe
Confidence 99999999853 45899999999999999999999998 999999999999999999999999999987655 456
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASL 547 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 547 (654)
.||+.|+|||+++.+.|..++|.|||||++|||+.|.+||....
T Consensus 202 CGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 202 CGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred cCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 88999999999999999999999999999999999999998643
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=320.63 Aligned_cols=249 Identities=25% Similarity=0.436 Sum_probs=197.9
Q ss_pred hhccccccCceeEEEEEecC------CcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLEE------GTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~------g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
+.+.||+|+||.||+|.... ...|++|.++.... ...++.+|++++++++||||+++++++.+.+..+++||
T Consensus 9 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e 88 (283)
T cd05048 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFE 88 (283)
T ss_pred hhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEe
Confidence 45779999999999998543 25799999875432 24568899999999999999999999998889999999
Q ss_pred ecCCCchhhhhccCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEec
Q 036334 422 YMPAGSLSALLHGSRGSG-----------RTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSD 490 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~D 490 (654)
|+++|+|.+++....... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~-i~H~dlkp~Nil~~~~~~~~L~d 167 (283)
T cd05048 89 YLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-FVHRDLAARNCLVGEGLTVKISD 167 (283)
T ss_pred cCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccccccceEEEcCCCcEEECC
Confidence 999999999997532111 145899999999999999999999998 99999999999999999999999
Q ss_pred cCCCCCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 036334 491 FGLNPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVR 563 (654)
Q Consensus 491 fgla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 563 (654)
||++...... ....++..|+|||.+.+..++.++|||||||++|||++ |..||...... +... .+.
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------~~~~-~i~ 240 (283)
T cd05048 168 FGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------EVIE-MIR 240 (283)
T ss_pred CcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHH-HHH
Confidence 9998754322 12233566999999988899999999999999999998 99998753321 1111 111
Q ss_pred hchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 564 EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
.... .........++.+++.+||+.||++||++.||++.|+.+
T Consensus 241 ~~~~----------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 241 SRQL----------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred cCCc----------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1110 011223345788888999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=314.13 Aligned_cols=249 Identities=24% Similarity=0.409 Sum_probs=203.3
Q ss_pred HHHhhccccccCceeEEEEEecCCcEEEEEEeccccc-CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 347 LRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV-GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 347 ~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.+.+.+.||+|+||.||+|...++..+++|.++.... ...++..|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence 3556788999999999999988899999999976644 466788999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 501 (654)
|+|.+++.... ...+++..+++++.|++.|++|||+++ |+||||||+||+++.++.+||+|||.+.......
T Consensus 87 ~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~-i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 87 GSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQN-SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred CCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence 99999997542 245899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
....+..|+|||.+....++.++||||||+++|+|++ |+.||...... ..+.... ... ....
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~------~~~~~~~-~~~----------~~~~ 225 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH------EVYDQIT-AGY----------RMPC 225 (261)
T ss_pred CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHHH-hCC----------cCCC
Confidence 1223456999999988899999999999999999998 89998653211 1111111 110 0011
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
.......+.+++.+||+.||++|||++++++.|+.+
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 122334677888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=313.91 Aligned_cols=242 Identities=22% Similarity=0.388 Sum_probs=203.5
Q ss_pred HHHhhccccccCceeEEEEE-ecCCcEEEEEEecccccCHH----HHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 347 LRASAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKR----EFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 347 ~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~----~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
.|++.+.||+|.||+|-+|. ...|+.||||.+++.....+ .+.+||++|..++||||+.++.+|++.+...||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 45667889999999999998 46799999999987754322 36789999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT 501 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 501 (654)
|..+|.|++++.. .+.|++.++.+++.||..|+.|+|.++ ++|||||.+|||+|.++++||+|||++..+....
T Consensus 134 YaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHknr-VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 134 YASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHKNR-VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred ecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhhcc-ceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 9999999999984 456999999999999999999999887 9999999999999999999999999999887654
Q ss_pred ---CCCccccccCccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 502 ---PPTRVAGYRAPEVVETRKVT-FKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 502 ---~~~~~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
...|.+-|.+||++.+.+|. +.+|.||+||+||-|+.|..||++. +....+.++.+..+...
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~------Dhk~lvrQIs~GaYrEP-------- 273 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR------DHKRLVRQISRGAYREP-------- 273 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc------hHHHHHHHhhcccccCC--------
Confidence 34556669999999998885 7899999999999999999999753 33444555544433211
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
+...+..-||++|+..+|++|.|+.+|...-
T Consensus 274 -----~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 -----ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -----CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1112344577799999999999999997654
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=328.55 Aligned_cols=234 Identities=23% Similarity=0.294 Sum_probs=188.1
Q ss_pred ccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 354 LGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 354 lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
||+|+||.||++... +++.||+|+++... .....+.+|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999965 47899999987532 2234577899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CCCC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPPT 504 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~~ 504 (654)
.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQR-----EGRFDLSRARFYTAELLCALENLHKFN-VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 999973 245899999999999999999999998 999999999999999999999999998754322 2234
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
++..|+|||++.+..++.++|||||||++|||++|+.||.... ............. ... ...
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~~~---------~~~---~~~ 216 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQEPL---------RFP---DGF 216 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcCCC---------CCC---CcC
Confidence 6788999999999999999999999999999999999997532 2222222221110 011 112
Q ss_pred HHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 036334 585 MVQLLQIAMGCVSTVPDQRPA---MQEVVR 611 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RPs---~~evl~ 611 (654)
..++.+++.+||+.||++||+ +.|+++
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 235667788999999999986 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.19 Aligned_cols=237 Identities=22% Similarity=0.285 Sum_probs=191.2
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
++||+|+||.||++... +|+.||+|++.... .....+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999854 58999999997542 22346778999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TP 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~ 502 (654)
+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGK-IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 99998863 345899999999999999999999998 999999999999999999999999998753221 22
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... .+ . .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~------~~~~~~~~~~~~-------~~--p---~ 216 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEDI-------KF--P---R 216 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH------HHHHHHhccCCc-------cC--C---C
Confidence 3567889999999988999999999999999999999999965321 111111111110 00 0 1
Q ss_pred HHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRP-----AMQEVVRM 612 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 612 (654)
....++.+++.+||+.||++|| ++.|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1223566777899999999997 88988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=334.40 Aligned_cols=254 Identities=22% Similarity=0.360 Sum_probs=198.7
Q ss_pred HHhhccccccCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHhccC-CCccccccEEEEeCCceEE
Q 036334 348 RASAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLL 418 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~l 418 (654)
+.+.++||+|+||.||+|... .+..||||+++.... ..+.+.+|+++++++. ||||++++++|.+.+..++
T Consensus 39 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (400)
T cd05105 39 LVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYI 118 (400)
T ss_pred eehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEE
Confidence 345688999999999999853 134799999975432 2456889999999996 9999999999999999999
Q ss_pred EEEecCCCchhhhhccCCCC------------------------------------------------------------
Q 036334 419 VYDYMPAGSLSALLHGSRGS------------------------------------------------------------ 438 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~------------------------------------------------------------ 438 (654)
||||+++|+|.++++..+..
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (400)
T cd05105 119 ITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEAS 198 (400)
T ss_pred EEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhh
Confidence 99999999999988643210
Q ss_pred -------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeE
Q 036334 439 -------------------------------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDAC 487 (654)
Q Consensus 439 -------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~k 487 (654)
....+++..+++++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivH~dikp~Nill~~~~~~k 277 (400)
T cd05105 199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN-CVHRDLAARNVLLAQGKIVK 277 (400)
T ss_pred hhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChHhEEEeCCCEEE
Confidence 0124788899999999999999999988 99999999999999999999
Q ss_pred EeccCCCCCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 036334 488 VSDFGLNPLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQS 560 (654)
Q Consensus 488 l~Dfgla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~ 560 (654)
|+|||++....... ...++..|+|||.+.+..++.++|||||||++|||++ |..||......+ .+..
T Consensus 278 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~------~~~~ 351 (400)
T cd05105 278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS------TFYN 351 (400)
T ss_pred EEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH------HHHH
Confidence 99999987653221 1223456999999998899999999999999999997 899986532211 1111
Q ss_pred HhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 561 VVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
....... ..........+.+++.+||+.+|++||++.+|.++|+++.+
T Consensus 352 ~~~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 352 KIKSGYR----------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHhcCCC----------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1111110 01112234567888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=322.19 Aligned_cols=235 Identities=23% Similarity=0.366 Sum_probs=186.0
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCH----HHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGK----REFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+..+||+|+||.||.|+.+ .|..+|+|++++...-. +-+..|-++|....+|+||+++-.|.+.+.+||||||++
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 4578999999999999965 49999999998874332 345678888999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC-----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN----- 499 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~----- 499 (654)
||++..+|.. ...|++..+..++.+.+.|++-+|+.| +|||||||+|+|||..|++||+|||++.-+..
T Consensus 225 GGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~~g-yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 225 GGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQLG-YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred CccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHHcC-cccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 9999999983 457999999999999999999999998 99999999999999999999999999742100
Q ss_pred -----------------C-----------------------------CCCCccccccCccccCCCCCCcchhHHHHHHHH
Q 036334 500 -----------------T-----------------------------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLL 533 (654)
Q Consensus 500 -----------------~-----------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil 533 (654)
. ....||+-|||||++.+..|+..+|.||+|||+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM 378 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence 0 013456679999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCC
Q 036334 534 LELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPA 605 (654)
Q Consensus 534 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 605 (654)
|||+.|.+||......+. ..+++. |... + .+....+...+..+||.+|+. ||++|..
T Consensus 379 yEmLvGyPPF~s~tp~~T------~rkI~n--wr~~-----l-~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 379 YEMLVGYPPFCSETPQET------YRKIVN--WRET-----L-KFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHhCCCCCCCCCHHHH------HHHHHH--Hhhh-----c-cCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999987544321 111110 0000 0 111111112345566668888 9999996
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=322.31 Aligned_cols=253 Identities=19% Similarity=0.245 Sum_probs=191.9
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.+.||+|+||.||++... +++.||+|+++... ...+.+.+|++++++++||||+++++++..++..++||||+++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07848 5 VLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK 84 (287)
T ss_pred EEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCC
Confidence 4578999999999999975 57899999987542 2345678899999999999999999999999999999999998
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 501 (654)
+.+..+... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 85 NMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKND-IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 877655431 235899999999999999999999988 9999999999999999999999999987754321
Q ss_pred -CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh------------hhchhh
Q 036334 502 -PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVV------------REEWTA 568 (654)
Q Consensus 502 -~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~------------~~~~~~ 568 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+.... ......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQL---FTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhCCCCHHHHHhhhccchhc
Confidence 234667799999999888999999999999999999999999764321100 0000000 000000
Q ss_pred hhhhHhhhccCC-----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 569 EVFDVELMRYHN-----IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 569 ~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
....+....... .......+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000 0012345788899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.45 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=199.1
Q ss_pred HHhhccccccCceeEEEEEecC------CcEEEEEEecccccC--HHHHHHHHHHHhccCCCccccccEEEEeCCceEEE
Q 036334 348 RASAEVLGKGSVGTSYKAVLEE------GTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 419 (654)
+.+.+.||+|+||.||+|...+ +..||||.++..... .+.+.+|++++++++|+||+++++++...+..++|
T Consensus 7 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 86 (280)
T cd05049 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMV 86 (280)
T ss_pred hhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEE
Confidence 3456789999999999998643 478999998765433 46789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEec
Q 036334 420 YDYMPAGSLSALLHGSRG---------SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSD 490 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~D 490 (654)
|||+++++|.+++..... .....+++..+..++.|++.|++|||+++ ++||||||+||+++.++.+||+|
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-i~h~dlkp~nili~~~~~~kl~d 165 (280)
T cd05049 87 FEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH-FVHRDLATRNCLVGYDLVVKIGD 165 (280)
T ss_pred EecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-eeccccccceEEEcCCCeEEECC
Confidence 999999999999975421 12345899999999999999999999998 99999999999999999999999
Q ss_pred cCCCCCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 036334 491 FGLNPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVR 563 (654)
Q Consensus 491 fgla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 563 (654)
||++...... .....+..|+|||++.+..++.++|||||||++|||++ |..||...... ..+..+.
T Consensus 166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~------~~~~~~~- 238 (280)
T cd05049 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE------EVIECIT- 238 (280)
T ss_pred cccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHH-
Confidence 9998754221 12223456999999999999999999999999999998 99998653221 1111111
Q ss_pred hchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 564 EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
.+... .........+.+++.+||+.||++||+++|+++.|++
T Consensus 239 ~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 QGRLL----------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred cCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11100 0011223467788889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.82 Aligned_cols=243 Identities=19% Similarity=0.304 Sum_probs=190.6
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
++||+|+||.||++... +++.||+|+++.... ....+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999865 588999999976422 234577889999888 699999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----CC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN----TT 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~----~~ 501 (654)
|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++..... ..
T Consensus 81 g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHERG-IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 999998863 245899999999999999999999998 99999999999999999999999999864321 12
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC--CCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEE--GIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||......+ ......+.......... . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~--~p- 225 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------R--IP- 225 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------C--CC-
Confidence 2356778999999999999999999999999999999999997432211 11122222222221110 0 01
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPA------MQEVVR 611 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl~ 611 (654)
.....++.+++.+|++.||.+||+ ++++++
T Consensus 226 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 226 --RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred --CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 112235677888999999999997 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=293.12 Aligned_cols=242 Identities=24% Similarity=0.329 Sum_probs=198.8
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
++++.||+|.||.||.|+.+ ++-.||+|++.+.. ....++.+|+++-..++||||++++++|.+....||++||.
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 45788999999999999954 57789999997653 23567889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC--CCC
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG--NTT 501 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~--~~~ 501 (654)
..|++...|...+ ...+++...+.++.|+|.|+.|+|.++ ++||||||+|+|++.++..||+|||-+.... ...
T Consensus 105 ~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~k~-VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~ 180 (281)
T KOG0580|consen 105 PRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHLKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRK 180 (281)
T ss_pred CCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhccCC-cccCCCCHHHhccCCCCCeeccCCCceeecCCCCce
Confidence 9999999998543 345888889999999999999999987 9999999999999999999999999876653 334
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...||.-|.+||...+..++..+|+|++|++.||++.|.+||......+ -++.+ ...++..+...
T Consensus 181 tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e------tYkrI---------~k~~~~~p~~i 245 (281)
T KOG0580|consen 181 TLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE------TYKRI---------RKVDLKFPSTI 245 (281)
T ss_pred eeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH------HHHHH---------HHccccCCccc
Confidence 5677788999999999999999999999999999999999998654211 11111 11111111223
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.. ...++|.+|+.++|.+|.+..|+++.
T Consensus 246 s~---~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 246 SG---GAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred Ch---hHHHHHHHHhccCccccccHHHHhhh
Confidence 33 34556679999999999999998864
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=326.74 Aligned_cols=233 Identities=25% Similarity=0.349 Sum_probs=187.9
Q ss_pred ccccccCceeEEEEEe----cCCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.||+|+||.||++.. ..|+.||+|+++.... ....+..|++++++++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999874 3578999999976432 23456789999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 82 GGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 9999999863 345899999999999999999999998 999999999999999999999999998765433
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ......+..... ..
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~~~~~------------~~ 217 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMILKAKL------------GM 217 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHHcCCC------------CC
Confidence 223467789999999988899999999999999999999999975321 111111111110 00
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQE 608 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~e 608 (654)
.......+.+++.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1112235667888999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.37 Aligned_cols=236 Identities=23% Similarity=0.294 Sum_probs=186.2
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHH---HhccCCCccccccEEEEeCCceEEEEEe
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEV---LGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~---l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+++ ++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 467999999999999854 58999999997542 122345566554 4567899999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 500 (654)
+++|+|..+++. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~-ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 84 AAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENK-IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred CCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC-eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 999999988862 35899999999999999999999998 999999999999999999999999998653221
Q ss_pred --CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 501 --TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~------~~~~~~i~~~~~------------ 218 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE------EEVFDSIVNDEV------------ 218 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC------------
Confidence 223467789999999999999999999999999999999999975321 111222211110
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRP-----AMQEVVR 611 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 611 (654)
.........+.+++.+||+.||.+|| ++.++++
T Consensus 219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 00111234567788899999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=301.86 Aligned_cols=245 Identities=23% Similarity=0.330 Sum_probs=199.3
Q ss_pred HHHhhccccccCceeEEEEEe-cCCcEEEEEEeccc---ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 347 LRASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEV---AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 347 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
.+.+.++||+|.|+.||+... ..|+.+|+|++... ..+.+++++|+.+-+.++||||+++.+...+.+..|+|+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 345667899999999999874 45889999987533 44667889999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC---CCeEEeccCCCCCcCC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD---HDACVSDFGLNPLFGN 499 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~---~~~kl~Dfgla~~~~~ 499 (654)
|.|++|..-+-. +...++..+-..+.||+++|.|+|.++ |||||+||+|+++-+. .-+|++|||+|...+.
T Consensus 92 m~G~dl~~eIV~-----R~~ySEa~aSH~~rQiLeal~yCH~n~-IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 92 VTGGELFEDIVA-----REFYSEADASHCIQQILEALAYCHSNG-IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred ccchHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHhcC-ceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 999999866642 234788889999999999999999998 9999999999999653 3589999999988874
Q ss_pred CC---CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhh
Q 036334 500 TT---PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576 (654)
Q Consensus 500 ~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (654)
.. ...||++|||||++...+|+..+|||+.|||||-|+.|..||.+.+. .+.++.+ .....|..-.
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~------~rlye~I-----~~g~yd~~~~ 234 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYEQI-----KAGAYDYPSP 234 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH------HHHHHHH-----hccccCCCCc
Confidence 43 35678999999999999999999999999999999999999986322 1222222 2333343333
Q ss_pred ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.+....++.+.|+ ++|+..||.+|.|+.|.++
T Consensus 235 ~w~~is~~Ak~Lv---rrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 235 EWDTVTPEAKSLI---RRMLTVNPKKRITADEALK 266 (355)
T ss_pred ccCcCCHHHHHHH---HHHhccChhhhccHHHHhC
Confidence 4556667766655 4999999999999998753
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=321.92 Aligned_cols=253 Identities=19% Similarity=0.275 Sum_probs=189.5
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
..+.||+|+||.||+|... ++..||+|+++... .....+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 9 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~- 87 (288)
T cd07871 9 KLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS- 87 (288)
T ss_pred EeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-
Confidence 3578999999999999865 58899999987542 2344677899999999999999999999998899999999974
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TP 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~ 502 (654)
+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 88 ~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~ 162 (288)
T cd07871 88 DLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHKRK-ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162 (288)
T ss_pred CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence 898888633 234789999999999999999999998 999999999999999999999999998754322 22
Q ss_pred CCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---chhhhhhhH-----
Q 036334 503 PTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE---EWTAEVFDV----- 573 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~----- 573 (654)
..++..|+|||++.+ ..++.++||||+||++|||++|+.||......+.. ..+...... .........
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL---HLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHHhhccccchhhhc
Confidence 345677999998865 56899999999999999999999999754322111 111111000 000000000
Q ss_pred -hhhcc--CC----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 574 -ELMRY--HN----IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 574 -~~~~~--~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..... .. ......+..+++.+|+..||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 00 0011234667888999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=322.64 Aligned_cols=244 Identities=20% Similarity=0.337 Sum_probs=206.1
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCc-eEEEEEe
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDE-KLLVYDY 422 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~-~~lv~e~ 422 (654)
|...+++|+|+||.++..+.+ ++..+++|.+.-... .++...+|+.++++++|||||.+.+.|..++. .+|||+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 345688999999999998754 578999999865532 34467899999999999999999999999888 8999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT- 501 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 501 (654)
++||++.+.+...+ ...++++.+.+++.|++.|++|||++. |+|||||+.|||++.++.|||+|||+|+.++...
T Consensus 86 ~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~-iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR-VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred cCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh-hhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 99999999998764 356899999999999999999999776 9999999999999999999999999999987653
Q ss_pred ---CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 502 ---PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 502 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
...||+.||.||.+.+.+|..|+||||+||++|||++-+++|... ++...+..+.+.. ..
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~------~m~~Li~ki~~~~-----------~~ 224 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS------NMSELILKINRGL-----------YS 224 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc------chHHHHHHHhhcc-----------CC
Confidence 467888999999999999999999999999999999999999763 2333333333222 11
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.....+..++..++..|++.+|+.||++.+++.+
T Consensus 225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2234455677888889999999999999999876
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=322.76 Aligned_cols=236 Identities=22% Similarity=0.297 Sum_probs=189.5
Q ss_pred ccccccCceeEEEEEe----cCCcEEEEEEecccc-----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVA-----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~----~~g~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
+.||+|+||.||++.. ..++.||+|+++... .....+..|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5699999999999985 357899999997542 1234567899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 500 (654)
+++|+|.+++.. ...+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQG-IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999999863 345788899999999999999999998 999999999999999999999999998643221
Q ss_pred --CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 501 --TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
....++..|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+..... ...
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~~~~---------~~~ 220 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILKGKL---------NLP 220 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCC---------CCC
Confidence 223567789999999988899999999999999999999999975321 112222221110 001
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRP-----AMQEVVR 611 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 611 (654)
. ....++.+++.+||+.||++|| +++++++
T Consensus 221 ~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 P---YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C---CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1 1123566788899999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=325.15 Aligned_cols=194 Identities=22% Similarity=0.357 Sum_probs=168.6
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
|.+.+.||+|+||.||++... ++..+|+|+++.... ....+.+|++++++++||||++++++|.+++..++||||++
T Consensus 7 y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (333)
T cd06650 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (333)
T ss_pred hheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCC
Confidence 445678999999999999965 578899998865422 23568899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--CC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--TP 502 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--~~ 502 (654)
+|+|.+++.. ...+++..+..++.|++.||.|||+++.|+||||||+|||++.++.+||+|||++...... ..
T Consensus 87 ~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 161 (333)
T cd06650 87 GGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 161 (333)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcccc
Confidence 9999999973 2358899999999999999999997644999999999999999999999999998765332 23
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQAS 546 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 546 (654)
..++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred CCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 35677899999999888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.72 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=197.4
Q ss_pred HhhccccccCceeEEEEEec-CCc----EEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGT----TVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
...+.||+|+||.||+|.+. +|+ .||+|+++... ...+++.+|+.+++.++||||++++|+|... ..++|+|
T Consensus 10 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e 88 (316)
T cd05108 10 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ 88 (316)
T ss_pred eeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeee
Confidence 34578999999999999854 333 48999987542 2346788899999999999999999998764 5789999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT 501 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 501 (654)
|+++|+|.+++... ...+++..+++++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~-iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 89 LMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEERR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred cCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHhcC-eeccccchhheEecCCCcEEEccccccccccCCC
Confidence 99999999999743 235889999999999999999999998 9999999999999999999999999998765332
Q ss_pred C------CCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 502 P------PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 502 ~------~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
. ...+..|+|||++.+..++.++|||||||++|||++ |+.||..... .. +.........
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~------~~-~~~~~~~~~~------- 229 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SE-ISSILEKGER------- 229 (316)
T ss_pred cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------HH-HHHHHhCCCC-------
Confidence 1 122446999999999999999999999999999998 9999864211 11 1111111110
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGET 621 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 621 (654)
......+..++.+++.+||..+|++||++.+++..|.++.+...
T Consensus 230 ---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 230 ---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 00111223467788899999999999999999999999976653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=314.08 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=187.7
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCC-----ceEEEEEecC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD-----EKLLVYDYMP 424 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-----~~~lv~e~~~ 424 (654)
.+++|+|+||.||+|... +++.||||+.-.... .-.+|+++|++++|||||+++-+|.... ...+|||||+
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 478999999999999954 478999998755432 3356899999999999999998887532 2359999997
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC-CCeEEeccCCCCCcCCCCCC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD-HDACVSDFGLNPLFGNTTPP 503 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~~ 503 (654)
. +|.++++... .....++.-.+.-+..||.+||+|||+.+ |+||||||.|+|+|.+ |.+||||||+|+........
T Consensus 106 ~-tL~~~~r~~~-~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~-IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn 182 (364)
T KOG0658|consen 106 E-TLYRVIRHYT-RANQRMPLLEIKLYTYQLFRGLAYLHSHG-ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN 182 (364)
T ss_pred H-HHHHHHHHHh-hcCCCCceeeeHHHHHHHHHHHHHHHhcC-cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence 6 9999887421 12345777888889999999999999987 9999999999999987 88999999999988665443
Q ss_pred Cc---cccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhh--hh-----
Q 036334 504 TR---VAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEV--FD----- 572 (654)
Q Consensus 504 ~~---~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~----- 572 (654)
.. +..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.+..+. ...+..++.-....++ +.
T Consensus 183 iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ---L~eIik~lG~Pt~e~I~~mn~~y~~ 259 (364)
T KOG0658|consen 183 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ---LVEIIKVLGTPTREDIKSMNPNYTE 259 (364)
T ss_pred eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH---HHHHHHHhCCCCHHHHhhcCccccc
Confidence 33 334999998866 5799999999999999999999999987543321 1112222111000000 00
Q ss_pred ---HhhhccC----ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 573 ---VELMRYH----NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 573 ---~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
+.+.... .......+.++++.+++..+|.+|.++.|++.
T Consensus 260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111100 12223456788888999999999999999875
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=312.37 Aligned_cols=243 Identities=25% Similarity=0.396 Sum_probs=197.5
Q ss_pred HhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.+.+.||+|+||.||++.++++..+|+|.+........++.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL 86 (256)
T ss_pred chhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCH
Confidence 34678999999999999987777899999876666667888999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC-----C
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP-----P 503 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----~ 503 (654)
.+++... ...+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 87 LNYLRER----KGKLGTEWLLDMCSDVCEAMEYLESNG-FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred HHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC-cccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 9999743 235899999999999999999999998 99999999999999999999999999876543211 1
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..+..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..... .... .. ....
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~-~~~~-----~~-----~~~~ 224 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE------VVESV-SAGY-----RL-----YRPK 224 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH------HHHHH-HcCC-----cC-----CCCC
Confidence 12236999999998899999999999999999999 788886432211 11111 1110 00 0111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
....++.+++.+||..+|++|||+.|+++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 2344678888899999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=329.46 Aligned_cols=232 Identities=25% Similarity=0.337 Sum_probs=189.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
...+||+|.||+|+++..+ +++.+|||++++... +-+..+.|-.++... +||.+++++..|..++++|+||||+
T Consensus 372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~ 451 (694)
T KOG0694|consen 372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV 451 (694)
T ss_pred EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence 3578999999999999965 578999999998743 234456677776655 5999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC----C
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG----N 499 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~----~ 499 (654)
.||++..+.+ ...+++..+.-++..|+.||+|||+++ |||||||.+|||+|.+|++||+|||+++..- .
T Consensus 452 ~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~~~-IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~ 524 (694)
T KOG0694|consen 452 AGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHENG-IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDR 524 (694)
T ss_pred CCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHhcC-ceeeecchhheEEcccCcEEecccccccccCCCCCc
Confidence 9999766665 345999999999999999999999998 9999999999999999999999999997643 2
Q ss_pred CCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 500 TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 500 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
.....||+.|||||++.+..|+.++|.|||||+||||+.|+.||.+.++++ ....++.++. .
T Consensus 525 TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------~FdsI~~d~~------------~ 586 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------VFDSIVNDEV------------R 586 (694)
T ss_pred cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHhcCCC------------C
Confidence 244577888999999999999999999999999999999999998765443 1222222211 1
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAM 606 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~ 606 (654)
++.-..++...++++++..+|++|.-+
T Consensus 587 yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCcccHHHHHHHHHHhccCcccccCC
Confidence 122233456677789999999999966
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=327.81 Aligned_cols=191 Identities=23% Similarity=0.354 Sum_probs=167.1
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
..+.||+|+||+||++... +++.||+|+++.... ....+.+|+.++.+++||||+++++.+.+....++||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 3578999999999999855 588999999975422 23457789999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 85 gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~g-ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 85 GGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQLG-FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999973 345899999999999999999999998 999999999999999999999999998754311
Q ss_pred -----------------------------------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 036334 501 -----------------------------------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQA 545 (654)
Q Consensus 501 -----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 545 (654)
....+|..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 123567889999999999999999999999999999999999975
Q ss_pred C
Q 036334 546 S 546 (654)
Q Consensus 546 ~ 546 (654)
.
T Consensus 239 ~ 239 (363)
T cd05628 239 E 239 (363)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=312.55 Aligned_cols=247 Identities=28% Similarity=0.420 Sum_probs=199.0
Q ss_pred HHhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 348 RASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
+.+.+.||+|+||.||+|...++..||+|+++......+++.+|++++++++||||+++++++. ....++||||+++|+
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~ 86 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS 86 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCc
Confidence 3456789999999999999877778999999876666678999999999999999999999874 456899999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC-----
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP----- 502 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~----- 502 (654)
|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.+........
T Consensus 87 L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~-i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~ 162 (262)
T cd05071 87 LLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162 (262)
T ss_pred HHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC-ccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence 999997432 235799999999999999999999998 99999999999999999999999999876543321
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
..++..|+|||+..+..++.++|||||||++|||++ |..||...... ...... .... .....
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------~~~~~~-~~~~----------~~~~~ 225 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQV-ERGY----------RMPCP 225 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------HHHHHH-hcCC----------CCCCc
Confidence 223446999999988889999999999999999999 78888643211 111111 1100 00112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
.+....+.+++.+|++.+|++||+++++++.|++.
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 23445678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=323.98 Aligned_cols=243 Identities=23% Similarity=0.288 Sum_probs=189.1
Q ss_pred hhccccccCceeEEEEEec----CCcEEEEEEecccc-----cCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE----EGTTVVVKRLKEVA-----VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv 419 (654)
+.+.||+|+||.||+++.. .++.||+|+++... ...+.+..|+++++++ +||||+++++++..++..++|
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (332)
T cd05614 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLI 83 (332)
T ss_pred EEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEE
Confidence 4578999999999998753 57899999987532 1234577899999999 499999999999999999999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 84 LDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHKLG-IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999999863 345899999999999999999999998 99999999999999999999999999876432
Q ss_pred C-----CCCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 500 T-----TPPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 500 ~-----~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
. ....++..|+|||++.+. .++.++|||||||++|||++|+.||........ .......+... +.
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~-------~~ 228 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRILKC-------DP 228 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHHhcC-------CC
Confidence 2 123467889999999765 478999999999999999999999975332211 11111111110 00
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRP-----AMQEVVRM 612 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 612 (654)
. ........+.+++.+||+.||++|| +++++++.
T Consensus 229 ~-----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 229 P-----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred C-----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0 0111223456778899999999999 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=312.17 Aligned_cols=246 Identities=26% Similarity=0.438 Sum_probs=199.0
Q ss_pred HHhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 348 RASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
+.+.+.||+|+||.||+|...++..||+|.++........+.+|+.++++++|+|++++++++. ....+++|||+++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~ 86 (260)
T cd05070 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGS 86 (260)
T ss_pred hhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCc
Confidence 4556889999999999999888889999999876666778999999999999999999999875 456899999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-----C
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-----P 502 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-----~ 502 (654)
|.++++... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++....... .
T Consensus 87 L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~-i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05070 87 LLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERMN-YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred HHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCccceEEEeCCceEEeCCceeeeeccCcccccccC
Confidence 999997432 345899999999999999999999998 9999999999999999999999999987654321 1
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
..++..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+.. ... ....
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~-~~~----------~~~~ 225 (260)
T cd05070 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------REVLEQVER-GYR----------MPCP 225 (260)
T ss_pred CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHc-CCC----------CCCC
Confidence 122346999999988889999999999999999999 8889864321 111111111 100 0011
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
......+.+++.+|+..+|++|||++++.+.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2223467788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=311.41 Aligned_cols=243 Identities=24% Similarity=0.346 Sum_probs=197.2
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
+.+.||+|+||.||+|...++..+|+|.++.......++.+|+.++++++||||+++++++......++||||+.+|+|.
T Consensus 8 ~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (256)
T cd05113 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL 87 (256)
T ss_pred EeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHH
Confidence 34679999999999999877778999998876666778999999999999999999999999888899999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-----CCC
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-----PPT 504 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-----~~~ 504 (654)
+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||.+....... ...
T Consensus 88 ~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05113 88 NYLREH----GKRFQPSQLLEMCKDVCEGMAYLESKQ-FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK 162 (256)
T ss_pred HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCc
Confidence 999743 225899999999999999999999998 9999999999999999999999999987553321 112
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
++..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+...... .....
T Consensus 163 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~-----------~~~~~ 225 (256)
T cd05113 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN------SETVEKVSQGLRL-----------YRPHL 225 (256)
T ss_pred cChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHHhcCCCC-----------CCCCC
Confidence 3346999999988889999999999999999998 9999864321 1111111111100 00111
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
....+.+++.+||+.+|++||++.++++.|+
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 2346788888999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.80 Aligned_cols=255 Identities=27% Similarity=0.386 Sum_probs=197.5
Q ss_pred HHHhhccccccCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccccccEEEEeC-Cce
Q 036334 347 LRASAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVPLRAFYYSK-DEK 416 (654)
Q Consensus 347 ~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~-~~~ 416 (654)
.+.+.++||+|+||.||+|... .++.||+|+++.... ....+.+|++++.++ +|+||++++++|... ...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 3456789999999999999632 247899999875432 234567899999999 799999999988754 467
Q ss_pred EEEEEecCCCchhhhhccCCCC--------------------------------------------------------CC
Q 036334 417 LLVYDYMPAGSLSALLHGSRGS--------------------------------------------------------GR 440 (654)
Q Consensus 417 ~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------~~ 440 (654)
+++|||+++|+|.+++...... ..
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 8999999999999998642210 01
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC------CCCccccccCccc
Q 036334 441 TPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT------PPTRVAGYRAPEV 514 (654)
Q Consensus 441 ~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~------~~~~~~~y~aPE~ 514 (654)
..+++..+.+++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++....... ...++..|+|||+
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~~~-ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 36899999999999999999999988 9999999999999999999999999997653221 1223456999999
Q ss_pred cCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHh
Q 036334 515 VETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAM 593 (654)
Q Consensus 515 ~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 593 (654)
+.+..++.++|||||||++|||++ |..||......+ ........... .........++.+++.
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~----------~~~~~~~~~~~~~l~~ 310 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTR----------MRAPEYATPEIYSIML 310 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCC----------CCCCccCCHHHHHHHH
Confidence 999999999999999999999998 999986532211 11111111110 0011122346788899
Q ss_pred hccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 594 GCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 594 ~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
+||+.+|++||++.|++++|+++.+
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=330.67 Aligned_cols=247 Identities=20% Similarity=0.270 Sum_probs=196.4
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||+|... +++.||+|+++... .....+..|++++..++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (333)
T cd05600 5 ILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVP 84 (333)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCC
Confidence 3578999999999999966 48899999997642 223467789999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-CCC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-TPP 503 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-~~~ 503 (654)
+|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 85 g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~ 158 (333)
T cd05600 85 GGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHELG-YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV 158 (333)
T ss_pred CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCc
Confidence 9999999973 345899999999999999999999998 999999999999999999999999998766442 345
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.++..|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..... .+.... .......
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~~---~~~~~~-~~~~~~~ 228 (333)
T cd05600 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE------TWENLKYWKE---TLQRPV-YDDPRFN 228 (333)
T ss_pred ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH------HHHHHHhccc---cccCCC-CCccccc
Confidence 67788999999999899999999999999999999999997532211 1111111000 000000 0000012
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
...++.+++.+||..+|++||+++++++.
T Consensus 229 ~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 229 LSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 23456778889999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=328.71 Aligned_cols=240 Identities=20% Similarity=0.201 Sum_probs=192.8
Q ss_pred HhhccccccCceeEEEEEecC--CcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE--GTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~--g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
.+.+.||+|+||.||+|.... +..||+|++.... .....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 33 ~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey 112 (340)
T PTZ00426 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEF 112 (340)
T ss_pred EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeC
Confidence 345789999999999998543 3689999986542 2235677899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-C
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-T 501 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-~ 501 (654)
+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...... .
T Consensus 113 ~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~ 186 (340)
T PTZ00426 113 VIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQSLN-IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY 186 (340)
T ss_pred CCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEccCCCHHHEEECCCCCEEEecCCCCeecCCCcc
Confidence 999999999973 245899999999999999999999998 999999999999999999999999999876433 2
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+...... .....
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~i~~~~~~---------~p~~~ 251 (340)
T PTZ00426 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP------LLIYQKILEGIIY---------FPKFL 251 (340)
T ss_pred eecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH------HHHHHHHhcCCCC---------CCCCC
Confidence 34577889999999988899999999999999999999999975321 1111122111100 01111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRP-----AMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 612 (654)
. ..+.+++.+|++.||++|+ +++++++.
T Consensus 252 ~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 252 D---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 2 2456677799999999995 78887654
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=311.52 Aligned_cols=252 Identities=21% Similarity=0.362 Sum_probs=200.9
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||+|... +++.||||.++... .....+.+|++++++++||||+++++++.+.+..++|+||++
T Consensus 6 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08228 6 IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELAD 85 (267)
T ss_pred eeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecC
Confidence 3577999999999999854 68999999876432 223467889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
+|+|.+++..... ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 163 (267)
T cd08228 86 AGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR-VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163 (267)
T ss_pred CCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC-eeCCCCCHHHEEEcCCCCEEECccccceeccchhHHH
Confidence 9999998864321 2345889999999999999999999988 9999999999999999999999999987764322
Q ss_pred -CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 502 -PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 502 -~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
...++..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+...+..... ....
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~----------~~~~ 229 (267)
T cd08228 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQCDY----------PPLP 229 (267)
T ss_pred hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcCCC----------CCCC
Confidence 23456679999999888899999999999999999999999864221 11222221111110 0011
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
.......+.+++.+||..+|++||++.++++.|++++
T Consensus 230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1223356788888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=310.78 Aligned_cols=247 Identities=24% Similarity=0.429 Sum_probs=200.1
Q ss_pred HHhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 348 RASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
+.+.++||+|+||.||+|...+++.||+|.+........++.+|+.++++++|+||+++++++. .+..+++|||+++++
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 86 (260)
T cd05067 8 LKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGS 86 (260)
T ss_pred ceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCC
Confidence 3456789999999999999888999999999877777788999999999999999999999864 557899999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-----C
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-----P 502 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-----~ 502 (654)
|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .
T Consensus 87 L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~-i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 87 LVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKN-YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred HHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC-eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence 999986432 345899999999999999999999988 9999999999999999999999999987654221 1
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
..++..|+|||++....++.++||||||+++||+++ |+.||..... ........ ..... ...
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~-~~~~~----------~~~ 225 (260)
T cd05067 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN------PEVIQNLE-RGYRM----------PRP 225 (260)
T ss_pred CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh------HHHHHHHH-cCCCC----------CCC
Confidence 223456999999988889999999999999999999 9999975321 11111111 11000 001
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
.....++.+++.+||+.+|++||+++++++.|+++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 11224577888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=306.95 Aligned_cols=261 Identities=21% Similarity=0.347 Sum_probs=197.4
Q ss_pred hhccccccCceeEEEEE-ecCCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCc-cccccEEEEeCC------ceEE
Q 036334 350 SAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDN-VVPLRAFYYSKD------EKLL 418 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpn-iv~l~~~~~~~~------~~~l 418 (654)
..++||+|+||+||+|+ ..+|+.||+|++.-... ......+|+.++++++|+| ||++++++...+ ..++
T Consensus 15 ~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~l 94 (323)
T KOG0594|consen 15 KVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYL 94 (323)
T ss_pred HHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEE
Confidence 34669999999999999 45689999999976533 3345689999999999999 999999998877 7889
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 419 VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
||||++. +|..++....... ..++...+..++.|+++||+|||+++ |+||||||.|||++++|.+||+|||+|+.+.
T Consensus 95 vfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~-IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 95 VFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG-ILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred EEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC-eecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 9999955 9999997553221 35777899999999999999999998 9999999999999999999999999998665
Q ss_pred CC----CCCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh----hhchhhh
Q 036334 499 NT----TPPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVV----REEWTAE 569 (654)
Q Consensus 499 ~~----~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~ 569 (654)
-. +....|..|+|||++.+. .|+...||||+|||++||+++++.|.+..+.+. +.. +-..+ .+.|...
T Consensus 172 ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q--l~~-If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 172 IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ--LFR-IFRLLGTPNEKDWPGV 248 (323)
T ss_pred CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH--HHH-HHHHcCCCCccCCCCc
Confidence 32 344566779999999875 799999999999999999999999987654221 111 11111 0111110
Q ss_pred h----hhHhhhccC---ChHHH----HHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhh
Q 036334 570 V----FDVELMRYH---NIEEE----MVQLLQIAMGCVSTVPDQRPAMQEVVRM--IENM 616 (654)
Q Consensus 570 ~----~~~~~~~~~---~~~~~----~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 616 (654)
. .+.....+. ..... ..+..+++.+|++.+|.+|.|++.++++ +.++
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 0 010111111 01110 1356788889999999999999999886 5544
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=324.39 Aligned_cols=238 Identities=19% Similarity=0.298 Sum_probs=186.2
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
++||+|+||+||++... +++.||+|+++.... ....+..|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 578999999976422 234466788887766 799999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----CC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN----TT 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~----~~ 501 (654)
|+|..++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++..... ..
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERG-IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 999988863 245899999999999999999999998 99999999999999999999999999875322 12
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC--CCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEE--GIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||....... ......++......... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----------~ 223 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----------R 223 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-----------C
Confidence 2356778999999999999999999999999999999999996432211 11122222222211110 0
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAM 606 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~ 606 (654)
.......++.+++.+||+.||++||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 011122356678889999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=311.55 Aligned_cols=239 Identities=23% Similarity=0.351 Sum_probs=187.8
Q ss_pred ccccccCceeEEEEEecC-------------CcEEEEEEeccccc-CHHHHHHHHHHHhccCCCccccccEEEEeCCceE
Q 036334 352 EVLGKGSVGTSYKAVLEE-------------GTTVVVKRLKEVAV-GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKL 417 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~-------------g~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 417 (654)
+.||+|+||.||+|.+.. ...|++|.+..... ....+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998532 23588898765432 2346778899999999999999999999999999
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC-------eEEec
Q 036334 418 LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD-------ACVSD 490 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~-------~kl~D 490 (654)
+||||+++|+|..++... ...+++..+++++.||+.||+|||+++ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLEDKD-LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCC-eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999988642 245899999999999999999999998 999999999999987664 89999
Q ss_pred cCCCCCcCCCCCCCccccccCccccC-CCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 491 FGLNPLFGNTTPPTRVAGYRAPEVVE-TRKVTFKSDVYSFGVLLLELL-TGKAPNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 491 fgla~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
||++..........++..|+|||.+. +..++.++|||||||++|||+ +|..||......+ .........
T Consensus 156 ~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~-- 226 (262)
T cd05077 156 PGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------KERFYEGQC-- 226 (262)
T ss_pred CCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------HHHHHhcCc--
Confidence 99987765555555677899999886 567899999999999999998 5888876432111 000000000
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
........++.+++.+||+.||++||++.+|++.++
T Consensus 227 ----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 227 ----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 001112245778888999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=328.33 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=208.2
Q ss_pred HHHHHhhccccccCceeEEEEEec-CC----cEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceE
Q 036334 345 DLLRASAEVLGKGSVGTSYKAVLE-EG----TTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKL 417 (654)
Q Consensus 345 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g----~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 417 (654)
|.+....++||+|+||+||+|.+- +| -+||+|++.... ....++.+|+..|.+++|||++|++|+|.... ..
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 344445688999999999999853 34 368999886653 34678999999999999999999999998765 88
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 418 LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
||++||+.|+|.++++..+ ..+.....+.+..|||+||.|||.++ +|||||.++|||+.+-.++||.|||+++..
T Consensus 774 lvtq~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~qr-lVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEEQR-LVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhcc-hhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 9999999999999998754 45888999999999999999999887 999999999999999999999999999988
Q ss_pred CCCCCCCcc------ccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhh
Q 036334 498 GNTTPPTRV------AGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEV 570 (654)
Q Consensus 498 ~~~~~~~~~------~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 570 (654)
......... +.|||-|.+....|+.++|||||||++||++| |..|++....++ +.+.++.+.
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dlle~ge---- 917 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLLEKGE---- 917 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHHhccc----
Confidence 765443333 34999999999999999999999999999999 999987643332 222222221
Q ss_pred hhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 571 FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 571 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
+...++-+..+++.++.+||..|++.||+|+++..++.++-+.
T Consensus 918 ------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 918 ------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 2334556777899999999999999999999999999877643
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=328.56 Aligned_cols=252 Identities=20% Similarity=0.298 Sum_probs=190.5
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
|.+.+.||+|+||.||++... .++.||+|... ...+.+|++++++++||||++++++|..+...++|+|++. +
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~ 167 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-T 167 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-C
Confidence 344678999999999999854 58899999753 2356789999999999999999999999999999999995 6
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----C
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-----T 501 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-----~ 501 (654)
+|..++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 168 ~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~~~-IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 168 DLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHENR-IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 88888863 235899999999999999999999998 999999999999999999999999998754321 2
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCC-ChhHHHHHHhhh------ch-------h
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGI-DLPRWVQSVVRE------EW-------T 567 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~------~~-------~ 567 (654)
...+|..|+|||++.+..++.++|||||||++|||++|+.||....+..+. +....+..++.. .+ .
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 245788899999999889999999999999999999999887643322111 111111111100 00 0
Q ss_pred hhhh-h--Hh-------hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 568 AEVF-D--VE-------LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 568 ~~~~-~--~~-------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
...+ . .. ...+....+...++.+++.+||+.||++|||++|+++
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 0 00 0000011123346788999999999999999999985
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=327.84 Aligned_cols=244 Identities=24% Similarity=0.378 Sum_probs=202.1
Q ss_pred HhhccccccCceeEEEEEecC--Cc--EEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE--GT--TVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~--g~--~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
...|+||+|.||.|++|.|.. |+ .||||.++.... ...+|.+|+.+|.+|+|||+++|||+..+ ...++|||+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 456889999999999999753 44 589999987643 45789999999999999999999999877 678999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP 502 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 502 (654)
++.|+|.+.|+.. ....+-....-.++.|||.||.||..++ +|||||..+|+++-....|||+|||+.+-++....
T Consensus 192 aplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLeskr-lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLESKR-LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhhhh-hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999862 3456888889999999999999999998 99999999999999999999999999887755432
Q ss_pred CCc-------cccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 503 PTR-------VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 503 ~~~-------~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
.+. ...|+|||.+....++.++|||+|||++|||+| |+.||.+..+. +.++. +| .
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------qIL~~----------iD-~ 330 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------QILKN----------ID-A 330 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH------HHHHh----------cc-c
Confidence 221 234999999999999999999999999999999 78888764332 11111 12 1
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
-.+....+.+.+++++++++||..+|++||||..|.+.+-
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 1133445667788999999999999999999999985554
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=311.96 Aligned_cols=246 Identities=24% Similarity=0.412 Sum_probs=197.6
Q ss_pred HhhccccccCceeEEEEEecC----CcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE----GTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
...+.||+|+||.||+|.+.. ...||||.++.... ...++.+|+.++++++||||+++++++...+..++||||
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 86 (266)
T cd05033 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEY 86 (266)
T ss_pred eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEc
Confidence 345789999999999998642 45799999875432 345688899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT- 501 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 501 (654)
+++++|.+++.... ..+++..+++++.|++.|++|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 87 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~-i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 87 MENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMN-YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred CCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 99999999997432 36899999999999999999999988 9999999999999999999999999988764211
Q ss_pred -----CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 502 -----PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 502 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
....+..|+|||.+.+..++.++||||||+++|||++ |..||...... .....+ ...+..
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~-~~~~~~------- 227 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ------DVIKAV-EDGYRL------- 227 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH------HHHHHH-HcCCCC-------
Confidence 1223356999999998899999999999999999998 99998543211 111111 111100
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
.........+.+++.+||+.+|++||++.|++++|+++
T Consensus 228 ---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ---PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01122334677888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=315.13 Aligned_cols=252 Identities=23% Similarity=0.401 Sum_probs=199.6
Q ss_pred hhccccccCceeEEEEEec------CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
+.+.||+|+||+||++... ++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (288)
T cd05093 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 88 (288)
T ss_pred eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 4578999999999999742 24568999887543 3345788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCC--------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCC
Q 036334 423 MPAGSLSALLHGSRG--------SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN 494 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla 494 (654)
+++++|.+++..... .....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~-i~H~dlkp~Nili~~~~~~kl~dfg~~ 167 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH-FVHRDLATRNCLVGENLLVKIGDFGMS 167 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccCcceEEEccCCcEEeccCCcc
Confidence 999999999874321 12235899999999999999999999998 999999999999999999999999998
Q ss_pred CCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchh
Q 036334 495 PLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWT 567 (654)
Q Consensus 495 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 567 (654)
...... ....++..|+|||++.+..++.++|||||||++|||++ |..||...... .....+.... .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~------~~~~~i~~~~-~ 240 (288)
T cd05093 168 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIECITQGR-V 240 (288)
T ss_pred ccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCC-c
Confidence 755322 11223456999999998899999999999999999998 88888643221 1111111111 0
Q ss_pred hhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 568 AEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
.. .......++.+++.+||+.||.+|||++|+.+.|+++...
T Consensus 241 ~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 241 LQ----------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 00 0111224578888999999999999999999999999855
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=317.21 Aligned_cols=260 Identities=24% Similarity=0.369 Sum_probs=203.2
Q ss_pred HHHHHhhccccccCceeEEEEEec--------CCcEEEEEEecccc--cCHHHHHHHHHHHhcc-CCCccccccEEEEeC
Q 036334 345 DLLRASAEVLGKGSVGTSYKAVLE--------EGTTVVVKRLKEVA--VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSK 413 (654)
Q Consensus 345 ~~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~ 413 (654)
...+.+.+.||+|+||.||+|... ++..||+|.++... ....++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 334456688999999999999731 24579999987542 2345788999999999 899999999999999
Q ss_pred CceEEEEEecCCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC
Q 036334 414 DEKLLVYDYMPAGSLSALLHGSRGS-----------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP 482 (654)
Q Consensus 414 ~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~ 482 (654)
...++||||+++|+|.+++...+.. ....+++..++.++.|++.||+|||+++ |+||||||+||+++.
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g-ivH~dlkp~Nili~~ 172 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK-CIHRDLAARNVLVTE 172 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC-eeecccccceEEEcC
Confidence 9999999999999999999753211 1235889999999999999999999998 999999999999999
Q ss_pred CCCeEEeccCCCCCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChh
Q 036334 483 DHDACVSDFGLNPLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLP 555 (654)
Q Consensus 483 ~~~~kl~Dfgla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~ 555 (654)
++.+||+|||++....... ...++..|+|||++.+..++.++||||||+++|||++ |..||.... ..
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~ 246 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VE 246 (304)
T ss_pred CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------HH
Confidence 9999999999987664321 1223456999999988889999999999999999998 778875421 22
Q ss_pred HHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 036334 556 RWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETD 622 (654)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 622 (654)
...... ..... ..........+.+++.+||+.+|++|||+.|+++.|+++..-.+.
T Consensus 247 ~~~~~~-~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 247 ELFKLL-KEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred HHHHHH-HcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 222211 11110 011122345677788899999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=328.78 Aligned_cols=255 Identities=23% Similarity=0.337 Sum_probs=188.0
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCC-----ceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD-----EKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-----~~~lv~ 420 (654)
+.++||+|+||.||+|... +|..||||+++... ....++.+|++++++++||||+++++++.... ..++||
T Consensus 4 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~ 83 (338)
T cd07859 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83 (338)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEE
Confidence 4578999999999999954 68999999987532 23346788999999999999999999886432 479999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+. ++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 84 e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 84 ELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred ecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9995 689988863 235899999999999999999999998 999999999999999999999999998754221
Q ss_pred -------CCCCccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHHHHHHh
Q 036334 501 -------TPPTRVAGYRAPEVVET--RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGID---------LPRWVQSVV 562 (654)
Q Consensus 501 -------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~---------~~~~~~~~~ 562 (654)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||.......... ...+...+.
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 12346778999999865 678999999999999999999999997543211000 000000000
Q ss_pred hhchhhhhhhHhhh-ccCCh----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 563 REEWTAEVFDVELM-RYHNI----EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 563 ~~~~~~~~~~~~~~-~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
. ......+..-.. ..... ......+.+++.+||+.||++|||++|+++.
T Consensus 237 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 237 N-EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred h-hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 000000000000 00000 0112346788889999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=322.00 Aligned_cols=232 Identities=23% Similarity=0.295 Sum_probs=183.8
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHH-HHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQME-VLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
++||+|+||+||+|... +|+.||+|++..... ...++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999965 689999999875421 2233444444 56789999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~g-ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLN-IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 999999873 345899999999999999999999998 999999999999999999999999998753221 2
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~---------~~~~-- 217 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------TAEMYDNILNKPL---------RLKP-- 217 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC------HHHHHHHHHcCCC---------CCCC--
Confidence 2346778999999999999999999999999999999999997532 1122222221110 0011
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQ 607 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~ 607 (654)
.....+.+++.+|++.||++||+++
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 -NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1133567788899999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=309.58 Aligned_cols=242 Identities=23% Similarity=0.356 Sum_probs=193.0
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
+.||+|+||.||+|... +++.||+|.+.... .....+.+|++++++++||||++++++|...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999864 68899999876542 2345688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC------
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP------ 502 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~------ 502 (654)
.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE----GPRLKVKELIQMVENAAAGMEYLESKH-CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998632 235899999999999999999999998 99999999999999999999999999875443211
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
......|+|||.+.++.++.++|||||||++|||++ |..||......+ ......... .....
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~----------~~~~~ 218 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGV----------RLPCP 218 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCC----------CCCCc
Confidence 111235999999998899999999999999999998 888886432110 111111000 00111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
......+.+++.+||+.+|++|||+.+++++|++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 2223467788889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=323.08 Aligned_cols=238 Identities=21% Similarity=0.308 Sum_probs=188.8
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
++||+|+||+||++... +++.||+|+++.... ..+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999865 578999999976432 234577888888888 699999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----CC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN----TT 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~----~~ 501 (654)
|+|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~-ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHERG-IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 999988863 245899999999999999999999998 99999999999999999999999999875321 12
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||.............++......... . ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~--~p~~- 225 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------R--IPRF- 225 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------C--CCCC-
Confidence 345677899999999999999999999999999999999999754433333333333332221110 0 0111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAM 606 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~ 606 (654)
....+.+++.+||+.||++|+++
T Consensus 226 --~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 226 --LSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred --CCHHHHHHHHHHhccCHHHcCCC
Confidence 12345678889999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=316.15 Aligned_cols=259 Identities=24% Similarity=0.351 Sum_probs=195.2
Q ss_pred hhccccccCceeEEEEEe-----cCCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeC--CceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL-----EEGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~ 420 (654)
..+.||+|+||+||++.. .++..||+|.++.... ....+.+|++++++++||||+++++++... ...++||
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred eceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEe
Confidence 457899999999988642 3577899999876532 356788999999999999999999988654 3578999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+++|+|.+++.. ..+++..++.++.|++.|++|||+++ |+||||||+||++++++.+||+|||++......
T Consensus 88 e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 88 EYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred cCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999963 24899999999999999999999998 999999999999999999999999998765432
Q ss_pred C-------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 T-------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 ~-------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
. ...++..|+|||.+.+..++.++||||||+++|||++|..||....... ....................+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhhc
Confidence 1 1223445999999988889999999999999999999999986432110 0000000000000000000000
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
.. ..........++.+++.+||+.+|++|||++++++.|+++.
T Consensus 240 ~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 240 GM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00 00111223456788888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=310.64 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=192.7
Q ss_pred hhccccccCceeEEEEEecC-Cc--EEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeC------CceE
Q 036334 350 SAEVLGKGSVGTSYKAVLEE-GT--TVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSK------DEKL 417 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~-g~--~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------~~~~ 417 (654)
++++||+|+||.||+|...+ +. .||+|.++... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 35789999999999999654 32 68999887542 2245678899999999999999999987532 2468
Q ss_pred EEEEecCCCchhhhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCC
Q 036334 418 LVYDYMPAGSLSALLHGSRG-SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPL 496 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~ 496 (654)
+||||+++|+|.+++...+. .....+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+|||++..
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS-FIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC-eeccccchhheEEcCCCCEEECCCCcccc
Confidence 99999999999998753321 12345899999999999999999999988 99999999999999999999999999887
Q ss_pred cCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhh
Q 036334 497 FGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAE 569 (654)
Q Consensus 497 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 569 (654)
..... ....+..|+|||.+.+..++.++|||||||++|||++ |+.||..... ...... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~-~~~~~~~- 233 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN------SEIYDY-LRQGNRL- 233 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH-HHcCCCC-
Confidence 64321 1223456999999998899999999999999999999 7888864221 111111 1111100
Q ss_pred hhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 570 VFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
.........+.+++.+||+.||++|||+.++++.|+++
T Consensus 234 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 ---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112234577888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=318.36 Aligned_cols=235 Identities=25% Similarity=0.314 Sum_probs=184.3
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhc-cCCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGK-IKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~-l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
++||+|+||.||+|... +++.||+|+++... ...+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 47899999997642 122344556666654 4899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... .
T Consensus 81 g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~-ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHKKG-IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 999999873 235899999999999999999999998 999999999999999999999999998754221 2
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~------------~~~ 216 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSILNDRP------------HFP 216 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC------------CCC
Confidence 33567889999999998999999999999999999999999975321 111111111100 001
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQ-EVV 610 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 610 (654)
.....++.+++.+||+.||++||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11223456777899999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=313.97 Aligned_cols=242 Identities=20% Similarity=0.309 Sum_probs=189.3
Q ss_pred ccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 354 LGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 354 lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
||+|+||+||++... +|+.||+|.+..... ..+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999854 688999999865422 224567899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----CCC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT----PPT 504 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~~~ 504 (654)
.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRR-IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 988754321 2346899999999999999999999998 9999999999999999999999999987654322 234
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
++..|+|||++.+..++.++|||||||++|||++|+.||....... ............ .. ......
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~---------~~---~~~~~~ 224 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRILND---------SV---TYPDKF 224 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--hHHHHHHhhccc---------CC---CCcccC
Confidence 6678999999999999999999999999999999999997533211 011111111100 00 011122
Q ss_pred HHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 036334 585 MVQLLQIAMGCVSTVPDQRP-----AMQEVVR 611 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 611 (654)
...+.+++.+||+.||++|| +++++++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 34567788899999999999 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=319.94 Aligned_cols=237 Identities=22% Similarity=0.298 Sum_probs=188.8
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
++||+|+||.||+|... .++.||+|+++... ...+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999865 47899999997642 2234566788888765 799999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
|+|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHRHG-VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 999998863 235899999999999999999999998 999999999999999999999999998753221 2
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+...... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~------~~~~~~i~~~~~~---------~p~-- 217 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE------DDLFESILHDDVL---------YPV-- 217 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCCC---------CCC--
Confidence 23467789999999988999999999999999999999999975322 1222222211110 000
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-------CHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRP-------AMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RP-------s~~evl~~ 612 (654)
....++.+++.+|++.||++|| +++++++.
T Consensus 218 -~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 -WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1123567788899999999999 77777644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=315.15 Aligned_cols=248 Identities=24% Similarity=0.386 Sum_probs=194.2
Q ss_pred hhccccccCceeEEEEEe-----cCCcEEEEEEecccccC--HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVL-----EEGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
+.+.||+|+||+||+|.. ..+..|++|.++..... ..++.+|++++++++||||+++++++..+...++||||
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 88 (283)
T cd05090 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEY 88 (283)
T ss_pred eeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEc
Confidence 347799999999999984 24678999998754322 35688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEec
Q 036334 423 MPAGSLSALLHGSRG------------SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSD 490 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~D 490 (654)
+++++|.+++..... .....+++.+.+.++.|++.||+|||+++ ++||||||+||++++++.+||+|
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-i~H~dlkp~nili~~~~~~kl~d 167 (283)
T cd05090 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF-FVHKDLAARNILIGEQLHVKISD 167 (283)
T ss_pred CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC-eehhccccceEEEcCCCcEEecc
Confidence 999999999853210 11235889999999999999999999998 99999999999999999999999
Q ss_pred cCCCCCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 036334 491 FGLNPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVR 563 (654)
Q Consensus 491 fgla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 563 (654)
||++...... ....++..|+|||++.+..++.++|||||||++|||++ |..||...... . +.....
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~------~-~~~~~~ 240 (283)
T cd05090 168 LGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ------E-VIEMVR 240 (283)
T ss_pred ccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHH
Confidence 9998765322 12223456999999988889999999999999999998 88888643211 1 111111
Q ss_pred hchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 564 EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
..... ........++.+++.+||+.||++||++.+|+++|+.
T Consensus 241 ~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 KRQLL----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred cCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11100 0111223456778889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=338.26 Aligned_cols=244 Identities=20% Similarity=0.277 Sum_probs=193.9
Q ss_pred HhhccccccCceeEEEEEec-C-CcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-E-GTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~-g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.+.+.||+|+||.||+|... + +..||+|.+.... .....+.+|+.+++.++||||++++++|..++..++||||+++
T Consensus 70 ~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~g 149 (478)
T PTZ00267 70 VLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149 (478)
T ss_pred EEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCC
Confidence 34578999999999999854 3 5778888765432 2234577899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----- 500 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----- 500 (654)
|+|.+++..... ...++++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 150 g~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~-ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 227 (478)
T PTZ00267 150 GDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRK-MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227 (478)
T ss_pred CCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence 999998864321 2456899999999999999999999998 999999999999999999999999999866432
Q ss_pred -CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 -TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....++.+|+|||++.+..++.++|||||||++|||++|+.||..... ...+......... .
T Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~~~-----------~ 290 (478)
T PTZ00267 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGKYD-----------P 290 (478)
T ss_pred ccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC-----------C
Confidence 223477889999999999999999999999999999999999964321 1222222111110 0
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.......++.+++.+||..||++||+++++++
T Consensus 291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01112245777888999999999999999864
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.53 Aligned_cols=237 Identities=22% Similarity=0.269 Sum_probs=189.6
Q ss_pred ccccccCceeEEEEEe-cCCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 352 EVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.||+|+||.||++.. .+|..||+|+++... ....++..|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999985 468899999997642 12345677899999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV-SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
+|..++.. ...+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||++...... .
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~~-ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCC-EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 99998863 3458999999999999999999997 56 999999999999999999999999998753221 2
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||...... .....+..... . . .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~~i~~~~~-------~--~---p 216 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEEI-------R--F---P 216 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHHHHhcCCC-------C--C---C
Confidence 234678899999999999999999999999999999999999653221 11111111100 0 0 0
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRP-----AMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 612 (654)
.....++.+++.+||+.||++|+ +++++++.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11223566778899999999997 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.76 Aligned_cols=246 Identities=26% Similarity=0.439 Sum_probs=201.3
Q ss_pred HhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.+.+.||+|+||.||+|...++..||||.+.......+++.+|+.++++++|+||+++++++......++||||+++++|
T Consensus 9 ~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 88 (261)
T cd05034 9 KLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSL 88 (261)
T ss_pred eeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCH
Confidence 34578999999999999988788999999987777778899999999999999999999999988899999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-----CC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-----PP 503 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-----~~ 503 (654)
.+++.... ...+++..+..++.|++.|++|||+++ ++|+||||+||++++++.+||+|||++....... ..
T Consensus 89 ~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~~-i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 164 (261)
T cd05034 89 LDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRN-YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164 (261)
T ss_pred HHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhcc
Confidence 99997532 235899999999999999999999998 9999999999999999999999999987664321 11
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..+..|+|||.+.+..++.++||||||+++||+++ |+.||...... ......... .. .....
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~~~~~~-~~----------~~~~~ 227 (261)
T cd05034 165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR------EVLEQVERG-YR----------MPRPP 227 (261)
T ss_pred CCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcC-CC----------CCCCC
Confidence 22346999999998889999999999999999999 99998643211 111111111 00 00011
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
.....+.+++.+|+..+|++||+++++.+.|++
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 228 NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 123467788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=327.50 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=198.2
Q ss_pred HHHhhccccccCceeEEEEEec------CCcEEEEEEecccccC--HHHHHHHHHHHhccC-CCccccccEEEEeCCceE
Q 036334 347 LRASAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVAVG--KREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKL 417 (654)
Q Consensus 347 ~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~ 417 (654)
.+.+.+.||+|+||.||+|.+. .+..||+|+++..... ...+.+|++++.++. ||||++++++|...+..+
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~ 117 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY 117 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence 3445788999999999999853 2468999999765322 346888999999997 999999999999999999
Q ss_pred EEEEecCCCchhhhhccCCCC-----------------------------------------------------------
Q 036334 418 LVYDYMPAGSLSALLHGSRGS----------------------------------------------------------- 438 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------------- 438 (654)
+||||+++|+|.++++..+..
T Consensus 118 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (401)
T cd05107 118 IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKG 197 (401)
T ss_pred EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchh
Confidence 999999999999999754210
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC
Q 036334 439 ----------------------------------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH 484 (654)
Q Consensus 439 ----------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~ 484 (654)
....+++..+++++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 198 TVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN-CVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-cCcccCCcceEEEeCCC
Confidence 1124788889999999999999999887 99999999999999999
Q ss_pred CeEEeccCCCCCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHH
Q 036334 485 DACVSDFGLNPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRW 557 (654)
Q Consensus 485 ~~kl~Dfgla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~ 557 (654)
.+||+|||++...... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ..
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~------~~ 350 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN------EQ 350 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch------HH
Confidence 9999999998754321 11234456999999988889999999999999999998 88898643211 11
Q ss_pred HHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 558 VQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
....+..+... ........++.+++.+||..+|++||+++||++.|+++.
T Consensus 351 ~~~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 FYNAIKRGYRM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111111100 001112346778888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=307.92 Aligned_cols=240 Identities=26% Similarity=0.361 Sum_probs=190.8
Q ss_pred cccccCceeEEEEEec---CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 353 VLGKGSVGTSYKAVLE---EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 353 ~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.||+|+||.||+|.++ ++..+|+|+++.... ..+++..|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 4899999999999743 478899999875432 2456888999999999999999999875 45678999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC----
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP---- 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---- 502 (654)
+|.+++.. ...+++..+.+++.|++.|++|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~-i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEETN-FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999963 235899999999999999999999998 99999999999999999999999999876543221
Q ss_pred ---CCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 503 ---PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 503 ---~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
..++..|+|||.+....++.++|||||||++|||++ |+.||...... .+... +.......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~-i~~~~~~~--------- 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------EVTQM-IESGERME--------- 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH-HHCCCCCC---------
Confidence 112356999999988889999999999999999998 99998753221 11111 11111100
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
.......++.+++.+||+.||++||++.+|.+.|++.
T Consensus 219 -~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 -CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 0112234567788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=312.13 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=195.0
Q ss_pred HHhhccccccCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEE
Q 036334 348 RASAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 419 (654)
+++.+.||+|+||.||+|... .+..||+|++..... ...++.+|+.+++.++||||+++++++..++..++|
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 87 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence 345678999999999998753 246799999865432 244678899999999999999999999999999999
Q ss_pred EEecCCCchhhhhccCCCC-----CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCC
Q 036334 420 YDYMPAGSLSALLHGSRGS-----GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN 494 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla 494 (654)
|||+++|+|.+++...+.. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~vH~dlkp~Nil~~~~~~~~l~dfg~~ 166 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMT 166 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCcchheEEEcCCCCEEECCCCCc
Confidence 9999999999998753211 1234688999999999999999999988 999999999999999999999999998
Q ss_pred CCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchh
Q 036334 495 PLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWT 567 (654)
Q Consensus 495 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 567 (654)
...... ....++..|+|||++.+..++.++|||||||++|||++ |..||..... ........... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~-~ 239 (277)
T cd05062 167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN------EQVLRFVMEGG-L 239 (277)
T ss_pred cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHcCC-c
Confidence 754322 11233556999999998899999999999999999999 6888864321 11111111111 0
Q ss_pred hhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 568 AEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
. .........+.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 240 L----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred C----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0 0011223457788889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=330.59 Aligned_cols=198 Identities=28% Similarity=0.376 Sum_probs=172.5
Q ss_pred HHHhhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccC-C-----CccccccEEEEeCCceEEE
Q 036334 347 LRASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-H-----DNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 347 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h-----pniv~l~~~~~~~~~~~lv 419 (654)
.|.+.++||+|+||.|-+|... .++.||||+++....-.++...|+.+|..++ | -|+|+++++|...+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 3456789999999999999954 5899999999988777777888999999987 4 4899999999999999999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC--CCeEEeccCCCCCc
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD--HDACVSDFGLNPLF 497 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~--~~~kl~Dfgla~~~ 497 (654)
+|.++. +|+++++.++ ...++...+..++.||+.||.+||+.+ |||+||||+|||+.+. ..+||+|||++.+.
T Consensus 267 fELL~~-NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~~l~-IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLHELG-IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ehhhhh-hHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999954 9999998764 456999999999999999999999888 9999999999999764 36999999999987
Q ss_pred CCCCC-CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 036334 498 GNTTP-PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGE 549 (654)
Q Consensus 498 ~~~~~-~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~ 549 (654)
..... -..+..|+|||+|.+.+|+.+.||||||||++||++|.+.|.+..+.
T Consensus 342 ~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 342 SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 65533 23344599999999999999999999999999999999989875543
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.92 Aligned_cols=245 Identities=26% Similarity=0.415 Sum_probs=196.7
Q ss_pred HhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.+.+.||+|+||.||+|....+..+|+|++.......+.+.+|++++++++|+|++++++++. .+..++||||+++|+|
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L 87 (260)
T cd05069 9 RLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSL 87 (260)
T ss_pred eeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCH
Confidence 345679999999999999877778999998766556678899999999999999999999875 4568999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-----CC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-----PP 503 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-----~~ 503 (654)
.++++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....... ..
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~-i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05069 88 LDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMN-YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred HHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence 99997432 235899999999999999999999988 9999999999999999999999999987654322 12
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
.++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ....... ..... ....
T Consensus 164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~-~~~~~----------~~~~ 226 (260)
T cd05069 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR------EVLEQVE-RGYRM----------PCPQ 226 (260)
T ss_pred ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH-cCCCC----------CCCc
Confidence 23456999999988889999999999999999999 89998653211 1111111 11100 0111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
.....+.+++.+||..||++||+++++++.|++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 227 GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 233467778889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.64 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=199.3
Q ss_pred hccccccCceeEEEEEec------CCcEEEEEEeccccc-CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 351 AEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVAV-GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+.||+|+||.||++... ++..+++|.++.... ..+.+.+|++.+++++|+||+++++++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence 467999999999999742 345688999865433 3457889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccC
Q 036334 424 PAGSLSALLHGSRG-----------SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFG 492 (654)
Q Consensus 424 ~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfg 492 (654)
++++|.+++..... .....+++..++.++.|++.|++|||+++ |+||||||+||+++.++.++|+|||
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-i~H~dlkp~Nil~~~~~~~~l~dfg 168 (291)
T cd05094 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH-FVHRDLATRNCLVGANLLVKIGDFG 168 (291)
T ss_pred CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccCcceEEEccCCcEEECCCC
Confidence 99999999964321 11235899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhc
Q 036334 493 LNPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREE 565 (654)
Q Consensus 493 la~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 565 (654)
++...... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ..+... ...
T Consensus 169 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------~~~~~~-~~~ 241 (291)
T cd05094 169 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------EVIECI-TQG 241 (291)
T ss_pred cccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH-hCC
Confidence 98755332 12233556999999998999999999999999999999 99998653221 111111 111
Q ss_pred hhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 566 WTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
.... ........+.+++.+||+.+|++||++++|+++|+++...
T Consensus 242 ~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 242 RVLE----------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCCC----------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1100 0111234677888899999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=306.85 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=191.5
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccc---ccCHHHHHHHHHHHhccCCCccccccEEEEe-----CCceEEEEE
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV---AVGKREFEMQMEVLGKIKHDNVVPLRAFYYS-----KDEKLLVYD 421 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-----~~~~~lv~e 421 (654)
.+.||+|+||.|+.|... +|+.||+|++... ....++..+|+++|+.++|+||+.+.+.+.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 367999999999999854 6899999998743 3445678899999999999999999998865 246799999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT- 500 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~- 500 (654)
+| ..+|...++. .+.++...+..++.|+++||.|+|+.+ |+||||||+|++++.+...||+|||+|+.....
T Consensus 107 lM-etDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHSAn-ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 107 LM-ETDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHSAN-VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred HH-hhHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhccc-ccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99 6699999983 345999999999999999999999998 999999999999999999999999999987532
Q ss_pred -----CCCCccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH--------HHhhhch
Q 036334 501 -----TPPTRVAGYRAPEVVE-TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQ--------SVVREEW 566 (654)
Q Consensus 501 -----~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--------~~~~~~~ 566 (654)
+.-..|..|+|||++. ...|+.+.||||.|||+.||++|++-|.+.+.-+...+...+. ..+....
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 2334466799999875 4689999999999999999999999998755433222111110 0010000
Q ss_pred hhhhhhH-------h-hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 567 TAEVFDV-------E-LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 567 ~~~~~~~-------~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
....+.. . ...+..... ..++|+.+|+..||.+|+|++|+++.
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p---~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANP---LAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCH---HHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000 0 001112222 34566669999999999999999874
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=318.37 Aligned_cols=236 Identities=25% Similarity=0.311 Sum_probs=188.5
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.||+|+||+||++... +++.||+|+++... .....+..|+.+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999865 47899999997642 2234566788888777 699999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++...... .
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~-ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHERG-IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 999998863 235899999999999999999999998 999999999999999999999999998653211 1
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... ...
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~~i~~~~~------------~~~ 216 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQSILEDEV------------RYP 216 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHHHHHcCCC------------CCC
Confidence 23467789999999999999999999999999999999999964321 111111111110 001
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAM-----QEVVR 611 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~ 611 (654)
......+.+++.+||+.||++||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1122356778889999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=312.53 Aligned_cols=238 Identities=23% Similarity=0.312 Sum_probs=185.9
Q ss_pred cccccCceeEEEEEecC-------------------------CcEEEEEEeccccc-CHHHHHHHHHHHhccCCCccccc
Q 036334 353 VLGKGSVGTSYKAVLEE-------------------------GTTVVVKRLKEVAV-GKREFEMQMEVLGKIKHDNVVPL 406 (654)
Q Consensus 353 ~lg~G~fg~Vy~~~~~~-------------------------g~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l 406 (654)
.||+|+||.||+|.+.. ...|++|++..... ...++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13588998865432 23567788899999999999999
Q ss_pred cEEEEeCCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC--
Q 036334 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH-- 484 (654)
Q Consensus 407 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~-- 484 (654)
+++|.++...++||||+++|+|..++... ...+++..+++++.|+++||+|||+++ |+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLEDKN-LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcCC-ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999998642 345889999999999999999999998 99999999999997644
Q ss_pred -----CeEEeccCCCCCcCCCCCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCCCCChhHH
Q 036334 485 -----DACVSDFGLNPLFGNTTPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELL-TGKAPNQASLGEEGIDLPRW 557 (654)
Q Consensus 485 -----~~kl~Dfgla~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~-tg~~pf~~~~~~~~~~~~~~ 557 (654)
.+|++|||++..........++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+ ...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~- 232 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---KER- 232 (274)
T ss_pred cCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---HHH-
Confidence 379999998765544444456677999998865 56899999999999999995 6899886532211 111
Q ss_pred HHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 558 VQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
...... ........++.+++.+||+.+|++|||++++++.|+
T Consensus 233 ---~~~~~~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 ---FYEKKH------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHhcc------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111000 000111235778888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.90 Aligned_cols=253 Identities=21% Similarity=0.370 Sum_probs=201.0
Q ss_pred HhhccccccCceeEEEEEe-cCCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 349 ASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+.+.||+|+||.||++.. .++..++||.+.... ....++.+|+.+++.++||||+++++++..++..+++|||+
T Consensus 5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08229 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA 84 (267)
T ss_pred hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEec
Confidence 3457799999999999995 478999999876532 22356788999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC--
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-- 501 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-- 501 (654)
++++|.+++..... ....+++..++.++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd08229 85 DAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRR-VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162 (267)
T ss_pred CCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc
Confidence 99999998864321 2346899999999999999999999988 9999999999999999999999999987664332
Q ss_pred --CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 502 --PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 502 --~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
...++..|+|||.+.+..++.++||||||+++|||++|..||..... .............. + ..
T Consensus 163 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~------~----~~ 228 (267)
T cd08229 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQCDY------P----PL 228 (267)
T ss_pred cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhhhcCCC------C----CC
Confidence 23456679999999888899999999999999999999999864321 11111111111000 0 00
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
........+.+++.+||..+|++|||+.+|+++++++.
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11123346778888999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=327.46 Aligned_cols=242 Identities=19% Similarity=0.298 Sum_probs=189.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
..+.||+|+||+||+|... +|+.||||+++... .....+.+|+++++.++||||+++++++.+++..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence 3578999999999999965 58899999997542 223457789999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
+|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 85 ~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 85 GGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHKLG-YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999999973 345899999999999999999999998 9999999999999999999999999986542110
Q ss_pred ---------------------------------------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 036334 502 ---------------------------------------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542 (654)
Q Consensus 502 ---------------------------------------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p 542 (654)
...+|+.|+|||++....++.++|||||||++|||++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 12477889999999988999999999999999999999999
Q ss_pred CCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 036334 543 NQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPA---MQEVVRM 612 (654)
Q Consensus 543 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~ 612 (654)
|..... ......+..... . .......... .++.+++.+|+. +|.+|++ ++|+++.
T Consensus 239 f~~~~~------~~~~~~i~~~~~--~---~~~~~~~~~s---~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 239 FCSDNP------QETYRKIINWKE--T---LQFPDEVPLS---PEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCH------HHHHHHHHcCCC--c---cCCCCCCCCC---HHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 975322 111111111000 0 0000111112 244566668886 9999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=320.52 Aligned_cols=235 Identities=26% Similarity=0.325 Sum_probs=185.7
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhc-cCCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGK-IKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~-l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.||+|+||+||+|... +++.||+|+++... .....+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999965 47899999997642 223445667777765 4899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----CC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN----TT 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~----~~ 501 (654)
|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++..... ..
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~-ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHSKG-IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 999999873 235889999999999999999999998 99999999999999999999999999865321 12
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... .. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~i~~~~-------~~-----~~ 216 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE------EELFQSIRMDN-------PC-----YP 216 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-------CC-----CC
Confidence 23467789999999998999999999999999999999999975321 11111111100 00 00
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQ-EVV 610 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 610 (654)
.....++.+++.+||+.||++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 11223466778899999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=312.65 Aligned_cols=244 Identities=21% Similarity=0.335 Sum_probs=191.1
Q ss_pred ccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 354 LGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 354 lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
||+|+||.||++... +|+.||+|++..... ....+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999854 589999999864321 233456799999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---CCCc
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---PPTR 505 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~~~~ 505 (654)
.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ...+
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLHSMD-IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHHCC-EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCC
Confidence 9888643 2345899999999999999999999998 9999999999999999999999999987654332 2456
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHH
Q 036334 506 VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585 (654)
Q Consensus 506 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (654)
+..|+|||++.+..++.++||||+||++|||++|+.||....... .............. .. . .....
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~-----~~---~---~~~~~ 223 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLEDEV-----KF---E---HQNFT 223 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhcccc-----cc---c---cccCC
Confidence 778999999998889999999999999999999999997532211 11111111111110 00 0 01123
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 586 VQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 586 ~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
.++.+++.+||+.||++||+++|+++.+.
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 35677888999999999999988764443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=318.31 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=188.6
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.||+|+||.||+|... +++.||+|+++... .....+.+|+.++++++||||+++++++.+++..++||||++ +
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~ 87 (303)
T cd07869 9 KLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-T 87 (303)
T ss_pred EeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-c
Confidence 3578999999999999965 68899999987543 223467789999999999999999999999999999999995 6
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TP 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~ 502 (654)
+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 88 ~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 162 (303)
T cd07869 88 DLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQRY-ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162 (303)
T ss_pred CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence 787777633 245889999999999999999999998 999999999999999999999999998654322 22
Q ss_pred CCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---h----chhh----hh
Q 036334 503 PTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR---E----EWTA----EV 570 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---~----~~~~----~~ 570 (654)
..++..|+|||++.+ ..++.++||||+||++|||++|+.||..... ....+..... . .+.. ..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD-----IQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc-----HHHHHHHHHHHhCCCChhhccchhhccc
Confidence 345677999999865 4588999999999999999999999975322 1111111100 0 0000 00
Q ss_pred hhHh-h--hccCChHH------HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 571 FDVE-L--MRYHNIEE------EMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 571 ~~~~-~--~~~~~~~~------~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
+++. . ........ ....+.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 0 00000000 1234667888999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.15 Aligned_cols=265 Identities=26% Similarity=0.371 Sum_probs=205.7
Q ss_pred cCHHHHHHHhhccccccCceeEEEEEecC--------CcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccccccEE
Q 036334 341 FDLEDLLRASAEVLGKGSVGTSYKAVLEE--------GTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVPLRAF 409 (654)
Q Consensus 341 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~l~~~ 409 (654)
+.+....+.+.+.||+|+||.||++.... +..||+|.++.... ..+++.+|+++++++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 34444455667899999999999997421 23689998875432 345788999999999 79999999999
Q ss_pred EEeCCceEEEEEecCCCchhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcE
Q 036334 410 YYSKDEKLLVYDYMPAGSLSALLHGSRG-----------SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNI 478 (654)
Q Consensus 410 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NI 478 (654)
|..++..+++|||+++|+|.+++..... .....+++.+++.++.|++.||+|||+++ |+||||||+||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-ivH~dlkp~Ni 165 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK-CIHRDLAARNV 165 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-eeccccccceE
Confidence 9999999999999999999999874321 11235899999999999999999999998 99999999999
Q ss_pred EECCCCCeEEeccCCCCCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 036334 479 LLRPDHDACVSDFGLNPLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEG 551 (654)
Q Consensus 479 ll~~~~~~kl~Dfgla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~ 551 (654)
+++.++.+||+|||++....... ....+..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---- 241 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---- 241 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC----
Confidence 99999999999999987654321 1122345999999999899999999999999999998 888886432
Q ss_pred CChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 036334 552 IDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDD 623 (654)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 623 (654)
.......+.. ... .........++.+++.+||+.+|++||++.|+++.|+++.......
T Consensus 242 --~~~~~~~~~~-~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~~ 300 (334)
T cd05100 242 --VEELFKLLKE-GHR----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTD 300 (334)
T ss_pred --HHHHHHHHHc-CCC----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCCC
Confidence 1222222111 110 0111223346778899999999999999999999999998665543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=320.48 Aligned_cols=237 Identities=23% Similarity=0.262 Sum_probs=184.6
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHH-HHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQME-VLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.||+|+||+||+|... +++.||+|++..... ....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 577899999875421 1223344443 56788999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...... .
T Consensus 81 ~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~g-iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLN-IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 999999973 234788889999999999999999998 999999999999999999999999998754221 2
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~---------~~~~-- 217 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKPL---------QLKP-- 217 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHHhCCc---------CCCC--
Confidence 33567889999999999999999999999999999999999975321 122222211110 0011
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.....+.+++.+|++.||.+||++.+.+.+
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 218 -NITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred -CCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 122346677779999999999988754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=314.27 Aligned_cols=252 Identities=28% Similarity=0.425 Sum_probs=198.6
Q ss_pred HHhhccccccCceeEEEEEecC------CcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEE
Q 036334 348 RASAEVLGKGSVGTSYKAVLEE------GTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLL 418 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~l 418 (654)
+.+.+.||+|+||.||++...+ ...+|+|.++.... ...++.+|++++.++ +|+||+++++++..++..++
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 93 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV 93 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence 3456789999999999998542 36799999876432 234578899999999 79999999999999999999
Q ss_pred EEEecCCCchhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeE
Q 036334 419 VYDYMPAGSLSALLHGSRG-----------SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDAC 487 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~k 487 (654)
+|||+++|+|.++++.... .....+++..+++++.|++.|++|||+.+ |+||||||+||+++.++.+|
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-ivH~dlkp~Nil~~~~~~~k 172 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK-CIHRDLAARNVLVTEDHVMK 172 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-ccccccceeeEEEcCCCeEE
Confidence 9999999999999864310 12346899999999999999999999988 99999999999999999999
Q ss_pred EeccCCCCCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 036334 488 VSDFGLNPLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQS 560 (654)
Q Consensus 488 l~Dfgla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~ 560 (654)
|+|||++....... ....+..|+|||++.+..++.++|||||||++|||++ |..||..... ......
T Consensus 173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~ 246 (293)
T cd05053 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------EELFKL 246 (293)
T ss_pred eCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH------HHHHHH
Confidence 99999987654321 1223456999999988899999999999999999998 8888864321 111111
Q ss_pred HhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 561 VVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
..... ...........+.+++.+||..+|++|||++|+++.|+++.
T Consensus 247 -~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 -LKEGY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111 00111223346778899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.31 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=194.0
Q ss_pred ccccccCceeEEEEEecC-Cc--EEEEEEecccc--cCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLEE-GT--TVVVKRLKEVA--VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~-g~--~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
++||+|+||.||+|...+ +. .+++|.++... ...+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999999754 33 46888887532 2345788899999999 799999999999999999999999999
Q ss_pred CchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCC
Q 036334 426 GSLSALLHGSRGS-----------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN 494 (654)
Q Consensus 426 g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla 494 (654)
|+|.+++...+.. ....+++.+++.++.|++.|++|||+.+ ++||||||+||++++++.+||+|||++
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~-i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccccceEEEcCCCeEEECCCCCc
Confidence 9999999754311 1234889999999999999999999988 999999999999999999999999998
Q ss_pred CCcCCC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhh
Q 036334 495 PLFGNT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEV 570 (654)
Q Consensus 495 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 570 (654)
...... .....+..|+|||++....++.++|||||||++|||++ |..||..... ......... .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~~~~~~~-~~~~-- 230 (270)
T cd05047 160 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLPQ-GYRL-- 230 (270)
T ss_pred cccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------HHHHHHHhC-CCCC--
Confidence 533211 11222446999999988889999999999999999997 9999864321 111221111 1100
Q ss_pred hhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 571 FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 571 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
........++.+++.+||..+|.+|||+.++++.|+++.
T Consensus 231 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 --------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 011122346778899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=329.96 Aligned_cols=242 Identities=20% Similarity=0.276 Sum_probs=187.7
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||+||++... +|+.||||++..... ....+++|++++++++||||+++++++.+++..|+||||++
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 3478999999999999854 688999999865421 23467889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 85 gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~g-ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 85 GGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHKLG-FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999973 345889999999999999999999998 999999999999999999999999998632110
Q ss_pred -----------------------------------------------CCCCccccccCccccCCCCCCcchhHHHHHHHH
Q 036334 501 -----------------------------------------------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLL 533 (654)
Q Consensus 501 -----------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil 533 (654)
....++..|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 012467789999999998999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCC---CCHHHHH
Q 036334 534 LELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQR---PAMQEVV 610 (654)
Q Consensus 534 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~evl 610 (654)
|||++|..||...... .....+...... ..+ ........++.+++.+|+. +|.+| +++.|++
T Consensus 239 ~elltG~~Pf~~~~~~------~~~~~i~~~~~~-----~~~---p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 239 FECLIGWPPFCSENSH------ETYRKIINWRET-----LYF---PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred hhhhcCCCCCCCCCHH------HHHHHHHccCCc-----cCC---CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 9999999999753221 111111110000 000 0001112345667778887 66665 5999987
Q ss_pred HH
Q 036334 611 RM 612 (654)
Q Consensus 611 ~~ 612 (654)
+.
T Consensus 304 ~h 305 (377)
T cd05629 304 SH 305 (377)
T ss_pred cC
Confidence 75
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=321.26 Aligned_cols=231 Identities=24% Similarity=0.289 Sum_probs=185.1
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
++||+|+||.||+|... +++.||+|+++... ...+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 57899999987542 2234566788888766 699999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 81 g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH~~~-ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKS-----RRFDEARARFYAAEITSALMFLHDKG-IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 9999988732 35899999999999999999999998 999999999999999999999999998753211 2
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+...... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~~---------~~--- 216 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDEVV---------YP--- 216 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCCCC---------CC---
Confidence 34567889999999988999999999999999999999999975321 1222222211100 00
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAM 606 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~ 606 (654)
.....++.+++.+|++.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1122356678889999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=313.91 Aligned_cols=252 Identities=27% Similarity=0.395 Sum_probs=198.0
Q ss_pred hhccccccCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
+.+.||+|+||.||+|... ....+++|.+..... ...++.+|+.+++.++||||+++++.|...+..++|+|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 3578999999999999853 235788888875432 23568889999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC
Q 036334 422 YMPAGSLSALLHGSRG-------------------SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP 482 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~ 482 (654)
|+.+|+|.+++...+. .....+++..++.++.|++.||+|||+.+ |+||||||+||++++
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-ivH~dikp~nill~~ 162 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK-LVHRDLAARNVLVAE 162 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC-eehhhhhhheEEEcC
Confidence 9999999999864321 11235899999999999999999999988 999999999999999
Q ss_pred CCCeEEeccCCCCCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChh
Q 036334 483 DHDACVSDFGLNPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLP 555 (654)
Q Consensus 483 ~~~~kl~Dfgla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~ 555 (654)
++.+||+|||++...... .....+..|+|||.+.+..++.++||||||+++|||++ |..||..... .
T Consensus 163 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~ 236 (290)
T cd05045 163 GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP------E 236 (290)
T ss_pred CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH------H
Confidence 999999999998754322 11223456999999988889999999999999999998 9999864321 1
Q ss_pred HHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 556 RWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
. +......... .........++.+++.+||+.+|++||+++|+++.|+++..+
T Consensus 237 ~-~~~~~~~~~~----------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 R-LFNLLKTGYR----------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred H-HHHHHhCCCC----------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1 1111111110 011122234677888999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.77 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=197.3
Q ss_pred hhccccccCceeEEEEEecC-Cc--EEEEEEecccc--cCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLEE-GT--TVVVKRLKEVA--VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~-g~--~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.++||+|+||.||+|..++ +. .+++|.++... ...+.+.+|++++.++ +||||+++++++......++||||+
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (297)
T cd05089 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYA 85 (297)
T ss_pred eeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEec
Confidence 35689999999999998654 33 47888887432 2345688899999999 7999999999999988999999999
Q ss_pred CCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccC
Q 036334 424 PAGSLSALLHGSRGS-----------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFG 492 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfg 492 (654)
++|+|.+++...... ....+++..++.++.|++.|++|||+++ |+||||||+||+++.++.+||+|||
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-ivH~dlkp~Nill~~~~~~kl~dfg 164 (297)
T cd05089 86 PYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ-FIHRDLAARNVLVGENLASKIADFG 164 (297)
T ss_pred CCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCcCCcceEEECCCCeEEECCcC
Confidence 999999999653211 1235889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCcCCC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 493 LNPLFGNT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 493 la~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
++...... .....+..|+|||++.+..++.++|||||||++|||++ |..||..... ......... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~------~~~~~~~~~-~~~- 236 (297)
T cd05089 165 LSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC------AELYEKLPQ-GYR- 236 (297)
T ss_pred CCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHhc-CCC-
Confidence 98643321 11122345999999988889999999999999999998 9999865322 111111111 100
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
..........+.+++.+||+.+|.+||+++++++.|+++.++.
T Consensus 237 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 237 ---------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0011122345778888999999999999999999999998665
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=311.23 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=192.6
Q ss_pred hhccccccCceeEEEEEec-CCc----EEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGT----TVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
..+.||+|+||+||+|.+. +|+ .|++|.+..... ...++..|+..+++++||||+++++++. ....++++||
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~ 89 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQL 89 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEe
Confidence 3578999999999999864 344 477777753322 2346777888899999999999999875 4567899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT- 501 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 501 (654)
+++|+|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++.......
T Consensus 90 ~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 90 SPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLEEHR-MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred CCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC-EeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 9999999999743 245899999999999999999999998 9999999999999999999999999987653221
Q ss_pred -----CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 502 -----PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 502 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
...++..|+|||.+.++.++.++|||||||++|||++ |+.||...... .+...+.......
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~------ 231 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVPDLLEKGERLA------ 231 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCcCC------
Confidence 1234456999999988899999999999999999998 99998653211 1111111111000
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
....+...+.+++.+||..+|++|||+.|+++.|+.+.+..
T Consensus 232 ----~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 232 ----QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 00112235677888999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=310.79 Aligned_cols=248 Identities=25% Similarity=0.346 Sum_probs=186.7
Q ss_pred cccccCceeEEEEEecC---CcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 353 VLGKGSVGTSYKAVLEE---GTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 353 ~lg~G~fg~Vy~~~~~~---g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
.||+|+||.||+|...+ +..+|+|.++.... ....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998643 45799998876532 23468889999999999999999999999889999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC------
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT------ 501 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~------ 501 (654)
|.+++...+.......++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC-EeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 999997543322345678888999999999999999998 9999999999999999999999999986543221
Q ss_pred CCCccccccCccccCCC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 502 PPTRVAGYRAPEVVETR-------KVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~-------~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
...++..|+|||++.+. .++.++||||||+++|||++ |+.||......+ .... ..... .....++
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~---~~~~~-~~~~~~~ 233 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY---TVREQ-QLKLPKP 233 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH---Hhhcc-cCCCCCC
Confidence 12344569999998642 35789999999999999996 999996532211 1000 01100 0001111
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
.. .......+.+++..|| .+|++|||++||++.|+
T Consensus 234 ~~-----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 234 RL-----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cc-----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 10 0011224566777999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=302.38 Aligned_cols=245 Identities=24% Similarity=0.370 Sum_probs=207.4
Q ss_pred HHHhhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 347 LRASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 347 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
...+.++||+|+||.||+|.++ .|..+|+|.... ..+-+++.+|+.+|++++.|+||++||.+.....+|+|||||..
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 3455678999999999999865 599999998753 45667889999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
|++.++++.. +.++.+.++..++.+.++||+|||... -+|||||+.|||++.+|.+|++|||.|..+.+. .
T Consensus 113 GSiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~~~-KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 113 GSISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHDLK-KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred CcHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHHHH-HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 9999999853 467999999999999999999999876 789999999999999999999999999876543 4
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...||+.|||||+++.-.|+.++||||+|++..||..|++||..-.+-..+.+ +.......+..+
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---------------IPT~PPPTF~KP 252 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---------------IPTKPPPTFKKP 252 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe---------------ccCCCCCCCCCh
Confidence 56788999999999999999999999999999999999999976433221100 011111244566
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
+++..++.++++.|+-+.|++|-|+-++++.
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 7888889999999999999999999888653
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=313.87 Aligned_cols=245 Identities=27% Similarity=0.345 Sum_probs=193.2
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
..++||+|+||+||++... +++.||+|++..... ....+.+|+.++++++||||+++++.+..++..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05605 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccC
Confidence 3578999999999999854 588999999865422 23456789999999999999999999999899999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
+|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05605 84 GGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHRER-IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR 159 (285)
T ss_pred CCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHHCC-cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccc
Confidence 99999888643 2345899999999999999999999998 9999999999999999999999999987654322
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++||||+||++|||++|+.||....... ....+...+... .....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~-----------~~~~~ 225 (285)
T cd05605 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKED-----------QEEYS 225 (285)
T ss_pred cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhc-----------ccccC
Confidence 2356778999999998899999999999999999999999997532211 111111111100 00111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRP-----AMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 612 (654)
......+.+++.+||..||++|| +++++++.
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 12334567788899999999999 77777554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=309.00 Aligned_cols=238 Identities=26% Similarity=0.399 Sum_probs=190.4
Q ss_pred ccccccCceeEEEEEecCCc-----------EEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEE
Q 036334 352 EVLGKGSVGTSYKAVLEEGT-----------TVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVY 420 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 420 (654)
+.||+|+||.||+|...+.. .|++|.+.........+.+|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46999999999999976432 57888876654446788999999999999999999999988 7789999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC-------CeEEeccCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH-------DACVSDFGL 493 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~-------~~kl~Dfgl 493 (654)
||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++ .+||+|||+
T Consensus 80 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 80 EYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKK-LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC-eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 9999999999997432 25899999999999999999999988 99999999999999887 799999999
Q ss_pred CCCcCCCCCCCccccccCccccCCC--CCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhh
Q 036334 494 NPLFGNTTPPTRVAGYRAPEVVETR--KVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEV 570 (654)
Q Consensus 494 a~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 570 (654)
+..........+...|+|||++.+. .++.++|||||||++|||++ |..||......+ ...+.. ...
T Consensus 155 a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~~----~~~---- 223 (259)
T cd05037 155 PITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQ----DQH---- 223 (259)
T ss_pred ccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHHh----cCC----
Confidence 9876654444556679999999776 78999999999999999999 577775532111 001000 000
Q ss_pred hhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 571 FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 571 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
.. . ......+.+++.+||..+|++|||+.++++.|+
T Consensus 224 ---~~-~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 ---RL-P----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---CC-C----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0 001157778889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.91 Aligned_cols=242 Identities=21% Similarity=0.319 Sum_probs=194.6
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||+||+|... +|+.||+|+++... .....+..|++++..++||||+++++++.+++..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (350)
T cd05573 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMP 84 (350)
T ss_pred EEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCC
Confidence 3578999999999999965 68999999997642 234567889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
+|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g-iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 85 GGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG-FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999999742 45899999999999999999999988 9999999999999999999999999987654322
Q ss_pred ------------------------------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 036334 502 ------------------------------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEG 551 (654)
Q Consensus 502 ------------------------------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~ 551 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~-- 236 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ-- 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH--
Confidence 234677899999999999999999999999999999999999754311
Q ss_pred CChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 036334 552 IDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPA-MQEVVRM 612 (654)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~ 612 (654)
.....+... .... .+.. ......++.+++.+|+. ||++||+ ++++++.
T Consensus 237 ----~~~~~i~~~--~~~~---~~p~---~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ----ETYNKIINW--KESL---RFPP---DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ----HHHHHHhcc--CCcc---cCCC---CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111111110 0000 0000 01123456677789997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=311.57 Aligned_cols=253 Identities=22% Similarity=0.367 Sum_probs=199.3
Q ss_pred HhhccccccCceeEEEEEecC-----CcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEe-CCceEEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE-----GTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYS-KDEKLLVY 420 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~-----g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~~~lv~ 420 (654)
.+.++||+|+||.||+|...+ +..|++|+++... .....+.+|+.++++++||||+++++++.. +...++++
T Consensus 9 ~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 88 (280)
T cd05043 9 TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLY 88 (280)
T ss_pred EEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEE
Confidence 446789999999999999765 6789999987542 224567889999999999999999998776 46789999
Q ss_pred EecCCCchhhhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 421 DYMPAGSLSALLHGSRGS---GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
||+++|+|.+++...+.. ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+
T Consensus 89 ~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-i~H~di~p~nil~~~~~~~kl~d~g~~~~~ 167 (280)
T cd05043 89 PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG-VIHKDIAARNCVIDEELQVKITDNALSRDL 167 (280)
T ss_pred EcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccCHhhEEEcCCCcEEECCCCCcccc
Confidence 999999999998654321 1246899999999999999999999887 999999999999999999999999999765
Q ss_pred CCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhh
Q 036334 498 GNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEV 570 (654)
Q Consensus 498 ~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 570 (654)
.... ...++..|+|||++.+..++.++|||||||++||+++ |+.||..... ..+.. .......
T Consensus 168 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~-~~~~~~~--- 237 (280)
T cd05043 168 FPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP------FEMAA-YLKDGYR--- 237 (280)
T ss_pred cCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH------HHHHH-HHHcCCC---
Confidence 3221 1233456999999988889999999999999999999 9999865321 11111 1111110
Q ss_pred hhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 571 FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 571 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
..........+.+++.+||..||++|||+.++++.|+++.+.
T Consensus 238 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 238 -------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 000111234577888899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.09 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=195.8
Q ss_pred hhccccccCceeEEEEEecC----CcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCc------e
Q 036334 350 SAEVLGKGSVGTSYKAVLEE----GTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDE------K 416 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~------~ 416 (654)
+.+.||+|+||.||+|.... +..||+|+++..... ...+.+|++.++.++||||+++++++...+. .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 35789999999999998642 367999998765332 3468889999999999999999998876554 6
Q ss_pred EEEEEecCCCchhhhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCC
Q 036334 417 LLVYDYMPAGSLSALLHGSRG-SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP 495 (654)
Q Consensus 417 ~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~ 495 (654)
++||||+++|+|..++...+. .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 161 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN-FIHRDLAARNCMLREDMTVCVADFGLSK 161 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-eeccccchheEEECCCCeEEECCcccee
Confidence 999999999999999864431 12346899999999999999999999988 9999999999999999999999999987
Q ss_pred CcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 496 LFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 496 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
...... ....+..|+|||.+.+..++.++|||||||++|||++ |..||..... .+..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~~-- 233 (273)
T cd05035 162 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN------HEIYDYLRHGNR-- 233 (273)
T ss_pred eccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCC--
Confidence 654321 1123446999999988899999999999999999999 8888864321 111111111110
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
.........++.+++.+||+.||++||++.|+++.|+++
T Consensus 234 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 ---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011122345688888899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=305.15 Aligned_cols=252 Identities=21% Similarity=0.401 Sum_probs=202.0
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
..+.||+|+||.||+|... +|+.||+|.++... ...+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (267)
T cd08224 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELAD 85 (267)
T ss_pred eeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCC
Confidence 3467999999999999976 78999999886432 224578899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
+|+|.+++..... ....+++..++.++.|++.|++|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 163 (267)
T cd08224 86 AGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKR-IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163 (267)
T ss_pred CCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC-EecCCcChhhEEECCCCcEEEeccceeeeccCCCccc
Confidence 9999999864322 2345899999999999999999999998 9999999999999999999999999987654332
Q ss_pred -CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 502 -PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 502 -~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
...++..|+|||.+.+..++.++|||||||++|||++|+.||.... ............... ....
T Consensus 164 ~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~----------~~~~ 229 (267)
T cd08224 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEKCDY----------PPLP 229 (267)
T ss_pred ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhcCCC----------CCCC
Confidence 2345667999999988889999999999999999999999986432 122222221111100 0001
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
.......+.+++.+||..+|++||++.+|+++|+++.
T Consensus 230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1123346778888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=314.79 Aligned_cols=254 Identities=27% Similarity=0.420 Sum_probs=193.7
Q ss_pred HhhccccccCceeEEEEEe-----cCCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeC--CceEEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVL-----EEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKLLVY 420 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~ 420 (654)
.+.+.||+|+||.||++.. .++..||+|.++... ...+.+.+|++++++++||||+++++++... ...++||
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 3457899999999999974 247899999987543 2345788999999999999999999987543 4679999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||++......
T Consensus 87 e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~~~-i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 87 EYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGSKR-YVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 999999999999743 235899999999999999999999998 999999999999999999999999998865432
Q ss_pred CC-------CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC------C---CChhHHHHHHhhh
Q 036334 501 TP-------PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEE------G---IDLPRWVQSVVRE 564 (654)
Q Consensus 501 ~~-------~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~---~~~~~~~~~~~~~ 564 (654)
.. ......|+|||++.+..++.++|||||||++|||++|..++......- . ......+......
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence 21 112234999999988889999999999999999999877654321100 0 0000000011100
Q ss_pred chhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 565 EWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
.. ..........++.+++.+||+.+|++|||++||++.|++++
T Consensus 242 ~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 242 NG----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred CC----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 00 01111222346778888999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.75 Aligned_cols=245 Identities=31% Similarity=0.460 Sum_probs=199.0
Q ss_pred ccccccCceeEEEEEecC----CcEEEEEEecccccC--HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLEE----GTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.||+|+||.||+|.... +..|++|.++..... .+.+.+|++.++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999654 788999999876443 57788999999999999999999999998999999999999
Q ss_pred CchhhhhccCCCC----CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-
Q 036334 426 GSLSALLHGSRGS----GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT- 500 (654)
Q Consensus 426 g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~- 500 (654)
++|.+++...... ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||.+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~-i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC-cccCccCcceEEECCCCcEEEccccccccccccc
Confidence 9999999754210 1256899999999999999999999988 999999999999999999999999998876542
Q ss_pred -----CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 501 -----TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 501 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
....++..|+|||.+....++.++||||+|+++|||++ |..||..... ......... ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~-~~-------- 224 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEVLEYLRK-GY-------- 224 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHc-CC--------
Confidence 22344567999999988889999999999999999999 6999875421 111111111 11
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
..........++.+++.+||+.+|++|||+.|+++.|+
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 --RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00111222456788888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.39 Aligned_cols=242 Identities=28% Similarity=0.413 Sum_probs=193.3
Q ss_pred ccccccCceeEEEEEecC----CcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLEE----GTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.||+|+||.||+|.+.. +..||+|.+..... ..+++.+|+++++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997432 26899999886644 4567889999999999999999999875 4568999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC---
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP--- 502 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~--- 502 (654)
|+|.+++... ..+++..++.++.|++.|++|||..+ ++||||||+||+++.++.+||+|||++........
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~~-i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLESKH-FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhcC-eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999999742 35899999999999999999999988 99999999999999999999999999876543321
Q ss_pred ----CCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 503 ----PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 503 ----~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
..++..|+|||.+.+..++.++|||||||++|||++ |..||....+ .+....+ ......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~------~~~~~~~-~~~~~~--------- 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG------AEVIAML-ESGERL--------- 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH------HHHHHHH-HcCCcC---------
Confidence 111245999999988899999999999999999998 9999865322 1111111 111100
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
.........+.+++.+||..+|++||++.++++.|+++.
T Consensus 218 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 -PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 111122346778888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=328.33 Aligned_cols=242 Identities=24% Similarity=0.308 Sum_probs=187.1
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.+.||+|+||+||+|... +++.||+|++..... ....+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g 85 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 467999999999999854 578999999976432 234578899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----- 500 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----- 500 (654)
|+|.+++.. ...+++..+..++.|++.||+|||..+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 86 g~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~~g-ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 86 GDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHKMG-FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 999999873 345889999999999999999999998 999999999999999999999999987532100
Q ss_pred ----------------------------------------------CCCCccccccCccccCCCCCCcchhHHHHHHHHH
Q 036334 501 ----------------------------------------------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLL 534 (654)
Q Consensus 501 ----------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~ 534 (654)
....++..|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 1124677899999999889999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhh--ccCCCCCCCCCHHHHHHH
Q 036334 535 ELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMG--CVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 535 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPs~~evl~~ 612 (654)
||++|+.||......+ ....+..... ............ ++.+++.+ |+..++..||+++|+++.
T Consensus 240 elltG~~Pf~~~~~~~------~~~~i~~~~~-----~~~~~~~~~~s~---~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 240 EMLVGQPPFLAPTPTE------TQLKVINWEN-----TLHIPPQVKLSP---EAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHhCCCCCcCCCHHH------HHHHHHcccc-----ccCCCCCCCCCH---HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999997543211 0111110000 000101111223 33444445 666777789999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=309.70 Aligned_cols=249 Identities=20% Similarity=0.346 Sum_probs=195.5
Q ss_pred HhhccccccCceeEEEEEec------CCcEEEEEEecccccC--HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVY 420 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 420 (654)
.+.+.||+|+||.||+|... ++..||+|+++..... .+.+.+|+.++..++||||+++++++...+..++++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (283)
T cd05091 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIF 87 (283)
T ss_pred HHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEE
Confidence 44678999999999999853 2478999998754322 356888999999999999999999999999999999
Q ss_pred EecCCCchhhhhccCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEe
Q 036334 421 DYMPAGSLSALLHGSR-----------GSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVS 489 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~ 489 (654)
||+.+++|.+++.... ......+++..+++++.|++.||+|||+++ |+||||||+||++++++.+||+
T Consensus 88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g-i~H~dlkp~Nil~~~~~~~kl~ 166 (283)
T cd05091 88 SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-VVHKDLATRNVLVFDKLNVKIS 166 (283)
T ss_pred EcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC-ccccccchhheEecCCCceEec
Confidence 9999999999985211 011235889999999999999999999998 9999999999999999999999
Q ss_pred ccCCCCCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHh
Q 036334 490 DFGLNPLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVV 562 (654)
Q Consensus 490 Dfgla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 562 (654)
|||++....... ...++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+...+.
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~i~ 240 (283)
T cd05091 167 DLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVIEMIR 240 (283)
T ss_pred ccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHH
Confidence 999987553221 2233457999999988889999999999999999998 7888764321 12222211
Q ss_pred hhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 563 REEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
.... ..........+.+++.+||+.+|++||++++|+..|+.
T Consensus 241 ~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 NRQV-----------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cCCc-----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1110 00112233457788889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=306.32 Aligned_cols=240 Identities=23% Similarity=0.377 Sum_probs=190.4
Q ss_pred ccccCceeEEEEEec---CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 354 LGKGSVGTSYKAVLE---EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 354 lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
||+|+||.||+|.+. .+..||+|++..... ..+++.+|+.++++++||||+++++++. ....++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999754 355799999875532 2456889999999999999999999875 4578999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC------
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP------ 502 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~------ 502 (654)
.+++... ...+++..+++++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 82 NKFLSGK----KDEITVSNVVELMHQVSMGMKYLEGKN-FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhcC-eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 9998642 345899999999999999999999998 99999999999999999999999999875533211
Q ss_pred -CCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 503 -PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 503 -~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
...+..|+|||.+....++.++|||||||++||+++ |..||...... .+.. .+..... ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~-~~~~~~~----------~~~ 219 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP------EVMS-FIEQGKR----------LDC 219 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH------HHHH-HHHCCCC----------CCC
Confidence 122356999999988889999999999999999996 99998753221 1111 1111110 011
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
......++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 112234677788899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=316.16 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=186.0
Q ss_pred HhhccccccCceeEEEEEec--CCcEEEEEEeccccc---CHHHHHHHHHHHhcc---CCCccccccEEEEe-----CCc
Q 036334 349 ASAEVLGKGSVGTSYKAVLE--EGTTVVVKRLKEVAV---GKREFEMQMEVLGKI---KHDNVVPLRAFYYS-----KDE 415 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~--~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l---~hpniv~l~~~~~~-----~~~ 415 (654)
.+.+.||+|+||+||+|... +|+.||+|+++.... ....+.+|+.+++.+ +||||++++++|.. ...
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~ 83 (290)
T cd07862 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 83 (290)
T ss_pred ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCc
Confidence 34577999999999999863 467899999865422 233556677776655 69999999999853 345
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCC
Q 036334 416 KLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP 495 (654)
Q Consensus 416 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~ 495 (654)
.++||||++ ++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~-iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 84 LTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred EEEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 799999996 68998886432 235899999999999999999999998 9999999999999999999999999987
Q ss_pred CcCCC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hchhh
Q 036334 496 LFGNT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR----EEWTA 568 (654)
Q Consensus 496 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~ 568 (654)
..... ....++..|+|||++.+..++.++|||||||++|||++|++||......+ ....+..... ..+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChhhchh
Confidence 65433 23345777999999988899999999999999999999999997643211 1111111100 00000
Q ss_pred hh-h-hHhhh--ccCCh----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 569 EV-F-DVELM--RYHNI----EEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 569 ~~-~-~~~~~--~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.. . ...+. ..... ......+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 0 00000 00000 011234567888999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.40 Aligned_cols=255 Identities=26% Similarity=0.378 Sum_probs=199.7
Q ss_pred HHhhccccccCceeEEEEEec--------CCcEEEEEEecccc--cCHHHHHHHHHHHhcc-CCCccccccEEEEeCCce
Q 036334 348 RASAEVLGKGSVGTSYKAVLE--------EGTTVVVKRLKEVA--VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEK 416 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~--------~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~ 416 (654)
+.+.+.||+|+||.||++... ++..+|+|.++... ....++..|+++++++ +||||+++++++...+..
T Consensus 20 ~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 99 (307)
T cd05098 20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 99 (307)
T ss_pred eEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 455688999999999999743 23469999987642 2335677899999999 799999999999999999
Q ss_pred EEEEEecCCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC
Q 036334 417 LLVYDYMPAGSLSALLHGSRGS-----------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD 485 (654)
Q Consensus 417 ~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~ 485 (654)
++||||+++|+|.+++...+.. ....+++.++++++.|++.||+|||+.+ ++||||||+||+++.++.
T Consensus 100 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-i~H~dlkp~Nill~~~~~ 178 (307)
T cd05098 100 YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVLVTEDNV 178 (307)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC-cccccccHHheEEcCCCc
Confidence 9999999999999999754321 1235899999999999999999999988 999999999999999999
Q ss_pred eEEeccCCCCCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHH
Q 036334 486 ACVSDFGLNPLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWV 558 (654)
Q Consensus 486 ~kl~Dfgla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~ 558 (654)
+||+|||++....... ....+..|+|||++.+..++.++|||||||++|||++ |..||.... .....
T Consensus 179 ~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------~~~~~ 252 (307)
T cd05098 179 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEELF 252 (307)
T ss_pred EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------HHHHH
Confidence 9999999987654321 1122346999999988889999999999999999998 888885421 11111
Q ss_pred HHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 559 QSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
. ....... .........++.+++.+||..+|++||++.++++.|+++.+..
T Consensus 253 ~-~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 253 K-LLKEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred H-HHHcCCC----------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1 1111111 1111223346777888999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=316.21 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=199.1
Q ss_pred HhhccccccCceeEEEEEec-CCc--EEEEEEecccc--cCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEe
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGT--TVVVKRLKEVA--VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~--~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
.+.+.||+|+||.||+|.+. ++. .+++|.++... ....++.+|++++.++ +||||+++++++..++..++||||
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 89 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence 34578999999999999864 344 45777776432 2345688899999999 899999999999999999999999
Q ss_pred cCCCchhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEecc
Q 036334 423 MPAGSLSALLHGSRG-----------SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDF 491 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Df 491 (654)
+++|+|.++++.... .....+++..++.++.|++.|++|||+.+ ++||||||+|||++.++.+||+||
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g-i~H~dlkp~Nili~~~~~~kl~df 168 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADF 168 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC-ccccccchheEEecCCCcEEeCcc
Confidence 999999999975421 11235899999999999999999999998 999999999999999999999999
Q ss_pred CCCCCcCCC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchh
Q 036334 492 GLNPLFGNT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWT 567 (654)
Q Consensus 492 gla~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 567 (654)
|++...... .....+..|+|||++.+..++.++|||||||++|||+| |..||...... ....... ...
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~~-~~~- 240 (303)
T cd05088 169 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKLP-QGY- 240 (303)
T ss_pred ccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHHHHHh-cCC-
Confidence 998643211 11222456999999988889999999999999999998 99998643221 1111111 110
Q ss_pred hhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 036334 568 AEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDDG 624 (654)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 624 (654)
...........+.+++.+||+.+|++||+++++++.|+++........
T Consensus 241 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~ 288 (303)
T cd05088 241 ---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 288 (303)
T ss_pred ---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhh
Confidence 000011122356788889999999999999999999999876654333
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=304.28 Aligned_cols=241 Identities=25% Similarity=0.404 Sum_probs=194.3
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
++||+|+||.||+|...++..||+|.++.... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999999875432 2346888999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-----CCC
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-----PPT 504 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-----~~~ 504 (654)
+++... ...+++..++.++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKK----KDELKTKQLVKFALDAAAGMAYLESKN-CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 998643 235899999999999999999999988 9999999999999999999999999986543321 112
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.+..|+|||++.+..++.++||||||+++||+++ |..||...... ..... ....... .....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~------~~~~~-~~~~~~~----------~~~~~ 218 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ------QAREQ-VEKGYRM----------SCPQK 218 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHH-HHcCCCC----------CCCCC
Confidence 2346999999988889999999999999999998 99998643211 11111 1111100 00112
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
...++.+++.+||..+|++||++.|++++|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2346778888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.68 Aligned_cols=246 Identities=26% Similarity=0.411 Sum_probs=200.3
Q ss_pred HhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.+.+.||+|+||.||+|... |+.||+|.++......+++.+|+.++++++|+||+++++++.+....++||||+++++|
T Consensus 9 ~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 87 (256)
T cd05039 9 KLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL 87 (256)
T ss_pred cceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcH
Confidence 34578999999999999876 78999999987655567888999999999999999999999988899999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC-CCccc
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP-PTRVA 507 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~ 507 (654)
.+++.... ...+++..+..++.|++.|+.|||+++ ++||||||+||+++.++.+||+|||.+........ ...+.
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~-i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 163 (256)
T cd05039 88 VDYLRSRG---RAVITLAQQLGFALDVCEGMEYLEEKN-FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV 163 (256)
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-ccchhcccceEEEeCCCCEEEcccccccccccccccCCCcc
Confidence 99997432 236899999999999999999999998 99999999999999999999999999887643322 22344
Q ss_pred cccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHH
Q 036334 508 GYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMV 586 (654)
Q Consensus 508 ~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (654)
.|+|||.+....++.++||||||+++||+++ |..||..... .. +.......+... .......
T Consensus 164 ~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~-~~~~~~~~~~~~----------~~~~~~~ 226 (256)
T cd05039 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KD-VVPHVEKGYRME----------APEGCPP 226 (256)
T ss_pred cccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH------HH-HHHHHhcCCCCC----------CccCCCH
Confidence 6999999988889999999999999999997 9999864321 11 111111111100 1112234
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 587 QLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 587 ~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
.+.+++.+||..+|++||+++|++++|+++
T Consensus 227 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 227 EVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 677888899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=319.96 Aligned_cols=237 Identities=23% Similarity=0.283 Sum_probs=185.9
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHH-HHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQME-VLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
++||+|+||+||+|... +|+.||+|++..... ...++..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999854 689999999875421 2234445554 46778999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----CC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN----TT 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~----~~ 501 (654)
|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~g-ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSIN-IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 999988863 345899999999999999999999998 99999999999999999999999999875322 12
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~------~~~~~~~~~~~~~---------~~~~-- 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD------VAEMYDNILHKPL---------VLRP-- 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC------HHHHHHHHHcCCc---------cCCC--
Confidence 3346778999999999999999999999999999999999997532 1122222221110 0011
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.....+.+++.+|++.+|.+||++++.+++
T Consensus 218 -~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 218 -GASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred -CCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 122356678889999999999988644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=317.81 Aligned_cols=235 Identities=25% Similarity=0.324 Sum_probs=185.3
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhc-cCCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGK-IKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~-l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
++||+|+||.||+|... +|+.||+|+++... .....+..|..++.. .+||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 58899999997642 223445667777765 4899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----CC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN----TT 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~----~~ 501 (654)
|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++..... ..
T Consensus 81 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKG-IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 999998863 245889999999999999999999998 99999999999999999999999999864321 12
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++||||+||++|||++|+.||..... ......+.... +.. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~------~~~~~~~~~~~-------~~~-----~ 216 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE------DELFESIRVDT-------PHY-----P 216 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-------CCC-----C
Confidence 34567889999999999999999999999999999999999975321 11111111000 000 0
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQ-EVV 610 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 610 (654)
.....++.+++.+||+.||++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11223566778899999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.15 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=196.1
Q ss_pred HHHhhccccccCceeEEEEEe-----cCCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeC--CceE
Q 036334 347 LRASAEVLGKGSVGTSYKAVL-----EEGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKL 417 (654)
Q Consensus 347 ~~~~~~~lg~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~ 417 (654)
.+.+.+.||+|+||.||++.. .++..||+|.++.... ....+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 345668899999999999973 3478899999875432 235788999999999999999999998775 5679
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 418 LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 85 lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~~g-i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecccchheEEEcCCCCEEECCCcccccc
Confidence 999999999999998632 235899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCC-------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC--------CC-CChhHHHHHH
Q 036334 498 GNTT-------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGE--------EG-IDLPRWVQSV 561 (654)
Q Consensus 498 ~~~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--------~~-~~~~~~~~~~ 561 (654)
.... ...++..|+|||++.+..++.++|||||||++|||++++.|+...... .. ......+. .
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 238 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-V 238 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-H
Confidence 4321 122344599999998888999999999999999999987765322110 00 00111111 0
Q ss_pred hhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 562 VREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
..... ...........+.+++.+||+.+|++||+++++++.|+++
T Consensus 239 ~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11000 0111122345688899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.31 Aligned_cols=247 Identities=26% Similarity=0.328 Sum_probs=184.7
Q ss_pred cccccCceeEEEEEecC---CcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 353 VLGKGSVGTSYKAVLEE---GTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 353 ~lg~G~fg~Vy~~~~~~---g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
.||+|+||.||+|...+ ...+++|.+..... ....+.+|+..++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 34688888764432 23567889999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC------C
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT------T 501 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~------~ 501 (654)
|.+++...+.......++...++++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++...... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC-EecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 999997654322344678888999999999999999998 999999999999999999999999998653221 1
Q ss_pred CCCccccccCccccC-------CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 502 PPTRVAGYRAPEVVE-------TRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~-------~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
...++..|+|||++. ...++.++|||||||++|||++ |..||...... ............ ...
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~~~-~~~-- 231 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQDI-KLP-- 231 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhccCc-cCC--
Confidence 222345699999874 2456889999999999999999 77887643221 111111111100 000
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
...........+.+++..|| .||++|||+++|++.|
T Consensus 232 ---~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 232 ---KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ---CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11111122334556777888 5999999999999987
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.78 Aligned_cols=256 Identities=27% Similarity=0.378 Sum_probs=196.6
Q ss_pred HHHhhccccccCceeEEEEEe------cCCcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccccccEEEEeC-Cce
Q 036334 347 LRASAEVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVPLRAFYYSK-DEK 416 (654)
Q Consensus 347 ~~~~~~~lg~G~fg~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~-~~~ 416 (654)
.+.+.+.||+|+||.||+|.. ..++.||||+++.... ....+.+|+.++.++ +||||++++++|... ...
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 87 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence 456678899999999999973 3467899999975432 234678899999999 689999999988654 457
Q ss_pred EEEEEecCCCchhhhhccCCCC----------------------------------------------------------
Q 036334 417 LLVYDYMPAGSLSALLHGSRGS---------------------------------------------------------- 438 (654)
Q Consensus 417 ~lv~e~~~~g~L~~~l~~~~~~---------------------------------------------------------- 438 (654)
++||||+++|+|.+++...+..
T Consensus 88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (343)
T cd05103 88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE 167 (343)
T ss_pred EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence 8999999999999998643210
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC------CCCcccc
Q 036334 439 ----GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT------PPTRVAG 508 (654)
Q Consensus 439 ----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~------~~~~~~~ 508 (654)
....+++..+.+++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++....... ...++..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 0124788899999999999999999998 9999999999999999999999999987653221 1223456
Q ss_pred ccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHH
Q 036334 509 YRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQ 587 (654)
Q Consensus 509 y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (654)
|+|||.+.+..++.++||||||+++|||++ |..||....... ............. .. .....+
T Consensus 247 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~-------~~---~~~~~~ 310 (343)
T cd05103 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMR-------AP---DYTTPE 310 (343)
T ss_pred eECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCCC-------CC---CCCCHH
Confidence 999999988899999999999999999997 888986532111 1111111111000 00 011235
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 588 LLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 588 l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
+.+++.+||+.+|++|||+.|+++.|+.+.+.
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 78888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.81 Aligned_cols=242 Identities=25% Similarity=0.382 Sum_probs=194.3
Q ss_pred ccccccCceeEEEEEecC--C--cEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLEE--G--TTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~--g--~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
++||+|++|.||+|.+.+ + ..||+|.+..... ..+++.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3689999977644 35678899999999999999999999988 889999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 501 (654)
|+|.+++..... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR-FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC-ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999975421 46899999999999999999999998 9999999999999999999999999987664321
Q ss_pred ---CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 502 ---PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 502 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
...++..|+|||.+.+..++.++|||||||++|||++ |+.||..... .+.......... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~~~~~----------~ 219 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG------SQILKKIDKEGE----------R 219 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcCC----------c
Confidence 1234457999999988899999999999999999999 9999864322 111111111110 0
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
..........+.+++.+||+.+|++||++.++++.|.
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0111122346778888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=309.73 Aligned_cols=239 Identities=23% Similarity=0.384 Sum_probs=187.6
Q ss_pred ccccccCceeEEEEEecC--------CcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 352 EVLGKGSVGTSYKAVLEE--------GTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
+.||+|+||.||+|.... ...|++|.+.... ...+++.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998542 2348888875543 2345678899999999999999999999998999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC--------eEEeccCCC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD--------ACVSDFGLN 494 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~--------~kl~Dfgla 494 (654)
+++|+|.++++.. ...+++..+++++.|++.||+|||+++ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLEDKG-LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999743 235899999999999999999999998 999999999999988765 599999998
Q ss_pred CCcCCCCCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCCCChhHHHHHHhhhchhhhhhh
Q 036334 495 PLFGNTTPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGK-APNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 495 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 572 (654)
..........++..|+|||++.+ ..++.++|||||||++|||++|. .||...... ... ......
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~~-~~~~~~------- 221 (258)
T cd05078 156 ITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KKL-QFYEDR------- 221 (258)
T ss_pred cccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HHH-HHHHcc-------
Confidence 77665555566778999999976 45789999999999999999985 554422110 000 000000
Q ss_pred HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 573 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
.........++.+++.+||+.+|++|||++++++.|+
T Consensus 222 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -----HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0001112245778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=303.34 Aligned_cols=245 Identities=27% Similarity=0.419 Sum_probs=195.0
Q ss_pred HhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEE-eCCceEEEEEecCCCc
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYY-SKDEKLLVYDYMPAGS 427 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~-~~~~~~lv~e~~~~g~ 427 (654)
.+.+.||+|+||.||++... |..|++|.++... ..+.+.+|+.++++++|+|++++++++. .++..++||||+++++
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 86 (256)
T cd05082 9 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86 (256)
T ss_pred eeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCc
Confidence 34578999999999999866 7889999986543 3557889999999999999999999765 4456899999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-CCCcc
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-PPTRV 506 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~ 506 (654)
|.+++.... ...+++..+++++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++....... ....+
T Consensus 87 L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 162 (256)
T cd05082 87 LVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEANN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 162 (256)
T ss_pred HHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-EeccccchheEEEcCCCcEEecCCccceeccccCCCCccc
Confidence 999987432 335899999999999999999999988 9999999999999999999999999987654322 22334
Q ss_pred ccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHH
Q 036334 507 AGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585 (654)
Q Consensus 507 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (654)
..|+|||++.+..++.++|||||||++|||++ |+.||.... .......+ ...+... ......
T Consensus 163 ~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~-~~~~~~~----------~~~~~~ 225 (256)
T cd05082 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRV-EKGYKMD----------APDGCP 225 (256)
T ss_pred eeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHH-hcCCCCC----------CCCCCC
Confidence 56999999988889999999999999999998 999986421 11222111 1111110 111223
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 586 VQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 586 ~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 226 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 226 PVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 4677888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.22 Aligned_cols=250 Identities=27% Similarity=0.369 Sum_probs=197.0
Q ss_pred HHhhccccccCceeEEEEEecC------CcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEE
Q 036334 348 RASAEVLGKGSVGTSYKAVLEE------GTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 419 (654)
+.+.+.||+|+||.||+|...+ +..||+|.+..... ....+.+|+.+++.++||||+++++++......++|
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 87 (277)
T cd05032 8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVV 87 (277)
T ss_pred eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEE
Confidence 3456789999999999998642 36899999865432 234678899999999999999999999999999999
Q ss_pred EEecCCCchhhhhccCCCC-----CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCC
Q 036334 420 YDYMPAGSLSALLHGSRGS-----GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN 494 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla 494 (654)
|||+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~di~p~nill~~~~~~kl~dfg~~ 166 (277)
T cd05032 88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK-FVHRDLAARNCMVAEDLTVKIGDFGMT 166 (277)
T ss_pred EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccChheEEEcCCCCEEECCcccc
Confidence 9999999999999753321 1235789999999999999999999988 999999999999999999999999998
Q ss_pred CCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchh
Q 036334 495 PLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWT 567 (654)
Q Consensus 495 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 567 (654)
...... ....++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ...... .....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------~~~~~~-~~~~~ 239 (277)
T cd05032 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE------EVLKFV-IDGGH 239 (277)
T ss_pred hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH------HHHHHH-hcCCC
Confidence 754322 12234567999999988889999999999999999998 89998643221 111111 11110
Q ss_pred hhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 568 AEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
. .........+.+++.+||+.+|++|||+.++++.|++
T Consensus 240 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 240 L----------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred C----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 0 0111224567888899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=308.23 Aligned_cols=246 Identities=22% Similarity=0.305 Sum_probs=192.7
Q ss_pred HhhccccccCceeEEEEEe-cCCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 349 ASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.+.||+|+||.||+|.. .+++.||+|++.... .....+++|+.++++++||||+++++++..++..++||||++++
T Consensus 12 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~ 91 (267)
T cd06646 12 ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGG 91 (267)
T ss_pred chhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCC
Confidence 4457899999999999995 468899999987543 23456788999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TP 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~ 502 (654)
+|.++++. ...+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 92 ~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06646 92 SLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHSKG-KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS 165 (267)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEECCCCCEEECcCccceeecccccccCc
Confidence 99999863 245899999999999999999999988 999999999999999999999999998765422 22
Q ss_pred CCccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 503 PTRVAGYRAPEVVE---TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 503 ~~~~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
..++..|+|||.+. ...++.++|||||||++|||++|+.||......+... ....... ... ...
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~~~~~~-----~~~--~~~ 232 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMSKSNF-----QPP--KLK 232 (267)
T ss_pred cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------eeecCCC-----CCC--CCc
Confidence 34556799999884 3457889999999999999999999986432211100 0000000 000 001
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
........+.+++.+||..+|++||+++++++.|
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1112234677888899999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=313.81 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=199.8
Q ss_pred HHHHhhccccccCceeEEEEEec--------CCcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccccccEEEEeCC
Q 036334 346 LLRASAEVLGKGSVGTSYKAVLE--------EGTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKD 414 (654)
Q Consensus 346 ~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~ 414 (654)
..+.+.+.||+|+||.||++... ....||+|.++.... ...++..|+++++++ +||||++++++|.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 34456788999999999999742 245789999875432 235678899999999 6999999999999988
Q ss_pred ceEEEEEecCCCchhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC
Q 036334 415 EKLLVYDYMPAGSLSALLHGSRG-----------SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD 483 (654)
Q Consensus 415 ~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~ 483 (654)
..++||||+++|+|.+++..... .....+++.++.+++.|++.||.|||+++ |+||||||+||+++.+
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-i~H~dlkp~Nill~~~ 170 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR-CIHRDLAARNVLVTED 170 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC-eeeccccceeEEEcCC
Confidence 99999999999999999975321 11245899999999999999999999988 9999999999999999
Q ss_pred CCeEEeccCCCCCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhH
Q 036334 484 HDACVSDFGLNPLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPR 556 (654)
Q Consensus 484 ~~~kl~Dfgla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~ 556 (654)
+.+||+|||++....... ....+..|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~------~~ 244 (314)
T cd05099 171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV------EE 244 (314)
T ss_pred CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH------HH
Confidence 999999999997654321 1122245999999988899999999999999999999 8888864321 11
Q ss_pred HHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 557 WVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
... ........ ........++.+++.+||..+|++||++.|+++.|+++....
T Consensus 245 ~~~-~~~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 245 LFK-LLREGHRM----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHH-HHHcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 111 11111100 011122335677888999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=340.69 Aligned_cols=256 Identities=22% Similarity=0.288 Sum_probs=199.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.++||+|+||.||+|... .|+.||+|+++.... ..+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 6 Ii~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~e 85 (932)
T PRK13184 6 IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIE 85 (932)
T ss_pred EEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence 3578999999999999965 588999999875422 24568899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCC------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 425 AGSLSALLHGSRGS------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 425 ~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
+|+|.+++...... ....+++..+++++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G-IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~ 164 (932)
T PRK13184 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG-VLHRDLKPDNILLGLFGEVVILDWGAAIFKK 164 (932)
T ss_pred CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC-ccccCCchheEEEcCCCCEEEEecCcceecc
Confidence 99999998643211 1234678888999999999999999998 9999999999999999999999999987651
Q ss_pred CC----------------------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhH
Q 036334 499 NT----------------------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPR 556 (654)
Q Consensus 499 ~~----------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~ 556 (654)
.. ....+++.|||||++.+..++.++|||||||++|||++|+.||......+.. .
T Consensus 165 ~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~---~ 241 (932)
T PRK13184 165 LEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS---Y 241 (932)
T ss_pred cccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh---h
Confidence 10 1134678899999999999999999999999999999999999753322110 0
Q ss_pred HHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhhhcCCC
Q 036334 557 WVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRP-AMQEVVRMIENMNRGET 621 (654)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~~~ 621 (654)
.... .++. ......+....+.+++.+|++.||++|| +++++.+.|++..+...
T Consensus 242 --~~~i--------~~P~--~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 242 --RDVI--------LSPI--EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred --hhhc--------cChh--hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 0000 0000 0000112234567788899999999996 77888888988876543
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.73 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=194.5
Q ss_pred HhhccccccCceeEEEEEecC------CcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE------GTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVY 420 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 420 (654)
.+.+.||+|+||.||+|.+.+ +..|++|.+..... ....+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 88 (277)
T cd05036 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL 88 (277)
T ss_pred EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence 345789999999999998653 56789998765432 2456888999999999999999999999988999999
Q ss_pred EecCCCchhhhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC---CeEEeccCCCC
Q 036334 421 DYMPAGSLSALLHGSRGS--GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH---DACVSDFGLNP 495 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~---~~kl~Dfgla~ 495 (654)
||+++++|.+++...+.. ....+++..+++++.||+.|++|||+++ ++||||||+||+++.++ .+||+|||++.
T Consensus 89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~ 167 (277)
T cd05036 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH-FIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167 (277)
T ss_pred ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccchheEEEeccCCCcceEeccCcccc
Confidence 999999999999754321 1235899999999999999999999998 99999999999998765 58999999987
Q ss_pred CcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 496 LFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 496 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
...... ....+..|+|||++.+..++.++|||||||++|||++ |..||......+ ....+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~-- 239 (277)
T cd05036 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VMEFVTGGGR-- 239 (277)
T ss_pred ccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHcCCc--
Confidence 653221 1122346999999998899999999999999999997 999987532211 1111111100
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
..........+.+++.+||+.+|++||++.+|++.|++
T Consensus 240 ---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 240 ---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 00111223467788889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.36 Aligned_cols=244 Identities=24% Similarity=0.335 Sum_probs=193.0
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCC--------ceE
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKD--------EKL 417 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~--------~~~ 417 (654)
+.+.||+|+||+||+|.. .+|+.||||++...... ...+.+|+..+..++|+||+++.+.+...+ ..+
T Consensus 36 i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~ 115 (496)
T PTZ00283 36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIA 115 (496)
T ss_pred EEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEE
Confidence 457899999999999985 46899999998754332 346778999999999999999988765432 257
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 418 LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
+||||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 116 lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~-IiHrDLKP~NILl~~~~~vkL~DFGls~~~ 193 (496)
T PTZ00283 116 LVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKH-MIHRDIKSANILLCSNGLVKLGDFGFSKMY 193 (496)
T ss_pred EEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEeCCCCEEEEecccCeec
Confidence 99999999999999874322 2356899999999999999999999998 999999999999999999999999998765
Q ss_pred CCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhh
Q 036334 498 GNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571 (654)
Q Consensus 498 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 571 (654)
... ....++..|+|||++.+..++.++|||||||++|||++|+.||.... ....+.........
T Consensus 194 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~~~~~~---- 263 (496)
T PTZ00283 194 AATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTLAGRYD---- 263 (496)
T ss_pred cccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHhcCCCC----
Confidence 422 22356788999999999999999999999999999999999996432 22222222211110
Q ss_pred hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 572 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
........++.+++.+||+.||++||++.++++.
T Consensus 264 -------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 -------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0011223457778889999999999999999764
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=304.49 Aligned_cols=241 Identities=24% Similarity=0.443 Sum_probs=196.8
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchhh
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSA 430 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~ 430 (654)
.+.||+|+||.||++.+.++..+|+|.++.......++.+|++++++++|||++++++++......++||||+++++|.+
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 88 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSD 88 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHH
Confidence 47799999999999998778899999988766667789999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-----CCCc
Q 036334 431 LLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-----PPTR 505 (654)
Q Consensus 431 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-----~~~~ 505 (654)
++... ...+++..++.++.|++.+++|||+.+ ++||||||+||+++.++.+||+|||.+....... ....
T Consensus 89 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 163 (256)
T cd05112 89 YLRAQ----RGKFSQETLLGMCLDVCEGMAYLESSN-VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF 163 (256)
T ss_pred HHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC-ccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCcc
Confidence 98743 235889999999999999999999888 9999999999999999999999999987543221 1223
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 506 VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 506 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
+.+|+|||.+.++.++.++||||||+++|||++ |..||..... ...+... ..... ...+ ...
T Consensus 164 ~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~-~~~~~--~~~~--------~~~ 226 (256)
T cd05112 164 PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVETI-NAGFR--LYKP--------RLA 226 (256)
T ss_pred chhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHH-hCCCC--CCCC--------CCC
Confidence 456999999998899999999999999999998 8999864321 1111111 11100 0000 112
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 585 MVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
...+.+++.+||+.+|++||+++|++++|
T Consensus 227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 227 SQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 34678889999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=306.94 Aligned_cols=243 Identities=23% Similarity=0.377 Sum_probs=191.4
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
..++||+|+||.||+|.. .++..||+|++.... ....++.+|++++++++||||+++++++...+..++||||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 84 (279)
T cd06619 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG 84 (279)
T ss_pred heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence 347899999999999985 468899999986542 22456888999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--CCCC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--TPPT 504 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--~~~~ 504 (654)
+|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++...... ....
T Consensus 85 ~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (279)
T cd06619 85 SLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK-ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV 154 (279)
T ss_pred ChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC-EeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence 997553 2688889999999999999999998 999999999999999999999999998765433 2345
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCCh-hHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDL-PRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
++..|+|||++.+..++.++||||||+++|||++|+.||......+.... ........... ...+ ....
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~----~~~~ 224 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVL----PVGQ 224 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCC----CCCc
Confidence 67789999999988999999999999999999999999975433221111 11111110000 0000 0111
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
...++.+++.+||+.+|++||+++|+++.
T Consensus 225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 225 FSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 22356778889999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=311.94 Aligned_cols=256 Identities=21% Similarity=0.309 Sum_probs=195.8
Q ss_pred HhhccccccCceeEEEEEecC-----------------CcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE-----------------GTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAF 409 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~ 409 (654)
.+.+.||+|+||.||+|...+ +..||+|.+.... ....++.+|++++++++||||++++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 87 (296)
T cd05051 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGV 87 (296)
T ss_pred cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 445789999999999987542 2458999987553 234678899999999999999999999
Q ss_pred EEeCCceEEEEEecCCCchhhhhccCCCC------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC
Q 036334 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGS------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD 483 (654)
Q Consensus 410 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~ 483 (654)
+..++..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.+
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-i~H~dlkp~Nili~~~ 166 (296)
T cd05051 88 CTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-FVHRDLATRNCLVGKN 166 (296)
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC-ccccccchhceeecCC
Confidence 99999999999999999999999754321 1236899999999999999999999988 9999999999999999
Q ss_pred CCeEEeccCCCCCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCCCCChh
Q 036334 484 HDACVSDFGLNPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT--GKAPNQASLGEEGIDLP 555 (654)
Q Consensus 484 ~~~kl~Dfgla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t--g~~pf~~~~~~~~~~~~ 555 (654)
+.++|+|||++...... .....+..|+|||.+.+..++.++|||||||++|||++ |..||...... ...
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~~ 243 (296)
T cd05051 167 YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ---QVI 243 (296)
T ss_pred CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH---HHH
Confidence 99999999998754322 12233457999999988889999999999999999998 66777542211 111
Q ss_pred HHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 556 RWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
..+............ .........++.+++.+||+.||++|||+.||++.|++
T Consensus 244 ~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 244 ENAGHFFRDDGRQIY-------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHhcccccccccc-------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111110000000 00111223468889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=305.72 Aligned_cols=245 Identities=23% Similarity=0.421 Sum_probs=196.2
Q ss_pred hhccccccCceeEEEEEecC-C---cEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLEE-G---TTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~-g---~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
..+.||+|+||.||+|.... + ..+++|.++... ...+++..|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcC
Confidence 35789999999999998652 3 379999986542 23456888999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC-
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP- 502 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~- 502 (654)
++++|.+++... ...+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~~-i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 89 ENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLSDMN-YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 999999999743 245899999999999999999999998 99999999999999999999999999876543211
Q ss_pred ------CCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 503 ------PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 503 ------~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
...+..|+|||++....++.++|||||||++|||++ |+.||..... ......+....
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~~i~~~~---------- 227 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMKAINDGF---------- 227 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHhcCC----------
Confidence 111235999999988889999999999999999998 9999865321 11122111110
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
......+....+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 -~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111122345678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=316.12 Aligned_cols=232 Identities=22% Similarity=0.300 Sum_probs=183.1
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHH-HHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQME-VLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
++||+|+||.||+|... +|+.||+|++..... ...++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 588999999875421 2234445544 57889999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
|+|...+.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLN-IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 999988863 345888999999999999999999988 999999999999999999999999998753221 2
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+.... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~---------~~~~--- 216 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILHKP---------LQLP--- 216 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhcCC---------CCCC---
Confidence 2346778999999998899999999999999999999999997532 122222222111 0011
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQ 607 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~ 607 (654)
......+.+++.+|++.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11233567788899999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=307.93 Aligned_cols=248 Identities=24% Similarity=0.399 Sum_probs=195.2
Q ss_pred hhccccccCceeEEEEEec-CCc----EEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGT----TVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
..++||+|+||+||+|.+. +|. .||+|+++.... ...++.+|+.+++.++||||+++++++.. ...++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~ 89 (279)
T cd05109 11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQL 89 (279)
T ss_pred eeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEc
Confidence 3478999999999999853 444 489999875432 34568889999999999999999999875 457899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP 502 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 502 (654)
+++|+|.++++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~-iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 90 MPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEEVR-LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred CCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 9999999999743 235899999999999999999999998 99999999999999999999999999876643221
Q ss_pred ------CCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 503 ------PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 503 ------~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
...+..|+|||.+.+..++.++|||||||++|||++ |..||...... .+.. .+.....
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~-------- 229 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPD----LLEKGER-------- 229 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHCCCc--------
Confidence 122456999999988899999999999999999998 88998643211 1111 1111100
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
.........++.+++.+||+.||++||++.++++.|+++.+..
T Consensus 230 --~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 230 --LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred --CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0011123346778888999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=311.47 Aligned_cols=256 Identities=22% Similarity=0.316 Sum_probs=194.7
Q ss_pred HhhccccccCceeEEEEEec-----------------CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-----------------EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAF 409 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-----------------~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~ 409 (654)
.+.+.||+|+||.||++... ++..||+|+++... ....++.+|++++++++|+||++++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~ 87 (296)
T cd05095 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAV 87 (296)
T ss_pred eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 44578999999999998532 23468999987543 234578899999999999999999999
Q ss_pred EEeCCceEEEEEecCCCchhhhhccCCCC------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC
Q 036334 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGS------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD 483 (654)
Q Consensus 410 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~ 483 (654)
+..++..++||||+++|+|.+++...... ....+++..+++++.|++.|++|||+.+ ++||||||+||+++.+
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-i~H~dlkp~Nili~~~ 166 (296)
T cd05095 88 CITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-FVHRDLATRNCLVGKN 166 (296)
T ss_pred EecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC-eecccCChheEEEcCC
Confidence 99999999999999999999998754311 1234788999999999999999999998 9999999999999999
Q ss_pred CCeEEeccCCCCCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCCCCChh
Q 036334 484 HDACVSDFGLNPLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT--GKAPNQASLGEEGIDLP 555 (654)
Q Consensus 484 ~~~kl~Dfgla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t--g~~pf~~~~~~~~~~~~ 555 (654)
+.++|+|||++....... ....+..|+|||...++.++.++|||||||++|||++ |..||......+ ..
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~---~~ 243 (296)
T cd05095 167 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ---VI 243 (296)
T ss_pred CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH---HH
Confidence 999999999987653321 1122356999999888889999999999999999998 678876432211 11
Q ss_pred HHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 556 RWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
.............. .......+...+.+++.+||+.||++||++.||++.|++
T Consensus 244 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 244 ENTGEFFRDQGRQV-------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHhhccccc-------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111000000 000111223567788899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=311.60 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=196.7
Q ss_pred HHhhccccccCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEE
Q 036334 348 RASAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLL 418 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~l 418 (654)
+...+.||+|+||.||++... .+..||||+++.... ..+.+.+|+++++++ +||||+++++++...+..++
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence 345688999999999999742 245799999876532 235688999999999 79999999999999999999
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 419 VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
||||+.+|+|.++++... ...+++.++..++.|++.||+|||+++ |+|+||||+||+++.++.+|++|||++....
T Consensus 117 v~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASKN-CIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred EEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-eehhhhccceEEEcCCCeEEECCCccccccc
Confidence 999999999999997432 233899999999999999999999988 9999999999999999999999999987654
Q ss_pred CCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhh
Q 036334 499 NTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571 (654)
Q Consensus 499 ~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 571 (654)
... ...++..|+|||.+.+..++.++||||+||++|||++ |..||......+ .+.......+..
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~--- 263 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEGYRM--- 263 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcCCcC---
Confidence 321 1223456999999998899999999999999999998 999986532211 111111111100
Q ss_pred hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 572 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
........++.+++.+||..+|++||++.|+++.|+++
T Consensus 264 -------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 -------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00111223577888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=302.07 Aligned_cols=245 Identities=27% Similarity=0.377 Sum_probs=188.8
Q ss_pred ccccccCceeEEEEEecC----CcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEe-CCceEEEEEecC
Q 036334 352 EVLGKGSVGTSYKAVLEE----GTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYS-KDEKLLVYDYMP 424 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~~~ 424 (654)
+.||+|+||.||+|.+.+ +..||+|.+.... .....+.+|+.+++.++||||+++++++.. ++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 3579999885432 224567889999999999999999998764 556799999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+|+|.+++... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLASKK-FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999999743 234678888999999999999999987 999999999999999999999999998754321
Q ss_pred ----CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 501 ----TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTG-KAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 501 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
....++..|+|||.+.+..++.++|||||||++|||++| .+||.... .............
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~~~--------- 220 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVYLLQGRR--------- 220 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcCCC---------
Confidence 122234569999999888999999999999999999995 55554321 1111111111110
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
..........+.+++.+||..+|++||++.|+++.|+++..
T Consensus 221 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 221 --LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred --CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00011122467788889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=309.09 Aligned_cols=238 Identities=19% Similarity=0.285 Sum_probs=197.8
Q ss_pred hccccccCceeEEEEE-ecCCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.||+|.|+.|-+|+ ...|..||||++.++.. ....+.+|+..|+.++|||||++|++......+|||+|+-++|
T Consensus 23 ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~G 102 (864)
T KOG4717|consen 23 EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGG 102 (864)
T ss_pred hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCc
Confidence 4679999999999998 45799999999987754 3456778999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEEC-CCCCeEEeccCCCCCcCCCCCC--
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR-PDHDACVSDFGLNPLFGNTTPP-- 503 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~-- 503 (654)
+|+++|.... ..+.+..+.+++.||+.|+.|+|+-+ +|||||||+||.+- .-|-|||.|||++..+.+....
T Consensus 103 Dl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHqLH-VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T 177 (864)
T KOG4717|consen 103 DLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQLH-VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT 177 (864)
T ss_pred hHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhhhh-hhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence 9999998653 34899999999999999999999887 99999999999775 4588999999999988776544
Q ss_pred -CccccccCccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 504 -TRVAGYRAPEVVETRKVT-FKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 504 -~~~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
.|...|-|||++.+..|+ +++||||+|||||-|++|++||+...+.+.. ..++|-++..+
T Consensus 178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDCKYtvP--- 239 (864)
T KOG4717|consen 178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDCKYTVP--- 239 (864)
T ss_pred ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhcccccCc---
Confidence 444559999999999887 7899999999999999999999987665532 22333332222
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.....+..+||..|+..||.+|.+.+||+.
T Consensus 240 shvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 240 SHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 223344556677999999999999999864
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.09 Aligned_cols=194 Identities=24% Similarity=0.400 Sum_probs=158.9
Q ss_pred hccccccCceeEEEEEec---CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEe--CCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLE---EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYS--KDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~ 425 (654)
+++||+|+||+||+|... +++.||+|.++.... ...+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 357999999999999864 467899999875432 3457789999999999999999998865 345789999985
Q ss_pred CchhhhhccCCCC----CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEE----CCCCCeEEeccCCCCCc
Q 036334 426 GSLSALLHGSRGS----GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL----RPDHDACVSDFGLNPLF 497 (654)
Q Consensus 426 g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll----~~~~~~kl~Dfgla~~~ 497 (654)
++|.+++...... ....+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-EEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 5888877533211 1235899999999999999999999998 9999999999999 45678999999999765
Q ss_pred CCC-------CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 036334 498 GNT-------TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASL 547 (654)
Q Consensus 498 ~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~ 547 (654)
... ....++..|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 432 22345677999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=306.93 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=200.5
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.+.||+|+||+||++... +|+.||+|++.... ...+.+.+|+++++.++||||+++++++......++||||++
T Consensus 7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (284)
T cd06620 7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMD 86 (284)
T ss_pred HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCC
Confidence 455688999999999999865 58899999876542 234678899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--CC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--TP 502 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--~~ 502 (654)
+++|.+++.. ...+++..+..++.+++.++.|||+...++||||||+||+++.++.++|+|||++...... ..
T Consensus 87 ~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~ 161 (284)
T cd06620 87 CGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT 161 (284)
T ss_pred CCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCc
Confidence 9999999863 2458999999999999999999997434999999999999999999999999998654322 22
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC-----CChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEG-----IDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
..++..|+|||++.+..++.++|||||||++|||++|+.||......+. .....++........ . .
T Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~---~ 232 (284)
T cd06620 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------P---R 232 (284)
T ss_pred cccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC------C---C
Confidence 3567789999999888999999999999999999999999986443211 011112222111110 0 0
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
....+...++.+++.+||+.||++|||+.|++++..-++
T Consensus 233 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 233 -LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred -CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 011123346778888999999999999999998754444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=305.01 Aligned_cols=245 Identities=24% Similarity=0.451 Sum_probs=197.3
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
..+.||+|+||.||++...++..+++|.++........+.+|++++++++|+||+++++++.+ ...+++|||+++|+|.
T Consensus 10 ~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 88 (260)
T cd05073 10 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLL 88 (260)
T ss_pred EEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHH
Confidence 357899999999999998778889999987665556778899999999999999999999877 7789999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC-----CC
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP-----PT 504 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----~~ 504 (654)
+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.+........ ..
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~-i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 164 (260)
T cd05073 89 DFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN-YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK 164 (260)
T ss_pred HHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCC-ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCc
Confidence 9997532 235789999999999999999999988 99999999999999999999999999876543211 12
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
++..|+|||++....++.++|||||||++||+++ |+.||..... ..... ........ .....
T Consensus 165 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~------~~~~~-~~~~~~~~----------~~~~~ 227 (260)
T cd05073 165 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------PEVIR-ALERGYRM----------PRPEN 227 (260)
T ss_pred ccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH------HHHHH-HHhCCCCC----------CCccc
Confidence 2345999999988889999999999999999999 8999864321 11111 11111110 01122
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
...++.+++.+||+.+|++||++.++.+.|+++
T Consensus 228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 228 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 334677888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=311.98 Aligned_cols=257 Identities=21% Similarity=0.295 Sum_probs=193.0
Q ss_pred HHhhccccccCceeEEEEEecC---------------CcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEE
Q 036334 348 RASAEVLGKGSVGTSYKAVLEE---------------GTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFY 410 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~~---------------g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~ 410 (654)
+.+.+.||+|+||.||++...+ ...||+|.++... .....+.+|++++++++|+||+++++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 86 (295)
T cd05097 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVC 86 (295)
T ss_pred CeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence 3456789999999999987542 2358999987542 2235688999999999999999999999
Q ss_pred EeCCceEEEEEecCCCchhhhhccCCCC-------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC
Q 036334 411 YSKDEKLLVYDYMPAGSLSALLHGSRGS-------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD 483 (654)
Q Consensus 411 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~ 483 (654)
...+..++||||+++++|.+++...... ....+++..+++++.|++.||+|||+.+ ++||||||+||+++.+
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-i~H~dlkp~Nill~~~ 165 (295)
T cd05097 87 VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN-FVHRDLATRNCLVGNH 165 (295)
T ss_pred cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-eeccccChhhEEEcCC
Confidence 9999999999999999999998643110 1124789999999999999999999998 9999999999999999
Q ss_pred CCeEEeccCCCCCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCCCCCCCChh
Q 036334 484 HDACVSDFGLNPLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT--GKAPNQASLGEEGIDLP 555 (654)
Q Consensus 484 ~~~kl~Dfgla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t--g~~pf~~~~~~~~~~~~ 555 (654)
+.+||+|||++....... ...++..|+|||++.++.++.++|||||||++|||++ |..||......+ ..
T Consensus 166 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~~ 242 (295)
T cd05097 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---VI 242 (295)
T ss_pred CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---HH
Confidence 999999999987543221 1222456999999988889999999999999999998 566765432211 11
Q ss_pred HHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 556 RWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
.............. ...........+.+++.+||+.+|++|||+.+|++.|++
T Consensus 243 ~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 243 ENTGEFFRNQGRQI-------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHhhhhccccc-------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111000000000 000011122468888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=332.22 Aligned_cols=254 Identities=19% Similarity=0.294 Sum_probs=186.0
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCC------CccccccEEEEeC-CceEEE
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKH------DNVVPLRAFYYSK-DEKLLV 419 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~h------pniv~l~~~~~~~-~~~~lv 419 (654)
|.+.++||+|+||+||+|... .++.||||+++......+++..|++++++++| .++++++++|..+ .+.++|
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv 210 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIV 210 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEE
Confidence 345678999999999999864 57889999997654444556778877777654 4588898988765 468899
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCeecCCCCCCcEEECCCC--------------
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS-GKIVHGNIKASNILLRPDH-------------- 484 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~ivHrDlk~~NIll~~~~-------------- 484 (654)
||++ +++|.+++.. ...+++..+..++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 211 ~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~g-IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 211 MPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHTELH-LMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred Eecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCC-eecCCCCHHHEEEecCCcccccccccccCCC
Confidence 9988 7788888863 34589999999999999999999974 6 99999999999998765
Q ss_pred --CeEEeccCCCCCcCCC-CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH
Q 036334 485 --DACVSDFGLNPLFGNT-TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSV 561 (654)
Q Consensus 485 --~~kl~Dfgla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~ 561 (654)
.+||+|||.+...... ....++..|+|||++.+..++.++|||||||++|||++|+.||......+. ...+...
T Consensus 284 ~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~---~~~i~~~ 360 (467)
T PTZ00284 284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH---LHLMEKT 360 (467)
T ss_pred CceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHH
Confidence 4999999987654322 345678889999999999999999999999999999999999976432211 1111111
Q ss_pred h---hhchh--------hhhh----------hHh-h---hccCChH--HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 562 V---REEWT--------AEVF----------DVE-L---MRYHNIE--EEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 562 ~---~~~~~--------~~~~----------~~~-~---~~~~~~~--~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
. ...+. ...+ ++. + ....... .....+.+|+.+||+.||++|||++|+++
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0 00000 0000 000 0 0000000 01234678999999999999999999987
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=306.63 Aligned_cols=245 Identities=24% Similarity=0.427 Sum_probs=195.0
Q ss_pred hhccccccCceeEEEEEecC-C---cEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLEE-G---TTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~-g---~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.+.||+|+||.||+|.... + ..||+|.++... ....+|..|+.++++++||||+++++++.+++..++||||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 87 (269)
T cd05065 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFM 87 (269)
T ss_pred EEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecC
Confidence 45789999999999998653 3 369999987542 23457889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC-
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP- 502 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~- 502 (654)
++|+|.+++... ...+++.+++.++.|++.|++|||+++ ++||||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~g-~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 88 ENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEMN-YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred CCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 999999998743 235899999999999999999999998 99999999999999999999999999876543211
Q ss_pred ------CC--ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 503 ------PT--RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 503 ------~~--~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
.. .+..|+|||.+.+..++.++|||||||++||+++ |..||...... .....+ ...+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~------~~~~~i-~~~~------- 228 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------DVINAI-EQDY------- 228 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH------HHHHHH-HcCC-------
Confidence 01 1235999999998899999999999999999887 99998643211 111111 1110
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
......+....+.+++.+||+.+|++||++++++..|+++
T Consensus 229 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ---RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011122334577888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=301.31 Aligned_cols=241 Identities=27% Similarity=0.389 Sum_probs=195.7
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccc---ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV---AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.||+|+||.||+|... +++.|++|.+... .....++.+|++++++++||||+++++++.+++..++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG 84 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence 467999999999999865 5889999998643 233567888999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----C
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT----P 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~ 502 (654)
+|.+++.... ...+++..+++++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....... .
T Consensus 85 ~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~-i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 85 DLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK-ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred cHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9999997532 346899999999999999999999988 9999999999999999999999999987654332 2
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..++..|+|||++.+..++.++|||||||++|||++|+.||..... ........... . .....
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~----------~~~~~ 223 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ------GALILKIIRGV-F----------PPVSQ 223 (256)
T ss_pred cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC-C----------CCCcc
Confidence 2455679999999998999999999999999999999999975321 11111111110 0 00111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 234567888889999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=305.53 Aligned_cols=243 Identities=23% Similarity=0.391 Sum_probs=190.8
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEEEeC------CceEEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSK------DEKLLVY 420 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~------~~~~lv~ 420 (654)
...+.||+|+||.||+|... +++.||+|++........++..|+.++.++ +|+||+++++++... ...++||
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 88 (272)
T cd06637 9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 88 (272)
T ss_pred hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEE
Confidence 44577999999999999864 578999999976666667788999999998 699999999998753 3578999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+++|+|.+++...+ ...+++..+..++.|++.|++|||+++ |+||||||+||++++++.+||+|||++......
T Consensus 89 e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~-ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 89 EFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred EcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 9999999999987532 345899999999999999999999998 999999999999999999999999998765322
Q ss_pred ----CCCCccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhh
Q 036334 501 ----TPPTRVAGYRAPEVVE-----TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571 (654)
Q Consensus 501 ----~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 571 (654)
....++..|+|||++. ...++.++|||||||++|||++|+.||....... ... .... ..
T Consensus 165 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~-~~~~-~~----- 232 (272)
T cd06637 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALF-LIPR-NP----- 232 (272)
T ss_pred cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHH-HHhc-CC-----
Confidence 2234566799999986 3468889999999999999999999986432110 000 0000 00
Q ss_pred hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 572 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
... ........++.+++.+||..+|.+|||+.|+++
T Consensus 233 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 APR----LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCC----CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 001112345778888999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=302.81 Aligned_cols=242 Identities=25% Similarity=0.395 Sum_probs=196.6
Q ss_pred HhhccccccCceeEEEEEecC-CcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
...+.||+|+||.||+|...+ +..|++|.+..... ..++.+|++++++++||||+++++++.++...++++||+++++
T Consensus 6 ~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 84 (256)
T cd06612 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84 (256)
T ss_pred hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCc
Confidence 345779999999999999765 78999999876543 6789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----CC
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT----PP 503 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~~ 503 (654)
|.+++... ...+++..++.++.|++.|+.|||+.+ ++||||+|+||+++.++.+||+|||++....... ..
T Consensus 85 L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~-i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (256)
T cd06612 85 VSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHSNK-KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV 159 (256)
T ss_pred HHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCcceEEECCCCcEEEcccccchhcccCccccccc
Confidence 99998642 346899999999999999999999988 9999999999999999999999999988664432 23
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.++..|+|||++.+..++.++||||||+++|||++|+.||......+.. ... ... .. ........
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~~~-~~~-~~-------~~~~~~~~ 224 (256)
T cd06612 160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------FMI-PNK-PP-------PTLSDPEK 224 (256)
T ss_pred cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------hhh-ccC-CC-------CCCCchhh
Confidence 3566799999998889999999999999999999999998753322110 000 000 00 00111122
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
....+.+++.+||+.+|++|||+.|+++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 2346778888999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=326.63 Aligned_cols=242 Identities=21% Similarity=0.293 Sum_probs=187.7
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||+|... +++.||||++.... .....+.+|++++++++||||+++++.+.+++..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (376)
T cd05598 5 KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (376)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCC
Confidence 3578999999999999854 58899999987542 223567889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC-----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN----- 499 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~----- 499 (654)
+|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+..
T Consensus 85 ~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~-ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 85 GGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHKMG-FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999999973 345889999999999999999999998 99999999999999999999999999753210
Q ss_pred ------------------------------------------CCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHH
Q 036334 500 ------------------------------------------TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELL 537 (654)
Q Consensus 500 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~ 537 (654)
.....++..|||||++.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 00124677899999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCC---CHHHHHHH
Q 036334 538 TGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRP---AMQEVVRM 612 (654)
Q Consensus 538 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~~evl~~ 612 (654)
+|+.||...... .....+... .... ......... .++.+++.+|+ .+|++|+ ++.|+++.
T Consensus 239 ~G~~Pf~~~~~~------~~~~~i~~~--~~~~---~~~~~~~~s---~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTPA------ETQLKVINW--ETTL---HIPSQAKLS---REASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCHH------HHHHHHhcc--Cccc---cCCCCCCCC---HHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999754321 111111110 0000 000011112 23445555665 4999999 88888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=321.44 Aligned_cols=243 Identities=20% Similarity=0.307 Sum_probs=192.3
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||+||++... +|+.||+|+++.... ....+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (330)
T cd05601 5 VKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQP 84 (330)
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCC
Confidence 3578999999999999854 588999999976532 34567889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~-i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 85 GGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQMG-YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 99999999743 245899999999999999999999998 9999999999999999999999999997654322
Q ss_pred --CCCccccccCccccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 502 --PPTRVAGYRAPEVVE------TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 502 --~~~~~~~y~aPE~~~------~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
...++..|+|||++. ...++.++|||||||++|||++|+.||..... ...+..+.......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~----- 228 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------AKTYNNIMNFQRFL----- 228 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------HHHHHHHHcCCCcc-----
Confidence 235677899999986 45678999999999999999999999975322 11122221111000
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
..........++.+++..|+. +|++||+++++++.
T Consensus 229 ---~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 ---KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 001111122346667778997 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=303.91 Aligned_cols=241 Identities=21% Similarity=0.297 Sum_probs=192.5
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc------CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV------GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
..+.||+|++|.||++... ++..||+|.++.... ....+.+|++++++++||||+++++++.+++..++|+||
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 4578999999999999854 589999999865422 124578899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 500 (654)
+++++|.+++.. ...+++..+.+++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||++......
T Consensus 86 ~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 86 MPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred CCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 999999999873 345889999999999999999999998 999999999999999999999999998755332
Q ss_pred -----CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 501 -----TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 501 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
....++..|+|||++.+..++.++||||+|+++|||++|+.||...... ..+.........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~-------- 225 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPTN-------- 225 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCCC--------
Confidence 1223455699999999888999999999999999999999998643211 111111111100
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
..........+.+++.+||..+|++|||+.++++.
T Consensus 226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 --PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01111223456778889999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=316.57 Aligned_cols=233 Identities=23% Similarity=0.279 Sum_probs=184.5
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCC-ccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHD-NVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hp-niv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.+.||+|+||.||+|... .++.||+|+++... ...+.+..|++++..+.|+ +|+++++++.+.+..|+||||+
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (324)
T cd05587 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (324)
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCC
Confidence 3578999999999999865 47789999997542 2335577888889888765 5888999999889999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
++|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 84 NGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHSKG-IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred CCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 99999999863 345889999999999999999999998 999999999999999999999999998643211
Q ss_pred -CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 -TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....++..|+|||++.+..++.++||||+||++|||++|+.||..... ......+..... . ..
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i~~~~~-------~--~~- 221 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------DELFQSIMEHNV-------S--YP- 221 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC-------C--CC-
Confidence 223467889999999999999999999999999999999999975321 111111111100 0 01
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAM 606 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~ 606 (654)
.....++.+++.+||..||.+|++.
T Consensus 222 --~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 --KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1122356678889999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=306.96 Aligned_cols=247 Identities=24% Similarity=0.373 Sum_probs=194.1
Q ss_pred hccccccCceeEEEEEec------CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 351 AEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+.||+|+||.||++... ++..+++|.++... .....+.+|++++++++|+||+++++++.+....++||||+
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM 89 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence 578999999999999632 35689999887543 33467899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCC
Q 036334 424 PAGSLSALLHGSRGS----------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL 493 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgl 493 (654)
++|+|.+++...... ....+++..++.++.|++.|++|||+.+ ++||||||+||++++++.+||+|||+
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-i~H~dlkp~nil~~~~~~~kL~dfg~ 168 (280)
T cd05092 90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH-FVHRDLATRNCLVGQGLVVKIGDFGM 168 (280)
T ss_pred CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC-eecccccHhhEEEcCCCCEEECCCCc
Confidence 999999998754210 1135899999999999999999999988 99999999999999999999999999
Q ss_pred CCCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhch
Q 036334 494 NPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEW 566 (654)
Q Consensus 494 a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 566 (654)
+...... .....+..|+|||.+.+..++.++|||||||++|||++ |..||...... ..+........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~~~~ 242 (280)
T cd05092 169 SRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT------EAIECITQGRE 242 (280)
T ss_pred eeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH------HHHHHHHcCcc
Confidence 8654322 11223456999999998899999999999999999998 89998643221 11111111100
Q ss_pred hhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 567 TAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
..........+.+++.+||+.||++||+++||++.|++
T Consensus 243 -----------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 243 -----------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 00011122456788889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=308.07 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=195.2
Q ss_pred hhccccccCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
..+.||+|+||.||+|... ++..||+|+++.... ...++.+|+.++++++||||+++++++.++...++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (288)
T cd05050 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFE 88 (288)
T ss_pred ecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEe
Confidence 4567999999999999853 467899999875432 34568899999999999999999999999899999999
Q ss_pred ecCCCchhhhhccCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC
Q 036334 422 YMPAGSLSALLHGSRG-----------------SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH 484 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~ 484 (654)
|+++|+|.+++..... .....+++..++.++.|++.||+|||.++ ++||||||+||+++.++
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~-i~H~dl~p~nil~~~~~ 167 (288)
T cd05050 89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK-FVHRDLATRNCLVGENM 167 (288)
T ss_pred cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-eecccccHhheEecCCC
Confidence 9999999999964321 11235789999999999999999999998 99999999999999999
Q ss_pred CeEEeccCCCCCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHH
Q 036334 485 DACVSDFGLNPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRW 557 (654)
Q Consensus 485 ~~kl~Dfgla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~ 557 (654)
.++|+|||++...... .....+..|+|||.+.+..++.++|||||||++|||++ |..||..... ...
T Consensus 168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~------~~~ 241 (288)
T cd05050 168 VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH------EEV 241 (288)
T ss_pred ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHH
Confidence 9999999998754322 11223446999999988899999999999999999998 8888854321 111
Q ss_pred HHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 558 VQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
..... ..... ........++.+++.+||+.+|++|||+.|+++.|++
T Consensus 242 ~~~~~-~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 242 IYYVR-DGNVL----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHh-cCCCC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 21111 11000 0011223467888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.85 Aligned_cols=191 Identities=28% Similarity=0.368 Sum_probs=165.4
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
..++||+|+||+||+|... +++.||+|++..... ....+.+|++++++++||||+++++++.+++..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 3478999999999999854 578999999875422 23467889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 85 gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~~~-ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 85 GGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHKMG-FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 99999998732 35889999999999999999999998 999999999999999999999999997532100
Q ss_pred -----------------------------------------------CCCCccccccCccccCCCCCCcchhHHHHHHHH
Q 036334 501 -----------------------------------------------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLL 533 (654)
Q Consensus 501 -----------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil 533 (654)
....++..|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 112467789999999999999999999999999
Q ss_pred HHHHhCCCCCCCC
Q 036334 534 LELLTGKAPNQAS 546 (654)
Q Consensus 534 ~el~tg~~pf~~~ 546 (654)
|||++|+.||...
T Consensus 239 ~elltG~~Pf~~~ 251 (382)
T cd05625 239 YEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=309.55 Aligned_cols=241 Identities=23% Similarity=0.352 Sum_probs=193.6
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
..+.||+|+||.||+|.. .++..|++|.+.... .....+.+|+.+++.++|+||+++++.+..+...++||||+++++
T Consensus 24 ~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~ 103 (296)
T cd06654 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (296)
T ss_pred eEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCC
Confidence 346799999999999985 468899999987543 334668889999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CCC
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPP 503 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~ 503 (654)
|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 104 L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~g-i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 176 (296)
T cd06654 104 LTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (296)
T ss_pred HHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEcCCCCEEECccccchhccccccccCcc
Confidence 9999863 34789999999999999999999998 999999999999999999999999998755332 123
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.++..|+|||.+.+..++.++|||||||++|||++|+.||....... .+.. ...... . .......
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----~~~~-~~~~~~-~--------~~~~~~~ 241 (296)
T cd06654 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALYL-IATNGT-P--------ELQNPEK 241 (296)
T ss_pred cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----hHHH-HhcCCC-C--------CCCCccc
Confidence 55667999999988889999999999999999999999996533211 1111 110000 0 0011122
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
....+.+++.+||..+|++||++.|+++.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 33457788889999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.23 Aligned_cols=245 Identities=31% Similarity=0.515 Sum_probs=193.3
Q ss_pred hhccccccCceeEEEEEecC-CcEEEEEEecccccCHHH---HHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKRE---FEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~---~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
..+.||+|+||+||++.... ++.||+|++......... ..+|+.++++++||||+++++++.+....++||||+++
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 82 (260)
T PF00069_consen 3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPG 82 (260)
T ss_dssp EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccc
Confidence 35789999999999999664 668999999876543333 34589999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCc----CCCC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF----GNTT 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~----~~~~ 501 (654)
++|.+++.. ...+++..++.++.|+++||++||+++ |+|+||||+||++++++.++|+|||.+... ....
T Consensus 83 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~~-i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 83 GSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSKG-IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp EBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHTT-EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred ccccccccc-----ccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc
Confidence 999999972 345899999999999999999999998 999999999999999999999999998753 1223
Q ss_pred CCCccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 502 PPTRVAGYRAPEVVE-TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
...++..|+|||++. +..++.++||||+|+++|+|++|..||......+ ....+....... ..... ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~~~-----~~~~~---~~ 225 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD---QLEIIEKILKRP-----LPSSS---QQ 225 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH---HHHHHHHHHHTH-----HHHHT---TS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchh---hhhhhhhccccc-----ccccc---cc
Confidence 345667799999998 8889999999999999999999999997541100 111111111100 00000 00
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.......+.+++.+||+.||++||++.++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111257888888999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=304.07 Aligned_cols=245 Identities=24% Similarity=0.440 Sum_probs=195.4
Q ss_pred hhccccccCceeEEEEEec----CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE----EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.+.||+|+||.||+|... .+..+|+|.++.... ..+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (267)
T cd05066 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYM 87 (267)
T ss_pred eeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence 4578999999999999853 234799999875432 2457889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC-
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP- 502 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~- 502 (654)
++++|.+++... ...+++.+++.++.|++.|++|||+.+ ++||||||+||+++.++.++++|||++........
T Consensus 88 ~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 88 ENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSDMG-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-EeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 999999999743 235899999999999999999999998 99999999999999999999999999876543221
Q ss_pred ------CCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 503 ------PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 503 ------~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
...+..|+|||.+.+..++.++|||||||++||+++ |..||......+ . ...+. ....
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~---~~~~~-~~~~-------- 227 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---V---IKAIE-EGYR-------- 227 (267)
T ss_pred eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---H---HHHHh-CCCc--------
Confidence 112346999999998899999999999999999887 999986532211 1 11111 1110
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
..........+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 --LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 001112234567888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=315.20 Aligned_cols=237 Identities=25% Similarity=0.361 Sum_probs=194.9
Q ss_pred ccccccCceeEEEEEe-cCCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 352 EVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+-||.|+||.||.|+. .+.+.||||++.-.. ..-.++.+|+.+|++++|||++.+.|+|..+...||||||| -|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence 5599999999999994 457889999985331 12356889999999999999999999999999999999999 56
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCCCCcc
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV 506 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 506 (654)
+-.|++.-. +.++.+.++..|+.+.+.||+|||+.+ .||||||+.|||+++.|.|||+|||.|....+.....||
T Consensus 111 SAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~~-~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvGT 185 (948)
T KOG0577|consen 111 SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN-RIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFVGT 185 (948)
T ss_pred cHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHhh-HHhhhccccceEecCCCeeeeccccchhhcCchhcccCC
Confidence 878877643 457899999999999999999999998 999999999999999999999999999999998899999
Q ss_pred ccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 507 AGYRAPEVVE---TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 507 ~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
+.|||||+|. .+.|+-|+||||+||+..||...++|+..+.. ...+..+-..+ .. .-...+
T Consensus 186 PywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYHIAQNe-------sP---tLqs~e 249 (948)
T KOG0577|consen 186 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE-------SP---TLQSNE 249 (948)
T ss_pred ccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHHHHhcC-------CC---CCCCch
Confidence 9999999984 57899999999999999999999999754321 11111111111 00 112345
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVV 610 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl 610 (654)
+...+..++..|+++-|.+|||.++++
T Consensus 250 WS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 250 WSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred hHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 556677788899999999999999874
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.69 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=196.1
Q ss_pred HHhhccccccCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEE
Q 036334 348 RASAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 419 (654)
+.+.+.||+|+||.||+|..+ .+..||+|.++.... ...++.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (288)
T cd05061 8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 87 (288)
T ss_pred ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 345678999999999999743 245799998865432 234577899999999999999999999999999999
Q ss_pred EEecCCCchhhhhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCC
Q 036334 420 YDYMPAGSLSALLHGSRG-----SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN 494 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla 494 (654)
|||+++|+|.+++..... ......++..+.+++.|++.||.|||+++ |+||||||+||++++++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~H~dikp~nili~~~~~~~L~Dfg~~ 166 (288)
T cd05061 88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMT 166 (288)
T ss_pred EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcCCCCChheEEEcCCCcEEECcCCcc
Confidence 999999999999974321 11345678889999999999999999998 999999999999999999999999998
Q ss_pred CCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchh
Q 036334 495 PLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWT 567 (654)
Q Consensus 495 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 567 (654)
....... ...++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+....+......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~~~ 240 (288)
T cd05061 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------EQVLKFVMDGGYL 240 (288)
T ss_pred ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCCC
Confidence 7543221 1122456999999998899999999999999999998 7888864321 1111111111100
Q ss_pred hhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 568 AEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
.........+.+++.+||+.||++|||+.++++.|++..
T Consensus 241 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 241 -----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 011122346788888999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=314.02 Aligned_cols=243 Identities=23% Similarity=0.340 Sum_probs=200.9
Q ss_pred HhhccccccCceeEEEEEecC-CcEEEEEEeccccc----CHHHHHHHHHHHhccC-CCccccccEEEEeCCceEEEEEe
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAV----GKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
.+.+.||+|.||.||++..+. |+.+|+|.+++... ....+.+|+++|+++. |||||.+.++|++....++|||+
T Consensus 38 ~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL 117 (382)
T KOG0032|consen 38 ELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMEL 117 (382)
T ss_pred EehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEe
Confidence 345779999999999999665 99999999977643 3468899999999998 99999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC----CCeEEeccCCCCCcC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD----HDACVSDFGLNPLFG 498 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~----~~~kl~Dfgla~~~~ 498 (654)
+.||.|.+.+... .+++..+..++.|++.+++|||+.+ |+||||||+|+|+... +.+|++|||++.+..
T Consensus 118 ~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g-vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 118 CEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG-VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred cCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999743 2899999999999999999999998 9999999999999654 479999999999887
Q ss_pred CC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 499 NT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 499 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
.. ....|++.|+|||++....|+..+||||+||++|.|++|..||.+...... ...+....+ +...
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~------~~~i~~~~~-----~f~~ 259 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI------FLAILRGDF-----DFTS 259 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH------HHHHHcCCC-----CCCC
Confidence 63 346788999999999999999999999999999999999999987543221 112222222 2222
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
..+....+.+ -+++..|+..||..|+|+.++++.
T Consensus 260 ~~w~~is~~a---kd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 260 EPWDDISESA---KDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCccccCHHH---HHHHHHhcccCcccCCCHHHHhcC
Confidence 2333334444 445669999999999999999984
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=305.90 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=198.2
Q ss_pred hhccccccCceeEEEEEec-----CCcEEEEEEecccccC--HHHHHHHHHHHhccCCCccccccEEEEe--CCceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-----EGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNVVPLRAFYYS--KDEKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~lv~ 420 (654)
..+.||+|+||.||++.+. .+..||||+++..... ..++.+|+++++++.||||+++++++.. ....++||
T Consensus 8 ~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 87 (284)
T cd05038 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIM 87 (284)
T ss_pred hheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEE
Confidence 3478999999999999853 3678999999876553 6789999999999999999999999887 55789999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||.+......
T Consensus 88 e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 88 EYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQR-YIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred ecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 9999999999997432 25899999999999999999999998 999999999999999999999999998876532
Q ss_pred CC-------CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCC--------ChhHHHHHHhhhc
Q 036334 501 TP-------PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGI--------DLPRWVQSVVREE 565 (654)
Q Consensus 501 ~~-------~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~--------~~~~~~~~~~~~~ 565 (654)
.. ......|+|||.+.+..++.++||||||+++|||++|+.|+......... .....+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC
Confidence 11 12234599999998888999999999999999999999998653221100 0000000111100
Q ss_pred hhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 566 WTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
. .......+..++.+++.+||+.+|++||++.||+++|+++
T Consensus 243 ~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 243 E----------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred C----------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0 0111122235688899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=313.06 Aligned_cols=253 Identities=19% Similarity=0.319 Sum_probs=189.4
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
..+.||+|+||.||+|... +++.||+|+++... .....+.+|++++++++||||+++++++..++..++||||+++
T Consensus 10 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 88 (309)
T cd07872 10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK- 88 (309)
T ss_pred EEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-
Confidence 3477999999999999865 57889999987542 2334677899999999999999999999999999999999975
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TP 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~ 502 (654)
+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 89 ~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~-ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (309)
T cd07872 89 DLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHRRK-VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163 (309)
T ss_pred CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence 888877643 235889999999999999999999998 999999999999999999999999998754322 12
Q ss_pred CCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh----chh-----hhhhh
Q 036334 503 PTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE----EWT-----AEVFD 572 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~-----~~~~~ 572 (654)
..++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.. ..+...... .|. ....+
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL---HLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 345677999998865 56889999999999999999999999764332111 111111000 000 00000
Q ss_pred HhhhccC------ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 573 VELMRYH------NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 573 ~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
....... .......++.+++.+|++.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000 00111234667888999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.72 Aligned_cols=246 Identities=22% Similarity=0.353 Sum_probs=192.6
Q ss_pred HHHhhccccccCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 347 LRASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 347 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
.+.+.+.||+|+||.||+|... ++..+++|.+.... .....+.+|+++++.++||||+++++++..++..++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3556688999999999999965 47788999886542 234568889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+++|..++... ..++++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~-i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 86 GGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENK-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred CCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 99999988632 246899999999999999999999998 999999999999999999999999998654322
Q ss_pred CCCCccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 501 TPPTRVAGYRAPEVVE-----TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
....++..|+|||++. +..++.++|||||||++|||++|+.||..... ...+......... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~~------~~ 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEPP------TL 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHhhcCCC------CC
Confidence 2234567799999984 34578899999999999999999999864321 1111111111100 00
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
........++.+++.+||+.+|++||++.++++.
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 ---AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011122456778889999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=321.48 Aligned_cols=243 Identities=19% Similarity=0.266 Sum_probs=191.2
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+.+.||+|+||.||++... +++.||+|++.... .....+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 46 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05596 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYM 125 (370)
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCC
Confidence 44578999999999999865 58899999996532 22345778999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
++|+|.+++.. ..++...+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 126 ~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 126 PGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred CCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 99999999863 24788889999999999999999998 999999999999999999999999998765432
Q ss_pred --CCCCccccccCccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 501 --TPPTRVAGYRAPEVVETR----KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~~----~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
....+++.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.......
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~~------ 266 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKNSL------ 266 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCcC------
Confidence 234577889999998653 478999999999999999999999975321 11122222111000
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQ--RPAMQEVVRM 612 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 612 (654)
..........++.+++.+|++.+|++ |++++|+++.
T Consensus 267 --~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 --TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00111112345667778999999987 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=307.37 Aligned_cols=243 Identities=27% Similarity=0.338 Sum_probs=191.6
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccccC----HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG----KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.++||+|+||.||++... +++.||+|.+...... ...+..|+.++++++|+||+++++.+.+.+..++||||+++
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 467999999999999855 5889999998654321 23467799999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---P 502 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~ 502 (654)
++|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 85 ~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~-iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 85 GDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred CcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC-EEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 99999886432 235899999999999999999999988 9999999999999999999999999987654322 2
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..++..|+|||++.+..++.++|||||||++|||++|+.||........ .......... .. .. ...
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~---~~~~~~~~~~-----~~-~~-----~~~ 226 (285)
T cd05630 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERLVKE-----VQ-EE-----YSE 226 (285)
T ss_pred CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch---HHHHHhhhhh-----hh-hh-----cCc
Confidence 3567789999999988999999999999999999999999975322110 0001111000 00 00 011
Q ss_pred HHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPA-----MQEVVR 611 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 611 (654)
....++.+++.+||+.||++||| ++|+++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 12235677888999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.94 Aligned_cols=233 Identities=24% Similarity=0.301 Sum_probs=184.4
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.+.||+|+||.||+|... +++.||+|+++.... ..+.+..|..++..+ +|++|+++++++.+.+..++||||+
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (323)
T cd05616 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (323)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCC
Confidence 3477999999999999865 478999999876421 223456677777766 5899999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 84 NGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred CCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 99999999863 245899999999999999999999998 999999999999999999999999998754321
Q ss_pred -CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 -TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... .
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~------~~~~~~i~~~~~------------~ 219 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNV------------A 219 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC------------C
Confidence 234567889999999999999999999999999999999999975322 111122111110 0
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAM 606 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~ 606 (654)
.......++.+++.+|++.||++|++.
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 011123356778889999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.04 Aligned_cols=253 Identities=21% Similarity=0.259 Sum_probs=188.3
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
.+.+.||+|+||.||++... .++.||||... ...+.+|++++++++|+|||++++++..++..++|||++. ++
T Consensus 172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~ 245 (461)
T PHA03211 172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SD 245 (461)
T ss_pred EEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CC
Confidence 44578999999999999965 47889999632 2345789999999999999999999999999999999995 68
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC------
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT------ 501 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~------ 501 (654)
|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 246 L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~g-IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 246 LYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIHGEG-IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-EEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 88888632 236999999999999999999999998 9999999999999999999999999987653321
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CCCCCChhHHHHHHhhhchh-hhhh--------
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASL-GEEGIDLPRWVQSVVREEWT-AEVF-------- 571 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~-------- 571 (654)
...++..|+|||++.+..++.++|||||||++|||++|..|+.... ..........+.+++..... ...+
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 2346788999999999999999999999999999999877653322 11111111112222111000 0000
Q ss_pred hHhh-------hc-------cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 572 DVEL-------MR-------YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 572 ~~~~-------~~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
...+ .. +.........+.+|+.+||+.||.+|||+.|+++.
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 00 00000111256778889999999999999999874
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=315.91 Aligned_cols=245 Identities=19% Similarity=0.229 Sum_probs=186.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||+||++... +++.||+|++.... .....+.+|+.++..++|+||+++++++.+++..|+||||++
T Consensus 5 i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~ 84 (331)
T cd05624 5 IIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYV 84 (331)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 4578999999999999965 57889999987532 123447788999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
+|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~~~-iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 85 GGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLH-YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred CCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 99999999742 235899999999999999999999998 9999999999999999999999999987654322
Q ss_pred --CCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 502 --PPTRVAGYRAPEVVET-----RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 502 --~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
...++..|+|||++.+ +.++.++|||||||++|||++|+.||..... ......+...... ..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~-----~~ 228 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEER-----FQ 228 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCc-----cc
Confidence 2346788999999865 4678999999999999999999999964321 1112222111100 00
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQ--RPAMQEVVRM 612 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 612 (654)
..........++.+++.+|+..++.+ |++++++++.
T Consensus 229 --~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 --FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00111112234556667888765543 5688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=299.27 Aligned_cols=242 Identities=26% Similarity=0.419 Sum_probs=194.7
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
++||+|+||.||++...+++.|++|.++.... ....+.+|++++++++|+||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999977799999999876543 3457889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC------C
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP------P 503 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~------~ 503 (654)
+++... ...+++..++.++.+++.+++|||+++ ++||||||+||+++.++.+||+|||.+........ .
T Consensus 81 ~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~~~-i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESKN-CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998643 235789999999999999999999888 99999999999999999999999999876542211 1
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..+..|+|||.+.+..++.++|||||||++|||++ |..||...... ... ....... ......
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~------~~~-~~~~~~~----------~~~~~~ 218 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ------QTR-ERIESGY----------RMPAPQ 218 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH------HHH-HHHhcCC----------CCCCCc
Confidence 12345999999988899999999999999999999 78888643211 111 1111100 001112
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
.....+.+++.+||..+|++||++.|+++.|+.
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 223467888889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=329.01 Aligned_cols=255 Identities=18% Similarity=0.253 Sum_probs=183.9
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeC--------CceEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK--------DEKLLV 419 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--------~~~~lv 419 (654)
.+.++||+|+||.||+|... .++.||||++.... ....+|+.++++++||||+++++++... ...++|
T Consensus 69 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence 34678999999999999964 58899999885432 2345799999999999999999987532 135799
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC-CeEEeccCCCCCcC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH-DACVSDFGLNPLFG 498 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~-~~kl~Dfgla~~~~ 498 (654)
|||+++ +|.+++..... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||++....
T Consensus 146 mE~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~-IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~ 222 (440)
T PTZ00036 146 MEFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222 (440)
T ss_pred EecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence 999975 77766643211 2346899999999999999999999998 99999999999999765 69999999998664
Q ss_pred CC---CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhh--hhh
Q 036334 499 NT---TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAE--VFD 572 (654)
Q Consensus 499 ~~---~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 572 (654)
.. ....++..|+|||++.+ ..++.++|||||||++|||++|.+||......+. +.. +........... ...
T Consensus 223 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~-i~~~~~~p~~~~~~~~~ 299 (440)
T PTZ00036 223 AGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVR-IIQVLGTPTEDQLKEMN 299 (440)
T ss_pred CCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCCCHHHHHHhc
Confidence 32 22345777999999865 4689999999999999999999999976432210 111 111100000000 000
Q ss_pred Hhh-----hc-------cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 573 VEL-----MR-------YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 573 ~~~-----~~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
+.. .. .........++.+++.+||..||.+|||+.|+++.
T Consensus 300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000 00 00001122457788889999999999999999854
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.42 Aligned_cols=246 Identities=27% Similarity=0.425 Sum_probs=193.4
Q ss_pred ccccccCceeEEEEEecC-------CcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 352 EVLGKGSVGTSYKAVLEE-------GTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~-------g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
+.||+|+||.||+|...+ +..+++|.+.... ....++.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 358999999999998643 2579999886543 3456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC-----CeEEeccCCCC
Q 036334 423 MPAGSLSALLHGSRGS--GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH-----DACVSDFGLNP 495 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~-----~~kl~Dfgla~ 495 (654)
+++++|.+++...... ....+++.+++.++.|++.|++|||+.+ ++|+||||+||+++.++ .++++|||++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH-FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC-cccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 9999999999743211 2234789999999999999999999988 99999999999999887 89999999987
Q ss_pred CcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 496 LFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 496 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
..... .....+..|+|||++.+..++.++|||||||++|||++ |+.||..... ......+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~------~~~~~~~~~~~--- 230 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN------QEVLQHVTAGG--- 230 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH------HHHHHHHhcCC---
Confidence 54322 11223456999999999999999999999999999998 9999864321 11111111100
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
...........+.+++.+||+.+|++||+++++++.|++
T Consensus 231 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 --------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 001111223467788889999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.23 Aligned_cols=245 Identities=19% Similarity=0.231 Sum_probs=186.7
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.++||+|+||.||++... .++.||+|++.+.. .....+..|+.++..++|+||+++++++.+++..++||||++
T Consensus 5 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~ 84 (332)
T cd05623 5 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYV 84 (332)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccC
Confidence 3578999999999999965 47789999986532 223447788999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 85 ~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~-iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 85 GGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLH-YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred CCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 99999999742 235899999999999999999999998 999999999999999999999999998654322
Q ss_pred -CCCCccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 501 -TPPTRVAGYRAPEVVE-----TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
....++..|+|||++. ...++.++|||||||++|||++|+.||.... .......+....... .
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~-----~ 228 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERF-----Q 228 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCccc-----c
Confidence 1235678899999986 3468899999999999999999999997532 222222222111000 0
Q ss_pred hhccCChHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHH
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVST--VPDQRPAMQEVVRM 612 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~--dP~~RPs~~evl~~ 612 (654)
..........++.+++.+|+.. ++..|++++|+++.
T Consensus 229 --~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 --FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0011111223455566676654 44447899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=287.19 Aligned_cols=242 Identities=23% Similarity=0.377 Sum_probs=192.3
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccccC---------HHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEE
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---------KREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---------~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv 419 (654)
.+.||+|..+.|.++..+ .|..+|+|++...... .+.-.+|+.+|+++ .||+|+.+.+++..+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 467999999999888754 5889999998644221 13345688999888 599999999999999999999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
+|.|+.|.|.|+|. ....+++....+|+.|+..|++|||.+. ||||||||+|||++++.++||+|||+|..+..
T Consensus 102 Fdl~prGELFDyLt-----s~VtlSEK~tR~iMrqlfegVeylHa~~-IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 102 FDLMPRGELFDYLT-----SKVTLSEKETRRIMRQLFEGVEYLHARN-IVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhcccchHHHHhh-----hheeecHHHHHHHHHHHHHHHHHHHHhh-hhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999997 3567999999999999999999999987 99999999999999999999999999998876
Q ss_pred CC---CCCccccccCccccCC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhh
Q 036334 500 TT---PPTRVAGYRAPEVVET------RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEV 570 (654)
Q Consensus 500 ~~---~~~~~~~y~aPE~~~~------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 570 (654)
.. ...||++|+|||.+.. ..|+..+|+||+|||||-|+.|.+||.-... -.+..++.+ ..
T Consensus 176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR~Ime----Gk 244 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLRMIME----GK 244 (411)
T ss_pred chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHHHHHh----cc
Confidence 53 4689999999999853 3588899999999999999999999863210 001111111 11
Q ss_pred hhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 571 FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 571 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
+......+....+. .-+|+.+|++.||++|.|++|+++.
T Consensus 245 yqF~speWadis~~---~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 245 YQFRSPEWADISAT---VKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cccCCcchhhcccc---HHHHHHHHHeeCchhcccHHHHhcC
Confidence 11121223333333 4456669999999999999999864
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=318.62 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=189.4
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCC-----ceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD-----EKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-----~~~lv~ 420 (654)
..+.||+|+||.||++.. .+|+.||+|++.... ...+++.+|+++++.++||||+++++++...+ ..++||
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 347799999999999995 468999999986542 23456788999999999999999999998776 789999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+. ++|.+.+.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 84 e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 84 ELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSAG-ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred eccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9996 578887752 345899999999999999999999998 999999999999999999999999998765322
Q ss_pred -----CCCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhch--------
Q 036334 501 -----TPPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEW-------- 566 (654)
Q Consensus 501 -----~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 566 (654)
....++..|+|||++.+. .++.++||||+||++|||++|+.||......+. ...+........
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ---LDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHHHhh
Confidence 123456679999998764 578999999999999999999999976432211 111111000000
Q ss_pred ---hhhhhhHh-----hh-ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 567 ---TAEVFDVE-----LM-RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 567 ---~~~~~~~~-----~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
........ .. ......+...++.+++.+|++.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 00 000001113456788889999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.80 Aligned_cols=241 Identities=23% Similarity=0.353 Sum_probs=194.3
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+...+.||+|+||.||+|... ++..||+|.++... ...+.+.+|++++++++||||+++++++..+...++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 344577999999999999854 57889999987443 234568899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
+++|.+++.. ..+++..+..++.|++.|+.|||+++ ++|+||+|+||++++++.++++|||++.......
T Consensus 86 ~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~-ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 86 GGSALDLLKP------GPLEETYIATILREILKGLDYLHSER-KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred CCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC-eeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 9999998862 35899999999999999999999988 9999999999999999999999999987654332
Q ss_pred -CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 502 -PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 502 -~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||....... .... ..... ....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~~~-~~~~~----------~~~~ 221 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR------VLFL-IPKNS----------PPTL 221 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh------HHhh-hhcCC----------CCCC
Confidence 1235567999999998889999999999999999999999986432211 0110 00000 0001
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 12233467788889999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.96 Aligned_cols=246 Identities=20% Similarity=0.290 Sum_probs=192.4
Q ss_pred HHHhhccccccCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 347 LRASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 347 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
.+.+.+.||+|+||.||+|... +++.||+|.++... .....+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 3455678999999999999854 58899999987543 223457789999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+++|.+++.. ...+++.+++.++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 90 ~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 90 GGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHSKG-KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 9999999863 345899999999999999999999998 999999999999999999999999998655322
Q ss_pred CCCCccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 501 TPPTRVAGYRAPEVVE---TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
....++..|+|||++. ...++.++|||||||++|||++|+.||....... .+.............
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~------~~~~~~~~~~~~~~~------ 231 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR------ALFLMTKSNFQPPKL------ 231 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh------hHHhhhccCCCCCcc------
Confidence 2335667899999874 4568899999999999999999999986432211 011111111000000
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.........+.+++.+|++.+|++||+++++++
T Consensus 232 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 -KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000011234667888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.96 Aligned_cols=185 Identities=23% Similarity=0.323 Sum_probs=158.2
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.+.||+|+||.||+|... .++.||+|+.... ....|+.++++++||||+++++++...+..++||||+. +
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 141 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-S 141 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-C
Confidence 445678999999999999965 4678999975432 23468899999999999999999999999999999994 6
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---CCC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TPP 503 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~~~ 503 (654)
+|.+++... ...+++..+++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 142 ~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 216 (357)
T PHA03209 142 DLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLHAQR-IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL 216 (357)
T ss_pred cHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEEecCccccccccCcccccc
Confidence 888888632 346899999999999999999999998 999999999999999999999999998754322 234
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPN 543 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf 543 (654)
.++..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 5677899999999999999999999999999999965554
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.44 Aligned_cols=189 Identities=28% Similarity=0.424 Sum_probs=160.5
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCC------ceEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD------EKLL 418 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------~~~l 418 (654)
...+.||+|+||.||++... .|..||+|++.... ....++.+|+.+++.++||||+++++++...+ ..++
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 103 (359)
T cd07876 24 QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL 103 (359)
T ss_pred EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEE
Confidence 34578999999999999864 58899999986542 23456778999999999999999999986543 4699
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 419 VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
||||+++ +|.+.++ ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~-ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 104 VMELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred EEeCCCc-CHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 9999965 5666654 13788999999999999999999998 9999999999999999999999999987653
Q ss_pred CC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 036334 499 NT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQAS 546 (654)
Q Consensus 499 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 546 (654)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 32 2345677899999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.78 Aligned_cols=243 Identities=19% Similarity=0.263 Sum_probs=188.0
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+.+.||+|+||.||++... +++.||+|++.+.. .....+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 46 ~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05621 46 DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYM 125 (370)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCC
Confidence 44578999999999999965 47899999986532 22345778999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
++|+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 126 ~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~~-IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 126 PGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSMG-LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred CCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 99999999963 24788999999999999999999998 999999999999999999999999998765432
Q ss_pred --CCCCccccccCccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 501 --TPPTRVAGYRAPEVVETR----KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~~----~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
....++..|+|||++.+. .++.++||||+||++|||++|+.||..... ......+....... .
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~-----~ 267 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNSL-----N 267 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCccc-----C
Confidence 234578889999998653 378899999999999999999999975321 11122221111000 0
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCC--CCCCHHHHHHH
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPD--QRPAMQEVVRM 612 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~--~RPs~~evl~~ 612 (654)
..........+.+++..|+..++. .|++++|+++.
T Consensus 268 ---~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 ---FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 001111123445566688875554 38899998876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=287.69 Aligned_cols=264 Identities=23% Similarity=0.370 Sum_probs=202.7
Q ss_pred cccCHHHHHHHhhccccccCceeEEEEE-ecCCcEEEEEEeccc-ccCHHHHHHHHHHHhccC-CCccccccEEEEeCCc
Q 036334 339 YSFDLEDLLRASAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEV-AVGKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDE 415 (654)
Q Consensus 339 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~-~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~ 415 (654)
..-.+++...-+.++||+|+++.|-.+. ...|..||||++.+. ...+.++-+|++++..++ |+||++++++|+++..
T Consensus 71 ~~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 71 LSGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred ccchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 3445778888889999999999999887 677999999999776 345677889999999985 9999999999999999
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC---eEEeccC
Q 036334 416 KLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD---ACVSDFG 492 (654)
Q Consensus 416 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~---~kl~Dfg 492 (654)
.|||||.|.||.|..+|+. +..+++.++.++..+|+.||.|||.++ |.|||+||+|||-.+... +|||||.
T Consensus 151 FYLVfEKm~GGplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~kg-IAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHTKG-IAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred EEEEEecccCchHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhhcC-cccccCCccceeecCCCCcCceeeeccc
Confidence 9999999999999999983 456999999999999999999999999 999999999999976654 8999998
Q ss_pred CCCCcCC--C---------CCCCccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC----C
Q 036334 493 LNPLFGN--T---------TPPTRVAGYRAPEVVE-----TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEG----I 552 (654)
Q Consensus 493 la~~~~~--~---------~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~----~ 552 (654)
++.-... . ..+.|...|||||+.. ...|+.++|.||+|||||-|+.|.+||.+.-+.+. .
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 8653321 1 2344555699999863 34689999999999999999999999988655432 1
Q ss_pred ChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 553 DLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 553 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
...+..++.+.+..-...+...-..+..+..+.++++. ..+..|+.+|.++..++.
T Consensus 305 e~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlis---nLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLIS---NLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHH---HHHhccHHhhhhhhhccC
Confidence 22222333222222111111111123344455555444 556689999999988876
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.56 Aligned_cols=249 Identities=23% Similarity=0.357 Sum_probs=196.1
Q ss_pred HhhccccccCceeEEEEEecC----CcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE----GTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
.+.+.||+|+||.||+|...+ ...|++|...... ...+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~ 87 (270)
T cd05056 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMEL 87 (270)
T ss_pred eeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEc
Confidence 345789999999999998643 2468999886543 234578899999999999999999998875 567899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT- 501 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 501 (654)
+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 88 APLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLESKR-FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred CCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 9999999999743 234899999999999999999999988 9999999999999999999999999987654321
Q ss_pred ----CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhh
Q 036334 502 ----PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576 (654)
Q Consensus 502 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (654)
.......|+|||.+....++.++||||||+++||+++ |..||......+ ...........
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~--------- 227 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND------VIGRIENGERL--------- 227 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHcCCcC---------
Confidence 1122346999999988889999999999999999996 999997543211 11111111100
Q ss_pred ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
.........+.+++.+|+..+|++|||+.++++.|+++..++
T Consensus 228 --~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 228 --PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 011122346777888999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.76 Aligned_cols=256 Identities=22% Similarity=0.307 Sum_probs=193.5
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.||+|+||.||++... ++..+|+|.++.... ...++.+|++++++++||||++++++|.+++..++||||++++
T Consensus 5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~ 84 (308)
T cd06615 5 KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 84 (308)
T ss_pred EEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence 4577999999999999855 578899998865422 2356788999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--CCCC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--TPPT 504 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--~~~~ 504 (654)
+|.++++.. ..+++..+..++.|+++||.|||++..++||||||+||+++.++.+||+|||++...... ....
T Consensus 85 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (308)
T cd06615 85 SLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 159 (308)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccCC
Confidence 999999732 458999999999999999999997534999999999999999999999999998765332 2334
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhch------------------
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEW------------------ 566 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~------------------ 566 (654)
++..|+|||.+.+..++.++|||||||++|||++|+.||....... ...+.........
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred CCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCCCccch
Confidence 5677999999988889999999999999999999999986432111 1110000000000
Q ss_pred --hhhhhhHhhh---ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 567 --TAEVFDVELM---RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 567 --~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
..+..+.... ..........++.+++.+||..+|++||+++++++.-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000000 0000001233577888899999999999999998874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=319.16 Aligned_cols=254 Identities=19% Similarity=0.242 Sum_probs=190.7
Q ss_pred HHhhccccccCceeEEEEEec---CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 348 RASAEVLGKGSVGTSYKAVLE---EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......++|||++.
T Consensus 94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 169 (392)
T PHA03207 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169 (392)
T ss_pred eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC
Confidence 344678999999999999753 3578999987643 345689999999999999999999999999999999995
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
++|.+++. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 170 -~~l~~~l~-----~~~~l~~~~~~~i~~ql~~aL~~LH~~g-ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 170 -CDLFTYVD-----RSGPLPLEQAITIQRRLLEALAYLHGRG-IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred -CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 68888884 2346899999999999999999999998 9999999999999999999999999987654321
Q ss_pred ---CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchh-------h---
Q 036334 502 ---PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWT-------A--- 568 (654)
Q Consensus 502 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~--- 568 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||..............+......... .
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 235678899999999999999999999999999999999999764432211111111111000000 0
Q ss_pred hhh---hHhhhccCCh------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 569 EVF---DVELMRYHNI------EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 569 ~~~---~~~~~~~~~~------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
..+ .......... .....++.+++.+|+..||++|||+.|++..
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0000000000 0112356678889999999999999999875
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=303.25 Aligned_cols=244 Identities=26% Similarity=0.329 Sum_probs=191.2
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.++||+|+||+||+|... +++.||+|.+..... ....+.+|++++++++|+||+++.+++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 467999999999999864 588999999865432 223467899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---CC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TP 502 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~~ 502 (654)
++|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+||++++++.+||+|||++...... ..
T Consensus 85 ~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~-iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 85 GDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHREN-TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred ccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 9999888643 2345999999999999999999999998 999999999999999999999999998655322 22
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..++..|+|||++.+..++.++|+|||||++|||++|..||....... ....+....... .. ....
T Consensus 161 ~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~~~~--------~~---~~~~ 226 (285)
T cd05632 161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRVLET--------EE---VYSA 226 (285)
T ss_pred CCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhhhcc--------cc---ccCc
Confidence 356778999999988899999999999999999999999997532211 000011111100 00 0011
Q ss_pred HHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPA-----MQEVVRM 612 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 612 (654)
.....+.+++..||+.||++||+ ++++++.
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 227 KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 12235677888999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=301.45 Aligned_cols=241 Identities=23% Similarity=0.348 Sum_probs=191.6
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEeccccc-------CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV-------GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
..+.||+|+||+||+|...+|+.+|+|.++.... ....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 4577999999999999988899999999864321 124578899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC---
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN--- 499 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~--- 499 (654)
+++++|.+++.. ...+++..+..++.|++.|++|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 84 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 84 VPGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHNNC-VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred CCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999963 235889999999999999999999988 99999999999999999999999998865421
Q ss_pred -------CCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhh
Q 036334 500 -------TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 500 -------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 572 (654)
.....++..|+|||++.+..++.++|||||||++|||++|+.||....... . .......... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~-~~~~~~~~~~----~ 227 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----A-MFYIGAHRGL----M 227 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----H-HHHhhhccCC----C
Confidence 112345667999999998889999999999999999999999996432111 0 0000000000 0
Q ss_pred HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 573 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
+. .......++.+++.+||+.+|++||++.++++
T Consensus 228 ~~-----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 PR-----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CC-----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 01122345677888999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=298.54 Aligned_cols=242 Identities=22% Similarity=0.317 Sum_probs=194.2
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccc--ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV--AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.||+|+||.||++... ++..||+|.++.. ....+.+..|+.++++++|+||+++++++.+++..++||||+++|
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 83 (255)
T cd08219 4 VLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG 83 (255)
T ss_pred EEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence 4578999999999999854 5889999998643 233466788999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----C
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT----P 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~ 502 (654)
+|.+++...+ ...+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.++++|||.+....... .
T Consensus 84 ~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~-i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 84 DLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEKR-VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 9999886432 235789999999999999999999998 9999999999999999999999999987654322 2
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..++..|+|||++.+..++.++||||||+++|+|++|+.||.... ............ ... ...
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~~----------~~~ 222 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS------WKNLILKVCQGS-YKP----------LPS 222 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC------HHHHHHHHhcCC-CCC----------CCc
Confidence 345667999999998889999999999999999999999996432 111111111111 000 011
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.....+.+++.+||+.||++||++.+++..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122356778889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=335.28 Aligned_cols=244 Identities=19% Similarity=0.315 Sum_probs=188.2
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeC--CceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e~~ 423 (654)
+.+.||+|+||+||++... .+..||+|.+..... ....+..|+.++++++|||||+++++|.+. ..+||||||+
T Consensus 17 Il~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~ 96 (1021)
T PTZ00266 17 VIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFC 96 (1021)
T ss_pred EEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCC
Confidence 4578999999999999965 467899999875432 245688899999999999999999988654 4689999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC------CeecCCCCCCcEEECCC--------------
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG------KIVHGNIKASNILLRPD-------------- 483 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~ivHrDlk~~NIll~~~-------------- 483 (654)
++|+|.++|..... ....+++..++.|+.||+.||+|||+.+ .|+||||||+|||++.+
T Consensus 97 ~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ 175 (1021)
T PTZ00266 97 DAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175 (1021)
T ss_pred CCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence 99999999974321 2346999999999999999999999732 39999999999999642
Q ss_pred ---CCeEEeccCCCCCcCCC---CCCCccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChh
Q 036334 484 ---HDACVSDFGLNPLFGNT---TPPTRVAGYRAPEVVET--RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLP 555 (654)
Q Consensus 484 ---~~~kl~Dfgla~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~ 555 (654)
+.+||+|||++...... ....+++.|+|||++.+ ..++.++||||||||||||++|+.||..... ..
T Consensus 176 ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~-----~~ 250 (1021)
T PTZ00266 176 NGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN-----FS 250 (1021)
T ss_pred CCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-----HH
Confidence 34899999998766432 23456788999999854 4588999999999999999999999964321 11
Q ss_pred HHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 556 RWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..+..+ .... .+ .......++.+|+..||..+|++||++.|++.
T Consensus 251 qli~~l-k~~p-------~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 251 QLISEL-KRGP-------DL----PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHH-hcCC-------CC----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 211111 1110 00 01112346778888999999999999999984
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.14 Aligned_cols=241 Identities=24% Similarity=0.364 Sum_probs=193.5
Q ss_pred HhhccccccCceeEEEEEe-cCCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 349 ASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
...+.||+|+||.||++.. .+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++..++..++||||++++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (297)
T cd06656 22 TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 101 (297)
T ss_pred eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCC
Confidence 4457899999999999995 468999999987543 33456788999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----C
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT----P 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~ 502 (654)
+|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... .
T Consensus 102 ~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~-i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 102 SLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred CHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 99999863 34789999999999999999999998 9999999999999999999999999987654322 2
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..++..|+|||.+.+..++.++|||||||++|+|++|+.||.......... ...... . + ......
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~-~-----~---~~~~~~ 239 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG-T-----P---ELQNPE 239 (297)
T ss_pred ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC-C-----C---CCCCcc
Confidence 345667999999998889999999999999999999999996543221100 000000 0 0 000111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.....+.+++.+||+.+|++||+++++++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22234667888999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.42 Aligned_cols=191 Identities=27% Similarity=0.346 Sum_probs=160.7
Q ss_pred hcccccc--CceeEEEEEe-cCCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 351 AEVLGKG--SVGTSYKAVL-EEGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 351 ~~~lg~G--~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
.++||+| +|++||++.. .+|+.||+|+++.... ..+.+++|+++++.++||||++++++|..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 7889999985 4689999999976532 23457789999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+|+|.+++.... ...+++..+++++.|++.||+|||+++ |+||||||+||+++.++.++++||+........
T Consensus 83 ~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~-iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 83 YGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHMG-YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999986432 234899999999999999999999988 999999999999999999999999864332111
Q ss_pred -------CCCCccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 036334 501 -------TPPTRVAGYRAPEVVET--RKVTFKSDVYSFGVLLLELLTGKAPNQA 545 (654)
Q Consensus 501 -------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~ 545 (654)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 11234456999999976 4689999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=313.16 Aligned_cols=235 Identities=23% Similarity=0.272 Sum_probs=180.2
Q ss_pred ccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhcc---CCCccccccEEEEeCCceEEEEEecCC
Q 036334 354 LGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKI---KHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 354 lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l---~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
||+|+||+||+|... +|+.||||++..... ....+..|..++.+. +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 589999999865322 112334455666554 699999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~~~-ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYD-IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 999998863 345899999999999999999999998 999999999999999999999999998754221 2
Q ss_pred CCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 502 PPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
...++..|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..... .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~-------~~~~--- 218 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIAFGKV-------RFPK--- 218 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHHcCCC-------CCCC---
Confidence 23467789999998754 589999999999999999999999965321 111122111110 0000
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCC----CHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRP----AMQEVVR 611 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RP----s~~evl~ 611 (654)
.....++.+++.+||+.||++|| ++.++++
T Consensus 219 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 -NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 01123456777899999999999 4555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=299.27 Aligned_cols=247 Identities=24% Similarity=0.335 Sum_probs=183.4
Q ss_pred cccccCceeEEEEEecCCc---EEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 353 VLGKGSVGTSYKAVLEEGT---TVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 353 ~lg~G~fg~Vy~~~~~~g~---~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
.||+|+||+||+|...++. .+++|.++... ...+.+.+|+.+++.++||||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5899999999999754433 45666665432 234678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC------CC
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN------TT 501 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~------~~ 501 (654)
|.++++.... .....++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++..... ..
T Consensus 82 L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~-i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 159 (268)
T cd05086 82 LKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKHN-FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159 (268)
T ss_pred HHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCC-eeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence 9999975422 1234677888999999999999999988 99999999999999999999999999754221 12
Q ss_pred CCCccccccCccccCC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 502 PPTRVAGYRAPEVVET-------RKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~-------~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
...++..|+|||++.. ..++.++|||||||++|||++ |..||..... ...+.....+.. ....++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~~-~~~~~~ 232 (268)
T cd05086 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKDQQ-VKLFKP 232 (268)
T ss_pred CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhhcc-cccCCC
Confidence 2345567999998753 245789999999999999997 4667753221 122222222211 111121
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
.+. ......+.+++..|| .+|++||++++|++.|.
T Consensus 233 ~~~-----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 233 QLE-----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccC-----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111 112235666777899 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.70 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=193.9
Q ss_pred hhccccccCceeEEEEEec-CCc----EEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGT----TVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
..+.||+|+||.||+|.+. +|. .||+|.+..... ...++.+|+.++++++||||++++++|... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 4578999999999999853 344 578888865432 234678899999999999999999998654 56799999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP 502 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 502 (654)
+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~-ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 90 MPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEERR-LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred cCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhhcC-eeccccccceeeecCCCceEEccccccccccCccc
Confidence 9999999998743 235899999999999999999999998 99999999999999999999999999976543211
Q ss_pred ------CCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 503 ------PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 503 ------~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
...+..|+|||.+.+..++.++|||||||++|||++ |+.||..... ............
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~-------- 229 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------REIPDLLEKGER-------- 229 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCCC--------
Confidence 122456999999998899999999999999999998 8899864321 111111111100
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
......+...+.+++.+||..+|++||+++++++.|+++....
T Consensus 230 --~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 230 --LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0001112346778888999999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=306.85 Aligned_cols=194 Identities=24% Similarity=0.394 Sum_probs=158.1
Q ss_pred hccccccCceeEEEEEec---CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEe--CCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLE---EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYS--KDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~ 425 (654)
+..||+|+||+||+|... ++..||+|.+..... ...+.+|++++++++||||+++++++.. +...++||||+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 357999999999999865 356899999875432 3467789999999999999999998854 4567999999864
Q ss_pred CchhhhhccCCC----CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEE----CCCCCeEEeccCCCCCc
Q 036334 426 GSLSALLHGSRG----SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL----RPDHDACVSDFGLNPLF 497 (654)
Q Consensus 426 g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll----~~~~~~kl~Dfgla~~~ 497 (654)
+|.+++..... .....+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++...
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-EEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 77777653221 12235899999999999999999999998 9999999999999 45678999999999766
Q ss_pred CCCC-------CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 036334 498 GNTT-------PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASL 547 (654)
Q Consensus 498 ~~~~-------~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~ 547 (654)
.... ...++..|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 4321 2345677999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.64 Aligned_cols=232 Identities=22% Similarity=0.288 Sum_probs=184.4
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccC-CCccccccEEEEeCCceEEEEEecC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
.++||+|+||+||+|... +|+.||+|+++... ...+.+..|..++..+. |++|+++++++.+.+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 467999999999999854 58899999987542 22345667888888775 5778889999998899999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+|+|.+++.. ...+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 85 ~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~-ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 85 GGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHRRG-IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence 9999999863 345899999999999999999999998 999999999999999999999999998754322
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
....++..|+|||++.+..++.++||||+||++|||++|+.||..... ...+..+..... ..
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i~~~~~------------~~ 220 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE------DELFQSIMEHNV------------SY 220 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC------------CC
Confidence 223467789999999988999999999999999999999999975321 111222211110 00
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAM 606 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~ 606 (654)
......++.+++.+|++.+|.+|++.
T Consensus 221 p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11122356778889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=299.95 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=197.2
Q ss_pred HhhccccccCceeEEEEEecC-Cc----EEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE-GT----TVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~-g~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
.+.+.||+|+||.||+|...+ |. .||+|.++.... ...++.+|+..+++++||||+++++++.. ...++|||
T Consensus 10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 88 (279)
T cd05057 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQ 88 (279)
T ss_pred EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEe
Confidence 445789999999999998543 33 589998876533 34568889999999999999999999887 78899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT 501 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 501 (654)
|+++|+|.+++... ...+++..++.++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~-i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 89 LMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEEKR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred cCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC-EEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 99999999999743 234899999999999999999999987 9999999999999999999999999987664332
Q ss_pred C------CCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 502 P------PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 502 ~------~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
. ...+..|+|||.+....++.++||||||+++||+++ |+.||..... ..+...+. ....
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~-~~~~------- 229 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------VEIPDLLE-KGER------- 229 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHh-CCCC-------
Confidence 1 112346999999988899999999999999999998 9999865321 11111111 1100
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
......+..++.+++.+||..+|.+||++.++++.|+++.+..
T Consensus 230 ---~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 230 ---LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 0001112235778888999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=306.63 Aligned_cols=191 Identities=24% Similarity=0.323 Sum_probs=164.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||+||++... +++.||+|++.+.. ...+.+.+|+.++..++|+||+++++++.+++..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (331)
T cd05597 5 ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYV 84 (331)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCC
Confidence 3578999999999999965 58899999987532 223457889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
+|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 85 GGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLG-YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred CCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 99999999642 235899999999999999999999998 9999999999999999999999999987654321
Q ss_pred --CCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 036334 502 --PPTRVAGYRAPEVVET-----RKVTFKSDVYSFGVLLLELLTGKAPNQA 545 (654)
Q Consensus 502 --~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~pf~~ 545 (654)
...++..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 1346788999999863 4578899999999999999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.38 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=190.3
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEEE-----eCCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYY-----SKDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~-----~~~~~~lv~e~ 422 (654)
+.+.||+|+||.||++... +++.+|+|++........++..|+.+++++ +||||+++++++. .++..++||||
T Consensus 22 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 101 (286)
T cd06638 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101 (286)
T ss_pred eeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence 4577999999999999864 578999999876555556788899999999 6999999999884 33468999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 500 (654)
+++++|.+++..... ....+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 102 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 179 (286)
T cd06638 102 CNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNK-TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179 (286)
T ss_pred cCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCC-ccccCCCHHhEEECCCCCEEEccCCceeecccCCC
Confidence 999999998764321 2346899999999999999999999988 999999999999999999999999998765432
Q ss_pred --CCCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 --TPPTRVAGYRAPEVVET-----RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....++..|+|||++.. ..++.++||||+||++|||++|+.||......+ . +.... ........
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-----~-~~~~~-~~~~~~~~-- 250 (286)
T cd06638 180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-----A-LFKIP-RNPPPTLH-- 250 (286)
T ss_pred ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----H-Hhhcc-ccCCCccc--
Confidence 22346678999998853 457889999999999999999999986532211 0 00000 00000000
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.......++.+++.+||+.||++|||+.|+++.
T Consensus 251 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 251 ------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 011122357788889999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=299.84 Aligned_cols=249 Identities=20% Similarity=0.337 Sum_probs=193.0
Q ss_pred hhccccccCceeEEEEEecC--CcEEEEEEecccc-----------cCHHHHHHHHHHHhc-cCCCccccccEEEEeCCc
Q 036334 350 SAEVLGKGSVGTSYKAVLEE--GTTVVVKRLKEVA-----------VGKREFEMQMEVLGK-IKHDNVVPLRAFYYSKDE 415 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~--g~~vavK~~~~~~-----------~~~~~~~~e~~~l~~-l~hpniv~l~~~~~~~~~ 415 (654)
+.+.||+|+||.||+|.... ++.+|+|.+.... ....++..|+.++.+ ++||||+++++++..++.
T Consensus 4 ~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 83 (269)
T cd08528 4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDR 83 (269)
T ss_pred hhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCe
Confidence 35679999999999999764 6789999875321 112345667877764 799999999999999999
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCC
Q 036334 416 KLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP 495 (654)
Q Consensus 416 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~ 495 (654)
.++||||+++++|.+++...+. ....+++..+++++.|++.||.|||+...++|+||+|+||+++.++.+||+|||.+.
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 162 (269)
T cd08528 84 LYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162 (269)
T ss_pred EEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccccee
Confidence 9999999999999998854221 234689999999999999999999964349999999999999999999999999987
Q ss_pred CcCCC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhh
Q 036334 496 LFGNT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 496 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 572 (654)
..... ....++..|+|||.+.+..++.++||||||+++|||++|+.||.... ..............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~------~~~~~~~~~~~~~~----- 231 (269)
T cd08528 163 QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN------MLSLATKIVEAVYE----- 231 (269)
T ss_pred ecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC------HHHHHHHHhhccCC-----
Confidence 65543 23345667999999998889999999999999999999999986421 11111111111100
Q ss_pred HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 573 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
..........+.+++.+||+.||++||++.|+..++++
T Consensus 232 -----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 232 -----PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred -----cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 00011123467788889999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=302.28 Aligned_cols=244 Identities=22% Similarity=0.347 Sum_probs=191.1
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
|++.+.||+|+||.||+|... ++..|++|.+.... .....+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG 93 (292)
T ss_pred hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence 345678999999999999965 48899999987543 2345678899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
++|..++... ...+++..+..++.|++.+++|||+.+ ++||||||+||+++.++.+||+|||++...... .
T Consensus 94 ~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 94 GAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHSMK-IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred CcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC-eeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 9998887633 235899999999999999999999987 999999999999999999999999987654322 2
Q ss_pred CCCccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhh
Q 036334 502 PPTRVAGYRAPEVVE-----TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (654)
...++..|+|||++. ...++.++|||||||++|||++|+.||..... ...+.........
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~--------- 233 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEPP--------- 233 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCCCc---------
Confidence 234556799999984 34578899999999999999999999864321 1111111111000
Q ss_pred ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..........++.+++.+||..+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00011222345778888999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=295.88 Aligned_cols=243 Identities=27% Similarity=0.423 Sum_probs=192.9
Q ss_pred HhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.+.+.||+|+||.||++.. .++.||+|.++... ....+.+|+.++++++|||++++++++..+ ..++||||+++++|
T Consensus 9 ~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L 85 (254)
T cd05083 9 TLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNL 85 (254)
T ss_pred eeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCH
Confidence 4467899999999999975 47889999986543 346788999999999999999999998654 57999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-CCCccc
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-PPTRVA 507 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~ 507 (654)
.+++... ....+++..++.++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++....... ......
T Consensus 86 ~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 161 (254)
T cd05083 86 VNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLESKK-LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV 161 (254)
T ss_pred HHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCCc
Confidence 9999743 2335899999999999999999999988 9999999999999999999999999987644321 222234
Q ss_pred cccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHH
Q 036334 508 GYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMV 586 (654)
Q Consensus 508 ~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (654)
.|+|||.+.+..++.++|||||||++|||++ |+.||..... ....... ...... ........
T Consensus 162 ~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~-~~~~~~----------~~~~~~~~ 224 (254)
T cd05083 162 KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEVKECV-EKGYRM----------EPPEGCPA 224 (254)
T ss_pred eecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HHHHHHH-hCCCCC----------CCCCcCCH
Confidence 6999999988899999999999999999998 8999865321 1111111 111100 11112234
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 587 QLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 587 ~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
.+.+++.+||+.+|++||+++++++.|++
T Consensus 225 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 225 DVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 56788889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=306.08 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=185.4
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhcc---CCCccccccEEEEeC-----CceE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKI---KHDNVVPLRAFYYSK-----DEKL 417 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l---~hpniv~l~~~~~~~-----~~~~ 417 (654)
+.+.||+|+||+||+|... +|+.||+|.++.... ....+.+|+++++++ +||||+++++++... ...+
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~ 83 (288)
T cd07863 4 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVT 83 (288)
T ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEE
Confidence 3567999999999999865 588999999875421 223456677766655 799999999988642 3478
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 418 LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
+||||+. ++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 84 lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 84 LVFEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHANC-IVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred EEEcccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEECccCccccc
Confidence 9999997 48888886432 245899999999999999999999998 999999999999999999999999998876
Q ss_pred CCC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hchhhh-
Q 036334 498 GNT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR----EEWTAE- 569 (654)
Q Consensus 498 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~- 569 (654)
... ....++..|+|||++.+..++.++||||+||++|||++|++||......+ .+.. +..... ..+...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGK-IFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHH-HHHHhCCCChhhCcccc
Confidence 433 22345677999999998899999999999999999999999986532211 0101 111000 000000
Q ss_pred -----hhhHhhhc--cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 570 -----VFDVELMR--YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 570 -----~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.+...... .....+....+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 0000112234678888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.48 Aligned_cols=239 Identities=23% Similarity=0.366 Sum_probs=192.2
Q ss_pred hccccccCceeEEEEEe-cCCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 351 AEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.+.||.|+||.||+|.. .+|+.|++|.+.... ...+.+.+|+.+++.++||||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 46799999999999985 468999999986543 3356778899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----CCC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT----PPT 504 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~~~ 504 (654)
.+++.. ..+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 104 ~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~-i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 176 (296)
T cd06655 104 TDVVTE------TCMDEAQIAAVCRECLQALEFLHANQ-VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176 (296)
T ss_pred HHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcC
Confidence 998862 34899999999999999999999998 9999999999999999999999999987654322 234
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
++..|+|||.+.+..++.++|||||||++|+|++|+.||......+ ......... .. ........
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~~~-~~--------~~~~~~~~ 241 (296)
T cd06655 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNG-TP--------ELQNPEKL 241 (296)
T ss_pred CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcC-Cc--------ccCCcccC
Confidence 5667999999998889999999999999999999999996532211 111110000 00 00111122
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 585 MVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
...+.+++.+||..||++||++.++++
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 335667888999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=317.50 Aligned_cols=190 Identities=23% Similarity=0.355 Sum_probs=166.4
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.+.||+|+||.||++... +++.||+|+++... .....+.+|+.++..++||||+++++.+.+++..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 477999999999999865 58899999997542 2234677899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----- 500 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----- 500 (654)
|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 86 g~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~~g-ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 86 GDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQLG-FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred ccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 999999973 345899999999999999999999998 999999999999999999999999998644211
Q ss_pred ----------------------------------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 036334 501 ----------------------------------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQAS 546 (654)
Q Consensus 501 ----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 546 (654)
....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 1234677899999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.03 Aligned_cols=245 Identities=23% Similarity=0.378 Sum_probs=193.9
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.+.+.||+|+||.||++... ++..||+|+++... .....+.+|++++++++||||+++++++..+...++||||+++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 455678999999999999964 58899999986543 2345688899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
++|.+++... ...+++..++.++.|++.|+.|||+.+ |+|+||||+||+++.++.++|+|||++...... .
T Consensus 87 ~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~-i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 87 GALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHK-VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred CcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 9999998743 235899999999999999999999998 999999999999999999999999987654332 2
Q ss_pred CCCccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhh
Q 036334 502 PPTRVAGYRAPEVVE-----TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (654)
...++..|+|||.+. ...++.++||||||+++|||++|+.||...... ..+.........
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~--------- 226 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKILKSEPP--------- 226 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHhcCCCC---------
Confidence 234567799999874 345778999999999999999999998753211 111111111100
Q ss_pred ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
..........++.+++.+||+.+|++||+++++++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001111223456778889999999999999999774
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=297.88 Aligned_cols=240 Identities=23% Similarity=0.343 Sum_probs=194.9
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
...+.||+|+||.||+|... .+..||+|.++... .....+.+|+++++++.||||+++++++.++...++||||+++
T Consensus 7 ~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06640 7 TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCC
Confidence 34567999999999999865 58899999987543 2345688899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 501 (654)
|+|.+++.. ..+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 87 ~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~-ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 87 GSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEK-KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC-ccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence 999999863 34889999999999999999999987 9999999999999999999999999986654322
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||........ .... .... .....
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~~-~~~~----------~~~~~ 222 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV------LFLI-PKNN----------PPTLT 222 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH------hhhh-hcCC----------CCCCc
Confidence 22345679999999888899999999999999999999999875432110 0000 0000 01112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
......+.+++.+||+.+|++||+++++++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 3345567889999999999999999999775
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.22 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=187.6
Q ss_pred HHhhccccccCceeEEEEEe-cCCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeC------CceE
Q 036334 348 RASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSK------DEKL 417 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------~~~~ 417 (654)
|...+.||+|+||.||+|.. .++..||||++.... .....+.+|+.++++++||||+++++++... ...+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07878 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY 96 (343)
T ss_pred hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence 34567899999999999985 457899999987542 2235577899999999999999999987543 3468
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 418 LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
+++|++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 97 ~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 97 LVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAG-IIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred EEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-eecccCChhhEEECCCCCEEEcCCccceec
Confidence 999988 7799888752 35899999999999999999999998 999999999999999999999999998876
Q ss_pred CCC-CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc---hhhhh--
Q 036334 498 GNT-TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREE---WTAEV-- 570 (654)
Q Consensus 498 ~~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~-- 570 (654)
... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+....... ....+
T Consensus 169 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred CCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHhcch
Confidence 543 23456778999999876 568999999999999999999999997532211 000000000000 00000
Q ss_pred --hh---HhhhccCC--h----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 571 --FD---VELMRYHN--I----EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 571 --~~---~~~~~~~~--~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.. ..+..... . ......+.+++.+|+..||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00000000 0 0011235688889999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=296.02 Aligned_cols=244 Identities=24% Similarity=0.365 Sum_probs=194.6
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
..+.||+|+||.||+|... +++.+++|.+.... ...+.+.+|++++++++||||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~ 86 (262)
T cd06613 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGS 86 (262)
T ss_pred EEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCc
Confidence 3467999999999999864 57889999987543 245678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CCC
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPP 503 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~ 503 (654)
|.+++... ...+++..+..++.|++.|++|||+.+ |+|+||+|+||+++.++.+||+|||++...... ...
T Consensus 87 l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~-i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 161 (262)
T cd06613 87 LQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHETG-KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF 161 (262)
T ss_pred HHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCChhhEEECCCCCEEECccccchhhhhhhhccccc
Confidence 99998743 245899999999999999999999988 999999999999999999999999998765432 223
Q ss_pred CccccccCccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 504 TRVAGYRAPEVVETR---KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~---~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
.++..|+|||.+.+. .++.++||||||+++|||++|+.||......+ -........ +... ....
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~------~~~~~~~~~-----~~~~--~~~~ 228 (262)
T cd06613 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR------ALFLISKSN-----FPPP--KLKD 228 (262)
T ss_pred cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcc-----CCCc--cccc
Confidence 456679999999776 88999999999999999999999987532211 011110110 0000 0111
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
......++.+++.+||..+|.+|||+.+++.
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2233456788899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=315.66 Aligned_cols=189 Identities=25% Similarity=0.390 Sum_probs=160.6
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCC------ceEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKD------EKLL 418 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------~~~l 418 (654)
...+.||+|+||.||++... .++.||||++..... ....+.+|+.+++.++||||+++++++.... ..++
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 99 (355)
T cd07874 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL 99 (355)
T ss_pred eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEE
Confidence 34578999999999999854 588999999875432 2356778999999999999999999886543 4699
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 419 VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
||||+++ ++.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 100 v~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 100 VMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred Ehhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 9999965 67666642 3788999999999999999999998 9999999999999999999999999998665
Q ss_pred CC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 036334 499 NT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQAS 546 (654)
Q Consensus 499 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 546 (654)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 43 2235677899999999989999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=302.45 Aligned_cols=244 Identities=25% Similarity=0.380 Sum_probs=190.5
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEEEeC-----CceEEEEEec
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSK-----DEKLLVYDYM 423 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~-----~~~~lv~e~~ 423 (654)
.+.||+|+||.||++... +++.+|+|++........++.+|+.+++++ +|||++++++++... +..++||||+
T Consensus 27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~ 106 (291)
T cd06639 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELC 106 (291)
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEEC
Confidence 467999999999999864 588999999876555556788899999998 799999999998754 3579999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
++|+|.++++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 107 ~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~ 184 (291)
T cd06639 107 NGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR-IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184 (291)
T ss_pred CCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHEEEcCCCCEEEeecccchhccccccc
Confidence 99999998864321 2345899999999999999999999988 999999999999999999999999998765432
Q ss_pred -CCCCccccccCccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 501 -TPPTRVAGYRAPEVVETR-----KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
....++..|+|||.+... .++.++|||||||++|||++|+.||...... ..+....+. ...
T Consensus 185 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------~~~~~~~~~-~~~------ 251 (291)
T cd06639 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------KTLFKIPRN-PPP------ 251 (291)
T ss_pred ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------HHHHHHhcC-CCC------
Confidence 223456679999998543 3689999999999999999999998653211 111111110 000
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.....+.....+.+++.+||+.+|++||++.|+++
T Consensus 252 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 252 --TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 01111223346788899999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=300.24 Aligned_cols=248 Identities=22% Similarity=0.387 Sum_probs=193.1
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
++.+.||+|+||.||++... .|..||+|.++.... ....+.+|++++++++||||+++++.+..++..++||||+++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCC
Confidence 45678999999999999965 689999998865422 235688899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--CCC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--TPP 503 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--~~~ 503 (654)
++|..++.... ....+++..+..++.|++.||.|||+...|+||||||+||+++.++.+||+|||++...... ...
T Consensus 84 ~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (286)
T cd06622 84 GSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN 161 (286)
T ss_pred CCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccccC
Confidence 99999887431 13468999999999999999999997534999999999999999999999999998765332 223
Q ss_pred CccccccCccccCCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 504 TRVAGYRAPEVVETR------KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~------~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
.++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ....+..+.... .
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~-----------~ 227 (286)
T cd06622 162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIVDGD-----------P 227 (286)
T ss_pred CCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHhhcC-----------C
Confidence 456679999998543 35789999999999999999999996432111 111111111000 0
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.........++.+++.+||+.+|++||++++++..
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 01112234566778889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=298.03 Aligned_cols=241 Identities=23% Similarity=0.343 Sum_probs=194.4
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
...+.||.|+||.||+|... +++.||+|++.... .....+.+|+++++.++|+||+++++++.++...++|+||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (274)
T cd06609 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG 83 (274)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence 34577999999999999965 58899999986543 2235688899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
++|.+++.. ..+++..++.++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||++...... .
T Consensus 84 ~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~~-i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 84 GSCLDLLKP------GKLDETYIAFILREVLLGLEYLHEEG-KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred CcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence 999999873 26899999999999999999999988 999999999999999999999999998776543 2
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||.+.+..++.++|||||||++|||++|+.||...... ..... .......... .
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~~~-~~~~~~~~~~-----~---- 220 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------RVLFL-IPKNNPPSLE-----G---- 220 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------HHHHH-hhhcCCCCCc-----c----
Confidence 334566799999998888999999999999999999999999643211 11111 1111110000 0
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
......+.+++.+||..+|++||+++++++.
T Consensus 221 ~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0023357778889999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=294.24 Aligned_cols=243 Identities=23% Similarity=0.372 Sum_probs=196.0
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
..++||+|+||.||.+.. .++..+++|.+.... ....++.+|++++++++|+||+++++++.+.+..+++|||+++
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (256)
T cd08221 4 PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG 83 (256)
T ss_pred EeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCC
Confidence 357899999999999884 458899999876542 2345688999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 501 (654)
++|.+++.... ...+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 84 GTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG-ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred CcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 99999997432 345899999999999999999999988 9999999999999999999999999987654332
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||.+.+..++.++||||||+++|||++|+.||.... ....+..+....... ..
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~~~~~-----------~~ 222 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN------PLNLVVKIVQGNYTP-----------VV 222 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCCCCC-----------Cc
Confidence 2345677999999988889999999999999999999999986432 122222222211110 01
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
.....++.+++.+||..+|++||+++++++.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 22234577788899999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=282.53 Aligned_cols=262 Identities=21% Similarity=0.373 Sum_probs=197.7
Q ss_pred ceeEee-CCccccCHHHHHHHhhccccccCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccc
Q 036334 330 KLVFFE-GGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVV 404 (654)
Q Consensus 330 ~~~~~~-~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv 404 (654)
..+... +..+..++.|+. ....||.|+.|.|+++..+ .|...|||.+..... ..+++.+.++++.+. ..|+||
T Consensus 77 g~lti~~g~r~~~dindl~--~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV 154 (391)
T KOG0983|consen 77 GYLTIGGGQRYQADINDLE--NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIV 154 (391)
T ss_pred eeEEecCCcccccChHHhh--hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeee
Confidence 334444 445666776663 3456999999999999965 488999999977633 334566666666554 489999
Q ss_pred cccEEEEeCCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC
Q 036334 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH 484 (654)
Q Consensus 405 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~ 484 (654)
+.+|||..+...++.||.|.. .+..+++.. .+++++..+-++...+.+||.||.+++.|+|||+||+|||+|+.|
T Consensus 155 ~c~GyFi~n~dV~IcMelMs~-C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G 229 (391)
T KOG0983|consen 155 QCFGYFITNTDVFICMELMST-CAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG 229 (391)
T ss_pred eeeeEEeeCchHHHHHHHHHH-HHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC
Confidence 999999999999999999843 666666543 456999999999999999999999888899999999999999999
Q ss_pred CeEEeccCCCCCcCCCC---CCCccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHH
Q 036334 485 DACVSDFGLNPLFGNTT---PPTRVAGYRAPEVVET---RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWV 558 (654)
Q Consensus 485 ~~kl~Dfgla~~~~~~~---~~~~~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~ 558 (654)
++|+||||++..+-+.. ...|.+.|||||.+.- ..|+-++|||||||+++||.||+.||.....+ .+...
T Consensus 230 niKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~lt-- 305 (391)
T KOG0983|consen 230 NIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLT-- 305 (391)
T ss_pred CEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHH--
Confidence 99999999998776543 3455566999999864 46899999999999999999999999864321 11111
Q ss_pred HHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 559 QSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.++.++. +.+ ........++.+++..|+.+|+.+||...++++.
T Consensus 306 -kvln~eP------P~L---~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 306 -KVLNEEP------PLL---PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -HHHhcCC------CCC---CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1111110 111 1111134467778889999999999999988654
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.29 Aligned_cols=253 Identities=21% Similarity=0.310 Sum_probs=191.6
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
..+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|++++++++||||+++++++......++||||+++
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (286)
T cd07847 5 KLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH 84 (286)
T ss_pred eeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCc
Confidence 3467999999999999966 58999999986542 2235678899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 501 (654)
++|..++.. ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 85 TVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHKHN-CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred cHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence 988887752 235899999999999999999999988 9999999999999999999999999988764432
Q ss_pred CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------------chhh
Q 036334 502 PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE------------EWTA 568 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------------~~~~ 568 (654)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||......+. ...+...... .+..
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChHHhhhcccccccc
Confidence 2334567999999876 5578999999999999999999999975433211 0000000000 0000
Q ss_pred hhhhHhhhccCCh----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 569 EVFDVELMRYHNI----EEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 569 ~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
....+........ ......+.+++.+||+.+|++||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000000 111345778888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=302.13 Aligned_cols=255 Identities=19% Similarity=0.313 Sum_probs=189.0
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.||+|+||.||+|... ++..||+|+++.... ....+.+|+.++++++||||+++++++.++...++||||++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-M 83 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence 467999999999999965 588999999865422 23567889999999999999999999999999999999997 6
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TP 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~ 502 (654)
+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 84 ~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (285)
T cd07861 84 DLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHSRR-VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH 160 (285)
T ss_pred CHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccC
Confidence 8888886432 2346899999999999999999999998 999999999999999999999999998755432 12
Q ss_pred CCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhch--hh--hhhhHh
Q 036334 503 PTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVV---REEW--TA--EVFDVE 574 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~---~~~~--~~--~~~~~~ 574 (654)
..++..|+|||++.+. .++.++|||||||++|||++|+.||......+ .......... ...| .. ......
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 3346679999988654 57899999999999999999999997532211 0000000000 0000 00 000000
Q ss_pred hhccC------ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 575 LMRYH------NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 575 ~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..... .......++.+++.+||..||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 00012235567888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=297.48 Aligned_cols=239 Identities=24% Similarity=0.379 Sum_probs=190.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC----------HHHHHHHHHHHhccCCCccccccEEEEeCCceEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG----------KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLL 418 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~----------~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 418 (654)
+...||+|+||.||+|... +++.||+|.+...... .+.+++|++++++++||||+++++++...+..++
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence 3567999999999999854 5789999988654221 1457789999999999999999999999999999
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 419 VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~~-ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 84 FLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHNRG-IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHhcC-cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999973 345889999999999999999999988 9999999999999999999999999987664
Q ss_pred CCC----------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 499 NTT----------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 499 ~~~----------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
... ...++..|+|||.+.+..++.++||||+||++|||++|+.||...... ..+..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~--- 227 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFKIGE-N--- 227 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHHHhc-c---
Confidence 211 123456799999999888999999999999999999999999753211 11111100 0
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.. ..........+.+++.+||+.||.+||++.|+++
T Consensus 228 --~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 --AS-----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --CC-----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00 0111122345677888999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.10 Aligned_cols=245 Identities=18% Similarity=0.253 Sum_probs=188.2
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
+.+.+.||+|+||.||++... +++.||+|++.... .....+.+|+.+++.++||||+++++++.++...++||||
T Consensus 45 y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (371)
T cd05622 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 124 (371)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 344678999999999999965 57899999986532 2234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 500 (654)
+++|+|.+++.. ..++...+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 125 ~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 125 MPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred CCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC-EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 999999999863 23788889999999999999999998 999999999999999999999999998765432
Q ss_pred ---CCCCccccccCccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 ---TPPTRVAGYRAPEVVETR----KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 ---~~~~~~~~y~aPE~~~~~----~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....+++.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.......
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~----- 266 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNSL----- 266 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCcc-----
Confidence 234577889999998653 378999999999999999999999975321 11222222111000
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQ--RPAMQEVVRMI 613 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L 613 (654)
..... ......+.+++.+|+..++.+ |++++|+++..
T Consensus 267 ~~~~~---~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 267 TFPDD---NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCc---CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 00011 112234556677899744433 77999888754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=310.99 Aligned_cols=189 Identities=24% Similarity=0.400 Sum_probs=160.9
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeC------CceEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSK------DEKLL 418 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------~~~~l 418 (654)
...+.||+|+||.||++... .++.||||++.... .....+.+|+.+++.++||||+++++++... ...++
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~l 106 (364)
T cd07875 27 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106 (364)
T ss_pred eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEE
Confidence 34578999999999999854 58899999987542 2345677899999999999999999987643 34699
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 419 VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
||||+++ +|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 107 v~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 107 VMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred EEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC-eecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 9999965 67776642 3788999999999999999999998 9999999999999999999999999998765
Q ss_pred CC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 036334 499 NT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQAS 546 (654)
Q Consensus 499 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 546 (654)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 43 2335677899999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=296.05 Aligned_cols=248 Identities=24% Similarity=0.368 Sum_probs=192.2
Q ss_pred hccccccCceeEEEEEec----CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCC------ceE
Q 036334 351 AEVLGKGSVGTSYKAVLE----EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKD------EKL 417 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------~~~ 417 (654)
.++||+|+||.||+|.+. .+..||||+++.... ..+++.+|++++++++||||+++++++...+ ..+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 467999999999999853 367899999876432 2456788999999999999999999886542 237
Q ss_pred EEEEecCCCchhhhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCC
Q 036334 418 LVYDYMPAGSLSALLHGSRG-SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPL 496 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~ 496 (654)
+++||+.+|+|.+++...+. .....+++...++++.|++.|++|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-i~H~dikp~nili~~~~~~kl~dfg~~~~ 162 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN-FIHRDLAARNCMLNENMTVCVADFGLSKK 162 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-EeecccchhhEEEcCCCCEEECccccccc
Confidence 89999999999988753321 12235899999999999999999999988 99999999999999999999999999876
Q ss_pred cCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhh
Q 036334 497 FGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAE 569 (654)
Q Consensus 497 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 569 (654)
..... .......|++||.+....++.++|||||||++|||++ |+.||..... ......+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~~~-- 234 (273)
T cd05074 163 IYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN------SEIYNYLIKGNRL-- 234 (273)
T ss_pred ccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH------HHHHHHHHcCCcC--
Confidence 53221 1223346999999988889999999999999999999 8888864321 1111111111000
Q ss_pred hhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 570 VFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
.........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 235 ---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 235 ---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01112334788889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=293.34 Aligned_cols=242 Identities=29% Similarity=0.450 Sum_probs=194.6
Q ss_pred hccccccCceeEEEEEecC-----CcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 351 AEVLGKGSVGTSYKAVLEE-----GTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+.||+|+||.||++...+ +..||+|+++.... ..+.+..|+.++++++|+||+++++++.+.+..+++|||+
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~ 83 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence 4679999999999999654 37899999976544 3567889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC--
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-- 501 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-- 501 (654)
++++|.+++.... ...+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~-~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 84 EGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLESKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred CCCCHHHHHHhhh---hccCCHHHHHHHHHHHHHHHHHHhcCC-eeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999997432 112899999999999999999999998 9999999999999999999999999987654331
Q ss_pred ---CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 502 ---PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 502 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
...++..|+|||.+.+..++.++||||+|+++|||++ |..||.... ............. .
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~~~~-~--------- 223 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS------NEEVLEYLKKGYR-L--------- 223 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcCCC-C---------
Confidence 1224567999999988889999999999999999998 788876421 1122222211110 0
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
........++.+++.+|+..+|++|||+.|+++.|
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 -PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01111344677888899999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=293.69 Aligned_cols=243 Identities=22% Similarity=0.338 Sum_probs=192.5
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeC-CceEEEEEec
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSK-DEKLLVYDYM 423 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-~~~~lv~e~~ 423 (654)
.+.+.||+|++|.||++... +++.||+|.+..... ..+.+.+|++++++++|+|++++++.+... ...++||||+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence 34578999999999999855 478899999865432 235678899999999999999999987643 4578999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
++++|.+++.... ...+++.+++.++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~-i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 83 EGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKH-ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred CCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 9999999997432 345899999999999999999999998 999999999999999999999999998765432
Q ss_pred -CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 -TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....++..|+|||++.+..++.++||||||++++||++|+.||.... ........... ... .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~~-~~~----------~ 221 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIEG-KLP----------P 221 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhc-CCC----------C
Confidence 22345667999999999899999999999999999999999986421 11222221111 100 0
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
........+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 112233467788889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=296.52 Aligned_cols=240 Identities=24% Similarity=0.333 Sum_probs=187.4
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
..||+|+||.||+|... ++..|++|.+.... ...+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 46999999999999854 57789999886553 34457889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCC--CHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC-CCCeEEeccCCCCCcCCC----CC
Q 036334 430 ALLHGSRGSGRTPL--DWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP-DHDACVSDFGLNPLFGNT----TP 502 (654)
Q Consensus 430 ~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~~----~~ 502 (654)
+++.... ..+ ++..+..++.|++.|++|||+++ |+||||||+||+++. ++.++|+|||++...... ..
T Consensus 94 ~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~-i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 168 (268)
T cd06624 94 ALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHDNQ-IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET 168 (268)
T ss_pred HHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHHCC-EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcccc
Confidence 9997432 234 78889999999999999999988 999999999999986 678999999998765322 12
Q ss_pred CCccccccCccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 503 PTRVAGYRAPEVVETR--KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
..++..|+|||++... .++.++||||||+++|||++|+.||....... ...+....... ....
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~~------------~~~~ 233 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFKI------------HPEI 233 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhcc------------CCCC
Confidence 3456779999998654 37899999999999999999999986432111 00000000000 0001
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
......++.+++.+||+.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 1122345677888999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.40 Aligned_cols=239 Identities=25% Similarity=0.371 Sum_probs=191.4
Q ss_pred cccccCceeEEEEEecC-CcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchhh
Q 036334 353 VLGKGSVGTSYKAVLEE-GTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSA 430 (654)
Q Consensus 353 ~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~ 430 (654)
+||+|.||+||.|++.+ ...+|||-+.... ...+-+..||.+.++++|.|||+++|.|..+++.-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999665 4578999886543 334557889999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCC--CHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC-CCCeEEeccCCCCCcCCC----CCC
Q 036334 431 LLHGSRGSGRTPL--DWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP-DHDACVSDFGLNPLFGNT----TPP 503 (654)
Q Consensus 431 ~l~~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~~----~~~ 503 (654)
+|+... +++ ++.+.-.+.+||++||.|||+.. |||||||-.|||++. .|.+||+|||-++.+... ...
T Consensus 662 LLrskW----GPlKDNEstm~fYtkQILeGLkYLHen~-IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKW----GPLKDNESTMNFYTKQILEGLKYLHENK-IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred HHHhcc----CCCccchhHHHHHHHHHHHHhhhhhhcc-eeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 998653 455 78888889999999999999887 999999999999975 688999999988766432 344
Q ss_pred CccccccCccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 504 TRVAGYRAPEVVETR--KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
.||..|||||++..+ .|..++|||||||++.||.||++||....... ..+++-+. +.. .+..+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--------AAMFkVGm----yKv---HP~iP 801 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--------AAMFKVGM----YKV---HPPIP 801 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--------Hhhhhhcc----eec---CCCCc
Confidence 667779999999754 68999999999999999999999997532211 01111111 110 12223
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
++...+...++.+|+.+||.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 444555677888999999999999999976
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=305.22 Aligned_cols=253 Identities=19% Similarity=0.292 Sum_probs=189.0
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
..+.||+|+||.||+|... +++.||+|.++... .....+.+|+.++++++||||+++++++..++..++||||++ +
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~ 88 (301)
T cd07873 10 KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 88 (301)
T ss_pred EeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-c
Confidence 3467999999999999865 57899999986542 234467789999999999999999999999999999999997 5
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----C
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT----P 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~ 502 (654)
+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 89 ~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (301)
T cd07873 89 DLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHRRK-VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163 (301)
T ss_pred CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence 898888643 235889999999999999999999998 9999999999999999999999999987543221 2
Q ss_pred CCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---chhhhhhh------
Q 036334 503 PTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE---EWTAEVFD------ 572 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~------ 572 (654)
..++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+ ....+...... ........
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhccccccc
Confidence 334667999998865 457889999999999999999999997543211 11111111000 00000000
Q ss_pred HhhhccC------ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 573 VELMRYH------NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 573 ~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
....... ........+.+++.+|++.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 00011234667888999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=297.73 Aligned_cols=246 Identities=27% Similarity=0.393 Sum_probs=193.4
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEEEeCC------ceEEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKD------EKLLVY 420 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~------~~~lv~ 420 (654)
.+.+.||+|+||.||+|... +++.+++|++........++.+|+++++++ .|+||+++++++.... ..++||
T Consensus 9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 88 (275)
T cd06608 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVM 88 (275)
T ss_pred eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEE
Confidence 34578999999999999965 578999999887666667899999999999 6999999999997654 479999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~-i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 166 (275)
T cd06608 89 ELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENK-VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166 (275)
T ss_pred EcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCC-cccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence 99999999999874321 1346899999999999999999999988 999999999999999999999999998765332
Q ss_pred ----CCCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhh
Q 036334 501 ----TPPTRVAGYRAPEVVET-----RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571 (654)
Q Consensus 501 ----~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 571 (654)
....++..|+|||++.. ..++.++|||||||++|||++|+.||...... .....+.... .
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~---- 235 (275)
T cd06608 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFKIPRNP-P---- 235 (275)
T ss_pred hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHHhhccC-C----
Confidence 22345667999998753 34678999999999999999999999643211 1111111100 0
Q ss_pred hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 572 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
............+.+++.+||..||++|||+.++++
T Consensus 236 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 236 ----PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ----CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 011112224456778888999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=289.31 Aligned_cols=242 Identities=24% Similarity=0.339 Sum_probs=194.1
Q ss_pred hhccccccCceeEEEEEecC-CcEEEEEEecccccC----HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVG----KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
..+.||.|.-|+||++.+.+ +..+|+|++.+.... ..+.+.|-++|+.+.||.+..||+.|+.++..|+|||||+
T Consensus 81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp 160 (459)
T KOG0610|consen 81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP 160 (459)
T ss_pred HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence 34679999999999999774 589999999876432 2456778899999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC-----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN----- 499 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~----- 499 (654)
||+|..+++... ...+++..+..++..|+.||+|||..| ||+|||||+||||.++|++-|+||.++.....
T Consensus 161 GGdL~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLHmlG-ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 161 GGDLHSLRQKQP---GKRFSESAARFYAAEVLLALEYLHMLG-IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred CccHHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHHhhc-eeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 999999998653 456999999999999999999999999 99999999999999999999999998532100
Q ss_pred ----------------------------C-C--------------------------CCCccccccCccccCCCCCCcch
Q 036334 500 ----------------------------T-T--------------------------PPTRVAGYRAPEVVETRKVTFKS 524 (654)
Q Consensus 500 ----------------------------~-~--------------------------~~~~~~~y~aPE~~~~~~~~~~~ 524 (654)
. . ..+||..|+|||++.+...+.++
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAV 316 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAV 316 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchh
Confidence 0 0 01233449999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCC
Q 036334 525 DVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRP 604 (654)
Q Consensus 525 DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 604 (654)
|.|+|||++|||+.|..||.+...++. +.+++.+. + .+....+......+||++.+.+||.+|.
T Consensus 317 DWWtfGIflYEmLyG~TPFKG~~~~~T------l~NIv~~~---------l-~Fp~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 317 DWWTFGIFLYEMLYGTTPFKGSNNKET------LRNIVGQP---------L-KFPEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred hHHHHHHHHHHHHhCCCCcCCCCchhh------HHHHhcCC---------C-cCCCCCcchhHHHHHHHHHhccChhhhh
Confidence 999999999999999999988655442 12222211 1 1112223345566778899999999999
Q ss_pred C----HHHHHH
Q 036334 605 A----MQEVVR 611 (654)
Q Consensus 605 s----~~evl~ 611 (654)
. +.||-+
T Consensus 381 g~~rGA~eIK~ 391 (459)
T KOG0610|consen 381 GSKRGAAEIKR 391 (459)
T ss_pred ccccchHHhhc
Confidence 8 666643
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=301.71 Aligned_cols=240 Identities=23% Similarity=0.373 Sum_probs=190.6
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
...||+|+||.||++... ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 456999999999999854 58899999986543 2345688899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----CCC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT----PPT 504 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~~~ 504 (654)
.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+||++++++.++|+|||++....... ...
T Consensus 107 ~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~-ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 179 (292)
T cd06658 107 TDIVTH------TRMNEEQIATVCLSVLRALSYLHNQG-VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV 179 (292)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceee
Confidence 998852 34889999999999999999999998 9999999999999999999999999986543221 234
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..+.. .... ..... ......
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~-~~~~-----~~~~~---~~~~~~ 244 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL------QAMRR-IRDN-----LPPRV---KDSHKV 244 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhc-----CCCcc---cccccc
Confidence 566799999998888999999999999999999999998643211 11111 1100 00000 001112
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 585 MVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
...+.+++.+||..||++|||++|+++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2346677789999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=302.08 Aligned_cols=239 Identities=22% Similarity=0.357 Sum_probs=191.3
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
..||+|+||.||++... +++.||+|++.... ...+.+.+|+.+++.++||||+++++++..++..++||||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 46999999999999854 68899999986542 33456788999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CCCCc
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPPTR 505 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~~~ 505 (654)
.++.. ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...... ....+
T Consensus 107 ~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~-ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 179 (297)
T cd06659 107 DIVSQ------TRLNEEQIATVCESVLQALCYLHSQG-VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 179 (297)
T ss_pred HHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceec
Confidence 98752 34899999999999999999999998 999999999999999999999999998654322 22345
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHH
Q 036334 506 VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585 (654)
Q Consensus 506 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (654)
+..|+|||++.+..++.++|||||||++|||++|+.||...... ..+... ...... . ........
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~-~~~~~~-----~---~~~~~~~~ 244 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMKRL-RDSPPP-----K---LKNAHKIS 244 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH-hccCCC-----C---ccccCCCC
Confidence 67799999998888999999999999999999999998743211 111111 110000 0 00011122
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 586 VQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 586 ~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
..+.+++.+||+.+|++||+++++++.
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 346778889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=299.13 Aligned_cols=243 Identities=23% Similarity=0.408 Sum_probs=190.1
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEEEe------CCceEEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYS------KDEKLLVY 420 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~------~~~~~lv~ 420 (654)
.+.+.||+|+||.||+|... +++.||+|++........++..|+.++.++ +|+||+++++++.. ....+++|
T Consensus 19 ~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 98 (282)
T cd06636 19 ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVM 98 (282)
T ss_pred hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEE
Confidence 44578999999999999964 588999999876555556788899999888 69999999999853 35679999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+++|+|.+++...+ ...+++..++.++.|++.|++|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 99 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~-ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~ 174 (282)
T cd06636 99 EFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174 (282)
T ss_pred EeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence 9999999999997543 235788899999999999999999998 999999999999999999999999998755322
Q ss_pred ----CCCCccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhh
Q 036334 501 ----TPPTRVAGYRAPEVVE-----TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571 (654)
Q Consensus 501 ----~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 571 (654)
....++..|+|||.+. ...++.++|||||||++|||++|+.||......+.. ....+..
T Consensus 175 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~------~~~~~~~------ 242 (282)
T cd06636 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL------FLIPRNP------ 242 (282)
T ss_pred ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh------hhHhhCC------
Confidence 2234566799999885 346788999999999999999999999653221100 0000000
Q ss_pred hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 572 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
. ..........++.+++.+||..||.+||++.|+++
T Consensus 243 ~----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 243 P----PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred C----CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 00011123346788888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=313.14 Aligned_cols=240 Identities=22% Similarity=0.373 Sum_probs=190.4
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEec---cccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCc--eEEEEEe
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLK---EVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDE--KLLVYDY 422 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~---~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~--~~lv~e~ 422 (654)
.++||+|+|-+||+|.+. +|..||--.++ .... ..++|..|+.+|+.|+|||||+++.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 357999999999999965 47777743332 1222 23789999999999999999999999987654 7899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC-CeecCCCCCCcEEECCC-CCeEEeccCCCCCcCCC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG-KIVHGNIKASNILLRPD-HDACVSDFGLNPLFGNT 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-~ivHrDlk~~NIll~~~-~~~kl~Dfgla~~~~~~ 500 (654)
+..|+|..++++. ..++....++|+.||++||.|||++. +|+|||||..||||+.+ |.|||+|+|+|+.....
T Consensus 125 ~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999854 45888999999999999999999876 79999999999999864 89999999999987654
Q ss_pred --CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 501 --TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
....||+.|||||++. ..|++.+||||||++|.||.|+..||..- .+..+.+..+..+-.. ..+. +.
T Consensus 200 ~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-----~n~AQIYKKV~SGiKP-~sl~----kV 268 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-----TNPAQIYKKVTSGIKP-AALS----KV 268 (632)
T ss_pred ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-----CCHHHHHHHHHcCCCH-HHhh----cc
Confidence 3468999999999997 78999999999999999999999999743 3334444444332211 1111 11
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
... ++.++|.+|+.. .++|||+.|+++.
T Consensus 269 --~dP---evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 --KDP---EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred --CCH---HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 122 355566699999 9999999999863
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=297.64 Aligned_cols=247 Identities=25% Similarity=0.404 Sum_probs=193.2
Q ss_pred hccccccCceeEEEEEec------CCcEEEEEEecccccC--HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 351 AEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
.+.||+|+||.||+|..+ +...|++|.+...... ..++.+|++++++++|+||+++++++.+....++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 467999999999999854 2457999988654332 46789999999999999999999999988899999999
Q ss_pred cCCCchhhhhccCCCCC----CCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 423 MPAGSLSALLHGSRGSG----RTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
+++|+|.+++....... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||++....
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~-i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~ 168 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR-FVHRDLAARNCLVSSQREVKVSLLSLSKDVY 168 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC-cccCcCccceEEEeCCCcEEEcccccccccC
Confidence 99999999997543111 125899999999999999999999988 9999999999999999999999999976543
Q ss_pred CC-----CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhh
Q 036334 499 NT-----TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 499 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 572 (654)
.. ....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...+.........
T Consensus 169 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~------~~~~~~~~~~~~~----- 237 (275)
T cd05046 169 NSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD------EEVLNRLQAGKLE----- 237 (275)
T ss_pred cccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch------HHHHHHHHcCCcC-----
Confidence 21 12233456999999988888999999999999999999 7888854221 1111111111100
Q ss_pred HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 573 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
..........+.+++.+||+.+|++||++.|+++.|.
T Consensus 238 -----~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 -----LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0001122246778888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=295.10 Aligned_cols=243 Identities=21% Similarity=0.344 Sum_probs=192.4
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEeccccc-------CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAV-------GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
..+.||+|+||.||++.. .+++.||+|.+..... ..+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 346799999999999985 5688999999865331 13567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC-CeEEeccCCCCCcCCC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH-DACVSDFGLNPLFGNT 500 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~ 500 (654)
|+++++|.+++.. ..++++..++.++.|++.||+|||+++ ++|+||+|+||+++.++ .+||+|||.+......
T Consensus 84 ~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~~~-i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 84 WMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHENQ-IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred ccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999973 245889999999999999999999998 99999999999998776 5999999998765432
Q ss_pred C--------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhh
Q 036334 501 T--------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 501 ~--------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 572 (654)
. ...++..|+|||.+.+..++.++||||+|+++|+|++|..||....... .............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~------ 228 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFKIASATT------ 228 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHHHhccCC------
Confidence 1 1234567999999988889999999999999999999999986432211 1111111100000
Q ss_pred HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 573 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..........++.+++.+|+..+|++||++.|+++
T Consensus 229 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01111223356778889999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=292.43 Aligned_cols=242 Identities=23% Similarity=0.374 Sum_probs=195.4
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
..+.||+|+||.||++... +|+.||+|++.... ....++.+|+.++++++||||+++++++...+..++||||+.+
T Consensus 4 ~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08218 4 KVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83 (256)
T ss_pred EEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCC
Confidence 3578999999999999854 58899999986532 2345788999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 501 (654)
++|.+++.... ...+++..+++++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 84 GDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDRK-ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 99999987432 235789999999999999999999988 9999999999999999999999999987654322
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++|||||||+++||++|+.||.... ....+......... ...
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~~~~-----------~~~ 222 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIRGSYP-----------PVS 222 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhcCCCC-----------CCc
Confidence 2345667999999988889999999999999999999999986421 12222222211110 011
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.....++.+++.+||+.+|++||++.||++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 2233467788889999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.69 Aligned_cols=243 Identities=24% Similarity=0.400 Sum_probs=196.3
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
..+.||+|+||.||++... ++..|++|++.........+.+|++++++++|+||+++++++...+..++|+||+++++|
T Consensus 23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 102 (286)
T cd06614 23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102 (286)
T ss_pred HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcH
Confidence 3467999999999999976 688999999976544566788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CCCC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPPT 504 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~~ 504 (654)
.+++.... ..+++..++.++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++...... ....
T Consensus 103 ~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g-i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 177 (286)
T cd06614 103 TDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN-VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV 177 (286)
T ss_pred HHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcccc
Confidence 99998432 36999999999999999999999988 999999999999999999999999987654432 2234
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .......... .. ........
T Consensus 178 ~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~--------~~~~~~~~ 242 (286)
T cd06614 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLITTKG-IP--------PLKNPEKW 242 (286)
T ss_pred CCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcC-CC--------CCcchhhC
Confidence 566799999998888999999999999999999999998643211 1111111100 00 01111113
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 585 MVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
...+.+++.+||+.+|.+||++.++++.
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 243 SPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 3467788889999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=290.93 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=200.5
Q ss_pred hccccccCceeEEEEEecC------CcEEEEEEecccccC--HHHHHHHHHHHhccCCCccccccEEEEeC-CceEEEEE
Q 036334 351 AEVLGKGSVGTSYKAVLEE------GTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNVVPLRAFYYSK-DEKLLVYD 421 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~l~~~~~~~-~~~~lv~e 421 (654)
..++-+|.||.||+|.+.+ .+.|.||.++..... -..+..|--++..+.|||+..+.+++..+ +..+++|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 4568899999999997653 345677777655432 23466777778888999999999998764 45689999
Q ss_pred ecCCCchhhhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 422 YMPAGSLSALLHGSRGS---GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
++..|+|..+|...++. ..+.+.-.+...++.|++.|++|||.++ +||.||.++|++||+.-++||+|=.+++.+-
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~-ViHkDiAaRNCvIdd~LqVkltDsaLSRDLF 447 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG-VIHKDIAARNCVIDDQLQVKLTDSALSRDLF 447 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC-cccchhhhhcceehhheeEEeccchhccccC
Confidence 99999999999844422 3456788889999999999999999998 9999999999999999999999999887653
Q ss_pred CC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhh
Q 036334 499 NT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571 (654)
Q Consensus 499 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 571 (654)
+. ....+...||+||.+....|+.++|||||||+||||+| |+.|+..-++.+ +...+.+++
T Consensus 448 P~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------m~~ylkdGy----- 515 (563)
T KOG1024|consen 448 PGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------MEHYLKDGY----- 515 (563)
T ss_pred cccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------HHHHHhccc-----
Confidence 32 33455667999999999999999999999999999999 899987543322 222222222
Q ss_pred hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 572 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
+...+.++..+|+.+|..||+.+|++||++++++.-|.++...
T Consensus 516 -----RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 516 -----RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred -----eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 3334556677899999999999999999999999999988643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=325.07 Aligned_cols=253 Identities=28% Similarity=0.383 Sum_probs=204.2
Q ss_pred HhhccccccCceeEEEEEec----C----CcEEEEEEecccccC--HHHHHHHHHHHhcc-CCCccccccEEEEeCCceE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE----E----GTTVVVKRLKEVAVG--KREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKL 417 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~----~----g~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~ 417 (654)
.+.+.||+|.||.|++|... . ...||||.++..... .+.+..|+++|+.+ +|+||+.++|+|...+..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 55569999999999999733 1 357999999876443 56789999999998 5999999999999999999
Q ss_pred EEEEecCCCchhhhhccCC---------CCCC--CCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCe
Q 036334 418 LVYDYMPAGSLSALLHGSR---------GSGR--TPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDA 486 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~ 486 (654)
+|+||++.|+|.++++..+ .... ..+...+.+.++.|||.|++||+++. ++||||.++|||+.++..+
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~-~vHRDLAaRNVLi~~~~~~ 457 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP-CVHRDLAARNVLITKNKVI 457 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC-ccchhhhhhhEEecCCCEE
Confidence 9999999999999998776 1111 23899999999999999999999987 9999999999999999999
Q ss_pred EEeccCCCCCcCCCCC-----CC--ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHH
Q 036334 487 CVSDFGLNPLFGNTTP-----PT--RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWV 558 (654)
Q Consensus 487 kl~Dfgla~~~~~~~~-----~~--~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~ 558 (654)
||+|||+|+....... .. -...|||||.+....|+.|+|||||||+|||++| |..||.+... ..+.
T Consensus 458 kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-----~~~l- 531 (609)
T KOG0200|consen 458 KIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-----TEEL- 531 (609)
T ss_pred EEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-----HHHH-
Confidence 9999999985433211 11 1234999999999999999999999999999999 8889865211 1111
Q ss_pred HHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 559 QSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
...++++. +...+..+..+++++|+.||+.+|++||+|.++++.++....
T Consensus 532 ~~~l~~G~----------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 532 LEFLKEGN----------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHhcCC----------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 22233332 223344556788899999999999999999999999998643
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=292.20 Aligned_cols=247 Identities=23% Similarity=0.366 Sum_probs=196.1
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
..+.||+|+||.||++... +++.|++|++.... ....++.+|++++++++||||+++++++..+...++|+||++++
T Consensus 5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (265)
T cd06605 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG 84 (265)
T ss_pred HHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCC
Confidence 3567999999999999965 58899999987653 23456888999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--CCC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV-SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--TPP 503 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--~~~ 503 (654)
+|.+++.... ..+++..+.+++.|++.|++|||+ .+ ++|+||||+||++++++.++|+|||.+...... ...
T Consensus 85 ~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~-i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (265)
T cd06605 85 SLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK-IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF 159 (265)
T ss_pred cHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC-eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcc
Confidence 9999997432 568999999999999999999998 77 999999999999999999999999998755322 124
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ......+......... . .....
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~------~----~~~~~ 228 (265)
T cd06605 160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEPPP------R----LPSGK 228 (265)
T ss_pred cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCCCC------C----CChhh
Confidence 45667999999998899999999999999999999999987543211 1112222222111100 0 00111
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
...++.+++.+||..+|++|||+.+++..
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 229 FSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred cCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 34457788889999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=292.60 Aligned_cols=239 Identities=24% Similarity=0.344 Sum_probs=191.3
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccccc------CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV------GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.++||+|+||+||+|... ++..|++|.+..... ..+.+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV 84 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence 467999999999999976 789999999865431 2356888999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
++++|.+++.. ...+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 85 PGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHDRN-TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEccCccceeccccccc
Confidence 99999999973 235889999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCccccccCccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 TPPTRVAGYRAPEVVETRK-VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....++..|+|||.+.... ++.++|+||||+++|+|++|+.||..... ............. ..
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~----------~~ 222 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKEL----------PP 222 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccC----------CC
Confidence 2334566799999987766 89999999999999999999999865321 1111111110000 00
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
........+.+++.+||..+|++||++.++++
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 01112345667888999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=300.12 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=190.1
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccccC------HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG------KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+.||+|+||.||+|... +|+.|++|.++..... ...+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM 84 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence 467999999999999964 5899999999765322 345678999999999999999999999988999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC--
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-- 501 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-- 501 (654)
+|+|.+++.... ..+++..+++++.|+++||+|||+++ |+|+||||+||+++.++.++|+|||++.......
T Consensus 85 -~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~-i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 85 -ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW-ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred -CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 899999997431 36899999999999999999999998 9999999999999999999999999987664432
Q ss_pred --CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh----ch-----hhh
Q 036334 502 --PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE----EW-----TAE 569 (654)
Q Consensus 502 --~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~-----~~~ 569 (654)
....+..|+|||.+.+ ..++.++|||||||++|||++|.+||......+ ........... .+ ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhhcccccc
Confidence 1233556999998854 467899999999999999999988776533211 00000000000 00 000
Q ss_pred hhhHhhhc----cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 570 VFDVELMR----YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 570 ~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
........ ..........+.+++.+||+.+|++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000 0001122356778899999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=293.35 Aligned_cols=243 Identities=27% Similarity=0.372 Sum_probs=192.8
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
...+.||+|+||.||+|... ++..|++|.++.... ..+.+..|++++++++|+||+++++++.+.+..++|+||++
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS 82 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence 34578999999999999854 688999999876544 35678899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC--
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP-- 502 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-- 502 (654)
+++|.+++.. ...+++..++.++.|++.|++|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~-i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 83 GGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHSHG-IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999973 234789999999999999999999998 99999999999999999999999999877643321
Q ss_pred ------CCccccccCccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 503 ------PTRVAGYRAPEVVETRK---VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 503 ------~~~~~~y~aPE~~~~~~---~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
..++..|+|||++.+.. ++.++||||||+++||+++|+.||...... ......... . ..+
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~-----~~~ 225 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVGA-G-----HKP 225 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHhc-C-----CCC
Confidence 23456799999998766 889999999999999999999999643211 011111000 0 000
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.+ .........+.+++.+||+.+|++||++.|++.
T Consensus 226 ~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PI---PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CC---CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 011112345667888999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=301.82 Aligned_cols=244 Identities=18% Similarity=0.252 Sum_probs=191.7
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.+.||+|+||.||++... .++.|++|.+..... ....+.+|+++++.++||||+++++.+..++..++||||+++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 467999999999999965 478999999875432 234677899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----- 500 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----- 500 (654)
++|.+++.. ...+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 86 ~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 86 GDCATLLKN-----IGALPVDMARMYFAETVLALEYLHNYG-IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 999999963 245899999999999999999999988 999999999999999999999999987632100
Q ss_pred --------------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhch
Q 036334 501 --------------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEW 566 (654)
Q Consensus 501 --------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 566 (654)
....++..|+|||.+.+..++.++|||||||++|||++|..||..... ..+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~~~~~~~~~ 233 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELFGQVISDDI 233 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhccc
Confidence 012345579999999888899999999999999999999999964321 111221111110
Q ss_pred hhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 567 TAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
. ...........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 234 ~---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 234 E---------WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred C---------CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0 000011223456788889999999999998777776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=293.19 Aligned_cols=239 Identities=22% Similarity=0.342 Sum_probs=184.5
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc------CHHHHHHHHHHHhccCCCccccccEEEEeC--CceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV------GKREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~ 420 (654)
..++||+|+||.||+|... .+..|++|++..... ....+.+|+.++++++||||+++++++.+. ...++++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 3578999999999999864 588999999864321 124578899999999999999999988753 5678999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+++++|.+++.. ...+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~-i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 86 EYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred eCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 99999999999973 235889999999999999999999887 999999999999999999999999998754321
Q ss_pred -------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 -------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+........ .+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~-----~~ 228 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT-----NP 228 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC-----CC
Confidence 123456679999999988899999999999999999999999974311 111111111000 00
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
. ........+..++ +||..+|++||+++|+++
T Consensus 229 ~-----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 229 Q-----LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred C-----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0 0111122334444 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=300.80 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=189.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
..+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++++++||||+++++++..++..++||||+++
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (286)
T cd07846 5 NLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH 84 (286)
T ss_pred EeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCc
Confidence 3478999999999999975 488999999865432 245678899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 501 (654)
++|..+... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 85 TVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSHN-IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred cHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence 999887753 234899999999999999999999998 9999999999999999999999999987654322
Q ss_pred CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh--chhhhhhh------
Q 036334 502 PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE--EWTAEVFD------ 572 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~------ 572 (654)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ...-+...... ......++
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2234567999999865 457889999999999999999999986432111 00000000000 00000000
Q ss_pred ----HhhhccC----ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 573 ----VELMRYH----NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 573 ----~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
+...... ........+.+++.+||..+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000 00112345778888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=282.39 Aligned_cols=198 Identities=27% Similarity=0.385 Sum_probs=168.7
Q ss_pred HHhhccccccCceeEEEEEecC-----CcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEe-CCceEE
Q 036334 348 RASAEVLGKGSVGTSYKAVLEE-----GTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYS-KDEKLL 418 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~~~l 418 (654)
|+....||+|.||.||+|.-.+ ...+|+|.++.... -....-+||.+++.++||||+.+..+|.. +...++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 4556779999999999996332 23789999986632 13456789999999999999999999887 778899
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC----CCeEEeccCCC
Q 036334 419 VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD----HDACVSDFGLN 494 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~----~~~kl~Dfgla 494 (654)
++||.+. +|.++++..+......++-..+..|+.||+.|+.|||++- |.||||||.|||+..+ |.|||+|||++
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW-vlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW-VLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh-eeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 9999977 9999998776655667999999999999999999999987 9999999999999887 89999999999
Q ss_pred CCcCCC-------CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 036334 495 PLFGNT-------TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASL 547 (654)
Q Consensus 495 ~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~ 547 (654)
+.+... ....-|..|+|||.+.+ ..|+.+.||||+|||+.||+|-++.|....
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 987654 23445678999999876 568999999999999999999999987643
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=289.58 Aligned_cols=242 Identities=21% Similarity=0.379 Sum_probs=193.2
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
..+.||+|+||.||++... +++.+|+|.+..... ....+.+|++++++++||||+++++.+..++..++||||+++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08220 4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPG 83 (256)
T ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCC
Confidence 4578999999999999854 578999999865432 345688899999999999999999999988999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC-CeEEeccCCCCCcCCCC---
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH-DACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~~--- 501 (654)
++|.+++.... ...+++..+++++.+++.+++|||+++ ++|+||||+||+++.++ .+||+|||.+.......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~-i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 84 GTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 99999997432 345899999999999999999999988 99999999999998654 57999999987665432
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...+......... ...
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------~~~~~~~~~~~~~-----------~~~ 222 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL------PALVLKIMSGTFA-----------PIS 222 (256)
T ss_pred ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch------HHHHHHHHhcCCC-----------CCC
Confidence 23456679999999988899999999999999999999999864321 1222221111100 001
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.....++.+++.+||+.+|++|||+.|+++.
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1123457788889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=297.38 Aligned_cols=242 Identities=24% Similarity=0.354 Sum_probs=192.9
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEeccc-ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV-AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.+.||+|+||.||++... ++..|++|.+... ....+.+.+|+.++++++||||+++++++...+..++|+||++++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (293)
T cd06647 22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGG 101 (293)
T ss_pred eeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCC
Confidence 34578999999999999854 5789999998643 233456788999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----C
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT----P 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~ 502 (654)
+|.+++.. ..+++..+..++.|++.|++|||+++ ++||||||+||+++.++.+||+|||++....... .
T Consensus 102 ~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~g-i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 102 SLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred cHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC-EeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 99999863 24789999999999999999999998 9999999999999999999999999876554322 2
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..++..|+|||.+....++.++|||||||++||+++|+.||......+... ....... .......
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~---------~~~~~~~ 239 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT---------PELQNPE 239 (293)
T ss_pred ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCC---------CCCCCcc
Confidence 245566999999988889999999999999999999999997543221100 0000000 0011111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.....+.+++.+||..+|++||++.+++.+
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 223356678889999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=294.64 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=194.0
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeC--CceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e~~~~ 425 (654)
.+.||.|++|.||++... +++.+|+|.+..... ...++.+|++++++++||||++++++|.+. ...++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 367999999999999974 578999999875432 346688999999999999999999998654 367999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--CCC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--TPP 503 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--~~~ 503 (654)
++|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 86 ~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~-i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 163 (287)
T cd06621 86 GSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK-IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF 163 (287)
T ss_pred CCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEecCCeEEEeeccccccccccccccc
Confidence 999988754321 2345889999999999999999999998 999999999999999999999999998755432 223
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.++..|+|||.+.+..++.++||||+||++|||++|+.||....... ............... ..+... ......
T Consensus 164 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~---~~~~~~ 237 (287)
T cd06621 164 TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVNMPN--PELKDE---PGNGIK 237 (287)
T ss_pred cCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhcCCc--hhhccC---CCCCCc
Confidence 45667999999998899999999999999999999999997653211 111111111111000 000000 000112
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
....+.+++.+||+.+|++|||+.|+++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 3456788899999999999999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=291.47 Aligned_cols=239 Identities=21% Similarity=0.270 Sum_probs=185.7
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc---c---CHHHHHHHHHHHhccCCCccccccEEEEeC--CceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---V---GKREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~ 420 (654)
+.++||+|+||.||+|... +|..||+|.+.... . ..+.+.+|++++++++||||+++++++.+. ...++||
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 3578999999999999864 58899999885321 1 124678899999999999999999988764 4578999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC-
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN- 499 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~- 499 (654)
||+++++|.+++.. ...+++..+++++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 86 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 86 EHMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHSNM-IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 99999999999863 234788999999999999999999998 99999999999999999999999999875432
Q ss_pred ------CCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 500 ------TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 500 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+........
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~------- 226 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPT------- 226 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHHHHhcCCC-------
Confidence 12234566799999998888999999999999999999999998642111 11111111000
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
...........+..++.+|+. +|++||+++|+++
T Consensus 227 ---~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 ---NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 011112233456677778884 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=289.64 Aligned_cols=243 Identities=25% Similarity=0.380 Sum_probs=197.6
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.||+|++|.||+|... +++.|++|++..... ...++.+|+..+.+++|+||+++++++..++..++||||++++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06623 5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG 84 (264)
T ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence 3578999999999999976 489999999876542 4567899999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC---
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV-SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP--- 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~--- 502 (654)
+|.+++... ..+++..++.++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 85 ~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~-~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 85 SLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC-CccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 999999732 468999999999999999999999 87 99999999999999999999999999877654332
Q ss_pred -CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 503 -PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 503 -~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
..++..|+|||.+.+..++.++||||||+++|||++|+.||...... ........+..... ....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~-----------~~~~ 224 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFELMQAICDGPP-----------PSLP 224 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc---CHHHHHHHHhcCCC-----------CCCC
Confidence 23456799999999889999999999999999999999999764321 11111111111100 0011
Q ss_pred HH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 582 EE-EMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 582 ~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.. ....+.+++.+||..+|++||++.++++.
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 33567788889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.64 Aligned_cols=244 Identities=25% Similarity=0.320 Sum_probs=192.0
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.+.||+|+||.||++... +++.||+|.+..... ..+.+..|+++++.++||||+++++++.+.+..++||||+.+
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence 467999999999999965 489999999976532 235678899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 501 (654)
++|.+++.... ...+++..+..++.|++.||+|||..+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (316)
T cd05574 86 GELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161 (316)
T ss_pred CCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCC-eeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence 99999987432 246899999999999999999999988 9999999999999999999999999876543211
Q ss_pred -----------------------------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 036334 502 -----------------------------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGI 552 (654)
Q Consensus 502 -----------------------------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~ 552 (654)
...++..|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-- 239 (316)
T cd05574 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE-- 239 (316)
T ss_pred cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH--
Confidence 1134567999999998889999999999999999999999997543211
Q ss_pred ChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 553 DLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 553 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
....+..... ...........+.+++.+||..||++||+++..++++.
T Consensus 240 ----~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 240 ----TFSNILKKEV----------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred ----HHHHHhcCCc----------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 1111111110 01111113456778888999999999999444444333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=292.52 Aligned_cols=247 Identities=27% Similarity=0.404 Sum_probs=194.7
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.||.|+||+||+|... ++..+++|++.... .....+.+|++.++.++|+||+++++.+...+..++||||++++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (267)
T cd06610 5 LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGG 84 (267)
T ss_pred eeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCC
Confidence 3577999999999999954 57899999986543 24567889999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC----
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP---- 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---- 502 (654)
+|.+++..... ...+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 85 ~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~-i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 161 (267)
T cd06610 85 SLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG-QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK 161 (267)
T ss_pred cHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccc
Confidence 99999974321 245899999999999999999999988 99999999999999999999999999765543221
Q ss_pred ----CCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 503 ----PTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 503 ----~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
..++..|+|||++... .++.++|||||||++|||++|+.||......+ .+........ .....
T Consensus 162 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~~------~~~~~ 229 (267)
T cd06610 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQNDP------PSLET 229 (267)
T ss_pred ccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCCC------CCcCC
Confidence 2356679999998776 78999999999999999999999997543211 1111111110 00000
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..........+.+++.+||..||++||+++++++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0001123356778888999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=297.92 Aligned_cols=244 Identities=24% Similarity=0.341 Sum_probs=192.9
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
+...+.||+|+||.||+|... +|+.||+|.+..... ...++.+|+++++.++||||++++++|.+++..++||||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 344578999999999999864 588999999864321 224678899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP 502 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 502 (654)
+. |++.+++... ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 97 ~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH~~~-i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~ 170 (307)
T cd06607 97 CL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLHSHE-RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS 170 (307)
T ss_pred hC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCcccEEECCCCCEEEeecCcceecCCCCC
Confidence 96 5777766532 235899999999999999999999988 99999999999999999999999999887665555
Q ss_pred CCccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 503 PTRVAGYRAPEVVE---TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 503 ~~~~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
..++..|+|||++. ...++.++||||||+++|||++|+.||..... ........... . ...
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~~~~~~~~~~~-~---------~~~ 234 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQND-S---------PTL 234 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------HHHHHHHhcCC-C---------CCC
Confidence 56677899999874 45688999999999999999999999864321 11111110000 0 000
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
........+.+++.+||..+|++||++.+++...
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 1123345678888999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=292.06 Aligned_cols=240 Identities=23% Similarity=0.359 Sum_probs=193.1
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
...+.||+|+||.||+|... ++..||+|.+.... .....+.+|+.++++++||||+++++++..+...++||||+++
T Consensus 7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06641 7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 86 (277)
T ss_pred hhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCC
Confidence 34567999999999999854 68899999976442 2235688899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 501 (654)
++|.+++.. ..+++..+..++.|++.++.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 87 ~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 87 GSALDLLEP------GPLDETQIATILREILKGLDYLHSEK-KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCC-eecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 999999863 35899999999999999999999988 9999999999999999999999999987654321
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||.+.+..++.++|||||||++|||++|..||..... ......+.... . ....
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~-~----------~~~~ 222 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVLFLIPKNN-P----------PTLE 222 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHHHHHhcCC-C----------CCCC
Confidence 22456679999999888899999999999999999999999864221 11111111100 0 0011
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.....++.+++.+||+.+|++||++.++++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1223456778889999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=299.25 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=191.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.+.||+|+||.||+|... +++.|++|+++... .....+.+|++++++++|+||+++++++..++..++||||+++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 84 (288)
T cd07833 5 VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER 84 (288)
T ss_pred EEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCC
Confidence 4577999999999999965 47899999987542 2346788999999999999999999999999999999999998
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 501 (654)
+.+..+... ...+++..++.++.|++.|++|||+.+ ++||||+|+||++++++.+||+|||++.......
T Consensus 85 ~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 85 TLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHN-IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 777766542 234899999999999999999999998 9999999999999999999999999987765432
Q ss_pred -CCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh------------hchh
Q 036334 502 -PPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR------------EEWT 567 (654)
Q Consensus 502 -~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~------------~~~~ 567 (654)
...++..|+|||++.+. .++.++||||||+++|||++|+.||......+ .......... ....
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID---QLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHhhhcccCccc
Confidence 22345669999999887 88999999999999999999999987532211 0000000000 0000
Q ss_pred h-----hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 568 A-----EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 568 ~-----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
. ...+..............++.+++++||..+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 0000000000001112456788899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.86 Aligned_cols=245 Identities=24% Similarity=0.385 Sum_probs=189.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc-----------CHHHHHHHHHHHhccCCCccccccEEEEeCCceE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV-----------GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKL 417 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-----------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 417 (654)
..+.||+|+||.||+|... +|+.||+|.++.... ..+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 4578999999999999854 588999998864211 1235778999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 418 LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKG-ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred EEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC-eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999743 46899999999999999999999988 999999999999999999999999998765
Q ss_pred CCCC------CCCccccccCccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhh
Q 036334 498 GNTT------PPTRVAGYRAPEVVETRK--VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAE 569 (654)
Q Consensus 498 ~~~~------~~~~~~~y~aPE~~~~~~--~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 569 (654)
.... ...++..|+|||.+.... ++.++||||||+++||+++|..||..... ... ........ ...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~-~~~~~~~~-~~~ 231 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAA-MFKLGNKR-SAP 231 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHH-HHHhhccc-cCC
Confidence 4321 223556799999987654 78999999999999999999999853211 111 11110000 000
Q ss_pred hhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 570 VFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.+... ........+.+++.+||..+|++||+++++++.
T Consensus 232 ~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 232 PIPPD-----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcc-----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00000 011223467778889999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=295.99 Aligned_cols=244 Identities=23% Similarity=0.360 Sum_probs=185.9
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHH-HhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV--GKREFEMQMEV-LGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~e~~~-l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.||+|+||.||++... +|+.||+|+++.... ...++..|+.. ++..+||||+++++++..++..++||||++ |
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 467999999999999965 589999999876532 23445556654 666789999999999999999999999996 6
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---CC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---PP 503 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~~ 503 (654)
+|.+++..... ....+++..++.++.|++.||+|||++..++||||||+||+++.++.+||+|||++....... ..
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (283)
T cd06617 85 SLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID 163 (283)
T ss_pred cHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 88888764332 235689999999999999999999987239999999999999999999999999987654322 23
Q ss_pred CccccccCccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 504 TRVAGYRAPEVVET----RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 504 ~~~~~y~aPE~~~~----~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
.++..|+|||.+.+ ..++.++|+|||||++|||++|+.||...... ...+........ ...
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~------~~~---- 228 (283)
T cd06617 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVEEPS------PQL---- 228 (283)
T ss_pred cCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHhcCC------CCC----
Confidence 45667999998865 45688999999999999999999998642110 111111111100 000
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.......++.+++.+||..+|++||+++++++
T Consensus 229 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 229 PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01112345778888999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=290.63 Aligned_cols=244 Identities=23% Similarity=0.361 Sum_probs=193.7
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEe--CCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYS--KDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~ 423 (654)
..+.||.|+||.||++.. .+|..||+|+++.... ..+++..|++++++++||||+++++++.. +...+++|||+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~ 83 (265)
T cd08217 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC 83 (265)
T ss_pred eeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence 346799999999999985 4678999999875432 23457789999999999999999998764 34578999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-----ccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH-----VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-----~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
++++|.+++...+. ....+++..++.++.|++.||+||| +.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~-i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 84 EGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT-VLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred cCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc-ceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 99999999975432 2456899999999999999999999 776 9999999999999999999999999988765
Q ss_pred CCC----CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 499 NTT----PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 499 ~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
... ...++..|+|||++.+..++.++||||||+++|+|++|+.||..... ......+ .....
T Consensus 162 ~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~-~~~~~------- 227 (265)
T cd08217 162 HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------LQLASKI-KEGKF------- 227 (265)
T ss_pred CCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------HHHHHHH-hcCCC-------
Confidence 433 23456779999999988899999999999999999999999975321 1111111 11100
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
..........+.+++.+|++.+|++||++++|++.
T Consensus 228 ---~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 ---RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 01112234567888889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.03 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=187.1
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
..+.||+|+||.||+|... +|+.||+|+++.... ....+.+|++++++++||||+++++++.+.+..++|+||++
T Consensus 4 ~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 82 (284)
T cd07839 4 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD- 82 (284)
T ss_pred eEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-
Confidence 3467999999999999965 588999999865422 23457789999999999999999999999999999999996
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 501 (654)
++|.+++... ...+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~-i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 83 QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHSHN-VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 5787777532 245899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---h----chh--hhhh
Q 036334 502 PPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR---E----EWT--AEVF 571 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---~----~~~--~~~~ 571 (654)
...++..|+|||.+.+. .++.++|||||||++|||++|+.|+...... ......+.. . .+. ....
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-----DDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-----HHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 23345679999998664 4789999999999999999999886432211 111111100 0 000 0000
Q ss_pred hHh-hhccC-------ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 572 DVE-LMRYH-------NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 572 ~~~-~~~~~-------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
+.. ..... .......++.+++.+||+.||.+|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 00000 00112235667888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=294.31 Aligned_cols=239 Identities=21% Similarity=0.274 Sum_probs=182.9
Q ss_pred cccccCceeEEEEEec-CCcEEEEEEecccccC----HHHHHHHHHH---HhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 353 VLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG----KREFEMQMEV---LGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 353 ~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~e~~~---l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+||+|+||.||++... +++.||+|.+...... ...+.+|..+ +...+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 5889999998654221 2223344433 333479999999999999899999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--CC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--TP 502 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--~~ 502 (654)
+|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++...... ..
T Consensus 81 ~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~-ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 154 (279)
T cd05633 81 GGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 154 (279)
T ss_pred CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cCCCCCCHHHEEECCCCCEEEccCCcceeccccCccC
Confidence 9999998863 345999999999999999999999998 999999999999999999999999998655432 22
Q ss_pred CCccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 503 PTRVAGYRAPEVVE-TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 503 ~~~~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
..++..|+|||.+. +..++.++||||+||++|||++|..||....... ...+...... . .....
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~------~-----~~~~~ 219 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTLT------V-----NVELP 219 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC----HHHHHHHhhc------C-----CcCCc
Confidence 35677899999986 4568999999999999999999999997543221 1111111100 0 00111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRP-----AMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 612 (654)
.....++.+++.+||..||++|| +++|+++.
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 12234567788899999999999 58888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=292.34 Aligned_cols=240 Identities=20% Similarity=0.271 Sum_probs=194.1
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||.|+||.||++... ++..||+|.+.... ...+.+.+|++++++++||||+++++++.++...++|+||++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (258)
T cd05578 4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLL 83 (258)
T ss_pred EEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCC
Confidence 4578999999999999965 58899999997542 234678889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---C
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---T 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~ 501 (654)
+++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++...... .
T Consensus 84 ~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~-i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 84 GGDLRYHLSQ-----KVKFSEEQVKFWICEIVLALEYLHSKG-IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157 (258)
T ss_pred CCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHeEEcCCCCEEEeecccccccCCCcccc
Confidence 9999999963 246899999999999999999999988 999999999999999999999999998766443 2
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ...++....... .....
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~-----------~~~~~ 222 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQETA-----------DVLYP 222 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhccc-----------cccCc
Confidence 334556799999998888999999999999999999999999764332 112221111110 01111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAM--QEVV 610 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~--~evl 610 (654)
......+.+++.+||+.||.+||++ +|++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1223567788889999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=292.73 Aligned_cols=241 Identities=20% Similarity=0.360 Sum_probs=191.4
Q ss_pred HhhccccccCceeEEEEEe-cCCcEEEEEEecccc--cCHHHHHHHHHHHhccC---CCccccccEEEEeCCceEEEEEe
Q 036334 349 ASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKIK---HDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
...+.||+|+||.||+|.. .++..||+|.++... ....++.+|+.++++++ |||++++++++..+...++||||
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83 (277)
T ss_pred hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence 3457799999999999995 468899999986542 23456888999998886 99999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT- 501 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 501 (654)
+++++|.+++.. ..+++..++.++.|++.|+.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~-i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 84 AEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKVG-VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred CCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999862 25899999999999999999999998 9999999999999999999999999987664332
Q ss_pred ---CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 502 ---PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 502 ---~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... .+... ... ..+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~~~-~~~-----~~~~~-- 222 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMMLI-PKS-----KPPRL-- 222 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhhcc-ccC-----CCCCC--
Confidence 2345667999998865 457899999999999999999999996532211 11100 000 00000
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.......++.+++.+||+.||++||++.|+++.
T Consensus 223 --~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 223 --EDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 001133467788889999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=294.44 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=203.8
Q ss_pred HHHhhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccC--CCc----cccccEEEEeCCceEEE
Q 036334 347 LRASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIK--HDN----VVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 347 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~--hpn----iv~l~~~~~~~~~~~lv 419 (654)
.|.+...+|+|.||.|-++... .+..||||+++....-.+...-|+++++++. .|+ +|.+.++|...++.+||
T Consensus 90 Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCiv 169 (415)
T KOG0671|consen 90 RYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIV 169 (415)
T ss_pred ceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEE
Confidence 4456678999999999999854 3789999999988777778888999999994 233 88899999999999999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC-----------------
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP----------------- 482 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~----------------- 482 (654)
+|.+ |-|+.++|..+ +..+++...+..|+.|++++++|||+.+ ++|.||||+|||+.+
T Consensus 170 fell-G~S~~dFlk~N---~y~~fpi~~ir~m~~QL~~sv~fLh~~k-l~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 170 FELL-GLSTFDFLKEN---NYIPFPIDHIRHMGYQLLESVAFLHDLK-LTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred Eecc-ChhHHHHhccC---CccccchHHHHHHHHHHHHHHHHHHhcc-eeecCCChheEEEeccceEEEeccCCccceec
Confidence 9998 66999999865 4567999999999999999999999987 999999999999842
Q ss_pred ---CCCeEEeccCCCCCcCCC-CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHH
Q 036334 483 ---DHDACVSDFGLNPLFGNT-TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWV 558 (654)
Q Consensus 483 ---~~~~kl~Dfgla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~ 558 (654)
+..+||+|||.|++.... .....|..|+|||++.+-.++.++||||+||||+|++||...|+...+.+.+.+...+
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerI 324 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERI 324 (415)
T ss_pred cCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHh
Confidence 235899999999987654 4456778899999999999999999999999999999999999987654432221111
Q ss_pred HH-----Hhhhchhhhh-----------------------hhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 036334 559 QS-----VVREEWTAEV-----------------------FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVV 610 (654)
Q Consensus 559 ~~-----~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 610 (654)
.. +......... ..+.........++..+|++|+++|+..||.+|+|+.|++
T Consensus 325 lGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL 404 (415)
T KOG0671|consen 325 LGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREAL 404 (415)
T ss_pred hCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHh
Confidence 10 0000000000 0000011123355667799999999999999999999997
Q ss_pred H
Q 036334 611 R 611 (654)
Q Consensus 611 ~ 611 (654)
.
T Consensus 405 ~ 405 (415)
T KOG0671|consen 405 S 405 (415)
T ss_pred c
Confidence 5
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=294.96 Aligned_cols=239 Identities=22% Similarity=0.372 Sum_probs=191.6
Q ss_pred hccccccCceeEEEEEe-cCCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 351 AEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.+.||+|++|.||++.. .+++.+++|++.... ...+.+.+|+.+++.++||||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 36899999999999985 468899999886443 2345578899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----CCC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT----PPT 504 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~~~ 504 (654)
.+++.. ..+++..+..++.|++.|++|||+.+ |+||||+|+||+++.++.++|+|||.+....... ...
T Consensus 104 ~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 104 TDIVTH------TRMNEEQIATVCLAVLKALSFLHAQG-VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred HHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence 999873 34899999999999999999999998 9999999999999999999999999876543321 234
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
++..|+|||.+.+..++.++|||||||++|||++|+.||..... .......... .. +.. ......
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~-~~-----~~~---~~~~~~ 241 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDN-LP-----PKL---KNLHKV 241 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhc-CC-----CCC---cccccC
Confidence 56779999999888899999999999999999999999864221 1111111111 00 000 001112
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 585 MVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
...+.+++.+||+.+|++||++.++++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 346788888999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=288.57 Aligned_cols=238 Identities=20% Similarity=0.278 Sum_probs=191.6
Q ss_pred ccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 354 LGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 354 lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
||+|+||.||++... .++.|++|++.... ...+.+.+|+.++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999965 48899999987543 2345688899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---CCCCc
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TPPTR 505 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~~~~~ 505 (654)
.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... ....+
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~-~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~ 154 (262)
T cd05572 81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLHNRG-IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCG 154 (262)
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccC
Confidence 9999742 34899999999999999999999988 999999999999999999999999998876543 22345
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHH
Q 036334 506 VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585 (654)
Q Consensus 506 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (654)
+..|++||.+.+..++.++|+||+|+++|||++|..||..... +.......+..... .........
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~----------~~~~~~~~~ 220 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILKGNG----------KLEFPNYID 220 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhccCC----------CCCCCcccC
Confidence 6679999999888899999999999999999999999976432 11222222221000 000111113
Q ss_pred HHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 036334 586 VQLLQIAMGCVSTVPDQRPA-----MQEVVR 611 (654)
Q Consensus 586 ~~l~~l~~~cl~~dP~~RPs-----~~evl~ 611 (654)
.++.+++.+||+.+|++||+ ++|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 46788888999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=296.97 Aligned_cols=197 Identities=25% Similarity=0.378 Sum_probs=163.6
Q ss_pred hhccccccCceeEEEEEec---CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeC--CceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE---EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~ 420 (654)
+.+.||+|+||.||+|... ++..||+|.+.... .....+.+|+.++++++||||+++++++.+. ...++||
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 83 (316)
T cd07842 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLF 83 (316)
T ss_pred EEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEE
Confidence 3467999999999999965 47899999997632 2235677899999999999999999999988 7899999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC----CCCeEEeccCCCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP----DHDACVSDFGLNPL 496 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~----~~~~kl~Dfgla~~ 496 (654)
||+++ +|.+++..........+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++..
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~ 161 (316)
T cd07842 84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161 (316)
T ss_pred eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC-EeeCCCCHHHEEEcCCCCccceEEECCCccccc
Confidence 99975 6777665443323346899999999999999999999998 999999999999999 89999999999876
Q ss_pred cCCCC-------CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 036334 497 FGNTT-------PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLG 548 (654)
Q Consensus 497 ~~~~~-------~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~ 548 (654)
..... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 162 FNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 54321 2234567999998765 4578999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=295.14 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=187.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
..+.||+|+||.||+|... +++.||+|.+..... ....+.+|++++++++|+||+++++++.+++..++||||+.+
T Consensus 9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 87 (291)
T cd07844 9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT- 87 (291)
T ss_pred EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-
Confidence 3478999999999999965 588999999865422 234567899999999999999999999999999999999974
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TP 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~ 502 (654)
+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 88 ~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 88 DLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCHQRR-VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 999988643 235899999999999999999999998 999999999999999999999999998654321 12
Q ss_pred CCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---chhhh---------
Q 036334 503 PTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE---EWTAE--------- 569 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~--------- 569 (654)
..++..|+|||++.+ ..++.++||||+||++|||++|+.||....... +....+...... .....
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 234567999998865 458899999999999999999999996543110 000000000000 00000
Q ss_pred ----hh-hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 570 ----VF-DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 570 ----~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.. ...+...........++.+++.+|++.+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 0000000000011245678889999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=295.75 Aligned_cols=247 Identities=25% Similarity=0.350 Sum_probs=195.2
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
...+.||+|+||.||++... ++..||+|.+..... ...++.+|++++++++|||++++++++.++...++||||+
T Consensus 28 ~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 107 (317)
T cd06635 28 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC 107 (317)
T ss_pred hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCC
Confidence 34577999999999999954 588999999864321 2346788999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCCC
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPP 503 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 503 (654)
. |+|.+.+... ..++++..+..++.|++.|+.|||+.+ |+||||+|+||+++.++.+||+|||++.........
T Consensus 108 ~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~-i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (317)
T cd06635 108 L-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN-MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF 181 (317)
T ss_pred C-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCcccEEECCCCCEEEecCCCccccCCcccc
Confidence 6 5787777532 345899999999999999999999998 999999999999999999999999998876655556
Q ss_pred CccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 504 TRVAGYRAPEVVE---TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 504 ~~~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
.++..|+|||++. .+.++.++|||||||++|||++|+.||...... ........... ....
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~----------~~~~ 245 (317)
T cd06635 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES----------PTLQ 245 (317)
T ss_pred cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhccC----------CCCC
Confidence 6777899999873 457899999999999999999999998643111 11111111110 0011
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
.......+.+++.+||+.+|.+||++.++++.+..+.
T Consensus 246 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 246 SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 1223345777888999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=296.35 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=192.9
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.+.||+|+||.||+|... +|+.|++|++..... ....+.+|+.++++++||||+++++++..+...++||||+ +
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~ 82 (286)
T cd07832 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-P 82 (286)
T ss_pred EEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-C
Confidence 4577999999999999964 689999999875432 2457889999999999999999999999999999999999 9
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 501 (654)
++|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 83 SDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHANG-IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9999998743 245899999999999999999999998 9999999999999999999999999987664432
Q ss_pred -CCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc-------------h
Q 036334 502 -PPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREE-------------W 566 (654)
Q Consensus 502 -~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-------------~ 566 (654)
...++..|+|||.+.+. .++.++||||+|+++|||++|.+||......+ ....+....... +
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcchh
Confidence 23456679999998654 46899999999999999999988876432211 111111110000 0
Q ss_pred hhhhhhHhh--hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 567 TAEVFDVEL--MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 567 ~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
....+.... .......+....+.+++.+|+..+|++||+++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 0000001123567888889999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=294.66 Aligned_cols=250 Identities=22% Similarity=0.275 Sum_probs=185.7
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
.+.||+|+||.||+|... +|..||+|+++.... ....+.+|+++++.++|+||+++++++.+++..++||||+. ++
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD 88 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence 467999999999999854 588999999865432 23467789999999999999999999999999999999995 67
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CCC
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPP 503 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~ 503 (654)
+.+.+... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++...... ...
T Consensus 89 l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 163 (291)
T cd07870 89 LAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHGQH-ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE 163 (291)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCc
Confidence 77766532 234788889999999999999999998 999999999999999999999999998754322 223
Q ss_pred CccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----------------hch
Q 036334 504 TRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR----------------EEW 566 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----------------~~~ 566 (654)
.++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ...+..... ..+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-----FEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-----HHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 346679999998753 5788999999999999999999999753321 011111000 000
Q ss_pred hhhhhh----HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 567 TAEVFD----VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 567 ~~~~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..+... ..+............+.+++.+|+..||++|||++|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 000000000011345667888999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=288.35 Aligned_cols=234 Identities=22% Similarity=0.287 Sum_probs=184.2
Q ss_pred ccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecCCCchhhh
Q 036334 354 LGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSAL 431 (654)
Q Consensus 354 lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 431 (654)
||+|+||.||++... ++..+|+|.+........ |+.....+ +||||+++++.+..++..++||||+++++|.++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~ 99 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL 99 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence 699999999999854 578899999875433221 22222212 699999999999999999999999999999999
Q ss_pred hccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC-CeEEeccCCCCCcCCCCCCCcccccc
Q 036334 432 LHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH-DACVSDFGLNPLFGNTTPPTRVAGYR 510 (654)
Q Consensus 432 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~~~~~~y~ 510 (654)
+... ..+++..+..++.|+++|++|||+.+ ++||||||+||+++.++ .++|+|||++..........++..|+
T Consensus 100 l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~ 173 (267)
T PHA03390 100 LKKE-----GKLSEAEVKKIIRQLVEALNDLHKHN-IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYF 173 (267)
T ss_pred HHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCccc
Confidence 9742 36899999999999999999999998 99999999999999998 99999999988776655566778899
Q ss_pred CccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHH
Q 036334 511 APEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQ 590 (654)
Q Consensus 511 aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 590 (654)
|||++.+..++.++||||||+++|||++|+.||.....+ ..+...+.... .. ...........+.+
T Consensus 174 aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~~------------~~~~~~~~~~~~~~ 239 (267)
T PHA03390 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ-QK------------KLPFIKNVSKNAND 239 (267)
T ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh-cc------------cCCcccccCHHHHH
Confidence 999999889999999999999999999999999844322 22222222111 00 00111123345677
Q ss_pred HHhhccCCCCCCCCC-HHHHHH
Q 036334 591 IAMGCVSTVPDQRPA-MQEVVR 611 (654)
Q Consensus 591 l~~~cl~~dP~~RPs-~~evl~ 611 (654)
++.+||+.+|.+||+ ++++++
T Consensus 240 li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 240 FVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHhccChhhCCchHHHHhc
Confidence 888999999999995 688874
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=286.07 Aligned_cols=241 Identities=29% Similarity=0.468 Sum_probs=196.1
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccccc-CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV-GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.+.||+|++|.||++... +++.+++|++..... ....+.+|++++++++|+||+++++++..++..++++||+++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 467999999999999975 688999999976543 456788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---CCCCc
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TPPTR 505 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~~~~~ 505 (654)
.+++.... ..+++..+..++.|++.|++|||..+ ++||||+|+||+++.++.++|+|||.+...... ....+
T Consensus 85 ~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~-i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 159 (253)
T cd05122 85 KDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG-IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG 159 (253)
T ss_pred HHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC-EecCCCCHHHEEEccCCeEEEeeccccccccccccccceec
Confidence 99987431 46899999999999999999999987 999999999999999999999999998876554 23445
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHH
Q 036334 506 VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585 (654)
Q Consensus 506 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (654)
+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........ .... .........
T Consensus 160 ~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~--------~~~~~~~~~ 224 (253)
T cd05122 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIAT-NGPP--------GLRNPEKWS 224 (253)
T ss_pred CCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHh-cCCC--------CcCcccccC
Confidence 66799999998888999999999999999999999998653211 11111111 0000 000111113
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 586 VQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 586 ~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 46778888999999999999999976
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.02 Aligned_cols=263 Identities=18% Similarity=0.252 Sum_probs=180.4
Q ss_pred HHhhccccccCceeEEEEEecC--CcEEEEE------------------EecccccCHHHHHHHHHHHhccCCCcccccc
Q 036334 348 RASAEVLGKGSVGTSYKAVLEE--GTTVVVK------------------RLKEVAVGKREFEMQMEVLGKIKHDNVVPLR 407 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~ 407 (654)
|.+.+.||+|+||+||++..+. +..+++| .++........+++|+.++++++||||++++
T Consensus 150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 229 (501)
T PHA03210 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIE 229 (501)
T ss_pred cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEe
Confidence 4456789999999999987542 2222222 1111122235678999999999999999999
Q ss_pred EEEEeCCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeE
Q 036334 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDAC 487 (654)
Q Consensus 408 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~k 487 (654)
+++.+.+..|+|+|++. ++|.+++...............+..++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 230 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g-IiHrDLKP~NILl~~~~~vk 307 (501)
T PHA03210 230 EILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK-LIHRDIKLENIFLNCDGKIV 307 (501)
T ss_pred EEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEE
Confidence 99999999999999995 57777765332111222346677889999999999999998 99999999999999999999
Q ss_pred EeccCCCCCcCCCC-----CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCC-CCCCCCCCCChhHHHHHH
Q 036334 488 VSDFGLNPLFGNTT-----PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPN-QASLGEEGIDLPRWVQSV 561 (654)
Q Consensus 488 l~Dfgla~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf-~~~~~~~~~~~~~~~~~~ 561 (654)
|+|||++..+.... ...++..|+|||++.+..++.++|||||||++|||++|+.++ ..........+...+...
T Consensus 308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~ 387 (501)
T PHA03210 308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387 (501)
T ss_pred EEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhc
Confidence 99999998764322 235677899999999999999999999999999999987644 322211111111111100
Q ss_pred h--hhchh---hhhhhH----hhh-ccCChHHH------HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 562 V--REEWT---AEVFDV----ELM-RYHNIEEE------MVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 562 ~--~~~~~---~~~~~~----~~~-~~~~~~~~------~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
. ..++. ...++. .+. ........ ..++.+++.+|++.||.+|||+.|+++.
T Consensus 388 ~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 388 SVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred ccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 00000 000000 000 00001111 1235667889999999999999999863
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=287.45 Aligned_cols=242 Identities=24% Similarity=0.374 Sum_probs=193.6
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
..+.||+|+||.||++... +|..||+|.+.... ...+.+.+|++++++++|+||+++++.+......++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (257)
T cd08225 4 IIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG 83 (257)
T ss_pred EEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCC
Confidence 3578999999999999965 58899999986542 2345678899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC-eEEeccCCCCCcCCCC---
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD-ACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~-~kl~Dfgla~~~~~~~--- 501 (654)
++|.+++.... ...+++..+..++.|++.|++|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~-i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 84 GDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDRK-ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 99999997432 235799999999999999999999988 999999999999998864 6999999987665432
Q ss_pred -CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 502 -PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 502 -~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
...++..|+|||++.+..++.++||||||+++|||++|+.||.... ...++........ .. .
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~~----------~ 222 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQGYF-AP----------I 222 (257)
T ss_pred cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhcccC-CC----------C
Confidence 2235567999999988889999999999999999999999986432 2222222221110 00 0
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
......++.+++.+||..+|++|||+.|+++.
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11122357778889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=303.33 Aligned_cols=241 Identities=23% Similarity=0.383 Sum_probs=194.0
Q ss_pred hccccccCceeEEEEEecCCc-EEEEEEeccc-ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 351 AEVLGKGSVGTSYKAVLEEGT-TVVVKRLKEV-AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~-~vavK~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
..-||-|+||+||+|..++.. ..|.|++... ...-+++.-||++|..+.||+||++++.|+.++.++++.|||.||-+
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV 116 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV 116 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence 344899999999999976533 4456766533 33456788899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC----CCCCCC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG----NTTPPT 504 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~----~~~~~~ 504 (654)
+.++-.- ...|.+.++.-+++|++.||.|||++. |||||||+.|||++-+|.++|+|||.+.... ......
T Consensus 117 DaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs~~-iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFI 191 (1187)
T KOG0579|consen 117 DAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQN-IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFI 191 (1187)
T ss_pred hHHHHHh----ccccchHHHHHHHHHHHHHHHHHhhcc-hhhhhccccceEEEecCcEeeecccccccchhHHhhhcccc
Confidence 9888643 346999999999999999999999997 9999999999999999999999999875442 235567
Q ss_pred ccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 505 RVAGYRAPEVVE-----TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 505 ~~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
||+.|||||+.. ..+|+.++||||||++|.||..+.+|-.. .+..+.+..+-..+ .+...
T Consensus 192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVllKiaKSe---------PPTLl 256 (1187)
T KOG0579|consen 192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLLKIAKSE---------PPTLL 256 (1187)
T ss_pred CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHHHHhhcC---------CCccc
Confidence 899999999874 46899999999999999999999999643 22233222221111 11223
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.+..+...+.+++.+|+.+||..||++.++++
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 44566777888888999999999999999854
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=293.84 Aligned_cols=238 Identities=19% Similarity=0.231 Sum_probs=191.1
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||++... +++.||+|+++... .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus 5 ~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (290)
T cd05580 5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP 84 (290)
T ss_pred EEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCC
Confidence 3478999999999999865 58999999987542 223567889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-CCC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-TPP 503 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-~~~ 503 (654)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++...... ...
T Consensus 85 ~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~~~-i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 158 (290)
T cd05580 85 GGELFSHLRK-----SGRFPEPVARFYAAQVVLALEYLHSLD-IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL 158 (290)
T ss_pred CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCC
Confidence 9999999873 245899999999999999999999988 999999999999999999999999998776443 233
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ............ . ... .
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-------~--~~~---~ 220 (290)
T cd05580 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKILEGKV-------R--FPS---F 220 (290)
T ss_pred CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCCc-------c--CCc---c
Confidence 466779999999888899999999999999999999999865321 111111111100 0 011 1
Q ss_pred HHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRP-----AMQEVVR 611 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 611 (654)
....+.+++.+||..+|.+|+ +++|+++
T Consensus 221 ~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 221 FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 123566788899999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=294.29 Aligned_cols=254 Identities=20% Similarity=0.304 Sum_probs=187.9
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.||+|+||.||+|... +|+.||||+++.... ....+.+|++++++++||||+++++++.+++..++||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 467999999999999865 588999999865422 23568889999999999999999999999999999999995 6
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----C
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT----P 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~ 502 (654)
+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++....... .
T Consensus 84 ~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~-i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 84 DLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred CHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 8988886432 345899999999999999999999988 9999999999999999999999999987654321 2
Q ss_pred CCccccccCccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh-chh----hhhh--hHh
Q 036334 503 PTRVAGYRAPEVVETRK-VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE-EWT----AEVF--DVE 574 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~--~~~ 574 (654)
..++..|+|||.+.+.. ++.++|||||||++|||+||+.||......+ ...+.+...-.. ... .... ...
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 23456799999886644 6889999999999999999999997532211 011101000000 000 0000 000
Q ss_pred hhc--cCCh----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 575 LMR--YHNI----EEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 575 ~~~--~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
... .... .....++.+++.+||+.||++||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000 0000 011234567888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=293.51 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=187.3
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccC-CCccccccEEEEeCCceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.||+|+||.||++... +++.||+|.+.... .....+.+|+.++.++. |+||+++++++..++..+++|||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 467999999999999854 58999999987543 23456788999999996 99999999999999999999999864
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---CCC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TPP 503 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~~~ 503 (654)
++.++...........+++..+..++.|++.||+|||+...++||||||+||+++.++.+||+|||++...... ...
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 167 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD 167 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccc
Confidence 55443321111123468999999999999999999997533999999999999999999999999998755432 223
Q ss_pred CccccccCccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 504 TRVAGYRAPEVVETR---KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~---~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
.++..|+|||++.+. .++.++|||||||++|||++|+.||.... .....+........ +.+ ....
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~~------~~~-~~~~ 235 (288)
T cd06616 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGDP------PIL-SNSE 235 (288)
T ss_pred cCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCCC------CcC-CCcC
Confidence 456779999999765 68999999999999999999999986532 11111111111100 000 0011
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
......++.+++.+||+.+|++|||+++|++.
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 236 EREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11234467788889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=283.43 Aligned_cols=249 Identities=21% Similarity=0.324 Sum_probs=190.8
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHH-HhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV--GKREFEMQMEV-LGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~e~~~-l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
..||.|+||+|+|..++ .|+..|||++..... ++.++..|.+. ++.-+.||||+++|.+..++..|+.||.|. -+
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 45999999999999855 599999999987644 45667777775 455579999999999999999999999994 47
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---CCC
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---PPT 504 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~~~ 504 (654)
|+.+-+.........+++...-+|..-...||.||-...+|+|||+||+|||++..|.+||||||++..+.++. ...
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~da 228 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDA 228 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhcc
Confidence 76554432222345688888888999999999999877789999999999999999999999999988776543 334
Q ss_pred ccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 505 RVAGYRAPEVVET--RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 505 ~~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
|...|||||.+.. ..|+-++||||+|++|||+.||+.||..... .-+.+..++...... +......-
T Consensus 229 GCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gdpp~------l~~~~~~~ 297 (361)
T KOG1006|consen 229 GCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGDPPI------LLFDKECV 297 (361)
T ss_pred CCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCCCCe------ecCccccc
Confidence 4556999999953 4589999999999999999999999875321 222222222222111 11111222
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
+....+..++..|+.+|-..||+..++.+.
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 345578888999999999999999998664
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=291.71 Aligned_cols=239 Identities=22% Similarity=0.388 Sum_probs=190.2
Q ss_pred ccccccCceeEEEEEe-cCCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 352 EVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
.+||+|+||.||++.. .+|+.||+|.+.... .....+.+|+.+++.++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999986 468999999985432 23456888999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CCCCc
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPPTR 505 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~~~ 505 (654)
+++.. ..+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||++...... ....+
T Consensus 106 ~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~g-ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 106 DIVTH------TRMNEEQIAAVCLAVLKALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred HHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 98752 34789999999999999999999998 999999999999999999999999987655332 12345
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHH
Q 036334 506 VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585 (654)
Q Consensus 506 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (654)
+..|+|||.+.+..++.++||||+|+++|||++|..||...... ..+. ...... .... .......
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~------~~~~-~~~~~~-----~~~~---~~~~~~~ 243 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMK-MIRDNL-----PPKL---KNLHKVS 243 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH-HHHhhC-----Cccc---CCcccCC
Confidence 67799999998888999999999999999999999998642211 1111 111110 0000 0111123
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 586 VQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 586 ~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
..+.+++.+||+.+|.+||++.++++.
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 356677889999999999999998873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=291.48 Aligned_cols=238 Identities=26% Similarity=0.346 Sum_probs=189.6
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
++||+|+||.||-++.+ .|+-+|.|++.+.. .+..-...|-.+|.+++.+.||.+--.|..++.+++|+..|+||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 67999999999999855 58899999885542 23334567888999999999999988899999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---CCC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TPP 503 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~~~ 503 (654)
+|.-+|.+.. ...+++..+..++.+|+.||++||..+ ||.||+||+|||+|+.|+++|+|.|+|..+... ...
T Consensus 271 DLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~~-iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~r 346 (591)
T KOG0986|consen 271 DLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRRR-IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGR 346 (591)
T ss_pred ceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhcc-eeeccCChhheeeccCCCeEeeccceEEecCCCCccccc
Confidence 9999998653 356999999999999999999999988 999999999999999999999999999887654 334
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.||.||||||++.++.|+...|.||+||++|||+.|+.||........ ...+.+.+ ........+...+
T Consensus 347 vGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---~eEvdrr~--------~~~~~ey~~kFS~ 415 (591)
T KOG0986|consen 347 VGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---REEVDRRT--------LEDPEEYSDKFSE 415 (591)
T ss_pred cCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh---HHHHHHHH--------hcchhhcccccCH
Confidence 789999999999999999999999999999999999999975332110 00011111 1111111233445
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQ 607 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~ 607 (654)
+.+.+.+ ..+.+||++|..-+
T Consensus 416 eakslc~---~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 416 EAKSLCE---GLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHH---HHHccCHHHhccCC
Confidence 5555555 67789999997544
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=287.39 Aligned_cols=242 Identities=21% Similarity=0.247 Sum_probs=186.3
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccccC----HHHHHHHHHH-HhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG----KREFEMQMEV-LGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~e~~~-l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.||+|+||.||+|... +|+.||+|+++..... ...+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 5889999998754321 1223344443 3455899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCCCCc
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR 505 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 505 (654)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++..........+
T Consensus 82 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (260)
T cd05611 82 GDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQRG-IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVG 155 (260)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCcEEEeecccceeccccccCCC
Confidence 999999973 245899999999999999999999988 99999999999999999999999999876655444566
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHH
Q 036334 506 VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585 (654)
Q Consensus 506 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (654)
+..|+|||.+.+..++.++||||||+++|||++|..||..... ............ +. .........
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-----~~---~~~~~~~~~ 221 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP------DAVFDNILSRRI-----NW---PEEVKEFCS 221 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhccc-----CC---CCcccccCC
Confidence 7789999999888899999999999999999999999964321 111111111100 00 000011223
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 586 VQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 586 ~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
..+.+++.+||..+|++||++.++.+.|
T Consensus 222 ~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 222 PEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 4677888899999999999776554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=288.29 Aligned_cols=237 Identities=22% Similarity=0.316 Sum_probs=185.0
Q ss_pred ccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 354 LGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 354 lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
||+|+||+||++... +|+.||+|.+.... .....+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 58899999986532 2234567899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---CCCCc
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TPPTR 505 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~~~~~ 505 (654)
.+++.... ...+++..++.++.|++.|+.|||+.+ ++||||+|+||++++++.+||+|||.+...... ....+
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~-i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 81 KYHIYNVG---EPGFPEARAIFYAAQIICGLEHLHQRR-IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred HHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccC
Confidence 99987432 236899999999999999999999998 999999999999999999999999998765432 12344
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHH
Q 036334 506 VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585 (654)
Q Consensus 506 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (654)
+..|+|||++.+..++.++|||||||++|+|++|+.||........ . ..+..... .... .......
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~-~~~~~~~~--------~~~~---~~~~~~~ 222 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--K-EELKRRTL--------EMAV---EYPDKFS 222 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--H-HHHHhccc--------cccc---cCCccCC
Confidence 5679999999888899999999999999999999999975432110 0 00110000 0000 0011123
Q ss_pred HHHHHHHhhccCCCCCCCCCHHH
Q 036334 586 VQLLQIAMGCVSTVPDQRPAMQE 608 (654)
Q Consensus 586 ~~l~~l~~~cl~~dP~~RPs~~e 608 (654)
..+.+++.+||+.+|++||++++
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCc
Confidence 35677888999999999995444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=292.84 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=188.7
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeC--CceEEEEEe
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKLLVYDY 422 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e~ 422 (654)
...+.||+|+||.||+|... +++.+++|.++..... ...+.+|++++++++||||+++++++... ...++||||
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~ 87 (293)
T cd07843 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEY 87 (293)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehh
Confidence 44578999999999999965 5889999999754322 23567899999999999999999998877 789999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 500 (654)
++ ++|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 88 ~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~-i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 88 VE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNW-ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred cC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 97 59998886432 35899999999999999999999998 999999999999999999999999998766443
Q ss_pred --CCCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh----ch-------
Q 036334 501 --TPPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE----EW------- 566 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~------- 566 (654)
....++..|+|||.+.+. .++.++||||+|+++|||++|+.||......+. ...+...... .|
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ---LNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchHHHHHhhccc
Confidence 123345679999998654 468999999999999999999999975432110 0000000000 00
Q ss_pred ------hhhhhhHhhhccCChHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 567 ------TAEVFDVELMRYHNIEE-EMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 567 ------~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
........+ ....... ....+.+++.+||+.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000 0000000 1345677888999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=289.19 Aligned_cols=239 Identities=23% Similarity=0.341 Sum_probs=190.0
Q ss_pred ccccCceeEEEEEecC-CcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 354 LGKGSVGTSYKAVLEE-GTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 354 lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
||+|+||.||++...+ |+.|++|++..... ....+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 89999999875532 345678899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--------
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-------- 500 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-------- 500 (654)
.+++... ..+++..+++++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~-i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLHSNG-IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcC-eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9999742 35899999999999999999999988 999999999999999999999999997654322
Q ss_pred ----CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhh
Q 036334 501 ----TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576 (654)
Q Consensus 501 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (654)
....++..|+|||.+....++.++||||||+++|||++|+.||..... ............
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~---------- 218 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP------EEIFQNILNGKI---------- 218 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCCc----------
Confidence 112345569999999888899999999999999999999999965321 111111111000
Q ss_pred ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
...........+.+++.+||+.+|++|||+.++.+.|+
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00001011346678888999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=295.58 Aligned_cols=259 Identities=22% Similarity=0.332 Sum_probs=190.0
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEeccc---ccCHHHHHHHHHHHhcc-CCCccccccEEEEeC--CceEEEE
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV---AVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSK--DEKLLVY 420 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~--~~~~lv~ 420 (654)
+.+.+.||+|+||.||+|... +|+.||+|++... ......+.+|+.+++++ +||||++++++|... ...++||
T Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07852 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF 88 (337)
T ss_pred HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence 345678999999999999965 5889999988643 22334577899999999 999999999998654 3579999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||++ ++|..++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~-i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 89 EYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHSGN-VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred cccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9997 599988863 25889999999999999999999988 999999999999999999999999998755332
Q ss_pred C---------CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH---------
Q 036334 501 T---------PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSV--------- 561 (654)
Q Consensus 501 ~---------~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~--------- 561 (654)
. ...++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ---LEKIIEVIGPPSAEDI 237 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHH
Confidence 1 1234567999998754 5678999999999999999999999965332110 0000000
Q ss_pred --hhhchhhhhhh----Hhhhc-cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhh
Q 036334 562 --VREEWTAEVFD----VELMR-YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM--IENMN 617 (654)
Q Consensus 562 --~~~~~~~~~~~----~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 617 (654)
.........++ ..... .........++.+++.+||+.||++|||+.++++. ++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 00000000000 00000 00001123467888999999999999999999975 45543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=293.00 Aligned_cols=254 Identities=19% Similarity=0.263 Sum_probs=187.7
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccC-CCccccccEEEEeCCc-----eEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDE-----KLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~-----~~lv 419 (654)
..+.||+|+||.||+|... +|+.||+|.++.... ....+.+|+.++++++ ||||+++++++...+. .++|
T Consensus 5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 3577999999999999965 588999999865432 2356788999999995 6999999999887665 7999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC-CCCeEEeccCCCCCcC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP-DHDACVSDFGLNPLFG 498 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~-~~~~kl~Dfgla~~~~ 498 (654)
|||+++ +|.+++..........+++..++.++.||+.||+|||+++ |+||||||+||+++. ++.+||+|||++....
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~-i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~ 162 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG-VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCChHHEEEecCCCeEEEeecccceecC
Confidence 999985 8888886543222346899999999999999999999998 999999999999998 8899999999987653
Q ss_pred CC----CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------chh
Q 036334 499 NT----TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE------EWT 567 (654)
Q Consensus 499 ~~----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------~~~ 567 (654)
.. ....++..|+|||++.+ ..++.++||||||+++|||++|..||...... .....+... ...
T Consensus 163 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 163 IPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL------QQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred CCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHHHhCCCChhhC
Confidence 22 22234567999998865 45789999999999999999999999753211 111111100 000
Q ss_pred hhhhhH----hhhc------cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 568 AEVFDV----ELMR------YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 568 ~~~~~~----~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
...... .... .........++.+++.+||..||.+||+++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 0000 0000112345778889999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=292.44 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=193.4
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
+...+.||+|+||.||+|... ++..+++|.+.... ....++.+|+++++.++|+|++++++++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 444577999999999999964 57889999986431 1234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP 502 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 502 (654)
+. |++.+++... ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 97 ~~-~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (308)
T cd06634 97 CL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN-MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX 170 (308)
T ss_pred cC-CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHhEEECCCCcEEECCcccceeecCccc
Confidence 96 6887777532 235899999999999999999999988 99999999999999999999999999887765555
Q ss_pred CCccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 503 PTRVAGYRAPEVVE---TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 503 ~~~~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
..++..|+|||.+. ...++.++|||||||++|||++|..||...... ........... ...
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~----------~~~ 234 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES----------PAL 234 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHHHhhcCC----------CCc
Confidence 56777899999874 356788999999999999999999998643211 11111111100 000
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
........+.+++.+||..+|++||++.++++.-...
T Consensus 235 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 1112334577788899999999999999998765433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=294.13 Aligned_cols=245 Identities=20% Similarity=0.337 Sum_probs=189.8
Q ss_pred HHHHHhhccccccCceeEEEEEecCCcEEEEEEeccccc---CHHHHHHHHHHHhccC-CCccccccEEEEeCCceEEEE
Q 036334 345 DLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV---GKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVY 420 (654)
Q Consensus 345 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~ 420 (654)
.-+|++.+.||+||.++||++...+.+.||+|+...... ....|..|+..|.+++ |.+||++++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 345566788999999999999988888899888765433 3456899999999995 999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||- ..+|..+|.... ....+| .++.+..|++.++.++|+++ |||.||||.|.|+- .|.+||+|||+|..+...
T Consensus 440 E~G-d~DL~kiL~k~~---~~~~~~-~lk~ywkqML~aV~~IH~~g-IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKK---SIDPDW-FLKFYWKQMLLAVKTIHQHG-IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred ecc-cccHHHHHHhcc---CCCchH-HHHHHHHHHHHHHHHHHHhc-eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 976 559999998543 222334 77889999999999999998 99999999999987 579999999999887654
Q ss_pred ------CCCCccccccCccccCCC-----------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 036334 501 ------TPPTRVAGYRAPEVVETR-----------KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR 563 (654)
Q Consensus 501 ------~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 563 (654)
....||..||+||.+... ..+.++||||+|||||+|+.|++||.... +....
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~aK------ 581 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIAK------ 581 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHHH------
Confidence 346788999999998532 25678999999999999999999996411 01111
Q ss_pred hchhhhhhhHhhh-ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 564 EEWTAEVFDVELM-RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 564 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
...+.++... .+.... .-.+++++|+.||+.||.+|||..|+++
T Consensus 582 ---l~aI~~P~~~Iefp~~~-~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 ---LHAITDPNHEIEFPDIP-ENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ---HHhhcCCCccccccCCC-CchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1122222110 111111 1112888999999999999999999975
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=290.68 Aligned_cols=255 Identities=21% Similarity=0.330 Sum_probs=190.6
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
..+.||+|++|.||+|... +|..||+|+++... .....+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 82 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK- 82 (284)
T ss_pred EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence 3477999999999999975 58899999987543 2345677899999999999999999999999999999999975
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TP 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~ 502 (654)
+|.+++.... ....+++..+.+++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++...... ..
T Consensus 83 ~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (284)
T cd07836 83 DLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHENR-VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159 (284)
T ss_pred cHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence 8888876432 1345899999999999999999999998 999999999999999999999999998755332 12
Q ss_pred CCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc---hhh-----hhhhH
Q 036334 503 PTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREE---WTA-----EVFDV 573 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~-----~~~~~ 573 (654)
..++..|++||.+.+ ..++.++|||||||++|||++|+.||......+ ....+....... ... .....
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED---QLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 334667999998865 457899999999999999999999997543221 000000000000 000 00000
Q ss_pred hhhc------cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 574 ELMR------YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 574 ~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.... ....+.....+.+++.+|++.||++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0000112345678888999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=292.07 Aligned_cols=248 Identities=14% Similarity=0.173 Sum_probs=175.5
Q ss_pred HhhccccccCceeEEEEEecCC----cEEEEEEecccccC---H---------HHHHHHHHHHhccCCCccccccEEEEe
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEG----TTVVVKRLKEVAVG---K---------REFEMQMEVLGKIKHDNVVPLRAFYYS 412 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g----~~vavK~~~~~~~~---~---------~~~~~e~~~l~~l~hpniv~l~~~~~~ 412 (654)
.+.++||+|+||+||+|...++ ..+|+|+....... . .....+...+..+.|+|++++++.+..
T Consensus 15 ~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 94 (294)
T PHA02882 15 KIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSF 94 (294)
T ss_pred EEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeE
Confidence 3457899999999999996543 45666653322111 0 111223344566789999999987655
Q ss_pred CC----ceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEE
Q 036334 413 KD----EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACV 488 (654)
Q Consensus 413 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl 488 (654)
.. ..++++|++. .++.+.+... ...++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++|
T Consensus 95 ~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~-iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 95 KRCRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEHG-ISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred ecCCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCcEEE
Confidence 43 3467888774 3666666522 23578889999999999999999998 999999999999999999999
Q ss_pred eccCCCCCcCCC-----------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHH
Q 036334 489 SDFGLNPLFGNT-----------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRW 557 (654)
Q Consensus 489 ~Dfgla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~ 557 (654)
+|||++..+... ....++..|+|||++.+..++.++|||||||++|||++|+.||....... .....
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~~~~~ 245 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--NLIHA 245 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--HHHHH
Confidence 999998765311 12346778999999999999999999999999999999999997642211 11110
Q ss_pred HHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 558 VQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
. .......+..... . .......+.+++..||..+|++||++.++++.|
T Consensus 246 ~----~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 A----KCDFIKRLHEGKI-K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred h----HHHHHHHhhhhhh-c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0 0111111111111 1 112235677888899999999999999999876
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=287.44 Aligned_cols=238 Identities=22% Similarity=0.299 Sum_probs=182.3
Q ss_pred cccccCceeEEEEEec-CCcEEEEEEecccccC----HHHHHHHH---HHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 353 VLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG----KREFEMQM---EVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 353 ~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~e~---~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+||+|+||.||+|... +++.||+|.+...... ...+..|. ..++...||||+++++++..++..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 5889999998654221 12233333 33445579999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--CC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--TP 502 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--~~ 502 (654)
+|+|.+++.. ...+++..+..++.|+++|++|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 81 g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~-i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 154 (278)
T cd05606 81 GGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 154 (278)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcC
Confidence 9999998863 346999999999999999999999988 999999999999999999999999998755432 23
Q ss_pred CCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 503 PTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
..++..|+|||.+.++ .++.++||||+||++|||++|+.||.......... ....... .+.. ..
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~------~~~~-----~~ 219 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------MAVE-----LP 219 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc------cCCC-----CC
Confidence 4566779999998754 68999999999999999999999997643221110 0000000 0000 01
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRP-----AMQEVVR 611 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 611 (654)
.....++.+++.+|+..+|.+|| ++.++++
T Consensus 220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11234677788899999999999 8988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=290.41 Aligned_cols=252 Identities=20% Similarity=0.266 Sum_probs=186.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHhccC-CCccccccEEEEeC--CceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIK-HDNVVPLRAFYYSK--DEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~--~~~~lv~e~~ 423 (654)
+.+.||+|+||.||+|... +++.||+|+++.... ......+|+.++.++. |+||+++++++.++ +..++||||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 3467999999999999854 588999999876422 2234456888888885 99999999999987 8899999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC--
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-- 501 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-- 501 (654)
+ |+|.+.+... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||++.......
T Consensus 83 ~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~-i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 83 D-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMHRNG-IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred C-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 6 5888877642 245899999999999999999999998 999999999999999 999999999987664332
Q ss_pred -CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchh--h------hhh
Q 036334 502 -PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWT--A------EVF 571 (654)
Q Consensus 502 -~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~------~~~ 571 (654)
...++..|+|||.+.. ..++.++|||||||++|||++|..||......+ ...+.......... . ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcccccc
Confidence 2235667999997644 567889999999999999999999997643211 11111111100000 0 000
Q ss_pred hHhhhc--c----CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 572 DVELMR--Y----HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 572 ~~~~~~--~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
+..... . .........+.+++.+||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000 0 001123467888999999999999999999976
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=292.08 Aligned_cols=256 Identities=22% Similarity=0.300 Sum_probs=189.8
Q ss_pred ccccc--CceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 353 VLGKG--SVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 353 ~lg~G--~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.||+| +||+||++... .|+.||+|++...... .+.+++|+.+++.++||||++++++|..++..++|+||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 99999999864 6899999998754322 356788999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC------
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT------ 500 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~------ 500 (654)
+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+......
T Consensus 85 ~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~-ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNG-YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999987542 234899999999999999999999988 999999999999999999999999754322110
Q ss_pred -----CCCCccccccCccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc--------
Q 036334 501 -----TPPTRVAGYRAPEVVETR--KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREE-------- 565 (654)
Q Consensus 501 -----~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 565 (654)
....++..|+|||++.+. .++.++|||||||++|||++|+.||....... .+.......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ------MLLQKLKGPPYSPLDIT 234 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH------HHHHHhcCCCCCCcccc
Confidence 011223459999998763 47899999999999999999999997542211 000000000
Q ss_pred ----------------------------hhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHh
Q 036334 566 ----------------------------WTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR--MIEN 615 (654)
Q Consensus 566 ----------------------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~--~L~~ 615 (654)
+........+ ...........+.+++.+||+.||++|||+.|+++ .+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 0000000000 11112334567889999999999999999999974 3455
Q ss_pred hhcC
Q 036334 616 MNRG 619 (654)
Q Consensus 616 ~~~~ 619 (654)
++..
T Consensus 314 ~~~~ 317 (328)
T cd08226 314 VKEQ 317 (328)
T ss_pred HHHh
Confidence 5443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=286.01 Aligned_cols=255 Identities=20% Similarity=0.319 Sum_probs=189.5
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
..+.||+|++|.||+|... +|..||+|++..... ....+.+|++++++++|||++++++++.+++..++||||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 3467999999999999854 689999999875432 23567889999999999999999999999999999999995
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
++|.+++.... ...+++..++.++.|+++||+|||+++ ++||||+|+||+++.++.++|+|||++...... .
T Consensus 82 ~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~~-~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 82 LDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHSHR-VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred cCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 68999887432 235899999999999999999999987 999999999999999999999999998765422 1
Q ss_pred CCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---ch--hhh--hhhH
Q 036334 502 PPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE---EW--TAE--VFDV 573 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~~--~~~--~~~~ 573 (654)
...++..|+|||++.+. .++.++||||||+++|||++|+.||......+ .+...+...... .+ ... .+..
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 22346679999988654 57899999999999999999999997532211 000100000000 00 000 0000
Q ss_pred hhhcc--C----ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 574 ELMRY--H----NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 574 ~~~~~--~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..... . ........+.+++.+||+.+|++||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 0 00111245778888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=282.23 Aligned_cols=240 Identities=25% Similarity=0.362 Sum_probs=195.4
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeC--CceEEEEEecC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKLLVYDYMP 424 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e~~~ 424 (654)
.+.||+|++|.||+|... +++.|++|++.... ...+.+.+|++++++++||||+++++.+.+. ...++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 467999999999999966 68899999987654 2356788999999999999999999999888 78999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
+++|.+++... ..+++..++.++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 85 ~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~-~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 85 GGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHSNG-IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 99999999743 36899999999999999999999988 9999999999999999999999999987665432
Q ss_pred ---CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 502 ---PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 502 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
...++..|+|||.+.+..++.++||||||+++|+|++|..||.... +............. ..
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~----------~~ 223 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGE----------PP 223 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCC----------Cc
Confidence 2345667999999988889999999999999999999999997543 11111111110000 00
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.........+.+++.+|++.+|++||++.|+++
T Consensus 224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111222456788888999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=299.56 Aligned_cols=257 Identities=19% Similarity=0.318 Sum_probs=190.9
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccc---ccCHHHHHHHHHHHhccCCCccccccEEEEeC-----CceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV---AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK-----DEKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-----~~~~lv~ 420 (654)
+.+.||+|+||+||+|... +++.||||.++.. ......+.+|+.+++.++|+||+++++++... ...++||
T Consensus 9 ~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07858 9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88 (337)
T ss_pred EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence 3568999999999999854 5899999998753 22344667899999999999999999988654 3479999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+. ++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~-i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 89 ELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHSAN-VLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred eCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 9995 689888863 345899999999999999999999998 999999999999999999999999998765433
Q ss_pred ----CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---c-------
Q 036334 501 ----TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE---E------- 565 (654)
Q Consensus 501 ----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~------- 565 (654)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......+ ....+...... .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChHHhhhcCc
Confidence 12345567999998864 468899999999999999999999997532111 00001100000 0
Q ss_pred -hhhhhh-------hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhhc
Q 036334 566 -WTAEVF-------DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM--IENMNR 618 (654)
Q Consensus 566 -~~~~~~-------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~ 618 (654)
...... +.... ........++.+++.+||+.+|++|||++|+++. ++.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFA--RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred hhhhHHHHhcCcccccCHH--HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 000000 00000 0001223457788899999999999999999987 665543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=291.88 Aligned_cols=256 Identities=20% Similarity=0.218 Sum_probs=186.7
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEeccc---ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEV---AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+++.+|.|+++.||++.. +++.||||++... ......+.+|++++++++|+||+++++++.+.+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 345556666666666655 5899999998754 223457889999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC------
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT------ 500 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~------ 500 (654)
+|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+......
T Consensus 85 ~l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~-ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHSKG-FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999997542 234889999999999999999999998 999999999999999999999999987644211
Q ss_pred -----CCCCccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hch---
Q 036334 501 -----TPPTRVAGYRAPEVVET--RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR----EEW--- 566 (654)
Q Consensus 501 -----~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~--- 566 (654)
....++..|+|||++.. ..++.++|||||||++|||++|+.||....... ........... ...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhh
Confidence 12234456999999865 358899999999999999999999997532111 00000000000 000
Q ss_pred ----hhh----hhhHh---hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 567 ----TAE----VFDVE---LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 567 ----~~~----~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
... ..+.. ............++.+++.+||..||++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 00000 00001112223457788999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=317.77 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=182.8
Q ss_pred ccccCHHHHHHHhhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEe--
Q 036334 338 VYSFDLEDLLRASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYS-- 412 (654)
Q Consensus 338 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-- 412 (654)
.|.-+++++ ++||+|+||.||+++.+ ||+.||||++.-.. .....+.+|+.++.+++|||||+++..+.+
T Consensus 476 RY~~DFEEL-----~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 476 RYLNDFEEL-----ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVEST 550 (1351)
T ss_pred hHhhhhHHH-----HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence 344556665 67999999999999955 89999999997663 334567889999999999999998765410
Q ss_pred -----------------------------------------------------C--------------------------
Q 036334 413 -----------------------------------------------------K-------------------------- 413 (654)
Q Consensus 413 -----------------------------------------------------~-------------------------- 413 (654)
.
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence 0
Q ss_pred --------------------------------------CceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHH
Q 036334 414 --------------------------------------DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSA 455 (654)
Q Consensus 414 --------------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i 455 (654)
..+||-||||+...+.++++.+... -.....|+++.+|
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreI 706 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREI 706 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHH
Confidence 0136788999998888888743210 1467889999999
Q ss_pred HHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC----------------------CCCCCCccccccCcc
Q 036334 456 ARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG----------------------NTTPPTRVAGYRAPE 513 (654)
Q Consensus 456 a~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~----------------------~~~~~~~~~~y~aPE 513 (654)
+.||+|+|+.+ ||||||||.||++++++.|||+|||+|+... ..+...||.-|+|||
T Consensus 707 lEGLaYIH~~g-iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 707 LEGLAYIHDQG-IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHHHHHHhCc-eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 99999999999 9999999999999999999999999997611 112345667799999
Q ss_pred ccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHH
Q 036334 514 VVETR---KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQ 590 (654)
Q Consensus 514 ~~~~~---~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 590 (654)
++.+. .|+.|+|+||+|||++||+. ||....+ ....+ ..++.+..... .....+.+..=.+
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME-----Ra~iL-~~LR~g~iP~~-------~~f~~~~~~~e~s 849 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME-----RASIL-TNLRKGSIPEP-------ADFFDPEHPEEAS 849 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHhc---cCCchHH-----HHHHH-HhcccCCCCCC-------cccccccchHHHH
Confidence 99764 49999999999999999994 4653211 11111 12222222111 0112223334457
Q ss_pred HHhhccCCCCCCCCCHHHHHH
Q 036334 591 IAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 591 l~~~cl~~dP~~RPs~~evl~ 611 (654)
+++++++.||.+|||+.|+++
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhh
Confidence 788999999999999999864
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=290.94 Aligned_cols=246 Identities=22% Similarity=0.374 Sum_probs=186.8
Q ss_pred HhhccccccCceeEEEEEecC-CcEEEEEEeccccc--CHHHHHHHHHHHhccC-CCccccccEEEEeCCceEEEEEecC
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAV--GKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
.+.+.||+|+||.||+|...+ ++.||||+++.... ...++.+|+.++.+.. ||||++++++|.+....++||||+.
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 456889999999999999765 88999999976432 2345666777666664 9999999999999999999999985
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
+++.+++... ...+++..+..++.|++.|++|||+...|+||||+|+||++++++.+||+|||++.......
T Consensus 98 -~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~ 172 (296)
T cd06618 98 -TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT 172 (296)
T ss_pred -cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCccc
Confidence 4777766532 23689999999999999999999975339999999999999999999999999987654322
Q ss_pred CCCccccccCccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 502 PPTRVAGYRAPEVVETRK----VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~----~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
...++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ............ ..
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~---------~~ 238 (296)
T cd06618 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEEP---------PS 238 (296)
T ss_pred CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCCC---------CC
Confidence 223456799999987554 788999999999999999999998642111 111111111110 00
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
.........++.+++.+||..||++||+++++++.-
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 000111234577888899999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=290.13 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=189.6
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeC--CceEEEEEecC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKLLVYDYMP 424 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e~~~ 424 (654)
.+.||+|+||.||+|... +|+.+|+|+++... .....+.+|++++++++|+|++++++++.+. +..++||||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 467999999999999966 48899999998653 2335678899999999999999999999888 78999999997
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
+ +|.+++... ...+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 84 ~-~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~-~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 84 H-DLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLHSNG-ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred c-cHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 5 888888632 246899999999999999999999988 9999999999999999999999999987665432
Q ss_pred --CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh----chh-------
Q 036334 502 --PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE----EWT------- 567 (654)
Q Consensus 502 --~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~------- 567 (654)
....+..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....+...... .+.
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccccchh
Confidence 2234556999998764 457899999999999999999999997533211 00111100000 000
Q ss_pred h------hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 568 A------EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 568 ~------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
. ......+ .......+...+.+++.+||..+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 235 FENLKPKKPYKRRL-REFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhHH-HHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 0000000 00000002456788999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=297.68 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=188.3
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCH---------------HHHHHHHHHHhccCCCccccccEEEEeC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGK---------------REFEMQMEVLGKIKHDNVVPLRAFYYSK 413 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---------------~~~~~e~~~l~~l~hpniv~l~~~~~~~ 413 (654)
..+.||+|+||.||+|... +++.||||.++...... ..+.+|++++++++|+||+++++++..+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 4577999999999999954 58999999986543221 2467899999999999999999999999
Q ss_pred CceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCC
Q 036334 414 DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL 493 (654)
Q Consensus 414 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgl 493 (654)
+..++||||+. |+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||+|+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~-i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHKWY-FMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eecccccHHHeEECCCCCEEECCccc
Confidence 99999999996 689998863 345899999999999999999999998 99999999999999999999999999
Q ss_pred CCCcCCC------------------CCCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCCh
Q 036334 494 NPLFGNT------------------TPPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDL 554 (654)
Q Consensus 494 a~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~ 554 (654)
+...... ....++..|+|||.+.+. .++.++|||||||++|||++|+.||......+ .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---~ 242 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---Q 242 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 8765411 112235569999998764 47899999999999999999999997543211 1
Q ss_pred hHHHHHHhhh----chhhhh-----------hhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 555 PRWVQSVVRE----EWTAEV-----------FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 555 ~~~~~~~~~~----~~~~~~-----------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
...+...... .|.... ....... .......++.+++.+||+.+|++||+++|++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT--IFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH--hCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111100 000000 0000000 00112345778889999999999999999986
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=299.45 Aligned_cols=256 Identities=20% Similarity=0.299 Sum_probs=188.5
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCC-----ceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD-----EKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-----~~~lv~e 421 (654)
+.+.||+|+||.||+|.. .+|+.||+|++.... .....+.+|+.++++++||||+++++++.... ..++|+|
T Consensus 9 i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 88 (336)
T cd07849 9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQE 88 (336)
T ss_pred EEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEeh
Confidence 457899999999999985 468999999986432 23456778999999999999999999876543 4799999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT 501 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 501 (654)
|+. ++|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~-ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 89 LME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred hcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 996 488877752 35899999999999999999999998 9999999999999999999999999987653321
Q ss_pred -------CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchh---hhh
Q 036334 502 -------PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWT---AEV 570 (654)
Q Consensus 502 -------~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 570 (654)
...++..|+|||.+.+ ..++.++||||+||++|||++|+.||....... ....+...+..... ..+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHHHh
Confidence 1245667999998754 568899999999999999999999996532111 11111111111000 000
Q ss_pred hhHh-------hh--ccCC----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhh
Q 036334 571 FDVE-------LM--RYHN----IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM--IENM 616 (654)
Q Consensus 571 ~~~~-------~~--~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 616 (654)
.+.. .. .... ......++.+++.+||+.+|++|||+.|+++. ++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000 00 0000 01123457789999999999999999999886 5544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=292.77 Aligned_cols=253 Identities=20% Similarity=0.261 Sum_probs=183.7
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCc--------eE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDE--------KL 417 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~--------~~ 417 (654)
..+.||+|+||.||+|... +++.||||.+..... ....+.+|++++++++||||+++++++...+. .+
T Consensus 16 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 95 (310)
T cd07865 16 KLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFY 95 (310)
T ss_pred EEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEE
Confidence 4578999999999999965 588999999864322 23345679999999999999999999876543 49
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 418 LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
+||||+. ++|.+.+... ...+++.+++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++...
T Consensus 96 lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 96 LVFEFCE-HDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHRNK-ILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred EEEcCCC-cCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 9999996 4888877632 235899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCC--------CCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---hc
Q 036334 498 GNTT--------PPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR---EE 565 (654)
Q Consensus 498 ~~~~--------~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---~~ 565 (654)
.... ...++..|+|||.+.+. .++.++||||||+++|||++|+.||....... ....+..... ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 246 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH---QLTLISQLCGSITPE 246 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChh
Confidence 4321 12344569999988654 47889999999999999999999987543211 1111111100 00
Q ss_pred hhh-----hhhhH---------hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 566 WTA-----EVFDV---------ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 566 ~~~-----~~~~~---------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
... ...+. ..............+.+++.+||..||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 00000 00000000001234567899999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=290.30 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=191.8
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.||+|++|.||++... +|+.+++|+++.... ....+..|++++++++|+||+++++++.++...++|+||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT- 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence 467999999999999864 688999999876533 245778899999999999999999999999999999999975
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----C
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT----P 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~ 502 (654)
+|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||.+....... .
T Consensus 83 ~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 83 DLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHSHG-ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHHCC-eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 888888642 246899999999999999999999998 9999999999999999999999999987665432 2
Q ss_pred CCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc---hhhhhhh------
Q 036334 503 PTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREE---WTAEVFD------ 572 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~------ 572 (654)
..++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+ ....+....... ......+
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 3345569999998776 78999999999999999999999996543211 000000000000 0000000
Q ss_pred Hhhhc------cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 573 VELMR------YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 573 ~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..... .....+...++.+++.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 0001223456788999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=298.38 Aligned_cols=254 Identities=20% Similarity=0.324 Sum_probs=188.3
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEe----CCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYS----KDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e 421 (654)
+.+.||+|+||.||+|... +|..||+|++.... .....+.+|+.++++++||||+++++++.. ....++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 9 PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence 4567999999999999854 58999999987542 234567789999999999999999998763 346799999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT 501 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 501 (654)
|+. |+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 89 LME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHSAN-VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred hhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 995 689988863 334899999999999999999999988 9999999999999999999999999987553221
Q ss_pred --------CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh----------
Q 036334 502 --------PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVV---------- 562 (654)
Q Consensus 502 --------~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~---------- 562 (654)
...++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~---~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH---QLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---HHHHHHHHhCCChhHhhhh
Confidence 1245567999998865 468899999999999999999999997543211 001111100
Q ss_pred -hhchhhhhhhH-hhhccCC----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 563 -REEWTAEVFDV-ELMRYHN----IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 563 -~~~~~~~~~~~-~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
.........+. ....... ......++.+++.+||+.+|++||++++++..-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 00000000000 0000000 011245678888899999999999999988753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=294.09 Aligned_cols=253 Identities=25% Similarity=0.332 Sum_probs=186.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeC--CceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e~~ 423 (654)
+.+.||+|+||.||+|... +|+.||+|+++..... ...+.+|+.++++++|+||+++++++... +..++||||+
T Consensus 11 ~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (309)
T cd07845 11 KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC 90 (309)
T ss_pred EeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecC
Confidence 3567999999999999965 5899999998754221 23456799999999999999999998765 4579999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC--
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-- 501 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-- 501 (654)
++ +|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~-~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 164 (309)
T cd07845 91 EQ-DLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHENF-IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164 (309)
T ss_pred CC-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence 64 888887643 245899999999999999999999998 9999999999999999999999999987664321
Q ss_pred --CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc---hh--------
Q 036334 502 --PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREE---WT-------- 567 (654)
Q Consensus 502 --~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~-------- 567 (654)
....+..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ ....+....... ..
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchhhhcccc
Confidence 2233556999999865 567899999999999999999999997543211 111111111000 00
Q ss_pred hhhhhHhhhccCCh----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 568 AEVFDVELMRYHNI----EEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 568 ~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
...+.......... ......+.+++.+|++.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000000000 011345667888999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=288.76 Aligned_cols=248 Identities=26% Similarity=0.359 Sum_probs=192.4
Q ss_pred CHHHHHHHhhccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCce
Q 036334 342 DLEDLLRASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEK 416 (654)
Q Consensus 342 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~ 416 (654)
+.+++ +...+.||+|+||+||+|... +|+.|++|++..... ....+.+|++++++++|||++++++++.+....
T Consensus 18 ~~~~~-~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 96 (313)
T cd06633 18 DPEEI-FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA 96 (313)
T ss_pred CHHHH-hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 34443 334467999999999999854 588999999864322 224577899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCC
Q 036334 417 LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPL 496 (654)
Q Consensus 417 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~ 496 (654)
++||||+. |++.+++... ..++++..++.++.|++.|++|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 97 ~lv~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH~~g-i~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 97 WLVMEYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN-MIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred EEEEecCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 99999995 5777777532 345899999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCCCCCccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 497 FGNTTPPTRVAGYRAPEVVE---TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 497 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
........++..|+|||++. ...++.++|||||||++|||++|..||..... ...+......... .
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~~-~---- 239 (313)
T cd06633 171 SSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNDSP-T---- 239 (313)
T ss_pred cCCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCC-C----
Confidence 55444556677899999984 45688999999999999999999999865321 1111111111100 0
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.........+.+++.+||+.+|++||++.++++.
T Consensus 240 -----~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 -----LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011122346778889999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=298.21 Aligned_cols=188 Identities=24% Similarity=0.413 Sum_probs=160.2
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeC------CceEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSK------DEKLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------~~~~lv 419 (654)
..+.||+|+||.||+|... +|+.||+|++.... ....++.+|+.++++++||||++++++|... ...++|
T Consensus 20 ~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 99 (353)
T cd07850 20 NLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99 (353)
T ss_pred EEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEE
Confidence 4578999999999999854 68999999986532 2234567899999999999999999988643 246999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
|||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 100 ~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g-i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 100 MELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred EeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 99995 588887752 2888999999999999999999998 99999999999999999999999999986654
Q ss_pred CC---CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 036334 500 TT---PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQAS 546 (654)
Q Consensus 500 ~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 546 (654)
.. ...++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 32 234566799999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=300.07 Aligned_cols=196 Identities=31% Similarity=0.447 Sum_probs=167.7
Q ss_pred hccccccCceeEEEEE-ecCCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCC------ceEEEEE
Q 036334 351 AEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD------EKLLVYD 421 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------~~~lv~e 421 (654)
.+.||+|+||.||+|+ ...|+.||||.+.... ...+...+|+++|++++|+|||+++++-.... ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 3669999999999999 4569999999998753 34566778999999999999999998755433 4589999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEEC--CCCC--eEEeccCCCCCc
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR--PDHD--ACVSDFGLNPLF 497 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~--~~~~--~kl~Dfgla~~~ 497 (654)
||.+|||+..|.... +...|++.+.+.++.+++.||.|||+++ |+||||||.||++- ++|. -||+|||.|+..
T Consensus 98 yC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn~-IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLRENG-IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHcC-ceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 999999999998543 3456999999999999999999999887 99999999999983 3343 799999999988
Q ss_pred CCCC---CCCccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 036334 498 GNTT---PPTRVAGYRAPEVVE-TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGE 549 (654)
Q Consensus 498 ~~~~---~~~~~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~ 549 (654)
.+.. ..+||..|.+||.+. .+.|+..+|.|||||++||..||..||....+.
T Consensus 175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 7664 457888899999998 488999999999999999999999999764433
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=280.55 Aligned_cols=239 Identities=25% Similarity=0.422 Sum_probs=193.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
..+.||+|++|.||++... +++.|++|.+..... ....+.+|++++++++|||++++++++.+.+..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (254)
T cd06627 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN 83 (254)
T ss_pred eeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCC
Confidence 3578999999999999865 578999999976643 345788999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC---
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP--- 502 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~--- 502 (654)
++|.+++... ..+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.++|+|||.+........
T Consensus 84 ~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 84 GSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG-VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 9999998732 46899999999999999999999998 99999999999999999999999999887654332
Q ss_pred -CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 503 -PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 503 -~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
..++..|+|||...+..++.++||||+|+++|+|++|+.||..... .... ....... .....
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~-~~~~~~~-----------~~~~~ 220 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAAL-FRIVQDD-----------HPPLP 220 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHH-HHHhccC-----------CCCCC
Confidence 3456679999999887889999999999999999999999864321 1111 1111000 00011
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
......+.+++.+||..+|++||++.+++.
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112345677888999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=289.30 Aligned_cols=250 Identities=20% Similarity=0.281 Sum_probs=185.1
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.||+|++|.||+|... +|+.||+|.+..... ..+.+.+|++++++++||||+++++++.+....++||||++ +
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 85 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-L 85 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-c
Confidence 467999999999999965 688999999865422 23567889999999999999999999999999999999996 5
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC-CCCeEEeccCCCCCcCCC----C
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP-DHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~~----~ 501 (654)
+|.+++.... ...+++..++.++.||+.||+|||+++ ++||||+|+||+++. ++.+||+|||++...... .
T Consensus 86 ~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~-i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (294)
T PLN00009 86 DLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSHR-VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (294)
T ss_pred cHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCCcceEEEECCCCEEEEcccccccccCCCccccc
Confidence 7877775322 233688889999999999999999998 999999999999985 457999999998765332 2
Q ss_pred CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh--chhhhh-------h
Q 036334 502 PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE--EWTAEV-------F 571 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~-------~ 571 (654)
...++..|+|||++.+ ..++.++||||+||++|+|++|+.||......+ .+...... ...... .
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID------ELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhCCCChhhccccccch
Confidence 2344567999998865 457899999999999999999999997532211 01111000 000000 0
Q ss_pred hHh--hhc--cC----ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 572 DVE--LMR--YH----NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 572 ~~~--~~~--~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
+.. ... .. .......++.+++.+|++.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000 00 00111234677888999999999999999986
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=279.62 Aligned_cols=243 Identities=24% Similarity=0.359 Sum_probs=195.2
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.+.||+|+||.||++... +++.+++|.+..... ...++.+|++++++++|+||+++++++.+....++||||+++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd08530 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPF 83 (256)
T ss_pred EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCC
Confidence 3467999999999999854 678999999876432 244677899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--CCC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--TPP 503 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--~~~ 503 (654)
++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++...... ...
T Consensus 84 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~-i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 161 (256)
T cd08530 84 GDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQK-ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ 161 (256)
T ss_pred CCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCC-cccCCCCcceEEEecCCcEEEeeccchhhhccCCcccc
Confidence 999999864321 2356899999999999999999999998 999999999999999999999999998766443 223
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.++..|+|||.+.+..++.++|+||+|+++|||++|+.||...... ........ ... ......
T Consensus 162 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~~~----------~~~~~~ 224 (256)
T cd08530 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DLRYKVQR-GKY----------PPIPPI 224 (256)
T ss_pred cCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc-CCC----------CCCchh
Confidence 4566799999999888999999999999999999999999653221 11111111 000 011123
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
...++.+++.+|+..+|++||++.|+++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 225 YSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 3456788889999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=278.58 Aligned_cols=243 Identities=22% Similarity=0.386 Sum_probs=196.5
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
..+.||+|+||.||++... ++..|++|++.... ....++.+|++++++++|||++++++.+...+..++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence 3467999999999999965 58899999987653 3456688899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 501 (654)
++|.+++..... ....+++..+..++.+++.|++|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~-~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (258)
T cd08215 84 GDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK-ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK 161 (258)
T ss_pred CcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC-EecccCChHHeEEcCCCcEEECCccceeecccCcceec
Confidence 999999975421 1356899999999999999999999997 9999999999999999999999999987665432
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||.+.+..++.++||||+|+++++|++|+.||.... ............. .. ..
T Consensus 162 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~~----------~~ 224 (258)
T cd08215 162 TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKILKGQY-PP----------IP 224 (258)
T ss_pred ceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHhcCCC-CC----------CC
Confidence 2344566999999988889999999999999999999999986432 1222222211110 00 01
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
......+.+++.+||..+|++||++.|+++
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 225 SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 122345777888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=273.75 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=188.1
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhc-cCCCccccccEEEEe----CCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGK-IKHDNVVPLRAFYYS----KDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~-l~hpniv~l~~~~~~----~~~~~lv~e~~ 423 (654)
..++||-|-.|+|..+..+ .|+.+|+|++.... ...+|+++.-. -.|||||+++++|.+ ..-+.+|||.|
T Consensus 66 s~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 66 SWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 3578999999999998854 58899999986543 34566665333 369999999999864 23568999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC---CCCeEEeccCCCCCcCCC
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP---DHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~---~~~~kl~Dfgla~~~~~~ 500 (654)
+||.|.+.+... +...+++.++..|+.||+.|+.|||+.+ |.||||||+|+|... +..+||+|||+|+.....
T Consensus 142 eGGeLfsriq~~---g~~afTErea~eI~~qI~~Av~~lH~~n-IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 142 EGGELFSRIQDR---GDQAFTEREASEIMKQIGLAVRYLHSMN-IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred cchHHHHHHHHc---ccccchHHHHHHHHHHHHHHHHHHHhcc-hhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 999999999854 4567999999999999999999999998 999999999999975 446899999999877533
Q ss_pred ---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 501 ---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 501 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
....-|+.|.|||++....|+..+|+||+||++|-|++|.+||....+. .+..-+...++.+. +...-..
T Consensus 218 ~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gq----y~FP~pE 290 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQ----YEFPEPE 290 (400)
T ss_pred ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccC----ccCCChh
Confidence 3456678899999999999999999999999999999999999875442 22221222222211 1111112
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
+....+. .-++++..++.+|++|.|+.+++..
T Consensus 291 Ws~VSe~---aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 291 WSCVSEA---AKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HhHHHHH---HHHHHHHHhcCCchhheeHHHhhcC
Confidence 2223333 3446668899999999999998754
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=282.25 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=187.8
Q ss_pred hccccccCceeEEEEEecC-CcEEEEEEecccccC---HHHHHHHHHHHhcc---CCCccccccEEEEeCCc-----eEE
Q 036334 351 AEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVG---KREFEMQMEVLGKI---KHDNVVPLRAFYYSKDE-----KLL 418 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~---~~~~~~e~~~l~~l---~hpniv~l~~~~~~~~~-----~~l 418 (654)
.+.||+|+||.||+|.... ++.||+|+++..... ...+.+|+.+++++ +||||+++++++...+. .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 4679999999999999764 899999999754221 23456677776655 69999999999988776 899
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 419 VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
+|||+. ++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 84 ~~e~~~-~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~-i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 84 VFEHVD-QDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHSHR-IVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred Eehhcc-cCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999996 48988886432 235899999999999999999999998 9999999999999999999999999987764
Q ss_pred CCC---CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---hchhhh---
Q 036334 499 NTT---PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR---EEWTAE--- 569 (654)
Q Consensus 499 ~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~--- 569 (654)
... ...++..|+|||++.+..++.++|||||||++|||++|..||......+ ....+...... ..+...
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcCCCccc
Confidence 332 2234567999999998899999999999999999999999987533211 01111110000 000000
Q ss_pred ---hhhHhhhc--cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 570 ---VFDVELMR--YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 570 ---~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.+...... .....+....+.+++.+||+.||++||+++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0001122355678889999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=294.63 Aligned_cols=259 Identities=21% Similarity=0.311 Sum_probs=195.4
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCC-----ceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD-----EKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-----~~~lv~ 420 (654)
+.+.||+|+||.||+|... .++.||+|++.... ...+.+.+|+.+++.++|+||+++++++.... ..++||
T Consensus 4 i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 83 (330)
T cd07834 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83 (330)
T ss_pred eeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEe
Confidence 4578999999999999965 48999999987643 23467888999999999999999999988775 789999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||++ ++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 84 e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~g-i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 84 ELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHSAN-VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred cchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9997 589888863 236999999999999999999999998 999999999999999999999999998766443
Q ss_pred C-------CCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh--------
Q 036334 501 T-------PPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE-------- 564 (654)
Q Consensus 501 ~-------~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-------- 564 (654)
. ...++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+ ....+......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID---QLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHhcCCCChhHhhh
Confidence 2 23345669999999887 88999999999999999999999997543211 00000000000
Q ss_pred ---chhhhhhhH-----hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhhc
Q 036334 565 ---EWTAEVFDV-----ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM--IENMNR 618 (654)
Q Consensus 565 ---~~~~~~~~~-----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~ 618 (654)
......+.. ..............+.+++.+||+.+|++||+++++++. +++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000000 000000001123457788889999999999999999985 666654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=323.17 Aligned_cols=240 Identities=27% Similarity=0.337 Sum_probs=187.4
Q ss_pred hccccccCceeEEEEE-ecCCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+||.|.||.||.|. ..+|+..|||-++-... .-....+|+.++..++|||+|+++|+-.+.+..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 5689999999999998 55689999998865432 3345778999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-----
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT----- 501 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----- 501 (654)
+|.+++...+ -.++.....+..|++.|++|||++| ||||||||.||+++.+|-+|.+|||.|.......
T Consensus 1320 sLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~g-IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1320 SLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEHG-IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred cHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhcC-ceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 9999997432 3556666678889999999999998 9999999999999999999999999998775543
Q ss_pred ---CCCccccccCccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 502 ---PPTRVAGYRAPEVVETR---KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 502 ---~~~~~~~y~aPE~~~~~---~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
...||+.|||||++.+. ...-++||||+|||+.||+||++||...+.+= . +.-.+..+.. +.
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~--a----IMy~V~~gh~-----Pq- 1461 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW--A----IMYHVAAGHK-----PQ- 1461 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh--H----HHhHHhccCC-----CC-
Confidence 34678889999999653 45678999999999999999999997643321 0 0001111111 11
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.+.....+- .+++.+|+..||++|+++.|+++.
T Consensus 1462 -~P~~ls~~g---~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 -IPERLSSEG---RDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -CchhhhHhH---HHHHHHHHhcCchhhhHHHHHHHh
Confidence 111123333 445559999999999988876653
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=285.12 Aligned_cols=247 Identities=22% Similarity=0.287 Sum_probs=191.7
Q ss_pred hhccccccCceeEEEEEe----cCCcEEEEEEecccc-----cCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVA-----VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~----~~g~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv 419 (654)
+.+.||+|+||.||++.. .+++.||||+++... .....+..|++++.++ +||||+++++.+..+...++|
T Consensus 4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 347799999999999874 357889999987542 2235678899999999 599999999999998999999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
|||+++|+|.+++.. ...+++..+..++.|++++|+|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~-~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 84 LDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQLG-IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999999863 235889999999999999999999988 99999999999999999999999999876533
Q ss_pred CC-----CCCccccccCccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhh
Q 036334 500 TT-----PPTRVAGYRAPEVVETRK--VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 500 ~~-----~~~~~~~y~aPE~~~~~~--~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 572 (654)
.. ...++..|+|||.+.+.. .+.++||||||+++|||++|..||....... .............
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~------- 228 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKSK------- 228 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHccC-------
Confidence 21 123566799999987654 7889999999999999999999986422111 1111111111110
Q ss_pred HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 573 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
..........+.+++.+||+.||++|||++++.+.|+..
T Consensus 229 -----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 -----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 001111223567788899999999999999888877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=283.12 Aligned_cols=256 Identities=22% Similarity=0.354 Sum_probs=189.7
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHhccC-CCccccccEEEEeCCceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.||+|+||+||+|... +++.|++|++..... ......+|+..+++++ |+||+++++++.+++..++||||+ +|
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 467999999999999975 478899999876533 2334557889999999 999999999999999999999999 88
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---CC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---PP 503 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~~ 503 (654)
+|.+++.... ...+++..++.++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 83 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~-i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 83 NLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG-FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred CHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 9999887432 246899999999999999999999988 9999999999999999999999999987665432 23
Q ss_pred CccccccCccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCC----------ChhHHHHHHhhhchhhhhhh
Q 036334 504 TRVAGYRAPEVVE-TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGI----------DLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 504 ~~~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~ 572 (654)
.++..|+|||++. ...++.++||||||+++|||++|+.||......+.. ....|.............+.
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 3566799999875 456789999999999999999999999654321100 00001000000000000000
Q ss_pred Hhhhc--cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 573 VELMR--YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 573 ~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..... .........++.+++.+||+.+|++||+++|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000 0000111346788899999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=279.39 Aligned_cols=239 Identities=21% Similarity=0.292 Sum_probs=186.1
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc------cCHHHHHHHHHHHhccCCCccccccEEEEeC--CceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA------VGKREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~ 420 (654)
+.+.||+|+||.||+|... ++..||+|.+.... .....+++|++++++++|+||+++++++.+. +..++|+
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (264)
T cd06653 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV 85 (264)
T ss_pred eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEE
Confidence 4578999999999999854 58899999875321 1234678899999999999999999998764 4578999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+++++|.+++.. ...+++...++++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 86 e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~~-i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 86 EYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999999863 234889999999999999999999998 999999999999999999999999998765321
Q ss_pred -------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 -------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+........
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~------- 226 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQPT------- 226 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHHHHHcCCC-------
Confidence 122356679999999888899999999999999999999999964311 111111111100
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
...........+.+++.+||. +|..||+..+++.
T Consensus 227 ---~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 ---KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 001112223456777779998 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=287.47 Aligned_cols=254 Identities=23% Similarity=0.293 Sum_probs=186.8
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCC----------
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD---------- 414 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~---------- 414 (654)
.+.+.||+|+||.||+|... +|+.||+|+++... .....+.+|++++++++||||+++++++.+..
T Consensus 10 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 89 (302)
T cd07864 10 DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKG 89 (302)
T ss_pred heeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCC
Confidence 44678999999999999975 58899999987542 22356778999999999999999999987654
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCC
Q 036334 415 EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN 494 (654)
Q Consensus 415 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla 494 (654)
..++|+||+++ ++...+... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 90 ~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 90 AFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKN-FLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred cEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999976 676666532 345899999999999999999999998 999999999999999999999999998
Q ss_pred CCcCCCC-----CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchh-
Q 036334 495 PLFGNTT-----PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWT- 567 (654)
Q Consensus 495 ~~~~~~~-----~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 567 (654)
....... ....+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....+.........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLCGSPCPA 240 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChh
Confidence 7654322 1233556999998864 45789999999999999999999999743211 111111111100000
Q ss_pred --hhh--------hhHhhhcc----CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 568 --AEV--------FDVELMRY----HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 568 --~~~--------~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..+ .+...... .........+.+++.+||+.+|++||+++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 00000000 000011345778888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=284.64 Aligned_cols=238 Identities=23% Similarity=0.339 Sum_probs=191.2
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccC-CCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
..+.||+|+||.||++... +|..|++|++.... ...+.+.+|+++++++. ||||+++++++.+++..++||||+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd05581 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYA 84 (280)
T ss_pred EeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCC
Confidence 3567999999999999965 68999999987632 22356788999999998 999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC-
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP- 502 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~- 502 (654)
++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++........
T Consensus 85 ~~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~~~-~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 85 PNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHSKG-IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred CCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999973 236999999999999999999999998 99999999999999999999999999876543221
Q ss_pred -----------------------CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 036334 503 -----------------------PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQ 559 (654)
Q Consensus 503 -----------------------~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~ 559 (654)
..++..|+|||.+....++.++||||||++++++++|+.||..... ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~ 232 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------YLTFQ 232 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------HHHHH
Confidence 1234569999999888899999999999999999999999975431 11111
Q ss_pred HHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 036334 560 SVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAM----QEVVR 611 (654)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~evl~ 611 (654)
...... ..........+.+++.+||+.+|++||++ +++++
T Consensus 233 ~~~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 KILKLE------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHhcC------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111100 01111223457788889999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=286.83 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=188.1
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEe-CCceEEEEEec
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYS-KDEKLLVYDYM 423 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~~ 423 (654)
...+.||+|+||.||++... +|+.||+|++.... ...+.+.+|++++++++||||++++++|.. .+..++|+||+
T Consensus 13 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~ 92 (328)
T cd07856 13 VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL 92 (328)
T ss_pred EEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh
Confidence 34578999999999999854 68999999886432 234567789999999999999999998876 45789999998
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-C
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-P 502 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~ 502 (654)
+++|..++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||.+....... .
T Consensus 93 -~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~-iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 164 (328)
T cd07856 93 -GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAG-VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG 164 (328)
T ss_pred -ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEeECCCCCEEeCccccccccCCCcCC
Confidence 5689888862 34788889999999999999999998 9999999999999999999999999987654332 2
Q ss_pred CCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCC---------ChhHHHHHHhhhchhhhhhh
Q 036334 503 PTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGI---------DLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~ 572 (654)
..++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ...++...............
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (328)
T cd07856 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS 244 (328)
T ss_pred CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence 345667999998765 57899999999999999999999999754321100 00111111100000000000
Q ss_pred HhhhccCChH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 573 VELMRYHNIE----EEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 573 ~~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.......... .....+.+++.+||+.+|++||++++++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000001 122467788889999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=275.02 Aligned_cols=231 Identities=26% Similarity=0.336 Sum_probs=187.9
Q ss_pred ccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 354 LGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 354 lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
||+|+||.||++... +++.+++|++..... ....+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 488999999876533 345788899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CCCC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPPT 504 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~~ 504 (654)
.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~~~-~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLHSLG-IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 9999733 35899999999999999999999987 999999999999999999999999998765432 2334
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
++..|+|||.+.+...+.++|+||||+++||+++|+.||..... ............ ......
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~------------~~~~~~ 216 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKDPL------------RFPEFL 216 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcCCC------------CCCCCC
Confidence 56679999999888889999999999999999999999965321 111222211100 001111
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHH
Q 036334 585 MVQLLQIAMGCVSTVPDQRPAMQE 608 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RPs~~e 608 (654)
...+.+++.+||..||++||++++
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 345677888999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=282.53 Aligned_cols=242 Identities=24% Similarity=0.321 Sum_probs=187.2
Q ss_pred hhccccccCceeEEEEEe----cCCcEEEEEEecccc-----cCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVA-----VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~----~~g~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv 419 (654)
+.+.||+|+||.||++.. .+|..||+|+++... ...+.+.+|+++++++ +|+||+++++.+..+...++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 346799999999999985 368899999987532 2245678899999999 599999999999988899999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~-i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 84 LDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999999873 245889999999999999999999988 99999999999999999999999999876543
Q ss_pred CC-----CCCccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhh
Q 036334 500 TT-----PPTRVAGYRAPEVVET--RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 500 ~~-----~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 572 (654)
.. ...++..|+|||.+.. ..++.++||||||+++|+|++|+.||...... .....+.........
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~------ 229 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEP------ 229 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccCC------
Confidence 21 2335667999999865 34678999999999999999999998642211 111111111111100
Q ss_pred HhhhccCChHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 036334 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRP-----AMQEVVR 611 (654)
Q Consensus 573 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 611 (654)
.........+.+++.+||+.||++|| +.++++.
T Consensus 230 ------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 ------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 00111233567788899999999997 6666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=292.45 Aligned_cols=239 Identities=21% Similarity=0.320 Sum_probs=192.5
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.+.||+|.|++|..|... .|..||+|.+.+.... ...+.+|+++|..++|||||+++.+...+..+|+||||+.+
T Consensus 60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence 3467999999999999854 5899999999887543 24478899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---CC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TP 502 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~~ 502 (654)
|.+++++... ..+.+..+..++.|+..|++|||++. |||||||++|||++.+.++||+|||++.++... ..
T Consensus 140 ge~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH~k~-ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt 213 (596)
T KOG0586|consen 140 GELFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCHSKN-IVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQT 213 (596)
T ss_pred chhHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHhhcc-eeccccchhhcccccccceeeeccccceeecccccccc
Confidence 9999999844 34556888899999999999999998 999999999999999999999999999988754 34
Q ss_pred CCccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 503 PTRVAGYRAPEVVETRKV-TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
..+++.|.|||++.+..| .+.+|+||+|+++|-|+.|..||++..-.+ ++. .++...+..+...
T Consensus 214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-----------Lr~----rvl~gk~rIp~~m 278 (596)
T KOG0586|consen 214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-----------LRP----RVLRGKYRIPFYM 278 (596)
T ss_pred cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-----------ccc----hheeeeeccccee
Confidence 566777999999998776 488999999999999999999998643211 001 1111111111112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.. +.-+++++++-.+|.+|++.+++.+.
T Consensus 279 s~---dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 279 SC---DCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ec---hhHHHHHHhhccCccccCCHHHhhhh
Confidence 22 33456668888999999999988543
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=293.67 Aligned_cols=254 Identities=23% Similarity=0.357 Sum_probs=187.7
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCC------ceEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD------EKLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------~~~lv 419 (654)
..+.||+|+||.||+|... +|+.||+|+++... .....+.+|++++++++||||+++++++.... ..++|
T Consensus 19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence 3478999999999999954 68999999987532 22345788999999999999999999987543 46899
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
+||+.. +|..++. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 99 ~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~-i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 99 MPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG-IIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred eccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 999964 7766653 24889999999999999999999998 99999999999999999999999999876543
Q ss_pred CC-CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------chhhhhh
Q 036334 500 TT-PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE------EWTAEVF 571 (654)
Q Consensus 500 ~~-~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 571 (654)
.. ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+..+... .......
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL------DQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHhcCCCCHHHHHHhc
Confidence 22 2344567999999866 46889999999999999999999999753211 111111100 0000000
Q ss_pred h-------Hhhhcc--CC----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhhc
Q 036334 572 D-------VELMRY--HN----IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM--IENMNR 618 (654)
Q Consensus 572 ~-------~~~~~~--~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~ 618 (654)
+ ...... .. ......++.+++.+||+.||++||+++++++. ++..+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0 000000 00 00122356788889999999999999999955 766654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=291.22 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=184.6
Q ss_pred hccccccCceeEEEEEe-cCCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeC------CceEEEE
Q 036334 351 AEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSK------DEKLLVY 420 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------~~~~lv~ 420 (654)
.+.||+|+||.||+|.. .+|+.||+|+++.... ..+.+.+|+.++++++||||+++++++... ...++++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 46799999999999985 4688999999875422 235677899999999999999999988643 2367888
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
+++ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 102 ~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~ 173 (345)
T cd07877 102 HLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173 (345)
T ss_pred hhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCChHHEEEcCCCCEEEeccccccccccc
Confidence 877 7899888752 24899999999999999999999998 999999999999999999999999998765433
Q ss_pred C-CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------chhhhhhh
Q 036334 501 T-PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE------EWTAEVFD 572 (654)
Q Consensus 501 ~-~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 572 (654)
. ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+..+... .......+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 174 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID------QLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhCCCCHHHHhhccc
Confidence 2 2345667999998866 568899999999999999999999996532211 11111000 00000000
Q ss_pred -------Hhhhcc-C-Ch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 573 -------VELMRY-H-NI----EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 573 -------~~~~~~-~-~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
..+... . .. .....++.+++.+|++.||.+||++.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000 0 00 0112356788889999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=277.85 Aligned_cols=242 Identities=24% Similarity=0.316 Sum_probs=187.7
Q ss_pred hhccccccCceeEEEEEecC-CcEEEEEEecccc------cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVA------VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~------~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
+.+.||+|+||.||++.... +..+++|.++... ....++..|+.++++++||||+++++++.+.+..++||||
T Consensus 4 i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (260)
T cd08222 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEY 83 (260)
T ss_pred eeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEe
Confidence 45779999999999998653 4456666665422 1233566788999999999999999999988899999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 500 (654)
+++++|.+++..... ....+++..++.++.|++.|+.|||+.+ ++|+||||+||+++. +.+||+|||++......
T Consensus 84 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~-i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~ 160 (260)
T cd08222 84 CEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRR-ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD 160 (260)
T ss_pred CCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcC-ccccCCChhheEeec-CCEeecccCceeecCCCcc
Confidence 999999998864322 2346899999999999999999999998 999999999999975 57999999998765332
Q ss_pred --CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 501 --TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ............ ..
T Consensus 161 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~~-----------~~ 223 (260)
T cd08222 161 LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEGP-----------TP 223 (260)
T ss_pred cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcCC-----------CC
Confidence 12345667999999988889999999999999999999999985321 111111111110 00
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
........++.+++.+||..+|++||++.|+++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111233456788889999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=284.67 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=182.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCC--------ceE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKD--------EKL 417 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~--------~~~ 417 (654)
+.+.||+|+||.||+|... +++.||+|++..... ....+.+|++++++++||||+++++++.... ..+
T Consensus 12 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 91 (311)
T cd07866 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91 (311)
T ss_pred EEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEE
Confidence 3577999999999999965 588999999865422 2345678999999999999999999875433 469
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 418 LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
+|+||+.+ ++...+... ...+++..+..++.|+++||+|||+++ |+||||||+||++++++.+||+|||++...
T Consensus 92 lv~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~-i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 92 MVTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHENH-ILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred EEEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 99999965 677766532 235899999999999999999999998 999999999999999999999999998755
Q ss_pred CCCCC---------------CCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH
Q 036334 498 GNTTP---------------PTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSV 561 (654)
Q Consensus 498 ~~~~~---------------~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~ 561 (654)
..... ..++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~~~~~~~ 242 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QLHLIFKL 242 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHH
Confidence 33211 123456999998765 458899999999999999999999997533211 00000000
Q ss_pred hhh----ch-----hhhh--------hhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 562 VRE----EW-----TAEV--------FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 562 ~~~----~~-----~~~~--------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
... .+ .... ....... ........+.+++.+|++.||++|||+.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE--RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHH--HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000 00 0000 0000000 00111245778899999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=279.25 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=191.0
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.||+|+||.||+|... +++.|++|++.... .....+..|++++++++|+|++++++++.+.+..++||||++ +
T Consensus 4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 357999999999999965 48999999987652 234567789999999999999999999999999999999997 5
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----C
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT----P 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~ 502 (654)
+|.+++.... ..+++..+++++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||++....... .
T Consensus 83 ~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~-i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 83 DLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR-ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred CHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 8999997431 35899999999999999999999998 9999999999999999999999999987664332 2
Q ss_pred CCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc---hhhhh-----hhH
Q 036334 503 PTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREE---WTAEV-----FDV 573 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----~~~ 573 (654)
...+..|+|||.+.+. .++.++|||||||++|||++|+.||......+ ....+....... ..... .+.
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2334569999998766 78999999999999999999999986533211 001111100000 00000 000
Q ss_pred hhhcc------CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 574 ELMRY------HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 574 ~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..... .........+.+++.+||+.||++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000 000111346888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=291.06 Aligned_cols=248 Identities=22% Similarity=0.324 Sum_probs=186.1
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCC------ceEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKD------EKLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------~~~lv 419 (654)
..+.||+|+||.||++.. .+|..||||++..... ....+.+|++++++++||||+++++++.... ..++|
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07880 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98 (343)
T ss_pred EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence 346799999999999984 4689999999865322 2346778999999999999999999987543 35899
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
|||+ +++|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 99 ~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~g-i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 99 MPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAG-IIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 9999 7799888852 35899999999999999999999988 99999999999999999999999999886654
Q ss_pred CC-CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------chhhhhh
Q 036334 500 TT-PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE------EWTAEVF 571 (654)
Q Consensus 500 ~~-~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 571 (654)
.. ...++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...... ......... .+...+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 171 EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL------DQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHhcCCCCHHHHHhhc
Confidence 32 2345667999999875 45889999999999999999999999753211 111111000 0000000
Q ss_pred h-------HhhhccC------ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 572 D-------VELMRYH------NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 572 ~-------~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
. ..+.... .......++.+++.+|++.||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0000000 00112234778888999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=286.66 Aligned_cols=254 Identities=20% Similarity=0.265 Sum_probs=182.9
Q ss_pred hhccccccCceeEEEEEec-C--CcEEEEEEecccc---cCHHHHHHHHHHHhcc-CCCccccccEEEEeC----CceEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-E--GTTVVVKRLKEVA---VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSK----DEKLL 418 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~--g~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~----~~~~l 418 (654)
+.+.||+|+||.||++... . +..||+|++.... .....+.+|+++++++ +||||+++++++... ...++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 83 (332)
T cd07857 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYL 83 (332)
T ss_pred EEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEE
Confidence 3577999999999999965 3 6789999987532 2245677899999999 599999999875432 35688
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 419 VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
++||+. ++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g-ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 84 YEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHSAN-VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 899885 689988863 345899999999999999999999998 9999999999999999999999999987653
Q ss_pred CC--------CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCC---------ChhHHHHH
Q 036334 499 NT--------TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGI---------DLPRWVQS 560 (654)
Q Consensus 499 ~~--------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~---------~~~~~~~~ 560 (654)
.. ....++..|+|||++.+ ..++.++||||+||++|+|++|+.||......+.. ....+...
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 22 11245667999998765 46899999999999999999999998753321100 00000000
Q ss_pred HhhhchhhhhhhH-hhhccCC----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 561 VVREEWTAEVFDV-ELMRYHN----IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 561 ~~~~~~~~~~~~~-~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
...... ...... ....... .......+.+++.+|++.||++|||+.++++
T Consensus 237 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 237 IGSPKA-QNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhH-HHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000 000000 0000000 0011346778888999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=268.12 Aligned_cols=230 Identities=26% Similarity=0.340 Sum_probs=184.0
Q ss_pred hccccccCceeEEEEE-ecCCcEEEEEEeccccc-CHHHH---HHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAV-GKREF---EMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~-~~~~~---~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.++||+|.||+|-.++ ...|+.+|+|++++... .+.+. ..|-++|+..+||.+..+--.|...+.+|+||||..|
T Consensus 173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanG 252 (516)
T KOG0690|consen 173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANG 252 (516)
T ss_pred HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccC
Confidence 4789999999999998 44689999999988643 33332 3467889999999999998889999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCc----CCCC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF----GNTT 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~----~~~~ 501 (654)
|.|.-+|... ..+++.....+...|..||.|||+++ ||.||||.+|.|+|.+|++||.|||+++.- ....
T Consensus 253 GeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLHs~~-ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~k 326 (516)
T KOG0690|consen 253 GELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLHSRN-IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTK 326 (516)
T ss_pred ceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhhhCC-eeeeechhhhheeccCCceEeeecccchhcccccceec
Confidence 9999999743 34788888889999999999999987 999999999999999999999999998643 2234
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...||+.|+|||++....|+.++|.|.+||++|||++|+.||...+.+.-..+ + ..+ .+.-+...
T Consensus 327 TFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL------I-----l~e----d~kFPr~l 391 (516)
T KOG0690|consen 327 TFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL------I-----LME----DLKFPRTL 391 (516)
T ss_pred cccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH------H-----Hhh----hccCCccC
Confidence 56788889999999999999999999999999999999999986543321111 0 111 11112233
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRP 604 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RP 604 (654)
..+.+.|+ ...+.+||.+|.
T Consensus 392 s~eAktLL---sGLL~kdP~kRL 411 (516)
T KOG0690|consen 392 SPEAKTLL---SGLLKKDPKKRL 411 (516)
T ss_pred CHHHHHHH---HHHhhcChHhhc
Confidence 44444444 478889999997
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=288.59 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=182.1
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeC--------------
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSK-------------- 413 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-------------- 413 (654)
..+.||+|+||.||+|... +|..||+|.+.... ...+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (342)
T cd07854 9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88 (342)
T ss_pred EEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccccc
Confidence 3477999999999999864 58899999986543 3345688899999999999999999876543
Q ss_pred CceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC-CCCeEEeccC
Q 036334 414 DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP-DHDACVSDFG 492 (654)
Q Consensus 414 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~-~~~~kl~Dfg 492 (654)
...++||||++ ++|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+|++|||
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g-ivH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSAN-VLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEEcCCCceEEECCcc
Confidence 34689999996 589888752 34889999999999999999999998 999999999999985 4578999999
Q ss_pred CCCCcCCC-------CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh
Q 036334 493 LNPLFGNT-------TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE 564 (654)
Q Consensus 493 la~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 564 (654)
++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+. .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~------~~~~~~~ 234 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ------MQLILES 234 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHHh
Confidence 98765322 11234567999998654 5688899999999999999999999975432110 0000000
Q ss_pred --------------chhhhhhhHhhhccCC----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 565 --------------EWTAEVFDVELMRYHN----IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 565 --------------~~~~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
................ ......++.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000000000000000 00122456788889999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=287.29 Aligned_cols=251 Identities=23% Similarity=0.328 Sum_probs=186.9
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCc------eEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDE------KLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~------~~lv 419 (654)
..+.||+|+||.||+|... ++..||+|++.... .....+.+|+.++++++||||+++++++...+. .++|
T Consensus 19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98 (343)
T ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence 3477999999999999965 57899999986532 223456789999999999999999998776554 8999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
+||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 99 ~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g-i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 99 THLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG-IIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 9999 6799998863 35899999999999999999999998 99999999999999999999999999887643
Q ss_pred C-CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---chhh------
Q 036334 500 T-TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE---EWTA------ 568 (654)
Q Consensus 500 ~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~------ 568 (654)
. ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+ ....+...... ....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCHHHHhhccchh
Confidence 3 22345567999998865 467899999999999999999999997532211 01111110000 0000
Q ss_pred --hhhhH-hhhccCCh----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 569 --EVFDV-ELMRYHNI----EEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 569 --~~~~~-~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..+.. ........ .....++.+++.+|+..+|++|||+.||++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000 00000000 012346778889999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=294.43 Aligned_cols=242 Identities=23% Similarity=0.393 Sum_probs=202.3
Q ss_pred hccccccCceeEEEEE-ecCCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEEEe-----CCceEEEEEec
Q 036334 351 AEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYS-----KDEKLLVYDYM 423 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~-----~~~~~lv~e~~ 423 (654)
.++||.|.+|.||++. .++|+.+|+|++.......++++.|+++++.. .|||++.++|+|.. ++++|||||||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC 103 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFC 103 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeecc
Confidence 4789999999999998 45689999999998888888999999998877 59999999999864 46799999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN---- 499 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~---- 499 (654)
.+|+..|++++.. ...+.|..+..|+..++.|+.|||... ++|||||-.|||++.++.||++|||.+.....
T Consensus 104 ~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk-viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~gr 179 (953)
T KOG0587|consen 104 GGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGR 179 (953)
T ss_pred CCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc-eeeecccCceEEEeccCcEEEeeeeeeeeeeccccc
Confidence 9999999998775 456999999999999999999999876 99999999999999999999999999876643
Q ss_pred CCCCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 500 TTPPTRVAGYRAPEVVET-----RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 500 ~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
.....||+.|||||++.. ..|+.++|+||+|++..||--|.+|+..+.+...+ -.+....
T Consensus 180 RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL---------------F~IpRNP 244 (953)
T KOG0587|consen 180 RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL---------------FLIPRNP 244 (953)
T ss_pred ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh---------------ccCCCCC
Confidence 345678889999999954 35788999999999999999999998765432211 1111111
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.+.....+.+.+++.++|..|+.+|-++||++.++++
T Consensus 245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1233445778889999999999999999999988753
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=270.51 Aligned_cols=219 Identities=21% Similarity=0.205 Sum_probs=172.5
Q ss_pred cCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchhhhhccC
Q 036334 357 GSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGS 435 (654)
Q Consensus 357 G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 435 (654)
|.||.||++... +++.||+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 899999999954 68899999987643 2334444555567999999999999999999999999999999998632
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-CCCccccccCccc
Q 036334 436 RGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-PPTRVAGYRAPEV 514 (654)
Q Consensus 436 ~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~~y~aPE~ 514 (654)
..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+....... ...++..|+|||.
T Consensus 80 -----~~l~~~~~~~~~~ql~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~ 153 (237)
T cd05576 80 -----LNIPEECVKRWAAEMVVALDALHREG-IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEV 153 (237)
T ss_pred -----cCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcc
Confidence 34899999999999999999999988 9999999999999999999999999876654332 2333456999999
Q ss_pred cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhh
Q 036334 515 VETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMG 594 (654)
Q Consensus 515 ~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 594 (654)
+....++.++||||+|+++|||++|+.|+....... ... ....+ .......+.+++.+
T Consensus 154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~-----~~~~~-----~~~~~~~~~~li~~ 211 (237)
T cd05576 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH-----TTLNI-----PEWVSEEARSLLQQ 211 (237)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc-----cccCC-----cccCCHHHHHHHHH
Confidence 988889999999999999999999998875321100 000 00000 01112356678889
Q ss_pred ccCCCCCCCCCHH
Q 036334 595 CVSTVPDQRPAMQ 607 (654)
Q Consensus 595 cl~~dP~~RPs~~ 607 (654)
|++.||++||++.
T Consensus 212 ~l~~dp~~R~~~~ 224 (237)
T cd05576 212 LLQFNPTERLGAG 224 (237)
T ss_pred HccCCHHHhcCCC
Confidence 9999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=308.81 Aligned_cols=139 Identities=24% Similarity=0.355 Sum_probs=124.2
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.+.||+|+||+||+|... +++.||+|+++.... ....+..|+.+++.++||||+++++++......|+||||+.+
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g 88 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG 88 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence 477999999999999965 688999999975432 135678899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP 495 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~ 495 (654)
++|.+++... ..+++..+++++.||+.||+|||..+ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~~g-IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 89 GDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHRHG-IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999732 35889999999999999999999987 9999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=282.66 Aligned_cols=237 Identities=21% Similarity=0.346 Sum_probs=188.1
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.++||.|.||+||-|.++ .|+.||||++.+.. ........|+.+|+.+.||.||.+...|+..+..++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 689999999999999854 69999999997652 3346688999999999999999999999999999999999955
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC---CCeEEeccCCCCCcCCC---
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD---HDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~---~~~kl~Dfgla~~~~~~--- 500 (654)
+..+.+-.. ....+++.....++.||+.||.|||.++ |+|+||||+|||+.+. -++||||||+|+++++.
T Consensus 648 DMLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~kn-IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 648 DMLEMILSS---EKGRLPERITKFLVTQILVALRYLHFKN-IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hHHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhcc-eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 555554433 3456999999999999999999999998 9999999999999764 36999999999998765
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC-
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH- 579 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 579 (654)
....||+.|+|||++..+.|...-|+||.|||+|--++|..||.... ++.+.+++. .++.+.
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----dIndQIQNA------------aFMyPp~ 786 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----DINDQIQNA------------AFMYPPN 786 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-----chhHHhhcc------------ccccCCC
Confidence 45788999999999999999999999999999999999999997532 222222221 111111
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEV 609 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 609 (654)
.-.+.....+++|...++..-.+|-|...-
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 112222344566667777777777776654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-33 Score=262.86 Aligned_cols=259 Identities=22% Similarity=0.340 Sum_probs=189.5
Q ss_pred HHHhhccccccCceeEEEEEec-CCcEEEEEEeccc---ccCHHHHHHHHHHHhccCCCccccccEEEEeC--------C
Q 036334 347 LRASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV---AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK--------D 414 (654)
Q Consensus 347 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--------~ 414 (654)
.++...+||+|.||+||+|+.+ .|+.||+|+.-.. ..-.....+|+++|..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4445578999999999999854 4778898876432 22234567899999999999999999988642 3
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCC
Q 036334 415 EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN 494 (654)
Q Consensus 415 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla 494 (654)
.+|+||++|+. +|..+|.+. ...++..++.+++.++..||.|+|... |+|||+|+.|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iHr~k-ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIHRNK-ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHHHhh-HHhhcccHhhEEEcCCceEEeeccccc
Confidence 47999999977 899988743 356899999999999999999999886 999999999999999999999999999
Q ss_pred CCcCCCC--------CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH-HHhhh
Q 036334 495 PLFGNTT--------PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQ-SVVRE 564 (654)
Q Consensus 495 ~~~~~~~--------~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~-~~~~~ 564 (654)
+.+.... ....|..|++||.+.+ +.|+++.|||+-|||+.||+||.+-+++..+.....+...+. ++..+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 7664332 1223567999998876 679999999999999999999999998755433222222111 11111
Q ss_pred chhhhhhhHhhh-----------ccCChHHHHH------HHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 565 EWTAEVFDVELM-----------RYHNIEEEMV------QLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 565 ~~~~~~~~~~~~-----------~~~~~~~~~~------~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.|. +....++. .....++.++ +-.+|+..++..||.+|+++.+++..
T Consensus 252 vWP-~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWP-NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCC-CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111 00000000 0011122222 45567779999999999999988654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=240.81 Aligned_cols=191 Identities=25% Similarity=0.369 Sum_probs=162.9
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
-++||+|.||+||+|+.. .++.||+|+.+-... -.....+||-+++.++|.|||+++++...++.+-+|+|||..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 467999999999999954 578999999875432 235678999999999999999999999999999999999954
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----C
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT----P 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----~ 502 (654)
+|..+.... .+.++.+.+..++.|+++|+.|+|+++ +.|||+||.|.+++.+|+.|++|||+++-++-.. .
T Consensus 86 dlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fchshn-vlhrdlkpqnllin~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 86 DLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCHSHN-VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred HHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhhhhh-hhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence 888777644 345899999999999999999999997 9999999999999999999999999998876542 3
Q ss_pred CCccccccCccccCC-CCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 036334 503 PTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLT-GKAPNQASL 547 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~t-g~~pf~~~~ 547 (654)
...|..|++|+++.+ +-|+...|+||-|||+.|+.. |++.|.+.+
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 455677999999876 468899999999999999998 566676543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=282.31 Aligned_cols=235 Identities=23% Similarity=0.279 Sum_probs=184.2
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
....+|.|+|+.|-++... .++..+||++.+.. .+-.+|+.++... +||||+++.+.+.++.+.|+|||++.++-
T Consensus 326 ~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~e 402 (612)
T KOG0603|consen 326 FREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGE 402 (612)
T ss_pred cccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccH
Confidence 3455999999999988854 57889999997662 2334566555444 79999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEE-CCCCCeEEeccCCCCCcCCC-CCCCc
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL-RPDHDACVSDFGLNPLFGNT-TPPTR 505 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll-~~~~~~kl~Dfgla~~~~~~-~~~~~ 505 (654)
+.+.+...+ .....+..|+.+|+.|+.|||.+| +|||||||+|||+ ++.++++|+|||.+...... ....-
T Consensus 403 ll~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~g-vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~ 475 (612)
T KOG0603|consen 403 LLRRIRSKP------EFCSEASQWAAELVSAVDYLHEQG-VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPAL 475 (612)
T ss_pred HHHHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcC-eeecCCChhheeecCCCCcEEEEEechhhhCchhhcccch
Confidence 888886332 223778889999999999999998 9999999999999 68999999999999887665 23355
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHH
Q 036334 506 VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585 (654)
Q Consensus 506 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (654)
|..|.|||++....|++++|+||||++||+|++|+.||...-.+ ..+...+... +. .....+..
T Consensus 476 t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~--------~~--s~~vS~~A 539 (612)
T KOG0603|consen 476 TLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMP--------KF--SECVSDEA 539 (612)
T ss_pred hhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCC--------cc--ccccCHHH
Confidence 66799999999999999999999999999999999999864332 1111111111 00 02334455
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 586 VQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 586 ~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
++| +.+|++.||.+||+|.++...=
T Consensus 540 KdL---l~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 540 KDL---LQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred HHH---HHHhccCChhhCcChhhhccCc
Confidence 554 4599999999999999987643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=259.86 Aligned_cols=234 Identities=28% Similarity=0.361 Sum_probs=188.8
Q ss_pred CceeEEEEEecC-CcEEEEEEecccccC--HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchhhhhcc
Q 036334 358 SVGTSYKAVLEE-GTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHG 434 (654)
Q Consensus 358 ~fg~Vy~~~~~~-g~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 434 (654)
+||.||+|...+ |+.+++|++...... .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 899999998765332 57889999999999999999999999999999999999999999999874
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---CCCCccccccC
Q 036334 435 SRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TPPTRVAGYRA 511 (654)
Q Consensus 435 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~~~~~~~~y~a 511 (654)
. ..+++..++.++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... ....++..|++
T Consensus 81 ~-----~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 154 (244)
T smart00220 81 R-----GRLSEDEARFYARQILSALEYLHSNG-IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA 154 (244)
T ss_pred c-----cCCCHHHHHHHHHHHHHHHHHHHHcC-eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence 3 22899999999999999999999987 999999999999999999999999998876543 33455667999
Q ss_pred ccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHH
Q 036334 512 PEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQI 591 (654)
Q Consensus 512 PE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 591 (654)
||.+.+..++.++||||||++++++++|..||..... .............. ..........++.++
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-----~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~ 220 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-----LLELFKKIGKPKPP---------FPPPEWKISPEAKDL 220 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHHhccCCC---------CccccccCCHHHHHH
Confidence 9999888899999999999999999999999865311 11111111111000 000000033467888
Q ss_pred HhhccCCCCCCCCCHHHHHH
Q 036334 592 AMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 592 ~~~cl~~dP~~RPs~~evl~ 611 (654)
+.+|+..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 89999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=293.26 Aligned_cols=191 Identities=25% Similarity=0.334 Sum_probs=170.1
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+.++||+|+||.|..++.+ .++.||+|++.+.. ....-|..|-++|...+.+=|+++.-.|.++.++|+|||||
T Consensus 78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~ 157 (1317)
T KOG0612|consen 78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYM 157 (1317)
T ss_pred HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecc
Confidence 45689999999999999965 47889999998742 23456888999999888999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
+||+|-.++... ..+++..+..++..|..||.-||+.| +|||||||.|||+|..|++||+|||.+..+...
T Consensus 158 pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~mg-yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 158 PGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHSMG-YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred cCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHhcc-ceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 999999999843 36999999999999999999999999 999999999999999999999999998777643
Q ss_pred --CCCCccccccCccccC----C-CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 036334 501 --TPPTRVAGYRAPEVVE----T-RKVTFKSDVYSFGVLLLELLTGKAPNQA 545 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~----~-~~~~~~~DvwslGvil~el~tg~~pf~~ 545 (654)
...+|||-|.+||++. + +.|+..+|.||+||++|||+.|..||..
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 3568999999999984 3 5789999999999999999999999975
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=264.95 Aligned_cols=230 Identities=24% Similarity=0.314 Sum_probs=179.4
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccccCH----HHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGK----REFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
..+||+|+||+|.+|..+ ..+.+|||++++...-+ +--..|-++|... +-|.++++...|..-+.+|+||||+.
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn 433 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN 433 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence 468999999999999855 35679999998763321 1223344555544 57899999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----C
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN----T 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~----~ 500 (654)
||+|--+++. .+.+.+..+..+|..||-||-+||+++ |+.||||..|||+|.+|++||+|||+++.--. .
T Consensus 434 GGDLMyhiQQ-----~GkFKEp~AvFYAaEiaigLFFLh~kg-IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TT 507 (683)
T KOG0696|consen 434 GGDLMYHIQQ-----VGKFKEPVAVFYAAEIAIGLFFLHSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTT 507 (683)
T ss_pred CchhhhHHHH-----hcccCCchhhhhhHHHHHHhhhhhcCC-eeeeeccccceEeccCCceEeeecccccccccCCcce
Confidence 9999999873 345778889999999999999999999 99999999999999999999999999875322 1
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
....+|+.|+|||++...+|+..+|.|||||+||||+.|++||++.++++ .++ .+.+.....+..
T Consensus 508 kTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e------lF~---------aI~ehnvsyPKs 572 (683)
T KOG0696|consen 508 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQ---------AIMEHNVSYPKS 572 (683)
T ss_pred eeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH------HHH---------HHHHccCcCccc
Confidence 33567788999999999999999999999999999999999998754432 111 122222212222
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCC
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRP 604 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RP 604 (654)
..++...+....+.+.|.+|.
T Consensus 573 ---lSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 573 ---LSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ---ccHHHHHHHHHHhhcCCcccc
Confidence 233444555577888998886
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=262.48 Aligned_cols=245 Identities=22% Similarity=0.314 Sum_probs=184.6
Q ss_pred hhccccccCceeEEEEE-ecCCcEEEEEEecccccCH--------HHHHHHHHHHhccCCCccccccEEEEe-CCceEEE
Q 036334 350 SAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGK--------REFEMQMEVLGKIKHDNVVPLRAFYYS-KDEKLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~--------~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~~~lv 419 (654)
...+||+|+|+.||+|. +...+.||||+-......+ +-..+|.++.+.+.||.||++++||.- .+.+|-|
T Consensus 467 lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTV 546 (775)
T KOG1151|consen 467 LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTV 546 (775)
T ss_pred HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceee
Confidence 35689999999999998 4567899999864332222 235678999999999999999999875 4568999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC-CeecCCCCCCcEEECC---CCCeEEeccCCCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG-KIVHGNIKASNILLRP---DHDACVSDFGLNP 495 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-~ivHrDlk~~NIll~~---~~~~kl~Dfgla~ 495 (654)
+|||+|.+|+-+|+. ...+++.++..|+.||..||.||.... +|+|-||||.|||+-+ -|.+||.|||+++
T Consensus 547 LEYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred eeecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 999999999999984 446899999999999999999998654 7999999999999954 4789999999999
Q ss_pred CcCCCC-----------CCCccccccCccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHH
Q 036334 496 LFGNTT-----------PPTRVAGYRAPEVVET----RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQS 560 (654)
Q Consensus 496 ~~~~~~-----------~~~~~~~y~aPE~~~~----~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~ 560 (654)
+++... ...||..|++||-+.- ...+.|+||||+|||+|..+.|+.||...... +.
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---------Qd 692 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---------QD 692 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH---------HH
Confidence 876432 2346677999997643 35788999999999999999999999753221 12
Q ss_pred HhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 561 VVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
++..+.+...-...++.-.....+. -.+|++|++..-++|....++..
T Consensus 693 ILqeNTIlkAtEVqFP~KPvVsseA---kaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 ILQENTILKATEVQFPPKPVVSSEA---KAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHhhhchhcceeccCCCCCccCHHH---HHHHHHHHHhhhhhhhhHHHHcc
Confidence 2222221111111111112223333 44666999999999998877653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=242.04 Aligned_cols=194 Identities=23% Similarity=0.397 Sum_probs=160.7
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccccC--HHHHHHHHHHH-hccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVG--KREFEMQMEVL-GKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~e~~~l-~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
....||+|++|.|-+.++ .+|+..|||+++....+ +++..+|+++. +...+|.+|.++|........++.||.|.-
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t 129 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT 129 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence 345699999999988774 46999999999876444 34556677764 455799999999999999999999999944
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC---
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP--- 502 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~--- 502 (654)
+|+.+-..... ....+++...-+|+..+..||.|||++-.++|||+||+|||++.+|++|+||||++.++.++..
T Consensus 130 -Sldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~ 207 (282)
T KOG0984|consen 130 -SLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTM 207 (282)
T ss_pred -hHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHH
Confidence 77766543322 2456899999999999999999999888899999999999999999999999999988766532
Q ss_pred CCccccccCccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 036334 503 PTRVAGYRAPEVVET----RKVTFKSDVYSFGVLLLELLTGKAPNQA 545 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~----~~~~~~~DvwslGvil~el~tg~~pf~~ 545 (654)
..|...|||||.+.. ..|+-|+||||+|+++.||.+++.||..
T Consensus 208 daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 208 DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 334455999998853 4799999999999999999999999874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=269.51 Aligned_cols=239 Identities=18% Similarity=0.239 Sum_probs=191.2
Q ss_pred ccccccCceeEEEEEecCCc-EEEEEEecccccC----HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 352 EVLGKGSVGTSYKAVLEEGT-TVVVKRLKEVAVG----KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~-~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
-.||-|+||.|-++...... .+|+|++++...- .+-+..|-.+|..++.|.||++|..|.+.+..|++||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 45999999999998865433 4899999876322 223456778999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC---C
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP---P 503 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~ 503 (654)
.|+..|+ .++.++...+..++..+.+|++|||+++ ||+|||||+|.+++.+|-+||.|||+|+..+.... .
T Consensus 506 ElWTiLr-----dRg~Fdd~tarF~~acv~EAfeYLH~k~-iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTF 579 (732)
T KOG0614|consen 506 ELWTILR-----DRGSFDDYTARFYVACVLEAFEYLHRKG-IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTF 579 (732)
T ss_pred hhhhhhh-----hcCCcccchhhhhHHHHHHHHHHHHhcC-ceeccCChhheeeccCCceEEeehhhHHHhccCCceeee
Confidence 9999998 4566888899999999999999999998 99999999999999999999999999999876543 4
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.||+.|.|||++.++..+.++|.||+|+++|||++|++||.+.++.. -+..++. +.-. ...+..
T Consensus 580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk------tYn~ILk-Gid~---------i~~Pr~ 643 (732)
T KOG0614|consen 580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK------TYNLILK-GIDK---------IEFPRR 643 (732)
T ss_pred cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH------HHHHHHh-hhhh---------hhcccc
Confidence 67888999999999999999999999999999999999998754322 1111221 1111 111122
Q ss_pred HHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPA-----MQEVVRM 612 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 612 (654)
..+.-.+++++.++.+|.+|.. +.||-+.
T Consensus 644 I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 644 ITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred cchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 2334556777888999999986 5555543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=282.43 Aligned_cols=253 Identities=19% Similarity=0.217 Sum_probs=160.1
Q ss_pred hhccccccCceeEEEEEecC-----CcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEE------EEeCCceEE
Q 036334 350 SAEVLGKGSVGTSYKAVLEE-----GTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAF------YYSKDEKLL 418 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~------~~~~~~~~l 418 (654)
..+.||+|+||.||+|.+.+ +..||+|++....... ....+ .+....+.++..++.. +..+...++
T Consensus 136 l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-IWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred EeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-HHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEE
Confidence 45789999999999999653 6899999876432211 11111 1222223333332222 234567899
Q ss_pred EEEecCCCchhhhhccCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC-
Q 036334 419 VYDYMPAGSLSALLHGSRGS---------------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP- 482 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~- 482 (654)
||||+++++|.+++...... .........+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g-IiHRDLKP~NILl~~~ 291 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG-IVHRDVKPQNIIFSEG 291 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC-EEeCcCCHHHEEEeCC
Confidence 99999999999998743100 0001223446689999999999999988 999999999999986
Q ss_pred CCCeEEeccCCCCCcCCC-----CCCCccccccCccccCCC----------------------CCCcchhHHHHHHHHHH
Q 036334 483 DHDACVSDFGLNPLFGNT-----TPPTRVAGYRAPEVVETR----------------------KVTFKSDVYSFGVLLLE 535 (654)
Q Consensus 483 ~~~~kl~Dfgla~~~~~~-----~~~~~~~~y~aPE~~~~~----------------------~~~~~~DvwslGvil~e 535 (654)
++.+||+|||+|...... ....+++.|||||.+... .++.++|||||||+|||
T Consensus 292 ~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~e 371 (566)
T PLN03225 292 SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 371 (566)
T ss_pred CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHH
Confidence 578999999999765322 233456789999966322 24456799999999999
Q ss_pred HHhCCCCCCCCC-------CCCCCChhHHHHHHhhhchhhhhhhHhhh-ccCChHHHHHHHHHHHhhccCCCCCCCCCHH
Q 036334 536 LLTGKAPNQASL-------GEEGIDLPRWVQSVVREEWTAEVFDVELM-RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQ 607 (654)
Q Consensus 536 l~tg~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 607 (654)
|+++..++.... ...+.+...|....... ...... .............+|+.+|++.||++|||++
T Consensus 372 l~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~ 445 (566)
T PLN03225 372 MAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK 445 (566)
T ss_pred HHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHH
Confidence 999776643210 00011111111111000 000000 0000001112345788899999999999999
Q ss_pred HHHHH
Q 036334 608 EVVRM 612 (654)
Q Consensus 608 evl~~ 612 (654)
|+++.
T Consensus 446 e~L~H 450 (566)
T PLN03225 446 AALAH 450 (566)
T ss_pred HHhCC
Confidence 99874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=254.82 Aligned_cols=273 Identities=21% Similarity=0.296 Sum_probs=200.7
Q ss_pred CCccccCHHHHH----HHhhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccC-----C---Cc
Q 036334 336 GGVYSFDLEDLL----RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-----H---DN 402 (654)
Q Consensus 336 ~~~~~~~~~~~~----~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----h---pn 402 (654)
||.+.+.+.+.. |.+.++||-|.|++||++.+. ..+.||+|+.+......+....||++|++++ | ..
T Consensus 64 GGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~ 143 (590)
T KOG1290|consen 64 GGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKC 143 (590)
T ss_pred CCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence 444444444443 345688999999999999954 5678999999988777778889999999884 3 36
Q ss_pred cccccEEEEe----CCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcE
Q 036334 403 VVPLRAFYYS----KDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNI 478 (654)
Q Consensus 403 iv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NI 478 (654)
||+|+++|.. +.+.++|+|++ |.+|..+|... ...-++...+.+|+.||+.||.|||.++.|||.||||+||
T Consensus 144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s---~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENv 219 (590)
T KOG1290|consen 144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS---NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENV 219 (590)
T ss_pred eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh---CCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCccee
Confidence 9999999975 45789999999 66888888765 3456999999999999999999999998899999999999
Q ss_pred EECCC---------------------------------------------------------------------------
Q 036334 479 LLRPD--------------------------------------------------------------------------- 483 (654)
Q Consensus 479 ll~~~--------------------------------------------------------------------------- 483 (654)
|+..+
T Consensus 220 Ll~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~ 299 (590)
T KOG1290|consen 220 LLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPN 299 (590)
T ss_pred eeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccc
Confidence 98410
Q ss_pred --------------------------------------------------------------------------------
Q 036334 484 -------------------------------------------------------------------------------- 483 (654)
Q Consensus 484 -------------------------------------------------------------------------------- 483 (654)
T Consensus 300 ~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~ 379 (590)
T KOG1290|consen 300 QESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPL 379 (590)
T ss_pred ccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccc
Confidence
Q ss_pred -----------CCeEEeccCCCCCcCCC-CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 036334 484 -----------HDACVSDFGLNPLFGNT-TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEG 551 (654)
Q Consensus 484 -----------~~~kl~Dfgla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~ 551 (654)
-.|||+|||.|...... +....|..|+|||++.+..|++.+||||++|++|||.||...|+...++.-
T Consensus 380 v~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y 459 (590)
T KOG1290|consen 380 VNPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENY 459 (590)
T ss_pred cCCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCC
Confidence 01445555555544332 222334459999999999999999999999999999999999986554331
Q ss_pred C---C-hhH---HHHHH----h-hhchhhhhhh------------------HhhhccCChHHHHHHHHHHHhhccCCCCC
Q 036334 552 I---D-LPR---WVQSV----V-REEWTAEVFD------------------VELMRYHNIEEEMVQLLQIAMGCVSTVPD 601 (654)
Q Consensus 552 ~---~-~~~---~~~~~----~-~~~~~~~~~~------------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 601 (654)
. + +.. .+..+ . ...+..+.|+ .-...+....++..++.+++.-|++.+|+
T Consensus 460 ~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~Pe 539 (590)
T KOG1290|consen 460 SRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPE 539 (590)
T ss_pred CccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcc
Confidence 1 1 111 11111 0 1111112221 11123456678889999999999999999
Q ss_pred CCCCHHHHHHH
Q 036334 602 QRPAMQEVVRM 612 (654)
Q Consensus 602 ~RPs~~evl~~ 612 (654)
+|||+.+.++.
T Consensus 540 KR~tA~~cl~h 550 (590)
T KOG1290|consen 540 KRPTAAQCLKH 550 (590)
T ss_pred ccccHHHHhcC
Confidence 99999999853
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=273.62 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=170.2
Q ss_pred hhccccccCceeEEEEEe-----------------cCCcEEEEEEeccccc-CH--------------HHHHHHHHHHhc
Q 036334 350 SAEVLGKGSVGTSYKAVL-----------------EEGTTVVVKRLKEVAV-GK--------------REFEMQMEVLGK 397 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-----------------~~g~~vavK~~~~~~~-~~--------------~~~~~e~~~l~~ 397 (654)
+.++||+|+||.||+|.. .+++.||||+++.... .. +....|+.++.+
T Consensus 149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 457899999999999963 2356899999864321 11 223446677777
Q ss_pred cCCCc-----cccccEEEEe--------CCceEEEEEecCCCchhhhhccCCCC-------------------CCCCCCH
Q 036334 398 IKHDN-----VVPLRAFYYS--------KDEKLLVYDYMPAGSLSALLHGSRGS-------------------GRTPLDW 445 (654)
Q Consensus 398 l~hpn-----iv~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~ 445 (654)
++|.+ +++++++|.. .+..++||||+++|+|.++++...+. ....+++
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 76655 4778888753 35679999999999999999743211 1123578
Q ss_pred HHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-----CCCccccccCccccCCCC-
Q 036334 446 DNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-----PPTRVAGYRAPEVVETRK- 519 (654)
Q Consensus 446 ~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-----~~~~~~~y~aPE~~~~~~- 519 (654)
..++.++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++....... ....++.|+|||.+....
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~~-ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~ 387 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRIG-IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQS 387 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHCC-eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCC
Confidence 889999999999999999988 9999999999999999999999999987653321 122356799999875322
Q ss_pred -------------------C--CcchhHHHHHHHHHHHHhCCC-CCCCCCCCC------CCChhHHHHHHhhhchhhhhh
Q 036334 520 -------------------V--TFKSDVYSFGVLLLELLTGKA-PNQASLGEE------GIDLPRWVQSVVREEWTAEVF 571 (654)
Q Consensus 520 -------------------~--~~~~DvwslGvil~el~tg~~-pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 571 (654)
+ ..+.||||+||+++||++|.. ||....... ..++..|.. . .....
T Consensus 388 ~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~----~~~~~ 461 (507)
T PLN03224 388 CPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--Y----KGQKY 461 (507)
T ss_pred CCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--h----cccCC
Confidence 1 134799999999999999875 664321100 001111110 0 00011
Q ss_pred hHhhhccCChHHHHHHHHHHHhhccCCCC---CCCCCHHHHHHH
Q 036334 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVP---DQRPAMQEVVRM 612 (654)
Q Consensus 572 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~evl~~ 612 (654)
+ +.......+ ...+++.+++..+| .+|+|++|++++
T Consensus 462 ~--~~~~d~~s~---~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 462 D--FSLLDRNKE---AGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred C--cccccccCh---HHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1 111122223 34556668888765 789999999863
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=278.67 Aligned_cols=237 Identities=27% Similarity=0.404 Sum_probs=181.1
Q ss_pred hccccccCce-eEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 351 AEVLGKGSVG-TSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 351 ~~~lg~G~fg-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.+++|.|+-| .||+|..+ |+.||||++-... ....++|++.|+.- +||||||+++.-.+....||..|.| ..+|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL 589 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSL 589 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhH
Confidence 4679999997 56999987 8999999986543 34567899999887 5999999999888888999999999 5599
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC---C--CCeEEeccCCCCCcCCC---
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP---D--HDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~---~--~~~kl~Dfgla~~~~~~--- 500 (654)
.+++... ..+.....-...+.+..|++.||+|||+-+ ||||||||.||||+. + ..++|+|||+++.....
T Consensus 590 ~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~-iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 590 QDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLK-IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred HHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcc-cccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 9999864 111111222455778899999999999987 999999999999976 3 46899999999887543
Q ss_pred ----CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 501 ----TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTG-KAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 501 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
....|+.||+|||++....-+.++||||+||++|+.++| ..||......+ .+++.......
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~------ 733 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLV------ 733 (903)
T ss_pred hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCcccee------
Confidence 345677889999999988888899999999999999995 99997643221 12222222111
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVV 610 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 610 (654)
......++ +..+||.+|+.++|..||++.+|+
T Consensus 734 -~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 734 -HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -eeccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 11111222 455677799999999999999995
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=231.46 Aligned_cols=251 Identities=16% Similarity=0.297 Sum_probs=186.5
Q ss_pred HHhhccccccCceeEEEEE-ecCCcEEEEEEecccccCHHHHHHHHHHHhccC-CCccccccEEEEeCC--ceEEEEEec
Q 036334 348 RASAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-HDNVVPLRAFYYSKD--EKLLVYDYM 423 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~--~~~lv~e~~ 423 (654)
|++.+.+|+|.+++||.|. ..++++++||++++.. .+.+.+|+.+|+.+. ||||+++++...++. ...||+||+
T Consensus 40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v 117 (338)
T KOG0668|consen 40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYV 117 (338)
T ss_pred HHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhh
Confidence 4566889999999999998 5568899999998764 467889999999997 999999999988764 457999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC-CCeEEeccCCCCCcCCCCC
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD-HDACVSDFGLNPLFGNTTP 502 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~ 502 (654)
++.+...+-. .++..++..++.++++||.|+|+.| |+|||+||.|+|+|.. ...+|+|||+|.++.....
T Consensus 118 ~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~G-ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 118 NNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred ccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcC-cccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence 9988776543 4777888999999999999999999 9999999999999975 4689999999999876532
Q ss_pred ---CCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhh-------hh
Q 036334 503 ---PTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAE-------VF 571 (654)
Q Consensus 503 ---~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~ 571 (654)
...+..|.-||.+.. ..|+..-|+|||||++..|+..+.||....+... ++.+ +..++....... .+
T Consensus 189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVk-IakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVK-IAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHH-HHHHhChHHHHHHHHHHccCC
Confidence 223344889998854 5689999999999999999999999865332211 1111 111111110000 01
Q ss_pred hHhhh------------ccC---ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 572 DVELM------------RYH---NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 572 ~~~~~------------~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
|+++. .+. +..-...+.++++...+..|-.+|+|++|...
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11111 000 11111234667777999999999999999865
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=235.83 Aligned_cols=256 Identities=21% Similarity=0.309 Sum_probs=187.9
Q ss_pred cCHHHHHHHhhccccccCceeEEEEEecC-CcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEE-EEeCCceE
Q 036334 341 FDLEDLLRASAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAF-YYSKDEKL 417 (654)
Q Consensus 341 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~-~~~~~~~~ 417 (654)
+++++ .+.+.+.||+|.||.+-++.++. .+.+++|.+.......++|.+|...--.+ .|.||+.-+++ |...+.++
T Consensus 20 v~l~d-~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 20 VDLED-VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred cchhh-hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 34444 34566889999999999999764 67899999998888899999998764444 59999987774 66778889
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEEC--CCCCeEEeccCCCC
Q 036334 418 LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR--PDHDACVSDFGLNP 495 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~--~~~~~kl~Dfgla~ 495 (654)
+++||++.|+|.+-+.. ..+.+....+++.|++.|+.|+|+++ +||||||.+||||- +...+||||||...
T Consensus 99 F~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHskn-lVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKN-LVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred EeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccc-hhhcccccceEEEecCCccEEEeeeccccc
Confidence 99999999999998863 34778888999999999999999998 99999999999993 23479999999987
Q ss_pred CcCCCCC-CCccccccCccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhh
Q 036334 496 LFGNTTP-PTRVAGYRAPEVVETR-----KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAE 569 (654)
Q Consensus 496 ~~~~~~~-~~~~~~y~aPE~~~~~-----~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 569 (654)
..+.... ...+-.|.+||..... ...+.+|||.||+++|.++||..||+..... ...+..|.+- .+.....
T Consensus 172 k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~w--~~rk~~~ 248 (378)
T KOG1345|consen 172 KVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQW--LKRKNPA 248 (378)
T ss_pred ccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHHH--hcccCcc
Confidence 6654322 2233459999976432 3568899999999999999999999854322 2223333322 1221111
Q ss_pred hhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 570 VFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
.. .........++++.++-+..++++|--..++.++..
T Consensus 249 ~P-------~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 249 LP-------KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred Cc-------hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 11 111122234566666899999999955555555443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-31 Score=247.79 Aligned_cols=256 Identities=22% Similarity=0.318 Sum_probs=189.3
Q ss_pred ccccccCceeEEEEEe-cCCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCC-----ceEEEEEe
Q 036334 352 EVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD-----EKLLVYDY 422 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-----~~~lv~e~ 422 (654)
+.||-|+||.||...+ ++|+.||.|++.... .+.+++-+|++++..++|.||+..++...-.. +.|+++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 5699999999999884 579999999987653 34567888999999999999999988765432 46899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT- 501 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 501 (654)
| ..+|..++- ..++++.+.+.-+..||++||.|||+.+ |.||||||.|.|++++...||||||+|+..+...
T Consensus 139 m-QSDLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLHsA~-ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 139 M-QSDLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLHTAN-ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred H-Hhhhhheec-----cCCCCCcchhhhhHHHHHhhhHHHhhcc-hhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 9 558988886 4677999999999999999999999998 9999999999999999999999999998765432
Q ss_pred ----CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh--------hhchhh
Q 036334 502 ----PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVV--------REEWTA 568 (654)
Q Consensus 502 ----~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~ 568 (654)
...-|..|+|||++.+ +.|+.+.||||.|||+.||+.++..|+...+.+..++..-+.... -++...
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 2334556999999976 569999999999999999999999998765543322211100000 000000
Q ss_pred hhhhH-----hh---hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 569 EVFDV-----EL---MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 569 ~~~~~-----~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
.+++. .+ .........-.+-..+...++..||+.|.+..+.+..+.
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 01110 00 011111122233455666889999999999998877653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=240.72 Aligned_cols=237 Identities=19% Similarity=0.319 Sum_probs=184.0
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccccCH----HHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGK----REFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
..+||+|+|++|..+.++ ..+.+|+|++++.-... .=.+.|-.+.... +||.+|-+...|..+..+++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 478999999999999855 46789999998763322 2245555555554 69999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----C
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN----T 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~----~ 500 (654)
+|+|--+++.. ..++++.+..+...|+.||.|||++| |+.||||..|||+|..|++|+.|||+++.--. .
T Consensus 335 ggdlmfhmqrq-----rklpeeharfys~ei~lal~flh~rg-iiyrdlkldnvlldaeghikltdygmcke~l~~gd~t 408 (593)
T KOG0695|consen 335 GGDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLHERG-IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTT 408 (593)
T ss_pred Ccceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHhhcC-eeeeeccccceEEccCCceeecccchhhcCCCCCccc
Confidence 99999888743 45999999999999999999999999 99999999999999999999999999875322 2
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASL-GEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....+|+.|.|||++.+..|...+|.|++||+++||+.|+.||+... .....+-.+++-+++.+.... .+.
T Consensus 409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--------ipr 480 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--------IPR 480 (593)
T ss_pred ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--------ccc
Confidence 34567888999999999999999999999999999999999998532 222233344444433322110 111
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCC
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRP 604 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RP 604 (654)
... .....+++.-+.+||.+|.
T Consensus 481 sls---vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 481 SLS---VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred eee---hhhHHHHHHhhcCCcHHhc
Confidence 111 1233455578889999886
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-28 Score=233.22 Aligned_cols=205 Identities=33% Similarity=0.533 Sum_probs=180.1
Q ss_pred ccccCceeEEEEEecC-CcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchhh
Q 036334 354 LGKGSVGTSYKAVLEE-GTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSA 430 (654)
Q Consensus 354 lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~ 430 (654)
||+|.+|.||++...+ ++.+++|++..... ....+.+|++.++.++|++|+++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 89999999986644 25678999999999999999999999999889999999999999999
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC-CCCeEEeccCCCCCcCCC----CCCCc
Q 036334 431 LLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP-DHDACVSDFGLNPLFGNT----TPPTR 505 (654)
Q Consensus 431 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~~----~~~~~ 505 (654)
++.... ..+++..++.++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+...... .....
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~-~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHSNG-IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence 987431 35899999999999999999999997 999999999999999 899999999998766543 23345
Q ss_pred cccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 506 VAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 506 ~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
...|++||.+... .++.+.|+|++|++++++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 5669999999877 888999999999999999
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 585 MVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
..+.+++..|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 256778889999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=258.31 Aligned_cols=190 Identities=23% Similarity=0.350 Sum_probs=164.0
Q ss_pred HhhccccccCceeEEEEEecC-CcEEEEEEecccccCH---------HHHHHHHHHHhccC---CCccccccEEEEeCCc
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGK---------REFEMQMEVLGKIK---HDNVVPLRAFYYSKDE 415 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~---------~~~~~e~~~l~~l~---hpniv~l~~~~~~~~~ 415 (654)
.+.+.+|+|+||.|+.|.++. ...|+||.+.+...-. ...-.||++|..++ |+||++++++|++++.
T Consensus 564 ttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~ 643 (772)
T KOG1152|consen 564 TTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDY 643 (772)
T ss_pred eeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCe
Confidence 345789999999999999664 5679999987653211 12456999999997 9999999999999999
Q ss_pred eEEEEEec-CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCC
Q 036334 416 KLLVYDYM-PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN 494 (654)
Q Consensus 416 ~~lv~e~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla 494 (654)
+||+||-. ++-+|.+++.. +..+++.++..|+.||+.|+++||+.+ |||||||-+||.++.+|-+||+|||.|
T Consensus 644 yyl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~~~-ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 644 YYLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHDQG-IVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred eEEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccccC-ceecccccccEEEecCCeEEEeeccch
Confidence 99999986 45689999973 456999999999999999999999999 999999999999999999999999999
Q ss_pred CCcCCC--CCCCccccccCccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCC
Q 036334 495 PLFGNT--TPPTRVAGYRAPEVVETRKVT-FKSDVYSFGVLLLELLTGKAPNQ 544 (654)
Q Consensus 495 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~ 544 (654)
.+.... ....||.+|.|||++.+..|- ..-|||++|++||-++....||.
T Consensus 718 a~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 876544 456789999999999988774 56899999999999999988875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-29 Score=258.21 Aligned_cols=273 Identities=22% Similarity=0.279 Sum_probs=204.2
Q ss_pred CCccccCHHHHHHH---hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccC------CCcccc
Q 036334 336 GGVYSFDLEDLLRA---SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIK------HDNVVP 405 (654)
Q Consensus 336 ~~~~~~~~~~~~~~---~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~------hpniv~ 405 (654)
.|.|.+.+.|++.. +.-..|+|-|++|.+|... .|..||||++.....-.+.=.+|+++|++|. --++++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 35677777777543 3456789999999999854 4889999999987766667788999999995 347999
Q ss_pred ccEEEEeCCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC-
Q 036334 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH- 484 (654)
Q Consensus 406 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~- 484 (654)
++..|...+++|||||-+ .-+|.++|+... ....|....+..++.|+.-||.+|-.-+ |+|.||||.|||+++..
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG--~nvGL~ikaVRsYaqQLflALklLK~c~-vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYG--RNVGLHIKAVRSYAQQLFLALKLLKKCG-VLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhC--cccceeehHHHHHHHHHHHHHHHHHhcC-eeecccCccceEeccCcc
Confidence 999999999999999988 449999998653 2345888899999999999999998666 99999999999999864
Q ss_pred CeEEeccCCCCCcCCCCCCC--ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHH-----
Q 036334 485 DACVSDFGLNPLFGNTTPPT--RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRW----- 557 (654)
Q Consensus 485 ~~kl~Dfgla~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----- 557 (654)
..||||||.|.+........ ....|.|||++.+..|+...|+||.||+||||+||+..|.+..+...+.+..-
T Consensus 575 iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred eeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 57999999998876543221 22349999999999999999999999999999999999988655432211100
Q ss_pred HHHHhhhch-hhhhhhH--------------------------------hhhc----cCChHHHHHHHHHHHhhccCCCC
Q 036334 558 VQSVVREEW-TAEVFDV--------------------------------ELMR----YHNIEEEMVQLLQIAMGCVSTVP 600 (654)
Q Consensus 558 ~~~~~~~~~-~~~~~~~--------------------------------~~~~----~~~~~~~~~~l~~l~~~cl~~dP 600 (654)
-..+++.+. ....||. .+.. .........+|.+|+..|+..||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 001111110 0111111 0100 01122345567888999999999
Q ss_pred CCCCCHHHHHHH
Q 036334 601 DQRPAMQEVVRM 612 (654)
Q Consensus 601 ~~RPs~~evl~~ 612 (654)
+.|.|..++++.
T Consensus 735 ~KRit~nqAL~H 746 (752)
T KOG0670|consen 735 EKRITVNQALKH 746 (752)
T ss_pred hhcCCHHHHhcC
Confidence 999999998763
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=255.50 Aligned_cols=194 Identities=26% Similarity=0.372 Sum_probs=164.0
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEecccccCH----HHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGK----REFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~----~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.||-|+||+|.++...| ...||.|.+.+...-. .-.+.|-++|.....+=||+|+-.|.+++.+|+||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 459999999999998554 5578999987653221 23567888999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC--------
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG-------- 498 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~-------- 498 (654)
++-.+|.. .+-+.+..+..++..+..|+++.|..| +|||||||.|||||.+|++||.|||+++-+.
T Consensus 715 DmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHkmG-FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 715 DMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHKMG-FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred cHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHhcc-ceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 99998873 345888888999999999999999998 9999999999999999999999999975321
Q ss_pred -CC-------------------------------------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCC
Q 036334 499 -NT-------------------------------------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGK 540 (654)
Q Consensus 499 -~~-------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~ 540 (654)
.. ....||+.|+|||++....|+.-+|.||.|||||||+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 10 0123455699999999999999999999999999999999
Q ss_pred CCCCCCCCCCC
Q 036334 541 APNQASLGEEG 551 (654)
Q Consensus 541 ~pf~~~~~~~~ 551 (654)
+||-.....+.
T Consensus 869 ~pf~~~tp~~t 879 (1034)
T KOG0608|consen 869 PPFLADTPGET 879 (1034)
T ss_pred CCccCCCCCcc
Confidence 99987766543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=256.46 Aligned_cols=242 Identities=22% Similarity=0.316 Sum_probs=192.8
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
..+.+|.|.+|.|||++. ..++..|||+++-.. ....-.++|+-+++..+|||||.++|.+...+..++.||||.+|+
T Consensus 19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs 98 (829)
T KOG0576|consen 19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS 98 (829)
T ss_pred heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence 347799999999999994 458999999998764 344567889999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----CCCC
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN----TTPP 503 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~----~~~~ 503 (654)
|.+.-+ ...++++.++..+++..++|++|||+.+ -+|||||-.||++++.|.+|++|||.+..+.. ....
T Consensus 99 lQdiy~-----~TgplselqiayvcRetl~gl~ylhs~g-k~hRdiKGanilltd~gDvklaDfgvsaqitati~Krksf 172 (829)
T KOG0576|consen 99 LQDIYH-----VTGPLSELQIAYVCRETLQGLKYLHSQG-KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSF 172 (829)
T ss_pred ccceee-----ecccchhHHHHHHHhhhhccchhhhcCC-cccccccccceeecccCceeecccCchhhhhhhhhhhhcc
Confidence 999887 3567999999999999999999999998 78999999999999999999999999766543 3556
Q ss_pred CccccccCcccc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 504 TRVAGYRAPEVV---ETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 504 ~~~~~y~aPE~~---~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
.||+.|||||+. ..+.|.+++|||+.|+...|+---++|........ ...-+ ...-+++. ....
T Consensus 173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr------~l~Lm-----TkS~~qpp--~lkD 239 (829)
T KOG0576|consen 173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR------ALFLM-----TKSGFQPP--TLKD 239 (829)
T ss_pred cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH------HHHHh-----hccCCCCC--cccC
Confidence 789999999986 35679999999999999999998888743211100 00000 01111111 1122
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVV 610 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 610 (654)
...+...+-++++.|+.++|++||+++.++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 233445577788899999999999998764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-28 Score=232.41 Aligned_cols=185 Identities=26% Similarity=0.399 Sum_probs=153.9
Q ss_pred ccccccCceeEEEEEe-cCCcEEEEEEeccc---ccCHHHHHHHHHHHhccCCCccccccEEEEeCC------ceEEEEE
Q 036334 352 EVLGKGSVGTSYKAVL-EEGTTVVVKRLKEV---AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD------EKLLVYD 421 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------~~~lv~e 421 (654)
..+|.|.- .|..|.+ -.++.||+|++... ....++..+|..++..++|+||++++.+|.-.+ +.|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 45777777 5555553 24789999987544 234567889999999999999999999987443 4699999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT- 500 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~- 500 (654)
|| .++|...++ ..++-.....+..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|..-+..
T Consensus 102 ~m-~~nl~~vi~-------~elDH~tis~i~yq~~~~ik~lhs~~-IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~ 172 (369)
T KOG0665|consen 102 LM-DANLCQVIL-------MELDHETISYILYQMLCGIKHLHSAG-IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF 172 (369)
T ss_pred hh-hhHHHHHHH-------HhcchHHHHHHHHHHHHHHHHHHhcc-eeecccCcccceecchhheeeccchhhcccCccc
Confidence 99 559998886 23777889999999999999999998 999999999999999999999999999865544
Q ss_pred --CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 036334 501 --TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQAS 546 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 546 (654)
+.-..+..|+|||++.+..|.+.+||||+||++.||++|+.-|.+.
T Consensus 173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 2233455699999999888999999999999999999999999853
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=228.21 Aligned_cols=190 Identities=32% Similarity=0.435 Sum_probs=166.3
Q ss_pred hccccccCceeEEEEEecC-CcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 351 AEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
.+.||+|++|.||++...+ ++.+++|.+..... ..+.+.+|++.+++++|+|++++++++......++++||+++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 4679999999999999765 88999999976543 35678899999999999999999999998889999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----CC
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-----TP 502 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-----~~ 502 (654)
|.+++.... ..+++..+..++.+++.++.+||..+ ++|+||+++||+++.++.++|+|||.+...... ..
T Consensus 84 L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~-i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 84 LFDYLRKKG----GKLSEEEARFYLRQILEALEYLHSLG-IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred HHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 999997432 11789999999999999999999987 999999999999999999999999998776543 23
Q ss_pred CCccccccCcccc-CCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 036334 503 PTRVAGYRAPEVV-ETRKVTFKSDVYSFGVLLLELLTGKAPNQA 545 (654)
Q Consensus 503 ~~~~~~y~aPE~~-~~~~~~~~~DvwslGvil~el~tg~~pf~~ 545 (654)
..+...|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 3445569999998 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=262.42 Aligned_cols=190 Identities=21% Similarity=0.248 Sum_probs=136.5
Q ss_pred ccCC-CccccccEEEE-------eCCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCe
Q 036334 397 KIKH-DNVVPLRAFYY-------SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468 (654)
Q Consensus 397 ~l~h-pniv~l~~~~~-------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~i 468 (654)
.++| .||++++++|. ..+..++++||+ +++|.+++... ...+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g-I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQG-I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCC-e
Confidence 4456 68888888872 234567888987 66999999732 345999999999999999999999998 9
Q ss_pred ecCCCCCCcEEECC-------------------CCCeEEeccCCCCCcCCC--------------------CCCCccccc
Q 036334 469 VHGNIKASNILLRP-------------------DHDACVSDFGLNPLFGNT--------------------TPPTRVAGY 509 (654)
Q Consensus 469 vHrDlk~~NIll~~-------------------~~~~kl~Dfgla~~~~~~--------------------~~~~~~~~y 509 (654)
+||||||+||||+. ++.+|++|||+++..... ....+|..|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 445666777766532110 012346669
Q ss_pred cCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHH
Q 036334 510 RAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLL 589 (654)
Q Consensus 510 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 589 (654)
||||++.+..|+.++|||||||+||||++|..|+.... ..+... .. ....+. ......+..
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~-~~----~~~~~~------~~~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSL-RH----RVLPPQ------ILLNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHH-HH----hhcChh------hhhcCHHHH
Confidence 99999999999999999999999999999888764210 011111 00 011110 011123345
Q ss_pred HHHhhccCCCCCCCCCHHHHHH
Q 036334 590 QIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 590 ~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.++.+||+.+|.+||++.|+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 6778999999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-26 Score=213.31 Aligned_cols=243 Identities=23% Similarity=0.362 Sum_probs=185.1
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
-+|.+...|+.|+|+++ |..+++|++.... .-.++|..|.-.++.+.||||+.++|.|..+....++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 35888999999999998 5667778876543 3356899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeec-CCCCCCcEEECCCCCeEEe--ccCCCCCcCCCCCCCc
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVH-GNIKASNILLRPDHDACVS--DFGLNPLFGNTTPPTR 505 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivH-rDlk~~NIll~~~~~~kl~--Dfgla~~~~~~~~~~~ 505 (654)
+.++++.. ...++-.++.+++.++|+|++|||+-.+++- --|.++.|++|++..++|. |-.++. .......
T Consensus 275 ynvlhe~t---~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf---qe~gr~y 348 (448)
T KOG0195|consen 275 YNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---QEVGRAY 348 (448)
T ss_pred HHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---ecccccc
Confidence 99999653 3457888999999999999999998765554 4689999999999988874 322211 1122233
Q ss_pred cccccCccccCCCCCC---cchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 506 VAGYRAPEVVETRKVT---FKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 506 ~~~y~aPE~~~~~~~~---~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
.+.||+||.++..+-+ .++|+|||++++|||.|...||....+.+.. + .+-.++ + +..-++
T Consensus 349 ~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-m-----kialeg-----l-----rv~ipp 412 (448)
T KOG0195|consen 349 SPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-M-----KIALEG-----L-----RVHIPP 412 (448)
T ss_pred CcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-h-----hhhhcc-----c-----cccCCC
Confidence 4569999999876543 6799999999999999999999875543311 0 000001 1 111122
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
.....+.+++.-|+..||.+||.|..|+-.||++.
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 22334566777899999999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-25 Score=207.18 Aligned_cols=170 Identities=24% Similarity=0.259 Sum_probs=127.3
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCCCCc
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR 505 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 505 (654)
|+|.++++.. ...+++.+++.++.|++.||+|||+++ ||+||+++.++.+|+ ||++....... ..+
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~-------kp~Nil~~~~~~~~~--fG~~~~~~~~~-~~g 66 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQA-------KSGNILLTWDGLLKL--DGSVAFKTPEQ-SRV 66 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC-------CcccEeEcCccceee--ccceEeecccc-CCC
Confidence 6899999742 245999999999999999999999775 999999999999999 99988765433 356
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHH
Q 036334 506 VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585 (654)
Q Consensus 506 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (654)
+..|||||++.+..++.++|||||||++|||++|+.||..... ....+........ ..... .........
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-----~~~~~~~~~~~~~-~~~~~----~~~~~~~~~ 136 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-----LSAILEILLNGMP-ADDPR----DRSNLESVS 136 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-----hcHHHHHHHHHhc-cCCcc----ccccHHHHH
Confidence 7889999999999999999999999999999999999864321 1111111111110 00000 000111112
Q ss_pred --HHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 586 --VQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 586 --~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
.++.+++.+||..+|++||++.|+++.+..+...
T Consensus 137 ~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 137 AARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred hhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 2588899999999999999999999999877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=220.87 Aligned_cols=188 Identities=28% Similarity=0.429 Sum_probs=158.0
Q ss_pred hhccccccCceeEEEEEec----CCcEEEEEEecccccCHHHHHHHHHHHhccC-CCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE----EGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
..++||+|.|++||++.+. .++.||+|.+..... ..++..|+++|..+. +.||+++.+++..++...+|+||++
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 4678999999999999843 367899999866543 446888999999985 9999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC-CCeEEeccCCCCCcC-----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD-HDACVSDFGLNPLFG----- 498 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~-~~~kl~Dfgla~~~~----- 498 (654)
.....++.. .++..++..++..+++||+|+|.+| ||||||||+|++.+.. +.-.|+|||+|....
T Consensus 119 H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~~G-IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 119 HDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHKNG-IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred ccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhccC-ccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence 999998886 2778999999999999999999998 9999999999999864 667899999986110
Q ss_pred ------------C-C------------------------------CCCCccccccCccccC-CCCCCcchhHHHHHHHHH
Q 036334 499 ------------N-T------------------------------TPPTRVAGYRAPEVVE-TRKVTFKSDVYSFGVLLL 534 (654)
Q Consensus 499 ------------~-~------------------------------~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGvil~ 534 (654)
. . ....||+||+|||++. ....++++||||.|||+.
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L 269 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL 269 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence 0 0 0123577899999985 456789999999999999
Q ss_pred HHHhCCCCCCCCC
Q 036334 535 ELLTGKAPNQASL 547 (654)
Q Consensus 535 el~tg~~pf~~~~ 547 (654)
-+++++.||....
T Consensus 270 slls~~~PFf~a~ 282 (418)
T KOG1167|consen 270 SLLSRRYPFFKAK 282 (418)
T ss_pred hhhccccccccCc
Confidence 9999999987543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=251.01 Aligned_cols=185 Identities=32% Similarity=0.552 Sum_probs=133.0
Q ss_pred ChhHHHHHHHHHhhCCCC--CCCCccCCCCCCCceeeEEcCCCCeEEEeecCCCCccccCCcccccCCCCccEEEeccCC
Q 036334 27 PTQDKQALLAFLSRTPHK--NRVQWNASDSACNWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNR 104 (654)
Q Consensus 27 ~~~~~~al~~~~~~~~~~--~~~~W~~~~~~C~w~gv~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~ 104 (654)
.+.|+.||++|++...++ ...+|+.+++||.|.||+|++ .++|+.|+|++|++.|.+++ .|..+++|++|+|++|.
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~-~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISS-AIFRLPYIQTINLSNNQ 104 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCCh-HHhCCCCCCEEECCCCc
Confidence 468999999999887543 347898888999999999985 35799999999999988876 58888888888888888
Q ss_pred ccCcCCCCCC-Ccccccccccccccccc----------------------ccchhhccccccceeccccccccccCCCcc
Q 036334 105 LSGEIPSDFS-NLTLLRSLYLQSNQFSG----------------------VFPASVTRMNRLTRLDLSSNNFSGKIPFDV 161 (654)
Q Consensus 105 l~~~~p~~~~-~l~~L~~L~Ls~N~l~~----------------------~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 161 (654)
++|.+|..+. ++++|++|+|++|+++| .+|..++++++|++|+|++|.+.+.+|..+
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~ 184 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhh
Confidence 8887776644 56666666666665554 455556666666666666666666666666
Q ss_pred ccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCCCc
Q 036334 162 NNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQS 213 (654)
Q Consensus 162 ~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~l 213 (654)
.++++|++|+|++|++.+.+|.. .+++|+.|+|++|++++.+|..++++++|
T Consensus 185 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 238 (968)
T PLN00113 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSL 238 (968)
T ss_pred hhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCC
Confidence 66666666666666666655543 56666666666666666666665555443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=208.62 Aligned_cols=152 Identities=24% Similarity=0.293 Sum_probs=118.0
Q ss_pred hhccccccCceeEEEEEec--CCcEEEEEEecccc------cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE--EGTTVVVKRLKEVA------VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~--~g~~vavK~~~~~~------~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
..+.||+|+||+||+|... +++.||||++.... .....+.+|+++|++++|+|++..+.. .+..++|||
T Consensus 22 ~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE 98 (365)
T PRK09188 22 ETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRG 98 (365)
T ss_pred EccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEE
Confidence 3578999999999999864 47788999875331 124568999999999999999853322 246899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCC-CCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNI-KASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDl-k~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
|+++++|... .. .. ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||+|..+...
T Consensus 99 ~~~G~~L~~~-~~--------~~---~~~~~~~i~~aL~~lH~~g-IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 99 WTEGVPLHLA-RP--------HG---DPAWFRSAHRALRDLHRAG-ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred ccCCCCHHHh-Cc--------cc---hHHHHHHHHHHHHHHHHCC-CeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 9999999732 10 01 1457889999999999998 999999 999999999999999999999866433
Q ss_pred C------------CCCccccccCccccCC
Q 036334 501 T------------PPTRVAGYRAPEVVET 517 (654)
Q Consensus 501 ~------------~~~~~~~y~aPE~~~~ 517 (654)
. ...++..|+|||.+..
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 2 1233456999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-22 Score=222.96 Aligned_cols=245 Identities=18% Similarity=0.226 Sum_probs=176.2
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEec----ccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLK----EVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~----~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
.+++|.|++|.|+..... ..+.++.|.+. ..... ...+..|+.+-..++|||++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 467999999988777632 33334444332 21111 11245566677888999998887777766666666999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 500 (654)
|++ +|..++... ..+...++-.++.|++.|++|+|+.| |.|||+|++|++++.+|.+||+|||.+..+...
T Consensus 403 ~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~G-iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 403 CPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSMG-LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred ccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhcC-ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 999 999999742 35788889999999999999999999 999999999999999999999999998765432
Q ss_pred ------CCCCccccccCccccCCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 ------TPPTRVAGYRAPEVVETRKVTFK-SDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 ------~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....+...|+|||++.+..|++. .||||.|+++..|.+|+.||......+... .......+......+
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIFEGP 550 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccccccCh
Confidence 22345556999999999999865 899999999999999999998876554321 000000000000000
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..-.......-..++.+|++.+|.+|.|+++|++
T Consensus 551 ----~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 551 ----NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ----HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0001122234456778999999999999999976
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-20 Score=193.55 Aligned_cols=252 Identities=28% Similarity=0.367 Sum_probs=189.3
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEeccccc----CHHHHHHHHHHHhccCCC-ccccccEEEEeCCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHD-NVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hp-niv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.+.||.|+||.||++... ..+++|.+..... ....+.+|+.+++.+.|+ +++++.+++......+++++|+.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 467999999999999977 7899999876533 256788999999999988 799999999777778999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC-CeEEeccCCCCCcCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH-DACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~---- 500 (654)
+++.+++...... ..+.......++.|++.++.|+|..+ ++|||+||+||+++..+ .++++|||.+......
T Consensus 83 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~-~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (384)
T COG0515 83 GSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG-IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159 (384)
T ss_pred CcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence 9999777633110 36889999999999999999999998 99999999999999988 7999999998755432
Q ss_pred ------CCCCccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhh
Q 036334 501 ------TPPTRVAGYRAPEVVET---RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571 (654)
Q Consensus 501 ------~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 571 (654)
....++..|+|||.+.+ ..+....|+||+|++++++++|..||...... .........+...... ..
T Consensus 160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP-SL 235 (384)
T ss_pred cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-cc
Confidence 34456777999999987 57889999999999999999999997654321 0011111111111100 00
Q ss_pred hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 572 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.... ...........+.+++..|+..+|..|.+..+....
T Consensus 236 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPL-SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccc-CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000 000001222456777789999999999999887765
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-20 Score=195.28 Aligned_cols=254 Identities=20% Similarity=0.244 Sum_probs=186.2
Q ss_pred HhhccccccCceeEEEEEecCC--cEEEEEEecccccC-HHHHHHHHHHHhccCC----CccccccEEE-EeCCceEEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEG--TTVVVKRLKEVAVG-KREFEMQMEVLGKIKH----DNVVPLRAFY-YSKDEKLLVY 420 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g--~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h----pniv~l~~~~-~~~~~~~lv~ 420 (654)
.+.+.||+|+||.||.+..... ..+|+|........ ...+..|..++..+.. +++..+++.. ..+...++||
T Consensus 21 ~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM 100 (322)
T KOG1164|consen 21 KLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVM 100 (322)
T ss_pred EEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEE
Confidence 4457899999999999996543 47888887654322 2267888888888863 5788888887 4677889999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC-----CCeEEeccCCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD-----HDACVSDFGLNP 495 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~-----~~~kl~Dfgla~ 495 (654)
+.+ |.+|.++..... ...++..+.++|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||+++
T Consensus 101 ~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G-~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 101 SLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG-FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred ecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC-cccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 988 779999886442 356999999999999999999999999 9999999999999865 358999999998
Q ss_pred CcC---CC-----------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH
Q 036334 496 LFG---NT-----------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSV 561 (654)
Q Consensus 496 ~~~---~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~ 561 (654)
.+. .. ....||..|+++....+...+.+.|+||++.++.|+..|..||........ ...+...
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~~~ 252 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFEKD 252 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHHHH
Confidence 221 11 112377789999999999999999999999999999999999965432211 0111111
Q ss_pred hhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 562 VREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
...... .. .......+...+.+ .+-..+..++|....+...|++.....
T Consensus 253 ~~~~~~----~~---~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKLLT----DR---FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhhcc----cc---ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000000 00 01112333344443 444589999999999999998887654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-22 Score=218.38 Aligned_cols=239 Identities=24% Similarity=0.334 Sum_probs=173.8
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEeccc--ccCHHHHHHHHHH--HhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEV--AVGKREFEMQMEV--LGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~e~~~--l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.||.+.|=+|.+|++.+|. |+||++-+. ..+-+.|.++++- ...++|||++.+.-+-..+..-|||-+|...
T Consensus 28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh- 105 (1431)
T KOG1240|consen 28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH- 105 (1431)
T ss_pred ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-
Confidence 467999999999999998887 899998654 2334444443332 5556899999998877777778899999855
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCC--CcCCC----
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP--LFGNT---- 500 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~--~~~~~---- 500 (654)
+|+|.+. .++-+...+.+.|+.|++.|+..+|..+ |+|+|||.+|||+++-+.+.|+||..-+ ++...
T Consensus 106 nLyDRlS-----TRPFL~~iEKkWiaFQLL~al~qcH~~g-VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 106 NLYDRLS-----TRPFLVLIEKKWIAFQLLKALSQCHKLG-VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred hhhhhhc-----cchHHHHHHHHHHHHHHHHHHHHHHHcC-ccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 9999997 3556888999999999999999999998 9999999999999999999999997632 11111
Q ss_pred -----CCCCccccccCccccCCC----------C-CCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 036334 501 -----TPPTRVAGYRAPEVVETR----------K-VTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVR 563 (654)
Q Consensus 501 -----~~~~~~~~y~aPE~~~~~----------~-~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 563 (654)
....+..+|.|||.+... . .+++.||||+||+++||++ |++||.-. +.+.
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---------QL~a---- 246 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---------QLLA---- 246 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---------HHHh----
Confidence 112233459999987431 2 5788999999999999999 78888531 1111
Q ss_pred hchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 564 EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
.......+++..- ...++ ..+.+++..|++.||++|.++++.++.-.
T Consensus 247 -Yr~~~~~~~e~~L-e~Ied--~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 247 -YRSGNADDPEQLL-EKIED--VSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred -HhccCccCHHHHH-HhCcC--ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 0001011111000 00000 14667888999999999999999998843
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.2e-21 Score=214.84 Aligned_cols=135 Identities=31% Similarity=0.568 Sum_probs=103.4
Q ss_pred CChhHHHHHHHHHhhCCCCCCCCccCCCCCC----CceeeEEcCCC----CeEEEeecCCCCccccCCcccccCCCCccE
Q 036334 26 EPTQDKQALLAFLSRTPHKNRVQWNASDSAC----NWVGVECDANR----SFVYSLRLPGVGLVGPIPPNTLGKLSQLRV 97 (654)
Q Consensus 26 ~~~~~~~al~~~~~~~~~~~~~~W~~~~~~C----~w~gv~C~~~~----~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~ 97 (654)
....|..||+++|.........+|+. +.|| .|.||.|+... .+|+.|+|++|++.|.+|+ .+++|++|+.
T Consensus 369 t~~~~~~aL~~~k~~~~~~~~~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~-~i~~L~~L~~ 446 (623)
T PLN03150 369 TLLEEVSALQTLKSSLGLPLRFGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLRHLQS 446 (623)
T ss_pred cCchHHHHHHHHHHhcCCcccCCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCH-HHhCCCCCCE
Confidence 45679999999998876544458964 3332 79999996321 2478888888888888877 4788888888
Q ss_pred EEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccc
Q 036334 98 LSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVN 162 (654)
Q Consensus 98 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 162 (654)
|+|++|.|.|.+|..++++++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+++|.+|..+.
T Consensus 447 L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~ 511 (623)
T PLN03150 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511 (623)
T ss_pred EECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHh
Confidence 88888888888887888888888888888888888888888888888888888877777776654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=182.74 Aligned_cols=139 Identities=16% Similarity=0.214 Sum_probs=108.8
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccccC----------HHH-----------------HHHHHHHHhccCCCccc
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG----------KRE-----------------FEMQMEVLGKIKHDNVV 404 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----------~~~-----------------~~~e~~~l~~l~hpniv 404 (654)
+.||+|+||.||+|...+|+.||||+++..... ... .+.|++.+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 569999999999999878999999999754211 011 23488999999888775
Q ss_pred cccEEEEeCCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hccCCeecCCCCCCcEEECCC
Q 036334 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL-HVSGKIVHGNIKASNILLRPD 483 (654)
Q Consensus 405 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~ivHrDlk~~NIll~~~ 483 (654)
....+.. ...++||||++++++...... ...++.....+++.|++.+|.|+ |+.+ |+||||||+|||++ +
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~g-iiHrDlkP~NIli~-~ 153 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCR-LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEEE-C
Confidence 4443322 234899999998877654321 23588999999999999999999 6777 99999999999998 5
Q ss_pred CCeEEeccCCCCCcCC
Q 036334 484 HDACVSDFGLNPLFGN 499 (654)
Q Consensus 484 ~~~kl~Dfgla~~~~~ 499 (654)
+.++|+|||+|.....
T Consensus 154 ~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 154 GKLYIIDVSQSVEHDH 169 (190)
T ss_pred CcEEEEEccccccCCC
Confidence 7899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.2e-20 Score=179.51 Aligned_cols=192 Identities=17% Similarity=0.227 Sum_probs=159.9
Q ss_pred HhhccccccCceeEEEEE-ecCCcEEEEEEecccccCHHHHHHHHHHHhccC-CCccccccEEEEeCCceEEEEEecCCC
Q 036334 349 ASAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.++++||+|.||.++.|. +-+++.||||.-. ......++..|+...+.+. .++|-..+-|-..+.+-.||+|.+ |-
T Consensus 31 rVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP 108 (449)
T KOG1165|consen 31 RVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP 108 (449)
T ss_pred eeccccccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence 457899999999999998 5579999999743 2334456677777777664 688888776666777889999998 66
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC-----CeEEeccCCCCCcCCC-
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH-----DACVSDFGLNPLFGNT- 500 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~-----~~kl~Dfgla~~~~~~- 500 (654)
+|.|+..-.. ..++..++.-+|.|++.-++|+|++. +|.|||||+|.||...+ .+.|+|||+|+.+.+.
T Consensus 109 SLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~k~-LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 109 SLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHEKD-LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred CHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHhcc-eeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 8888886542 34899999999999999999999998 99999999999997543 4789999999877543
Q ss_pred ----------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 036334 501 ----------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASL 547 (654)
Q Consensus 501 ----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 547 (654)
....||+.||+---..++..+.+.|+=|+|-++++++-|..||++..
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 34567889999999999999999999999999999999999998754
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.7e-21 Score=184.07 Aligned_cols=164 Identities=12% Similarity=0.202 Sum_probs=128.6
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHH----------HHHHHHHHhccCCCccccccEEEEeC------
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKRE----------FEMQMEVLGKIKHDNVVPLRAFYYSK------ 413 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~----------~~~e~~~l~~l~hpniv~l~~~~~~~------ 413 (654)
..+++|.|+||.||.+.. ++..+|+|.+.......+. +++|+..+.++.|++|..+.+++...
T Consensus 35 ~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~ 113 (232)
T PRK10359 35 TIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLR 113 (232)
T ss_pred EEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccc
Confidence 357899999999999766 5778999999765433222 58899999999999999999886643
Q ss_pred --CceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEecc
Q 036334 414 --DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDF 491 (654)
Q Consensus 414 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Df 491 (654)
+..++||||++|.+|.++.. ++. ....+++.++..+|..+ ++|||+||+||+++.++ ++|+||
T Consensus 114 ~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g-i~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 114 YAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG-MVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC-CccCCCChHHEEEeCCC-EEEEEC
Confidence 35789999999999988742 222 24568999999999998 99999999999999988 999999
Q ss_pred CCCCCcCCCCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHH
Q 036334 492 GLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELL 537 (654)
Q Consensus 492 gla~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~ 537 (654)
|........... ..++....|+.++|+|+||+++..+.
T Consensus 179 g~~~~~~e~~a~--------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK--------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH--------HHHHHHhHhcccccccceeEeehHHH
Confidence 987655322111 11334556778999999999987665
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.9e-20 Score=177.51 Aligned_cols=138 Identities=19% Similarity=0.284 Sum_probs=110.5
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccccC---------------------------HHHHHHHHHHHhccCCCccc
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG---------------------------KREFEMQMEVLGKIKHDNVV 404 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---------------------------~~~~~~e~~~l~~l~hpniv 404 (654)
..||+|+||.||+|...+|+.||||+++..... ...++.|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 569999999999999778999999998754211 11235788899999999886
Q ss_pred cccEEEEeCCceEEEEEecCCCchhhh-hccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCeecCCCCCCcEEECC
Q 036334 405 PLRAFYYSKDEKLLVYDYMPAGSLSAL-LHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV-SGKIVHGNIKASNILLRP 482 (654)
Q Consensus 405 ~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~ivHrDlk~~NIll~~ 482 (654)
....+... ..++||||++++++... +. ...++.....+++.|++.++.++|+ .+ |+||||||+||+++
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~------~~~~~~~~~~~i~~~l~~~l~~lH~~~g-ivHrDlkP~NIll~- 152 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLK------DVPLEEEEAEELYEQVVEQMRRLYQEAG-LVHGDLSEYNILYH- 152 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhh------hccCCHHHHHHHHHHHHHHHHHHHHhCC-EecCCCChhhEEEE-
Confidence 55554333 34899999998855433 32 2347788999999999999999999 77 99999999999999
Q ss_pred CCCeEEeccCCCCCcCC
Q 036334 483 DHDACVSDFGLNPLFGN 499 (654)
Q Consensus 483 ~~~~kl~Dfgla~~~~~ 499 (654)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=170.68 Aligned_cols=178 Identities=17% Similarity=0.147 Sum_probs=135.2
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEecccccCHH-----HHHHHHHHHhccC-CCccccccEEEEeCCceEEEEEecC
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKR-----EFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~-----~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
...|++|+||+||.+.. ++.+++.+.+.......+ .+.+|+++|+++. |++|.+++++ +..+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 36799999999997765 578888888776543222 5789999999995 5889888886 45799999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCC-CCCcEEECCCCCeEEeccCCCCCcCCCCCC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNI-KASNILLRPDHDACVSDFGLNPLFGNTTPP 503 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDl-k~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 503 (654)
|.+|...+.. ....++.|++.++.++|..+ |+|||| ||+|||++.++.++|+|||+|.........
T Consensus 82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~G-IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 82 GAAMYQRPPR------------GDLAYFRAARRLLQQLHRCG-VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred CccHHhhhhh------------hhHHHHHHHHHHHHHHHHCc-CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 9998754321 11347789999999999998 999999 799999999999999999999865543210
Q ss_pred -----------------CccccccCccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 036334 504 -----------------TRVAGYRAPEVVE--TRKVTFKSDVYSFGVLLLELLTGKAPNQAS 546 (654)
Q Consensus 504 -----------------~~~~~y~aPE~~~--~~~~~~~~DvwslGvil~el~tg~~pf~~~ 546 (654)
..++.|+.|+... ...--.+.+.++-|.-+|.++|++.++-..
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 1133466665432 122225678899999999999999886543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.1e-20 Score=194.56 Aligned_cols=215 Identities=27% Similarity=0.424 Sum_probs=163.5
Q ss_pred HhccCCCccccccEEEEeCCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCC
Q 036334 395 LGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIK 474 (654)
Q Consensus 395 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk 474 (654)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....++|.....+..++++||+|||...-.+|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence 4568899999999999999999999999999999999985 245699999999999999999999987633999999
Q ss_pred CCcEEECCCCCeEEeccCCCCCcCCC------CCCCccccccCccccCCC-------CCCcchhHHHHHHHHHHHHhCCC
Q 036334 475 ASNILLRPDHDACVSDFGLNPLFGNT------TPPTRVAGYRAPEVVETR-------KVTFKSDVYSFGVLLLELLTGKA 541 (654)
Q Consensus 475 ~~NIll~~~~~~kl~Dfgla~~~~~~------~~~~~~~~y~aPE~~~~~-------~~~~~~DvwslGvil~el~tg~~ 541 (654)
++|+++|....+|+.|||+....... .......-|.|||.+... ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998776431 111111239999998653 14677999999999999999999
Q ss_pred CCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 542 PNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 542 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
||......+.. ...+.. +.. .....+.+.+.... +...++..++.+||..+|++||++++|...++.+....
T Consensus 157 ~~~~~~~~~~~--~eii~~-~~~-~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 157 PFDLRNLVEDP--DEIILR-VKK-GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccccCCh--HHHHHH-HHh-cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 99864332221 111222 111 11111222221111 22336888999999999999999999999999887654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.2e-20 Score=170.40 Aligned_cols=192 Identities=21% Similarity=0.292 Sum_probs=156.1
Q ss_pred hhccccccCceeEEEEE-ecCCcEEEEEEecccccCHHHHHHHHHHHhccCC-CccccccEEEEeCCceEEEEEecCCCc
Q 036334 350 SAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKH-DNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
..+.||.|+||.+|.|. ..+|+.||+|.-.... ....+..|..+.+.+++ ..|..+..|..+.....+|||.. |-+
T Consensus 19 lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPs 96 (341)
T KOG1163|consen 19 LVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPS 96 (341)
T ss_pred EEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Ccc
Confidence 35789999999999998 6679999999865432 23456677777777764 56666777777888889999998 779
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC---CCeEEeccCCCCCcCCC----
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD---HDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~---~~~kl~Dfgla~~~~~~---- 500 (654)
|.++..-.. ..++..+++-++-|++.-++|+|.++ ++||||||+|.|+.-+ ..+.++|||+|+.+.+.
T Consensus 97 LEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~r~-fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~ 171 (341)
T KOG1163|consen 97 LEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHLRN-FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ 171 (341)
T ss_pred HHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHhhc-cccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence 998886542 34888999999999999999999998 9999999999999754 45779999999876432
Q ss_pred -------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 036334 501 -------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLG 548 (654)
Q Consensus 501 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~ 548 (654)
....||+.|.+-....+...+.+.|+=|+|.+|.++--|..||++...
T Consensus 172 HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 172 HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 334677789888777777778899999999999999999999997544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.2e-20 Score=195.66 Aligned_cols=224 Identities=24% Similarity=0.319 Sum_probs=174.3
Q ss_pred cccccCceeEEEEE----ecCCcEEEEEEecccccC---HHHHHHHHHHHhccC-CCccccccEEEEeCCceEEEEEecC
Q 036334 353 VLGKGSVGTSYKAV----LEEGTTVVVKRLKEVAVG---KREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 353 ~lg~G~fg~Vy~~~----~~~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
++|+|.||.|+.+. ...|..+|.|.+++.... +.....|..++..++ ||.+|++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999998764 223677888888654211 113345677788786 9999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCCCC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPT 504 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 504 (654)
+|+|...+.. ...+++.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-......
T Consensus 81 gg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~l~-iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~c 154 (612)
T KOG0603|consen 81 GGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHKLG-IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIAC 154 (612)
T ss_pred cchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcchhH-HHHhcccccceeecccCccccCCchhhhHhHhhhhcc
Confidence 9999988873 345677777888889999999999998 9999999999999999999999999998876655558
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
++.-|||||++. .....+|.||||++++||+||..||.. +....+... ......+.
T Consensus 155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~------------~~~~p~~l 210 (612)
T KOG0603|consen 155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA------------ELEMPREL 210 (612)
T ss_pred cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh------------ccCCchhh
Confidence 888899999997 677899999999999999999999975 111222211 11222333
Q ss_pred HHHHHHHHhhccCCCCCCCCCH
Q 036334 585 MVQLLQIAMGCVSTVPDQRPAM 606 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RPs~ 606 (654)
......++..+...+|..|.-.
T Consensus 211 ~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 211 SAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hHHHHHHHHHHHhhCHHHHhcc
Confidence 3344455667778888888754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.2e-19 Score=177.51 Aligned_cols=229 Identities=21% Similarity=0.331 Sum_probs=142.5
Q ss_pred hccccccCceeEEEEEecC-CcEEEEEEecccc----cCHHHHHHHHHHHhccC----------CCccccccEEEE----
Q 036334 351 AEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVA----VGKREFEMQMEVLGKIK----------HDNVVPLRAFYY---- 411 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~----------hpniv~l~~~~~---- 411 (654)
++.||.|+++.||.+.+.+ |+.+|||++.... ...+++++|.-....+. |-.++-.++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 4679999999999999764 8999999985432 22345555554443332 212222222221
Q ss_pred -----eC---C-----ceEEEEEecCCCchhhhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCC
Q 036334 412 -----SK---D-----EKLLVYDYMPAGSLSALLHGSRGS--GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKAS 476 (654)
Q Consensus 412 -----~~---~-----~~~lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~ 476 (654)
.. . ..+++|+-+ .++|.+++..-... ....+....++.+..|+.+.+++||+.| ++|+||+|+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G-lVHgdi~~~ 174 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG-LVHGDIKPE 174 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-EEEST-SGG
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc-eEeccccee
Confidence 11 1 236788877 56888776421100 1123455566777889999999999999 999999999
Q ss_pred cEEECCCCCeEEeccCCCCCcCCCCC-CCccccccCccccCC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 036334 477 NILLRPDHDACVSDFGLNPLFGNTTP-PTRVAGYRAPEVVET--------RKVTFKSDVYSFGVLLLELLTGKAPNQASL 547 (654)
Q Consensus 477 NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~tg~~pf~~~~ 547 (654)
|++++.+|.++|+||+.....+.... ...+..|.+||.... -.++.+.|.|++|+++|.|++|..||....
T Consensus 175 nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~ 254 (288)
T PF14531_consen 175 NFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSS 254 (288)
T ss_dssp GEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCG
T ss_pred eEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCC
Confidence 99999999999999988766554433 233456999997643 247889999999999999999999998654
Q ss_pred CCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCC
Q 036334 548 GEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQR 603 (654)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 603 (654)
....... . +....+....+..|+..+++.+|++|
T Consensus 255 ~~~~~~~-------------------~---f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 255 PEADPEW-------------------D---FSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp GGSTSGG-------------------G---GTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccccccc-------------------c---chhcCCcCHHHHHHHHHHccCCcccC
Confidence 3221110 1 11122333455667779999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.4e-18 Score=164.17 Aligned_cols=132 Identities=17% Similarity=0.152 Sum_probs=102.2
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEeccc-ccCHHHHHHHHHHHhcc-----CCCccccccEEEEeCC---ceE-EEE
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEV-AVGKREFEMQMEVLGKI-----KHDNVVPLRAFYYSKD---EKL-LVY 420 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~-~~~~~~~~~e~~~l~~l-----~hpniv~l~~~~~~~~---~~~-lv~ 420 (654)
.++||+|+||.||. ...++.. +||++... ....+++.+|+.+++.+ .||||++++|++.++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 36799999999996 3333444 68887654 23456789999999999 5799999999998864 333 789
Q ss_pred Ee--cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHH-HHhhccCCeecCCCCCCcEEECCC----CCeEEeccCC
Q 036334 421 DY--MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGL-AHLHVSGKIVHGNIKASNILLRPD----HDACVSDFGL 493 (654)
Q Consensus 421 e~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~ivHrDlk~~NIll~~~----~~~kl~Dfgl 493 (654)
|| +.+|+|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++.. ..++|+||+.
T Consensus 85 e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~-IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR-IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC-EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 99 5579999999632 25544 35677888777 9999998 9999999999999743 3799999543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=164.59 Aligned_cols=144 Identities=17% Similarity=0.239 Sum_probs=109.4
Q ss_pred HHhhccccccCceeEEEEE--ecCCcEEEEEEecccccC-------------------------HHHHHHHHHHHhccCC
Q 036334 348 RASAEVLGKGSVGTSYKAV--LEEGTTVVVKRLKEVAVG-------------------------KREFEMQMEVLGKIKH 400 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~--~~~g~~vavK~~~~~~~~-------------------------~~~~~~e~~~l~~l~h 400 (654)
+.+.+.||+|+||.||+|. ..+|+.||+|+++..... ...++.|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3556889999999999998 567999999998753210 1235679999999875
Q ss_pred CccccccEEEEeCCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEE
Q 036334 401 DNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL 480 (654)
Q Consensus 401 pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll 480 (654)
.. +.+..++.. ...++||||+++++|...... ...+.......++.|++.++++||..+.|+||||||+||++
T Consensus 110 ~~-i~~p~~~~~-~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 110 AG-VPVPKPIAW-RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred cC-CCCCeeeEe-cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 33 222222222 245899999999888765431 22355667789999999999999988669999999999999
Q ss_pred CCCCCeEEeccCCCCCcCC
Q 036334 481 RPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 481 ~~~~~~kl~Dfgla~~~~~ 499 (654)
+ ++.++|+|||.+...+.
T Consensus 183 ~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 183 H-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred E-CCCEEEEEChhhhccCC
Confidence 9 88999999999876544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.2e-17 Score=159.43 Aligned_cols=133 Identities=18% Similarity=0.402 Sum_probs=113.4
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEeccccc---------CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV---------GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
+.||+|++|.||+|.. .|..|++|+...... ....+.+|++++..+.|++|.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999987 578899998654321 123577899999999999998888888888889999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPL 496 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~ 496 (654)
+++++|.+++... .+ .+..++.+++.++.++|+.+ ++|||++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~-i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG-IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC-cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998632 12 78899999999999999998 99999999999999 78999999998765
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-17 Score=164.14 Aligned_cols=192 Identities=22% Similarity=0.253 Sum_probs=133.5
Q ss_pred CCCccccccEEEEe---------------------------CCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHH
Q 036334 399 KHDNVVPLRAFYYS---------------------------KDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRI 451 (654)
Q Consensus 399 ~hpniv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i 451 (654)
+|||||++.++|.+ +..+|+||..++. +|.+++-. ...+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc------CCCchHHHHHH
Confidence 59999999998753 2245899998844 99999863 23566666778
Q ss_pred HHHHHHHHHHhhccCCeecCCCCCCcEEE--CCCC--CeEEeccCCCCCcCC----------CCCCCccccccCccccCC
Q 036334 452 ALSAARGLAHLHVSGKIVHGNIKASNILL--RPDH--DACVSDFGLNPLFGN----------TTPPTRVAGYRAPEVVET 517 (654)
Q Consensus 452 ~~~ia~~l~~LH~~~~ivHrDlk~~NIll--~~~~--~~kl~Dfgla~~~~~----------~~~~~~~~~y~aPE~~~~ 517 (654)
+.|+++|+.|||.++ |.|||+|++|||+ |+|+ ...|+|||++--... .....|...-||||+...
T Consensus 347 laQlLEav~hL~~hg-vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHG-VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHHHcc-chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999998 9999999999998 4444 356899998643221 112334455899999854
Q ss_pred CC------CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHH
Q 036334 518 RK------VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQI 591 (654)
Q Consensus 518 ~~------~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 591 (654)
.+ ...|+|.|+.|-+.||+++...||.... +...+...+ ++.. + +...+.....+.++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~Y-----qe~q--------L--Palp~~vpp~~rql 489 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRTY-----QESQ--------L--PALPSRVPPVARQL 489 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhhh-----hhhh--------C--CCCcccCChHHHHH
Confidence 21 2468999999999999999999998622 111111111 1110 0 11122233345677
Q ss_pred HhhccCCCCCCCCCHHHHHHHHH
Q 036334 592 AMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 592 ~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
+...++.||.+|++..-....|+
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHH
Confidence 77899999999999876666554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-17 Score=188.11 Aligned_cols=185 Identities=26% Similarity=0.363 Sum_probs=146.5
Q ss_pred HhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccC---CCccccccEEEEeCCceEEEEEecCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIK---HDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.+.+.||+|+||+||+|...+|+.||+|+-+..... +|.-=.+++.+|+ -+-|+.+...+.-.+.-+||+||.+.
T Consensus 701 ~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~ 778 (974)
T KOG1166|consen 701 CISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPY 778 (974)
T ss_pred EEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccc
Confidence 345679999999999999888999999997765433 2222234455554 23455555555556778899999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC-------CCCeEEeccCCCCCcC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP-------DHDACVSDFGLNPLFG 498 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~-------~~~~kl~Dfgla~~~~ 498 (654)
|+|.+++.. ...++|...+.+..|+++.+++||..+ |||+||||+|.||.. .-.++|+|||-+-.+.
T Consensus 779 Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~-IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 779 GTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMG-IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred ccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcc-eecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 999999983 345899999999999999999999988 999999999999953 2358999999886553
Q ss_pred C---C---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 036334 499 N---T---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKA 541 (654)
Q Consensus 499 ~---~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~ 541 (654)
- . .....|-++-.+|+..++.+++.+|.|.++-+++-|+.|+.
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 2 2 12234455888999999999999999999999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.9e-17 Score=156.39 Aligned_cols=130 Identities=23% Similarity=0.390 Sum_probs=107.7
Q ss_pred cccccCceeEEEEEecCCcEEEEEEeccccc---------CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 353 VLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV---------GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 353 ~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.||+|+||.||+|.+ +|..|++|+...... ...++.+|++++..+.|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 478899998654211 1245678999999999988776666667777789999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
++++|.+++... . . .++.+++.+|.+||..+ ++|+|++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~-----~-~------~~~~~i~~~l~~lH~~g-i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG-----N-D------ELLREIGRLVGKLHKAG-IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc-----H-H------HHHHHHHHHHHHHHHCC-eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999987521 0 0 78999999999999998 99999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=8e-17 Score=155.73 Aligned_cols=136 Identities=15% Similarity=0.198 Sum_probs=106.9
Q ss_pred HHhhccccccCceeEEEEEecCCcEEEEEEeccccc-----------------------CHHHHHHHHHHHhccCCCc--
Q 036334 348 RASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV-----------------------GKREFEMQMEVLGKIKHDN-- 402 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~-----------------------~~~~~~~e~~~l~~l~hpn-- 402 (654)
+.+.+.||+|+||.||++...+|+.||||++..... ....+..|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 345678999999999999988899999998754321 1123567888888888774
Q ss_pred cccccEEEEeCCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC
Q 036334 403 VVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP 482 (654)
Q Consensus 403 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~ 482 (654)
+...++ ....++||||+++++|...... .....++.+++.++.++|+.+ |+||||||+||++++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g-i~H~Dl~p~Nill~~ 160 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG-IIHGDLSEFNILVDD 160 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC-CCcCCCCcccEEEcC
Confidence 333333 3456899999999998765430 235678899999999999988 999999999999999
Q ss_pred CCCeEEeccCCCCCcCC
Q 036334 483 DHDACVSDFGLNPLFGN 499 (654)
Q Consensus 483 ~~~~kl~Dfgla~~~~~ 499 (654)
++.++|+|||.+.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=175.98 Aligned_cols=131 Identities=22% Similarity=0.353 Sum_probs=108.1
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEe-ccc-c-------cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRL-KEV-A-------VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~-~~~-~-------~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
.+.||+|+||+||+|.+... .+++|+. .+. . ...+++.+|++++++++|++++....++.+....++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 57899999999999987643 3444432 221 1 112457889999999999999988888888788899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
|+++++|.+++. ....++.+++++|.|||+.+ ++||||||+||++ .++.++|+|||++...
T Consensus 417 ~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g-iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 417 YIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG-IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC-CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999998874 34678999999999999998 9999999999999 6789999999998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.7e-17 Score=171.95 Aligned_cols=118 Identities=24% Similarity=0.351 Sum_probs=102.9
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCC
Q 036334 415 EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN 494 (654)
Q Consensus 415 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla 494 (654)
..|+.|++|...+|.++|...+. ....++...+.++.|++.|+.| ++ .+|||+||.||++..+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k~-~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---KG-LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---cc-chhhhccccccccccchhhhhhhhhhe
Confidence 56899999999999999975432 3457888999999999999999 66 899999999999999999999999997
Q ss_pred CCcCCC----------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh
Q 036334 495 PLFGNT----------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT 538 (654)
Q Consensus 495 ~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t 538 (654)
...... +...+|..||+||.+.+..|+.|+||||+|++|+|++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 655432 34566777999999999999999999999999999997
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.7e-18 Score=149.11 Aligned_cols=147 Identities=30% Similarity=0.508 Sum_probs=133.0
Q ss_pred CCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhcccccccee
Q 036334 67 RSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRL 146 (654)
Q Consensus 67 ~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (654)
..+++.|.|++|.++ .+||+ +..|.+|+.|++++|+|+ .+|..++.|++|+.|+++-|++. .+|..|+.++.|+.|
T Consensus 32 ~s~ITrLtLSHNKl~-~vppn-ia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPN-IAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred hhhhhhhhcccCcee-ecCCc-HHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 345899999999997 57774 999999999999999999 89999999999999999999999 899999999999999
Q ss_pred cccccccc-ccCCCccccccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccCcccccCCCCc---cccCC
Q 036334 147 DLSSNNFS-GKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATLSKFPQS---SFTGN 218 (654)
Q Consensus 147 ~l~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p~~~~~~~~l---~~~~n 218 (654)
||++|++. ..+|..|..|+.|+.|+|++|.|.-.+|+. .+++|+.|.+.+|.+- ++|..++.+..| -.+||
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 99999997 468999999999999999999999888888 9999999999999998 899888876654 45555
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-16 Score=177.17 Aligned_cols=200 Identities=23% Similarity=0.262 Sum_probs=132.8
Q ss_pred hccccccCceeEEEEEecC-CcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 351 AEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
.+.|..|++|.||..+++. .+.+|.|+=+..-.-+. ++.....|.+| |+-.
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNkq~lilRn-------ilt~a~npfvv---------------------gDc~ 139 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQNLILRN-------ILTFAGNPFVV---------------------GDCA 139 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcccccchhhhc-------cccccCCccee---------------------chhh
Confidence 4779999999999998664 45677754322111000 12222233332 5555
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----------
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN---------- 499 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~---------- 499 (654)
..++. .++++... +.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+.+....
T Consensus 140 tllk~-----~g~lPvdm--------vla~Eylh~yg-ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~ 205 (1205)
T KOG0606|consen 140 TLLKN-----IGPLPVDM--------VLAVEYLHSYG-IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH 205 (1205)
T ss_pred hhccc-----CCCCcchh--------hHHhHhhccCC-eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence 55652 22344322 77899999998 99999999999999999999999998653211
Q ss_pred ---------CCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhh
Q 036334 500 ---------TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEV 570 (654)
Q Consensus 500 ---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 570 (654)
.....+|+.|+|||++..+.|...+|.|++|+|+||++-|..||.+...++- +..++.+..
T Consensus 206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg~visd~i---- 275 (1205)
T KOG0606|consen 206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQVISDDI---- 275 (1205)
T ss_pred hHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hhhhhhhhc----
Confidence 1234678889999999999999999999999999999999999987654431 111221110
Q ss_pred hhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHH
Q 036334 571 FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQ 607 (654)
Q Consensus 571 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 607 (654)
.-.+..+....+..+++.+.++.+|.+|--..
T Consensus 276 -----~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 276 -----EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred -----cccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 01111222223444555577888888887433
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=1e-15 Score=146.60 Aligned_cols=136 Identities=19% Similarity=0.270 Sum_probs=96.9
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEecccccCHHHH-------------------------HHHHHHHhccCCCc--c
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREF-------------------------EMQMEVLGKIKHDN--V 403 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~-------------------------~~e~~~l~~l~hpn--i 403 (654)
.+.||+|+||+||+|...+|+.||||+++......... ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35799999999999998889999999987542211111 23445555554332 3
Q ss_pred ccccEEEEeCCceEEEEEecCCCchhhh-hccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCeecCCCCCCcEEEC
Q 036334 404 VPLRAFYYSKDEKLLVYDYMPAGSLSAL-LHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV-SGKIVHGNIKASNILLR 481 (654)
Q Consensus 404 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~ivHrDlk~~NIll~ 481 (654)
.+.+++ ...++||||++++.+... +... ... .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------~~~-~~~~~~~~~~~~~l~~lh~~~~-ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV------RLL-EDPEELYDQILELMRKLYREAG-LVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh------hhc-ccHHHHHHHHHHHHHHHhhccC-cCcCCCChhhEEEE
Confidence 333332 346899999998654321 2110 011 5678899999999999998 76 99999999999999
Q ss_pred CCCCeEEeccCCCCCcCC
Q 036334 482 PDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 482 ~~~~~kl~Dfgla~~~~~ 499 (654)
++.++++|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 89999999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.8e-15 Score=138.95 Aligned_cols=132 Identities=19% Similarity=0.179 Sum_probs=111.1
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCC--CccccccEEEEeCCceEEEEEecCCCchh
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKH--DNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
+.||+|.++.||++...+ ..+++|....... ...+..|+..++.++| .++.++++++...+..+++|||++++.+.
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 569999999999999764 7899999866543 5678899999999976 58889988888778899999999887765
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC--CeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG--KIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
.+ +......++.+++++++++|... .++|+|++|+||++++.+.+++.|||.+...
T Consensus 82 ~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 82 EV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 43 45667778999999999999742 3999999999999999899999999988653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.2e-15 Score=144.91 Aligned_cols=137 Identities=21% Similarity=0.300 Sum_probs=106.8
Q ss_pred Hhhcccc-ccCceeEEEEEecCCcEEEEEEecccc--------------cCHHHHHHHHHHHhccCCCcc--ccccEEEE
Q 036334 349 ASAEVLG-KGSVGTSYKAVLEEGTTVVVKRLKEVA--------------VGKREFEMQMEVLGKIKHDNV--VPLRAFYY 411 (654)
Q Consensus 349 ~~~~~lg-~G~fg~Vy~~~~~~g~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~hpni--v~l~~~~~ 411 (654)
....+|| .|+.|+||.+... +..++||++.... .....+.+|++++.++.|++| .+.+++..
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 3356788 8999999999876 7789999885311 123467889999999998875 66777654
Q ss_pred eCCc----eEEEEEecCC-CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCe
Q 036334 412 SKDE----KLLVYDYMPA-GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDA 486 (654)
Q Consensus 412 ~~~~----~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~ 486 (654)
.... .++||||+++ .+|.+++.. ..++.. .+.+++.++.+||+.+ |+||||||.|||++.++.+
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~~G-I~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHDAG-VYHADLNAHNILLDPDGKF 181 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHHCC-CCCCCCCchhEEEcCCCCE
Confidence 3322 2599999997 689888753 234443 3568999999999998 9999999999999999999
Q ss_pred EEeccCCCCCc
Q 036334 487 CVSDFGLNPLF 497 (654)
Q Consensus 487 kl~Dfgla~~~ 497 (654)
+|+|||.+...
T Consensus 182 ~LIDfg~~~~~ 192 (239)
T PRK01723 182 WLIDFDRGELR 192 (239)
T ss_pred EEEECCCcccC
Confidence 99999988764
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.6e-16 Score=138.63 Aligned_cols=137 Identities=28% Similarity=0.474 Sum_probs=126.2
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCcccccccccccccccc-ccchhhccccccceecc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSG-VFPASVTRMNRLTRLDL 148 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~l 148 (654)
+..|++.+|++. .+|+ .+..|+.|+.|+++-|.+. .+|..|+.++-|+.|||++|+++. .+|+.|..|+.|+.|+|
T Consensus 58 levln~~nnqie-~lp~-~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl 134 (264)
T KOG0617|consen 58 LEVLNLSNNQIE-ELPT-SISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYL 134 (264)
T ss_pred hhhhhcccchhh-hcCh-hhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHh
Confidence 677899999986 5777 6999999999999999999 899999999999999999999985 58999999999999999
Q ss_pred ccccccccCCCccccccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccCcccccCCC
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATLSKFP 211 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p~~~~~~~ 211 (654)
++|.+. .+|..+++|++|+.|.+..|.+-..+... .+..|+.|.+.+|+++ .+|..++++.
T Consensus 135 ~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~ 196 (264)
T KOG0617|consen 135 GDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT-VLPPELANLD 196 (264)
T ss_pred cCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee-ecChhhhhhh
Confidence 999999 99999999999999999999998777766 8899999999999999 8998887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=4e-15 Score=165.14 Aligned_cols=242 Identities=24% Similarity=0.341 Sum_probs=176.7
Q ss_pred ccccccCceeEEEEEecC--CcEEEEEEecccccC---HHHHHHHHHHHhccC-CCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLEE--GTTVVVKRLKEVAVG---KREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~--g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.||+|+|+.|-...... ...+|+|.+...... ......|..+-..+. |+|++++++...+.+..+++++|..+
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 458999999998877543 345666666544322 233344666666676 99999999999999999999999999
Q ss_pred Cchhhhh-ccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-ccCCeecCCCCCCcEEECCCC-CeEEeccCCCCCcCC-C-
Q 036334 426 GSLSALL-HGSRGSGRTPLDWDNRMRIALSAARGLAHLH-VSGKIVHGNIKASNILLRPDH-DACVSDFGLNPLFGN-T- 500 (654)
Q Consensus 426 g~L~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~ivHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~-~- 500 (654)
+++.+.+ +.. ....+...+-.++.|+..++.|+| ..+ +.|||+||+|.+++..+ ..+++|||+|..+.. .
T Consensus 106 ~~~f~~i~~~~----~~~~~~~~~~~~~~ql~s~l~~~H~~~~-~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g 180 (601)
T KOG0590|consen 106 GSLFSKISHPD----STGTSSSSASRYLPQLNSGLSYLHPENG-VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG 180 (601)
T ss_pred cccccccccCC----ccCCCCcchhhhhhhhccCccccCcccc-cccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence 9999988 422 123566677789999999999999 777 99999999999999999 999999999987755 2
Q ss_pred -----CCCCc-cccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 -----TPPTR-VAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 -----~~~~~-~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....+ +..|+|||...+. ...+..|+||.|+++.-+++|..|+........ ....|...... .
T Consensus 181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~~~---------~ 250 (601)
T KOG0590|consen 181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNKGR---------F 250 (601)
T ss_pred cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccccc---------c
Confidence 22445 7779999999874 556889999999999999999999886554432 11222211100 0
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
....+... .....++..+++..+|..|.+.+++..
T Consensus 251 ~~~~~~~~---~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 TQLPWNSI---SDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccCccccC---ChhhhhcccccccCCchhccccccccc
Confidence 00011111 123445566888899999999887744
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=5e-15 Score=153.97 Aligned_cols=133 Identities=26% Similarity=0.264 Sum_probs=103.6
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 149 (654)
+..|+|+.|+++. +....+.+|+.|+.||||+|.|..+-++.|...++|++|+|++|+|+...+++|..|..|+.|+|+
T Consensus 271 me~l~L~~N~l~~-vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs 349 (873)
T KOG4194|consen 271 MEHLNLETNRLQA-VNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLS 349 (873)
T ss_pred cceeecccchhhh-hhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccc
Confidence 7889999999874 444468889999999999999998888889889999999999999998888888888888888888
Q ss_pred cccccccCCCccccccccCccccccccccCCCCCC-----CCCCCCeEEccCCcccccCc
Q 036334 150 SNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-----NPANLRDFNVSNNNLNGSIP 204 (654)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-----~~~~L~~L~l~~N~l~g~~p 204 (654)
+|+|+..-...|..+++|+.|||++|.|+..+.+. .+++|+.|+|.+|+|. .||
T Consensus 350 ~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~ 408 (873)
T KOG4194|consen 350 HNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIP 408 (873)
T ss_pred ccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecc
Confidence 88887555566777777777777777777665542 4555666666666665 444
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.3e-14 Score=144.56 Aligned_cols=64 Identities=31% Similarity=0.414 Sum_probs=56.4
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccc-ccccccc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQS-NQFSGVF 133 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~ 133 (654)
..+.|+|..|+|+ .||+++|+.+++|+.||||+|+|+.+-|..|.+|++|..|-+.+ |+|+...
T Consensus 68 ~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~ 132 (498)
T KOG4237|consen 68 ETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLP 132 (498)
T ss_pred cceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhh
Confidence 4788999999997 79999999999999999999999988999999999887776655 8888553
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=8e-15 Score=152.46 Aligned_cols=156 Identities=22% Similarity=0.273 Sum_probs=135.4
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 149 (654)
+..|+|+.|.+.. |..+...-.++|++|+|++|+|+...+..|..|.+|++|+|++|+++..-...|..+++|+.|||+
T Consensus 295 L~~L~lS~NaI~r-ih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr 373 (873)
T KOG4194|consen 295 LEQLDLSYNAIQR-IHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR 373 (873)
T ss_pred hhhhccchhhhhe-eecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence 5679999999975 444468888999999999999998888899999999999999999998888899999999999999
Q ss_pred cccccccCCC---ccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCC--CCccccCCCCCC
Q 036334 150 SNNFSGKIPF---DVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKF--PQSSFTGNLDLC 222 (654)
Q Consensus 150 ~N~l~~~~p~---~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~--~~l~~~~n~~~c 222 (654)
+|.|++.+.. .|..|++|+.|+|.+|+|..+.... .+.+|++|||.+|.|...-|.+|..+ +.|-+.....+|
T Consensus 374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflC 453 (873)
T KOG4194|consen 374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLC 453 (873)
T ss_pred CCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEE
Confidence 9999987754 4778999999999999999766543 89999999999999998899998876 345565666788
Q ss_pred CCCC
Q 036334 223 GGPL 226 (654)
Q Consensus 223 ~~~~ 226 (654)
+|..
T Consensus 454 DCql 457 (873)
T KOG4194|consen 454 DCQL 457 (873)
T ss_pred eccH
Confidence 8764
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.6e-15 Score=153.83 Aligned_cols=76 Identities=29% Similarity=0.403 Sum_probs=43.8
Q ss_pred hhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccCcccccCCCC
Q 036334 135 ASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATLSKFPQ 212 (654)
Q Consensus 135 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p~~~~~~~~ 212 (654)
.++..|.+|..+|||.|++. .+|..+-++.+|+.|+||+|+|+..-... ...+|++|+||.|+|+ .+|+++.+++.
T Consensus 216 tsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~k 292 (1255)
T KOG0444|consen 216 TSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTK 292 (1255)
T ss_pred CchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHH
Confidence 33344444444444444444 44555555555666666666655433322 3456777888888887 78877766554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.9e-13 Score=143.46 Aligned_cols=140 Identities=22% Similarity=0.302 Sum_probs=98.2
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccccCH-----------------------------------------HHHHH
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGK-----------------------------------------REFEM 390 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-----------------------------------------~~~~~ 390 (654)
+.||.|++|.||+|.+.+|+.||||+.++..... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5699999999999999999999999986531100 01333
Q ss_pred HHHHHhcc----CCCccccccEEE-EeCCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHH-HHHHhhc
Q 036334 391 QMEVLGKI----KHDNVVPLRAFY-YSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR-GLAHLHV 464 (654)
Q Consensus 391 e~~~l~~l----~hpniv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~l~~LH~ 464 (654)
|...+.++ +|.+-+.+-.++ ......++||||++|++|.++..... ... .+.+++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----AGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh----cCC---CHHHHHHHHHHHHHHHHHh
Confidence 44444444 233223333333 22446799999999999988765211 112 23456666665 4678888
Q ss_pred cCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 465 ~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
.+ ++|+|+||.||+++.++.++++|||++..+..
T Consensus 276 ~g-~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DG-FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CC-ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 87 99999999999999999999999999876643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=9.1e-15 Score=145.86 Aligned_cols=141 Identities=28% Similarity=0.438 Sum_probs=93.5
Q ss_pred EeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccc
Q 036334 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSN 151 (654)
Q Consensus 72 ~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 151 (654)
.|++.+|.+. .+|++.+ +++.|++||.-+|.++ .+|++++.+.+|+-|||..|++. .+| .|.+++.|+.|+++.|
T Consensus 164 ~l~~~~n~l~-~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N 238 (565)
T KOG0472|consen 164 KLDLEGNKLK-ALPENHI-AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGEN 238 (565)
T ss_pred Hhhccccchh-hCCHHHH-HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhccc
Confidence 3445555554 2444333 3666666666666666 66667777777777777777776 555 6777777777777777
Q ss_pred cccccCCCccc-cccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccCcccccCCC--CccccCCC
Q 036334 152 NFSGKIPFDVN-NLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATLSKFP--QSSFTGNL 219 (654)
Q Consensus 152 ~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p~~~~~~~--~l~~~~n~ 219 (654)
+|. .+|.... ++++|.+|||..|+++..+... .+.+|+.||||+|.|+ .+|.+++++. .|...|||
T Consensus 239 ~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnlhL~~L~leGNP 308 (565)
T KOG0472|consen 239 QIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDIS-SLPYSLGNLHLKFLALEGNP 308 (565)
T ss_pred HHH-hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccc-cCCcccccceeeehhhcCCc
Confidence 777 6666554 7777777788888877666655 6677888888888887 6777777762 33445665
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.4e-14 Score=145.68 Aligned_cols=151 Identities=25% Similarity=0.369 Sum_probs=128.0
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
++..+||+.|+|. +-|+.+.++++|+.|+||+|.|+ .+....+...+|++|+||.|+|+ .+|+++..|++|+.|.+
T Consensus 223 NL~dvDlS~N~Lp--~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~ 298 (1255)
T KOG0444|consen 223 NLRDVDLSENNLP--IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYA 298 (1255)
T ss_pred hhhhccccccCCC--cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHh
Confidence 4778899999995 33457999999999999999999 66667777789999999999999 89999999999999999
Q ss_pred cccccc-ccCCCccccccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccCcccccC---CCCccccCCCCCCC
Q 036334 149 SSNNFS-GKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATLSK---FPQSSFTGNLDLCG 223 (654)
Q Consensus 149 ~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p~~~~~---~~~l~~~~n~~~c~ 223 (654)
.+|+++ .-||..++.|.+|+.+.+++|++.-.+... .|..|+.|.|+.|+|- .+|+.+-- +..|++-.|+.+--
T Consensus 299 n~NkL~FeGiPSGIGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVM 377 (1255)
T KOG0444|consen 299 NNNKLTFEGIPSGIGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVM 377 (1255)
T ss_pred ccCcccccCCccchhhhhhhHHHHhhccccccCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccC
Confidence 999987 358899999999999999999998666666 8999999999999998 89987654 44566667777654
Q ss_pred C
Q 036334 224 G 224 (654)
Q Consensus 224 ~ 224 (654)
.
T Consensus 378 P 378 (1255)
T KOG0444|consen 378 P 378 (1255)
T ss_pred C
Confidence 3
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=9.3e-12 Score=135.64 Aligned_cols=139 Identities=18% Similarity=0.242 Sum_probs=88.1
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEecccccC-----------------------------------HHH------HH
Q 036334 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVG-----------------------------------KRE------FE 389 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-----------------------------------~~~------~~ 389 (654)
+.||+|++|.||+|.+++ |+.||||+.++.... .+. +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999887 999999999754100 011 22
Q ss_pred HHHHHHhcc----CCCccccccEEEEe-CCceEEEEEecCCCchhhhhcc-CCCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 036334 390 MQMEVLGKI----KHDNVVPLRAFYYS-KDEKLLVYDYMPAGSLSALLHG-SRGSGRTPLDWDNRMRIALSAARGLAHLH 463 (654)
Q Consensus 390 ~e~~~l~~l----~hpniv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~l~~~~~~~i~~~ia~~l~~LH 463 (654)
+|+..+.++ .+.+.+.+-.++.+ ....+|||||++|+.+.++-.- ..+.....+....+..++.|+ .
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 233323222 23333333333322 3456899999999999874321 111011123333333334443 3
Q ss_pred ccCCeecCCCCCCcEEECCCC----CeEEeccCCCCCcC
Q 036334 464 VSGKIVHGNIKASNILLRPDH----DACVSDFGLNPLFG 498 (654)
Q Consensus 464 ~~~~ivHrDlk~~NIll~~~~----~~kl~Dfgla~~~~ 498 (654)
..+ ++|+|+||.||+++.++ .++++|||+...++
T Consensus 278 ~~G-ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 RDG-FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred hCC-eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 466 99999999999999988 89999999976554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.6e-12 Score=137.90 Aligned_cols=246 Identities=22% Similarity=0.267 Sum_probs=174.9
Q ss_pred CHHHHHHHhhccccc--cCceeEEEEEe---cCCcEEEEEEecccc---cCHHHHHHHHHHHhcc-CCCccccccEEEEe
Q 036334 342 DLEDLLRASAEVLGK--GSVGTSYKAVL---EEGTTVVVKRLKEVA---VGKREFEMQMEVLGKI-KHDNVVPLRAFYYS 412 (654)
Q Consensus 342 ~~~~~~~~~~~~lg~--G~fg~Vy~~~~---~~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~ 412 (654)
+..+...-+.+.+|. |.+|.||.+.. .++..+|+|+-+... .....-.+|+...+++ .|+|.++....+..
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 333433344567899 99999999985 357889999844321 2223334566655566 49999999999999
Q ss_pred CCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHH----HHHHhhccCCeecCCCCCCcEEECCC-CCeE
Q 036334 413 KDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR----GLAHLHVSGKIVHGNIKASNILLRPD-HDAC 487 (654)
Q Consensus 413 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~ivHrDlk~~NIll~~~-~~~k 487 (654)
.+..++-+|++. .+|..+.+.. ...++....+.+..+..+ |+.++|... ++|-|+||.||+...+ ...+
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~-~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN-IVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred CCcceeeecccc-chhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccCCCc-ccccccchhheecccccceee
Confidence 999999999995 6888887743 223677778888888888 999999887 9999999999999999 8899
Q ss_pred EeccCCCCCcCCCC---------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHH
Q 036334 488 VSDFGLNPLFGNTT---------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWV 558 (654)
Q Consensus 488 l~Dfgla~~~~~~~---------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~ 558 (654)
++|||+...++... ...+.+.|++||... +.++.+.|+|++|.+..+..++..++....... |.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~ 336 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS------WS 336 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC------cc
Confidence 99999877665432 124455699999875 478899999999999999999877765432211 11
Q ss_pred HHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 559 QSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
+ .+..+. .....+.-..++...+..|++.+|-.|++.+.+..
T Consensus 337 ~--~r~~~i---------p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 Q--LRQGYI---------PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred c--cccccC---------chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 011110 00111111223444777899999999998886643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.2e-12 Score=118.23 Aligned_cols=128 Identities=18% Similarity=0.177 Sum_probs=96.4
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCcccc-ccEEEEeCCceEEEEEecCCCchhh
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVP-LRAFYYSKDEKLLVYDYMPAGSLSA 430 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~-l~~~~~~~~~~~lv~e~~~~g~L~~ 430 (654)
+.|+.|.++.||++... |..|++|...........++.|+.+++.+.+.+++. ++.+ .....++||||+++.++..
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence 45899999999999876 788999997655433345678899988886655543 4433 3344689999999988764
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCC----eecCCCCCCcEEECCCCCeEEeccCCCCC
Q 036334 431 LLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK----IVHGNIKASNILLRPDHDACVSDFGLNPL 496 (654)
Q Consensus 431 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----ivHrDlk~~NIll~~~~~~kl~Dfgla~~ 496 (654)
.- . ....++.+++++++.||..+. ++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 30 0 112356789999999998761 59999999999999 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=4e-11 Score=128.51 Aligned_cols=162 Identities=17% Similarity=0.239 Sum_probs=123.0
Q ss_pred ecCCcEEEEEEecccccC-HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchhhhhccCCCCCCCCCCH
Q 036334 367 LEEGTTVVVKRLKEVAVG-KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDW 445 (654)
Q Consensus 367 ~~~g~~vavK~~~~~~~~-~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~ 445 (654)
..++.+|.|..++..... .....+-++.|+.++||||++++..++.++..|+|+|.+.. |..++.. +..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~--------l~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE--------LGK 103 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH--------hHH
Confidence 446788888887654332 23356677889999999999999999999999999998744 5555542 334
Q ss_pred HHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC----CCccccccCccccCCCCCC
Q 036334 446 DNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP----PTRVAGYRAPEVVETRKVT 521 (654)
Q Consensus 446 ~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~----~~~~~~y~aPE~~~~~~~~ 521 (654)
......+.||+.||.|||.++.++|++|.-..|++++.|+.||++|.++........ ...-..|..|+.+....
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--
Confidence 556667889999999999888899999999999999999999999988654433221 11112377777654322
Q ss_pred cchhHHHHHHHHHHHHhCC
Q 036334 522 FKSDVYSFGVLLLELLTGK 540 (654)
Q Consensus 522 ~~~DvwslGvil~el~tg~ 540 (654)
-..|.|-|||+++|++.|.
T Consensus 182 ~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cchhhhhHHHHHHHHhCcc
Confidence 4579999999999999993
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2e-13 Score=136.46 Aligned_cols=128 Identities=29% Similarity=0.456 Sum_probs=87.1
Q ss_pred EEEeecCCCCccccCCc-----------------------ccccCCCCccEEEeccCCccCcCCCCCCCccccccccccc
Q 036334 70 VYSLRLPGVGLVGPIPP-----------------------NTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQS 126 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~-----------------------~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 126 (654)
|+.++++.|++. ++|. ..++.+++|..|+|++|.+. .+|.+++.+..|++||||.
T Consensus 390 Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~ 467 (565)
T KOG0472|consen 390 VTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSF 467 (565)
T ss_pred eEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccc
Confidence 778888877753 2332 24666777777777777766 6677777777777777777
Q ss_pred cccccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC-CCCCCCeEEccCCccc
Q 036334 127 NQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLN 200 (654)
Q Consensus 127 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~ 200 (654)
|+|. .+|..+..+..|+.+-.++|++....|..+.+|.+|.+|||.+|.|..++|.. ++.+|++|+|++|+|.
T Consensus 468 NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 468 NRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 7776 66777666667777766667776444444777777777777777777666666 6777777777777775
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.3e-12 Score=142.29 Aligned_cols=112 Identities=32% Similarity=0.597 Sum_probs=96.0
Q ss_pred ccccccccccccccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEcc
Q 036334 118 LLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVS 195 (654)
Q Consensus 118 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~ 195 (654)
.++.|+|++|.++|.+|..+..|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|.. .+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 3778899999999999999999999999999999999999988999999999999999999888875 88899999999
Q ss_pred CCcccccCcccccCC----CCccccCCCCCCCCCC-CCC
Q 036334 196 NNNLNGSIPATLSKF----PQSSFTGNLDLCGGPL-PPC 229 (654)
Q Consensus 196 ~N~l~g~~p~~~~~~----~~l~~~~n~~~c~~~~-~~C 229 (654)
+|+|+|.+|..+..+ ..+.+.+|+.+|+.+. ..|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCC
Confidence 999999999887653 3567889999998653 345
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.5e-11 Score=118.87 Aligned_cols=149 Identities=23% Similarity=0.391 Sum_probs=114.5
Q ss_pred HHHhccCCCccccccEEEEeCC-----ceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC-
Q 036334 393 EVLGKIKHDNVVPLRAFYYSKD-----EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG- 466 (654)
Q Consensus 393 ~~l~~l~hpniv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~- 466 (654)
.-+-.+.|.|||++..|+.+.+ ...+++|||.-|++..+|++.+. ....+......+++.||..||.|||+-.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 3344567999999999987654 35899999999999999987653 2345777888899999999999999655
Q ss_pred CeecCCCCCCcEEECCCCCeEEeccCCCCC---cC-----CCCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh
Q 036334 467 KIVHGNIKASNILLRPDHDACVSDFGLNPL---FG-----NTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT 538 (654)
Q Consensus 467 ~ivHrDlk~~NIll~~~~~~kl~Dfgla~~---~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t 538 (654)
+|+|+++..+-|++..+|-+|++--.-... .. ......+.++|.|||.=.....+.++|||+||....||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 699999999999999999888742111000 00 1112334578999998766677889999999999999998
Q ss_pred CCCC
Q 036334 539 GKAP 542 (654)
Q Consensus 539 g~~p 542 (654)
+..-
T Consensus 278 lEiq 281 (458)
T KOG1266|consen 278 LEIQ 281 (458)
T ss_pred heec
Confidence 7643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.9e-10 Score=107.85 Aligned_cols=136 Identities=15% Similarity=0.184 Sum_probs=96.9
Q ss_pred ccccccCceeEEEEEecC-------CcEEEEEEeccccc----------------------C-HHHH----HHHHHHHhc
Q 036334 352 EVLGKGSVGTSYKAVLEE-------GTTVVVKRLKEVAV----------------------G-KREF----EMQMEVLGK 397 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~----------------------~-~~~~----~~e~~~l~~ 397 (654)
..||.|.=+.||.|...+ +..+|||+.+.... + ...+ ++|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 458999999999998543 47999999853210 0 1112 378888888
Q ss_pred cCC--CccccccEEEEeCCceEEEEEecCCCchhh-hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hccCCeecCCC
Q 036334 398 IKH--DNVVPLRAFYYSKDEKLLVYDYMPAGSLSA-LLHGSRGSGRTPLDWDNRMRIALSAARGLAHL-HVSGKIVHGNI 473 (654)
Q Consensus 398 l~h--pniv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~ivHrDl 473 (654)
+.. -++-+++++ ...++||||+.++.+.. .+. ...++......+..+++.+|..| |..+ |||+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk------d~~~~~~~~~~i~~~i~~~l~~l~H~~g-lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK------DAKLNDEEMKNAYYQVLSMMKQLYKECN-LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh------ccccCHHHHHHHHHHHHHHHHHHHHhCC-eecCCC
Confidence 753 345555543 56789999997654422 222 12245556677889999999999 7666 999999
Q ss_pred CCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 474 KASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 474 k~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
++.||+++ ++.+.|+|||.+.....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999997 57899999998776543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.7e-12 Score=138.24 Aligned_cols=127 Identities=31% Similarity=0.423 Sum_probs=111.9
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
.+..|.|.+|.|....-| .|.+..+|+.|+|++|+|.......+.++..|++|+||+|+|+ .+|..+..+..|++|..
T Consensus 360 ~Lq~LylanN~Ltd~c~p-~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFP-VLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHhcCcccccchh-hhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 477899999999888766 5999999999999999999444446889999999999999999 88999999999999999
Q ss_pred ccccccccCCCccccccccCccccccccccCC-CCCCCC-CCCCeEEccCCcc
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGN-LPSINP-ANLRDFNVSNNNL 199 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~~~~~~-~~L~~L~l~~N~l 199 (654)
.+|+|. ..| .+..+++|+.+|++.|+|+.. ++.... ++|++|||++|.-
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 999999 788 899999999999999999854 344433 8999999999984
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.4e-10 Score=111.23 Aligned_cols=139 Identities=23% Similarity=0.293 Sum_probs=107.0
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEeccccc--CHHHHHHHHHHHhccCC--CccccccEEEEeC---CceEEEEEecC
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKH--DNVVPLRAFYYSK---DEKLLVYDYMP 424 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h--pniv~l~~~~~~~---~~~~lv~e~~~ 424 (654)
+.|+.|.++.||++...+|+.+++|....... ....+..|+++++.+.+ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 45899999999999887678999999765433 35578889999998875 3456677766553 25689999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc---------------------------------------
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS--------------------------------------- 465 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~--------------------------------------- 465 (654)
+.++.+.+.. ..++..+...++.+++++|.+||+.
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9988776531 2367777777888888888888731
Q ss_pred ----------------CCeecCCCCCCcEEECC--CCCeEEeccCCCCC
Q 036334 466 ----------------GKIVHGNIKASNILLRP--DHDACVSDFGLNPL 496 (654)
Q Consensus 466 ----------------~~ivHrDlk~~NIll~~--~~~~kl~Dfgla~~ 496 (654)
..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 13799999999999998 56688999997764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.8e-12 Score=137.68 Aligned_cols=149 Identities=25% Similarity=0.353 Sum_probs=120.7
Q ss_pred EEEeecCCCCccccCCccccc-------------------------CCCCccEEEeccCCccCcCCCCCCCccccccccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLG-------------------------KLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYL 124 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~-------------------------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 124 (654)
+.+|+|..|+|. .+|+..|. .++.|+.|+|.+|.|+...-+.|.+.++|+.|+|
T Consensus 312 L~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhL 390 (1081)
T KOG0618|consen 312 LRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHL 390 (1081)
T ss_pred eeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeee
Confidence 888999888874 34332111 2355888899999998766668889999999999
Q ss_pred cccccccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCccc-ccC
Q 036334 125 QSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN-GSI 203 (654)
Q Consensus 125 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~-g~~ 203 (654)
++|+|.......+.++..|+.|+||+|+|+ .+|..+.++..|++|...+|+|...+....++.|+.+|||.|+|+ +.+
T Consensus 391 syNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fPe~~~l~qL~~lDlS~N~L~~~~l 469 (1081)
T KOG0618|consen 391 SYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFPELAQLPQLKVLDLSCNNLSEVTL 469 (1081)
T ss_pred cccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeechhhhhcCcceEEecccchhhhhhh
Confidence 999999555556888999999999999999 889999999999999999999997774449999999999999997 345
Q ss_pred cccc--cCCCCccccCCCC
Q 036334 204 PATL--SKFPQSSFTGNLD 220 (654)
Q Consensus 204 p~~~--~~~~~l~~~~n~~ 220 (654)
|... .+++.|++.||.+
T Consensus 470 ~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 470 PEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhhCCCcccceeeccCCcc
Confidence 5443 4777888999985
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.1e-11 Score=112.18 Aligned_cols=107 Identities=33% Similarity=0.441 Sum_probs=29.9
Q ss_pred ccCCCCccEEEeccCCccCcCCCCCC-CccccccccccccccccccchhhccccccceeccccccccccCCCcc-ccccc
Q 036334 89 LGKLSQLRVLSLRSNRLSGEIPSDFS-NLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDV-NNLTH 166 (654)
Q Consensus 89 l~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~ 166 (654)
+.+...++.|+|++|.|+ .+. .++ .+.+|+.|||++|+|+. ++ .+..+++|++|++++|+|+ .+...+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 444455666666666666 232 344 45666666666666663 22 4556666666666666666 333233 24666
Q ss_pred cCccccccccccCCCCC---CCCCCCCeEEccCCccc
Q 036334 167 LTGLFLENNKFSGNLPS---INPANLRDFNVSNNNLN 200 (654)
Q Consensus 167 L~~L~l~~N~l~~~~~~---~~~~~L~~L~l~~N~l~ 200 (654)
|+.|+|++|+|...-.- ..+++|+.|+|.+|+++
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 66666666666543221 15677777777777776
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.1e-11 Score=111.38 Aligned_cols=119 Identities=26% Similarity=0.364 Sum_probs=49.2
Q ss_pred eEEEeecCCCCccccCCccccc-CCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhh-cccccccee
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLG-KLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV-TRMNRLTRL 146 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L 146 (654)
+++.|+|.+|.++. |. .++ .+.+|+.|||++|.|+ .+. .+..+++|++|+|++|+|+. +.+.+ ..+++|+.|
T Consensus 20 ~~~~L~L~~n~I~~-Ie--~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 20 KLRELNLRGNQIST-IE--NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EE
T ss_pred cccccccccccccc-cc--chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEE
Confidence 37889999999974 43 366 6889999999999999 444 68889999999999999994 44445 468999999
Q ss_pred ccccccccccCC-CccccccccCccccccccccCCCCCC------CCCCCCeEEc
Q 036334 147 DLSSNNFSGKIP-FDVNNLTHLTGLFLENNKFSGNLPSI------NPANLRDFNV 194 (654)
Q Consensus 147 ~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~------~~~~L~~L~l 194 (654)
+|++|+|...-- ..+..+++|+.|+|.+|.+... +.. .+++|+.||-
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 999999984211 3467889999999999999855 321 6777777753
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.2e-10 Score=131.42 Aligned_cols=73 Identities=25% Similarity=0.451 Sum_probs=51.8
Q ss_pred cccceeccccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCCC---ccccC
Q 036334 141 NRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQ---SSFTG 217 (654)
Q Consensus 141 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~~---l~~~~ 217 (654)
.+|+.|+|++|+|+ .+|.. .++|+.|++++|+|++. |.. +.+|+.|+|++|+|+ .+|..+.+++. +.+.+
T Consensus 382 ~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~LssI-P~l-~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~ 454 (788)
T PRK15387 382 SGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTSL-PML-PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 454 (788)
T ss_pred cccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCCC-Ccc-hhhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence 36777888888887 45543 25788888888888864 432 457888999999998 88987776655 44556
Q ss_pred CCC
Q 036334 218 NLD 220 (654)
Q Consensus 218 n~~ 220 (654)
|+.
T Consensus 455 N~L 457 (788)
T PRK15387 455 NPL 457 (788)
T ss_pred CCC
Confidence 653
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-11 Score=119.66 Aligned_cols=126 Identities=24% Similarity=0.317 Sum_probs=88.9
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 149 (654)
++.|||++|.++. |-. +..-++.++.|+||+|.|. .+- .+..|++|+.||||+|.++ .+-++-..|-+.++|.|+
T Consensus 286 LtelDLS~N~I~~-iDE-SvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 286 LTELDLSGNLITQ-IDE-SVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhccccccchhh-hhh-hhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 5667888887753 332 4667778888888888877 333 3777788888888888887 556666667778888888
Q ss_pred cccccccCCCccccccccCccccccccccCCCC--CC-CCCCCCeEEccCCccccc
Q 036334 150 SNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLP--SI-NPANLRDFNVSNNNLNGS 202 (654)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~-~~~~L~~L~l~~N~l~g~ 202 (654)
+|.|. .+ ..++.|-+|..||+++|+|...-. .+ .++.|+.|.|.+|+|.+.
T Consensus 361 ~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 361 QNKIE-TL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhHh-hh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 88776 33 256677778888888888864322 23 677788888888888743
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.07 E-value=5.4e-12 Score=131.61 Aligned_cols=135 Identities=25% Similarity=0.408 Sum_probs=97.5
Q ss_pred eecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecccccc
Q 036334 73 LRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNN 152 (654)
Q Consensus 73 L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 152 (654)
|.|..|.+- .||+ .+++|..|++|||+.|+++ .+|..+..| -|+.|-+++|+++ .+|..++.+..|..||.+.|+
T Consensus 103 liLy~n~~r-~ip~-~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~ne 177 (722)
T KOG0532|consen 103 LILYHNCIR-TIPE-AICNLEALTFLDLSSNQLS-HLPDGLCDL-PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNE 177 (722)
T ss_pred HHHHhccce-ecch-hhhhhhHHHHhhhccchhh-cCChhhhcC-cceeEEEecCccc-cCCcccccchhHHHhhhhhhh
Confidence 444444442 3444 4777777777777777777 666666555 3677777777777 677777777788888888888
Q ss_pred ccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCCCcc
Q 036334 153 FSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQSS 214 (654)
Q Consensus 153 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~~l~ 214 (654)
|. .+|..++.+.+|+.|++..|++...++....-.|..||+|.|+++ .||..|.+|+.|.
T Consensus 178 i~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq 237 (722)
T KOG0532|consen 178 IQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQ 237 (722)
T ss_pred hh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhhe
Confidence 87 677778888888888888888887777665456788888888888 8888888777654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.9e-09 Score=98.67 Aligned_cols=132 Identities=24% Similarity=0.378 Sum_probs=99.0
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEe-cccc--------cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRL-KEVA--------VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~-~~~~--------~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
..+++|+=+.+|.+.+. |..+++|.= ++.- ....+-.+|..++.+++--.|-..+=++.+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999776 455666643 3221 1123456788888888765665555567788888999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
++|-.|.+.+... ...++..+=.-+.-||..+ |+|+||.++||.+..++ +.++|||++.+..
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g-ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHKAG-IVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC-eecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 9999999888632 2446666777778899988 99999999999998665 9999999987543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.3e-10 Score=123.65 Aligned_cols=239 Identities=18% Similarity=0.159 Sum_probs=166.8
Q ss_pred ccccccCceeEEEEEe--cCCcEEEEEEecccccCH---HHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVL--EEGTTVVVKRLKEVAVGK---REFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~---~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
..||.|.|+.|++... .++..|++|.+....... ..-..|+.+...+ .|.++++....+......|+--||+++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 5699999999999774 357889999876653221 1123344444444 488999988888877788899999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC-CCeEEeccCCCCCcCCCCC-C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD-HDACVSDFGLNPLFGNTTP-P 503 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~-~ 503 (654)
+++...+. -...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||.++.+.-... .
T Consensus 351 ~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s~~-~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~~ 424 (524)
T KOG0601|consen 351 GSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHSKL-FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGVF 424 (524)
T ss_pred cchhhhhH-----HHHhcCcchhhhhHHHHHhccccccchh-hhcccccccceeeccchhhhhccccccccccceecccc
Confidence 98877663 2345788889999999999999999998 9999999999999886 7788999999875332211 1
Q ss_pred Ccccccc--CccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 504 TRVAGYR--APEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 504 ~~~~~y~--aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
....+++ +++......+..+.|++|||..+.|.+++..--..... | ..+..........
T Consensus 425 ~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~----------~~i~~~~~p~~~~- 485 (524)
T KOG0601|consen 425 HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------S----------LTIRSGDTPNLPG- 485 (524)
T ss_pred cccccccccchhhccccccccccccccccccccccccCcccCccccc--------c----------eeeecccccCCCc-
Confidence 2223344 44455566788999999999999999998654221100 0 0011111111111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
...++..+.+.+...++..||.+.++....+-..
T Consensus 486 --~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 486 --LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred --hHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 1145556666788999999999998877655443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.5e-11 Score=119.73 Aligned_cols=133 Identities=23% Similarity=0.290 Sum_probs=113.2
Q ss_pred CccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecccc-ccccccCCCccccccccCcccc
Q 036334 94 QLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSS-NNFSGKIPFDVNNLTHLTGLFL 172 (654)
Q Consensus 94 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l 172 (654)
.-+.|+|..|+|+.+.|..|+.+++|+.||||+|+|+.+-|++|.++.+|.+|-+-+ |+|+......|++|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 357899999999977777999999999999999999999999999999998876666 9999666668999999999999
Q ss_pred ccccccCCCCCC--CCCCCCeEEccCCcccccCcc-cccCCCC---ccccCCCCCCCCCCC
Q 036334 173 ENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPA-TLSKFPQ---SSFTGNLDLCGGPLP 227 (654)
Q Consensus 173 ~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~-~~~~~~~---l~~~~n~~~c~~~~~ 227 (654)
.-|++.-..... .+++|..|.|-+|.+. .|+. .|..+.. +-..-|++.|.|.++
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~ 207 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLP 207 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccc
Confidence 999999877765 8899999999999998 6665 5665554 445678888887764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.6e-10 Score=129.43 Aligned_cols=117 Identities=32% Similarity=0.521 Sum_probs=66.1
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 149 (654)
.+.|+|++++++ .+|.. +. ++|+.|+|++|.|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|+
T Consensus 180 ~~~L~L~~~~Lt-sLP~~-Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 180 KTELRLKILGLT-TIPAC-IP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred ceEEEeCCCCcC-cCCcc-cc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 566777777765 34432 22 35667777777776 4554443 36666666666666 4454443 356666666
Q ss_pred cccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCccc
Q 036334 150 SNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN 200 (654)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~ 200 (654)
+|+|. .+|..+. .+|+.|+|++|+|+. +|.....+|+.|+|++|+|+
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~~sL~~L~Ls~N~Lt 296 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKISC-LPENLPEELRYLSVYDNSIR 296 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccCc-cccccCCCCcEEECCCCccc
Confidence 66665 4554443 356666666666653 23322345666666666665
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.5e-09 Score=96.33 Aligned_cols=141 Identities=17% Similarity=0.340 Sum_probs=103.5
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEe-cc----c----ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRL-KE----V----AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~-~~----~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
.+|-+|+-+.|+++.+. |+..+||.= .+ . .....+-.+|++.+.++.--.|.-..-++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 56889999999999887 777676642 22 1 22345677899999888755555555567777788999999
Q ss_pred cCC-CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC---eEEeccCCCCCc
Q 036334 423 MPA-GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD---ACVSDFGLNPLF 497 (654)
Q Consensus 423 ~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~---~kl~Dfgla~~~ 497 (654)
+++ .++.+++..... ..........++..|-+.+.-||..+ |+|+||..+||++.+++. +.++|||++...
T Consensus 92 ~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~nd-iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 92 IDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHDND-IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhhCC-eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 976 477777764321 12222333678888889999999888 999999999999977654 479999997643
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.1e-10 Score=127.86 Aligned_cols=118 Identities=25% Similarity=0.432 Sum_probs=70.1
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
+++.|+|++|.+. .+|.. + ..+|+.|+|++|+|. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|
T Consensus 221 nL~~L~Ls~N~Lt-sLP~~-l--~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~L 290 (754)
T PRK15370 221 NIKTLYANSNQLT-SIPAT-L--PDTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSV 290 (754)
T ss_pred CCCEEECCCCccc-cCChh-h--hccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEEC
Confidence 4777888888876 45542 3 236777777777777 5665543 46777777777777 4565543 46777777
Q ss_pred ccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCccc
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN 200 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~ 200 (654)
++|+|+ .+|..+. ++|+.|++++|+|+.. |....++|+.|++++|.|+
T Consensus 291 s~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~L-P~~l~~sL~~L~Ls~N~Lt 338 (754)
T PRK15370 291 YDNSIR-TLPAHLP--SGITHLNVQSNSLTAL-PETLPPGLKTLEAGENALT 338 (754)
T ss_pred CCCccc-cCcccch--hhHHHHHhcCCccccC-CccccccceeccccCCccc
Confidence 777776 3444332 3455666666666543 2222244555555555554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=6.5e-10 Score=125.62 Aligned_cols=94 Identities=24% Similarity=0.361 Sum_probs=57.7
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 149 (654)
++.|+|.+|+|+. +|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|.|+ .+|..+ ++|+.|+|+
T Consensus 224 L~~L~L~~N~Lt~-LP~----lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls 290 (788)
T PRK15387 224 ITTLVIPDNNLTS-LPA----LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWIF 290 (788)
T ss_pred CCEEEccCCcCCC-CCC----CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhhch---hhcCEEECc
Confidence 5666666666653 442 2456677777777776 34532 346666677777666 344322 456677777
Q ss_pred cccccccCCCccccccccCccccccccccCC
Q 036334 150 SNNFSGKIPFDVNNLTHLTGLFLENNKFSGN 180 (654)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 180 (654)
+|+|+ .+|.. +++|+.|+|++|+|++.
T Consensus 291 ~N~Lt-~LP~~---p~~L~~LdLS~N~L~~L 317 (788)
T PRK15387 291 GNQLT-SLPVL---PPGLQELSVSDNQLASL 317 (788)
T ss_pred CCccc-ccccc---ccccceeECCCCccccC
Confidence 77777 45542 35678888888888764
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.9e-10 Score=85.66 Aligned_cols=61 Identities=36% Similarity=0.558 Sum_probs=43.8
Q ss_pred CCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccc
Q 036334 93 SQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNF 153 (654)
Q Consensus 93 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 153 (654)
++|++|+|++|+|+...+..|.++++|++|+|++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4677777777777755555677777777777777777766666777777777777777764
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.3e-08 Score=102.05 Aligned_cols=141 Identities=15% Similarity=0.142 Sum_probs=100.1
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEeccccc------------CHHHHHHHHHHHhccCCCc--cccccEEEEe----
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV------------GKREFEMQMEVLGKIKHDN--VVPLRAFYYS---- 412 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------~~~~~~~e~~~l~~l~hpn--iv~l~~~~~~---- 412 (654)
++++-+-....|++..+ +|+.|.||+...... ....+.+|...+.++..-+ +..++++...
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 44555455555777665 478999997743321 1124778888888774333 3344555543
Q ss_pred -CCceEEEEEecCCC-chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC-------C
Q 036334 413 -KDEKLLVYDYMPAG-SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP-------D 483 (654)
Q Consensus 413 -~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~-------~ 483 (654)
...-+||||++++. +|.+++.... ..+.+...+..++.+++..+..||..| |+|+|++++|||++. +
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G-i~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG-INHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc-CccCCCChhhEEEeccccCCCCC
Confidence 23468999999886 7988875321 123556777889999999999999998 999999999999975 4
Q ss_pred CCeEEeccCCCCC
Q 036334 484 HDACVSDFGLNPL 496 (654)
Q Consensus 484 ~~~kl~Dfgla~~ 496 (654)
..+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6789999998753
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1e-10 Score=113.05 Aligned_cols=124 Identities=23% Similarity=0.272 Sum_probs=99.3
Q ss_pred CCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccCcc
Q 036334 91 KLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGL 170 (654)
Q Consensus 91 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 170 (654)
....|+.||||+|.|+ .+-.+..-+++++.|+||+|.+. .+. .+..|.+|+.||||+|.++ .+-.+-..|.+++.|
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 4467999999999999 77778888899999999999999 444 3899999999999999999 666666788899999
Q ss_pred ccccccccCCCCCCCCCCCCeEEccCCcccccCc--ccccCCCCc---cccCCC
Q 036334 171 FLENNKFSGNLPSINPANLRDFNVSNNNLNGSIP--ATLSKFPQS---SFTGNL 219 (654)
Q Consensus 171 ~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p--~~~~~~~~l---~~~~n~ 219 (654)
.|+.|.|....---.+-+|..||+++|+|. .+. ..+++++.| .+.+||
T Consensus 358 ~La~N~iE~LSGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 358 KLAQNKIETLSGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred ehhhhhHhhhhhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCC
Confidence 999999985443336778999999999997 333 346666654 445555
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.7e-10 Score=120.62 Aligned_cols=132 Identities=26% Similarity=0.380 Sum_probs=116.9
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
.++.|||+.|+++ .+|. .++.|+ |+.|-+++|+++ .+|..++.+.+|..||.+.|.+. .+|..++.+.+|+.|++
T Consensus 122 ~lt~l~ls~NqlS-~lp~-~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~v 196 (722)
T KOG0532|consen 122 ALTFLDLSSNQLS-HLPD-GLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNV 196 (722)
T ss_pred HHHHhhhccchhh-cCCh-hhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHH
Confidence 4778999999997 4665 478876 999999999999 89999999999999999999999 88999999999999999
Q ss_pred ccccccccCCCccccccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccCccccc
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATLS 208 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p~~~~ 208 (654)
..|++. .+|..+..|+ |..||+++|+++.++-.+ .++.|++|-|.+|+|. .-|..+.
T Consensus 197 rRn~l~-~lp~El~~Lp-Li~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 197 RRNHLE-DLPEELCSLP-LIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred hhhhhh-hCCHHHhCCc-eeeeecccCceeecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 999999 7888888655 899999999999777666 9999999999999998 6566553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=4.1e-10 Score=125.82 Aligned_cols=192 Identities=25% Similarity=0.270 Sum_probs=136.1
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+-+-+|.++.++.+.-. .|...+.|..+.... ..+....+-.++-..+||-+++..--+......+|+++|..++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 36788999999887633 243344444322211 1112222222232345677776655555566789999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC-------C
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG-------N 499 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~-------~ 499 (654)
+|...++.. ...+..........+..+.+|||... +.|||++|.|++...+++.++.|||.....+ .
T Consensus 890 ~~~Skl~~~-----~~~saepaRs~i~~~vqs~e~L~s~~-r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 890 DLPSKLHNS-----GCLSAEPARSPILERVQSLESLHSSL-RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred CchhhhhcC-----CCcccccccchhHHHHhhhhccccch-hhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence 999999854 34555555566677888999999886 8999999999999999999999998422110 0
Q ss_pred ----------------------------CCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 036334 500 ----------------------------TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGE 549 (654)
Q Consensus 500 ----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~ 549 (654)
.....+++.|.+||...+......+|.|++|++++|.++|.+||......
T Consensus 964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred ccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 01223456699999999999999999999999999999999999875543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.87 E-value=9.8e-10 Score=83.98 Aligned_cols=61 Identities=36% Similarity=0.460 Sum_probs=53.0
Q ss_pred cccccccccccccccccchhhccccccceeccccccccccCCCccccccccCccccccccc
Q 036334 117 TLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKF 177 (654)
Q Consensus 117 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 177 (654)
++|++|+|++|+|+...+..|.++++|++|+|++|+|+...|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4788999999999977667888899999999999999977778889999999999988875
|
... |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.1e-10 Score=119.60 Aligned_cols=133 Identities=23% Similarity=0.285 Sum_probs=96.2
Q ss_pred CeEEEeecCCCCccccCCcccccCCCC---ccEEEeccCCccC----cCCCCCCCc-cccccccccccccccc----cch
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQ---LRVLSLRSNRLSG----EIPSDFSNL-TLLRSLYLQSNQFSGV----FPA 135 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~----~p~ 135 (654)
.+++.|+|++|.+.+..+. .+..+.+ |++|+|++|.+++ .+...+..+ ++|+.|+|++|.+++. ++.
T Consensus 81 ~~L~~L~l~~~~~~~~~~~-~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 81 CGLQELDLSDNALGPDGCG-VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred CceeEEEccCCCCChhHHH-HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 4588999999888764443 3555554 9999999998873 233345566 8889999999998843 344
Q ss_pred hhccccccceecccccccccc----CCCccccccccCccccccccccCCCCC-----C-CCCCCCeEEccCCcccc
Q 036334 136 SVTRMNRLTRLDLSSNNFSGK----IPFDVNNLTHLTGLFLENNKFSGNLPS-----I-NPANLRDFNVSNNNLNG 201 (654)
Q Consensus 136 ~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~-----~-~~~~L~~L~l~~N~l~g 201 (654)
.+..+.+|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++.... . .+++|+.|++++|++++
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 566777899999999988842 333455567899999999988744321 1 56789999999998875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.85 E-value=5.4e-09 Score=126.59 Aligned_cols=87 Identities=26% Similarity=0.400 Sum_probs=54.3
Q ss_pred ceeeEEcCCCCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhh
Q 036334 58 WVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV 137 (654)
Q Consensus 58 w~gv~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 137 (654)
|.|+.+ -.+++.|+|+++...+.+|. ++.+++|+.|+|++|.....+|..++++++|+.|+|++|..-+.+|..+
T Consensus 627 ~~~~~~---l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i 701 (1153)
T PLN03210 627 WDGVHS---LTGLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI 701 (1153)
T ss_pred cccccc---CCCCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC
Confidence 666543 23477788887765566663 7777778888887776555777777777777777777654333555443
Q ss_pred ccccccceecccc
Q 036334 138 TRMNRLTRLDLSS 150 (654)
Q Consensus 138 ~~l~~L~~L~l~~ 150 (654)
++++|+.|+|++
T Consensus 702 -~l~sL~~L~Lsg 713 (1153)
T PLN03210 702 -NLKSLYRLNLSG 713 (1153)
T ss_pred -CCCCCCEEeCCC
Confidence 344444444433
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.84 E-value=8e-09 Score=125.12 Aligned_cols=144 Identities=22% Similarity=0.260 Sum_probs=80.5
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 149 (654)
++.|++.++.+ ..+|.. | .+.+|+.|+|++|.+. .++..+..+++|+.|+|++|...+.+| .+..+++|+.|+|+
T Consensus 591 Lr~L~~~~~~l-~~lP~~-f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~ 665 (1153)
T PLN03210 591 LRLLRWDKYPL-RCMPSN-F-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLS 665 (1153)
T ss_pred cEEEEecCCCC-CCCCCc-C-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEec
Confidence 34444444433 234432 2 3456666666666665 455566666666666666655444555 35666666666666
Q ss_pred cccccccCCCccccccccCccccccccccCCCCC-CCCCCCCeEEccCCcccccCcccccCCCCccccCC
Q 036334 150 SNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS-INPANLRDFNVSNNNLNGSIPATLSKFPQSSFTGN 218 (654)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~L~~L~l~~N~l~g~~p~~~~~~~~l~~~~n 218 (654)
+|.....+|..+.++++|+.|++++|..-+.+|. ..+++|+.|+|++|...+.+|....++..|.+.+|
T Consensus 666 ~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n 735 (1153)
T PLN03210 666 DCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDET 735 (1153)
T ss_pred CCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCC
Confidence 6655556666666666666666666533333333 35666666666666555555554445544444433
|
syringae 6; Provisional |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.7e-08 Score=96.59 Aligned_cols=137 Identities=26% Similarity=0.314 Sum_probs=98.2
Q ss_pred HHHHhhccccccCceeEEEEEecCCcEEEEEEecccc-----------------------cCHHHHHHHHHHHhccCCC-
Q 036334 346 LLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVA-----------------------VGKREFEMQMEVLGKIKHD- 401 (654)
Q Consensus 346 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~-----------------------~~~~~~~~e~~~l~~l~hp- 401 (654)
..+++++.||.|.=+.||.|...+|.++|||.=+... .+....++|++.|.++...
T Consensus 91 ~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 91 IVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred hHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3456788999999999999999999999999642110 1123467899999988644
Q ss_pred -ccccccEEEEeCCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEE
Q 036334 402 -NVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL 480 (654)
Q Consensus 402 -niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll 480 (654)
.|.+.+++ +...+||||++|--|...- ++....-.++..|+.-+..+-..| |||+|+++-||++
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G-iVHGDlSefNIlV 235 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG-IVHGDLSEFNILV 235 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC-ccccCCchheEEE
Confidence 56666543 5678999999886665432 122333344555555555555566 9999999999999
Q ss_pred CCCCCeEEeccCCCCCc
Q 036334 481 RPDHDACVSDFGLNPLF 497 (654)
Q Consensus 481 ~~~~~~kl~Dfgla~~~ 497 (654)
+++|.+.++||--+...
T Consensus 236 ~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 236 TEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ecCCCEEEEeCcccccC
Confidence 99999999999655433
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.3e-08 Score=94.53 Aligned_cols=125 Identities=20% Similarity=0.291 Sum_probs=81.4
Q ss_pred eEEEEEecCCcEEEEEEeccccc---------------------------CHHHHHHHHHHHhccCCC--ccccccEEEE
Q 036334 361 TSYKAVLEEGTTVVVKRLKEVAV---------------------------GKREFEMQMEVLGKIKHD--NVVPLRAFYY 411 (654)
Q Consensus 361 ~Vy~~~~~~g~~vavK~~~~~~~---------------------------~~~~~~~e~~~l~~l~hp--niv~l~~~~~ 411 (654)
.||.|...+|..+|||+.+.... .....++|++.|.++..- ++-+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999988899999999853210 012356799999999765 44555543
Q ss_pred eCCceEEEEEecC--CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hccCCeecCCCCCCcEEECCCCCeEE
Q 036334 412 SKDEKLLVYDYMP--AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL-HVSGKIVHGNIKASNILLRPDHDACV 488 (654)
Q Consensus 412 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~ivHrDlk~~NIll~~~~~~kl 488 (654)
...+|||||++ +..+..+.... ++......++.+++..+..+ |..+ |+|+||.+.||+++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~g-ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAG-IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTT-EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcC-ceecCCChhhEEeecc-eEEE
Confidence 25679999998 54454433211 11334566777888766654 6676 9999999999999987 9999
Q ss_pred eccCCCCCcC
Q 036334 489 SDFGLNPLFG 498 (654)
Q Consensus 489 ~Dfgla~~~~ 498 (654)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999876554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.4e-07 Score=98.66 Aligned_cols=168 Identities=26% Similarity=0.361 Sum_probs=125.2
Q ss_pred eeEEEEE-ecCCcEEEEEEeccccc-CHHHHHHHHHHHhccCCCccccccEEEEe----CCceEEEEEecCCC-chhhhh
Q 036334 360 GTSYKAV-LEEGTTVVVKRLKEVAV-GKREFEMQMEVLGKIKHDNVVPLRAFYYS----KDEKLLVYDYMPAG-SLSALL 432 (654)
Q Consensus 360 g~Vy~~~-~~~g~~vavK~~~~~~~-~~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~~~~g-~L~~~l 432 (654)
.+.||+. ..||..|++|+++.... .......-+++++++.|+|||++.++|.. +..+++||+|+++. +|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 5779987 55799999999944321 12223445788999999999999998873 34679999998764 566544
Q ss_pred ccCC----------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC
Q 036334 433 HGSR----------GSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP 502 (654)
Q Consensus 433 ~~~~----------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 502 (654)
-... .......++...|.++.|+..||.++|+.| +.-+-|.+++|+++.+.+++|...|..........
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG-LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~ 448 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG-LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT 448 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC-ceeecccHhHeEeeCcceEEEecccceeeecCCCC
Confidence 3221 112335788999999999999999999998 88899999999999999999998887665543320
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKA 541 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~ 541 (654)
|-+++ -.+-|.=.||.++..|.||..
T Consensus 449 ----------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 449 ----------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ----------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 11111 236788899999999999853
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=3.6e-07 Score=93.18 Aligned_cols=260 Identities=16% Similarity=0.190 Sum_probs=152.7
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEE------EeCC-ceEEEEEe
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFY------YSKD-EKLLVYDY 422 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~------~~~~-~~~lv~e~ 422 (654)
++-||+|+-+.+|..--. +.. +.|++.......+ .+.+.+|... .||-+-.-+.+= -+.. ..-++|..
T Consensus 16 gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CccccCCccceeeecchh-hch-hheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 456999999999975322 222 4477655432211 1223334333 466443311110 1122 24677777
Q ss_pred cCCCc-hhhhhc-cCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 423 MPAGS-LSALLH-GSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 423 ~~~g~-L~~~l~-~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
+.+.. ...++. ..+.......+|...++++..+|.+.+-||..| .+-+|+.++|+|+++++.|.+.|=..-....+.
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G-h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng 170 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG-HVVGDVNQNSFLVSDDSKVVLVDSDSFQINANG 170 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC-CcccccCccceeeecCceEEEEcccceeeccCC
Confidence 76542 222222 122334567899999999999999999999998 778999999999999999999875432222222
Q ss_pred ---CCCCccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCC--CCCChhHHHHHH-------h
Q 036334 501 ---TPPTRVAGYRAPEVVE-----TRKVTFKSDVYSFGVLLLELLTG-KAPNQASLGE--EGIDLPRWVQSV-------V 562 (654)
Q Consensus 501 ---~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg-~~pf~~~~~~--~~~~~~~~~~~~-------~ 562 (654)
.-..+...|.+||.-. +..-+...|-|.+||++++++.| +.||.+---. ...-+..-+... -
T Consensus 171 ~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~ 250 (637)
T COG4248 171 TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQ 250 (637)
T ss_pred ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhc
Confidence 2345566799999643 34557789999999999999996 9999763211 100000000000 0
Q ss_pred hhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHHHHhhhcCCC
Q 036334 563 REEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVST--VPDQRPAMQEVVRMIENMNRGET 621 (654)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~RPs~~evl~~L~~~~~~~~ 621 (654)
+.+.... +.-..+..... .+..+..+|+.. .+.-|||++-.+..|.++.++-.
T Consensus 251 ~~g~~p~---P~~~P~~~Lpp---~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 251 RRGLKPP---PRSIPLSMLPP---DVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred cCCCCCC---CCCCChhhcCH---HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 0000000 00001111122 344455588865 36789999999988887765443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.1e-09 Score=113.40 Aligned_cols=137 Identities=34% Similarity=0.536 Sum_probs=104.4
Q ss_pred eEEEeecCCCCccccCCcccccCCC-CccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLS-QLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
.++.|++.+|.+. .+++ ..+.+. +|+.|++++|.+. .+|..+.++++|+.|++++|+++ .+|...+.+++|+.|+
T Consensus 117 ~l~~L~l~~n~i~-~i~~-~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPP-LIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred ceeEEecCCcccc-cCcc-ccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 4889999999997 4555 366664 9999999999999 77778999999999999999999 6777777889999999
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccCcccccCCC
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATLSKFP 211 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p~~~~~~~ 211 (654)
+++|+++ .+|..+..+..|+.|.+++|++...+... .+.++..|.+++|++. .++..+.++.
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~ 255 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLS 255 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccchhcccc
Confidence 9999999 77776666677888999888544333332 6666666667777665 3344444333
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.5e-09 Score=111.82 Aligned_cols=153 Identities=29% Similarity=0.360 Sum_probs=124.3
Q ss_pred CCceeeEEcCCCCeEE---EeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCcc-cccccccccccccc
Q 036334 56 CNWVGVECDANRSFVY---SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLT-LLRSLYLQSNQFSG 131 (654)
Q Consensus 56 C~w~gv~C~~~~~~v~---~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~ 131 (654)
+.+.+..+.... +. .|++..+.+...+.+ +..++.++.|++.+|.++ .+|.....++ +|+.|++++|++.
T Consensus 80 ~~~l~~~~~~~~--~~~~~~l~~~~~~~~~~~~~--~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~- 153 (394)
T COG4886 80 ISSLDGSENLLN--LLPLPSLDLNLNRLRSNISE--LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE- 153 (394)
T ss_pred cccccccccccC--CCCCceeeccccccccCchh--hhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-
Confidence 455555555433 33 588888888555543 677799999999999999 7787888885 9999999999999
Q ss_pred ccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccCcccccCC
Q 036334 132 VFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATLSKF 210 (654)
Q Consensus 132 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p~~~~~~ 210 (654)
.+|..+..+++|+.|++++|+++ .+|...+.+++|+.|++++|+++..++.. .+..|+.|.+++|++. .++..+.++
T Consensus 154 ~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~ 231 (394)
T COG4886 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNL 231 (394)
T ss_pred hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhc
Confidence 77788999999999999999999 77777778999999999999999887775 5566999999999755 666667766
Q ss_pred CCcccc
Q 036334 211 PQSSFT 216 (654)
Q Consensus 211 ~~l~~~ 216 (654)
.++...
T Consensus 232 ~~l~~l 237 (394)
T COG4886 232 KNLSGL 237 (394)
T ss_pred cccccc
Confidence 665444
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.2e-10 Score=115.99 Aligned_cols=132 Identities=22% Similarity=0.243 Sum_probs=96.0
Q ss_pred EEEeecCCCCccc------cCCcccccCCCCccEEEeccCCccCcCCCCCCCccc---ccccccccccccc----ccchh
Q 036334 70 VYSLRLPGVGLVG------PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTL---LRSLYLQSNQFSG----VFPAS 136 (654)
Q Consensus 70 v~~L~l~~~~l~~------~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~----~~p~~ 136 (654)
++.|+++++.+.+ .++. .+..+++|+.|+|++|.+.+..+..+..+.+ |++|+|++|++++ .+...
T Consensus 53 l~~l~l~~~~~~~~~~~~~~~~~-~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~ 131 (319)
T cd00116 53 LKELCLSLNETGRIPRGLQSLLQ-GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKG 131 (319)
T ss_pred ceEEeccccccCCcchHHHHHHH-HHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHH
Confidence 7777887777652 1222 4677889999999999988666666666655 9999999998883 34445
Q ss_pred hccc-cccceecccccccccc----CCCccccccccCccccccccccCCC----CC-C-CCCCCCeEEccCCccccc
Q 036334 137 VTRM-NRLTRLDLSSNNFSGK----IPFDVNNLTHLTGLFLENNKFSGNL----PS-I-NPANLRDFNVSNNNLNGS 202 (654)
Q Consensus 137 ~~~l-~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~----~~-~-~~~~L~~L~l~~N~l~g~ 202 (654)
+..+ ++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++.. +. . .+++|++|+|++|.+++.
T Consensus 132 l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 208 (319)
T cd00116 132 LKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE 208 (319)
T ss_pred HHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChH
Confidence 6667 8899999999998843 3344566778999999999988521 11 1 456899999999988744
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.2e-08 Score=103.95 Aligned_cols=85 Identities=28% Similarity=0.401 Sum_probs=50.6
Q ss_pred CccccccccccccccccccchhhccccccceeccccccccccCC--CccccccccCccccccccccCC-CCC-------C
Q 036334 115 NLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIP--FDVNNLTHLTGLFLENNKFSGN-LPS-------I 184 (654)
Q Consensus 115 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~-~~~-------~ 184 (654)
.+++|+.|+|..|..-+.--.....+..|+.|||++|++- ..+ ...+.++.|+.|+++.+.|... .|+ .
T Consensus 220 ~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~ 298 (505)
T KOG3207|consen 220 TFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTH 298 (505)
T ss_pred hCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhc
Confidence 3455666666666322222223334567777777777766 333 3456777777777777777643 122 1
Q ss_pred CCCCCCeEEccCCccc
Q 036334 185 NPANLRDFNVSNNNLN 200 (654)
Q Consensus 185 ~~~~L~~L~l~~N~l~ 200 (654)
.+++|++|+++.|++.
T Consensus 299 ~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 299 TFPKLEYLNISENNIR 314 (505)
T ss_pred ccccceeeecccCccc
Confidence 5677888888888775
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.7e-09 Score=90.45 Aligned_cols=138 Identities=22% Similarity=0.230 Sum_probs=102.7
Q ss_pred EEEeecCCCCccccCCc--ccccCCCCccEEEeccCCccCcCCCCCC-Cccccccccccccccccccchhhcccccccee
Q 036334 70 VYSLRLPGVGLVGPIPP--NTLGKLSQLRVLSLRSNRLSGEIPSDFS-NLTLLRSLYLQSNQFSGVFPASVTRMNRLTRL 146 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~--~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (654)
.-.++|+++.|- .++. ..+....+|+..+|++|.|. ..|+.|. +++.+++|+|++|.|+ .+|..+..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 345777777663 2332 12556678888899999998 5555554 5579999999999999 778889999999999
Q ss_pred ccccccccccCCCccccccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccCcccccCCC
Q 036334 147 DLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATLSKFP 211 (654)
Q Consensus 147 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p~~~~~~~ 211 (654)
+++.|.|. ..|..+..|.+|..|+..+|.+....-+. ..+..-..++.+|++.+.-+..+..+.
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~~~~klqa~k 170 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDETKKKLQALK 170 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCcccccCcccccccC
Confidence 99999999 77778888999999999999887554443 333444556688888877776555443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.2e-06 Score=83.39 Aligned_cols=136 Identities=16% Similarity=0.190 Sum_probs=100.4
Q ss_pred ccccCceeEEEEEecCCcEEEEEEeccc-------ccCHHHHHHHHHHHhccCCC--ccccccEEEE-e--C--CceEEE
Q 036334 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEV-------AVGKREFEMQMEVLGKIKHD--NVVPLRAFYY-S--K--DEKLLV 419 (654)
Q Consensus 354 lg~G~fg~Vy~~~~~~g~~vavK~~~~~-------~~~~~~~~~e~~~l~~l~hp--niv~l~~~~~-~--~--~~~~lv 419 (654)
-|+||-+-|++-... |..+-+|+-... ..+...|.+|+..+.++..- .+.+.+ ++. . + ..-+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 367888899987765 557888886421 23567899999998888532 244444 332 1 1 135799
Q ss_pred EEecCC-CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC--eEEeccCCCC
Q 036334 420 YDYMPA-GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD--ACVSDFGLNP 495 (654)
Q Consensus 420 ~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~--~kl~Dfgla~ 495 (654)
+|-+++ -+|.+++... ...+.+...+..+..+++..+.-||..+ +.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH~~G-v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMHSVN-RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHHHCC-CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997753 4888887532 1234677888899999999999999998 999999999999987777 9999997544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.5e-07 Score=100.48 Aligned_cols=140 Identities=21% Similarity=0.314 Sum_probs=90.2
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccccCH-------------------------------HH----------HHH
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGK-------------------------------RE----------FEM 390 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-------------------------------~~----------~~~ 390 (654)
+.|+.++-|.||+|++.+|+.||||+.++..... ++ +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5688999999999999999999999986431100 01 222
Q ss_pred HHHHHhcc----C-CCccccccEEEEeCCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHH-HHHhhc
Q 036334 391 QMEVLGKI----K-HDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARG-LAHLHV 464 (654)
Q Consensus 391 e~~~l~~l----~-hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~-l~~LH~ 464 (654)
|..-+.++ + .+++.=..=|+.......|+|||++|-.+.+...-. ....+. ..++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~----~~g~d~---k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK----SAGIDR---KELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH----hcCCCH---HHHHHHHHHHHHHHHHh
Confidence 33333333 1 333322222233356778999999999988874311 122442 2333333332 222223
Q ss_pred cCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 465 ~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
.+ ++|.|.+|.||+++.++.+.+.|||+.....+
T Consensus 284 dg-ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DG-FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cC-ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 55 99999999999999999999999999776654
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1e-07 Score=66.80 Aligned_cols=37 Identities=46% Similarity=0.879 Sum_probs=27.5
Q ss_pred hhHHHHHHHHHhhCCC-C--CCCCccCC--CCCCCceeeEEc
Q 036334 28 TQDKQALLAFLSRTPH-K--NRVQWNAS--DSACNWVGVECD 64 (654)
Q Consensus 28 ~~~~~al~~~~~~~~~-~--~~~~W~~~--~~~C~w~gv~C~ 64 (654)
.+|++||++||..+.. + ...+|+.+ .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 5799999999998874 2 35789976 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.6e-09 Score=114.55 Aligned_cols=125 Identities=29% Similarity=0.318 Sum_probs=87.5
Q ss_pred CccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCC-ccccccccCcccc
Q 036334 94 QLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPF-DVNNLTHLTGLFL 172 (654)
Q Consensus 94 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l 172 (654)
.|.+.+.+.|.+. ..-.++.-++.|+.|||++|+++.. ..+..|+.|++|||++|.++ .+|. ....+. |+.|+|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 3666777778777 5555677778888888888888855 27777888888888888888 4443 333444 888888
Q ss_pred ccccccCCCCCCCCCCCCeEEccCCcccccCc----ccccCCCCccccCCCCCCC
Q 036334 173 ENNKFSGNLPSINPANLRDFNVSNNNLNGSIP----ATLSKFPQSSFTGNLDLCG 223 (654)
Q Consensus 173 ~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p----~~~~~~~~l~~~~n~~~c~ 223 (654)
+||.++....-.++.+|+.|||+.|-|++.-- ..++.+..|.+.|||-.|.
T Consensus 240 rnN~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 240 RNNALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred cccHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 88888765554577888888888887764322 2345556667778887663
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=4e-08 Score=106.24 Aligned_cols=144 Identities=24% Similarity=0.265 Sum_probs=95.6
Q ss_pred HHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC-------------CCccccccCccccCCCC
Q 036334 453 LSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP-------------PTRVAGYRAPEVVETRK 519 (654)
Q Consensus 453 ~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-------------~~~~~~y~aPE~~~~~~ 519 (654)
.+++.|+.|+|.+.++||+.|.|++|.++..+.+||+.|+++........ .....-|.|||++....
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 34558999999887899999999999999999999999998654433110 01112399999999988
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCC
Q 036334 520 VTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVST 598 (654)
Q Consensus 520 ~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 598 (654)
.+.++|+||+||++|-+.. |+.-+............ .... .........+-..++.+=+.+++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-----~~~~---------~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-----RNLL---------NAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-----hccc---------ccccccccccCcHHHHHHHHHHhcC
Confidence 8999999999999999995 45444432211110000 0000 0001111122233455556678889
Q ss_pred CCCCCCCHHHHH
Q 036334 599 VPDQRPAMQEVV 610 (654)
Q Consensus 599 dP~~RPs~~evl 610 (654)
++.-||++.++.
T Consensus 252 ~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 252 DSAVRPTLDLLL 263 (700)
T ss_pred CcccCcchhhhh
Confidence 999999776663
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=8.8e-07 Score=85.95 Aligned_cols=107 Identities=24% Similarity=0.335 Sum_probs=82.4
Q ss_pred HHHHHHHHHHHhccCC--CccccccEEEEeCC----ceEEEEEecCCC-chhhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 036334 385 KREFEMQMEVLGKIKH--DNVVPLRAFYYSKD----EKLLVYDYMPAG-SLSALLHGSRGSGRTPLDWDNRMRIALSAAR 457 (654)
Q Consensus 385 ~~~~~~e~~~l~~l~h--pniv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 457 (654)
.....+|...+.++.. -.+.+.+++..... ..++|+|++++. +|.+++... ...+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHHHHHHHHHH
Confidence 4567788887777743 23455666655432 348999999874 799988742 12566678889999999
Q ss_pred HHHHhhccCCeecCCCCCCcEEECCCC---CeEEeccCCCCCc
Q 036334 458 GLAHLHVSGKIVHGNIKASNILLRPDH---DACVSDFGLNPLF 497 (654)
Q Consensus 458 ~l~~LH~~~~ivHrDlk~~NIll~~~~---~~kl~Dfgla~~~ 497 (654)
.++-||..+ |+|+|+++.|||++.++ .+.++||+-+...
T Consensus 130 ~i~~lH~~g-i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHDAG-IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHCc-CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999998 99999999999999887 7899999876643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.9e-06 Score=82.52 Aligned_cols=136 Identities=15% Similarity=0.188 Sum_probs=83.9
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCc--cccccEEEEeCCceEEEEEecCCCc-h
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDN--VVPLRAFYYSKDEKLLVYDYMPAGS-L 428 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~l~~~~~~~~~~~lv~e~~~~g~-L 428 (654)
..||+|..+.||+. .|..+++|..... ....+..+|.++++.+..-. +.+.+++....+...+|||+++|.. +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999984 2556788887653 34556788999998886433 3566777777777889999998863 2
Q ss_pred hhh---------------------hccCCCCCCCCCCHHHHHH-HHH----------HHHH-HHHHhh---ccCCeecCC
Q 036334 429 SAL---------------------LHGSRGSGRTPLDWDNRMR-IAL----------SAAR-GLAHLH---VSGKIVHGN 472 (654)
Q Consensus 429 ~~~---------------------l~~~~~~~~~~l~~~~~~~-i~~----------~ia~-~l~~LH---~~~~ivHrD 472 (654)
... +|.... .......... +-. .+.. ...+|. ....++|+|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~---~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKC---DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCC---CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 111 121100 0111111100 000 0001 112221 122478999
Q ss_pred CCCCcEEECCCCCeEEeccCCCC
Q 036334 473 IKASNILLRPDHDACVSDFGLNP 495 (654)
Q Consensus 473 lk~~NIll~~~~~~kl~Dfgla~ 495 (654)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.6e-06 Score=81.24 Aligned_cols=136 Identities=18% Similarity=0.255 Sum_probs=91.0
Q ss_pred cccccCceeEEEEEecCCcEEEEEEecccccCHH----------H---------------HHHHHHHHhccC--CCcccc
Q 036334 353 VLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKR----------E---------------FEMQMEVLGKIK--HDNVVP 405 (654)
Q Consensus 353 ~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~----------~---------------~~~e~~~l~~l~--hpniv~ 405 (654)
.|..|.-+.||+|...++..+|||+++.....-+ + .++|+.-|.++. +-.+-+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 4778888999999988899999999975422110 1 123444455442 223333
Q ss_pred ccEEEEeCCceEEEEEecCCC-chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC
Q 036334 406 LRAFYYSKDEKLLVYDYMPAG-SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH 484 (654)
Q Consensus 406 l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~ 484 (654)
.+++. ...|||||+... .-.-.|. ..++...+...+..++++.+.-|-....+||+||+.-|||+. ++
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~Lk------Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLK------DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcc------cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC
Confidence 44332 347999998553 1111222 112333356777888888888887644599999999999999 88
Q ss_pred CeEEeccCCCCCcCC
Q 036334 485 DACVSDFGLNPLFGN 499 (654)
Q Consensus 485 ~~kl~Dfgla~~~~~ 499 (654)
.+.|+|||-|.....
T Consensus 204 ~p~iID~~QaV~~~h 218 (268)
T COG1718 204 EPYIIDVSQAVTIDH 218 (268)
T ss_pred eEEEEECccccccCC
Confidence 999999998876653
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.5e-08 Score=108.91 Aligned_cols=107 Identities=26% Similarity=0.327 Sum_probs=85.2
Q ss_pred cccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchh-hccccccceeccccccccccCCCccccccc
Q 036334 88 TLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPAS-VTRMNRLTRLDLSSNNFSGKIPFDVNNLTH 166 (654)
Q Consensus 88 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 166 (654)
++.-++.|++|||++|+++... .+..|++|++|||++|.|. .+|.. ...+ .|+.|+|++|-++ .+- .+.+|.+
T Consensus 182 SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrnN~l~-tL~-gie~Lks 255 (1096)
T KOG1859|consen 182 SLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRNNALT-TLR-GIENLKS 255 (1096)
T ss_pred HHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeeeecccHHH-hhh-hHHhhhh
Confidence 4677889999999999998443 7888999999999999999 55532 2334 4999999999988 442 5789999
Q ss_pred cCccccccccccCCC---CCCCCCCCCeEEccCCccc
Q 036334 167 LTGLFLENNKFSGNL---PSINPANLRDFNVSNNNLN 200 (654)
Q Consensus 167 L~~L~l~~N~l~~~~---~~~~~~~L~~L~l~~N~l~ 200 (654)
|+.|||++|-|++.- |-..+..|..|+|.+|++-
T Consensus 256 L~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 256 LYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 999999999987643 3337778899999999885
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.27 E-value=3.1e-07 Score=93.93 Aligned_cols=132 Identities=24% Similarity=0.233 Sum_probs=97.5
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccc--hhhccccccce
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFP--ASVTRMNRLTR 145 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~ 145 (654)
.+++.|.|++|+|+-.---..+..+++|+.|+|+.|..-+.-......+..|+.|||++|++- ..+ ..++.++.|+.
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhh
Confidence 458889999999863211124567899999999999644344445667899999999999988 344 56788999999
Q ss_pred ecccccccccc-CCCc-----cccccccCccccccccccCCCC--CC-CCCCCCeEEccCCccc
Q 036334 146 LDLSSNNFSGK-IPFD-----VNNLTHLTGLFLENNKFSGNLP--SI-NPANLRDFNVSNNNLN 200 (654)
Q Consensus 146 L~l~~N~l~~~-~p~~-----~~~l~~L~~L~l~~N~l~~~~~--~~-~~~~L~~L~l~~N~l~ 200 (654)
|+++.+.|... +|.. ...+++|++|+++.|+|..... .. .+.+|+.|....|.|+
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 99999999843 2322 3677899999999999964332 22 5566777777777765
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.2e-07 Score=81.98 Aligned_cols=112 Identities=21% Similarity=0.288 Sum_probs=91.2
Q ss_pred CCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhcccccccee
Q 036334 67 RSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRL 146 (654)
Q Consensus 67 ~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (654)
..+++.++|++|++. .+|+..-..++.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|-.|
T Consensus 52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~L 128 (177)
T KOG4579|consen 52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDML 128 (177)
T ss_pred CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHh
Confidence 345899999999997 466654556679999999999999 88999999999999999999999 778888889999999
Q ss_pred ccccccccccCCCccccccccCccccccccccCCCC
Q 036334 147 DLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLP 182 (654)
Q Consensus 147 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 182 (654)
+..+|.+. .+|-.+..-+++-..++.+|.+.+.-+
T Consensus 129 ds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 129 DSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred cCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 99999988 677654333444455667777776544
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.7e-07 Score=101.21 Aligned_cols=124 Identities=24% Similarity=0.308 Sum_probs=71.8
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 149 (654)
+..++|..|.+..... .+..+++|+.|+|.+|.|. .+...+..+++|++|+|++|+|+.. ..+..++.|+.|+++
T Consensus 74 l~~l~l~~n~i~~~~~--~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 74 LKELNLRQNLIAKILN--HLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLS 148 (414)
T ss_pred HHhhccchhhhhhhhc--ccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhhheec
Confidence 3344455555543111 3566666666677666666 3332355666666667776666644 234555556666666
Q ss_pred cccccccCCCccccccccCccccccccccCCCC--CCCCCCCCeEEccCCccc
Q 036334 150 SNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLP--SINPANLRDFNVSNNNLN 200 (654)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~L~~L~l~~N~l~ 200 (654)
+|.|+ .+. .+..+++|+.+++++|++....+ ...+.+|+.+++++|.+.
T Consensus 149 ~N~i~-~~~-~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 149 GNLIS-DIS-GLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIR 199 (414)
T ss_pred cCcch-hcc-CCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchh
Confidence 66666 332 34446666666666666665555 245666666666666664
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=4.2e-07 Score=98.20 Aligned_cols=127 Identities=25% Similarity=0.260 Sum_probs=100.3
Q ss_pred cCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccCc
Q 036334 90 GKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTG 169 (654)
Q Consensus 90 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 169 (654)
..+..++.++|..|.+.. +-..+..+++|+.|+|.+|+|. .+...+..+.+|++|+|++|.|+... .+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhh
Confidence 467788888899999984 4456888999999999999999 44544888999999999999999544 4778888999
Q ss_pred cccccccccCCCCCCCCCCCCeEEccCCcccccCc---ccccCCCCccccCCCC
Q 036334 170 LFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIP---ATLSKFPQSSFTGNLD 220 (654)
Q Consensus 170 L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p---~~~~~~~~l~~~~n~~ 220 (654)
|++++|.|+...-...+.+|+.+++++|+++..-+ ..+-++..+...+|..
T Consensus 145 L~l~~N~i~~~~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i 198 (414)
T KOG0531|consen 145 LNLSGNLISDISGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSI 198 (414)
T ss_pred heeccCcchhccCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCch
Confidence 99999999965554468999999999999985544 3344455555555543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=7.9e-07 Score=95.28 Aligned_cols=179 Identities=21% Similarity=0.208 Sum_probs=127.2
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCc-cccccEEEEeCCceEEEEEecCCC-chh
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDN-VVPLRAFYYSKDEKLLVYDYMPAG-SLS 429 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~~~~g-~L~ 429 (654)
+-.++|+.+++||.+-...+...++.+... ....-++++|.+++||| .++.++-+..+...+++++++..+ +-.
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 346889999999987443333334444332 34556889999999999 777776666667789999999887 332
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---CCCCcc
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TPPTRV 506 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~~~~~~ 506 (654)
..... ....+...+...+...-+++++++|+.. -+||| ||+..+ +..|..||+....+... ....++
T Consensus 324 ~~~~~----se~~~~~~~~~~~~r~et~~l~~l~~~~-~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~ 393 (829)
T KOG0576|consen 324 LEMTV----SEIALEQYQFAYPLRKETRPLAELHSSY-KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGT 393 (829)
T ss_pred ccCCh----hhHhhhhhhhhhhhhhhccccccccccc-ccCcc----cccccc-cccccccccCCcccCcccccccCCCC
Confidence 22211 1112333444556666778999999764 58999 776654 78999999998776554 234456
Q ss_pred ccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 036334 507 AGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQ 544 (654)
Q Consensus 507 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~ 544 (654)
..|+|||+.....+..+.|+|+.|+--.++--|-+|-.
T Consensus 394 ~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 394 PEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 67999999999999999999999987777777777643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 654 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-47 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-47 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-26 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-16 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-16 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-16 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-16 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-16 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-16 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-16 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-16 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-16 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-16 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-16 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-16 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-16 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-16 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-16 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-16 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-16 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-16 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-16 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-16 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-16 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-09 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 3e-91
Identities = 118/314 (37%), Positives = 180/314 (57%), Gaps = 24/314 (7%)
Query: 336 GGVYSFDLEDLLRA-----SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV--GKREF 388
G + F L +L A + +LG+G G YK L +GT V VKRLKE G+ +F
Sbjct: 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74
Query: 389 EMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNR 448
+ ++E++ H N++ LR F + E+LLVY YM GS+++ L R + PLDW R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKR 133
Query: 449 MRIALSAARGLAHLH--VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF--GNTTPPT 504
RIAL +ARGLA+LH KI+H ++KA+NILL + +A V DFGL L +T T
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193
Query: 505 RVAG---YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQAS--LGEEGIDLPRWVQ 559
V G + APE + T K + K+DV+ +GV+LLEL+TG+ + ++ + L WV+
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 560 SVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM------I 613
+++E+ + DV+L + + +EE+ QL+Q+A+ C + P +RP M EVVRM
Sbjct: 254 GLLKEKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312
Query: 614 ENMNRGETDDGLRQ 627
E + ++ RQ
Sbjct: 313 ERWEEWQKEEMFRQ 326
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 1e-82
Identities = 93/313 (29%), Positives = 145/313 (46%), Gaps = 15/313 (4%)
Query: 314 SSKDDITGGAAEADRNKLVFFEGGVYSFDLEDLLRA-----SAEVLGKGSVGTSYKAVLE 368
SK + + Y L DL A ++G G G YK VL
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 369 EGTTVVVKRLKEVAV-GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427
+G V +KR + G EFE ++E L +H ++V L F ++E +L+Y YM G+
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDAC 487
L L+GS + W+ R+ I + AARGL +LH + I+H ++K+ NILL +
Sbjct: 122 LKRHLYGS-DLPTMSMSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSINILLDENFVPK 179
Query: 488 VSDFGL---NPLFGNTTPPTRVAG---YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKA 541
++DFG+ T T V G Y PE ++T KSDVYSFGV+L E+L ++
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 542 PNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPD 601
SL E ++L W ++ D L E + + A+ C++ +
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIR-PESLRKFGDTAVKCLALSSE 298
Query: 602 QRPAMQEVVRMIE 614
RP+M +V+ +E
Sbjct: 299 DRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 1e-78
Identities = 92/305 (30%), Positives = 147/305 (48%), Gaps = 32/305 (10%)
Query: 335 EGGVYSFDLEDLLRA-----------SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV 383
+ +SF +L +G+G G YK + TTV VK+L +
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVD 67
Query: 384 -----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGS 438
K++F+ +++V+ K +H+N+V L F D+ LVY YMP GSL L
Sbjct: 68 ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-- 125
Query: 439 GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---NP 495
G PL W R +IA AA G+ LH +H +IK++NILL A +SDFGL +
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 496 LFGNTTPPTRVAG---YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGI 552
F T +R+ G Y APE + ++T KSD+YSFGV+LLE++TG +
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-- 241
Query: 553 DLPRWVQSVVREEWT-AEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
L + + EE T + D ++ + + +A C+ ++RP +++V +
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMNDAD--STSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
Query: 612 MIENM 616
+++ M
Sbjct: 300 LLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 1e-62
Identities = 75/312 (24%), Positives = 113/312 (36%), Gaps = 41/312 (13%)
Query: 341 FDLEDLLRAS-----AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVL 395
E+L S EV +G G +KA L V VK + E ++ L
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSL 72
Query: 396 GKIKHDNVVPLRAF----YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRI 451
+KH+N++ + L+ + GSLS L + W+ I
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK------ANVVSWNELCHI 126
Query: 452 ALSAARGLAHLHVSG---------KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP 502
A + ARGLA+LH I H +IK+ N+LL+ + AC++DFGL F
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 503 P---TRVAG---YRAPEVVE-----TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEG 551
G Y APEV+E R + D+Y+ G++L EL + + E
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 552 IDLPRWVQSVVREEWTAEVFDVELMRYH-----NIEEEMVQLLQIAMGCVSTVPDQRPAM 606
+ + E EV + R M L + C + R +
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 607 QEVVRMIENMNR 618
V I M R
Sbjct: 307 GCVGERITQMQR 318
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-50
Identities = 44/178 (24%), Positives = 74/178 (41%), Gaps = 30/178 (16%)
Query: 80 LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLT-LLRSLYLQSNQFSGVFPASVT 138
L G +PP ++ L L ++ NR+SG IP + + + L S+ + N+ +G P +
Sbjct: 137 LSGTLPP-SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA 195
Query: 139 RMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNN 197
+N L +DLS N G + + + L N + +L + NL ++ NN
Sbjct: 196 NLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNN 254
Query: 198 NLNGSIPATL--------------------------SKFPQSSFTGNLDLCGGPLPPC 229
+ G++P L +F S++ N LCG PLP C
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-48
Identities = 58/214 (27%), Positives = 84/214 (39%), Gaps = 33/214 (15%)
Query: 29 QDKQALLAFLSRTPHKNRVQ-WNASDSACN--WVGVECDA--NRSFVYSLRLPGVGLVG- 82
QDKQALL + + W + CN W+GV CD V +L L G+ L
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 83 -PIP------------------------PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLT 117
PIP P + KL+QL L + +SG IP S +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 118 LLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHL-TGLFLENNK 176
L +L N SG P S++ + L + N SG IP + + L T + + N+
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185
Query: 177 FSGNLP-SINPANLRDFNVSNNNLNGSIPATLSK 209
+G +P + NL ++S N L G
Sbjct: 186 LTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGS 219
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 4e-49
Identities = 75/311 (24%), Positives = 138/311 (44%), Gaps = 39/311 (12%)
Query: 342 DLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHD 401
D +++ EV+G+G+ G KA V +K+++ + ++ F +++ L ++ H
Sbjct: 6 DYKEIEVE--EVVGRGAFGVVCKAKWR-AKDVAIKQIESESE-RKAFIVELRQLSRVNHP 61
Query: 402 NVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
N+V L + LV +Y GSL +LHG+ + M L ++G+A+
Sbjct: 62 NIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAY 117
Query: 462 LH--VSGKIVHGNIKASNILLRPDHDAC-VSDFGLNPLFGNTTPPTRVAG---YRAPEVV 515
LH ++H ++K N+LL + DFG T G + APEV
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEVF 175
Query: 516 ETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRW-VQSVVREEWTAEVFDVE 574
E + K DV+S+G++L E++T + P + I P + + V +
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPF------DEIGGPAFRIMWAVHNGTRPPLIK-- 227
Query: 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDDGLRQSSDDPSK 634
N+ + + L+ C S P QRP+M+E+V+++ ++ R +D+P +
Sbjct: 228 -----NLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMR------YFPGADEPLQ 273
Query: 635 GSDGHTPPPES 645
H+ PP
Sbjct: 274 YPCQHSLPPGE 284
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 66/307 (21%), Positives = 106/307 (34%), Gaps = 51/307 (16%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREF--EMQMEVLGKIKHDNVVPL--- 406
E++G+G G YK L+ V VK ++ F E + + ++HDN+
Sbjct: 19 ELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 407 --RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
R + E LLV +Y P GSL L DW + R+A S RGLA+LH
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLS------LHTSDWVSSCRLAHSVTRGLAYLHT 129
Query: 465 SG--------KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---------TPPTRVA 507
I H ++ + N+L++ D +SDFGL+
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 508 G---YRAPEVVE-------TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLP-- 555
G Y APEV+E + D+Y+ G++ E+ +
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249
Query: 556 RWVQSVVREEWTAEVFDVELMR------YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEV 609
V + E + E R + + L + C + R Q
Sbjct: 250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309
Query: 610 VRMIENM 616
+ +
Sbjct: 310 EERMAEL 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-47
Identities = 78/275 (28%), Positives = 131/275 (47%), Gaps = 27/275 (9%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGK---REFEMQMEVLGKIKHDNVVPLRA 408
E +G GS GT ++A G+ V VK L E EF ++ ++ +++H N+V
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG-K 467
+V +Y+ GSL LLH + R LD R+ +A A+G+ +LH
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPP-TRVAG---YRAPEVVETRKVTFK 523
IVH N+K+ N+L+ + V DFGL+ L +T AG + APEV+ K
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 524 SDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583
SDVYSFGV+L EL T + P ++ + V +V + E+ N+
Sbjct: 220 SDVYSFGVILWELATLQQPW------GNLNPAQVVAAVGFKCKRLEIPR-------NLNP 266
Query: 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
++ +++ GC + P +RP+ ++ ++ + +
Sbjct: 267 QVAAIIE---GCWTNEPWKRPSFATIMDLLRPLIK 298
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 73/292 (25%), Positives = 123/292 (42%), Gaps = 42/292 (14%)
Query: 342 DLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLK-----EVAVGKREFEMQMEVLG 396
D +L E++G G G Y+A G V VK + +++ + ++
Sbjct: 5 DFAELTLE--EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 397 KIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAA 456
+KH N++ LR + LV ++ G L+ +L G R + D + A+ A
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIA 115
Query: 457 RGLAHLHVSG--KIVHGNIKASNILL-------RPDHDAC-VSDFGLNPLFGNTTPPTRV 506
RG+ +LH I+H ++K+SNIL+ + ++DFGL + TT +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
Query: 507 AGYR--APEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE 564
Y APEV+ + SDV+S+GVLL ELLTG+ P GID V
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF------RGIDGLAVAYGVAMN 229
Query: 565 EWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
+ + E +L++ C + P RP+ ++ + +
Sbjct: 230 KLALPIPS-------TCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 7e-46
Identities = 62/306 (20%), Positives = 130/306 (42%), Gaps = 48/306 (15%)
Query: 333 FFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEE-GTTVVVKRLK--------EVAV 383
F + + + ++ + +GKG G +K L + + V +K L E+
Sbjct: 8 FPKSRLPTLADNEIEYE--KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE 65
Query: 384 GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPL 443
+EF+ ++ ++ + H N+V L + +V +++P G L L P+
Sbjct: 66 KFQEFQREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKA----HPI 119
Query: 444 DWDNRMRIALSAARGLAHLHVSG-KIVHGNIKASNILLRPDHDAC-----VSDFGLNPLF 497
W ++R+ L A G+ ++ IVH ++++ NI L+ + V+DFGL+
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179
Query: 498 GNTTPPTRVAG---YRAPEV--VETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGI 552
++ + + G + APE E T K+D YSF ++L +LTG+ P +
Sbjct: 180 VHSV--SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF------DEY 231
Query: 553 DLP--RWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVV 610
+++ + E + + + + ++++ C S P +RP +V
Sbjct: 232 SYGKIKFINMIREEGLRPTIPE-------DCPPRLRNVIEL---CWSGDPKKRPHFSYIV 281
Query: 611 RMIENM 616
+ + +
Sbjct: 282 KELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-45
Identities = 66/288 (22%), Positives = 112/288 (38%), Gaps = 40/288 (13%)
Query: 342 DLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGK---REFEMQMEVLGKI 398
D + L L + G +K + G +VVK LK R+F + L
Sbjct: 8 DFKQLNFL--TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 399 KHDNVVPLRAFYYSKDEKLL--VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAA 456
H NV+P+ S + +MP GSL +LH +D ++ AL A
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF---VVDQSQAVKFALDMA 121
Query: 457 RGLAHLHVSGK-IVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPPTRVAGYRA 511
RG+A LH I + + ++++ D A +S + F + P + A
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPA-----WVA 176
Query: 512 PEVVETRK---VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTA 568
PE ++ + +D++SF VLL EL+T + P + V E
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF------ADLSNMEIGMKVALEGLRP 230
Query: 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
+ I + +L++I C++ P +RP +V ++E M
Sbjct: 231 TIPP-------GISPHVSKLMKI---CMNEDPAKRPKFDMIVPILEKM 268
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 66/302 (21%), Positives = 111/302 (36%), Gaps = 48/302 (15%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY- 410
+ +GKG G + G V VK E ++ ++H+N++ F
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENIL---GFIA 98
Query: 411 ------YSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
S + L+ DY GSL L T LD + +++A S+ GL HLH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 465 SG-------KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-----PPTRVAG---Y 509
I H ++K+ NIL++ + C++D GL F + T PP G Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 510 RAPEVVETR------KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLP----RWVQ 559
PEV++ + +D+YSFG++L E+ E LP
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG---IVEEYQLPYHDLVPSD 269
Query: 560 SVVREEWTAEVFD---VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
+ + +E + Q+ ++ C + P R V + + M
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
Query: 617 NR 618
+
Sbjct: 330 SE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-43
Identities = 67/311 (21%), Positives = 112/311 (36%), Gaps = 68/311 (21%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY- 410
E +GKG G ++ + G V VK E ++ ++H+N++ F
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENIL---GFIA 69
Query: 411 ------YSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
+S + L+ Y GSL L T LD + +RI LS A GLAHLH+
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 465 SG-------KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-----PPTRVAG---Y 509
I H ++K+ NIL++ + C++D GL + +T G Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 510 RAPEV------VETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR 563
APEV V+ + D+++FG++L E+ N E P
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG---IVEDYKPP-------F 233
Query: 564 EEWTAEVFDVELMRY-----------------HNIEEEMVQLLQIAMGCVSTVPDQRPAM 606
+ E MR + +L++ C P R
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE---CWYQNPSARLTA 290
Query: 607 QEVVRMIENMN 617
+ + + ++
Sbjct: 291 LRIKKTLTKID 301
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 62/302 (20%), Positives = 112/302 (37%), Gaps = 48/302 (15%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRA--- 408
E +GKG G ++ G V VK E ++ ++H+N++ A
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 409 -FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG- 466
+ + LV DY GSL L+ R + + +++ALS A GLAHLH+
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 467 ------KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-----PPTRVAG---YRAP 512
I H ++K+ NIL++ + C++D GL + T P G Y AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 513 EV------VETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLP----RWVQSVV 562
EV ++ + ++D+Y+ G++ E+ + E LP V
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG---IHEDYQLPYYDLVPSDPSV 277
Query: 563 REEWTAEVFDV------ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
E + M ++++ C R + + + +
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLSQL 334
Query: 617 NR 618
++
Sbjct: 335 SQ 336
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-42
Identities = 52/166 (31%), Positives = 71/166 (42%), Gaps = 5/166 (3%)
Query: 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQF 129
+ G L +LS ++ S G F N + L + N
Sbjct: 586 ECHGAGNLLEFQGIRSEQ-LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644
Query: 130 SGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS--INPA 187
SG P + M L L+L N+ SG IP +V +L L L L +NK G +P
Sbjct: 645 SGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALT 704
Query: 188 NLRDFNVSNNNLNGSIPAT--LSKFPQSSFTGNLDLCGGPLPPCNP 231
L + ++SNNNL+G IP FP + F N LCG PLP C+P
Sbjct: 705 MLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-40
Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 6/152 (3%)
Query: 80 LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTR 139
L G IP + LG LS+LR L L N L GEIP + + L +L L N +G P+ ++
Sbjct: 430 LSGTIPSS-LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNN 197
L + LS+N +G+IP + L +L L L NN FSGN+P+ + +L +++ N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548
Query: 198 NLNGSIPATLSKFPQSSFTGNLDLCGGPLPPC 229
NG+IPA + K + G
Sbjct: 549 LFNGTIPAAMFKQSGKIAANFIA---GKRYVY 577
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-39
Identities = 56/156 (35%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 80 LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTR 139
G IPP TL S+L L L N LSG IPS +L+ LR L L N G P +
Sbjct: 406 FTGKIPP-TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
Query: 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLP-SI-NPANLRDFNVSNN 197
+ L L L N+ +G+IP ++N T+L + L NN+ +G +P I NL +SNN
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524
Query: 198 NLNGSIPATLSKFPQSSFTGNLDLCG----GPLPPC 229
+ +G+IPA L + LDL G +P
Sbjct: 525 SFSGNIPAELGDCRSLIW---LDLNTNLFNGTIPAA 557
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-38
Identities = 59/167 (35%), Positives = 79/167 (47%), Gaps = 12/167 (7%)
Query: 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTL-LRSLYLQSNQFS 130
SL L G +P +TL K+ L+VL L N SGE+P +NL+ L +L L SN FS
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381
Query: 131 GVFPASV--TRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS--INP 186
G ++ N L L L +N F+GKIP ++N + L L L N SG +PS +
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441
Query: 187 ANLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDLCG----GPLPPC 229
+ LRD + N L G IP L L L G +P
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLET---LILDFNDLTGEIPSG 485
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-38
Identities = 55/160 (34%), Positives = 70/160 (43%), Gaps = 13/160 (8%)
Query: 80 LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV-T 138
G IP G L L L N G +P F + +LL SL L SN FSG P
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
Query: 139 RMNRLTRLDLSSNNFSGKIPFDVNNLT-HLTGLFLENNKFSGNLPS----INPANLRDFN 193
+M L LDLS N FSG++P + NL+ L L L +N FSG + L++
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400
Query: 194 VSNNNLNGSIPATLSKFPQSSFTGNLDLCG----GPLPPC 229
+ NN G IP TLS + L L G +P
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVS---LHLSFNYLSGTIPSS 437
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-37
Identities = 37/139 (26%), Positives = 62/139 (44%), Gaps = 5/139 (3%)
Query: 72 SLRLPGVGLVGPIPPN--TLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQF 129
L L + G +L+ L++ N++SG++ S L L + SN F
Sbjct: 155 VLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNF 212
Query: 130 SGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANL 189
S P + + L LD+S N SG ++ T L L + +N+F G +P + +L
Sbjct: 213 STGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSL 271
Query: 190 RDFNVSNNNLNGSIPATLS 208
+ +++ N G IP LS
Sbjct: 272 QYLSLAENKFTGEIPDFLS 290
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-36
Identities = 46/135 (34%), Positives = 63/135 (46%), Gaps = 6/135 (4%)
Query: 80 LVGPIPPNTLGKLS-QLRVLSLRSNRLSGEIPSDFSNLTL--LRSLYLQSNQFSGVFPAS 136
G +P +L LS L L L SN SG I + L+ LYLQ+N F+G P +
Sbjct: 355 FSGELPE-SLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413
Query: 137 VTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNV 194
++ + L L LS N SG IP + +L+ L L L N G +P L +
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473
Query: 195 SNNNLNGSIPATLSK 209
N+L G IP+ LS
Sbjct: 474 DFNDLTGEIPSGLSN 488
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-35
Identities = 42/212 (19%), Positives = 79/212 (37%), Gaps = 35/212 (16%)
Query: 29 QDKQALLAFLSRTPHKNRVQ-WNASDSACNWVGVECDANRSFVYSLRLPGVGLVGPIPPN 87
++ L++F P KN + W+++ + C + GV C ++ V S+ L L
Sbjct: 12 REIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCRDDK--VTSIDLSSKPL------- 62
Query: 88 TLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147
N + S +LT L SL+L ++ +G LT LD
Sbjct: 63 ---------------NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106
Query: 148 LSSNNFSGKIPFDVN--NLTHLTGLFLENNKFSGNLP---SINPANLRDFNVSNNNLNGS 202
LS N+ SG + + + + L L + +N + +L ++S N+++G+
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 203 IPATLSKFPQSSFTGNLDLCG----GPLPPCN 230
+L + G G +
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVDVSR 198
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-34
Identities = 44/139 (31%), Positives = 62/139 (44%), Gaps = 8/139 (5%)
Query: 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDF---SNLTLLRSLYLQSNQ 128
L + L P + KL+ L VL L +N +SG + L+ L + N+
Sbjct: 130 FLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNK 189
Query: 129 FSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NP 186
SG S R L LD+SSNNFS IPF + + + L L + NK SG+
Sbjct: 190 ISGDVDVS--RCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTC 246
Query: 187 ANLRDFNVSNNNLNGSIPA 205
L+ N+S+N G IP
Sbjct: 247 TELKLLNISSNQFVGPIPP 265
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-30
Identities = 42/158 (26%), Positives = 64/158 (40%), Gaps = 16/158 (10%)
Query: 80 LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTR 139
L G IP L + L +SL +NRL+GEIP L L L L +N FSG PA +
Sbjct: 478 LTGEIPS-GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536
Query: 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS--INPANLRDFNVSNN 197
L LDL++N F+G IP + + + N +G N ++ + + N
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGN 592
Query: 198 --NLNGSIPATLSKFPQSSFTGNLDLCG----GPLPPC 229
G L++ + ++ G P
Sbjct: 593 LLEFQGIRSEQLNRLSTRNP---CNITSRVYGGHTSPT 627
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 9e-42
Identities = 66/303 (21%), Positives = 115/303 (37%), Gaps = 52/303 (17%)
Query: 341 FDLEDLLRASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEV-AVGKREFEMQMEVLGKI 398
F DL+ EVLGKG G + K E G +V+K L +R F +++V+ +
Sbjct: 7 FRPSDLIHG--EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 399 KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARG 458
+H NV+ Y + +Y+ G+L ++ W R+ A A G
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIASG 120
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL------------------NPLFGNT 500
+A+LH S I+H ++ + N L+R + + V+DFGL P
Sbjct: 121 MAYLH-SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQS 560
+ APE++ R K DV+SFG++L E++
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA------------------ 221
Query: 561 VVREEWTAEVFDVELMRYHNIEEEMVQ-----LLQIAMGCVSTVPDQRPAMQEVVRMIEN 615
++ D L ++ I + C P++RP+ ++ +E
Sbjct: 222 --DPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET 279
Query: 616 MNR 618
+
Sbjct: 280 LRM 282
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 7e-40
Identities = 76/286 (26%), Positives = 124/286 (43%), Gaps = 46/286 (16%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKR---EFEMQMEVLGKIKHDNVVPLRA 408
+ +G GS GT YK V VK L A + F+ ++ VL K +H N++
Sbjct: 30 QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 409 FYYSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
YS +L +V + SL LH + T + + IA ARG+ +LH +
Sbjct: 88 --YSTAPQLAIVTQWCEGSSLYHHLH----ASETKFEMKKLIDIARQTARGMDYLH-AKS 140
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG------YRAPEVV---ETR 518
I+H ++K++NI L D+ + DFGL + + + APEV+ ++
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 519 KVTFKSDVYSFGVLLLELLTGKAP------NQASLGEEGIDLPRWVQSVVREEWTAEVFD 572
+F+SDVY+FG++L EL+TG+ P + G S VR
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS-------- 252
Query: 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
N + M +L+ C+ D+RP+ ++ IE + R
Sbjct: 253 -------NCPKRMKRLMAE---CLKKKRDERPSFPRILAEIEELAR 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-39
Identities = 51/314 (16%), Positives = 112/314 (35%), Gaps = 55/314 (17%)
Query: 342 DLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGK---REFEMQMEVLGKI 398
E L E++GKG G Y V ++ + + + F+ ++ +
Sbjct: 31 PFEQLEIG--ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 399 KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARG 458
+H+NVV S ++ +L +++ + LD + +IA +G
Sbjct: 87 RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR----DAKIVLDVNKTRQIAQEIVKG 142
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDAC-VSDFGL------NPLFGNTTPPTRVAG--- 508
+ +LH + I+H ++K+ N+ D+ ++DFGL G
Sbjct: 143 MGYLH-AKGILHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 509 YRAPEVVETRKV---------TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQ 559
+ APE++ + SDV++ G + EL + P + +
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP------FKTQPAEAIIW 253
Query: 560 SVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619
+ + + +E+ +L + C + ++RP +++ M+E + +
Sbjct: 254 QMGTGMKP-------NLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDMLEKLPK- 302
Query: 620 ETDDGLRQSSDDPS 633
+ P
Sbjct: 303 -----RNRRLSHPG 311
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 30/209 (14%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKRE---FEMQMEVLGKIKHDNVVPLR 407
+G+GS T YK + E V L++ + K E F+ + E+L ++H N+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV--- 88
Query: 408 AFYYS------KDEKLLVY-DYMPAGSLSALL--HGSRGSGRTPLDWDNRMRIALSAARG 458
FY S + +++ + M +G+L L + +G
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-------VMKIKVLRSWCRQILKG 141
Query: 459 LAHLHVSGK-IVHGNIKASNILL-RPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPE 513
L LH I+H ++K NI + P + D GL L + V G + APE
Sbjct: 142 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAPE 200
Query: 514 VVETRKVTFKSDVYSFGVLLLELLTGKAP 542
+ E K DVY+FG+ +LE+ T + P
Sbjct: 201 MYE-EKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 58/280 (20%), Positives = 110/280 (39%), Gaps = 34/280 (12%)
Query: 352 EVLGKGSVGTSYKAVLEEGTT-VVVKRLKEVAVGKREFEMQME--VLGKIKHDNVVPLRA 408
E +G+G+ G + L T V VK +E + + E +L + H N+V L
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
K +V + + G L L +++ AA G+ +L S
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGAR----LRVKTLLQMVGDAAAGMEYLE-SKCC 234
Query: 469 VHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR-------APEVVETRKVT 521
+H ++ A N L+ + +SDFG++ + G R APE + + +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVY-AASGGLRQVPVKWTAPEALNYGRYS 293
Query: 522 FKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580
+SDV+SFG+LL E + G +P + + + V + L
Sbjct: 294 SESDVWSFGILLWETFSLGASPYP------NLSNQQTREFVEKGGR--------LPCPEL 339
Query: 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620
+ + +L+ C + P QRP+ + + ++++ +
Sbjct: 340 CPDAVFRLM---EQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-30
Identities = 34/144 (23%), Positives = 50/144 (34%), Gaps = 3/144 (2%)
Query: 73 LRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV 132
L L + L L L + F+ L+ L L + N F
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460
Query: 133 FPASV-TRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANL 189
F + T + LT LDLS P N+L+ L L + +N F +L
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 520
Query: 190 RDFNVSNNNLNGSIPATLSKFPQS 213
+ + S N++ S L FP S
Sbjct: 521 QVLDYSLNHIMTSKKQELQHFPSS 544
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 31/147 (21%), Positives = 57/147 (38%), Gaps = 4/147 (2%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+ + +L+VL L + + +L+ L +L L N + + + ++ L
Sbjct: 43 LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSL 102
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKF-SGNLPSI--NPANLRDFNVSNNNLN 200
+L N + F + +L L L + +N S LP N NL ++S+N +
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 201 GSIPATLSKFPQSSFTG-NLDLCGGPL 226
L Q +LDL P+
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPM 189
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-27
Identities = 28/133 (21%), Positives = 44/133 (33%), Gaps = 5/133 (3%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV-TRMNR 142
+ + L+ L L N + + S+F L L L Q + + SV +
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPA---NLRDFNVSNNNL 199
L LD+S + N L+ L L + N F N NL ++S L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 200 NGSIPATLSKFPQ 212
P +
Sbjct: 483 EQLSPTAFNSLSS 495
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 29/141 (20%), Positives = 50/141 (35%), Gaps = 5/141 (3%)
Query: 80 LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTR 139
P+ +L L L L +L P+ F++L+ L+ L + N F +
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 516
Query: 140 MNRLTRLDLSSNNFSGKIPFDVNNL-THLTGLFLENNKFSGNLPSI----NPANLRDFNV 194
+N L LD S N+ ++ + + L L L N F+ + R V
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLV 576
Query: 195 SNNNLNGSIPATLSKFPQSSF 215
+ + P+ P S
Sbjct: 577 EVERMECATPSDKQGMPVLSL 597
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 31/181 (17%), Positives = 53/181 (29%), Gaps = 11/181 (6%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV-FPASVTRMNR 142
+ LS L+ L L+ +L L+ L + N P + +
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPA-----NLRDFNVSNN 197
L LDLSSN D+ L + L L + + I P L + NN
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 198 NLNGSIPATLSKFPQSSFTGNLDLCGGPLPPCNPFFPSPAPSPSLPPPVAPVHKKSNKLS 257
+ ++ T + L G S + + + +L+
Sbjct: 211 FDSLNVMKTC--IQGLAGLEVHRLVLGEFRNEGNL---EKFDKSALEGLCNLTIEEFRLA 265
Query: 258 T 258
Sbjct: 266 Y 266
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 22/132 (16%), Positives = 44/132 (33%), Gaps = 10/132 (7%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+P + + L L N L F + L+ L L + + + ++ L
Sbjct: 26 LPFS-------TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNG 201
+ L L+ N + L+ L L + + L++ NV++N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 202 -SIPATLSKFPQ 212
+P S
Sbjct: 139 FKLPEYFSNLTN 150
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-20
Identities = 28/149 (18%), Positives = 47/149 (31%), Gaps = 17/149 (11%)
Query: 80 LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLR----SLYLQSNQFSGVFPA 135
+ P L+ L L L SN++ +D L + SL L N + + P
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 136 SVTRMNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSG--NLPSINPA---NL 189
+ + L +L L +N S + L L L +F NL + + L
Sbjct: 196 AFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL 254
Query: 190 RDFNVSNNNLN------GSIPATLSKFPQ 212
+ + L I +
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-18
Identities = 29/155 (18%), Positives = 44/155 (28%), Gaps = 24/155 (15%)
Query: 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSG 131
RL + + L+ + SL S + DFS + L L + +F
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQ 318
Query: 132 VFPASVTRMNR-------------------LTRLDLSSN--NFSGKIPFDVNNLTHLTGL 170
+ + R L LDLS N +F G T L L
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 171 FLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIP 204
L N + L + ++NL
Sbjct: 379 DLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSE 413
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 25/145 (17%), Positives = 44/145 (30%), Gaps = 11/145 (7%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
I P ++ L L+LR+N S + L L L +F +
Sbjct: 192 IQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 143 LTRL--------DLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINPANLRDFN 193
L L L+ ++ D+ N LT+++ L + +
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 194 VSNNNLNGSIPATLSKFPQSSFTGN 218
+ N L + +FT N
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSN 335
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 23/142 (16%), Positives = 41/142 (28%), Gaps = 12/142 (8%)
Query: 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEI---PSDFSNLTLLRSLYLQSNQ 128
L L + + L+ L V L E D S L L +L ++ +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 129 FS------GVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLP 182
+ + ++ L S F L L N KF P
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQ-FP 320
Query: 183 SINPANLRDFNVSNNNLNGSIP 204
++ +L+ ++N +
Sbjct: 321 TLKLKSLKRLTFTSNKGGNAFS 342
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 65/311 (20%), Positives = 117/311 (37%), Gaps = 34/311 (10%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQM---EVLGKIKHDNVVPLR 407
+ +G+GS G + E+G V+K + + +E E VL +KH N+V R
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
+ +V DY G L ++ +G D + + L H+H K
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVH-DRK 145
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR-VAG---YRAPEVVETRKVTFK 523
I+H +IK+ NI L D + DFG+ + +T R G Y +PE+ E + K
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNK 205
Query: 524 SDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583
SD+++ G +L EL T K +A + V ++ + +
Sbjct: 206 SDIWALGCVLYELCTLKHAFEAG------SMKNLVLKIISG------------SFPPVSL 247
Query: 584 EM-VQLLQIAMGCVSTVPDQRPAMQEVVR---MIENMNRGETDDGLRQSSDDPSKGSDGH 639
L + P RP++ ++ + + + + + + + + G
Sbjct: 248 HYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGS 307
Query: 640 TPPPESRTPPT 650
P P R
Sbjct: 308 QPIPAKRPASG 318
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 58/278 (20%), Positives = 123/278 (44%), Gaps = 29/278 (10%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVK--RLKEVAVGK-REFEMQ-MEVLGKIKHDNVVPL 406
+ +G+G Y+A L +G V +K ++ ++ K R ++ +++L ++ H NV+
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
A + +E +V + AG LS ++ + + + + L H+H S
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIK-HFKKQKRLIPERTVWKYFVQLCSALEHMH-SR 155
Query: 467 KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR-VAG---YRAPEVVETRKVTF 522
+++H +IK +N+ + + D GL F + T + G Y +PE + F
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 215
Query: 523 KSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582
KSD++S G LL E+ ++P + ++L + + + + Y +
Sbjct: 216 KSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLCKKIEQCD------------YPPLP 259
Query: 583 EEMV--QLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
+ +L Q+ C++ P++RP + V + + M+
Sbjct: 260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 4e-29
Identities = 44/269 (16%), Positives = 89/269 (33%), Gaps = 32/269 (11%)
Query: 352 EVLGKGSVGTSYKAV------LEEGTTVVVKRLKEVAVGKREFEMQM-EVLGKIKHDNVV 404
+LG+G+ Y+A + V+K K + Q+ E L +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
+ + ++ +LV + G+L ++ + + + + A+ + +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH- 189
Query: 465 SGKIVHGNIKASNILLRPDHDA-----------CVSDFGL---NPLFGNTTPPTRVAG-- 508
+I+HG+IK N +L + D G LF T T
Sbjct: 190 DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETS 249
Query: 509 -YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEG---IDLPRWVQSVVRE 564
++ E++ + ++ D + + +L G + G E R +
Sbjct: 250 GFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPH---LD 306
Query: 565 EWTAEVFDVELMRYHNIEEEMVQLLQIAM 593
W E F V L + LL+ +
Sbjct: 307 MWN-EFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 63/285 (22%), Positives = 120/285 (42%), Gaps = 42/285 (14%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYY 411
+ LG G G + A + T V VK +K ++ F + V+ ++HD +V L A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV-V 252
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
+K+ ++ ++M GSL L + + + + A G+A + +H
Sbjct: 253 TKEPIYIITEFMAKGSLLDFL---KSDEGSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHR 308
Query: 472 NIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-----YRAPEVVETRKVTFKSDV 526
+++A+NIL+ ++DFGL + + R + APE + T KSDV
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 527 YSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVR-------EEWTAEVFDVELMRY 578
+SFG+LL+E++T G+ P G+ P ++++ R E E++ +M
Sbjct: 369 WSFGILLMEIVTYGRIPYP------GMSNPEVIRALERGYRMPRPENCPEELY--NIMMR 420
Query: 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDD 623
C P++RP + + ++++
Sbjct: 421 ----------------CWKNRPEERPTFEYIQSVLDDFYTATESQ 449
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-28
Identities = 77/281 (27%), Positives = 119/281 (42%), Gaps = 42/281 (14%)
Query: 352 EVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
LG G G Y+ V + TV VK LKE + EF + V+ +IKH N+V L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 411 YSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVH 470
+ ++ ++M G+L L R R + + +A + + +L +H
Sbjct: 286 TREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIH 341
Query: 471 GNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-----YRAPEVVETRKVTFKSD 525
N+ A N L+ +H V+DFGL+ L T + APE + K + KSD
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 526 VYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVR-------EEWTAEVFDVELMR 577
V++FGVLL E+ T G +P GIDL + + + + E +V+ ELMR
Sbjct: 402 VWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRMERPEGCPEKVY--ELMR 453
Query: 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
C P RP+ E+ + E M +
Sbjct: 454 A----------------CWQWNPSDRPSFAEIHQAFETMFQ 478
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-28
Identities = 22/161 (13%), Positives = 49/161 (30%), Gaps = 28/161 (17%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQF--------SGVFPASV 137
L L + + + ++P+ L ++ + + N+ A
Sbjct: 242 DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADA 301
Query: 138 TRMNRLTRLDLSSNNF-SGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVS 195
++ + + NN + + + + L L N+ G LP+ + L N++
Sbjct: 302 PVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLA 361
Query: 196 NNNLNGSIPAT-----------------LSKFPQSSFTGNL 219
N + IPA L P ++
Sbjct: 362 YNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSV 401
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-27
Identities = 32/144 (22%), Positives = 55/144 (38%), Gaps = 19/144 (13%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV-------FPASVT 138
T K + ++L +N++S FS + L S+ L N + + +
Sbjct: 426 DPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFK 485
Query: 139 RMNRLTRLDLSSNNFSGKIP--FDVNNLTHLTGLFLENNKFSGNLPS--INPANLRDFNV 194
LT +DL N + + F L +L G+ L N FS P+ +N + L+ F +
Sbjct: 486 NTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGI 543
Query: 195 SN------NNLNGSIPATLSKFPQ 212
N N P ++ P
Sbjct: 544 RNQRDAQGNRTLREWPEGITLCPS 567
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-26
Identities = 26/150 (17%), Positives = 52/150 (34%), Gaps = 14/150 (9%)
Query: 80 LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV-FPASVT 138
L G +P G +L L+L N+++ + + +L N+ +
Sbjct: 342 LEGKLP--AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAK 399
Query: 139 RMNRLTRLDLSSNNFSG-------KIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANL 189
++ ++ +D S N + +++ + L NN+ S + + L
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL 459
Query: 190 RDFNVSNNNLNGSIPATLSKFPQSSFTGNL 219
N+ N L IP K +F N
Sbjct: 460 SSINLMGNMLTE-IPKNSLKDENENF-KNT 487
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-24
Identities = 17/138 (12%), Positives = 43/138 (31%), Gaps = 16/138 (11%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTR 145
+ +L++LR + ++ E + + Q + LT
Sbjct: 199 SKAVMRLTKLRQFYMGNSPFVAENI-----CEAWENENSEYAQQYKTEDLKWDNLKDLTD 253
Query: 146 LDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSG---------NLPSI-NPANLRDFNVS 195
+++ + K+P + L + + + N+ L ++ +
Sbjct: 254 VEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIG 313
Query: 196 NNNL-NGSIPATLSKFPQ 212
NNL + +L K +
Sbjct: 314 YNNLKTFPVETSLQKMKK 331
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 25/139 (17%), Positives = 46/139 (33%), Gaps = 11/139 (7%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDF--SNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
L + LR N+L+ + DF + L L + L N FS FP + L
Sbjct: 481 NENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538
Query: 144 TRL------DLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNN 197
D N + P + LT L + +N + N+ ++ +N
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITPNISVLDIKDN 597
Query: 198 NLNGSIPATLSKFPQSSFT 216
+ + + ++
Sbjct: 598 PNISIDLSYVCPYIEAGMY 616
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 32/220 (14%), Positives = 61/220 (27%), Gaps = 27/220 (12%)
Query: 22 YVNSEPTQDKQALLAFLSRTPHKN-RVQWNASDSACNWVGVECDANRSFVYSLRLPGVGL 80
+E +D AL KN Q + NW + N+ PGV
Sbjct: 23 SRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANW-----NFNKELDMWGAQPGV-- 75
Query: 81 VGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSG----VFPAS 136
+L ++ LSL SG +P LT L L L S+ P
Sbjct: 76 -------SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKG 128
Query: 137 VTRMNRLTRLDLSSNNFSGKIPFDV--NNLTHLTGLFLENNKFSGNLPSI--NPANLRDF 192
++ + ++ + + L + ++ ++
Sbjct: 129 ISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188
Query: 193 NVSNNNLNGSIPATLSKFPQSSFTGNLDLCGGPLPPCNPF 232
+NN+ + + + + + P N
Sbjct: 189 GQLSNNI-TFVSKAVMRLTKLRQ---FYMGNSPFVAENIC 224
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 22/147 (14%), Positives = 43/147 (29%), Gaps = 19/147 (12%)
Query: 84 IPPNT-LGKLSQLRVLSLRSNRLSG-------EIPSDFSNLTLLRSLYLQSNQFSGVFPA 135
IP +S + + N + + + S+ L +NQ S
Sbjct: 392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451
Query: 136 SVTRMNRLTRLDLSSNNFSG-------KIPFDVNNLTHLTGLFLENNKFSGNLPSINPAN 188
+ + L+ ++L N + + N LT + L NK +
Sbjct: 452 LFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATT 511
Query: 189 ---LRDFNVSNNNLNGSIPATLSKFPQ 212
L ++S N+ + P
Sbjct: 512 LPYLVGIDLSYNSFSK-FPTQPLNSST 537
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-16
Identities = 19/97 (19%), Positives = 28/97 (28%), Gaps = 9/97 (9%)
Query: 86 PNTLGKLSQLRVLSLR------SNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTR 139
P S L+ +R NR E P + L L + SN V +
Sbjct: 529 PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKV-NEKI-- 585
Query: 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNK 176
++ LD+ N V L +K
Sbjct: 586 TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 77/330 (23%), Positives = 128/330 (38%), Gaps = 77/330 (23%)
Query: 311 GTSSSKDDITGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEG 370
G+ +++D+ + +L + +GKG G G
Sbjct: 3 GSVAAQDEFYRSGWALNMKELKLLQ-----------------TIGKGEFGDVMLGDYR-G 44
Query: 371 TTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKL-LVYDYMPAGSLS 429
V VK +K A + F + V+ +++H N+V L + L +V +YM GSL
Sbjct: 45 NKVAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 103
Query: 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVS 489
L R GR+ L D ++ +L + +L VH ++ A N+L+ D+ A VS
Sbjct: 104 DYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDNVAKVS 159
Query: 490 DFGLNPLFGNTTPPTRVAGYR-----------APEVVETRKVTFKSDVYSFGVLLLELLT 538
DFGL T+ A APE + +K + KSDV+SFG+LL E+ +
Sbjct: 160 DFGL----------TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
Query: 539 -GKAPNQASLGEEGIDLPRWVQSVVR-------EEWTAEVFDVELMRYHNIEEEMVQLLQ 590
G+ P I L V V + + V+ E+M+
Sbjct: 210 FGRVPYP------RIPLKDVVPRVEKGYKMDAPDGCPPAVY--EVMKN------------ 249
Query: 591 IAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620
C RP+ ++ +E++ E
Sbjct: 250 ----CWHLDAAMRPSFLQLREQLEHIKTHE 275
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 61/332 (18%), Positives = 128/332 (38%), Gaps = 46/332 (13%)
Query: 327 DRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEE-GTTVVVK--RLKEVAV 383
+ + V +D + LG G+ G +K + G + K L+
Sbjct: 16 RLEAFLTQKQKVGELKDDDFEKI--SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA 73
Query: 384 GKREFEMQMEVLGKIKHDNVVPLRAFY--YSKDEKL-LVYDYMPAGSLSALLHGSRGSGR 440
+ + +++VL + +V FY + D ++ + ++M GSL +L + +GR
Sbjct: 74 IRNQIIRELQVLHECNSPYIV---GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGR 127
Query: 441 TPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500
P +++++ +GL +L KI+H ++K SNIL+ + + DFG++ ++
Sbjct: 128 IPEQI--LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185
Query: 501 TPPTRV--AGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP------NQASLGEEGI 552
+ V Y +PE ++ + +SD++S G+ L+E+ G+ P + L
Sbjct: 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 245
Query: 553 DLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMG------------------ 594
++ R + M L I
Sbjct: 246 VEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 305
Query: 595 --CVSTVPDQRPAMQEVVRM--IENMNRGETD 622
C+ P +R +++++ I+ + E D
Sbjct: 306 NKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 337
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 42/280 (15%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYY 411
+ +GKG G G V VK +K A + F + V+ +++H N+V L
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 412 SKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVH 470
+ L +V +YM GSL L R GR+ L D ++ +L + +L VH
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE-GNNFVH 312
Query: 471 GNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR--APEVVETRKVTFKSDVYS 528
++ A N+L+ D+ A VSDFGL +T ++ + APE + +K + KSDV+S
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-VKWTAPEALREKKFSTKSDVWS 371
Query: 529 FGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVR-------EEWTAEVFDVELMRYHN 580
FG+LL E+ + G+ P I L V V + + V+ ++M+
Sbjct: 372 FGILLWEIYSFGRVPYP------RIPLKDVVPRVEKGYKMDAPDGCPPAVY--DVMKN-- 421
Query: 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620
C RP ++ +E++ E
Sbjct: 422 --------------CWHLDAATRPTFLQLREQLEHIRTHE 447
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 56/276 (20%), Positives = 105/276 (38%), Gaps = 34/276 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQ---MEVLGKIKHDNVVPLR 407
+G GS G K +G +V K L ++ + E +M + +L ++KH N+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 408 AFYYSKDEKLL--VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH-- 463
+ L V +Y G L++++ + LD + +R+ L H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-YLDEEFVLRVMTQLTLALKECHRR 130
Query: 464 --VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR-VAG---YRAPEVVET 517
++H ++K +N+ L + + DFGL + + T + G Y +PE +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 518 RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577
KSD++S G LL EL P A + +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAF------SQKELAGKIREG------------K 232
Query: 578 YHNIEEEM-VQLLQIAMGCVSTVPDQRPAMQEVVRM 612
+ I +L +I ++ RP+++E++
Sbjct: 233 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 42/285 (14%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYY 411
E LG G G + T V VK LK+ ++ F + ++ +++H +V L A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
+++ ++ +YM GSL L + L + + +A A G+A + +H
Sbjct: 78 TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHR 133
Query: 472 NIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YR--APEVVETRKVTFKSDV 526
+++A+NIL+ ++DFGL L + R + APE + T KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 527 YSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVR-------EEWTAEVFDVELMRY 578
+SFG+LL E++T G+ P G+ P +Q++ R + E++ +LMR
Sbjct: 194 WSFGILLTEIVTHGRIPYP------GMTNPEVIQNLERGYRMVRPDNCPEELY--QLMRL 245
Query: 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDD 623
C P+ RP + ++E+
Sbjct: 246 ----------------CWKERPEDRPTFDYLRSVLEDFFTATEGQ 274
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 27/211 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
E++G G G +KA +G T V+K V + E +++ L K+ H N+V +
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIK---RVKYNNEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 411 YSKDEKL----------------LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALS 454
D + ++ G+L + RG LD + +
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQ 130
Query: 455 AARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YRA 511
+G+ ++H S K+++ ++K SNI L + DFGL N TR G Y +
Sbjct: 131 ITKGVDYIH-SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 189
Query: 512 PEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
PE + ++ + D+Y+ G++L ELL
Sbjct: 190 PEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 67/290 (23%), Positives = 120/290 (41%), Gaps = 37/290 (12%)
Query: 352 EVLGKGSVGTSYKAVLE-----EGTTVVVKRLKEVAVGK--REFEMQMEVLGKIKHDNVV 404
LG+G G + G V VK LK + G + + ++E+L + H+N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 405 PLRAFYYSKDEK--LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
+ L+ +++P+GSL L ++ ++ +++ A+ +G+ +L
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMDYL 142
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR-------APEVV 515
S + VH ++ A N+L+ +H + DFGL V R APE +
Sbjct: 143 G-SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 516 ETRKVTFKSDVYSFGVLLLELLT--GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD- 572
K SDV+SFGV L ELLT + +L + I +V + +
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV------TRLVNT 255
Query: 573 VE----LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
++ L N +E+ QL+ C P R + Q ++ E + +
Sbjct: 256 LKEGKRLPCPPNCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-27
Identities = 31/142 (21%), Positives = 49/142 (34%), Gaps = 4/142 (2%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+ T + L L L SN + + F L +L L N S + ++ L
Sbjct: 88 LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENL 147
Query: 144 TRLDLSSNNFSG--KIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNL 199
L LS+N D+ + L L L +N+ P L ++N L
Sbjct: 148 QELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL 207
Query: 200 NGSIPATLSKFPQSSFTGNLDL 221
S+ L ++ NL L
Sbjct: 208 GPSLTEKLCLELANTSIRNLSL 229
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-27
Identities = 37/145 (25%), Positives = 59/145 (40%), Gaps = 8/145 (5%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMN-- 141
I N K L L L N LS L L+ L L +N+ + +
Sbjct: 112 IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANS 171
Query: 142 RLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS-----INPANLRDFNVSN 196
L +L+LSSN P + + L GLFL N + +L + ++R+ ++SN
Sbjct: 172 SLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSN 231
Query: 197 NNLNGSIPATLSKFPQSSFTGNLDL 221
+ L+ + T ++ T LDL
Sbjct: 232 SQLSTTSNTTFLGLKWTNLT-MLDL 255
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-27
Identities = 37/142 (26%), Positives = 54/142 (38%), Gaps = 3/142 (2%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+P + SQL L + N +S P L +L+ L LQ N+ S + + L
Sbjct: 40 LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNL 99
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNG 201
T L L SN+ +L L L +N S NL++ +SNN +
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
Query: 202 SIPATLSKFPQSSFTGNLDLCG 223
L F SS L+L
Sbjct: 160 LKSEELDIFANSSLK-KLELSS 180
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-27
Identities = 36/133 (27%), Positives = 52/133 (39%), Gaps = 4/133 (3%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+ P KL L+VL+L+ N LS F+ T L L+L SN + + L
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSG----NLPSINPANLRDFNVSNNNL 199
LDLS N S L +L L L NNK L ++L+ +S+N +
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183
Query: 200 NGSIPATLSKFPQ 212
P +
Sbjct: 184 KEFSPGCFHAIGR 196
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-24
Identities = 27/145 (18%), Positives = 50/145 (34%), Gaps = 12/145 (8%)
Query: 80 LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV--FPASV 137
+ + L + + L N+ + F+ + L+ L L+ V P+
Sbjct: 417 IGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476
Query: 138 TRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPA---------- 187
+ LT LDLS+NN + + L L L L++N + NP
Sbjct: 477 QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS 536
Query: 188 NLRDFNVSNNNLNGSIPATLSKFPQ 212
+L N+ +N + +
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFE 561
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-24
Identities = 30/131 (22%), Positives = 54/131 (41%), Gaps = 5/131 (3%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+P + + + VL+L N+L ++F+ + L SL + N S + P ++ L
Sbjct: 19 VPDDLP---TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNG 201
L+L N S T+LT L L +N + NL ++S+N L+
Sbjct: 76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 202 SIPATLSKFPQ 212
+ T +
Sbjct: 136 TKLGTQVQLEN 146
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 30/138 (21%), Positives = 46/138 (33%), Gaps = 7/138 (5%)
Query: 82 GPIPPNTLGKL--SQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV-T 138
+ T L S L +L+L N++S FS L L L L N+
Sbjct: 368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
Query: 139 RMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINP----ANLRDFNV 194
+ + + LS N + + L L L S +P NL ++
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487
Query: 195 SNNNLNGSIPATLSKFPQ 212
SNNN+ L +
Sbjct: 488 SNNNIANINDDMLEGLEK 505
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 29/138 (21%), Positives = 45/138 (32%), Gaps = 9/138 (6%)
Query: 84 IPPNTLG--KLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVT--- 138
+ L S L+ L L SN++ P F + L L+L + Q +
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLEL 219
Query: 139 RMNRLTRLDLSSNNFSGKIP--FDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNV 194
+ L LS++ S F T+LT L L N + L F +
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279
Query: 195 SNNNLNGSIPATLSKFPQ 212
NN+ +L
Sbjct: 280 EYNNIQHLFSHSLHGLFN 297
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-23
Identities = 30/133 (22%), Positives = 50/133 (37%), Gaps = 11/133 (8%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLS--------GEIPSDFSNLTLLRSLYLQSNQFSGVFPA 135
I + L L +L +L L+ N L+ G L+ L L L+SN F +
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
Query: 136 SVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI---NPANLRDF 192
+ L +DL NN + NN L L L+ N + + NL +
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614
Query: 193 NVSNNNLNGSIPA 205
++ N + + +
Sbjct: 615 DMRFNPFDCTCES 627
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-21
Identities = 30/132 (22%), Positives = 47/132 (35%), Gaps = 6/132 (4%)
Query: 85 PPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLT 144
P L LS L +L+L SN F +L L+ + L N + + + L
Sbjct: 528 PIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK 587
Query: 145 RLDLSSNNFSGKIP--FDVNNLTHLTGLFLENNKFSGNLPSINPANLRDF-NVSNNNLNG 201
L+L N + F +LT L + N F SI ++ N ++ N+
Sbjct: 588 SLNLQKNLITSVEKKVFG-PAFRNLTELDMRFNPFDCTCESIAW--FVNWINETHTNIPE 644
Query: 202 SIPATLSKFPQS 213
L P
Sbjct: 645 LSSHYLCNTPPH 656
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 29/146 (19%), Positives = 51/146 (34%), Gaps = 15/146 (10%)
Query: 84 IPPNTLG--KLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMN 141
T K + L +L L N L+ F+ L L +L+ N +F S+ +
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLF 296
Query: 142 RLTRLDLSSN---------NFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLR 190
+ L+L + + F L L L +E+N G ++ NL+
Sbjct: 297 NVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLK 356
Query: 191 DFNVSNNNLNGS--IPATLSKFPQSS 214
++SN+ + T S
Sbjct: 357 YLSLSNSFTSLRTLTNETFVSLAHSP 382
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-18
Identities = 26/139 (18%), Positives = 44/139 (31%), Gaps = 17/139 (12%)
Query: 84 IPPNTLGKLSQLRVLSLRSN---------RLSGEIPSDFSNLTLLRSLYLQSNQFSGVFP 134
+ ++L L +R L+L+ + L F L L L ++ N G+
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346
Query: 135 ASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTG-----LFLENNKFSGNLPSI--NPA 187
T + L L LS++ S L L L NK S
Sbjct: 347 NMFTGLINLKYLSLSNSFTS-LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405
Query: 188 NLRDFNVSNNNLNGSIPAT 206
+L ++ N + +
Sbjct: 406 HLEVLDLGLNEIGQELTGQ 424
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-18
Identities = 31/119 (26%), Positives = 47/119 (39%), Gaps = 6/119 (5%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV-TRMNR 142
IP L +L+++ L N L+ S F+N L+SL LQ N + V
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 143 LTRLDLSSNNFSGKIPF-----DVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSN 196
LT LD+ N F + N TH L ++ P + +R F+ S+
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSS 669
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 15/73 (20%), Positives = 28/73 (38%), Gaps = 5/73 (6%)
Query: 142 RLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNL 199
D S + ++P D+ T++T L L +N+ + + L +V N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 200 NGSIPATLSKFPQ 212
+ P K P
Sbjct: 62 SKLEPELCQKLPM 74
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 75/289 (25%), Positives = 119/289 (41%), Gaps = 62/289 (21%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVV-VKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
LG G G Y+ V ++ + V VK LKE + EF + V+ +IKH N+V L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 411 YSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVH 470
+ ++ ++M G+L L R R + + +A + + +L +H
Sbjct: 79 TREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIH 134
Query: 471 GNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YR------------APEVV 515
++ A N L+ +H V+DFGL +R+ Y APE +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGL----------SRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 516 ETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVR-------EEWT 567
K + KSDV++FGVLL E+ T G +P GIDL + + + + E
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRMERPEGCP 238
Query: 568 AEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
+V+ ELMR C P RP+ E+ + E M
Sbjct: 239 EKVY--ELMRA----------------CWQWNPSDRPSFAEIHQAFETM 269
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 77/324 (23%), Positives = 125/324 (38%), Gaps = 64/324 (19%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNV 403
LG+GS G Y+ V E T V +K + E A + EF + V+ + +V
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSR-----GSGRTPLDWDNRMRIALSAARG 458
V L L++ + M G L + L R P +++A A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG----YR---- 510
+A+L+ + K VH ++ A N ++ D + DFG+ TR YR
Sbjct: 151 MAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGM----------TRDIYETDYYRKGGK 199
Query: 511 --------APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSV 561
+PE ++ T SDV+SFGV+L E+ T + P Q E+ + V
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF---VMEG 256
Query: 562 VREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGET 621
L + N + + +L+ C P RP+ E++ I+
Sbjct: 257 GL-----------LDKPDNCPDMLFELM---RMCWQYNPKMRPSFLEIISSIKEE----M 298
Query: 622 DDGLRQSSDDPSKGSDGHTPPPES 645
+ G R+ S S+ + P PE
Sbjct: 299 EPGFREVSFYYSE--ENKLPEPEE 320
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 68/297 (22%), Positives = 116/297 (39%), Gaps = 57/297 (19%)
Query: 352 EVLGKGSVGTSYKAVLE-----EGTTVVVKRLKEVAVGK--REFEMQMEVLGKIKHDNVV 404
LG+G G + G V VK LK A + ++ ++++L + H++++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 405 PLRAFYYSKDEK--LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
+ LV +Y+P GSL L L + A G+A+L
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMAYL 150
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR-------APEVV 515
H + +H ++ A N+LL D + DFGL RV APE +
Sbjct: 151 H-AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 516 ETRKVTFKSDVYSFGVLLLELLT--GKAPNQASLGEEGIDLPRWVQSVVR---------- 563
+ K + SDV+SFGV L ELLT + + + E I + + +V+R
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269
Query: 564 ----EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
++ AEV+ LM+ C T RP + ++ +++ +
Sbjct: 270 LPRPDKCPAEVY--HLMKN----------------CWETEASFRPTFENLIPILKTV 308
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 65/281 (23%), Positives = 113/281 (40%), Gaps = 44/281 (15%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYY 411
+ +G G G + V +K ++E A+ + +F + EV+ K+ H +V L
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
+ LV ++M G LS L RG + + + L G+A+L ++H
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRTQRGL----FAAETLLGMCLDVCEGMAYLE-EACVIHR 128
Query: 472 NIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR------APEVVETRKVTFKSD 525
++ A N L+ + VSDFG+ + T G + +PEV + + KSD
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 526 VYSFGVLLLELLT-GKAP-----NQASLG--EEGIDLPRWVQSVVREEWTAEVFDVELMR 577
V+SFGVL+ E+ + GK P N + G L + + V+ ++M
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK------PRLASTHVY--QIM- 238
Query: 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
C P+ RPA ++R + +
Sbjct: 239 ---------------NHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 64/288 (22%), Positives = 113/288 (39%), Gaps = 51/288 (17%)
Query: 352 EVLGKGSVGTSYKAVL-----EEGTTVVVKRLKEVAVGK--REFEMQMEVLGKIKHDNVV 404
+VLG G+ GT YK + + V +K L+E K +E + V+ + + +V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 405 PLRAFYY---SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
L L+ MP G L + + + + + + A+G+ +
Sbjct: 81 RL----LGICLTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNY 132
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR------APEVV 515
L ++VH ++ A N+L++ ++DFGL L G G + A E +
Sbjct: 133 LE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 516 ETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVR----EEWTAEV 570
R T +SDV+S+GV + EL+T G P G ++ ++ R T +V
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGERLPQPPICTIDV 248
Query: 571 FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
+ + M + C D RP +E++ M R
Sbjct: 249 YMI-----------MRK-------CWMIDADSRPKFRELIIEFSKMAR 278
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 72/296 (24%), Positives = 113/296 (38%), Gaps = 59/296 (19%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVAVGKRE---FEMQMEVLGKIKHDNVV 404
+LGKG G+ +A L V VK LK + + F + + + H +V
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 405 PL------RAFYYSKDEKLLVYDYMPAGSLSALLHGSR-GSGRTPLDWDNRMRIALSAAR 457
L +++ +M G L A L SR G L +R + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 458 GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG----YR--- 510
G+ +L S +H ++ A N +L D CV+DFGL +R YR
Sbjct: 149 GMEYLS-SRNFIHRDLAARNCMLAEDMTVCVADFGL----------SRKIYSGDYYRQGC 197
Query: 511 ---------APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQS 560
A E + T SDV++FGV + E++T G+ P G E ++ ++
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA---GIENAEIYNYLIG 254
Query: 561 VVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
R L + EE+ L+ C S P QRP+ + +EN+
Sbjct: 255 GNR-----------LKQPPECMEEVYDLM---YQCWSADPKQRPSFTCLRMELENI 296
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 50/202 (24%), Positives = 83/202 (41%), Gaps = 21/202 (10%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
+G+GS G ++ + G VK+++ E + + +VPL
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGLSSPRIVPLYGAV 119
Query: 411 YSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVH 470
+ + + GSL L+ L D + A GL +LH + +I+H
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMG-----CLPEDRALYYLGQALEGLEYLH-TRRILH 173
Query: 471 GNIKASNILLRPDHDAC-VSDFG----LNPLFGNTTPPTR--VAG---YRAPEVVETRKV 520
G++KA N+LL D + DFG L P + T + G + APEVV +
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 521 TFKSDVYSFGVLLLELLTGKAP 542
K D++S ++L +L G P
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHP 255
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 72/282 (25%), Positives = 116/282 (41%), Gaps = 42/282 (14%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYY 411
LG+G G + T V +K LK + F + +V+ K++H+ +V L A
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
S++ +V +YM GSL L +G L + +A A G+A++ VH
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHR 304
Query: 472 NIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-----YRAPEVVETRKVTFKSDV 526
+++A+NIL+ + V+DFGL L + R + APE + T KSDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 527 YSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVR-------EEWTAEVFDVELMRY 578
+SFG+LL EL T G+ P G+ + V R E + +LM
Sbjct: 365 WSFGILLTELTTKGRVPYP------GMVNREVLDQVERGYRMPCPPECPESLH--DLMCQ 416
Query: 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620
C P++RP + + +E+
Sbjct: 417 ----------------CWRKEPEERPTFEYLQAFLEDYFTST 442
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 71/339 (20%), Positives = 118/339 (34%), Gaps = 85/339 (25%)
Query: 352 EVLGKGSVGTSYKAVL-----EEGTTVVVKRLKEVAV-GKREFEMQMEVLGKIKHDNVVP 405
LGKG+ G+ G V VK+L+ +R+F+ ++++L + D +V
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 406 LRAFYYSKDEK--LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
R Y + LV +Y+P+G L L R LD + + +G+ +L
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGMEYLG 144
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-----YR-------- 510
S + VH ++ A NIL+ + ++DFGL ++ Y
Sbjct: 145 -SRRCVHRDLAARNILVESEAHVKIADFGL----------AKLLPLDKDYYVVREPGQSP 193
Query: 511 ----APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVRE- 564
APE + + +SDV+SFGV+L EL T S + +
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253
Query: 565 --------------EWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVV 610
AEV ELM+ C + P RP+ +
Sbjct: 254 LELLEEGQRLPAPPACPAEVH--ELMKL----------------CWAPSPQDRPSFSALG 295
Query: 611 RMIENMNRGETDDGLRQSSDDPSKGSDGHTPPPESRTPP 649
++ + G G + T PE +
Sbjct: 296 PQLDMLWSGS--RGCETHA---------FTAHPEGKHHS 323
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 67/282 (23%), Positives = 109/282 (38%), Gaps = 40/282 (14%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVAVGK--REFEMQMEVLGKIKHDNVVP 405
EV+G+G G Y L + VK L + +F + ++ H NV+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 406 LRAFYYSKDEKLL-VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
L + L V YM G L + + + + L A+G+ +L
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKYLA- 145
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR---------APEVV 515
S K VH ++ A N +L V+DFGL + V A E +
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY-YSVHNKTGAKLPVKWMALESL 204
Query: 516 ETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574
+T+K T KSDV+SFGVLL EL+T G P D+ ++ R
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYP---DVNTFDITVYLLQGRR----------- 250
Query: 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
L++ + + +++ + C + RP+ E+V I +
Sbjct: 251 LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAI 289
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 63/283 (22%), Positives = 112/283 (39%), Gaps = 44/283 (15%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYY 411
+ LG G G + V VK +KE ++ + EF + + + K+ H +V
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
+ +V +Y+ G L L L+ + + G+A L S + +H
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGKG----LEPSQLLEMCYDVCEGMAFLE-SHQFIHR 128
Query: 472 NIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR------APEVVETRKVTFKSD 525
++ A N L+ D VSDFG+ + G + APEV K + KSD
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 526 VYSFGVLLLELLT-GKAP-----NQASLG--EEGIDLPRWVQSVVREEWTAEVFDVELMR 577
V++FG+L+ E+ + GK P N + +G L R + ++ ++M
Sbjct: 188 VWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR------PHLASDTIY--QIM- 238
Query: 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620
C +P++RP Q+++ IE + +
Sbjct: 239 ---------------YSCWHELPEKRPTFQQLLSSIEPLREKD 266
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 64/291 (21%), Positives = 123/291 (42%), Gaps = 39/291 (13%)
Query: 352 EVLGKGSVGTSYKAVLE-----EGTTVVVKRLKEVAVG-KREFEMQMEVLGKIKHDNVVP 405
+ LGKG+ G+ + G V VK+L+ R+FE ++E+L ++HDN+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 406 LRAFYYSKDEK--LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
+ YS + L+ +Y+P GSL L + +D ++ +G+ +L
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 131
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR-------APEVVE 516
+ + +H ++ NIL+ ++ + DFGL + +V APE +
Sbjct: 132 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576
K + SDV+SFGV+L EL T +++ E + Q VF +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ------GQMIVFHL--- 241
Query: 577 RYHNIEE--EM-------VQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
++ + ++ I C + +QRP+ +++ ++ +
Sbjct: 242 -IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 66/301 (21%), Positives = 116/301 (38%), Gaps = 58/301 (19%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVAVGKRE---FEMQMEVLGKIKHDNVV 404
++LG+G G+ + L V VK +K +RE F + + H NV+
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 405 PL-----RAFYYSKDEKLLVYDYMPAGSLSALLHGSR-GSGRTPLDWDNRMRIALSAARG 458
L + +++ +M G L L SR +G + ++ + A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA----GYR---- 510
+ +L + +H ++ A N +LR D CV+DFGL ++ YR
Sbjct: 160 MEYLS-NRNFLHRDLAARNCMLRDDMTVCVADFGL----------SKKIYSGDYYRQGRI 208
Query: 511 --------APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSV 561
A E + R T KSDV++FGV + E+ T G P G + ++ ++
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP---GVQNHEMYDYLLHG 265
Query: 562 VREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGET 621
R L + + +E+ +++ C T P RP + +E +
Sbjct: 266 HR-----------LKQPEDCLDELYEIM---YSCWRTDPLDRPTFSVLRLQLEKLLESLP 311
Query: 622 D 622
D
Sbjct: 312 D 312
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 61/283 (21%), Positives = 110/283 (38%), Gaps = 44/283 (15%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYY 411
+ LG G G V +K +KE ++ + EF + +V+ + H+ +V L
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
+ ++ +YM G L L R + + + +L S + +H
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLE-SKQFLHR 144
Query: 472 NIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR------APEVVETRKVTFKSD 525
++ A N L+ VSDFGL+ + T G + PEV+ K + KSD
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 526 VYSFGVLLLELLT-GKAP-----NQASLG--EEGIDLPRWVQSVVREEWTAEVFDVELMR 577
+++FGVL+ E+ + GK P N + +G+ L R + +V+ +M
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------PHLASEKVY--TIM- 254
Query: 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620
C D+RP + ++ I ++ E
Sbjct: 255 ---------------YSCWHEKADERPTFKILLSNILDVMDEE 282
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 64/289 (22%), Positives = 123/289 (42%), Gaps = 39/289 (13%)
Query: 352 EVLGKGSVGTSYKAVLE-----EGTTVVVKRLKEVAVG-KREFEMQMEVLGKIKHDNVVP 405
+ LGKG+ G+ + G V VK+L+ R+FE ++E+L ++HDN+V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 406 LRAFYYSKDEK--LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
+ YS + L+ +Y+P GSL L + +D ++ +G+ +L
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 162
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR-------APEVVE 516
+ + +H ++ NIL+ ++ + DFGL + +V APE +
Sbjct: 163 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576
K + SDV+SFGV+L EL T +++ E + Q VF +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ------GQMIVFHL--- 272
Query: 577 RYHNIEE--EM-------VQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
++ + ++ I C + +QRP+ +++ ++ +
Sbjct: 273 -IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 72/300 (24%), Positives = 117/300 (39%), Gaps = 67/300 (22%)
Query: 352 EVLGKGSVGTSYKAVL---EEGTTVVVKRLKEVAVG--KREFEMQMEVLGKI-KHDNVVP 405
+V+G+G+ G KA + +KR+KE A R+F ++EVL K+ H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNR-----------MRIALS 454
L + L +Y P G+L L SR P + A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 455 AARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-YR--- 510
ARG+ +L + +H ++ A NIL+ ++ A ++DFGL +R Y
Sbjct: 151 VARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGL----------SRGQEVYVKKT 199
Query: 511 ---------APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQS 560
A E + T SDV+S+GVLL E+++ G P E + +
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---LPQ 256
Query: 561 VVR----EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
R EV+ +LMR C P +RP+ +++ + M
Sbjct: 257 GYRLEKPLNCDDEVY--DLMRQ----------------CWREKPYERPSFAQILVSLNRM 298
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 26/232 (11%)
Query: 328 RNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEE-GTTVVVKRLK-EVAVGK 385
KL + F EDL +G+G+ G+ K V + G + VKR++ V +
Sbjct: 6 SGKLKISPEQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE 63
Query: 386 REFEMQME---VLGKIKHDNVVPLRAFY--YSKDEKL-LVYDYMPAGSLSALLHGSRGSG 439
++ ++ M+ V+ +V FY ++ + + M + S
Sbjct: 64 QK-QLLMDLDVVMRSSDCPYIV---QFYGALFREGDCWICMELM-STSFDKFYKYVYSVL 118
Query: 440 RTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACV--SDFGLNPLF 497
+ + +I L+ + L HL + KI+H +IK SNILL D + DFG++
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL--DRSGNIKLCDFGISGQL 176
Query: 498 GNTTPPTRVAG---YRAPEVVETRKV----TFKSDVYSFGVLLLELLTGKAP 542
++ TR AG Y APE ++ +SDV+S G+ L EL TG+ P
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 75/311 (24%), Positives = 115/311 (36%), Gaps = 81/311 (26%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKI-KHDN 402
+ LG+G+ G +A TV VK LKE A R ++++L I H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 403 VVPLRAFYYSKDEKLLV-YDYMPAGSLSALLHGSRGSG-----------RTPLDWDNRMR 450
VV L L+V ++ G+LS L R + L ++ +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 451 IALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-- 508
+ A+G+ L S K +H ++ A NILL + + DFGL R
Sbjct: 153 YSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGL----------ARDIYKD 201
Query: 509 --YR------------APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGID 553
Y APE + R T +SDV+SFGVLL E+ + G +P G+
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVK 255
Query: 554 LPRWVQSVVR--------EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPA 605
+ ++ + T E++ M C P QRP
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQ--TMLD----------------CWHGEPSQRPT 297
Query: 606 MQEVVRMIENM 616
E+V + N+
Sbjct: 298 FSELVEHLGNL 308
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 71/316 (22%), Positives = 117/316 (37%), Gaps = 47/316 (14%)
Query: 352 EVLGKGSVGTSYKAVL-----EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVV 404
+VLG G GT +K V V +K +++ + + M +G + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
L LV Y+P GSL + RG+ L + + A+G+ +L
Sbjct: 79 RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGA----LGPQLLLNWGVQIAKGMYYLE- 132
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR------APEVVETR 518
+VH N+ A N+LL+ V+DFG+ L + + A E +
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 519 KVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVR----EEWTAEVFDV 573
K T +SDV+S+GV + EL+T G P G ++P ++ R + T +V+ V
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEPYA---GLRLAEVPDLLEKGERLAQPQICTIDVYMV 249
Query: 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDDGLRQSSDDPS 633
MV+ C + RP +E+ M R +
Sbjct: 250 -----------MVK-------CWMIDENIRPTFKELANEFTRMARDPPR--YLVIKRESG 289
Query: 634 KGSDGHTPPPESRTPP 649
G P
Sbjct: 290 PGIAPGPEPHGLTNKK 305
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 65/287 (22%), Positives = 108/287 (37%), Gaps = 42/287 (14%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNV 403
LG G+ G Y+ + V VK L EV + +F M+ ++ K H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSG--RTPLDWDNRMRIALSAARGLAH 461
V + ++ + M G L + L +R + L + + +A A G +
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 462 LHVSGKIVHGNIKASNILLR---PDHDACVSDFGL-NPLFGNTTPPTRVAGYR------- 510
L +H +I A N LL P A + DFG+ ++ + R G
Sbjct: 156 LE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY--YRKGGCAMLPVKWM 212
Query: 511 APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAE 569
PE T K+D +SFGVLL E+ + G P + +E ++ V S R
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---VTSGGR------ 263
Query: 570 VFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
+ N + +++ C P+ RP ++ IE
Sbjct: 264 -----MDPPKNCPGPVYRIM---TQCWQHQPEDRPNFAIILERIEYC 302
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 23/210 (10%)
Query: 352 EVLGKG--SVGTSYKAV-LEEGTTVVVKRLK-EVAVGKREFEMQME--VLGKIKHDNVVP 405
V+GKG + T A G V V+R+ E + +Q E V H N+VP
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
RA + + +E +V +M GS L+ ++ I + L ++H
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKALDYIHHM 147
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--------TPPTRVAG---YRAPEV 514
G + H ++KAS+IL+ D +S N + P + +PEV
Sbjct: 148 GYV-HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 515 VETRKV--TFKSDVYSFGVLLLELLTGKAP 542
++ KSD+YS G+ EL G P
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 48/209 (22%), Positives = 88/209 (42%), Gaps = 28/209 (13%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRL--KEVAVGKREFEMQMEVLGKI-KHDNVVPLRA 408
+VLG G+ GT + + V VKR+ + + RE +++L + +H NV+
Sbjct: 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE----VQLLRESDEHPNVIRYFC 85
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
+ + + + +L + + L+ ++ S GLAHLH S I
Sbjct: 86 TEKDRQFQYIAIELCA-ATLQEYVE-QKDFAHLGLEPITLLQQTTS---GLAHLH-SLNI 139
Query: 469 VHGNIKASNILL-RPDHDACV----SDFGL-------NPLFGNTTPPTRVAGYRAPEVVE 516
VH ++K NIL+ P+ + SDFGL F + G+ APE++
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 517 ---TRKVTFKSDVYSFGVLLLELLTGKAP 542
T+ D++S G + +++ +
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 72/282 (25%), Positives = 116/282 (41%), Gaps = 42/282 (14%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYY 411
LG+G G + T V +K LK + F + +V+ K++H+ +V L A
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 331
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
S++ +V +YM GSL L +G L + +A A G+A++ VH
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHR 387
Query: 472 NIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-----YRAPEVVETRKVTFKSDV 526
+++A+NIL+ + V+DFGL L + R + APE + T KSDV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 527 YSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVR-------EEWTAEVFDVELMRY 578
+SFG+LL EL T G+ P G+ + V R E + +LM
Sbjct: 448 WSFGILLTELTTKGRVPYP------GMVNREVLDQVERGYRMPCPPECPESLH--DLMCQ 499
Query: 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620
C P++RP + + +E+
Sbjct: 500 ----------------CWRKEPEERPTFEYLQAFLEDYFTST 525
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 65/281 (23%), Positives = 108/281 (38%), Gaps = 38/281 (13%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVAVGK--REFEMQMEVLGKIKHDNVVP 405
V+GKG G Y + +K L + + F + ++ + H NV+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 406 LRAFYYSKDE-KLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
L + ++ YM G L + + + + + L ARG+ +L
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN----PTVKDLISFGLQVARGMEYLA- 141
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--TPPTRVAGYR------APEVVE 516
K VH ++ A N +L V+DFGL + + R A E ++
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 517 TRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575
T + T KSDV+SFGVLL ELLT G P + + DL ++ R L
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPPYR---HIDPFDLTHFLAQGRR-----------L 247
Query: 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
+ + + Q++ C P RP + +V +E +
Sbjct: 248 PQPEYCPDSLYQVM---QQCWEADPAVRPTFRVLVGEVEQI 285
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 69/302 (22%), Positives = 105/302 (34%), Gaps = 66/302 (21%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVAVGK--REFEMQMEVLGKIKHDNVVP 405
EV+G+G G Y L + VK L + +F + ++ H NV+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 406 LRAFYYSKDEKLL-VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
L + L V YM G L + + + + L A+G+ L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKFLA- 209
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV------AGYR-------- 510
S K VH ++ A N +L V+DFGL R
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGL----------ARDMYDKEFDSVHNKTGAKLP 259
Query: 511 ----APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVR-- 563
A E ++T+K T KSDV+SFGVLL EL+T G P D+ ++ R
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP---DVNTFDITVYLLQGRRLL 316
Query: 564 --EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGET 621
E ++ E+M C + RP+ E+V I +
Sbjct: 317 QPEYCPDPLY--EVMLK----------------CWHPKAEMRPSFSELVSRISAIFSTFI 358
Query: 622 DD 623
+
Sbjct: 359 GE 360
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQME--VLGKIKHDNVVPLRA 408
EV+G G+ A + V +KR+ E+ E + + H N+V +
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV---S 77
Query: 409 FY--YSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIAL---SAARGLAHL 462
+Y + ++L LV + GS+ ++ G + IA GL +L
Sbjct: 78 YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFG----LNPLFGNTTPPTR--VAG---YRAPE 513
H +G+I H ++KA NILL D ++DFG L T R G + APE
Sbjct: 138 HKNGQI-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 514 VVETRKV-TFKSDVYSFGVLLLELLTGKAPN 543
V+E + FK+D++SFG+ +EL TG AP
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGAAPY 227
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 75/311 (24%), Positives = 124/311 (39%), Gaps = 67/311 (21%)
Query: 352 EVLGKGSVGTSYKAVL--------EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKI-KH 400
+ LG+G+ G A +E TV VK LK+ A + +ME++ I KH
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 401 DNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNR-----------M 449
N++ L ++ +Y G+L L R G NR +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 450 RIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG- 508
ARG+ +L S K +H ++ A N+L+ ++ ++DFGL R
Sbjct: 161 SCTYQLARGMEYL-ASQKCIHRDLAARNVLVTENNVMKIADFGL----------ARDINN 209
Query: 509 ---YR------------APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGI 552
Y+ APE + R T +SDV+SFGVL+ E+ T G +P EE
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 553 DLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612
L ++ R + + N E+ ++ C VP QRP +++V
Sbjct: 270 KL---LKEGHR-----------MDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVED 312
Query: 613 IENMNRGETDD 623
++ + T++
Sbjct: 313 LDRILTLTTNE 323
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 70/309 (22%), Positives = 113/309 (36%), Gaps = 76/309 (24%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAVG--KREFEMQMEVLGKI-KHDN 402
+ LG G+ G +A + TV VK LK A + +++VL + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 403 VVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNR-------------M 449
+V L L++ +Y G L L R S +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 450 RIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG- 508
+ A+G+A L S +H ++ A NILL + DFGL R
Sbjct: 149 SFSYQVAKGMAFL-ASKNCIHRDLAARNILLTHGRITKICDFGL----------ARDIKN 197
Query: 509 ---YR------------APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQA-SLGEEG 551
Y APE + TF+SDV+S+G+ L EL + G +P + +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256
Query: 552 IDLPRWVQSVVR----EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQ 607
+ ++ R E AE++D +M+ C P +RP +
Sbjct: 257 --FYKMIKEGFRMLSPEHAPAEMYD--IMKT----------------CWDADPLKRPTFK 296
Query: 608 EVVRMIENM 616
++V++IE
Sbjct: 297 QIVQLIEKQ 305
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 76/308 (24%), Positives = 119/308 (38%), Gaps = 75/308 (24%)
Query: 352 EVLGKGSVGTSYKAVL--------EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKI-KH 400
+ LG+G+ G A T V VK LK A + +ME++ I KH
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 401 DNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSR-----------GSGRTPLDWDNRM 449
N++ L ++ +Y G+L L R + L + +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 450 RIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG- 508
A ARG+ +L S K +H ++ A N+L+ D+ ++DFGL R
Sbjct: 195 SCAYQVARGMEYL-ASKKCIHRDLAARNVLVTEDNVMKIADFGL----------ARDIHH 243
Query: 509 ---YR------------APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGI 552
Y+ APE + R T +SDV+SFGVLL E+ T G +P EE
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303
Query: 553 DLPRWVQSVVR----EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQE 608
L ++ R T E++ +MR C VP QRP ++
Sbjct: 304 KL---LKEGHRMDKPSNCTNELY--MMMRD----------------CWHAVPSQRPTFKQ 342
Query: 609 VVRMIENM 616
+V ++ +
Sbjct: 343 LVEDLDRI 350
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 66/287 (22%), Positives = 108/287 (37%), Gaps = 42/287 (14%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNV 403
LG G+ G Y+ + V VK L EV + +F M+ ++ K H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSR--GSGRTPLDWDNRMRIALSAARGLAH 461
V + ++ + M G L + L +R S + L + + +A A G +
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 462 LHVSGKIVHGNIKASNILLR---PDHDACVSDFGL-NPLFGNTTPPTRVAGYR------- 510
L +H +I A N LL P A + DFG+ ++ R G
Sbjct: 197 LE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY--YRKGGCAMLPVKWM 253
Query: 511 APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAE 569
PE T K+D +SFGVLL E+ + G P + +E ++ V S R
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---VTSGGR------ 304
Query: 570 VFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
+ N + +++ C P+ RP ++ IE
Sbjct: 305 -----MDPPKNCPGPVYRIM---TQCWQHQPEDRPNFAIILERIEYC 343
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 65/285 (22%), Positives = 114/285 (40%), Gaps = 45/285 (15%)
Query: 352 EVLGKGSVGTSYKAVL-----EEGTTVVVKRLKEVAVGK--REFEMQMEVLGKIKHDNVV 404
+VLG G+ GT YK + + V +K L+E K +E + V+ + + +V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
L L+ MP G L + + + + + + A+G+ +L
Sbjct: 81 RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNYLE- 134
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR------APEVVETR 518
++VH ++ A N+L++ ++DFGL L G G + A E + R
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 519 KVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVR----EEWTAEVFDV 573
T +SDV+S+GV + EL+T G P G ++ ++ R T +V+ +
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGERLPQPPICTIDVYMI 251
Query: 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
MV+ C D RP +E++ M R
Sbjct: 252 -----------MVK-------CWMIDADSRPKFRELIIEFSKMAR 278
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGK-REFEMQMEVLGKIKHDNVVPLRAF 409
VLGKG+ G Y L + +K + E + ++ + +KH N+V
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83
Query: 410 YY---SKDEKLLVY-DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
Y S++ + ++ + +P GSLSALL G + GL +LH +
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 466 GKIVHGNIKASNILLRPDHDACV--SDFGL-NPLFGNTTPPTRVAG---YRAPEVVE--T 517
IVH +IK N+L+ + + SDFG L G G Y APE+++
Sbjct: 142 Q-IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 518 RKVTFKSDVYSFGVLLLELLTGKAP 542
R +D++S G ++E+ TGK P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 49/199 (24%), Positives = 72/199 (36%), Gaps = 15/199 (7%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFE---MQMEVLGKI-KHDNVVPL 406
LG GS G +K E+G VKR G ++ ++ K+ +H V L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+ L + SL L LAHLH S
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWGA----SLPEAQVWGYLRDTLLALAHLH-SQ 176
Query: 467 KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKVTFK 523
+VH ++K +NI L P + DFGL G G Y APE+++
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTA 235
Query: 524 SDVYSFGVLLLELLTGKAP 542
+DV+S G+ +LE+
Sbjct: 236 ADVFSLGLTILEVACNMEL 254
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 74/304 (24%), Positives = 120/304 (39%), Gaps = 67/304 (22%)
Query: 352 EVLGKGSVGTSYKAVL--------EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKI-KH 400
+ LG+G G A +E TV VK LK+ A + +ME++ I KH
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 401 DNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNR-----------M 449
N++ L ++ +Y G+L L R G NR +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 450 RIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG- 508
ARG+ +L S K +H ++ A N+L+ ++ ++DFGL R
Sbjct: 207 SCTYQLARGMEYL-ASQKCIHRDLAARNVLVTENNVMKIADFGL----------ARDINN 255
Query: 509 ---YR------------APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGI 552
Y+ APE + R T +SDV+SFGVL+ E+ T G +P EE
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315
Query: 553 DLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612
L ++ R + + N E+ ++ C VP QRP +++V
Sbjct: 316 KL---LKEGHR-----------MDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVED 358
Query: 613 IENM 616
++ +
Sbjct: 359 LDRI 362
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 49/241 (20%), Positives = 90/241 (37%), Gaps = 44/241 (18%)
Query: 333 FFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAV-LEEGTTVVVKRL-----KEVAVGKR 386
+F+G + D + L + LG+G L +G +KR+ ++ +R
Sbjct: 18 YFQGHMVIIDNKHYLFI--QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQR 75
Query: 387 EFEMQMEVLGKIKHDNVVPLRAFYYSKDEK----LLVYDYMPAGSLSALLHGSRGSGRTP 442
E ++ H N++ L A+ + L+ + G+L +
Sbjct: 76 E----ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIE-RLKDKGNF 130
Query: 443 LDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL-NPLFG--- 498
L D + + L RGL +H + H ++K +NILL + + D G N
Sbjct: 131 LTEDQILWLLLGICRGLEAIH-AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189
Query: 499 --------------NTTPPTRVAGYRAPEVVETRK---VTFKSDVYSFGVLLLELLTGKA 541
T YRAPE+ + + ++DV+S G +L ++ G+
Sbjct: 190 GSRQALTLQDWAAQRCTIS-----YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
Query: 542 P 542
P
Sbjct: 245 P 245
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-24
Identities = 21/135 (15%), Positives = 40/135 (29%), Gaps = 13/135 (9%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV---------FP 134
+ L L + L + ++P +L L+SL + N+
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA 541
Query: 135 ASVTRMNRLTRLDLSSNNFSG-KIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDF 192
++ + NN + + L L +NK +L + L D
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDL 600
Query: 193 NVSNNNLNGSIPATL 207
+ N + IP
Sbjct: 601 KLDYNQIE-EIPEDF 614
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 23/154 (14%), Positives = 48/154 (31%), Gaps = 16/154 (10%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSD--FSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
L + LR N+L+ + D + L L ++ + N FS FP ++L
Sbjct: 721 DGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQL 778
Query: 144 TRLDL------SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNN 197
+ N + P + L L + +N + L ++++N
Sbjct: 779 KAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDIADN 837
Query: 198 NL-NGSIPATLSKFPQSSFT----GNLDLCGGPL 226
+ + + + D+ G
Sbjct: 838 PNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDA 871
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 23/142 (16%), Positives = 45/142 (31%), Gaps = 12/142 (8%)
Query: 80 LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTR 139
L +L K+ +L +L N++ + + F L L L NQ +
Sbjct: 560 LEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEEIPEDFCAF 617
Query: 140 MNRLTRLDLSSNNFSGKIP--FDVNNLTHLTGLFLENNKFSG-------NLPSINPANLR 190
+++ L S N IP F+ ++ + + NK ++ N
Sbjct: 618 TDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAS 676
Query: 191 DFNVSNNNLNGSIPATLSKFPQ 212
+S N + +
Sbjct: 677 TVTLSYNEIQKFPTELFATGSP 698
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 4e-21
Identities = 24/145 (16%), Positives = 49/145 (33%), Gaps = 19/145 (13%)
Query: 85 PPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFS-------GVFPASV 137
K ++L N + F+ + + ++ L +N + +
Sbjct: 665 CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNY 724
Query: 138 TRMNRLTRLDLSSNNFSGKIP--FDVNNLTHLTGLFLENNKFSGNLPS--INPANLRDFN 193
LT +DL N + + F L +L+ + + N FS P+ +N + L+ F
Sbjct: 725 KNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFG 782
Query: 194 ------VSNNNLNGSIPATLSKFPQ 212
N + P ++ P
Sbjct: 783 IRHQRDAEGNRILRQWPTGITTCPS 807
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 7e-21
Identities = 17/151 (11%), Positives = 45/151 (29%), Gaps = 32/151 (21%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSG-------------------EIPSDFSNLTLLRSLYLQS 126
+ +L++L+++ ++ + +SNL L + L +
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500
Query: 127 NQFSGVFPASVTRMNRLTRLDLSSNNFSG---------KIPFDVNNLTHLTGLFLENNKF 177
P + + L L+++ N ++ D + + ++ N
Sbjct: 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560
Query: 178 SGNLPSI---NPANLRDFNVSNNNLNGSIPA 205
S L + +N + + A
Sbjct: 561 EEFPASASLQKMVKLGLLDCVHNKVR-HLEA 590
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 3e-20
Identities = 26/150 (17%), Positives = 50/150 (33%), Gaps = 16/150 (10%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGV-FPASVTRMNRL 143
G +L L L N++ EIP D + + L N+ + + + +
Sbjct: 588 LEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVM 646
Query: 144 TRLDLSSNNFSGKIP-----FDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSN 196
+D S N + D + + + L N+ + + + +SN
Sbjct: 647 GSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSN 706
Query: 197 NNLNGSIPATLSKFPQSSFTG-----NLDL 221
N + SIP K ++ +DL
Sbjct: 707 NLM-TSIPENSLKPKDGNYKNTYLLTTIDL 735
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 4e-20
Identities = 30/173 (17%), Positives = 60/173 (34%), Gaps = 33/173 (19%)
Query: 66 NRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQ 125
N S + + + PI ++ L + + +NR++ I LT L+ +Y
Sbjct: 399 NLSDLLQDAINRNPEMKPIKKDSRISLKDTQ-IGNLTNRITF-ISKAIQRLTKLQIIYFA 456
Query: 126 SNQFSGV-------------------FPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTH 166
++ F+ S + + LT ++L + ++P + +L
Sbjct: 457 NSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPE 516
Query: 167 LTGLFLENNKFSG---------NLPSI--NPANLRDFNVSNNNLNGSIPATLS 208
L L + N+ L ++ F + NNL PA+ S
Sbjct: 517 LQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASAS 568
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 7e-20
Identities = 27/141 (19%), Positives = 48/141 (34%), Gaps = 13/141 (9%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPS--DFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+ ++++ + N L E P+ + L L N+ + + +L
Sbjct: 541 ADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRHL-E-AFGTNVKL 597
Query: 144 TRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSI----NPANLRDFNVSNNN 198
T L L N IP D + GL +NK +P+I + + + S N
Sbjct: 598 TDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNK 655
Query: 199 LNGSIPATLSKFPQSSFTGNL 219
+ GS +S N
Sbjct: 656 I-GSEGRNISCSMDDYKGINA 675
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-19
Identities = 22/145 (15%), Positives = 45/145 (31%), Gaps = 17/145 (11%)
Query: 84 IPPNT-LGKLSQLRVLSLRSNRLSGEIPSDFSNLTL-----LRSLYLQSNQFSGVFPASV 137
IP + + + N++ E + ++ ++ L N+
Sbjct: 634 IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELF 693
Query: 138 TRMNRLTRLDLSSNNFS-------GKIPFDVNNLTHLTGLFLENNKFSGNLPSI---NPA 187
+ ++ + LS+N + + N LT + L NK +
Sbjct: 694 ATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLP 753
Query: 188 NLRDFNVSNNNLNGSIPATLSKFPQ 212
L + +VS N + S P Q
Sbjct: 754 YLSNMDVSYNCFS-SFPTQPLNSSQ 777
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 7e-19
Identities = 30/200 (15%), Positives = 59/200 (29%), Gaps = 25/200 (12%)
Query: 24 NSEPTQDKQALLAFLS----RTPHKNRVQWNASDSACNWVGVECDANRSFVYSLRLPGVG 79
+E +D +AL A + N + + NW + N+ PGV
Sbjct: 264 TAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW-----NFNKELDMWGDQPGV- 317
Query: 80 LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTR 139
L ++ LSL G +P LT L+ L ++ +
Sbjct: 318 --------DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDE 369
Query: 140 MNRLTRLDLSSNNFSGKI-PFDVNNLTHLTGLFLENNKFSGN-----LPSINPANLRDFN 193
+ + ++ L L + + N + + +L+D
Sbjct: 370 ELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQ 429
Query: 194 VSN-NNLNGSIPATLSKFPQ 212
+ N N I + + +
Sbjct: 430 IGNLTNRITFISKAIQRLTK 449
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 14/120 (11%), Positives = 35/120 (29%), Gaps = 3/120 (2%)
Query: 96 RVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSG 155
L ++ R ++ + + + + + + R+T L L+ G
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337
Query: 156 KIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRD--FNVSNNNLNGSIPATLSKFPQS 213
++P + LT L L + + + L + + + Q
Sbjct: 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 11/69 (15%), Positives = 19/69 (27%), Gaps = 3/69 (4%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
P + L L + SN + ++ L L + N + SV
Sbjct: 797 QWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEA 853
Query: 144 TRLDLSSNN 152
L +
Sbjct: 854 GMYVLLYDK 862
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 59/291 (20%), Positives = 102/291 (35%), Gaps = 53/291 (18%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEV--LGKIKHDNVVPLRA 408
+ LG+G G ++A + +KR++ ++ EV L K++H +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 409 FYYSKDE---------KLLVY---DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAA 456
+ K+ K+ +Y +L ++G + + I L A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIA 128
Query: 457 RGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL-----NPLFGNTTPPTRVAG--- 508
+ LH S ++H ++K SNI D V DFGL T A
Sbjct: 129 EAVEFLH-SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 509 --------YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQS 560
Y +PE + + K D++S G++L ELL + +
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVR-------TLT 238
Query: 561 VVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
VR +F + + E MVQ +S P +RP ++
Sbjct: 239 DVRNLKFPPLFT----QKYPCEYVMVQD------MLSPSPMERPEAINIIE 279
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 78/313 (24%), Positives = 117/313 (37%), Gaps = 80/313 (25%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNV 403
+ LG+G G KA TTV VK LKE A R+ + VL ++ H +V
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNR--------------- 448
+ L LL+ +Y GSL L SR G L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 449 ----MRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPT 504
+ A ++G+ +L K+VH ++ A NIL+ +SDFGL +
Sbjct: 149 MGDLISFAWQISQGMQYLA-EMKLVHRDLAARNILVAEGRKMKISDFGL----------S 197
Query: 505 RVAG----YR------------APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASL 547
R Y A E + T +SDV+SFGVLL E++T G P
Sbjct: 198 RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 548 GEEGIDLPRWVQSVVR----EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQR 603
E +L +++ R + + E++ LM C PD+R
Sbjct: 258 PERLFNL---LKTGHRMERPDNCSEEMYR--LMLQ----------------CWKQEPDKR 296
Query: 604 PAMQEVVRMIENM 616
P ++ + +E M
Sbjct: 297 PVFADISKDLEKM 309
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 62/314 (19%), Positives = 113/314 (35%), Gaps = 77/314 (24%)
Query: 352 EVLGKGSVGTSYKAVL--------EEGTTVVVKRLKEVAV-GKREFEMQMEVLGKIKHDN 402
E LG+G+ +K V T V++K L + F ++ K+ H +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 403 VVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
+V DE +LV +++ GSL L ++ ++ ++ +A A + L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC----INILWKLEVAKQLAAAMHFL 129
Query: 463 HVSGKIVHGNIKASNILLRPDHDAC--------VSDFGLNPLFGNTTPPTRV----AGYR 510
++HGN+ A NILL + D +SD G+ + +
Sbjct: 130 E-ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI----------SITVLPKDILQ 178
Query: 511 ------APEVVETRKV-TFKSDVYSFGVLLLELLT-GKAP-----NQASLG--EEGIDLP 555
PE +E K +D +SFG L E+ + G P +Q L E+ LP
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLP 238
Query: 556 RWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615
+ E+ + L+ C+ PD RP+ + ++R + +
Sbjct: 239 -------APKAA-ELAN--LI----------------NNCMDYEPDHRPSFRAIIRDLNS 272
Query: 616 MNRGETDDGLRQSS 629
+ +
Sbjct: 273 LFTPDLVPRGSHHH 286
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 61/284 (21%), Positives = 109/284 (38%), Gaps = 49/284 (17%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVP 405
+G+G G ++ + V +K K + +F + + + H ++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
L +++ ++ + G L + L + S LD + + A + LA+L S
Sbjct: 456 LIGVI-TENPVWIIMELCTLGELRSFLQVRKFS----LDLASLILYAYQLSTALAYLE-S 509
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-----YRAPEVVETRKV 520
+ VH +I A N+L+ + + DFGL+ ++T G + APE + R+
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 521 TFKSDVYSFGVLLLELLT-GKAP-----NQASLG--EEGIDLPRWVQSVVREEWTAEVFD 572
T SDV+ FGV + E+L G P N +G E G LP ++
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------PPNCPPTLY- 622
Query: 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
LM C + P +RP E+ + +
Sbjct: 623 -SLM----------------TKCWAYDPSRRPRFTELKAQLSTI 649
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 45/223 (20%), Positives = 84/223 (37%), Gaps = 41/223 (18%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQME---VLGKI-KHDNVVPL 406
E +G G G+ +K V +G +KR K+ G + + + + +H +VV
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 75
Query: 407 RAFYYS---KDEKLLVY-DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
Y+S +D+ +L+ +Y GSL+ + + + L RGL ++
Sbjct: 76 ---YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS-YFKEAELKDLLLQVGRGLRYI 131
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVS-------------------DFGLNPLFGNTTPP 503
H S +VH +IK SNI + + D G + P
Sbjct: 132 H-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--PQ 188
Query: 504 TRVAG---YRAPEVV-ETRKVTFKSDVYSFGVLLLELLTGKAP 542
G + A EV+ E K+D+++ + ++ +
Sbjct: 189 VEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 47/221 (21%), Positives = 84/221 (38%), Gaps = 38/221 (17%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
VLG+G+ G KA + +K+++ ++ +L + H VV A +
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 411 YSKDEKL-------------LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR 457
+ + + +Y G+L L+H S D R+
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH----SENLNQQRDEYWRLFRQILE 127
Query: 458 GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---------------NPLFGNTTP 502
L+++H S I+H ++K NI + + + DFGL L G++
Sbjct: 128 ALSYIH-SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 503 PTRVAG---YRAPEVVETRKV-TFKSDVYSFGVLLLELLTG 539
T G Y A EV++ K D+YS G++ E++
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-24
Identities = 28/142 (19%), Positives = 49/142 (34%), Gaps = 4/142 (2%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+ + S+L+ L L + + L L +L L N P S + + L
Sbjct: 47 LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSL 106
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSG-NLPSI--NPANLRDFNVSNNNLN 200
L + F + L L L + +N LP+ N NL ++S N +
Sbjct: 107 ENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166
Query: 201 GSIPATLSKFPQSSFTG-NLDL 221
L ++ +LD+
Sbjct: 167 TITVNDLQFLRENPQVNLSLDM 188
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 29/120 (24%), Positives = 47/120 (39%), Gaps = 3/120 (2%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
L+ L L + N S+ F+N T L L L Q + ++R
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLN 200
L L++S NN N L L+ L N+ + + P +L FN++NN++
Sbjct: 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 27/136 (19%), Positives = 41/136 (30%), Gaps = 3/136 (2%)
Query: 80 LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV-T 138
L + L +L L + + F LT L +L + N F ++V
Sbjct: 411 LKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470
Query: 139 RMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSN 196
LT LDLS + L L L + +N S +L + S
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530
Query: 197 NNLNGSIPATLSKFPQ 212
N + S
Sbjct: 531 NRIETSKGILQHFPKS 546
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-21
Identities = 21/106 (19%), Positives = 34/106 (32%)
Query: 73 LRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV 132
L++ G N + L L L +L F L L+ L + N +
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512
Query: 133 FPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFS 178
+ ++ L+ LD S N + L L NN +
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-20
Identities = 30/135 (22%), Positives = 44/135 (32%), Gaps = 7/135 (5%)
Query: 84 IPPNTL--GKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV-TRM 140
+ + LR L L N + ++F L L+ L Q + V S +
Sbjct: 365 SGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL 423
Query: 141 NRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNN 197
+L LD+S N LT L L + N F N S N NL ++S
Sbjct: 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483
Query: 198 NLNGSIPATLSKFPQ 212
L +
Sbjct: 484 QLEQISWGVFDTLHR 498
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-20
Identities = 27/123 (21%), Positives = 46/123 (37%), Gaps = 3/123 (2%)
Query: 93 SQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNN 152
S + + L N L FSN + L+ L L + + + ++ L+ L L+ N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 153 FSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNG-SIPATLSK 209
P + LT L L K + L+ NV++N ++ +PA S
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 210 FPQ 212
Sbjct: 152 LTN 154
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-18
Identities = 26/142 (18%), Positives = 48/142 (33%), Gaps = 8/142 (5%)
Query: 84 IPPNTLGKLSQLRV--LSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMN 141
P+ + L + + L + F L + ++ L + V +
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLE--DVPKHF 307
Query: 142 RLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNG 201
+ L + P +L L L L NK S + + +L ++S N L+
Sbjct: 308 KWQSLSIIRCQLKQ-FPT--LDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSF 364
Query: 202 SIPATLSKFPQSSFTGNLDLCG 223
S + S +S +LDL
Sbjct: 365 SGCCSYSDLGTNSLR-HLDLSF 385
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-16
Identities = 26/148 (17%), Positives = 41/148 (27%), Gaps = 16/148 (10%)
Query: 80 LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLT----LLRSLYLQSNQFSGVFPA 135
+ P L+ L + L N + +D L + SL + N
Sbjct: 140 IHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQD 198
Query: 136 SVTRMNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSG--NLPSINPA----- 187
+ +L L L N S I NL L L +F NL P+
Sbjct: 199 QAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGL 258
Query: 188 ---NLRDFNVSNNNLNGSIPATLSKFPQ 212
+ +F ++ N
Sbjct: 259 CDVTIDEFRLTYTNDFSDDIVKFHCLAN 286
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 19/135 (14%), Positives = 34/135 (25%), Gaps = 10/135 (7%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMN- 141
I + L L+LR N S I NL L L +F + +
Sbjct: 196 IQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 142 -------RLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNV 194
+ L+ N + L +++ + L + ++
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSI 314
Query: 195 SNNNLNGSIPATLSK 209
L L
Sbjct: 315 IRCQLKQFPTLDLPF 329
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 24/144 (16%), Positives = 40/144 (27%), Gaps = 26/144 (18%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD--------------------FSNLTLLRSLY 123
L+ + +SL + + +L L+SL
Sbjct: 276 DDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLT 334
Query: 124 LQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIP--FDVNNLTHLTGLFLENNKFSGNL 181
L N+ S F + L+ LDLS N S + L L L N
Sbjct: 335 LTMNKGSISFKK--VALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMS 392
Query: 182 PSI-NPANLRDFNVSNNNLNGSIP 204
+ L+ + ++ L
Sbjct: 393 ANFMGLEELQHLDFQHSTLKRVTE 416
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 24/153 (15%), Positives = 47/153 (30%), Gaps = 21/153 (13%)
Query: 84 IPPNTLGKLSQLR----VLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSG-VFPASVT 138
I N L L + L + N + F + L L L+ N S + +
Sbjct: 168 ITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKL-HELTLRGNFNSSNIMKTCLQ 226
Query: 139 RMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGL----FLENNKFSGNLPSINPA------N 188
+ L L F + ++ + + GL E N S + N
Sbjct: 227 NLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLAN 286
Query: 189 LRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDL 221
+ +++ ++ L P+ +L +
Sbjct: 287 VSAMSLAGVSIK-----YLEDVPKHFKWQSLSI 314
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKR--LKEVAVGKREFEMQMEVLGKIKHDNVVPLRA 408
E +GKGS G +K + V +K L+E + + ++ VL + V
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT---K 84
Query: 409 FY--YSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
+Y Y KD KL ++ +Y+ GS LL PLD I +GL +LH
Sbjct: 85 YYGSYLKDTKLWIIMEYLGGGSALDLLE------PGPLDETQIATILREILKGLDYLHSE 138
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLN-PLFGNTTPPTRVAG---YRAPEVVETRKVT 521
KI H +IKA+N+LL + ++DFG+ L G + APEV++
Sbjct: 139 KKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 197
Query: 522 FKSDVYSFGVLLLELLTGKAPN 543
K+D++S G+ +EL G+ P+
Sbjct: 198 SKADIWSLGITAIELARGEPPH 219
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 61/317 (19%), Positives = 103/317 (32%), Gaps = 87/317 (27%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKI-KHDN 402
+VLG G+ G A V VK LKE A + +++++ ++ H+N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 403 VVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNR-------------- 448
+V L L+++Y G L L R
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 449 ----MRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPT 504
+ A A+G+ L VH ++ A N+L+ + DFGL
Sbjct: 171 FEDLLCFAYQVAKGMEFL-EFKSCVHRDLAARNVLVTHGKVVKICDFGL----------A 219
Query: 505 RVAG----YR------------APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASL 547
R Y APE + T KSDV+S+G+LL E+ + G P
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP--- 276
Query: 548 GEEGIDLPRWVQSVVR--------EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTV 599
GI + +++ T E++ +M+ C +
Sbjct: 277 ---GIPVDANFYKLIQNGFKMDQPFYATEEIYI--IMQS----------------CWAFD 315
Query: 600 PDQRPAMQEVVRMIENM 616
+RP+ + +
Sbjct: 316 SRKRPSFPNLTSFLGCQ 332
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 61/284 (21%), Positives = 109/284 (38%), Gaps = 49/284 (17%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVP 405
+G+G G ++ + V +K K + +F + + + H ++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
L +++ ++ + G L + L + S LD + + A + LA+L S
Sbjct: 81 LIGVI-TENPVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALAYLE-S 134
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG-----YRAPEVVETRKV 520
+ VH +I A N+L+ + + DFGL+ ++T G + APE + R+
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 521 TFKSDVYSFGVLLLELLT-GKAP-----NQASLG--EEGIDLPRWVQSVVREEWTAEVFD 572
T SDV+ FGV + E+L G P N +G E G LP ++
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------PPNCPPTLY- 247
Query: 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
LM C + P +RP E+ + +
Sbjct: 248 -SLM----------------TKCWAYDPSRRPRFTELKAQLSTI 274
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 27/140 (19%), Positives = 50/140 (35%), Gaps = 3/140 (2%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
I T +L L L L ++ F + L +L L +N + +++ L
Sbjct: 48 IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKAL 107
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNG 201
L S ++N L L+L +N S L+ + NN ++
Sbjct: 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
Query: 202 SIPATLSKFPQSSFTGNLDL 221
+S Q++ +L+L
Sbjct: 168 LSKEDMSSLQQATNL-SLNL 186
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 35/135 (25%), Positives = 55/135 (40%), Gaps = 8/135 (5%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
I NT S L+ L L + LS E+PS L+ L+ L L +N+F + S + L
Sbjct: 269 ISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327
Query: 144 TRLDLSSNNFSGKI-PFDVNNLTHLTGLFLENNKFSGNLPSINPA-----NLRDFNVSNN 197
T L + N ++ + NL +L L L ++ N +L+ N+S N
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE-TSDCCNLQLRNLSHLQSLNLSYN 386
Query: 198 NLNGSIPATLSKFPQ 212
+ PQ
Sbjct: 387 EPLSLKTEAFKECPQ 401
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 31/132 (23%), Positives = 45/132 (34%), Gaps = 6/132 (4%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSG-EIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
+ + QL +L L RL + S F NL LL+ L L + +
Sbjct: 391 LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPA 450
Query: 143 LTRLDLSSNNFSGKIPFDVN---NLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNN 197
L L+L N+F N L L L L S + + ++S+N
Sbjct: 451 LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHN 510
Query: 198 NLNGSIPATLSK 209
L S LS
Sbjct: 511 RLTSSSIEALSH 522
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-22
Identities = 25/136 (18%), Positives = 39/136 (28%), Gaps = 6/136 (4%)
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV-TRMN 141
L LS L+ L+L N F L L L + S ++
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425
Query: 142 RLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPA-----NLRDFNVSN 196
L L+LS + + L L L L+ N F + L +S
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 197 NNLNGSIPATLSKFPQ 212
+L+ +
Sbjct: 486 CDLSSIDQHAFTSLKM 501
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 8e-21
Identities = 35/165 (21%), Positives = 61/165 (36%), Gaps = 13/165 (7%)
Query: 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSG 131
L L L + L L+VL+L + L F L L+ L LQ N F
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
Query: 132 VF---PASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPA 187
S+ + RL L LS + S +L + + L +N+ + + +
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL 523
Query: 188 NLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDLCGGPLPPCNPF 232
N+++N+++ +P+ L Q ++L NP
Sbjct: 524 KGIYLNLASNHISIILPSLLPILSQQR---TINLRQ------NPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 8e-21
Identities = 31/155 (20%), Positives = 50/155 (32%), Gaps = 5/155 (3%)
Query: 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRL--SGEIPSDFSNLTLLRSLYLQSNQF 129
L + G + L L LR L L + + S NL+ L+SL L N+
Sbjct: 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP 388
Query: 130 SGVFPASVTRMNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSI--NP 186
+ + +L LDL+ K NL L L L ++ + +
Sbjct: 389 LSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGL 448
Query: 187 ANLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDL 221
L+ N+ N+ + L L
Sbjct: 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 9e-21
Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 6/124 (4%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEI---PSDFSNLTLLRSLYLQSNQFSGVFPASVTRM 140
L L+ L+L+ N + L L L L S + + T +
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499
Query: 141 NRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNN 198
+ +DLS N + +++L + L L +N S LPS+ + R N+ N
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNP 558
Query: 199 LNGS 202
L+ +
Sbjct: 559 LDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-20
Identities = 24/143 (16%), Positives = 44/143 (30%), Gaps = 6/143 (4%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
I L L L L SN +S L+ L Q+N + ++ + +
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179
Query: 144 TRLDLS-SNNFSGKIPFDVNNLTHLTGLFLENNKFSG----NLPSINPANLRDFNVSNNN 198
T L L+ + N I + L + L + +L + +
Sbjct: 180 TNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMD 239
Query: 199 LNGSIPATLSKFPQSSFTGNLDL 221
PA + S +++L
Sbjct: 240 DEDISPAVFEGLCEMSVE-SINL 261
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 24/130 (18%), Positives = 38/130 (29%), Gaps = 5/130 (3%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
IP + L N L + FS L L L L Q + + +RL
Sbjct: 27 IPGTLP---NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNG 201
L L++N ++ L LF S N L + +N+++
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 202 SIPATLSKFP 211
Sbjct: 144 IKLPKGFPTE 153
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-18
Identities = 29/130 (22%), Positives = 56/130 (43%), Gaps = 6/130 (4%)
Query: 84 IPPNTLGKLS--QLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMN 141
I P L + ++L+ + + F + L+ L L + S + P+ + ++
Sbjct: 243 ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL-PSGLVGLS 301
Query: 142 RLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI---NPANLRDFNVSNNN 198
L +L LS+N F +N LT L ++ N L + N NLR+ ++S+++
Sbjct: 302 TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDD 361
Query: 199 LNGSIPATLS 208
+ S L
Sbjct: 362 IETSDCCNLQ 371
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-18
Identities = 27/140 (19%), Positives = 52/140 (37%), Gaps = 23/140 (16%)
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
N+L L +L +L L LS F++L ++ + L N+ + +++ +
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGN----------------LPSIN- 185
+ L+L+SN+ S +P + L+ + L N L
Sbjct: 526 IY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQKLEDTED 584
Query: 186 -----PANLRDFNVSNNNLN 200
P LR +S+ L+
Sbjct: 585 TLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-17
Identities = 21/137 (15%), Positives = 39/137 (28%), Gaps = 9/137 (6%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLR--SLYLQSNQFSGVFPASVTRMN 141
I +L+VL ++N + D S+L SL L N +G+
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGI-EPGAFDSA 202
Query: 142 RLTRLDLSSNNFSGKIP--FDVNNLTHLTGLFLENNKFSGNLPSINPA----NLRDFNVS 195
L+ I + + L E+ P++ ++ N+
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262
Query: 196 NNNLNGSIPATLSKFPQ 212
+ T F
Sbjct: 263 KHYFFNISSNTFHCFSG 279
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 25/132 (18%), Positives = 46/132 (34%), Gaps = 15/132 (11%)
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTL--LRSLYLQSNQFSGVFPASVTRM 140
+ L + + P+ F L + S+ LQ + F + +
Sbjct: 218 IFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCF 277
Query: 141 NRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSG-------NLPSINPANLRDFN 193
+ L LDL++ + S ++P + L+ L L L NKF N P +L +
Sbjct: 278 SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFP-----SLTHLS 331
Query: 194 VSNNNLNGSIPA 205
+ N +
Sbjct: 332 IKGNTKRLELGT 343
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 61/304 (20%), Positives = 108/304 (35%), Gaps = 70/304 (23%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKI-KHDN 402
+ LG G+ G +A + V VK LK A K +++++ + +H+N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 403 VVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSR---------GSGRTPLDWDNRMRIAL 453
+V L L++ +Y G L L + + + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 454 SAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR-VAG---Y 509
A+G+A L S +H ++ A N+LL H A + DFGL R + Y
Sbjct: 172 QVAQGMAFLA-SKNCIHRDVAARNVLLTNGHVAKIGDFGL----------ARDIMNDSNY 220
Query: 510 R------------APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPR 556
APE + T +SDV+S+G+LL E+ + G P L +
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYK 278
Query: 557 WVQSVVR----EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612
V+ + ++ +M+ C + P RP Q++
Sbjct: 279 LVKDGYQMAQPAFAPKNIYS--IMQA----------------CWALEPTHRPTFQQICSF 320
Query: 613 IENM 616
++
Sbjct: 321 LQEQ 324
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 69/309 (22%), Positives = 115/309 (37%), Gaps = 70/309 (22%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAVG-KREFEMQMEVLGKIKHDNVV 404
LG+G+ G + A ++ V VK LKE + +++F+ + E+L ++H ++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSR----------GSGRTPLDWDNRMRIALS 454
L+V++YM G L+ L PL + +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 455 AARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG----YR 510
A G+ +L VH ++ N L+ + DFG+ +R YR
Sbjct: 167 VAAGMVYLA-GLHFVHRDLATRNCLVGQGLVVKIGDFGM----------SRDIYSTDYYR 215
Query: 511 ------------APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRW 557
PE + RK T +SDV+SFGV+L E+ T GK P E ID
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC--- 272
Query: 558 VQSVVR----EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613
+ EV+ +MR C P QR ++++V +
Sbjct: 273 ITQGRELERPRACPPEVY--AIMRG----------------CWQREPQQRHSIKDVHARL 314
Query: 614 ENMNRGETD 622
+ + +
Sbjct: 315 QALAQAPPV 323
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 31/207 (14%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQ-MEVLGKIKHDNVVPLRAF 409
E +G+G+ GT Y A+ + G V ++++ K+E + + V+ + K+ N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV---NY 82
Query: 410 Y--YSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
Y ++L +V +Y+ GSL+ ++ T +D + + L LH +
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 467 KIVHGNIKASNILLRPDHDACVSDFG----LNPLFG--NT---TPPTRVAGY-RAPEVVE 516
I H +IK+ NILL D ++DFG + P +T TP Y APEVV
Sbjct: 137 VI-HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP------YWMAPEVVT 189
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKAPN 543
+ K D++S G++ +E++ G+ P
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 66/291 (22%), Positives = 115/291 (39%), Gaps = 51/291 (17%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVAVGKREFEMQME--VLGKIKHDNVVP 405
+LG+G G Y+ V E V VK K+ + + E ++ + H ++V
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
L ++ ++ + P G L L ++ S L + +L + +A+L S
Sbjct: 78 LIGII-EEEPTWIIMELYPYGELGHYLERNKNS----LKVLTLVLYSLQICKAMAYLE-S 131
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR------APEVVETRK 519
VH +I NIL+ + DFGL+ + + + R +PE + R+
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-YYKASVTRLPIKWMSPESINFRR 190
Query: 520 VTFKSDVYSFGVLLLELLT-GKAP-----NQASLG--EEGIDLPRWVQSVVREEWTAEVF 571
T SDV+ F V + E+L+ GK P N+ +G E+G LP+ + ++
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK------PDLCPPVLY 244
Query: 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETD 622
LM C P RP E+V + ++ + E D
Sbjct: 245 --TLM----------------TRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 342 DLEDLLRASAEVLGKGSVGTSYKAVLEE-GTTVVVKRLK-EVAVGKREFEMQME---VLG 396
DLE + LG+G+ G K G + VKR++ V +++ + M+ +
Sbjct: 8 DLEPI-----MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK-RLLMDLDISMR 61
Query: 397 KIKHDNVVPLRAFY--YSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIAL 453
+ V FY ++ + + + M SL G+ + D +IA+
Sbjct: 62 TVDCPFTV---TFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQ-TIPEDILGKIAV 116
Query: 454 SAARGLAHLHVSGKIVHGNIKASNILLRPDHDACV--SDFGLNPLFGNTTPPTRVAG--- 508
S + L HLH ++H ++K SN+L+ + V DFG++ + AG
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLI--NALGQVKMCDFGISGYLVDDVAKDIDAGCKP 174
Query: 509 YRAPEVVETRKV----TFKSDVYSFGVLLLELLTGKAP 542
Y APE + + KSD++S G+ ++EL + P
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 65/288 (22%), Positives = 112/288 (38%), Gaps = 50/288 (17%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKE--VAVGKREFEMQMEVLGKIKHDNVVP 405
+++G G G L + V +K LK +R+F + ++G+ H N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
L ++V +YM GSL L G + + G+ +L
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ----FTIMQLVGMLRGVGAGMRYLS-D 169
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA-GYR------APEVVETR 518
VH ++ A N+L+ + VSDFGL+ + + G + APE + R
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 519 KVTFKSDVYSFGVLLLELLT-GKAP-----NQASLG--EEGIDLPRWVQSVVREEWTAEV 570
+ SDV+SFGV++ E+L G+ P N+ + EEG LP +
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA------PMGCPHAL 283
Query: 571 FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
+LM + C QRP ++V +++ + R
Sbjct: 284 H--QLM----------------LDCWHKDRAQRPRFSQIVSVLDALIR 313
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 62/305 (20%), Positives = 113/305 (37%), Gaps = 72/305 (23%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNV 403
E LG+ G YK L E+ V +K LK+ A G + EF + + +++H NV
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNR-----------MRIA 452
V L +++ Y G L L D+R + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 453 LSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV----AG 508
A G+ +L S +VH ++ N+L+ + +SD GL R
Sbjct: 135 AQIAAGMEYLS-SHHVVHKDLATRNVLVYDKLNVKISDLGL----------FREVYAADY 183
Query: 509 YR------------APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLP 555
Y+ APE + K + SD++S+GV+L E+ + G P ++ +++
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM- 242
Query: 556 RWVQSVVR----EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
+++ ++ A V+ LM C + P +RP +++
Sbjct: 243 --IRNRQVLPCPDDCPAWVY--ALMIE----------------CWNEFPSRRPRFKDIHS 282
Query: 612 MIENM 616
+
Sbjct: 283 RLRAW 287
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 71/313 (22%), Positives = 120/313 (38%), Gaps = 80/313 (25%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNV 403
+G+G+ G ++A E T V VK LKE A + +F+ + ++ + + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSR-------------------GSGRTPLD 444
V L L+++YM G L+ L G PL
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 445 WDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPT 504
++ IA A G+A+L K VH ++ N L+ + ++DFGL +
Sbjct: 173 CAEQLCIARQVAAGMAYLS-ERKFVHRDLATRNCLVGENMVVKIADFGL----------S 221
Query: 505 RVAG----YR------------APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASL 547
R Y+ PE + + T +SDV+++GV+L E+ + G P
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281
Query: 548 GEEGIDLPRWVQSVVR----EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQR 603
EE I V+ E E+++ LMR C S +P R
Sbjct: 282 HEEVIYY---VRDGNILACPENCPLELYN--LMR----------------LCWSKLPADR 320
Query: 604 PAMQEVVRMIENM 616
P+ + R+++ M
Sbjct: 321 PSFCSIHRILQRM 333
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 74/322 (22%), Positives = 129/322 (40%), Gaps = 63/322 (19%)
Query: 352 EVLGKGSVGTSYKAVL-----EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVV 404
+V+G G G YK +L ++ V +K LK + +F + ++G+ H N++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
L +++ +YM G+L L G + + A G+ +L
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLA- 164
Query: 465 SGKIVHGNIKASNILLRPDHDAC-VSDFGLNPLFGNTTPPTRVA-GYR------APEVVE 516
+ VH ++ A NIL+ + C VSDFGL+ + + T G + APE +
Sbjct: 165 NMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 517 TRKVTFKSDVYSFGVLLLELLT-GKAP-----NQASLG--EEGIDLPRWVQSVVREEWTA 568
RK T SDV+SFG+++ E++T G+ P N + +G LP + +
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT------PMDCPS 277
Query: 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDDGLRQS 628
++ +LM M C +RP ++V +++ + R
Sbjct: 278 AIY--QLM----------------MQCWQQERARRPKFADIVSILDKLIR---------- 309
Query: 629 SDDPSKGSDGHTPPPESRTPPT 650
+ D K P R P T
Sbjct: 310 APDSLKTLADFDPRVSIRLPST 331
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 6e-23
Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 33/208 (15%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQME--VLGKIKHDNVVPLRA 408
+G+GS G A G V VK + ++ +R + E ++ +H NVV
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHFNVV---E 106
Query: 409 FY--YSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
Y Y E+L ++ +++ G+L+ ++ + L+ + + + + LA+LH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVS------QVRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFG----LNPLFG--NT---TPPTRVAGY-RAPEVV 515
G I H +IK+ +ILL D +SDFG ++ + TP Y APEV+
Sbjct: 161 GVI-HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP------YWMAPEVI 213
Query: 516 ETRKVTFKSDVYSFGVLLLELLTGKAPN 543
+ D++S G++++E++ G+ P
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPPY 241
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 48/232 (20%), Positives = 93/232 (40%), Gaps = 25/232 (10%)
Query: 326 ADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGK 385
+ + G Y ++ DL +G G+ G +K + V+ + + K
Sbjct: 7 GKQTGYLTIGGQRYQAEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK 64
Query: 386 REFE---MQMEVLGK-IKHDNVVPLRAFY--YSKDEKL-LVYDYMPAGSLSALLHGSRGS 438
E + M ++V+ K +V + + + + + + M + R
Sbjct: 65 EENKRILMDLDVVLKSHDCPYIV---QCFGTFITNTDVFIAMELMGTCAEKLKK---RMQ 118
Query: 439 GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498
G P ++ ++ + L +L ++H ++K SNILL + DFG++
Sbjct: 119 GPIPERI--LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176
Query: 499 NTTPPTRVAG---YRAPEVVETRKV-----TFKSDVYSFGVLLLELLTGKAP 542
+ R AG Y APE ++ ++DV+S G+ L+EL TG+ P
Sbjct: 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 69/303 (22%), Positives = 123/303 (40%), Gaps = 63/303 (20%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAVG-KREFEMQMEVLGKIKHDNVV 404
LG+G+ G + A ++ V VK LK+ + +++F+ + E+L ++H+++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNR-----------MRIAL 453
D ++V++YM G L+ L +D R + IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 454 SAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG----Y 509
A G+ +L S VH ++ N L+ + + DFG+ +R Y
Sbjct: 141 QIASGMVYLA-SQHFVHRDLATRNCLVGANLLVKIGDFGM----------SRDVYSTDYY 189
Query: 510 R------------APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPR 556
R PE + RK T +SDV+SFGV+L E+ T GK P E I+
Sbjct: 190 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC-- 247
Query: 557 WVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
+ L R +E+ ++ +GC P QR ++E+ +++ +
Sbjct: 248 -ITQGRV-----------LERPRVCPKEVYDVM---LGCWQREPQQRLNIKEIYKILHAL 292
Query: 617 NRG 619
+
Sbjct: 293 GKA 295
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 8e-23
Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 15/198 (7%)
Query: 353 VLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQM----EVLGKIKHDNVVPLR 407
LGKG G Y A + + +K L + + K E Q+ E+ ++H N++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
+++ L+ +Y P G++ L + + D A L++ H S +
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYREL---QKLSK--FDEQRTATYITELANALSYCH-SKR 129
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKVTFKS 524
++H +IK N+LL + ++DFG + ++ + G Y PE++E R K
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMIEGRMHDEKV 188
Query: 525 DVYSFGVLLLELLTGKAP 542
D++S GVL E L GK P
Sbjct: 189 DLWSLGVLCYEFLVGKPP 206
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 69/319 (21%), Positives = 127/319 (39%), Gaps = 52/319 (16%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVAVGK--REFEMQMEVLGKIKHDNVVP 405
+V+G G G L ++ +V +K LK K R+F + ++G+ H N++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
L ++V +YM GSL + L + + A G+ +L
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLS-D 165
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA-GYR------APEVVETR 518
VH ++ A NIL+ + VSDFGL + + G + +PE + R
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 519 KVTFKSDVYSFGVLLLELLT-GKAP-----NQASLG--EEGIDLPRWVQSVVREEWTAEV 570
K T SDV+S+G++L E+++ G+ P NQ + +EG LP + A +
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP------PMDCPAAL 279
Query: 571 FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDDGLRQSSD 630
+ +LM + C + RP +++V +++ + R L+ +
Sbjct: 280 Y--QLM----------------LDCWQKDRNNRPKFEQIVSILDKLIR--NPGSLKIITS 319
Query: 631 DPSKGSDGHTPPPESRTPP 649
++ S+
Sbjct: 320 AAARPSNLLLDQSNVDITT 338
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 33/208 (15%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQME--VLGKIKHDNVVPLRA 408
E LG+GS G+ YKA+ E G V +K++ V E+ E ++ + +VV
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQEIIKEISIMQQCDSPHVV---K 88
Query: 409 FY--YSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
+Y Y K+ L +V +Y AGS+S ++ L D I S +GL +LH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK----TLTEDEIATILQSTLKGLEYLHFM 144
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFG----LNPLFG--NT---TPPTRVAGY-RAPEVV 515
KI H +IKA NILL + A ++DFG L NT TP + APEV+
Sbjct: 145 RKI-HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTP------FWMAPEVI 197
Query: 516 ETRKVTFKSDVYSFGVLLLELLTGKAPN 543
+ +D++S G+ +E+ GK P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPY 225
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 49/202 (24%), Positives = 85/202 (42%), Gaps = 23/202 (11%)
Query: 353 VLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQM----EVLGKIKHDNVVPLR 407
LGKG G Y A + + +K L + + K E Q+ E+ ++H N++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
+++ + L+ ++ P G L L + GR D A L + H K
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKEL---QKHGR--FDEQRSATFMEELADALHYCH-ERK 134
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-------TPPTRVAGYRAPEVVETRKV 520
++H +IK N+L+ + ++DFG + + T Y PE++E +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLD-----YLPPEMIEGKTH 189
Query: 521 TFKSDVYSFGVLLLELLTGKAP 542
K D++ GVL E L G P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 3e-22
Identities = 54/344 (15%), Positives = 94/344 (27%), Gaps = 67/344 (19%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQME----------------- 393
VLG+ +A E G + V QM+
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 394 ---------VLGKIKHDNVVPLRAFYYSKDEKLLVYDYM----PAGSLSALLH--GSRGS 438
+K + + + ++ + +L S S
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 439 GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498
L R+++ L R LA LH G +VH ++ +I+L ++ F G
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG-LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 499 NTTPPTRVAGYRAPEVV----------ETRKVTFKSDVYSFGVLLLELLTGKAPNQASLG 548
+ G+ PE +TF D ++ G+ + + PN
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD-- 320
Query: 549 EEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQE 608
+ + R NI + + LL G + + R +
Sbjct: 321 ----AALGGSEWIFRSC-------------KNIPQPVRALL---EGFLRYPKEDRLLPLQ 360
Query: 609 VVRMIE-NMNRGETDDGLRQSSDDPSKGSDGHTPPPESRTPPTA 651
+ E R E L D +G PP + P A
Sbjct: 361 AMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEA 404
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 4e-22
Identities = 42/264 (15%), Positives = 82/264 (31%), Gaps = 53/264 (20%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRL--------KEVAVGKRE--------------- 387
VLG+ +A E G + V + K E
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 388 ------FEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM-PAGSLSALLH--GSRGS 438
F +++ + ++ +R + Y +L S S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 439 GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498
L R+++ L R LA LH G +VH ++ +I+L ++ F G
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG-LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 499 NTTPPTRVAGYRAPEVVETR-----------KVTFKSDVYSFGVLLLELLTGKAP----N 543
+ G+ PE+ R +TF D ++ G+++ + P
Sbjct: 258 ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDA 317
Query: 544 QASLGE----EGIDLPRWVQSVVR 563
E ++P+ V++++
Sbjct: 318 ALGGSEWIFRSCKNIPQPVRALLE 341
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 4e-22
Identities = 38/296 (12%), Positives = 74/296 (25%), Gaps = 47/296 (15%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQM----EVLGKIKHDNVVPL 406
E L G + +E +K A R ++ ++ ++
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 407 RAFY--------------------------YSKDEKLLVYDYMPAGSLSALLH--GSRGS 438
R Y+ LL+ + L L
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYV 186
Query: 439 GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498
R + R A+L G +VHG+ N+ + PD + D G
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKG-LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 499 NTTPPTRV-AGYRAPEVVETRK--VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLP 555
P + V Y E + T + + G+ + + P
Sbjct: 246 TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305
Query: 556 RWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
R V + + + + + L+ ++ +R E +
Sbjct: 306 RPSLRVPGTD------SLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEAME 352
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 68/305 (22%), Positives = 112/305 (36%), Gaps = 52/305 (17%)
Query: 345 DLLRASAEVLGKGSVGTSYKAVL---EEGTTVVVKRLKEVAV---GKREFEMQMEVLGKI 398
LL + LG G+ GT K + TV VK LK A K E + V+ ++
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75
Query: 399 KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARG 458
+ +V + + +LV + G L+ L +R + N + + + G
Sbjct: 76 DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMG 129
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR-------A 511
+ +L VH ++ A N+LL H A +SDFGL+ + + A
Sbjct: 130 MKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 188
Query: 512 PEVVETRKVTFKSDVYSFGVLLLELLT-GKAP-----NQASLG--EEGIDLPRWVQSVVR 563
PE + K + KSDV+SFGVL+ E + G+ P E+G +
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC------P 242
Query: 564 EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDD 623
E++D+ M C + + RP V + N ++
Sbjct: 243 AGCPREMYDL-----------MNL-------CWTYDVENRPGFAAVELRLRNYYYDVVNE 284
Query: 624 GLRQS 628
G
Sbjct: 285 GHHHH 289
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 36/213 (16%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQME--VLGKIKHDNVVPLRA 408
LG G+ G YKA E G K ++ + + E + +E +L H +V
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIV---K 80
Query: 409 FY--YSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
Y D KL ++ ++ P G++ A++ L + L LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVVCRQMLEALNFLHSK 136
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFG----LNPLFG--NT---TPPTRVAGY-RAPEVV 515
I H ++KA N+L+ + D ++DFG ++ TP Y APEVV
Sbjct: 137 RII-HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP------YWMAPEVV 189
Query: 516 ETRKVT-----FKSDVYSFGVLLLELLTGKAPN 543
+ +K+D++S G+ L+E+ + P+
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 19/202 (9%)
Query: 354 LGKGSVGTSYKAVL---EEGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNVVPLRA 408
LG G+ G+ + V ++ V +K LK+ E + +++ ++ + +V L
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
+ +LV + G L L G R + N + + G+ +L
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLE-EKNF 131
Query: 469 VHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR-------APEVVETRKVT 521
VH ++ A N+LL H A +SDFGL+ G APE + RK +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 522 FKSDVYSFGVLLLELLT-GKAP 542
+SDV+S+GV + E L+ G+ P
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKP 213
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 98.1 bits (244), Expect = 2e-21
Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 19/212 (8%)
Query: 344 EDLLRASAEVLGKGSVGTSYKAVLEEG---TTVVVKRLKE--VAVGKREFEMQMEVLGKI 398
D L + LG G+ G+ + V V +K LK+ E + +++ ++
Sbjct: 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393
Query: 399 KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARG 458
+ +V L + +LV + G L L G R + N + + G
Sbjct: 394 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMG 448
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR-------A 511
+ +L VH N+ A N+LL H A +SDFGL+ G A
Sbjct: 449 MKYLE-EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 507
Query: 512 PEVVETRKVTFKSDVYSFGVLLLELLT-GKAP 542
PE + RK + +SDV+S+GV + E L+ G+ P
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 53/207 (25%), Positives = 83/207 (40%), Gaps = 22/207 (10%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKE----VAVGKREFEMQMEVLGKIKHDNV 403
E LG GS G + + +V VK LK +F ++ + + H N+
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
+ L +V + P GSL L +G R A+ A G+ +L
Sbjct: 84 IRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYLE 138
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYR-------APEVVE 516
S + +H ++ A N+LL + DFGL + +R APE ++
Sbjct: 139 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 517 TRKVTFKSDVYSFGVLLLELLT-GKAP 542
TR + SD + FGV L E+ T G+ P
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 49/211 (23%), Positives = 82/211 (38%), Gaps = 23/211 (10%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRL-KEVAVGKREFEMQ-MEVLGKIKHDNVVPLRA 408
++LG+G+ ++ + G +K + + +M+ EVL K+ H N+V L A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 409 FYYSKDEKL--LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+ L+ ++ P GSL +L + L + + G+ HL
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSN-AYGLPESEFLIVLRDVVGGMNHLR-EN 131
Query: 467 KIVHGNIKASNILLRPDHDAC----VSDFGLNPLFGNTTPPTRVAG---YRAPEVVE--- 516
IVH NIK NI+ D ++DFG + + G Y P++ E
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191
Query: 517 -----TRKVTFKSDVYSFGVLLLELLTGKAP 542
+K D++S GV TG P
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 3e-21
Identities = 28/125 (22%), Positives = 58/125 (46%), Gaps = 8/125 (6%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L L+ L + N+++ P +N+T L SL + +N+ + + P + +++LT L++
Sbjct: 195 LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEI 250
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATL 207
+N S +LT L L + +N+ S ++ + N + L ++NN L +
Sbjct: 251 GTNQISDINAVK--DLTKLKMLNVGSNQIS-DISVLNNLSQLNSLFLNNNQLGNEDMEVI 307
Query: 208 SKFPQ 212
Sbjct: 308 GGLTN 312
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 9e-20
Identities = 28/122 (22%), Positives = 48/122 (39%), Gaps = 9/122 (7%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
I P L L+++ L+L +N S SN+T L L + ++ V P + + L
Sbjct: 125 ISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDL 179
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINP-ANLRDFNVSNNNLNGS 202
L L+ N P +LT L N+ + ++ + L + NN +
Sbjct: 180 YSLSLNYNQIEDISPLA--SLTSLHYFTAYVNQIT-DITPVANMTRLNSLKIGNNKITDL 236
Query: 203 IP 204
P
Sbjct: 237 SP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 31/122 (25%), Positives = 59/122 (48%), Gaps = 9/122 (7%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
I P L L +L L + +N+++ S NLT LR LYL + S + P + + ++
Sbjct: 81 ISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKM 134
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGS 202
L+L +N+ + ++N+T L L + +K ++ I N +L +++ N +
Sbjct: 135 YSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVK-DVTPIANLTDLYSLSLNYNQIEDI 192
Query: 203 IP 204
P
Sbjct: 193 SP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 31/116 (26%), Positives = 58/116 (50%), Gaps = 6/116 (5%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+ P L LSQL L + +N++S + +LT L+ L + SNQ S + + + +++L
Sbjct: 236 LSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQL 289
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNL 199
L L++N + + LT+LT LFL N + P + + + + +N +
Sbjct: 290 NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 33/123 (26%), Positives = 58/123 (47%), Gaps = 10/123 (8%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
I P + +++L L + +N+++ P +NL+ L L + +NQ S + +V + +L
Sbjct: 214 ITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKL 267
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNG 201
L++ SN S NNL+ L LFL NN+ + NL +S N++
Sbjct: 268 KMLNVGSNQISDISVL--NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
Query: 202 SIP 204
P
Sbjct: 326 IRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 30/117 (25%), Positives = 53/117 (45%), Gaps = 7/117 (5%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
+ L+ L L+L N+++ P SNL L +LY+ +N+ + +++ + L L L
Sbjct: 62 IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYL 117
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIP 204
+ +N S P NLT + L L N +L + N L V+ + + P
Sbjct: 118 NEDNISDISPLA--NLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP 172
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 23/126 (18%), Positives = 55/126 (43%), Gaps = 10/126 (7%)
Query: 88 TLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147
L++ L+ ++ + L + L + + + + + + L L+
Sbjct: 17 PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASI--QGIEYLTNLEYLN 72
Query: 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPAT 206
L+ N + P +NL LT L++ NK + ++ ++ N NLR+ ++ +N++ P
Sbjct: 73 LNGNQITDISPL--SNLVKLTNLYIGTNKIT-DISALQNLTNLRELYLNEDNISDISP-- 127
Query: 207 LSKFPQ 212
L+ +
Sbjct: 128 LANLTK 133
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 25/93 (26%), Positives = 45/93 (48%), Gaps = 4/93 (4%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTR 145
N + L++L++L++ SN++S S +NL+ L SL+L +NQ + + LT
Sbjct: 258 INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT 315
Query: 146 LDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFS 178
L LS N+ + P +L+ + N
Sbjct: 316 LFLSQNHITDIRPLA--SLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 21/118 (17%), Positives = 43/118 (36%), Gaps = 8/118 (6%)
Query: 95 LRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFS 154
L+ ++ +I D ++L LQ + V + +T+L ++ +
Sbjct: 2 AATLATLPAPIN-QIFPD-ADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 155 GKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQ 212
I + LT+L L L N+ + P N L + + N + + + L
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKI--TDISALQNLTN 111
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 4e-21
Identities = 65/327 (19%), Positives = 108/327 (33%), Gaps = 54/327 (16%)
Query: 352 EVLGKGSVGTSYKAV--LEEGTTVVVKRLKEV--AVGKREFEMQMEVLGKIKHDNVVPLR 407
+ G +G Y A+ G VV+K L A + + + L ++ H ++V +
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 408 AFYYSKDEKL-----LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
F D +V +Y+ SL L + L L++L
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYL 198
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGL-------NPLFGNTTPPTRVAGYRAPEVV 515
H G +V+ ++K NI+L + + D G L+G TP G++APE+V
Sbjct: 199 HSIG-LVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYLYG--TP-----GFQAPEIV 249
Query: 516 ETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575
T T +D+Y+ G L L + T + + L
Sbjct: 250 RTG-PTVATDIYTVGRTLAALTLDLPTRNG-------RYVDGLPEDDPVLKTYDSYGRLL 301
Query: 576 M---------RYHNIEEEMVQLLQIAMGCVSTVPD-QRPAMQEVVRMIENMNRGETDDGL 625
R+ EE QL + V+ RP + + +R L
Sbjct: 302 RRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFS----PSRSTFGVDL 357
Query: 626 RQSSDDPSKGSDGHTPPPESRTPPTAL 652
+ D H + TAL
Sbjct: 358 LVAHTDVYLDGQVHAEKLTANEIVTAL 384
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-21
Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM---QMEVLGKIKHDNVVPLR 407
+ LG G+ G +K +++ +V ++ VL + H N++ L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 408 AFYYSKDEKLLVYDYMPAGSL-SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
F+ K LV + G L ++H + + D ++ LS + +LH
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEV---DAAVIIKQVLSG---VTYLHKHN 156
Query: 467 KIVHGNIKASNILLR-PDHDACV--SDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKV 520
IVH ++K N+LL + DA + DFGL+ +F N G Y APEV+ +K
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKY 214
Query: 521 TFKSDVYSFGVLLLELLTGKAP 542
K DV+S GV+L LL G P
Sbjct: 215 DEKCDVWSIGVILFILLAGYPP 236
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 97.1 bits (241), Expect = 4e-21
Identities = 59/283 (20%), Positives = 102/283 (36%), Gaps = 32/283 (11%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEV--LGKIKHDNVVPLRA 408
E LG G G + + + G V +K+ ++ K +E+ + K+ H NVV R
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 409 FY------YSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
D LL +Y G L L+ + L + + L +L
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN--QFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 463 HVSGKIVHGNIKASNILLRPDHDAC---VSDFGLNPLFGNTTPPTRVAG---YRAPEVVE 516
H +I+H ++K NI+L+P + D G T G Y APE++E
Sbjct: 138 H-ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLE 196
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKAP----NQASL------GEEGIDLPRWVQSVVREEW 566
+K T D +SFG L E +TG P Q + + + ++
Sbjct: 197 QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKF 256
Query: 567 TAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEV 609
++ + + ++ + LQ + QR +
Sbjct: 257 SSVLPT-PNHLSGILAGKLERWLQCML---MWHQRQRGTDPQN 295
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 22/204 (10%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM--QMEVL--GKIKHDNVVPL 406
+ LG G + T Y A V +K + K E + EV ++ H N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV-- 74
Query: 407 RAFY-YSKDEKL--LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
+ +++ LV +Y+ +LS + S G PL D + G+ H H
Sbjct: 75 -SMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHG----PLSVDTAINFTNQILDGIKHAH 128
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--TPPTRVAG---YRAPEVVETR 518
IVH +IK NIL+ + + DFG+ T T V G Y +PE +
Sbjct: 129 DMR-IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 519 KVTFKSDVYSFGVLLLELLTGKAP 542
+D+YS G++L E+L G+ P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP 211
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 9e-21
Identities = 49/211 (23%), Positives = 82/211 (38%), Gaps = 23/211 (10%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRL-KEVAVGKREFEMQ-MEVLGKIKHDNVVPLRA 408
++LG+G+ ++ + G +K + + +M+ EVL K+ H N+V L A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 409 FYYSKDEKL--LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+ L+ ++ P GSL +L + L + + G+ HL
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSN-AYGLPESEFLIVLRDVVGGMNHLR-EN 131
Query: 467 KIVHGNIKASNILLRPDHDAC----VSDFGLNPLFGNTTPPTRVAG---YRAPEVVET-- 517
IVH NIK NI+ D ++DFG + + G Y P++ E
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191
Query: 518 ------RKVTFKSDVYSFGVLLLELLTGKAP 542
+K D++S GV TG P
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 71/273 (26%), Positives = 111/273 (40%), Gaps = 30/273 (10%)
Query: 284 KKRRRQRPGKAPKPPAAATARAVTMEAGTSSSKDDITGGAAEADRNKLVFFEGGVYSF-D 342
R K A T R TS+ DI A D + +G V SF
Sbjct: 31 DSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYT 90
Query: 343 LEDLLRASAEVLGKGSVGTSYKAVLEEGT-------TVVVKRLKEVAVGKREFEMQMEVL 395
+ E+LG G G +K E T + + +K+ K E + V+
Sbjct: 91 VS-----KTEILGGGRFGQVHKCE-ETATGLKLAAKIIKTRGMKDKEEVKNE----ISVM 140
Query: 396 GKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL-SALLHGSRGSGRTPLDWDNRMRIALS 454
++ H N++ L + SK++ +LV +Y+ G L ++ T LD M+
Sbjct: 141 NQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII--DESYNLTELDTILFMKQICE 198
Query: 455 AARGLAHLHVSGKIVHGNIKASNILL--RPDHDACVSDFGLNPLFGNTTPPTRVAG---Y 509
G+ H+H I+H ++K NIL R + DFGL + G +
Sbjct: 199 ---GIRHMHQMY-ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEF 254
Query: 510 RAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
APEVV V+F +D++S GV+ LL+G +P
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 43/215 (20%), Positives = 86/215 (40%), Gaps = 34/215 (15%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEM---QMEVLGKIKH--DNVVPL 406
+ +G G ++ + E+ +K + + + ++ L K++ D ++ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+ + +V + L++ L + S +D R + + +H
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLK-KKKS----IDPWERKSYWKNMLEAVHTIH-QH 146
Query: 467 KIVHGNIKASNILLRPDHDACV--SDFGL-NPLFGNTTPPTR--VAG---YRAPEVVE-- 516
IVH ++K +N L+ D + DFG+ N + +TT + G Y PE ++
Sbjct: 147 GIVHSDLKPANFLI---VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 517 ---------TRKVTFKSDVYSFGVLLLELLTGKAP 542
K++ KSDV+S G +L + GK P
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-20
Identities = 50/224 (22%), Positives = 83/224 (37%), Gaps = 39/224 (17%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRL--KEVAVGKREFEMQMEVLGKIK-HDNVVPLRA 408
++LG GS GT +G V VKR+ + E +++L + H NV+
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALME----IKLLTESDDHPNVIRYYC 76
Query: 409 FYYSKDEKLLVYDYMPAGSLSALL--HGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+ + + +L L+ N + + A G+AHLH S
Sbjct: 77 SETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-SL 134
Query: 467 KIVHGNIKASNILLRPDHDAC-------------VSDFGL------NPLFGNTTPPTRV- 506
KI+H ++K NIL+ +SDFGL T
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 507 -AGYRAPEV-------VETRKVTFKSDVYSFGVLLLELLTGKAP 542
+G+RAPE+ R++T D++S G + +L+
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 43/215 (20%), Positives = 86/215 (40%), Gaps = 34/215 (15%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEM---QMEVLGKIKH--DNVVPL 406
+ +G G ++ + E+ +K + + + ++ L K++ D ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+ + +V + L++ L + S +D R + + +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLK-KKKS----IDPWERKSYWKNMLEAVHTIH-QH 127
Query: 467 KIVHGNIKASNILLRPDHDACV--SDFGL-NPLFGNTTPPTR--VAG---YRAPEVVE-- 516
IVH ++K +N L+ D + DFG+ N + +TT + G Y PE ++
Sbjct: 128 GIVHSDLKPANFLI---VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 517 ---------TRKVTFKSDVYSFGVLLLELLTGKAP 542
K++ KSDV+S G +L + GK P
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-20
Identities = 31/147 (21%), Positives = 56/147 (38%), Gaps = 4/147 (2%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+ + +L+VL L + + +L+ L +L L N + + + ++ L
Sbjct: 43 LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSL 102
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKF-SGNLPSI--NPANLRDFNVSNNNLN 200
+L N + F + +L L L + +N S LP N NL ++S+N +
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 201 GSIPATLSKFPQSSFTGN-LDLCGGPL 226
L Q LDL P+
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPM 189
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-19
Identities = 28/134 (20%), Positives = 44/134 (32%), Gaps = 5/134 (3%)
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV-TRMN 141
+ + L+ L L N + + S+F L L L Q + + SV +
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 142 RLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPA---NLRDFNVSNNN 198
L LD+S + N L+ L L + N F N NL ++S
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 199 LNGSIPATLSKFPQ 212
L P +
Sbjct: 482 LEQLSPTAFNSLSS 495
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 29/155 (18%), Positives = 46/155 (29%), Gaps = 8/155 (5%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV-FPASVTRMNR 142
+ LS L+ L L+ +L L+ L + N P + +
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPA-----NLRDFNVSNN 197
L LDLSSN D+ L + L L + + I P L + NN
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 198 NLNGSIPATLSKFPQSSFTGNLDLCGGPLPPCNPF 232
+ ++ T + L G
Sbjct: 211 FDSLNVMKTC--IQGLAGLEVHRLVLGEFRNEGNL 243
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-18
Identities = 30/123 (24%), Positives = 50/123 (40%), Gaps = 6/123 (4%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
LS L VL + N D F+ L L L L Q + P + ++
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495
Query: 143 LTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINPANLRDF-NVSNNNLN 200
L L+++SN +P + + LT L ++L N + + P I+ L + N ++
Sbjct: 496 LQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY--LSRWLNKNSQKEQ 552
Query: 201 GSI 203
GS
Sbjct: 553 GSA 555
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 27/125 (21%), Positives = 47/125 (37%), Gaps = 7/125 (5%)
Query: 85 PPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV-TRMNRL 143
+ L L L + F+ L+ L L + N F F + T + L
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 144 TRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNNNL 199
T LDLS ++ N+L+ L L + +N+ ++P +L+ + N
Sbjct: 473 TFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 530
Query: 200 NGSIP 204
+ S P
Sbjct: 531 DCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 25/124 (20%), Positives = 43/124 (34%), Gaps = 6/124 (4%)
Query: 87 NTLGKLSQLRVLSLRSNRLS--GEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLT 144
+ L L L L N LS G T L+ L L N + ++ + +L
Sbjct: 341 FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLE 399
Query: 145 RLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNG 201
LD +N F V +L +L L + + I ++L ++ N+
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459
Query: 202 SIPA 205
+
Sbjct: 460 NFLP 463
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-15
Identities = 22/124 (17%), Positives = 44/124 (35%), Gaps = 5/124 (4%)
Query: 93 SQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNN 152
+ L L N L F + L+ L L + + + ++ L+ L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 153 FSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI---NPANLRDFNVSNNNLN-GSIPATLS 208
+ L+ L L + +L + + L++ NV++N + +P S
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 209 KFPQ 212
Sbjct: 147 NLTN 150
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 21/82 (25%), Positives = 37/82 (45%)
Query: 73 LRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV 132
L++ G P+ +L L L L +L P+ F++L+ L+ L + SNQ V
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSV 509
Query: 133 FPASVTRMNRLTRLDLSSNNFS 154
R+ L ++ L +N +
Sbjct: 510 PDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 30/142 (21%), Positives = 46/142 (32%), Gaps = 9/142 (6%)
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSG---EIPSDFSNLTLLRSLYLQSNQFSGVFPASVTR 139
+ L L L + R L +I F+ LT + S L S V S
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--Y 302
Query: 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNL 199
L+L + F P L L L +NK ++ +L ++S N L
Sbjct: 303 NFGWQHLELVNCKFGQ-FPT--LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGL 359
Query: 200 NGSIPATLSKFPQSSFTGNLDL 221
+ ++ LDL
Sbjct: 360 S-FKGCCSQSDFGTTSLKYLDL 380
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 21/142 (14%), Positives = 39/142 (27%), Gaps = 12/142 (8%)
Query: 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSL------RSNRLSGEIPSDFSNLTLLRSLYLQ 125
L L + + L+ L V L L S L L +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 126 SNQ---FSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLP 182
+ + ++ L S ++ D + L L N KF P
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVK-DFSYNFGWQHLELVNCKFG-QFP 320
Query: 183 SINPANLRDFNVSNNNLNGSIP 204
++ +L+ ++N +
Sbjct: 321 TLKLKSLKRLTFTSNKGGNAFS 342
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 24/154 (15%), Positives = 43/154 (27%), Gaps = 27/154 (17%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
I P ++ L L+LR+N S + L L L +F
Sbjct: 192 IQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN--------EGN 242
Query: 143 LTR----------------LDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSIN 185
L + L+ ++ D+ N LT+++ L +
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY 302
Query: 186 PANLRDFNVSNNNLNGSIPATLSKFPQSSFTGNL 219
+ + N L + +FT N
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNK 336
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 52/281 (18%), Positives = 102/281 (36%), Gaps = 45/281 (16%)
Query: 288 RQRPGKAPKPPAAATARA--VTMEAGTSSSKDDITGGAAEADRNKLVFFEGGVYSFDLED 345
G P+ A + S A + N+ + +G +YS
Sbjct: 5 HHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL--- 61
Query: 346 LLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEM---QMEVLGKIKH-- 400
+ +G G ++ + E+ +K + + + ++ L K++
Sbjct: 62 ------KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 401 DNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLA 460
D ++ L + + +V + L++ L + S +D R + +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKKS----IDPWERKSYWKNMLEAVH 169
Query: 461 HLHVSGKIVHGNIKASNILLRPDHDACV--SDFGL-NPLFGNTTPPTR--VAG---YRAP 512
+H IVH ++K +N L+ D + DFG+ N + +TT + G Y P
Sbjct: 170 TIH-QHGIVHSDLKPANFLI---VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 513 EVVE-----------TRKVTFKSDVYSFGVLLLELLTGKAP 542
E ++ K++ KSDV+S G +L + GK P
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-20
Identities = 36/119 (30%), Positives = 51/119 (42%), Gaps = 6/119 (5%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTR 145
+ L KL+ L L +N++S P LT L L L NQ + ++ + LT
Sbjct: 192 ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTD 247
Query: 146 LDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIP 204
LDL++N S P LT LT L L N+ S P L + ++ N L P
Sbjct: 248 LDLANNQISNLAPLS--GLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-19
Identities = 36/145 (24%), Positives = 56/145 (38%), Gaps = 10/145 (6%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
I P L L+ L L L N+L P SNL L L L N S + P V+ + +L
Sbjct: 280 ISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKL 333
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSI 203
RL +N S NLT++ L +N+ S P N + +++ +
Sbjct: 334 QRLFFYNNKVSDVSSLA--NLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAP 391
Query: 204 PATLSKFPQSSFTGNLDLCGGPLPP 228
+ + N+ G + P
Sbjct: 392 VNYKANVSIPNTVKNVT--GALIAP 414
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-17
Identities = 32/120 (26%), Positives = 59/120 (49%), Gaps = 9/120 (7%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTR 145
+ L L+ L+ LS N+++ P +NLT L L + SN+ S + + ++ L
Sbjct: 149 ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLES 203
Query: 146 LDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIP 204
L ++N S P LT+L L L N+ ++ ++ + NL D +++NN ++ P
Sbjct: 204 LIATNNQISDITPL--GILTNLDELSLNGNQLK-DIGTLASLTNLTDLDLANNQISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-17
Identities = 35/122 (28%), Positives = 57/122 (46%), Gaps = 11/122 (9%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
I P L L+ L L+L +N+++ P NLT L L L SN S + ++++ + L
Sbjct: 105 ITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSL 158
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGS 202
+L N + P NLT L L + +NK S ++ + NL +NN ++
Sbjct: 159 QQLSF-GNQVTDLKPLA--NLTTLERLDISSNKVS-DISVLAKLTNLESLIATNNQISDI 214
Query: 203 IP 204
P
Sbjct: 215 TP 216
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-17
Identities = 24/118 (20%), Positives = 48/118 (40%), Gaps = 8/118 (6%)
Query: 88 TLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147
T L++ L ++ + ++L + +L V +N LT+++
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQIN 74
Query: 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIP 204
S+N + P NLT L + + NN+ + ++ + N NL + NN + P
Sbjct: 75 FSNNQLTDITPLK--NLTKLVDILMNNNQIA-DITPLANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-16
Identities = 27/114 (23%), Positives = 49/114 (42%), Gaps = 6/114 (5%)
Query: 88 TLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147
+ L Q+ L + L L + +NQ + + P + + +L +
Sbjct: 41 SQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 96
Query: 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNG 201
+++N + P NLT+LTGL L NN+ + P N NL +S+N ++
Sbjct: 97 MNNNQIADITPL--ANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 20/112 (17%), Positives = 47/112 (41%), Gaps = 4/112 (3%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
+ L++L+ L +N++S S +NLT + L NQ S + P + + R+T+L L
Sbjct: 327 VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 382
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN 200
+ ++ N++ + + + + +++ N +
Sbjct: 383 NDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 17/97 (17%), Positives = 32/97 (32%), Gaps = 8/97 (8%)
Query: 117 TLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNK 176
L + Q + +F + + + L N + + +L +T L +
Sbjct: 2 PLGSATITQDTPINQIFTDTA--LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLG 57
Query: 177 FSGNLPSI-NPANLRDFNVSNNNLNGSIPATLSKFPQ 212
++ + NL N SNN L P L +
Sbjct: 58 IK-SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTK 91
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 14/98 (14%), Positives = 34/98 (34%), Gaps = 27/98 (27%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+ P L L+++ L L + + +N+++ ++ + + PA+++
Sbjct: 368 LTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSY 423
Query: 144 TRLDLSSN-----------------------NFSGKIP 158
T D++ N FSG +
Sbjct: 424 TEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 57/206 (27%), Positives = 83/206 (40%), Gaps = 26/206 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKRE--FEMQME--VLGKIKHDNVVPL 406
+G GS G Y A + V +K++ E ++ E L K++H N +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI-- 117
Query: 407 RAFY--YSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
+ Y ++ LV +Y GS S LL + PL + A +GLA+LH
Sbjct: 118 -QYRGCYLREHTAWLVMEYC-LGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLH 171
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKV 520
I H ++KA NILL + DFG P G + APEV+
Sbjct: 172 SHNMI-HRDVKAGNILLSEPGLVKLGDFGSA---SIMAPANSFVGTPYWMAPEVILAMDE 227
Query: 521 T---FKSDVYSFGVLLLELLTGKAPN 543
K DV+S G+ +EL K P
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPPL 253
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 47/219 (21%), Positives = 92/219 (42%), Gaps = 25/219 (11%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKR-LKEVAVGKREFEMQMEVLGKIKHDNVVPLRAF 409
+ G+G+ GT + G +V +K+ +++ RE ++ M+ L + H N+V L+++
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNIVQLQSY 87
Query: 410 YYSKDEK-------LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
+Y+ E+ +V +Y+P +L + + R + L
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPD-TLHRCCR-NYYRRQVAPPPILIKVFLFQLIRSIGCL 145
Query: 463 H-VSGKIVHGNIKASNILLRP-DHDACVSDFGLNPLFGNTTPPTR-VAG--YRAPEVVET 517
H S + H +IK N+L+ D + DFG + P + YRAPE++
Sbjct: 146 HLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFG 205
Query: 518 -RKVTFKSDVYSFGVLLLELLTGKA--PNQASLGEEGID 553
+ T D++S G + E++ G+ G+
Sbjct: 206 NQHYTTAVDIWSVGCIFAEMMLGEPIFR-----GDNSAG 239
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRL-KEVAVGKREFEMQMEVLGKIKHDNVVPLRAF 409
E LG G+ G ++ V G V K + + K + ++ ++ ++ H ++ L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
+ K E +L+ +++ G L + + + + N MR A GL H+H IV
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACE---GLKHMHEHS-IV 171
Query: 470 HGNIKASNILL--RPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKVTFKS 524
H +IK NI+ + + DFGL + APE+V+ V F +
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 231
Query: 525 DVYSFGVLLLELLTGKAP 542
D+++ GVL LL+G +P
Sbjct: 232 DMWAIGVLGYVLLSGLSP 249
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 8e-20
Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 30/213 (14%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLK--------------EVAVGKREFEMQMEVLG 396
LG G+ G + +K +K + E ++ +L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 397 KIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL-SALLHGSRGSGRTPLDWDNRMRIALSA 455
+ H N++ L + K LV ++ G L +++ + D N M+ LS
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC---DAANIMKQILSG 158
Query: 456 ARGLAHLHVSGKIVHGNIKASNILLR-PDHDAC--VSDFGLNPLFGNTTPPTRVAG---Y 509
+ +LH IVH +IK NILL + + DFGL+ F G Y
Sbjct: 159 ---ICYLHKHN-IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 510 RAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
APEV++ +K K DV+S GV++ LL G P
Sbjct: 215 IAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-20
Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 16/202 (7%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRL--KEVAVGKREFEMQMEVLGKIKHDNVVPLRA 408
LG G+ G + G V+K + V + E ++EVL + H N++ +
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 409 FYYSKDEKLLVYDYMPAGSL-SALLHGSRGSGR-TPLDWDNRMRIALSAARGLAHLHVSG 466
+ +V + G L ++ + M+ ++A LA+ H
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFHSQH 144
Query: 467 KIVHGNIKASNILLR-PDHDAC--VSDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKV 520
+VH ++K NIL + + + DFGL LF + T AG Y APEV + R V
Sbjct: 145 -VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDV 202
Query: 521 TFKSDVYSFGVLLLELLTGKAP 542
TFK D++S GV++ LLTG P
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLP 224
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 8e-20
Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKRE----FEMQMEVLGKIKHDNVVPL 406
VLGKGS G G VK + + V ++ ++++L ++ H N++ L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 407 RAFYYSKDEKLLVYDYMPAGSL-SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
F+ K LV + G L ++ R S D +R LS + ++H +
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV---DAARIIRQVLSG---ITYMHKN 145
Query: 466 GKIVHGNIKASNILLR-PDHDACV--SDFGLNPLFGNTTPPTRVAG---YRAPEVVETRK 519
IVH ++K N+LL DA + DFGL+ F + G Y APEV+
Sbjct: 146 K-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GT 203
Query: 520 VTFKSDVYSFGVLLLELLTGKAP 542
K DV+S GV+L LL+G P
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPP 226
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 8e-20
Identities = 36/225 (16%), Positives = 75/225 (33%), Gaps = 46/225 (20%)
Query: 353 VLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQM------------------EV 394
L +G ++ +K+ ++ + K+ + ++
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 395 LGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALS 454
+ IK++ + + DE ++Y+YM S+ LD + I +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY-----FFVLDKNYTCFIPIQ 151
Query: 455 AAR--------GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT------ 500
+ +++H I H ++K SNIL+ + +SDFG + +
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR 211
Query: 501 -TPPTRVAGYRAPEVVETRKVT--FKSDVYSFGVLLLELLTGKAP 542
T + PE K D++S G+ L + P
Sbjct: 212 GTYE-----FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 8e-20
Identities = 55/202 (27%), Positives = 85/202 (42%), Gaps = 19/202 (9%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM---QMEVLGKIKHDNVVPLR 407
+LGKGS G K VK + + + ++ ++E+L K+ H N++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 408 AFYYSKDEKLLVYDYMPAGSL-SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+V + G L ++ R S D ++ S + ++H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH---DAARIIKQVFSG---ITYMHKHN 141
Query: 467 KIVHGNIKASNILLR-PDHDAC--VSDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKV 520
IVH ++K NILL + D + DFGL+ F T G Y APEV+
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTY 199
Query: 521 TFKSDVYSFGVLLLELLTGKAP 542
K DV+S GV+L LL+G P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 27/128 (21%), Positives = 44/128 (34%), Gaps = 8/128 (6%)
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV-TRMN 141
+ + L+ L L N + + S+F L L L Q + + SV +
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 142 RLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNN 197
L LD+S + + N L+ L L + N F N NL ++S
Sbjct: 127 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185
Query: 198 NLNGSIPA 205
L +
Sbjct: 186 QLE-QLSP 192
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 28/123 (22%), Positives = 42/123 (34%), Gaps = 8/123 (6%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
LS L VL + N D F+ L L L L Q + P + ++
Sbjct: 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 200
Query: 143 LTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLP----SINPANLRDFNVSNN 197
L L++S NNF + L L L N P++L N++ N
Sbjct: 201 LQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258
Query: 198 NLN 200
+
Sbjct: 259 DFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 34/151 (22%), Positives = 55/151 (36%), Gaps = 15/151 (9%)
Query: 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFS 130
L L + L L L + + F+ L+ L L + N F
Sbjct: 105 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQ 163
Query: 131 GVFPASV-TRMNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINPA- 187
F + T + LT LDLS ++ N+L+ L L + +N F S++
Sbjct: 164 ENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF----SLDTFP 218
Query: 188 -----NLRDFNVSNNNLNGSIPATLSKFPQS 213
+L+ + S N++ S L FP S
Sbjct: 219 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 249
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 27/126 (21%), Positives = 49/126 (38%), Gaps = 9/126 (7%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSD--FSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+ L QL L + + L ++ F +L L L + F ++ L
Sbjct: 94 SSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 152
Query: 144 TRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNNNL 199
L ++ N+F D+ L +LT L L + L + ++L+ N+S+NN
Sbjct: 153 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNF 211
Query: 200 NGSIPA 205
S+
Sbjct: 212 F-SLDT 216
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 30/128 (23%), Positives = 43/128 (33%), Gaps = 16/128 (12%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQ--FSGVFPASVTRMN 141
IP + L L SN+L F LT L L L SN F G S
Sbjct: 26 IPSSA-------TRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 142 RLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINP----ANLRDFNVSNN 197
L LDLS N + + L L L +++ + + NL ++S+
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHT 136
Query: 198 NLNGSIPA 205
+
Sbjct: 137 HTR-VAFN 143
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 28/128 (21%), Positives = 43/128 (33%), Gaps = 3/128 (2%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTR 145
P ++ L L+ L +R++ LS + +L L L L+ +P L R
Sbjct: 199 PASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR 257
Query: 146 LDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLP-SI-NPANLRDFNVSNNNLNGSI 203
L L + +P D++ LT L L L LP I V +
Sbjct: 258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLD 317
Query: 204 PATLSKFP 211
P
Sbjct: 318 QHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 33/135 (24%), Positives = 58/135 (42%), Gaps = 15/135 (11%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTR 145
P+ +LS L+ +++ + L E+P L +L L N PAS+ +NRL
Sbjct: 97 PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRE 154
Query: 146 LDLSSNNFSGKIP---------FDVNNLTHLTGLFLENNKFSGNLP-SI-NPANLRDFNV 194
L + + ++P + L +L L LE +LP SI N NL+ +
Sbjct: 155 LSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKI 213
Query: 195 SNNNLNGSIPATLSK 209
N+ L+ ++ +
Sbjct: 214 RNSPLS-ALGPAIHH 227
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 29/135 (21%), Positives = 57/135 (42%), Gaps = 13/135 (9%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTL---------LRSLYLQSNQFSGVFPAS 136
P ++ L++LR LS+R+ E+P ++ L+SL L+ PAS
Sbjct: 143 PASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPAS 201
Query: 137 VTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNV 194
+ + L L + ++ S + +++L L L L N P I A L+ +
Sbjct: 202 IANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260
Query: 195 SNNNLNGSIPATLSK 209
+ + ++P + +
Sbjct: 261 KDCSNLLTLPLDIHR 275
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 24/142 (16%), Positives = 45/142 (31%), Gaps = 8/142 (5%)
Query: 82 GPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTL--LRSLYLQSNQFSGVFPASVTR 139
+ ++ + L + T +L L+S FP R
Sbjct: 45 RWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102
Query: 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLP-SI-NPANLRDFNVSNN 197
++ L + + + ++P + L L L N LP SI + LR+ ++
Sbjct: 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRAC 160
Query: 198 NLNGSIPATLSKFPQSSFTGNL 219
+P L+ S L
Sbjct: 161 PELTELPEPLASTDASGEHQGL 182
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 26/137 (18%), Positives = 49/137 (35%), Gaps = 17/137 (12%)
Query: 86 PNTLGKLSQ--LRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+ L +Q L LRS L + P L+ L+ + + + P ++ + L
Sbjct: 72 ADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGL 129
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS-----------INPANLRDF 192
L L+ N +P + +L L L + LP NL+
Sbjct: 130 ETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188
Query: 193 NVSNNNLNGSIPATLSK 209
+ + S+PA+++
Sbjct: 189 RLEWTGIR-SLPASIAN 204
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 16/145 (11%), Positives = 33/145 (22%), Gaps = 34/145 (23%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVT------------- 138
S L + + S + + S
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKA 70
Query: 139 --------RMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFS------GNLPSI 184
L+L S + P L+HL + ++
Sbjct: 71 TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFA-- 127
Query: 185 NPANLRDFNVSNNNLNGSIPATLSK 209
L ++ N L ++PA+++
Sbjct: 128 ---GLETLTLARNPLR-ALPASIAS 148
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 28/132 (21%), Positives = 53/132 (40%), Gaps = 15/132 (11%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSN 151
++ ++ + + L + S + ++ L L N S + A + +L L+LSSN
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 152 NFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFP 211
+ + +L+ L L L NN L ++ + +NNN +S+
Sbjct: 69 VLYETLDLE--SLSTLRTLDLNNNYVQ-ELL--VGPSIETLHAANNN--------ISRVS 115
Query: 212 QSSFTG--NLDL 221
S G N+ L
Sbjct: 116 CSRGQGKKNIYL 127
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 23/129 (17%), Positives = 43/129 (33%), Gaps = 8/129 (6%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+ ++ L L N LS +D + T L L L SN + ++ L
Sbjct: 25 ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTL 82
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSI 203
LDL++N ++ + L NN S + ++ ++NN +
Sbjct: 83 RTLDLNNNYVQ-ELL----VGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLR 136
Query: 204 PATLSKFPQ 212
+
Sbjct: 137 DLDEGCRSR 145
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 28/145 (19%), Positives = 50/145 (34%), Gaps = 11/145 (7%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV-FPASVTRMNR 142
+ + + + L +N+++ D + ++ L L+ N+ V F +
Sbjct: 114 VSCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINP-ANLRDFNVSNNNLNG 201
L L+L N + V L L L +NK + P A + ++ NN L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV- 227
Query: 202 SIPATLSKFPQSSFTGNLDLCGGPL 226
I L + DL G
Sbjct: 228 LIEKALRFSQNLE---HFDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 26/146 (17%), Positives = 43/146 (29%), Gaps = 7/146 (4%)
Query: 85 PPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLT 144
L L+L+ N + ++ L++L L SN+ + + +T
Sbjct: 161 FAELAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLAFM-GPEFQSAAGVT 217
Query: 145 RLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFS-GNLPSINPANLRDFNVSNNNLNG-- 201
+ L +N I + +L L N F G L N R V+ +
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLT 276
Query: 202 SIPATLSKFPQSSFTGNLDLCGGPLP 227
P G P P
Sbjct: 277 GQNEEECTVPTLGHYGAYCCEDLPAP 302
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 18/115 (15%), Positives = 36/115 (31%), Gaps = 7/115 (6%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFS-GVFPASVTRMNRLT 144
+ + +SLR+N+L I L L+ N F G ++ R+
Sbjct: 207 GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265
Query: 145 RLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNL 199
+ + K+ + L +LP P R + +++
Sbjct: 266 TVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCEDLP--APFADRLIALGHHHH 315
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 20/118 (16%), Positives = 40/118 (33%), Gaps = 11/118 (9%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
+ LS L L + ++ + + S LT L L + + + + ++ +DL
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFS-----GNLPSINPANLRDFNVSNNNLNG 201
S N I + L L L ++ + + P L + + G
Sbjct: 144 SYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIEDFP-----KLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 19/125 (15%), Positives = 49/125 (39%), Gaps = 5/125 (4%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
+ ++ L++ + + + S L+ L L + + +++ + LT LD+
Sbjct: 62 IEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATL 207
S + I +N L + + L N ++ + L+ N+ + ++ +
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRG--I 177
Query: 208 SKFPQ 212
FP+
Sbjct: 178 EDFPK 182
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-15
Identities = 20/132 (15%), Positives = 53/132 (40%), Gaps = 17/132 (12%)
Query: 88 TLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147
T +++ L ++L + ++ ++ + ++ L + + + P ++ ++ L RL
Sbjct: 39 TEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94
Query: 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFS-------GNLPSINPANLRDFNVSNNNLN 200
+ + + +++ LT LT L + ++ LP + ++S N
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP-----KVNSIDLSYNGAI 149
Query: 201 GSIPATLSKFPQ 212
I L P+
Sbjct: 150 TDIMP-LKTLPE 160
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 14/96 (14%), Positives = 31/96 (32%), Gaps = 3/96 (3%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
L L+ L +L + + I + + L + S+ L N + + L
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IMPLKTLPEL 161
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSG 179
L++ + + + L L+ + G
Sbjct: 162 KSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 15/123 (12%), Positives = 51/123 (41%), Gaps = 9/123 (7%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSN 151
L + + + ++LT + L + + + + + + L +++
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNSLT---YITLANINVTDL--TGIEYAHNIKDLTINNI 76
Query: 152 NFSGKIPFDVNNLTHLTGLFLENNKFSGN-LPSINP-ANLRDFNVSNNNLNGSIPATLSK 209
+ + P + L++L L + + + +P+++ +L ++S++ + SI ++
Sbjct: 77 HATNYNPI--SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 210 FPQ 212
P+
Sbjct: 135 LPK 137
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 17/100 (17%), Positives = 35/100 (35%), Gaps = 7/100 (7%)
Query: 114 SNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLE 173
S + L + + + A MN LT + L++ N + + + ++ L +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQ---MNSLTYITLANINVT-DLTG-IEYAHNIKDLTIN 74
Query: 174 NNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATLSKFPQ 212
N + N I +NL + ++ LS
Sbjct: 75 NIHAT-NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTS 113
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 9/44 (20%), Positives = 18/44 (40%), Gaps = 2/44 (4%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV 132
L L +L+ L+++ + + + + L LY S G
Sbjct: 155 LKTLPELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFSQTIGGK 196
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 46/245 (18%), Positives = 77/245 (31%), Gaps = 55/245 (22%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVK-----RLKEVAVGKRE-FEMQMEVLGKIKHDNVV 404
+G+GS G A+ + +K +++++ E + ++ ++ K+ H N+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSL-------------------------SALLHGSRGSG 439
L Y + LV + G L
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 440 RTPLDWDNRMRIALS---AAR-------GLAHLHVSGKIVHGNIKASNILLRPDHDACV- 488
+ + + + L +LH G I H +IK N L + +
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG-ICHRDIKPENFLFSTNKSFEIK 210
Query: 489 -SDFGLNPLFGNTTPPTRV--------AGYRAPEVVE--TRKVTFKSDVYSFGVLLLELL 537
DFGL+ F + APEV+ K D +S GVLL LL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 538 TGKAP 542
G P
Sbjct: 271 MGAVP 275
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 53/269 (19%), Positives = 102/269 (37%), Gaps = 21/269 (7%)
Query: 283 LKKRRRQRPGKAPKPPAAATARAVTMEAGTSSSKDDITGGAAEADRNKLVFFEGGVYS-- 340
+ + V + SS+ D+ + + V +
Sbjct: 99 PVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDH 158
Query: 341 FDLEDLLRASAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKRE-FEMQMEVLGKI 398
+D+ E LG G+ G ++ G K + +E +++ + +
Sbjct: 159 YDIH-------EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL 211
Query: 399 KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARG 458
+H +V L + +E +++Y++M G L + + + MR G
Sbjct: 212 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCK---G 267
Query: 459 LAHLHVSGKIVHGNIKASNILL--RPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPE 513
L H+H + VH ++K NI+ + ++ + DFGL G + APE
Sbjct: 268 LCHMHENN-YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 326
Query: 514 VVETRKVTFKSDVYSFGVLLLELLTGKAP 542
V E + V + +D++S GVL LL+G +P
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 39/197 (19%), Positives = 82/197 (41%), Gaps = 11/197 (5%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
E LG+G G ++ V T + K +K + + ++ +L +H N++ L +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 411 YSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVH 470
S +E +++++++ + + + + + + L LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCE---ALQFLHSHN-IGH 125
Query: 471 GNIKASNILLRPDHDACV--SDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKVTFKSD 525
+I+ NI+ + + + +FG + Y APEV + V+ +D
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 526 VYSFGVLLLELLTGKAP 542
++S G L+ LL+G P
Sbjct: 186 MWSLGTLVYVLLSGINP 202
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 2e-19
Identities = 28/132 (21%), Positives = 53/132 (40%), Gaps = 15/132 (11%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSN 151
++ ++ + + L + S + ++ L L N S + A + +L L+LSSN
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 152 NFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFP 211
+ + +L+ L L L NN L ++ + +NNN +S+
Sbjct: 69 VLYETLDLE--SLSTLRTLDLNNNYVQ-ELL--VGPSIETLHAANNN--------ISRVS 115
Query: 212 QSSFTG--NLDL 221
S G N+ L
Sbjct: 116 CSRGQGKKNIYL 127
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 2e-19
Identities = 23/129 (17%), Positives = 43/129 (33%), Gaps = 8/129 (6%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+ ++ L L N LS +D + T L L L SN + ++ L
Sbjct: 25 ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTL 82
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSI 203
LDL++N ++ + L NN S + ++ ++NN +
Sbjct: 83 RTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLR 136
Query: 204 PATLSKFPQ 212
+
Sbjct: 137 DLDEGCRSR 145
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 25/135 (18%), Positives = 46/135 (34%), Gaps = 16/135 (11%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV-FPASVTRMNR 142
+ + + + L +N+++ D + ++ L L+ N+ V F +
Sbjct: 114 VSCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPA-----NLRDFNVSNN 197
L L+L N + V L L L +NK L + P + ++ NN
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNK----LAFMGPEFQSAAGVTWISLRNN 224
Query: 198 NLNGSIPATLSKFPQ 212
L I L
Sbjct: 225 KLV-LIEKALRFSQN 238
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 19/146 (13%), Positives = 37/146 (25%), Gaps = 9/146 (6%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFS-GVFPASVTRMNRLT 144
+ + +SLR+N+L I L L+ N F G ++ R+
Sbjct: 207 GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265
Query: 145 RLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIP 204
+ + + T T +LP+ L + L
Sbjct: 266 TVAKQTVKKLTGQNEE--ECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLSGQG 322
Query: 205 ATLSKFPQSSFTGN----LDLCGGPL 226
+ + +D
Sbjct: 323 SETERLECERENQARQREIDALKEQY 348
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 15/124 (12%), Positives = 27/124 (21%), Gaps = 7/124 (5%)
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSG----EIPSDFSNLTLLRSLYLQSNQFSGVFPASVT 138
+P +L L+ G + + N R + Q+ V
Sbjct: 298 DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTL 357
Query: 139 RMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNK---FSGNLPSINPANLRDFNVS 195
R L+ ++ L G + +P L V
Sbjct: 358 RKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVK 417
Query: 196 NNNL 199
Sbjct: 418 RYEE 421
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 34/213 (15%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM--QMEVL--GKIKHDNVV-- 404
E+LG G + + A L + V VK L+ F + + E + H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 405 --------PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAA 456
P Y +V +Y+ +L ++H + G P+ + + A
Sbjct: 78 YDTGEAETPAGPLPY------IVMEYVDGVTLRDIVH-TEG----PMTPKRAIEVIADAC 126
Query: 457 RGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL-NPLFGNTTPPTRV------AGY 509
+ L H +G I+H ++K +NI++ + V DFG+ + + T+ A Y
Sbjct: 127 QALNFSHQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 510 RAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
+PE V +SDVYS G +L E+LTG+ P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 31/127 (24%), Positives = 54/127 (42%), Gaps = 6/127 (4%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
I ++ L + N + +P F N+ LL L L+ N S + +
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 142
Query: 143 LTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNG 201
LT L +S+NN +I D T L L L +N+ + ++ +L NVS N L+
Sbjct: 143 LTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS- 199
Query: 202 SIPATLS 208
++ ++
Sbjct: 200 TLAIPIA 206
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 30/145 (20%), Positives = 58/145 (40%), Gaps = 18/145 (12%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
+P L Q+ +L+L ++ EI + F+ ++ LY+ N + P +
Sbjct: 60 LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 118
Query: 143 LTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNNN 198
LT L L N+ S +P + +N LT L + NN + +L++ +S+N
Sbjct: 119 LTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 176
Query: 199 LNGSIPATLSKFPQSSFTG--NLDL 221
L+ S + ++
Sbjct: 177 --------LTHVDLSLIPSLFHANV 193
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 30/154 (19%), Positives = 52/154 (33%), Gaps = 22/154 (14%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+ +L +L L+ N L+ + N L + L N+ + +M RL
Sbjct: 220 VRGPVN---VELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 274
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNK---FSGNLPSINPANLRDFNVSNNNLN 200
RL +S+N + + L L L +N N P + L + + +N+
Sbjct: 275 ERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFD--RLENLYLDHNS-- 329
Query: 201 GSIPATLSKFPQSSFTG--NLDLCGGPLPPCNPF 232
+ S+ NL L CN
Sbjct: 330 ------IVTLKLSTHHTLKNLTLSHNDW-DCNSL 356
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 18/140 (12%), Positives = 40/140 (28%), Gaps = 14/140 (10%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTR 145
+ L + + + L + + +++ + A + ++
Sbjct: 14 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 73
Query: 146 LDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNNNLNG 201
L+L+ +I + L++ N LP N L + N+
Sbjct: 74 LNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND--- 128
Query: 202 SIPATLSKFPQSSFTGNLDL 221
LS P+ F L
Sbjct: 129 -----LSSLPRGIFHNTPKL 143
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 10/103 (9%), Positives = 34/103 (33%), Gaps = 7/103 (6%)
Query: 109 IPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDV-NNLTHL 167
I S+ + +++ F +N + ++ K+P + ++ +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 168 TGLFLENNKFSGNLPS---INPANLRDFNVSNNNLNGSIPATL 207
L L + + + + ++ + N + +P +
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHV 112
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVP---- 405
E++G G+ G YK ++ G +K + + E + ++ +L K H N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 406 -LRAFYYSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
++ D++L LV ++ AGS++ L+ ++G+ L + I RGL+HLH
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---TLKEEWIAYICREILRGLSHLH 146
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFG----LNPLFG--NT---TPPTRVAGY-RAPE 513
I H +IK N+LL + + + DFG L+ G NT TP Y APE
Sbjct: 147 QHKVI-HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP------YWMAPE 199
Query: 514 VVETRKVT-----FKSDVYSFGVLLLELLTGKAPN 543
V+ + FKSD++S G+ +E+ G P
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 27/213 (12%)
Query: 345 DLLRASAEVLGKGSVGTSYKAVLEEGTTVV--VKRL-KEVAVGKREFEMQM---EVLGKI 398
R VLG+G G + A + T + K+L K+ ++ ++ M ++L K+
Sbjct: 188 LDFR----VLGRGGFGEVF-ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 399 KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR-----IAL 453
+V L + +K + LV M G + H P + R I
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 454 SAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL--NPLFGNTTPPTRV--AGY 509
GL HLH I++ ++K N+LL D + +SD GL G T G+
Sbjct: 301 ----GLEHLHQRN-IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355
Query: 510 RAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
APE++ + F D ++ GV L E++ + P
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-19
Identities = 34/169 (20%), Positives = 57/169 (33%), Gaps = 15/169 (8%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
+ + +L L+ L + I ++ F L+ L L L NQF + + +
Sbjct: 45 LNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLAN 104
Query: 143 LTRLDLSSNNF-SGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINPA-------NLRDFN 193
L L L+ N + + LT L L L +N + I PA +
Sbjct: 105 LEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN----IKKIQPASFFLNMRRFHVLD 160
Query: 194 VSNNNLNGSIPATLSKFPQSSFTGNLDLCGGPLPPCNPFFPSPAPSPSL 242
++ N + L F FT L L L N ++ +
Sbjct: 161 LTFNKVKSICEEDLLNFQGKHFT-LLRLSSITLQDMNEYWLGWEKCGNP 208
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 32/158 (20%), Positives = 50/158 (31%), Gaps = 9/158 (5%)
Query: 73 LRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQF-S 130
L++ I NT LS L +L L N+ ++ + F+ L L L L
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDG 117
Query: 131 GVFPASV-TRMNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFS----GNLPSI 184
V + + L L L NN P N+ L L NK +L +
Sbjct: 118 AVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNF 177
Query: 185 NPANLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDLC 222
+ +S+ L L + N +
Sbjct: 178 QGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSIT 215
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 30/98 (30%), Positives = 39/98 (39%), Gaps = 8/98 (8%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
I N L+ L L+L N L I S F NL L L L N + S +
Sbjct: 314 IDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPN 372
Query: 143 LTRLDLSSNNFSGKIP---FDVNNLTHLTGLFLENNKF 177
L L L +N +P FD LT L ++L N +
Sbjct: 373 LKELALDTNQLK-SVPDGIFD--RLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 29/131 (22%), Positives = 51/131 (38%), Gaps = 17/131 (12%)
Query: 84 IPPNTLGKL--SQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRM 140
T L S ++ L +++ + FS+ T L L L N+ + + + +
Sbjct: 264 PDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGL 322
Query: 141 NRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINPA------NLRDFN 193
L +L+LS N I + NL L L L N + ++ NL++
Sbjct: 323 THLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNH----IRALGDQSFLGLPNLKELA 377
Query: 194 VSNNNLNGSIP 204
+ N L S+P
Sbjct: 378 LDTNQLK-SVP 387
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 24/125 (19%), Positives = 43/125 (34%), Gaps = 14/125 (11%)
Query: 81 VGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV-TR 139
V +P + + L N ++ + FS L L+ L ++ V +
Sbjct: 25 VPELPAHV-------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRG 77
Query: 140 MNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKF-SGNLPS---INPANLRDFNV 194
++ L L L N F ++ N L +L L L L +L +
Sbjct: 78 LSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVL 136
Query: 195 SNNNL 199
+NN+
Sbjct: 137 RDNNI 141
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 22/107 (20%), Positives = 44/107 (41%), Gaps = 9/107 (8%)
Query: 101 RSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFD 160
+ L ++P +++ + L N + + S +R+ L L + I +
Sbjct: 18 INRGLH-QVPELPAHVN---YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN 73
Query: 161 V-NNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNNNLNGSI 203
L+ L L L+ N+F L + ANL ++ NL+G++
Sbjct: 74 TFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAV 119
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 28/144 (19%), Positives = 49/144 (34%), Gaps = 22/144 (15%)
Query: 81 VGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNL---TLLRSLYLQ----------SN 127
+G K + + L L N + F + T ++SL L
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259
Query: 128 QFSGVFPASVTRM--NRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS- 183
F + + + + DLS + + V ++ T L L L N+ + +
Sbjct: 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDN 317
Query: 184 --INPANLRDFNVSNNNLNGSIPA 205
+L N+S N L GSI +
Sbjct: 318 AFWGLTHLLKLNLSQNFL-GSIDS 340
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 22/204 (10%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFE--MQME--VLGKIKHDNVVPL 406
++G+G +G Y+A V +K + E F MQ E G+++ +VVP+
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 407 RAFYYSKDEKL--LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
+ + + + + L+A+L + PL + I L H
Sbjct: 100 --HDFGEIDGQLYVDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHA 152
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV------AGYRAPEVVETR 518
+G H ++K NIL+ D A + DFG+ + T++ Y APE
Sbjct: 153 AG-ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSES 210
Query: 519 KVTFKSDVYSFGVLLLELLTGKAP 542
T+++D+Y+ +L E LTG P
Sbjct: 211 HATYRADIYALTCVLYECLTGSPP 234
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 340 SFDLEDLLRASAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKI 398
+ + D + S +VLG G G + G +K L + ++E + + G
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASG-- 80
Query: 399 KHDNVVPLRAFY----YSKDEKLLVYDYMPAGSL-SALLHGSRGSGR-TPLDWDNRMRIA 452
++V + Y + K L++ + M G L S + RG T + MR
Sbjct: 81 -GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQAFTEREAAEIMRDI 137
Query: 453 LSAARGLAHLHVSGKIVHGNIKASNILLR-PDHDACV--SDFGLNPLFGNTTPPTRV--A 507
+A + LH I H ++K N+L + DA + +DFG T
Sbjct: 138 GTA---IQFLHSHN-IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTP 193
Query: 508 GYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
Y APEV+ K D++S GV++ LL G P
Sbjct: 194 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 9e-19
Identities = 62/335 (18%), Positives = 117/335 (34%), Gaps = 69/335 (20%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRL-----KEVAVGKREFEMQMEVLGKIKHDNVVP 405
VL +G Y+A + G +KRL ++ +E M+ L H N+V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCF-MKKL--SGHPNIVQ 90
Query: 406 LRAFYYSKDEK-------LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARG 458
+ E+ L+ + G L L G L D ++I R
Sbjct: 91 FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP--LSCDTVLKIFYQTCRA 148
Query: 459 LAHLHVSGK-IVHGNIKASNILLRPDHDACVSDFGL------NPLFG------------- 498
+ H+H I+H ++K N+LL + DFG P +
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 499 --NTTPPTRVAGYRAPEVVETRK---VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGID 553
NTTP YR PE+++ + K D+++ G +L L + P +
Sbjct: 209 TRNTTPM-----YRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA------ 257
Query: 554 LPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613
+V +++ + + L++ + P++R ++ EVV +
Sbjct: 258 ----KLRIVNGKYS-------IPPHDTQYTVFHSLIR---AMLQVNPEERLSIAEVVHQL 303
Query: 614 ENMNRGETDDGLRQSSDDPSKGSDGHTPPPESRTP 648
+ + + + + + + G+ SR P
Sbjct: 304 QEI-AAARNVNPKSPITELLEQNGGYGSATLSRGP 337
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 37/151 (24%), Positives = 53/151 (35%), Gaps = 17/151 (11%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
+ P T L +L L L L E+ F L L+ LYLQ N + + +
Sbjct: 96 VDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN 154
Query: 143 LTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINPA------NLRDFNVS 195
LT L L N S +P L L L L N+ + ++P L +
Sbjct: 155 LTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA----HVHPHAFRDLGRLMTLYLF 209
Query: 196 NNNLNGSIPATLSKFPQSSFTGNLDLCGGPL 226
NNL+ ++P L L P
Sbjct: 210 ANNLS-ALPTEA--LAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 30/126 (23%), Positives = 49/126 (38%), Gaps = 13/126 (10%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
IP + + + L NR+S + F L L+L SN + + A+ T + L
Sbjct: 30 IPAAS-------QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 144 TRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNNNL 199
+LDLS N + + L L L L+ L A L+ + +N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 200 NGSIPA 205
++P
Sbjct: 142 Q-ALPD 146
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 1e-18
Identities = 31/127 (24%), Positives = 54/127 (42%), Gaps = 6/127 (4%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
I ++ L + N + +P F N+ LL L L+ N S + +
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 148
Query: 143 LTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNG 201
LT L +S+NN +I D T L L L +N+ + ++ +L NVS N L+
Sbjct: 149 LTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS- 205
Query: 202 SIPATLS 208
++ ++
Sbjct: 206 TLAIPIA 212
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 88.1 bits (218), Expect = 2e-18
Identities = 26/124 (20%), Positives = 45/124 (36%), Gaps = 5/124 (4%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
I + K+ +L L + +NRL + + L+ L L N V + + +RL
Sbjct: 269 IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHV-ERNQPQFDRL 326
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSI 203
L L N+ + L L L +N + N N+ V + + + I
Sbjct: 327 ENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 383
Query: 204 PATL 207
L
Sbjct: 384 DYQL 387
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 7e-18
Identities = 28/146 (19%), Positives = 50/146 (34%), Gaps = 6/146 (4%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
L L + L N L +I F + L LY+ +N+ +
Sbjct: 245 TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 302
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNG- 201
L LDLS N+ + + L L+L++N L L++ +S+N+ +
Sbjct: 303 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDCN 360
Query: 202 SIPATLSKFPQSSFTGNLDLCGGPLP 227
S+ A + + C
Sbjct: 361 SLRALFRNVARPAVDDADQHCKIDYQ 386
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 6e-17
Identities = 30/145 (20%), Positives = 58/145 (40%), Gaps = 18/145 (12%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
+P L Q+ +L+L ++ EI + F+ ++ LY+ N + P +
Sbjct: 66 LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 124
Query: 143 LTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNNN 198
LT L L N+ S +P + +N LT L + NN + +L++ +S+N
Sbjct: 125 LTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 182
Query: 199 LNGSIPATLSKFPQSSFTG--NLDL 221
L+ S + ++
Sbjct: 183 --------LTHVDLSLIPSLFHANV 199
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 4e-13
Identities = 29/149 (19%), Positives = 46/149 (30%), Gaps = 28/149 (18%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIP-----------------SDFSNLTLLRSLYLQS 126
I +T + L+ L L SNRL+ + S + + L
Sbjct: 162 IEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASH 220
Query: 127 NQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS--- 183
N + V LT L L NN + + N L + L N+ +
Sbjct: 221 NSINVVRGPV---NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPF 274
Query: 184 INPANLRDFNVSNNNLNGSIPATLSKFPQ 212
+ L +SNN L ++ P
Sbjct: 275 VKMQRLERLYISNNRLV-ALNLYGQPIPT 302
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 20/142 (14%), Positives = 47/142 (33%), Gaps = 18/142 (12%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTL--LRSLYLQSNQFSGVFPASVTRMNRL 143
+ L + + + + ++ F ++TL + + +++ + A + ++
Sbjct: 20 DSNLQYDCVFYDVHI--DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 144 TRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNNNL 199
L+L+ +I + L++ N LP N L + N+
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND- 134
Query: 200 NGSIPATLSKFPQSSFTGNLDL 221
LS P+ F L
Sbjct: 135 -------LSSLPRGIFHNTPKL 149
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 10/104 (9%), Positives = 34/104 (32%), Gaps = 7/104 (6%)
Query: 108 EIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDV-NNLTH 166
I S+ + +++ F +N + ++ K+P + ++
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76
Query: 167 LTGLFLENNKFSGNLPS---INPANLRDFNVSNNNLNGSIPATL 207
+ L L + + + + ++ + N + +P +
Sbjct: 77 VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHV 118
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 55/202 (27%), Positives = 85/202 (42%), Gaps = 19/202 (9%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM---QMEVLGKIKHDNVVPLR 407
+LGKGS G K VK + + + ++ ++E+L K+ H N++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 408 AFYYSKDEKLLVYDYMPAGSL-SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+V + G L ++ R S D ++ S + ++H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH---DAARIIKQVFSG---ITYMHKHN 141
Query: 467 KIVHGNIKASNILLR-PDHDACV--SDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKV 520
IVH ++K NILL + D + DFGL+ F T G Y APEV+
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTY 199
Query: 521 TFKSDVYSFGVLLLELLTGKAP 542
K DV+S GV+L LL+G P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 2e-18
Identities = 30/132 (22%), Positives = 56/132 (42%), Gaps = 4/132 (3%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPAS--VTRMN 141
+ K+S L +N L+ + + +LT L +L LQ NQ + + T+M
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374
Query: 142 RLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN 200
L +LD+S N+ S + L L + +N + + P ++ ++ +N +
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK 434
Query: 201 GSIPATLSKFPQ 212
SIP + K
Sbjct: 435 -SIPKQVVKLEA 445
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 32/141 (22%), Positives = 50/141 (35%), Gaps = 15/141 (10%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+ T +L++ N +S SD +L+ LR L + N+ + + L
Sbjct: 19 LSQKT-------TILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINP----ANLRDFNVSNNNL 199
LDLS N KI +L L L N F LP + L+ +S +L
Sbjct: 72 EYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHL 127
Query: 200 NGSIPATLSKFPQSSFTGNLD 220
S ++ S L
Sbjct: 128 EKSSVLPIAHLNISKVLLVLG 148
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 27/125 (21%), Positives = 45/125 (36%), Gaps = 14/125 (11%)
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMN 141
++ L+ L + N +S + S L SL + SN + +
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP-- 421
Query: 142 RLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPA------NLRDFNVS 195
R+ LDL SN IP V L L L + +N+ L S+ +L+ +
Sbjct: 422 RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQ----LKSVPDGIFDRLTSLQKIWLH 476
Query: 196 NNNLN 200
N +
Sbjct: 477 TNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 24/149 (16%), Positives = 52/149 (34%), Gaps = 12/149 (8%)
Query: 66 NRSFVYSLRLPGVGLVGPIPPNTLG----KLSQLRVLSLRSNRLSGEIPSDFSNLTLLRS 121
+ V+ + V L G + L L + + S+ + + +
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 122 LYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGN 180
+ V ++++ LD S+N + F+ +LT L L L+ N+
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETLILQMNQLK-E 362
Query: 181 LPSI-----NPANLRDFNVSNNNLNGSIP 204
L I +L+ ++S N+++
Sbjct: 363 LSKIAEMTTQMKSLQQLDISQNSVSYDEK 391
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 25/108 (23%), Positives = 42/108 (38%), Gaps = 9/108 (8%)
Query: 73 LRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV 132
L + + L L++ SN L+ I ++ L L SN+
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-S 435
Query: 133 FPASVTRMNRLTRLDLSSNNFSGKIP---FDVNNLTHLTGLFLENNKF 177
P V ++ L L+++SN +P FD LT L ++L N +
Sbjct: 436 IPKQVVKLEALQELNVASNQLK-SVPDGIFD--RLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 22/137 (16%), Positives = 43/137 (31%), Gaps = 7/137 (5%)
Query: 90 GKLSQLRVLSLRSNRL-SGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L+ L L N + I +F N++ L+ L L + + +N L +
Sbjct: 87 HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146
Query: 149 SSNNFSGKIPFDV---NNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPA 205
+ K + N L +F N +F L + + N+ +N+ +
Sbjct: 147 LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFIL---DVSVKTVANLELSNIKCVLED 203
Query: 206 TLSKFPQSSFTGNLDLC 222
+ S
Sbjct: 204 NKCSYFLSILAKLQTNP 220
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 19/169 (11%), Positives = 44/169 (26%), Gaps = 11/169 (6%)
Query: 85 PPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPA---SVTRMN 141
G +SQL+ L L + L ++L + + L + +
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166
Query: 142 RLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINP--------ANLRDFN 193
L + ++ F + V + +L ++ L +
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLT 226
Query: 194 VSNNNLNGSIPATLSKFPQSSFTGNLDLCGGPLPPCNPFFPSPAPSPSL 242
++N + + + + + L F SL
Sbjct: 227 LNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSL 275
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 24/203 (11%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQM----EVLGKIKHDNVVPLRA 408
LGKGS Y+A + G V +K + + A+ K ++ ++ ++KH +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
++ + LV + G ++ L P + G+ +LH S I
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEARHFMHQIITGMLYLH-SHGI 133
Query: 469 VHGNIKASNILLRPDHDACVSDFGLNPLFGNT---------TPPTRVAGYRAPEVVETRK 519
+H ++ SN+LL + + ++DFGL TP Y +PE+
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN-----YISPEIATRSA 188
Query: 520 VTFKSDVYSFGVLLLELLTGKAP 542
+SDV+S G + LL G+ P
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPP 211
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 64/205 (31%), Positives = 89/205 (43%), Gaps = 26/205 (12%)
Query: 353 VLGKGSVGTSYKAVLEEGTTVV--VKRL-KEVAVGKREFEMQM---EVLGKIKHDNVVPL 406
VLGKG G A T + K+L K+ ++ M + ++L K+ VV L
Sbjct: 191 VLGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR-----IALSAARGLAH 461
Y +KD LV M G L H G+ + R I GL
Sbjct: 250 AYAYETKDALCLVLTLMNGGDL--KFHIYH-MGQAGFP-EARAVFYAAEICC----GLED 301
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGL--NPLFGNTTPPTRV--AGYRAPEVVET 517
LH IV+ ++K NILL +SD GL + G T RV GY APEVV+
Sbjct: 302 LHRER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK-GRVGTVGYMAPEVVKN 359
Query: 518 RKVTFKSDVYSFGVLLLELLTGKAP 542
+ TF D ++ G LL E++ G++P
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 47/253 (18%), Positives = 88/253 (34%), Gaps = 44/253 (17%)
Query: 385 KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVY---DYMPAGSLSALLHGSRGSGRT 441
+++ ++ + K+ +Y +L + +R
Sbjct: 103 SPMDAPSVKI-RRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM--NRRCSLE 159
Query: 442 PLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL-----NPL 496
+ + I + A + LH S ++H ++K SNI D V DFGL
Sbjct: 160 DREHGVCLHIFIQIAEAVEFLH-SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218
Query: 497 FGNTTPP--------TRVAG---YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQA 545
T T G Y +PE + + K D++S G++L ELL +
Sbjct: 219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST--- 275
Query: 546 SLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPA 605
E + + + V + F + + + E MVQ + +S P +RP
Sbjct: 276 --QMERVRI---ITDVRNLK-----FPLLFTQKYPQEHMMVQDM------LSPSPTERPE 319
Query: 606 MQEVVRM--IENM 616
+++ EN+
Sbjct: 320 ATDIIENAIFENL 332
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 55/265 (20%), Positives = 88/265 (33%), Gaps = 39/265 (14%)
Query: 292 GKAPKPPAAATARAVTMEAGTSSSKDDITGGAAEADRNKLVFFEGGVYSFDLEDLLRASA 351
G AP P A V +++ D + G
Sbjct: 1 GPAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRG-------------- 46
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQM----EVLGKIKHDNVVPL 406
LGKG ++ + K + + + K +M + + H +VV
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
F+ D +V + SL L R L G +LH
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVLGCQYLH-RN 160
Query: 467 KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---------TPPTRVAGYRAPEVVET 517
+++H ++K N+ L D + + DFGL TP Y APEV+
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN-----YIAPEVLSK 215
Query: 518 RKVTFKSDVYSFGVLLLELLTGKAP 542
+ +F+ DV+S G ++ LL GK P
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 49/242 (20%), Positives = 84/242 (34%), Gaps = 27/242 (11%)
Query: 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSD--FSNLTLLRSLYLQSNQF 129
+ L L L ++ L++L L NR S D S L L+L N
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENML 463
Query: 130 SGVFPASVTR-----MNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS 183
+ + ++ L L L+ N + +P V ++LT L GL L +N+ + +
Sbjct: 464 QLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSHN 522
Query: 184 INPANLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDLCGGPL----------------P 227
PANL ++S N L P T N +C L P
Sbjct: 523 DLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGP 582
Query: 228 PCNPFFPSPAPSPSLP-PPVAPVHKKSNKLSTAAIVGIAVGGAVFIVLLLLLLLFCLKKR 286
P + + P + ++ ++ + + + V + L L+ +L K R
Sbjct: 583 PADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFR 642
Query: 287 RR 288
Sbjct: 643 GF 644
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 4e-18
Identities = 32/144 (22%), Positives = 48/144 (33%), Gaps = 9/144 (6%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVF--PASVTRM 140
I L LR+L L S+++ + D F L L L L S +
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122
Query: 141 NRLTRLDLSSNNFSG-KIPFDVNNLTHLTGLFLENNKFS----GNLPSINPANLRDFNVS 195
LTRLDLS N + L L + +N+ L + L F+++
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182
Query: 196 NNNLNGSIPATLSKFPQSSFTGNL 219
N+L + K L
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVL 206
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 8e-17
Identities = 43/225 (19%), Positives = 77/225 (34%), Gaps = 18/225 (8%)
Query: 85 PPNTLGKLSQLRVLSLRSNRLSGEIPSD-----FSNLTLLRSLYLQSNQFSGVFPASVTR 139
T + L L L N L ++ F L+ L+ LYL N + + P +
Sbjct: 443 GDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSH 502
Query: 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNL 199
+ L L L+SN + + + +L L + N+ +L ++++N
Sbjct: 503 LTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLL-APNPDVFVSLSVLDITHNKF 559
Query: 200 NGSIPATLSKFPQSSFTGNLDLCGGP--LPPCNPFFPSPAPSPSLPPPVAPVHKKSNKLS 257
LS F N+ + G P + P S SL + L
Sbjct: 560 ICECE--LSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLK 617
Query: 258 TAAIVGIAVGGAVFIVLLLLLLLF------CLKKRRRQRPGKAPK 296
+ + V +F++ +L + F C K +R P+
Sbjct: 618 FSLFIVCTVTLTLFLMTILTVTKFRGFCFICYKTAQRLVFKDHPQ 662
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 4e-16
Identities = 30/140 (21%), Positives = 58/140 (41%), Gaps = 14/140 (10%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
+ L L+VL+L N+++ +I + F L L+ L L N ++ ++ + +
Sbjct: 281 LNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPK 339
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGS 202
+ +DL N+ + L L L L +N + + I ++ D +S N
Sbjct: 340 VAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIHFIP--SIPDIFLSGNK---- 392
Query: 203 IPATLSKFPQSSFTGN-LDL 221
L P+ + T N + L
Sbjct: 393 ----LVTLPKINLTANLIHL 408
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 3e-15
Identities = 24/121 (19%), Positives = 43/121 (35%), Gaps = 4/121 (3%)
Query: 84 IPPNTLGKL--SQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMN 141
NT L S +R L L + F L L+ L L N+ + + + ++
Sbjct: 255 PDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLD 314
Query: 142 RLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNL 199
L L+LS N + L + + L+ N + L+ ++ +N L
Sbjct: 315 NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL 374
Query: 200 N 200
Sbjct: 375 T 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 4e-15
Identities = 28/136 (20%), Positives = 41/136 (30%), Gaps = 12/136 (8%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV-TRMNR 142
+P L+ L L N + S F L L+ L L S +
Sbjct: 19 VPQV----LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74
Query: 143 LTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINP----ANLRDFNVSNN 197
L LDL S+ + D L HL L L S + L ++S N
Sbjct: 75 LRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN 133
Query: 198 NLNG-SIPATLSKFPQ 212
+ + + K
Sbjct: 134 QIRSLYLHPSFGKLNS 149
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 6e-14
Identities = 29/162 (17%), Positives = 55/162 (33%), Gaps = 24/162 (14%)
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSG-EIPSDFSNLTLLRSLYLQSNQFSGVFPASVT--R 139
+ L L L L N++ + F L L+S+ SNQ V + +
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172
Query: 140 MNRLTRLDLSSNNFSGKIPFD-VNNLTHLTGLFLENNKFSGNLPSINPA----------- 187
L+ L++N+ ++ D + + LE SGN +++
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232
Query: 188 --------NLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDL 221
++ +N+ T + +SS +LDL
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVR-HLDL 273
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 6e-13
Identities = 23/112 (20%), Positives = 42/112 (37%), Gaps = 9/112 (8%)
Query: 96 RVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSG 155
R+ R L+ ++P + L L N V +S + +L L+L S
Sbjct: 7 RIAFYRFCNLT-QVPQVLNTTE---RLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 156 KIPFDV-NNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNNNLNGSI 203
I + NL +L L L ++K L +L + + L+ ++
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAV 113
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 33/183 (18%), Positives = 55/183 (30%), Gaps = 54/183 (29%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFP--------- 134
I T L +L+ L LR N L+ + + ++L N+ +
Sbjct: 353 IQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIH 407
Query: 135 ------------ASVTRMNRLTRLDLSSNNFSGKIPFDV--NNLTHLTGLFLENNKFSGN 180
+ R+ L L L+ N FS D + L LFL N
Sbjct: 408 LSENRLENLDILYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLA 466
Query: 181 LPSINPA-------NLRDFNVSNNNLNGSIPAT-----------------LSKFPQSSFT 216
+ +L+ +++N LN S+P L+ +
Sbjct: 467 WETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP 525
Query: 217 GNL 219
NL
Sbjct: 526 ANL 528
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 41/214 (19%), Positives = 70/214 (32%), Gaps = 21/214 (9%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+ + LS L+VL L N L+ P FS+LT LR L L SN+ + + + L
Sbjct: 471 LCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANL 528
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSI 203
LD+S N + + L+ L + +NKF + ++ N
Sbjct: 529 EILDISRNQLLA---PNPDVFVSLSVLDITHNKFIC---ECELSTFINWLNHTNVTIAGP 582
Query: 204 PATLSKFPQSSFTGN--LDLCGGPLPPCNPFFPSPAPSPSLPPPVAPVHKKSNKLSTAAI 261
PA + SF+G L C+ + SL ++
Sbjct: 583 PADIYCVYPDSFSGVSLFSL---STEGCDEEEVLKSLKFSLFIVCT--------VTLTLF 631
Query: 262 VGIAVGGAVFIVLLLLLLLFCLKKRRRQRPGKAP 295
+ + F + + + P
Sbjct: 632 LMTILTVTKFRGFCFICYKTAQRLVFKDHPQGTE 665
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 31/175 (17%), Positives = 51/175 (29%), Gaps = 39/175 (22%)
Query: 73 LRLPGVGLVGPIPPNTLGKLSQLRVLSLR-----SNRLSGEIPSDFSN------------ 115
L L + + ++ R + L N + +I +FSN
Sbjct: 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLIL 238
Query: 116 LTLLRSLYLQSNQFSGVFPASVTRMNR--LTRLDLSSNNFSGKIPFDV-NNLTHLTGLFL 172
+ + + + R + LDLS + V L L L L
Sbjct: 239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNL 297
Query: 173 ENNKFSGNLPSINPA------NLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDL 221
NK + I NL+ N+S N L + S+F G +
Sbjct: 298 AYNKIN----KIADEAFYGLDNLQVLNLSYNL--------LGELYSSNFYGLPKV 340
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 4e-18
Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 37/210 (17%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKRE-FEMQMEVLGKIKHDNVVPLRAF 409
EVLG G+ + G +K +K+ + E ++ VL KIKH+N+V L
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDW----------DNR--MRIALSAAR 457
Y S LV + G L D D ++ LSA
Sbjct: 75 YESTTHYYLVMQLVSGGEL--------------FDRILERGVYTEKDASLVIQQVLSA-- 118
Query: 458 GLAHLHVSGKIVHGNIKASNILLR-PDHDACV--SDFGLNPLFGNTTPPTRV--AGYRAP 512
+ +LH +G IVH ++K N+L P+ ++ + +DFGL+ + N T GY AP
Sbjct: 119 -VKYLHENG-IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAP 176
Query: 513 EVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
EV+ + + D +S GV+ LL G P
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 67/217 (30%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREF-EMQMEVLGKIKHDNVVPLRAF 409
+V+G GS G Y+A L + G V +K++ + + + E+Q+ + K+ H N+V LR F
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQI--MRKLDHCNIVRLRYF 115
Query: 410 YYSKDEKL------LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
+YS EK LV DY+P ++ + + L R LA++H
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVAR-HYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 464 VSGKIVHGNIKASNILLRPDHDAC-VSDFGLNPLFGNTTPPTR-VAG--YRAPEVV-ETR 518
S I H +IK N+LL PD + DFG P + YRAPE++
Sbjct: 174 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 232
Query: 519 KVTFKSDVYSFGVLLLELLTGKA--PNQASLGEEGID 553
T DV+S G +L ELL G+ P G+ G+D
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQPIFP-----GDSGVD 264
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 7e-18
Identities = 32/129 (24%), Positives = 50/129 (38%), Gaps = 13/129 (10%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
I + +QL L N+++ E+ D S LL L +N + + + + +L
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKIT-EL--DVSQNKLLNRLNCDTNNITKL---DLNQNIQL 214
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSI 203
T LD SSN + DV LT LT N + L + L + +L I
Sbjct: 215 TFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQTDLL-EI 269
Query: 204 PATLSKFPQ 212
L+ Q
Sbjct: 270 D--LTHNTQ 276
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 21/119 (17%), Positives = 41/119 (34%), Gaps = 8/119 (6%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
I + +QL +L ++ ++ E+ D S L LYL + + + + V+ +L
Sbjct: 288 IKELDVTHNTQLYLLDCQAAGIT-EL--DLSQNPKLVYLYLNNTELTEL---DVSHNTKL 341
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGS 202
L + + V + L F + N VS + L+
Sbjct: 342 KSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQF 398
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 29/124 (23%), Positives = 52/124 (41%), Gaps = 12/124 (9%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L + + L L+ SN+L+ + + LT L L +N+ + + V++ LT L+
Sbjct: 81 LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL---DVSQNPLLTYLNC 134
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLS 208
+ N + DV++ T LT L NK L L + S N + + +S
Sbjct: 135 ARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT-ELD--VS 188
Query: 209 KFPQ 212
+
Sbjct: 189 QNKL 192
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 27/143 (18%), Positives = 50/143 (34%), Gaps = 12/143 (8%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L +QL R E+ D ++ T L L Q+ + + +++ +L L L
Sbjct: 271 LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYL 325
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATL 207
++ + DV++ T L L N + S+ L + + TL
Sbjct: 326 NNTELTE---LDVSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTITMPKETL 381
Query: 208 SKFPQSSFTGN--LDLCGGPLPP 228
+ + LD G P+
Sbjct: 382 TNNSLTIAVSPDLLDQFGNPMNI 404
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 12/124 (9%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L + QL L SN+L+ EI D + LT L N + + V+ +++LT L
Sbjct: 208 LNQNIQLTFLDCSSNKLT-EI--DVTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHC 261
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLS 208
+ D+ + T L E + L + L + + + LS
Sbjct: 262 IQTDLLE---IDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LS 315
Query: 209 KFPQ 212
+ P+
Sbjct: 316 QNPK 319
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 24/117 (20%), Positives = 42/117 (35%), Gaps = 6/117 (5%)
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
N + + L L SL ++ + + + ++
Sbjct: 8 TQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTG 65
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNL 199
LT+L +SNN + D++ T+LT L ++NK + NL L N N L
Sbjct: 66 LTKLICTSNNITT---LDLSQNTNLTYLACDSNKLT-NLDVTPLTKLTYLNCDTNKL 118
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 28/137 (20%), Positives = 52/137 (37%), Gaps = 14/137 (10%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L + +L L L + L+ E+ D S+ T L+SL + +SV ++ L
Sbjct: 314 LSQNPKLVYLYLNNTELT-EL--DVSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFE 368
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKF--SGNLPSINPANLRDFNVSNN-----NLNG 201
+ +P + LT + + + GN +I P + ++ + N NL+
Sbjct: 369 AEGQTI-TMPKETLTNNSLT-IAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLST 426
Query: 202 SIPATLSKFPQSSFTGN 218
PA F +
Sbjct: 427 DNPAVTYTFTSENGAIV 443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 17/94 (18%), Positives = 35/94 (37%), Gaps = 6/94 (6%)
Query: 119 LRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFS 178
S + + S ++ LT LD +++ + + + LT LT L +N +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 179 GNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQ 212
L NL +N L ++ ++ +
Sbjct: 78 -TLDLSQNTNLTYLACDSNKLT-NLD--VTPLTK 107
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 51/220 (23%), Positives = 86/220 (39%), Gaps = 49/220 (22%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVK-------RLKEVAVGKREFEMQMEVLGKIKHDNV 403
E LG G K G K R V + E E ++ +L ++ H NV
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIA----LS---AA 456
+ L Y ++ + +L+ + + G L +D +A LS A
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGEL----------------FD---FLAQKESLSEEEAT 118
Query: 457 R-------GLAHLHVSGKIVHGNIKASNILLR-PDHDAC---VSDFGLNPLFGNTTPPTR 505
G+ +LH I H ++K NI+L + + DFGL +
Sbjct: 119 SFIKQILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 506 VAG---YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
+ G + APE+V + ++D++S GV+ LL+G +P
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 49/207 (23%), Positives = 87/207 (42%), Gaps = 23/207 (11%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVK-------RLKEVAVGKREFEMQMEVLGKIKHDNV 403
E LG G K G K V + E E ++ +L +I+H N+
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSL-SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
+ L + +K + +L+ + + G L L + S T + ++ L G+ +L
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFLA--EKES-LTEDEATQFLKQILD---GVHYL 124
Query: 463 HVSGKIVHGNIKASNILL----RPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVV 515
H I H ++K NI+L P+ + DFG+ + G + APE+V
Sbjct: 125 HSKR-IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 516 ETRKVTFKSDVYSFGVLLLELLTGKAP 542
+ ++D++S GV+ LL+G +P
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 31/135 (22%), Positives = 54/135 (40%), Gaps = 8/135 (5%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
I L + L+VL L+S+R++ I D F +L L L L N S + + ++
Sbjct: 41 IGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSS 99
Query: 143 LTRLDLSSNNFSGKIPFD--VNNLTHLTGLFLENNKFSGNLPSI---NPANLRDFNVSNN 197
L L+L N + + NLT+L L + N + + I +L + +
Sbjct: 100 LKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158
Query: 198 NLNGSIPATLSKFPQ 212
+L +L
Sbjct: 159 SLRNYQSQSLKSIRD 173
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 8e-17
Identities = 31/155 (20%), Positives = 42/155 (27%), Gaps = 27/155 (17%)
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
L L L L + N +P +R L L S V
Sbjct: 377 QKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCI---PQT 432
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGS 202
L LD+S+NN L L L++ NK + L +S N
Sbjct: 433 LEVLDVSNNNLD-SFS---LFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQ---- 484
Query: 203 IPATLSKFPQSSFTG-----NLDLCGGPLPPCNPF 232
L P F + L NP+
Sbjct: 485 ----LKSVPDGIFDRLTSLQKIWLHT------NPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 25/153 (16%), Positives = 55/153 (35%), Gaps = 15/153 (9%)
Query: 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSG----EIPSD-FSNLTLLRSLYL 124
L G+G P + + +L ++ +++R + S +S L ++ + +
Sbjct: 258 FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITV 317
Query: 125 QSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFD---VNNLTHLTGLFLENNKFSGNL 181
++++ V + + L LDLS N + + L L L N ++
Sbjct: 318 ENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SM 376
Query: 182 PSINPA-----NLRDFNVSNNNLNGSIPATLSK 209
NL ++S N + +P +
Sbjct: 377 QKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW 408
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-14
Identities = 30/143 (20%), Positives = 52/143 (36%), Gaps = 25/143 (17%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
IP + ++ L L N+++ D L+ L L+S++ + + + + L
Sbjct: 20 IPSGLT---AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76
Query: 144 TRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFS--------GNLPSINPANLRDFNV 194
LDLS N+ S + L+ L L L N + NL NL+ +
Sbjct: 77 EHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT-----NLQTLRI 130
Query: 195 SNNNLNGSIPATLSKFPQSSFTG 217
N S+ + F G
Sbjct: 131 GNVET-------FSEIRRIDFAG 146
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 22/125 (17%), Positives = 45/125 (36%), Gaps = 1/125 (0%)
Query: 85 PPNTLGKLSQLRVLSLRSNRLSGEIP-SDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+ L+ L+ L + + EI DF+ LT L L +++ S+ + +
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI 174
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSI 203
L L + + + + L+ + L L + + S P + + GS+
Sbjct: 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234
Query: 204 PATLS 208
S
Sbjct: 235 LTDES 239
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 19/150 (12%), Positives = 43/150 (28%), Gaps = 12/150 (8%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
I L+ L L +++ L ++ + L L ++ + + ++ +
Sbjct: 139 IRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSV 198
Query: 144 TRLDLSSNN--------FSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPA-NLRDFNV 194
L+L N G L + F+ L + L +
Sbjct: 199 RYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEF 258
Query: 195 SNNNLNG---SIPATLSKFPQSSFTGNLDL 221
+ LNG P+ + + +
Sbjct: 259 DDCTLNGLGDFNPSESDVVSELGKVETVTI 288
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 21/152 (13%), Positives = 46/152 (30%), Gaps = 12/152 (7%)
Query: 66 NRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQ 125
+ SF L+L + + + + + +R L++
Sbjct: 237 DESFNELLKLLR--YILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIP 294
Query: 126 SNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSI 184
+ + ++ R+ + ++ +P +L L L L N
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMV-EEYLK 352
Query: 185 NPA------NLRDFNVSNNNLNGSIPATLSKF 210
N A +L+ +S N+L S+ T
Sbjct: 353 NSACKGAWPSLQTLVLSQNHLR-SMQKTGEIL 383
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 23/207 (11%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVK-------RLKEVAVGKREFEMQMEVLGKIKHDNV 403
E LG G K G K + V + + E ++ +L +I+H NV
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSL-SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
+ L Y +K + +L+ + + G L L + S T + ++ L+ + +L
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELFDFLA--EKES-LTEEEATEFLKQILNG---VYYL 130
Query: 463 HVSGKIVHGNIKASNILLR----PDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVV 515
H I H ++K NI+L P + DFGL + G + APE+V
Sbjct: 131 HSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 516 ETRKVTFKSDVYSFGVLLLELLTGKAP 542
+ ++D++S GV+ LL+G +P
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASP 216
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 57/285 (20%), Positives = 97/285 (34%), Gaps = 31/285 (10%)
Query: 284 KKRRRQRPGKAPKPPAAATARAVTMEAGTSSSKDDITGGAAEADRNKLVFFEGGVYSFDL 343
+ + P AP PP A+ + +
Sbjct: 6 QGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQI------KKNAI 59
Query: 344 EDLLRASAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDN 402
D + +++VLG G G + +K L++ +RE E+ +
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ---CPH 116
Query: 403 VVPLRAFY----YSKDEKLLVYDYMPAGSL-SALLHGSRGSGR-TPLDWDNRMRIALSAA 456
+V + Y + L+V + + G L S + RG T + M+ A
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEA- 173
Query: 457 RGLAHLHVSGKIVHGNIKASNILLR-PDHDACV--SDFGLNPLFGNTTP-PTRV--AGYR 510
+ +LH I H ++K N+L +A + +DFG + T Y
Sbjct: 174 --IQYLHSIN-IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 230
Query: 511 APEVVETRKVTFKSDVYSFGVLLLELLTGKAP---NQASLGEEGI 552
APEV+ K D++S GV++ LL G P N G+
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 275
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 47/205 (22%), Positives = 76/205 (37%), Gaps = 25/205 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQM----EVLGKIKHDNVVPL 406
LGKG ++ + K + + + K +M + + H +VV
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
F+ D +V + SL L R L G +LH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVLGCQYLH-RN 134
Query: 467 KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---------TPPTRVAGYRAPEVVET 517
+++H ++K N+ L D + + DFGL TP Y APEV+
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN-----YIAPEVLSK 189
Query: 518 RKVTFKSDVYSFGVLLLELLTGKAP 542
+ +F+ DV+S G ++ LL GK P
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 50/220 (22%), Positives = 86/220 (39%), Gaps = 49/220 (22%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVK-------RLKEVAVGKREFEMQMEVLGKIKHDNV 403
E LG G K G K R V + E E ++ +L ++ H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIA----LS---AA 456
+ L Y ++ + +L+ + + G L +D +A LS A
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGEL----------------FD---FLAQKESLSEEEAT 118
Query: 457 R-------GLAHLHVSGKIVHGNIKASNILL--RPDHDACV--SDFGLNPLFGNTTPPTR 505
G+ +LH I H ++K NI+L + + DFGL +
Sbjct: 119 SFIKQILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 506 VAG---YRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
+ G + APE+V + ++D++S GV+ LL+G +P
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGK-REFEMQMEVLGKIKHDNVVPLRAFY 410
+V+G GS G ++A L E V +K++ + K RE ++ + +KH NVV L+AF+
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQI----MRIVKHPNVVDLKAFF 101
Query: 411 YSKDEKL------LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
YS +K LV +Y+P ++ + + R LA++H
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TVYRASR-HYAKLKQTMPMLLIKLYMYQLLRSLAYIH- 158
Query: 465 SGKIVHGNIKASNILLRPDHDAC-VSDFGLNPLFGNTTPPTR-VAG--YRAPEVVET-RK 519
S I H +IK N+LL P + DFG + P + YRAPE++
Sbjct: 159 SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATN 218
Query: 520 VTFKSDVYSFGVLLLELLTGKA--PNQASLGEEGID 553
T D++S G ++ EL+ G+ P GE GID
Sbjct: 219 YTTNIDIWSTGCVMAELMQGQPLFP-----GESGID 249
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 30/133 (22%), Positives = 44/133 (33%), Gaps = 10/133 (7%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFS----NLTLLRSLYLQSNQF---SGVFPAS 136
+ L L L N GE + L+ L L++ SGV A
Sbjct: 164 FSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223
Query: 137 VTRMNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINPANLRDFNVS 195
+L LDLS N+ + + L L L +P PA L ++S
Sbjct: 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPAKLSVLDLS 282
Query: 196 NNNLNGSIPATLS 208
N L+ P+
Sbjct: 283 YNRLD-RNPSPDE 294
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 32/163 (19%), Positives = 53/163 (32%), Gaps = 16/163 (9%)
Query: 66 NRSFVYSLRLPGVGLVGPIPPNTL-GKLSQLRVLSLRSNRLSGE--IPSDFSNLTL--LR 120
S + L L + + G PP L L +L+LR+ + ++ L+
Sbjct: 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLK 152
Query: 121 SLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFD----VNNLTHLTGLFLENNK 176
L + V L+ LDLS N G+ L L L N
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 177 FSGNLPSINPA------NLRDFNVSNNNLNGSIPATLSKFPQS 213
+ A L+ ++S+N+L + A +P
Sbjct: 213 ME-TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 23/122 (18%), Positives = 42/122 (34%), Gaps = 4/122 (3%)
Query: 79 GLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV- 137
GL+ + P L L + + SG + + L+ L L N A
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 138 TRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNN 197
++L L+LS ++P + L+ L L N+ N + + ++ N
Sbjct: 250 DWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGN 306
Query: 198 NL 199
Sbjct: 307 PF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 23/98 (23%), Positives = 31/98 (31%), Gaps = 6/98 (6%)
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIP-SDFSNLTLLRSLYLQSNQFSGVFPASVTRMN 141
+ QL+ L L N L + L SL L V +
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAK-- 275
Query: 142 RLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSG 179
L+ LDLS N P + L + L L+ N F
Sbjct: 276 -LSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 37/203 (18%), Positives = 63/203 (31%), Gaps = 24/203 (11%)
Query: 53 DSACNWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSD 112
+CN+ + D + +F L V L G G S +L +D
Sbjct: 12 SCSCNFSDPKPDWSSAFN-CLGAADVELYG-------GGRSLEYLLKRVDTEADLGQFTD 63
Query: 113 FSNLTLLRSLYLQSNQFSGVFPASVTR---MNRLTRLDLSSNNFSGKIPFDVNNLTH--L 167
L+ L +++ + R ++ L L L + +G P + T L
Sbjct: 64 IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDL 123
Query: 168 TGLFLENNK------FSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDL 221
L L N + L L+ +++ + + FP S LDL
Sbjct: 124 NILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALST---LDL 180
Query: 222 CGGPLPPCNPFFPSPAPS--PSL 242
P + P P+L
Sbjct: 181 SDNPELGERGLISALCPLKFPTL 203
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 32/121 (26%), Positives = 49/121 (40%), Gaps = 8/121 (6%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
I LS LR L+L L EIP + + L L L L N S + P S + L
Sbjct: 176 ISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHL 233
Query: 144 TRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNNNL 199
+L + + I + +NL L + L +N + LP +L ++ +N
Sbjct: 234 QKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
Query: 200 N 200
N
Sbjct: 292 N 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 33/127 (25%), Positives = 51/127 (40%), Gaps = 8/127 (6%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
I N+ L L +L L N + I F+ L L +L L N+ + + + +++
Sbjct: 79 IKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSK 137
Query: 143 LTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNNN 198
L L L +N IP N + L L L K + +NLR N++ N
Sbjct: 138 LKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCN 196
Query: 199 LNGSIPA 205
L IP
Sbjct: 197 LR-EIPN 202
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 36/154 (23%), Positives = 52/154 (33%), Gaps = 27/154 (17%)
Query: 63 CDANRSFVY--SLRLPGVGLVGP--IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTL 118
C S V L V P I NT R+L+L N++ + F +L
Sbjct: 41 CSNQFSKVICVRKNLREV----PDGISTNT-------RLLNLHENQIQIIKVNSFKHLRH 89
Query: 119 LRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKF 177
L L L N + + + L L+L N + IP L+ L L+L NN
Sbjct: 90 LEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI 148
Query: 178 SGNLPSINPA------NLRDFNVSNNNLNGSIPA 205
SI +LR ++ I
Sbjct: 149 E----SIPSYAFNRIPSLRRLDLGELKRLSYISE 178
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEM---QMEVLGKIKHDNVVPLR 407
E LGKG+ + V + G K + + R+F+ + + K++H N+V L
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 408 AFYYSKDEKLLVYDYMPAGSL-SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+ LV+D + G L ++ +R + D + ++ L + +A+ H +G
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIV--AREF-YSEADASHCIQQILES---IAYCHSNG 125
Query: 467 KIVHGNIKASNILLR-PDHDACV--SDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKV 520
IVH N+K N+LL A V +DFGL ++ AG Y +PEV++
Sbjct: 126 -IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 521 TFKSDVYSFGVLLLELLTGKAP 542
+ D+++ GV+L LL G P
Sbjct: 185 SKPVDIWACGVILYILLVGYPP 206
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 15/212 (7%)
Query: 342 DLEDLLRASAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM---QMEVLGK 397
+ + +++ LG+G + + G K LK+ G+ ++ VL
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 398 IKHD-NVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAA 456
K V+ L Y + E +L+ +Y G + +L + D ++ L
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE-- 142
Query: 457 RGLAHLHVSGKIVHGNIKASNILL---RPDHDACVSDFGLNPLFGNTTPPTRVAG---YR 510
G+ +LH + IVH ++K NILL P D + DFG++ G+ + G Y
Sbjct: 143 -GVYYLHQNN-IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYL 200
Query: 511 APEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
APE++ +T +D+++ G++ LLT +P
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 5e-17
Identities = 48/200 (24%), Positives = 81/200 (40%), Gaps = 17/200 (8%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRL-KEVAVGKREFEMQMEVLGKIKHDNVVPLRAF 409
+G+GS G AV + K++ K F+ ++E++ + H N++ L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 410 YYSKDEKLLVYDYMPAGSL-SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
+ + LV + G L ++H D M+ LSA +A+ H +
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRES---DAARIMKDVLSA---VAYCHKLN-V 127
Query: 469 VHGNIKASNILLR-PDHDAC--VSDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKVTF 522
H ++K N L D+ + DFGL F G Y +P+V+E
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE-GLYGP 186
Query: 523 KSDVYSFGVLLLELLTGKAP 542
+ D +S GV++ LL G P
Sbjct: 187 ECDEWSAGVMMYVLLCGYPP 206
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-17
Identities = 29/139 (20%), Positives = 48/139 (34%), Gaps = 16/139 (11%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
IP L L L VL LR ++ I F L L+ L + + +
Sbjct: 167 IPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN 225
Query: 143 LTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNNN 198
LT L ++ N + +P+ +L +L L L N S + L++ +
Sbjct: 226 LTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQ 283
Query: 199 LNGSIPATLSKFPQSSFTG 217
L+ +F G
Sbjct: 284 --------LAVVEPYAFRG 294
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-17
Identities = 26/129 (20%), Positives = 50/129 (38%), Gaps = 8/129 (6%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
IP LS L L + N++ + F +L L+SL + N + + + +N
Sbjct: 95 IPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNS 153
Query: 143 LTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNNN 198
L +L L N + IP + ++L L L L + + + L+ +S+
Sbjct: 154 LEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWP 211
Query: 199 LNGSIPATL 207
++
Sbjct: 212 YLDTMTPNC 220
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 25/97 (25%), Positives = 45/97 (46%), Gaps = 4/97 (4%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
+P + L LR L+L N +S I L L+ + L Q + V P + +N
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNY 297
Query: 143 LTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFS 178
L L++S N + + V +++ +L L L++N +
Sbjct: 298 LRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 39/142 (27%), Positives = 55/142 (38%), Gaps = 21/142 (14%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
IP T R+L L NR+ +F++ L L L N S V P + + L
Sbjct: 30 IPTET-------RLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 144 TRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSI---NPANLRDFNVSNNNL 199
L L SN IP V L++LT L + NK L + NL+ V +N+
Sbjct: 83 RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDND- 139
Query: 200 NGSIPATLSKFPQSSFTGNLDL 221
L +F+G L
Sbjct: 140 -------LVYISHRAFSGLNSL 154
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 52/211 (24%), Positives = 80/211 (37%), Gaps = 27/211 (12%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKRE---FEMQM-------EV--LGKIK 399
+ GS G V EG V +KR+ R E+ L
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 400 HDNVVPLRAFYYSKDEKL-----LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALS 454
H N++ LR + +E LV + M L+ ++H R + +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH----DQRIVISPQHIQYFMYH 142
Query: 455 AARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR-VAG--YRA 511
GL LH +VH ++ NILL ++D + DF L T V YRA
Sbjct: 143 ILLGLHVLH-EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRA 201
Query: 512 PEVV-ETRKVTFKSDVYSFGVLLLELLTGKA 541
PE+V + + T D++S G ++ E+ KA
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 9e-17
Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 25/211 (11%)
Query: 345 DLLRASAEVLGKGSVGTSYKAVLEEGTTVV--VKRL-KEVAVGKREFEMQM---EVLGKI 398
+ R ++G+G G Y + T + +K L K+ K+ + + +L +
Sbjct: 192 SVHR----IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 399 KHDN---VVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRI-ALS 454
+ +V + +++ D+ + D M G L L G MR A
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEA---DMRFYAAE 300
Query: 455 AARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV--AGYRAP 512
GL H+H +V+ ++K +NILL +SD GL F P V GY AP
Sbjct: 301 IILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAP 359
Query: 513 EVVETRKV-TFKSDVYSFGVLLLELLTGKAP 542
EV++ +D +S G +L +LL G +P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 30/151 (19%), Positives = 57/151 (37%), Gaps = 12/151 (7%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
+ + +L+VL L + I + +L+ L +L L N + + + ++
Sbjct: 43 LGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101
Query: 143 LTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS----INPANLRDFNVSNN 197
L +L N + + +L L L + +N + N NL ++S+N
Sbjct: 102 LQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSN 159
Query: 198 NLNGSIPA-TLSKFPQ-SSFTGNLDLCGGPL 226
+ SI L Q +LDL P+
Sbjct: 160 KIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPM 189
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 24/129 (18%), Positives = 47/129 (36%), Gaps = 22/129 (17%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFS----GVFPASVTR 139
+P +T + L L N L F + L+ L L + G +
Sbjct: 26 LPFST-------KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY----QS 74
Query: 140 MNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSI---NPANLRDFNVS 195
++ L+ L L+ N + + L+ L L + +L + + L++ NV+
Sbjct: 75 LSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVA 132
Query: 196 NNNLNGSIP 204
+N + S
Sbjct: 133 HNLIQ-SFK 140
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 30/122 (24%), Positives = 54/122 (44%), Gaps = 10/122 (8%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRL-SGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
+ +G L L+ L++ N + S ++P FSNLT L L L SN+ ++ + +++
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 143 LT----RLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVS 195
+ LDLS N + I L L L+ N+ ++P +L+ +
Sbjct: 175 MPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLH 232
Query: 196 NN 197
N
Sbjct: 233 TN 234
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 26/205 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEV----AVGKREF-EMQMEVLGKIKHDNVVP 405
+ +G G+ G A V +K+L KR + E+ + + + H N++
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL--MKCVNHKNIIG 88
Query: 406 LRAFYYSKDEKL------LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGL 459
L + + +V + M A +L ++ + LD + + G+
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI-------QMELDHERMSYLLYQMLCGI 140
Query: 460 AHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR-VAG--YRAPEVVE 516
HLH S I+H ++K SNI+++ D + DFGL G + T V YRAPEV+
Sbjct: 141 KHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKA 541
D++S G ++ E++ G
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 37/308 (12%), Positives = 78/308 (25%), Gaps = 64/308 (20%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLK----EVAVGKREFEMQMEVLGKIKHDNVVPL 406
G ++A+ V + + +E + L +I V +
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+++ L+V +++ GSL + T +R S A H +G
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA-------DTSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 467 KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDV 526
+ S + + D D ++ + D+
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYPA----------------TMPD-------ANPQDDI 185
Query: 527 YSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMV 586
G L LL + P + G+ + + + + + +I +
Sbjct: 186 RGIGASLYALLVNRWPLPEAGVRSGL-------APAERDTAGQPIEPADID-RDIPFQ-- 235
Query: 587 QLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDDGLRQSSDDPSKGSDGHTPPPESR 646
+ +A V R A L + +D
Sbjct: 236 -ISAVAARSVQGDGGIRSA-----------------STLLNLMQQATAVADRTEVLGPID 277
Query: 647 TPPTALTP 654
P + P
Sbjct: 278 EAPVSAAP 285
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 26/185 (14%), Positives = 54/185 (29%), Gaps = 37/185 (20%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASV----- 137
I ++ L L L L N LS + S F L+ L L L N + + S+
Sbjct: 91 IEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLT 149
Query: 138 ---------------------TRMNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENN 175
+ L L++ +++ ++ +++ L L
Sbjct: 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMK 208
Query: 176 KFS-------GNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDLCGGPLPP 228
+ S+ LRD ++ + + + + N+ + L
Sbjct: 209 QHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ 268
Query: 229 CNPFF 233
Sbjct: 269 VMKLL 273
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 18/131 (13%), Positives = 39/131 (29%), Gaps = 10/131 (7%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
I L+ L L + ++ L P ++ + L L Q + V + +
Sbjct: 165 IQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSV 224
Query: 144 TRLDLSSNNFSG-------KIPFDV-NNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNV 194
L+L + + + + + + + + L +
Sbjct: 225 ECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEF 284
Query: 195 SNNNLNGSIPA 205
S N L S+P
Sbjct: 285 SRNQLK-SVPD 294
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 29/126 (23%), Positives = 47/126 (37%), Gaps = 12/126 (9%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+ + L L +NR++ SD L++L L SN + + S + + L
Sbjct: 50 LTEAV-------KSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 144 TRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINPA---NLRDFNVSNNNL 199
LDLS N S + L+ LT L L N + + + L+ V N +
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT 161
Query: 200 NGSIPA 205
I
Sbjct: 162 FTKIQR 167
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 17/103 (16%), Positives = 36/103 (34%), Gaps = 11/103 (10%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSG----EIPSD----FSNLTLLRSLYLQSNQFSGVFPA 135
+ + S + L LR L E+ + R++ +
Sbjct: 213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMK 271
Query: 136 SVTRMNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKF 177
+ +++ L L+ S N +P + + LT L ++L N +
Sbjct: 272 LLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 14/71 (19%), Positives = 27/71 (38%), Gaps = 1/71 (1%)
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
N+L K R + + L ++ + ++ L L NQ V R+
Sbjct: 244 TGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTS 302
Query: 143 LTRLDLSSNNF 153
L ++ L +N +
Sbjct: 303 LQKIWLHTNPW 313
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM---QMEVLGKIKHDNVVPLR 407
E LGKG+ + V G K + + R+F+ + + K++H N+V L
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 408 AFYYSKDEKLLVYDYMPAGSL-SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+ LV+D + G L ++ +R + D + ++ L + +A+ H +G
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIV--AREF-YSEADASHCIQQILES---IAYCHSNG 148
Query: 467 KIVHGNIKASNILLR-PDHDACV--SDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKV 520
IVH N+K N+LL A V +DFGL ++ AG Y +PEV++
Sbjct: 149 -IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 521 TFKSDVYSFGVLLLELLTGKAP 542
+ D+++ GV+L LL G P
Sbjct: 208 SKPVDIWACGVILYILLVGYPP 229
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 51/222 (22%), Positives = 86/222 (38%), Gaps = 51/222 (22%)
Query: 347 LRASAEVLGKGSVGTSYKAV-LEEGTTVVVKRL--KEVAVGKREFEMQMEVLGKIK-HDN 402
L + LG+GS K V + VK + + A ++E + L + H N
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKE----ITALKLCEGHPN 67
Query: 403 VVPLRAFYYSKDEKLLVYDYMPAGSL---------------SALLHGSRGSGRTPLDWDN 447
+V L ++ + LV + + G L S +
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI---------------- 111
Query: 448 RMRIALSAARGLAHLHVSGKIVHGNIKASNILLR-PDHDACV--SDFGLNPLFGNTTPP- 503
MR +SA ++H+H G +VH ++K N+L + + + DFG L P
Sbjct: 112 -MRKLVSA---VSHMHDVG-VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166
Query: 504 -TRV--AGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
T Y APE++ D++S GV+L +L+G+ P
Sbjct: 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 4e-16
Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 57/227 (25%)
Query: 345 DLLRASAEVLGKGSVGTSYKAVL-EEGTTVVVKRL-------KEVAVGKREFEMQME--V 394
+LL+ VLG+GS G K L ++ + ++L K + +ME +
Sbjct: 27 ELLK----VLGQGSFG---KVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 395 LGKIKHDNVVPLRAFYYS--KDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR- 450
L ++ H +V L +Y+ + KL L+ D++ G L S+ + ++
Sbjct: 80 LVEVNHPFIVKL---HYAFQTEGKLYLILDFLRGGDL--FTRLSK-EVMFTEE---DVKF 130
Query: 451 ----IALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD--ACVSDFGL---NPLFGNT- 500
+AL L HLH G I++ ++K NILL D + ++DFGL +
Sbjct: 131 YLAELAL----ALDHLHSLG-IIYRDLKPENILL--DEEGHIKLTDFGLSKESIDHEKKA 183
Query: 501 -----TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
T Y APEVV R T +D +SFGVL+ E+LTG P
Sbjct: 184 YSFCGTV-----EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 20/207 (9%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLK------EVAVGKREFEMQMEVLGKIKHDNVV 404
EV+GKG + + E G VK + + + + + + +KH ++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSL--SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
L Y S +V+++M L + G + + MR L A L +
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA---LRYC 146
Query: 463 HVSGKIVHGNIKASNILLR-PDHDACV--SDFGLNPLFGNTTPP--TRV--AGYRAPEVV 515
H + I+H ++K +LL ++ A V FG+ G + RV + APEVV
Sbjct: 147 HDNN-IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 516 ETRKVTFKSDVYSFGVLLLELLTGKAP 542
+ DV+ GV+L LL+G P
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 21/101 (20%), Positives = 40/101 (39%), Gaps = 9/101 (8%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV------FPASV 137
+ +L LR L L +N+L ++P ++ ++ +YL +N S + P
Sbjct: 231 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN 289
Query: 138 TRMNRLTRLDLSSNNFS-GKIPFDV-NNLTHLTGLFLENNK 176
T+ + + L SN +I + + L N K
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 32/128 (25%), Positives = 56/128 (43%), Gaps = 11/128 (8%)
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMN 141
I + +L + + ++ IP +LT L+L N+ + V AS+ +N
Sbjct: 161 GIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLT---ELHLDGNKITKVDAASLKGLN 216
Query: 142 RLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS--INPANLRDFNVSNNN 198
L +L LS N+ S + N HL L L NNK +P + ++ + NNN
Sbjct: 217 NLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNN 274
Query: 199 LNGSIPAT 206
++ +I +
Sbjct: 275 IS-AIGSN 281
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 26/128 (20%), Positives = 46/128 (35%), Gaps = 19/128 (14%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
+ +L L+ L L L N +S + + +N LR L+L +N+ V P +
Sbjct: 207 VDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKY 264
Query: 143 LTRLDLSSNNFSGKIPFDV-------NNLTHLTGLFLENNKFSGNLPSINPA------NL 189
+ + L +NN S I + +G+ L +N I P+
Sbjct: 265 IQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ--YWEIQPSTFRCVYVR 321
Query: 190 RDFNVSNN 197
+ N
Sbjct: 322 AAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 31/140 (22%), Positives = 57/140 (40%), Gaps = 26/140 (18%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+PP+T +L L++N+++ DF NL L +L L +N+ S + P + + +L
Sbjct: 50 LPPDT-------ALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPA------NLRDFNVSNN 197
RL LS N ++P + L L + N+ + + + + + N
Sbjct: 103 ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT----KVRKSVFNGLNQMIVVELGTN 155
Query: 198 NLNGSIPATLSKFPQSSFTG 217
L S +F G
Sbjct: 156 PL------KSSGIENGAFQG 169
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 36/131 (27%), Positives = 50/131 (38%), Gaps = 17/131 (12%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFS----GVFPASVT 138
+P +L L L + N+L +P F L L L L NQ VF
Sbjct: 76 LPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVF----D 130
Query: 139 RMNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS---INPANLRDFNV 194
+ +LT L L N +P V + LT L L L NN+ +P L+ +
Sbjct: 131 SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKL 188
Query: 195 SNNNLNGSIPA 205
NN L +P
Sbjct: 189 DNNQLK-RVPE 198
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 37/127 (29%), Positives = 57/127 (44%), Gaps = 16/127 (12%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV-TRMNR 142
IP +T + L L+SN+LS F LT LR LYL N+ + PA + +
Sbjct: 35 IPADT-------KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTL-PAGIFKELKN 86
Query: 143 LTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNNN 198
L L ++ N +P V + L +L L L+ N+ +LP + L ++ N
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE 144
Query: 199 LNGSIPA 205
L S+P
Sbjct: 145 LQ-SLPK 150
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 29/94 (30%), Positives = 44/94 (46%), Gaps = 4/94 (4%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
+PP L++L LSL N L +P F LT L+ L L +NQ V + ++
Sbjct: 124 LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTE 182
Query: 143 LTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENN 175
L L L +N ++P ++L L L L+ N
Sbjct: 183 LKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 24/78 (30%), Positives = 37/78 (47%), Gaps = 8/78 (10%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
+P KL+ L+ L L +N+L +P F LT L++L L +NQ V + + +
Sbjct: 148 LPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEK 206
Query: 143 LTRLDLSSNNFSGKIPFD 160
L L L N P+D
Sbjct: 207 LKMLQLQEN------PWD 218
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 62/282 (21%), Positives = 115/282 (40%), Gaps = 51/282 (18%)
Query: 284 KKRRRQRPGKAPKPPAAATARAVTMEAGTSSSKDDITGGAAEADRNKLVFFEGGVYSFDL 343
+ Q A TA V S++D ++ D + +
Sbjct: 16 ENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALS------DF----------FEVE- 58
Query: 344 EDLLRASAEVLGKGSVGTSYKAVLEEGTTVVV------KRLKEVAVGKREFEMQMEVLGK 397
LG+G+ Y+ ++GT K + + V + E + VL +
Sbjct: 59 --------SELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDKKIV-RTE----IGVLLR 104
Query: 398 IKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL-SALLHGSRGSGRTPLDWDNRMRIALSAA 456
+ H N++ L+ + + E LV + + G L ++ +G + D + ++ L A
Sbjct: 105 LSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV--EKGY-YSERDAADAVKQILEA- 160
Query: 457 RGLAHLHVSGKIVHGNIKASNILLR-PDHDACV--SDFGLNPLFGNTTPPTRVAG---YR 510
+A+LH +G IVH ++K N+L P DA + +DFGL+ + + V G Y
Sbjct: 161 --VAYLHENG-IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYC 217
Query: 511 APEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGI 552
APE++ + D++S G++ LL G P G++ +
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 7e-16
Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 36/216 (16%)
Query: 345 DLLRASAEVLGKGSVGTSYKAVL--EEGTTVV--VKRL-KEVAVGKREFE-MQME--VLG 396
+ L+ +LGKG+ G K +L E+ T +K L KEV V K E E VL
Sbjct: 151 EYLK----LLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 397 KIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRI-ALSA 455
+H + L+ + + D V +Y G L H SR D R R
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSR-ERVFSED---RARFYGAEI 257
Query: 456 ARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---NPLFGNT------TPPTRV 506
L +LH +V+ ++K N++L D ++DFGL G T TP
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP---- 313
Query: 507 AGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
Y APEV+E D + GV++ E++ G+ P
Sbjct: 314 -EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 65/227 (28%), Positives = 92/227 (40%), Gaps = 36/227 (15%)
Query: 342 DLEDLLRASAEVLGKGSVGTSYKAV-LEEGTTVVVK-----RLKEVAVGKREFEMQMEVL 395
ED+ + +VLG+G+ + L VK + RE EM +
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 396 GKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL-SALLHGSRGSGRTPLDWDNRMRIALS 454
G H NV+ L F+ +D LV++ M GS+ S + R L+ ++ S
Sbjct: 69 G---HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH--KRRH-FNELEASVVVQDVAS 122
Query: 455 AARGLAHLHVSGKIVHGNIKASNILLR-PDHDACV--SDFGL------NPLFGNTTPP-- 503
A L LH G I H ++K NIL P+ + V DF L N + P
Sbjct: 123 A---LDFLHNKG-IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 504 -TRV--AGYRAPEVVETRKVTFKS-----DVYSFGVLLLELLTGKAP 542
T A Y APEVVE D++S GV+L LL+G P
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 50/205 (24%), Positives = 88/205 (42%), Gaps = 26/205 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEV----AVGKREF-EMQMEVLGKIKHDNVVP 405
+ +G G+ G A V +K+L KR + E+ + + + H N++
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL--MKCVNHKNIIS 125
Query: 406 LRAFYYSK------DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGL 459
L + + + LV + M A +L ++ + LD + + G+
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI-------QMELDHERMSYLLYQMLCGI 177
Query: 460 AHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR-VAG--YRAPEVVE 516
HLH S I+H ++K SNI+++ D + DFGL G + T V YRAPEV+
Sbjct: 178 KHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKA 541
D++S G ++ E++ K
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 26/210 (12%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRL---KEVAVGKREFEMQ------MEVLGKIKHD 401
+ LG G+ G A + V ++ + K RE + +E+L K+ H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 402 NVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
++ ++ F+ ++D +V + M G L + G L + +
Sbjct: 201 CIIKIKNFFDAED-YYIVLELMEGGELF-----DKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 462 LHVSGKIVHGNIKASNILLRPDHDAC---VSDFGLNPLFGNTTPPTRVAG---YRAPEVV 515
LH +G I+H ++K N+LL + C ++DFG + + G T+ + G Y APEV+
Sbjct: 255 LHENG-IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313
Query: 516 E---TRKVTFKSDVYSFGVLLLELLTGKAP 542
T D +S GV+L L+G P
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 36/151 (23%), Positives = 62/151 (41%), Gaps = 18/151 (11%)
Query: 84 IPPNTLGKLSQLRVLSL-RSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMN 141
IP ++ L L L +L I F L L+ L L + ++T +
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLV 218
Query: 142 RLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPA------NLRDFNVS 195
L L++S N+F P + L+ L L++ N++ + I +L + N++
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ----VSLIERNAFDGLASLVELNLA 274
Query: 196 NNNLNGSIPATLSKFPQSSFTGNLDLCGGPL 226
+NNL+ S+P L F + L L P
Sbjct: 275 HNNLS-SLPHDL--FTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 36/155 (23%), Positives = 49/155 (31%), Gaps = 27/155 (17%)
Query: 62 ECDANRSFVY--SLRLPGVGLVGP--IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLT 117
C S V L V P IP NT R L+L N + F +L
Sbjct: 51 SCSNQFSKVVCTRRGLSEV----PQGIPSNT-------RYLNLMENNIQMIQADTFRHLH 99
Query: 118 LLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNK 176
L L L N + + + L L+L N + IP L+ L L+L NN
Sbjct: 100 HLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNP 158
Query: 177 FSGNLPSINPA------NLRDFNVSNNNLNGSIPA 205
SI +L ++ I
Sbjct: 159 IE----SIPSYAFNRVPSLMRLDLGELKKLEYISE 189
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 37/140 (26%), Positives = 63/140 (45%), Gaps = 8/140 (5%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L LS L+VL L N+++ I S + LT L+ L + + Q S + P + +++LT L
Sbjct: 125 LAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA 180
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLS 208
N S I + +L +L + L+NN+ S P N +NL ++N + +
Sbjct: 181 DDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITNQPVFYNN 238
Query: 209 KFPQSSFTGNLDLCGGPLPP 228
+ G P+ P
Sbjct: 239 NLVVPNVVKGPS--GAPIAP 256
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 33/121 (27%), Positives = 56/121 (46%), Gaps = 8/121 (6%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L L+ L+ LS+ + ++S ++ + +NL+ L +L N+ S + P + + L + L
Sbjct: 147 LAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHL 202
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSI-PATL 207
+N S P N ++L + L N + N P NL NV I PAT+
Sbjct: 203 KNNQISDVSPL--ANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPSGAPIAPATI 259
Query: 208 S 208
S
Sbjct: 260 S 260
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 26/125 (20%), Positives = 47/125 (37%), Gaps = 8/125 (6%)
Query: 88 TLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147
T L + LS ++ I L L L L+ NQ + + P + + ++T L+
Sbjct: 36 TQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91
Query: 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATL 207
LS N L + L L + + + P +NL+ + N + +I L
Sbjct: 92 LSGNPLKNVSAIA--GLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQIT-NISP-L 147
Query: 208 SKFPQ 212
+
Sbjct: 148 AGLTN 152
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 21/125 (16%), Positives = 49/125 (39%), Gaps = 10/125 (8%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L+ ++ + ++ + ++L + +L + + V +N L L+L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATL 207
N + P NLT +T L L N N+ +I +++ ++++ + P L
Sbjct: 71 KDNQITDLAPLK--NLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQITDVTP--L 125
Query: 208 SKFPQ 212
+
Sbjct: 126 AGLSN 130
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 28/118 (23%), Positives = 50/118 (42%), Gaps = 11/118 (9%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSN 151
L ++ +N+L E+P + NL L ++Y +N + L + +N
Sbjct: 172 PPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKKLPD----LPLSLESIVAGNN 225
Query: 152 NFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSK 209
++P ++ NL LT ++ +NN LP P +L NV +N L +P
Sbjct: 226 ILE-ELP-ELQNLPFLTTIYADNNLLK-TLPD-LPPSLEALNVRDNYLT-DLPELPQS 278
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 26/122 (21%), Positives = 47/122 (38%), Gaps = 13/122 (10%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L S L+++ + +N L ++P +L + +NQ P + + LT +
Sbjct: 149 LQNSSFLKIIDVDNNSLK-KLPDLPPSLE---FIAAGNNQLE-ELP-ELQNLPFLTAIYA 202
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATL 207
+N+ K+P + L + NN LP + N L NN L ++P
Sbjct: 203 DNNSLK-KLP---DLPLSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLK-TLPDLP 256
Query: 208 SK 209
Sbjct: 257 PS 258
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 24/126 (19%), Positives = 47/126 (37%), Gaps = 15/126 (11%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+P L L L + +N L ++P +L S+ +N + + L
Sbjct: 188 LPE--LQNLPFLTAIYADNNSLK-KLPDLPLSLE---SIVAGNNILE--ELPELQNLPFL 239
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSI 203
T + +N +P +L L + +N + +LP + P +L +VS N + +
Sbjct: 240 TTIYADNNLLK-TLPDLPPSLEALN---VRDNYLT-DLPEL-PQSLTFLDVSENIFS-GL 292
Query: 204 PATLSK 209
Sbjct: 293 SELPPN 298
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 29/118 (24%), Positives = 44/118 (37%), Gaps = 15/118 (12%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSN 151
L L++R N L+ ++P +LT L + S + P L L+ SSN
Sbjct: 256 PPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSN 307
Query: 152 NFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSK 209
+ + L L + NNK LP+ P L S N+L +P
Sbjct: 308 EIR-SLC---DLPPSLEELNVSNNKLI-ELPA-LPPRLERLIASFNHLA-EVPELPQN 358
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 23/154 (14%), Positives = 37/154 (24%), Gaps = 36/154 (23%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTL-------------LRSLYLQSNQFSGV 132
P + + P L L + S
Sbjct: 27 PVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-S 85
Query: 133 FPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSG------------- 179
P L L S N+ + ++P +L L S
Sbjct: 86 LPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNN 141
Query: 180 ---NLPSI-NPANLRDFNVSNNNLNGSIPATLSK 209
LP + N + L+ +V NN+L +P
Sbjct: 142 QLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPS 174
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 25/120 (20%), Positives = 43/120 (35%), Gaps = 16/120 (13%)
Query: 90 GKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149
L L++ +N+L E+P+ L L N + V P L +L +
Sbjct: 314 DLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAEV-PELPQ---NLKQLHVE 365
Query: 150 SNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSK 209
N + P ++ L N+ + +P + P NL+ +V N L P
Sbjct: 366 YNPLR-EFPDIPESVEDLR----MNSHLA-EVPEL-PQNLKQLHVETNPLR-EFPDIPES 417
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 29/139 (20%), Positives = 49/139 (35%), Gaps = 23/139 (16%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVT----- 138
I P + + L+ S+ L+ E+P + N+ Y +++ P
Sbjct: 3 INPRNVS-NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 139 --------RMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLR 190
+ L+L++ S +P HL L N + LP P +L+
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPE-LPQSLK 114
Query: 191 DFNVSNNNLN--GSIPATL 207
V NNNL +P L
Sbjct: 115 SLLVDNNNLKALSDLPPLL 133
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 16/103 (15%), Positives = 30/103 (29%), Gaps = 21/103 (20%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTL----------------LRSLYLQSNQFSGVFPA 135
L+ L + N L E P ++ L+ L++++N FP
Sbjct: 356 PQNLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPD 413
Query: 136 SVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFS 178
+ L ++S F L E++
Sbjct: 414 I---PESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 30/147 (20%), Positives = 54/147 (36%), Gaps = 20/147 (13%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPS-DFSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
IP + L++L L N++ I D + L L L NQ + S++ +
Sbjct: 187 IPKDLPETLNELH---LDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPT 242
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNK--------FSGNLPSINPANLRDFNV 194
L L L +N S ++P + +L L ++L N F + A ++
Sbjct: 243 LRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISL 301
Query: 195 SNNNLNGSIPATLSKFPQSSFTGNLDL 221
NN + + ++F D
Sbjct: 302 FNNPV------PYWEVQPATFRCVTDR 322
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 31/128 (24%), Positives = 50/128 (39%), Gaps = 19/128 (14%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
I L + S+L L L N++ I + S L LR L+L +N+ S V PA + +
Sbjct: 208 IELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSRV-PAGLPDLKL 265
Query: 143 LTRLDLSSNNFSGKIPFDV-------NNLTHLTGLFLENNKFSGNLPSINPA------NL 189
L + L +NN + K+ + + G+ L NN + PA +
Sbjct: 266 LQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP--YWEVQPATFRCVTDR 322
Query: 190 RDFNVSNN 197
N
Sbjct: 323 LAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 23/101 (22%), Positives = 40/101 (39%), Gaps = 9/101 (8%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFS----GVFP--ASV 137
I +L L LR L L +N+LS +P+ +L LL+ +YL +N + F
Sbjct: 232 IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFG 290
Query: 138 TRMNRLTRLDLSSNNFS-GKIPFDV-NNLTHLTGLFLENNK 176
+ + L +N ++ +T + N K
Sbjct: 291 VKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 33/139 (23%), Positives = 52/139 (37%), Gaps = 19/139 (13%)
Query: 83 PIPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMN 141
P L L L + +L+ IP D L L+L N+ + + R +
Sbjct: 163 GFEPGAFDGLK-LNYLRISEAKLT-GIPKDLPETLN---ELHLDHNKIQAIELEDLLRYS 217
Query: 142 RLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNN 198
+L RL L N I + L L L L+NNK S +P+ + L+ + NN
Sbjct: 218 KLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNN 275
Query: 199 LNGSIPATLSKFPQSSFTG 217
++K + F
Sbjct: 276 --------ITKVGVNDFCP 286
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 33/138 (23%), Positives = 61/138 (44%), Gaps = 22/138 (15%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
I P+T +L L++N +S E+ D F L L +L L +N+ S + + + + +
Sbjct: 52 ISPDT-------TLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRK 103
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNNNL 199
L +L +S N+ +IP ++ + L L + +N+ +P N+ + N L
Sbjct: 104 LQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPL 159
Query: 200 NGSIPATLSKFPQSSFTG 217
S F +F G
Sbjct: 160 ------ENSGFEPGAFDG 171
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 61/235 (25%), Positives = 104/235 (44%), Gaps = 47/235 (20%)
Query: 332 VFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVL----EEGTTVVVKRL-KEVAVGKR 386
VF E +FD ++LR +GKGS G K + + +K + K+ V +
Sbjct: 5 VFDENEDVNFDHFEILR----AIGKGSFG---KVCIVQKNDTKKMYAMKYMNKQKCVERN 57
Query: 387 EFE-MQME--VLGKIKHDNVVPLRAFYYS--KDEKL-LVYDYMPAGSLSALLHGSRGSGR 440
E + E ++ ++H +V L YS +E + +V D + G L H + +
Sbjct: 58 EVRNVFKELQIMQGLEHPFLVNLW---YSFQDEEDMFMVVDLLLGGDL--RYHLQQ-NVH 111
Query: 441 TPLDWDNRMR-----IALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD--ACVSDFGL 493
+ ++ + + L +L + +I+H ++K NILL D ++DF +
Sbjct: 112 FKEE---TVKLFICELVM----ALDYLQ-NQRIIHRDMKPDNILL--DEHGHVHITDFNI 161
Query: 494 NPLFGNTTPPTRVAG---YRAPEVVETRKV---TFKSDVYSFGVLLLELLTGKAP 542
+ T T +AG Y APE+ +RK +F D +S GV ELL G+ P
Sbjct: 162 AAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 19/203 (9%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM---QMEVLGKIKHDNVVPLR 407
E LGKG+ + V + G + + R+ + + + +KH N+V L
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 408 AFYYSKDEKLLVYDYMPAGSL-SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+ L++D + G L ++ +R + D + ++ L A + H H G
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIV--AREY-YSEADASHCIQQILEA---VLHCHQMG 130
Query: 467 KIVHGNIKASNILLR-PDHDACV--SDFGLNPLFGNTTPP--TRV--AGYRAPEVVETRK 519
+VH N+K N+LL A V +DFGL GY +PEV+
Sbjct: 131 -VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 520 VTFKSDVYSFGVLLLELLTGKAP 542
D+++ GV+L LL G P
Sbjct: 190 YGKPVDLWACGVILYILLVGYPP 212
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 50/218 (22%), Positives = 78/218 (35%), Gaps = 53/218 (24%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEV---LGKIKHDNVVPLR 407
E +G GS + + VK + K + + E+ L +H N++ L+
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIID-----KSKRDPTEEIEILLRYGQHPNIITLK 82
Query: 408 AFYYSKDEKLLVYDYMPAGSL---------------SALLHGSRGSGRTPLDWDNRMRIA 452
Y +V + M G L SA+ +
Sbjct: 83 DVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----------------LFTI 125
Query: 453 LSAARGLAHLHVSGKIVHGNIKASNILLR-PDHDA---CVSDFGLNPLF--GNTTPPTRV 506
+ +LH G +VH ++K SNIL + + DFG N T
Sbjct: 126 TKT---VEYLHAQG-VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 507 --AGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
A + APEV+E + D++S GVLL +LTG P
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 37/129 (28%), Positives = 50/129 (38%), Gaps = 17/129 (13%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
I + LR L L SN L + FS+L L L L +N V + M +
Sbjct: 79 ISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQ 137
Query: 143 LTRLDLSSNNFSGKIPFDV----NNLTHLTGLFLENNKFS-------GNLPSINPANLRD 191
L +L LS N S + P ++ N L L L L +NK LP+ L
Sbjct: 138 LQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY- 195
Query: 192 FNVSNNNLN 200
+ NN L
Sbjct: 196 --LHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 35/147 (23%), Positives = 57/147 (38%), Gaps = 30/147 (20%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD--FSNLTLLRSLYLQSNQFSGVFPASVTRMN 141
+P T +L L N LS + ++ + LT L SL L N + + + +
Sbjct: 37 LPSYT-------ALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP 88
Query: 142 RLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINP------ANLRDFNV 194
L LDLSSN+ + + ++L L L L NN + ++ A L+ +
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNH----IVVVDRNAFEDMAQLQKLYL 143
Query: 195 SNNNLNGSIPATLSKFPQSSFTGNLDL 221
S N +S+FP L
Sbjct: 144 SQNQ--------ISRFPVELIKDGNKL 162
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 32/151 (21%), Positives = 60/151 (39%), Gaps = 22/151 (14%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPA--SVTRM 140
+ ++ LS++ + +R+ R I D L LL+ L + + +FP V
Sbjct: 71 LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYST 129
Query: 141 NRLTRLDLSSNNFSGKIPFDV-NNLTHLTG-LFLENNKFSGNLPS--INPANLRDFNVSN 196
+ L+++ N + IP + L + T L L NN F+ ++ N L ++
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188
Query: 197 NNLNGSIPATLSKFPQSSFTG------NLDL 221
N L+ + +F G LD+
Sbjct: 189 NKY-------LTVIDKDAFGGVYSGPSLLDV 212
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 28/135 (20%), Positives = 51/135 (37%), Gaps = 21/135 (15%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD--FSNLTLLRSLYLQSNQFSGVFPASVTR-- 139
I P+ L +L L+ L + + L P + + L + N + P + +
Sbjct: 96 IDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGL 154
Query: 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNK---------FSGNLPSINPANLR 190
N L L +N F+ + N T L ++L NK F G + S
Sbjct: 155 CNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGG-VYS----GPS 208
Query: 191 DFNVSNNNLNGSIPA 205
+VS ++ ++P+
Sbjct: 209 LLDVSQTSVT-ALPS 222
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 9e-12
Identities = 23/138 (16%), Positives = 50/138 (36%), Gaps = 16/138 (11%)
Query: 93 SQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNN 152
Q + + IPS ++L L + + + + ++R+ +S +
Sbjct: 11 HQEEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 153 FSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINPA------NLRDFNVSNNNLNGSIPA 205
++ NL+ +T + + N + NL I+P L+ + N L P
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTR---NLTYIDPDALKELPLLKFLGIFNTGLK-MFPD 122
Query: 206 TLSKFPQSSFTGNLDLCG 223
L+K + L++
Sbjct: 123 -LTKVYSTDIFFILEITD 139
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 18/135 (13%), Positives = 43/135 (31%), Gaps = 20/135 (14%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQF-----SGVFPASV 137
IP + L + + + + ++ S F NL+ + + +++ +
Sbjct: 46 IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL---- 101
Query: 138 TRMNRLTRLDLSSNNFSGKIPFD--VNNLTHLTGLFLENNKFSGNLPSIN-----PANLR 190
+ L L + + P V + L + +N + ++P N
Sbjct: 102 KELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV-NAFQGLCNETL 159
Query: 191 DFNVSNNNLNGSIPA 205
+ NN S+
Sbjct: 160 TLKLYNNGFT-SVQG 173
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 63/220 (28%), Positives = 92/220 (41%), Gaps = 45/220 (20%)
Query: 345 DLLRASAEVLGKGSVGTSYKAVL--EEGTTVV--VKRL-KEVAVGKREFE-MQME--VLG 396
D L+ +LGKG+ G K +L E+ T +K L KEV + K E E VL
Sbjct: 8 DYLK----LLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 397 KIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR-----I 451
+H + L+ + + D V +Y G L H SR + R R I
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSR-ERVFTEE---RARFYGAEI 114
Query: 452 ALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---NPLFGNT------TP 502
L +LH +V+ +IK N++L D ++DFGL G T TP
Sbjct: 115 VS----ALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 169
Query: 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
Y APEV+E D + GV++ E++ G+ P
Sbjct: 170 -----EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 31/124 (25%), Positives = 46/124 (37%), Gaps = 16/124 (12%)
Query: 90 GKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149
G L L L L N+L +P L L L + N+ + + ++ + L L L
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLK 132
Query: 150 SNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINPA-------NLRDFNVSNNNLNG 201
N +P + L L L NN L + PA NL + N+L
Sbjct: 133 GNELK-TLPPGLLTPTPKLEKLSLANNN----LTEL-PAGLLNGLENLDTLLLQENSLY- 185
Query: 202 SIPA 205
+IP
Sbjct: 186 TIPK 189
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 25/94 (26%), Positives = 37/94 (39%), Gaps = 5/94 (5%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASV-TRMN 141
+P L L +L+ L L+ N L +P + L L L +N + + PA + +
Sbjct: 115 LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTEL-PAGLLNGLE 172
Query: 142 RLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENN 175
L L L N+ IP L FL N
Sbjct: 173 NLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 29/127 (22%), Positives = 46/127 (36%), Gaps = 19/127 (14%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFS--GVFPASVTRMN 141
+P +T +L L N L + T L L L + + V +
Sbjct: 29 LPKDT-------TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD----GTLP 77
Query: 142 RLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNNN 198
L LDLS N +P L LT L + N+ + +LP L++ + N
Sbjct: 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNE 135
Query: 199 LNGSIPA 205
L ++P
Sbjct: 136 LK-TLPP 141
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 29/206 (14%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEV----AVGKREF-EMQMEVLGKIKHDNVVP 405
+G G+ G+ A+ G V +K+L KR + E+ + L ++H+NV+
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL--LKHMQHENVIG 87
Query: 406 LRAFYYSKDEKL------LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGL 459
L + LV +M L ++ + + +GL
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM-------GLKFSEEKIQYLVYQMLKGL 139
Query: 460 AHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL-NPLFGNTTP--PTRVAGYRAPEVV- 515
++H S +VH ++K N+ + D + + DFGL T TR YRAPEV+
Sbjct: 140 KYIH-SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW--YRAPEVIL 196
Query: 516 ETRKVTFKSDVYSFGVLLLELLTGKA 541
D++S G ++ E+LTGK
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 25/118 (21%), Positives = 43/118 (36%), Gaps = 15/118 (12%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSN 151
+LR L + N+L+ +P L L + L +L + N
Sbjct: 80 PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGN 131
Query: 152 NFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSK 209
+ +P L L + +N+ + +LP+ P+ L NN L S+P S
Sbjct: 132 QLT-SLP---VLPPGLQELSVSDNQLA-SLPA-LPSELCKLWAYNNQLT-SLPMLPSG 182
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 30/124 (24%), Positives = 49/124 (39%), Gaps = 18/124 (14%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTR 145
P L +L + S L L L++ NQ + P L
Sbjct: 97 PVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLT-SLPVLPP---GLQE 145
Query: 146 LDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPA 205
L +S N + +P + L L NN+ + +LP P+ L++ +VS+N L S+P
Sbjct: 146 LSVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPM-LPSGLQELSVSDNQLA-SLPT 198
Query: 206 TLSK 209
S+
Sbjct: 199 LPSE 202
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 5e-13
Identities = 34/135 (25%), Positives = 60/135 (44%), Gaps = 18/135 (13%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSN 151
S L+ LS+ N+L+ +P+ S L L+ +N+ + PA + L L +S N
Sbjct: 180 PSGLQELSVSDNQLA-SLPTLPSELY---KLWAYNNRLT-SLPALPS---GLKELIVSGN 231
Query: 152 NFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFP 211
+ +P + L L + N+ + +LP P+ L +V N L +P +L
Sbjct: 232 RLTS-LP---VLPSELKELMVSGNRLT-SLPM-LPSGLLSLSVYRNQLT-RLPESLIHLS 284
Query: 212 QSSFTGNLDLCGGPL 226
+ ++L G PL
Sbjct: 285 SET---TVNLEGNPL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 23/117 (19%), Positives = 44/117 (37%), Gaps = 14/117 (11%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSN 151
+ VL++ + L+ +P + +L + N + PA L L++S N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPP---ELRTLEVSGN 91
Query: 152 NFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLS 208
+ +P L L+ +LP++ P+ L + N L S+P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLT----HLPAL-PSGLCKLWIFGNQLT-SLPVLPP 141
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 8e-12
Identities = 22/109 (20%), Positives = 42/109 (38%), Gaps = 10/109 (9%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSN 151
S L+ L + NRL+ +P S L L + N+ + + P + L L + N
Sbjct: 220 PSGLKELIVSGNRLT-SLPVLPSELK---ELMVSGNRLTSL-PML---PSGLLSLSVYRN 271
Query: 152 NFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN 200
+ ++P + +L+ T + LE N S + + +
Sbjct: 272 QLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPII 318
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 24/119 (20%), Positives = 44/119 (36%), Gaps = 5/119 (4%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSN 151
S+L+ L + NRL+ +P S L SL + NQ + P S+ ++ T ++L N
Sbjct: 240 PSELKELMVSGNRLT-SLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 152 NFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKF 210
S + + +T G +F S + + L + +
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPA 353
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 18/74 (24%), Positives = 32/74 (43%), Gaps = 6/74 (8%)
Query: 139 RMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNN 198
N L++ + + +P + H+T L + +N + +LP+ P LR VS N
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPA-LPPELRTLEVSGNQ 92
Query: 199 LNGSIPATLSKFPQ 212
L S+P +
Sbjct: 93 LT-SLPVLPPGLLE 105
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 16/91 (17%), Positives = 26/91 (28%), Gaps = 4/91 (4%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTR 145
P +L LS ++L N LS +T S S A +
Sbjct: 277 PESLIHLSSETTVNLEGNPLSERTLQALREIT---SAPGYSGPIIRFDMAGASAPRETRA 333
Query: 146 LDLSSNN-FSGKIPFDVNNLTHLTGLFLENN 175
L L++ + + E+N
Sbjct: 334 LHLAAADWLVPAREGEPAPADRWHMFGQEDN 364
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 30/212 (14%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFE-------MQMEVLGKIKHDNVVPL 406
+G+G+ G YKA ++G K+ A+ + E ++ +L ++KH NV+ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDD-----KDYALKQIEGTGISMSACREIALLRELKHPNVISL 83
Query: 407 R-AFYYSKDEKL-LVYDYMP---AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
+ F D K+ L++DY + L + G+ +
Sbjct: 84 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 462 LHVSGKIVHGNIKASNILLRPDHDAC----VSDFGLNPLFGN-----TTPPTRVAG--YR 510
LH + ++H ++K +NIL+ + ++D G LF + V YR
Sbjct: 144 LH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 511 APEV-VETRKVTFKSDVYSFGVLLLELLTGKA 541
APE+ + R T D+++ G + ELLT +
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEP 234
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 33/209 (15%)
Query: 353 VLGKGSVGTSYKAVL-EEGTTVVVKRL-KEVAVGKREFE-MQME--VLGKIKHDNVVPLR 407
+LG+GS T A +K L K + + + + E V+ ++ H V L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 408 AFYYS--KDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR-----IALSAARGL 459
Y++ DEKL Y G L + R G R I L
Sbjct: 96 --YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDET---CTRFYTAEIVS----AL 143
Query: 460 AHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV------AGYRAPE 513
+LH G I+H ++K NILL D ++DFG + + R A Y +PE
Sbjct: 144 EYLHGKG-IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
Query: 514 VVETRKVTFKSDVYSFGVLLLELLTGKAP 542
++ + SD+++ G ++ +L+ G P
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 54/262 (20%), Positives = 95/262 (36%), Gaps = 85/262 (32%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGK-REFE-MQMEVLGKIKHDNVVPLRA 408
+ LG GS G + +E G +K++ + K RE + M++ + H N++ L
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKV-----LDHVNIIKLVD 67
Query: 409 FYYSKDEKL--------------------------------------LVYDYMPAGSLSA 430
++Y+ ++ ++ +Y+P +L
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHK 126
Query: 431 LLHGSRGSGRTPLDWDNRMRIALSAA----------RGLAHLHVSGKIVHGNIKASNILL 480
+L SGR+ + R + +H S I H +IK N+L+
Sbjct: 127 VLKSFIRSGRS-----------IPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNLLV 174
Query: 481 RPDHDA---CVSDFGLNPLFGNTTPPTR-VAG--YRAPEVV-ETRKVTFKSDVYSFGVLL 533
+ C DFG + P + YRAPE++ + T D++S G +
Sbjct: 175 NSKDNTLKLC--DFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 534 LELLTGKA--PNQASLGEEGID 553
EL+ GK GE ID
Sbjct: 233 GELILGKPLFS-----GETSID 249
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 36/154 (23%), Positives = 47/154 (30%), Gaps = 31/154 (20%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFS----GVFPASVTR 139
+PP T + LSL N +S D S L+ LR L L N+ VF
Sbjct: 50 LPPRT-------KALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVF----LF 98
Query: 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFS--------GNLPSINPANLRD 191
L LD+S N I + L L L N F GNL L
Sbjct: 99 NQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLT-----KLTF 150
Query: 192 FNVSNNNLNGSIPATLSKFPQSSFTGNLDLCGGP 225
+S ++ S +L
Sbjct: 151 LGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIK 184
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 29/133 (21%), Positives = 52/133 (39%), Gaps = 6/133 (4%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPAS--VTRMN 141
I S L+ N + + S L L++L LQ N F + M+
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMS 403
Query: 142 RLTRLDLSSNNFSGKIPFD--VNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNL 199
L LD+S N+ + +D + L L +N +G++ P ++ ++ NN +
Sbjct: 404 SLETLDVSLNSLN-SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRI 462
Query: 200 NGSIPATLSKFPQ 212
SIP ++
Sbjct: 463 M-SIPKDVTHLQA 474
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 25/125 (20%), Positives = 38/125 (30%), Gaps = 21/125 (16%)
Query: 86 PNTLGKLSQLRVLSLRSNRL----SGEIPSDFSNLTLLRSLYLQSNQF-SGVFPASVTRM 140
+ L L S + + L L SN VF +
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK- 451
Query: 141 NRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFS-------GNLPSINPANLRDFN 193
+ LDL +N IP DV +L L L + +N+ L S L+
Sbjct: 452 --VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTS-----LQYIW 503
Query: 194 VSNNN 198
+ +N
Sbjct: 504 LHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 27/90 (30%), Positives = 44/90 (48%), Gaps = 11/90 (12%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTL-LRSLYLQSNQFSGVFPASVTRMNRLTRLDLSS 150
+ VL+L SN L+G + F L ++ L L +N+ P VT + L L+++S
Sbjct: 427 AESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVAS 482
Query: 151 NNFSGKIP---FDVNNLTHLTGLFLENNKF 177
N +P FD LT L ++L +N +
Sbjct: 483 NQLK-SVPDGVFD--RLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 20/136 (14%), Positives = 43/136 (31%), Gaps = 8/136 (5%)
Query: 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQF 129
+Y+L + + L L + +++ + +S + L +
Sbjct: 283 IYNLTITERI-DREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD- 340
Query: 130 SGVFPASV-TRMNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSI--N 185
+ + T L+ + N F+ F + L L L L+ N N +
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGCSTLKRLQTLILQRNGLK-NFFKVALM 398
Query: 186 PANLRDFNVSNNNLNG 201
N+ + +LN
Sbjct: 399 TKNMSSLETLDVSLNS 414
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 30/133 (22%), Positives = 46/133 (34%), Gaps = 3/133 (2%)
Query: 90 GKLSQLRVLSLRSNRL-SGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMN-RLTRLD 147
++ LR L L N + +F NLT L L L + +F + V ++ LD
Sbjct: 118 CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLD 177
Query: 148 LSSNNFSGKIPFDVNNL-THLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPAT 206
L S + G + T + L N +++ L +SN LN
Sbjct: 178 LVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQR 237
Query: 207 LSKFPQSSFTGNL 219
L F G
Sbjct: 238 LMTFLSELTRGPT 250
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 14/45 (31%), Positives = 24/45 (53%), Gaps = 2/45 (4%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQF 129
P + L L+ L++ SN+L +P F LT L+ ++L N +
Sbjct: 466 PKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 61/291 (20%), Positives = 101/291 (34%), Gaps = 53/291 (18%)
Query: 284 KKRRRQRPGKAPKPPAAATARAVTMEAGTSSSKDDITGGAAEADRNKLVFFEGGVYSFDL 343
++RR P +A A + + K + F
Sbjct: 35 EQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQ 94
Query: 344 EDLLRASAEVLGKGSVGTSYKAVLEE-GTTVVVK-------RLKEVAVGKREFEMQMEV- 394
+ + +V+G+G + V G VK RL + + + E
Sbjct: 95 KYDPK---DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 395 -LGKIK-HDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDW------- 445
L ++ H +++ L Y S LV+D M G L D+
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL--------------FDYLTEKVAL 197
Query: 446 ---DNR--MRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500
+ R MR L A ++ LH + IVH ++K NILL + +SDFG +
Sbjct: 198 SEKETRSIMRSLLEA---VSFLHANN-IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253
Query: 501 TPPTRVAG---YRAPEVVETRKVTF------KSDVYSFGVLLLELLTGKAP 542
+ G Y APE+++ + D+++ GV+L LL G P
Sbjct: 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 52/214 (24%), Positives = 83/214 (38%), Gaps = 36/214 (16%)
Query: 353 VLGKGSVGTSYKAVLEEGTTVV--VKRL-KEVAVGKREFEMQME---VLGKIKHDNVVPL 406
V+G+G+ V + T V +K + K + + E E VL + L
Sbjct: 68 VIGRGAFSEVAV-VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 407 RAFYYS--KDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIA--LSAARGLAH 461
+++ + L LV +Y G L LL S+ R P + R +A + A +
Sbjct: 127 ---HFAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEM-ARFYLAEIVMA---IDS 177
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGL---NPLFGNTTPPTRVAG---YRAPEVV 515
+H G VH +IK NILL ++DFG G V G Y +PE++
Sbjct: 178 VHRLG-YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEIL 235
Query: 516 ETRKVTFKSDVY-------SFGVLLLELLTGKAP 542
+ + Y + GV E+ G+ P
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 28/206 (13%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEV----AVGKREF-EMQMEVLGKIKHDNVVP 405
+ +G G+ G AV G V +K+L KR + E+++ L ++H+NV+
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL--LKHMRHENVIG 88
Query: 406 LRAFYYSKDEKL------LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGL 459
L + + LV +M L L+ L D + +GL
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE------KLGEDRIQFLVYQMLKGL 141
Query: 460 AHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL-NPLFGNTTP--PTRVAGYRAPEVV- 515
++H + I+H ++K N+ + D + + DFGL T TR YRAPEV+
Sbjct: 142 RYIH-AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW--YRAPEVIL 198
Query: 516 ETRKVTFKSDVYSFGVLLLELLTGKA 541
+ T D++S G ++ E++TGK
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 9e-14
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 42/212 (19%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQME-------------VLGKI 398
E +G+G+ G YKA +G V +KR++ + E +L ++
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIR----------LDAEDEGIPSTAIREISLLKEL 76
Query: 399 KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARG 458
H N+V L +S+ LV+++M L +L +T L RG
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLD----ENKTGLQDSQIKIYLYQLLRG 131
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDAC--VSDFGLNPLFGNTTPP------TRVAGYR 510
+AH H +I+H ++K N+L+ + D ++DFGL FG T YR
Sbjct: 132 VAHCH-QHRILHRDLKPQNLLI--NSDGALKLADFGLARAFGIPVRSYTHEVVTL--WYR 186
Query: 511 APEV-VETRKVTFKSDVYSFGVLLLELLTGKA 541
AP+V + ++K + D++S G + E++TGK
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 55/224 (24%), Positives = 82/224 (36%), Gaps = 51/224 (22%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVK--------RLKEVAVGKREFEMQMEV--LGKIK- 399
E+LG+G + + + VK V + EV L K+
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 400 HDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDW----------DNR- 448
H N++ L+ Y + LV+D M G L D+ + R
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGEL--------------FDYLTEKVTLSEKETRK 128
Query: 449 -MRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA 507
MR L + LH IVH ++K NILL D + ++DFG + V
Sbjct: 129 IMRALLEV---ICALHKLN-IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184
Query: 508 G---YRAPEVVETRKVTFKS------DVYSFGVLLLELLTGKAP 542
G Y APE++E D++S GV++ LL G P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 54/224 (24%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVK---RLKEVAVGKREFEMQ------MEVLGKIKHD 401
+ LG G+ G A + V +K + K RE + +E+L K+ H
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 402 NVVPLRAFYYSKDEKLLVYDYMPAGSL--------------SALLHGSRGSGRTPLDWDN 447
++ ++ F+ ++D +V + M G L L
Sbjct: 76 CIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLY--------------- 119
Query: 448 RMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDAC---VSDFGLNPLFGNTTPPT 504
L A + +LH +G I+H ++K N+LL + C ++DFG + + G T+
Sbjct: 120 -FYQMLLA---VQYLHENG-IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 505 RVAG---YRAPEVVE---TRKVTFKSDVYSFGVLLLELLTGKAP 542
+ G Y APEV+ T D +S GV+L L+G P
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 49/188 (26%), Positives = 78/188 (41%), Gaps = 32/188 (17%)
Query: 440 RTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499
+ L ++ + + A+G+ L S K +H ++ A NILL + + DFGL
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245
Query: 500 TTPPTRVAGYR------APEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGI 552
R R APE + R T +SDV+SFGVLL E+ + G +P +E
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 303
Query: 553 DLPRWVQSVVR----EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQE 608
+ R ++ R + T E++ + M C P QRP E
Sbjct: 304 EFCRRLKEGTRMRAPDYTTPEMY--QTMLD----------------CWHGEPSQRPTFSE 345
Query: 609 VVRMIENM 616
+V + N+
Sbjct: 346 LVEHLGNL 353
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 29/125 (23%), Positives = 55/125 (44%), Gaps = 10/125 (8%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
+ L + L L N+L+ +I +NL L L+L N+ + + + +L L L
Sbjct: 61 IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSL 116
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATL 207
N S I + +L L L+L NNK + ++ + L ++ +N ++ I L
Sbjct: 117 EHNGIS-DING-LVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQIS-DIVP-L 171
Query: 208 SKFPQ 212
+ +
Sbjct: 172 AGLTK 176
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 30/112 (26%), Positives = 55/112 (49%), Gaps = 8/112 (7%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L L L L L N++ ++ S +L L+SL L+ N S + + + +L L L
Sbjct: 83 LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYL 138
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNL 199
+N + I ++ LT L L LE+N+ S ++ + L++ +S N++
Sbjct: 139 GNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHI 187
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 3e-12
Identities = 26/130 (20%), Positives = 49/130 (37%), Gaps = 4/130 (3%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L +L++L LSL N++S +I + LT L++LYL N S + + + L L+L
Sbjct: 149 LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLEL 204
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLS 208
S K +NL + + + + NV + + +
Sbjct: 205 FSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFI 264
Query: 209 KFPQSSFTGN 218
+ +
Sbjct: 265 FYQPVTIGKA 274
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 3e-12
Identities = 22/113 (19%), Positives = 46/113 (40%), Gaps = 8/113 (7%)
Query: 88 TLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147
T +L+ + + ++ + + L + L+L N+ + + P +T + L L
Sbjct: 38 TQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93
Query: 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINP-ANLRDFNVSNNNL 199
L N + + +L L L LE+N S ++ + L + NN +
Sbjct: 94 LDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKI 143
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 24/125 (19%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
++ +L+ ++ + + L + + ++ V + + +T+L L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFL 72
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATL 207
+ N + I + NL +L LFL+ NK +L S+ + L+ ++ +N ++ I L
Sbjct: 73 NGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSSLKDLKKLKSLSLEHNGIS-DING-L 127
Query: 208 SKFPQ 212
PQ
Sbjct: 128 VHLPQ 132
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 9e-11
Identities = 36/116 (31%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L L QL L L +N+++ +I + S LT L +L L+ NQ S + P + + +L L L
Sbjct: 127 LVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 182
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIP 204
S N+ S + + L +L L L + + N P + +NL N + N +GS+
Sbjct: 183 SKNHIS-DLRA-LAGLKNLDVLELFSQECL-NKPINHQSNLVVPN-TVKNTDGSLV 234
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 16/106 (15%), Positives = 36/106 (33%), Gaps = 6/106 (5%)
Query: 95 LRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFS 154
+ S + +I L+ + +N + ++ ++++
Sbjct: 1 MGETITVSTPIK-QI-FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 155 GKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN 200
+ + L ++T LFL NK + P N NL + N +
Sbjct: 57 -SVQG-IQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIK 100
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 28/206 (13%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEV----AVGKREF-EMQMEVLGKIKHDNVVP 405
+G G+ G+ A + G V VK+L KR + E+++ L +KH+NV+
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL--LKHMKHENVIG 92
Query: 406 LRAFYYSKDEKL------LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGL 459
L + LV M A L+ ++ L D+ + RGL
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQ------KLTDDHVQFLIYQILRGL 145
Query: 460 AHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL-NPLFGNTTP--PTRVAGYRAPEVV- 515
++H S I+H ++K SN+ + D + + DFGL T TR YRAPE++
Sbjct: 146 KYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW--YRAPEIML 202
Query: 516 ETRKVTFKSDVYSFGVLLLELLTGKA 541
D++S G ++ ELLTG+
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 38/220 (17%)
Query: 345 DLLRASAEVLGKGSVGTSYKAVLEEGTTVV--VKRL-KEVAVGKREFEMQME---VLGKI 398
++L+ V+G+G+ G V + V +K L K + + E E VL
Sbjct: 77 EILK----VIGRGAFGEVAV-VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 399 KHDNVVPLRAFYYS--KDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIA--L 453
+ L +Y+ D L LV DY G L LL S+ R P + R +A +
Sbjct: 132 DSKWITTL---HYAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEM-ARFYLAEMV 185
Query: 454 SAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---NPLFGNTTPPTRVAG-- 508
A + +H VH +IK NIL+ + ++DFG G V G
Sbjct: 186 IA---IDSVHQLH-YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTP 240
Query: 509 -YRAPEVVETRKVTFKS-----DVYSFGVLLLELLTGKAP 542
Y +PE+++ + D +S GV + E+L G+ P
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 2e-13
Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 34/208 (16%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQME-----------VLGKIKH 400
E +G+G+ G YKA G T +K+++ E + E +L ++KH
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIR--------LEKEDEGIPSTTIREISILKELKH 59
Query: 401 DNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLA 460
N+V L ++K +LV++++ L LL L+ L G+A
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLD----VCEGGLESVTAKSFLLQLLNGIA 114
Query: 461 HLHVSGKIVHGNIKASNILLRPDHDAC--VSDFGLNPLFGNTTPP--TRVAG--YRAPEV 514
+ H +++H ++K N+L+ + + ++DFGL FG + YRAP+V
Sbjct: 115 YCH-DRRVLHRDLKPQNLLI--NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 515 -VETRKVTFKSDVYSFGVLLLELLTGKA 541
+ ++K + D++S G + E++ G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTP 199
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 30/112 (26%), Positives = 55/112 (49%), Gaps = 8/112 (7%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L L L L L N++ ++ S +L L+SL L+ N S + + + +L L L
Sbjct: 86 LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYL 141
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNL 199
+N + I ++ LT L L LE+N+ S ++ + L++ +S N++
Sbjct: 142 GNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHI 190
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 29/125 (23%), Positives = 55/125 (44%), Gaps = 10/125 (8%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
+ L + L L N+L+ +I +NL L L+L N+ + + + +L L L
Sbjct: 64 IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSL 119
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATL 207
N S I + +L L L+L NNK + ++ + L ++ +N ++ I L
Sbjct: 120 EHNGIS-DING-LVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQIS-DIVP-L 174
Query: 208 SKFPQ 212
+ +
Sbjct: 175 AGLTK 179
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 36/115 (31%), Positives = 59/115 (51%), Gaps = 8/115 (6%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L L QL L L +N+++ +I + S LT L +L L+ NQ S + P + + +L L L
Sbjct: 130 LVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 185
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSI 203
S N+ S + + L +L L L + + N P + +NL N + N +GS+
Sbjct: 186 SKNHIS-DLR-ALAGLKNLDVLELFSQECL-NKPINHQSNLVVPN-TVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 21/113 (18%), Positives = 45/113 (39%), Gaps = 8/113 (7%)
Query: 88 TLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147
T +L+ + + ++ + + L + L+L N+ + + P + + L L
Sbjct: 41 TQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLF 96
Query: 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINP-ANLRDFNVSNNNL 199
L N + + +L L L LE+N S ++ + L + NN +
Sbjct: 97 LDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKI 146
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 26/112 (23%), Positives = 45/112 (40%), Gaps = 4/112 (3%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L +L++L LSL N++S +I + LT L++LYL N S + + + L L+L
Sbjct: 152 LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLEL 207
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN 200
S K +NL + + + + NV +
Sbjct: 208 FSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 19/117 (16%), Positives = 47/117 (40%), Gaps = 16/117 (13%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
++ +L+ ++ + + L + + ++ V + + +T+L L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFL 75
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFS-----GNLPSINPANLRDFNVSNNNLN 200
+ N + I + NL +L LFL+ NK +L L+ ++ +N ++
Sbjct: 76 NGNKLT-DI-KPLANLKNLGWLFLDENKVKDLSSLKDLK-----KLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 14/89 (15%), Positives = 31/89 (34%), Gaps = 4/89 (4%)
Query: 111 SDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGL 170
L+ + +N + ++ ++++ + + L ++T L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 73
Query: 171 FLENNKFSGNLPSINPANLRDFNVSNNNL 199
FL NK + P N NL + N +
Sbjct: 74 FLNGNKLTDIKPLANLKNLGWLFLDENKV 102
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 48/232 (20%)
Query: 336 GGVYSFDLED--LLRASAEVLGKGSVGTSYKAVLEE----GTTVVVKRL-KEVAVGKREF 388
G + L+D LLR V+G+GS K +L +K + KE+ +
Sbjct: 1 GAMDPLGLQDFDLLR----VIGRGSYA---KVLLVRLKKTDRIYAMKVVKKELVNDDEDI 53
Query: 389 E-MQME--VLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLD 444
+ +Q E V + H +V L + + ++ V +Y+ G L + H R + P +
Sbjct: 54 DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR-QRKLPEE 110
Query: 445 WDNRMR-----IALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---NPL 496
R I+L L +LH G I++ ++K N+LL + ++D+G+
Sbjct: 111 ---HARFYSAEISL----ALNYLHERG-IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162
Query: 497 FGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
G+T TP Y APE++ F D ++ GVL+ E++ G++P
Sbjct: 163 PGDTTSTFCGTP-----NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 25/99 (25%), Positives = 38/99 (38%), Gaps = 14/99 (14%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFS----GVFPASVTR 139
I S + + L SNRL F L L++L L+SN+ + F
Sbjct: 72 IEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSF----IG 127
Query: 140 MNRLTRLDLSSNNFSGKIP---FDVNNLTHLTGLFLENN 175
++ + L L N + + FD L L+ L L N
Sbjct: 128 LSSVRLLSLYDNQIT-TVAPGAFD--TLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 32/158 (20%), Positives = 57/158 (36%), Gaps = 28/158 (17%)
Query: 56 CNWVGVECDANR---------SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLS 106
C V+C + + LRL KL QLR ++ +N+++
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 107 GEIPSD-FSNLTLLRSLYLQSNQF----SGVFPASVTRMNRLTRLDLSSNNFSGKIPFDV 161
+I F + + + L SN+ +F + L L L SN + + D
Sbjct: 71 -DIEEGAFEGASGVNEILLTSNRLENVQHKMF----KGLESLKTLMLRSNRIT-CVGNDS 124
Query: 162 -NNLTHLTGLFLENNKFSG-------NLPSINPANLRD 191
L+ + L L +N+ + L S++ NL
Sbjct: 125 FIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLA 162
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-12
Identities = 31/115 (26%), Positives = 53/115 (46%), Gaps = 9/115 (7%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
+ L L+ L LRSNR++ + +D F L+ +R L L NQ + V P + ++
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS 154
Query: 143 LTRLDLSSNNFSGKIPFDVN-NLTHLTGLFLENNKFSGNLPSINPANLRDFNVSN 196
L+ L+L +N PF+ N L L + +GN P L++ + +
Sbjct: 155 LSTLNLLAN------PFNCNCYLAWLGEWLRKKRIVTGNPRCQKPYFLKEIPIQD 203
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 34/162 (20%), Positives = 53/162 (32%), Gaps = 41/162 (25%)
Query: 56 CNWVGVECDANRSFVYSLRLPGVGLVGP--IPPNTLGKLSQLRVLSLRSNRLSGEIPSDF 113
C+ V+C L + P +P + L N + P F
Sbjct: 11 CSNNIVDC-------RGKGLTEI----PTNLPETI-------TEIRLEQNTIKVIPPGAF 52
Query: 114 SNLTLLRSLYLQSNQFS----GVFPASVTRMNRLTRLDLSSNNFSGKIPFDV-NNLTHLT 168
S LR + L +NQ S F + L L L N + ++P + L L
Sbjct: 53 SPYKKLRRIDLSNNQISELAPDAF----QGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQ 107
Query: 169 GLFLENNKFSGNLPSINP------ANLRDFNVSNNNLNGSIP 204
L L NK + + NL ++ +N L +I
Sbjct: 108 LLLLNANK----INCLRVDAFQDLHNLNLLSLYDNKLQ-TIA 144
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 21/93 (22%), Positives = 38/93 (40%), Gaps = 2/93 (2%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
+ P+ L L L L N+++ E+P F L L+ L L +N+ + + + ++
Sbjct: 71 LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHN 129
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENN 175
L L L N + L + + L N
Sbjct: 130 LNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 17/78 (21%), Positives = 35/78 (44%), Gaps = 8/78 (10%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
+P + L L++L L +N+++ + D F +L L L L N+ + + + +
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 143 LTRLDLSSNNFSGKIPFD 160
+ + L+ N PF
Sbjct: 154 IQTMHLAQN------PFI 165
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 35/211 (16%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQME------------VLGKI 398
E LG G+ T YK + G V +K +K + E ++ ++
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVK----------LDSEEGTPSTAIREISLMKEL 60
Query: 399 KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALL-HGSRGSGRTPLDWDNRMRIALSAAR 457
KH+N+V L +++++ LV+++M L + + G+ L+ + +
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 458 GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPP------TRVAGYRA 511
GLA H KI+H ++K N+L+ + DFGL FG T YRA
Sbjct: 120 GLAFCH-ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL--WYRA 176
Query: 512 PEV-VETRKVTFKSDVYSFGVLLLELLTGKA 541
P+V + +R + D++S G +L E++TGK
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKP 207
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLK---EVAVGKREF-EMQMEVLGKIKHDNVVPL 406
+G+G+ G A V +K++ +R E+++ L + +H+N++ +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKI--LLRFRHENIIGI 90
Query: 407 RAFYYSKDEKL-----LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
+ + +V D M L LL L D+ RGL +
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ------HLSNDHICYFLYQILRGLKY 143
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGL----NPLFGNTTPPTR-VAG--YRAPEV 514
+H S ++H ++K SN+LL D + DFGL +P +T T VA YRAPE+
Sbjct: 144 IH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 515 V-ETRKVTFKSDVYSFGVLLLELLTGKA 541
+ ++ T D++S G +L E+L+ +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 6e-13
Identities = 29/119 (24%), Positives = 43/119 (36%), Gaps = 14/119 (11%)
Query: 91 KLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSS 150
++Q L L LS +P + + L + N P L LD
Sbjct: 57 LINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPA---SLEYLDACD 109
Query: 151 NNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSK 209
N S +P L L ++NN+ + LP + PA L N NN L +P +
Sbjct: 110 NRLS-TLP---ELPASLKHLDVDNNQLT-MLPEL-PALLEYINADNNQLT-MLPELPTS 161
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 16/122 (13%), Positives = 39/122 (31%), Gaps = 6/122 (4%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTLLRS----LYLQSNQFSGVFPASVTRMNRLTRLD 147
L L + +N L +P+ + N+ + + P ++ ++ +
Sbjct: 179 PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITHI-PENILSLDPTCTII 236
Query: 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATL 207
L N S +I ++ T FS + N + + + + +
Sbjct: 237 LEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDV 296
Query: 208 SK 209
S+
Sbjct: 297 SQ 298
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 20/114 (17%), Positives = 44/114 (38%), Gaps = 16/114 (14%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSN 151
+ L ++ +N+L+ +P ++L L +++NQ + P L LD+S+N
Sbjct: 139 PALLEYINADNNQLT-MLPELPTSL---EVLSVRNNQLT-FLPEL---PESLEALDVSTN 190
Query: 152 NFSGKIPFDVNNLTHLT----GLFLENNKFSGNLPS--INPANLRDFNVSNNNL 199
+P H N+ + ++P ++ + +N L
Sbjct: 191 LLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL 242
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 22/111 (19%), Positives = 31/111 (27%), Gaps = 6/111 (5%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTR 145
P + L + L N LS I S T + FS
Sbjct: 223 PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS--MSDGQQNTLHRPL 280
Query: 146 LDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNL----PSINPANLRDF 192
D + F DV+ + H N FS L +++ N F
Sbjct: 281 ADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGF 331
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 16/112 (14%), Positives = 34/112 (30%), Gaps = 13/112 (11%)
Query: 98 LSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKI 157
+ L N + F N + Y + ++ + + + N +
Sbjct: 3 IMLPINNNFSLSQNSFYNT--ISGTYAD-------YFSAWDKWEKQALPGENRNEAVSLL 53
Query: 158 PFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSK 209
+ + L L S +LP P + ++ N L S+P +
Sbjct: 54 KE--CLINQFSELQLNRLNLS-SLPDNLPPQITVLEITQNAL-ISLPELPAS 101
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 23/203 (11%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM-------QMEVLGKIKHDNV 403
++G+GS G K + G V +K+ E + +M ++++L +++H+N+
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLE----SDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
V L K LV++++ ++ L LD+ + G+ H
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH-TILDDLE----LFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPP--TRVAG--YRAPEV-VETR 518
S I+H +IK NIL+ + DFG VA YRAPE+ V
Sbjct: 142 -SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 519 KVTFKSDVYSFGVLLLELLTGKA 541
K DV++ G L+ E+ G+
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEP 223
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 49/236 (20%), Positives = 95/236 (40%), Gaps = 37/236 (15%)
Query: 335 EGGVYSFDLEDLLRAS----AEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFE 389
GG + + + + LG G T + A + T V +K ++ V E
Sbjct: 4 PGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE 63
Query: 390 MQMEVLGKIK-----------HDNVVPL-RAFYYSKDEKL---LVYDYMPAGSLSALLHG 434
++++L ++ ++++ L F + + +V++ + +L AL+
Sbjct: 64 DEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKK 122
Query: 435 SRGSGRTPLDWDNRMR-IALSAARGLAHLHVSGKIVHGNIKASNILLR-PDHDAC----- 487
G PL ++ I+ GL ++H I+H +IK N+L+ D
Sbjct: 123 YEHRG-IPLI---YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 178
Query: 488 VSDFGLNPLFGNTTPP---TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGK 540
++D G + TR YR+PEV+ +D++S L+ EL+TG
Sbjct: 179 IADLGNACWYDEHYTNSIQTRE--YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 35/215 (16%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLK---EVAVGKREF-EMQMEVLGKIKHDNVVPL 406
+LG+G+ G A G V +K+++ + R E+++ L KH+N++ +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI--LKHFKHENIITI 74
Query: 407 RAFYYSKDEKL-----LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
+ ++ + M L ++ L D+ R +
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQT-DLHRVIST------QMLSDDHIQYFIYQTLRAVKV 127
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGL----NPLFGNTTPPTRVAG--------- 508
LH ++H ++K SN+L+ + D V DFGL + + + PT
Sbjct: 128 LH-GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 509 -YRAPEVV-ETRKVTFKSDVYSFGVLLLELLTGKA 541
YRAPEV+ + K + DV+S G +L EL +
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 9e-13
Identities = 60/235 (25%), Positives = 92/235 (39%), Gaps = 71/235 (30%)
Query: 345 DLLRASAEVLGKGSVGTSYKAVLEEGTT----------------VVVKRLKEVAVGKREF 388
+LLR VLGKG G K T ++V+ K+ A
Sbjct: 20 ELLR----VLGKGGYG---KVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA------ 66
Query: 389 EMQME--VLGKIKHDNVVPLRAFYYS--KDEKL-LVYDYMPAGSLSALLHGSRGSGRTPL 443
+ E +L ++KH +V L Y+ KL L+ +Y+ G L + R G
Sbjct: 67 HTKAERNILEEVKHPFIVDL---IYAFQTGGKLYLILEYLSGGEL--FMQLER-EGIFME 120
Query: 444 DWDNRMR-----IALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD--ACVSDFGL--- 493
D I++ L HLH G I++ ++K NI+L +H ++DFGL
Sbjct: 121 D---TACFYLAEISM----ALGHLHQKG-IIYRDLKPENIML--NHQGHVKLTDFGLCKE 170
Query: 494 NPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
+ G T Y APE++ D +S G L+ ++LTG P
Sbjct: 171 SIHDGTVTHTFCGTI-----EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 9e-13
Identities = 85/408 (20%), Positives = 137/408 (33%), Gaps = 42/408 (10%)
Query: 158 PFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQSSFTG 217
D + ++ + + NL + + + + S
Sbjct: 153 GTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQK 212
Query: 218 NLDLCGGPLPPCNPFFPSPAPSPSLPPPVAPVHKKSNKLSTAAIVGIAVGGAVFIVLLLL 277
+ P N F ++ + S +G G + +
Sbjct: 213 TKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGV 272
Query: 278 LLLFCLKKRRRQRPGKAPKPPAAATARAVTMEAGTSSSKDDITGGAAEADRNKLVFFE-- 335
F L + P PP + + + T E N + F+
Sbjct: 273 DGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNN 332
Query: 336 GGVYSFDLED--LLRASAEVLGKGSVGTSYKAVLEE----GTTVVVKRL-KEVAVGKREF 388
G L D L VLGKGS G K +L E VK L K+V + +
Sbjct: 333 GNRDRMKLTDFNFLM----VLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQDDDV 385
Query: 389 E-MQME--VLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLD 444
E +E VL K + L + + + D V +Y+ G L + H + GR
Sbjct: 386 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQ-VGRFKEP 442
Query: 445 WDNRMRI-ALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---NPLFGNT 500
A A GL L G I++ ++K N++L + ++DFG+ N G T
Sbjct: 443 ---HAVFYAAEIAIGLFFLQSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498
Query: 501 ------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
TP Y APE++ + D ++FGVLL E+L G+AP
Sbjct: 499 TKTFCGTP-----DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 46/221 (20%)
Query: 345 DLLRASAEVLGKGSVGTSYKAVLEE----GTTVVVKRL-KEVAVGKREFE-MQME--VLG 396
DLLR V+G+GS K +L ++ + KE+ + + +Q E V
Sbjct: 55 DLLR----VIGRGSYA---KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFE 107
Query: 397 KI-KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR----- 450
+ H +V L + + ++ V +Y+ G L + H R + P + R
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR-QRKLPEE---HARFYSAE 161
Query: 451 IALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---NPLFGNT------T 501
I+L L +LH G I++ ++K N+LL + ++D+G+ G+T T
Sbjct: 162 ISL----ALNYLHERG-IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT 216
Query: 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
P Y APE++ F D ++ GVL+ E++ G++P
Sbjct: 217 P-----NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.2 bits (171), Expect = 1e-12
Identities = 29/119 (24%), Positives = 45/119 (37%), Gaps = 10/119 (8%)
Query: 85 PPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLT 144
+ + +RVL L L+ + L L+ L L N+ + P ++ + L
Sbjct: 433 NSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRAL-PPALAALRCLE 489
Query: 145 RLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINP----ANLRDFNVSNNNL 199
L S N + V NL L L L NN+ +I P L N+ N+L
Sbjct: 490 VLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 23/91 (25%), Positives = 32/91 (35%), Gaps = 4/91 (4%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L +L + L L NRL +P + L L L N V V + RL L L
Sbjct: 459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLL 515
Query: 149 SSNNFSG-KIPFDVNNLTHLTGLFLENNKFS 178
+N + + L L L+ N
Sbjct: 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.1 bits (124), Expect = 4e-07
Identities = 19/70 (27%), Positives = 27/70 (38%), Gaps = 3/70 (4%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV-FPASVTRMNRLT 144
P L L L VL N L + +NL L+ L L +N+ + RL
Sbjct: 479 PPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV 536
Query: 145 RLDLSSNNFS 154
L+L N+
Sbjct: 537 LLNLQGNSLC 546
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 65/379 (17%), Positives = 114/379 (30%), Gaps = 112/379 (29%)
Query: 335 EGGVYSFDLEDLLRASAEVLGK---GSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM 390
+GG + + DL V+ K G T + + ++ V +K +K
Sbjct: 23 KGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD 82
Query: 391 QMEVLGKIK--------HDNVVPLR-AFYYSKDE---KLLVYDYMPAG-SLSALLHGSRG 437
++ +L ++ + VV L F S +V++ G L + S
Sbjct: 83 EIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNY 140
Query: 438 SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPL- 496
G L +I +GL +LH +I+H +IK NILL +
Sbjct: 141 QG---LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEW 197
Query: 497 ------------------------------------------FGNTTPP---------TR 505
GN TR
Sbjct: 198 QRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTR 257
Query: 506 VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEG----------IDL- 554
YR+ EV+ +D++S + EL TG + GEE I+L
Sbjct: 258 Q--YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315
Query: 555 ----PRWVQSVVREEWTAEVFD------------------VELMRYHNIEEEMVQLLQIA 592
+ + +++ E F V + +Y +EE
Sbjct: 316 GKVPRKLIV---AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFL 372
Query: 593 MGCVSTVPDQRPAMQEVVR 611
+ + +P++R E +R
Sbjct: 373 LPMLELIPEKRATAAECLR 391
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 49/205 (23%), Positives = 82/205 (40%), Gaps = 27/205 (13%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKE---------VAVGKREFEMQMEVLGKIKHD 401
+G+GS G +K + G V +K+ E +A+ RE M L ++KH
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL--REIRM----LKQLKHP 62
Query: 402 NVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
N+V L + K LV++Y ++ L + + I + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCD-HTVLHELD----RYQRGVPEHLVKSITWQTLQAVNF 117
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPP--TRVAG--YRAPEV-VE 516
H +H ++K NIL+ + DFG L + VA YR+PE+ V
Sbjct: 118 CH-KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKA 541
+ DV++ G + ELL+G
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVP 201
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 24/112 (21%), Positives = 48/112 (42%), Gaps = 9/112 (8%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
+ + L+ L L N++S ++ S +LT L L + N+ + L+RL L
Sbjct: 59 MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIP---SACLSRLFL 113
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNL 199
+N + +L +L L + NNK ++ + + L ++ N +
Sbjct: 114 DNNELR-DTD-SLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEI 162
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 22/111 (19%), Positives = 42/111 (37%), Gaps = 7/111 (6%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L+ +L ++ ++ L+ +++ ++ + + L L L
Sbjct: 15 DPGLANAVKQNLGKQSVT-DL-VSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHL 70
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNL 199
S N S + + +LT L L + N+ NL I A L + NN L
Sbjct: 71 SHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNNEL 118
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 22/113 (19%), Positives = 43/113 (38%), Gaps = 11/113 (9%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTL--LRSLYLQSNQFSGVFPASVTRMNRLTRL 146
L L++L LS+ NRL + + + L L+L +N+ S+ + L L
Sbjct: 81 LKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELRDT--DSLIHLKNLEIL 133
Query: 147 DLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNL 199
+ +N I + L+ L L L N+ + + +++
Sbjct: 134 SIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 26/119 (21%), Positives = 53/119 (44%), Gaps = 21/119 (17%)
Query: 88 TLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147
+ +LS ++ + ++ + + + T L+ L+L NQ S + P + + +L L
Sbjct: 36 SQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91
Query: 148 LSSNNFSGKIPFDVNNLTH--LTGLFLENNKFS-----GNLPSINPANLRDFNVSNNNL 199
++ N ++N + L+ LFL+NN+ +L NL ++ NN L
Sbjct: 92 VNRNRLK-----NLNGIPSACLSRLFLDNNELRDTDSLIHLK-----NLEILSIRNNKL 140
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 22/112 (19%), Positives = 41/112 (36%), Gaps = 4/112 (3%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L L L +LS+R+N+L I L+ L L L N+ + +TR+ ++ +DL
Sbjct: 124 LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDL 179
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN 200
+ + L + + ++ N + D V
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPV 231
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 46/214 (21%), Positives = 76/214 (35%), Gaps = 40/214 (18%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
+VLG G G + +K L++ +RE E+ ++V + Y
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ---CPHIVRIVDVY 80
Query: 411 ----YSKDEKLLVYDYMPAGSL-SALLHGSRGSGR-TPLDWDNRMRIALSAARGLAHLHV 464
+ L+V + + G L S + RG T + M+ A + +LH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEA---IQYLHS 135
Query: 465 SGKIVHGNIKASNILLR-PDHDACV--SDFGLNPLFGNTTPPTRVAGYRAPEVVETRKVT 521
I H ++K N+L +A + +DFG A E K
Sbjct: 136 IN-IAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------AKETTG-EKYD 176
Query: 522 FKSDVYSFGVLLLELLTGKAP---NQASLGEEGI 552
D++S GV++ LL G P N G+
Sbjct: 177 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 210
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 21/93 (22%), Positives = 34/93 (36%), Gaps = 2/93 (2%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPS-DFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLT 144
+ L L L + + + + D L LR+L + + V P + RL+
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83
Query: 145 RLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKF 177
RL+LS N + + L L L N
Sbjct: 84 RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 1e-08
Identities = 16/102 (15%), Positives = 35/102 (34%), Gaps = 4/102 (3%)
Query: 102 SNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPA-SVTRMNRLTRLDLSSNNFSGKIPFD 160
+ + + L LY+++ Q + + L L + + P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 161 VNNLTHLTGLFLENNKFSGNLPS--INPANLRDFNVSNNNLN 200
+ L+ L L N +L + +L++ +S N L+
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 18/82 (21%), Positives = 28/82 (34%), Gaps = 3/82 (3%)
Query: 73 LRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSG 131
L + + + L L +LR L++ + L + D F L L L N
Sbjct: 36 LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALES 94
Query: 132 VFPASVTRMNRLTRLDLSSNNF 153
+ + L L LS N
Sbjct: 95 L-SWKTVQGLSLQELVLSGNPL 115
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 46/221 (20%)
Query: 345 DLLRASAEVLGKGSVGTSYKAVLEE----GTTVVVKRL-KEVAVGKREFE-MQME--VLG 396
+ L VLGKGS G K +L E VK L K+V + + E +E VL
Sbjct: 23 NFLM----VLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 75
Query: 397 KI-KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR----- 450
K + L + + + D V +Y+ G L + H + GR
Sbjct: 76 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQ-VGRFKEP---HAVFYAAE 129
Query: 451 IALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---NPLFGNT------T 501
IA+ GL L G I++ ++K N++L + ++DFG+ N G T T
Sbjct: 130 IAI----GLFFLQSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGT 184
Query: 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
P Y APE++ + D ++FGVLL E+L G+AP
Sbjct: 185 P-----DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 48/220 (21%)
Query: 345 DLLRASAEVLGKGSVGTSYKAVL----EEGTTVVVKRL-KEVAVGKREFE-MQME--VLG 396
+LR LG GS G + L G +K L KE+ V ++ E E +L
Sbjct: 9 QILR----TLGTGSFG---RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 397 KIKHDNVVPLRAFYYSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR----- 450
+ H ++ + + +++ ++ DY+ G L +LL R S R P + +
Sbjct: 62 IVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFP---NPVAKFYAAE 114
Query: 451 IALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD--ACVSDFGLNPLFGNT------TP 502
+ L L +LH S I++ ++K NILL D + ++DFG + TP
Sbjct: 115 VCL----ALEYLH-SKDIIYRDLKPENILL--DKNGHIKITDFGFAKYVPDVTYTLCGTP 167
Query: 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
Y APEVV T+ D +SFG+L+ E+L G P
Sbjct: 168 D-----YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 45/208 (21%), Positives = 86/208 (41%), Gaps = 34/208 (16%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEMQME------------VLGKI 398
+ LG+G+ T YK + V +K ++ ++ E +L +
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIR----------LEHEEGAPCTAIREVSLLKDL 57
Query: 399 KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARG 458
KH N+V L +++ LV++Y+ L L ++ N RG
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD----DCGNIINMHNVKLFLFQLLRG 112
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPP--TRVAG--YRAPEV 514
LA+ H K++H ++K N+L+ + ++DFGL T V YR P++
Sbjct: 113 LAYCH-RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171
Query: 515 -VETRKVTFKSDVYSFGVLLLELLTGKA 541
+ + + + D++ G + E+ TG+
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGRP 199
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 31/155 (20%), Positives = 55/155 (35%), Gaps = 20/155 (12%)
Query: 84 IPPNTLGKLSQLRVLSL-RSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMN 141
I + L +L + + ++N L I + F NL L+ L + + +
Sbjct: 70 IEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 128
Query: 142 RLTRLDLSSNNFSGKIPFDV-NNLTH-LTGLFLENNKFSGNLPS--INPANLRDFNVSNN 197
+ LD+ N I + L+ L+L N + + N L + N+S+N
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDN 187
Query: 198 NLNGSIPATLSKFPQSSFTG-----NLDLCGGPLP 227
N L + P F G LD+ +
Sbjct: 188 NN-------LEELPNDVFHGASGPVILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 24/118 (20%), Positives = 41/118 (34%), Gaps = 9/118 (7%)
Query: 84 IPPNTLGKLS-QLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMN 141
I N+ LS + +L L N + EI + F+ L +N + +
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGAS 202
Query: 142 RLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINP-ANLRDFNVSNN 197
LD+S +P NL L N K LP++ L + +++
Sbjct: 203 GPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 20/129 (15%), Positives = 43/129 (33%), Gaps = 9/129 (6%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQ-SNQFSGVFPASVTRMN 141
I L + + N + I +D FSNL L + ++ +N + P + +
Sbjct: 45 IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLP 104
Query: 142 RLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSIN----PANLRDFNVSN 196
L L +S+ +P + L +++N + + ++
Sbjct: 105 NLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 163
Query: 197 NNLNGSIPA 205
N + I
Sbjct: 164 NGIQ-EIHN 171
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 29/133 (21%), Positives = 50/133 (37%), Gaps = 21/133 (15%)
Query: 96 RVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSG 155
RV + ++++ EIPSD L + + + + L ++++S N+
Sbjct: 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 156 KIPFDV-NNLTHLTGLFLENNKFSGNLPSINP------ANLRDFNVSNNNLNGSIPATLS 208
I DV +NL L + +E NL INP NL+ +SN +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKAN---NLLYINPEAFQNLPNLQYLLISNTG--------IK 117
Query: 209 KFPQSSFTGNLDL 221
P +L
Sbjct: 118 HLPDVHKIHSLQK 130
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 46/213 (21%), Positives = 82/213 (38%), Gaps = 35/213 (16%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVK-----RLKEVAVGKREFEMQMEV--LGKIKHD-- 401
+LG G G+ Y + + + V +K R+ + + MEV L K+
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 402 NVVPLRAFYYSKDEKLLVYDY-MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLA 460
V+ L ++ D +L+ + P L + + R L + +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI-----TERGALQEELARSFFWQVLEAVR 163
Query: 461 HLHVSGKIVHGNIKASNILLRPDHDAC---VSDFGLNPLFGNT-------TPPTRVAGYR 510
H H + ++H +IK NIL+ D + + DFG L +T T Y
Sbjct: 164 HCH-NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRV-----YS 215
Query: 511 APEVVETRKVT-FKSDVYSFGVLLLELLTGKAP 542
PE + + + V+S G+LL +++ G P
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 46/217 (21%), Positives = 88/217 (40%), Gaps = 37/217 (17%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRL--KEVAVGKREF-EMQMEVLGKIKHDNVVPLR 407
+ LG G G + AV + V +K++ + K E+++ + ++ HDN+V +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKI--IRRLDHDNIVKVF 74
Query: 408 AFYYSKDEKL--------------LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIAL 453
+L +V +YM L+ +L PL ++
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQG------PLLEEHARLFMY 127
Query: 454 SAARGLAHLHVSGKIVHGNIKASNILL-RPDHDACVSDFGLNPLFGNTTPPTR-----VA 507
RGL ++H S ++H ++K +N+ + D + DFGL + +
Sbjct: 128 QLLRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 508 G--YRAPEV-VETRKVTFKSDVYSFGVLLLELLTGKA 541
YR+P + + T D+++ G + E+LTGK
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 69/226 (30%), Positives = 95/226 (42%), Gaps = 56/226 (24%)
Query: 345 DLLRASAEVLGKGSVGTSYKAVLEE--GTTVV--VKRL-KEVAVGKREFE-MQME--VLG 396
L+ V+GKGS G K +L V VK L K+ + K+E + + E VL
Sbjct: 41 HFLK----VIGKGSFG---KVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 397 K-IKHDNVVPLRAFYYS--KDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR-- 450
K +KH +V L ++S +KL V DY+ G L H R R R
Sbjct: 94 KNVKHPFLVGL---HFSFQTADKLYFVLDYINGGEL--FYHLQR-ERCFLEP---RARFY 144
Query: 451 ---IALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD--ACVSDFGL---NPLFGNT-- 500
IA L +LH IV+ ++K NILL D ++DFGL N +T
Sbjct: 145 AAEIAS----ALGYLHSLN-IVYRDLKPENILL--DSQGHIVLTDFGLCKENIEHNSTTS 197
Query: 501 ----TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
TP Y APEV+ + D + G +L E+L G P
Sbjct: 198 TFCGTP-----EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 48/215 (22%), Positives = 81/215 (37%), Gaps = 37/215 (17%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVK-----RLKEVAVGKREFEMQMEVL------GKIK 399
+LGKG GT + L + V +K R+ + +EV
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 400 HDNVVPLRAFYYSKDEKLLVYDY-MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARG 458
H V+ L ++ +++ +LV + +PA L + + + PL
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-----TEKGPLGEGPSRCFFGQVVAA 151
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDAC---VSDFGLNPLFGNT-------TPPTRVAG 508
+ H H S +VH +IK NIL+ D + DFG L + T
Sbjct: 152 IQHCH-SRGVVHRDIKDENILI--DLRRGCAKLIDFGSGALLHDEPYTDFDGTRV----- 203
Query: 509 YRAPEVVETRKVT-FKSDVYSFGVLLLELLTGKAP 542
Y PE + + + V+S G+LL +++ G P
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 59/261 (22%), Positives = 96/261 (36%), Gaps = 50/261 (19%)
Query: 305 AVTMEAGTSSSKDDITGGAAEADRNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYK 364
A + S + A E K D D ++ LG GS G +
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIK----TLGTGSFG---R 56
Query: 365 AVL----EEGTTVVVKRL-KEVAVGKREFEMQM---EVLGKIKHDNVVPLRAFYYSKDEK 416
+L E G +K L K+ V ++ E + +L + +V L + KD
Sbjct: 57 VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL--EFSFKDNS 114
Query: 417 LL--VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR-----IALSAARGLAHLHVSGKIV 469
L V +Y+ G + + L R GR + R I L +LH S ++
Sbjct: 115 NLYMVMEYVAGGEMFSHL---RRIGRFS---EPHARFYAAQIVL----TFEYLH-SLDLI 163
Query: 470 HGNIKASNILLRPDHD--ACVSDFGLNPLFGNT------TPPTRVAGYRAPEVVETRKVT 521
+ ++K N+L+ D V+DFG TP APE++ ++
Sbjct: 164 YRDLKPENLLI--DQQGYIQVTDFGFAKRVKGRTWTLCGTPE-----ALAPEIILSKGYN 216
Query: 522 FKSDVYSFGVLLLELLTGKAP 542
D ++ GVL+ E+ G P
Sbjct: 217 KAVDWWALGVLIYEMAAGYPP 237
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 52/219 (23%), Positives = 80/219 (36%), Gaps = 45/219 (20%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRL-KEVAVGKREFEMQME----VLGKIKHDNVVP 405
++LG+GS G + + E VK L K+ E ++ +L +++H NV+
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 406 LRAFYY--SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR------ 457
L Y K + +V +Y G L R + A
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK------------RFPVCQAHGYFCQL 118
Query: 458 --GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG------- 508
GL +LH S IVH +IK N+LL +S G+ P
Sbjct: 119 IDGLEYLH-SQGIVHKDIKPGNLLLTTGGTLKISALGV----AEALHPFAADDTCRTSQG 173
Query: 509 ---YRAPEVVETRKV--TFKSDVYSFGVLLLELLTGKAP 542
++ PE+ FK D++S GV L + TG P
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 50/222 (22%), Positives = 85/222 (38%), Gaps = 49/222 (22%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQME-----------VLGKIK 399
+G+G+ G +KA + G V +K++ E + E +L +K
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVL--------MENEKEGFPITALREIKILQLLK 74
Query: 400 HDNVVPLRAFYYSKDEKL--------LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRI 451
H+NVV L +K LV+D+ L+ LL + R+
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS----NVLVKFTLSEIKRV 129
Query: 452 ALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG--- 508
GL ++H KI+H ++KA+N+L+ D ++DFGL F
Sbjct: 130 MQMLLNGLYYIH-RNKILHRDMKAANVLITRDGVLKLADFGLARAFS---LAKNSQPNRY 185
Query: 509 --------YRAPEVV-ETRKVTFKSDVYSFGVLLLELLTGKA 541
YR PE++ R D++ G ++ E+ T
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 49/215 (22%), Positives = 85/215 (39%), Gaps = 45/215 (20%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQME----VLGKIKHDNVVPL 406
+ LG G+ G G V VK L + + +++ L +H +++ L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALL--HGSRGSGRTPLDWDNRMRIALSAAR------- 457
+ + +V +Y+ G L + HG R+ AR
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHG---------------RVEEMEARRLFQQIL 121
Query: 458 -GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--------TPPTRVAG 508
+ + H +VH ++K N+LL +A ++DFGL+ + + +P
Sbjct: 122 SAVDYCH-RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN----- 175
Query: 509 YRAPEVVETRKVT-FKSDVYSFGVLLLELLTGKAP 542
Y APEV+ R + D++S GV+L LL G P
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 48/214 (22%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVK-----RLKEVAVGKREFEMQMEVLGKIKHDNVVPLR 407
+GKG+ A + G V +K +L ++ K E++ ++ + H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVR--IMKILNHPNIVKLF 80
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALL--HGSRGSGRTPLDWDNRMRIALSAAR-------- 457
++ L+ +Y G + L HG R+ AR
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHG---------------RMKEKEARSKFRQIVS 125
Query: 458 GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF--GNT------TPPTRVAGY 509
+ + H +IVH ++KA N+LL D + ++DFG + F G PP Y
Sbjct: 126 AVQYCH-QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP-----Y 179
Query: 510 RAPEVVETRKVT-FKSDVYSFGVLLLELLTGKAP 542
APE+ + +K + DV+S GV+L L++G P
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 60/221 (27%), Positives = 90/221 (40%), Gaps = 46/221 (20%)
Query: 345 DLLRASAEVLGKGSVGTSYKAVLEE----GTTVVVKRL-KEVAVGKREFE-MQME--VLG 396
+ +R VLGKGS G K +L G VK L K+V + + E E +L
Sbjct: 26 EFIR----VLGKGSFG---KVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 397 KI-KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR----- 450
H + L + + D V +++ G L + H + S R R R
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQK-SRRFDEA---RARFYAAE 132
Query: 451 IALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---NPLFGNT------T 501
I L LH I++ ++K N+LL + ++DFG+ G T T
Sbjct: 133 IIS----ALMFLH-DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGT 187
Query: 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
P Y APE+++ D ++ GVLL E+L G AP
Sbjct: 188 P-----DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 5e-12
Identities = 49/215 (22%), Positives = 86/215 (40%), Gaps = 45/215 (20%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQME-------------VLGK 397
E +G+G+ GT +KA E V +KR++ + + +L +
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVR----------LDDDDEGVPSSALREICLLKE 57
Query: 398 IKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR 457
+KH N+V L +S + LV+++ L S LD + +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD----SCNGDLDPEIVKSFLFQLLK 112
Query: 458 GLAHLHVSGKIVHGNIKASNILLRPDHDAC--VSDFGLNPLFGNTTPPTRVAG------- 508
GL H S ++H ++K N+L+ + + +++FGL FG P R
Sbjct: 113 GLGFCH-SRNVLHRDLKPQNLLI--NRNGELKLANFGLARAFGI---PVRCYSAEVVTLW 166
Query: 509 YRAPEV-VETRKVTFKSDVYSFGVLLLELLTGKAP 542
YR P+V + + D++S G + EL P
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGK--REFEMQMEVLGKIKHDNVVPLRA 408
LG+G ++A+ + VVVK LK V K RE ++ + G N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG---GPNIITLAD 98
Query: 409 FYYSKDEK--LLVYDYMPAGSLSALLHGSRGSGRTPL-DWDNR--MRIALSAARGLAHLH 463
+ LV++++ L L D+D R M L + L + H
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEIL---KALDYCH 147
Query: 464 VSGKIVHGNIKASNILLRPDHDAC---VSDFGLNPLFGNTTPPT-RVAG--YRAPEV-VE 516
S I+H ++K N+++ DH+ + D+GL + RVA ++ PE+ V+
Sbjct: 148 -SMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 204
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKAP 542
+ + D++S G +L ++ K P
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 65/221 (29%), Positives = 95/221 (42%), Gaps = 46/221 (20%)
Query: 345 DLLRASAEVLGKGSVGTSYKAVLEE----GTTVVVKRL-KEVAVGKREFE-MQME--VLG 396
L + +LGKGS G K L E +K L K+V + + E +E VL
Sbjct: 20 ILHK----MLGKGSFG---KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 72
Query: 397 K-IKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR----- 450
+H + + + +K+ V +Y+ G L + H + L R
Sbjct: 73 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQS-CHKFDLS---RATFYAAE 126
Query: 451 IALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---NPLFGNT------T 501
I L GL LH G IV+ ++K NILL D ++DFG+ N L T
Sbjct: 127 IIL----GLQFLHSKG-IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT 181
Query: 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542
P Y APE++ +K D +SFGVLL E+L G++P
Sbjct: 182 P-----DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 42/180 (23%), Positives = 75/180 (41%), Gaps = 46/180 (25%)
Query: 385 KREFEMQMEVLGKIKHDNVVPLRAFYY--SKDEKLLVYDYMPAGSLSALLHGSRGSGRTP 442
+E + +L K+ H NVV L ++D +V++ + G +
Sbjct: 84 YQE----IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-------------- 125
Query: 443 LDWDNRMRIALSAAR--------GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN 494
++ ++ AR G+ +LH KI+H +IK SN+L+ D ++DFG++
Sbjct: 126 MEVPTLKPLSEDQARFYFQDLIKGIEYLH-YQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 495 PLFGNT---------TPPTRVAGYRAPEVVETRKVTF---KSDVYSFGVLLLELLTGKAP 542
F + TP + APE + + F DV++ GV L + G+ P
Sbjct: 185 NEFKGSDALLSNTVGTPA-----FMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 56/210 (26%), Positives = 85/210 (40%), Gaps = 29/210 (13%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGK----------REFEMQMEVLGKIKHD 401
+G+G+ G +KA + V LK V V RE + L +H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVA-LKRVRVQTGEEGMPLSTIREVAVLRH-LETFEHP 74
Query: 402 NVVPLR----AFYYSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAA 456
NVV L ++ KL LV++++ L+ L G + M L
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL--- 130
Query: 457 RGLAHLHVSGKIVHGNIKASNILLRPDHDAC--VSDFGLNPLFGNTTPPT-RVAG--YRA 511
RGL LH S ++VH ++K NIL+ ++DFGL ++ T V YRA
Sbjct: 131 RGLDFLH-SHRVVHRDLKPQNILV--TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 512 PEVVETRKVTFKSDVYSFGVLLLELLTGKA 541
PEV+ D++S G + E+ K
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 30/208 (14%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGK----------REFEMQMEVLGKIKH 400
+ LG+G T YKA V +K++K + RE +++L ++ H
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE----IKLLQELSH 71
Query: 401 DNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLA 460
N++ L + K LV+D+M L ++ L + L +GL
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMET-DLEVIIK----DNSLVLTPSHIKAYMLMTLQGLE 126
Query: 461 HLHVSGKIVHGNIKASNILLRPDHDAC--VSDFGLNPLFGNTTPP--TRVAG--YRAPEV 514
+LH I+H ++K +N+LL D + ++DFGL FG+ +V YRAPE+
Sbjct: 127 YLH-QHWILHRDLKPNNLLL--DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183
Query: 515 -VETRKVTFKSDVYSFGVLLLELLTGKA 541
R D+++ G +L ELL
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRVP 211
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 9e-12
Identities = 43/212 (20%), Positives = 82/212 (38%), Gaps = 37/212 (17%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQME-----------VLGKIK 399
LG+G+ G YKA+ TV +KR++ E + E +L +++
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIR--------LEHEEEGVPGTAIREVSLLKELQ 91
Query: 400 HDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGL 459
H N++ L++ + L+++Y L + + + G+
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKN-----PDVSMRVIKSFLYQLINGV 145
Query: 460 AHLHVSGKIVHGNIKASNILLRPDHDAC-----VSDFGLNPLFGNTTPP--TRVAG--YR 510
H S + +H ++K N+LL + + DFGL FG + YR
Sbjct: 146 NFCH-SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR 204
Query: 511 APEV-VETRKVTFKSDVYSFGVLLLELLTGKA 541
PE+ + +R + D++S + E+L
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 54/217 (24%), Positives = 85/217 (39%), Gaps = 47/217 (21%)
Query: 353 VLGKGSVGTSYKAVLEEGTTVV--VKRL-KEVAVGKREFEMQME---VLGKIKHDNVVPL 406
V+G+G+ G V + T V +K L K + + + E ++ VV L
Sbjct: 76 VIGRGAFGEVQL-VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 407 RAFYYS--KDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR------ 457
+Y+ D L +V +YMP G L L+ + + AR
Sbjct: 135 ---FYAFQDDRYLYMVMEYMPGGDLVNLM--------------SNYDVPEKWARFYTAEV 177
Query: 458 --GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---NPLFGNTTPPTRVAG---Y 509
L +H G +H ++K N+LL ++DFG G T V G Y
Sbjct: 178 VLALDAIHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDY 235
Query: 510 RAPEVVETRKVTFK----SDVYSFGVLLLELLTGKAP 542
+PEV++++ D +S GV L E+L G P
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 22/113 (19%), Positives = 39/113 (34%), Gaps = 8/113 (7%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
+ R L LR ++ I + + L ++ N+ + + RL L +
Sbjct: 15 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLV 71
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINP----ANLRDFNVSNN 197
++N L LT L L NN L ++P +L + N
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRN 123
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-11
Identities = 28/113 (24%), Positives = 47/113 (41%), Gaps = 10/113 (8%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L L + L+L +N + +I S S + LR L L N + + L L +
Sbjct: 44 LSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKKIENLD-AVADTLEELWI 100
Query: 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINP----ANLRDFNVSNN 197
S N + + + L +L L++ NNK + N I+ L D ++ N
Sbjct: 101 SYNQIA-SLS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 24/108 (22%), Positives = 40/108 (37%), Gaps = 14/108 (12%)
Query: 98 LSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKI 157
L + ++ + S L + L L +N + +S++ M L L L N KI
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KI 85
Query: 158 PFDVNNLTHLTGLFLENNKFS-----GNLPSINPANLRDFNVSNNNLN 200
L L++ N+ + L NLR +SNN +
Sbjct: 86 ENLDAVADTLEELWISYNQIASLSGIEKLV-----NLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 7e-08
Identities = 23/101 (22%), Positives = 42/101 (41%), Gaps = 4/101 (3%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L + LR+LSL N + +I + + L L++ NQ + + + + ++ L L +
Sbjct: 66 LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYM 122
Query: 149 SSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINPAN 188
S+N + D L L L L N + N +
Sbjct: 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATS 163
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 3e-11
Identities = 57/211 (27%), Positives = 86/211 (40%), Gaps = 29/211 (13%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLK-----EVAVGK-----REFEMQMEVLGKIKH 400
+G G+ GT YKA G V +K ++ G RE + L +H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR-LEAFEH 73
Query: 401 DNVVPLR----AFYYSKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSA 455
NVV L ++ K+ LV++++ L L + G + MR L
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL-- 130
Query: 456 ARGLAHLHVSGKIVHGNIKASNILLRPDHDAC--VSDFGLNPLFGNTTPPT-RVAG--YR 510
RGL LH + IVH ++K NIL+ ++DFGL ++ T V YR
Sbjct: 131 -RGLDFLH-ANCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQMALTPVVVTLWYR 186
Query: 511 APEVVETRKVTFKSDVYSFGVLLLELLTGKA 541
APEV+ D++S G + E+ K
Sbjct: 187 APEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 45/214 (21%), Positives = 81/214 (37%), Gaps = 37/214 (17%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVK-----RLKEVAVGKREFEMQ----MEVLGKIKHD 401
LG G+ G + AV E+ VVVK ++ E + + + +L +++H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 402 NVVPLRAFYYSKDEKLLVYD-YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR--- 457
N++ + + ++ LV + + L A + D R+ A
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI-------------DRHPRLDEPLASYIF 136
Query: 458 -----GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---Y 509
+ +L I+H +IK NI++ D + DFG G Y
Sbjct: 137 RQLVSAVGYLR-LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195
Query: 510 RAPEVVETRKVT-FKSDVYSFGVLLLELLTGKAP 542
APEV+ + +++S GV L L+ + P
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 48/243 (19%), Positives = 77/243 (31%), Gaps = 67/243 (27%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEV----AVGKREF-EMQMEVLGKIKHDNVVP 405
++G+GS G Y A V +K++ + KR E+ + L ++K D ++
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITI--LNRLKSDYIIR 89
Query: 406 LRAFYYSKDEKL-----LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAA---- 456
L D +V + + L L + I L+
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIADS-DLKKLF---------------KTPIFLTEEHIKT 133
Query: 457 ------RGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL----NPLFGNTTPPTRV 506
G +H I+H ++K +N LL D V DFGL N
Sbjct: 134 ILYNLLLGENFIH-ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 507 AG----------------------YRAPEV-VETRKVTFKSDVYSFGVLLLELLTGKAPN 543
YRAPE+ + T D++S G + ELL +
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252
Query: 544 QAS 546
Sbjct: 253 IND 255
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 16/100 (16%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQF----SGVFPASVT 138
+ L++L L L +N+L+ +P F +LT L LYL NQ SGVF
Sbjct: 74 LSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVF----D 128
Query: 139 RMNRLTRLDLSSNNFSGKIP---FDVNNLTHLTGLFLENN 175
R+ +L L L++N IP FD LT+L L L N
Sbjct: 129 RLTKLKELRLNTNQLQ-SIPAGAFD--KLTNLQTLSLSTN 165
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 39/132 (29%), Positives = 57/132 (43%), Gaps = 26/132 (19%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV-TRMNR 142
IP +T L L+S L+ + F LT L L L NQ + A V +
Sbjct: 33 IPADT-------EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTL-SAGVFDDLTE 84
Query: 143 LTRLDLSSNNFSGKIP---FDVNNLTHLTGLFLENNKFSGNLPSINP------ANLRDFN 193
L L L++N + +P FD +LT L L+L N+ L S+ L++
Sbjct: 85 LGTLGLANNQLA-SLPLGVFD--HLTQLDKLYLGGNQ----LKSLPSGVFDRLTKLKELR 137
Query: 194 VSNNNLNGSIPA 205
++ N L SIPA
Sbjct: 138 LNTNQLQ-SIPA 148
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 23/71 (32%), Positives = 38/71 (53%), Gaps = 2/71 (2%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
+P +L++L+ L L +N+L IP+ F LT L++L L +NQ V + R+ +
Sbjct: 122 LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGK 180
Query: 143 LTRLDLSSNNF 153
L + L N F
Sbjct: 181 LQTITLFGNQF 191
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 48/215 (22%), Positives = 85/215 (39%), Gaps = 45/215 (20%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQME----VLGKIKHDNVVPL 406
+ LG G+ G G V VK L + + ++ L +H +++ L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALL--HGSRGSGRTPLDWDNRMRIALSAAR------- 457
+ + +V +Y+ G L + +G R+ +R
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNG---------------RLDEKESRRLFQQIL 126
Query: 458 -GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN--------TTPPTRVAG 508
G+ + H +VH ++K N+LL +A ++DFGL+ + + +P
Sbjct: 127 SGVDYCH-RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN----- 180
Query: 509 YRAPEVVETRKVT-FKSDVYSFGVLLLELLTGKAP 542
Y APEV+ R + D++S GV+L LL G P
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 55/230 (23%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQME---VLGKIK-------H 400
+ LGKG+ G +K++ G V VK++ + F+ + +I H
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA------FQNSTDAQRTFREIMILTELSGH 68
Query: 401 DNVVPLRAFYYSKDEK--LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR-IALSAAR 457
+N+V L + +++ LV+DYM L A++ + L+ + + +
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN------ILE-PVHKQYVVYQLIK 120
Query: 458 GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL---------------NPLFGNTTP 502
+ +LH SG ++H ++K SNILL + V+DFGL + NT
Sbjct: 121 VIKYLH-SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 503 PTRVAG----------YRAPEV-VETRKVTFKSDVYSFGVLLLELLTGKA 541
YRAPE+ + + K T D++S G +L E+L GK
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 51/203 (25%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHD-----NVV 404
+V+GKGS G KA + V +K ++ R+ ++ +L + K D NV+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
+ + ++ + ++ + + +L L+ ++ G + A S + L LH
Sbjct: 163 HMLENFTFRNHICMTFELL-SMNLYELIKKNKFQG---FSLPLVRKFAHSILQCLDALH- 217
Query: 465 SGKIVHGNIKASNILLRPDHDAC---VSDFGLNPLFGNTTPP---TRVAGYRAPEVVETR 518
+I+H ++K NILL+ V DFG + +R YRAPEV+
Sbjct: 218 KNRIIHCDLKPENILLK-QQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--YRAPEVILGA 274
Query: 519 KVTFKSDVYSFGVLLLELLTGKA 541
+ D++S G +L ELLTG
Sbjct: 275 RYGMPIDMWSLGCILAELLTGYP 297
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 38/109 (34%), Positives = 48/109 (44%), Gaps = 20/109 (18%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQF----SGVFPASVT 138
+P KL+ L+ L L N+L +P F LT L L L NQ GVF
Sbjct: 100 LPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVF----D 154
Query: 139 RMNRLTRLDLSSNNFSGKIP---FDVNNLTHLTGLFLENNKFSGNLPSI 184
++ LT LDLS N +P FD LT L L L N+ L S+
Sbjct: 155 KLTNLTELDLSYNQLQ-SLPEGVFD--KLTQLKDLRLYQNQ----LKSV 196
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 28/121 (23%), Positives = 48/121 (39%), Gaps = 15/121 (12%)
Query: 91 KLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFS--GVFPASVTRMNRLTRLDL 148
+L+ + + ++ + L +R L L N+ + LT L L
Sbjct: 39 ELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLHDISAL----KELTNLTYLIL 92
Query: 149 SSNNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPS---INPANLRDFNVSNNNLNGSIP 204
+ N +P V + LT+L L L N+ +LP NL N+++N L S+P
Sbjct: 93 TGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLP 149
Query: 205 A 205
Sbjct: 150 K 150
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 36/122 (29%), Positives = 54/122 (44%), Gaps = 15/122 (12%)
Query: 91 KLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSS 150
L +R L+L N+L +I + LT L L L NQ + ++ L L L
Sbjct: 61 YLPNVRYLALGGNKLH-DISA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE 118
Query: 151 NNFSGKIPFDV-NNLTHLTGLFLENNKFSGNLPSINP------ANLRDFNVSNNNLNGSI 203
N +P V + LT+LT L L +N+ L S+ NL + ++S N L S+
Sbjct: 119 NQLQ-SLPDGVFDKLTNLTYLNLAHNQ----LQSLPKGVFDKLTNLTELDLSYNQLQ-SL 172
Query: 204 PA 205
P
Sbjct: 173 PE 174
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 27/96 (28%), Positives = 36/96 (37%), Gaps = 32/96 (33%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNR 142
+P KL+ L L L N+L +P F LT L+ L L NQ
Sbjct: 148 LPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQ-------------- 192
Query: 143 LTRLDLSSNNFSGKIP---FDVNNLTHLTGLFLENN 175
L S +P FD LT L ++L +N
Sbjct: 193 -----LKS------VPDGVFD--RLTSLQYIWLHDN 215
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 25/111 (22%), Positives = 50/111 (45%), Gaps = 8/111 (7%)
Query: 92 LSQLRVLSLRSNRLS-GEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSS 150
+ +R L L + + + G+I + L L L + V +++ ++ +L +L+LS
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSE 80
Query: 151 NNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINP----ANLRDFNVSNN 197
N G + L +LT L L NK ++ ++ P L+ ++ N
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 25/104 (24%), Positives = 35/104 (33%), Gaps = 3/104 (2%)
Query: 73 LRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV 132
L L + L LSL + L + S+ L L+ L L N+ G
Sbjct: 29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGG 86
Query: 133 FPASVTRMNRLTRLDLSSNNFSGKIPFDV-NNLTHLTGLFLENN 175
++ LT L+LS N + L L L L N
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 72/265 (27%), Positives = 106/265 (40%), Gaps = 52/265 (19%)
Query: 309 EAGTSSSKDDITGGAAEADRN-KLVFFEGGVYSFDLED--LLRASAEVLGKGSVGTSY-- 363
AGTS+ D + G +E+ LL+ VLG G+ G +
Sbjct: 18 AAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK----VLGTGAYGKVFLV 73
Query: 364 KAVLEEGTTVV--VKRL-KEVAVGKREFE--MQME--VLGKIKHDN-VVPLRAFYYS--K 413
+ + T + +K L K V K + + E VL I+ +V L +Y+
Sbjct: 74 RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL---HYAFQT 130
Query: 414 DEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMR-----IALSAARGLAHLHVSGK 467
+ KL L+ DY+ G L H S+ R ++ I L L HLH G
Sbjct: 131 ETKLHLILDYINGGEL--FTHLSQ-RERFTEH---EVQIYVGEIVL----ALEHLHKLG- 179
Query: 468 IVHGNIKASNILLRPDHD--ACVSDFGL---NPLFGNTTPPTRVAG---YRAPEVVETRK 519
I++ +IK NILL D + ++DFGL G Y AP++V
Sbjct: 180 IIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIVRGGD 236
Query: 520 VTFKSDV--YSFGVLLLELLTGKAP 542
V +S GVL+ ELLTG +P
Sbjct: 237 SGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 28/112 (25%), Positives = 46/112 (41%), Gaps = 16/112 (14%)
Query: 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFS 130
L L L G+L L L L+ N+L+ I + F + ++ L L N+
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 131 ----GVFPASVTRMNRLTRLDLSSNNFSGKIP---FDVNNLTHLTGLFLENN 175
+F +++L L+L N S + F+ +L LT L L +N
Sbjct: 92 EISNKMF----LGLHQLKTLNLYDNQISC-VMPGSFE--HLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 25/114 (21%), Positives = 43/114 (37%), Gaps = 21/114 (18%)
Query: 101 RSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASV-TRMNRLTRLDLSSNNFSGKIP- 158
L EIP D T L L N+ + + R+ L +L+L N + I
Sbjct: 16 TGRGLK-EIPRDIPLHT--TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEP 71
Query: 159 --FDVNNLTHLTGLFLENNKFSGNLPSINP------ANLRDFNVSNNNLNGSIP 204
F+ +H+ L L NK + I+ L+ N+ +N ++ +
Sbjct: 72 NAFE--GASHIQELQLGENK----IKEISNKMFLGLHQLKTLNLYDNQIS-CVM 118
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 18/46 (39%), Positives = 24/46 (52%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQF 129
I L QL+ L+L N++S +P F +L L SL L SN F
Sbjct: 93 ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-10
Identities = 28/112 (25%), Positives = 52/112 (46%), Gaps = 8/112 (7%)
Query: 91 KLSQLRVLSLRSNRLS-GEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149
S ++ L L ++R + G++ L L + + + A++ ++N+L +L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 150 SNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINP----ANLRDFNVSNN 197
N SG + +LT L L NK +L +I P NL+ ++ N
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK-DLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 25/107 (23%), Positives = 37/107 (34%), Gaps = 7/107 (6%)
Query: 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSG 131
L L + +L LS + L+ I ++ L L+ L L N+ SG
Sbjct: 21 ELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSG 78
Query: 132 VFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNL---THLTGLFLENN 175
+ LT L+LS N + L +L L L N
Sbjct: 79 GLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNC 123
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 4e-10
Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 50/216 (23%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRL-KEVAVG-----KREFEMQMEVLGKIKHDNVVPL 406
LG+G+ G AV V VK + + AV K+E + + + H+NVV
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR--------G 458
+ + L +Y G L + + + + A+ G
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRI-------------EPDIGMPEPDAQRFFHQLMAG 117
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-----------TPPTRVA 507
+ +LH I H +IK N+LL + +SDFGL +F T P
Sbjct: 118 VVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP---- 172
Query: 508 GYRAPEVVETRKVT-FKSDVYSFGVLLLELLTGKAP 542
Y APE+++ R+ DV+S G++L +L G+ P
Sbjct: 173 -YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 61/316 (19%), Positives = 100/316 (31%), Gaps = 82/316 (25%)
Query: 288 RQRPGKAPKP-PAAATARAVTMEAGTSSSKDDITGGAAEADRNKLVFFEGGVYSFDLEDL 346
A + + + + G + + A R + Y
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIR---- 58
Query: 347 LRASAEVLGKGSVGTSYKAV-LEEGTTVVVKRLKEV----AVGKREF-EMQMEVLGKIKH 400
++G GS G +A E V +K++ V KR E+ + L ++ H
Sbjct: 59 -----HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAI--LNRLNH 111
Query: 401 DNVVPLRAFYYSKDEKL-----LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSA 455
D+VV + KD + +V + + L R + L+
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF---------------RTPVYLTE 155
Query: 456 A----------RGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL-----NPLFGNT 500
G+ ++H S I+H ++K +N L+ D V DFGL P GN+
Sbjct: 156 LHIKTLLYNLLVGVKYVH-SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 501 TPPTRVAG--------------------------YRAPEV-VETRKVTFKSDVYSFGVLL 533
P YRAPE+ + T DV+S G +
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274
Query: 534 LELLTGKAPNQASLGE 549
ELL N A +
Sbjct: 275 AELLNMIKENVAYHAD 290
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 28/100 (28%), Positives = 38/100 (38%), Gaps = 22/100 (22%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFS----GVFPASVTR 139
IP + L L N+ + +P + SN L + L +N+ S F +
Sbjct: 29 IPRDV-------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSF----SN 76
Query: 140 MNRLTRLDLSSNNFSGKIP---FDVNNLTHLTGLFLENNK 176
M +L L LS N IP FD L L L L N
Sbjct: 77 MTQLLTLILSYNRLRC-IPPRTFD--GLKSLRLLSLHGND 113
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 22/73 (30%), Positives = 31/73 (42%), Gaps = 10/73 (13%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFS----GVFPASVT 138
+ + ++QL L L NRL IP F L LR L L N S G F
Sbjct: 69 LSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAF----N 123
Query: 139 RMNRLTRLDLSSN 151
++ L+ L + +N
Sbjct: 124 DLSALSHLAIGAN 136
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 48/215 (22%), Positives = 89/215 (41%), Gaps = 46/215 (21%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQME----VLGKIKHDNVVPL 406
E LG+GS G A + V +K + + K + M++E L ++H +++ L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALL--HGSRGSGRTPLDWDNRMRIALSAAR------- 457
+ + ++V +Y G L + R+ R
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKK---------------RMTEDEGRRFFQQII 118
Query: 458 -GLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--------TPPTRVAG 508
+ + H KIVH ++K N+LL + + ++DFGL+ + + +P
Sbjct: 119 CAIEYCH-RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN----- 172
Query: 509 YRAPEVVETRKVT-FKSDVYSFGVLLLELLTGKAP 542
Y APEV+ + + DV+S G++L +L G+ P
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 42/133 (31%), Positives = 58/133 (43%), Gaps = 31/133 (23%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQF----SGVFPASVTR 139
IP N ++L L N+++ P F +L L+ LYL SNQ GVF
Sbjct: 38 IPTNA-------QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVF----DS 86
Query: 140 MNRLTRLDLSSNNFSGKIP---FDVNNLTHLTGLFLENNKFSGNLPSI-----NPANLRD 191
+ +LT LDL +N + +P FD L HL LF+ NK L + +L
Sbjct: 87 LTQLTVLDLGTNQLT-VLPSAVFD--RLVHLKELFMCCNK----LTELPRGIERLTHLTH 139
Query: 192 FNVSNNNLNGSIP 204
+ N L SIP
Sbjct: 140 LALDQNQLK-SIP 151
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 9e-09
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 7/95 (7%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+P L+QL VL L +N+L+ + F L L+ L++ N+ + + P + R+ L
Sbjct: 79 LPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTEL-PRGIERLTHL 137
Query: 144 TRLDLSSNNFSGKIP---FDVNNLTHLTGLFLENN 175
T L L N IP FD L+ LT +L N
Sbjct: 138 THLALDQNQLK-SIPHGAFD--RLSSLTHAYLFGN 169
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 50/216 (23%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVKRL-KEVAVG-----KREFEMQMEVLGKIKHDNVVPL 406
LG+G+ G AV V VK + + AV K+E + + + H+NVV
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAAR--------G 458
+ + L +Y G L + + + + A+ G
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRI-------------EPDIGMPEPDAQRFFHQLMAG 117
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-----------TPPTRVA 507
+ +LH I H +IK N+LL + +SDFGL +F T P
Sbjct: 118 VVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP---- 172
Query: 508 GYRAPEVVETRKVT-FKSDVYSFGVLLLELLTGKAP 542
Y APE+++ R+ DV+S G++L +L G+ P
Sbjct: 173 -YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 2e-09
Identities = 46/364 (12%), Positives = 99/364 (27%), Gaps = 117/364 (32%)
Query: 312 TSSSKDDITGGAAEADRNKLVFF------EGGVYSFDLEDLLRASAEVLGKGSVGTSYKA 365
+ D I +F+ E V F +E++LR +YK
Sbjct: 47 SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKF-VEEVLR------------INYKF 93
Query: 366 VLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLL-----VY 420
++ + ++ ++ R + Q + L +++ + S+ + L +
Sbjct: 94 LMSP----IKTEQRQPSMMTRMYIEQRDRL----YNDNQVFAKYNVSRLQPYLKLRQALL 145
Query: 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVH----GNIKAS 476
+ PA ++ L+ G GSG+T + AL + N +
Sbjct: 146 ELRPAKNV--LIDGVLGSGKTWV--------ALDVCLSYKVQCKMDFKIFWLNLKNCNSP 195
Query: 477 NILLRPDHDACV---SDFGLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLL 533
+L ++ + R + + KS Y +L+
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIK------LRIHSIQAELRRLLKSKPYENCLLV 249
Query: 534 LELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAM 593
L + V+ F++
Sbjct: 250 LL-----------------N--------VQNAKAWNAFNL-------------------- 264
Query: 594 GC---VST----VPDQRPAMQEVVRMIENMNRGETDDGLRQ---------SSDDPSKGSD 637
C ++T V D A +++ + T D ++ D P +
Sbjct: 265 SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLT 324
Query: 638 GHTP 641
+ P
Sbjct: 325 TN-P 327
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 8e-06
Identities = 92/643 (14%), Positives = 172/643 (26%), Gaps = 202/643 (31%)
Query: 26 EPTQDKQALLAF-LSRTPHKNRVQW---NASDSACNW----VGVECDA----NRSFVYSL 73
L F + + VQ + + E R ++
Sbjct: 57 SKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQR 116
Query: 74 -RLPGVGLVGPIPPNTLG---KLSQLR--VLSLRSNRL--------SGEIPSDFSNLTL- 118
RL + +LR +L LR + SG+ + + L
Sbjct: 117 DRLYND--NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK-----TWVALD 169
Query: 119 -LRSLYLQSNQFSGVF---------PASVTRM--NRLTRLD---LSSNNFSGKIPFDVNN 163
S +Q +F P +V M L ++D S ++ S I +++
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 164 LTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDL-C 222
+ L++ + L + L + V N + F +L C
Sbjct: 230 IQAELRRLLKSKPYENCL-LV----LLN--VQN-------AKAWNAF---------NLSC 266
Query: 223 GGPLPPCNPFFPSPAPSPSLPPPVAPVHKK----SNKLSTAAIVGIAVGGAVFIVLLLL- 277
K + + A + + +
Sbjct: 267 -----------------------------KILLTTRFKQVTDFLSAATTTHISLDHHSMT 297
Query: 278 --------LLLFCLKKRRRQRPGKAPK--PPAAATARAVTMEAGTSSSKDDITGGAAEAD 327
LLL L R + P + P R +++ A S +D + A D
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDLPREVLTTNP------RRLSIIA--ESIRDGL----ATWD 345
Query: 328 RNKLVFFEGGVYSFDLEDLLRASAEVLGKGSVGTSYK--AVLEEGTTVVVKRLKEVAVGK 385
K V + L ++ +S VL + +V + L +
Sbjct: 346 NWKHVNCD------KLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILL-SLIWFD 398
Query: 386 REFEMQMEVLGKIKHDNVVPLRAFYYS---KDEKLLVYDYMPAGSLSALLHGSRGSGRTP 442
M V+ K+ H YS K K +
Sbjct: 399 VIKSDVMVVVNKL-HK---------YSLVEKQPKESTIS----------IPS-------- 430
Query: 443 LDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG---N 499
+ + ++++ LH I + NI D D D L +
Sbjct: 431 IYLELKVKL-----ENEYALH--RSI----VDHYNIPKTFDSD----DLIPPYLDQYFYS 475
Query: 500 TTPPTRVAGYRAPEVVETRKVTFKSDVY-SFGVLLLEL-LTGKAPN-QASLGEEGIDLPR 556
G+ + ++T V+ F L ++ A N S+ L
Sbjct: 476 HI------GHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKF 529
Query: 557 WVQSVVREEWTAEVFDVELMRY-HNIEEEMVQ-----LLQIAM 593
+ + + E ++ + IEE ++ LL+IA+
Sbjct: 530 YKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIAL 572
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 22/223 (9%)
Query: 335 EGGVYSFDLEDLLRASAEV---LGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEM 390
+ Y + E+ +GKGS G KA E V +K +K + ++
Sbjct: 40 DNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI 99
Query: 391 QMEVLGKI-KHD-----NVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLD 444
++ +L + KHD +V L+ + ++ LV++ + + +L LL R + +
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLL---RNTNFRGVS 155
Query: 445 WDNRMRIALSAARGLAHLHVSG-KIVHGNIKASNILLR-PDHDAC-VSDFGLNPLFGNTT 501
+ + A L L I+H ++K NILL P A + DFG + G
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 215
Query: 502 PP---TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKA 541
+R YR+PEV+ D++S G +L+E+ TG+
Sbjct: 216 YQYIQSRF--YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 42/135 (31%), Positives = 55/135 (40%), Gaps = 34/135 (25%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQF----SGVFPASVTR 139
IP T L L +N L F LT L LYL N+ +GVF +
Sbjct: 26 IPAQT-------TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF----NK 74
Query: 140 MNRLTRLDLSSNNFSGKIP---FDVNNLTHLTGLFLENNKFSGNLPSINPA-------NL 189
+ LT L+LS+N +P FD LT L L L N+ L S+ P L
Sbjct: 75 LTSLTYLNLSTNQLQ-SLPNGVFD--KLTQLKELALNTNQ----LQSL-PDGVFDKLTQL 126
Query: 190 RDFNVSNNNLNGSIP 204
+D + N L S+P
Sbjct: 127 KDLRLYQNQLK-SVP 140
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 16/100 (16%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQF----SGVFPASVT 138
+P KL+ L L+L +N+L +P+ F LT L+ L L +NQ GVF
Sbjct: 67 LPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVF----D 121
Query: 139 RMNRLTRLDLSSNNFSGKIP---FDVNNLTHLTGLFLENN 175
++ +L L L N +P FD LT L ++L +N
Sbjct: 122 KLTQLKDLRLYQNQLKS-VPDGVFD--RLTSLQYIWLHDN 158
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-09
Identities = 32/100 (32%), Positives = 40/100 (40%), Gaps = 21/100 (21%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQF----SGVFPASVTR 139
IP + L L SN+L F LT L L L NQ GVF +
Sbjct: 26 IPSSA-------TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVF----DK 74
Query: 140 MNRLTRLDLSSNNFSGKIP---FDVNNLTHLTGLFLENNK 176
+ +LT L L N +P FD LT L L L+ N+
Sbjct: 75 LTKLTILYLHENKLQ-SLPNGVFD--KLTQLKELALDTNQ 111
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 32/99 (32%), Positives = 45/99 (45%), Gaps = 14/99 (14%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQF----SGVFPASVTR 139
+P KL+QL LSL N++ F LT L LYL N+ +GVF +
Sbjct: 43 LPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVF----DK 98
Query: 140 MNRLTRLDLSSNNFSGKIP---FDVNNLTHLTGLFLENN 175
+ +L L L +N +P FD LT L ++L N
Sbjct: 99 LTQLKELALDTNQLK-SVPDGIFD--RLTSLQKIWLHTN 134
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 21/99 (21%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQF----SGVFPASVTR 139
IP + + L L +N+++ P F +L L+ LY SN+ +GVF +
Sbjct: 31 IPTDK-------QRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVF----DK 79
Query: 140 MNRLTRLDLSSNNFSGKIP---FDVNNLTHLTGLFLENN 175
+ +LT+LDL+ N+ IP FD NL LT ++L NN
Sbjct: 80 LTQLTQLDLNDNHLKS-IPRGAFD--NLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 28/83 (33%), Positives = 37/83 (44%), Gaps = 24/83 (28%)
Query: 109 IPSDFSNLTLLRSLYLQSNQF----SGVFPASVTRMNRLTRLDLSSNNFSGKIP---FDV 161
IP+D + L+L +NQ GVF + L +L +SN + IP FD
Sbjct: 31 IPTD------KQRLWLNNNQITKLEPGVF----DHLVNLQQLYFNSNKLT-AIPTGVFD- 78
Query: 162 NNLTHLTGLFLENNKFSGNLPSI 184
LT LT L L +N L SI
Sbjct: 79 -KLTQLTQLDLNDNH----LKSI 96
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 48/213 (22%), Positives = 79/213 (37%), Gaps = 47/213 (22%)
Query: 354 LGKGSVGTSYKAV-LEEGTTVVVK-----RLKEVAVGKREFEMQMEVLGKIKHDNVVPLR 407
+G G+ G + V VK + V +RE + ++H N+V +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV-QRE----IINHRSLRHPNIVRFK 82
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALL--HGSRGSGRTPLDWDNRMRIALSAAR-------- 457
+ ++ +Y G L + G R + AR
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAG---------------RFSEDEARFFFQQLLS 127
Query: 458 GLAHLHVSGKIVHGNIKASNILLRPDHDAC----VSDFGLNPLFGNTTPPTRVAG---YR 510
G+++ H S +I H ++K N LL D + DFG + + P G Y
Sbjct: 128 GVSYCH-SMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 184
Query: 511 APEVVETRKVT-FKSDVYSFGVLLLELLTGKAP 542
APEV+ ++ +DV+S GV L +L G P
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 5e-08
Identities = 35/99 (35%), Positives = 48/99 (48%), Gaps = 21/99 (21%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQF----SGVFPASVTR 139
IP T +VL L N+++ P F LT L L L +NQ +GVF +
Sbjct: 28 IPTTT-------QVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVF----DK 76
Query: 140 MNRLTRLDLSSNNFSGKIP---FDVNNLTHLTGLFLENN 175
+ +LT+L L+ N IP FD NL LT ++L NN
Sbjct: 77 LTQLTQLSLNDNQLKS-IPRGAFD--NLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 9e-05
Identities = 31/83 (37%), Positives = 40/83 (48%), Gaps = 24/83 (28%)
Query: 109 IPSDFSNLTLLRSLYLQSNQF----SGVFPASVTRMNRLTRLDLSSNNFSGKIP---FDV 161
IP+ + LYL NQ GVF R+ +LTRLDL +N + +P FD
Sbjct: 28 IPTT------TQVLYLYDNQITKLEPGVF----DRLTQLTRLDLDNNQLT-VLPAGVFD- 75
Query: 162 NNLTHLTGLFLENNKFSGNLPSI 184
LT LT L L +N+ L SI
Sbjct: 76 -KLTQLTQLSLNDNQ----LKSI 93
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 44/236 (18%), Positives = 76/236 (32%), Gaps = 65/236 (27%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQ----MEVLGKIKHD----- 401
+G G+ G ++ VK ++ +++ ++L KI++D
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVR----NIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 402 NVVPLRAFYYSKD------EKLL--VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIAL 453
N+V + D E L +Y+ + + ++ +
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGPSLYEII------------TRNNYNGFHIEDIKLYCI 144
Query: 454 SAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPL----------------- 496
+ L +L + H ++K NILL +
Sbjct: 145 EILKALNYLR-KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 497 --FGNTTPP---------TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKA 541
FG T TR YRAPEV+ SD++SFG +L EL TG
Sbjct: 204 IDFGCATFKSDYHGSIINTRQ--YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 41/232 (17%), Positives = 75/232 (32%), Gaps = 61/232 (26%)
Query: 352 EVLGKGSVGTSYKAV--LEEGTTVVVKRLKEVAVGKREFEMQ----MEVLGKI-KHD--- 401
LG+G+ G + + + V +K ++ ++ + VL KI + D
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIR----NVGKYREAARLEINVLKKIKEKDKEN 80
Query: 402 --NVVPLRAFYYSKD------EKLL--VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRI 451
V + ++ E L ++++ + + P + +
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFL------------KENNFQPYPLPHVRHM 128
Query: 452 ALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPL-------------FG 498
A L LH ++ H ++K NIL + + + FG
Sbjct: 129 AYQLCHALRFLH-ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 499 NTTPP---------TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKA 541
+ T TR YR PEV+ DV+S G +L E G
Sbjct: 188 SATFDHEHHTTIVATRH--YRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 48/232 (20%), Positives = 81/232 (34%), Gaps = 61/232 (26%)
Query: 352 EVLGKGSVGTSYKAV--LEEGTTVVVKRLKEVAVGKREFEMQ----MEVLGKI-KHD--- 401
+ LG+G+ G + + G V VK +K + ++VL + D
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVK----NVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 402 --NVVPLRAFYYSKD------EKLL--VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRI 451
V + ++ E L YD++ + +G P D+ ++
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELLGLSTYDFI------------KENGFLPFRLDHIRKM 123
Query: 452 ALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPL-------------FG 498
A + + LH S K+ H ++K NIL + + FG
Sbjct: 124 AYQICKSVNFLH-SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 499 NTTPP---------TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKA 541
+ T TR YRAPEV+ + DV+S G +L+E G
Sbjct: 183 SATYDDEHHSTLVSTRH--YRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 2e-05
Identities = 22/190 (11%), Positives = 48/190 (25%), Gaps = 43/190 (22%)
Query: 354 LGKGSVGTSYKAVLEEGTTVVVKRL-------------KEVAVGKREFEMQMEV-----L 395
+G+G G ++ + + T V +K + K E + E+
Sbjct: 28 IGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 396 GKIKHDNVVPLRAFYYSKDEK----LLVYDYMPAGSLSALLHGSRGSGRTP--------- 442
+ + + L + + + L +D+ + SA
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 443 -----------LDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDF 491
I LA S + H ++ N+LL+ +
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYT 206
Query: 492 GLNPLFGNTT 501
+
Sbjct: 207 LNGKSSTIPS 216
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 22/143 (15%), Positives = 39/143 (27%), Gaps = 21/143 (14%)
Query: 79 GLVGPIPPNTLGKLSQLRVLSLRSNRLSGE----IPSDFSNLTLLRSLYLQSNQFS--GV 132
L LR + NRL F + LL ++ + N G+
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204
Query: 133 FPA---SVTRMNRLTRLDLSSNNFSGK----IPFDVNNLTHLTGLFLENNK--------F 177
+ L LDL N F+ + + + +L L L +
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 264
Query: 178 SGNLPSINPANLRDFNVSNNNLN 200
+ L+ + N +
Sbjct: 265 VDAFSKLENIGLQTLRLQYNEIE 287
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 24/105 (22%), Positives = 32/105 (30%), Gaps = 15/105 (14%)
Query: 89 LGKLSQLRVLSLRSNRLSGE----IPSDFSNLTLLRSLYLQSNQFS-----GVFPASVTR 139
L +L+VL L+ N + + + LR L L S V A
Sbjct: 212 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271
Query: 140 MNR-LTRLDLSSNNFSGK-----IPFDVNNLTHLTGLFLENNKFS 178
N L L L N + L L L N+FS
Sbjct: 272 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 4e-05
Identities = 16/105 (15%), Positives = 34/105 (32%), Gaps = 16/105 (15%)
Query: 90 GKLSQLRVLSL---RSNRLSGEIPSDFS------NLTLLRSLYLQSNQFSGVFP---ASV 137
L L L L + + F L+ L + + V
Sbjct: 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLES 275
Query: 138 TRMNRLTRLDLSSNNFSGK----IPFDVNNLTHLTGLFLENNKFS 178
+ +L +D+S+ + + + V+ + HL + ++ N S
Sbjct: 276 DILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 26/132 (19%), Positives = 42/132 (31%), Gaps = 22/132 (16%)
Query: 89 LGKLSQLRVLSLRSNRLSGE-----IPSDFSNLTLLRSLYLQSNQFS---GVFPASVTRM 140
L L L+ L L N L L L L+ S ASV R
Sbjct: 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRA 168
Query: 141 NR-LTRLDLSSNNFSGK-----IPFDVNNLTHLTGLFLENNKFS-------GNLPSINPA 187
L +S+N+ + ++ L L LE+ + + +
Sbjct: 169 KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKA- 227
Query: 188 NLRDFNVSNNNL 199
+LR+ + +N L
Sbjct: 228 SLRELALGSNKL 239
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 34/138 (24%), Positives = 52/138 (37%), Gaps = 34/138 (24%)
Query: 89 LGKLSQLRVLSLRSNRLSGE-----IPSDFSNLTLLRSLYLQSNQFS---GVFPASVTRM 140
L L+ LSL N L E + L SL+++S F+ +SV
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ 339
Query: 141 NR-LTRLDLSSNNFSGKIPFDV----------NNLTHLTGLFLENNKFSGN--------L 181
NR L L +S+N D + L L+L + S + L
Sbjct: 340 NRFLLELQISNNRLE-----DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATL 394
Query: 182 PSINPANLRDFNVSNNNL 199
+ N +LR+ ++SNN L
Sbjct: 395 LA-NH-SLRELDLSNNCL 410
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 30/130 (23%), Positives = 46/130 (35%), Gaps = 24/130 (18%)
Query: 93 SQLRVLSLRSNRLSGEIPSDF-----SNLTLLRSLYLQSNQFS--GV--FPASVTRMN-R 142
+ + L+L N L + + + + SL L N S ++ +
Sbjct: 51 ASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFT 110
Query: 143 LTRLDLSSNNFSGK-----IPFDVNNLTHLTGLFLENNKFSGN--------LPSINPANL 189
+T LDL N+FS K N +T L L N L +I AN+
Sbjct: 111 ITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIP-ANV 169
Query: 190 RDFNVSNNNL 199
N+ NNL
Sbjct: 170 NSLNLRGNNL 179
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 654 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.92 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.91 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.87 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.83 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.82 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.75 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.74 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.74 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.73 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.73 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.72 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.71 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.71 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.71 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.71 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.71 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.71 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.71 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.7 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.7 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.7 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.7 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.7 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.7 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.69 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.69 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.69 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.68 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.68 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.67 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.67 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.67 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.66 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.66 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.66 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.65 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.65 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.65 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.64 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.64 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.64 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.63 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.63 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.63 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.62 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.62 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.62 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.62 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.62 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.62 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.61 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.61 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.61 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.61 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.61 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.6 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.6 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.59 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.59 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.59 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.59 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.58 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.58 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.58 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.58 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.56 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.56 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.55 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.55 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.54 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.54 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.54 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.53 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.53 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.53 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.53 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.53 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.53 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.52 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.52 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.52 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.51 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.5 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.46 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.46 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.46 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.46 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.45 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.45 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.44 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.44 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.43 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.42 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.4 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.4 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.39 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.38 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.38 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.38 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.38 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.35 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.31 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.3 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.3 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.29 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.28 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.25 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.19 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 99.16 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.14 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.09 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.07 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.0 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.93 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.88 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.82 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.62 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.6 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.59 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.52 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.51 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.36 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.32 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.31 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.3 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.27 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.19 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.17 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.14 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.11 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.08 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.92 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.89 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.58 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.52 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.46 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.45 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.41 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.29 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.25 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.17 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.11 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.98 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.98 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.93 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.93 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.91 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.9 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.88 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.87 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.8 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.78 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.75 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.61 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.55 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.46 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.28 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.89 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.94 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.03 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.07 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 92.78 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 91.68 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.3 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.82 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 88.1 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.26 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-53 Score=436.98 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=201.7
Q ss_pred hccccccCceeEEEEEec------CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 351 AEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+.||+|+||+||+|.+. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..+||||||
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 125 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM 125 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 467999999999999864 47889999997653 33567999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCC
Q 036334 424 PAGSLSALLHGSRGS----------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL 493 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgl 493 (654)
++|+|.++++..... ...+++|.++++|+.|||+||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-iiHRDLKp~NILl~~~~~~Ki~DFGl 204 (329)
T 4aoj_A 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-FVHRDLATRNCLVGQGLVVKIGDFGM 204 (329)
T ss_dssp TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC-eecccccHhhEEECCCCcEEEccccc
Confidence 999999999764321 2356999999999999999999999988 99999999999999999999999999
Q ss_pred CCCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhch
Q 036334 494 NPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEW 566 (654)
Q Consensus 494 a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 566 (654)
|+..... ....+|+.|||||++.+..|+.++|||||||+||||+| |+.||..... ...+..+.....
T Consensus 205 a~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~~~i~~g~~ 278 (329)
T 4aoj_A 205 SRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------TEAIDCITQGRE 278 (329)
T ss_dssp ---------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH------HHHHHHHHHTCC
T ss_pred ceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH------HHHHHHHHcCCC
Confidence 9865332 23457788999999999999999999999999999999 8999975322 222222222110
Q ss_pred hhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 567 TAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
...+..+..++.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus 279 -----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 279 -----------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111122334677888899999999999999999999999765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=435.40 Aligned_cols=253 Identities=24% Similarity=0.405 Sum_probs=205.0
Q ss_pred hhccccccCceeEEEEEec------CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
+.+.||+|+||+||+|.+. ++..||||+++... ...++|.+|+++|++++|||||+++|+|.+++..+|||||
T Consensus 17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEc
Confidence 3578999999999999864 47789999997653 3356799999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCC
Q 036334 423 MPAGSLSALLHGSR--------GSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN 494 (654)
Q Consensus 423 ~~~g~L~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla 494 (654)
|++|+|.++|+... ......++|.++++++.|||+||+|||+++ |+||||||+|||+++++.+||+|||+|
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-iiHRDlKp~NILl~~~~~~Ki~DFGla 175 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH-FVHRDLATRNCLVGENLLVKIGDFGMS 175 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCSCH
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCccCHhhEEECCCCcEEECCcccc
Confidence 99999999997532 123456999999999999999999999998 999999999999999999999999999
Q ss_pred CCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchh
Q 036334 495 PLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWT 567 (654)
Q Consensus 495 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 567 (654)
+..... ....+|+.|||||++.++.|+.++|||||||++|||+| |+.||..... .+.+..+.....
T Consensus 176 ~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~~~i~~~~~- 248 (299)
T 4asz_A 176 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEVIECITQGRV- 248 (299)
T ss_dssp HHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHHTCC-
T ss_pred eecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHcCCC-
Confidence 755332 22346788999999999999999999999999999999 8999975322 222222222111
Q ss_pred hhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 568 AEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
...+..+..++.+|+.+||+.||++||||+||++.|+++.+..
T Consensus 249 ----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 249 ----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1111223346778888999999999999999999999987653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-53 Score=432.79 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=203.5
Q ss_pred hccccccCceeEEEEEec------CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 351 AEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
.+.||+|+||+||+|.+. +++.||||+++... ...++|.+|+.++++++|||||+++|+|.+++..+|||||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey 110 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 110 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence 467999999999999863 46789999997653 3457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEecc
Q 036334 423 MPAGSLSALLHGSRGS-----------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDF 491 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Df 491 (654)
|++|+|.++|...... ....++|.++++|+.|||+||+|||+++ ||||||||+|||+++++.+||+||
T Consensus 111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~-iiHRDLK~~NILl~~~~~~Ki~DF 189 (308)
T 4gt4_A 111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-VVHKDLATRNVLVYDKLNVKISDL 189 (308)
T ss_dssp CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCS
T ss_pred CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-CCCCCccccceEECCCCCEEECCc
Confidence 9999999999643211 1246999999999999999999999998 999999999999999999999999
Q ss_pred CCCCCcCC------CCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhh
Q 036334 492 GLNPLFGN------TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVRE 564 (654)
Q Consensus 492 gla~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 564 (654)
|+|+.... .....+|+.|||||++.++.|+.++|||||||+||||+| |+.||..... .+.+..+ ..
T Consensus 190 Glar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------~~~~~~i-~~ 262 (308)
T 4gt4_A 190 GLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVVEMI-RN 262 (308)
T ss_dssp CCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------HHHHHHH-HT
T ss_pred ccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-Hc
Confidence 99976532 223467788999999999999999999999999999999 8999975422 2222222 11
Q ss_pred chhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 565 EWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
+.. ...+.++..++.+|+.+||+.||++||||+||++.|+.+.
T Consensus 263 ~~~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 263 RQV----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 111 1112234456788899999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=424.18 Aligned_cols=250 Identities=28% Similarity=0.436 Sum_probs=198.8
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.||+|+||+||+|.+. ..||||+++..... .++|.+|+++|++++|||||+++|+|.+ +..+||||||++|
T Consensus 40 l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gG 116 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGS 116 (307)
T ss_dssp EEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSC
T ss_pred EeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCC
Confidence 3578999999999999876 36999999755332 4578999999999999999999998854 5689999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC------
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT------ 500 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~------ 500 (654)
+|.++|+.. ...++|.++++|+.|||+||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 117 sL~~~l~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~-IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 117 SLYKHLHVQ----ETKFQMFQLIDIARQTAQGMDYLHAKN-IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp BHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred CHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence 999999743 346999999999999999999999998 999999999999999999999999999865422
Q ss_pred CCCCccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 501 TPPTRVAGYRAPEVVET---RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
....||+.|||||++.+ +.|+.++|||||||+||||+||+.||..... ...+...+...... +.+.
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~------~~~~~~~~~~~~~~----p~~~- 260 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN------RDQIIFMVGRGYAS----PDLS- 260 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHHTTCCC----CCST-
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh------HHHHHHHHhcCCCC----CCcc-
Confidence 23568899999999853 4689999999999999999999999975322 12222222222111 1100
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
....++..++.+|+.+||+.||++||||.||++.|+.++..
T Consensus 261 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 261 -KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp -TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred -cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 11122334677888899999999999999999999988754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=430.45 Aligned_cols=258 Identities=22% Similarity=0.328 Sum_probs=199.6
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCC----ceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD----EKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~----~~~lv~e~~~~g 426 (654)
.+.||+|+||+||+|.+. |+.||||+++........++.|+..+.+++|||||+++++|.+++ .++||||||++|
T Consensus 8 ~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~g 86 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCC
Confidence 578999999999999985 899999999765444444556777778899999999999998754 579999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc--------CCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS--------GKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~--------~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
+|.++++. ..++|..+++++.|+++||+|||++ + |+||||||+|||++.++.+||+|||+|+...
T Consensus 87 sL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~-IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 87 SLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp BHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC-EECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred cHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC-EeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 99999973 3589999999999999999999976 5 9999999999999999999999999987654
Q ss_pred CC--------CCCCccccccCccccCCC------CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCC--------hhH
Q 036334 499 NT--------TPPTRVAGYRAPEVVETR------KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGID--------LPR 556 (654)
Q Consensus 499 ~~--------~~~~~~~~y~aPE~~~~~------~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~--------~~~ 556 (654)
.. ....+|+.|||||++.+. .++.++|||||||+||||+||..||......+... ...
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 32 123578899999999754 46789999999999999999998876533221100 011
Q ss_pred HHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 557 WVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
.+...+. ....++.+.......+....+.+|+.+||+.||++||||.||++.|+++.+.+
T Consensus 240 ~~~~~~~----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 240 EMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHT----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHh----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 1111111 11112222111223356677889999999999999999999999999998664
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=435.62 Aligned_cols=242 Identities=23% Similarity=0.373 Sum_probs=195.7
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
.+.+.||+|+||+||+|... +|+.||||++..... ..+.+.+|+++|++++|||||++++++.+++..|||||||+
T Consensus 27 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~ 106 (350)
T 4b9d_A 27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCE 106 (350)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 34578999999999999964 689999999976533 24568899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+|+|.+++...+ ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 107 gg~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~-IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 107 GGDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDRK-ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp TCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT-CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred CCcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 999999997442 345899999999999999999999998 999999999999999999999999999877543
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
....||+.|||||++.+..|+.++|||||||++|||++|+.||... +....+..+....... ..
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~------~~~~~~~~i~~~~~~~--------~~-- 246 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG------SMKNLVLKIISGSFPP--------VS-- 246 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHTCCCC--------CC--
T ss_pred cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHHHHcCCCCC--------CC--
Confidence 2245889999999999999999999999999999999999999753 2233333333322110 01
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.....++.+|+.+||+.||++|||++|+++
T Consensus 247 -~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 247 -LHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112235667888999999999999999976
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=421.49 Aligned_cols=246 Identities=22% Similarity=0.234 Sum_probs=200.5
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
..++||+|+||+||+|... +|+.||||+++.... ..+|+.++++++|||||+++++|.+++..|||||||++|+|
T Consensus 62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 3467999999999999965 589999999976432 24689999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC-CeEEeccCCCCCcCCC-------
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH-DACVSDFGLNPLFGNT------- 500 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~------- 500 (654)
.++++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ ++||+|||+|+.....
T Consensus 138 ~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~-IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 138 GQLIKQ-----MGCLPEDRALYYLGQALEGLEYLHTRR-ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp HHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTT-EECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred HHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 999974 346999999999999999999999998 99999999999999987 6999999999876432
Q ss_pred --CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 501 --TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
....||+.|||||++.+..|+.++|||||||++|||++|+.||......+ +. ..+........ . ..
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~---~~i~~~~~~~~----~--~~ 279 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LC---LKIASEPPPIR----E--IP 279 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CH---HHHHHSCCGGG----G--SC
T ss_pred cCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HH---HHHHcCCCCch----h--cC
Confidence 12358899999999999999999999999999999999999997643322 11 12222111000 0 11
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
. .....+.+++.+||+.||++|||+.|+++.|....+..
T Consensus 280 ~---~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 280 P---SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred c---cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 1 12235667778999999999999999999998887543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=425.04 Aligned_cols=240 Identities=22% Similarity=0.369 Sum_probs=198.5
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccc-ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV-AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.+.||+|+||+||+|... +|+.||||++... ....+.+.+|+++|++++|||||+++++|.+++..|||||||++|+|
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999965 5899999999754 33456688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CCCC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPPT 504 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~~ 504 (654)
.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|...... ....
T Consensus 159 ~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~~~-IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~ 231 (346)
T 4fih_A 159 TDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 231 (346)
T ss_dssp HHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred HHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccc
Confidence 999973 34899999999999999999999998 999999999999999999999999999876433 3457
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
||+.|||||++.+..|+.++|||||||++|||++|+.||.... ....+..+. .... +.+ ......
T Consensus 232 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~-~~~~-----~~~---~~~~~~ 296 (346)
T 4fih_A 232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------PLKAMKMIR-DNLP-----PRL---KNLHKV 296 (346)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHH-HSSC-----CCC---SCGGGS
T ss_pred cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHH-cCCC-----CCC---CccccC
Confidence 8899999999999999999999999999999999999997532 112222221 1110 001 111122
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 585 MVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
..++.+|+.+||+.||++|||++|+++.
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2356677889999999999999998763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=423.22 Aligned_cols=255 Identities=26% Similarity=0.359 Sum_probs=205.0
Q ss_pred HhhccccccCceeEEEEEecC------CcEEEEEEeccccc--CHHHHHHHHHHHhccCC-CccccccEEEEeC-CceEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE------GTTVVVKRLKEVAV--GKREFEMQMEVLGKIKH-DNVVPLRAFYYSK-DEKLL 418 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h-pniv~l~~~~~~~-~~~~l 418 (654)
.+.+.||+|+||+||+|.+.. ++.||||+++.... ..++|.+|+++|.+++| ||||+++|+|.+. +..++
T Consensus 67 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~i 146 (353)
T 4ase_A 67 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 146 (353)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred EEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEE
Confidence 456789999999999998542 35799999976532 34678999999999975 8999999999765 56899
Q ss_pred EEEecCCCchhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeE
Q 036334 419 VYDYMPAGSLSALLHGSRG-----------SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDAC 487 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~k 487 (654)
|||||++|+|.++|+..+. .....+++..++.++.|||+||+|||+++ ||||||||+|||+++++.+|
T Consensus 147 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~-iiHRDLK~~NILl~~~~~vK 225 (353)
T 4ase_A 147 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVK 225 (353)
T ss_dssp EEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEE
T ss_pred EEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC-eecCccCccceeeCCCCCEE
Confidence 9999999999999975431 11345899999999999999999999998 99999999999999999999
Q ss_pred EeccCCCCCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 036334 488 VSDFGLNPLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQS 560 (654)
Q Consensus 488 l~Dfgla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~ 560 (654)
|+|||+|+...... ...+|+.|||||++.++.|+.++|||||||+||||+| |+.||...... ..+..
T Consensus 226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~------~~~~~ 299 (353)
T 4ase_A 226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCR 299 (353)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS------HHHHH
T ss_pred ECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH------HHHHH
Confidence 99999998764332 2345678999999999999999999999999999998 89999754321 22222
Q ss_pred HhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 561 VVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
.+..+... ..+..+..++.+++.+||+.||++||||.||+++|+++.+..
T Consensus 300 ~i~~g~~~----------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 300 RLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp HHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHcCCCC----------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 22222111 111223346778888999999999999999999999987654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=409.43 Aligned_cols=239 Identities=24% Similarity=0.379 Sum_probs=191.0
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEe----CCceEEEEEec
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYS----KDEKLLVYDYM 423 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~~ 423 (654)
+.||+|+||+||+|.+. ++..||+|++..... ..+.|.+|+++|++++|||||+++++|.+ ++..|||||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~ 111 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence 56999999999999965 588999999976533 24568999999999999999999999875 34579999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC-CeecCCCCCCcEEECC-CCCeEEeccCCCCCcCCC-
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG-KIVHGNIKASNILLRP-DHDACVSDFGLNPLFGNT- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-~ivHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~~- 500 (654)
++|+|.+++.. ...+++..+..++.||+.||+|||+++ +|+||||||+|||++. ++.+||+|||+|+.....
T Consensus 112 ~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~ 186 (290)
T 3fpq_A 112 TSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186 (290)
T ss_dssp CSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc
Confidence 99999999974 346999999999999999999999875 5999999999999984 789999999999865433
Q ss_pred -CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 -TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....||+.|||||++.+ .|+.++|||||||++|||+||+.||..... .......+ ........++ .
T Consensus 187 ~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~~~~~i-~~~~~~~~~~------~ 253 (290)
T 3fpq_A 187 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRV-TSGVKPASFD------K 253 (290)
T ss_dssp BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHH-TTTCCCGGGG------G
T ss_pred cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHHHHHHH-HcCCCCCCCC------c
Confidence 23568899999999865 699999999999999999999999964321 11222222 1111111111 1
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.. ..++.+++.+||+.||++|||++|+++
T Consensus 254 ~~---~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 254 VA---IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CC---CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cC---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 124667888999999999999999976
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=426.36 Aligned_cols=241 Identities=22% Similarity=0.371 Sum_probs=198.6
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
..+.||+|+||+||+|... +|+.||||++.... ...+.+.+|+.+|++++|||||+++++|.+++.+|||||||++|+
T Consensus 155 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~ 234 (423)
T 4fie_A 155 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 234 (423)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCc
Confidence 3467999999999999965 58999999997543 345668899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CCC
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPP 503 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~ 503 (654)
|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|..+... ...
T Consensus 235 L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~~~-IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 235 LTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp HHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCC
T ss_pred HHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHCC-eecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccc
Confidence 9999973 34899999999999999999999998 999999999999999999999999999876433 345
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.||+.|||||++.+..|+.++|||||||++|||++|+.||.... ....+..+. .... +.+......
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~-~~~~-----~~~~~~~~~-- 373 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------PLKAMKMIR-DNLP-----PRLKNLHKV-- 373 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHH-HSCC-----CCCSCTTSS--
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHH-cCCC-----CCCcccccC--
Confidence 68899999999999999999999999999999999999997532 112222221 1110 011111122
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
..++.+|+.+||..||++|||++|+++.
T Consensus 374 -s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 374 -SPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2355667779999999999999998763
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=412.13 Aligned_cols=239 Identities=19% Similarity=0.256 Sum_probs=199.3
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV----AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+.++||+|+||+||+|... +|+.||||++.+. ....+.+.+|+++|++++|||||+++++|.+++..|+||||+
T Consensus 35 ~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~ 114 (311)
T 4aw0_A 35 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA 114 (311)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 34688999999999999964 6899999999754 234567899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 115 ~gG~L~~~i~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~-IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 115 KNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKG-IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp TTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred CCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999974 345999999999999999999999998 999999999999999999999999999876422
Q ss_pred ---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 501 ---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 501 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
....||+.|||||++.+..|+.++||||+||++|||++|+.||.... ....+..+...... .
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~~~~~---------~ 253 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EGLIFAKIIKLEYD---------F 253 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCC---------C
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCCCC---------C
Confidence 23468899999999999999999999999999999999999997532 22233333322210 1
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
+.... .++.+|+.+||+.||++|||++|++.
T Consensus 254 p~~~s---~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 254 PEKFF---PKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp CTTCC---HHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CcccC---HHHHHHHHHHccCCHhHCcChHHHcC
Confidence 11122 34566778999999999999998743
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=399.83 Aligned_cols=237 Identities=22% Similarity=0.337 Sum_probs=185.4
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||+||+|... +|+.||||++.+.. .....+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 17 i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~- 95 (275)
T 3hyh_A 17 IVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA- 95 (275)
T ss_dssp EEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-
Confidence 4578999999999999954 68999999997542 23457899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---C
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---T 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~ 501 (654)
+|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+..... .
T Consensus 96 ~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~-IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~ 169 (275)
T 3hyh_A 96 GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHRHK-IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK 169 (275)
T ss_dssp CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCChHHeEECCCCCEEEeecCCCeecCCCCccC
Confidence 6899999873 346999999999999999999999998 999999999999999999999999999876543 3
Q ss_pred CCCccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 502 PPTRVAGYRAPEVVETRKV-TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
...||+.|||||++.+..| +.++||||+||++|||++|+.||... +....+..+...... .+..
T Consensus 170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~------~~~~~~~~i~~~~~~---------~p~~ 234 (275)
T 3hyh_A 170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE------SIPVLFKNISNGVYT---------LPKF 234 (275)
T ss_dssp -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCC---------CCTT
T ss_pred CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHcCCCC---------CCCC
Confidence 4578899999999988876 58999999999999999999999753 222233333222110 0111
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.. .++.+++.+||+.||++|||++|+++
T Consensus 235 ~s---~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 235 LS---PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp SC---HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC---HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22 34567788999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-50 Score=406.76 Aligned_cols=234 Identities=24% Similarity=0.321 Sum_probs=187.2
Q ss_pred HhhccccccCceeEEEEEec----CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE----EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
.+.+.||+|+||+||+|+.. .++.||||++++.. ....++.+|+++|++++|||||++++++.+++..|+|||
T Consensus 27 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 106 (304)
T 3ubd_A 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILD 106 (304)
T ss_dssp EEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEEC
T ss_pred EEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEE
Confidence 45688999999999999852 36799999997542 234468889999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC--
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN-- 499 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~-- 499 (654)
||++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 107 y~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~-IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 107 FLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp CCTTCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred cCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999999974 346999999999999999999999998 99999999999999999999999999986532
Q ss_pred --CCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 500 --TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 500 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
.....||+.|||||++.+..|+.++||||+||++|||++|+.||.... ....+..+...... .
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~~~---------~ 245 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD------RKETMTMILKAKLG---------M 245 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC---------C
T ss_pred ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC------HHHHHHHHHcCCCC---------C
Confidence 234568899999999999999999999999999999999999997532 22223333222110 1
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAM 606 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 606 (654)
+.... .++.+++.+||+.||++|||+
T Consensus 246 p~~~s---~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 246 PQFLS---PEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CTTSC---HHHHHHHHHHTCSSGGGSTTC
T ss_pred CCcCC---HHHHHHHHHHcccCHHHCCCC
Confidence 11122 346677789999999999984
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=394.44 Aligned_cols=241 Identities=21% Similarity=0.348 Sum_probs=182.9
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCC-----------
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD----------- 414 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~----------- 414 (654)
.+.+.||+|+||+||+|... +|+.||||+++... ...+.+.+|+++|++++|||||+++++|.+.+
T Consensus 8 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~ 87 (299)
T 4g31_A 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87 (299)
T ss_dssp EEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------C
T ss_pred EEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCC
Confidence 34578999999999999964 68999999987543 23467889999999999999999999987644
Q ss_pred -ceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCC
Q 036334 415 -EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL 493 (654)
Q Consensus 415 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgl 493 (654)
..|+|||||++|+|.+++.... .....++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 88 ~~l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~~~-IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 88 VYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHSKG-LMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp EEEEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred cEEEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHHCc-CccccCcHHHeEECCCCcEEEccCcc
Confidence 3689999999999999997432 1234677889999999999999999998 99999999999999999999999999
Q ss_pred CCCcCCC----------------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHH
Q 036334 494 NPLFGNT----------------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRW 557 (654)
Q Consensus 494 a~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~ 557 (654)
|+..... ....||+.|||||++.+..|+.++|||||||++|||++ ||.... +....
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~~~ 236 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERVRT 236 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHHHH
Confidence 9876432 12358889999999999999999999999999999996 765311 00111
Q ss_pred HHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 558 VQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
+... ..... . .........+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~-~~~~~----p------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 LTDV-RNLKF----P------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH-HTTCC----C------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH-hcCCC----C------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 11000 0 011222334567888999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=388.20 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=191.5
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeC------CceEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSK------DEKLL 418 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~------~~~~l 418 (654)
.+.+.||+|+||+||+|... +|+.||||+++..... .+.+.+|+++|++++|||||++++++... +..||
T Consensus 57 ~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~i 136 (398)
T 4b99_A 57 EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 136 (398)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEE
Confidence 34578999999999999964 6999999999765332 35678899999999999999999987643 56899
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 419 VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
|||||+ |+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 137 vmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~~~-iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 137 VLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHSAQ-VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCc-CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 999995 689999973 356999999999999999999999998 9999999999999999999999999998653
Q ss_pred CC--------CCCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchh--
Q 036334 499 NT--------TPPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWT-- 567 (654)
Q Consensus 499 ~~--------~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 567 (654)
.. ....||+.|||||++.+. .|+.++||||+||++|||++|+.||.+.... ..+..+......
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~------~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV------HQLQLIMMVLGTPS 283 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH------HHHHHHHHHHCCCC
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH------HHHHHHHHhcCCCC
Confidence 21 235688899999998764 5799999999999999999999999764321 112211110000
Q ss_pred hhh--------hhH---hhhc--cCChH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 568 AEV--------FDV---ELMR--YHNIE----EEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 568 ~~~--------~~~---~~~~--~~~~~----~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
... ... .+.. ..... ....++.+|+.+||..||++|||++|+++.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 000 0000 00000 012346678889999999999999998763
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=379.50 Aligned_cols=188 Identities=26% Similarity=0.437 Sum_probs=163.6
Q ss_pred HhhccccccCceeEEEEEec----CCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEec
Q 036334 349 ASAEVLGKGSVGTSYKAVLE----EGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+.+.||+|+||+||+|..+ .++.||+|++.... ...++.+|+++|+++ +|||||+++++|.++++.|+||||+
T Consensus 24 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~ 102 (361)
T 4f9c_A 24 KIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYL 102 (361)
T ss_dssp EEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECC
T ss_pred EEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCC
Confidence 34578999999999999853 46789999986543 345678999999988 6999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC-CCeEEeccCCCCCcCCC--
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD-HDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~-~~~kl~Dfgla~~~~~~-- 500 (654)
++|+|.+++. .+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 103 ~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g-IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 103 EHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG-IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp CCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred CcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC-eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 9999999984 2899999999999999999999998 9999999999999877 79999999999754321
Q ss_pred ------------------------------CCCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 036334 501 ------------------------------TPPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQAS 546 (654)
Q Consensus 501 ------------------------------~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~ 546 (654)
....||+.|||||++.+. .|+.++||||+||++|||++|+.||...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 123588899999999775 5899999999999999999999999653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=370.14 Aligned_cols=266 Identities=32% Similarity=0.519 Sum_probs=222.9
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
.+.||+|+||.||+|...+|+.||||++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 46799999999999998889999999987653 33567899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC------CCC
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT------TPP 503 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~------~~~ 503 (654)
+++..... ....+++..+++++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 124 ~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 201 (321)
T 2qkw_B 124 RHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTRA-IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV 201 (321)
T ss_dssp GGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCC
T ss_pred HHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCCC-eecCCCCHHHEEECCCCCEEEeeccccccccccccccccccc
Confidence 99975432 2346999999999999999999999998 999999999999999999999999998754322 223
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.++..|+|||++.+..++.++|||||||++|||++|+.||......+......|.............++... ......+
T Consensus 202 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 280 (321)
T 2qkw_B 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL-ADKIRPE 280 (321)
T ss_dssp EEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC-TTCSCHH
T ss_pred CCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh-ccccCHH
Confidence 467789999999888999999999999999999999999988776666666666555444433333333332 1223466
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
....+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 281 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 281 SLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp HHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 778899999999999999999999999999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=395.52 Aligned_cols=241 Identities=21% Similarity=0.289 Sum_probs=191.6
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHH---HHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFE---MQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~---~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
+.++||+|+||+||+|... +|+.||||++++.. .....+. .++.+++.++|||||+++++|.+++.+|+|||
T Consensus 193 i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmE 272 (689)
T 3v5w_A 193 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272 (689)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEe
Confidence 3578999999999999965 58999999997542 1222233 34567778899999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT- 500 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~- 500 (654)
|++||+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||||+|||++.+|++||+|||+|......
T Consensus 273 y~~GGdL~~~l~~-----~~~l~E~~a~~y~~qIl~aL~yLH~~g-IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~ 346 (689)
T 3v5w_A 273 LMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346 (689)
T ss_dssp CCCSCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence 9999999999974 345999999999999999999999998 999999999999999999999999999876543
Q ss_pred -CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 501 -TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
....||+.|||||++.. ..|+.++||||+||++|||++|+.||......+ .......+.... ...+
T Consensus 347 ~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~~~i~~~~---------~~~p 414 (689)
T 3v5w_A 347 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLTMA---------VELP 414 (689)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHHHHHHHCC---------CCCC
T ss_pred CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhhcCCC---------CCCC
Confidence 34678999999999964 579999999999999999999999997543222 211111111111 0011
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPA-----MQEVVR 611 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 611 (654)
.... .++.+|+.+||+.||++|++ ++||.+
T Consensus 415 ~~~S---~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 415 DSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp TTSC---HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ccCC---HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1222 34566777999999999998 677754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=369.29 Aligned_cols=262 Identities=27% Similarity=0.355 Sum_probs=204.2
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCc----eEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDE----KLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~----~~lv~e~~~~ 425 (654)
+.++||+|+||+||+|... ++.||||+++........+++|+.++++++||||+++++++.+... .++||||+++
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 28 LLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred hhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 3578999999999999876 7999999998766556667789999999999999999999987543 6999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc----------CCeecCCCCCCcEEECCCCCeEEeccCCCC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS----------GKIVHGNIKASNILLRPDHDACVSDFGLNP 495 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~----------~~ivHrDlk~~NIll~~~~~~kl~Dfgla~ 495 (654)
|+|.+++.. ..+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++.
T Consensus 107 g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~-ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 107 GSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA-ISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp CBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE-EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC-EEeCCCChHhEEECCCCeEEEccCCccc
Confidence 999999973 3489999999999999999999988 7 9999999999999999999999999997
Q ss_pred CcCCC------CCCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH---
Q 036334 496 LFGNT------TPPTRVAGYRAPEVVET-----RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSV--- 561 (654)
Q Consensus 496 ~~~~~------~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~--- 561 (654)
..... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||..................
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence 65432 22456788999999976 35667899999999999999999999875543322221110000
Q ss_pred --hhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 562 --VREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 562 --~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
...........+.+...........++.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 260 EDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0000000000011111111234456688999999999999999999999999999754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=397.21 Aligned_cols=244 Identities=22% Similarity=0.386 Sum_probs=199.6
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.+.||+|+||+||+|..+ +|+.||+|++.... ...+.+.+|+++|+.++|||||+++++|.+++..|+|||||++|
T Consensus 160 ~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg 239 (573)
T 3uto_A 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239 (573)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCC
Confidence 34678999999999999965 58999999987653 34567889999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC--CCeEEeccCCCCCcCCCC---
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD--HDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~--~~~kl~Dfgla~~~~~~~--- 501 (654)
+|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|..+....
T Consensus 240 ~L~~~i~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~-iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 240 ELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENN-YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp BHHHHHTCT----TSCEEHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred cHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 999999643 345999999999999999999999998 9999999999999864 899999999998876543
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...||+.|||||++.+..|+.++||||+||++|||++|+.||.+... ...+..+....+.. .. ..+...
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~------~~~~~~i~~~~~~~---~~--~~~~~~ 383 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDWNM---DD--SAFSGI 383 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTCCCC---CS--GGGTTS
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHhCCCCC---Cc--ccccCC
Confidence 34678889999999999999999999999999999999999975322 22223332222110 00 011122
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
. .++.+|+.+||+.||++|||+.|+++
T Consensus 384 s---~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 384 S---EDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp C---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2 24556777999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=366.42 Aligned_cols=266 Identities=40% Similarity=0.668 Sum_probs=218.7
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.+.||+|+||.||+|...+|+.||||+++... .....+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 35 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 114 (326)
T 3uim_A 35 KNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114 (326)
T ss_dssp TTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBH
T ss_pred ceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCH
Confidence 57899999999999998889999999997653 2334789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc---CCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS---GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----- 500 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----- 500 (654)
.+++..... ....+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||++......
T Consensus 115 ~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 192 (326)
T 3uim_A 115 ASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192 (326)
T ss_dssp HHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC-EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEE
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEeCCCchhhEEECCCCCEEeccCccccccCccccccc
Confidence 999985432 345699999999999999999999998 7 999999999999999999999999999765432
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASL--GEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .........|+.............+... ..
T Consensus 193 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 271 (326)
T 3uim_A 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL-QG 271 (326)
T ss_dssp CCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTC-TT
T ss_pred ccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhh-cc
Confidence 22347888999999988889999999999999999999999996322 2233345555554444444444444333 23
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
....+....+.+++.+||+.||++|||+.||+++|++..-.
T Consensus 272 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 272 NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 34567788899999999999999999999999999975433
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=356.30 Aligned_cols=249 Identities=24% Similarity=0.421 Sum_probs=203.7
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccc-ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV-AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.++||+|+||+||+|... +++.||+|++... ....+.+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 94 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence 578999999999999965 5899999988654 33456789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-------
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT------- 501 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~------- 501 (654)
.+++... ...+++.+++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 169 (310)
T 3s95_A 95 RGIIKSM----DSQYPWSQRVSFAKDIASGMAYLHSMN-IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169 (310)
T ss_dssp HHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSTTSEEECTTSCEEECCCTTCEECC----------
T ss_pred HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCCcCeEEECCCCCEEEeecccceecccccccccccc
Confidence 9999753 345899999999999999999999998 9999999999999999999999999997654321
Q ss_pred -----------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhh
Q 036334 502 -----------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEV 570 (654)
Q Consensus 502 -----------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 570 (654)
...+++.|+|||++.+..++.++|||||||++|||++|..||........... .........
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-~~~~~~~~~------ 242 (310)
T 3s95_A 170 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-LNVRGFLDR------ 242 (310)
T ss_dssp ----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-BCHHHHHHH------
T ss_pred cccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-hhhhccccc------
Confidence 33577889999999999999999999999999999999999876443321110 000110000
Q ss_pred hhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 571 FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 571 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
. ........+.+++.+||+.||++|||++|+++.|+++...
T Consensus 243 ---~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 243 ---Y-----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ---T-----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---c-----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 0111123577788899999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=351.20 Aligned_cols=249 Identities=25% Similarity=0.414 Sum_probs=208.1
Q ss_pred HhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
...+.||+|+||.||+|...+++.||+|++.......+++.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 92 (269)
T 4hcu_A 13 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 92 (269)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred eeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcH
Confidence 34578999999999999988899999999988777788899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----CCC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-----TPP 503 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-----~~~ 503 (654)
.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 93 ~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 167 (269)
T 4hcu_A 93 SDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEAC-VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 167 (269)
T ss_dssp HHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred HHHHHhc----CcccCHHHHHHHHHHHHHHHHHHHhCC-eecCCcchheEEEcCCCCEEeccccccccccccccccccCc
Confidence 9999743 345899999999999999999999998 999999999999999999999999999765432 233
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
.++..|+|||++.+..++.++||||+|+++|||++ |+.||..... ......+... . ......
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~------~~~~~~~~~~-~----------~~~~~~ 230 (269)
T 4hcu_A 168 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTG-F----------RLYKPR 230 (269)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTT-C----------CCCCCT
T ss_pred ccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHhcC-c----------cCCCCC
Confidence 45567999999998899999999999999999999 9999875321 1112221111 0 000111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
.....+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 1233577788899999999999999999999999865
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=357.94 Aligned_cols=253 Identities=31% Similarity=0.424 Sum_probs=196.8
Q ss_pred HhhccccccCceeEEEEEecCCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.+.+.||+|+||+||+|... |+.||||++...... .+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 40 ~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 3p86_A 40 NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118 (309)
T ss_dssp EEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTT
T ss_pred eeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCC
Confidence 34578999999999999874 889999999765433 34688999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC-CeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG-KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
|+|.+++.... ....+++..++.++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||++......
T Consensus 119 ~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 196 (309)
T 3p86_A 119 GSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS 196 (309)
T ss_dssp CBHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------------
T ss_pred CcHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccccc
Confidence 99999997432 1124899999999999999999999875 3999999999999999999999999998765432
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
....++..|+|||++.+..++.++|||||||++|||++|+.||..... ............ ....
T Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~------~~~~~~~~~~~~----------~~~~ 260 (309)
T 3p86_A 197 KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP------AQVVAAVGFKCK----------RLEI 260 (309)
T ss_dssp -----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHHSCC----------CCCC
T ss_pred ccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcCC----------CCCC
Confidence 234577889999999999999999999999999999999999975321 111111111100 0011
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
......++.+++.+||+.||++|||++++++.|+.+.+..
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 1122335778888999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=366.93 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=203.6
Q ss_pred hhccccccCceeEEEEEec--------CCcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE--------EGTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLL 418 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~l 418 (654)
+.+.||+|+||.||+|... ++..||||+++.... ..+++.+|+++++++ +||||++++++|.+.+..++
T Consensus 85 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 164 (370)
T 2psq_A 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 164 (370)
T ss_dssp EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEE
Confidence 4578999999999999852 356799999976532 345788999999999 89999999999999999999
Q ss_pred EEEecCCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeE
Q 036334 419 VYDYMPAGSLSALLHGSRGS-----------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDAC 487 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~k 487 (654)
||||+++|+|.+++...... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~k 243 (370)
T 2psq_A 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVLVTENNVMK 243 (370)
T ss_dssp EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTCCEE
T ss_pred EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-eeccccchhhEEECCCCCEE
Confidence 99999999999999754311 1245899999999999999999999998 99999999999999999999
Q ss_pred EeccCCCCCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 036334 488 VSDFGLNPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQS 560 (654)
Q Consensus 488 l~Dfgla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~ 560 (654)
|+|||++...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 244 l~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~------~~~~~ 317 (370)
T 2psq_A 244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE------ELFKL 317 (370)
T ss_dssp ECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------GHHHH
T ss_pred EccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH
Confidence 9999999765432 22334567999999999999999999999999999999 99999753221 11111
Q ss_pred HhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 561 VVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
+..... .........++.+++.+||+.||++||++.|+++.|+++....
T Consensus 318 -~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 318 -LKEGHR----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp -HHTTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HhcCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 111110 0111223346778888999999999999999999999987543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=354.33 Aligned_cols=241 Identities=23% Similarity=0.356 Sum_probs=197.8
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEeccc-ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEV-AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
..+.||+|+||+||+|.. .+|+.||||++... ....+.+.+|+.++++++||||+++++++..++..++||||+++|+
T Consensus 24 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (297)
T 3fxz_A 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (297)
T ss_dssp CCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred eeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCC
Confidence 347899999999999985 56899999998655 3445678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CCC
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPP 503 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~ 503 (654)
|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 104 L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 176 (297)
T 3fxz_A 104 LTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (297)
T ss_dssp HHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred HHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCc
Confidence 9999973 24899999999999999999999998 999999999999999999999999998765433 234
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.++..|+|||++.+..++.++|||||||++|||++|+.||..... ............. .......
T Consensus 177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~---------~~~~~~~ 241 (297)
T 3fxz_A 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTP---------ELQNPEK 241 (297)
T ss_dssp CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSC---------CCSCGGG
T ss_pred cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC---------CCCCccc
Confidence 577889999999999999999999999999999999999965321 1111111111110 0111122
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
....+.+++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 23456778889999999999999999863
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=347.95 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=205.8
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
+.+.||+|+||.||+|...++..||+|+++......+++.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (268)
T 3sxs_A 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91 (268)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHH
Confidence 45789999999999999988889999999887777888999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-----CCC
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-----PPT 504 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-----~~~ 504 (654)
+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 92 ~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 166 (268)
T 3sxs_A 92 NYLRSH----GKGLEPSQLLEMCYDVCEGMAFLESHQ-FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK 166 (268)
T ss_dssp HHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT-EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCC
T ss_pred HHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCC
Confidence 999743 234899999999999999999999998 9999999999999999999999999987654332 233
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
++..|+|||++.+..++.++||||||+++|||++ |+.||..... ............ ......
T Consensus 167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~-----------~~~~~~ 229 (268)
T 3sxs_A 167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN------SEVVLKVSQGHR-----------LYRPHL 229 (268)
T ss_dssp CCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHTTCC-----------CCCCTT
T ss_pred cCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh------HHHHHHHHcCCC-----------CCCCCc
Confidence 4556999999988889999999999999999999 9999865322 111111111110 000111
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
....+.+++.+||+.||++|||++|+++.|+++++.
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 230 ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 123577788899999999999999999999999765
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=356.16 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=201.7
Q ss_pred hhccccccCceeEEEEEec----CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE----EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.+.||+|+||.||+|.+. .+..||||+++... ...+++.+|+.++++++||||+++++++.+++..++||||+
T Consensus 53 i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 132 (325)
T 3kul_A 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYM 132 (325)
T ss_dssp EEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECC
T ss_pred EeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCC
Confidence 4578999999999999974 35569999997642 23467899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC--
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-- 501 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-- 501 (654)
++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 133 ~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 133 ENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLSDLG-YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp TTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred CCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC-eeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence 999999999743 245999999999999999999999998 9999999999999999999999999998764331
Q ss_pred -----CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 502 -----PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 502 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
...++..|+|||++.+..++.++|||||||++|||++ |+.||..... ......+....
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------~~~~~~~~~~~---------- 271 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN------RDVISSVEEGY---------- 271 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHHHHTTC----------
T ss_pred eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHHcCC----------
Confidence 1233456999999998899999999999999999999 9999965322 11111111110
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
...........+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 272 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 272 -RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred -CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 01111223346778888999999999999999999999998653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=351.96 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=193.3
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhc--cCCCccccccEEEEeC----CceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGK--IKHDNVVPLRAFYYSK----DEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~--l~hpniv~l~~~~~~~----~~~~lv~e~~ 423 (654)
+.+.||+|+||+||+|.. +|+.||||++.... ...+.+|.+++.. ++||||+++++++... ...++||||+
T Consensus 12 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~ 88 (301)
T 3q4u_A 12 LLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88 (301)
T ss_dssp EEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred EEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence 357899999999999988 58999999987543 3445556665554 7999999999987653 3579999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------ccCCeecCCCCCCcEEECCCCCeEEeccCCCC
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH--------VSGKIVHGNIKASNILLRPDHDACVSDFGLNP 495 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~ 495 (654)
++|+|.++++. ..+++..+++++.|++.||+||| +.+ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 89 EMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA-IAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp TTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE-EECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC-eecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 99999999962 35999999999999999999999 777 9999999999999999999999999986
Q ss_pred CcCCC--------CCCCccccccCccccCCC------CCCcchhHHHHHHHHHHHHhC----------CCCCCCCCCCCC
Q 036334 496 LFGNT--------TPPTRVAGYRAPEVVETR------KVTFKSDVYSFGVLLLELLTG----------KAPNQASLGEEG 551 (654)
Q Consensus 496 ~~~~~--------~~~~~~~~y~aPE~~~~~------~~~~~~DvwslGvil~el~tg----------~~pf~~~~~~~~ 551 (654)
..... ....++..|+|||++.+. .++.++|||||||++|||++| +.||........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~ 241 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence 54332 223678889999999876 455799999999999999999 778765433221
Q ss_pred CChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 552 IDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
. . ..+......... .+..............+.+++.+||+.||++|||++|+++.|+++
T Consensus 242 ~-~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 242 S-F-EDMRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp C-H-HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred c-h-hhhhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1 1 111111111100 111111111234566788999999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=353.75 Aligned_cols=252 Identities=13% Similarity=0.176 Sum_probs=202.5
Q ss_pred hccccccCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 351 AEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.+.||+|+||+||+|.. .+|+.||||++.... ....+.+|+++++++ +||||+++++++.+.+..++||||+ +++|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSL 91 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCH
Confidence 57899999999999995 568999999986543 234688999999999 9999999999999999999999999 9999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC-----eEEeccCCCCCcCCC---
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD-----ACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~-----~kl~Dfgla~~~~~~--- 500 (654)
.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++......
T Consensus 92 ~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~ 166 (330)
T 2izr_A 92 EDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKN-LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166 (330)
T ss_dssp HHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred HHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence 9999753 246999999999999999999999998 999999999999999887 999999999765322
Q ss_pred --------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhh
Q 036334 501 --------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 501 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 572 (654)
....++..|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..+....... .
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~---~~~~~~~i~~~~~~~---~ 240 (330)
T 2izr_A 167 KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT---LKERYQKIGDTKRAT---P 240 (330)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS---HHHHHHHHHHHHHHS---C
T ss_pred ccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc---HHHHHHHHHhhhccC---C
Confidence 23457788999999999999999999999999999999999998653322 222222221111100 0
Q ss_pred HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 573 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
... .... .. ++.+++..||+.||.+||++.+|++.|+++....
T Consensus 241 ~~~-~~~~---~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 241 IEV-LCEN---FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHH-HTTT---CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHH-Hhcc---Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 000 0001 11 6778888999999999999999999999887544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=346.49 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=204.5
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
+.+.||+|+||.||++...++..||+|+++......+++.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (283)
T 3gen_A 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107 (283)
T ss_dssp EEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHH
T ss_pred hHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHH
Confidence 45789999999999999988889999999887777888999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----CCCC
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-----TPPT 504 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-----~~~~ 504 (654)
+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...... ....
T Consensus 108 ~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 182 (283)
T 3gen_A 108 NYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQ-FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 182 (283)
T ss_dssp HHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTT
T ss_pred HHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCCCccceEEEcCCCCEEEccccccccccccccccccCCc
Confidence 999743 235899999999999999999999998 999999999999999999999999999766432 2334
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+.... .......
T Consensus 183 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~------~~~~~~~~~~~-----------~~~~~~~ 245 (283)
T 3gen_A 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEHIAQGL-----------RLYRPHL 245 (283)
T ss_dssp SCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHTTC-----------CCCCCTT
T ss_pred cCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh------hHHHHHHhccc-----------CCCCCCc
Confidence 5567999999998899999999999999999998 9999975322 11111111110 0000111
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
....+.+++.+||+.||++|||++|+++.|+++.+.+
T Consensus 246 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 246 ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 1235777888999999999999999999999987543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=370.92 Aligned_cols=249 Identities=25% Similarity=0.460 Sum_probs=206.2
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
+.+.||+|+||+||+|.+.++..||||+++......+++.+|+.+|++++||||+++++++. .+..++||||+++|+|.
T Consensus 192 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~ 270 (454)
T 1qcf_A 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLL 270 (454)
T ss_dssp EEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred EEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHH
Confidence 35789999999999999988899999999887777889999999999999999999999986 66789999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----CCCC
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-----TPPT 504 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-----~~~~ 504 (654)
+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 271 ~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 346 (454)
T 1qcf_A 271 DFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN-YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK 346 (454)
T ss_dssp HHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSS
T ss_pred HHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCc
Confidence 9997432 235889999999999999999999998 999999999999999999999999999876432 2233
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
++..|+|||++....++.++|||||||++|||++ |+.||..... ......+.. .. .......
T Consensus 347 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~------~~~~~~i~~-~~----------~~~~~~~ 409 (454)
T 1qcf_A 347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------PEVIRALER-GY----------RMPRPEN 409 (454)
T ss_dssp SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHH-TC----------CCCCCTT
T ss_pred ccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHc-CC----------CCCCCCC
Confidence 4567999999998899999999999999999999 9999975321 122221111 11 0111122
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
...++.+++.+||+.||++|||+++|++.|+++....
T Consensus 410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 410 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 3346778888999999999999999999999987554
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=342.80 Aligned_cols=258 Identities=33% Similarity=0.528 Sum_probs=206.7
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccc-----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVA-----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.||+|+||.||+|.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 37 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 115 (307)
T 2nru_A 37 NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115 (307)
T ss_dssp CEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred CccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCC
Confidence 6799999999999987 48899999986532 22467889999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC------
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT------ 500 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~------ 500 (654)
+|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 116 ~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 192 (307)
T 2nru_A 116 SLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHENH-HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192 (307)
T ss_dssp BHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred cHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC-eecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence 9999997433 2346999999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc-hhhhhhhHhhhccC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREE-WTAEVFDVELMRYH 579 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 579 (654)
....++..|+|||++.+ .++.++||||||+++|||++|..||....... ....+........ .....++..+ ..
T Consensus 193 ~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~--~~ 267 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLDIKEEIEDEEKTIEDYIDKKM--ND 267 (307)
T ss_dssp SSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BTTHHHHHHHTTSCCHHHHSCSSC--SC
T ss_pred cccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HHHHHHHHhhhhhhhhhhhccccc--cc
Confidence 22356788999998865 58899999999999999999999998654332 1222222221111 1111122111 12
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
........+.+++.+||+.||++|||++++++.|+++..
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 345566788999999999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=367.36 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=203.1
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCC-ceEEEEEecCCCch
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD-EKLLVYDYMPAGSL 428 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e~~~~g~L 428 (654)
+.+.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.+|++++||||+++++++...+ ..++||||+++|+|
T Consensus 197 ~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274 (450)
T ss_dssp EEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred EEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence 3578999999999999986 7899999998654 4578999999999999999999999987765 78999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-CCCCccc
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-TPPTRVA 507 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~~ 507 (654)
.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... ....++.
T Consensus 275 ~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 350 (450)
T 1k9a_A 275 VDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 350 (450)
T ss_dssp HHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTSCEEECCCTTCEECC------CCCT
T ss_pred HHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCCc
Confidence 9999753 2334799999999999999999999998 999999999999999999999999998765432 2234566
Q ss_pred cccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHH
Q 036334 508 GYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMV 586 (654)
Q Consensus 508 ~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (654)
.|+|||++.+..++.++|||||||++|||++ |+.||......+ . ...+ ..+.. ......+..
T Consensus 351 ~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~---~~~i-~~~~~----------~~~p~~~~~ 413 (450)
T 1k9a_A 351 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V---VPRV-EKGYK----------MDAPDGCPP 413 (450)
T ss_dssp TTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---H---HHHH-HTTCC----------CCCCTTCCH
T ss_pred ceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHH-HcCCC----------CCCCCcCCH
Confidence 7999999999999999999999999999998 999997643321 1 1111 11111 111122334
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 587 QLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 587 ~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
.+.+++.+||+.||++|||+.++++.|+++...+
T Consensus 414 ~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 6778888999999999999999999999998654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=355.82 Aligned_cols=242 Identities=21% Similarity=0.279 Sum_probs=193.3
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.||+|+||+||+|... +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+++..++||||+++|
T Consensus 11 i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 90 (323)
T 3tki_A 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 90 (323)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred eeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCC
Confidence 3578999999999999965 68999999986542 23456889999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC------
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT------ 500 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~------ 500 (654)
+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 91 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~g-ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 91 ELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp EGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred cHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 99999973 345999999999999999999999998 999999999999999999999999999755321
Q ss_pred CCCCccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 TPPTRVAGYRAPEVVETRKV-TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....++..|+|||++.+..+ +.++|||||||++|||++|+.||....... ............ ..
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~----------~~ 229 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----QEYSDWKEKKTY----------LN 229 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-----HHHHHHHTTCTT----------ST
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-----HHHHHHhccccc----------CC
Confidence 24567888999999987765 788999999999999999999997643321 011111111000 00
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
........+.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 011122356678889999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=373.49 Aligned_cols=250 Identities=27% Similarity=0.396 Sum_probs=207.4
Q ss_pred hhccccccCceeEEEEEecC-CcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 350 SAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
+.+.||+|+||.||+|.+.. +..||||+++......++|.+|+.+|++++||||++++++|.+.+..++||||+++|+|
T Consensus 224 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L 303 (495)
T 1opk_A 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 303 (495)
T ss_dssp EEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCH
Confidence 45789999999999999765 88999999987777788899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----CCC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-----TPP 503 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-----~~~ 503 (654)
.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 304 ~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 379 (495)
T 1opk_A 304 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN-FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 379 (495)
T ss_dssp HHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTC
T ss_pred HHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCC
Confidence 99997542 345899999999999999999999998 999999999999999999999999999876432 122
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
.++..|+|||++.+..++.++|||||||++|||++ |..||...... . +...+..... .....
T Consensus 380 ~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~------~-~~~~~~~~~~----------~~~~~ 442 (495)
T 1opk_A 380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------Q-VYELLEKDYR----------MERPE 442 (495)
T ss_dssp CCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------G-HHHHHHTTCC----------CCCCT
T ss_pred cCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCC----------CCCCC
Confidence 34567999999998899999999999999999999 99998754321 1 1111111111 11112
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
....++.+++.+||+.||++|||+.+|++.|+++....
T Consensus 443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 23346778888999999999999999999999986543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=348.27 Aligned_cols=240 Identities=21% Similarity=0.327 Sum_probs=197.0
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 50 ~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 129 (321)
T 2c30_A 50 YVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129 (321)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred cEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCH
Confidence 357999999999999976 69999999997553 3456788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CCCC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPPT 504 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~~ 504 (654)
.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...... ....
T Consensus 130 ~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 202 (321)
T 2c30_A 130 TDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQG-VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 202 (321)
T ss_dssp HHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred HHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccccc
Confidence 999863 35899999999999999999999998 999999999999999999999999998765432 3346
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+.. .... . .......
T Consensus 203 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------~~~~~~~~~-~~~~-----~---~~~~~~~ 267 (321)
T 2c30_A 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAMKRLRD-SPPP-----K---LKNSHKV 267 (321)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHH-SSCC-----C---CTTGGGS
T ss_pred CCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhc-CCCC-----C---cCccccC
Confidence 78889999999999999999999999999999999999975321 111111111 1000 0 0011112
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 585 MVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
...+.+++.+||+.||++|||++|+++.
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2356778889999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=352.14 Aligned_cols=239 Identities=20% Similarity=0.296 Sum_probs=196.8
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.+.||+|+||.||+|.. .+|+.||||++...... .+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 19 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 98 (328)
T 3fe3_A 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98 (328)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCC
Confidence 357899999999999996 57999999999765433 35678899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---CC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TP 502 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~~ 502 (654)
|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 99 ~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~-ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 172 (328)
T 3fe3_A 99 GEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQKR-IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172 (328)
T ss_dssp CBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence 9999999742 45899999999999999999999998 999999999999999999999999999765433 34
Q ss_pred CCccccccCccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 503 PTRVAGYRAPEVVETRKVT-FKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
..+++.|+|||++.+..++ .++||||+||++|||++|+.||.... .......+...... ..
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~---------~p--- 234 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLRGKYR---------IP--- 234 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC---------CC---
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCC---------CC---
Confidence 5678889999999887765 89999999999999999999997532 22222222222110 01
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.....++.+++.+||..||++|||++|+++.
T Consensus 235 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122356678889999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=365.86 Aligned_cols=248 Identities=22% Similarity=0.342 Sum_probs=201.6
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.||+|+||.||+|.+. +++.||||+++.... ..+++.+|++++++++||||+++++++.+++..++||||+++|
T Consensus 118 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 197 (377)
T 3cbl_A 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197 (377)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred EeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence 4578999999999999976 689999999875432 2346788999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC------
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT------ 500 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~------ 500 (654)
+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 198 ~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 198 DFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLESKC-CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp BHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 999999743 235899999999999999999999998 999999999999999999999999998764432
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....++..|+|||++.+..++.++|||||||++|||++ |..||...... .+...+..... ..
T Consensus 273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~----------~~ 335 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKGGR----------LP 335 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTTCC----------CC
T ss_pred CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCC----------CC
Confidence 11223556999999988889999999999999999998 99998753221 11111111110 01
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
........+.+++.+||+.||++|||++++++.|+++.+.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1112234677888899999999999999999999998754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=348.21 Aligned_cols=253 Identities=27% Similarity=0.414 Sum_probs=195.9
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
+.+.||+|+||.||+|... ++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||+++|+|.
T Consensus 12 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~ 87 (307)
T 2eva_A 12 VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLY 87 (307)
T ss_dssp EEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHH
T ss_pred eeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHH
Confidence 3578999999999999986 789999998643 34567899999999999999999999876 4589999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc---cCCeecCCCCCCcEEECCCCC-eEEeccCCCCCcCCC-CCCC
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV---SGKIVHGNIKASNILLRPDHD-ACVSDFGLNPLFGNT-TPPT 504 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~---~~~ivHrDlk~~NIll~~~~~-~kl~Dfgla~~~~~~-~~~~ 504 (654)
+++.... ....+++..++.++.|+++||+|||+ ++ |+||||||+||+++.++. +||+|||++...... ....
T Consensus 88 ~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~-ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (307)
T 2eva_A 88 NVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA-LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK 164 (307)
T ss_dssp HHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSC-CCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred HHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCC-eecCCCChhHEEEeCCCCEEEEcccccccccccccccCC
Confidence 9997542 12357899999999999999999998 66 999999999999998887 799999998765433 3345
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
++..|+|||++.+..++.++||||||+++|||++|+.||...... ............ . .......
T Consensus 165 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~-~----------~~~~~~~ 229 (307)
T 2eva_A 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAVHNGT-R----------PPLIKNL 229 (307)
T ss_dssp CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHHHTTC-C----------CCCBTTC
T ss_pred CCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHHhcCC-C----------CCccccc
Confidence 788899999999999999999999999999999999999753221 111111111110 0 0111122
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 036334 585 MVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDDG 624 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 624 (654)
...+.+++.+||+.||++|||++|+++.|+++.+......
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 2356778889999999999999999999999987654433
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=360.56 Aligned_cols=249 Identities=25% Similarity=0.428 Sum_probs=193.9
Q ss_pred hhccccccCceeEEEEEec----CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE----EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.+.||+|+||.||+|... ++..||||+++... ...+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 49 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 128 (373)
T 2qol_A 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128 (373)
T ss_dssp CCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCC
Confidence 3578999999999999864 47789999997643 23467899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC-
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP- 502 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~- 502 (654)
++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 129 ~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 129 ENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLSDMG-YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp TTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 999999999743 345899999999999999999999998 99999999999999999999999999987643311
Q ss_pred ------CCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 503 ------PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 503 ------~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
..++..|+|||++.+..++.++|||||||++|||++ |+.||..... ......+ ....
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~------~~~~~~i-~~~~--------- 267 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN------QDVIKAV-DEGY--------- 267 (373)
T ss_dssp ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH------HHHHHHH-HTTE---------
T ss_pred ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-HcCC---------
Confidence 123456999999998999999999999999999998 9999965321 1111111 1110
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
...........+.+++.+||+.||++||++.++++.|+++.+..
T Consensus 268 -~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 268 -RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 01111223346788889999999999999999999999997654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=357.47 Aligned_cols=259 Identities=26% Similarity=0.376 Sum_probs=206.2
Q ss_pred hhccccccCceeEEEEEec--------CCcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE--------EGTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLL 418 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~l 418 (654)
+.+.||+|+||.||+|... .+..||||+++.... ...++.+|+++++++ +||||++++++|.+++..++
T Consensus 73 i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 152 (382)
T 3tt0_A 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 152 (382)
T ss_dssp EEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEE
Confidence 4578999999999999852 245799999976533 236688999999999 89999999999999999999
Q ss_pred EEEecCCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeE
Q 036334 419 VYDYMPAGSLSALLHGSRGS-----------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDAC 487 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~k 487 (654)
||||+++|+|.+++...... ....+++..+++++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~k 231 (382)
T 3tt0_A 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVLVTEDNVMK 231 (382)
T ss_dssp EEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEE
T ss_pred EEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCcceEEEcCCCcEE
Confidence 99999999999999754311 1245999999999999999999999998 99999999999999999999
Q ss_pred EeccCCCCCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 036334 488 VSDFGLNPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQS 560 (654)
Q Consensus 488 l~Dfgla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~ 560 (654)
|+|||++...... ....++..|+|||++.+..++.++|||||||++|||++ |..||.... .......
T Consensus 232 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~------~~~~~~~ 305 (382)
T 3tt0_A 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEELFKL 305 (382)
T ss_dssp ECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHHH
T ss_pred EcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHH
Confidence 9999999866432 22344567999999999999999999999999999999 999986532 1122211
Q ss_pred HhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCCCCCC
Q 036334 561 VVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDDGLR 626 (654)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~ 626 (654)
+ ..... .........++.+++.+||+.||++|||++|+++.|+++..........
T Consensus 306 ~-~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 360 (382)
T 3tt0_A 306 L-KEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMG 360 (382)
T ss_dssp H-HTTCC----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC--
T ss_pred H-HcCCC----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCC
Confidence 1 11110 0011122346778888999999999999999999999998665444433
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=349.88 Aligned_cols=256 Identities=24% Similarity=0.390 Sum_probs=195.9
Q ss_pred HhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhc--cCCCccccccEEEEeC----CceEEEEEe
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGK--IKHDNVVPLRAFYYSK----DEKLLVYDY 422 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~--l~hpniv~l~~~~~~~----~~~~lv~e~ 422 (654)
.+.+.||+|+||.||+|... |+.||||++..... ..+.+|.+++.. ++||||+++++++... ...++||||
T Consensus 40 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 116 (337)
T 3mdy_A 40 QMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116 (337)
T ss_dssp EEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECC
T ss_pred EEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEec
Confidence 45688999999999999986 89999999865433 334445555444 5899999999999887 678999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc--------CCeecCCCCCCcEEECCCCCeEEeccCCC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS--------GKIVHGNIKASNILLRPDHDACVSDFGLN 494 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~--------~~ivHrDlk~~NIll~~~~~~kl~Dfgla 494 (654)
+++|+|.+++.. ..+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 117 HENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp CTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC-EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC-EEecccchHHEEECCCCCEEEEeCCCc
Confidence 999999999963 2489999999999999999999987 7 999999999999999999999999999
Q ss_pred CCcCCCC--------CCCccccccCccccCCCCCCcc------hhHHHHHHHHHHHHhC----------CCCCCCCCCCC
Q 036334 495 PLFGNTT--------PPTRVAGYRAPEVVETRKVTFK------SDVYSFGVLLLELLTG----------KAPNQASLGEE 550 (654)
Q Consensus 495 ~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~------~DvwslGvil~el~tg----------~~pf~~~~~~~ 550 (654)
....... ...++..|+|||++.+..++.+ +|||||||++|||++| +.||.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 269 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence 7654321 3357788999999987766655 9999999999999999 55554432222
Q ss_pred CCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 551 GIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
. .. ............ .+.........+...++.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 270 ~-~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 270 P-SY-EDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp C-CH-HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred C-ch-hhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 1 11 111111111111 1111111112356677889999999999999999999999999998654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=366.37 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=201.7
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
+.+.||+|+||.||+|.+.++..||||+++......+++.+|+++|++++||||+++++++.+ +..++||||+++|+|.
T Consensus 188 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~ 266 (452)
T 1fmk_A 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 266 (452)
T ss_dssp EEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred eeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHH
Confidence 357899999999999999888889999998776677889999999999999999999999866 6789999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-----CCC
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-----PPT 504 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-----~~~ 504 (654)
+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 267 ~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 342 (452)
T 1fmk_A 267 DFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 342 (452)
T ss_dssp HHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCCTTC--------------
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCc
Confidence 9997431 235899999999999999999999998 9999999999999999999999999998764321 223
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
++..|+|||++.+..++.++|||||||++|||++ |+.||..... ......+. .+.. ......
T Consensus 343 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------~~~~~~i~-~~~~----------~~~~~~ 405 (452)
T 1fmk_A 343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVE-RGYR----------MPCPPE 405 (452)
T ss_dssp CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHH-TTCC----------CCCCTT
T ss_pred ccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHHHH-cCCC----------CCCCCC
Confidence 4567999999998899999999999999999999 9999975321 11121111 1110 011122
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
....+.+++.+||+.||++|||++++++.|+++....
T Consensus 406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 3346778888999999999999999999999987553
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=353.23 Aligned_cols=242 Identities=21% Similarity=0.346 Sum_probs=197.5
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc-------CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV-------GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
+.+.||+|+||.||+|... +|+.||+|+++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 16 ~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e 95 (361)
T 2yab_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILE 95 (361)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEE
Confidence 4578999999999999965 589999999976532 24678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC----CeEEeccCCCCCc
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH----DACVSDFGLNPLF 497 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~----~~kl~Dfgla~~~ 497 (654)
|+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++...
T Consensus 96 ~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 96 LVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp CCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 9999999999963 346999999999999999999999998 99999999999998877 7999999999876
Q ss_pred CCC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 498 GNT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 498 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
... ....+++.|+|||++.+..++.++|||||||++|||++|..||..... ...+..+....+. ++..
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------~~~~~~i~~~~~~---~~~~ 240 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITAVSYD---FDEE 240 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTCCC---CCHH
T ss_pred CCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcCCC---CCch
Confidence 543 345678889999999999999999999999999999999999975321 2222222221110 0111
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
. +... ...+.+++.+||..||++|||+.|+++
T Consensus 241 ~--~~~~---s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 241 F--FSQT---SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp H--HTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred h--ccCC---CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 1111 234667788999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=349.76 Aligned_cols=256 Identities=24% Similarity=0.421 Sum_probs=197.9
Q ss_pred hhccccccCceeEEEEEe-----cCCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeC--CceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL-----EEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e 421 (654)
+.+.||+|+||+||+|.+ .+++.||||+++... ...+.+.+|++++++++||||+++++++... ...++|||
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 93 (295)
T 3ugc_A 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93 (295)
T ss_dssp EEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEE
T ss_pred hhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEE
Confidence 457899999999999984 358899999997653 2346788999999999999999999998653 45899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT- 500 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~- 500 (654)
|+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 94 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (295)
T 3ugc_A 94 YLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168 (295)
T ss_dssp CCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred eCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHhcCC-cccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence 99999999999753 234899999999999999999999998 999999999999999999999999999876432
Q ss_pred ------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-------CCCC--hhHHHHHHhhhc
Q 036334 501 ------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGE-------EGID--LPRWVQSVVREE 565 (654)
Q Consensus 501 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-------~~~~--~~~~~~~~~~~~ 565 (654)
....++..|+|||++.+..++.++||||||+++|||++|..||...... .... ....+.......
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (295)
T 3ugc_A 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248 (295)
T ss_dssp -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence 1233455699999999999999999999999999999999998642110 0000 000000000000
Q ss_pred hhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 566 WTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
. ..........++.+++.+||+.||++|||++|+++.|+++.+.-
T Consensus 249 ~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 249 G----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp C----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred C----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0 11112233456778888999999999999999999999998653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=338.89 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=206.9
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
..+.||+|+||.||+|...+++.||+|+++......+++.+|++++++++||||+++++++.+++..++||||+++++|.
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (267)
T 3t9t_A 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91 (267)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred eeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHH
Confidence 35789999999999999888899999999887777788999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----CCCC
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-----TPPT 504 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-----~~~~ 504 (654)
+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...... ....
T Consensus 92 ~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 166 (267)
T 3t9t_A 92 DYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEAC-VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 166 (267)
T ss_dssp HHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred HHHhhC----cccCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCchheEEECCCCCEEEccccccccccccccccccccc
Confidence 999743 245899999999999999999999998 999999999999999999999999998765432 2334
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+... .. ......
T Consensus 167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~i~~~-~~----------~~~~~~ 229 (267)
T 3t9t_A 167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTG-FR----------LYKPRL 229 (267)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTT-CC----------CCCCTT
T ss_pred ccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHHHHhcC-Cc----------CCCCcc
Confidence 5567999999988899999999999999999999 8999875321 1112221111 00 000111
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
....+.+++.+||+.||++|||++++++.|+++.++
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 233577788899999999999999999999999764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=356.15 Aligned_cols=273 Identities=16% Similarity=0.161 Sum_probs=199.3
Q ss_pred hhccccccCceeEEEEEecC------CcEEEEEEeccccc------------CHHHHHHHHHHHhccCCCccccccEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLEE------GTTVVVKRLKEVAV------------GKREFEMQMEVLGKIKHDNVVPLRAFYY 411 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~------g~~vavK~~~~~~~------------~~~~~~~e~~~l~~l~hpniv~l~~~~~ 411 (654)
+.+.||+|+||.||+|.+.. ++.||||++..... ....+..|+..++.++||||+++++++.
T Consensus 39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 118 (364)
T 3op5_A 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGL 118 (364)
T ss_dssp EEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEE
T ss_pred EEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeee
Confidence 35789999999999998754 47899999865421 1122334555677788999999999987
Q ss_pred eC----CceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEEC--CCCC
Q 036334 412 SK----DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR--PDHD 485 (654)
Q Consensus 412 ~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~--~~~~ 485 (654)
.. ...++||||+ +++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++ .++.
T Consensus 119 ~~~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~-iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 119 HDKNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIHEHE-YVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEEESSCTTC
T ss_pred eccCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEEecCCHHHEEEecCCCCe
Confidence 65 3479999999 99999999743 245999999999999999999999998 99999999999999 8899
Q ss_pred eEEeccCCCCCcCCC-----------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCCh
Q 036334 486 ACVSDFGLNPLFGNT-----------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDL 554 (654)
Q Consensus 486 ~kl~Dfgla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~ 554 (654)
+||+|||++..+... ....+|..|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~--~~ 270 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP--KY 270 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH--HH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH--HH
Confidence 999999999655321 12337888999999999999999999999999999999999998533221 11
Q ss_pred hHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCCCCCCCCCCCCCC
Q 036334 555 PRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDDGLRQSSDDPSK 634 (654)
Q Consensus 555 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~ 634 (654)
.......... .....++..+. ......++.+++..||+.||++||++.++++.|+++...... ......++...
T Consensus 271 ~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~-~~~~~~dw~~~ 344 (364)
T 3op5_A 271 VRDSKIRYRE-NIASLMDKCFP----AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS-KDDGKLDLSVV 344 (364)
T ss_dssp HHHHHHHHHH-CHHHHHHHHSC----TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC-CCCCCCCC---
T ss_pred HHHHHHHhhh-hHHHHHHHhcc----cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC-CcCCccceEec
Confidence 1111111111 11122222110 011234677788899999999999999999999998765432 23344455543
Q ss_pred CC
Q 036334 635 GS 636 (654)
Q Consensus 635 ~~ 636 (654)
..
T Consensus 345 ~~ 346 (364)
T 3op5_A 345 EN 346 (364)
T ss_dssp --
T ss_pred cC
Confidence 33
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=350.08 Aligned_cols=244 Identities=20% Similarity=0.312 Sum_probs=199.6
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
+.+.||+|+||.||+|... +++.||+|.++........+.+|+.+++.++||||+++++++.+.+..++||||+++|+|
T Consensus 9 ~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L 88 (321)
T 1tki_A 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred eeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCH
Confidence 3578999999999999965 588999999986655567788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC--CCCeEEeccCCCCCcCCCC---CC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP--DHDACVSDFGLNPLFGNTT---PP 503 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~--~~~~kl~Dfgla~~~~~~~---~~ 503 (654)
.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||++....... ..
T Consensus 89 ~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g-ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 163 (321)
T 1tki_A 89 FERINTS----AFELNEREIVSYVHQVCEALQFLHSHN-IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp HHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence 9999743 245899999999999999999999998 999999999999997 7899999999998765432 23
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.+++.|+|||++.+..++.++|||||||++|||++|..||..... ...+..+....... +.. .+. .
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~---~~~--~~~---~ 229 (321)
T 1tki_A 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEYTF---DEE--AFK---E 229 (321)
T ss_dssp ESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCC---CHH--HHT---T
T ss_pred cCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHcCCCCC---Chh--hhc---c
Confidence 467789999999988899999999999999999999999975321 22222222221110 000 001 1
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
...++.+++.+||..||++|||+.|+++.
T Consensus 230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 230 ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 12356778889999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=343.34 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=200.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 94 (294)
T 4eqm_A 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIE 94 (294)
T ss_dssp EEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCC
Confidence 3578999999999999954 588999999864422 23568899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 95 g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 95 GPTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAHDMR-IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp SCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence 9999999974 245899999999999999999999998 999999999999999999999999999876433
Q ss_pred -CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 -TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....+++.|+|||++.+..++.++||||||+++|||++|+.||..... ............. .......
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~----~~~~~~~- 237 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDSVP----NVTTDVR- 237 (294)
T ss_dssp ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSCCC----CHHHHSC-
T ss_pred cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhccCC----Ccchhcc-
Confidence 223467889999999999999999999999999999999999975321 1111111111110 0000000
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhhhcCCC
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRP-AMQEVVRMIENMNRGET 621 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~~~ 621 (654)
......+.+++.+||+.||++|| +++++.+.|+++.....
T Consensus 238 --~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 238 --KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp --TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred --cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 11224577788899999999999 99999999999876543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=357.85 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=201.2
Q ss_pred hhccccccCceeEEEEEec------CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
+.+.||+|+||+||+|.+. ++..||||+++... ....++.+|+.++++++||||+++++++.+....++|||
T Consensus 75 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 154 (367)
T 3l9p_A 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE 154 (367)
T ss_dssp EEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEE
Confidence 3578999999999999843 36789999997543 234568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC---CeEEeccCCCCC
Q 036334 422 YMPAGSLSALLHGSRG--SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH---DACVSDFGLNPL 496 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~---~~kl~Dfgla~~ 496 (654)
|+++|+|.+++...+. .....+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~ 233 (367)
T 3l9p_A 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 233 (367)
T ss_dssp CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChhhEEEecCCCCceEEECCCccccc
Confidence 9999999999975432 12345999999999999999999999998 99999999999999655 499999999864
Q ss_pred cC------CCCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhh
Q 036334 497 FG------NTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAE 569 (654)
Q Consensus 497 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 569 (654)
.. ......++..|+|||++.+..++.++|||||||++|||++ |..||..... ......+.....
T Consensus 234 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~------~~~~~~i~~~~~--- 304 (367)
T 3l9p_A 234 IYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFVTSGGR--- 304 (367)
T ss_dssp HHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTTCC---
T ss_pred cccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCC---
Confidence 31 1222345678999999998999999999999999999998 9999975321 111222111110
Q ss_pred hhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 570 VFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
..........+.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 305 --------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 305 --------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 011112234577888899999999999999999999998765
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=342.79 Aligned_cols=263 Identities=20% Similarity=0.285 Sum_probs=205.2
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCC--ceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD--EKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~--~~~lv~e~~~ 424 (654)
+.++||+|+||+||+|... +|+.||||+++... ...+.+.+|++++++++||||+++++++.... ..++||||++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (319)
T 4euu_A 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (319)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCT
T ss_pred EEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCC
Confidence 3578999999999999966 48999999997643 34567889999999999999999999998765 6799999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEE----CCCCCeEEeccCCCCCcCCC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL----RPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll----~~~~~~kl~Dfgla~~~~~~ 500 (654)
+|+|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 93 ~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~ 169 (319)
T 4euu_A 93 CGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG-IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169 (319)
T ss_dssp TCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT
T ss_pred CCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC
Confidence 999999998543 2234899999999999999999999998 9999999999999 77788999999999876543
Q ss_pred C---CCCccccccCccccC--------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhh-
Q 036334 501 T---PPTRVAGYRAPEVVE--------TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTA- 568 (654)
Q Consensus 501 ~---~~~~~~~y~aPE~~~--------~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 568 (654)
. ...++..|+|||++. +..++.++|||||||++|||++|+.||....... .....+..+.......
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~p~~~ 247 (319)
T 4euu_A 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKIITGKPSGA 247 (319)
T ss_dssp CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG--GCHHHHHHHHHHCCTTC
T ss_pred CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc--hhHHHHHHHhcCCCccc
Confidence 2 345778899999885 5788999999999999999999999997543322 1122222222211100
Q ss_pred --hh-------h--hHhhh-ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 569 --EV-------F--DVELM-RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 569 --~~-------~--~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
.. + ...+. ...........+.+++.+||+.||++|||++|+++...+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 00 0 00000 11223455667888999999999999999999999988654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=352.20 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=202.1
Q ss_pred hhccccccCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
+.+.||+|+||.||+|... +++.||||+++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 130 (343)
T 1luf_A 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130 (343)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEe
Confidence 4578999999999999964 347899999976532 24678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC
Q 036334 422 YMPAGSLSALLHGSRGS-------------------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP 482 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~ 482 (654)
|+++|+|.+++...... ....+++.+++.++.|++.||+|||+++ |+||||||+||+++.
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-ivH~Dlkp~NIl~~~ 209 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-FVHRDLATRNCLVGE 209 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECG
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCcceEEECC
Confidence 99999999999754211 1256999999999999999999999998 999999999999999
Q ss_pred CCCeEEeccCCCCCcCC------CCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChh
Q 036334 483 DHDACVSDFGLNPLFGN------TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLP 555 (654)
Q Consensus 483 ~~~~kl~Dfgla~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~ 555 (654)
++.+||+|||++..... .....++..|+|||++.+..++.++|||||||++|||++ |..||..... .
T Consensus 210 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~ 283 (343)
T 1luf_A 210 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH------E 283 (343)
T ss_dssp GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------H
T ss_pred CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh------H
Confidence 99999999999865432 223455677999999998899999999999999999999 9999975321 1
Q ss_pred HHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 556 RWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
.....+.... .. .........+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 284 ~~~~~~~~~~-~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 284 EVIYYVRDGN-IL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp HHHHHHHTTC-CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred HHHHHHhCCC-cC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 1111111111 00 011122346778888999999999999999999999987654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=339.79 Aligned_cols=243 Identities=26% Similarity=0.424 Sum_probs=188.2
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEeccccc-----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV-----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~-----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.+.||+|+||.||+|.+. |+.||||+++.... ..+.+.+|+++++.++||||+++++++.+++..++||||+++
T Consensus 12 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (271)
T 3dtc_A 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG 90 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTT
T ss_pred eeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCC
Confidence 478999999999999976 89999999875422 246788999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC--CeecCCCCCCcEEECC--------CCCeEEeccCCCC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG--KIVHGNIKASNILLRP--------DHDACVSDFGLNP 495 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~ivHrDlk~~NIll~~--------~~~~kl~Dfgla~ 495 (654)
++|.+++.. ..+++..++.++.|++.||+|||+++ +|+||||||+||+++. ++.+||+|||++.
T Consensus 91 ~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 91 GPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp EEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred CCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 999999862 35899999999999999999999886 3889999999999986 6789999999998
Q ss_pred CcCCC--CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 496 LFGNT--TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 496 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
..... ....++..|+|||.+.+..++.++||||||+++|||++|+.||..... .............
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~------ 232 (271)
T 3dtc_A 165 EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVAMNKLA------ 232 (271)
T ss_dssp -----------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHTSCCC------
T ss_pred ccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHhhhcCCCC------
Confidence 66433 234677889999999988999999999999999999999999975321 1111111111110
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
..........+.+++.+||+.||++|||+.|++++|+++
T Consensus 233 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 233 ----LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 011112234577888899999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=345.60 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=193.4
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
.+.||+|+||+||+|...+|+.||+|+++..... ...+.+|++++++++||||+++++++.+++..++||||+++ +
T Consensus 26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~ 104 (311)
T 3niz_A 26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-D 104 (311)
T ss_dssp EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-E
T ss_pred hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-C
Confidence 4789999999999999988999999999754322 35688999999999999999999999999999999999975 8
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CCC
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPP 503 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~ 503 (654)
|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 105 l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 179 (311)
T 3niz_A 105 LKKVLDEN----KTGLQDSQIKIYLYQLLRGVAHCHQHR-ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE 179 (311)
T ss_dssp HHHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CC
T ss_pred HHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCC
Confidence 88887643 345899999999999999999999998 999999999999999999999999999766432 234
Q ss_pred CccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhh---hhhHh-----
Q 036334 504 TRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAE---VFDVE----- 574 (654)
Q Consensus 504 ~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~----- 574 (654)
.++..|+|||++.+ ..++.++||||+||++|||++|+.||......+ ....+........... ..+..
T Consensus 180 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T 3niz_A 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPNPREWPQVQELPLWKQR 256 (311)
T ss_dssp CCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred cccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence 56788999999876 568999999999999999999999997654332 1122222111100000 00000
Q ss_pred -hhc--cCC----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 575 -LMR--YHN----IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 575 -~~~--~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
... ... ......++.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 000 0112245678888999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.12 Aligned_cols=239 Identities=22% Similarity=0.259 Sum_probs=196.4
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV----AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
..+.||+|+||+||+|... +|+.||+|++++. ......+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~ 88 (337)
T 1o6l_A 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 3578999999999999965 5899999999764 2345678899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 89 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 162 (337)
T 1o6l_A 89 GGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp TCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-eecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence 99999999742 45899999999999999999999998 999999999999999999999999999764322
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+...... ..
T Consensus 163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~~~---------~p-- 225 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HERLFELILMEEIR---------FP-- 225 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC---------CC--
T ss_pred cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC------HHHHHHHHHcCCCC---------CC--
Confidence 33457888999999999999999999999999999999999997532 12222222221110 01
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRP-----AMQEVVRM 612 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 612 (654)
.....++.+++.+||+.||++|| +++|+++.
T Consensus 226 -~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 226 -RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11223566778899999999999 89998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=345.09 Aligned_cols=244 Identities=22% Similarity=0.345 Sum_probs=198.1
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEeccccc-------CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEE
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV-------GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 419 (654)
|.+.+.||+|+||.||+|... +|+.||+|+++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 92 (326)
T 2y0a_A 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 92 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 345688999999999999965 589999999975422 356789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC----CeEEeccCCCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH----DACVSDFGLNP 495 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~----~~kl~Dfgla~ 495 (654)
|||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++.
T Consensus 93 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 93 LELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHHCC-eEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999973 346999999999999999999999998 99999999999999887 79999999997
Q ss_pred CcCCC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhh
Q 036334 496 LFGNT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 496 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 572 (654)
..... ....+++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...... +.
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~~---~~ 237 (326)
T 2y0a_A 167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVSAVNYE---FE 237 (326)
T ss_dssp ECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHTCCC---CC
T ss_pred ECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHHhcCCC---cC
Confidence 76432 334678889999999989999999999999999999999999965321 1112221111100 00
Q ss_pred HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 573 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
... .. .....+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~--~~---~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 238 DEY--FS---NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHH--HT---TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccc--cc---cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 01 11235667888999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=371.09 Aligned_cols=250 Identities=27% Similarity=0.409 Sum_probs=206.1
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
+.+.||+|+||.||+|.+.++..||||+++......++|.+|+++|++++||||+++++++.+ +..++||||+++|+|.
T Consensus 271 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~ 349 (535)
T 2h8h_A 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 349 (535)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHH
T ss_pred hheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHH
Confidence 457899999999999999888899999998776677889999999999999999999999866 6789999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----CCCC
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-----TPPT 504 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-----~~~~ 504 (654)
+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 350 ~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 425 (535)
T 2h8h_A 350 DFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 425 (535)
T ss_dssp HHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTT
T ss_pred HHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCc
Confidence 9997431 235899999999999999999999998 999999999999999999999999999876432 2234
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
++..|+|||++.+..++.++|||||||++|||++ |+.||..... ...+..+ ..... ......
T Consensus 426 ~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------~~~~~~i-~~~~~----------~~~~~~ 488 (535)
T 2h8h_A 426 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQV-ERGYR----------MPCPPE 488 (535)
T ss_dssp SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------HHHHHHH-HTTCC----------CCCCTT
T ss_pred CcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-HcCCC----------CCCCCC
Confidence 4567999999998899999999999999999999 8999975321 1112111 11110 011122
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGET 621 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 621 (654)
+...+.+++.+||+.||++|||+++|++.|+++.....
T Consensus 489 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 33467788889999999999999999999999875543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=356.26 Aligned_cols=253 Identities=27% Similarity=0.373 Sum_probs=200.4
Q ss_pred hhccccccCceeEEEEEe------cCCcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccccccEEEEeCCc-eEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDE-KLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~-~~lv 419 (654)
+.+.||+|+||.||+|.+ .+++.||||+++.... ..+.+.+|++++.++ +||||+++++++.+.+. .++|
T Consensus 26 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv 105 (359)
T 3vhe_A 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 105 (359)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred eceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEE
Confidence 457899999999999973 2357899999976532 235689999999999 79999999999987654 8999
Q ss_pred EEecCCCchhhhhccCCCCC------------------------------------------------------------
Q 036334 420 YDYMPAGSLSALLHGSRGSG------------------------------------------------------------ 439 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~------------------------------------------------------------ 439 (654)
|||+++|+|.+++.......
T Consensus 106 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3vhe_A 106 VEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDL 185 (359)
T ss_dssp EECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CT
T ss_pred EEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccch
Confidence 99999999999997543210
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC------CCCCccccccCc
Q 036334 440 -RTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT------TPPTRVAGYRAP 512 (654)
Q Consensus 440 -~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~------~~~~~~~~y~aP 512 (654)
...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... ....++..|+||
T Consensus 186 ~~~~l~~~~~~~~~~ql~~aL~~LH~~~-ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 264 (359)
T 3vhe_A 186 YKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264 (359)
T ss_dssp TTTCBCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCH
T ss_pred hccccCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeECh
Confidence 122899999999999999999999998 999999999999999999999999999865432 223456679999
Q ss_pred cccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHH
Q 036334 513 EVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQI 591 (654)
Q Consensus 513 E~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 591 (654)
|++.+..++.++|||||||++|||++ |+.||......+ .+.......... ........++.++
T Consensus 265 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~----------~~~~~~~~~l~~l 328 (359)
T 3vhe_A 265 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRM----------RAPDYTTPEMYQT 328 (359)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCC----------CCCTTCCHHHHHH
T ss_pred hhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCCC----------CCCCCCCHHHHHH
Confidence 99999999999999999999999998 999997543221 111111111110 0111122357788
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 592 AMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 592 ~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
+.+||+.||++|||++|++++|+++.+.
T Consensus 329 i~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 8899999999999999999999998753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.07 Aligned_cols=239 Identities=22% Similarity=0.329 Sum_probs=187.7
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc---------------------------CHHHHHHHHHHHhccCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---------------------------GKREFEMQMEVLGKIKHD 401 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---------------------------~~~~~~~e~~~l~~l~hp 401 (654)
+.+.||+|+||.||+|... +|+.||||++..... ..+.+.+|++++++++||
T Consensus 17 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 96 (298)
T 2zv2_A 17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHP 96 (298)
T ss_dssp EEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCT
T ss_pred EEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCC
Confidence 3578999999999999864 588999999865421 124688999999999999
Q ss_pred ccccccEEEEe--CCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEE
Q 036334 402 NVVPLRAFYYS--KDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNIL 479 (654)
Q Consensus 402 niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIl 479 (654)
||+++++++.+ .+..++||||+++++|.+++. ...+++..++.++.|++.||+|||+++ |+||||||+|||
T Consensus 97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~Nil 169 (298)
T 2zv2_A 97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLHYQK-IIHRDIKPSNLL 169 (298)
T ss_dssp TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEE
T ss_pred CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEE
Confidence 99999999987 567899999999999988764 346999999999999999999999998 999999999999
Q ss_pred ECCCCCeEEeccCCCCCcCCC----CCCCccccccCccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 036334 480 LRPDHDACVSDFGLNPLFGNT----TPPTRVAGYRAPEVVETRK---VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGI 552 (654)
Q Consensus 480 l~~~~~~kl~Dfgla~~~~~~----~~~~~~~~y~aPE~~~~~~---~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~ 552 (654)
++.++.+||+|||++...... ....++..|+|||++.+.. ++.++|||||||++|||++|+.||....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----- 244 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER----- 244 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS-----
T ss_pred ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc-----
Confidence 999999999999999766433 2356788899999997655 4788999999999999999999996431
Q ss_pred ChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 553 DLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 553 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.......+..... ..........++.+++.+||+.||++|||+.|+++
T Consensus 245 -~~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 -IMCLHSKIKSQAL----------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -HHHHHHHHHHCCC----------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -HHHHHHHHhcccC----------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1111111111110 00001112235677888999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=339.98 Aligned_cols=254 Identities=15% Similarity=0.172 Sum_probs=202.5
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+.+++++ +|+|++++++++.+....++||||+ +++
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 91 (298)
T 1csn_A 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 91 (298)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCC
Confidence 357899999999999995 568999999986543 334678899999999 7999999999999999999999999 999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC-----eEEeccCCCCCcCCC--
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD-----ACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~-----~kl~Dfgla~~~~~~-- 500 (654)
|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++. +||+|||++......
T Consensus 92 L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 92 LEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKS-LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp HHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred HHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 99999743 235999999999999999999999998 999999999999988776 999999998765432
Q ss_pred ---------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhh
Q 036334 501 ---------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571 (654)
Q Consensus 501 ---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 571 (654)
....++..|+|||++.+..++.++|||||||++|||++|+.||....... ....+..+.........
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~- 242 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT---NKQKYERIGEKKQSTPL- 242 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC---HHHHHHHHHHHHHHSCH-
T ss_pred cccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc---cHHHHHHHHhhccCccH-
Confidence 23356778999999999999999999999999999999999998643322 11111111111100000
Q ss_pred hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 572 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
... . .....++.+++.+||+.||++||++++|++.|+++.+..
T Consensus 243 -~~~--~---~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 243 -REL--C---AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp -HHH--T---TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -HHH--H---hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 000 0 112346778888999999999999999999999997654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=346.13 Aligned_cols=254 Identities=26% Similarity=0.370 Sum_probs=192.0
Q ss_pred HhhccccccCceeEEEEEecCC----cEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCce-----
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEG----TTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEK----- 416 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g----~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~----- 416 (654)
.+.+.||+|+||.||+|..... ..||||+++... ...+++.+|++++++++||||+++++++...+..
T Consensus 26 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (323)
T 3qup_A 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPI 105 (323)
T ss_dssp EEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------C
T ss_pred EEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCc
Confidence 4568899999999999986543 279999997642 2346788999999999999999999999877655
Q ss_pred -EEEEEecCCCchhhhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCC
Q 036334 417 -LLVYDYMPAGSLSALLHGSRG-SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN 494 (654)
Q Consensus 417 -~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla 494 (654)
++||||+++|+|.+++..... .....+++..+++++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-ivH~Dikp~NIli~~~~~~kl~Dfg~a 184 (323)
T 3qup_A 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN-FIHRDLAARNCMLAEDMTVCVADFGLS 184 (323)
T ss_dssp EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC-cccCCCCcceEEEcCCCCEEEeecccc
Confidence 999999999999999964321 12235899999999999999999999998 999999999999999999999999999
Q ss_pred CCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchh
Q 036334 495 PLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWT 567 (654)
Q Consensus 495 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 567 (654)
....... ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ ..........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~~~~~~- 257 (323)
T 3qup_A 185 RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------IYNYLIGGNR- 257 (323)
T ss_dssp ----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCC-
T ss_pred ccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH------HHHHHhcCCC-
Confidence 7654321 2334567999999999999999999999999999999 899997543221 1111111110
Q ss_pred hhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 568 AEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
.........++.+++.+||+.||++|||+.++++.|+++....
T Consensus 258 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 258 ----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp ----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 0111222346778888999999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=338.61 Aligned_cols=249 Identities=26% Similarity=0.438 Sum_probs=203.9
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
+.+.||+|+||.||+|...++..||||+++......+.+.+|++++++++||||+++++++. .+..++||||+++++|.
T Consensus 17 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 95 (279)
T 1qpc_A 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (279)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred heeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHH
Confidence 45789999999999999888889999999877767788999999999999999999999876 45689999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----CCCC
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-----TPPT 504 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-----~~~~ 504 (654)
+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...... ....
T Consensus 96 ~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 171 (279)
T 1qpc_A 96 DFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171 (279)
T ss_dssp HHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCC
T ss_pred HHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCC
Confidence 9997421 125899999999999999999999998 999999999999999999999999998766432 2233
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+... .. ......
T Consensus 172 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~-~~----------~~~~~~ 234 (279)
T 1qpc_A 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLERG-YR----------MVRPDN 234 (279)
T ss_dssp CCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTT-CC----------CCCCTT
T ss_pred CccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH------HHHHHHHhcc-cC----------CCCccc
Confidence 4567999999988889999999999999999999 8999865321 1222221111 10 001112
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
...++.+++.+||+.||++|||+.++++.|+++....
T Consensus 235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 2346778888999999999999999999999997553
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=351.08 Aligned_cols=245 Identities=18% Similarity=0.230 Sum_probs=191.0
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
+.+.||+|+||.||++... +++.||||++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 24 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 103 (361)
T 3uc3_A 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103 (361)
T ss_dssp EEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence 3578999999999999965 689999999987666667889999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC--eEEeccCCCCCcCC---CCCC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD--ACVSDFGLNPLFGN---TTPP 503 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~--~kl~Dfgla~~~~~---~~~~ 503 (654)
.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++. +||+|||++..... ....
T Consensus 104 ~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~~-ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 177 (361)
T 3uc3_A 104 YERICN-----AGRFSEDEARFFFQQLLSGVSYCHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 177 (361)
T ss_dssp HHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCSCCCCGGGEEECSSSSCCEEECCCCCC------------
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCC
Confidence 999963 235899999999999999999999998 999999999999987765 99999999874432 2345
Q ss_pred CccccccCccccCCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 504 TRVAGYRAPEVVETRKVTFK-SDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
.+++.|+|||++.+..++.+ +|||||||++|||++|+.||....... .....+..+....... ....
T Consensus 178 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~~-------~~~~--- 245 (361)
T 3uc3_A 178 VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVKYSI-------PDDI--- 245 (361)
T ss_dssp ---CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTCCCC-------CTTS---
T ss_pred cCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCCCCC-------CCcC---
Confidence 67888999999988877665 899999999999999999997643322 2222222222211100 0000
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
....++.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 246 RISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 112356678889999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=359.26 Aligned_cols=245 Identities=21% Similarity=0.294 Sum_probs=196.2
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
|.+.+.||+|+||.||+|... +|+.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 92 (444)
T 3soa_A 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLV 92 (444)
T ss_dssp EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeC
Confidence 445688999999999999854 689999999876532 3456889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEEC---CCCCeEEeccCCCCCcCCC
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR---PDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~---~~~~~kl~Dfgla~~~~~~ 500 (654)
++|+|.+.+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 93 ~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~~g-ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 93 TGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMG-VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp BCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred CCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999999874 345999999999999999999999998 99999999999998 4578999999999776543
Q ss_pred ----CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhh
Q 036334 501 ----TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576 (654)
Q Consensus 501 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (654)
....+++.|+|||++.+..++.++||||+||++|||++|..||..... ......+..... +....
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~-----~~~~~ 235 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ------HRLYQQIKAGAY-----DFPSP 235 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCC-----CCCTT
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhCCC-----CCCcc
Confidence 234678889999999999999999999999999999999999965321 122222222111 00000
Q ss_pred ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.+... ..++.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~---s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 236 EWDTV---TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccC---CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11112 2356677889999999999999999863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.88 Aligned_cols=253 Identities=27% Similarity=0.385 Sum_probs=202.9
Q ss_pred HhhccccccCceeEEEEEe------cCCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVY 420 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 420 (654)
.+.+.||+|+||.||+|.. .+++.||||+++.... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 105 (314)
T 2ivs_A 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV 105 (314)
T ss_dssp EEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEE
Confidence 3457899999999999985 2357899999976432 3467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhccCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEEC
Q 036334 421 DYMPAGSLSALLHGSRGS-------------------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR 481 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~ 481 (654)
||+++|+|.+++...... ....+++..++.++.|++.||+|||+++ |+||||||+||+++
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dikp~NIli~ 184 (314)
T 2ivs_A 106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-LVHRDLAARNILVA 184 (314)
T ss_dssp ECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEE
T ss_pred eecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC-CcccccchheEEEc
Confidence 999999999999754321 1234899999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccCCCCCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCCh
Q 036334 482 PDHDACVSDFGLNPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDL 554 (654)
Q Consensus 482 ~~~~~kl~Dfgla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~ 554 (654)
.++.+||+|||++...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 185 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---- 260 (314)
T 2ivs_A 185 EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER---- 260 (314)
T ss_dssp TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----
T ss_pred CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence 9999999999998765432 22344567999999988889999999999999999999 999997543211
Q ss_pred hHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 555 PRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 555 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
+...+..... ..........+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 261 ---~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 261 ---LFNLLKTGHR----------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp ---HHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---HHHHhhcCCc----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 1111111110 011112234677888899999999999999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=348.40 Aligned_cols=248 Identities=18% Similarity=0.295 Sum_probs=197.8
Q ss_pred HHHhhccccccCceeEEEEEec-CCcEEEEEEecccc------cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEE
Q 036334 347 LRASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA------VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 347 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 419 (654)
.|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3455788999999999999864 58999999986431 2467789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC---eEEeccCCCCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD---ACVSDFGLNPL 496 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~---~kl~Dfgla~~ 496 (654)
|||+++|+|.+.+..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++..
T Consensus 105 ~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNN-IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999888754321 2345899999999999999999999998 999999999999987655 99999999977
Q ss_pred cCCC----CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhh
Q 036334 497 FGNT----TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 497 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 572 (654)
.... ....+++.|+|||++.+..++.++|||||||++|||++|+.||.... ......+...... +.
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~i~~~~~~---~~ 252 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-------ERLFEGIIKGKYK---MN 252 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-------HHHHHHHHHTCCC---CC
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-------HHHHHHHHcCCCC---CC
Confidence 6543 23457888999999999999999999999999999999999997521 1112222211110 00
Q ss_pred HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 573 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.. .+.. ...++.+++.+||+.||++|||+.|+++
T Consensus 253 ~~--~~~~---~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 253 PR--QWSH---ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HH--HHTT---SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cc--cccc---CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0011 1235677888999999999999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=345.96 Aligned_cols=256 Identities=27% Similarity=0.411 Sum_probs=205.1
Q ss_pred HhhccccccCceeEEEEEe------cCCcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv 419 (654)
...+.||+|+||.||+|.. .+++.||||+++.... ..+.+.+|+++++++ +||||+++++++.+++..++|
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 105 (313)
T 1t46_A 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI 105 (313)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEE
Confidence 3457899999999999984 2467899999976532 346788999999999 899999999999999999999
Q ss_pred EEecCCCchhhhhccCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCe
Q 036334 420 YDYMPAGSLSALLHGSRGS-------------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDA 486 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~ 486 (654)
|||+++|+|.+++...... ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~ 184 (313)
T 1t46_A 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-CIHRDLAARNILLTHGRIT 184 (313)
T ss_dssp EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEETTTEE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCccceEEEcCCCCE
Confidence 9999999999999754321 1235899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCCCCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 036334 487 CVSDFGLNPLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQ 559 (654)
Q Consensus 487 kl~Dfgla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~ 559 (654)
||+|||++....... ...++..|+|||++.+..++.++||||||+++|||++ |+.||...... ..+.
T Consensus 185 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~ 258 (313)
T 1t46_A 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------SKFY 258 (313)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS------HHHH
T ss_pred EEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch------hHHH
Confidence 999999998765432 2234557999999988899999999999999999999 99998754321 1111
Q ss_pred HHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 036334 560 SVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGET 621 (654)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 621 (654)
........ ..........+.+++.+||+.||++|||+.|+++.|+++....+
T Consensus 259 ~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 259 KMIKEGFR----------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HHHHHTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHhccCCC----------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 11111110 00111223467788889999999999999999999999876543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.70 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=205.9
Q ss_pred hhccccccCceeEEEEEecC-CcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 350 SAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
+.+.||+|+||.||+|.... +..||+|+++......+.+.+|++++++++||||+++++++.+++..++||||+++++|
T Consensus 17 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 96 (288)
T 3kfa_A 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96 (288)
T ss_dssp EEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEH
T ss_pred EEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcH
Confidence 45789999999999999764 88999999987766678899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-----CC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-----PP 503 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-----~~ 503 (654)
.+++... ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 97 ~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 172 (288)
T 3kfa_A 97 LDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172 (288)
T ss_dssp HHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHHHHT-CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTE
T ss_pred HHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHHHCC-ccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCC
Confidence 9999754 2356899999999999999999999998 9999999999999999999999999998765432 12
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
.++..|+|||++.+..++.++||||||+++|||++ |..||...... .... ....... .....
T Consensus 173 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~------~~~~-~~~~~~~----------~~~~~ 235 (288)
T 3kfa_A 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYE-LLEKDYR----------MERPE 235 (288)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------GHHH-HHHTTCC----------CCCCT
T ss_pred ccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHH-HHhccCC----------CCCCC
Confidence 33456999999998899999999999999999999 99998753221 1111 1111110 01111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
.....+.+++.+||+.||++|||++++++.|+++...
T Consensus 236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 2234677888899999999999999999999988654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=350.79 Aligned_cols=241 Identities=20% Similarity=0.284 Sum_probs=195.2
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||++... +++.||+|++.... ...+.+.+|++++++++||||++++++|.+.+..++||||+.
T Consensus 19 i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~ 98 (384)
T 4fr4_A 19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLL 98 (384)
T ss_dssp EEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 4578999999999999965 48899999997542 334678899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---C
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---T 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~ 501 (654)
+|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 99 gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 172 (384)
T 4fr4_A 99 GGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQNQR-IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172 (384)
T ss_dssp TEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBC
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCcHHHeEECCCCCEEEeccceeeeccCCCcee
Confidence 9999999973 345999999999999999999999998 999999999999999999999999999876433 3
Q ss_pred CCCccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 502 PPTRVAGYRAPEVVET---RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+....... .
T Consensus 173 ~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~~~~~~~~~------------~ 237 (384)
T 4fr4_A 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS---SKEIVHTFETTV------------V 237 (384)
T ss_dssp CCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC---HHHHHHHHHHCC------------C
T ss_pred ccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhhcc------------c
Confidence 4567888999999864 458999999999999999999999997543322 111111111110 0
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPA-MQEVVR 611 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~ 611 (654)
.........+.+++.+||+.||++||+ ++++.+
T Consensus 238 ~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111122346777888999999999998 666653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=345.84 Aligned_cols=248 Identities=24% Similarity=0.382 Sum_probs=197.3
Q ss_pred hhccccccCceeEEEEEecC-C-------cEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLEE-G-------TTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~-g-------~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 420 (654)
+.+.||+|+||+||+|.... + ..||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (289)
T 4fvq_A 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQ 91 (289)
T ss_dssp EEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEE
T ss_pred eeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEE
Confidence 35789999999999998543 3 479999987653 44577899999999999999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC--------eEEeccC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD--------ACVSDFG 492 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~--------~kl~Dfg 492 (654)
||+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|||
T Consensus 92 e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg 166 (289)
T 4fvq_A 92 EFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLEENT-LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166 (289)
T ss_dssp ECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred ECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHhhCC-eECCCcCcceEEEecCCcccccccceeeeccCc
Confidence 999999999999743 234899999999999999999999998 999999999999998887 9999999
Q ss_pred CCCCcCCCCCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhh
Q 036334 493 LNPLFGNTTPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571 (654)
Q Consensus 493 la~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 571 (654)
++..........++..|+|||++.+ ..++.++|||||||++|||++|..|+..... ...... ......
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~~~~-~~~~~~----- 235 (289)
T 4fvq_A 167 ISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----SQRKLQ-FYEDRH----- 235 (289)
T ss_dssp SCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHHHH-HHHTTC-----
T ss_pred ccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-----hHHHHH-HhhccC-----
Confidence 9977655444456778999999987 7799999999999999999996555432211 111111 111000
Q ss_pred hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 572 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
........++.+++.+||+.||++|||++|+++.|+++....
T Consensus 236 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 236 -------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp -------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 000011234677888999999999999999999999998654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=343.63 Aligned_cols=250 Identities=24% Similarity=0.419 Sum_probs=197.2
Q ss_pred hccccccCceeEEEEEecC-----CcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 351 AEVLGKGSVGTSYKAVLEE-----GTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+.||+|+||.||+|.... +..||||+++.... ...++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 4789999999999998653 23699999976432 3456889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC--
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-- 501 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-- 501 (654)
++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 129 ~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 129 ENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMN-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp TTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred CCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 999999999743 245899999999999999999999998 9999999999999999999999999998764321
Q ss_pred -----CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 502 -----PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 502 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
...++..|+|||++.+..++.++|||||||++|||++ |+.||..... ......+. ...
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~~~~-~~~--------- 267 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAIN-DGF--------- 267 (333)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHH-TTC---------
T ss_pred ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHH-CCC---------
Confidence 1223557999999998899999999999999999999 9999964321 11111111 110
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETD 622 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 622 (654)
...........+.+++.+||+.||++||++.++++.|+++.+....
T Consensus 268 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 268 -RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp -CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred -cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 0011112234577888899999999999999999999999876443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.68 Aligned_cols=238 Identities=22% Similarity=0.298 Sum_probs=194.2
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||+||+|.. .+|+.||||++.... .....+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 13 i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~- 91 (336)
T 3h4j_B 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA- 91 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-
Confidence 357899999999999996 568999999987542 23457899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---C
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---T 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~ 501 (654)
+|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 92 ~g~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~ 165 (336)
T 3h4j_B 92 GGELFDYIVE-----KKRMTEDEGRRFFQQIICAIEYCHRHK-IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK 165 (336)
T ss_dssp CEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHT-CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence 7899998863 245999999999999999999999998 999999999999999999999999999876543 3
Q ss_pred CCCccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 502 PPTRVAGYRAPEVVETRKV-TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
...+++.|+|||++.+..+ +.++|||||||++|||++|+.||......+.... +.... ...
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~---------------i~~~~---~~~ 227 (336)
T 3h4j_B 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK---------------VNSCV---YVM 227 (336)
T ss_dssp CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---------------CCSSC---CCC
T ss_pred cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---------------HHcCC---CCC
Confidence 4567888999999988776 7899999999999999999999976432221100 00000 000
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.......+.+++.+||+.||.+|||++|+++.
T Consensus 228 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 228 PDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11112356678889999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=348.76 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=194.9
Q ss_pred hhccccccCceeEEEEEec-CCc----EEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGT----TVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
..++||+|+||+||+|.+. +|+ +||+|.++... ...+++.+|+.++++++||||++++++|.++ ..++|+||
T Consensus 19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~ 97 (327)
T 3poz_A 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 97 (327)
T ss_dssp EEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEEC
T ss_pred cceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEe
Confidence 3578999999999999854 344 46888876442 3457899999999999999999999999865 47899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT- 501 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 501 (654)
+.+|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 98 MPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp CTTCBHHHHHHHS----TTSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred cCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCC-eeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 9999999999753 345899999999999999999999998 9999999999999999999999999987654322
Q ss_pred -----CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 502 -----PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 502 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
...++..|+|||++.+..++.++|||||||++|||++ |+.||......+ +...+....
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~--------- 236 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGE--------- 236 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTC---------
T ss_pred cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-------HHHHHHcCC---------
Confidence 2234567999999999999999999999999999999 999997543221 111111111
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
..........++.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 237 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 237 -RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0111122334677888899999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=343.99 Aligned_cols=241 Identities=20% Similarity=0.327 Sum_probs=190.8
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCC-----------
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD----------- 414 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~----------- 414 (654)
.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|++++++++||||++++++|.+..
T Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~ 88 (332)
T 3qd2_B 9 EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEI 88 (332)
T ss_dssp EEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-
T ss_pred ceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhh
Confidence 34578999999999999976 68999999997543 34567899999999999999999999986643
Q ss_pred ----------------------------------------------ceEEEEEecCCCchhhhhccCCCCCCCCCCHHHH
Q 036334 415 ----------------------------------------------EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNR 448 (654)
Q Consensus 415 ----------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~ 448 (654)
..++||||+++|+|.+++.... .....++..+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~ 166 (332)
T 3qd2_B 89 WLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDREHGVC 166 (332)
T ss_dssp -------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGSCHHHH
T ss_pred hhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--CccchhhHHH
Confidence 2799999999999999998543 2344678889
Q ss_pred HHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----------------CCCCccccccCc
Q 036334 449 MRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----------------TPPTRVAGYRAP 512 (654)
Q Consensus 449 ~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----------------~~~~~~~~y~aP 512 (654)
++++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...... ....++..|+||
T Consensus 167 ~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLHSKG-LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHHHHhCC-eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 999999999999999998 999999999999999999999999998766443 223577889999
Q ss_pred cccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHH
Q 036334 513 EVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIA 592 (654)
Q Consensus 513 E~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 592 (654)
|++.+..++.++|||||||++|||++|..|+... ....... .... ..........++.+++
T Consensus 246 E~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~~~~~~-~~~~----------~~~~~~~~~~~~~~li 306 (332)
T 3qd2_B 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VRIITDV-RNLK----------FPLLFTQKYPQEHMMV 306 (332)
T ss_dssp HHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HHHHHHH-HTTC----------CCHHHHHHCHHHHHHH
T ss_pred HHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HHHHHHh-hccC----------CCcccccCChhHHHHH
Confidence 9999999999999999999999999987664210 0001110 0000 0001123334567888
Q ss_pred hhccCCCCCCCCCHHHHHH
Q 036334 593 MGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 593 ~~cl~~dP~~RPs~~evl~ 611 (654)
.+||+.||++|||++|+++
T Consensus 307 ~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHH
T ss_pred HHHccCCCCcCCCHHHHhh
Confidence 9999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=349.76 Aligned_cols=245 Identities=21% Similarity=0.305 Sum_probs=197.4
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
|.+.+.||+|+||.||+|... +|+.||+|++...... .+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 110 (362)
T 2bdw_A 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 110 (362)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 445688999999999999865 5899999999765332 356788999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC---CeEEeccCCCCCcCCC
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH---DACVSDFGLNPLFGNT 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~---~~kl~Dfgla~~~~~~ 500 (654)
++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++......
T Consensus 111 ~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 111 TGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNG-IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred CCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 99999999873 345899999999999999999999998 99999999999998654 5999999999876543
Q ss_pred C---CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 501 T---PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 501 ~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
. ...+++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....... ....
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~i~~~~~~~-----~~~~ 253 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAYDY-----PSPE 253 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCC-----CTTG
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCCC-----Cccc
Confidence 2 34678889999999998999999999999999999999999975321 12222222211100 0000
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
+ .....++.+++.+||+.||++|||+.|+++.
T Consensus 254 ~---~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 254 W---DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp G---GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred c---cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 1112356678889999999999999998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=349.77 Aligned_cols=240 Identities=19% Similarity=0.295 Sum_probs=190.6
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC----HHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG----KREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.++||+|+||+||+|... +++.||+|++++.... .+.+..|..++.++ +||||++++++|.+.+..++||||+
T Consensus 56 ~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~ 135 (396)
T 4dc2_A 56 LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 135 (396)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcC
Confidence 4578999999999999965 4789999999865322 24577889998877 8999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN---- 499 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~---- 499 (654)
++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g-ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~ 209 (396)
T 4dc2_A 136 NGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG-IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 209 (396)
T ss_dssp TTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-EEeccCCHHHEEECCCCCEEEeecceeeecccCCCc
Confidence 999999999743 45899999999999999999999998 99999999999999999999999999976322
Q ss_pred CCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC--CChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 500 TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEG--IDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 500 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+. ......+...+.... .
T Consensus 210 ~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------~-- 279 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------I-- 279 (396)
T ss_dssp BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--------C--
T ss_pred cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--------c--
Confidence 2345678889999999999999999999999999999999999975432221 111111211111110 0
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAM 606 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 606 (654)
........++.+++.+||+.||++||++
T Consensus 280 -~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0111122356678889999999999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=346.03 Aligned_cols=245 Identities=20% Similarity=0.331 Sum_probs=178.2
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccC-CCccccccEEEEeCCceEEEEEecCCCch
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.+.||+|+||.||+|... +|+.||||++... ....+.+|+.+++++. ||||+++++++.+++..++||||+++|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 367999999999999965 5899999998653 3467788999999997 99999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC---CeEEeccCCCCCcCCC----C
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH---DACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~---~~kl~Dfgla~~~~~~----~ 501 (654)
.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||++...... .
T Consensus 94 ~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 167 (325)
T 3kn6_A 94 FERIKK-----KKHFSETEASYIMRKLVSAVSHMHDVG-VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167 (325)
T ss_dssp HHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccc
Confidence 999974 346999999999999999999999998 99999999999998766 7999999999765433 2
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCC-ChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGI-DLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||......... ........+....... ... .
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~---~~~--~--- 239 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF---EGE--A--- 239 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC---CSH--H---
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC---Ccc--c---
Confidence 345577899999999999999999999999999999999999865432211 1222222222111100 000 0
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
......++.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0112345777888999999999999998864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=348.57 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=195.0
Q ss_pred hhccccccCceeEEEEEec-CCcE----EEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTT----VVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~----vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
..+.||+|+||+||+|.+. +++. ||+|.+.... .....+.+|+.++++++||||+++++++. .+..++||||
T Consensus 17 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~ 95 (325)
T 3kex_A 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQY 95 (325)
T ss_dssp EEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEEC
T ss_pred eeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEe
Confidence 3578999999999999854 3443 7888775432 22356778999999999999999999886 5678999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT- 501 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 501 (654)
+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 96 LPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEEHG-MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp CTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHHTT-CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred CCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHhCC-CCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 9999999999743 235889999999999999999999998 9999999999999999999999999998764332
Q ss_pred -----CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 502 -----PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 502 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
...++..|+|||++.+..++.++|||||||++|||++ |+.||......+ .. ..+.....
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~~-------- 235 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VP----DLLEKGER-------- 235 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HH----HHHHTTCB--------
T ss_pred cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HH----HHHHcCCC--------
Confidence 2334567999999998899999999999999999999 999997643211 11 11111100
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
.........++.+++.+||+.||++|||++|+++.|+++...
T Consensus 236 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 236 --LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp --CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred --CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 000111222567788899999999999999999999999754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=336.39 Aligned_cols=246 Identities=25% Similarity=0.419 Sum_probs=194.7
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccccC--------HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG--------KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--------~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
.+.||+|+||.||+|... +++.||+|++...... .+.+.+|++++++++||||+++++++.+.. ++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e 101 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVME 101 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEE
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEE
Confidence 478999999999999964 6899999998654221 167889999999999999999999986544 79999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCC-eecCCCCCCcEEECCCCC-----eEEeccCCCC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK-IVHGNIKASNILLRPDHD-----ACVSDFGLNP 495 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-ivHrDlk~~NIll~~~~~-----~kl~Dfgla~ 495 (654)
|+++|+|.+++... ...+++..++.++.|++.||+|||+++. |+||||||+||+++.++. +||+|||++.
T Consensus 102 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~ 177 (287)
T 4f0f_A 102 FVPCGDLYHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177 (287)
T ss_dssp CCTTCBHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCB
T ss_pred ecCCCCHHHHHhcc----cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccc
Confidence 99999999988643 3469999999999999999999998753 999999999999988876 9999999997
Q ss_pred CcCCC-CCCCccccccCcccc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhh
Q 036334 496 LFGNT-TPPTRVAGYRAPEVV--ETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 496 ~~~~~-~~~~~~~~y~aPE~~--~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 572 (654)
..... ....++..|+|||++ ....++.++|||||||++|||++|+.||......+ ..............
T Consensus 178 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~---- 249 (287)
T 4f0f_A 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEGLRP---- 249 (287)
T ss_dssp CCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHHHSCCCC----
T ss_pred cccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHhccCCCC----
Confidence 65443 335677889999998 44567899999999999999999999997543221 11111111111110
Q ss_pred HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 573 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
.........+.+++.+||+.||++|||++|+++.|+++
T Consensus 250 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 250 ------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11112234677888899999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=334.66 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=198.9
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeC--CceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e~~~ 424 (654)
..+.||+|+||.||+|... |+.||||+++.... ..+++.+|+.++++++||||+++++++.+. +..++||||++
T Consensus 14 ~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (271)
T 3kmu_A 14 FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92 (271)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCT
T ss_pred HHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccC
Confidence 3578999999999999986 89999999976533 245688999999999999999999999877 67899999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC-CeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCCC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG-KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPP 503 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 503 (654)
+|+|.+++.... ...+++..++.++.|++.||+|||+.+ .|+||||||+||+++.++.++|+|||++..... ...
T Consensus 93 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-~~~ 168 (271)
T 3kmu_A 93 YGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-PGR 168 (271)
T ss_dssp TCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-TTC
T ss_pred CCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-cCc
Confidence 999999998532 235899999999999999999999764 499999999999999999999999888765433 334
Q ss_pred CccccccCccccCCCCCCc---chhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 504 TRVAGYRAPEVVETRKVTF---KSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~---~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
.++..|+|||++.+..++. ++|||||||++|||++|+.||..... .............. ..
T Consensus 169 ~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~----------~~ 232 (271)
T 3kmu_A 169 MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGLRP----------TI 232 (271)
T ss_dssp BSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCCCC----------CC
T ss_pred cCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCCCC----------CC
Confidence 6678899999998765544 79999999999999999999975321 11122222111111 01
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
......++.+++.+||+.||++|||++|+++.|+++.+
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11223457788889999999999999999999999865
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=345.44 Aligned_cols=266 Identities=24% Similarity=0.312 Sum_probs=194.0
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEe-----CCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYS-----KDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-----~~~~~lv~e~~~~ 425 (654)
.+.||+|+||.||+|.. +++.||||++..........+.|+..+..++||||+++++++.. ....++||||+++
T Consensus 18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~ 96 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPN 96 (336)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTT
T ss_pred eeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCC
Confidence 47899999999999987 48999999997544333333344444566899999999986643 2256899999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc---------CCeecCCCCCCcEEECCCCCeEEeccCCCCC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS---------GKIVHGNIKASNILLRPDHDACVSDFGLNPL 496 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~ 496 (654)
|+|.+++... ..++..+++++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++..
T Consensus 97 g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~-ivH~Dikp~Nill~~~~~~kL~DFG~a~~ 169 (336)
T 3g2f_A 97 GSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA-ISHRDLNSRNVLVKNDGTCVISDFGLSMR 169 (336)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC-EECSSCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccc-eeecccccceEEEcCCCcEEEeeccceee
Confidence 9999999743 358999999999999999999988 7 99999999999999999999999999976
Q ss_pred cCCC------------CCCCccccccCccccCC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhH-
Q 036334 497 FGNT------------TPPTRVAGYRAPEVVET-------RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPR- 556 (654)
Q Consensus 497 ~~~~------------~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~- 556 (654)
.... ....++..|+|||++.+ ..++.++|||||||++|||++|..||.............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~ 249 (336)
T 3g2f_A 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249 (336)
T ss_dssp CSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTH
T ss_pred cccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhh
Confidence 5322 12357788999999976 456788999999999999999977765433322111100
Q ss_pred ----------HHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCCCCCC
Q 036334 557 ----------WVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDDGLR 626 (654)
Q Consensus 557 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~ 626 (654)
..............+.. ..........++.+++.+||+.||++|||++|+++.|+++...-.++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~ 326 (336)
T 3g2f_A 250 TEVGNHPTFEDMQVLVSREKQRPKFPE---AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326 (336)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCT---TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC----
T ss_pred cccCCCchHHHHHhhhcccccCCCCCc---ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccC
Confidence 00000000000000000 11122335567889999999999999999999999999999776555554
Q ss_pred C
Q 036334 627 Q 627 (654)
Q Consensus 627 ~ 627 (654)
.
T Consensus 327 ~ 327 (336)
T 3g2f_A 327 S 327 (336)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=349.19 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=193.7
Q ss_pred hhccccccCceeEEEEEec--CC--cEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEe-CCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLE--EG--TTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYS-KDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~--~g--~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~ 422 (654)
..++||+|+||.||+|.+. ++ ..||||.++.... ..+++.+|+.++++++||||++++++|.. ++..++||||
T Consensus 93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence 3478999999999999854 22 3689999875432 34678899999999999999999998765 4578999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 500 (654)
+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 173 ~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 173 MKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp CTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCCCHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC-EecCccchheEEECCCCCEEEeecccccccccccc
Confidence 9999999999743 345899999999999999999999998 999999999999999999999999999765322
Q ss_pred ------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 ------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....++..|+|||++.+..++.++|||||||++|||++ |.+||......+ .... ......
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~---~~~~~~------- 314 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LLQGRR------- 314 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH---HHTTCC-------
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH---HHcCCC-------
Confidence 12234567999999999999999999999999999999 677776533221 1111 111110
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCCCCC
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDDGL 625 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~ 625 (654)
..........+.+++.+||+.||++|||++|+++.|+++...-.++..
T Consensus 315 ----~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~ 362 (373)
T 3c1x_A 315 ----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 362 (373)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccce
Confidence 001111234577888899999999999999999999999877655443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.79 Aligned_cols=256 Identities=22% Similarity=0.339 Sum_probs=200.4
Q ss_pred HhhccccccCceeEEEEEe------cCCcEEEEEEecccc--cCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~------~~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv 419 (654)
.+.+.||+|+||.||+|.. .++..||||+++... ...+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 48 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 127 (344)
T 1rjb_A 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127 (344)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEE
Confidence 4467899999999999985 235689999997542 3346789999999999 899999999999999999999
Q ss_pred EEecCCCchhhhhccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEEC
Q 036334 420 YDYMPAGSLSALLHGSRGS------------------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR 481 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~ 481 (654)
|||+++|+|.+++...... ....+++..++.++.|++.||+|||+++ |+||||||+||+++
T Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIll~ 206 (344)
T 1rjb_A 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-CVHRDLAARNVLVT 206 (344)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-EEETTCSGGGEEEE
T ss_pred EecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCChhhEEEc
Confidence 9999999999999754321 1134899999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccCCCCCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCCh
Q 036334 482 PDHDACVSDFGLNPLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDL 554 (654)
Q Consensus 482 ~~~~~kl~Dfgla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~ 554 (654)
.++.+||+|||++....... ...++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 207 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----- 281 (344)
T 1rjb_A 207 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD----- 281 (344)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-----
T ss_pred CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH-----
Confidence 99999999999998664332 2234557999999988899999999999999999998 99999754321
Q ss_pred hHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 036334 555 PRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGET 621 (654)
Q Consensus 555 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 621 (654)
..+.......... ........++.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 282 -~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 282 -ANFYKLIQNGFKM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp -HHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred -HHHHHHHhcCCCC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 1122222211110 0111123457778889999999999999999999999976654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=342.08 Aligned_cols=238 Identities=22% Similarity=0.266 Sum_probs=197.1
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||+||+|... +|+.||+|++++.. ...+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 10 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~ 89 (318)
T 1fot_A 10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 89 (318)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCC
Confidence 3578999999999999965 68999999997642 334667889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-CCC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-TPP 503 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-~~~ 503 (654)
+|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 90 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~ 163 (318)
T 1fot_A 90 GGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKD-IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL 163 (318)
T ss_dssp SCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCC
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCChheEEEcCCCCEEEeecCcceecCCccccc
Confidence 99999999742 45899999999999999999999998 999999999999999999999999999876543 345
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.+++.|+|||++.+..++.++|||||||++|||++|+.||.... .......+...... ... .
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~---------~p~---~ 225 (318)
T 1fot_A 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNAELR---------FPP---F 225 (318)
T ss_dssp CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHCCCC---------CCT---T
T ss_pred cCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCC---------CCC---C
Confidence 67888999999999999999999999999999999999997532 12222222222110 011 1
Q ss_pred HHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRP-----AMQEVVR 611 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 611 (654)
...++.+++.+|+..||++|| +++|+++
T Consensus 226 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 226 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 123566778899999999999 8888874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=338.78 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=199.1
Q ss_pred hhccccccCceeEEEEEecC----CcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCce-EEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLEE----GTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEK-LLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~-~lv~e~ 422 (654)
..++||+|+||+||+|.+.+ +..||+|++..... ..+.+.+|+.++++++||||+++++++.+.+.. ++||||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 35789999999999998532 23799999876432 346788999999999999999999999876665 999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 500 (654)
+.+|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 105 ~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 105 MCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLAEQK-FVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ccCCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 9999999999742 345899999999999999999999998 999999999999999999999999999754321
Q ss_pred ------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 501 ------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 501 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
....++..|+|||.+.+..++.++||||||+++|||++|..|+...... ........... .
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~~~~~-~------- 246 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-----FDLTHFLAQGR-R------- 246 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-----GGHHHHHHTTC-C-------
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-----HHHHHHhhcCC-C-------
Confidence 2334566799999999999999999999999999999966664432211 11111111111 0
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDD 623 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 623 (654)
..........+.+++.+||+.||++|||++++++.|+++......+
T Consensus 247 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 247 ---LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred ---CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 0011112235778888999999999999999999999998765443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=337.02 Aligned_cols=248 Identities=21% Similarity=0.338 Sum_probs=190.6
Q ss_pred HhhccccccCceeEEEEEecC----CcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE----GTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
.+.+.||+|+||.||+|.... +..||+|+++... ...+.+.+|+.++++++||||+++++++ .++..++||||
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 96 (281)
T 1mp8_A 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMEL 96 (281)
T ss_dssp EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred EEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEec
Confidence 345789999999999998643 4579999987543 2345688999999999999999999997 45678999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT- 501 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 501 (654)
+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 97 CTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp CTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECC------------
T ss_pred CCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 9999999999743 235899999999999999999999998 9999999999999999999999999998764432
Q ss_pred ----CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhh
Q 036334 502 ----PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576 (654)
Q Consensus 502 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (654)
...++..|+|||++.+..++.++||||||+++|||++ |..||......+ ....+.....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~------~~~~i~~~~~---------- 235 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGER---------- 235 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCC----------
T ss_pred cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH------HHHHHHcCCC----------
Confidence 2334567999999998899999999999999999997 999997543221 1111111110
Q ss_pred ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
..........+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 236 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 236 -LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 001112234577788899999999999999999999998654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=334.65 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=200.9
Q ss_pred ccccccCceeEEEEEec---CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 352 EVLGKGSVGTSYKAVLE---EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.||+|+||.||+|... ++..||||+++... ...+++.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 47999999999999853 57889999998643 2356788999999999999999999998 556789999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC------
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT------ 500 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~------ 500 (654)
+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 95 ~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 169 (287)
T 1u59_A 95 PLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN-FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 169 (287)
T ss_dssp EHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred CHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHHCC-EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeec
Confidence 999999642 345899999999999999999999998 999999999999999999999999998766432
Q ss_pred -CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 501 -TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
....++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+..... .
T Consensus 170 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~i~~~~~-----------~ 232 (287)
T 1u59_A 170 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAFIEQGKR-----------M 232 (287)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------HHHHHHHTTCC-----------C
T ss_pred cccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHhcCCc-----------C
Confidence 12334677999999988889999999999999999998 99999754321 11111111110 0
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETD 622 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 622 (654)
........++.+++.+||+.||++||++.++++.|+++..+...
T Consensus 233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 233 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 11112234677888899999999999999999999999765533
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=339.78 Aligned_cols=253 Identities=23% Similarity=0.380 Sum_probs=197.5
Q ss_pred hhccccccCceeEEEEEe-----cCCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeC--CceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL-----EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-----~~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~ 420 (654)
..+.||+|+||.||+|.+ .+++.||||+++... ...+.+.+|++++++++||||+++++++.+. ...++||
T Consensus 25 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 104 (302)
T 4e5w_A 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 104 (302)
T ss_dssp EEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEE
T ss_pred hhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEE
Confidence 457899999999999983 358899999997543 3457789999999999999999999999876 5689999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 105 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 105 EFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp ECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhhcCC-cccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 999999999999643 245899999999999999999999998 999999999999999999999999999766433
Q ss_pred -------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------CCCCChhHHHHHHhhhc
Q 036334 501 -------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLG--------EEGIDLPRWVQSVVREE 565 (654)
Q Consensus 501 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--------~~~~~~~~~~~~~~~~~ 565 (654)
....++..|+|||++.+..++.++||||||+++|||++|..|+..... .........+.......
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence 234456669999999888899999999999999999999998653210 00000000000000000
Q ss_pred hhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 566 WTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
. ...........+.+++.+||+.||++|||++|+++.|+++.
T Consensus 260 ~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 260 K----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp C----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0 11111223346778888999999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.18 Aligned_cols=192 Identities=22% Similarity=0.343 Sum_probs=170.4
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHhccC-----CCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-----HDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.+.||+|+||+||+|.. .+++.||||+++......+.+..|+.+++++. ||||+++++++...+..++||||+
T Consensus 39 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 118 (360)
T 3llt_A 39 VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL 118 (360)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC
Confidence 457899999999999996 46889999999866555667888999999886 999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC---------------------
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP--------------------- 482 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~--------------------- 482 (654)
+++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 119 -~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~ 193 (360)
T 3llt_A 119 -GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRKMS-LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193 (360)
T ss_dssp -CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEE
T ss_pred -CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCcccEEEccccccccccchhcccccccccc
Confidence 999999997542 345899999999999999999999998 999999999999975
Q ss_pred ----CCCeEEeccCCCCCcCCC-CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 036334 483 ----DHDACVSDFGLNPLFGNT-TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQAS 546 (654)
Q Consensus 483 ----~~~~kl~Dfgla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 546 (654)
++.+||+|||++...... ....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 194 ~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 194 YRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp EEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 788999999999865443 3456788899999999999999999999999999999999999754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=369.56 Aligned_cols=244 Identities=24% Similarity=0.357 Sum_probs=198.0
Q ss_pred cccccCceeEEEEEec---CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 353 VLGKGSVGTSYKAVLE---EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 353 ~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
.||+|+||.||+|.+. ++..||||+++... ...+++.+|+++|++++|||||+++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999864 46679999998653 346789999999999999999999999876 56899999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC------
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT------ 501 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~------ 501 (654)
|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 422 L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~-iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN-FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 99999743 345999999999999999999999998 9999999999999999999999999998764321
Q ss_pred -CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 502 -PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 502 -~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
...++..|+|||++.+..++.++|||||||++|||++ |+.||...... .....+ ..+.. ..
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~~~~~i-~~~~~----------~~ 559 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAFI-EQGKR----------ME 559 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH------HHHHHH-HTTCC----------CC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH------HHHHHH-HcCCC----------CC
Confidence 1223467999999998999999999999999999998 99999764321 111111 11110 11
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
....+..++.+++.+||+.||++||++.+|++.|+++...
T Consensus 560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 1122335677888899999999999999999999998644
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=343.63 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=202.8
Q ss_pred HhhccccccCceeEEEEEec--------CCcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccccccEEEEeCCceE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE--------EGTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKL 417 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~ 417 (654)
.+.+.||+|+||.||+|... ++..||||+++.... ..+++.+|+++++++ +||||+++++++.+.+..+
T Consensus 38 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 117 (334)
T 2pvf_A 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 117 (334)
T ss_dssp EEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCE
T ss_pred EEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceE
Confidence 34578999999999999863 467899999976532 345688999999999 8999999999999999999
Q ss_pred EEEEecCCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCe
Q 036334 418 LVYDYMPAGSLSALLHGSRGS-----------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDA 486 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~ 486 (654)
+||||+++|+|.+++...... ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+
T Consensus 118 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~ 196 (334)
T 2pvf_A 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVLVTENNVM 196 (334)
T ss_dssp EEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCE
T ss_pred EEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCCccceEEEcCCCCE
Confidence 999999999999999854321 1234899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCCCCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 036334 487 CVSDFGLNPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQ 559 (654)
Q Consensus 487 kl~Dfgla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~ 559 (654)
||+|||++...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ......
T Consensus 197 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~~~~~~ 270 (334)
T 2pvf_A 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFK 270 (334)
T ss_dssp EECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHH
T ss_pred EEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC------HHHHHH
Confidence 99999998765432 22344567999999988889999999999999999999 999986532 111111
Q ss_pred HHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 036334 560 SVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGET 621 (654)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 621 (654)
.+. .... .........++.+++.+||+.||++|||++|+++.|+++.....
T Consensus 271 ~~~-~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 271 LLK-EGHR----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHH-HTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHh-cCCC----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 111 1110 01111223467788889999999999999999999999976543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=347.35 Aligned_cols=255 Identities=16% Similarity=0.229 Sum_probs=190.7
Q ss_pred hhccccccCceeEEEEEec----CCcEEEEEEeccccc------------CHHHHHHHHHHHhccCCCccccccEEEEe-
Q 036334 350 SAEVLGKGSVGTSYKAVLE----EGTTVVVKRLKEVAV------------GKREFEMQMEVLGKIKHDNVVPLRAFYYS- 412 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~------------~~~~~~~e~~~l~~l~hpniv~l~~~~~~- 412 (654)
+.+.||+|+||.||+|... .+..||+|++..... ....+.+|+..++.++||||+++++++..
T Consensus 41 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~ 120 (345)
T 2v62_A 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE 120 (345)
T ss_dssp EEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEE
T ss_pred EEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccc
Confidence 3578999999999999975 477899999865421 12346678888999999999999999988
Q ss_pred ---CCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC--CeE
Q 036334 413 ---KDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH--DAC 487 (654)
Q Consensus 413 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~--~~k 487 (654)
....++||||+ +++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+|
T Consensus 121 ~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 121 FKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIHENE-YVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp SSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEESSSTTSEE
T ss_pred cCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-eeCCCcCHHHEEEccCCCCcEE
Confidence 67889999999 99999999743 26999999999999999999999998 99999999999999887 999
Q ss_pred EeccCCCCCcCCC-----------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhH
Q 036334 488 VSDFGLNPLFGNT-----------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPR 556 (654)
Q Consensus 488 l~Dfgla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~ 556 (654)
|+|||++...... ....++..|+|||++.+..++.++|||||||++|||++|+.||....... ....
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~ 271 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP--VAVQ 271 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH--HHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc--HHHH
Confidence 9999999765321 23356778999999999899999999999999999999999996432111 0011
Q ss_pred HHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 557 WVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
......... +...............++.+++.+||+.||++|||+++|++.|+++.-
T Consensus 272 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 272 TAKTNLLDE-----LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHT-----TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHhhccc-----ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111111111 111110100011223467788889999999999999999999998764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=359.15 Aligned_cols=253 Identities=19% Similarity=0.253 Sum_probs=197.5
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHhccCCC-ccccccEEEEeCCceEEEEEecCCCc
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHD-NVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp-niv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
+.++||+|+||.||+|.. .+++.||||++..... ..++.+|+++++.++|+ +|..+..++...+..++||||+ +++
T Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~s 88 (483)
T 3sv0_A 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (483)
T ss_dssp CCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCC
Confidence 357899999999999995 5689999998765432 34578899999999875 4555556667778889999999 999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEE---CCCCCeEEeccCCCCCcCCCC---
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL---RPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll---~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++.......
T Consensus 89 L~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~g-IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (483)
T 3sv0_A 89 LEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (483)
T ss_dssp HHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred HHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence 99999743 245999999999999999999999998 9999999999999 588999999999997654321
Q ss_pred --------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 502 --------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 502 --------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||....... ....+..+...... ....
T Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~i~~~~~~-~~~~- 238 (483)
T 3sv0_A 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KKQKYEKISEKKVA-TSIE- 238 (483)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS---HHHHHHHHHHHHHH-SCHH-
T ss_pred ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh---HHHHHHHHhhcccc-ccHH-
Confidence 3457788999999999999999999999999999999999998654322 11222221111110 0000
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
.+ ......++.+++..||+.+|++||++.+|++.|+++...
T Consensus 239 ~l-----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 239 AL-----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HH-----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HH-----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 00 011124678888899999999999999999999998643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.33 Aligned_cols=250 Identities=22% Similarity=0.358 Sum_probs=192.1
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.||+|+||+||+|...+|+.||+|+++.... ....+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 84 (288)
T 1ob3_A 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-
T ss_pred hhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-
Confidence 3578999999999999988899999999865432 246788999999999999999999999999999999999975
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TP 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~ 502 (654)
+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 85 ~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (288)
T 1ob3_A 85 DLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR-VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (288)
T ss_dssp EHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence 999988743 245899999999999999999999998 999999999999999999999999998765422 23
Q ss_pred CCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---h----chhh----hh
Q 036334 503 PTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR---E----EWTA----EV 570 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---~----~~~~----~~ 570 (654)
..++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..+.. . .+.. ..
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA------DQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHHCCCChhhchhhhcccc
Confidence 456788999999876 45899999999999999999999999753221 11111111 0 0000 00
Q ss_pred hhHhhhcc------CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 571 FDVELMRY------HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 571 ~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.+...... ........++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 000112245677888999999999999999976
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=349.98 Aligned_cols=238 Identities=23% Similarity=0.275 Sum_probs=192.4
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV----AVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.++||+|+||+||+|... +|+.||||++++. ....+.+.+|..+++.+ +||||+++++++.+.+..|+||||+
T Consensus 27 ~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 106 (353)
T 3txo_A 27 FIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFV 106 (353)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCC
Confidence 3578999999999999965 5899999999764 23345677899999888 6999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 107 ~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 180 (353)
T 3txo_A 107 NGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHDKG-IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180 (353)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCCHHHEEECCCCCEEEccccceeecccCCcc
Confidence 999999999743 45899999999999999999999998 999999999999999999999999999864322
Q ss_pred -CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 -TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...... ..
T Consensus 181 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~~---------~p- 244 (353)
T 3txo_A 181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDEVV---------YP- 244 (353)
T ss_dssp -----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---------CC-
T ss_pred ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCC---------CC-
Confidence 234578889999999988899999999999999999999999975322 2222222222110 01
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAM------QEVVR 611 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~ 611 (654)
.....++.+++.+||+.||++||++ +|+++
T Consensus 245 --~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 245 --TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1122346677889999999999998 66654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=347.44 Aligned_cols=262 Identities=23% Similarity=0.284 Sum_probs=196.9
Q ss_pred hhcccccc--CceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKG--SVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G--~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.+.||+| +||.||+|... +|+.||||+++..... .+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 29 ~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 108 (389)
T 3gni_B 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 108 (389)
T ss_dssp EEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEcc
Confidence 35789999 99999999976 6899999999765433 356778999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC-----
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG----- 498 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~----- 498 (654)
++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+....
T Consensus 109 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~ 184 (389)
T 3gni_B 109 AYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHHMG-YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184 (389)
T ss_dssp TTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEE
T ss_pred CCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEcccccceeecccccc
Confidence 9999999997542 245899999999999999999999998 9999999999999999999999999875331
Q ss_pred ------CCCCCCccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------
Q 036334 499 ------NTTPPTRVAGYRAPEVVET--RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE------ 564 (654)
Q Consensus 499 ------~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------ 564 (654)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+. +...+......
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTST 262 (389)
T ss_dssp CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC-------------
T ss_pred ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCccccccc
Confidence 1122356777999999987 6799999999999999999999999976433221 00000000000
Q ss_pred ---ch-------------hhhhhh--------HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhh
Q 036334 565 ---EW-------------TAEVFD--------VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM--IENMN 617 (654)
Q Consensus 565 ---~~-------------~~~~~~--------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 617 (654)
.. ...... ..............++.+++.+||+.||++|||++|+++. ++++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 00 000000 0000000111223457788999999999999999999865 44443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=339.60 Aligned_cols=257 Identities=20% Similarity=0.322 Sum_probs=197.8
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEeccc-ccCHHHHHHHHHHHhccCCCccccccEEEEe----CCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEV-AVGKREFEMQMEVLGKIKHDNVVPLRAFYYS----KDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~~ 423 (654)
+.+.||+|+||.||++.. .+|+.||||++... ....+.+.+|++++++++||||+++++++.. ....++||||+
T Consensus 33 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 112 (317)
T 2buj_A 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112 (317)
T ss_dssp EEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECC
T ss_pred EEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeC
Confidence 357899999999999996 56899999998654 2345678899999999999999999999873 34679999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC--
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-- 501 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-- 501 (654)
++|+|.+++..... ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 113 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~ 190 (317)
T 2buj_A 113 KRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG-YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190 (317)
T ss_dssp TTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEES
T ss_pred CCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEEcCCCCEEEEecCcchhccccccc
Confidence 99999999975322 2356999999999999999999999998 9999999999999999999999999987653211
Q ss_pred -----------CCCccccccCccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchh
Q 036334 502 -----------PPTRVAGYRAPEVVETRK---VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWT 567 (654)
Q Consensus 502 -----------~~~~~~~y~aPE~~~~~~---~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 567 (654)
...++..|+|||++.+.. ++.++|||||||++|||++|+.||........ .... ......
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~~~~~~- 264 (317)
T 2buj_A 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL----AVQNQL- 264 (317)
T ss_dssp HHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH----HHHCC--
T ss_pred ccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH----HhhccC-
Confidence 112467799999987554 68999999999999999999999864211110 1110 011000
Q ss_pred hhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 036334 568 AEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDD 623 (654)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 623 (654)
...........+.+++.+||+.||++|||++++++.|+++......+
T Consensus 265 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 265 ---------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred ---------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 00111122346778888999999999999999999999987655433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=342.66 Aligned_cols=240 Identities=19% Similarity=0.295 Sum_probs=190.1
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC----HHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG----KREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
..+.||+|+||.||+|... +|+.||+|++++.... .+.+.+|..++.++ +||||+++++++.+.+..++||||+
T Consensus 13 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~ 92 (345)
T 3a8x_A 13 LLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 92 (345)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCC
Confidence 3578999999999999965 5889999999765322 34577899999887 8999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN---- 499 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~---- 499 (654)
++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++++||+|||++.....
T Consensus 93 ~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~ 166 (345)
T 3a8x_A 93 NGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG-IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166 (345)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence 999999999742 35899999999999999999999998 99999999999999999999999999976422
Q ss_pred CCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCC--ChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 500 TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGI--DLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 500 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||......+.. .....+...+.... .
T Consensus 167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--------~-- 236 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------I-- 236 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--------C--
T ss_pred ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--------C--
Confidence 23346788899999999999999999999999999999999999753221111 11111111111110 0
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAM 606 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 606 (654)
........++.+++.+||+.||++||++
T Consensus 237 -~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 -RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 0011122356678889999999999995
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=342.86 Aligned_cols=256 Identities=23% Similarity=0.389 Sum_probs=200.7
Q ss_pred HhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhc--cCCCccccccEEEEeCC----ceEEEEEe
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGK--IKHDNVVPLRAFYYSKD----EKLLVYDY 422 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~--l~hpniv~l~~~~~~~~----~~~lv~e~ 422 (654)
.+.+.||+|+||.||+|... |+.||||++... ....+.+|++++.. ++||||+++++++.... ..++||||
T Consensus 45 ~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~ 121 (342)
T 1b6c_B 45 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 121 (342)
T ss_dssp EEEEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECC
T ss_pred EEEeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEee
Confidence 34688999999999999985 899999998654 34567778888776 78999999999998776 78999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------ccCCeecCCCCCCcEEECCCCCeEEeccCCC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH--------VSGKIVHGNIKASNILLRPDHDACVSDFGLN 494 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla 494 (654)
+++|+|.+++.. ..+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||++
T Consensus 122 ~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~-ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 122 HEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp CTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE-EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred cCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC-eeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 999999999973 24899999999999999999999 676 999999999999999999999999998
Q ss_pred CCcCCC--------CCCCccccccCccccCCC------CCCcchhHHHHHHHHHHHHhC----------CCCCCCCCCCC
Q 036334 495 PLFGNT--------TPPTRVAGYRAPEVVETR------KVTFKSDVYSFGVLLLELLTG----------KAPNQASLGEE 550 (654)
Q Consensus 495 ~~~~~~--------~~~~~~~~y~aPE~~~~~------~~~~~~DvwslGvil~el~tg----------~~pf~~~~~~~ 550 (654)
...... ....++..|+|||++.+. .++.++|||||||++|||++| ..||......+
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 274 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence 765432 234577889999998765 234789999999999999999 67776543222
Q ss_pred CCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 551 GIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
.....+......... .+.+.......+....+.+++.+||+.||++|||++|+++.|+++.++.
T Consensus 275 -~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 275 -PSVEEMRKVVCEQKL-----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp -CCHHHHHHHHTTSCC-----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred -ccHHHHHHHHHHHHh-----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 112222222211111 1111111112355667889999999999999999999999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=334.42 Aligned_cols=251 Identities=20% Similarity=0.287 Sum_probs=190.5
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
..+.||+|+||+||+|... +|+.||||+++..... ...+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 85 (292)
T 3o0g_A 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC
Confidence 3578999999999999965 5899999999754332 36788999999999999999999999999999999999976
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
++.+.+... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...... .
T Consensus 86 -~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~-ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 86 -DLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN-VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp -EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred -CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence 555555432 345999999999999999999999998 999999999999999999999999999766432 2
Q ss_pred CCCccccccCccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---chhh---hhhh--
Q 036334 502 PPTRVAGYRAPEVVETRK-VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE---EWTA---EVFD-- 572 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~---~~~~-- 572 (654)
...++..|+|||++.+.. ++.++|||||||++|||++|+.||..... ....+..+... .... ....
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-----VDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-----HHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC-----HHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 345677899999997755 89999999999999999999888643221 11222222110 0000 0000
Q ss_pred -H--------hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 573 -V--------ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 573 -~--------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
. .............++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00000001112345667888999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=347.49 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=192.5
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.++||+|+||.||+|... +|+.||+|+++... ...+++.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 367999999999999864 68999999997653 3456789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEE--CCCCCeEEeccCCCCCcCCC---CCC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL--RPDHDACVSDFGLNPLFGNT---TPP 503 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll--~~~~~~kl~Dfgla~~~~~~---~~~ 503 (654)
.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++...... ...
T Consensus 174 ~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~ 248 (373)
T 2x4f_A 174 FDRIIDE----SYNLTELDTILFMKQICEGIRHMHQMY-ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN 248 (373)
T ss_dssp HHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence 9988643 235899999999999999999999998 9999999999999 56788999999999876543 234
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.+++.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+....+... .. ... .
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~~~~~--~~---~~~---~ 314 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------AETLNNILACRWDLE--DE---EFQ---D 314 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCSC--SG---GGT---T
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhccCCCC--hh---hhc---c
Confidence 578889999999988999999999999999999999999975322 222333332222110 00 011 1
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
...++.+++.+||+.||++|||++|+++
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1235677888999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=331.41 Aligned_cols=255 Identities=16% Similarity=0.197 Sum_probs=200.9
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEE-EeCCceEEEEEecCCCc
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY-YSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~-~~~~~~~lv~e~~~~g~ 427 (654)
+.+.||+|+||.||+|.. .+|+.||||++.... ...++.+|+.++++++|++++..+.++ ...+..++||||+ +++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 3uzp_A 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCC
Confidence 357899999999999996 568999999986543 335688999999999999887777766 4566779999999 999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEE---CCCCCeEEeccCCCCCcCCC----
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL---RPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll---~~~~~~kl~Dfgla~~~~~~---- 500 (654)
|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||++......
T Consensus 91 L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (296)
T 3uzp_A 91 LEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN-FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp HHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred HHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence 99999743 245999999999999999999999998 9999999999999 47889999999998765432
Q ss_pred -------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 -------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....++..|+|||++.+..++.++|||||||++|||++|+.||..............+......... .
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~ 240 (296)
T 3uzp_A 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----E 240 (296)
T ss_dssp BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----H
T ss_pred ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-----H
Confidence 2345677899999999999999999999999999999999999875443332222222111000000 0
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGET 621 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 621 (654)
.+ . .....++.+++.+||+.||++|||++++++.|+++.....
T Consensus 241 ~~--~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 241 VL--C---KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HH--T---TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HH--H---hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 00 0 1112457788889999999999999999999999976543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=341.36 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=186.9
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
...+.||+|+||.||+|... +|+.||+|+++... .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~- 86 (317)
T 2pmi_A 8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD- 86 (317)
T ss_dssp -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-
T ss_pred eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-
Confidence 34578999999999999864 58999999987543 234678899999999999999999999999999999999997
Q ss_pred CchhhhhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 426 GSLSALLHGSR-GSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 426 g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
|+|.+++.... ......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (317)
T 2pmi_A 87 NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165 (317)
T ss_dssp CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCC
T ss_pred CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCChHHeEEcCCCCEEECcCccceecCCCcccC
Confidence 59999886432 112345899999999999999999999998 999999999999999999999999999765432
Q ss_pred CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---chhhhh-----h
Q 036334 501 TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE---EWTAEV-----F 571 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~-----~ 571 (654)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+...... ...... .
T Consensus 166 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T 2pmi_A 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPSVTKLPKY 242 (317)
T ss_dssp CCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred CCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhhhhhhhhc
Confidence 23456788999999876 468999999999999999999999997543211 11111111000 000000 0
Q ss_pred hHhh-----------hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 572 DVEL-----------MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 572 ~~~~-----------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.... ...........++.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000 0000001122357788889999999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.16 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=199.2
Q ss_pred hhccccccCceeEEEEEe-----cCCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEe--CCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL-----EEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYS--KDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e 421 (654)
+.+.||+|+||.||+|.+ .+++.||||++.... ...+.+.+|++++++++||||+++++++.. ....++|||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 106 (327)
T 3lxl_A 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME 106 (327)
T ss_dssp EEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEE
T ss_pred hhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEe
Confidence 457899999999999984 358899999997653 334568999999999999999999999874 456899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT- 500 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~- 500 (654)
|+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 107 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 181 (327)
T 3lxl_A 107 YLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSRR-CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181 (327)
T ss_dssp CCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred ecCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence 99999999999743 235899999999999999999999998 999999999999999999999999999866432
Q ss_pred ------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC--------CCCChhHHHHHHhhhch
Q 036334 501 ------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGE--------EGIDLPRWVQSVVREEW 566 (654)
Q Consensus 501 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--------~~~~~~~~~~~~~~~~~ 566 (654)
....++..|+|||++.+..++.++||||||+++|||++|+.||...... ........+........
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (327)
T 3lxl_A 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261 (327)
T ss_dssp SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC
T ss_pred ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc
Confidence 2234566699999998888999999999999999999999998643211 00000000000110000
Q ss_pred hhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 567 TAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
...........+.+++.+||+.||++|||++|+++.|+.+....
T Consensus 262 ----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 262 ----------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred ----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11112223346778888999999999999999999999997665
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=344.47 Aligned_cols=237 Identities=16% Similarity=0.194 Sum_probs=196.9
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 125 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 478999999999999965 58999999997542 3346788899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-CCCC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-TPPT 504 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-~~~~ 504 (654)
|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 126 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~~ 199 (350)
T 1rdq_E 126 GEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC 199 (350)
T ss_dssp CBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCE
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-cccccCccceEEECCCCCEEEcccccceeccCCccccc
Confidence 9999999742 35899999999999999999999998 999999999999999999999999999876543 3456
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
+++.|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... ......
T Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~~------------~~p~~~ 261 (350)
T 1rdq_E 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSGKV------------RFPSHF 261 (350)
T ss_dssp ECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC------------CCCTTC
T ss_pred CCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC------HHHHHHHHHcCCC------------CCCCCC
Confidence 7888999999999999999999999999999999999997532 1222222222111 001112
Q ss_pred HHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 036334 585 MVQLLQIAMGCVSTVPDQRPA-----MQEVVR 611 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 611 (654)
..++.+++.+||+.||++||+ ++|+++
T Consensus 262 ~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 235677888999999999998 787765
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.51 Aligned_cols=251 Identities=25% Similarity=0.354 Sum_probs=196.4
Q ss_pred hhccccccCceeEEEEEecC----CcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEe-CCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLEE----GTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYS-KDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~ 422 (654)
+.++||+|+||.||+|...+ ...||+|.+..... ..+.+.+|+.++++++||||+++++++.. ++..++||||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 108 (298)
T 3f66_A 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 108 (298)
T ss_dssp EEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred hcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeC
Confidence 45789999999999998543 23689999875432 34568899999999999999999998654 5578999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 500 (654)
+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 109 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 109 MKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp CTTCBHHHHHHCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred CCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 9999999999743 345899999999999999999999998 999999999999999999999999999765432
Q ss_pred ------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 ------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTG-KAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....++..|+|||.+.+..++.++||||||+++|||++| .+||......+ .. ........
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~---~~~~~~~~------- 250 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---IT---VYLLQGRR------- 250 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HH---HHHHTTCC-------
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HH---HHHhcCCC-------
Confidence 223445679999999989999999999999999999995 55554432211 11 11111110
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETD 622 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 622 (654)
..........+.+++.+||+.||++|||++|+++.|+++...-..
T Consensus 251 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 251 ----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred ----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 000111223577888899999999999999999999999876443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.87 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=192.9
Q ss_pred HhhccccccCceeEEEEEec----CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCc-----e
Q 036334 349 ASAEVLGKGSVGTSYKAVLE----EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDE-----K 416 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~-----~ 416 (654)
.+.+.||+|+||.||+|... .+..||+|+++..... .+.+.+|+.++++++||||+++++++.+.+. .
T Consensus 37 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 116 (313)
T 3brb_A 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKP 116 (313)
T ss_dssp EEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CE
T ss_pred eeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCccc
Confidence 44678999999999999854 2458999999765333 3568899999999999999999999987553 4
Q ss_pred EEEEEecCCCchhhhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCC
Q 036334 417 LLVYDYMPAGSLSALLHGSRG-SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP 495 (654)
Q Consensus 417 ~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~ 495 (654)
++||||+++|+|.+++...+. .....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 117 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dikp~NIli~~~~~~kl~Dfg~~~ 195 (313)
T 3brb_A 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-FLHRDLAARNCMLRDDMTVCVADFGLSK 195 (313)
T ss_dssp EEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT-CCCCCCSGGGEEECTTSCEEECSCSCC-
T ss_pred EEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCcceEEEcCCCcEEEeecCcce
Confidence 999999999999999853321 13456999999999999999999999998 9999999999999999999999999987
Q ss_pred CcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 496 LFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 496 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
..... ....++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ..........
T Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~~~~~-- 267 (313)
T 3brb_A 196 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------MYDYLLHGHR-- 267 (313)
T ss_dssp ---------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------HHHHHHTTCC--
T ss_pred ecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHHcCCC--
Confidence 65432 22344567999999999999999999999999999999 888986543211 1111111110
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
..........+.+++.+||+.||++|||+.++++.|+++.+.-
T Consensus 268 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 268 ---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp ---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0111222346778888999999999999999999999987643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.52 Aligned_cols=265 Identities=19% Similarity=0.283 Sum_probs=206.5
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCC--ceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD--EKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~--~~~lv~e~~~ 424 (654)
+.++||+|+||+||+|... +|+.||||+++... ...+.+.+|++++++++||||+++++++...+ ..++||||++
T Consensus 13 i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 92 (396)
T 4eut_A 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (396)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCT
T ss_pred EEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCC
Confidence 3578999999999999976 48999999997643 34567889999999999999999999998765 6799999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEE----CCCCCeEEeccCCCCCcCCC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL----RPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll----~~~~~~kl~Dfgla~~~~~~ 500 (654)
+|+|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 93 ~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~ 169 (396)
T 4eut_A 93 CGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG-IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169 (396)
T ss_dssp TEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG
T ss_pred CCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC-EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC
Confidence 999999997543 1234899999999999999999999998 9999999999999 77778999999999876543
Q ss_pred ---CCCCccccccCccccCC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhh
Q 036334 501 ---TPPTRVAGYRAPEVVET--------RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAE 569 (654)
Q Consensus 501 ---~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 569 (654)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .....+..+........
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~~p~~~ 247 (396)
T 4eut_A 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKIITGKPSGA 247 (396)
T ss_dssp GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT--TCHHHHHHHHHSCCTTC
T ss_pred CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc--chHHHHHHHhcCCCccc
Confidence 23457788999999864 567889999999999999999999997543322 11222233322211000
Q ss_pred h----------h--hHhhh-ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 570 V----------F--DVELM-RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 570 ~----------~--~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
. + ...+. ...........+.+++.+||+.||++||+++|+++.++++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0 0 00000 0112245566788899999999999999999999999988654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.72 Aligned_cols=244 Identities=24% Similarity=0.337 Sum_probs=197.6
Q ss_pred HHhhccccccCceeEEEEEe-cCCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 348 RASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
+...+.||+|+||+||+|.. .+|+.||||++..... ..+++.+|++++++++||||+++++++.+++..++||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 34457899999999999995 5689999999875422 235688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP 502 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 502 (654)
+. |+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 136 ~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 209 (348)
T 1u5q_A 136 CL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN-MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 209 (348)
T ss_dssp CS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred CC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEECCCCCEEEeeccCceecCCCCc
Confidence 97 6888887532 345899999999999999999999998 99999999999999999999999999988877667
Q ss_pred CCccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 503 PTRVAGYRAPEVVE---TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 503 ~~~~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
..++..|+|||++. ...++.++|||||||++|||++|+.||.... ....+..+...... . .
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~------~~~~~~~~~~~~~~-~---------~ 273 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNESP-A---------L 273 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCCC-C---------C
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCCC-C---------C
Confidence 78889999999984 5678999999999999999999999986532 11222222211110 0 0
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
........+.+++.+||+.||++|||++++++..
T Consensus 274 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 274 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 0111223566788899999999999999998653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=340.30 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=192.1
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccccC----HHHHHHHHHHHhccCCCccccccEEEEeCCce----EEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVG----KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEK----LLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~----~lv~ 420 (654)
+.+.||+|+||.||+|.. .+++.||||+++..... ...+.+|+.++++++||||+++++++...... ++||
T Consensus 16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~ 95 (311)
T 3ork_A 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 95 (311)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEE
Confidence 357899999999999995 56899999999765322 24678899999999999999999998765543 9999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 96 e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 96 EYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp ECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 99999999999974 245899999999999999999999998 999999999999999999999999999765432
Q ss_pred -------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 -------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....++..|+|||++.+..++.++|||||||++|||++|+.||..... .............. .
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~----~ 239 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP----P 239 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC----H
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCC----c
Confidence 123467889999999999999999999999999999999999975321 11122222111110 0
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHHHhhhcCC
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPA-MQEVVRMIENMNRGE 620 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~L~~~~~~~ 620 (654)
.. ... ....++.+++.+||+.||++||+ ++++.+.+.++....
T Consensus 240 ~~-~~~---~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 283 (311)
T 3ork_A 240 SA-RHE---GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283 (311)
T ss_dssp HH-HST---TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred cc-ccC---CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence 00 011 12235677888999999999995 555666777766543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=342.65 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=193.2
Q ss_pred hhccccccCceeEEEEEec-CCc----EEEEEEeccc--ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGT----TVVVKRLKEV--AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~----~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
..+.||+|+||.||+|.+. +++ +||+|.+... ....+++.+|+.++++++||||+++++++..+ ..++|+||
T Consensus 19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~v~~~ 97 (327)
T 3lzb_A 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 97 (327)
T ss_dssp EEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEEEECC
T ss_pred EEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceEEEEe
Confidence 3578999999999999854 344 3577777543 23467889999999999999999999999865 48899999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT- 501 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 501 (654)
+.+|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 98 MPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp CSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred cCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCC-CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 9999999999753 345899999999999999999999998 9999999999999999999999999998764321
Q ss_pred -----CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 502 -----PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 502 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
...++..|+|||++.+..++.++|||||||++|||++ |+.||......+ +...+....
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~--------- 236 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGE--------- 236 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTC---------
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCC---------
Confidence 2234557999999999999999999999999999999 999997543221 111111111
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
..........++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 237 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 -RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0011112233577888899999999999999999999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.84 Aligned_cols=245 Identities=23% Similarity=0.375 Sum_probs=197.8
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.+.||+|+||.||+|... +|+.||+|++.... .....+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 54 ~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg 133 (387)
T 1kob_A 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133 (387)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCC
Confidence 34578999999999999965 58899999987543 34457889999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC--CCCeEEeccCCCCCcCCCC---
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP--DHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~--~~~~kl~Dfgla~~~~~~~--- 501 (654)
+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||++.......
T Consensus 134 ~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 208 (387)
T 1kob_A 134 ELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS-IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208 (387)
T ss_dssp BHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence 999999742 235899999999999999999999998 999999999999974 4679999999998765432
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+....+.. +. ...
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~~~~~~---~~-----~~~ 274 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDWEF---DE-----DAF 274 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCCCC---CS-----STT
T ss_pred eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC---Cc-----ccc
Confidence 23567889999999999999999999999999999999999975321 22222222221110 00 001
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.....++.+++.+||+.||++|||+.|+++.
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1122356778889999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=345.38 Aligned_cols=237 Identities=24% Similarity=0.310 Sum_probs=193.3
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV----AVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.++||+|+||+||+|... +|+.||+|+++.. ......+..|..++..+ +||||+++++++.+.+..++||||+
T Consensus 21 ~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~ 100 (345)
T 1xjd_A 21 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 100 (345)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCC
Confidence 3578999999999999975 5889999999764 23445677888888876 8999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN---- 499 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~---- 499 (654)
++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 101 ~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 174 (345)
T 1xjd_A 101 NGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG-IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 174 (345)
T ss_dssp TTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCc
Confidence 999999999742 35899999999999999999999998 99999999999999999999999999976432
Q ss_pred CCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 500 TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 500 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... . .
T Consensus 175 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~-------~--~-- 237 (345)
T 1xjd_A 175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRMDNP-------F--Y-- 237 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC-------C--C--
T ss_pred ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHhCCC-------C--C--
Confidence 2345678889999999999999999999999999999999999975321 122222221110 0 0
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQ-EVV 610 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 610 (654)
......++.+++.+||..||++||++. +++
T Consensus 238 -p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 -PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 011123566778899999999999997 664
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=344.03 Aligned_cols=242 Identities=21% Similarity=0.326 Sum_probs=182.3
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
+.+.||+|+||.||+|... +++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 57 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 135 (349)
T 2w4o_A 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135 (349)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCH
Confidence 3578999999999999976 47899999997643 346688899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC---CCCeEEeccCCCCCcCCC---CC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP---DHDACVSDFGLNPLFGNT---TP 502 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~---~~~~kl~Dfgla~~~~~~---~~ 502 (654)
.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++...... ..
T Consensus 136 ~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 209 (349)
T 2w4o_A 136 FDRIVE-----KGYYSERDAADAVKQILEAVAYLHENG-IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT 209 (349)
T ss_dssp HHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eEecCCCcccEEEecCCCCCCEEEccCccccccCccccccc
Confidence 999973 345899999999999999999999998 999999999999975 889999999999876543 23
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..++..|+|||++.+..++.++|||||||++|||++|+.||...... ......+....... .. ....
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~i~~~~~~~--~~------~~~~ 276 (349)
T 2w4o_A 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-----QFMFRRILNCEYYF--IS------PWWD 276 (349)
T ss_dssp ---CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-----HHHHHHHHTTCCCC--CT------TTTT
T ss_pred ccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-----HHHHHHHHhCCCcc--CC------chhh
Confidence 45778899999999999999999999999999999999999653221 11122222111100 00 0011
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
+...++.+++.+||+.||++|||+.|+++
T Consensus 277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22335677888999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=346.45 Aligned_cols=243 Identities=21% Similarity=0.286 Sum_probs=186.2
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHH-hccCCCccccccEEEEe----CCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVL-GKIKHDNVVPLRAFYYS----KDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l-~~l~hpniv~l~~~~~~----~~~~~lv~e~~~~ 425 (654)
++||+|+||+||++... +|+.||||+++. ...+.+|++++ +..+||||++++++|.. .+..++||||+++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 67999999999999965 588999999864 24567788876 44589999999999875 5568999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC---CCCeEEeccCCCCCcCCC--
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP---DHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~---~~~~kl~Dfgla~~~~~~-- 500 (654)
|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++......
T Consensus 144 g~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~ 219 (400)
T 1nxk_A 144 GELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219 (400)
T ss_dssp EEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred CcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCcCcceEEEecCCCCccEEEEecccccccCCCCc
Confidence 9999999753 2345999999999999999999999998 999999999999998 788999999999866433
Q ss_pred -CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 -TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....++..|+|||++.+..++.++|||||||++|||++|+.||.......... .....+....+. .....+
T Consensus 220 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~i~~~~~~-----~~~~~~- 291 (400)
T 1nxk_A 220 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKTRIRMGQYE-----FPNPEW- 291 (400)
T ss_dssp -------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC--SHHHHHHHTCCC-----CCTTTT-
T ss_pred cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH--HHHHHHHcCccc-----CCCccc-
Confidence 33456788999999999999999999999999999999999997654332111 011111111110 000001
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.....++.+++.+||+.||++|||+.|+++.
T Consensus 292 --~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 292 --SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp --TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122356778889999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=342.58 Aligned_cols=235 Identities=22% Similarity=0.310 Sum_probs=193.9
Q ss_pred HHhhccccccCceeEEEEEe-cCCcEEEEEEeccccc---------CHHHHHHHHHHHhccCCCccccccEEEEeCCceE
Q 036334 348 RASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAV---------GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKL 417 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 417 (654)
|.+.+.||+|+||.||+|.. .+|+.||||+++.... ....+.+|+.++++++||||+++++++.+.+..+
T Consensus 26 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 105 (335)
T 3dls_A 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ 105 (335)
T ss_dssp EEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEE
Confidence 34567899999999999985 4688999999976532 2335778999999999999999999999999999
Q ss_pred EEEEecCCC-chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCC
Q 036334 418 LVYDYMPAG-SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPL 496 (654)
Q Consensus 418 lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~ 496 (654)
+||||+..| +|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 106 lv~e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 106 LVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLRLKD-IIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999777 99999973 345999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCC---CCCccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhh
Q 036334 497 FGNTT---PPTRVAGYRAPEVVETRKV-TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 497 ~~~~~---~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 572 (654)
..... ...++..|+|||++.+..+ +.++|||||||++|||++|+.||....... . ....
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------~-----~~~~ 242 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------E-----AAIH 242 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------T-----TCCC
T ss_pred CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------h-----hccC
Confidence 65433 2346788999999988776 789999999999999999999996422110 0 0000
Q ss_pred HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 573 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.... ...++.+++.+||+.||++|||++|+++.
T Consensus 243 ----~~~~---~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 243 ----PPYL---VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----CSSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----CCcc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111 12356778889999999999999999885
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=330.45 Aligned_cols=255 Identities=16% Similarity=0.204 Sum_probs=199.5
Q ss_pred HhhccccccCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEE-EeCCceEEEEEecCCC
Q 036334 349 ASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY-YSKDEKLLVYDYMPAG 426 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~-~~~~~~~lv~e~~~~g 426 (654)
.+.+.||+|+||.||+|.. .+++.||||++..... ..++.+|++++++++|++++..+.++ ...+..++||||+ ++
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 4hgt_A 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CC
Confidence 3457899999999999995 5688999998655432 34578899999999998888877766 5566789999999 99
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEE---CCCCCeEEeccCCCCCcCCC---
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL---RPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll---~~~~~~kl~Dfgla~~~~~~--- 500 (654)
+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 90 ~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 164 (296)
T 4hgt_A 90 SLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN-FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp BHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence 999999743 235999999999999999999999998 9999999999999 78899999999998765432
Q ss_pred --------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhh
Q 036334 501 --------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 501 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 572 (654)
....++..|+|||++.+..++.++|||||||++|||++|+.||..............+......... .
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~--- 240 (296)
T 4hgt_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-E--- 240 (296)
T ss_dssp CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-H---
T ss_pred ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-h---
Confidence 2345677899999999999999999999999999999999999875544333222211111000000 0
Q ss_pred HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 573 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
.. . .....++.+++.+||+.||++|||++++++.|+++....
T Consensus 241 -~~--~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 241 -VL--C---KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp -HH--T---TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -hh--h---ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 00 0 011236778888999999999999999999999997554
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=353.72 Aligned_cols=238 Identities=21% Similarity=0.345 Sum_probs=196.7
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||+|... +|+.||||++.... .....+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 20 l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~ 99 (476)
T 2y94_A 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVS 99 (476)
T ss_dssp EEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 3578999999999999965 68999999997542 234678899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---C
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---T 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~ 501 (654)
+|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 100 gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 173 (476)
T 2y94_A 100 GGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 173 (476)
T ss_dssp SEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHTTT-EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBC
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCcccccHHHEEEecCCCeEEEeccchhhcccccccc
Confidence 9999999973 345999999999999999999999998 999999999999999999999999999876543 2
Q ss_pred CCCccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 502 PPTRVAGYRAPEVVETRKV-TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
...+++.|+|||++.+..+ +.++||||+||++|||++|+.||.... .......+...... ...
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~------~~~~~~~i~~~~~~---------~p~- 237 (476)
T 2y94_A 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH------VPTLFKKICDGIFY---------TPQ- 237 (476)
T ss_dssp CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS------SHHHHHHHHTTCCC---------CCT-
T ss_pred ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC------HHHHHHHHhcCCcC---------CCc-
Confidence 3567888999999988766 689999999999999999999997532 12222222221110 011
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
....++.+++.+||+.||++|||++|+++
T Consensus 238 --~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 238 --YLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 11235677888999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=352.12 Aligned_cols=241 Identities=20% Similarity=0.279 Sum_probs=194.4
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.++||+|+||+||+|... +++.||+|++++.. .....+.+|+.+++.++||||++++++|.+++..|+||||+++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 153 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 478999999999999965 48899999997532 2334578899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----- 500 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----- 500 (654)
|+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||++......
T Consensus 154 g~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~~g-ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 226 (410)
T 3v8s_A 154 GDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMG-FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226 (410)
T ss_dssp EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEEC
T ss_pred CcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccc
Confidence 999999973 24899999999999999999999998 999999999999999999999999999766543
Q ss_pred CCCCccccccCccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhh
Q 036334 501 TPPTRVAGYRAPEVVETRK----VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~----~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (654)
....+|+.|+|||++.+.. ++.++|||||||++|||++|+.||.... .......+....... ...
T Consensus 227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~~~~~-----~~p 295 (410)
T 3v8s_A 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKIMNHKNSL-----TFP 295 (410)
T ss_dssp CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTHHHHC-----CCC
T ss_pred cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC------hhhHHHHHHhccccc-----cCC
Confidence 2456888999999997655 7899999999999999999999997532 222222222211000 000
Q ss_pred ccCChHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 036334 577 RYHNIEEEMVQLLQIAMGCVSTVPDQ--RPAMQEVVRM 612 (654)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 612 (654)
..... ..++.+++.+||..+|.+ ||+++||++.
T Consensus 296 ~~~~~---s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 296 DDNDI---SKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp TTCCC---CHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred Ccccc---cHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 11112 234566777999999988 9999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.62 Aligned_cols=255 Identities=20% Similarity=0.373 Sum_probs=194.4
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||+|.. .+|+.||||+++... ....++.+|+.++++++||||+++++++...+..++||||++
T Consensus 36 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 115 (310)
T 2wqm_A 36 IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115 (310)
T ss_dssp EEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCC
Confidence 457899999999999995 468999999997532 234568899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+|+|.+++..... ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 116 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 193 (310)
T 2wqm_A 116 AGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRR-VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 193 (310)
T ss_dssp SCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCC-------------
T ss_pred CCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCC-eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccc
Confidence 9999999864221 2345899999999999999999999998 999999999999999999999999998766433
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
....++..|+|||++.+..++.++||||||+++|||++|+.||.... .........+....... ..
T Consensus 194 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~----------~~ 259 (310)
T 2wqm_A 194 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEQCDYPP----------LP 259 (310)
T ss_dssp -----CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCHHHHHHHHHTTCSCC----------CC
T ss_pred cccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc----hhHHHHHHHhhcccCCC----------Cc
Confidence 22356778999999999999999999999999999999999996432 12222222221111100 00
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
......++.+++.+||+.||++|||+.++++.|+++....
T Consensus 260 ~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 0112235777888999999999999999999999998654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=335.99 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=194.5
Q ss_pred HhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeC-CceEEEEEecCCCc
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK-DEKLLVYDYMPAGS 427 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-~~~~lv~e~~~~g~ 427 (654)
.+.+.||+|+||.||++... |+.||||+++... ..+.+.+|++++++++||||+++++++.+. +..++||||+++|+
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~ 101 (278)
T 1byg_A 24 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101 (278)
T ss_dssp EEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred eEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCC
Confidence 34578999999999999875 8999999987543 456789999999999999999999997654 47899999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-CCCCcc
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-TPPTRV 506 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~ 506 (654)
|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...... ....++
T Consensus 102 L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 177 (278)
T 1byg_A 102 LVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 177 (278)
T ss_dssp HHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTSCEEECCCCC------------CC
T ss_pred HHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCcceEEEeCCCcEEEeeccccccccccccCCCcc
Confidence 999997431 223789999999999999999999998 999999999999999999999999998765433 233456
Q ss_pred ccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHH
Q 036334 507 AGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585 (654)
Q Consensus 507 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (654)
..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+. .... ........
T Consensus 178 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~~~~-~~~~----------~~~~~~~~ 240 (278)
T 1byg_A 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVE-KGYK----------MDAPDGCP 240 (278)
T ss_dssp TTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG------GHHHHHT-TTCC----------CCCCTTCC
T ss_pred ccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHh-cCCC----------CCCcccCC
Confidence 77999999988899999999999999999998 99998753221 1111111 1110 01111223
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 586 VQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 586 ~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
..+.+++.+||+.||++|||+.|+++.|++++..+
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 46777888999999999999999999999997654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=348.22 Aligned_cols=245 Identities=15% Similarity=0.227 Sum_probs=196.9
Q ss_pred hhccccccCceeEEEEE------ecCCcEEEEEEecccccCHHHHHHHHHHHhccC---CCccccccEEEEeCCceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAV------LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIK---HDNVVPLRAFYYSKDEKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hpniv~l~~~~~~~~~~~lv~ 420 (654)
+.+.||+|+||+||+|. ...++.||||+++.. ...++.+|++++++++ |+||+++++++...+..++||
T Consensus 69 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~ 146 (365)
T 3e7e_A 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146 (365)
T ss_dssp EEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEE
T ss_pred EEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEE
Confidence 34789999999999994 446889999998754 3567788888888886 999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC-----------CCCeEEe
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP-----------DHDACVS 489 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~-----------~~~~kl~ 489 (654)
||+++|+|.+++...+......+++..++.++.|++.||+|||+++ |+||||||+|||++. ++.+||+
T Consensus 147 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~-ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~ 225 (365)
T 3e7e_A 147 ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE-IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225 (365)
T ss_dssp CCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCSGGGEEECGGGTCC------CTTEEEC
T ss_pred eccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC-eecCCCCHHHEEecccccCccccccccCCEEEe
Confidence 9999999999997543323456999999999999999999999998 999999999999998 8999999
Q ss_pred ccCCCCCcC---C---CCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 036334 490 DFGLNPLFG---N---TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR 563 (654)
Q Consensus 490 Dfgla~~~~---~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 563 (654)
|||++.... . .....+|.+|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 226 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------------ 293 (365)
T 3e7e_A 226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------------ 293 (365)
T ss_dssp CCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------------
T ss_pred eCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------------
Confidence 999996542 1 1345678899999999999999999999999999999999999865322110
Q ss_pred hchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHHHhhhcC
Q 036334 564 EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQR-PAMQEVVRMIENMNRG 619 (654)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~evl~~L~~~~~~ 619 (654)
..... +... ...+ .+.+++..|++.+|.+| |+++++.+.|+++...
T Consensus 294 --~~~~~----~~~~-~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 --KPEGL----FRRL-PHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp --EECSC----CTTC-SSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --eechh----cccc-CcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 00000 0011 1122 34556679999999988 5889999999988654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=340.75 Aligned_cols=261 Identities=23% Similarity=0.355 Sum_probs=199.9
Q ss_pred hhccccccCceeEEEEEec-----CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeC--CceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-----EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSK--DEKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-----~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--~~~~lv~ 420 (654)
+.+.||+|+||+||++.+. +|+.||||+++... ...+.+.+|++++++++||||+++++++.+. ...++||
T Consensus 35 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 114 (318)
T 3lxp_A 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVM 114 (318)
T ss_dssp EEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEE
T ss_pred hhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEE
Confidence 3578999999999988642 58899999997653 2345688999999999999999999999874 5679999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+++|+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 115 e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~-ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 115 EYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp CCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred ecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 999999999999732 3899999999999999999999998 999999999999999999999999999876543
Q ss_pred -------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 -------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....++..|+|||++.+..++.++||||||+++|||++|+.||........ ....+................
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHHHT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHHhc
Confidence 223455669999999988899999999999999999999999864211000 000000000000000000000
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
.. ..........++.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 267 ~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 267 GE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cc-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 00 1111223345678888899999999999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=340.60 Aligned_cols=238 Identities=21% Similarity=0.275 Sum_probs=187.1
Q ss_pred hhccccccCceeEEEEEe----cCCcEEEEEEecccc-----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVA-----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~----~~g~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 420 (654)
+.+.||+|+||.||++.. .+|+.||+|+++... .....+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 100 (327)
T 3a62_A 21 LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLIL 100 (327)
T ss_dssp EEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEE
T ss_pred EEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEE
Confidence 457899999999999986 468999999997642 22345778999999999999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 101 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~-ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 101 EYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQKG-IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp ECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred eCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC-EEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 999999999999742 35899999999999999999999998 999999999999999999999999998754322
Q ss_pred ----CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhh
Q 036334 501 ----TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576 (654)
Q Consensus 501 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (654)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... ....+..+.....
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~~---------- 238 (327)
T 3a62_A 175 GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN------RKKTIDKILKCKL---------- 238 (327)
T ss_dssp ----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTCC----------
T ss_pred CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhCCC----------
Confidence 23457888999999999999999999999999999999999997532 1222222222111
Q ss_pred ccCChHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 036334 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRP-----AMQEVVR 611 (654)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 611 (654)
........++.+++.+||+.||++|| +++|+++
T Consensus 239 --~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 --NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 00111223567788899999999999 7777765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=368.34 Aligned_cols=243 Identities=26% Similarity=0.344 Sum_probs=196.3
Q ss_pred ccccccCceeEEEEEec---CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLE---EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.||+|+||.||+|.+. .++.||||+++.... ..+++.+|++++++++|||||+++++|. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999753 467899999986533 2478999999999999999999999986 4568999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----- 500 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----- 500 (654)
|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 454 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~-iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHHCC-EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999973 345899999999999999999999998 999999999999999999999999998765432
Q ss_pred --CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 501 --TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
....++..|+|||++.+..++.++|||||||++|||++ |+.||...... . +...+.....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~-~~~~i~~~~~---------- 590 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------E-VTAMLEKGER---------- 590 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCC----------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCC----------
Confidence 12234567999999999999999999999999999998 99999754321 1 1111111111
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
.........++.+++.+||+.||++||++++|++.|+++..
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11112233567788889999999999999999999998753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.71 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=189.5
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.||+|+||.||+|... ..||||+++..... .+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 28 ~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~ 104 (289)
T 3og7_A 28 VGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGS 104 (289)
T ss_dssp EEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEE
T ss_pred eeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCC
Confidence 3578999999999999865 36999999765433 35688999999999999999999965 556789999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC------
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT------ 500 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~------ 500 (654)
+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 105 ~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~-i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (289)
T 3og7_A 105 SLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAKS-IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179 (289)
T ss_dssp EHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred cHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC-cccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence 999999643 345899999999999999999999998 999999999999999999999999998765421
Q ss_pred CCCCccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 501 TPPTRVAGYRAPEVVE---TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
....++..|+|||++. +..++.++||||||+++|||++|+.||...... ..+..............
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~----- 248 (289)
T 3og7_A 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGSLSPDLS----- 248 (289)
T ss_dssp ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTSCCCCTT-----
T ss_pred cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhcccccCcchh-----
Confidence 2235678899999986 567889999999999999999999999753221 11222221111110000
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
.........+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 249 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 249 -KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0011223467788889999999999999999999999865
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=331.80 Aligned_cols=239 Identities=23% Similarity=0.273 Sum_probs=186.5
Q ss_pred HHHhhccccccCceeEEEEEec-CCcEEEEEEecccccCH---HHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEE
Q 036334 347 LRASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGK---REFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 347 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e 421 (654)
.+...++||+|+||+||+|... +|+.||||++....... .++..|+..+.++ +||||++++++|.+++..++|||
T Consensus 58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e 137 (311)
T 3p1a_A 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE 137 (311)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEe
Confidence 3445678999999999999976 68999999987653332 2344455555444 89999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT- 500 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~- 500 (654)
|+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 138 ~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 138 LC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHSQG-LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp CC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred cc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-EecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 99 67999888743 245999999999999999999999998 999999999999999999999999998766533
Q ss_pred --CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 501 --TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
....++.+|+|||++.+ .++.++|||||||++|||++|..|+..... ... +..... .....
T Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~~~-~~~~~~----~~~~~-- 274 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------WQQ-LRQGYL----PPEFT-- 274 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------HHH-HTTTCC----CHHHH--
T ss_pred CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HHH-HhccCC----Ccccc--
Confidence 23457888999999876 799999999999999999999777643110 111 111111 11110
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.....++.+++.+||+.||++|||++|+++
T Consensus 275 ---~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 ---AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 112245778888999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.77 Aligned_cols=243 Identities=22% Similarity=0.374 Sum_probs=197.3
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEe---------------
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYS--------------- 412 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--------------- 412 (654)
...+.||+|+||.||+|... +|+.||+|+++... ..+.+|++++++++||||+++++++..
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp EEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred ceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 44678999999999999976 68999999987543 457789999999999999999998864
Q ss_pred -CCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEecc
Q 036334 413 -KDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDF 491 (654)
Q Consensus 413 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Df 491 (654)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKK-LINRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCC
T ss_pred CcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCCHHHEEEcCCCCEEECcc
Confidence 345799999999999999997432 245899999999999999999999998 999999999999999999999999
Q ss_pred CCCCCcCCC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 492 GLNPLFGNT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 492 gla~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
|++...... ....++..|+|||++.+..++.++||||||+++|||++|..|+... ...... .......
T Consensus 167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~~-~~~~~~~ 237 (284)
T 2a19_B 167 GLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFTD-LRDGIIS 237 (284)
T ss_dssp TTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHHH-HHTTCCC
T ss_pred hhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHHH-hhccccc
Confidence 998766433 3345778899999999999999999999999999999998886421 111111 1111000
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
......+.+++.+||+.||++|||+.|+++.|+.++...
T Consensus 238 -------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 238 -------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp -------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred -------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 111234667888999999999999999999999998654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=333.88 Aligned_cols=250 Identities=20% Similarity=0.292 Sum_probs=193.1
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC----HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG----KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus 38 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 2h34_A 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLIN 117 (309)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecC
Confidence 3578999999999999965 6889999999765322 3668899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 118 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 118 GVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAG-ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc-CCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 99999999742 45899999999999999999999998 999999999999999999999999998766433
Q ss_pred -CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 -TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....++..|+|||++.+..++.++||||||+++|||++|+.||..... ..+......... .... .
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~----~~~~-~-- 257 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAIP----RPST-V-- 257 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCCC----CGGG-T--
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCCC----Cccc-c--
Confidence 234567789999999999999999999999999999999999975321 111111111110 0000 0
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhhhcCC
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRP-AMQEVVRMIENMNRGE 620 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~~ 620 (654)
......++.+++.+||+.||++|| +++++++.|+++....
T Consensus 258 -~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 258 -RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 111223567788899999999999 9999999999887554
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=335.81 Aligned_cols=244 Identities=22% Similarity=0.342 Sum_probs=198.4
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEeccccc-------CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEE
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV-------GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv 419 (654)
|.+.+.||+|+||.||+|... +|+.||+|+++.... ..+++.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (321)
T 2a2a_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLI 93 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 345688999999999999965 589999999975432 356799999999999999999999999999999999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC----CeEEeccCCCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH----DACVSDFGLNP 495 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~----~~kl~Dfgla~ 495 (654)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++.
T Consensus 94 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~-ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 94 LELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp ECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 999999999999973 345899999999999999999999998 99999999999999888 79999999997
Q ss_pred CcCCC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhh
Q 036334 496 LFGNT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 496 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 572 (654)
..... ....++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... .++
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~---~~~ 238 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITSVSY---DFD 238 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTCC---CCC
T ss_pred ecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhccc---ccC
Confidence 66543 234577889999999999999999999999999999999999965321 122222211110 001
Q ss_pred HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 573 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
... .. .....+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~--~~---~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 239 EEF--FS---HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHH--HT---TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hhh--hc---ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 110 00 11235677888999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=338.03 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=191.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
..+.||+|+||+||+|... +|+.||||++...... .+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 7 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (311)
T 4agu_A 7 KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH 86 (311)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCC
Confidence 3578999999999999975 4899999998665433 35678899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...... .
T Consensus 87 ~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (311)
T 4agu_A 87 TVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHKHN-CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160 (311)
T ss_dssp EHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred chHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC-CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence 999998873 345899999999999999999999998 999999999999999999999999999776532 2
Q ss_pred CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------------chhh
Q 036334 502 PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE------------EWTA 568 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------------~~~~ 568 (654)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ...+...... .+..
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhcccccccccccccccccc
Confidence 3456778999999875 6789999999999999999999999976432211 1111111100 0000
Q ss_pred hhhhHhhhccCC----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 569 EVFDVELMRYHN----IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 569 ~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
....+....... .......+.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000 01123357788889999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=334.09 Aligned_cols=247 Identities=23% Similarity=0.311 Sum_probs=189.8
Q ss_pred ccccccCceeEEEEEe-cCCcEEEEEEecccc-cCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 352 EVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA-VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
++||+|+||+||+|.. .+++.||||++.... .....+.+|++++.++ +||||+++++++.+++..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 6799999999999995 468999999997653 3467789999999885 799999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC---eEEeccCCCCCcCCC-----
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD---ACVSDFGLNPLFGNT----- 500 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~---~kl~Dfgla~~~~~~----- 500 (654)
.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++. +||+|||++......
T Consensus 99 ~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (316)
T 2ac3_A 99 LSHIHKR-----RHFNELEASVVVQDVASALDFLHNKG-IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172 (316)
T ss_dssp HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred HHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence 9999742 35899999999999999999999998 999999999999998776 999999998765321
Q ss_pred ------CCCCccccccCccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCCh-----h---HHHHHH
Q 036334 501 ------TPPTRVAGYRAPEVVET-----RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDL-----P---RWVQSV 561 (654)
Q Consensus 501 ------~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~-----~---~~~~~~ 561 (654)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+.... . ..+...
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
T 2ac3_A 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252 (316)
T ss_dssp ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHH
T ss_pred ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHH
Confidence 12347788999999865 5688999999999999999999999986543321100 0 000011
Q ss_pred hhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 562 VREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
+.... ......... .....+.+++.+||+.||++|||++|+++
T Consensus 253 i~~~~----~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 253 IQEGK----YEFPDKDWA---HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHCC----CCCCHHHHT---TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhccC----cccCchhcc---cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11100 000000000 11235778888999999999999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=326.10 Aligned_cols=242 Identities=21% Similarity=0.283 Sum_probs=194.8
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (276)
T 2yex_A 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 89 (276)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCC
Confidence 34678999999999999965 68999999987543 2346788999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC------
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN------ 499 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~------ 499 (654)
++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 90 GELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp EEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhCC-eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 999999973 345899999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 500 TTPPTRVAGYRAPEVVETRKV-TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 500 ~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
.....++..|+|||++.+..+ +.++||||||+++|||++|+.||....... ............ .
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~---~------- 228 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----QEYSDWKEKKTY---L------- 228 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-----HHHHHHHTTCTT---S-------
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-----HHHHHhhhcccc---c-------
Confidence 123456778999999987665 788999999999999999999997643221 001111111000 0
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.........+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001112235667888999999999999999876
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=336.62 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=199.9
Q ss_pred hhccccccCceeEEEEEec-CCcE--EEEEEeccc--ccCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTT--VVVKRLKEV--AVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~--vavK~~~~~--~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.+.||+|+||.||+|... +|.. ||+|+++.. ....+.+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~ 108 (327)
T 1fvr_A 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 108 (327)
T ss_dssp EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecC
Confidence 4578999999999999854 4554 499988753 23446788999999999 8999999999999999999999999
Q ss_pred CCCchhhhhccCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccC
Q 036334 424 PAGSLSALLHGSR-----------GSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFG 492 (654)
Q Consensus 424 ~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfg 492 (654)
++|+|.+++.... ......+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIl~~~~~~~kL~Dfg 187 (327)
T 1fvr_A 109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFG 187 (327)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECGGGCEEECCTT
T ss_pred CCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCccceEEEcCCCeEEEcccC
Confidence 9999999997542 012346999999999999999999999998 9999999999999999999999999
Q ss_pred CCCCcCC---CCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 493 LNPLFGN---TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 493 la~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
++..... .....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ......+. ....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~~~~-~~~~- 259 (327)
T 1fvr_A 188 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLP-QGYR- 259 (327)
T ss_dssp CEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHGG-GTCC-
T ss_pred cCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------HHHHHHhh-cCCC-
Confidence 9875432 223345667999999988889999999999999999998 9999965321 11111111 1100
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGET 621 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 621 (654)
..........+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 260 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 260 ---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp ---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 01111222457778889999999999999999999999987653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=330.74 Aligned_cols=245 Identities=25% Similarity=0.344 Sum_probs=196.0
Q ss_pred cccccCceeEEEEEec---CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 353 VLGKGSVGTSYKAVLE---EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 353 ~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.||+|+||.||+|.+. .++.||||+++..... .+++.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 7999999999999642 3678999999765322 46788999999999999999999998 667889999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-----
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT----- 501 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~----- 501 (654)
+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 103 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 176 (291)
T 1xbb_A 103 PLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 176 (291)
T ss_dssp EHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHhCC-eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccc
Confidence 999999742 35899999999999999999999998 9999999999999999999999999987664332
Q ss_pred --CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 502 --PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 502 --~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||...... . +...+..... .
T Consensus 177 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~----------~ 239 (291)
T 1xbb_A 177 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------E-VTAMLEKGER----------M 239 (291)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCC----------C
T ss_pred cccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCC----------C
Confidence 1234567999999988889999999999999999999 99999753221 1 1111111110 0
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCC
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGET 621 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 621 (654)
.........+.+++.+||+.||++||++.++++.|+++....+
T Consensus 240 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 240 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1111223467788889999999999999999999999876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=333.91 Aligned_cols=245 Identities=25% Similarity=0.353 Sum_probs=191.4
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.+.+.||+|+||.||++... ++..||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 104 (285)
T 3is5_A 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG 104 (285)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSC
T ss_pred eecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCC
Confidence 44688999999999999964 58899999987653 3457899999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEE---CCCCCeEEeccCCCCCcCCC--
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL---RPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll---~~~~~~kl~Dfgla~~~~~~-- 500 (654)
|+|.+++..... ....+++..++.++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||++......
T Consensus 105 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~-ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 182 (285)
T 3is5_A 105 GELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQH-VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182 (285)
T ss_dssp CBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------
T ss_pred CcHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC-EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc
Confidence 999998854311 1245999999999999999999999998 9999999999999 45678999999999876433
Q ss_pred -CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 -TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....++..|+|||++. +.++.++||||||+++|||++|+.||..... ............... .
T Consensus 183 ~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~---------~ 246 (285)
T 3is5_A 183 STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------EEVQQKATYKEPNYA---------V 246 (285)
T ss_dssp ----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCCC---------C
T ss_pred CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH------HHHHhhhccCCcccc---------c
Confidence 3345677899999986 5789999999999999999999999975321 111111111110000 0
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.......++.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00011235667888999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.64 Aligned_cols=240 Identities=24% Similarity=0.354 Sum_probs=194.3
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||+|... ++..||+|++.... .....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (279)
T 3fdn_A 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 92 (279)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCC
Confidence 3578999999999999865 47799999986542 235678899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--CC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--TP 502 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--~~ 502 (654)
+|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 93 ~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~-i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 166 (279)
T 3fdn_A 93 LGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD 166 (279)
T ss_dssp TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT-CEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-EecccCChHhEEEcCCCCEEEEeccccccCCcccccc
Confidence 99999999743 35899999999999999999999998 999999999999999999999999998665433 33
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..++..|+|||.+.+..++.++||||||+++|||++|+.||.... .......+..... ....
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~------------~~~~ 228 (279)
T 3fdn_A 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETYKRISRVEF------------TFPD 228 (279)
T ss_dssp -CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTCC------------CCCT
T ss_pred cCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc------HHHHHHHHHhCCC------------CCCC
Confidence 466788999999999999999999999999999999999997432 1111111111110 0111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
.....+.+++.+||+.||++|||++|+++.-
T Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 229 FVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred cCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 1223566788899999999999999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.51 Aligned_cols=238 Identities=23% Similarity=0.284 Sum_probs=193.7
Q ss_pred hhccccccCceeEEEEEecC-CcEEEEEEecccc----cCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVA----VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.++||+|+||+||+|.... |+.||+|++++.. ...+.+..|..++..+ +||||+++++++.+.+..|+||||+
T Consensus 24 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~ 103 (353)
T 2i0e_A 24 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 103 (353)
T ss_dssp EEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCC
Confidence 35789999999999999764 7899999997642 3445678899999887 7999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN---- 499 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~---- 499 (654)
++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 104 ~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 177 (353)
T 2i0e_A 104 NGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177 (353)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence 999999999742 35899999999999999999999998 99999999999999999999999999976432
Q ss_pred CCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 500 TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 500 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+...... .
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~~~---------~-- 240 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------EDELFQSIMEHNVA---------Y-- 240 (353)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC---------C--
T ss_pred cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC------HHHHHHHHHhCCCC---------C--
Confidence 234567888999999999999999999999999999999999997532 12222222221110 0
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPA-----MQEVVR 611 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 611 (654)
......++.+++.+||..||++||+ ++|+++
T Consensus 241 -p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 241 -PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1112235677888999999999995 466654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=331.50 Aligned_cols=247 Identities=22% Similarity=0.337 Sum_probs=196.3
Q ss_pred hhccccccCceeEEEEEecC----CcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLEE----GTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.+.||+|+||.||+|...+ +..||+|+++... ...+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 94 (281)
T 3cc6_A 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELY 94 (281)
T ss_dssp EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecC
Confidence 35789999999999998543 3369999987652 235678899999999999999999999764 4678999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 95 PYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLESIN-CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp TTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred CCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence 999999999743 245899999999999999999999998 999999999999999999999999998766433
Q ss_pred --CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 501 --TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
....++..|+|||++.+..++.++||||||+++|||++ |+.||......+ . .... .....
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~---~~~~-~~~~~---------- 232 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---V---IGVL-EKGDR---------- 232 (281)
T ss_dssp ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---H---HHHH-HHTCC----------
T ss_pred ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---H---HHHH-hcCCC----------
Confidence 22344567999999988899999999999999999998 999997533221 1 1111 11100
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
..........+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 001111223577788899999999999999999999988653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=344.08 Aligned_cols=248 Identities=21% Similarity=0.349 Sum_probs=182.1
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHhccC-CCccccccEEEEe--------CCceEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIK-HDNVVPLRAFYYS--------KDEKLL 418 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~--------~~~~~l 418 (654)
+.++||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++++. ||||+++++++.. ....++
T Consensus 32 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~l 111 (337)
T 3ll6_A 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111 (337)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEE
T ss_pred EEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEE
Confidence 4578999999999999964 68999999986543 33456889999999996 9999999999853 334799
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC-CeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 419 VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG-KIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
||||++ |+|.+++.... ....+++..++.++.|++.||+|||+++ +|+||||||+|||++.++.+||+|||++...
T Consensus 112 v~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 188 (337)
T 3ll6_A 112 LTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188 (337)
T ss_dssp EEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCC
T ss_pred EEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceec
Confidence 999995 79999886432 2346999999999999999999999774 4999999999999999999999999999876
Q ss_pred CCCC----------------CCCccccccCcccc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHH
Q 036334 498 GNTT----------------PPTRVAGYRAPEVV---ETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWV 558 (654)
Q Consensus 498 ~~~~----------------~~~~~~~y~aPE~~---~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~ 558 (654)
.... ...++..|+|||++ .+..++.++|||||||++|||++|+.||....... ..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~ 262 (337)
T 3ll6_A 189 SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR------IV 262 (337)
T ss_dssp SSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred cccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH------hh
Confidence 5321 22367779999998 56778999999999999999999999997532211 00
Q ss_pred HHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 559 QSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
...... .........+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 263 ----~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 263 ----NGKYSI----------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -------CCC----------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ----cCcccC----------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 000000 000111123667888999999999999999999999997654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=339.97 Aligned_cols=255 Identities=27% Similarity=0.374 Sum_probs=201.1
Q ss_pred HhhccccccCceeEEEEEe------cCCcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccccccEEEEeCC-ceEE
Q 036334 349 ASAEVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKD-EKLL 418 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~-~~~l 418 (654)
.+.+.||+|+||.||+|.. .+++.||||+++.... ..+.+.+|+.++.++ +||||+++++++...+ ..++
T Consensus 30 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~l 109 (316)
T 2xir_A 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 109 (316)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred eeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEE
Confidence 3457899999999999984 2467899999976533 345688999999999 6999999999988755 4899
Q ss_pred EEEecCCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeE
Q 036334 419 VYDYMPAGSLSALLHGSRGS-----------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDAC 487 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~k 487 (654)
||||+++|+|.+++...... ....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+|
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-i~H~dikp~Nil~~~~~~~k 188 (316)
T 2xir_A 110 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVK 188 (316)
T ss_dssp EEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEE
T ss_pred EEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC-cccccCccceEEECCCCCEE
Confidence 99999999999999754321 0123899999999999999999999998 99999999999999999999
Q ss_pred EeccCCCCCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 036334 488 VSDFGLNPLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQS 560 (654)
Q Consensus 488 l~Dfgla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~ 560 (654)
|+|||++....... ...++..|+|||++.+..++.++|||||||++|||++ |..||......+ .+..
T Consensus 189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~ 262 (316)
T 2xir_A 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCR 262 (316)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------HHHH
T ss_pred ECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH------HHHH
Confidence 99999998664332 2234567999999998999999999999999999998 999997543211 1111
Q ss_pred HhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 561 VVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
........ ........++.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 263 ~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 263 RLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HhccCccC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11111100 001112235778888999999999999999999999987543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=327.52 Aligned_cols=243 Identities=20% Similarity=0.292 Sum_probs=195.9
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEeccc-ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV-AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
|.+.+.||+|+||.||+|... ++..||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (277)
T 3f3z_A 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90 (277)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCC
Confidence 345678999999999999965 4778999998765 34567899999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEE---CCCCCeEEeccCCCCCcCCC--
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL---RPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll---~~~~~~kl~Dfgla~~~~~~-- 500 (654)
++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||++......
T Consensus 91 ~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 91 GELFERVVH-----KRVFRESDAARIMKDVLSAVAYCHKLN-VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp CBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 999998874 245899999999999999999999998 9999999999999 78899999999998765433
Q ss_pred -CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 -TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....++..|+|||++.+ .++.++||||||+++|||++|+.||..... ......+........ .. ...
T Consensus 165 ~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~--~~---~~~ 232 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD------SEVMLKIREGTFTFP--EK---DWL 232 (277)
T ss_dssp BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCCC--HH---HHT
T ss_pred hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCCCC--ch---hhh
Confidence 33457788999999865 499999999999999999999999975322 111222111111000 00 000
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.....+.+++.+||+.||++|||+.++++
T Consensus 233 ---~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 233 ---NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12245777888999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.45 Aligned_cols=241 Identities=20% Similarity=0.312 Sum_probs=189.2
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccC---HHHHHHHHHHHhccCC--CccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKH--DNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||++...+++.||||++...... .+.+.+|+.++++++| |||+++++++.+++..++||| +.
T Consensus 13 i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~ 91 (343)
T 3dbq_A 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 91 (343)
T ss_dssp EEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CC
T ss_pred EEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CC
Confidence 35789999999999999888999999998755333 3568899999999986 999999999999999999999 55
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
+|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++ ++.+||+|||++.......
T Consensus 92 ~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~-iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 92 NIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHG-IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp SEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 8899999974 345899999999999999999999998 99999999999997 6789999999998764332
Q ss_pred ---CCCccccccCccccCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchh
Q 036334 502 ---PPTRVAGYRAPEVVET-----------RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWT 567 (654)
Q Consensus 502 ---~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 567 (654)
...+++.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+.........
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNHE 239 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTTSC
T ss_pred cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHhcCCcc
Confidence 3457888999999864 6789999999999999999999999964321 11112221111110
Q ss_pred hhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 568 AEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
. ........++.+++.+||+.||++|||+.|+++.-
T Consensus 240 ~----------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 240 I----------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp C----------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred c----------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 0 00111123567788899999999999999998753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=327.33 Aligned_cols=252 Identities=21% Similarity=0.356 Sum_probs=200.7
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEeccccc-------CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV-------GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVY 420 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 420 (654)
.+.+.||+|+||.||+|... +|+.||+|+++.... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 87 (283)
T 3bhy_A 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLIL 87 (283)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEE
Confidence 34678999999999999976 589999999875421 3577899999999999999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC----CeEEeccCCCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH----DACVSDFGLNPL 496 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~----~~kl~Dfgla~~ 496 (654)
||+++++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++ .+||+|||++..
T Consensus 88 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 88 ELVSGGELFDFLAE-----KESLTEDEATQFLKQILDGVHYLHSKR-IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp ECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999999973 245899999999999999999999998 99999999999999877 799999999876
Q ss_pred cCCC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 497 FGNT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 497 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
.... ....++..|+|||++.+..++.++||||||+++|||++|+.||..... ......+...... .+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~---~~~ 232 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK------QETLTNISAVNYD---FDE 232 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCCC---CCH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch------HHHHHHhHhcccC---Ccc
Confidence 6433 234567789999999989999999999999999999999999975321 1111111111100 000
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhhhcCC
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR--MIENMNRGE 620 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~--~L~~~~~~~ 620 (654)
.. . ......+.+++.+||+.||++|||+.|+++ .++++....
T Consensus 233 ~~--~---~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 233 EY--F---SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HH--H---TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred hh--c---ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 00 0 011235677888999999999999999997 467776554
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=337.64 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=202.2
Q ss_pred HhhccccccCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVY 420 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 420 (654)
.+.+.||+|+||.||+|... .++.||||++..... ...++.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 107 (322)
T 1p4o_A 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 107 (322)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEE
Confidence 34578999999999999854 367899999975432 3346889999999999999999999999999999999
Q ss_pred EecCCCchhhhhccCC-----CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCC
Q 036334 421 DYMPAGSLSALLHGSR-----GSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP 495 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~ 495 (654)
||+++|+|.+++...+ ......+++..+++++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 108 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dikp~NIli~~~~~~kl~Dfg~~~ 186 (322)
T 1p4o_A 108 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTR 186 (322)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred EeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-CccCCCccceEEEcCCCeEEECcCcccc
Confidence 9999999999997431 011245799999999999999999999998 9999999999999999999999999987
Q ss_pred CcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 496 LFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 496 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
..... ....++..|+|||++.+..++.++||||||+++|||++ |..||..... ......+.....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~~-- 258 (322)
T 1p4o_A 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRFVMEGGL-- 258 (322)
T ss_dssp GGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHHHHHTTCC--
T ss_pred ccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH------HHHHHHHHcCCc--
Confidence 65332 12334567999999998899999999999999999999 8899865321 111221111110
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
..........+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 259 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 259 ---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 0011122345777888999999999999999999999886543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.12 Aligned_cols=245 Identities=18% Similarity=0.239 Sum_probs=194.2
Q ss_pred hhccccccCceeEEEEEecC-CcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.++||+|+||+||+|...+ ++.||+|++++.. .....+.+|+.++..++||||++++++|.+++..++||||++
T Consensus 78 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~ 157 (437)
T 4aw2_A 78 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYV 157 (437)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCC
Confidence 35789999999999999764 7899999997532 223348889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 158 gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~~g-iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 232 (437)
T 4aw2_A 158 GGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLH-YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232 (437)
T ss_dssp TCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred CCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence 99999999742 245999999999999999999999998 999999999999999999999999999765432
Q ss_pred -CCCCccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 501 -TPPTRVAGYRAPEVVE-----TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
....+|+.|+|||++. ...++.++|||||||++|||++|+.||.... .......+......
T Consensus 233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~------~~~~~~~i~~~~~~------- 299 (437)
T 4aw2_A 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKER------- 299 (437)
T ss_dssp CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTHHHH-------
T ss_pred cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC------hhHHHHhhhhcccc-------
Confidence 2346788999999986 5678999999999999999999999997532 22222222211100
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQ--RPAMQEVVRM 612 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 612 (654)
+...........++.+++.+|+..+|++ ||+++|+++.
T Consensus 300 ~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 300 FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0000110112234566777999888888 9999999763
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=329.04 Aligned_cols=243 Identities=21% Similarity=0.305 Sum_probs=195.7
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.+.||+|+||.||+|... +|+.||+|++...... .+.+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 89 (284)
T 3kk8_A 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89 (284)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred hhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCC
Confidence 3578999999999999865 5889999999765433 35678899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC---eEEeccCCCCCcCCCC-
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD---ACVSDFGLNPLFGNTT- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~---~kl~Dfgla~~~~~~~- 501 (654)
++|.+.+... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++. +||+|||++.......
T Consensus 90 ~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 90 GELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG-IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 9999888732 45899999999999999999999998 999999999999987665 9999999997665432
Q ss_pred --CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 502 --PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 502 --~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
...++..|+|||++.+..++.++||||||+++|||++|+.||..... ......+....... .....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~-----~~~~~- 231 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAYDY-----PSPEW- 231 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCC-----CTTTT-
T ss_pred ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch------hHHHHHHHhccccC-----Cchhh-
Confidence 34577889999999999999999999999999999999999965321 12222221111100 00000
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.....++.+++.+||+.||++|||++|+++.
T Consensus 232 --~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 232 --DTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp --TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --cccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1122356778889999999999999999884
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=327.90 Aligned_cols=239 Identities=21% Similarity=0.363 Sum_probs=177.2
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 15 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (278)
T 3cok_A 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCH 94 (278)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCC
Confidence 357899999999999996 468999999996542 224678899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 169 (278)
T 3cok_A 95 NGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHSHG-ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169 (278)
T ss_dssp TEEHHHHHHTC----SSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred CCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence 99999999743 246899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
....++..|+|||.+.+..++.++||||||+++|||++|+.||......+. ......... ..
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~------------~~ 231 (278)
T 3cok_A 170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------LNKVVLADY------------EM 231 (278)
T ss_dssp ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSSCC------------CC
T ss_pred eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------HHHHhhccc------------CC
Confidence 234567789999999988999999999999999999999999976432221 011110000 00
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
......++.+++.+||+.||++|||++++++
T Consensus 232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1112235677888999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.80 Aligned_cols=245 Identities=21% Similarity=0.313 Sum_probs=191.9
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecCC
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
|.+.+.||+|+||.||++... +|+.||||+++.... ...+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g 100 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence 345678999999999999965 588999999976543 235678888777 799999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC-C---CeEEeccCCCCCcCCC-
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD-H---DACVSDFGLNPLFGNT- 500 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~-~---~~kl~Dfgla~~~~~~- 500 (654)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+..+ + .+||+|||++......
T Consensus 101 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~g-ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 101 GELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQG-VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 999999973 345899999999999999999999998 9999999999998543 3 4999999999865432
Q ss_pred ---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 501 ---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 501 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
....+++.|+|||++.+..++.++|||||||++|||++|+.||...... ........+....... ....
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~~~~i~~~~~~~-----~~~~ 246 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD---TPEEILARIGSGKFSL-----SGGY 246 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS---CHHHHHHHHHHCCCCC-----CSTT
T ss_pred CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC---CHHHHHHHHccCCccc-----Cccc
Confidence 2345678899999998888999999999999999999999999753221 1222222222211100 0000
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
+. ....++.+++.+||..||++|||+.|+++.
T Consensus 247 ~~---~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 247 WN---SVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TT---TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cc---cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 122356677889999999999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=343.22 Aligned_cols=240 Identities=20% Similarity=0.303 Sum_probs=189.6
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEeccccc---CHHHHHHHHHHHhccC--CCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV---GKREFEMQMEVLGKIK--HDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~--hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||++...+++.||||++..... ..+.+.+|++++++++ ||||+++++++..++..++||| +.
T Consensus 60 ~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~ 138 (390)
T 2zmd_A 60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 138 (390)
T ss_dssp EEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CC
T ss_pred EEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cC
Confidence 3578999999999999988899999999875433 2456889999999996 5999999999999999999999 56
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||++......
T Consensus 139 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~-ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 139 NIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG-IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp SEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHTTT-CCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 88999999743 35899999999999999999999998 99999999999996 589999999999876432
Q ss_pred --CCCCccccccCccccCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchh
Q 036334 501 --TPPTRVAGYRAPEVVET-----------RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWT 567 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 567 (654)
....+++.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+..+......
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNHE 286 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHCTTSC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHhCcccc
Confidence 23457888999999864 4689999999999999999999999964321 11222222211110
Q ss_pred hhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 568 AEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
. . ..... ..++.+++.+||+.||++|||+.|+++.
T Consensus 287 ~-----~--~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 287 I-----E--FPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp C-----C--CCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C-----C--CCccc---hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 0 0 00111 2356778889999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=344.32 Aligned_cols=258 Identities=21% Similarity=0.275 Sum_probs=198.5
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccC--------CCccccccEEEE----eCCc
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIK--------HDNVVPLRAFYY----SKDE 415 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~--------hpniv~l~~~~~----~~~~ 415 (654)
.+.+.||+|+||+||+|... +++.||||+++......+.+.+|+.++++++ |+||+++++++. +...
T Consensus 40 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~ 119 (397)
T 1wak_A 40 HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTH 119 (397)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEE
T ss_pred EEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCce
Confidence 34578999999999999854 5889999999876555677889999998885 788999999987 4557
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCeecCCCCCCcEEECCCC----------
Q 036334 416 KLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS-GKIVHGNIKASNILLRPDH---------- 484 (654)
Q Consensus 416 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~ivHrDlk~~NIll~~~~---------- 484 (654)
.++||||+ +++|.+.+... ....+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 120 ~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~g-ivHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 120 ICMVFEVL-GHHLLKWIIKS---NYQGLPLPCVKKIIQQVLQGLDYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EEEEECCC-CCBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTC-EECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred EEEEEecc-CccHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHeeEeccchhhhhhhhhh
Confidence 89999999 55666665433 234599999999999999999999998 7 99999999999999775
Q ss_pred ---------------------------------------CeEEeccCCCCCcCCC-CCCCccccccCccccCCCCCCcch
Q 036334 485 ---------------------------------------DACVSDFGLNPLFGNT-TPPTRVAGYRAPEVVETRKVTFKS 524 (654)
Q Consensus 485 ---------------------------------------~~kl~Dfgla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~ 524 (654)
.+||+|||++...... ....++..|+|||++.+..++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 274 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHH
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHH
Confidence 7999999999766543 345678889999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---h---------chhhhhh------------------hHh
Q 036334 525 DVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR---E---------EWTAEVF------------------DVE 574 (654)
Q Consensus 525 DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---~---------~~~~~~~------------------~~~ 574 (654)
|||||||++|||++|+.||......+.......+..+.. . .+....+ +..
T Consensus 275 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (397)
T 1wak_A 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL 354 (397)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHH
T ss_pred HHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhh
Confidence 999999999999999999986554432211111111110 0 0000000 000
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
........+....+.+|+.+||+.||++|||++|+++
T Consensus 355 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0112234566678899999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=335.29 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=190.7
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEeccccc------CHHHHHHHHHHHhccC---CCccccccEEEEeCC-----
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAV------GKREFEMQMEVLGKIK---HDNVVPLRAFYYSKD----- 414 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~e~~~l~~l~---hpniv~l~~~~~~~~----- 414 (654)
+.+.||+|+||+||+|.. .+|+.||||+++.... ....+.+|++++++++ ||||++++++|....
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~ 92 (308)
T 3g33_A 13 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREI 92 (308)
T ss_dssp EEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEE
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCce
Confidence 457899999999999995 4689999999874321 2346777887776664 999999999998765
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCC
Q 036334 415 EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN 494 (654)
Q Consensus 415 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla 494 (654)
..++||||+. |+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 93 ~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 93 KVTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHANC-IVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp EEEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred eEEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 4799999996 59999997542 234999999999999999999999998 999999999999999999999999999
Q ss_pred CCcCCCCC---CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh-------
Q 036334 495 PLFGNTTP---PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE------- 564 (654)
Q Consensus 495 ~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------- 564 (654)
........ ..++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+..+...
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 168 RIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA------DQLGKIFDLIGLPPED 241 (308)
T ss_dssp TTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH------HHHHHHHHHHCCCCTT
T ss_pred cccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCChh
Confidence 87654332 35577899999999999999999999999999999999999754321 111111110
Q ss_pred chhhhhh--hHhhhc--cCC----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 565 EWTAEVF--DVELMR--YHN----IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 565 ~~~~~~~--~~~~~~--~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.+..... ...+.. ... ..+....+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000000 000000 000 0112245677888999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=354.07 Aligned_cols=243 Identities=27% Similarity=0.332 Sum_probs=197.1
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV----AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.++||+|+||.||+|... +|+.||+|++... ......+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 268 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence 478999999999999965 6899999999754 23345688999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---CC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---TP 502 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~~ 502 (654)
|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 269 g~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~g-IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~ 344 (576)
T 2acx_A 269 GDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 344 (576)
T ss_dssp CBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEEC
T ss_pred CcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-EeccCCchheEEEeCCCCeEEEecccceecccCccccc
Confidence 99999997532 345899999999999999999999998 999999999999999999999999999876543 23
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..+|+.|+|||++.+..++.++|||||||++|||++|+.||....... .... +...+.... .....
T Consensus 345 ~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--~~~~-i~~~i~~~~-----------~~~p~ 410 (576)
T 2acx_A 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREE-VERLVKEVP-----------EEYSE 410 (576)
T ss_dssp CCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--CHHH-HHHHHHHCC-----------CCCCT
T ss_pred cCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--hHHH-HHHHhhccc-----------ccCCc
Confidence 567888999999999899999999999999999999999997643221 1111 111111100 00011
Q ss_pred HHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRP-----AMQEVVR 611 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 611 (654)
....++.+++.+||+.||++|| +++|+++
T Consensus 411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1223566788899999999999 7788865
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=337.22 Aligned_cols=250 Identities=21% Similarity=0.222 Sum_probs=193.0
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEecccc------cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEE
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA------VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVY 420 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 420 (654)
|.+.+.||+|+||.||+|... ++..||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 107 (345)
T 3hko_A 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107 (345)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEE
Confidence 345788999999999999864 58899999986542 23467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhccCCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcc
Q 036334 421 DYMPAGSLSALLHGSRGS-----------------------------------GRTPLDWDNRMRIALSAARGLAHLHVS 465 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~ 465 (654)
||+++|+|.+++...... ....+++..++.++.|++.||+|||++
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 187 (345)
T 3hko_A 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ 187 (345)
T ss_dssp ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 999999999998521100 011246778889999999999999999
Q ss_pred CCeecCCCCCCcEEECCCC--CeEEeccCCCCCcCC--------CCCCCccccccCccccCC--CCCCcchhHHHHHHHH
Q 036334 466 GKIVHGNIKASNILLRPDH--DACVSDFGLNPLFGN--------TTPPTRVAGYRAPEVVET--RKVTFKSDVYSFGVLL 533 (654)
Q Consensus 466 ~~ivHrDlk~~NIll~~~~--~~kl~Dfgla~~~~~--------~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil 533 (654)
+ |+||||||+||+++.++ .+||+|||++..... .....++..|+|||++.+ ..++.++|||||||++
T Consensus 188 ~-ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il 266 (345)
T 3hko_A 188 G-ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266 (345)
T ss_dssp T-EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHH
T ss_pred C-ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHH
Confidence 8 99999999999998776 899999999975432 123456788999999865 6789999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 534 LELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 534 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
|||++|+.||..... ...+..+......... + . .......+.+++.+||+.||++|||+.|+++.
T Consensus 267 ~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~~--~---~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 267 HLLLMGAVPFPGVND------ADTISQVLNKKLCFEN--P---N---YNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHSSCSSCCSSH------HHHHHHHHHCCCCTTS--G---G---GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHCCCCCCCCCh------HHHHHHHHhcccccCC--c---c---cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 999999999975322 1222222222111100 0 0 01122356778889999999999999999873
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=336.36 Aligned_cols=239 Identities=22% Similarity=0.333 Sum_probs=195.6
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||++... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 45 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 124 (335)
T 2owb_A 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 124 (335)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCC
Confidence 3578999999999999965 47899999987543 234568889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 125 ~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (335)
T 2owb_A 125 RRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198 (335)
T ss_dssp TCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred CCCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence 9999999873 245899999999999999999999998 999999999999999999999999998765422
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
....++..|+|||++.+..++.++||||||+++|||++|+.||.... .......+..... ..
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~------------~~ 260 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETYLRIKKNEY------------SI 260 (335)
T ss_dssp CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTCC------------CC
T ss_pred cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC------HHHHHHHHhcCCC------------CC
Confidence 23456778999999998899999999999999999999999996532 1111111111110 00
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.......+.+++.+||+.||++|||++|+++.
T Consensus 261 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 261 PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112356778889999999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=343.15 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=200.7
Q ss_pred hhccccccCceeEEEEEecC------CcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLEE------GTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~------g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 420 (654)
+.+.||+|+||.||+|.... +..||+|+++.... ..+.+.+|+.+++++ +||||+++++++.+.+..++||
T Consensus 50 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 129 (333)
T 2i1m_A 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVIT 129 (333)
T ss_dssp EEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEE
Confidence 35789999999999998642 24799999976532 346688999999999 8999999999999999999999
Q ss_pred EecCCCchhhhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEecc
Q 036334 421 DYMPAGSLSALLHGSRG---------SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDF 491 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Df 491 (654)
||+++|+|.+++..... .....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 130 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~NIl~~~~~~~kl~Df 208 (333)
T 2i1m_A 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-CIHRDVAARNVLLTNGHVAKIGDF 208 (333)
T ss_dssp ECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGCEEEGGGEEEBCCC
T ss_pred ecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC-cccCCcccceEEECCCCeEEECcc
Confidence 99999999999864310 01245899999999999999999999998 999999999999999999999999
Q ss_pred CCCCCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhh
Q 036334 492 GLNPLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVRE 564 (654)
Q Consensus 492 gla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 564 (654)
|++....... ...++..|+|||++.+..++.++|||||||++|||++ |..||...... ..+......
T Consensus 209 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------~~~~~~~~~ 282 (333)
T 2i1m_A 209 GLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN------SKFYKLVKD 282 (333)
T ss_dssp GGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS------HHHHHHHHH
T ss_pred ccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh------HHHHHHHhc
Confidence 9998653321 2334567999999988899999999999999999999 89998753321 111222221
Q ss_pred chhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 565 EWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
.... .........+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 283 ~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 283 GYQM----------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC----------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 1110 00111224577888899999999999999999999988643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=353.77 Aligned_cols=239 Identities=21% Similarity=0.256 Sum_probs=188.3
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+.++||+|+||.||+|... +|+.||||+++... .....+.+|+.++++++||||++++++|.+.+..++||||+
T Consensus 151 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 230 (446)
T 4ejn_A 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 230 (446)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCC
T ss_pred EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeC
Confidence 34578999999999999954 58999999997542 22345678999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV-SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 500 (654)
++|+|.+++... ..+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||++......
T Consensus 231 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~g-iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 231 NGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp SSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHHTC-CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCC-EEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 999999999742 458999999999999999999997 77 999999999999999999999999999764322
Q ss_pred --CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 501 --TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+......
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~~~----------- 367 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HEKLFELILMEEIR----------- 367 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC-----------
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC------HHHHHHHHHhCCCC-----------
Confidence 34567888999999999999999999999999999999999996532 12222222211110
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRP-----AMQEVVR 611 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 611 (654)
.......++.+++.+||+.||++|| +++|+++
T Consensus 368 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 -FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0111223567788899999999999 9999876
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.87 Aligned_cols=240 Identities=25% Similarity=0.273 Sum_probs=186.2
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC----HHHHHHHHHH-HhccCCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG----KREFEMQMEV-LGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~e~~~-l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.++||+|+||+||+|... +++.||+|++++.... ...+.+|..+ ++.++||||+++++++.+.+..|+||||+
T Consensus 42 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 121 (373)
T 2r5t_A 42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 121 (373)
T ss_dssp EEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCC
Confidence 3578999999999999965 4789999999765322 2345556665 57789999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN---- 499 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~---- 499 (654)
++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||++.....
T Consensus 122 ~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~ 195 (373)
T 2r5t_A 122 NGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN-IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST 195 (373)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCC
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCHHHEEECCCCCEEEeeCccccccccCCCc
Confidence 999999999742 35899999999999999999999998 99999999999999999999999999976322
Q ss_pred CCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 500 TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 500 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... ....
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~~---------~~~~ 260 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN------TAEMYDNILNKPL---------QLKP 260 (373)
T ss_dssp CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB------HHHHHHHHHHSCC---------CCCS
T ss_pred cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhccc---------CCCC
Confidence 233467888999999999999999999999999999999999997532 1222222222111 0111
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
.. ...+.+++.+||+.||++||++.+.++++
T Consensus 261 ~~---~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 261 NI---TNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp SS---CHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred CC---CHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 12 23466777899999999999986444333
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=337.43 Aligned_cols=254 Identities=24% Similarity=0.425 Sum_probs=198.5
Q ss_pred hhccccccCceeEEEEEe-----cCCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCC--ceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL-----EEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD--EKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~--~~~lv~e 421 (654)
+.+.||+|+||.||++.. .+|+.||||++.... ...+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 124 (326)
T 2w1i_A 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124 (326)
T ss_dssp EEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEEC
T ss_pred eeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEE
Confidence 457899999999999983 358899999997643 23467899999999999999999999987654 6899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT 501 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 501 (654)
|+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 125 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 125 YLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp CCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred CCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC-EeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 99999999999753 235899999999999999999999998 9999999999999999999999999998764332
Q ss_pred -------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-------CCCC-C-hhHHHHHHhhhc
Q 036334 502 -------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLG-------EEGI-D-LPRWVQSVVREE 565 (654)
Q Consensus 502 -------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~~~-~-~~~~~~~~~~~~ 565 (654)
...++..|+|||++.+..++.++||||||+++|||++|..||..... .... . ....+...+...
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence 23345569999999888899999999999999999999998764210 0000 0 000000011000
Q ss_pred hhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 566 WTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
. ..........++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 280 ~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 280 G----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp C----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 011112233467788889999999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=353.25 Aligned_cols=236 Identities=18% Similarity=0.273 Sum_probs=182.3
Q ss_pred hccccccCceeEEEEEe-cCCcEEEEEEeccc----ccCHHHHHHHH---HHHhccCCCcccccc-------EEEEeCCc
Q 036334 351 AEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEV----AVGKREFEMQM---EVLGKIKHDNVVPLR-------AFYYSKDE 415 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~e~---~~l~~l~hpniv~l~-------~~~~~~~~ 415 (654)
.+.||+|+||+||+|.. .+|+.||||++... ....+.+.+|+ +.+++++||||++++ +++.+++.
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 57899999999999995 46899999999743 22346788999 455666899999998 66665532
Q ss_pred -----------------eEEEEEecCCCchhhhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCC
Q 036334 416 -----------------KLLVYDYMPAGSLSALLHGSRGS--GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKAS 476 (654)
Q Consensus 416 -----------------~~lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~ 476 (654)
.++||||+ +|+|.+++...... ....+++..++.++.||+.||+|||+++ |+||||||+
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrDikp~ 235 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-LVHTYLRPV 235 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGG
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHH
Confidence 78999999 68999999743211 1123556889999999999999999998 999999999
Q ss_pred cEEECCCCCeEEeccCCCCCcCCC-CCCCccccccCccccCCC-----------CCCcchhHHHHHHHHHHHHhCCCCCC
Q 036334 477 NILLRPDHDACVSDFGLNPLFGNT-TPPTRVAGYRAPEVVETR-----------KVTFKSDVYSFGVLLLELLTGKAPNQ 544 (654)
Q Consensus 477 NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslGvil~el~tg~~pf~ 544 (654)
|||++.++.+||+|||++...... ....+ ..|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 236 NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~ 314 (377)
T 3byv_A 236 DIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314 (377)
T ss_dssp GEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred HEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCc
Confidence 999999999999999999865543 23345 789999999877 89999999999999999999999997
Q ss_pred CCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 545 ASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.......... +.. ..... ..++.+++.+||+.||++|||+.|+++
T Consensus 315 ~~~~~~~~~~---------------~~~----~~~~~---~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 315 KDAALGGSEW---------------IFR----SCKNI---PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp -----CCSGG---------------GGS----SCCCC---CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred ccccccchhh---------------hhh----hccCC---CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 6433221100 000 00111 235677888999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=335.76 Aligned_cols=243 Identities=21% Similarity=0.306 Sum_probs=193.6
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccC-CCccccccEEEEeCCceEEEEEecCCC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.||+|+||.||+|... +|+.||+|+++... ....++.+|+.+++++. ||||+++++++.+.+..++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 78999999999999865 58999999997653 33567889999999985 699999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC---CCCeEEeccCCCCCcCCC---
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP---DHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~---~~~~kl~Dfgla~~~~~~--- 500 (654)
+|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+||+++. ++.+||+|||++......
T Consensus 115 ~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH~~g-ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 190 (327)
T 3lm5_A 115 EIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQNN-IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL 190 (327)
T ss_dssp EGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------
T ss_pred cHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC-eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcccc
Confidence 999998643 2356999999999999999999999998 999999999999998 789999999999876543
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
....+++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... +.. ...
T Consensus 191 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~-----~~~---~~~ 256 (327)
T 3lm5_A 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN------QETYLNISQVNV-----DYS---EET 256 (327)
T ss_dssp ---CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC-----CCC---TTT
T ss_pred ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHHHhccc-----ccC---chh
Confidence 234578889999999999999999999999999999999999975322 111111111100 000 000
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.......+.+++.+||+.||++|||++|+++.
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11223456778889999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.83 Aligned_cols=243 Identities=22% Similarity=0.324 Sum_probs=185.3
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEeccccc---------CHHHHHHHHHHHhccCCCccccccEEEEeCCceEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---------GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLL 418 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~l 418 (654)
.+.+.||+|+||+||+|... +++.||||++..... ....+.+|++++++++||||+++++++. .+..++
T Consensus 138 ~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~l 216 (419)
T 3i6u_A 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYI 216 (419)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEE
T ss_pred EEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEE
Confidence 34678999999999999865 578999999875421 1224789999999999999999999975 456899
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC---CeEEeccCCCC
Q 036334 419 VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH---DACVSDFGLNP 495 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~---~~kl~Dfgla~ 495 (654)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||++.
T Consensus 217 v~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 217 VLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENG-IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred EEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCChHhEEEecCCCcceEEEeecccce
Confidence 9999999999999873 346999999999999999999999998 99999999999997654 59999999998
Q ss_pred CcCCCC---CCCccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhh
Q 036334 496 LFGNTT---PPTRVAGYRAPEVVET---RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAE 569 (654)
Q Consensus 496 ~~~~~~---~~~~~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 569 (654)
...... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+...+ .......
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i----~~~~~~~ 364 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI----TSGKYNF 364 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHH----HTTCCCC
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHH----hcCCCCC
Confidence 775432 3456788999999853 678899999999999999999999997543222 111111 1110000
Q ss_pred hhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 570 VFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.+. .. ......+.+++.+||+.||++|||++|+++
T Consensus 365 --~~~--~~---~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 365 --IPE--VW---AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp --CHH--HH---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --Cch--hh---cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000 00 011235677888999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=349.59 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=186.2
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCC------ceEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD------EKLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------~~~lv 419 (654)
+.+.||+|+||+||+|... +|+.||||++.... ...+++.+|+.+++.++||||+++++++...+ ..|+|
T Consensus 66 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv 145 (464)
T 3ttj_A 66 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145 (464)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEE
Confidence 4578999999999999854 58899999997643 23456789999999999999999999997553 46999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
|||+++ +|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 146 ~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~-iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 146 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred EeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 999976 56666642 3899999999999999999999998 99999999999999999999999999987654
Q ss_pred C---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------chhh--
Q 036334 500 T---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE------EWTA-- 568 (654)
Q Consensus 500 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~-- 568 (654)
. ....+|..|+|||++.+..|+.++||||+||++|||++|+.||.+.... ..+..+... ....
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~------~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI------DQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCSCCHHHHTTS
T ss_pred CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHhcCCCCHHHHHHc
Confidence 3 3346788899999999999999999999999999999999999764321 111111110 0000
Q ss_pred --------------------hhhhHhhhccCC--hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 569 --------------------EVFDVELMRYHN--IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 569 --------------------~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
..+...+..... ......++.+|+.+||..||++|||++|+++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 01124567888999999999999999999763
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.74 Aligned_cols=189 Identities=30% Similarity=0.460 Sum_probs=154.6
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccC-CCccccccEEEEeCC--ceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIK-HDNVVPLRAFYYSKD--EKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~--~~~lv~e~ 422 (654)
+.+.||+|+||.||+|... +|+.||||++.... ....++.+|+.+++++. ||||+++++++...+ ..|+||||
T Consensus 13 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 92 (388)
T 3oz6_A 13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY 92 (388)
T ss_dssp EEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEEC
T ss_pred EEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecc
Confidence 4578999999999999854 68999999986542 23456778999999997 999999999997654 68999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 500 (654)
++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 93 ME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHSGG-LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp CS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred cC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC-EEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 97 699999873 35899999999999999999999998 999999999999999999999999999754321
Q ss_pred -----------------------CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 036334 501 -----------------------TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQAS 546 (654)
Q Consensus 501 -----------------------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~ 546 (654)
....+|..|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 12356778999999876 67899999999999999999999999764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=340.21 Aligned_cols=255 Identities=16% Similarity=0.188 Sum_probs=197.0
Q ss_pred hhccccccCceeEEEEEecC---------CcEEEEEEecccccCHHHHHHHHHHHhccCCCcccc---------------
Q 036334 350 SAEVLGKGSVGTSYKAVLEE---------GTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVP--------------- 405 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~--------------- 405 (654)
+.+.||+|+||.||+|.... ++.||||++... +.+.+|++++++++||||++
T Consensus 46 ~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp EEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred EEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 35789999999999999763 789999998754 46888999999999999998
Q ss_pred ccEEEEe-CCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC
Q 036334 406 LRAFYYS-KDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH 484 (654)
Q Consensus 406 l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~ 484 (654)
+++++.. ++..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dikp~NIl~~~~~ 196 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENE-YVHGNVTAENIFVDPED 196 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT-CBCSCCCGGGEEEETTE
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCCCCCHHHEEEcCCC
Confidence 6777776 67789999999 999999998531 246999999999999999999999998 99999999999999998
Q ss_pred --CeEEeccCCCCCcCCC-----------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 036334 485 --DACVSDFGLNPLFGNT-----------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEG 551 (654)
Q Consensus 485 --~~kl~Dfgla~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~ 551 (654)
.+||+|||++...... ....++..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 275 (352)
T 2jii_A 197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT- 275 (352)
T ss_dssp EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-
T ss_pred CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH-
Confidence 8999999999765422 22356778999999999999999999999999999999999997643211
Q ss_pred CChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 552 IDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
..+....... ... .....+.. ... .....++.+++.+||+.||++|||++++++.|+++....
T Consensus 276 ~~~~~~~~~~-~~~-~~~~~~~~-~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 276 EDIMKQKQKF-VDK-PGPFVGPC-GHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp HHHHHHHHHH-HHS-CCCEECTT-SCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhc-cCC-hhhhhhhc-ccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 0011111100 000 00000000 000 011245777888999999999999999999999997654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=349.94 Aligned_cols=192 Identities=24% Similarity=0.317 Sum_probs=168.4
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhcc------CCCccccccEEEEeCCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKI------KHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l------~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
+.++||+|+||+||+|... +++.||||+++......+++.+|+.+++.+ .|+||+++++++...+..++||||
T Consensus 101 ~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 180 (429)
T 3kvw_A 101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFEL 180 (429)
T ss_dssp EEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECC
T ss_pred EEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEec
Confidence 4578999999999999865 488999999987655566778888888776 577999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC--eEEeccCCCCCcCCC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD--ACVSDFGLNPLFGNT 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~--~kl~Dfgla~~~~~~ 500 (654)
+. ++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++......
T Consensus 181 ~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~ 255 (429)
T 3kvw_A 181 LS-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255 (429)
T ss_dssp CC-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHHT-EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred cC-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEEccCCCcceEEeecccceecCCc
Confidence 95 69999987542 345899999999999999999999998 999999999999999987 999999999766543
Q ss_pred -CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 036334 501 -TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQAS 546 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 546 (654)
....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 256 VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 3456788899999999999999999999999999999999999764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=327.94 Aligned_cols=241 Identities=18% Similarity=0.244 Sum_probs=193.7
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEec
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
...+.||+|+||.||+|... +++.||+|+++... ....++.+|+..+.++ +||||+++++++.+++..++||||+
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 93 (289)
T 1x8b_A 14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYC 93 (289)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEec
Confidence 44678999999999999975 68999999997542 2345678899999888 8999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC-------------------C
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD-------------------H 484 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~-------------------~ 484 (654)
++|+|.+++..... ....+++..++.++.|++.||+|||+++ |+||||||+||+++.+ .
T Consensus 94 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 171 (289)
T 1x8b_A 94 NGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMS-LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171 (289)
T ss_dssp TTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEC--------------------CC
T ss_pred CCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCC-EeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence 99999999974321 1245899999999999999999999998 9999999999999844 4
Q ss_pred CeEEeccCCCCCcCCCCCCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 036334 485 DACVSDFGLNPLFGNTTPPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR 563 (654)
Q Consensus 485 ~~kl~Dfgla~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 563 (654)
.+||+|||++..........++..|+|||++.+. .++.++|||||||++|||++|.+++.... .......
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~~~~~~ 242 (289)
T 1x8b_A 172 MFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---------QWHEIRQ 242 (289)
T ss_dssp CEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---------HHHHHHT
T ss_pred EEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---------HHHHHHc
Confidence 7999999999888777677788999999999765 56789999999999999999988764321 0111111
Q ss_pred hchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 564 EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..... ........+.+++.+||+.||++|||+.|+++
T Consensus 243 -~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 243 -GRLPR----------IPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -TCCCC----------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCC----------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11000 01112235677888999999999999999976
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=347.20 Aligned_cols=243 Identities=19% Similarity=0.203 Sum_probs=192.2
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.++||+|+||+||++... +|+.||+|++++.. .....+.+|..++.+++||||++++++|.+.+..|+||||+++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g 145 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence 578999999999999975 68999999997532 1234578899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----- 500 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----- 500 (654)
|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||++......
T Consensus 146 g~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g-iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~ 220 (412)
T 2vd5_A 146 GDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLG-YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220 (412)
T ss_dssp CBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecccCHHHeeecCCCCEEEeechhheeccCCCcccc
Confidence 9999999743 235899999999999999999999998 999999999999999999999999999766433
Q ss_pred CCCCccccccCccccC-------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 TPPTRVAGYRAPEVVE-------TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....+|+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+......
T Consensus 221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~------ 288 (412)
T 2vd5_A 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------AETYGKIVHYKEH------ 288 (412)
T ss_dssp SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTHHHH------
T ss_pred ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhcccC------
Confidence 2346788999999986 35789999999999999999999999975321 1222222211100
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCC---CCHHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQR---PAMQEVVRM 612 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~evl~~ 612 (654)
............++.+++.+||. +|++| |+++|+++.
T Consensus 289 -~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 289 -LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred -cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 00000001122356677779999 99998 588888653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.42 Aligned_cols=244 Identities=24% Similarity=0.305 Sum_probs=196.6
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEeccc---ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV---AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
|.+.++||+|+||+||+|... +|+.||||++... ......+.+|++++++++||||+++++++.+....++||||+
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 103 (486)
T 3mwu_A 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELY 103 (486)
T ss_dssp EEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcC
Confidence 345688999999999999965 6899999999654 334677899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEEC---CCCCeEEeccCCCCCcCCC
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR---PDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~---~~~~~kl~Dfgla~~~~~~ 500 (654)
++|+|.+.+... ..+++..++.++.|++.||+|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 104 ~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 104 TGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN-IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 999999988642 45899999999999999999999998 99999999999995 4567999999999876543
Q ss_pred ---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 501 ---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 501 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
....+++.|+|||++.+ .++.++||||+||++|+|++|+.||..... ...+..+........ ...
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~~-----~~~ 245 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVETGKYAFD-----LPQ 245 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCSC-----SGG
T ss_pred CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCCC-----Ccc
Confidence 23467888999999875 599999999999999999999999975321 222222222211110 001
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
+. ....++.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~---~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 246 WR---TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GG---GSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred cC---CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 112356678889999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=334.74 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=196.8
Q ss_pred hhccccccCceeEEEEEe------cCCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~------~~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
+.+.||+|+||.||+|.+ .++..||||++.... ....++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 34 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (327)
T 2yfx_A 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILME 113 (327)
T ss_dssp EEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEe
Confidence 357899999999999984 246789999996542 334578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC---CCeEEeccCCCCC
Q 036334 422 YMPAGSLSALLHGSRGS--GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD---HDACVSDFGLNPL 496 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~---~~~kl~Dfgla~~ 496 (654)
|+++|+|.+++...... ....+++..++.++.|++.||+|||+++ |+||||||+||+++.+ ..+||+|||++..
T Consensus 114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~ 192 (327)
T 2yfx_A 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH-FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192 (327)
T ss_dssp CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC-eecCcCCHhHEEEecCCCcceEEECccccccc
Confidence 99999999999754321 2245899999999999999999999998 9999999999999954 4699999999864
Q ss_pred cCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhh
Q 036334 497 FGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAE 569 (654)
Q Consensus 497 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 569 (654)
.... ....++..|+|||++.+..++.++||||||+++|||++ |..||..... ......+.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~~~~~~~--- 263 (327)
T 2yfx_A 193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFVTSGGR--- 263 (327)
T ss_dssp HHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTTCC---
T ss_pred cccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH------HHHHHHHhcCCC---
Confidence 3221 22344667999999988899999999999999999998 8999865321 111111111110
Q ss_pred hhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 570 VFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
..........+.+++.+||+.||++||++.++++.|+.+...
T Consensus 264 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 264 --------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 001112234577888899999999999999999999988754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=349.14 Aligned_cols=240 Identities=20% Similarity=0.325 Sum_probs=194.5
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.++||+|+||+||+|... +|+.||+|++.+.. .....+.+|++++++++||||+++++++.+.+..|+||||+++
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 367999999999999975 58999999997542 2346788999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 501 (654)
|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 270 g~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g-IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 347 (543)
T 3c4z_A 270 GDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRN-IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347 (543)
T ss_dssp CBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBC
T ss_pred CCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcC-CcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccc
Confidence 999999975432 2346999999999999999999999998 9999999999999999999999999998764332
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...+|+.|+|||++.+..++.++|||||||++|||++|+.||...... .........+..... ...
T Consensus 348 ~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~--~~~~~~~~~i~~~~~------------~~p 413 (543)
T 3c4z_A 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK--VENKELKQRVLEQAV------------TYP 413 (543)
T ss_dssp CCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC--CCHHHHHHHHHHCCC------------CCC
T ss_pred cccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc--hhHHHHHHHHhhccc------------CCC
Confidence 236788899999999999999999999999999999999999764321 122222222221110 001
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAM 606 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~ 606 (654)
......+.+++.+||+.||++||++
T Consensus 414 ~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 414 DKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred cccCHHHHHHHHHhccCCHhHCCCC
Confidence 1122356677889999999999976
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.99 Aligned_cols=239 Identities=21% Similarity=0.321 Sum_probs=195.5
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
..+.||+|+||.||++... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 98 (294)
T 2rku_A 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 98 (294)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCC
Confidence 3578999999999999976 47899999987543 234567889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 99 ~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 172 (294)
T 2rku_A 99 RRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 172 (294)
T ss_dssp TCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence 9999998863 245899999999999999999999998 999999999999999999999999998765422
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ............ ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~------------~~ 234 (294)
T 2rku_A 173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNEY------------SI 234 (294)
T ss_dssp CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCC------------CC
T ss_pred ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhhccC------------CC
Confidence 234567789999999998999999999999999999999999965321 111111111110 00
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.......+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11122356778889999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=335.31 Aligned_cols=255 Identities=19% Similarity=0.283 Sum_probs=198.0
Q ss_pred hhccccccCceeEEEEEe--cCCcEEEEEEecccccCHHHHHHHHHHHhccCCC------ccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL--EEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHD------NVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp------niv~l~~~~~~~~~~~lv~e 421 (654)
+.+.||+|+||.||+|.. .+|+.||||+++......+.+.+|+++++.++|+ +++++++++.+.+..++|||
T Consensus 18 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 97 (339)
T 1z57_A 18 IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE 97 (339)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEE
T ss_pred EEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEc
Confidence 357899999999999986 3588999999987655567788999999888655 49999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC-------------------
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP------------------- 482 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~------------------- 482 (654)
|+ +++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 98 ~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~ 172 (339)
T 1z57_A 98 LL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSNK-LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172 (339)
T ss_dssp CC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred CC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHCC-CcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence 99 889999997542 346899999999999999999999998 999999999999987
Q ss_pred CCCeEEeccCCCCCcCCC-CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH
Q 036334 483 DHDACVSDFGLNPLFGNT-TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSV 561 (654)
Q Consensus 483 ~~~~kl~Dfgla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~ 561 (654)
++.+||+|||++...... ....++..|+|||++.+..++.++|||||||++|||++|+.||......+ ....+...
T Consensus 173 ~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~ 249 (339)
T 1z57_A 173 NPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE---HLAMMERI 249 (339)
T ss_dssp CCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH---HHHHHHHH
T ss_pred CCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHH
Confidence 668999999999876543 34567888999999999999999999999999999999999997543221 11111111
Q ss_pred hhh---chhh--------------------------hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 562 VRE---EWTA--------------------------EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 562 ~~~---~~~~--------------------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
... .... ..................++.+++.+||+.||++|||++|+++.
T Consensus 250 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 100 0000 00000000011123445678899999999999999999999854
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=338.64 Aligned_cols=190 Identities=22% Similarity=0.363 Sum_probs=167.3
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
.+.||+|+||.||+|... +|..||+|+++... ...+.+.+|+.++++++||||+++++++.+++..++||||+++|+
T Consensus 38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 117 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117 (360)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence 478999999999999965 68999999987652 234678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCeecCCCCCCcEEECCCCCeEEeccCCCCCcC--CCCCCC
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS-GKIVHGNIKASNILLRPDHDACVSDFGLNPLFG--NTTPPT 504 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~--~~~~~~ 504 (654)
|.+++... ..+++..+..++.|++.||+|||++ + |+||||||+||+++.++.+||+|||++.... ......
T Consensus 118 L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 191 (360)
T 3eqc_A 118 LDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 191 (360)
T ss_dssp HHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC-CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----C
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC-EEcCCccHHHEEECCCCCEEEEECCCCcccccccccCCC
Confidence 99999743 3589999999999999999999986 6 9999999999999999999999999986542 223346
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQAS 546 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 546 (654)
++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp CCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred CCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 788899999999999999999999999999999999999753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.85 Aligned_cols=244 Identities=22% Similarity=0.332 Sum_probs=194.6
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.+.||+|+||.||++... +|+.||+|+++... ...+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (304)
T 2jam_A 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGG 91 (304)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCc
Confidence 34678999999999999965 68999999997653 33456889999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEE---CCCCCeEEeccCCCCCcCCCC--
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL---RPDHDACVSDFGLNPLFGNTT-- 501 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll---~~~~~~kl~Dfgla~~~~~~~-- 501 (654)
+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||++.......
T Consensus 92 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (304)
T 2jam_A 92 ELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHENG-IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165 (304)
T ss_dssp BHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTH
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccc
Confidence 999998632 35899999999999999999999998 9999999999999 778899999999987654332
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+....... .. ...
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~~~---~~-----~~~ 231 (304)
T 2jam_A 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE------SKLFEKIKEGYYEF---ES-----PFW 231 (304)
T ss_dssp HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHCCCCC---CT-----TTT
T ss_pred cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCCCC---Cc-----ccc
Confidence 12367789999999999999999999999999999999999975321 11122221111100 00 001
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
......+.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 232 DDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1122456778889999999999999999873
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=326.04 Aligned_cols=242 Identities=23% Similarity=0.304 Sum_probs=191.4
Q ss_pred ccccccCceeEEEEEe-cCCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 352 EVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
.+||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4799999999999995 458899999987653 33567889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC-CCCeEEeccCCCCCcCCC----CCCC
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP-DHDACVSDFGLNPLFGNT----TPPT 504 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~~----~~~~ 504 (654)
+++.... ....+++..++.++.|++.||+|||+++ |+||||||+||+++. ++.+||+|||++...... ....
T Consensus 108 ~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 184 (295)
T 2clq_A 108 ALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHDNQ-IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT 184 (295)
T ss_dssp HHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCC
T ss_pred HHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHhCC-EEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccC
Confidence 9997542 2345789999999999999999999998 999999999999987 899999999998766432 2345
Q ss_pred ccccccCccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 505 RVAGYRAPEVVETR--KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 505 ~~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
++..|+|||++.+. .++.++||||||+++|||++|+.||....... ........... ......
T Consensus 185 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~----------~~~~~~ 249 (295)
T 2clq_A 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGMFKV----------HPEIPE 249 (295)
T ss_dssp CCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHHHCC----------CCCCCT
T ss_pred CCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhccccc----------cccccc
Confidence 67789999998764 38899999999999999999999996432110 00000000000 001111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
....++.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22345677888999999999999999976
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.81 Aligned_cols=239 Identities=20% Similarity=0.278 Sum_probs=195.9
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||+|... +++.||+|++.... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 18 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 97 (284)
T 2vgo_A 18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAP 97 (284)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred eeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCC
Confidence 4578999999999999965 57889999986542 234678899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--CC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--TP 502 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--~~ 502 (654)
+|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 98 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 171 (284)
T 2vgo_A 98 RGELYKELQKH-----GRFDEQRSATFMEELADALHYCHERK-VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT 171 (284)
T ss_dssp TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCHHHEEEcCCCCEEEecccccccCccccccc
Confidence 99999999743 35899999999999999999999998 999999999999999999999999998655432 33
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..++..|+|||++.+..++.++||||||+++|||++|+.||..... ......+..... . . ..
T Consensus 172 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~-------~--~---~~ 233 (284)
T 2vgo_A 172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHRRIVNVDL-------K--F---PP 233 (284)
T ss_dssp CCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCC-------C--C---CT
T ss_pred ccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHHHHhcccc-------C--C---CC
Confidence 4567889999999999999999999999999999999999975321 111111111110 0 0 11
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.....+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 234 FLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred cCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 122356778889999999999999999873
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=326.93 Aligned_cols=240 Identities=24% Similarity=0.390 Sum_probs=190.2
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEe----CCceEEEEEe
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYS----KDEKLLVYDY 422 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~ 422 (654)
.+.||+|+||.||+|... ++..||+|++...... .+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 467999999999999864 5789999998765332 4568899999999999999999999875 3457999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC-CeecCCCCCCcEEEC-CCCCeEEeccCCCCCcCCC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG-KIVHGNIKASNILLR-PDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-~ivHrDlk~~NIll~-~~~~~kl~Dfgla~~~~~~ 500 (654)
+++|+|.+++... ..+++..++.++.|++.||+|||+.+ +|+||||||+||+++ .++.+||+|||++......
T Consensus 111 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 111 MTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred cCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 9999999999742 45899999999999999999999875 499999999999998 7899999999999765443
Q ss_pred C--CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 501 T--PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 501 ~--~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
. ...++..|+|||++. +.++.++|||||||++|||++|+.||..... .......... ......++
T Consensus 186 ~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~-~~~~~~~~------ 252 (290)
T 1t4h_A 186 FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTS-GVKPASFD------ 252 (290)
T ss_dssp SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTT-TCCCGGGG------
T ss_pred ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HHHHHHHHhc-cCCccccC------
Confidence 2 345678899999886 4589999999999999999999999965322 1122221111 11111111
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.....++.+++.+||+.||++|||++|+++
T Consensus 253 ---~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 253 ---KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 011135778888999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=326.37 Aligned_cols=241 Identities=23% Similarity=0.346 Sum_probs=197.5
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
..+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 105 (303)
T 3a7i_A 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 105 (303)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred HhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence 3578999999999999854 58899999987543 34578899999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TP 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~ 502 (654)
+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 106 ~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (303)
T 3a7i_A 106 SALDLLEP------GPLDETQIATILREILKGLDYLHSEK-KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178 (303)
T ss_dssp EHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence 99999862 35899999999999999999999998 999999999999999999999999998765432 23
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..++..|+|||++.+..++.++||||||+++|||++|+.||..... ......+ ...... ....
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~-~~~~~~----------~~~~ 241 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP------MKVLFLI-PKNNPP----------TLEG 241 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHH-HHSCCC----------CCCS
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH------HHHHHHh-hcCCCC----------CCcc
Confidence 4567789999999999999999999999999999999999964321 1111111 111000 0011
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 614 (654)
.....+.+++.+||+.||++|||+.|+++...
T Consensus 242 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 242 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 12235777888999999999999999988644
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=335.85 Aligned_cols=242 Identities=21% Similarity=0.349 Sum_probs=193.4
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC---------HHHHHHHHHHHhcc-CCCccccccEEEEeCCceEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---------KREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLL 418 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---------~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~l 418 (654)
+.+.||+|+||.||+|... +|+.||||++...... .+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 98 ~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 177 (365)
T 2y7j_A 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177 (365)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEE
T ss_pred cceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEE
Confidence 3478999999999999975 6999999998654311 34577899999999 79999999999999999999
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 419 VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 178 v~e~~~g~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~g-i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 178 VFDLMRKGELFDYLTE-----KVALSEKETRSIMRSLLEAVSFLHANN-IVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 9999999999999973 245899999999999999999999998 9999999999999999999999999987665
Q ss_pred CC---CCCCccccccCccccCC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhh
Q 036334 499 NT---TPPTRVAGYRAPEVVET------RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAE 569 (654)
Q Consensus 499 ~~---~~~~~~~~y~aPE~~~~------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 569 (654)
.. ....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.......
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~~- 324 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------ILMLRMIMEGQYQF- 324 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCC-
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCCC-
Confidence 33 33567788999999853 3588999999999999999999999965321 11111111111100
Q ss_pred hhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 570 VFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
....+. .....+.+++.+||+.||++|||++|+++
T Consensus 325 ----~~~~~~---~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 325 ----SSPEWD---DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ----CHHHHS---SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----CCcccc---cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000001 11235677888999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.37 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=191.3
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
..+.||+|+||.||+|... +|+.||||++...... .+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 108 (331)
T 4aaa_A 29 NLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108 (331)
T ss_dssp EEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCc
Confidence 4578999999999999965 4899999998655333 34577899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... .
T Consensus 109 ~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~-ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (331)
T 4aaa_A 109 TILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHSHN-IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182 (331)
T ss_dssp EHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred chHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHCC-EEccCcChheEEEcCCCcEEEEeCCCceeecCCccccC
Confidence 999988763 345899999999999999999999998 999999999999999999999999999765432 2
Q ss_pred CCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh-----------hc-hhh
Q 036334 502 PPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR-----------EE-WTA 568 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~-----------~~-~~~ 568 (654)
...++..|+|||++.+. .++.++|||||||++|||++|+.||......+ ....+..... .. ...
T Consensus 183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID---QLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhhhHhhhccccc
Confidence 34567789999999775 78999999999999999999999997643211 0000000000 00 000
Q ss_pred hhhhHhhhccCCh----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 569 EVFDVELMRYHNI----EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 569 ~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
....+........ ......+.+++.+||+.||++|||++|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000000 0123457788889999999999999998763
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=346.10 Aligned_cols=183 Identities=26% Similarity=0.373 Sum_probs=147.3
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeC-----CceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSK-----DEKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-----~~~~lv~ 420 (654)
+.++||+|+||+||+|... +|+.||||++..... ..+++.+|++++++++||||+++++++... ...|+||
T Consensus 57 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 136 (458)
T 3rp9_A 57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136 (458)
T ss_dssp ECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred EeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEE
Confidence 4578999999999999855 689999999876432 345688999999999999999999998543 4689999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+ +|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~-iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 137 EIA-DSDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHSAG-ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CCC-SEEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred ecc-ccchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC-cCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 998 5799999873 346999999999999999999999998 999999999999999999999999999876421
Q ss_pred -------------------------------CCCCccccccCcccc-CCCCCCcchhHHHHHHHHHHHHhC
Q 036334 501 -------------------------------TPPTRVAGYRAPEVV-ETRKVTFKSDVYSFGVLLLELLTG 539 (654)
Q Consensus 501 -------------------------------~~~~~~~~y~aPE~~-~~~~~~~~~DvwslGvil~el~tg 539 (654)
....+|..|+|||++ .+..++.++|||||||++|||++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 122457779999986 566799999999999999999993
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=336.98 Aligned_cols=253 Identities=18% Similarity=0.270 Sum_probs=187.7
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC--HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG--KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.||+|+||+||+|... +++.||||+++..... ...+.+|++++++++||||+++++++.+++..++||||++ |
T Consensus 6 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (324)
T 3mtl_A 6 KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 84 (324)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-E
T ss_pred EEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-c
Confidence 3578999999999999965 6899999998754322 2245579999999999999999999999999999999997 5
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TP 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~ 502 (654)
+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 85 ~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 159 (324)
T 3mtl_A 85 DLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHRQK-VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159 (324)
T ss_dssp EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-EEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence 899888743 345899999999999999999999998 999999999999999999999999998765432 22
Q ss_pred CCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc---hhhhhhh-Hhhhc
Q 036334 503 PTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREE---WTAEVFD-VELMR 577 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-~~~~~ 577 (654)
..++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+....... ....... .....
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 355778999999876 568999999999999999999999997643211 111111111100 0000000 00000
Q ss_pred -------cCC----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 578 -------YHN----IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 578 -------~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
... ......++.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000 0011235677888999999999999999987
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=328.21 Aligned_cols=249 Identities=18% Similarity=0.279 Sum_probs=191.2
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHhccC-CCccccccEEEEe--CCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-HDNVVPLRAFYYS--KDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~--~~~~~lv~e~~~~ 425 (654)
+.+.||+|+||.||+|.. .+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.+ ....++||||+++
T Consensus 40 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 117 (330)
T 3nsz_A 40 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117 (330)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred EEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence 357899999999999985 56899999998743 3567899999999997 9999999999987 5678999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC-CeEEeccCCCCCcCCC---C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH-DACVSDFGLNPLFGNT---T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~---~ 501 (654)
++|.+++. .+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||++...... .
T Consensus 118 ~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~ 188 (330)
T 3nsz_A 118 TDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 188 (330)
T ss_dssp CCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred hhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCC-eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccc
Confidence 99999985 2889999999999999999999998 99999999999999777 8999999999765433 2
Q ss_pred CCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh------
Q 036334 502 PPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE------ 574 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 574 (654)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .....+............++..
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (330)
T 3nsz_A 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDKYNIELDP 266 (330)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTTCCCCT
T ss_pred cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCCchhhhHHHHhcccccc
Confidence 3456777999999877 678999999999999999999999996432211 0000011111000000000000
Q ss_pred ----------------hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 575 ----------------LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 575 ----------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
............++.+++.+||+.||++|||++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000011112346778888999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=322.95 Aligned_cols=239 Identities=21% Similarity=0.317 Sum_probs=189.4
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (276)
T 2h6d_A 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94 (276)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccC
Confidence 3578999999999999975 68999999986542 234678899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---C
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---T 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---~ 501 (654)
+++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...... .
T Consensus 95 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 168 (276)
T 2h6d_A 95 GGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 168 (276)
T ss_dssp SCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHC-SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred CCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCChhhEEECCCCCEEEeecccccccCCCccee
Confidence 99999999742 35899999999999999999999998 999999999999999999999999998876543 2
Q ss_pred CCCccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 502 PPTRVAGYRAPEVVETRKV-TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
...++..|+|||.+.+..+ +.++||||||+++|||++|+.||.... .......+..... ..
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~------------~~ 230 (276)
T 2h6d_A 169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH------VPTLFKKIRGGVF------------YI 230 (276)
T ss_dssp --------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC------------CC
T ss_pred cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHhhcCcc------------cC
Confidence 3456778999999987765 689999999999999999999996431 1111111111100 00
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.......+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11112356778889999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=334.27 Aligned_cols=258 Identities=21% Similarity=0.301 Sum_probs=196.1
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHhccC-----------CCccccccEEEEeCC---
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-----------HDNVVPLRAFYYSKD--- 414 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------hpniv~l~~~~~~~~--- 414 (654)
+.+.||+|+||+||+|.. .+++.||||++.........+.+|++++++++ ||||+++++++...+
T Consensus 23 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 102 (373)
T 1q8y_A 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 102 (373)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCC
Confidence 357899999999999996 46899999999876555677889999988876 899999999988654
Q ss_pred -ceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCeecCCCCCCcEEEC------CCCCe
Q 036334 415 -EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS-GKIVHGNIKASNILLR------PDHDA 486 (654)
Q Consensus 415 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~ivHrDlk~~NIll~------~~~~~ 486 (654)
..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ + |+||||||+|||++ ..+.+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~~-ivH~Dikp~NIll~~~~~~~~~~~~ 177 (373)
T 1q8y_A 103 VHVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQI 177 (373)
T ss_dssp EEEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC-EECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ceEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHhcCC-EEecCCChHHeEEeccCCCcCcceE
Confidence 689999999 889999997542 34589999999999999999999998 7 99999999999994 34479
Q ss_pred EEeccCCCCCcCCC-CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh-
Q 036334 487 CVSDFGLNPLFGNT-TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE- 564 (654)
Q Consensus 487 kl~Dfgla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~- 564 (654)
||+|||++...... ....++..|+|||++.+..++.++|||||||++|||++|+.||..............+..+...
T Consensus 178 kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (373)
T 1q8y_A 178 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 257 (373)
T ss_dssp EECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHH
T ss_pred EEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhc
Confidence 99999999776543 3456788899999999999999999999999999999999999865433222111111111100
Q ss_pred -c----------hhhhhh------------------hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 565 -E----------WTAEVF------------------DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 565 -~----------~~~~~~------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
. +....+ +..............++.+++.+||+.||++|||++|+++.
T Consensus 258 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 258 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred CCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 0 000000 00000122335566788899999999999999999999873
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.66 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=190.8
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeC--------CceE
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSK--------DEKL 417 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--------~~~~ 417 (654)
+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|++++++++||||+++++++... +..+
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 100 (351)
T 3mi9_A 21 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 100 (351)
T ss_dssp EEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEE
T ss_pred EEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEE
Confidence 457899999999999996 468999999986543 2245778999999999999999999999873 4689
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 418 LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
+||||+++ +|.+.+... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 101 lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 101 LVFDFCEH-DLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp EEEECCSE-EHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCC-CHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 99999975 777777643 245999999999999999999999998 999999999999999999999999998765
Q ss_pred CCC--------CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---c
Q 036334 498 GNT--------TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE---E 565 (654)
Q Consensus 498 ~~~--------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~ 565 (654)
... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+...... .
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGSITPE 251 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTT
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChh
Confidence 421 23345778999999876 468999999999999999999999997643211 11111111100 0
Q ss_pred hhhhhhhHhhh--------ccCChHHH------HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 566 WTAEVFDVELM--------RYHNIEEE------MVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 566 ~~~~~~~~~~~--------~~~~~~~~------~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.....-..... ......+. ...+.+++.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000000 00011111 2347788999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.11 Aligned_cols=246 Identities=13% Similarity=0.033 Sum_probs=174.7
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHH---HHhccCCCcccccc-------EEEEeCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV----GKREFEMQME---VLGKIKHDNVVPLR-------AFYYSKD 414 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~e~~---~l~~l~hpniv~l~-------~~~~~~~ 414 (654)
..+.||+|+||.||+|.+. +|+.||||+++.... ..+.+.+|+. .++. +||||++++ +++..++
T Consensus 66 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~ 144 (371)
T 3q60_A 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQS 144 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETT
T ss_pred eeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCC
Confidence 3578999999999999965 689999999987532 2345667754 4555 799977754 5554432
Q ss_pred -----------------ceEEEEEecCCCchhhhhccCCCCCCCCCCHHHH------HHHHHHHHHHHHHhhccCCeecC
Q 036334 415 -----------------EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNR------MRIALSAARGLAHLHVSGKIVHG 471 (654)
Q Consensus 415 -----------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~~ivHr 471 (654)
..++||||++ |+|.+++.... ..+.+..+ +.++.|++.||+|||+++ |+||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-ivHr 218 (371)
T 3q60_A 145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQSKG-LVHG 218 (371)
T ss_dssp SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-EEET
T ss_pred CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-CccC
Confidence 3799999998 89999997531 12455555 778899999999999998 9999
Q ss_pred CCCCCcEEECCCCCeEEeccCCCCCcCCCC-CCCccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 036334 472 NIKASNILLRPDHDACVSDFGLNPLFGNTT-PPTRVAGYRAPEVVET--RKVTFKSDVYSFGVLLLELLTGKAPNQASLG 548 (654)
Q Consensus 472 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~ 548 (654)
||||+|||++.++.+||+|||++....... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 999999999999999999999998776544 4455688999999987 6799999999999999999999999987543
Q ss_pred CCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 549 EEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
......... .......... ...........+.+++.+||+.||++|||+.|+++
T Consensus 299 ~~~~~~~~~--------~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 299 GIKGSWKRP--------SLRVPGTDSL-AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TCTTCCCBC--------CTTSCCCCSC-CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred ccccchhhh--------hhhhcccccc-chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 221110000 0000000000 00000122345677888999999999999999964
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=338.26 Aligned_cols=245 Identities=23% Similarity=0.306 Sum_probs=193.8
Q ss_pred HhhccccccCceeEEEEEe----cCCcEEEEEEecccc-----cCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEE
Q 036334 349 ASAEVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVA-----VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLL 418 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~----~~g~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~l 418 (654)
.+.+.||+|+||.||++.. .+|+.||||+++... ...+.+.+|+++++++ +||||+++++++...+..++
T Consensus 57 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 136 (355)
T 1vzo_A 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL 136 (355)
T ss_dssp EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEE
Confidence 3457899999999999986 368999999997542 2345677899999999 69999999999999999999
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 419 VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 137 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 137 ILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999999742 35899999999999999999999998 9999999999999999999999999987653
Q ss_pred CC-----CCCCccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhh
Q 036334 499 NT-----TPPTRVAGYRAPEVVET--RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571 (654)
Q Consensus 499 ~~-----~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 571 (654)
.. ....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .............
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~------ 282 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE------ 282 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHCC------
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhccC------
Confidence 22 22356788999999975 357899999999999999999999997543222 1222222211110
Q ss_pred hHhhhccCChHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 036334 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRP-----AMQEVVRMI 613 (654)
Q Consensus 572 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 613 (654)
.....+....+.+++.+||..||++|| +++|+++..
T Consensus 283 ------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 011112223567788899999999999 899988754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=350.58 Aligned_cols=242 Identities=24% Similarity=0.334 Sum_probs=192.9
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc--------------cCHHHHHHHHHHHhccCCCccccccEEEEeCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--------------VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD 414 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~ 414 (654)
+.+.||+|+||+||+|... +++.||+|+++... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 40 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 119 (504)
T 3q5i_A 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK 119 (504)
T ss_dssp EEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred EEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 4578999999999999965 57899999997543 23467889999999999999999999999999
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC---CeEEecc
Q 036334 415 EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH---DACVSDF 491 (654)
Q Consensus 415 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~---~~kl~Df 491 (654)
..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 120 ~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 120 YFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHKHN-IVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-eEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 999999999999999998642 45999999999999999999999998 99999999999999876 6999999
Q ss_pred CCCCCcCCC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 492 GLNPLFGNT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 492 gla~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
|++...... ....+++.|+|||++. +.++.++||||+||++|+|++|..||..... ...+..+.......
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND------QDIIKKVEKGKYYF 266 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC
T ss_pred CCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCCC
Confidence 999876543 3456788899999987 4699999999999999999999999975322 22222222221110
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
+ ...+... ..++.+++.+||+.||.+|||++|+++.
T Consensus 267 ---~--~~~~~~~---s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 267 ---D--FNDWKNI---SDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ---C--HHHHTTS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---C--ccccCCC---CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 0011111 2356778889999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=328.39 Aligned_cols=241 Identities=25% Similarity=0.395 Sum_probs=192.2
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
+.+.||+|+||.||+|... +|+.||+|++.... ...++.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 33 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 111 (314)
T 3com_A 33 VLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111 (314)
T ss_dssp EEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred hheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCH
Confidence 4578999999999999965 48999999987643 356788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CCCC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPPT 504 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~~ 504 (654)
.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...... ....
T Consensus 112 ~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 186 (314)
T 3com_A 112 SDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFMR-KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI 186 (314)
T ss_dssp HHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCC
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-CcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccC
Confidence 9998632 345899999999999999999999998 999999999999999999999999998765432 2345
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
++..|+|||.+.+..++.++||||||+++|||++|+.||..... ........... .. ........
T Consensus 187 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~--------~~~~~~~~ 251 (314)
T 3com_A 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMIPTNP-PP--------TFRKPELW 251 (314)
T ss_dssp SCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC-CC--------CCSSGGGS
T ss_pred CCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCC-Cc--------ccCCcccC
Confidence 67789999999998999999999999999999999999975321 11111111000 00 00011112
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 585 MVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
...+.+++.+||+.||++|||+.++++
T Consensus 252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 252 SDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 346778888999999999999999976
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=331.24 Aligned_cols=249 Identities=23% Similarity=0.360 Sum_probs=189.4
Q ss_pred hhccccccCceeEEEEEec--CCc--EEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE--EGT--TVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~--~g~--~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
+.+.||+|+||.||+|.+. +++ .||||+++... ...+.+.+|++++++++||||+++++++.++. .++|||
T Consensus 22 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e 100 (291)
T 1u46_A 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTE 100 (291)
T ss_dssp EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEE
T ss_pred eeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEe
Confidence 3578999999999999853 233 68999987542 23467889999999999999999999987654 899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT 501 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 501 (654)
|+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 101 LAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp CCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred cccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHHhCC-cccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 99999999999743 235899999999999999999999998 9999999999999999999999999987764332
Q ss_pred -------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 502 -------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 502 -------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
...++..|+|||++.+..++.++||||||+++|||++ |+.||..... ...+..+......
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~------ 243 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGER------ 243 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCC------
T ss_pred cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccCCC------
Confidence 2334557999999988889999999999999999999 9999975321 2222222211110
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
.........++.+++.+||+.||++|||+.++++.|+++....
T Consensus 244 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 244 ----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ----CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 0111122346778888999999999999999999999987654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=349.61 Aligned_cols=244 Identities=23% Similarity=0.334 Sum_probs=192.0
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
|.+.+.||+|+||+||+|... ++..||+|+++... .....+.+|+.++++++||||++++++|.+.+..++||||+
T Consensus 39 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 118 (494)
T 3lij_A 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118 (494)
T ss_dssp EEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence 445688999999999999965 58899999997642 33567889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC---CCeEEeccCCCCCcCCC
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD---HDACVSDFGLNPLFGNT 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~---~~~kl~Dfgla~~~~~~ 500 (654)
++|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.. +.+||+|||++......
T Consensus 119 ~~g~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 119 KGGELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHKHN-IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred CCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999998863 245899999999999999999999998 9999999999999764 45999999999766433
Q ss_pred ---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 501 ---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 501 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
....+++.|+|||++. +.++.++||||+||++|||++|..||..... ...+..+....... ....
T Consensus 193 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~-----~~~~ 260 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD------QEILRKVEKGKYTF-----DSPE 260 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCC-----CSGG
T ss_pred ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC-----Cchh
Confidence 3356788899999986 5699999999999999999999999975322 22222222211110 0001
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
+... ...+.+++.+||+.||++|||+.|+++.
T Consensus 261 ~~~~---s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 261 WKNV---SEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp GTTS---CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred cccC---CHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1112 2346677889999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=333.57 Aligned_cols=249 Identities=22% Similarity=0.327 Sum_probs=186.5
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCC------ceEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKD------EKLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------~~~lv 419 (654)
..+.||+|+||.||+|... +|+.||||++...... .+++.+|++++++++||||+++++++...+ ..++|
T Consensus 29 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv 108 (367)
T 1cm8_A 29 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108 (367)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEE
Confidence 3578999999999999964 6899999998654322 456789999999999999999999997653 45999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
|||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 109 ~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 109 MPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG-IIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp EECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 9999 8899999973 35899999999999999999999998 99999999999999999999999999987654
Q ss_pred C-CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc------hhhhhh
Q 036334 500 T-TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREE------WTAEVF 571 (654)
Q Consensus 500 ~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 571 (654)
. ....++..|+|||++.+ ..++.++||||+||++|||++|+.||..... ...+..+.... ....+.
T Consensus 181 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH------LDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHhcCCCCHHHHHHhh
Confidence 3 33466788999999876 6899999999999999999999999975432 11111111100 000000
Q ss_pred h-------Hhhhc------cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 572 D-------VELMR------YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 572 ~-------~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
. ..+.. ..........+.+++.+||..||++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0 00000 00001123456778889999999999999999873
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=351.26 Aligned_cols=244 Identities=26% Similarity=0.361 Sum_probs=197.3
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV----AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
|...++||+|+||.||+|... +|+.||||++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 28 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 107 (484)
T 3nyv_A 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 107 (484)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 345688999999999999965 6899999998654 23467789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEE---CCCCCeEEeccCCCCCcCC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL---RPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll---~~~~~~kl~Dfgla~~~~~ 499 (654)
+.+|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 108 ~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 108 YTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CCSCBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred CCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 999999999873 345999999999999999999999998 9999999999999 5678999999999877654
Q ss_pred CC---CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhh
Q 036334 500 TT---PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576 (654)
Q Consensus 500 ~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (654)
.. ...+++.|+|||++.+ .++.++||||+||++|||++|+.||..... ...+..+........ ..
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~~-----~~ 249 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE------YDILKKVEKGKYTFE-----LP 249 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCCC-----SG
T ss_pred ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCCCCC-----Cc
Confidence 42 2356788999999865 699999999999999999999999975322 222222222211110 00
Q ss_pred ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.+. .....+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~---~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 250 QWK---KVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp GGG---GSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccc---cCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 111 122356678889999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=332.34 Aligned_cols=252 Identities=16% Similarity=0.236 Sum_probs=196.3
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCH------------------HHHHHHHHHHhccCCCccccccEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGK------------------REFEMQMEVLGKIKHDNVVPLRAFYY 411 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~------------------~~~~~e~~~l~~l~hpniv~l~~~~~ 411 (654)
+.+.||+|+||.||+|.. +|+.||||++....... +.+.+|++++++++||||+++++++.
T Consensus 35 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 113 (348)
T 2pml_X 35 IIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT 113 (348)
T ss_dssp EEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEE
T ss_pred EEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 457899999999999999 79999999997542211 78999999999999999999999999
Q ss_pred eCCceEEEEEecCCCchhhh------hccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCeecCCCCCCcEEECCCC
Q 036334 412 SKDEKLLVYDYMPAGSLSAL------LHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV-SGKIVHGNIKASNILLRPDH 484 (654)
Q Consensus 412 ~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~ivHrDlk~~NIll~~~~ 484 (654)
+.+..++||||+++|+|.++ +... ....+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++
T Consensus 114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-i~H~dl~p~Nil~~~~~ 189 (348)
T 2pml_X 114 NYDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKNG 189 (348)
T ss_dssp SSSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHTSC-EECCCCCGGGEEECTTS
T ss_pred eCCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhccCC-EeecCCChHhEEEcCCC
Confidence 99999999999999999999 5422 24569999999999999999999998 77 99999999999999999
Q ss_pred CeEEeccCCCCCcCCC--CCCCccccccCccccCCC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHH
Q 036334 485 DACVSDFGLNPLFGNT--TPPTRVAGYRAPEVVETR-KVTF-KSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQS 560 (654)
Q Consensus 485 ~~kl~Dfgla~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~-~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~ 560 (654)
.+||+|||++...... ....++..|+|||++.+. .++. ++|||||||++|||++|+.||...... ......
T Consensus 190 ~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~ 264 (348)
T 2pml_X 190 RVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-----VELFNN 264 (348)
T ss_dssp CEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-----HHHHHH
T ss_pred cEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHH
Confidence 9999999998765432 345677889999999877 6666 999999999999999999999754321 112222
Q ss_pred Hhhhchhhhh----hhHhhhc---cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 561 VVREEWTAEV----FDVELMR---YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 561 ~~~~~~~~~~----~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
+......... ....... .........++.+++.+||+.||++|||++|+++
T Consensus 265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2111110000 0000000 0000122345778888999999999999999976
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=339.95 Aligned_cols=194 Identities=24% Similarity=0.397 Sum_probs=152.9
Q ss_pred hccccccCceeEEEEEec---CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEe--CCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLE---EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYS--KDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~ 425 (654)
+++||+|+||+||+|... +++.||||++..... ...+.+|+.++++++||||+++++++.. ....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~- 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence 568999999999999965 478999999976533 3467899999999999999999999965 567899999996
Q ss_pred CchhhhhccCC----CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEE----CCCCCeEEeccCCCCCc
Q 036334 426 GSLSALLHGSR----GSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL----RPDHDACVSDFGLNPLF 497 (654)
Q Consensus 426 g~L~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll----~~~~~~kl~Dfgla~~~ 497 (654)
|+|.+++...+ ......+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 182 (405)
T 3rgf_A 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182 (405)
T ss_dssp EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC--
T ss_pred CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-EeCCCcCHHHeEEecCCCCCCcEEEEECCCceec
Confidence 58887775321 112235999999999999999999999998 9999999999999 67789999999999876
Q ss_pred CCC-------CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 036334 498 GNT-------TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASL 547 (654)
Q Consensus 498 ~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~ 547 (654)
... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 432 23456788999999977 458999999999999999999999997644
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=322.08 Aligned_cols=240 Identities=22% Similarity=0.350 Sum_probs=188.7
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc-----cCHHHHHHHHHHHhccCCCccccccEEEE--eCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-----VGKREFEMQMEVLGKIKHDNVVPLRAFYY--SKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~hpniv~l~~~~~--~~~~~~lv~e 421 (654)
+.+.||+|+||.||++... +++.||+|+++... .....+.+|++++++++||||+++++++. +....++|||
T Consensus 9 i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (305)
T 2wtk_C 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME 88 (305)
T ss_dssp CCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEE
T ss_pred EeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEeh
Confidence 3578999999999999964 58899999997642 23467899999999999999999999984 4457899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT- 500 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~- 500 (654)
|++++ |.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 89 ~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~-i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 89 YCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQG-IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp CCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred hccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHCC-eeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 99876 767665432 346899999999999999999999998 999999999999999999999999998765422
Q ss_pred -----CCCCccccccCccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 -----TPPTRVAGYRAPEVVETRK--VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 -----~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....++..|+|||++.+.. ++.++||||||+++|||++|+.||.... .......+.....
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~~~~~------- 230 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFENIGKGSY------- 230 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCC-------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHHhcCCC-------
Confidence 2345677899999987643 4789999999999999999999997532 2222222211110
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.........+.+++.+||+.||++|||++|+++.
T Consensus 231 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 -----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111123356778889999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=339.61 Aligned_cols=188 Identities=26% Similarity=0.379 Sum_probs=160.1
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeC-----CceEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSK-----DEKLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-----~~~~lv~ 420 (654)
+.+.||+|+||.||+|... +|+.||||+++.... ..+++.+|++++++++||||+++++++... ...|+||
T Consensus 30 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~ 109 (432)
T 3n9x_A 30 IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109 (432)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred EEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEE
Confidence 4578999999999999965 588999999976432 346788999999999999999999998776 5689999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||++ |+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 110 e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~g-ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 110 EIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHESG-IIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp ECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred ecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 9996 599999973 345999999999999999999999998 999999999999999999999999999765432
Q ss_pred --------------------------CCCCccccccCcccc-CCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 036334 501 --------------------------TPPTRVAGYRAPEVV-ETRKVTFKSDVYSFGVLLLELLTGKAPNQ 544 (654)
Q Consensus 501 --------------------------~~~~~~~~y~aPE~~-~~~~~~~~~DvwslGvil~el~tg~~pf~ 544 (654)
....+|..|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 234567789999986 56679999999999999999998655554
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=337.31 Aligned_cols=249 Identities=18% Similarity=0.253 Sum_probs=184.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.+.||+|+||+||+|... +|+.||||+++..... .+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 116 (329)
T 3gbz_A 38 RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE- 116 (329)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-
Confidence 4578999999999999854 6899999999755322 3457789999999999999999999999999999999997
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEEC-----CCCCeEEeccCCCCCcCCC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR-----PDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~-----~~~~~kl~Dfgla~~~~~~ 500 (654)
|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 117 ~~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH~~~-ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 117 NDLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCHSRR-CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred CCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 5999999743 35899999999999999999999998 99999999999994 4455999999998765422
Q ss_pred ----CCCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhch------hhh
Q 036334 501 ----TPPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEW------TAE 569 (654)
Q Consensus 501 ----~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~ 569 (654)
....++..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..+..... ...
T Consensus 191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI------DQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCCCTTTSTT
T ss_pred ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH------HHHHHHHHHhCCCchhhhhh
Confidence 234557889999999774 5899999999999999999999999753221 11111111000 000
Q ss_pred hh-----hHhhh--ccCChHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 570 VF-----DVELM--RYHNIEE-----EMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 570 ~~-----~~~~~--~~~~~~~-----~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.. ..... ....... ...++.+++.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 00000 0000000 1245678888999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.63 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=191.5
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEecccccC------HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEE
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG------KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVY 420 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 420 (654)
|...+.||+|+||.||+|... +|+.||||+++..... .+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 91 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEE
Confidence 345678999999999999965 5899999999754221 246789999999999999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+++ +|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 92 e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 92 DFMET-DLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW-ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp ECCSE-EHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EcCCC-CHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCC-EECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 99976 888888643 345888999999999999999999998 999999999999999999999999999876432
Q ss_pred ----CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh-------chhh
Q 036334 501 ----TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE-------EWTA 568 (654)
Q Consensus 501 ----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~ 568 (654)
....++..|+|||++.+ ..++.++|||||||++|||++|..||..... ...+..+... .|..
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~------~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD------LDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCCTTTSSS
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHHHcCCCChhhhhh
Confidence 23456788999999865 4589999999999999999999999875422 1112221111 0000
Q ss_pred hhhhHhhhc---c-CCh-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 569 EVFDVELMR---Y-HNI-----EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 569 ~~~~~~~~~---~-~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
......... . ... .....++.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000000 0 000 1122467788889999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=331.93 Aligned_cols=247 Identities=19% Similarity=0.327 Sum_probs=190.5
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.||+|+||.||+|...+ .||+|+++... ...+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 37 ~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 114 (319)
T 2y4i_B 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR 114 (319)
T ss_dssp CCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSE
T ss_pred EeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCC
Confidence 35789999999999998763 49999987542 22355778999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC-------
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN------- 499 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~------- 499 (654)
+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++ ++.+||+|||++.....
T Consensus 115 ~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~-i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~ 188 (319)
T 2y4i_B 115 TLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHAKG-ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE 188 (319)
T ss_dssp EHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHHHTT-CCCCCCCSTTEEEC---CCEECCCSCCC----------C
T ss_pred cHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCChhhEEEe-CCCEEEeecCCccccccccccccc
Confidence 999999743 245899999999999999999999998 99999999999998 68999999999775431
Q ss_pred --CCCCCccccccCccccCC---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 500 --TTPPTRVAGYRAPEVVET---------RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 500 --~~~~~~~~~y~aPE~~~~---------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+... ...
T Consensus 189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~-~~~ 261 (319)
T 2y4i_B 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------EAIIWQMGTG-MKP 261 (319)
T ss_dssp CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------HHHHHHHHTT-CCC
T ss_pred cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHhccC-CCC
Confidence 122346778999999864 4578999999999999999999999975321 1111111111 000
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
... . .....++.+++.+||..||++|||+.+++++|+++....
T Consensus 262 ~~~-----~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 262 NLS-----Q----IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CCC-----C----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCC-----c----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 000 0 011235677888999999999999999999999998664
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=326.85 Aligned_cols=244 Identities=23% Similarity=0.351 Sum_probs=188.9
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEeccccc---------CHHHHHHHHHHHhccCCCccccccEEEEeCCceE
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---------GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKL 417 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~ 417 (654)
|.+.+.||+|+||.||+|... +++.||||++..... ....+.+|++++++++||||+++++++..+ ..+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 90 (322)
T 2ycf_A 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYY 90 (322)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred eeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-ceE
Confidence 345688999999999999865 578999999865421 123578899999999999999999998665 489
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC---eEEeccCCC
Q 036334 418 LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD---ACVSDFGLN 494 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~---~kl~Dfgla 494 (654)
+||||+++|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++. +||+|||++
T Consensus 91 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 91 IVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENG-IIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp EEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred EEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 99999999999999873 346899999999999999999999998 999999999999987665 999999999
Q ss_pred CCcCCCC---CCCccccccCccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 495 PLFGNTT---PPTRVAGYRAPEVVE---TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 495 ~~~~~~~---~~~~~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
....... ...++..|+|||++. ...++.++|||||||++|||++|+.||....... .+...+. .....
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~----~~~~~ 238 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT----SGKYN 238 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHH----HTCCC
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHH----hCccc
Confidence 8765432 234677899999973 5678999999999999999999999997543322 1211111 11000
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..+.. . ......+.+++.+||+.||++|||++|+++
T Consensus 239 --~~~~~--~---~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 --FIPEV--W---AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --CCHHH--H---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --cCchh--h---hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 0 112245778888999999999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.31 Aligned_cols=242 Identities=24% Similarity=0.407 Sum_probs=189.6
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEEEe------CCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYS------KDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~------~~~~~lv~e 421 (654)
+.+.||+|+||.||+|... +|+.||||++.........+.+|+.+++++ +||||+++++++.. .+..++|||
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 107 (326)
T 2x7f_A 28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEE
T ss_pred EEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEE
Confidence 3578999999999999964 689999999987666678899999999999 79999999999987 457899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT- 500 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~- 500 (654)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 108 ~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 183 (326)
T 2x7f_A 108 FCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183 (326)
T ss_dssp CCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEECTTCCEEECCCTTTC------
T ss_pred cCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc
Confidence 999999999997542 245899999999999999999999998 999999999999999999999999998876432
Q ss_pred ---CCCCccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhh
Q 036334 501 ---TPPTRVAGYRAPEVVE-----TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572 (654)
Q Consensus 501 ---~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 572 (654)
....++..|+|||++. +..++.++|||||||++|||++|+.||..... ............ .
T Consensus 184 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~---- 252 (326)
T 2x7f_A 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALFLIPRNPA-P---- 252 (326)
T ss_dssp -------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-C----
T ss_pred cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHhhcCcc-c----
Confidence 2345677899999986 56789999999999999999999999964321 111111111100 0
Q ss_pred HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 573 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.. . .......+.+++.+||..||++||+++++++
T Consensus 253 -~~-~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 253 -RL-K---SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -CC-S---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -cC-C---ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 0 0111235677888999999999999999976
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.81 Aligned_cols=242 Identities=21% Similarity=0.352 Sum_probs=190.4
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccc-ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV-AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
+.+.||+|+||.||+|... +|+.||+|++... ....+.+.+|++++++++||||+++++++.+++..++||||+++++
T Consensus 23 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (302)
T 2j7t_A 23 IVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGA 102 (302)
T ss_dssp EEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEE
T ss_pred ecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCc
Confidence 4578999999999999976 4889999998755 3445788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC----CCCCC
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG----NTTPP 503 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~----~~~~~ 503 (654)
|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.... .....
T Consensus 103 l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 177 (302)
T 2j7t_A 103 VDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKR-IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF 177 (302)
T ss_dssp HHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC----
T ss_pred HHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcCC-cccCCCCHHHEEECCCCCEEEEECCCCccccccccccccc
Confidence 99988642 245899999999999999999999998 9999999999999999999999999864321 22334
Q ss_pred CccccccCcccc-----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 504 TRVAGYRAPEVV-----ETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 504 ~~~~~y~aPE~~-----~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
.++..|+|||++ .+..++.++||||||+++|||++|+.||..... .............. .
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~---------~ 242 (302)
T 2j7t_A 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDPPT---------L 242 (302)
T ss_dssp -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCCC---------C
T ss_pred cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCCcc---------c
Confidence 577889999998 467789999999999999999999999975321 12222221111100 0
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.........+.+++.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011122345778888999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=329.96 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=178.6
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.||+|+||.||+|... +++.||||++.... ...+++.+|+.++++++||||+++++++...+..++||||++++
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 98 (303)
T 2vwi_A 19 LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 98 (303)
T ss_dssp EEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTC
T ss_pred hhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCC
Confidence 3578999999999999854 68899999986542 33467888999999999999999999999999999999999999
Q ss_pred chhhhhccCC---CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 427 SLSALLHGSR---GSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 427 ~L~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
+|.+++.... ......+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 99 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 177 (303)
T 2vwi_A 99 SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG-QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177 (303)
T ss_dssp BHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEECTTCCEEECCCHHHHHCC-----
T ss_pred chHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCc
Confidence 9999986321 112345899999999999999999999998 999999999999999999999999987654321
Q ss_pred ------CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 ------TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 ------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+ .......... ... ..
T Consensus 178 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~-~~~-~~ 249 (303)
T 2vwi_A 178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK------VLMLTLQNDP-PSL-ET 249 (303)
T ss_dssp ----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHTSSC-CCT-TC
T ss_pred cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh------HHHHHhccCC-Ccc-cc
Confidence 22356778999999865 568999999999999999999999997543211 1111111110 000 00
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.............++.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00000001112235677888999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=330.87 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=185.5
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEecccccC------------HHHHHHHHHHHhccCCCccccccEEEEeC-----
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG------------KREFEMQMEVLGKIKHDNVVPLRAFYYSK----- 413 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~hpniv~l~~~~~~~----- 413 (654)
.+.||+|+||.||+|...+|+.||||++...... .+.+.+|++++++++||||+++++++...
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 106 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTC
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCc
Confidence 5789999999999999888999999998654221 26788999999999999999999998653
Q ss_pred CceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCC
Q 036334 414 DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGL 493 (654)
Q Consensus 414 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgl 493 (654)
...++||||++ |+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 180 (362)
T 3pg1_A 107 HKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHEAG-VVHRDLHPGNILLADNNDITICDFNL 180 (362)
T ss_dssp CEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCTTC
T ss_pred ceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCc-CEecCCChHHEEEcCCCCEEEEecCc
Confidence 35799999997 6888888743 346999999999999999999999998 99999999999999999999999999
Q ss_pred CCCcCCC---CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---ch
Q 036334 494 NPLFGNT---TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE---EW 566 (654)
Q Consensus 494 a~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~~ 566 (654)
+...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+... ..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF------YNQLNKIVEVVGTPK 254 (362)
T ss_dssp ---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCC
T ss_pred ccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHcCCCC
Confidence 9755432 23456777999999876 6789999999999999999999999975432 1111111110 00
Q ss_pred hhh-----------hhhHhhhcc--CC----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 567 TAE-----------VFDVELMRY--HN----IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 567 ~~~-----------~~~~~~~~~--~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
... ......... .. .......+.+++.+||+.||++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000 000000000 00 01112357788889999999999999999873
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=327.48 Aligned_cols=244 Identities=20% Similarity=0.310 Sum_probs=178.7
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccccCH---HHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVGK---REFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
..+.||+|+||.||+|.. .+|+.||||+++...... +.+.++...++.++||||+++++++.+++..++||||++
T Consensus 11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~- 89 (290)
T 3fme_A 11 PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD- 89 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-
T ss_pred hHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-
Confidence 357899999999999996 468999999997653322 223344455888899999999999999999999999997
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS-GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
|+|.+++..... ....+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 167 (290)
T 3fme_A 90 TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD 167 (290)
T ss_dssp EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSC-CCCCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCC-eecCCCCHHHEEECCCCCEEEeecCCccccccccccc
Confidence 588777753211 235699999999999999999999998 7 9999999999999999999999999997764432
Q ss_pred CCCccccccCcccc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 502 PPTRVAGYRAPEVV----ETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 502 ~~~~~~~y~aPE~~----~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
...++..|+|||++ .+..++.++|||||||++|||++|+.||..... ....+..........
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~--------- 233 (290)
T 3fme_A 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----PFQQLKQVVEEPSPQ--------- 233 (290)
T ss_dssp --CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----HHHHHHHHHHSCCCC---------
T ss_pred ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----hHHHHHHHhccCCCC---------
Confidence 23577889999996 566789999999999999999999999964211 111111111111100
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
........++.+++.+||+.||++|||++|+++
T Consensus 234 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 -LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 001112345778888999999999999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=325.23 Aligned_cols=249 Identities=21% Similarity=0.283 Sum_probs=194.2
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEe--CCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYS--KDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~ 423 (654)
+.+.||+|+||.||++... +|+.||+|++..... ..+.+.+|++++++++||||+++++++.+ .+..++||||+
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 89 (279)
T 2w5a_A 10 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89 (279)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECC
T ss_pred eehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCC
Confidence 3578999999999999965 689999999975432 34568899999999999999999998864 56789999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCC----eecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK----IVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
++|+|.+++..... ....+++..++.++.|++.||+|||+.+. |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~ 168 (279)
T 2w5a_A 90 EGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168 (279)
T ss_dssp TTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC--
T ss_pred CCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecc
Confidence 99999999974321 23458999999999999999999998752 99999999999999999999999999876644
Q ss_pred CC----CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 500 TT----PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 500 ~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
.. ...++..|+|||++.+..++.++||||||+++|||++|+.||..... ......+.. ....
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i~~-~~~~------- 234 (279)
T 2w5a_A 169 DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGKIRE-GKFR------- 234 (279)
T ss_dssp -CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-TCCC-------
T ss_pred ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH------HHHHHHHhh-cccc-------
Confidence 32 12456779999999988999999999999999999999999975321 111111111 1110
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
........++.+++.+||+.||++|||++|+++.+...
T Consensus 235 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 235 ---RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ---cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 00111234677888899999999999999999876543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=332.23 Aligned_cols=248 Identities=21% Similarity=0.312 Sum_probs=184.8
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCC------ceEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKD------EKLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------~~~lv 419 (654)
..+.||+|+||.||+|... +|+.||||++..... ..+.+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 29 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv 108 (371)
T 2xrw_A 29 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEE
T ss_pred EeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEE
Confidence 3578999999999999854 588999999975432 2356788999999999999999999997655 67999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
|||++ |+|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 109 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 109 MELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred EEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC-eecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 99996 478888752 3899999999999999999999998 99999999999999999999999999987654
Q ss_pred C---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc------hh---
Q 036334 500 T---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREE------WT--- 567 (654)
Q Consensus 500 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~------~~--- 567 (654)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||...... .....+.... ..
T Consensus 180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI------DQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCCHHHHHHh
Confidence 3 2345677899999999999999999999999999999999999764321 1111111000 00
Q ss_pred -------------------hhhhhHhhhccC--ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 568 -------------------AEVFDVELMRYH--NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 568 -------------------~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
...+........ .......++.+++.+||..||++|||++|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000000 011224567889999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=358.21 Aligned_cols=238 Identities=23% Similarity=0.285 Sum_probs=194.2
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV----AVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.++||+|+||+||+|... +++.||||++++. ....+.+..|..++..+ +||||+++++++.+.+..|+||||+
T Consensus 345 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~ 424 (674)
T 3pfq_A 345 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV 424 (674)
T ss_dssp EEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECC
T ss_pred EEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCc
Confidence 3578999999999999965 5789999999754 23345677889999887 7999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN---- 499 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~---- 499 (654)
++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||++.....
T Consensus 425 ~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g-IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~ 498 (674)
T 3pfq_A 425 NGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG-IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498 (674)
T ss_dssp CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTS-EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCC
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-eEeccCChhhEEEcCCCcEEEeecceeeccccCCcc
Confidence 999999999743 35899999999999999999999998 99999999999999999999999999875322
Q ss_pred CCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 500 TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 500 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
.....+|+.|+|||++.+..|+.++|||||||++|||++|+.||.... ....+..+...... ..
T Consensus 499 ~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~------~~~~~~~i~~~~~~---------~p- 562 (674)
T 3pfq_A 499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------EDELFQSIMEHNVA---------YP- 562 (674)
T ss_dssp BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHSSCCC---------CC-
T ss_pred cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC------HHHHHHHHHhCCCC---------CC-
Confidence 234567888999999999999999999999999999999999997532 22223333222110 11
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAM-----QEVVR 611 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~ 611 (654)
.....++.+|+.+||+.||++||++ +||++
T Consensus 563 --~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 563 --KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1122356777889999999999997 55543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=354.70 Aligned_cols=248 Identities=21% Similarity=0.325 Sum_probs=198.1
Q ss_pred HHhhccccccCceeEEEEEecC----CcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 348 RASAEVLGKGSVGTSYKAVLEE----GTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
+.+.+.||+|+||.||+|.+.. +..||+|+++.... ..+.+.+|+.++++++||||+++++++. ++..++|||
T Consensus 392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E 470 (656)
T 2j0j_A 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 470 (656)
T ss_dssp EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEE
Confidence 3456789999999999998642 46799999875432 2367889999999999999999999984 567899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT 501 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 501 (654)
|+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 471 ~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 471 LCTLGELRSFLQVR----KFSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp CCTTCBHHHHHHHT----TTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred cCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 99999999999743 235899999999999999999999998 9999999999999999999999999998765432
Q ss_pred -----CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 502 -----PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 502 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
...++..|+|||++.+..++.++|||||||++|||++ |..||..... ...+..+.....
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~------~~~~~~i~~~~~--------- 610 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------NDVIGRIENGER--------- 610 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHHTCC---------
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHcCCC---------
Confidence 2334567999999988899999999999999999997 9999975321 122222211110
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
..........+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 611 --~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 611 --LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 01111223467788889999999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=331.38 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=175.1
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeC------CceEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSK------DEKLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------~~~~lv 419 (654)
..+.||+|+||.||+|.. .+|+.||||++..... ..+.+.+|+++++.++||||+++++++... ...++|
T Consensus 33 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv 112 (367)
T 2fst_X 33 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112 (367)
T ss_dssp EEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred EeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEE
Confidence 357899999999999985 4689999999975432 345678999999999999999999998754 457999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
+||+ +++|.+++.. ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g-ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 113 THLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp EECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECC---------
T ss_pred eccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-eeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 9999 7899998863 35999999999999999999999998 99999999999999999999999999987654
Q ss_pred C-CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------chhhhhh
Q 036334 500 T-TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE------EWTAEVF 571 (654)
Q Consensus 500 ~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 571 (654)
. ....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+..+... .....+.
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH------IDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCSCCHHHHTTCC
T ss_pred cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCCHHHHHHhh
Confidence 3 33467788999999876 6789999999999999999999999976432 1111111110 0000000
Q ss_pred h-------Hhhhc--cCChH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 572 D-------VELMR--YHNIE----EEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 572 ~-------~~~~~--~~~~~----~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
. ..+.. ..... .....+.+|+.+||..||++|||++|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 00000 00000 112346778889999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=331.27 Aligned_cols=254 Identities=21% Similarity=0.286 Sum_probs=194.6
Q ss_pred hhccccccCceeEEEEEec-CC-cEEEEEEecccccCHHHHHHHHHHHhccCCCc------cccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EG-TTVVVKRLKEVAVGKREFEMQMEVLGKIKHDN------VVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn------iv~l~~~~~~~~~~~lv~e 421 (654)
+.+.||+|+||+||+|... ++ +.||+|+++......+.+.+|+.++++++|++ ++.+++++...+..++|||
T Consensus 23 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T 2eu9_A 23 IVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE 102 (355)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEE
T ss_pred EEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEe
Confidence 4578999999999999864 34 68999999876555677888999999887665 8999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEE-------------------CC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILL-------------------RP 482 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll-------------------~~ 482 (654)
|+ ++++.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||+ +.
T Consensus 103 ~~-~~~l~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~-ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 177 (355)
T 2eu9_A 103 LL-GKNTFEFLKEN---NFQPYPLPHVRHMAYQLCHALRFLHENQ-LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177 (355)
T ss_dssp CC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred cc-CCChHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEEEecccccccccccccccccccC
Confidence 99 66777776543 2346999999999999999999999998 9999999999999 56
Q ss_pred CCCeEEeccCCCCCcCCC-CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH
Q 036334 483 DHDACVSDFGLNPLFGNT-TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSV 561 (654)
Q Consensus 483 ~~~~kl~Dfgla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~ 561 (654)
++.+||+|||++...... ....++..|+|||++.+..++.++|||||||++|||++|+.||......+ ....+...
T Consensus 178 ~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~ 254 (355)
T 2eu9_A 178 NTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE---HLVMMEKI 254 (355)
T ss_dssp CCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHH
T ss_pred CCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHH
Confidence 789999999999865443 34567888999999999999999999999999999999999997543211 11111111
Q ss_pred hhh---chhh--------------------------hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 562 VRE---EWTA--------------------------EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 562 ~~~---~~~~--------------------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
... .+.. +.................++.+++.+||+.||++|||++|+++
T Consensus 255 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 255 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 100 0000 0000000001112234457889999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=333.97 Aligned_cols=192 Identities=24% Similarity=0.356 Sum_probs=165.1
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccC-CC-----ccccccEEEEeCCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-HD-----NVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hp-----niv~l~~~~~~~~~~~lv~e~ 422 (654)
+.+.||+|+||+||+|... +++.||||+++.......++..|+.+++.++ |+ +|+++++++...+..++||||
T Consensus 58 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 137 (382)
T 2vx3_A 58 IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM 137 (382)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEec
Confidence 4578999999999999865 5889999999866555567788888888775 44 499999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc--cCCeecCCCCCCcEEEC--CCCCeEEeccCCCCCcC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV--SGKIVHGNIKASNILLR--PDHDACVSDFGLNPLFG 498 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~--~~~ivHrDlk~~NIll~--~~~~~kl~Dfgla~~~~ 498 (654)
++ |+|.+++.... ...+++..++.++.|++.||.|||. .+ |+||||||+|||++ .++.+||+|||++....
T Consensus 138 ~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~~~-ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~ 212 (382)
T 2vx3_A 138 LS-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212 (382)
T ss_dssp CC-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTSTTTC-EECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred CC-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccCCCC-EEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence 95 59999997542 2458999999999999999999995 45 99999999999995 47789999999998765
Q ss_pred CC-CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 036334 499 NT-TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQAS 546 (654)
Q Consensus 499 ~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 546 (654)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 213 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 213 QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 43 3456788899999999999999999999999999999999999764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=331.49 Aligned_cols=252 Identities=19% Similarity=0.289 Sum_probs=190.9
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeC-----CceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSK-----DEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-----~~~~lv~e 421 (654)
+.+.||+|+||.||+|... +++.||||++..... ....+.+|++++++++||||+++++++... ...++|||
T Consensus 31 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e 110 (364)
T 3qyz_A 31 NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 110 (364)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEc
Confidence 3578999999999999865 588999999975432 236788999999999999999999999765 36799999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT- 500 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~- 500 (654)
|++ |+|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 111 ~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 111 LME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp CCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred ccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 997 599999863 34899999999999999999999998 999999999999999999999999999765422
Q ss_pred ------CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchh---hhh
Q 036334 501 ------TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWT---AEV 570 (654)
Q Consensus 501 ------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 570 (654)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+......... ...
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCCHHHHHTC
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHh
Confidence 23467888999998754 458999999999999999999999997643322 11111111100000 000
Q ss_pred hh-------Hhhhc--cCCh----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 571 FD-------VELMR--YHNI----EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 571 ~~-------~~~~~--~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.+ ..... .... .....++.+++.+||+.||++|||++|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00000 0000 1112457788889999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.81 Aligned_cols=259 Identities=20% Similarity=0.288 Sum_probs=182.3
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCc-------eEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDE-------KLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~-------~~lv~e 421 (654)
+.+.||+|+||.||+|... +|+.||||++.........+.++++.++.++||||++++++|...+. .++|||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e 106 (360)
T 3e3p_A 27 VERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVME 106 (360)
T ss_dssp EC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEee
Confidence 3578999999999999965 58999999987665555667788888999999999999999976443 789999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--ccCCeecCCCCCCcEEECC-CCCeEEeccCCCCCcC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH--VSGKIVHGNIKASNILLRP-DHDACVSDFGLNPLFG 498 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--~~~~ivHrDlk~~NIll~~-~~~~kl~Dfgla~~~~ 498 (654)
|+++ +|.+.+..... ....+++..++.++.|++.||.||| +.+ |+||||||+|||++. ++.+||+|||++....
T Consensus 107 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~-ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~ 183 (360)
T 3e3p_A 107 YVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183 (360)
T ss_dssp CCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC-CBCSCCCGGGEEEETTTTEEEECCCTTCBCCC
T ss_pred cccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCC-eecCcCCHHHEEEeCCCCcEEEeeCCCceecC
Confidence 9986 54443332111 2456899999999999999999999 887 999999999999997 8999999999998765
Q ss_pred CCC---CCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhch--hhhh--
Q 036334 499 NTT---PPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEW--TAEV-- 570 (654)
Q Consensus 499 ~~~---~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~-- 570 (654)
... ...++..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..+.+... ..+.
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3e3p_A 184 PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA------GQLHEIVRVLGCPSREVLR 257 (360)
T ss_dssp TTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCCCHHHHH
T ss_pred CCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH------HHHHHHHHHcCCCCHHHHH
Confidence 432 34567789999998654 4899999999999999999999999764321 11111111000 0000
Q ss_pred ------hhHhhh----------ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhh
Q 036334 571 ------FDVELM----------RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM--IENMN 617 (654)
Q Consensus 571 ------~~~~~~----------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 617 (654)
.+.... ..........++.+++.+||+.||++|||+.|+++. ++++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 000000 000111134567888889999999999999999874 44443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=327.16 Aligned_cols=251 Identities=21% Similarity=0.308 Sum_probs=190.3
Q ss_pred hhccccccCceeEEEEEe--cCCcEEEEEEeccccc---CHHHHHHHHHHHhcc---CCCccccccEEEE-----eCCce
Q 036334 350 SAEVLGKGSVGTSYKAVL--EEGTTVVVKRLKEVAV---GKREFEMQMEVLGKI---KHDNVVPLRAFYY-----SKDEK 416 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~--~~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l---~hpniv~l~~~~~-----~~~~~ 416 (654)
+.+.||+|+||.||+|.. .+|+.||+|+++.... ....+.+|+.+++.+ +||||+++++++. .....
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 94 (326)
T 1blx_A 15 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 94 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred eeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceE
Confidence 457899999999999997 3588999999875432 223566777777666 8999999999987 45568
Q ss_pred EEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCC
Q 036334 417 LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPL 496 (654)
Q Consensus 417 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~ 496 (654)
++||||++ |+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 95 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g-i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 95 TLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp EEEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 99999997 69999987542 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh-------ch
Q 036334 497 FGNT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE-------EW 566 (654)
Q Consensus 497 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-------~~ 566 (654)
.... ....++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+..+... .+
T Consensus 170 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 170 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV------DQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCCCCGGGS
T ss_pred ccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHHHcCCCCcccC
Confidence 6532 3345677899999999989999999999999999999999999754321 111111110 00
Q ss_pred hhhhh--hHhhh------ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 567 TAEVF--DVELM------RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 567 ~~~~~--~~~~~------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..... ..... ...........+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 00000 00000112235667888999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.10 Aligned_cols=248 Identities=20% Similarity=0.317 Sum_probs=188.3
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCce------EEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEK------LLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~------~lv 419 (654)
..+.||+|+||.||+|... +|+.||||+++..... .+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus 46 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 125 (371)
T 4exu_A 46 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred EEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEE
Confidence 3578999999999999865 5899999999765333 45678999999999999999999999877654 999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
|||+. ++|.+++. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 126 ~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 126 MPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHSAG-VVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp EECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred Ecccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCC-CcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99997 68888874 23899999999999999999999998 99999999999999999999999999987654
Q ss_pred C-CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc------hhhhh-
Q 036334 500 T-TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREE------WTAEV- 570 (654)
Q Consensus 500 ~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~- 570 (654)
. ....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+..+.... +....
T Consensus 197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 197 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY------LDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCHHHHTTCS
T ss_pred CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCcHHHHHHhh
Confidence 3 33466888999999877 7899999999999999999999999975321 11111111100 00000
Q ss_pred ------hhHhhhc--cCCh----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 571 ------FDVELMR--YHNI----EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 571 ------~~~~~~~--~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
....... .... ......+.+++.+||+.||++|||++|+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000 0000 1123467788889999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=321.22 Aligned_cols=242 Identities=21% Similarity=0.322 Sum_probs=193.6
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----------cCHHHHHHHHHHHhccC-CCccccccEEEEeCCceE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----------VGKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKL 417 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----------~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~ 417 (654)
..+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+++++++. ||||+++++++.+++..+
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 100 (298)
T 1phk_A 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 100 (298)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred eeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEE
Confidence 3578999999999999975 58899999986542 12345778999999996 999999999999999999
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 418 LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 101 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 101 LVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLN-IVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp EEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 99999999999999974 245899999999999999999999998 999999999999999999999999998766
Q ss_pred CCC---CCCCccccccCccccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 498 GNT---TPPTRVAGYRAPEVVE------TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 498 ~~~---~~~~~~~~y~aPE~~~------~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
... ....++..|+|||++. ...++.++||||||+++|||++|+.||..... ......+.......
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRMIMSGNYQF 248 (298)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCC
T ss_pred CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHHHHHhcCCccc
Confidence 433 2345677899999884 45688999999999999999999999965321 11112221111100
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
. ..........+.+++.+||+.||++|||+.|+++
T Consensus 249 ~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 249 G--------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp C--------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred C--------cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0 0001122346778888999999999999999976
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.53 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=185.3
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCc------eEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDE------KLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~------~~lv~e~~ 423 (654)
..++||+|+||.||+|....+..||+|++..... ...+|+++++.++||||++++++|...+. .++||||+
T Consensus 44 ~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~ 120 (394)
T 4e7w_A 44 NCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120 (394)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECC
T ss_pred EeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeecc
Confidence 4578999999999999987777799998865332 22468999999999999999999975443 78999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEEC-CCCCeEEeccCCCCCcCCC--
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR-PDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~-~~~~~kl~Dfgla~~~~~~-- 500 (654)
+++.+........ ....+++..++.++.|+++||+|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 121 ~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~ 197 (394)
T 4e7w_A 121 PETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSIG-ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197 (394)
T ss_dssp SEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred CccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC
Confidence 8754443332111 2346899999999999999999999998 99999999999999 7899999999999765432
Q ss_pred -CCCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---chhhh--hhhH
Q 036334 501 -TPPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE---EWTAE--VFDV 573 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~~ 573 (654)
....++..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..+... ..... ..+.
T Consensus 198 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~------~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 198 NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI------DQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCCCHHHHHHHCG
T ss_pred CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCCHHHHHhhCh
Confidence 234567789999998664 5899999999999999999999999764321 111111110 00000 0000
Q ss_pred hhh-------ccCC-----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 574 ELM-------RYHN-----IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 574 ~~~-------~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
... .... ......++.+++.+||+.||++|||+.|+++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000 0000 00122467788889999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=315.58 Aligned_cols=242 Identities=24% Similarity=0.312 Sum_probs=193.4
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 25 ~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (287)
T 2wei_A 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104 (287)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccC
Confidence 44688999999999999975 68999999986543 345678899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC---CCeEEeccCCCCCcCCCC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD---HDACVSDFGLNPLFGNTT 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~---~~~kl~Dfgla~~~~~~~ 501 (654)
+++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.+ +.+||+|||++.......
T Consensus 105 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 105 GGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN-IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 99999988632 35899999999999999999999998 9999999999999764 469999999988765432
Q ss_pred C---CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 502 P---PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 502 ~---~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
. ..++..|+|||.+.+ .++.++||||||+++|||++|+.||..... ......+....... .....
T Consensus 179 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~-----~~~~~ 246 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVETGKYAF-----DLPQW 246 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC-----CSGGG
T ss_pred ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCCC-----Cchhh
Confidence 2 235667999999875 489999999999999999999999975321 12222221111100 00011
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
. ....++.+++.+||+.||++|||+.|+++
T Consensus 247 ~---~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 247 R---TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h---hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1 12235677888999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.99 Aligned_cols=244 Identities=25% Similarity=0.360 Sum_probs=182.4
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
.++||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++++.+++..++||||++ |+|.
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 46799999999987777779999999986532 35678899999876 89999999999999999999999995 6999
Q ss_pred hhhccCCCCCC--CCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC-------------CCeEEeccCCC
Q 036334 430 ALLHGSRGSGR--TPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD-------------HDACVSDFGLN 494 (654)
Q Consensus 430 ~~l~~~~~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~-------------~~~kl~Dfgla 494 (654)
+++........ ...++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a 175 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK-IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTC
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC-ccccCCChHhEEEecCcccccccccCCCceEEEEcccccc
Confidence 99975432111 11234456789999999999999998 9999999999999754 47999999999
Q ss_pred CCcCCCC--------CCCccccccCccccCC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHH
Q 036334 495 PLFGNTT--------PPTRVAGYRAPEVVET-------RKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWV 558 (654)
Q Consensus 495 ~~~~~~~--------~~~~~~~y~aPE~~~~-------~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~ 558 (654)
....... ...++.+|+|||++.+ ..++.++|||||||++|||++ |+.||......+
T Consensus 176 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-------- 247 (434)
T 2rio_A 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-------- 247 (434)
T ss_dssp EECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--------
T ss_pred eecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--------
Confidence 8765431 2357788999999865 678999999999999999999 999996432110
Q ss_pred HHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 559 QSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..+......... ...........++.+++.+||+.||++|||+.|+++
T Consensus 248 ~~i~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 SNIIRGIFSLDE-----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHTCCCCCC-----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhcCCCCccc-----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111111110000 011112344567788899999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=323.93 Aligned_cols=245 Identities=19% Similarity=0.243 Sum_probs=167.1
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEe----CCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYS----KDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~~~~ 425 (654)
.++||+|+||+||+|... +|+.||||++..... ...+....++.++||||+++++++.. ....++||||+++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~g 110 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTT
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCC
Confidence 357999999999999966 689999999865322 22223334667789999999999876 3457999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC---CCeEEeccCCCCCcCCC--
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD---HDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~---~~~kl~Dfgla~~~~~~-- 500 (654)
|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.+ +.+||+|||++......
T Consensus 111 g~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~-ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~ 186 (336)
T 3fhr_A 111 GELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHSHN-IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 186 (336)
T ss_dssp EEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred CCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-eecCCCCHHHEEEEecCCCceEEEeccccceecccccc
Confidence 99999998542 346999999999999999999999998 9999999999999864 45999999999765433
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
....++..|+|||++.+..++.++|||||||++|||++|+.||.......... .......... .......
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~-----~~~~~~~--- 256 (336)
T 3fhr_A 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRRIRLGQ-----YGFPNPE--- 256 (336)
T ss_dssp -----------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CCCTTT---
T ss_pred ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHhhhccc-----cccCchh---
Confidence 33456788999999988889999999999999999999999997643322100 0000000000 0000000
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
......++.+++.+||+.||++|||++|+++.
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01223456778889999999999999999983
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.05 Aligned_cols=256 Identities=18% Similarity=0.278 Sum_probs=187.8
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeC---------------
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK--------------- 413 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~--------------- 413 (654)
+.+.||+|+||+||+|.. .+|+.||||++..... ...+|+++++.++||||++++++|...
T Consensus 11 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 87 (383)
T 3eb0_A 11 LGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87 (383)
T ss_dssp EEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC---------------
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccc
Confidence 457899999999999985 5689999999865432 234699999999999999999998543
Q ss_pred -----------------------CceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeec
Q 036334 414 -----------------------DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVH 470 (654)
Q Consensus 414 -----------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivH 470 (654)
...++||||++ |+|.+.+..... ....+++..++.++.|+++||+|||+++ |+|
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g-i~H 164 (383)
T 3eb0_A 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSLG-ICH 164 (383)
T ss_dssp ----------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT-EEC
T ss_pred cccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCc-Ccc
Confidence 23789999997 587777753211 2356999999999999999999999998 999
Q ss_pred CCCCCCcEEEC-CCCCeEEeccCCCCCcCCC---CCCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 036334 471 GNIKASNILLR-PDHDACVSDFGLNPLFGNT---TPPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQA 545 (654)
Q Consensus 471 rDlk~~NIll~-~~~~~kl~Dfgla~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~ 545 (654)
|||||+|||++ .++.+||+|||++...... ....++..|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 244 (383)
T 3eb0_A 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG 244 (383)
T ss_dssp SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence 99999999998 6889999999999865433 234567779999998764 589999999999999999999999976
Q ss_pred CCCCCCCChhHHHHHHhh---hchhhhhh--hHhh-----h--ccC-----ChHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 036334 546 SLGEEGIDLPRWVQSVVR---EEWTAEVF--DVEL-----M--RYH-----NIEEEMVQLLQIAMGCVSTVPDQRPAMQE 608 (654)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~---~~~~~~~~--~~~~-----~--~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 608 (654)
.... +.+..+.. ........ ++.. . ... .......++.+++.+||+.||++|||+.|
T Consensus 245 ~~~~------~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (383)
T 3eb0_A 245 ETSI------DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318 (383)
T ss_dssp SSHH------HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CChH------HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 4321 11111111 00000000 0000 0 000 00112235778888999999999999999
Q ss_pred HHH--HHHhhh
Q 036334 609 VVR--MIENMN 617 (654)
Q Consensus 609 vl~--~L~~~~ 617 (654)
+++ .++++.
T Consensus 319 ~l~hp~f~~~~ 329 (383)
T 3eb0_A 319 AMAHPFFDHLR 329 (383)
T ss_dssp HHTSGGGHHHH
T ss_pred HhcCHHHHHHH
Confidence 985 244443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.26 Aligned_cols=242 Identities=21% Similarity=0.351 Sum_probs=186.0
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEe-------------CC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYS-------------KD 414 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-------------~~ 414 (654)
...+.||+|+||.||+|... +|+.||||+++......+.+.+|+.++++++||||+++++++.+ .+
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (303)
T 1zy4_A 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88 (303)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEE
T ss_pred hhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCC
Confidence 34578999999999999964 68999999997665556778999999999999999999998865 34
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCC
Q 036334 415 EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLN 494 (654)
Q Consensus 415 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla 494 (654)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 89 TLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIHSQG-IIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp EEEEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred ceEEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHHhCC-eecccCCHHhEEEcCCCCEEEeeCcch
Confidence 679999999999999999743 235788999999999999999999998 999999999999999999999999998
Q ss_pred CCcCCC------------------CCCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChh
Q 036334 495 PLFGNT------------------TPPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLP 555 (654)
Q Consensus 495 ~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~ 555 (654)
...... ....++..|+|||++.+. .++.++|||||||++|||++ ||.... +..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-----~~~ 235 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-----ERV 235 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-----hHH
Confidence 765421 123456779999999764 78999999999999999998 543210 011
Q ss_pred HHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 556 RWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
........... .+. ..........+.+++.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~---~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 NILKKLRSVSI---EFP-----PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHSTTC---CCC-----TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcccccc---ccC-----ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11111110000 000 0111222345677888999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.09 Aligned_cols=256 Identities=25% Similarity=0.347 Sum_probs=186.7
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCC------ceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD------EKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------~~~lv~e~ 422 (654)
..++||+|+||.||+|.+. +|+.||||++.... ....+|++++++++||||++++++|.... ..++||||
T Consensus 58 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 58 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 4578999999999999975 58999999986542 23346999999999999999999986422 25799999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC-CCeEEeccCCCCCcCCC-
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD-HDACVSDFGLNPLFGNT- 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~-~~~kl~Dfgla~~~~~~- 500 (654)
+++ ++.+.+..... ....+++..++.++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+++.....
T Consensus 135 ~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~-ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~ 211 (420)
T 1j1b_A 135 VPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211 (420)
T ss_dssp CCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT-EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred ccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCChhhEEEeCCCCeEEeccchhhhhcccCC
Confidence 975 66665542111 2356999999999999999999999998 9999999999999965 56899999999865432
Q ss_pred --CCCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---chhhhh--hh
Q 036334 501 --TPPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE---EWTAEV--FD 572 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~--~~ 572 (654)
....++..|+|||++.+. .++.++|||||||++|||++|+.||...... +.+..++.. .....+ .+
T Consensus 212 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~------~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 212 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV------DQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCSCCHHHHHHHC
T ss_pred CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCCHHHHHhhC
Confidence 234567789999998764 7999999999999999999999999764321 111111110 000000 00
Q ss_pred H-----hhhc--cC-----ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhh
Q 036334 573 V-----ELMR--YH-----NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM--IENMN 617 (654)
Q Consensus 573 ~-----~~~~--~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 617 (654)
+ .+.. .. .......++.+|+.+||..||++|||+.|+++. ++++.
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 0 0000 00 001112457788889999999999999999863 44443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.49 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=187.7
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCCc------eEEEE
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKDE------KLLVY 420 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~------~~lv~ 420 (654)
.+.||+|+||.||+|... +|+.||||++...... .+.+.+|+.++++++||||+++++++...+. .++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 108 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence 478999999999999964 5899999999764332 3567889999999999999999999987654 49999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||++ |+|.+++. ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 109 e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~-ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 109 PFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHSAG-VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp ECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred cccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC-cccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 9997 68888874 23899999999999999999999998 999999999999999999999999999876543
Q ss_pred -CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------chhhhhhh
Q 036334 501 -TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE------EWTAEVFD 572 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 572 (654)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+..+... .+.....+
T Consensus 180 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY------LDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH------HHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCCHHHHHHHhh
Confidence 23456788999999876 6789999999999999999999999975432 1111111110 00000000
Q ss_pred H-------hhhc------cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 573 V-------ELMR------YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 573 ~-------~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
. .+.. .........++.+++.+||+.||++|||++|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 0000 00011223467788889999999999999999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=319.25 Aligned_cols=249 Identities=19% Similarity=0.298 Sum_probs=182.6
Q ss_pred hhccccccCceeEEEEEecC-CcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEE--------------eC
Q 036334 350 SAEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYY--------------SK 413 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~--------------~~ 413 (654)
..+.||+|+||.||+|.... |+.||+|++.... ...+++.+|++++++++||||+++++++. +.
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 94 (320)
T 2i6l_A 15 DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94 (320)
T ss_dssp EEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSC
T ss_pred EEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccccc
Confidence 35789999999999999764 8999999987543 33467889999999999999999999874 34
Q ss_pred CceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEEC-CCCCeEEeccC
Q 036334 414 DEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR-PDHDACVSDFG 492 (654)
Q Consensus 414 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~-~~~~~kl~Dfg 492 (654)
...++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+||+++ +++.+||+|||
T Consensus 95 ~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 95 NSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN-VLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp SEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred CceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC-EecCCCCHHHEEEcCCCCeEEEccCc
Confidence 56799999997 699999862 45899999999999999999999998 99999999999997 56789999999
Q ss_pred CCCCcCCC-------CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh
Q 036334 493 LNPLFGNT-------TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE 564 (654)
Q Consensus 493 la~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 564 (654)
++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~~~~~ 240 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL------EQMQLILES 240 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHH
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHh
Confidence 99876432 12234667999998865 67899999999999999999999999754321 111111111
Q ss_pred ch------hhh-------hhhHhhhccCCh-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 565 EW------TAE-------VFDVELMRYHNI-----EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 565 ~~------~~~-------~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.. ..+ ............ .....++.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00 000 000000000000 1123457788889999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=319.48 Aligned_cols=241 Identities=20% Similarity=0.305 Sum_probs=187.8
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEeccccc---CHHHHHHHHHHHhccC--CCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV---GKREFEMQMEVLGKIK--HDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~--hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||.||++...+++.||||++..... ..+.+.+|++++++++ ||||+++++++.+++..++||| +.
T Consensus 32 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~ 110 (313)
T 3cek_A 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 110 (313)
T ss_dssp EEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CC
T ss_pred EEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cC
Confidence 3478999999999999988899999999965433 2456889999999997 5999999999999999999999 56
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
+++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++ ++.+||+|||++.......
T Consensus 111 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 111 NIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG-IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp SEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEEE-TTEEEECCCSSSCC--------
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCcccEEEE-CCeEEEeeccccccccCccccc
Confidence 88999999742 45899999999999999999999998 99999999999996 4899999999998764332
Q ss_pred ---CCCccccccCccccCC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchh
Q 036334 502 ---PPTRVAGYRAPEVVET-----------RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWT 567 (654)
Q Consensus 502 ---~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 567 (654)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+.........
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~ 258 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNHE 258 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTTSC
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHHHhcccc
Confidence 2356788999999865 4788999999999999999999999964321 11111111111110
Q ss_pred hhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036334 568 AEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMI 613 (654)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 613 (654)
.. .... ...++.+++.+||+.||++|||++|+++.-
T Consensus 259 ~~-------~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 259 IE-------FPDI---PEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp CC-------CCCC---SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cC-------Cccc---chHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 00 0011 123567788899999999999999998753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=323.74 Aligned_cols=250 Identities=21% Similarity=0.297 Sum_probs=188.4
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeC-----CceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSK-----DEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-----~~~~lv~e 421 (654)
+.+.||+|+||.||+|... +|+.||||++..... ...++.+|++++++++||||+++++++... ...++|||
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 94 (353)
T 2b9h_A 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQE 94 (353)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEEC
T ss_pred EeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEe
Confidence 3578999999999999965 588999999965432 245678999999999999999999988754 56899999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT- 500 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~- 500 (654)
|+. |+|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~-ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 95 LMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSN-VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp CCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC-eecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 996 699999873 35899999999999999999999998 999999999999999999999999998765422
Q ss_pred -------------CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhch
Q 036334 501 -------------TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEW 566 (654)
Q Consensus 501 -------------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 566 (654)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGIIGTPH 243 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCC
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCc
Confidence 11345778999998754 778999999999999999999999997643111 0000000000000
Q ss_pred ----h--------hhhhhHhhhcc--CC----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 567 ----T--------AEVFDVELMRY--HN----IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 567 ----~--------~~~~~~~~~~~--~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
. .+... .+... .. ......++.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIK-SLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp STTTTTTCCCHHHHHHHH-TSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccccchhhHHhh-cccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 00000 00000 00 0112345678888999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.04 Aligned_cols=247 Identities=22% Similarity=0.353 Sum_probs=171.7
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHH-HHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV--GKREFEMQME-VLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~e~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.||+|+||.||+|... +|+.||||+++.... ...++..|+. +++.++||||+++++++.+++..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 478999999999999975 689999999976532 2334555655 67888999999999999999999999999975
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---C
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS-GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---P 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~ 502 (654)
+|.+++..........+++..+.+++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++....... .
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 184 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR 184 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS-CCCSCCCGGGEEEETTTEEEECCCSSSCC---------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC-EeECCCCHHHEEEcCCCCEEEccCCCceeccccccccc
Confidence 887777532111245689999999999999999999998 7 9999999999999999999999999998764432 2
Q ss_pred CCccccccCcccc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 503 PTRVAGYRAPEVV----ETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 503 ~~~~~~y~aPE~~----~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
..++..|+|||++ .+..++.++|||||||++|||++|+.||........ .+....... . ..+ ..
T Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~-~-----~~~-~~ 252 (327)
T 3aln_A 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVVKGD-P-----PQL-SN 252 (327)
T ss_dssp ---------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCSC-C-----CCC-CC
T ss_pred CCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHhcCC-C-----CCC-CC
Confidence 3567789999998 456789999999999999999999999975322110 000000000 0 000 00
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.........+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000112345778888999999999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.08 Aligned_cols=233 Identities=21% Similarity=0.369 Sum_probs=189.6
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEeccccc-------CHHHHHHHHHHHhccC--CCccccccEEEEeCCceEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAV-------GKREFEMQMEVLGKIK--HDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~--hpniv~l~~~~~~~~~~~lv 419 (654)
+.+.||+|+||.||+|.. .+|+.||||+++.... ....+.+|+.++++++ ||||+++++++.+++..++|
T Consensus 47 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv 126 (320)
T 3a99_A 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 126 (320)
T ss_dssp EEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEE
Confidence 357899999999999985 4688999999976532 2245678999999996 59999999999999999999
Q ss_pred EEecCC-CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEEC-CCCCeEEeccCCCCCc
Q 036334 420 YDYMPA-GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR-PDHDACVSDFGLNPLF 497 (654)
Q Consensus 420 ~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~-~~~~~kl~Dfgla~~~ 497 (654)
|||+.+ ++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++ .++.+||+|||++...
T Consensus 127 ~e~~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 127 LERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp EECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEcCCCCccHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-cEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 999976 899999974 245899999999999999999999998 99999999999999 7789999999998876
Q ss_pred CCC--CCCCccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 498 GNT--TPPTRVAGYRAPEVVETRKV-TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 498 ~~~--~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
... ....++..|+|||++.+..+ +.++|||||||++|||++|+.||.... ........
T Consensus 201 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~~~~~~------- 261 (320)
T 3a99_A 201 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQVF------- 261 (320)
T ss_dssp CSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCCC-------
T ss_pred ccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhhccccc-------
Confidence 543 23457788999999977666 688999999999999999999996421 01111000
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.... ...++.+++.+||+.||++|||++|+++.
T Consensus 262 --~~~~---~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 262 --FRQR---VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --CSSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --cccc---CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011 12356778889999999999999999873
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=314.16 Aligned_cols=227 Identities=14% Similarity=0.099 Sum_probs=178.4
Q ss_pred hccccccCceeEEEEEecC-CcEEEEEEecccccC----HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 351 AEVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVG----KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.+.||+|+||.||+|.... |+.||||++...... .+.+.+|+..+++++||||+++++++.+++..|+||||+++
T Consensus 36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 115 (286)
T 3uqc_A 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG 115 (286)
T ss_dssp EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCE
T ss_pred EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCC
Confidence 4789999999999999754 899999999866433 26788999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCCCCc
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR 505 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 505 (654)
++|.+++.. . ....++.+++.|++.||+|||+++ |+||||||+|||++.++.+||+++|
T Consensus 116 ~~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH~~g-ivH~Dikp~NIll~~~g~~kl~~~~------------- 174 (286)
T 3uqc_A 116 GSLQEVADT------S-PSPVGAIRAMQSLAAAADAAHRAG-VALSIDHPSRVRVSIDGDVVLAYPA------------- 174 (286)
T ss_dssp EEHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred CCHHHHHhc------C-CChHHHHHHHHHHHHHHHHHHHCC-CccCCCCcccEEEcCCCCEEEEecc-------------
Confidence 999999952 1 355678899999999999999998 9999999999999999999998554
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHH
Q 036334 506 VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585 (654)
Q Consensus 506 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (654)
|++| ++.++|||||||++|||++|+.||......+...... ...... ...... .... ..
T Consensus 175 ---~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~----~~~~~~-~~~~---~~ 233 (286)
T 3uqc_A 175 ---TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTAGQ----PIEPAD-IDRD---IP 233 (286)
T ss_dssp ---CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTTSC----BCCHHH-HCTT---SC
T ss_pred ---ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhccC----CCChhh-cccC---CC
Confidence 4443 6889999999999999999999998754432110000 000000 000000 0011 12
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 586 VQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 586 ~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
.++.+++.+||+.||++| |+.|+++.|+++....
T Consensus 234 ~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 234 FQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 346778889999999999 9999999999998654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=317.39 Aligned_cols=243 Identities=20% Similarity=0.309 Sum_probs=173.0
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccccCH---HHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGK---REFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
...+.||+|+||.||+|... +|+.||||++....... +.+.++..+++.++||||+++++++.+++..++||||+
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 106 (318)
T 2dyl_A 28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106 (318)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred cccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence 34578999999999999975 68999999997653322 23334445678889999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS-GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
++.+..+.... ...+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||++......
T Consensus 107 ~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~-i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (318)
T 2dyl_A 107 GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181 (318)
T ss_dssp SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHC-CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCC-EEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc
Confidence 55665555422 24589999999999999999999985 7 999999999999999999999999998765433
Q ss_pred CCCCccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 501 TPPTRVAGYRAPEVVE-----TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
....++..|+|||++. ...++.++|||||||++|||++|+.||..... ....+......... ..
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~------~~ 250 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----DFEVLTKVLQEEPP------LL 250 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHHSCCC------CC
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----cHHHHHHHhccCCC------CC
Confidence 2345677899999984 45788999999999999999999999974221 11222222221110 00
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
... .....++.+++.+||+.||.+||+++|+++
T Consensus 251 ~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 PGH---MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CSS---SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred Ccc---CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000 112235677888999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=319.36 Aligned_cols=234 Identities=23% Similarity=0.390 Sum_probs=184.6
Q ss_pred HhhccccccCceeEEEEEe-cCCcEEEEEEeccccc-------CHHHHHHHHHHHhcc----CCCccccccEEEEeCCce
Q 036334 349 ASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAV-------GKREFEMQMEVLGKI----KHDNVVPLRAFYYSKDEK 416 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-------~~~~~~~e~~~l~~l----~hpniv~l~~~~~~~~~~ 416 (654)
.+.+.||+|+||.||+|.. .+++.||||+++.... ....+.+|+.++.++ +||||+++++++.+.+..
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~ 113 (312)
T 2iwi_A 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGF 113 (312)
T ss_dssp EEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----C
T ss_pred EEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeE
Confidence 3467899999999999985 4688999999975432 223456788888888 899999999999999999
Q ss_pred EEEEEe-cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEEC-CCCCeEEeccCCC
Q 036334 417 LLVYDY-MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR-PDHDACVSDFGLN 494 (654)
Q Consensus 417 ~lv~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~-~~~~~kl~Dfgla 494 (654)
++|||| +.+++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++ .++.+||+|||++
T Consensus 114 ~~v~e~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 114 MLVLERPLPAQDLFDYITE-----KGPLGEGPSRCFFGQVVAAIQHCHSRG-VVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp EEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHT-EECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred EEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 999999 789999999974 235899999999999999999999998 99999999999999 7899999999998
Q ss_pred CCcCCC--CCCCccccccCccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhh
Q 036334 495 PLFGNT--TPPTRVAGYRAPEVVETRKVT-FKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571 (654)
Q Consensus 495 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 571 (654)
...... ....++..|+|||++.+..+. .++||||||+++|||++|+.||.... .......
T Consensus 188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~~~~~----- 250 (312)
T 2iwi_A 188 ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------EILEAEL----- 250 (312)
T ss_dssp EECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHTCC-----
T ss_pred hhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------HHhhhcc-----
Confidence 876543 334567789999998776664 58999999999999999999996421 0111000
Q ss_pred hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 572 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
........++.+++.+||+.||++|||++|+++.
T Consensus 251 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 251 -------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011122356778889999999999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=328.28 Aligned_cols=238 Identities=23% Similarity=0.339 Sum_probs=178.8
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
.++||+|+||+||.....+|+.||||++..... ..+.+|+++++++ +||||+++++++.+.+..++||||++ |+|.
T Consensus 29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~ 105 (432)
T 3p23_A 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ 105 (432)
T ss_dssp EEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred CCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHH
Confidence 478999999997766666799999999865432 2356799999999 79999999999999999999999996 6999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC-----CCeEEeccCCCCCcCCC----
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD-----HDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~-----~~~kl~Dfgla~~~~~~---- 500 (654)
+++.... ....+..++.++.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|||++......
T Consensus 106 ~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~ 180 (432)
T 3p23_A 106 EYVEQKD----FAHLGLEPITLLQQTTSGLAHLHSLN-IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180 (432)
T ss_dssp HHHHSSS----CCCCSSCHHHHHHHHHHHHHHHHHTT-CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred HHHHhcC----CCccchhHHHHHHHHHHHHHHHHHCc-CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcce
Confidence 9997543 22444556789999999999999998 9999999999999532 35789999998766432
Q ss_pred ---CCCCccccccCccccC---CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 ---TPPTRVAGYRAPEVVE---TRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 ---~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....+|..|+|||++. ...++.++|||||||++|||++ |..||..... ....... .......
T Consensus 181 ~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-------~~~~~~~-~~~~~~~--- 249 (432)
T 3p23_A 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-------RQANILL-GACSLDC--- 249 (432)
T ss_dssp -----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-------HHHHHHT-TCCCCTT---
T ss_pred eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-------HHHHHHh-ccCCccc---
Confidence 2345788899999997 4567889999999999999999 8999854221 1111111 1100000
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..........+.+++.+||+.||++|||++|+++
T Consensus 250 ----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 ----LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ----SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0111122334667888999999999999999983
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=348.25 Aligned_cols=234 Identities=20% Similarity=0.267 Sum_probs=190.3
Q ss_pred hhccccccCceeEEEEEec--CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCc-----eEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE--EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDE-----KLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~-----~~lv~ 420 (654)
+.+.||+|+||+||+|.+. +|+.||||++.... .....+.+|++++++++||||+++++++...+. .|+||
T Consensus 84 i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~ 163 (681)
T 2pzi_A 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVM 163 (681)
T ss_dssp EEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred EEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEE
Confidence 3578999999999999975 58999999986542 234568899999999999999999999987665 69999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+++++|.+++.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.+ .+||+|||++......
T Consensus 164 E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g-iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 164 EYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG-LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp ECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred EeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC-CeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 99999999987752 5899999999999999999999998 9999999999999975 8999999999888776
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
....+|++|+|||++.+. ++.++|||||||++|||++|..||......... .. ..
T Consensus 235 ~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~---------------~~---------~~ 289 (681)
T 2pzi_A 235 GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP---------------ED---------DP 289 (681)
T ss_dssp SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC---------------TT---------CH
T ss_pred CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc---------------cc---------cc
Confidence 667789999999998765 489999999999999999999887643211100 00 00
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhhh
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRP-AMQEVVRMIENMN 617 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~ 617 (654)
.......+.+++.+||+.||++|| +++++.+.|..+.
T Consensus 290 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 011223577888899999999999 5777878777664
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.03 Aligned_cols=235 Identities=19% Similarity=0.243 Sum_probs=173.1
Q ss_pred hccccccCceeEEEEEe-cCCcEEEEEEecccc----cCHHHHHHHHHHHhccCC-Cccccc---------c--------
Q 036334 351 AEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA----VGKREFEMQMEVLGKIKH-DNVVPL---------R-------- 407 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h-pniv~l---------~-------- 407 (654)
.++||+|+||+||+|.+ .+|+.||||+++... ...+.+.+|+.+++.++| +|.... .
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 46899999999999995 468999999987432 234678899999999977 321111 1
Q ss_pred ----EEEEe-----CCceEEEEEecCCCchhhhhccCC--CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCC
Q 036334 408 ----AFYYS-----KDEKLLVYDYMPAGSLSALLHGSR--GSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKAS 476 (654)
Q Consensus 408 ----~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~ 476 (654)
.++.. ....+++|+++ +++|.+++.... ......+++..++.++.|+++||+|||+++ |+||||||+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-iiHrDiKp~ 240 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-LVHTYLRPV 240 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGG
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCcccc
Confidence 11111 12356777766 689999884210 012345889999999999999999999998 999999999
Q ss_pred cEEECCCCCeEEeccCCCCCcCCC-CCCCccccccCcccc----------CCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 036334 477 NILLRPDHDACVSDFGLNPLFGNT-TPPTRVAGYRAPEVV----------ETRKVTFKSDVYSFGVLLLELLTGKAPNQA 545 (654)
Q Consensus 477 NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~~~y~aPE~~----------~~~~~~~~~DvwslGvil~el~tg~~pf~~ 545 (654)
|||++.++.+||+|||++...... ....+ ..|+|||++ ....++.++|||||||++|||++|+.||..
T Consensus 241 NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~ 319 (413)
T 3dzo_A 241 DIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319 (413)
T ss_dssp GEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCT
T ss_pred eEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999998766543 23445 889999999 556688999999999999999999999976
Q ss_pred CCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 036334 546 SLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVV 610 (654)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 610 (654)
....+... .++. ..... ..++.+++.+||+.||++||++.+++
T Consensus 320 ~~~~~~~~---------------~~~~----~~~~~---~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 320 DAALGGSE---------------WIFR----SCKNI---PQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp TGGGSCSG---------------GGGS----SCCCC---CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred cchhhhHH---------------HHHh----hcccC---CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 43322110 0110 11111 13577788899999999999976664
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=338.52 Aligned_cols=263 Identities=22% Similarity=0.294 Sum_probs=196.6
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEe------CCceEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYS------KDEKLLV 419 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~------~~~~~lv 419 (654)
.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|++++++++||||+++++++.. ++..++|
T Consensus 17 ~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LV 96 (676)
T 3qa8_A 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96 (676)
T ss_dssp CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCE
T ss_pred EEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEE
Confidence 45688999999999999864 58999999987542 234568899999999999999999998765 5677999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC---eEEeccCCCCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD---ACVSDFGLNPL 496 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~---~kl~Dfgla~~ 496 (654)
|||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 97 mEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs~g-IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 97 MEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHENR-IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp EECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHHTT-BCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred EEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-CccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 99999999999998543 2335889999999999999999999998 999999999999997765 89999999987
Q ss_pred cCCC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh--------hc
Q 036334 497 FGNT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR--------EE 565 (654)
Q Consensus 497 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~--------~~ 565 (654)
.... ....++..|+|||++.+..++.++|||||||++|||++|+.||..... ...|...... ..
T Consensus 174 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 174 LDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp TTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC------CCSCC
T ss_pred cccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccchhhhhhh
Confidence 6543 234567889999999999999999999999999999999999965311 0000000000 00
Q ss_pred hhhhh--hhHhhhc-cCChHHHHHHHHHHHhhccCCCCCCCCCHHH-----HHHHHHhhhcC
Q 036334 566 WTAEV--FDVELMR-YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQE-----VVRMIENMNRG 619 (654)
Q Consensus 566 ~~~~~--~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e-----vl~~L~~~~~~ 619 (654)
..... +...... ..........+.+++.+||..||++|||++| ..+.++++...
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00000 0000000 0112234456788888999999999999987 45666666543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=300.95 Aligned_cols=225 Identities=19% Similarity=0.256 Sum_probs=172.6
Q ss_pred ccccccCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHH-hccCCCccccccEEEEe----CCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVGKREFEMQMEVL-GKIKHDNVVPLRAFYYS----KDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~e~~~l-~~l~hpniv~l~~~~~~----~~~~~lv~e~~~~ 425 (654)
++||+|+||.||+|.. .+++.||+|+++. ...+.+|+.++ +..+||||+++++++.. ....++||||+++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 99 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 99 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence 6799999999999996 4689999999864 34567788887 56689999999999887 6678999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC---CCCeEEeccCCCCCcCCCCC
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP---DHDACVSDFGLNPLFGNTTP 502 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~---~~~~kl~Dfgla~~~~~~~~ 502 (654)
|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++. ++.+||+|||++....
T Consensus 100 ~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---- 171 (299)
T 3m2w_A 100 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---- 171 (299)
T ss_dssp CBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence 99999997542 346999999999999999999999998 999999999999998 7889999999986433
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
+..++.++|||||||++|||++|+.||........... ................. .
T Consensus 172 --------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~---~ 227 (299)
T 3m2w_A 172 --------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------MKTRIRMGQYEFPNPEW---S 227 (299)
T ss_dssp --------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-------SCCSSCTTCCSSCHHHH---T
T ss_pred --------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-------HHHHHhhccccCCchhc---c
Confidence 24577899999999999999999999975432211000 00000000000000000 1
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
....++.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 123457778889999999999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.42 Aligned_cols=239 Identities=12% Similarity=0.151 Sum_probs=178.1
Q ss_pred HHHhhccccccCceeEEEEEecCCcEEEEEEeccccc---------CHHHHHHHHHHHhccC---------CCccccccE
Q 036334 347 LRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV---------GKREFEMQMEVLGKIK---------HDNVVPLRA 408 (654)
Q Consensus 347 ~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~---------hpniv~l~~ 408 (654)
.|.+.+.||+|+||+||+|.. +|+.||||+++.... ..+.+.+|+.++++++ ||||+++.+
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~ 99 (336)
T 2vuw_A 21 KLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS 99 (336)
T ss_dssp HHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred cchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence 456778999999999999998 589999999976432 2367889999988886 666666655
Q ss_pred EE-----------------Ee-------------CCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 036334 409 FY-----------------YS-------------KDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARG 458 (654)
Q Consensus 409 ~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~ 458 (654)
++ .+ .+..++||||+++|++.+.+.. ..+++..++.++.||+.|
T Consensus 100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHH
T ss_pred eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHH
Confidence 43 32 6789999999999987776642 348999999999999999
Q ss_pred HHHhh-ccCCeecCCCCCCcEEECCCC--------------------CeEEeccCCCCCcCCCCCCCccccccCccccCC
Q 036334 459 LAHLH-VSGKIVHGNIKASNILLRPDH--------------------DACVSDFGLNPLFGNTTPPTRVAGYRAPEVVET 517 (654)
Q Consensus 459 l~~LH-~~~~ivHrDlk~~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~y~aPE~~~~ 517 (654)
|+||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...+|..|+|||++.+
T Consensus 174 L~~lH~~~~-ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 174 LAVAEASLR-FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHHHC-CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGCC
T ss_pred HHHHHHhCC-EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhcC
Confidence 99999 888 99999999999999887 8999999999876543 3467888999999987
Q ss_pred CCCCcchhHHHHHHH-HHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhcc
Q 036334 518 RKVTFKSDVYSFGVL-LLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCV 596 (654)
Q Consensus 518 ~~~~~~~DvwslGvi-l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl 596 (654)
.. +.++||||++++ .+++++|..||.. ..|.......-......... ...........++.+++.+||
T Consensus 252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dli~~~L 320 (336)
T 2vuw_A 252 DG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDKMLKQMTFKTK-CNTPAMKQIKRKIQEFHRTML 320 (336)
T ss_dssp CS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHHHHHTCCCSSC-CCSHHHHHHHHHHHHHHHHGG
T ss_pred CC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHhhhhhhccCcc-cchhhhhhcCHHHHHHHHHHh
Confidence 66 899999998777 7888889988742 11111111000000000000 000112344567888899999
Q ss_pred CCCCCCCCCHHHHH
Q 036334 597 STVPDQRPAMQEVV 610 (654)
Q Consensus 597 ~~dP~~RPs~~evl 610 (654)
+.| |++|++
T Consensus 321 ~~d-----sa~e~l 329 (336)
T 2vuw_A 321 NFS-----SATDLL 329 (336)
T ss_dssp GSS-----SHHHHH
T ss_pred ccC-----CHHHHH
Confidence 976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-29 Score=281.46 Aligned_cols=180 Identities=18% Similarity=0.104 Sum_probs=126.7
Q ss_pred ccccCceeEEEEE-ecCCcEEEEEEecccc-----------cCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEE
Q 036334 354 LGKGSVGTSYKAV-LEEGTTVVVKRLKEVA-----------VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVY 420 (654)
Q Consensus 354 lg~G~fg~Vy~~~-~~~g~~vavK~~~~~~-----------~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 420 (654)
.+.|++|.+..++ .--|+.|+||++.... ...++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5666776666544 2238899999996541 2235689999999999 6999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||++|++|.++|.. ..+++.. +|+.||+.||+|+|+++ ||||||||+|||++.+|.+||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~~G-IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEKQG-FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHHTT-CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHHCC-ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999974 3456654 58899999999999998 999999999999999999999999999876543
Q ss_pred CC----CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 036334 501 TP----PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPN 543 (654)
Q Consensus 501 ~~----~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf 543 (654)
.. ..+|++|||||++.+ .+..++|+||+|++++++.++..++
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 22 346778999999975 4677899999999998887665543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=253.68 Aligned_cols=186 Identities=33% Similarity=0.605 Sum_probs=170.5
Q ss_pred CCChhHHHHHHHHHhhCCCC-CCCCccCCCCCCC--ceeeEEcCCC--CeEEEeecCCCCccc--cCCcccccCCCCccE
Q 036334 25 SEPTQDKQALLAFLSRTPHK-NRVQWNASDSACN--WVGVECDANR--SFVYSLRLPGVGLVG--PIPPNTLGKLSQLRV 97 (654)
Q Consensus 25 ~~~~~~~~al~~~~~~~~~~-~~~~W~~~~~~C~--w~gv~C~~~~--~~v~~L~l~~~~l~~--~~~~~~l~~l~~L~~ 97 (654)
.|.++|++||++||.+..++ ...+|+.+++||. |.||+|+... ++|+.|+|++|++.| .+|+ .|+++++|++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L~~ 80 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hHhCCCCCCe
Confidence 46789999999999988654 3478988889998 9999998654 679999999999999 8887 6999999999
Q ss_pred EEecc-CCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccCcccccccc
Q 036334 98 LSLRS-NRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNK 176 (654)
Q Consensus 98 L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 176 (654)
|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|.++++|++|+|++|+|++.+|..+..+++|++|+|++|+
T Consensus 81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence 99995 99999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCC--CCC-CCCeEEccCCcccccCcccccCCC
Q 036334 177 FSGNLPSI--NPA-NLRDFNVSNNNLNGSIPATLSKFP 211 (654)
Q Consensus 177 l~~~~~~~--~~~-~L~~L~l~~N~l~g~~p~~~~~~~ 211 (654)
|++.+|.. .++ +|+.|+|++|+++|.+|..+..+.
T Consensus 161 l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~ 198 (313)
T 1ogq_A 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN 198 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC
T ss_pred ccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc
Confidence 99888765 666 999999999999999999887764
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=254.69 Aligned_cols=177 Identities=16% Similarity=0.219 Sum_probs=144.4
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEeccccc---------CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV---------GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
.++||+|+||+||+|... +..+++|+...... ..+++.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 568999999999999544 78899998644321 13457899999999999999988888888888999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT 501 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 501 (654)
|+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||++. .+||+|||+++......
T Consensus 420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g-IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND-VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT-EECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc-CccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 9999999999973 4679999999999999998 999999999999998 99999999998876531
Q ss_pred -----------CCCccccccCccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 036334 502 -----------PPTRVAGYRAPEVVET--RKVTFKSDVYSFGVLLLELLTGKAPNQ 544 (654)
Q Consensus 502 -----------~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~ 544 (654)
...+|+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2356778999999976 668888999999999988888777663
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.5e-26 Score=261.60 Aligned_cols=183 Identities=27% Similarity=0.363 Sum_probs=124.6
Q ss_pred CChhHHHHHHHHHhhCCCC-CCCCccCCCCCCCceeeEEcCCCCeEEEeecCCCCcccc---CCc---------------
Q 036334 26 EPTQDKQALLAFLSRTPHK-NRVQWNASDSACNWVGVECDANRSFVYSLRLPGVGLVGP---IPP--------------- 86 (654)
Q Consensus 26 ~~~~~~~al~~~~~~~~~~-~~~~W~~~~~~C~w~gv~C~~~~~~v~~L~l~~~~l~~~---~~~--------------- 86 (654)
+.++|++||++||++..++ ...+|+.+++||+|.||+|+ .++|+.|+|+++++.|. +++
T Consensus 9 ~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~ 86 (768)
T 3rgz_A 9 SLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSN 86 (768)
T ss_dssp CHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTT
T ss_pred CCHHHHHHHHHHHhhCCCcccccCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccccCCcC
Confidence 4578999999999987554 45789888899999999998 46899999999999887 554
Q ss_pred -------ccccCCCCccEEEeccCCccCcCCC--CCCCccccccccccccccccccchhh-ccccccceecccccccccc
Q 036334 87 -------NTLGKLSQLRVLSLRSNRLSGEIPS--DFSNLTLLRSLYLQSNQFSGVFPASV-TRMNRLTRLDLSSNNFSGK 156 (654)
Q Consensus 87 -------~~l~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~ 156 (654)
+.|+++++|++|||++|.++|.+|. .|+++++|++|+|++|++++.+|..+ .++++|++|+|++|++++.
T Consensus 87 ~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 166 (768)
T 3rgz_A 87 SHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166 (768)
T ss_dssp SCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEE
T ss_pred CCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCc
Confidence 2466777777777777777776666 67777777777777777776666554 5566666666666666655
Q ss_pred CCCc---cccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCC
Q 036334 157 IPFD---VNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFP 211 (654)
Q Consensus 157 ~p~~---~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~ 211 (654)
.|.. +.++++|++|++++|++++.++...+++|++|+|++|.+++.+|. +++++
T Consensus 167 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~ 223 (768)
T 3rgz_A 167 NVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCS 223 (768)
T ss_dssp THHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCC
T ss_pred CChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCC
Confidence 5443 445555555555555555444444455555555555555554444 44333
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=254.42 Aligned_cols=184 Identities=25% Similarity=0.390 Sum_probs=157.7
Q ss_pred ChhHHHHHHHHHhhCCCCCC----------CCccCCCCCCCc---eeeEEcCCCCeEEEeecCCCCccccCCcccccCCC
Q 036334 27 PTQDKQALLAFLSRTPHKNR----------VQWNASDSACNW---VGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLS 93 (654)
Q Consensus 27 ~~~~~~al~~~~~~~~~~~~----------~~W~~~~~~C~w---~gv~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l~ 93 (654)
...|+.||++|+.+.....+ .+|+.+.+||.| .||+|+.. ++|+.|+|+++++.|.+|+ .|++|+
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~-~l~~L~ 105 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPD-AIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECG-GGGGCT
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCCh-HHhcCc
Confidence 35699999999888754332 279988899999 99999865 6899999999999999998 699999
Q ss_pred CccEEEeccCC---------------------------------------------------------------------
Q 036334 94 QLRVLSLRSNR--------------------------------------------------------------------- 104 (654)
Q Consensus 94 ~L~~L~Ls~N~--------------------------------------------------------------------- 104 (654)
+|++|+|++|.
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~ 185 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCT
T ss_pred cceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhh
Confidence 99999999984
Q ss_pred ---------ccCcCCCCCCCccccccccccccccccc-----------------cchhhc--cccccceecccccccccc
Q 036334 105 ---------LSGEIPSDFSNLTLLRSLYLQSNQFSGV-----------------FPASVT--RMNRLTRLDLSSNNFSGK 156 (654)
Q Consensus 105 ---------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~L~l~~N~l~~~ 156 (654)
|+| +|..|+++++|++|+|++|+|+|. +|..++ ++++|++|+|++|++.+.
T Consensus 186 l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~ 264 (636)
T 4eco_A 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264 (636)
T ss_dssp TTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSS
T ss_pred hhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCcc
Confidence 445 788899999999999999999986 899988 999999999999999999
Q ss_pred CCCccccccccCcccccccc-ccC-CCCCC--CC------CCCCeEEccCCcccccCcc--cccCCCCcc
Q 036334 157 IPFDVNNLTHLTGLFLENNK-FSG-NLPSI--NP------ANLRDFNVSNNNLNGSIPA--TLSKFPQSS 214 (654)
Q Consensus 157 ~p~~~~~l~~L~~L~l~~N~-l~~-~~~~~--~~------~~L~~L~l~~N~l~g~~p~--~~~~~~~l~ 214 (654)
+|..++++++|++|+|++|+ |+| .+|.. .+ ++|+.|+|++|+++ .+|. .++++++|.
T Consensus 265 ~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~ 333 (636)
T 4eco_A 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLG 333 (636)
T ss_dssp CCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCC
T ss_pred ChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCC
Confidence 99999999999999999998 887 66643 33 88899999999988 8888 777766654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.4e-25 Score=255.49 Aligned_cols=183 Identities=27% Similarity=0.418 Sum_probs=158.2
Q ss_pred CChhHHHHHHHHHhhCCCCCCCCccCCC-----CC--CCc------------eeeEEcCCCCeEEEeecCCCCccccCCc
Q 036334 26 EPTQDKQALLAFLSRTPHKNRVQWNASD-----SA--CNW------------VGVECDANRSFVYSLRLPGVGLVGPIPP 86 (654)
Q Consensus 26 ~~~~~~~al~~~~~~~~~~~~~~W~~~~-----~~--C~w------------~gv~C~~~~~~v~~L~l~~~~l~~~~~~ 86 (654)
+...|+.||++||.+..++ +|+.++ +| |+| .||+|+. .++|+.|+|+++++.|.+|+
T Consensus 266 ~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEECG
T ss_pred cchHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCch
Confidence 3467999999999998654 787544 55 999 9999986 46799999999999999998
Q ss_pred ccccCCCCccEEEe-ccCCccCc---------------------------------------------------------
Q 036334 87 NTLGKLSQLRVLSL-RSNRLSGE--------------------------------------------------------- 108 (654)
Q Consensus 87 ~~l~~l~~L~~L~L-s~N~l~~~--------------------------------------------------------- 108 (654)
.|++|++|++|+| ++|.++|.
T Consensus 342 -~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~ 420 (876)
T 4ecn_A 342 -AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420 (876)
T ss_dssp -GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred -HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence 6999999999999 77765544
Q ss_pred -------------------CCCCCCCcccccccccccccccc-----------------ccchhhc--cccccceecccc
Q 036334 109 -------------------IPSDFSNLTLLRSLYLQSNQFSG-----------------VFPASVT--RMNRLTRLDLSS 150 (654)
Q Consensus 109 -------------------~p~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l~~L~~L~l~~ 150 (654)
+|..|++|++|++|+|++|+|+| .+|..++ ++++|++|+|++
T Consensus 421 ~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~ 500 (876)
T 4ecn_A 421 SRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500 (876)
T ss_dssp CCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEES
T ss_pred cccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcC
Confidence 78889999999999999999998 3899987 999999999999
Q ss_pred ccccccCCCccccccccCcccccccc-ccC-CCCCC---------CCCCCCeEEccCCcccccCcc--cccCCCCcc
Q 036334 151 NNFSGKIPFDVNNLTHLTGLFLENNK-FSG-NLPSI---------NPANLRDFNVSNNNLNGSIPA--TLSKFPQSS 214 (654)
Q Consensus 151 N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~-~~~~~---------~~~~L~~L~l~~N~l~g~~p~--~~~~~~~l~ 214 (654)
|++.+.+|..|.+|++|+.|+|++|+ |++ .+|.. .+++|+.|+|++|+|+ .+|. .|.++++|.
T Consensus 501 N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~ 576 (876)
T 4ecn_A 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLG 576 (876)
T ss_dssp CTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCC
T ss_pred CCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCC
Confidence 99999999999999999999999998 888 56542 4569999999999999 8998 787776654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.8e-23 Score=208.57 Aligned_cols=139 Identities=19% Similarity=0.255 Sum_probs=114.9
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEeccccc-------------------CHHHHHHHHHHHhccCCCccccccEEEE
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV-------------------GKREFEMQMEVLGKIKHDNVVPLRAFYY 411 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~-------------------~~~~~~~e~~~l~~l~hpniv~l~~~~~ 411 (654)
.+.||+|+||.||+|...+|+.||+|+++.... ....+.+|++++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 478999999999999997799999999964321 2356889999999998 5 77777654
Q ss_pred eCCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEecc
Q 036334 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDF 491 (654)
Q Consensus 412 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Df 491 (654)
. +..++||||+++|+|.+ +.. .....++.|++.||+|||+.+ |+||||||+|||++ ++.+||+||
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g-iiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG-IVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT-EECSCCSTTSEEEE-TTEEEECCC
T ss_pred c-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC-CEeCCCCHHHEEEE-CCcEEEEEC
Confidence 4 56799999999999998 531 124579999999999999998 99999999999999 999999999
Q ss_pred CCCCCcCCCCCCCccccccCccccC
Q 036334 492 GLNPLFGNTTPPTRVAGYRAPEVVE 516 (654)
Q Consensus 492 gla~~~~~~~~~~~~~~y~aPE~~~ 516 (654)
|++... ..|+|||++.
T Consensus 237 G~a~~~---------~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVEV---------GEEGWREILE 252 (282)
T ss_dssp TTCEET---------TSTTHHHHHH
T ss_pred CCCeEC---------CCCCHHHHHH
Confidence 998643 3478999874
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.4e-23 Score=214.50 Aligned_cols=185 Identities=22% Similarity=0.326 Sum_probs=156.2
Q ss_pred CCChhHHHHHHHHHhhCC-CC-C-CCCcc----CCCCCCCceeeEEcC--------CCCeEEEeecCCCCccccCCcccc
Q 036334 25 SEPTQDKQALLAFLSRTP-HK-N-RVQWN----ASDSACNWVGVECDA--------NRSFVYSLRLPGVGLVGPIPPNTL 89 (654)
Q Consensus 25 ~~~~~~~~al~~~~~~~~-~~-~-~~~W~----~~~~~C~w~gv~C~~--------~~~~v~~L~l~~~~l~~~~~~~~l 89 (654)
.+..+|+.||++|+.... +. . ..+|. .+.++|.|.|+.|.. ...+|+.|+|++|++. .+|+ .+
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~-~l 100 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD-QA 100 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS-CG
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh-hh
Confidence 355789999999998552 22 2 25783 466899999999952 3356999999999998 7877 48
Q ss_pred cCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCcccc------
Q 036334 90 GKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNN------ 163 (654)
Q Consensus 90 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~------ 163 (654)
+++++|++|+|++|.|+ .+|..|+++++|++|+|++|+++ .+|..+.++++|++|+|++|++.+.+|..+..
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 88999999999999999 89999999999999999999999 88999999999999999999999999988765
Q ss_pred ---ccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccCcccccCCCCcc
Q 036334 164 ---LTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATLSKFPQSS 214 (654)
Q Consensus 164 ---l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p~~~~~~~~l~ 214 (654)
+++|+.|+|++|+|+..+..+ .+++|+.|+|++|+++ .+|..+.++++|.
T Consensus 179 ~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~ 232 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE 232 (328)
T ss_dssp EEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCC
T ss_pred hccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCC
Confidence 999999999999999444344 7899999999999999 5776777666543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.7e-22 Score=232.57 Aligned_cols=162 Identities=37% Similarity=0.613 Sum_probs=139.2
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCC------------------------------------
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSD------------------------------------ 112 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~------------------------------------ 112 (654)
+++.|+|++|.+.|.+|. .++++++|++|+|++|.++|.+|..
T Consensus 515 ~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (768)
T 3rgz_A 515 NLAILKLSNNSFSGNIPA-ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNL 593 (768)
T ss_dssp TCCEEECCSSCCEEECCG-GGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEE
T ss_pred CCCEEECCCCcccCcCCH-HHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccc
Confidence 467777777777777776 4788888888888888877666643
Q ss_pred ----------------------------------CCCccccccccccccccccccchhhccccccceeccccccccccCC
Q 036334 113 ----------------------------------FSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIP 158 (654)
Q Consensus 113 ----------------------------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 158 (654)
|+++++|+.|||++|+++|.+|..|+++++|+.|+|++|+|+|.+|
T Consensus 594 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip 673 (768)
T 3rgz_A 594 LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIP 673 (768)
T ss_dssp EECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCC
T ss_pred cccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCC
Confidence 3345678889999999999999999999999999999999999999
Q ss_pred CccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcc--cccCCCCccccCCCCCCCCCCCCCCC
Q 036334 159 FDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPA--TLSKFPQSSFTGNLDLCGGPLPPCNP 231 (654)
Q Consensus 159 ~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~--~~~~~~~l~~~~n~~~c~~~~~~C~~ 231 (654)
..++++++|+.|||++|+|+|.+|.. .+++|++|+|++|+|+|.||. .|..++...|.||+.+||.+..+|..
T Consensus 674 ~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~ 750 (768)
T 3rgz_A 674 DEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCS
T ss_pred hHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCC
Confidence 99999999999999999999999876 889999999999999999996 47788889999999999998888863
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.85 E-value=3.1e-21 Score=192.63 Aligned_cols=169 Identities=23% Similarity=0.285 Sum_probs=139.0
Q ss_pred CCCCceeeEEcCC------------------CCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCC
Q 036334 54 SACNWVGVECDAN------------------RSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSN 115 (654)
Q Consensus 54 ~~C~w~gv~C~~~------------------~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 115 (654)
+||.|.|++|... ...++.|+|++|++.+..+ ..|.++++|++|+|++|.|++..+..|.+
T Consensus 3 ~Cp~~~gC~C~~~~~~l~~~~~~l~~~p~~~~~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 81 (251)
T 3m19_A 3 TCETVTGCTCNEGKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSD-ATFRGLTKLTWLNLDYNQLQTLSAGVFDD 81 (251)
T ss_dssp -CHHHHSSEEEGGGTEEECTTCCCSSCCSCCCTTCCEEECTTSCCCCCCT-TTTTTCTTCCEEECTTSCCCCCCTTTTTT
T ss_pred cCCCCCceEcCCCCeEEecCCCCccccCCCCCCCCCEEEccCCCcCccCH-hHhcCcccCCEEECCCCcCCccCHhHhcc
Confidence 4677878888321 1247789999999986544 46899999999999999999888888999
Q ss_pred ccccccccccccccccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEE
Q 036334 116 LTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFN 193 (654)
Q Consensus 116 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~ 193 (654)
+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++.++.. .+++|+.|+
T Consensus 82 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 161 (251)
T 3m19_A 82 LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLS 161 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEE
Confidence 999999999999999888888899999999999999999777777889999999999999999888753 789999999
Q ss_pred ccCCcccccCcccccCCC---CccccCCCCCCC
Q 036334 194 VSNNNLNGSIPATLSKFP---QSSFTGNLDLCG 223 (654)
Q Consensus 194 l~~N~l~g~~p~~~~~~~---~l~~~~n~~~c~ 223 (654)
|++|+|++..+..|.+++ .+.+.+|+..|.
T Consensus 162 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 162 LSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 999999977666666555 456677877664
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=186.01 Aligned_cols=155 Identities=25% Similarity=0.299 Sum_probs=104.9
Q ss_pred CccCCCCCCCceeeEEcCCC---------CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccc
Q 036334 48 QWNASDSACNWVGVECDANR---------SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTL 118 (654)
Q Consensus 48 ~W~~~~~~C~w~gv~C~~~~---------~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 118 (654)
-|....+.|+|.+|.|++.. ..++.|+|++|.+.+..+. .|..+++|++|+|++|.|++..+..|.++++
T Consensus 11 ~~~~~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~ 89 (229)
T 3e6j_A 11 AACPSQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPG-VFDSLINLKELYLGSNQLGALPVGVFDSLTQ 89 (229)
T ss_dssp CCCCTTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTT-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred ccCCCCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHH-HhhCccCCcEEECCCCCCCCcChhhcccCCC
Confidence 45567788999999997532 2366677777777654443 5667777777777777776544455667777
Q ss_pred cccccccccccccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccC
Q 036334 119 LRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSN 196 (654)
Q Consensus 119 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~ 196 (654)
|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++.. .+++|+.|+|++
T Consensus 90 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 168 (229)
T 3e6j_A 90 LTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG 168 (229)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred cCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeC
Confidence 777777777777665556667777777777777777 66666677777777777777777665543 566777777777
Q ss_pred CcccccCc
Q 036334 197 NNLNGSIP 204 (654)
Q Consensus 197 N~l~g~~p 204 (654)
|++.+..+
T Consensus 169 N~~~c~c~ 176 (229)
T 3e6j_A 169 NPWDCECR 176 (229)
T ss_dssp SCBCTTBG
T ss_pred CCccCCcc
Confidence 77765443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.1e-20 Score=187.48 Aligned_cols=145 Identities=23% Similarity=0.322 Sum_probs=121.8
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
.++.|+|++|.+.+ +++..|.++++|++|+|++|.|+...+..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 38 ~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 38 DTKKLDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TCSEEECCSSCCSC-CCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCEEECcCCCCCe-eCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 37788999998875 55557999999999999999999666666789999999999999999877778899999999999
Q ss_pred ccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCCCcc
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQSS 214 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~l~ 214 (654)
++|+|++..+..|..+++|++|+|++|+|++.++.. .+++|+.|+|++|++++..+..|.++++|.
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 184 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELK 184 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcC
Confidence 999999887778889999999999999999877753 788999999999999866666666555543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.82 E-value=7e-21 Score=196.57 Aligned_cols=160 Identities=34% Similarity=0.616 Sum_probs=107.6
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCcc-ccccccccccccccccchhhcccccccee
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLT-LLRSLYLQSNQFSGVFPASVTRMNRLTRL 146 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (654)
.+++.|+|++|.+.+.+|. .|..+++|++|+|++|.|++.+|..|++++ +|++|+|++|++++.+|..+..++ |+.|
T Consensus 125 ~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L 202 (313)
T 1ogq_A 125 KTLVTLDFSYNALSGTLPP-SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFV 202 (313)
T ss_dssp TTCCEEECCSSEEESCCCG-GGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEE
T ss_pred CCCCEEeCCCCccCCcCCh-HHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEE
Confidence 3477888888888877776 477888888888888888877787777776 777777777777777666666655 6666
Q ss_pred ccccccccccCCCccccc-----------------------cccCccccccccccCCCCCC--CCCCCCeEEccCCcccc
Q 036334 147 DLSSNNFSGKIPFDVNNL-----------------------THLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNG 201 (654)
Q Consensus 147 ~l~~N~l~~~~p~~~~~l-----------------------~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g 201 (654)
+|++|++++.+|..+..+ ++|++|+|++|+|++.+|.. .+++|+.|+|++|+++|
T Consensus 203 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 282 (313)
T 1ogq_A 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred ECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccc
Confidence 666666655555544444 45555555555555444443 55666666676676666
Q ss_pred cCccc--ccCCCCccccCCCCCCCCCCCCC
Q 036334 202 SIPAT--LSKFPQSSFTGNLDLCGGPLPPC 229 (654)
Q Consensus 202 ~~p~~--~~~~~~l~~~~n~~~c~~~~~~C 229 (654)
.+|.. +.++..+.+.+|+++||.|.+.|
T Consensus 283 ~ip~~~~l~~L~~l~l~~N~~lc~~p~~~C 312 (313)
T 1ogq_A 283 EIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp ECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred cCCCCccccccChHHhcCCCCccCCCCCCC
Confidence 66653 33455566778888888776666
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-20 Score=182.52 Aligned_cols=133 Identities=21% Similarity=0.224 Sum_probs=68.2
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 149 (654)
++.|+|++|.+.+..+.+.|..+++|++|+|++|.|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 113 (220)
T 2v70_A 34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR 113 (220)
T ss_dssp CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECT
T ss_pred CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECC
Confidence 34455555555444343344555555555555555554444455555555555555555554444445555555555555
Q ss_pred cccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCccccc
Q 036334 150 SNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGS 202 (654)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~ 202 (654)
+|+|++..|..|..+++|+.|+|++|+|++..|.. .+++|+.|+|++|++++.
T Consensus 114 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 114 SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp TSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 55555444555555555555555555555544432 445555555555555443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=5.4e-20 Score=178.08 Aligned_cols=151 Identities=23% Similarity=0.306 Sum_probs=125.2
Q ss_pred CCCCCceeeEEcCCC---------CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCcccccccc
Q 036334 53 DSACNWVGVECDANR---------SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLY 123 (654)
Q Consensus 53 ~~~C~w~gv~C~~~~---------~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 123 (654)
...|+|.+|.|+... .+++.|+|++|++.+ ++++.|..+++|++|+|++|.|++..+..|.++++|++|+
T Consensus 4 ~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 82 (208)
T 2o6s_A 4 RCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKS-LPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLN 82 (208)
T ss_dssp TCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCc-CChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEE
Confidence 345899999997532 348889999999874 5555688999999999999999976666788899999999
Q ss_pred ccccccccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccc
Q 036334 124 LQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNG 201 (654)
Q Consensus 124 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g 201 (654)
|++|++++..+..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|+|++.++.. .+++|+.|+|++|++.+
T Consensus 83 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 162 (208)
T 2o6s_A 83 LSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 162 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred CCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence 9999999777777888999999999999999777767888999999999999999877763 68889999999988876
Q ss_pred cCc
Q 036334 202 SIP 204 (654)
Q Consensus 202 ~~p 204 (654)
..|
T Consensus 163 ~~~ 165 (208)
T 2o6s_A 163 TCP 165 (208)
T ss_dssp CTT
T ss_pred CCC
Confidence 554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-19 Score=176.70 Aligned_cols=148 Identities=25% Similarity=0.293 Sum_probs=103.1
Q ss_pred eecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecccccc
Q 036334 73 LRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNN 152 (654)
Q Consensus 73 L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 152 (654)
++++++++. .+|.. +. ++|+.|+|++|.|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 16 v~c~~~~l~-~iP~~-l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 16 VDCRGKGLT-EIPTN-LP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EECTTSCCS-SCCSS-CC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEcCCCCcC-cCCCc-cC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 344444553 34442 22 567788888888876666677778888888888888887777778888888888888888
Q ss_pred ccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCC---CccccCCCCCCCC
Q 036334 153 FSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFP---QSSFTGNLDLCGG 224 (654)
Q Consensus 153 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~---~l~~~~n~~~c~~ 224 (654)
|+...+..|..+++|+.|+|++|+|++..+.. .+++|+.|+|++|+|++..+..|..++ .+.+.+|+..|.+
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 87555555677788888888888887776654 677788888888888766555555544 3456677777653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.1e-19 Score=191.54 Aligned_cols=173 Identities=21% Similarity=0.220 Sum_probs=147.3
Q ss_pred CCCCCCceeeEEcCC---------CCeEEEeecCCCCccccCCccccc-CCCCccEEEeccCCccCcCCCCCCCcccccc
Q 036334 52 SDSACNWVGVECDAN---------RSFVYSLRLPGVGLVGPIPPNTLG-KLSQLRVLSLRSNRLSGEIPSDFSNLTLLRS 121 (654)
Q Consensus 52 ~~~~C~w~gv~C~~~---------~~~v~~L~l~~~~l~~~~~~~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 121 (654)
....|.|..+.|..+ ...++.|+|++|.+.+ +++..|. ++++|++|+|++|.|++..+..|.++++|++
T Consensus 14 ~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~-l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~ 92 (361)
T 2xot_A 14 ANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRY 92 (361)
T ss_dssp TTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCE-ECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred CCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCc-cChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCE
Confidence 334477888899753 1237789999999986 4444677 9999999999999999888888999999999
Q ss_pred ccccccccccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC-----CCCCCCeEEccC
Q 036334 122 LYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-----NPANLRDFNVSN 196 (654)
Q Consensus 122 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-----~~~~L~~L~l~~ 196 (654)
|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.++.. .+++|+.|+|++
T Consensus 93 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~ 172 (361)
T 2xot_A 93 LDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSS 172 (361)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCS
T ss_pred EECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCC
Confidence 999999999888888999999999999999999888999999999999999999999876653 489999999999
Q ss_pred CcccccCcccccCCC-----CccccCCCCCCCCC
Q 036334 197 NNLNGSIPATLSKFP-----QSSFTGNLDLCGGP 225 (654)
Q Consensus 197 N~l~g~~p~~~~~~~-----~l~~~~n~~~c~~~ 225 (654)
|+|++..+..+..++ .+.+.+|+..|+|.
T Consensus 173 N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 173 NKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp SCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred CCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 999955446666664 47888999999764
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=6.9e-19 Score=171.84 Aligned_cols=150 Identities=21% Similarity=0.279 Sum_probs=134.1
Q ss_pred CCCCCCceeeEEcCCC---------CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccc
Q 036334 52 SDSACNWVGVECDANR---------SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSL 122 (654)
Q Consensus 52 ~~~~C~w~gv~C~~~~---------~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 122 (654)
+...|.|..|.|.+.. ..++.|+|++|++.+ +++..|..+++|++|+|++|.|++..|..|.++++|++|
T Consensus 7 ~~C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~-i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L 85 (220)
T 2v9t_B 7 AACTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSL 85 (220)
T ss_dssp TTSEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCE-ECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEE
T ss_pred CCCEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCC-cCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEE
Confidence 3445889999997532 358999999999985 555579999999999999999998889999999999999
Q ss_pred cccccccccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCccc
Q 036334 123 YLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLN 200 (654)
Q Consensus 123 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~ 200 (654)
+|++|+|+...+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+.. .+++|+.|+|++|++.
T Consensus 86 ~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 86 VLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 99999999776777899999999999999999988999999999999999999999988864 7899999999999997
Q ss_pred cc
Q 036334 201 GS 202 (654)
Q Consensus 201 g~ 202 (654)
..
T Consensus 166 c~ 167 (220)
T 2v9t_B 166 CD 167 (220)
T ss_dssp CS
T ss_pred CC
Confidence 54
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.4e-19 Score=178.50 Aligned_cols=134 Identities=17% Similarity=0.188 Sum_probs=103.2
Q ss_pred hccccccCceeEEEEEe-cCCcE--EEEEEecccccC-------------------------HHHHHHHHHHHhccCCCc
Q 036334 351 AEVLGKGSVGTSYKAVL-EEGTT--VVVKRLKEVAVG-------------------------KREFEMQMEVLGKIKHDN 402 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~-~~g~~--vavK~~~~~~~~-------------------------~~~~~~e~~~l~~l~hpn 402 (654)
.+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+|+..+.++.|++
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 46799999999999997 67889 999997543111 125788999999998886
Q ss_pred cccccEEEEeCCceEEEEEecCC-C----chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-ccCCeecCCCCCC
Q 036334 403 VVPLRAFYYSKDEKLLVYDYMPA-G----SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH-VSGKIVHGNIKAS 476 (654)
Q Consensus 403 iv~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~ivHrDlk~~ 476 (654)
+....-+.. +..++||||+.+ | +|.++... .++..+..++.|++.+|.||| +.+ |+||||||+
T Consensus 132 i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g-ivHrDlkp~ 200 (258)
T 1zth_A 132 VSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE-LVHADLSEY 200 (258)
T ss_dssp CCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC-EECSSCSTT
T ss_pred CCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC-EEeCCCCHH
Confidence 532222222 367899999942 4 66665431 224457789999999999999 887 999999999
Q ss_pred cEEECCCCCeEEeccCCCCCc
Q 036334 477 NILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 477 NIll~~~~~~kl~Dfgla~~~ 497 (654)
|||++. .++|+|||+|...
T Consensus 201 NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS--SEEECCCTTCEET
T ss_pred HEEEcC--cEEEEECcccccC
Confidence 999998 9999999999754
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=7.7e-19 Score=171.52 Aligned_cols=160 Identities=16% Similarity=0.240 Sum_probs=134.4
Q ss_pred CCceeeEEcCCCCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCC-CCCCCccccccccccccccccccc
Q 036334 56 CNWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIP-SDFSNLTLLRSLYLQSNQFSGVFP 134 (654)
Q Consensus 56 C~w~gv~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p 134 (654)
|. .++.|... .+++++|++. .+|.. + ...+++|+|++|.|++..| ..|.++++|++|+|++|+|++..+
T Consensus 5 CP-~~C~C~~~-----~l~~s~n~l~-~iP~~-~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~ 74 (220)
T 2v70_A 5 CP-EKCRCEGT-----TVDCSNQKLN-KIPEH-I--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEE 74 (220)
T ss_dssp CC-TTCEEETT-----EEECCSSCCS-SCCSC-C--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECT
T ss_pred CC-CCCEECCC-----EeEeCCCCcc-cCccC-C--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECH
Confidence 44 35667532 5778888886 46653 3 3457899999999997755 458999999999999999998888
Q ss_pred hhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCCC
Q 036334 135 ASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQ 212 (654)
Q Consensus 135 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~ 212 (654)
..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|.. .+++|+.|+|++|+|++..|..|..+++
T Consensus 75 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 154 (220)
T 2v70_A 75 GAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS 154 (220)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTT
T ss_pred HHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCC
Confidence 89999999999999999999888888999999999999999999998765 8899999999999999888988876665
Q ss_pred ---ccccCCCCCCCCC
Q 036334 213 ---SSFTGNLDLCGGP 225 (654)
Q Consensus 213 ---l~~~~n~~~c~~~ 225 (654)
+.+.+|+..|.++
T Consensus 155 L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 155 LSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCEEECCSCCEECSGG
T ss_pred CCEEEecCcCCcCCCc
Confidence 5677888887644
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.5e-18 Score=175.37 Aligned_cols=154 Identities=25% Similarity=0.281 Sum_probs=136.0
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
.+++.|+|++|.+.+ ++ .+..+++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+
T Consensus 63 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 63 PNVRYLALGGNKLHD-IS--ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp TTCCEEECTTSCCCC-CG--GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCC-ch--hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 459999999999987 33 599999999999999999988888899999999999999999988888899999999999
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCCC---ccccCCCCCC
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQ---SSFTGNLDLC 222 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~---l~~~~n~~~c 222 (654)
|++|+|++..+..+..+++|+.|++++|+|++.++.. .+++|+.|+|++|++++..|..+.++++ +.+.+|+..|
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 9999999877777899999999999999999888865 7899999999999999887776666554 5567887776
Q ss_pred CC
Q 036334 223 GG 224 (654)
Q Consensus 223 ~~ 224 (654)
.+
T Consensus 220 ~~ 221 (272)
T 3rfs_A 220 TC 221 (272)
T ss_dssp CT
T ss_pred cC
Confidence 53
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=3.5e-19 Score=170.04 Aligned_cols=150 Identities=25% Similarity=0.364 Sum_probs=121.5
Q ss_pred EeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCC-CCCCccccccccccccccccccchhhccccccceecccc
Q 036334 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPS-DFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSS 150 (654)
Q Consensus 72 ~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 150 (654)
.|+++++++ +.+|.. +. .+|++|+|++|.|++..+. .|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 12 ~l~~s~~~l-~~ip~~-~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 12 TVDCTGRGL-KEIPRD-IP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EEECTTSCC-SSCCSC-CC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EEEcCCCCc-CcCccC-CC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 467777777 467763 43 3899999999999976664 489999999999999999999999999999999999999
Q ss_pred ccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCccc-ccC-CCCccccCCCCCCCCC
Q 036334 151 NNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPAT-LSK-FPQSSFTGNLDLCGGP 225 (654)
Q Consensus 151 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~-~~~-~~~l~~~~n~~~c~~~ 225 (654)
|+|++..+..|..+++|++|+|++|+|++.+|.. .+++|+.|+|++|++++..+-. +.. +....+.++...|+.|
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 9999888888999999999999999999988865 7899999999999999887632 211 2222344555566544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.4e-18 Score=168.06 Aligned_cols=159 Identities=22% Similarity=0.317 Sum_probs=133.7
Q ss_pred CceeeEEcCCCCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchh
Q 036334 57 NWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPAS 136 (654)
Q Consensus 57 ~w~gv~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 136 (654)
.|....|+. +.++.+++++. .+|.. + .++|++|+|++|.|++..|..|.++++|++|+|++|+|+...+..
T Consensus 13 ~~~~~~Cs~-----~~v~c~~~~l~-~ip~~-~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~ 83 (229)
T 3e6j_A 13 CPSQCSCSG-----TTVDCRSKRHA-SVPAG-I--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGV 83 (229)
T ss_dssp CCTTCEEET-----TEEECTTSCCS-SCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred CCCCCEEeC-----CEeEccCCCcC-ccCCC-C--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhh
Confidence 355678874 34788888885 67753 3 389999999999999988999999999999999999999777777
Q ss_pred hccccccceeccccccccccCCCccccccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccCcccccCCC---C
Q 036334 137 VTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATLSKFP---Q 212 (654)
Q Consensus 137 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p~~~~~~~---~ 212 (654)
|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+..+... .+++|+.|+|++|+|++..+..|.+++ .
T Consensus 84 ~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 163 (229)
T 3e6j_A 84 FDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH 163 (229)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCE
Confidence 899999999999999999777777899999999999999999665555 889999999999999966656666555 4
Q ss_pred ccccCCCCCCCC
Q 036334 213 SSFTGNLDLCGG 224 (654)
Q Consensus 213 l~~~~n~~~c~~ 224 (654)
+.+.+|+..|.+
T Consensus 164 L~l~~N~~~c~c 175 (229)
T 3e6j_A 164 AYLFGNPWDCEC 175 (229)
T ss_dssp EECTTSCBCTTB
T ss_pred EEeeCCCccCCc
Confidence 567789887754
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.7e-18 Score=174.63 Aligned_cols=144 Identities=22% Similarity=0.211 Sum_probs=97.2
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCC-ccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNR-LSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
+++.|+|++|.+.+..+. .|.++++|++|+|++|. ++...|..|.++++|++|+|++|++++..|..+.++++|++|+
T Consensus 57 ~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 135 (285)
T 1ozn_A 57 NLTILWLHSNVLARIDAA-AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135 (285)
T ss_dssp TCCEEECCSSCCCEECTT-TTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEEECCCCccceeCHh-hcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEE
Confidence 467777777777654333 57777777777777775 6655566677777777777777777766666677777777777
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCCCc
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQS 213 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~l 213 (654)
|++|++++..+..+..+++|+.|+|++|+|++.++.. .+++|+.|+|++|++++..|..|.++++|
T Consensus 136 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 203 (285)
T 1ozn_A 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203 (285)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred CCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccc
Confidence 7777777555555667777777777777777665542 56677777777777776666666555443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.74 E-value=5.8e-18 Score=172.61 Aligned_cols=132 Identities=24% Similarity=0.283 Sum_probs=69.7
Q ss_pred cCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccCc
Q 036334 90 GKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTG 169 (654)
Q Consensus 90 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 169 (654)
+.+++|++|+|++|.|+ .+|..+.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.
T Consensus 74 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 152 (290)
T 1p9a_G 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152 (290)
T ss_dssp SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCE
Confidence 34444555555555554 44445555555555555555555544455555555555555555555444444555555555
Q ss_pred cccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCC---CccccCCCCCCC
Q 036334 170 LFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFP---QSSFTGNLDLCG 223 (654)
Q Consensus 170 L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~---~l~~~~n~~~c~ 223 (654)
|+|++|+|++.++.. .+++|+.|+|++|+|+ .+|..+..+. .+.+.+|++.|.
T Consensus 153 L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp EECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred EECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence 555555555444433 4555555555555555 4554443332 233445555554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.6e-18 Score=180.45 Aligned_cols=165 Identities=24% Similarity=0.269 Sum_probs=136.9
Q ss_pred CccCCCCCCCceeeEEcCC-----------CCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCc
Q 036334 48 QWNASDSACNWVGVECDAN-----------RSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNL 116 (654)
Q Consensus 48 ~W~~~~~~C~w~gv~C~~~-----------~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 116 (654)
.|.....+|.|.|+ |+-. ..+++.|+|++|++.+ ++++.|.++++|++|+|++|.+++..|..|.++
T Consensus 22 ~~~~~~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 99 (353)
T 2z80_A 22 SSNQASLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSL 99 (353)
T ss_dssp -----CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred CCCccCCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcc-cCHHHhccCCCCCEEECCCCccCccCHhhcCCC
Confidence 45556678999987 7522 2358999999999985 555579999999999999999998888899999
Q ss_pred cccccccccccccccccchhhccccccceeccccccccccCC-CccccccccCcccccccc-ccCCCCCC--CCCCCCeE
Q 036334 117 TLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIP-FDVNNLTHLTGLFLENNK-FSGNLPSI--NPANLRDF 192 (654)
Q Consensus 117 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~-l~~~~~~~--~~~~L~~L 192 (654)
++|++|+|++|++++..+..|.++++|++|+|++|++++..+ ..+..+++|+.|++++|+ +.+..+.. .+++|+.|
T Consensus 100 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L 179 (353)
T 2z80_A 100 GSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEEL 179 (353)
T ss_dssp TTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEE
T ss_pred CCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEE
Confidence 999999999999997666669999999999999999994433 378999999999999994 66665544 78999999
Q ss_pred EccCCcccccCcccccCCCCcc
Q 036334 193 NVSNNNLNGSIPATLSKFPQSS 214 (654)
Q Consensus 193 ~l~~N~l~g~~p~~~~~~~~l~ 214 (654)
+|++|++++..|..+.++++|.
T Consensus 180 ~l~~n~l~~~~~~~l~~l~~L~ 201 (353)
T 2z80_A 180 EIDASDLQSYEPKSLKSIQNVS 201 (353)
T ss_dssp EEEETTCCEECTTTTTTCSEEE
T ss_pred ECCCCCcCccCHHHHhccccCC
Confidence 9999999988899888877654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.73 E-value=4e-18 Score=175.19 Aligned_cols=131 Identities=23% Similarity=0.245 Sum_probs=62.6
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCC-CCCCCccccccccccccccccccchhhccccccceecc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIP-SDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
++.|+|++|.+.. ++. .+..+++|++|+|++|.+++..+ ..|.++++|++|+|++|++++..|..+..+++|++|+|
T Consensus 80 L~~L~Ls~n~i~~-l~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 157 (306)
T 2z66_A 80 LKYLDLSFNGVIT-MSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 157 (306)
T ss_dssp CCEEECCSCSEEE-EEE-EEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEEC
T ss_pred cCEEECCCCcccc-Chh-hcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEEC
Confidence 5555555555542 332 24445555555555555543322 34444555555555555555444444444555555555
Q ss_pred ccccccc-cCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCccccc
Q 036334 149 SSNNFSG-KIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGS 202 (654)
Q Consensus 149 ~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~ 202 (654)
++|.+++ .+|..+..+++|+.|+|++|+|++..|.. .+++|+.|+|++|++++.
T Consensus 158 ~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 214 (306)
T 2z66_A 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 214 (306)
T ss_dssp TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBC
T ss_pred CCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCcc
Confidence 5555443 34444444555555555555554443332 444455555555544433
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.73 E-value=3.6e-18 Score=177.37 Aligned_cols=148 Identities=24% Similarity=0.350 Sum_probs=127.9
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCC---------ccccccccccccccccccchhhc
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSN---------LTLLRSLYLQSNQFSGVFPASVT 138 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~---------l~~L~~L~Ls~N~l~~~~p~~~~ 138 (654)
.+++.|+|++|.+. .+|. .++++++|++|+|++|++.+.+|..+.. +++|++|+|++|+++ .+|..+.
T Consensus 127 ~~L~~L~Ls~n~l~-~lp~-~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~ 203 (328)
T 4fcg_A 127 AGLETLTLARNPLR-ALPA-SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA 203 (328)
T ss_dssp TTCSEEEEESCCCC-CCCG-GGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGG
T ss_pred CCCCEEECCCCccc-cCcH-HHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhc
Confidence 35889999999998 7776 5999999999999999998899988765 999999999999999 8888999
Q ss_pred cccccceeccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCCCcc--
Q 036334 139 RMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQSS-- 214 (654)
Q Consensus 139 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~l~-- 214 (654)
++++|++|+|++|+++ .+|..+..+++|+.|+|++|++.+.+|.. .+++|+.|+|++|++.+.+|..+.++++|.
T Consensus 204 ~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L 282 (328)
T 4fcg_A 204 NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282 (328)
T ss_dssp GCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEE
T ss_pred CCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEE
Confidence 9999999999999999 46668999999999999999999888875 788999999999999999998887776654
Q ss_pred -ccCCC
Q 036334 215 -FTGNL 219 (654)
Q Consensus 215 -~~~n~ 219 (654)
+.+|.
T Consensus 283 ~L~~n~ 288 (328)
T 4fcg_A 283 DLRGCV 288 (328)
T ss_dssp ECTTCT
T ss_pred eCCCCC
Confidence 44544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=6.9e-18 Score=161.03 Aligned_cols=171 Identities=22% Similarity=0.286 Sum_probs=136.7
Q ss_pred CCCCCceeeEEcCCC---------CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCcccccccc
Q 036334 53 DSACNWVGVECDANR---------SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLY 123 (654)
Q Consensus 53 ~~~C~w~gv~C~~~~---------~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 123 (654)
...|.|..+.|+.+. ..++.|+|++|.+.+..+...|+.+++|++|+|++|.|++..|..|.++++|++|+
T Consensus 5 ~C~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 84 (192)
T 1w8a_A 5 MCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84 (192)
T ss_dssp TSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCEECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEE
Confidence 344889999997541 25889999999998665544589999999999999999999899999999999999
Q ss_pred ccccccccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCCC-CCCCCeEEccCCccccc
Q 036334 124 LQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSIN-PANLRDFNVSNNNLNGS 202 (654)
Q Consensus 124 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~~L~~L~l~~N~l~g~ 202 (654)
|++|+|++..|..|.++++|++|+|++|+|++.+|..+..+++|+.|+|++|.+++..+... ...++...+..+.....
T Consensus 85 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~ 164 (192)
T 1w8a_A 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCC
Confidence 99999999999889999999999999999999999999999999999999999997665321 11122334455556666
Q ss_pred CcccccCCCCccccCCCCCCC
Q 036334 203 IPATLSKFPQSSFTGNLDLCG 223 (654)
Q Consensus 203 ~p~~~~~~~~l~~~~n~~~c~ 223 (654)
.|..+....-..+..+...|.
T Consensus 165 ~P~~l~~~~l~~l~~~~~~C~ 185 (192)
T 1w8a_A 165 APSKVRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp SSTTTTTSBGGGSCTTTCCCC
T ss_pred CChHHcCCChhhCcHhhcCcC
Confidence 677776665555555555554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=3.5e-18 Score=190.42 Aligned_cols=158 Identities=22% Similarity=0.260 Sum_probs=138.5
Q ss_pred CCCceeeEEcCC-----------CCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCcccccccc
Q 036334 55 ACNWVGVECDAN-----------RSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLY 123 (654)
Q Consensus 55 ~C~w~gv~C~~~-----------~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 123 (654)
.|.|.|+ |+.. ..+++.|+|++|.+.+..+. .|.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 80 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHG-DLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLD 80 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSS-TTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChh-hhhcCCcccEEECCCCCcCccChhhccccccCCEEE
Confidence 5999998 8642 13589999999999865554 699999999999999999988889999999999999
Q ss_pred ccccccccccchhhccccccceeccccccccc-cCCCccccccccCccccccccccCCCC-C-C-CCCCCCeEEccCCcc
Q 036334 124 LQSNQFSGVFPASVTRMNRLTRLDLSSNNFSG-KIPFDVNNLTHLTGLFLENNKFSGNLP-S-I-NPANLRDFNVSNNNL 199 (654)
Q Consensus 124 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~~-~-~-~~~~L~~L~l~~N~l 199 (654)
|++|++++..|..|+++++|++|+|++|.+++ .+|..+.++++|++|++++|++.+.++ . + .+++|++|+|++|.+
T Consensus 81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 99999999888889999999999999999996 467789999999999999999655554 3 3 889999999999999
Q ss_pred cccCcccccCCCCcc
Q 036334 200 NGSIPATLSKFPQSS 214 (654)
Q Consensus 200 ~g~~p~~~~~~~~l~ 214 (654)
++.+|..+.+++++.
T Consensus 161 ~~~~~~~l~~l~~L~ 175 (549)
T 2z81_A 161 RNYQSQSLKSIRDIH 175 (549)
T ss_dssp CEECTTTTTTCSEEE
T ss_pred cccChhhhhccccCc
Confidence 999999888776543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2e-17 Score=164.92 Aligned_cols=134 Identities=24% Similarity=0.284 Sum_probs=122.6
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
.+++.|+|++|.+.+.. +..|..+++|++|+|++|.|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 59 ~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 59 TKLTWLNLDYNQLQTLS-AGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp TTCCEEECTTSCCCCCC-TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccCCEEECCCCcCCccC-HhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 45999999999998744 45799999999999999999988888899999999999999999988777889999999999
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCccccc
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGS 202 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~ 202 (654)
|++|+|++..+..|..+++|+.|+|++|+|++.++.. .+++|+.|+|++|++++.
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9999999777778999999999999999999888754 789999999999999876
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=5.5e-18 Score=191.91 Aligned_cols=145 Identities=20% Similarity=0.247 Sum_probs=130.0
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
..++.|||++|.|++ +++..|.++++|++|||++|+|++..|..|.+|++|++|+|++|+|++..+..|.++++|++|+
T Consensus 52 ~~~~~LdLs~N~i~~-l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp TTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred cCCCEEEeeCCCCCC-CCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 358999999999984 6666899999999999999999988788899999999999999999988888999999999999
Q ss_pred cccccccccCCCccccccccCccccccccccCC-CCCC--CCCCCCeEEccCCcccccCcccccCCCCc
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGN-LPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQS 213 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~l 213 (654)
|++|+|++..+..|+++++|++|+|++|+|++. +|.. .+++|++|+|++|+|++..|..|..+.++
T Consensus 131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l 199 (635)
T 4g8a_A 131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 199 (635)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTC
T ss_pred CCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhh
Confidence 999999987777899999999999999999864 4444 78999999999999998888887766544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=4.3e-18 Score=174.99 Aligned_cols=160 Identities=21% Similarity=0.258 Sum_probs=127.6
Q ss_pred CCCCCceeeEEcCCC---------CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccC--cCCCCCCCcccccc
Q 036334 53 DSACNWVGVECDANR---------SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSG--EIPSDFSNLTLLRS 121 (654)
Q Consensus 53 ~~~C~w~gv~C~~~~---------~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~ 121 (654)
...|.|.+|.|++.. .+++.|+|++|++. .+++..|.++++|++|+|++|.++. ..|..+..+++|++
T Consensus 4 ~C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~ 82 (306)
T 2z66_A 4 RCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82 (306)
T ss_dssp TCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCE
T ss_pred CCeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCE
Confidence 345899999997532 35899999999997 6777778999999999999999983 33566777888999
Q ss_pred ccccccccccccchhhccccccceeccccccccccCC-CccccccccCccccccccccCCCCCC--CCCCCCeEEccCCc
Q 036334 122 LYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIP-FDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNN 198 (654)
Q Consensus 122 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~ 198 (654)
|+|++|+++ .+|..+..+++|++|+|++|++++..+ ..+..+++|++|++++|++.+..+.. .+++|+.|+|++|.
T Consensus 83 L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 161 (306)
T 2z66_A 83 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 161 (306)
T ss_dssp EECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCE
T ss_pred EECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCc
Confidence 999999888 567778888888888888888886554 56788888888888888888777664 67888888888888
Q ss_pred ccc-cCcccccCCCCcc
Q 036334 199 LNG-SIPATLSKFPQSS 214 (654)
Q Consensus 199 l~g-~~p~~~~~~~~l~ 214 (654)
+++ .+|..+..+++|.
T Consensus 162 l~~~~~~~~~~~l~~L~ 178 (306)
T 2z66_A 162 FQENFLPDIFTELRNLT 178 (306)
T ss_dssp EGGGEECSCCTTCTTCC
T ss_pred cccccchhHHhhCcCCC
Confidence 876 5677776665543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=6.5e-17 Score=156.30 Aligned_cols=156 Identities=22% Similarity=0.303 Sum_probs=130.0
Q ss_pred eeEEcCCCCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhcc
Q 036334 60 GVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTR 139 (654)
Q Consensus 60 gv~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 139 (654)
++.|.. +.++.+++++. .+|. ...++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..
T Consensus 4 ~C~C~~-----~~v~c~~~~l~-~~p~---~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 74 (208)
T 2o6s_A 4 RCSCSG-----TTVECYSQGRT-SVPT---GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNK 74 (208)
T ss_dssp TCEEET-----TEEECCSSCCS-SCCS---CCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTT
T ss_pred CCEECC-----CEEEecCCCcc-CCCC---CCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCC
Confidence 577854 35778888886 4554 23568999999999999777777999999999999999999777777899
Q ss_pred ccccceeccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCC---Ccc
Q 036334 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFP---QSS 214 (654)
Q Consensus 140 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~---~l~ 214 (654)
+++|++|+|++|+|++..+..+..+++|+.|+|++|+|++.++.. .+++|+.|+|++|++++..+..+.+++ .+.
T Consensus 75 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 154 (208)
T 2o6s_A 75 LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 154 (208)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEE
Confidence 999999999999999777777899999999999999999888864 789999999999999966665566554 456
Q ss_pred ccCCCCCCCC
Q 036334 215 FTGNLDLCGG 224 (654)
Q Consensus 215 ~~~n~~~c~~ 224 (654)
+.+|+..|.+
T Consensus 155 l~~N~~~~~~ 164 (208)
T 2o6s_A 155 LHDNPWDCTC 164 (208)
T ss_dssp CCSCCBCCCT
T ss_pred ecCCCeecCC
Confidence 7788777654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=9.8e-18 Score=182.23 Aligned_cols=157 Identities=22% Similarity=0.294 Sum_probs=137.0
Q ss_pred CCCCcee--eEEcCCC--------CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcC-CCCCCCccccccc
Q 036334 54 SACNWVG--VECDANR--------SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEI-PSDFSNLTLLRSL 122 (654)
Q Consensus 54 ~~C~w~g--v~C~~~~--------~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L 122 (654)
..|.|.+ |.|+... .+++.|+|++|.+.+..+. .|.++++|++|+|++|.+.+.+ +..|.++++|++|
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L 84 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNET-SFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL 84 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTT-TTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChh-HhccCccccEEECcCCcccceECcccccccccCCEE
Confidence 3566666 8887543 4689999999999875554 6999999999999999998666 5679999999999
Q ss_pred cccccccccccchhhccccccceeccccccccccCCCc--cccccccCccccccccccCCCCC--C-CCCCCCeEEccCC
Q 036334 123 YLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFD--VNNLTHLTGLFLENNKFSGNLPS--I-NPANLRDFNVSNN 197 (654)
Q Consensus 123 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~~~--~-~~~~L~~L~l~~N 197 (654)
+|++|++++..|..|.++++|++|+|++|++++.+|.. +..+++|++|+|++|+|++..|. . .+++|+.|+|++|
T Consensus 85 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n 164 (455)
T 3v47_A 85 KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164 (455)
T ss_dssp ECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTC
T ss_pred eCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCC
Confidence 99999999999999999999999999999999866544 89999999999999999998775 3 8899999999999
Q ss_pred cccccCcccccCCC
Q 036334 198 NLNGSIPATLSKFP 211 (654)
Q Consensus 198 ~l~g~~p~~~~~~~ 211 (654)
++++..|..+.++.
T Consensus 165 ~l~~~~~~~l~~l~ 178 (455)
T 3v47_A 165 KVKSICEEDLLNFQ 178 (455)
T ss_dssp CBSCCCTTTSGGGT
T ss_pred cccccChhhhhccc
Confidence 99999998887764
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2.4e-17 Score=166.41 Aligned_cols=138 Identities=26% Similarity=0.300 Sum_probs=125.1
Q ss_pred CCCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccce
Q 036334 66 NRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTR 145 (654)
Q Consensus 66 ~~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 145 (654)
.-.+++.|+|++|.+.+ +++..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..+..+++|+.
T Consensus 83 ~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 161 (272)
T 3rfs_A 83 ELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTE 161 (272)
T ss_dssp TCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCCCEEECCCCccCc-cChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCE
Confidence 33569999999999985 45556899999999999999999888878999999999999999999888888999999999
Q ss_pred eccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCc
Q 036334 146 LDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIP 204 (654)
Q Consensus 146 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p 204 (654)
|+|++|+|++..+..+..+++|+.|+|++|+|++.++.. .+++|+.|+|++|++.+..|
T Consensus 162 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 162 LDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred EECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 999999999888878899999999999999999988864 78999999999999987766
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=2.7e-17 Score=167.20 Aligned_cols=150 Identities=22% Similarity=0.270 Sum_probs=131.0
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccc-cccccchhhcccccccee
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQ-FSGVFPASVTRMNRLTRL 146 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L 146 (654)
..++.|+|++|.+.+ ++++.|.++++|++|+|++|.+++..|..|.++++|++|+|++|+ ++...|..|..+++|++|
T Consensus 32 ~~l~~L~l~~n~i~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 32 AASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp TTCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCceEEEeeCCcCCc-cCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 358899999999986 555579999999999999999998889999999999999999997 887778999999999999
Q ss_pred ccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCCCc---cccCC
Q 036334 147 DLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQS---SFTGN 218 (654)
Q Consensus 147 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~l---~~~~n 218 (654)
+|++|++++..|..+.++++|++|++++|+|++..+.. .+++|+.|+|++|++++..+..|.++++| .+.+|
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 187 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCC
Confidence 99999999888889999999999999999999888764 78999999999999996665667766654 44454
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.5e-17 Score=164.21 Aligned_cols=161 Identities=24% Similarity=0.328 Sum_probs=131.5
Q ss_pred CCCCCceeeEEcCCCCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccc
Q 036334 53 DSACNWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV 132 (654)
Q Consensus 53 ~~~C~w~gv~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 132 (654)
.++|.|.|+.|.-. ..++.++++++++. .+|.. +. ++|++|+|++|.|++..+..|.++++|++|+|++|+++..
T Consensus 2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~-~ip~~-~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i 76 (270)
T 2o6q_A 2 EALCKKDGGVCSCN-NNKNSVDCSSKKLT-AIPSN-IP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTL 76 (270)
T ss_dssp CCCBGGGTCSBEEE-TTTTEEECTTSCCS-SCCSC-CC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCC
T ss_pred CccCCCCCCCCEeC-CCCCEEEccCCCCC-ccCCC-CC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCee
Confidence 47899998877532 13568999999997 46653 33 6899999999999977777899999999999999999976
Q ss_pred cchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCC
Q 036334 133 FPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKF 210 (654)
Q Consensus 133 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~ 210 (654)
.+..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|+|++..+.. .+++|++|+|++|.|++..+..|.++
T Consensus 77 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 156 (270)
T 2o6q_A 77 PAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKL 156 (270)
T ss_dssp CTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred ChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCC
Confidence 6667788999999999999999777777899999999999999999888764 78999999999999996555556665
Q ss_pred CCc---cccCC
Q 036334 211 PQS---SFTGN 218 (654)
Q Consensus 211 ~~l---~~~~n 218 (654)
++| .+.+|
T Consensus 157 ~~L~~L~L~~n 167 (270)
T 2o6q_A 157 TSLKELRLYNN 167 (270)
T ss_dssp TTCCEEECCSS
T ss_pred cccceeEecCC
Confidence 554 44454
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.7e-17 Score=154.67 Aligned_cols=134 Identities=26% Similarity=0.359 Sum_probs=114.0
Q ss_pred CCCceeeEEcCCCCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccc
Q 036334 55 ACNWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFP 134 (654)
Q Consensus 55 ~C~w~gv~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 134 (654)
.|+|.++.|+.+ ++. .+|.. ..++|++|+|++|.+++..+..|.++++|++|+|++|+|++..+
T Consensus 6 ~C~~~~l~~~~~------------~l~-~~p~~---~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 69 (177)
T 2o6r_A 6 SCSGTEIRCNSK------------GLT-SVPTG---IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPD 69 (177)
T ss_dssp EEETTEEECCSS------------CCS-SCCTT---CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred EeCCCEEEecCC------------CCc-cCCCC---CCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeCh
Confidence 466777777543 333 34432 23689999999999997777788999999999999999998777
Q ss_pred hhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCc
Q 036334 135 ASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIP 204 (654)
Q Consensus 135 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p 204 (654)
..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|+|++.++.. .+++|+.|+|++|++++..|
T Consensus 70 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 70 GVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 78899999999999999999877777899999999999999999887764 68999999999999998776
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-17 Score=187.41 Aligned_cols=173 Identities=17% Similarity=0.167 Sum_probs=142.7
Q ss_pred CCCCccCCCCCCC----ceeeEEcCC----------------CCeEEEeecCCCCccccCCcccccCCCCccEEEeccCC
Q 036334 45 NRVQWNASDSACN----WVGVECDAN----------------RSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNR 104 (654)
Q Consensus 45 ~~~~W~~~~~~C~----w~gv~C~~~----------------~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~ 104 (654)
...+|.++.+||. |.++.|+.. -..+..|++++|.+. .+|+..|.++++|++|+|++|.
T Consensus 8 ~l~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~ 86 (597)
T 3oja_B 8 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQ 86 (597)
T ss_dssp ---CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSC
T ss_pred cccCCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCC
Confidence 3467887777774 766655410 023567888888775 5777778999999999999999
Q ss_pred ccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC
Q 036334 105 LSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI 184 (654)
Q Consensus 105 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 184 (654)
|++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.|++..+..|.++++|++|+|++|.|++.+|..
T Consensus 87 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 166 (597)
T 3oja_B 87 IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT 166 (597)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTT
T ss_pred CCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhh
Confidence 99888889999999999999999999998989999999999999999999666666799999999999999999988864
Q ss_pred --CCCCCCeEEccCCcccccCcccccCCCCccccCC
Q 036334 185 --NPANLRDFNVSNNNLNGSIPATLSKFPQSSFTGN 218 (654)
Q Consensus 185 --~~~~L~~L~l~~N~l~g~~p~~~~~~~~l~~~~n 218 (654)
.+++|+.|+|++|.|++.-+..+.++..+.+.+|
T Consensus 167 ~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n 202 (597)
T 3oja_B 167 FQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 202 (597)
T ss_dssp TTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSS
T ss_pred hhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccC
Confidence 8899999999999999765566677766666655
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.6e-18 Score=194.89 Aligned_cols=180 Identities=19% Similarity=0.243 Sum_probs=120.3
Q ss_pred CChhHHHHHHHHHhhCCC---CCCCCccC-CCCCCCceeeEEcCCCCeEEEeecCCCC------------------ccc-
Q 036334 26 EPTQDKQALLAFLSRTPH---KNRVQWNA-SDSACNWVGVECDANRSFVYSLRLPGVG------------------LVG- 82 (654)
Q Consensus 26 ~~~~~~~al~~~~~~~~~---~~~~~W~~-~~~~C~w~gv~C~~~~~~v~~L~l~~~~------------------l~~- 82 (654)
....++++|+++...... .....|.. ++..+.|.++.++... ++.|+|.+|+ +.+
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~--~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~ 206 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPL--TPKIELFANGKDEANQALLQHKKLSQYSIDED 206 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCCc--cceEEeeCCCCCcchhhHhhcCccCcccccCc
Confidence 346688999999765432 22245743 4456789998887643 5555554433 322
Q ss_pred -------cCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccc
Q 036334 83 -------PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSG 155 (654)
Q Consensus 83 -------~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 155 (654)
.++++.+..+++|+.|+|++|.|. .+|..+.++++|++|+|++|+|+ .+|..|++|++|++|+|++|+|+
T Consensus 207 ~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 207 DDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred cccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 134556889999999999999999 78888889999999999999999 89999999999999999999999
Q ss_pred cCCCccccccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccCcccccCC
Q 036334 156 KIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATLSKF 210 (654)
Q Consensus 156 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p~~~~~~ 210 (654)
.+|..|++|++|++|+|++|.|+..+..+ .+++|+.|+|++|+|+|.+|..+..+
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 339 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEK 339 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHH
T ss_pred ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhc
Confidence 88999999999999999999998665555 88999999999999999999887654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.7e-17 Score=194.30 Aligned_cols=138 Identities=26% Similarity=0.291 Sum_probs=124.4
Q ss_pred ccCCCCccEEEeccCCccCcCCC-CCCCccccccccccccccc-----cccchhhccccccceeccccccccccCCCccc
Q 036334 89 LGKLSQLRVLSLRSNRLSGEIPS-DFSNLTLLRSLYLQSNQFS-----GVFPASVTRMNRLTRLDLSSNNFSGKIPFDVN 162 (654)
Q Consensus 89 l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 162 (654)
+.++++|++|+|++|.+++..+. .+..+++|+.|+|++|.++ +..+..|.++++|+.|+|++|+|++..|..|.
T Consensus 422 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 501 (844)
T 3j0a_A 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS 501 (844)
T ss_dssp HTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSS
T ss_pred hhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHcc
Confidence 45889999999999999966554 4667899999999999998 45567789999999999999999999999999
Q ss_pred cccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCCCccccCCCCCCCCCC
Q 036334 163 NLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDLCGGPL 226 (654)
Q Consensus 163 ~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~~l~~~~n~~~c~~~~ 226 (654)
.+++|+.|+|++|+|++.++....++|+.|+|++|+|++..|..|.++..+.+.||+..|+|+.
T Consensus 502 ~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 502 HLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp SCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred chhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence 9999999999999999988877668999999999999999999999999999999999998764
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.7e-17 Score=187.30 Aligned_cols=157 Identities=20% Similarity=0.133 Sum_probs=107.3
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCcccccccccccccccc-ccchhhccccccceec
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSG-VFPASVTRMNRLTRLD 147 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ 147 (654)
.++.|+|++|.+.+..+...+.++++|++|+|++|.+++..|..|.++++|++|+|++|++++ .+|..+..+++|+.|+
T Consensus 400 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 479 (606)
T 3vq2_A 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479 (606)
T ss_dssp TCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEE
Confidence 355666666666655553456677777777777777776667777777777777777777776 3666777777777777
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCC----CCccccCCCCC
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKF----PQSSFTGNLDL 221 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~----~~l~~~~n~~~ 221 (654)
|++|++++..|..+..+++|+.|+|++|++++.+|.. .+++|+.|+|++|+|+ .+|..+..+ ..+.+.+|+..
T Consensus 480 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~ 558 (606)
T 3vq2_A 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVA 558 (606)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCC
T ss_pred CCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcc
Confidence 7777777766777777777777777777777765543 6677777777777777 666655543 34556677777
Q ss_pred CCCCC
Q 036334 222 CGGPL 226 (654)
Q Consensus 222 c~~~~ 226 (654)
|+++.
T Consensus 559 c~c~~ 563 (606)
T 3vq2_A 559 CICEH 563 (606)
T ss_dssp CSSTT
T ss_pred cCCcc
Confidence 76553
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=3.3e-17 Score=165.77 Aligned_cols=155 Identities=21% Similarity=0.274 Sum_probs=81.5
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 149 (654)
++.|+|++|.+.+ +++..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..+..+++|++|+|+
T Consensus 54 L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 132 (276)
T 2z62_A 54 LQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132 (276)
T ss_dssp CSEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECC
T ss_pred CcEEECCCCcCCc-cCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECc
Confidence 5555555555543 222245555555555555555554444455555555555555555554444445555555555555
Q ss_pred ccccccc-CCCccccccccCccccccccc----------------------------cCCCCCC-CCCCCCeEEccCCcc
Q 036334 150 SNNFSGK-IPFDVNNLTHLTGLFLENNKF----------------------------SGNLPSI-NPANLRDFNVSNNNL 199 (654)
Q Consensus 150 ~N~l~~~-~p~~~~~l~~L~~L~l~~N~l----------------------------~~~~~~~-~~~~L~~L~l~~N~l 199 (654)
+|++++. +|..+..+++|+.|+|++|+| ++..+.. ...+|+.|+|++|+|
T Consensus 133 ~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l 212 (276)
T 2z62_A 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQL 212 (276)
T ss_dssp SSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCC
T ss_pred CCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCce
Confidence 5555432 344455555555555555554 4443333 334677777777777
Q ss_pred cccCcccccCCC---CccccCCCCCCCCC
Q 036334 200 NGSIPATLSKFP---QSSFTGNLDLCGGP 225 (654)
Q Consensus 200 ~g~~p~~~~~~~---~l~~~~n~~~c~~~ 225 (654)
++..+..|.+++ .+.+.+|+..|.++
T Consensus 213 ~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 213 KSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp SCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred eecCHhHhcccccccEEEccCCcccccCC
Confidence 754444444443 45566777776543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.69 E-value=4.1e-17 Score=177.32 Aligned_cols=156 Identities=19% Similarity=0.197 Sum_probs=119.8
Q ss_pred ceeeEEcCCC---------CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccc
Q 036334 58 WVGVECDANR---------SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQ 128 (654)
Q Consensus 58 w~gv~C~~~~---------~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 128 (654)
|..|.|.+.. .+++.|+|++|++.+..+ +.|.++++|++|+|++|.|++..|..|.++++|++|+|++|+
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQA-DTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECH-HHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 5678886432 358899999999987554 479999999999999999998888899999999999999999
Q ss_pred cccccchhhccccccceeccccccccccCCCc-------------------------cccccccCccccccccccCCCCC
Q 036334 129 FSGVFPASVTRMNRLTRLDLSSNNFSGKIPFD-------------------------VNNLTHLTGLFLENNKFSGNLPS 183 (654)
Q Consensus 129 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-------------------------~~~l~~L~~L~l~~N~l~~~~~~ 183 (654)
|++..+..|..+++|++|+|++|+|++..+.. |.++++|+.|+|++|+|++.+..
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~ 214 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNL 214 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCCC
T ss_pred CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccccc
Confidence 99777777999999999999999988554434 44555566666666666654322
Q ss_pred CCCCCCCeEEccCCcccccCcccccCCCCcc
Q 036334 184 INPANLRDFNVSNNNLNGSIPATLSKFPQSS 214 (654)
Q Consensus 184 ~~~~~L~~L~l~~N~l~g~~p~~~~~~~~l~ 214 (654)
..+++|+.|+|++|+|++..|..|.++++|.
T Consensus 215 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 245 (452)
T 3zyi_A 215 TPLVGLEELEMSGNHFPEIRPGSFHGLSSLK 245 (452)
T ss_dssp TTCTTCCEEECTTSCCSEECGGGGTTCTTCC
T ss_pred cccccccEEECcCCcCcccCcccccCccCCC
Confidence 2667777777777777777777766665543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=3e-17 Score=166.05 Aligned_cols=143 Identities=20% Similarity=0.242 Sum_probs=127.1
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
.++.|+|++|++.+.. +..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|++
T Consensus 29 ~l~~L~ls~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 29 STKNLDLSFNPLRHLG-SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TCCEEECTTCCCCEEC-TTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CccEEECCCCcccccC-HhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 4899999999998644 446999999999999999999877789999999999999999999888899999999999999
Q ss_pred ccccccccCCCccccccccCccccccccccCC-CCCC--CCCCCCeEEccCCcccccCcccccCCCC
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGN-LPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQ 212 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~ 212 (654)
++|++++..+..+..+++|+.|++++|++++. +|.. .+++|+.|+|++|++++..+..+..+..
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 174 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHT
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhh
Confidence 99999987777899999999999999999874 3544 7899999999999999777776665443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.8e-17 Score=176.51 Aligned_cols=171 Identities=17% Similarity=0.164 Sum_probs=136.3
Q ss_pred CCccCCCCCCC----ceeeEEcC------C----------CCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCcc
Q 036334 47 VQWNASDSACN----WVGVECDA------N----------RSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLS 106 (654)
Q Consensus 47 ~~W~~~~~~C~----w~gv~C~~------~----------~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~ 106 (654)
.+|....+||. |.++.|+. . -..++.|+++++.+. .+|+..|..+++|++|+|++|.++
T Consensus 4 ~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~ 82 (390)
T 3o6n_A 4 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE 82 (390)
T ss_dssp ---CCEECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCC
T ss_pred CCCCCccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchh-hCChhHhcccccCcEEECCCCccc
Confidence 56877767775 54444431 0 134677888888875 577767899999999999999999
Q ss_pred CcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC--
Q 036334 107 GEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-- 184 (654)
Q Consensus 107 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-- 184 (654)
+..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|+...+..|.++++|++|++++|++++..+..
T Consensus 83 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 162 (390)
T 3o6n_A 83 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 162 (390)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTS
T ss_pred ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhcc
Confidence 877789999999999999999999988889999999999999999999544445689999999999999999888764
Q ss_pred CCCCCCeEEccCCcccccCcccccCCCCccccCC
Q 036334 185 NPANLRDFNVSNNNLNGSIPATLSKFPQSSFTGN 218 (654)
Q Consensus 185 ~~~~L~~L~l~~N~l~g~~p~~~~~~~~l~~~~n 218 (654)
.+++|+.|+|++|++++.-...+.++..+.+.+|
T Consensus 163 ~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 163 ATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 196 (390)
T ss_dssp SCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSS
T ss_pred CCCCCCEEECCCCcCCccccccccccceeecccc
Confidence 7899999999999999665455666666666555
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.6e-17 Score=153.36 Aligned_cols=135 Identities=22% Similarity=0.202 Sum_probs=118.7
Q ss_pred CeEEEeecCCCCcc-ccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhcccccccee
Q 036334 68 SFVYSLRLPGVGLV-GPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRL 146 (654)
Q Consensus 68 ~~v~~L~l~~~~l~-~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (654)
.+++.|+|++|++. +.+|. .+..+++|++|+|++|.|++. ..|..+++|++|+|++|++++.+|..+..+++|++|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEG-LTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSS-CCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred ccCCEEECCCCCCChhhHHH-HHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 34899999999998 77876 589999999999999999966 789999999999999999998889888889999999
Q ss_pred ccccccccccC-CCccccccccCccccccccccCCCC----CC-CCCCCCeEEccCCcccccCccc
Q 036334 147 DLSSNNFSGKI-PFDVNNLTHLTGLFLENNKFSGNLP----SI-NPANLRDFNVSNNNLNGSIPAT 206 (654)
Q Consensus 147 ~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~----~~-~~~~L~~L~l~~N~l~g~~p~~ 206 (654)
+|++|+|++.. +..+..+++|+.|++++|.|++.++ .. .+++|+.|++++|.+. .+|..
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 99999999642 2688999999999999999998877 23 7899999999999987 66643
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=3.1e-17 Score=185.03 Aligned_cols=158 Identities=20% Similarity=0.236 Sum_probs=137.1
Q ss_pred CCCCce----eeEEcCC---------CCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccc
Q 036334 54 SACNWV----GVECDAN---------RSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLR 120 (654)
Q Consensus 54 ~~C~w~----gv~C~~~---------~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 120 (654)
++|.|. .|.|++. ..+++.|+|++|.+.+..+ ..|.++++|++|+|++|.+++..|..|.++++|+
T Consensus 5 ~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~ 83 (606)
T 3vq2_A 5 NPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKS-YSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83 (606)
T ss_dssp -CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeCh-hhccCCccCcEEeCCCCcccccCHHHhhchhhcC
Confidence 456653 5777542 2458999999999986554 4699999999999999999988899999999999
Q ss_pred cccccccccccccchhhccccccceeccccccccccCCCccccccccCccccccccccC-CCCCC--CCCCCCeEEccCC
Q 036334 121 SLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSG-NLPSI--NPANLRDFNVSNN 197 (654)
Q Consensus 121 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~--~~~~L~~L~l~~N 197 (654)
+|+|++|++++..|..|+++++|++|+|++|++++..+..++++++|++|+|++|++++ .+|.. .+++|++|+|++|
T Consensus 84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp EEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred EeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 99999999999889999999999999999999998877889999999999999999986 44654 8999999999999
Q ss_pred cccccCcccccCCCC
Q 036334 198 NLNGSIPATLSKFPQ 212 (654)
Q Consensus 198 ~l~g~~p~~~~~~~~ 212 (654)
++++..|..++.+.+
T Consensus 164 ~l~~~~~~~~~~l~~ 178 (606)
T 3vq2_A 164 YIQTITVNDLQFLRE 178 (606)
T ss_dssp CCCEECTTTTHHHHH
T ss_pred cceecChhhhhhhhc
Confidence 999888887766553
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=3.8e-17 Score=178.77 Aligned_cols=157 Identities=22% Similarity=0.229 Sum_probs=134.7
Q ss_pred CceeeEEcCC---------CCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCcccccccccccc
Q 036334 57 NWVGVECDAN---------RSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSN 127 (654)
Q Consensus 57 ~w~gv~C~~~---------~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 127 (654)
.|..|.|... ...++.|+|++|.+.+..+ ..|.++++|++|+|++|.|++..|..|.++++|++|+|++|
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQ-DEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECT-TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECH-hHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 3678888643 2357899999999987544 47999999999999999999888999999999999999999
Q ss_pred ccccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcc
Q 036334 128 QFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPA 205 (654)
Q Consensus 128 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~ 205 (654)
++++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|++++..+.. .+++|+.|+|++|++++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 999777777899999999999999999888999999999999999999999887754 789999999999999966555
Q ss_pred cccCCCCcc
Q 036334 206 TLSKFPQSS 214 (654)
Q Consensus 206 ~~~~~~~l~ 214 (654)
.|.++++|.
T Consensus 171 ~l~~l~~L~ 179 (477)
T 2id5_A 171 ALSHLHGLI 179 (477)
T ss_dssp HHTTCTTCC
T ss_pred HhcccCCCc
Confidence 666655543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.67 E-value=9.8e-17 Score=163.46 Aligned_cols=148 Identities=24% Similarity=0.238 Sum_probs=125.0
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
..++.|+|++|.+.+..+ ..|.++++|++|+|++|.|++..+ . +.+++|++|+|++|+|+ .+|..+..+++|++|+
T Consensus 31 ~~l~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~ 106 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSL-ATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLD 106 (290)
T ss_dssp TTCCEEECTTSCCSEEEG-GGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEE
T ss_pred CCCCEEEcCCCcCCccCH-HHhhcCCCCCEEECCCCccCcccC-C-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEE
Confidence 358899999999976554 479999999999999999995433 3 88999999999999999 7888999999999999
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCCC---ccccCCC
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQ---SSFTGNL 219 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~---l~~~~n~ 219 (654)
|++|+|++..|..|..+++|+.|+|++|+|++.++.. .+++|+.|+|++|+|++..+..|.++++ |.+.+|.
T Consensus 107 l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~ 183 (290)
T 1p9a_G 107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183 (290)
T ss_dssp CCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCc
Confidence 9999999777788999999999999999999888765 7899999999999999544445555555 4455553
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=5.7e-17 Score=182.88 Aligned_cols=156 Identities=18% Similarity=0.159 Sum_probs=137.7
Q ss_pred ceeeEEcCC---------CCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccc
Q 036334 58 WVGVECDAN---------RSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQ 128 (654)
Q Consensus 58 w~gv~C~~~---------~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 128 (654)
+.-+.|.+. ...++.|+|++|.+.+..+ ..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQN-TTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECT-TTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCCh-hHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 445778642 2358999999999986544 479999999999999999999889999999999999999999
Q ss_pred cccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCC-CCC-CCCCCCeEEccCCcccccCccc
Q 036334 129 FSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNL-PSI-NPANLRDFNVSNNNLNGSIPAT 206 (654)
Q Consensus 129 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~-~~~~L~~L~l~~N~l~g~~p~~ 206 (654)
+++..|..|+++++|++|+|++|+|++..|..+.++++|++|+|++|++++.. |.. .+++|+.|+|++|++++..|..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 99999999999999999999999999877888999999999999999999853 444 7899999999999999888888
Q ss_pred ccCCCCcc
Q 036334 207 LSKFPQSS 214 (654)
Q Consensus 207 ~~~~~~l~ 214 (654)
++.++++.
T Consensus 173 ~~~l~~L~ 180 (606)
T 3t6q_A 173 MSSLQQAT 180 (606)
T ss_dssp HHTTTTCC
T ss_pred hhhhcccc
Confidence 87777654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1e-16 Score=173.50 Aligned_cols=155 Identities=19% Similarity=0.217 Sum_probs=100.6
Q ss_pred ceeeEEcCC---------CCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccc
Q 036334 58 WVGVECDAN---------RSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQ 128 (654)
Q Consensus 58 w~gv~C~~~---------~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 128 (654)
|..|.|.+. ...++.|+|++|.+.+..+ ..|.++++|++|+|++|.|++..+..|.++++|++|+|++|+
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKV-NSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECT-TTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCH-HHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 567777642 1346778888888875443 467888888888888888876666777778888888888888
Q ss_pred cccccchhhccccccceeccccccccccCCCcccc-------------------------ccccCccccccccccCCCCC
Q 036334 129 FSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNN-------------------------LTHLTGLFLENNKFSGNLPS 183 (654)
Q Consensus 129 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-------------------------l~~L~~L~l~~N~l~~~~~~ 183 (654)
|++..+..|..+++|++|+|++|+|++..+..|.+ +++|+.|+|++|+|+..+..
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~ 203 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNL 203 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCCCC
T ss_pred CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccccc
Confidence 87666667777777777777777777544444444 44555555555555533222
Q ss_pred CCCCCCCeEEccCCcccccCcccccCCCCc
Q 036334 184 INPANLRDFNVSNNNLNGSIPATLSKFPQS 213 (654)
Q Consensus 184 ~~~~~L~~L~l~~N~l~g~~p~~~~~~~~l 213 (654)
..+++|+.|+|++|+|++..|..|.++++|
T Consensus 204 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 233 (440)
T 3zyj_A 204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHL 233 (440)
T ss_dssp TTCSSCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred CCCcccCEEECCCCccCccChhhhccCccC
Confidence 255566666666666665555555554443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=173.79 Aligned_cols=132 Identities=20% Similarity=0.212 Sum_probs=65.2
Q ss_pred CCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccCcccc
Q 036334 93 SQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFL 172 (654)
Q Consensus 93 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 172 (654)
++|++|+|++|.+++.+|..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|++..|..+..+++|+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 34555555555555555555555555555555555555544555555555555555555555444444555555555555
Q ss_pred ccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCC---CCccccCCCCCCCC
Q 036334 173 ENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKF---PQSSFTGNLDLCGG 224 (654)
Q Consensus 173 ~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~---~~l~~~~n~~~c~~ 224 (654)
++|+|++..|.. .+++|++|+|++|+|++..+..+..+ ..+.+.+|+..|.+
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 411 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 411 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCC
Confidence 555555444432 44555555555555553333233322 22334445544443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.8e-16 Score=171.67 Aligned_cols=157 Identities=23% Similarity=0.284 Sum_probs=91.4
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccch-------------
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPA------------- 135 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~------------- 135 (654)
+++.|+|++|.+.+ +++..|.++++|++|+|++|.|++..+..|.++++|++|+|++|++++..+.
T Consensus 89 ~L~~L~Ls~n~i~~-i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l 167 (440)
T 3zyj_A 89 HLEILQLSRNHIRT-IEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDL 167 (440)
T ss_dssp SCCEEECCSSCCCE-ECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCc-cChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCC
Confidence 35666666666553 3333455566666666666666544444455555555555555555433221
Q ss_pred ------------hhccccc----------------------cceeccccccccccCCCccccccccCccccccccccCCC
Q 036334 136 ------------SVTRMNR----------------------LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNL 181 (654)
Q Consensus 136 ------------~~~~l~~----------------------L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 181 (654)
.|.++++ |+.|+|++|+|++..|..|.++++|+.|+|++|+|++..
T Consensus 168 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 247 (440)
T 3zyj_A 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIE 247 (440)
T ss_dssp CCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEEC
T ss_pred CCCCCcceeCcchhhcccccCeecCCCCcCccccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEC
Confidence 2333444 444444455555555556666666666666666666655
Q ss_pred CCC--CCCCCCeEEccCCcccccCcccccCC---CCccccCCCCCCCCCC
Q 036334 182 PSI--NPANLRDFNVSNNNLNGSIPATLSKF---PQSSFTGNLDLCGGPL 226 (654)
Q Consensus 182 ~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~---~~l~~~~n~~~c~~~~ 226 (654)
+.. .+++|+.|+|++|+|++..+..|..+ ..+.+.+|++.|+|..
T Consensus 248 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 248 RNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp TTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred hhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCc
Confidence 543 67788888888888885555555544 4456778888887653
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.5e-16 Score=172.77 Aligned_cols=157 Identities=22% Similarity=0.244 Sum_probs=98.8
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccch------------
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPA------------ 135 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~------------ 135 (654)
.+++.|+|++|.+.+.. +..|.++++|++|+|++|.|++..+..|.++++|++|+|++|++++..+.
T Consensus 99 ~~L~~L~Ls~n~i~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 177 (452)
T 3zyi_A 99 HHLEVLQLGRNSIRQIE-VGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLD 177 (452)
T ss_dssp TTCCEEECCSSCCCEEC-TTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCCcC-hhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEe
Confidence 34677777777776533 33577777777777777777755555566677777777777666643332
Q ss_pred -------------hhcccccccee----------------------ccccccccccCCCccccccccCccccccccccCC
Q 036334 136 -------------SVTRMNRLTRL----------------------DLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGN 180 (654)
Q Consensus 136 -------------~~~~l~~L~~L----------------------~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 180 (654)
.|.++++|++| +|++|+|++..|..|.++++|+.|+|++|+|++.
T Consensus 178 l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 257 (452)
T 3zyi_A 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI 257 (452)
T ss_dssp CCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEE
T ss_pred CCCCCCccccChhhccCCCCCCEEECCCCcccccccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceE
Confidence 23344444444 4444445444455566666666666666666666
Q ss_pred CCCC--CCCCCCeEEccCCcccccCcccccCC---CCccccCCCCCCCCC
Q 036334 181 LPSI--NPANLRDFNVSNNNLNGSIPATLSKF---PQSSFTGNLDLCGGP 225 (654)
Q Consensus 181 ~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~---~~l~~~~n~~~c~~~ 225 (654)
.+.. .+++|+.|+|++|+|++..+..|..+ ..+.+.+|++.|+|.
T Consensus 258 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 258 ERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred CHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence 5543 66788888888888885555555444 445677888888765
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.5e-16 Score=151.89 Aligned_cols=126 Identities=25% Similarity=0.295 Sum_probs=111.6
Q ss_pred EeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccc
Q 036334 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSN 151 (654)
Q Consensus 72 ~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 151 (654)
.++++++++. .+|.. + .++|++|+|++|.|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 14 ~l~~~~~~l~-~ip~~-~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKG-I--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EEECTTSCCS-SCCSC-C--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEcCCCCCC-cCCCC-C--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 4677777775 56653 3 368999999999998 78889999999999999999999888889999999999999999
Q ss_pred cccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCccccc
Q 036334 152 NFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGS 202 (654)
Q Consensus 152 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~ 202 (654)
+|++..|..|..+++|+.|+|++|+|++.++.. .+++|+.|+|++|++...
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 999888889999999999999999999888764 789999999999999743
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.6e-16 Score=163.68 Aligned_cols=147 Identities=20% Similarity=0.221 Sum_probs=68.9
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCc--C--CCCCCCccccccccccccccccccch----hhcccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGE--I--PSDFSNLTLLRSLYLQSNQFSGVFPA----SVTRMN 141 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~ 141 (654)
++.|+|++|.+.+.. +..|+.+++|++|+|++|.+.+. + +..++++++|++|+|++|+++ .++. .+..++
T Consensus 147 L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~ 224 (310)
T 4glp_A 147 LKVLSIAQAHSPAFS-CEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGV 224 (310)
T ss_dssp CCEEEEECCSSCCCC-TTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTC
T ss_pred CCEEEeeCCCcchhh-HHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCC
Confidence 455555555553322 22355555555555555554431 1 112244555555555555554 2222 134455
Q ss_pred ccceeccccccccccCCCccccc---cccCccccccccccCCCCCCCCCCCCeEEccCCcccc-cCcccccCCCCccccC
Q 036334 142 RLTRLDLSSNNFSGKIPFDVNNL---THLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNG-SIPATLSKFPQSSFTG 217 (654)
Q Consensus 142 ~L~~L~l~~N~l~~~~p~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g-~~p~~~~~~~~l~~~~ 217 (654)
+|++|+|++|+|++..|..+..+ ++|+.|+|++|+|+. +|....++|+.|+|++|+|++ ..+..+.++..|.+.+
T Consensus 225 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~-lp~~~~~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L~~ 303 (310)
T 4glp_A 225 QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ-VPKGLPAKLRVLDLSSNRLNRAPQPDELPEVDNLTLDG 303 (310)
T ss_dssp CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS-CCSCCCSCCSCEECCSCCCCSCCCTTSCCCCSCEECSS
T ss_pred CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc-hhhhhcCCCCEEECCCCcCCCCchhhhCCCccEEECcC
Confidence 55555555555555445444444 355555555555552 232223455555555555554 2333344444444444
Q ss_pred CC
Q 036334 218 NL 219 (654)
Q Consensus 218 n~ 219 (654)
|+
T Consensus 304 N~ 305 (310)
T 4glp_A 304 NP 305 (310)
T ss_dssp TT
T ss_pred CC
Confidence 43
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-16 Score=179.87 Aligned_cols=145 Identities=23% Similarity=0.210 Sum_probs=93.0
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCC-CCCccccccccccccccccccchhhcccccccee
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRL 146 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (654)
.+++.|+|++|.+.+..+. .|..+++|++|+|++|.+++..|.. |.++++|++|+|++|++++..|..+..+++|++|
T Consensus 376 ~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 454 (606)
T 3t6q_A 376 SHLQSLNLSYNEPLSLKTE-AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL 454 (606)
T ss_dssp TTCCEEECCSCSCEEECTT-TTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEE
T ss_pred CCCCEEECCCCcCCcCCHH-HhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEE
Confidence 3467777777777654443 4666777777777777776555443 6666777777777777766666666666677777
Q ss_pred cccccccccc---CCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCCCc
Q 036334 147 DLSSNNFSGK---IPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQS 213 (654)
Q Consensus 147 ~l~~N~l~~~---~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~l 213 (654)
+|++|.+++. .+..+..+++|+.|+|++|++++.+|.. .+++|+.|+|++|++++..|..+.+++.+
T Consensus 455 ~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 526 (606)
T 3t6q_A 455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI 526 (606)
T ss_dssp ECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC
T ss_pred ECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc
Confidence 7777666652 2244666666666666666666665543 56666666666666666666666655544
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.7e-16 Score=179.52 Aligned_cols=157 Identities=22% Similarity=0.199 Sum_probs=140.4
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCcccccccccccccc-ccccchhhccccccceec
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQF-SGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~ 147 (654)
.+..+++..++.....+...+..+++|+.++++.|.+.+..+..+..+++|+.|+|++|++ .+.+|..|..+++|++|+
T Consensus 421 ~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~ 500 (635)
T 4g8a_A 421 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 500 (635)
T ss_dssp TCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred cccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEE
Confidence 4667788888877777777789999999999999999999999999999999999999985 456888999999999999
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCC----CCccccCCCCC
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKF----PQSSFTGNLDL 221 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~----~~l~~~~n~~~ 221 (654)
|++|+|++..|..|.++++|+.|+|++|+|++.++.. .+++|+.|+|++|+|++..|..+..+ ..+...+|++.
T Consensus 501 Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~ 580 (635)
T 4g8a_A 501 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 580 (635)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBC
T ss_pred CCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCc
Confidence 9999999999999999999999999999999988865 88999999999999999999887655 45678899999
Q ss_pred CCCC
Q 036334 222 CGGP 225 (654)
Q Consensus 222 c~~~ 225 (654)
|+|.
T Consensus 581 C~C~ 584 (635)
T 4g8a_A 581 CTCE 584 (635)
T ss_dssp CSGG
T ss_pred ccCC
Confidence 9765
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=2.1e-16 Score=184.98 Aligned_cols=161 Identities=24% Similarity=0.198 Sum_probs=136.7
Q ss_pred CCceeeEEcCCCCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcC-CCCCCCccccccccccccccccccc
Q 036334 56 CNWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEI-PSDFSNLTLLRSLYLQSNQFSGVFP 134 (654)
Q Consensus 56 C~w~gv~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p 134 (654)
|+|..|.+ -..+++.|+|++|.+.+..+. .|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++..|
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~-~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p 90 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTAS-SFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP 90 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSS-SCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChh-HCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH
Confidence 45666665 335699999999999876554 6999999999999999777676 7789999999999999999999999
Q ss_pred hhhccccccceeccccccccccCCCc--cccccccCccccccccccCCCCC--C-CCCCCCeEEccCCcccccCccccc-
Q 036334 135 ASVTRMNRLTRLDLSSNNFSGKIPFD--VNNLTHLTGLFLENNKFSGNLPS--I-NPANLRDFNVSNNNLNGSIPATLS- 208 (654)
Q Consensus 135 ~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~~~--~-~~~~L~~L~l~~N~l~g~~p~~~~- 208 (654)
..|.++++|++|+|++|.+++.+|.. +.++++|+.|+|++|++++..+. + .+++|+.|+|++|.+++..|..+.
T Consensus 91 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~ 170 (844)
T 3j0a_A 91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170 (844)
T ss_dssp TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHH
T ss_pred hHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccc
Confidence 99999999999999999999877765 89999999999999999987653 3 899999999999999988888775
Q ss_pred ----CCCCccccCCC
Q 036334 209 ----KFPQSSFTGNL 219 (654)
Q Consensus 209 ----~~~~l~~~~n~ 219 (654)
++..+.+.+|.
T Consensus 171 l~~~~L~~L~L~~n~ 185 (844)
T 3j0a_A 171 LQGKTLSFFSLAANS 185 (844)
T ss_dssp HHHCSSCCCEECCSB
T ss_pred ccCCccceEECCCCc
Confidence 44555555553
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.64 E-value=6.9e-17 Score=147.23 Aligned_cols=126 Identities=22% Similarity=0.202 Sum_probs=104.1
Q ss_pred CeEEEeecCCCCcc-ccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhcccccccee
Q 036334 68 SFVYSLRLPGVGLV-GPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRL 146 (654)
Q Consensus 68 ~~v~~L~l~~~~l~-~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (654)
.+++.|++++|++. +.+|. .+..+++|++|+|++|.+++. ..|.++++|++|+|++|++++.+|..+..+++|++|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCS-CCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred ccCeEEEccCCcCChhHHHH-HHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 34888999999988 67776 578899999999999998865 678889999999999999998788888888999999
Q ss_pred cccccccccc-CCCccccccccCccccccccccCCCC---C-C-CCCCCCeEEccC
Q 036334 147 DLSSNNFSGK-IPFDVNNLTHLTGLFLENNKFSGNLP---S-I-NPANLRDFNVSN 196 (654)
Q Consensus 147 ~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~~---~-~-~~~~L~~L~l~~ 196 (654)
+|++|+|++. .+..+..+++|+.|++++|++++.++ . . .+++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999998863 34678888889999999998888776 2 2 678888888764
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.1e-16 Score=153.40 Aligned_cols=143 Identities=15% Similarity=0.256 Sum_probs=107.4
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 149 (654)
++.|+|++|++. .++ .+..+++|++|+|++|.++ .+ ..+.++++|++|+|++|++++..|..+..+++|++|+|+
T Consensus 46 L~~L~l~~n~i~-~l~--~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 46 LTYITLANINVT-DLT--GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp CCEEEEESSCCS-CCT--TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred ccEEeccCCCcc-ChH--HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 778888888887 455 3788888888888888765 23 378888888888888888888778888888888888888
Q ss_pred cccccccCCCccccccccCcccccccc-ccCCCCCCCCCCCCeEEccCCcccccCcccccCCC---CccccCCC
Q 036334 150 SNNFSGKIPFDVNNLTHLTGLFLENNK-FSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFP---QSSFTGNL 219 (654)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~---~l~~~~n~ 219 (654)
+|++++..|..+..+++|+.|+|++|+ ++...+-..+++|+.|+|++|++++ ++ .+..++ .|.+.+|.
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 888887777778888888888888887 5554322277888888888888874 43 444444 44444543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.64 E-value=5.4e-17 Score=183.88 Aligned_cols=149 Identities=19% Similarity=0.320 Sum_probs=134.7
Q ss_pred CeEEEeecCCCCcccc-----------------CCccccc--CCCCccEEEeccCCccCcCCCCCCCccccccccccccc
Q 036334 68 SFVYSLRLPGVGLVGP-----------------IPPNTLG--KLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQ 128 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~-----------------~~~~~l~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 128 (654)
.+++.|+|++|.+.|. +|. .++ ++++|++|+|++|.+.|.+|..|+++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~-~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE-DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCch-hhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 4589999999999996 887 588 99999999999999999999999999999999999999
Q ss_pred -ccc-ccchhhccc------cccceeccccccccccCCC--ccccccccCccccccccccCCCCCC-CCCCCCeEEccCC
Q 036334 129 -FSG-VFPASVTRM------NRLTRLDLSSNNFSGKIPF--DVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNN 197 (654)
Q Consensus 129 -l~~-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N 197 (654)
++| .+|..++.+ ++|++|+|++|+++ .+|. .++++++|+.|+|++|+++|.+|.+ .+++|+.|+|++|
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N 363 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYN 363 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCC
Confidence 999 899999887 99999999999999 8998 8999999999999999999888855 7889999999999
Q ss_pred cccccCcccccCCCC-c---cccCCC
Q 036334 198 NLNGSIPATLSKFPQ-S---SFTGNL 219 (654)
Q Consensus 198 ~l~g~~p~~~~~~~~-l---~~~~n~ 219 (654)
+++ .+|..+.+++. | .+.+|.
T Consensus 364 ~l~-~lp~~l~~l~~~L~~L~Ls~N~ 388 (636)
T 4eco_A 364 QIT-EIPANFCGFTEQVENLSFAHNK 388 (636)
T ss_dssp EEE-ECCTTSEEECTTCCEEECCSSC
T ss_pred ccc-cccHhhhhhcccCcEEEccCCc
Confidence 999 89988776655 4 444554
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.7e-16 Score=156.88 Aligned_cols=146 Identities=14% Similarity=0.186 Sum_probs=122.8
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCC-ccCcCCCCCCCccccccccccc-cccccccchhhcccccccee
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNR-LSGEIPSDFSNLTLLRSLYLQS-NQFSGVFPASVTRMNRLTRL 146 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L 146 (654)
.++.|+|++|++.+ +++..|.++++|++|+|++|. +++..+..|.++++|++|+|++ |++++..+..|.++++|++|
T Consensus 32 ~l~~L~l~~n~l~~-i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 32 STQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TCCEEEEESCCCSE-ECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred cccEEEEeCCcceE-ECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 58999999999975 555579999999999999997 8866667899999999999999 99998777889999999999
Q ss_pred ccccccccccCCCccccccccC---ccccccc-cccCCCCCC--CCCCCC-eEEccCCcccccCcccccC---CCCcccc
Q 036334 147 DLSSNNFSGKIPFDVNNLTHLT---GLFLENN-KFSGNLPSI--NPANLR-DFNVSNNNLNGSIPATLSK---FPQSSFT 216 (654)
Q Consensus 147 ~l~~N~l~~~~p~~~~~l~~L~---~L~l~~N-~l~~~~~~~--~~~~L~-~L~l~~N~l~g~~p~~~~~---~~~l~~~ 216 (654)
+|++|++++ +|. +..+++|+ .|++++| ++++..+.. .+++|+ .|+|++|+++ .+|..... +..+.+.
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~ 187 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcC
Confidence 999999995 776 88888888 9999999 999887764 788999 9999999998 77754332 3344455
Q ss_pred CC
Q 036334 217 GN 218 (654)
Q Consensus 217 ~n 218 (654)
+|
T Consensus 188 ~n 189 (239)
T 2xwt_C 188 KN 189 (239)
T ss_dssp TC
T ss_pred CC
Confidence 55
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=5.2e-16 Score=177.54 Aligned_cols=156 Identities=21% Similarity=0.228 Sum_probs=122.1
Q ss_pred EEEeecCCCCcc--ccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccc--------hhhcc
Q 036334 70 VYSLRLPGVGLV--GPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFP--------ASVTR 139 (654)
Q Consensus 70 v~~L~l~~~~l~--~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~ 139 (654)
++.|++++|.+. +.+|. .|.++++|++|+|++|.|++..+..|.++++|++|+|++|++++..+ ..|.+
T Consensus 456 L~~L~l~~n~l~~~~~~p~-~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~ 534 (680)
T 1ziw_A 456 LQRLMLRRVALKNVDSSPS-PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534 (680)
T ss_dssp CCEEECTTSCCBCTTCSSC-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTT
T ss_pred cccchhccccccccccCCc-ccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcC
Confidence 334444444443 33443 57888889999999999887777778889999999999998886532 23778
Q ss_pred ccccceeccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCccc----ccCCCCc
Q 036334 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPAT----LSKFPQS 213 (654)
Q Consensus 140 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~----~~~~~~l 213 (654)
+++|+.|+|++|+|+...+..|.++++|+.|+|++|+|++.++.. .+++|+.|+|++|+|++..|.. +.++..+
T Consensus 535 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l 614 (680)
T 1ziw_A 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEE
T ss_pred CCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEE
Confidence 899999999999999444456899999999999999999877765 7899999999999999777764 4577778
Q ss_pred cccCCCCCCCCCC
Q 036334 214 SFTGNLDLCGGPL 226 (654)
Q Consensus 214 ~~~~n~~~c~~~~ 226 (654)
.+.+|++.|+|+.
T Consensus 615 ~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 615 DMRFNPFDCTCES 627 (680)
T ss_dssp ECTTCCCCBCCCC
T ss_pred EccCCCcccCCcc
Confidence 8899999998763
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=5.2e-16 Score=161.64 Aligned_cols=134 Identities=13% Similarity=0.161 Sum_probs=96.1
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccC---------------HHH--------HHHHHHHHhccCCCccccc
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG---------------KRE--------FEMQMEVLGKIKHDNVVPL 406 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---------------~~~--------~~~e~~~l~~l~hpniv~l 406 (654)
+.+.||+|+||.||+|...+|+.||||+++..... ... .++|...|.++.+.++.-.
T Consensus 99 I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp 178 (397)
T 4gyi_A 99 VGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP 178 (397)
T ss_dssp EEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred ecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 46789999999999999989999999998642110 111 1345555555544333221
Q ss_pred cEEEEeCCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCC-
Q 036334 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHD- 485 (654)
Q Consensus 407 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~- 485 (654)
.-+.. ...+|||||++++.|..+... .....++.|++.+|.|||..+ ||||||||.|||+++++.
T Consensus 179 ~p~~~--~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~~g-IVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 179 EPIAQ--SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAKHG-LIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CEEEE--ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHHTT-EECSCCSTTSEEEEEEECS
T ss_pred eeeec--cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHHCC-CcCCCCCHHHEEEeCCCCc
Confidence 11111 234799999999888765431 124568899999999999988 999999999999988763
Q ss_pred ---------eEEeccCCCCCc
Q 036334 486 ---------ACVSDFGLNPLF 497 (654)
Q Consensus 486 ---------~kl~Dfgla~~~ 497 (654)
+.|+||+-+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 789999976543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.5e-16 Score=176.06 Aligned_cols=155 Identities=21% Similarity=0.238 Sum_probs=122.3
Q ss_pred CCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccC--cCCCCCCCccccccccccccccccccch-hhcccccc
Q 036334 67 RSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSG--EIPSDFSNLTLLRSLYLQSNQFSGVFPA-SVTRMNRL 143 (654)
Q Consensus 67 ~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L 143 (654)
..+++.|+|++|.+.+.++. .++++++|++|+|++|.+++ .+|..|.++++|++|+|++|++++.+|. .+..+++|
T Consensus 352 l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L 430 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQ-GCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTT-TCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred CCCceEEECCCCccccchhh-hhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence 34588899999988887765 58889999999999998886 3456788889999999999999875554 47788899
Q ss_pred ceeccccccccccCCCccccccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccCccc-ccCCC---CccccCC
Q 036334 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPAT-LSKFP---QSSFTGN 218 (654)
Q Consensus 144 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p~~-~~~~~---~l~~~~n 218 (654)
+.|+|++|+|++.+|..+. ++|+.|+|++|+|+..++.. .+++|+.|+|++|+|+ .+|.. +..++ .+.+.+|
T Consensus 431 ~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N 507 (562)
T 3a79_B 431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507 (562)
T ss_dssp CEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSC
T ss_pred CEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCC
Confidence 9999999999887776654 68899999999998655555 7889999999999998 67765 55544 4567788
Q ss_pred CCCCCCC
Q 036334 219 LDLCGGP 225 (654)
Q Consensus 219 ~~~c~~~ 225 (654)
+..|.++
T Consensus 508 ~~~c~c~ 514 (562)
T 3a79_B 508 PWDCTCP 514 (562)
T ss_dssp CBCCCHH
T ss_pred CcCCCcc
Confidence 8877643
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.7e-16 Score=175.53 Aligned_cols=134 Identities=24% Similarity=0.340 Sum_probs=65.9
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCcccccccccccccccc--ccchhhccccccceec
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSG--VFPASVTRMNRLTRLD 147 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ 147 (654)
++.|++++|++.+.. .+..+++|++|+|++|.+++.+|..|+++++|++|+|++|++++ .+|..+..+++|++|+
T Consensus 304 L~~L~l~~n~l~~~~---~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~ 380 (520)
T 2z7x_B 304 IKNFTVSGTRMVHML---CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380 (520)
T ss_dssp CSEEEEESSCCCCCC---CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEE
T ss_pred eeEEEcCCCcccccc---chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEE
Confidence 455555555543211 12445555555555555555555555555555555555555554 3344455555555555
Q ss_pred cccccccccCCC-ccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccc
Q 036334 148 LSSNNFSGKIPF-DVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATL 207 (654)
Q Consensus 148 l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~ 207 (654)
|++|++++.+|. .+..+++|+.|++++|++++..|....++|+.|+|++|+|+ .+|..+
T Consensus 381 Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~ 440 (520)
T 2z7x_B 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQV 440 (520)
T ss_dssp CCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGG
T ss_pred CCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhh
Confidence 555555543333 24445555555555555544443332244555555555554 444443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.63 E-value=6e-17 Score=166.95 Aligned_cols=129 Identities=19% Similarity=0.225 Sum_probs=85.0
Q ss_pred EEEeecCCCCc-cccCCccccc-------CCCCccEEEeccCCccCcCCCCC--CCccccccccccccccccccchhhcc
Q 036334 70 VYSLRLPGVGL-VGPIPPNTLG-------KLSQLRVLSLRSNRLSGEIPSDF--SNLTLLRSLYLQSNQFSGVFPASVTR 139 (654)
Q Consensus 70 v~~L~l~~~~l-~~~~~~~~l~-------~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~~ 139 (654)
++.|+|++|.+ .+.++. .+. ++++|++|+|++|.+++.+|..+ .++++|++|+|++|++++. |..+..
T Consensus 65 L~~L~L~~n~l~~~~~~~-~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~ 142 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPS-RILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAE 142 (312)
T ss_dssp HHHCCCCEEEEEEEECBH-HHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHH
T ss_pred HhhcccccccccCCCcCH-HHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHH
Confidence 56667777766 334443 233 56777777777777777676665 6677777777777777765 666666
Q ss_pred c-----cccceeccccccccccCCCccccccccCccccccccccCCCC---C---CCCCCCCeEEccCCccc
Q 036334 140 M-----NRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLP---S---INPANLRDFNVSNNNLN 200 (654)
Q Consensus 140 l-----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~---~---~~~~~L~~L~l~~N~l~ 200 (654)
+ ++|++|+|++|+|++..|..+..+++|+.|+|++|++.+.++ . ..+++|++|+|++|+|+
T Consensus 143 l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 143 LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214 (312)
T ss_dssp HHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred HHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence 6 677777777777776666677777777777777777655321 1 25567777777777776
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=2.8e-16 Score=179.77 Aligned_cols=162 Identities=23% Similarity=0.253 Sum_probs=135.9
Q ss_pred CCceeeEEcCC---------CCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccc
Q 036334 56 CNWVGVECDAN---------RSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQS 126 (654)
Q Consensus 56 C~w~gv~C~~~---------~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 126 (654)
|.+.-|.|+.. ..+++.|+|++|.+.+ +++..|.++++|++|+|++|.+++..|..|+++++|++|+|++
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 82 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCC-CCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCC-cCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence 45555677532 2458999999999986 5555799999999999999999998899999999999999999
Q ss_pred cccccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCc
Q 036334 127 NQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIP 204 (654)
Q Consensus 127 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p 204 (654)
|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++.++.. .+++|++|+|++|.+++..|
T Consensus 83 n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 162 (680)
T 1ziw_A 83 NELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162 (680)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCH
T ss_pred CccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCH
Confidence 9999766667999999999999999999777788999999999999999999887765 88999999999999997777
Q ss_pred cccc-----CCCCccccCC
Q 036334 205 ATLS-----KFPQSSFTGN 218 (654)
Q Consensus 205 ~~~~-----~~~~l~~~~n 218 (654)
..+. ++..|.+.+|
T Consensus 163 ~~~~~~~~~~L~~L~L~~n 181 (680)
T 1ziw_A 163 EELDIFANSSLKKLELSSN 181 (680)
T ss_dssp HHHGGGTTCEESEEECTTC
T ss_pred HHhhccccccccEEECCCC
Confidence 6543 4455555555
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.7e-16 Score=173.78 Aligned_cols=150 Identities=19% Similarity=0.124 Sum_probs=122.9
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhc-ccccccee
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVT-RMNRLTRL 146 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L 146 (654)
..++.|+|++|.+.+..+ ..+++|+.|+|++|.|++..|..|+++++|++|+|++|+|++.+|..+. .+++|+.|
T Consensus 99 ~~L~~L~L~~N~l~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L 174 (487)
T 3oja_A 99 PSIETLHAANNNISRVSC----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174 (487)
T ss_dssp TTCCEEECCSSCCCCEEE----CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred CCcCEEECcCCcCCCCCc----cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEE
Confidence 447888888888876543 2468899999999999988888899999999999999999988888886 78999999
Q ss_pred ccccccccccCCCccccccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccCcccccCCC---CccccCCCCCC
Q 036334 147 DLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATLSKFP---QSSFTGNLDLC 222 (654)
Q Consensus 147 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p~~~~~~~---~l~~~~n~~~c 222 (654)
+|++|.|++..+ +..+++|+.|+|++|+|++.++.+ .+++|+.|+|++|.|++ +|..+..++ .+.+.+|+..|
T Consensus 175 ~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c 251 (487)
T 3oja_A 175 NLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC 251 (487)
T ss_dssp ECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCH
T ss_pred ecCCCccccccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcC
Confidence 999999996633 446889999999999999887776 78899999999999984 777766554 45677888877
Q ss_pred CC
Q 036334 223 GG 224 (654)
Q Consensus 223 ~~ 224 (654)
+.
T Consensus 252 ~~ 253 (487)
T 3oja_A 252 GT 253 (487)
T ss_dssp HH
T ss_pred cc
Confidence 53
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.62 E-value=1e-16 Score=165.18 Aligned_cols=135 Identities=21% Similarity=0.251 Sum_probs=85.5
Q ss_pred eEEEeecCCCCccccCCcccc-cCCCCccEEEeccCCccCcCCCCCCCc-----cccccccccccccccccchhhccccc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTL-GKLSQLRVLSLRSNRLSGEIPSDFSNL-----TLLRSLYLQSNQFSGVFPASVTRMNR 142 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l-~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~ 142 (654)
+++.|+|++|.+.+.+|...+ ..+++|++|+|++|.|++. |..|+++ ++|++|+|++|++++..|..|+++++
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 467777777777766666422 6677777777777777755 6666665 67777777777777666667777777
Q ss_pred cceecccccccccc--CCCcc--ccccccCccccccccccCCC--C-CC--CCCCCCeEEccCCcccccCc
Q 036334 143 LTRLDLSSNNFSGK--IPFDV--NNLTHLTGLFLENNKFSGNL--P-SI--NPANLRDFNVSNNNLNGSIP 204 (654)
Q Consensus 143 L~~L~l~~N~l~~~--~p~~~--~~l~~L~~L~l~~N~l~~~~--~-~~--~~~~L~~L~l~~N~l~g~~p 204 (654)
|++|+|++|++.+. +|..+ ..+++|+.|+|++|+|++.. + .. .+++|+.|+|++|++++.+|
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 245 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence 77777777776554 22223 56666666666666666321 1 11 45666666666666665554
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-15 Score=157.96 Aligned_cols=157 Identities=20% Similarity=0.315 Sum_probs=104.2
Q ss_pred CCCCCceeeEEcCC---------CCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCcccccccc
Q 036334 53 DSACNWVGVECDAN---------RSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLY 123 (654)
Q Consensus 53 ~~~C~w~gv~C~~~---------~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 123 (654)
...|.|..+.|+.. ...++.|+|++|.+.+ +++..|.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus 28 ~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (330)
T 1xku_A 28 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 106 (330)
T ss_dssp TCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCE-eChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence 34578999999742 2358889999999986 4444699999999999999999988899999999999999
Q ss_pred ccccccccccchh----------------------hccccccceecccccccc--ccCCCccccccccCccccccccccC
Q 036334 124 LQSNQFSGVFPAS----------------------VTRMNRLTRLDLSSNNFS--GKIPFDVNNLTHLTGLFLENNKFSG 179 (654)
Q Consensus 124 Ls~N~l~~~~p~~----------------------~~~l~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L~l~~N~l~~ 179 (654)
|++|+++ .+|.. +.++++|+.|+|++|.++ +..+..+..+++|+.|++++|+++.
T Consensus 107 Ls~n~l~-~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 107 LSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp CCSSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCCCcCC-ccChhhcccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 9999887 44544 344444444444444443 2334445555555555555555553
Q ss_pred CCCCCCCCCCCeEEccCCcccccCcccccCCCC
Q 036334 180 NLPSINPANLRDFNVSNNNLNGSIPATLSKFPQ 212 (654)
Q Consensus 180 ~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~~ 212 (654)
.+ ....++|+.|+|++|++++..|..|.++++
T Consensus 186 l~-~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 217 (330)
T 1xku_A 186 IP-QGLPPSLTELHLDGNKITKVDAASLKGLNN 217 (330)
T ss_dssp CC-SSCCTTCSEEECTTSCCCEECTGGGTTCTT
T ss_pred CC-ccccccCCEEECCCCcCCccCHHHhcCCCC
Confidence 22 222255566666666665555555554443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.62 E-value=7.3e-16 Score=160.25 Aligned_cols=158 Identities=21% Similarity=0.308 Sum_probs=117.6
Q ss_pred CCCceeeEEcCCC---------CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCcccccccccc
Q 036334 55 ACNWVGVECDANR---------SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQ 125 (654)
Q Consensus 55 ~C~w~gv~C~~~~---------~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 125 (654)
.|.|..+.|+... .+++.|+|++|.+.+ ++++.|.++++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus 32 ~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCc-cCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 3788888886432 357888999988875 444468889999999999999987778888889999999999
Q ss_pred ccccccccchhhccccccceeccccccccccCCCccccccccCccccccccccC--CCCCC--CCCCCCeEEccCCcccc
Q 036334 126 SNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSG--NLPSI--NPANLRDFNVSNNNLNG 201 (654)
Q Consensus 126 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~--~~~~L~~L~l~~N~l~g 201 (654)
+|+++ .+|..+. ++|++|+|++|+|++..+..+..+++|+.|++++|.++. ..+.. .+ +|+.|++++|++++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 99888 5666555 788888888888886655567888888888888888863 44433 33 77788888888774
Q ss_pred cCcccc-cCCCCccccCC
Q 036334 202 SIPATL-SKFPQSSFTGN 218 (654)
Q Consensus 202 ~~p~~~-~~~~~l~~~~n 218 (654)
+|..+ .++..|.+.+|
T Consensus 187 -l~~~~~~~L~~L~l~~n 203 (332)
T 2ft3_A 187 -IPKDLPETLNELHLDHN 203 (332)
T ss_dssp -CCSSSCSSCSCCBCCSS
T ss_pred -cCccccCCCCEEECCCC
Confidence 55443 35555555554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.7e-16 Score=174.12 Aligned_cols=151 Identities=26% Similarity=0.355 Sum_probs=122.5
Q ss_pred CCccCCCCCC-----Cceee-EEcCCCCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccc
Q 036334 47 VQWNASDSAC-----NWVGV-ECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLR 120 (654)
Q Consensus 47 ~~W~~~~~~C-----~w~gv-~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 120 (654)
.+|..+.++| .|.|+ .|..+. ++.|+|++|++.+ +|+. + +++|++|+|++|.|+ .+| ..+++|+
T Consensus 34 ~~W~~~~~~~~~~~~~~~~l~~C~~~~--L~~L~Ls~n~L~~-lp~~-l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~ 103 (571)
T 3cvr_A 34 DKWEKQALPGENRNEAVSLLKECLINQ--FSELQLNRLNLSS-LPDN-L--PPQITVLEITQNALI-SLP---ELPASLE 103 (571)
T ss_dssp HHHHTTCCTTCCHHHHHHHHHHHHHTT--CSEEECCSSCCSC-CCSC-C--CTTCSEEECCSSCCS-CCC---CCCTTCC
T ss_pred HHHhccCCccccccchhhhccccccCC--ccEEEeCCCCCCc-cCHh-H--cCCCCEEECcCCCCc-ccc---cccCCCC
Confidence 3576666788 69999 787544 9999999999987 8764 4 378999999999999 677 4578999
Q ss_pred cccccccccccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCccc
Q 036334 121 SLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN 200 (654)
Q Consensus 121 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~ 200 (654)
+|+|++|+|++ +|. +.+ +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++.++ .+++|+.|+|++|+|+
T Consensus 104 ~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~--~l~~L~~L~Ls~N~L~ 173 (571)
T 3cvr_A 104 YLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPE--LPTSLEVLSVRNNQLT 173 (571)
T ss_dssp EEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC--CCTTCCEEECCSSCCS
T ss_pred EEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcCCC--cCCCcCEEECCCCCCC
Confidence 99999999997 777 665 99999999999996 776 67899999999999998444 6789999999999998
Q ss_pred ccCccccc-CCCCccccCCC
Q 036334 201 GSIPATLS-KFPQSSFTGNL 219 (654)
Q Consensus 201 g~~p~~~~-~~~~l~~~~n~ 219 (654)
+ +|. |. ++..|.+.+|.
T Consensus 174 ~-lp~-l~~~L~~L~Ls~N~ 191 (571)
T 3cvr_A 174 F-LPE-LPESLEALDVSTNL 191 (571)
T ss_dssp C-CCC-CCTTCCEEECCSSC
T ss_pred C-cch-hhCCCCEEECcCCC
Confidence 6 777 54 45555555553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=6.2e-16 Score=172.95 Aligned_cols=156 Identities=21% Similarity=0.238 Sum_probs=125.1
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCC-CCCCCccccccccccccccccccchhhcccccccee
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIP-SDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRL 146 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (654)
.+++.|+|++|.+.+ +++. +..+++|++|+|++|.+.+..| ..|.++++|++|+|++|++++.+|..+.++++|+.|
T Consensus 373 ~~L~~L~l~~n~l~~-~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 450 (570)
T 2z63_A 373 TSLKYLDLSFNGVIT-MSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450 (570)
T ss_dssp SCCCEEECCSCSEEE-EEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred CccCEEECCCCcccc-cccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEE
Confidence 346677777777764 3333 7888888888888888887666 468888999999999999988888888889999999
Q ss_pred cccccccc-ccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCCC---ccccCCCC
Q 036334 147 DLSSNNFS-GKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQ---SSFTGNLD 220 (654)
Q Consensus 147 ~l~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~---l~~~~n~~ 220 (654)
+|++|.++ +.+|..+..+++|+.|+|++|++++..|.. .+++|+.|+|++|++++..|..|.+++. +.+.+|+.
T Consensus 451 ~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~ 530 (570)
T 2z63_A 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530 (570)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred ECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcc
Confidence 99999987 678888889999999999999998887654 7889999999999998777776765554 45678887
Q ss_pred CCCCC
Q 036334 221 LCGGP 225 (654)
Q Consensus 221 ~c~~~ 225 (654)
.|.++
T Consensus 531 ~~~~~ 535 (570)
T 2z63_A 531 DCSCP 535 (570)
T ss_dssp CCCTT
T ss_pred cCCCc
Confidence 77654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.1e-16 Score=182.96 Aligned_cols=148 Identities=20% Similarity=0.290 Sum_probs=132.8
Q ss_pred CeEEEeecCCCCccc-----------------cCCccccc--CCCCccEEEeccCCccCcCCCCCCCccccccccccccc
Q 036334 68 SFVYSLRLPGVGLVG-----------------PIPPNTLG--KLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQ 128 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~-----------------~~~~~~l~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 128 (654)
.+++.|+|++|.++| .+|+ .++ ++++|++|+|++|.+.+.+|..|++|++|+.|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~-~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE-ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCCh-hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 458999999999999 4887 477 99999999999999999999999999999999999998
Q ss_pred -ccc-ccchhhcccc-------ccceeccccccccccCCC--ccccccccCccccccccccCCCCCC-CCCCCCeEEccC
Q 036334 129 -FSG-VFPASVTRMN-------RLTRLDLSSNNFSGKIPF--DVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSN 196 (654)
Q Consensus 129 -l~~-~~p~~~~~l~-------~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~ 196 (654)
++| .+|..+++++ +|+.|+|++|+|+ .+|. .+.++++|+.|+|++|+|+ .+|.+ .+++|+.|+|++
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~ 604 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDY 604 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCS
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcC
Confidence 999 8999888877 9999999999999 8998 8999999999999999999 66655 889999999999
Q ss_pred CcccccCcccccCCCC-c---cccCCC
Q 036334 197 NNLNGSIPATLSKFPQ-S---SFTGNL 219 (654)
Q Consensus 197 N~l~g~~p~~~~~~~~-l---~~~~n~ 219 (654)
|+++ .+|..+.++++ | .+.+|.
T Consensus 605 N~l~-~lp~~l~~l~~~L~~L~Ls~N~ 630 (876)
T 4ecn_A 605 NQIE-EIPEDFCAFTDQVEGLGFSHNK 630 (876)
T ss_dssp SCCS-CCCTTSCEECTTCCEEECCSSC
T ss_pred Cccc-cchHHHhhccccCCEEECcCCC
Confidence 9999 99988876655 4 455554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=6.3e-16 Score=169.10 Aligned_cols=146 Identities=20% Similarity=0.192 Sum_probs=131.7
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
.+++.|+|++|.+.+..+. .|.++++|++|+|++|.|++..+..|.++++|++|+|++|++++..|..|.++++|+.|+
T Consensus 56 ~~L~~L~L~~n~i~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 134 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPG-AFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134 (477)
T ss_dssp TTCCEEECTTSCCCEECTT-TTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCEeChh-hhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence 4599999999999875554 799999999999999999976667799999999999999999999999999999999999
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCCCcc
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQSS 214 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~l~ 214 (654)
|++|.+++..|..|..+++|+.|+|++|++++.++.. .+++|+.|+|++|.+++..+..|.++++|.
T Consensus 135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~ 203 (477)
T 2id5_A 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203 (477)
T ss_dssp ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCC
T ss_pred CCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccc
Confidence 9999999888999999999999999999999877653 889999999999999987777777766554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.61 E-value=7.2e-16 Score=147.59 Aligned_cols=129 Identities=16% Similarity=0.228 Sum_probs=112.5
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
.+++.|+|++|.+.. .+ .+..+++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..+..+++|++|+
T Consensus 66 ~~L~~L~l~~n~~~~--~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 66 HNIKDLTINNIHATN--YN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp TTCSEEEEESCCCSC--CG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCEEEccCCCCCc--ch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 358999999996643 23 589999999999999999988899999999999999999999998999999999999999
Q ss_pred ccccc-ccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccc
Q 036334 148 LSSNN-FSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNG 201 (654)
Q Consensus 148 l~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g 201 (654)
|++|. ++ .+| .+..+++|+.|++++|+|++..+-..+++|+.|++++|++.+
T Consensus 143 L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 143 LSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred ccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence 99998 65 666 799999999999999999986644489999999999999864
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.9e-15 Score=158.97 Aligned_cols=142 Identities=27% Similarity=0.309 Sum_probs=122.9
Q ss_pred CCCCceeeEEcCCCCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCC-Cccccccccccccccccc
Q 036334 54 SACNWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFS-NLTLLRSLYLQSNQFSGV 132 (654)
Q Consensus 54 ~~C~w~gv~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~ 132 (654)
..|. .++.|... .+++++++|.. +|.. +. ..|+.|+|++|.|++..+..|. ++++|++|+|++|+|++.
T Consensus 10 ~~Cp-~~C~C~~~-----~l~c~~~~l~~-iP~~-~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i 79 (361)
T 2xot_A 10 VSCP-ANCLCASN-----ILSCSKQQLPN-VPQS-LP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFI 79 (361)
T ss_dssp TTCC-TTCEEETT-----EEECCSSCCSS-CCSS-CC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEE
T ss_pred CCCC-CCCEECCC-----EEEeCCCCcCc-cCcc-CC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCcc
Confidence 4576 57899742 57899999874 6653 33 4689999999999987787787 999999999999999988
Q ss_pred cchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCccc
Q 036334 133 FPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPAT 206 (654)
Q Consensus 133 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~ 206 (654)
.+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+.. .+++|+.|+|++|+|++ +|..
T Consensus 80 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~ 154 (361)
T 2xot_A 80 SSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVE 154 (361)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGG
T ss_pred ChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHH
Confidence 8889999999999999999999877778999999999999999999887765 88999999999999994 5543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.2e-15 Score=171.66 Aligned_cols=111 Identities=23% Similarity=0.211 Sum_probs=93.7
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
+++.|+|++|.+.+..+ ..|+.+++|++|+|++|.|++..|..|+++++|++|+|++|+|++..+..|+++++|++|+|
T Consensus 76 ~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 76 QVELLNLNDLQIEEIDT-YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCSEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCcEEECCCCCCCCCCh-HHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 48889999998876544 46889999999999999999888878889999999999999998666666788999999999
Q ss_pred ccccccccCCCccccccccCccccccccccCC
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGN 180 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 180 (654)
++|.|++..|..|..+++|+.|+|++|+|++.
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 186 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 186 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence 99999888888888888898888888888754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.60 E-value=5.3e-16 Score=169.87 Aligned_cols=141 Identities=21% Similarity=0.158 Sum_probs=94.4
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCC----------------CCCCccccccccccccccccc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPS----------------DFSNLTLLRSLYLQSNQFSGV 132 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~----------------~~~~l~~L~~L~Ls~N~l~~~ 132 (654)
+++.|+|++|.+.+..+ |+.+++|++|+|++|.|++..+. ....+++|+.|+|++|++++.
T Consensus 59 ~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~~ 135 (487)
T 3oja_A 59 KLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITML 135 (487)
T ss_dssp TCCEEECTTSCCEEEEE---CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCSG
T ss_pred CCCEEEeeCCCCCCCcc---cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCCC
Confidence 35666666666655432 55555555555555555432211 001234566666677777776
Q ss_pred cchhhccccccceeccccccccccCCCccc-cccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCC
Q 036334 133 FPASVTRMNRLTRLDLSSNNFSGKIPFDVN-NLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFP 211 (654)
Q Consensus 133 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~ 211 (654)
.|..++.+++|+.|+|++|.|++.+|..+. .+++|+.|+|++|.|++.++...+++|+.|+|++|.|++. |..+..++
T Consensus 136 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~ 214 (487)
T 3oja_A 136 RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFM-GPEFQSAA 214 (487)
T ss_dssp GGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCEE-CGGGGGGT
T ss_pred CchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCCCCCCCC-CHhHcCCC
Confidence 777788888888888888888887777775 7888888888888888876666788888888888888854 44465555
Q ss_pred Cc
Q 036334 212 QS 213 (654)
Q Consensus 212 ~l 213 (654)
.|
T Consensus 215 ~L 216 (487)
T 3oja_A 215 GV 216 (487)
T ss_dssp TC
T ss_pred Cc
Confidence 44
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.59 E-value=7e-16 Score=152.43 Aligned_cols=144 Identities=17% Similarity=0.187 Sum_probs=121.3
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEecc-CCccCcCCCCCCCccccccccccccccccccchhhccccccc--
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRS-NRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLT-- 144 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-- 144 (654)
.+++.|+|++|.....+++..|.++++|++|+|++ |.|++..+..|.++++|++|+|++|++++ +|. +..+++|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence 45899999999833467766799999999999999 99997777789999999999999999996 676 88888888
Q ss_pred -eeccccc-cccccCCCccccccccC-ccccccccccCCCCCC-CCCCCCeEEccCCc-ccccCcccccCC-CCc
Q 036334 145 -RLDLSSN-NFSGKIPFDVNNLTHLT-GLFLENNKFSGNLPSI-NPANLRDFNVSNNN-LNGSIPATLSKF-PQS 213 (654)
Q Consensus 145 -~L~l~~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~-l~g~~p~~~~~~-~~l 213 (654)
+|++++| ++++..+..|..+++|+ .|++++|+|+...+.. ..++|+.|+|++|+ +++..+..|..+ ++|
T Consensus 133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L 207 (239)
T 2xwt_C 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207 (239)
T ss_dssp EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCC
T ss_pred cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCC
Confidence 9999999 99977777799999999 9999999999555543 44799999999995 985556667666 544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.4e-15 Score=143.43 Aligned_cols=126 Identities=23% Similarity=0.353 Sum_probs=109.9
Q ss_pred cEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccCccccccc
Q 036334 96 RVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENN 175 (654)
Q Consensus 96 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 175 (654)
+++++++|.|+ .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 57999999999 7787664 68999999999999 78899999999999999999999888888999999999999999
Q ss_pred cccCCCCCC--CCCCCCeEEccCCcccccCcccccCC---CCccccCCCCCCCCC
Q 036334 176 KFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKF---PQSSFTGNLDLCGGP 225 (654)
Q Consensus 176 ~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~---~~l~~~~n~~~c~~~ 225 (654)
+|++.++.. .+++|+.|+|++|+|++..+..|..+ ..+.+.+|+..|++.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 999998864 88999999999999995555556655 456678999888644
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=5.7e-16 Score=159.45 Aligned_cols=141 Identities=19% Similarity=0.223 Sum_probs=103.2
Q ss_pred EEEeecCCCCccccCCcccc-cCCCCccEEEeccCCccCcCC----CCCCCccccccccccccccccccchhhccccccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTL-GKLSQLRVLSLRSNRLSGEIP----SDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLT 144 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l-~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 144 (654)
++.|+|++|.+.+.+|...+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|++++..|..|..+++|+
T Consensus 93 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 172 (310)
T 4glp_A 93 LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALT 172 (310)
T ss_dssp CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCC
T ss_pred eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCC
Confidence 77888888888887776422 788888888888888886555 3345678888888888888877778888888888
Q ss_pred eecccccccccc--C--CCccccccccCccccccccccCCCCC---C--CCCCCCeEEccCCcccccCcccccCC
Q 036334 145 RLDLSSNNFSGK--I--PFDVNNLTHLTGLFLENNKFSGNLPS---I--NPANLRDFNVSNNNLNGSIPATLSKF 210 (654)
Q Consensus 145 ~L~l~~N~l~~~--~--p~~~~~l~~L~~L~l~~N~l~~~~~~---~--~~~~L~~L~l~~N~l~g~~p~~~~~~ 210 (654)
+|+|++|++.+. + +..+..+++|++|+|++|+|+..... . .+++|++|+|++|+|++.+|..+..+
T Consensus 173 ~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 173 SLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp EEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred EEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 888888887642 2 22346778888888888888643332 1 56788888888888887777665544
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=3.8e-15 Score=154.69 Aligned_cols=140 Identities=22% Similarity=0.318 Sum_probs=104.7
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCcc--CcCCCCCCCccccccccccccccccccchhhcccccccee
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLS--GEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRL 146 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (654)
.++.|+|++|.+.+ +++..|.++++|++|+|++|.++ +..+..|.++++|++|+|++|+++ .+|..+. ++|++|
T Consensus 122 ~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L 197 (330)
T 1xku_A 122 TLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTEL 197 (330)
T ss_dssp TCCEEECCSSCCCB-BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEE
T ss_pred cccEEECCCCcccc-cCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEE
Confidence 47888888888875 44446888888888888888885 366777888888888888888887 4555443 677888
Q ss_pred ccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCCCc
Q 036334 147 DLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQS 213 (654)
Q Consensus 147 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~l 213 (654)
+|++|++++..|..+..+++|+.|+|++|+|++..+.. .+++|+.|+|++|+++ .+|..+..++.|
T Consensus 198 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L 265 (330)
T 1xku_A 198 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 265 (330)
T ss_dssp ECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSC
T ss_pred ECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCc
Confidence 88888887777777777788888888888887766643 6777888888888877 777766655544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.58 E-value=4.8e-16 Score=141.63 Aligned_cols=123 Identities=22% Similarity=0.328 Sum_probs=108.6
Q ss_pred CCCCccEEEeccCCcc-CcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccCc
Q 036334 91 KLSQLRVLSLRSNRLS-GEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTG 169 (654)
Q Consensus 91 ~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 169 (654)
..++|+.|+|++|.++ +.+|..+..+++|++|+|++|++++. ..+..+++|++|+|++|+|++.+|..+..+++|+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 4578999999999999 88999999999999999999999976 78999999999999999999878888888999999
Q ss_pred cccccccccCCC--CCC-CCCCCCeEEccCCcccccCc---ccccCCCCccc
Q 036334 170 LFLENNKFSGNL--PSI-NPANLRDFNVSNNNLNGSIP---ATLSKFPQSSF 215 (654)
Q Consensus 170 L~l~~N~l~~~~--~~~-~~~~L~~L~l~~N~l~g~~p---~~~~~~~~l~~ 215 (654)
|++++|+|++.. ... .+++|+.|++++|++++..+ ..+..+++|..
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~ 144 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTY 144 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCE
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCccc
Confidence 999999999853 334 88999999999999996655 46777776654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.3e-15 Score=141.86 Aligned_cols=125 Identities=21% Similarity=0.296 Sum_probs=109.1
Q ss_pred cCCCCccEEEeccCCcc-CcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccC
Q 036334 90 GKLSQLRVLSLRSNRLS-GEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLT 168 (654)
Q Consensus 90 ~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 168 (654)
...++|++|+|++|.++ +.+|..+..+++|+.|+|++|++++. ..+..+++|++|+|++|+|++.+|..+..+++|+
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 98 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence 34578999999999998 88999999999999999999999976 7899999999999999999987888888899999
Q ss_pred ccccccccccCCC--CCC-CCCCCCeEEccCCcccccCc---ccccCCCCcccc
Q 036334 169 GLFLENNKFSGNL--PSI-NPANLRDFNVSNNNLNGSIP---ATLSKFPQSSFT 216 (654)
Q Consensus 169 ~L~l~~N~l~~~~--~~~-~~~~L~~L~l~~N~l~g~~p---~~~~~~~~l~~~ 216 (654)
.|+|++|+|++.. ... .+++|+.|+|++|++++..+ ..+..+++|...
T Consensus 99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L 152 (168)
T 2ell_A 99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152 (168)
T ss_dssp EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEE
T ss_pred EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEe
Confidence 9999999999865 344 88999999999999995544 367777766543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.58 E-value=4.5e-15 Score=154.26 Aligned_cols=144 Identities=22% Similarity=0.328 Sum_probs=101.8
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCcc--CcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLS--GEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
++.|+|++|.+. .+++..|.++++|++|+|++|.++ +..|..|..+ +|++|+|++|++++ +|..+. ++|+.|+
T Consensus 125 L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~ 199 (332)
T 2ft3_A 125 LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELH 199 (332)
T ss_dssp CCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCB
T ss_pred CCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEE
Confidence 444555555544 233334666666666666666664 3555556665 66666666666663 444443 6888899
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCCCc---cccCCC
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQS---SFTGNL 219 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~l---~~~~n~ 219 (654)
|++|++++..+..+..+++|+.|+|++|+|++..+.. .+++|+.|+|++|+++ .+|..+.+++.| .+.+|.
T Consensus 200 l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~ 275 (332)
T 2ft3_A 200 LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNN 275 (332)
T ss_dssp CCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSC
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCC
Confidence 9999999888888999999999999999999887754 7889999999999998 888877766654 444554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.1e-15 Score=168.71 Aligned_cols=138 Identities=22% Similarity=0.242 Sum_probs=129.2
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccc-cccchhhcccccccee
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFS-GVFPASVTRMNRLTRL 146 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L 146 (654)
.+++.|+|++|.+.+..+...+.++++|++|+|++|.+.+..|..|.++++|++|+|++|+++ +.+|..+..+++|+.|
T Consensus 396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L 475 (570)
T 2z63_A 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475 (570)
T ss_dssp TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEE
Confidence 458899999999998877667999999999999999999999999999999999999999998 6899999999999999
Q ss_pred ccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcc
Q 036334 147 DLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPA 205 (654)
Q Consensus 147 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~ 205 (654)
+|++|++++..|..+..+++|+.|+|++|+|++.++.. .+++|+.|+|++|++++.+|.
T Consensus 476 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 99999999988999999999999999999999988864 889999999999999998884
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.8e-15 Score=158.44 Aligned_cols=111 Identities=23% Similarity=0.240 Sum_probs=88.2
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
+++.|+|++|.+.+ +++..|..+++|++|+|++|.+++..|..|+++++|++|+|++|+++...+..|.++++|++|+|
T Consensus 70 ~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 70 QVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCcEEECCCCcccc-cChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 47888888888865 44446888888888888888888777777888888888888888888554445678888888888
Q ss_pred ccccccccCCCccccccccCccccccccccCC
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGN 180 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 180 (654)
++|++++..|..+..+++|+.|++++|++++.
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 180 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 180 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence 88888877777788888888888888887754
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=8.2e-16 Score=171.21 Aligned_cols=153 Identities=21% Similarity=0.187 Sum_probs=83.1
Q ss_pred EEEeecCCCCccccCCc--ccccCCCCccEEEeccCCccCcCC--CCCCCccccccccccccccccccchhhccccccce
Q 036334 70 VYSLRLPGVGLVGPIPP--NTLGKLSQLRVLSLRSNRLSGEIP--SDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTR 145 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~--~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 145 (654)
++.|+|++|.+.+.+++ ..++.+++|++|+|++|.|++..+ ..+..+++|++|+|++|+++ .+|..+..+++|++
T Consensus 336 L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~ 414 (549)
T 2z81_A 336 LEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRF 414 (549)
T ss_dssp CCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCE
T ss_pred ccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccE
Confidence 55566666665554431 124555555555555555553321 23555555566666666555 45555555555555
Q ss_pred eccccccccccCCCcc------------------ccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccc
Q 036334 146 LDLSSNNFSGKIPFDV------------------NNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATL 207 (654)
Q Consensus 146 L~l~~N~l~~~~p~~~------------------~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~ 207 (654)
|+|++|+|+ .+|..+ ..+++|+.|+|++|+|+..+....+++|+.|+|++|+|++..|..+
T Consensus 415 L~Ls~N~l~-~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~~ip~~~~l~~L~~L~Ls~N~l~~~~~~~~ 493 (549)
T 2z81_A 415 LNLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIF 493 (549)
T ss_dssp EECTTSCCS-CCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCGGGCTTCCEEECCSSCCCCCCTTGG
T ss_pred EECCCCCcc-cccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccCcCCCcccCccCCEEecCCCccCCcCHHHH
Confidence 555555554 222211 2456666666666666633332256677777777777776666555
Q ss_pred cCCC---CccccCCCCCCCC
Q 036334 208 SKFP---QSSFTGNLDLCGG 224 (654)
Q Consensus 208 ~~~~---~l~~~~n~~~c~~ 224 (654)
.+++ .+.+.+|+..|.+
T Consensus 494 ~~l~~L~~L~l~~N~~~~~~ 513 (549)
T 2z81_A 494 DRLTSLQKIWLHTNPWDCSC 513 (549)
T ss_dssp GGCTTCCEEECCSSCBCCCH
T ss_pred hcCcccCEEEecCCCccCCC
Confidence 5443 3455666666643
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.56 E-value=2.1e-15 Score=155.73 Aligned_cols=115 Identities=21% Similarity=0.123 Sum_probs=58.9
Q ss_pred CCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhc-cccccceeccccccccccCCCccccccccCcc
Q 036334 92 LSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVT-RMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGL 170 (654)
Q Consensus 92 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 170 (654)
+++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..+. .+++|++|+|++|+|++. +. ...+++|+.|
T Consensus 119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L 196 (317)
T 3o53_A 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTL 196 (317)
T ss_dssp CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEE
T ss_pred cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEE
Confidence 34455555555555544444555555555555555555554444442 455555555555555533 21 2235555555
Q ss_pred ccccccccCCCCCC-CCCCCCeEEccCCcccccCcccccC
Q 036334 171 FLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATLSK 209 (654)
Q Consensus 171 ~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p~~~~~ 209 (654)
+|++|+|++.++.. .+++|+.|+|++|+|+ .+|..+..
T Consensus 197 ~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~ 235 (317)
T 3o53_A 197 DLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235 (317)
T ss_dssp ECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCC
T ss_pred ECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhc
Confidence 55555555544443 4455555555555555 34544433
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.56 E-value=6.4e-15 Score=150.10 Aligned_cols=134 Identities=28% Similarity=0.390 Sum_probs=98.2
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
+++.|+|++|.+.+. ++ +.++++|++|+|++|.+++ +| .+.++++|++|+|++|++++. ..+..+++|+.|+|
T Consensus 69 ~L~~L~L~~n~l~~~-~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 69 NVTKLFLNGNKLTDI-KP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYL 141 (291)
T ss_dssp TCCEEECCSSCCCCC-GG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEEC
T ss_pred CCCEEEccCCccCCC-cc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEc
Confidence 477888888887653 33 7788888888888888874 33 477788888888888888753 46777888888888
Q ss_pred ccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCCCc
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQS 213 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~~l 213 (654)
++|+|++. ..+..+++|+.|+|++|+|++..+-..+++|+.|+|++|+|++ +|. +.++++|
T Consensus 142 ~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~-l~~-l~~l~~L 202 (291)
T 1h6t_A 142 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LRA-LAGLKNL 202 (291)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CGG-GTTCTTC
T ss_pred cCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCC-Chh-hccCCCC
Confidence 88888754 4677888888888888888877664477888888888888874 443 5554443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.9e-16 Score=179.94 Aligned_cols=140 Identities=24% Similarity=0.324 Sum_probs=121.4
Q ss_pred CCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhcccccccee
Q 036334 67 RSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRL 146 (654)
Q Consensus 67 ~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (654)
...++.|+|++|.+. .++++ +.++++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|++|++|++|
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 298 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISAN-IFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYF 298 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCGG-GGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEE
T ss_pred CCCCcEEECCCCCCC-CCChh-hcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEE
Confidence 345899999999997 78874 679999999999999999 89999999999999999999999 889999999999999
Q ss_pred ccccccccccCCCccccccccCccccccccccCCCCCC--CC-CCCCeEEccCCcccccCcccccCCC
Q 036334 147 DLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NP-ANLRDFNVSNNNLNGSIPATLSKFP 211 (654)
Q Consensus 147 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~-~~L~~L~l~~N~l~g~~p~~~~~~~ 211 (654)
+|++|.|+ .+|..|++|++|+.|+|++|.|++.+|.. .+ ..+..|+|++|.++|.+|..+..+.
T Consensus 299 ~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l~ 365 (727)
T 4b8c_D 299 YFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFIE 365 (727)
T ss_dssp ECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----
T ss_pred ECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccceeE
Confidence 99999998 88989999999999999999999988865 11 1233578999999999998776554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=4.4e-15 Score=164.24 Aligned_cols=148 Identities=20% Similarity=0.204 Sum_probs=96.4
Q ss_pred eEEEeecCCCCccccCCcccc-----cCCCCccEEEeccCCccCcCCC-------------------------C-CCCcc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTL-----GKLSQLRVLSLRSNRLSGEIPS-------------------------D-FSNLT 117 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l-----~~l~~L~~L~Ls~N~l~~~~p~-------------------------~-~~~l~ 117 (654)
+++.|+|++|.+.|.+|.. + +++++|+.|++++|.+ .+|. . +..++
T Consensus 248 ~L~~L~l~~n~l~~~~p~~-~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~ 324 (520)
T 2z7x_B 248 TVWYFSISNVKLQGQLDFR-DFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324 (520)
T ss_dssp SCSEEEEEEEEEESCCCCC-CCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCC
T ss_pred cccEEEeecccccCccccc-hhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCC
Confidence 3666666666666666653 3 5555555555555554 2221 1 15667
Q ss_pred ccccccccccccccccchhhccccccceeccccccccc--cCCCccccccccCccccccccccCCCCC--C-CCCCCCeE
Q 036334 118 LLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSG--KIPFDVNNLTHLTGLFLENNKFSGNLPS--I-NPANLRDF 192 (654)
Q Consensus 118 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~~~--~-~~~~L~~L 192 (654)
+|++|+|++|++++.+|..+..+++|++|+|++|+|++ .+|..+..+++|+.|+|++|++++.+|. . .+++|+.|
T Consensus 325 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L 404 (520)
T 2z7x_B 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL 404 (520)
T ss_dssp CCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEE
T ss_pred cccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEE
Confidence 77777777777777777777777777777777777775 4555677777777777777777774442 2 56777777
Q ss_pred EccCCcccccCcccc-cCCCCccccCCC
Q 036334 193 NVSNNNLNGSIPATL-SKFPQSSFTGNL 219 (654)
Q Consensus 193 ~l~~N~l~g~~p~~~-~~~~~l~~~~n~ 219 (654)
+|++|++++.+|..+ .++..|.+.+|.
T Consensus 405 ~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~ 432 (520)
T 2z7x_B 405 NMSSNILTDTIFRCLPPRIKVLDLHSNK 432 (520)
T ss_dssp ECCSSCCCGGGGGSCCTTCCEEECCSSC
T ss_pred ECcCCCCCcchhhhhcccCCEEECCCCc
Confidence 777777777777666 356666655553
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.54 E-value=9.5e-15 Score=163.15 Aligned_cols=124 Identities=21% Similarity=0.276 Sum_probs=102.7
Q ss_pred cCCCCccEEEeccCCccCcCCCCCCCcccccccccccccccc--ccchhhccccccceeccccccccccCCC-ccccccc
Q 036334 90 GKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSG--VFPASVTRMNRLTRLDLSSNNFSGKIPF-DVNNLTH 166 (654)
Q Consensus 90 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~ 166 (654)
..+++|++|+|++|.+++.+|..|+++++|++|+|++|++++ .+|..+.++++|++|+|++|++++.+|. .+..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 678889999999999998888889999999999999999986 3456788899999999999999875665 4778899
Q ss_pred cCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCCCcc
Q 036334 167 LTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQSS 214 (654)
Q Consensus 167 L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~~l~ 214 (654)
|+.|+|++|+|++.+|....++|+.|+|++|+|+ .+|..+.+++.|.
T Consensus 430 L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~ 476 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQ 476 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCS
T ss_pred CCEEECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCC
Confidence 9999999999988776654478999999999998 7887766666543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.54 E-value=8.3e-15 Score=136.63 Aligned_cols=107 Identities=26% Similarity=0.371 Sum_probs=83.7
Q ss_pred EEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecccc
Q 036334 71 YSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSS 150 (654)
Q Consensus 71 ~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 150 (654)
+.|++++|++.. +|.. + .++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 12 ~~l~~s~n~l~~-ip~~-~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTG-I--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TEEECTTSCCSS-CCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCcc-C--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 356777777764 6653 3 37888899999999887788888888888888888888877777778888888888888
Q ss_pred ccccccCCCccccccccCccccccccccCCC
Q 036334 151 NNFSGKIPFDVNNLTHLTGLFLENNKFSGNL 181 (654)
Q Consensus 151 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 181 (654)
|+|++..+..|..+++|+.|+|++|.++...
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 8888666666778888877777777776544
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=2.6e-15 Score=140.91 Aligned_cols=126 Identities=21% Similarity=0.246 Sum_probs=103.7
Q ss_pred eEEEeecCCCCccccCCcccccCCC-CccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLS-QLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
.++.|+|++|.+.. ++ .+..+. +|++|+|++|.|++. ..|.++++|++|+|++|+|++..+..+..+++|++|+
T Consensus 20 ~L~~L~l~~n~l~~-i~--~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 20 RDRELDLRGYKIPV-IE--NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp SCEEEECTTSCCCS-CC--CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CceEEEeeCCCCch-hH--HhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 48899999999874 44 255555 999999999999865 6888999999999999999976556668899999999
Q ss_pred cccccccccCCC--ccccccccCccccccccccCCCCC----C-CCCCCCeEEccCCccc
Q 036334 148 LSSNNFSGKIPF--DVNNLTHLTGLFLENNKFSGNLPS----I-NPANLRDFNVSNNNLN 200 (654)
Q Consensus 148 l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~~~----~-~~~~L~~L~l~~N~l~ 200 (654)
|++|+|+ .+|. .+..+++|+.|++++|.++..++. . .+++|+.|++++|.+.
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 9999996 5665 788899999999999999866553 3 7889999999998876
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.1e-14 Score=136.22 Aligned_cols=118 Identities=25% Similarity=0.434 Sum_probs=92.9
Q ss_pred CCCceeeEEcCCCCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccc
Q 036334 55 ACNWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFP 134 (654)
Q Consensus 55 ~C~w~gv~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 134 (654)
.|. .+++|.. +.+++++|++. .+|.. +. ++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+
T Consensus 5 ~CP-~~C~C~~-----~~l~~~~n~l~-~iP~~-~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~ 74 (174)
T 2r9u_A 5 GCP-SQCSCDQ-----TLVNCQNIRLA-SVPAG-IP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPT 74 (174)
T ss_dssp SSC-TTSEECS-----SEEECCSSCCS-SCCSC-CC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CCC-CCCEECC-----cEEEeCCCCCC-ccCCC-cC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccCh
Confidence 455 4567743 46888888884 67763 43 789999999999998888889999999999999999997666
Q ss_pred hhhccccccceeccccccccccCCCccccccccCccccccccccCCCC
Q 036334 135 ASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLP 182 (654)
Q Consensus 135 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 182 (654)
..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|.|....+
T Consensus 75 ~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 75 GVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred hHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 667888999999999999986655568888888888888888775443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.8e-15 Score=154.76 Aligned_cols=143 Identities=22% Similarity=0.204 Sum_probs=121.5
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCC-Cccccccccccccccccccchhhcccccccee
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFS-NLTLLRSLYLQSNQFSGVFPASVTRMNRLTRL 146 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (654)
..++.|+|++|.+.+..+ ..++.+++|++|+|++|.+++..+..+. ++++|++|+|++|++++. |. ...+++|++|
T Consensus 120 ~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L 196 (317)
T 3o53_A 120 QGKKNIYLANNKITMLRD-LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTL 196 (317)
T ss_dssp SSCEEEECCSSCCCSGGG-BCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEE
T ss_pred CCCCEEECCCCCCCCccc-hhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEE
Confidence 347888899998876444 4689999999999999999988777774 799999999999999965 43 3459999999
Q ss_pred ccccccccccCCCccccccccCccccccccccCCCCCC-CCCCCCeEEccCCccc-ccCcccccCCCCcc
Q 036334 147 DLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLN-GSIPATLSKFPQSS 214 (654)
Q Consensus 147 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~-g~~p~~~~~~~~l~ 214 (654)
+|++|+|++ +|..+..+++|+.|+|++|+|++.++.. .+++|+.|+|++|+++ +.+|..+.+++.+.
T Consensus 197 ~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~ 265 (317)
T 3o53_A 197 DLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265 (317)
T ss_dssp ECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHH
T ss_pred ECCCCcCCc-chhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccce
Confidence 999999995 5556999999999999999999766555 8899999999999999 88888888776543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.53 E-value=5.3e-17 Score=155.64 Aligned_cols=143 Identities=24% Similarity=0.326 Sum_probs=122.1
Q ss_pred eEEEeecCCCCccccCCc-----ccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhcccccc
Q 036334 69 FVYSLRLPGVGLVGPIPP-----NTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~-----~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 143 (654)
+|+.++|+.+.+.|.+|+ ..+..+++|++|+|++|.|++ +| .+.++++|++|+|++|+++ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 367778888888887764 248899999999999999996 77 8999999999999999999 788888889999
Q ss_pred ceeccccccccccCCCccccccccCccccccccccCCCC--CC-CCCCCCeEEccCCcccccCccc----------ccCC
Q 036334 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLP--SI-NPANLRDFNVSNNNLNGSIPAT----------LSKF 210 (654)
Q Consensus 144 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~-~~~~L~~L~l~~N~l~g~~p~~----------~~~~ 210 (654)
++|+|++|+|++ +| .+..+++|+.|+|++|+|++..+ .. .+++|++|+|++|++++.+|.. +.++
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l 173 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL 173 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHC
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhC
Confidence 999999999996 56 68999999999999999997554 23 8899999999999999887753 6677
Q ss_pred CCcccc
Q 036334 211 PQSSFT 216 (654)
Q Consensus 211 ~~l~~~ 216 (654)
++|...
T Consensus 174 ~~L~~L 179 (198)
T 1ds9_A 174 PNLKKL 179 (198)
T ss_dssp SSCSEE
T ss_pred CCcEEE
Confidence 776543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.53 E-value=1.3e-14 Score=149.15 Aligned_cols=141 Identities=24% Similarity=0.390 Sum_probs=104.2
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
.+++.|+|++|.+.+ +++ +..+++|++|+|++|.+++ ++ .+.++++|++|+|++|++++. +. +..+++|+.|+
T Consensus 63 ~~L~~L~L~~n~i~~-~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 63 NNLIGLELKDNQITD-LAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLY 135 (308)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEE
T ss_pred CCCCEEEccCCcCCC-Chh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEE
Confidence 348888888888865 333 7888888888888888885 33 688888888888888888854 43 78888888888
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCC---CccccCCC
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFP---QSSFTGNL 219 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~---~l~~~~n~ 219 (654)
|++|++++..+ +..+++|+.|+|++|+|++..+-..+++|+.|+|++|++++..+ +..++ .|.+.+|.
T Consensus 136 l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~ 206 (308)
T 1h6u_A 136 LDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQ 206 (308)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSC
T ss_pred CCCCccCcCcc--ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCc
Confidence 88888885443 77888888888888888876664477888888888888874433 44443 34444443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.53 E-value=1.2e-14 Score=149.26 Aligned_cols=122 Identities=25% Similarity=0.426 Sum_probs=65.7
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 149 (654)
++.|+++++++.. ++ .+..+++|++|+|++|.+++..+ +.++++|++|+|++|++++. + .+..+++|+.|+|+
T Consensus 43 L~~L~l~~~~i~~-l~--~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~ 115 (308)
T 1h6u_A 43 ITTLSAFGTGVTT-IE--GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLT 115 (308)
T ss_dssp CCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECT
T ss_pred cCEEEeeCCCccC-ch--hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECC
Confidence 5555555555543 32 25555555556665555553332 55555555566655555532 2 45555555556665
Q ss_pred cccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCccc
Q 036334 150 SNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN 200 (654)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~ 200 (654)
+|+|++ ++ .+..+++|+.|++++|++++..+-..+++|+.|+|++|+++
T Consensus 116 ~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~ 164 (308)
T 1h6u_A 116 STQITD-VT-PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVS 164 (308)
T ss_dssp TSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCCCC-ch-hhcCCCCCCEEECCCCccCcCccccCCCCccEEEccCCcCC
Confidence 555553 22 25555555555565555555444225555555556555555
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.53 E-value=9.5e-15 Score=137.16 Aligned_cols=113 Identities=27% Similarity=0.371 Sum_probs=102.0
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
.++.|+|++|.+.+ +++..|..+++|++|+|++|.|++..+..|.++++|++|+|++|+|++..+..+..+++|++|+|
T Consensus 29 ~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 29 SATRLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCcEEEeCCCcccE-eCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 48999999999985 56557899999999999999999777777899999999999999999888888999999999999
Q ss_pred ccccccccCCCccccccccCccccccccccCCCC
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLP 182 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 182 (654)
++|+|++..+..+..+++|+.|+|++|.+.+..+
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 9999997666667899999999999999997665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.53 E-value=1.7e-14 Score=134.47 Aligned_cols=107 Identities=26% Similarity=0.334 Sum_probs=97.0
Q ss_pred ccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccCcccccc
Q 036334 95 LRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLEN 174 (654)
Q Consensus 95 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 174 (654)
.+.|++++|.|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 478999999999 5787664 8999999999999999899999999999999999999977777789999999999999
Q ss_pred ccccCCCCCC--CCCCCCeEEccCCcccccCc
Q 036334 175 NKFSGNLPSI--NPANLRDFNVSNNNLNGSIP 204 (654)
Q Consensus 175 N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p 204 (654)
|+|++.++.. .+++|+.|+|++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9999988864 88999999999999986644
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=6.9e-15 Score=163.47 Aligned_cols=104 Identities=26% Similarity=0.351 Sum_probs=58.8
Q ss_pred ccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccCcccccc
Q 036334 95 LRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLEN 174 (654)
Q Consensus 95 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 174 (654)
|+.|+|++|.|++ +|. |+++++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .++.+++|+.|+|++
T Consensus 443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred ceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 5556666665553 443 555556666666666655 555555556666666666666553 44 555556666666666
Q ss_pred ccccCCC-CCC--CCCCCCeEEccCCcccccC
Q 036334 175 NKFSGNL-PSI--NPANLRDFNVSNNNLNGSI 203 (654)
Q Consensus 175 N~l~~~~-~~~--~~~~L~~L~l~~N~l~g~~ 203 (654)
|+|++.+ |.. .+++|+.|+|++|+|++..
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 549 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 549 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence 6665553 332 5555666666666665443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.52 E-value=9.8e-15 Score=152.90 Aligned_cols=155 Identities=21% Similarity=0.254 Sum_probs=114.4
Q ss_pred CCCceeeEEcCCC---------CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCC-CCCCcccccc-cc
Q 036334 55 ACNWVGVECDANR---------SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPS-DFSNLTLLRS-LY 123 (654)
Q Consensus 55 ~C~w~gv~C~~~~---------~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~-L~ 123 (654)
-|.|..|.|+++. .+++.|+|++|.|+ .||++.|.+|++|++|+|++|.+.+.+|. .|.++++|++ ++
T Consensus 8 ~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~ 86 (350)
T 4ay9_X 8 HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86 (350)
T ss_dssp EEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEE
T ss_pred EeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhc
Confidence 3789999997531 35889999999997 68887899999999999999999877764 6888988765 67
Q ss_pred ccccccccccchhhccccccceeccccccccccCCCc-------------------------cccc-cccCccccccccc
Q 036334 124 LQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFD-------------------------VNNL-THLTGLFLENNKF 177 (654)
Q Consensus 124 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-------------------------~~~l-~~L~~L~l~~N~l 177 (654)
+++|+|+...|..|..+++|++|++++|+|++..+.. |..+ ..|+.|+|++|+|
T Consensus 87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i 166 (350)
T 4ay9_X 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166 (350)
T ss_dssp EEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred ccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccc
Confidence 7789999888888999999999999999887443322 2222 2466788888888
Q ss_pred cCCCCCC-CCCCCCeEEccC-CcccccCcc-cccCCC
Q 036334 178 SGNLPSI-NPANLRDFNVSN-NNLNGSIPA-TLSKFP 211 (654)
Q Consensus 178 ~~~~~~~-~~~~L~~L~l~~-N~l~g~~p~-~~~~~~ 211 (654)
+...+.. ...+|+.|++++ |.++ .+|. .|..++
T Consensus 167 ~~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~ 202 (350)
T 4ay9_X 167 QEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGAS 202 (350)
T ss_dssp CEECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEE
T ss_pred cCCChhhccccchhHHhhccCCccc-CCCHHHhccCc
Confidence 7665554 555677777764 4444 5553 344333
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.4e-14 Score=145.30 Aligned_cols=140 Identities=20% Similarity=0.269 Sum_probs=108.7
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
+++.|+|++|++. .++ .+..+++|++|+|++|.|++..+ |.++++|++|+|++|++++ +|.. .. ++|+.|+|
T Consensus 42 ~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L 113 (263)
T 1xeu_A 42 GVQNFNGDNSNIQ-SLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFL 113 (263)
T ss_dssp TCSEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEEC
T ss_pred cCcEEECcCCCcc-cch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEc
Confidence 4888999999886 355 48889999999999999986554 8889999999999999985 4433 33 88999999
Q ss_pred ccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCCC---ccccCCCC
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQ---SSFTGNLD 220 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~~---l~~~~n~~ 220 (654)
++|+|++ ++ .+..+++|+.|+|++|+|++..+-..+++|+.|+|++|++++. ..+.++++ +.+.+|+.
T Consensus 114 ~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~ 184 (263)
T 1xeu_A 114 DNNELRD-TD-SLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKC 184 (263)
T ss_dssp CSSCCSB-SG-GGTTCTTCCEEECTTSCCCBCGGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEE
T ss_pred cCCccCC-Ch-hhcCcccccEEECCCCcCCCChHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcc
Confidence 9999985 44 5888999999999999998875333788999999999999865 45555544 44555543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.6e-15 Score=157.44 Aligned_cols=150 Identities=19% Similarity=0.164 Sum_probs=125.4
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccc-hhhcccccccee
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFP-ASVTRMNRLTRL 146 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L 146 (654)
.+++.|+|++|.+.+..+ ..|.++++|++|+|++|.|++..+..|.++++|++|+|++|++++..+ ..+.++++|++|
T Consensus 76 ~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L 154 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEE-DSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL 154 (353)
T ss_dssp TTCCEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCCCEEECCCCccCccCH-hhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEE
Confidence 459999999999986544 469999999999999999996555559999999999999999995444 478999999999
Q ss_pred ccccc-cccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCccc----ccCCCCccccCCC
Q 036334 147 DLSSN-NFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPAT----LSKFPQSSFTGNL 219 (654)
Q Consensus 147 ~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~----~~~~~~l~~~~n~ 219 (654)
++++| .+++..+..+.++++|+.|++++|++++..|.. .+++|++|+|++|+++ .+|.. +.++..|.+.+|.
T Consensus 155 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~ 233 (353)
T 2z80_A 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTD 233 (353)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCB
T ss_pred ECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCc
Confidence 99999 577667788999999999999999999987765 8899999999999996 55643 3445556666554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.51 E-value=2.2e-14 Score=146.09 Aligned_cols=134 Identities=22% Similarity=0.368 Sum_probs=115.6
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
+++.|++++|++.. ++ .+..+++|++|+|++|.+++..+ +.++++|++|+|++|++++ +| .+..+++|++|+|
T Consensus 47 ~L~~L~l~~~~i~~-~~--~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L 119 (291)
T 1h6t_A 47 SIDQIIANNSDIKS-VQ--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (291)
T ss_dssp TCCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred cccEEEccCCCccc-Ch--hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEEC
Confidence 48999999999975 44 48999999999999999997655 9999999999999999996 44 4999999999999
Q ss_pred ccccccccCCCccccccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccCcccccCCCCcc
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPATLSKFPQSS 214 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p~~~~~~~~l~ 214 (654)
++|+|++. ..+..+++|+.|++++|+|++. +.. .+++|+.|+|++|++++..| +..+++|.
T Consensus 120 ~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~ 181 (291)
T 1h6t_A 120 EHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 181 (291)
T ss_dssp TTSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCC
T ss_pred CCCcCCCC--hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCccC
Confidence 99999964 4789999999999999999987 444 89999999999999996555 66666544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.50 E-value=3.2e-14 Score=159.12 Aligned_cols=141 Identities=26% Similarity=0.362 Sum_probs=117.5
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
.+++.|+|++|.+.+. ++ +..+++|+.|+|++|.|++ +| .|.++++|+.|+|++|+|++. ..+..|++|+.|+
T Consensus 65 ~~L~~L~Ls~N~l~~~-~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~ 137 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDI-KP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLY 137 (605)
T ss_dssp TTCCEEECTTSCCCCC-GG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEE
T ss_pred CCCCEEEeeCCCCCCC-hh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEE
Confidence 4589999999999864 33 8999999999999999985 44 799999999999999999963 4688999999999
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCCCc---cccCCC
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQS---SFTGNL 219 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~~l---~~~~n~ 219 (654)
|++|+|++. ..+..|++|+.|+|++|+|++.+|...+++|+.|+|++|+|++ +| .+..+++| .+.+|.
T Consensus 138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~ 208 (605)
T 1m9s_A 138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQE 208 (605)
T ss_dssp CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECCSEE
T ss_pred CCCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEccCCc
Confidence 999999965 5788999999999999999998884588999999999999985 44 45555554 444543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=4.2e-14 Score=132.34 Aligned_cols=105 Identities=23% Similarity=0.297 Sum_probs=95.1
Q ss_pred ccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccCcccccc
Q 036334 95 LRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLEN 174 (654)
Q Consensus 95 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 174 (654)
-+.+++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 378999999997 7887775 8999999999999999999999999999999999999976666679999999999999
Q ss_pred ccccCCCCCC--CCCCCCeEEccCCccccc
Q 036334 175 NKFSGNLPSI--NPANLRDFNVSNNNLNGS 202 (654)
Q Consensus 175 N~l~~~~~~~--~~~~L~~L~l~~N~l~g~ 202 (654)
|+|++.++.. .+++|+.|+|++|++...
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 9999888863 789999999999999843
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.46 E-value=7.9e-14 Score=151.94 Aligned_cols=133 Identities=32% Similarity=0.418 Sum_probs=88.4
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
+++.|+|++|.+.+ ++ .+..+++|++|+|++|.+++..+ +.++++|+.|+|++|++++..+ +..+++|+.|+|
T Consensus 222 ~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 294 (466)
T 1o6v_A 222 NLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLEL 294 (466)
T ss_dssp TCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred CCCEEECCCCCccc-ch--hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEc
Confidence 47777777777764 22 46777777777777777775544 6677777777777777775443 666777777777
Q ss_pred ccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCCC
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQ 212 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~~ 212 (654)
++|++++..+ +..+++|+.|+|++|++++..|...+++|+.|++++|++++. ..+.++++
T Consensus 295 ~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~ 354 (466)
T 1o6v_A 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV--SSLANLTN 354 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTT
T ss_pred CCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc--hhhccCCC
Confidence 7777775443 666777777777777777666644666777777777776643 23444443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.46 E-value=3e-14 Score=159.63 Aligned_cols=151 Identities=26% Similarity=0.361 Sum_probs=106.3
Q ss_pred CCccCCCCCCCceee--------EEcCCCCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccc
Q 036334 47 VQWNASDSACNWVGV--------ECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTL 118 (654)
Q Consensus 47 ~~W~~~~~~C~w~gv--------~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 118 (654)
.+|....+||.|.|. .|.... ++.|++++|++. .+|.. +. ++|++|+|++|.|+ .+|. .+++
T Consensus 13 ~~W~~~~~~~~~~~r~~~~~~~~~c~~~~--l~~L~ls~n~L~-~lp~~-l~--~~L~~L~L~~N~l~-~lp~---~l~~ 82 (622)
T 3g06_A 13 SAWRRAAPAEESRGRAAVVQKMRACLNNG--NAVLNVGESGLT-TLPDC-LP--AHITTLVIPDNNLT-SLPA---LPPE 82 (622)
T ss_dssp HHHHHTCCGGGHHHHHHHHHHHHHHHHHC--CCEEECCSSCCS-CCCSC-CC--TTCSEEEECSCCCS-CCCC---CCTT
T ss_pred HHHHhcCCcchhccccccCcccccccCCC--CcEEEecCCCcC-ccChh-hC--CCCcEEEecCCCCC-CCCC---cCCC
Confidence 468777789999663 343333 888999999987 67763 43 78999999999988 5665 5688
Q ss_pred cccccccccccccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCc
Q 036334 119 LRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNN 198 (654)
Q Consensus 119 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~ 198 (654)
|++|+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|+.|++++|+|++.+. .+++|++|+|++|+
T Consensus 83 L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~lp~--~l~~L~~L~Ls~N~ 152 (622)
T 3g06_A 83 LRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTSLPV--LPPGLQELSVSDNQ 152 (622)
T ss_dssp CCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSCCCC--CCTTCCEEECCSSC
T ss_pred CCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCcCCC--CCCCCCEEECcCCc
Confidence 889999999888 4565 67888888888888884 444 45677777777777776443 24667777777777
Q ss_pred ccccCcccccCCCCccccCC
Q 036334 199 LNGSIPATLSKFPQSSFTGN 218 (654)
Q Consensus 199 l~g~~p~~~~~~~~l~~~~n 218 (654)
|+ .+|..+.++..|.+.+|
T Consensus 153 l~-~l~~~~~~L~~L~L~~N 171 (622)
T 3g06_A 153 LA-SLPALPSELCKLWAYNN 171 (622)
T ss_dssp CS-CCCCCCTTCCEEECCSS
T ss_pred CC-CcCCccCCCCEEECCCC
Confidence 76 35555555555544433
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.46 E-value=9.4e-14 Score=150.64 Aligned_cols=139 Identities=22% Similarity=0.193 Sum_probs=92.5
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
..++.|++++|...+.++ ++.+++|++|+|++|.|++ +| ++.+++|+.|+|++|++++. .++.+++|+.|+
T Consensus 148 ~~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~ 218 (457)
T 3bz5_A 148 TQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLD 218 (457)
T ss_dssp TTCCEEECTTCSCCCCCC---CTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEE
T ss_pred CcCCEEECCCCCcccccc---cccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEE
Confidence 347778888887666662 6777888888888888875 44 77777788888888887764 377777778888
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCC--CCC-------CCCeEEccCCcccccCcc-cccCCCCccccC
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPA-------NLRDFNVSNNNLNGSIPA-TLSKFPQSSFTG 217 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~-------~L~~L~l~~N~l~g~~p~-~~~~~~~l~~~~ 217 (654)
|++|+|++ +| +..+++|+.|++++|+|++.++.. .+. +|+.|++++|++.|.+|. .+.++..+.+.+
T Consensus 219 Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~ 295 (457)
T 3bz5_A 219 CSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTH 295 (457)
T ss_dssp CCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTT
T ss_pred CcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCcccccccccCCEEECCC
Confidence 88887775 55 677777777777777777655332 221 445555666665566652 223444444444
Q ss_pred C
Q 036334 218 N 218 (654)
Q Consensus 218 n 218 (654)
|
T Consensus 296 n 296 (457)
T 3bz5_A 296 N 296 (457)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.46 E-value=3.1e-14 Score=133.53 Aligned_cols=123 Identities=18% Similarity=0.183 Sum_probs=103.4
Q ss_pred cccCCCCccEEEeccCCccCcCCCCCCCcc-ccccccccccccccccchhhccccccceeccccccccccCCCccccccc
Q 036334 88 TLGKLSQLRVLSLRSNRLSGEIPSDFSNLT-LLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTH 166 (654)
Q Consensus 88 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 166 (654)
.+.++++|++|+|++|.++ .+| .+..+. +|++|+|++|+|++. ..+..+++|++|+|++|+|++..+..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~-~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIE-NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCC-CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhH-HhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 4778899999999999999 455 466665 999999999999975 68999999999999999999655555599999
Q ss_pred cCccccccccccCCCC--CC-CCCCCCeEEccCCcccccCccc----ccCCCCccc
Q 036334 167 LTGLFLENNKFSGNLP--SI-NPANLRDFNVSNNNLNGSIPAT----LSKFPQSSF 215 (654)
Q Consensus 167 L~~L~l~~N~l~~~~~--~~-~~~~L~~L~l~~N~l~g~~p~~----~~~~~~l~~ 215 (654)
|+.|+|++|+|+...+ .. .+++|+.|+|++|+++ .+|.. +..+++|..
T Consensus 90 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~ 144 (176)
T 1a9n_A 90 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRV 144 (176)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSE
T ss_pred CCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccce
Confidence 9999999999976554 33 7899999999999998 66764 777766654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.45 E-value=6.8e-14 Score=146.11 Aligned_cols=143 Identities=26% Similarity=0.351 Sum_probs=105.8
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
..++.|++++|.+.+ +++ +..+++|+.|++++|.+++..+ +..+++|++|+|++|++++..+ +..+++|++|+
T Consensus 177 ~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 249 (347)
T 4fmz_A 177 TDLYSLSLNYNQIED-ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLE 249 (347)
T ss_dssp TTCSEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred CCCCEEEccCCcccc-ccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEE
Confidence 358889999988864 332 7788888888888888885544 7788888888888888885544 77888888888
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCCCc---cccCCC
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQS---SFTGNL 219 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~~l---~~~~n~ 219 (654)
|++|.+++ + ..+..+++|+.|++++|++++......+++|+.|+|++|++++..|..+.++++| .+.+|.
T Consensus 250 l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 322 (347)
T 4fmz_A 250 IGTNQISD-I-NAVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322 (347)
T ss_dssp CCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSS
T ss_pred CCCCccCC-C-hhHhcCCCcCEEEccCCccCCChhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCc
Confidence 88888875 3 3577888888888888888875322277788888888888887777766655544 444554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.45 E-value=9.6e-14 Score=139.12 Aligned_cols=125 Identities=19% Similarity=0.285 Sum_probs=108.1
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
.+++.|+|++|.+.+ +++ +..+++|++|+|++|.|++ +|. +.. ++|+.|+|++|++++. + .+..+++|+.|+
T Consensus 63 ~~L~~L~L~~N~i~~-~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 63 TNLKELHLSHNQISD-LSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILS 134 (263)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEE
T ss_pred CCCCEEECCCCccCC-Chh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCCC-h-hhcCcccccEEE
Confidence 459999999999986 443 8999999999999999995 453 333 9999999999999964 4 699999999999
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCccccc
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGS 202 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ 202 (654)
|++|+|++. + .+..+++|+.|+|++|+|++...-..+++|+.|+|++|++++.
T Consensus 135 Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 135 IRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBCTTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCCcCCCC-h-HHccCCCCCEEECCCCcCcchHHhccCCCCCEEeCCCCcccCC
Confidence 999999964 4 7899999999999999999883333899999999999999855
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.6e-13 Score=151.82 Aligned_cols=117 Identities=26% Similarity=0.356 Sum_probs=87.9
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
+++.|+|++|.+. .+| ..+++|++|+|++|.|++ +|. |.+ +|++|+|++|+|++ +|. .+++|+.|+|
T Consensus 81 ~L~~L~Ls~N~l~-~ip----~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 81 QITVLEITQNALI-SLP----ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp TCSEEECCSSCCS-CCC----CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCEEECcCCCCc-ccc----cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 4888888888887 566 346788888888888886 666 655 88888888888886 565 5778888888
Q ss_pred ccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcc
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPA 205 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~ 205 (654)
++|+|++ +|. .+++|+.|+|++|+|++.++ +. ++|+.|+|++|+|+ .+|.
T Consensus 148 s~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~-l~-~~L~~L~Ls~N~L~-~lp~ 197 (571)
T 3cvr_A 148 DNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE-LP-ESLEALDVSTNLLE-SLPA 197 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC-CC-TTCCEEECCSSCCS-SCCC
T ss_pred CCCccCc-CCC---cCCCcCEEECCCCCCCCcch-hh-CCCCEEECcCCCCC-chhh
Confidence 8888885 565 46778888888888877443 33 77788888888777 6666
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.2e-13 Score=154.43 Aligned_cols=126 Identities=27% Similarity=0.389 Sum_probs=112.6
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
.+++.|+|++|.+.+ ++ .|..+++|++|+|++|.|++ + ..|.+|++|+.|+|++|+|++. ..+..|++|+.|+
T Consensus 87 ~~L~~L~Ls~N~l~~-l~--~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~ 159 (605)
T 1m9s_A 87 KNLGWLFLDENKIKD-LS--SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLS 159 (605)
T ss_dssp TTCCEEECCSSCCCC-CT--TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEE
T ss_pred CCCCEEECcCCCCCC-Ch--hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEE
Confidence 458999999999986 44 59999999999999999996 3 3699999999999999999976 6899999999999
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCccccc
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGS 202 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~ 202 (654)
|++|+|++..| +..|++|+.|+|++|+|++...-..+++|+.|+|++|++++.
T Consensus 160 Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 160 LEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCSEEEECC
T ss_pred CcCCcCCCchh--hccCCCCCEEECcCCCCCCChHHccCCCCCEEEccCCcCcCC
Confidence 99999997776 999999999999999999874333899999999999999854
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.43 E-value=1.3e-13 Score=150.09 Aligned_cols=142 Identities=30% Similarity=0.403 Sum_probs=121.1
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
.+++.|+|++|.+.+..+ +..+++|++|+|++|.+++..+ +..+++|+.|+|++|++++..| +..+++|+.|+
T Consensus 243 ~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 315 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLT 315 (466)
T ss_dssp TTCSEEECCSSCCCCCGG---GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEE
T ss_pred CCCCEEECCCCccccchh---hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEE
Confidence 458999999999987543 8999999999999999997555 8899999999999999997655 88999999999
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCCC---ccccCCCC
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQ---SSFTGNLD 220 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~~---l~~~~n~~ 220 (654)
|++|++++..| +..+++|+.|++++|++++...-..+++|+.|+|++|++++..| +.+++. +...+|..
T Consensus 316 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~ 387 (466)
T 1o6v_A 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEE
T ss_pred CcCCcCCCchh--hccCccCCEeECCCCccCCchhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcc
Confidence 99999998776 78999999999999999987433489999999999999998887 555554 44555544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=1.4e-13 Score=152.99 Aligned_cols=127 Identities=24% Similarity=0.340 Sum_probs=97.3
Q ss_pred cccCCCCccEEE-eccCCccCcCCC------CCCC--ccccccccccccccccccchhhccccccceeccccccccccCC
Q 036334 88 TLGKLSQLRVLS-LRSNRLSGEIPS------DFSN--LTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIP 158 (654)
Q Consensus 88 ~l~~l~~L~~L~-Ls~N~l~~~~p~------~~~~--l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 158 (654)
.++.|++|+.|+ ++.|.+. .++. .+.. ...|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|
T Consensus 404 ~l~~l~~L~~L~~l~~n~~~-~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp 479 (567)
T 1dce_A 404 TLQYFSTLKAVDPMRAAYLD-DLRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALP 479 (567)
T ss_dssp HHHHHHHHHHHCGGGHHHHH-HHHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCC
T ss_pred HHHHHHhcccCcchhhcccc-hhhhhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccc
Confidence 567788888888 5555433 1110 0111 1258899999999996 676 999999999999999999 888
Q ss_pred CccccccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccC-cccccCCCCc---cccCCC
Q 036334 159 FDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSI-PATLSKFPQS---SFTGNL 219 (654)
Q Consensus 159 ~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~-p~~~~~~~~l---~~~~n~ 219 (654)
..++.+++|+.|+|++|+|++. |.+ .+++|+.|+|++|+|++.. |..|.++++| .+.+|+
T Consensus 480 ~~~~~l~~L~~L~Ls~N~l~~l-p~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~ 544 (567)
T 1dce_A 480 PALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 544 (567)
T ss_dssp GGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred hhhhcCCCCCEEECCCCCCCCC-cccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCc
Confidence 8999999999999999999985 455 8899999999999999776 8888777665 445554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.40 E-value=2.4e-13 Score=142.08 Aligned_cols=109 Identities=25% Similarity=0.264 Sum_probs=87.9
Q ss_pred CCceeeEEcCCCCeEEEeecCCCCccccCCcccccCCCCccEEEecc-CCccCcCCCCCCCccccccccccccccccccc
Q 036334 56 CNWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRS-NRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFP 134 (654)
Q Consensus 56 C~w~gv~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 134 (654)
|.|..|.|++. |+|. .||. |..+++|++|+|++ |.|++..+..|.+|++|+.|+|++|+|++..|
T Consensus 8 C~~~~v~~~~~-----------n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 73 (347)
T 2ifg_A 8 HGSSGLRCTRD-----------GALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73 (347)
T ss_dssp SSSSCEECCSS-----------CCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT
T ss_pred ccCCEEEcCCC-----------CCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCH
Confidence 88877777542 1454 3665 88899999999996 99997777889999999999999999999888
Q ss_pred hhhccccccceeccccccccccCCCccccccccCccccccccccC
Q 036334 135 ASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSG 179 (654)
Q Consensus 135 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 179 (654)
..|.+|++|+.|+|++|+|++..+..+..++ |+.|+|++|.|..
T Consensus 74 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp TGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred HHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 8999999999999999999965555555555 8888888887764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.40 E-value=6.5e-14 Score=151.80 Aligned_cols=102 Identities=17% Similarity=0.187 Sum_probs=54.0
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCcccc-------------ccccccccccccccc
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLL-------------RSLYLQSNQFSGVFP 134 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------------~~L~Ls~N~l~~~~p 134 (654)
.+++.|++++|.+ |.+|+ .+++|++|++|+|++|.++|.+|..++++++| ++|++++|++++ +|
T Consensus 11 ~~L~~L~l~~n~l-~~iP~-~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp 87 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPV-EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LP 87 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CC
T ss_pred ccchhhhcccCch-hhCCh-hHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CC
Confidence 3488899999999 88887 58999999999999999999999999888765 778888888775 34
Q ss_pred hhhccccccceeccccccccccCCCccccccccCccccccccccC
Q 036334 135 ASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSG 179 (654)
Q Consensus 135 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 179 (654)
.. .++|++|++++|++++ +|..+ ++|+.|++++|++++
T Consensus 88 ~~---~~~L~~L~l~~n~l~~-lp~~~---~~L~~L~l~~n~l~~ 125 (454)
T 1jl5_A 88 EL---PPHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLKA 125 (454)
T ss_dssp SC---CTTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSC
T ss_pred CC---cCCCCEEEccCCcCCc-ccccc---CCCcEEECCCCccCc
Confidence 31 2566667777776664 45332 344444444444443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.39 E-value=6.9e-13 Score=143.82 Aligned_cols=129 Identities=22% Similarity=0.180 Sum_probs=94.4
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
.+++.|+|++|.+.+ ++ ++.+++|++|+|++|.|++. + ++++++|++|+|++|+..+.+ .+..+++|+.|+
T Consensus 106 ~~L~~L~L~~N~l~~-l~---~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ 176 (457)
T 3bz5_A 106 TKLTYLNCDTNKLTK-LD---VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLD 176 (457)
T ss_dssp TTCCEEECCSSCCSC-CC---CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEE
T ss_pred CcCCEEECCCCcCCe-ec---CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEE
Confidence 458899999999887 43 78889999999999999863 3 777888888888888655555 467777888888
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCCC
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQ 212 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~~ 212 (654)
|++|+|++ +| +..+++|+.|++++|+|++. +-..+++|+.|+|++|++++ +| +..++.
T Consensus 177 ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~ 234 (457)
T 3bz5_A 177 CSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQ 234 (457)
T ss_dssp CCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-CCTTCTTCSEEECCSSCCSC-CC--CTTCTT
T ss_pred CCCCccce-ec--cccCCCCCEEECcCCcCCee-ccccCCCCCEEECcCCcccc-cC--ccccCC
Confidence 88888775 44 66777777777777777765 33366777777777777775 55 444443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.38 E-value=9.9e-15 Score=151.76 Aligned_cols=141 Identities=18% Similarity=0.234 Sum_probs=98.6
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCc-CCCCCCCccccccccccccccccccchhhcccccccee
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGE-IPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRL 146 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 146 (654)
..++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+.++++|++|+|++|++++..|..+..+++|++|
T Consensus 70 ~~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L 147 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 147 (336)
T ss_dssp TTCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred ccceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEE
Confidence 3477788888888776554 56778888888888887755 66677778888888888888887777778788888888
Q ss_pred ccccc-ccccc-CCCccccccccCccccccc-cccCC-CCCC--CCC-CCCeEEccCC--ccc-ccCcccccCC
Q 036334 147 DLSSN-NFSGK-IPFDVNNLTHLTGLFLENN-KFSGN-LPSI--NPA-NLRDFNVSNN--NLN-GSIPATLSKF 210 (654)
Q Consensus 147 ~l~~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~-~~~~--~~~-~L~~L~l~~N--~l~-g~~p~~~~~~ 210 (654)
+|++| .+++. ++..+.++++|+.|++++| ++++. ++.. .++ +|+.|+|++| .++ +.+|..+.++
T Consensus 148 ~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~ 221 (336)
T 2ast_B 148 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRC 221 (336)
T ss_dssp ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHC
T ss_pred ECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhC
Confidence 88888 56652 5555677777888888777 77653 2322 556 7777777777 444 3455444333
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.38 E-value=3.2e-13 Score=141.04 Aligned_cols=141 Identities=26% Similarity=0.355 Sum_probs=108.2
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
..++.|++++|.+.+..+ +..+++|++|+|++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|+
T Consensus 155 ~~L~~L~l~~~~~~~~~~---~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~ 227 (347)
T 4fmz_A 155 TGLNYLTVTESKVKDVTP---IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227 (347)
T ss_dssp TTCCEEECCSSCCCCCGG---GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEE
T ss_pred CCCcEEEecCCCcCCchh---hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEE
Confidence 458889999988865332 7888999999999999885443 8888999999999999986644 88889999999
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCC---CCccccCCC
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKF---PQSSFTGNL 219 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~---~~l~~~~n~ 219 (654)
|++|++++..+ +..+++|+.|++++|++++......+++|+.|+|++|++++ +| .+..+ ..|.+.+|.
T Consensus 228 l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L~~n~ 298 (347)
T 4fmz_A 228 IGNNKITDLSP--LANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFLNNNQ 298 (347)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSC
T ss_pred ccCCccCCCcc--hhcCCCCCEEECCCCccCCChhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEECcCCc
Confidence 99999985444 88889999999999998875333378899999999999885 34 34444 444455553
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.38 E-value=9.8e-13 Score=142.49 Aligned_cols=128 Identities=23% Similarity=0.401 Sum_probs=90.6
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
.++.|+|++|.+.+ ++. + .++|++|+|++|.+++ +| .|+++++|++|+|++|++++ +|..+ .+|++|++
T Consensus 112 ~L~~L~l~~n~l~~-l~~--~--~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L 180 (454)
T 1jl5_A 112 SLKSLLVDNNNLKA-LSD--L--PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAA 180 (454)
T ss_dssp TCCEEECCSSCCSC-CCS--C--CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEEC
T ss_pred CCcEEECCCCccCc-ccC--C--CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEEC
Confidence 35566666665543 221 1 1578888888888885 67 58888888888888888885 56443 48888888
Q ss_pred ccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCCCc
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQS 213 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~~l 213 (654)
++|++++ +| .+.++++|+.|++++|++++.+. ..++|+.|++++|.++ .+|. +.++++|
T Consensus 181 ~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~--~~~~L~~L~l~~n~l~-~lp~-~~~l~~L 239 (454)
T 1jl5_A 181 GNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPD--LPLSLESIVAGNNILE-ELPE-LQNLPFL 239 (454)
T ss_dssp CSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCC--CCTTCCEEECCSSCCS-SCCC-CTTCTTC
T ss_pred cCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCC--CcCcccEEECcCCcCC-cccc-cCCCCCC
Confidence 8888885 56 58888888888888888886332 2257888888888887 6774 5555543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.38 E-value=1.5e-14 Score=150.36 Aligned_cols=138 Identities=17% Similarity=0.252 Sum_probs=68.7
Q ss_pred CceeeEEcCCCCeEEEeecCCCCccccCCcccccCC--CCccEEEeccCCccCcCCCCCCCccccccccccccccccc-c
Q 036334 57 NWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKL--SQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV-F 133 (654)
Q Consensus 57 ~w~gv~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~ 133 (654)
+|.++.|+... ++.|+++++.+. +..+..+ ++|+.|+|++|.+.+..+. +.++++|++|+|++|.+++. +
T Consensus 38 ~W~~~~~~~~~--~~~l~l~~~~~~----~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~ 110 (336)
T 2ast_B 38 RWYRLASDESL--WQTLDLTGKNLH----PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTL 110 (336)
T ss_dssp HHHHHHTCSTT--SSEEECTTCBCC----HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHH
T ss_pred HHHHHhcCchh--heeeccccccCC----HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHH
Confidence 35555543222 445555555443 1234444 5555555555555544332 33455555555555555543 5
Q ss_pred chhhccccccceeccccccccccCCCccccccccCccccccc-cccCC-CCCC--CCCCCCeEEccCC-cccc
Q 036334 134 PASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENN-KFSGN-LPSI--NPANLRDFNVSNN-NLNG 201 (654)
Q Consensus 134 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~~~~--~~~~L~~L~l~~N-~l~g 201 (654)
|..+..+++|++|+|++|.+++..+..+..+++|+.|+|++| .+++. ++.. .+++|++|+|++| .+++
T Consensus 111 ~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~ 183 (336)
T 2ast_B 111 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE 183 (336)
T ss_dssp HHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH
T ss_pred HHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcCh
Confidence 555555555555555555555545545555555555555555 34431 2221 4455555555555 5543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.35 E-value=8.3e-13 Score=137.93 Aligned_cols=106 Identities=16% Similarity=0.173 Sum_probs=95.1
Q ss_pred cEEEeccC-CccCcCCCCCCCccccccccccc-cccccccchhhccccccceeccccccccccCCCccccccccCccccc
Q 036334 96 RVLSLRSN-RLSGEIPSDFSNLTLLRSLYLQS-NQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLE 173 (654)
Q Consensus 96 ~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 173 (654)
..+++++| +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 34689998 898 5888 99999999999996 99999888999999999999999999999999999999999999999
Q ss_pred cccccCCCCCC-CCCCCCeEEccCCcccccC
Q 036334 174 NNKFSGNLPSI-NPANLRDFNVSNNNLNGSI 203 (654)
Q Consensus 174 ~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~ 203 (654)
+|+|++.++.. ...+|+.|+|++|+|....
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHCSC 119 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccCCC
Confidence 99999888765 3344999999999998543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.1e-13 Score=145.45 Aligned_cols=136 Identities=24% Similarity=0.234 Sum_probs=83.6
Q ss_pred EEEeecCCCCccccCCc---ccccCCC-CccEEEeccCCccCcCCCCCCCc-----cccccccccccccccccchhhccc
Q 036334 70 VYSLRLPGVGLVGPIPP---NTLGKLS-QLRVLSLRSNRLSGEIPSDFSNL-----TLLRSLYLQSNQFSGVFPASVTRM 140 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~---~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l 140 (654)
++.|+|++|.+.+..+. +.|..++ +|++|+|++|.|++..+..|..+ ++|++|+|++|++++..+..+...
T Consensus 24 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~ 103 (362)
T 3goz_A 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT 103 (362)
T ss_dssp CCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH
T ss_pred ceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHH
Confidence 67777777776543220 2456666 67777777777776655555554 677777777777776666544443
Q ss_pred -----cccceeccccccccccCCCcccc-----ccccCccccccccccCCCCCC------CC-CCCCeEEccCCcccccC
Q 036334 141 -----NRLTRLDLSSNNFSGKIPFDVNN-----LTHLTGLFLENNKFSGNLPSI------NP-ANLRDFNVSNNNLNGSI 203 (654)
Q Consensus 141 -----~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~~~~~~------~~-~~L~~L~l~~N~l~g~~ 203 (654)
++|++|+|++|+|++..+..+.. .++|++|+|++|+|++..... .+ ++|+.|+|++|+|++..
T Consensus 104 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~ 183 (362)
T 3goz_A 104 LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKN 183 (362)
T ss_dssp HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSC
T ss_pred HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhh
Confidence 67777777777776554433322 246777777777776432211 23 36777777777776555
Q ss_pred cc
Q 036334 204 PA 205 (654)
Q Consensus 204 p~ 205 (654)
+.
T Consensus 184 ~~ 185 (362)
T 3goz_A 184 CA 185 (362)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.30 E-value=6.9e-14 Score=148.50 Aligned_cols=147 Identities=18% Similarity=0.259 Sum_probs=103.4
Q ss_pred CeEEEeecCCC---CccccCCccc------ccCCCCccEEEeccCCccC----cCCCCCCCccccccccccccccccccc
Q 036334 68 SFVYSLRLPGV---GLVGPIPPNT------LGKLSQLRVLSLRSNRLSG----EIPSDFSNLTLLRSLYLQSNQFSGVFP 134 (654)
Q Consensus 68 ~~v~~L~l~~~---~l~~~~~~~~------l~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p 134 (654)
.+++.|+|++| .+.+.+|... |..+++|++|+|++|.|++ .+|..+.++++|++|+|++|++++..+
T Consensus 60 ~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~ 139 (386)
T 2ca6_A 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 139 (386)
T ss_dssp TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred CCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHH
Confidence 34778888875 4455555421 3678888888888888886 466677788888888888888875544
Q ss_pred hhhcc----c---------cccceecccccccc-ccCC---CccccccccCcccccccccc--C---CCC-CC-CCCCCC
Q 036334 135 ASVTR----M---------NRLTRLDLSSNNFS-GKIP---FDVNNLTHLTGLFLENNKFS--G---NLP-SI-NPANLR 190 (654)
Q Consensus 135 ~~~~~----l---------~~L~~L~l~~N~l~-~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~~-~~-~~~~L~ 190 (654)
..+.. + ++|++|+|++|+|+ +.+| ..+..+++|+.|+|++|+|+ | ..+ .. .+++|+
T Consensus 140 ~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~ 219 (386)
T 2ca6_A 140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219 (386)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred HHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCcc
Confidence 44433 3 78888888888887 4444 35667788888888888887 2 333 33 677888
Q ss_pred eEEccCCccc----ccCcccccCCCCcc
Q 036334 191 DFNVSNNNLN----GSIPATLSKFPQSS 214 (654)
Q Consensus 191 ~L~l~~N~l~----g~~p~~~~~~~~l~ 214 (654)
.|+|++|.|+ +.+|..+.++++|.
T Consensus 220 ~L~Ls~n~l~~~g~~~l~~~l~~~~~L~ 247 (386)
T 2ca6_A 220 VLDLQDNTFTHLGSSALAIALKSWPNLR 247 (386)
T ss_dssp EEECCSSCCHHHHHHHHHHHGGGCTTCC
T ss_pred EEECcCCCCCcHHHHHHHHHHccCCCcC
Confidence 8888888886 56777666655543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.30 E-value=5e-14 Score=149.57 Aligned_cols=134 Identities=22% Similarity=0.284 Sum_probs=84.3
Q ss_pred CeEEEeecCCCCccc----cCCcccccCCCCccEEEeccCCccCcCCCCC----CCc---------cccccccccccccc
Q 036334 68 SFVYSLRLPGVGLVG----PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDF----SNL---------TLLRSLYLQSNQFS 130 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~----~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~----~~l---------~~L~~L~Ls~N~l~ 130 (654)
.+++.|+|++|.+.+ .++. .+..+++|++|+|++|.|++..+..+ ..+ ++|++|+|++|+++
T Consensus 94 ~~L~~L~Ls~n~l~~~~~~~l~~-~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~ 172 (386)
T 2ca6_A 94 PKLHTVRLSDNAFGPTAQEPLID-FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172 (386)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHH-HHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred CcccEEECCCCcCCHHHHHHHHH-HHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCC
Confidence 347777777777765 3443 46677777777777777764333223 233 67777777777776
Q ss_pred -cccc---hhhccccccceecccccccc--c---cCCCccccccccCcccccccccc----CCCCCC--CCCCCCeEEcc
Q 036334 131 -GVFP---ASVTRMNRLTRLDLSSNNFS--G---KIPFDVNNLTHLTGLFLENNKFS----GNLPSI--NPANLRDFNVS 195 (654)
Q Consensus 131 -~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~~L~l~~N~l~----~~~~~~--~~~~L~~L~l~ 195 (654)
+.+| ..+..+++|++|+|++|+|+ | .+|..+..+++|+.|+|++|.|+ +.++.. .+++|+.|+|+
T Consensus 173 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~ 252 (386)
T 2ca6_A 173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 252 (386)
T ss_dssp GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred cHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECC
Confidence 3444 35566677777777777776 2 34446667777777777777774 333322 56667777777
Q ss_pred CCccccc
Q 036334 196 NNNLNGS 202 (654)
Q Consensus 196 ~N~l~g~ 202 (654)
+|+|++.
T Consensus 253 ~n~i~~~ 259 (386)
T 2ca6_A 253 DCLLSAR 259 (386)
T ss_dssp TCCCCHH
T ss_pred CCCCchh
Confidence 7777654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.29 E-value=2.2e-13 Score=143.25 Aligned_cols=146 Identities=24% Similarity=0.232 Sum_probs=117.7
Q ss_pred EeecCCCCccccCCcccccCCCCccEEEeccCCccCcCC----CCCCCcc-ccccccccccccccccchhhccc-----c
Q 036334 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIP----SDFSNLT-LLRSLYLQSNQFSGVFPASVTRM-----N 141 (654)
Q Consensus 72 ~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~ 141 (654)
.++|+.|+++|.+|. .+...++|++|||++|.|++..+ ..|.+++ +|++|+|++|++++..+..+..+ +
T Consensus 2 ~~~ls~n~~~~~~~~-~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 2 NYKLTLHPGSNPVEE-FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80 (362)
T ss_dssp EEECCCCTTCCHHHH-HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred ccccccccchHHHHH-HHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence 367899999998875 46666679999999999997666 6788888 99999999999999888888886 9
Q ss_pred ccceeccccccccccCCCccccc-----cccCccccccccccCCCCCC------C-CCCCCeEEccCCcccccCcccc--
Q 036334 142 RLTRLDLSSNNFSGKIPFDVNNL-----THLTGLFLENNKFSGNLPSI------N-PANLRDFNVSNNNLNGSIPATL-- 207 (654)
Q Consensus 142 ~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~~~~------~-~~~L~~L~l~~N~l~g~~p~~~-- 207 (654)
+|++|+|++|+|++..+..+... ++|+.|+|++|+|++..+.. . .++|++|+|++|.|++..+..+
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 160 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ 160 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence 99999999999997776655443 89999999999998776542 2 4699999999999996444333
Q ss_pred --c----CCCCccccCC
Q 036334 208 --S----KFPQSSFTGN 218 (654)
Q Consensus 208 --~----~~~~l~~~~n 218 (654)
. ++..|.+.+|
T Consensus 161 ~l~~~~~~L~~L~Ls~n 177 (362)
T 3goz_A 161 ILAAIPANVNSLNLRGN 177 (362)
T ss_dssp HHHTSCTTCCEEECTTS
T ss_pred HHhcCCccccEeeecCC
Confidence 2 4555555555
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.28 E-value=7.8e-12 Score=140.03 Aligned_cols=94 Identities=24% Similarity=0.375 Sum_probs=57.4
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
+++.|+|++|.+. .+|. .+++|++|+|++|.|+ .+|. .+++|++|+|++|+|++ +|. .+++|+.|+|
T Consensus 62 ~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L 128 (622)
T 3g06_A 62 HITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWI 128 (622)
T ss_dssp TCSEEEECSCCCS-CCCC----CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEEC
T ss_pred CCcEEEecCCCCC-CCCC----cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEEC
Confidence 4777777777776 4553 4577777777777777 4554 55677777777777774 333 3455666666
Q ss_pred ccccccccCCCccccccccCccccccccccC
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSG 179 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 179 (654)
++|+|++ +|.. +++|++|+|++|+|++
T Consensus 129 ~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~ 155 (622)
T 3g06_A 129 FGNQLTS-LPVL---PPGLQELSVSDNQLAS 155 (622)
T ss_dssp CSSCCSC-CCCC---CTTCCEEECCSSCCSC
T ss_pred CCCCCCc-CCCC---CCCCCEEECcCCcCCC
Confidence 6666552 4432 2455555555555554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.25 E-value=4.1e-14 Score=135.45 Aligned_cols=128 Identities=23% Similarity=0.261 Sum_probs=107.9
Q ss_pred ccCCCCccEEEeccCCccCcCCC------CCCCccccccccccccccccccchhhccccccceeccccccccccCCCccc
Q 036334 89 LGKLSQLRVLSLRSNRLSGEIPS------DFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVN 162 (654)
Q Consensus 89 l~~l~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 162 (654)
+.....++.++|+.|.++|.+|. .|.++++|++|+|++|++++ +| .+.++++|++|+|++|+|+ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 56677889999999999999887 89999999999999999996 67 9999999999999999999 7888888
Q ss_pred cccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccCc-ccccCCCC---ccccCCCC
Q 036334 163 NLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIP-ATLSKFPQ---SSFTGNLD 220 (654)
Q Consensus 163 ~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p-~~~~~~~~---l~~~~n~~ 220 (654)
.+++|+.|+|++|+|++.. .. .+++|+.|+|++|++++.-+ ..+.++++ +.+.+|+.
T Consensus 91 ~~~~L~~L~L~~N~l~~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l 152 (198)
T 1ds9_A 91 VADTLEELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152 (198)
T ss_dssp HHHHCSEEEEEEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHH
T ss_pred cCCcCCEEECcCCcCCcCC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcc
Confidence 8999999999999999854 44 78899999999999984322 35555554 44555543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=4.1e-11 Score=119.73 Aligned_cols=133 Identities=16% Similarity=0.063 Sum_probs=104.5
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccc-cCHHHHHHHHHHHhccC-CCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
..++.|+++.||++... |..+++|+..... .....+.+|+++++.+. +..+.++++++.+.+..|+||||++|.+|.
T Consensus 20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 45777888999999755 6899999987532 33456889999998884 677888999998888999999999999998
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc--------------------------------------------
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS-------------------------------------------- 465 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-------------------------------------------- 465 (654)
+.+.. ......++.+++++++.||+.
T Consensus 99 ~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 99 EEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred hccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 76421 112346788999999999971
Q ss_pred --------------CCeecCCCCCCcEEECCCCCeEEeccCCCC
Q 036334 466 --------------GKIVHGNIKASNILLRPDHDACVSDFGLNP 495 (654)
Q Consensus 466 --------------~~ivHrDlk~~NIll~~~~~~kl~Dfgla~ 495 (654)
..++|+|+++.||+++++..+.|+||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 128999999999999876556799998754
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.19 E-value=2.8e-11 Score=126.51 Aligned_cols=141 Identities=16% Similarity=0.150 Sum_probs=108.3
Q ss_pred eEEcCCCCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccch-hhcc
Q 036334 61 VECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPA-SVTR 139 (654)
Q Consensus 61 v~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~ 139 (654)
+.|+.. .++-++++|+ .||.+ + .++|++|+|++|+|+...+..|.+|++|++|+|++|++.+.+|. .|.+
T Consensus 7 C~C~~~-----~v~C~~~~Lt-~iP~~-l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~ 77 (350)
T 4ay9_X 7 CHCSNR-----VFLCQESKVT-EIPSD-L--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSN 77 (350)
T ss_dssp SEEETT-----EEEEESTTCC-SCCTT-C--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCS
T ss_pred cEeeCC-----EEEecCCCCC-ccCcC-c--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhc
Confidence 789753 2456788886 57764 3 36899999999999955556799999999999999999777664 6788
Q ss_pred ccccce-eccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccC-CcccccCcccccCC
Q 036334 140 MNRLTR-LDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSN-NNLNGSIPATLSKF 210 (654)
Q Consensus 140 l~~L~~-L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~-N~l~g~~p~~~~~~ 210 (654)
+++|+. +.+++|+|+...|..|..+++|++|++++|+|++.++.. ...++..|++.+ |++...-+..|..+
T Consensus 78 L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~ 152 (350)
T 4ay9_X 78 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 152 (350)
T ss_dssp CTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTS
T ss_pred chhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhc
Confidence 988775 677789999888889999999999999999999877654 445566777755 45553333344443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=99.16 E-value=3.1e-13 Score=134.14 Aligned_cols=187 Identities=14% Similarity=0.133 Sum_probs=129.2
Q ss_pred hhHHHHHHHHHhhCCC-CCC-CCcc--C------------CCCCCCceeeEEcCCCCeEEEeecCC---CCccccCCccc
Q 036334 28 TQDKQALLAFLSRTPH-KNR-VQWN--A------------SDSACNWVGVECDANRSFVYSLRLPG---VGLVGPIPPNT 88 (654)
Q Consensus 28 ~~~~~al~~~~~~~~~-~~~-~~W~--~------------~~~~C~w~gv~C~~~~~~v~~L~l~~---~~l~~~~~~~~ 88 (654)
..|++-|+.++...-. .-. ..|. . ....|+|.|+.|+.+..+|+.+...+ ..+.+.+.++.
T Consensus 34 ky~k~~ll~~i~~~~~~~f~p~~~~~~~~~~~ffV~~~~~A~~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~ 113 (267)
T 3rw6_A 34 KYDKAWLLSMIQSKCSVPFTPIEFHYENTRAQFFVEDASTASALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQ 113 (267)
T ss_dssp GSCHHHHHHHHHHTCSSCCCCEEEEEETTEEEEEESCHHHHHHHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHH
T ss_pred ccCHHHHHHHHHHhCCCCcEeEEEEEeCCEEEEEeCChHHHHHHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHH
Confidence 4477788888665432 111 2342 1 11358999999987766676666655 45667777666
Q ss_pred ccCCCCccEEEeccCCccCcCCC-CCCCcccccc--ccccccccc---cccchhhccccccceeccccccccc--cCCCc
Q 036334 89 LGKLSQLRVLSLRSNRLSGEIPS-DFSNLTLLRS--LYLQSNQFS---GVFPASVTRMNRLTRLDLSSNNFSG--KIPFD 160 (654)
Q Consensus 89 l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~--L~Ls~N~l~---~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~ 160 (654)
+..++. .|...+|..++.+.- .|...+.|+. ++++.|+.. +.++....++++|+.|+|++|+|++ .+|..
T Consensus 114 ~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~ 191 (267)
T 3rw6_A 114 VEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSI 191 (267)
T ss_dssp HHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTH
T ss_pred HHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhH
Confidence 555554 455556666655543 3677778887 888999544 3333334568999999999999997 56677
Q ss_pred cccccccCccccccccccCCCCCCCCC--CCCeEEccCCcccccCcc-------cccCCCCcccc
Q 036334 161 VNNLTHLTGLFLENNKFSGNLPSINPA--NLRDFNVSNNNLNGSIPA-------TLSKFPQSSFT 216 (654)
Q Consensus 161 ~~~l~~L~~L~l~~N~l~~~~~~~~~~--~L~~L~l~~N~l~g~~p~-------~~~~~~~l~~~ 216 (654)
+..+++|+.|+|++|+|++...-..+. +|++|+|++|++++.+|. .+..+++|...
T Consensus 192 ~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~L 256 (267)
T 3rw6_A 192 VQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRL 256 (267)
T ss_dssp HHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEE
T ss_pred HhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeE
Confidence 889999999999999999863222233 999999999999987773 35677777654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.14 E-value=6.9e-13 Score=144.04 Aligned_cols=152 Identities=18% Similarity=0.159 Sum_probs=114.0
Q ss_pred CeEEEeecCCCCcccc----CCcccccCCCCccEEEeccCCccCc----CCCCCCCccccccccccccccccccchhhcc
Q 036334 68 SFVYSLRLPGVGLVGP----IPPNTLGKLSQLRVLSLRSNRLSGE----IPSDFSNLTLLRSLYLQSNQFSGVFPASVTR 139 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~----~~~~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 139 (654)
.+++.|+|++|.+.+. +.+..+..+++|++|+|++|.++.. ++..+.++++|++|+|++|++++..+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 3488999999988653 2232344688999999999999854 6667778899999999999998766655554
Q ss_pred c-----cccceecccccccccc----CCCccccccccCccccccccccCCCCCC-------CCCCCCeEEccCCcccc--
Q 036334 140 M-----NRLTRLDLSSNNFSGK----IPFDVNNLTHLTGLFLENNKFSGNLPSI-------NPANLRDFNVSNNNLNG-- 201 (654)
Q Consensus 140 l-----~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~~-------~~~~L~~L~l~~N~l~g-- 201 (654)
. ++|+.|+|++|.+++. ++..+..+++|+.|+|++|+|++..+.. ..++|+.|+|++|.+++
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~ 386 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 386 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhh
Confidence 3 6899999999998865 4566777889999999999988654321 26789999999999986
Q ss_pred --cCcccccCCC---CccccCCC
Q 036334 202 --SIPATLSKFP---QSSFTGNL 219 (654)
Q Consensus 202 --~~p~~~~~~~---~l~~~~n~ 219 (654)
.+|..+.+++ .+.+.+|.
T Consensus 387 ~~~l~~~l~~~~~L~~L~l~~N~ 409 (461)
T 1z7x_W 387 CSSLAATLLANHSLRELDLSNNC 409 (461)
T ss_dssp HHHHHHHHHHCCCCCEEECCSSS
T ss_pred HHHHHHHHHhCCCccEEECCCCC
Confidence 7777665444 44555554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.10 E-value=3e-10 Score=113.08 Aligned_cols=126 Identities=14% Similarity=0.104 Sum_probs=95.2
Q ss_pred cccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCc--cccccEEEEeCCceEEEEEecCCCchhhhh
Q 036334 355 GKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDN--VVPLRAFYYSKDEKLLVYDYMPAGSLSALL 432 (654)
Q Consensus 355 g~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l 432 (654)
+.|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.++++++..++..++||||++|.+|. .
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~ 104 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S 104 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence 356669999998777888999997654 2346788999988886544 456888887777889999999998884 2
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC----------------------------------------------
Q 036334 433 HGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG---------------------------------------------- 466 (654)
Q Consensus 433 ~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~---------------------------------------------- 466 (654)
.. .+ ...++.++++.+..||+..
T Consensus 105 ~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 105 SH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp SC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred Cc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 21 11 2256677777788887532
Q ss_pred -----------CeecCCCCCCcEEECCCCCeEEeccCCCC
Q 036334 467 -----------KIVHGNIKASNILLRPDHDACVSDFGLNP 495 (654)
Q Consensus 467 -----------~ivHrDlk~~NIll~~~~~~kl~Dfgla~ 495 (654)
.++|+|++|.||++++++.+.|+|||.+.
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 19999999999999877667799999865
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.09 E-value=1.1e-12 Score=142.43 Aligned_cols=150 Identities=19% Similarity=0.221 Sum_probs=117.3
Q ss_pred eEEEeecCCCCcccc----CCcccccCCCCccEEEeccCCccCcC-----CCCCCCccccccccccccccccc----cch
Q 036334 69 FVYSLRLPGVGLVGP----IPPNTLGKLSQLRVLSLRSNRLSGEI-----PSDFSNLTLLRSLYLQSNQFSGV----FPA 135 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~----~~~~~l~~l~~L~~L~Ls~N~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~----~p~ 135 (654)
+++.|+|++|.+.+. ++. .+..+++|++|+|++|.+++.. +..+..+++|++|+|++|++++. ++.
T Consensus 200 ~L~~L~L~~n~l~~~~~~~l~~-~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~ 278 (461)
T 1z7x_W 200 QLEALKLESCGVTSDNCRDLCG-IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCR 278 (461)
T ss_dssp CCCEEECTTSCCBTTHHHHHHH-HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred CceEEEccCCCCcHHHHHHHHH-HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHH
Confidence 599999999999764 444 5788999999999999988532 33344689999999999999975 788
Q ss_pred hhccccccceeccccccccccCCCcccc-----ccccCccccccccccCCC----CCC--CCCCCCeEEccCCcccccCc
Q 036334 136 SVTRMNRLTRLDLSSNNFSGKIPFDVNN-----LTHLTGLFLENNKFSGNL----PSI--NPANLRDFNVSNNNLNGSIP 204 (654)
Q Consensus 136 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~~~----~~~--~~~~L~~L~l~~N~l~g~~p 204 (654)
.+..+++|++|+|++|.|++..+..+.. .++|+.|+|++|.+++.. +.. .+++|+.|+|++|++++..+
T Consensus 279 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~ 358 (461)
T 1z7x_W 279 VLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV 358 (461)
T ss_dssp HHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHH
T ss_pred HHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccH
Confidence 8888999999999999998654444433 269999999999998752 222 67899999999999987655
Q ss_pred cccc--------CCCCccccCCC
Q 036334 205 ATLS--------KFPQSSFTGNL 219 (654)
Q Consensus 205 ~~~~--------~~~~l~~~~n~ 219 (654)
..+. ++..|.+.+|.
T Consensus 359 ~~l~~~l~~~~~~L~~L~L~~n~ 381 (461)
T 1z7x_W 359 RELCQGLGQPGSVLRVLWLADCD 381 (461)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHHHHHHcCCCCceEEEECCCCC
Confidence 5443 55666666653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.07 E-value=4.7e-10 Score=117.59 Aligned_cols=137 Identities=20% Similarity=0.303 Sum_probs=104.1
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEec--ccc--cCHHHHHHHHHHHhccC--CCccccccEEEEeC---CceEEEEEe
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLK--EVA--VGKREFEMQMEVLGKIK--HDNVVPLRAFYYSK---DEKLLVYDY 422 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~--~~~--~~~~~~~~e~~~l~~l~--hpniv~l~~~~~~~---~~~~lv~e~ 422 (654)
+.|+.|.++.||+.... +..+++|+.. ... .....+.+|+.+++.+. +..+.+++.++.+. +..|+||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 45889999999998876 4678888876 332 23456788999998887 45578888888766 347999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-------------------------------------
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS------------------------------------- 465 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------------------- 465 (654)
++|..+.+.. ...++..++..++.++++.|+.||..
T Consensus 123 v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9998775422 12377888899999999999999961
Q ss_pred --------------------CCeecCCCCCCcEEECCCCC--eEEeccCCCCC
Q 036334 466 --------------------GKIVHGNIKASNILLRPDHD--ACVSDFGLNPL 496 (654)
Q Consensus 466 --------------------~~ivHrDlk~~NIll~~~~~--~kl~Dfgla~~ 496 (654)
..++|+|+++.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 24999999999999998764 68999998764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=4.6e-12 Score=133.27 Aligned_cols=62 Identities=15% Similarity=0.225 Sum_probs=27.3
Q ss_pred cccccccccccccccc----cchhhccccccceecccccccccc----CCCccccccccCcccccccccc
Q 036334 117 TLLRSLYLQSNQFSGV----FPASVTRMNRLTRLDLSSNNFSGK----IPFDVNNLTHLTGLFLENNKFS 178 (654)
Q Consensus 117 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 178 (654)
++|++|+|++|+|+.. ++..+..+++|++|+|++|.|+.. +...+..+++|+.|+|++|.|+
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 4455555555554431 222334444455555555554421 1223334444555555555544
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.93 E-value=1.4e-09 Score=112.48 Aligned_cols=55 Identities=11% Similarity=0.146 Sum_probs=38.2
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCcccccccccc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQ 125 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 125 (654)
.++.|+|++ ++. .|+...|.++++|+.|+|++|.+....+..|.++.+|..|.++
T Consensus 102 ~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~ 156 (329)
T 3sb4_A 102 TLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLG 156 (329)
T ss_dssp TCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTT
T ss_pred CCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCc
Confidence 388888888 665 5777789999999999999998764444455555444444433
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.88 E-value=1.8e-11 Score=128.69 Aligned_cols=150 Identities=18% Similarity=0.143 Sum_probs=108.5
Q ss_pred eEEEeecCCCCccccCCccccc-----CCCCccEEEeccCCccCcCCCCC-CCccccccccccccccccccchhhc----
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLG-----KLSQLRVLSLRSNRLSGEIPSDF-SNLTLLRSLYLQSNQFSGVFPASVT---- 138 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~-----~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~---- 138 (654)
.++.|+|++|.++..-.. .|. ..++|++|+|++|.|+..-...+ ..+++|+.|+|++|+|++.....+.
T Consensus 73 ~L~~L~Ls~n~l~~~~~~-~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCT-VVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TCCEEECTTSCCCHHHHH-HHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hCCEEEecCCCCCHHHHH-HHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 488999999998653221 222 33799999999999975433333 3578999999999999876555553
Q ss_pred -cccccceeccccccccc----cCCCccccccccCccccccccccCCC----CC-C-CCCCCCeEEccCCccccc----C
Q 036334 139 -RMNRLTRLDLSSNNFSG----KIPFDVNNLTHLTGLFLENNKFSGNL----PS-I-NPANLRDFNVSNNNLNGS----I 203 (654)
Q Consensus 139 -~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~----~~-~-~~~~L~~L~l~~N~l~g~----~ 203 (654)
..++|++|+|++|.|+. .++..+..+++|++|+|++|+|++.- .. . .+++|+.|+|++|.|+.. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 46889999999999974 24445577889999999999998532 11 1 567899999999999853 2
Q ss_pred cccc---cCCCCccccCCC
Q 036334 204 PATL---SKFPQSSFTGNL 219 (654)
Q Consensus 204 p~~~---~~~~~l~~~~n~ 219 (654)
+..+ .++..|.+.+|.
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~ 250 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNE 250 (372)
T ss_dssp HHHHHHCSSCCEEECTTSS
T ss_pred HHHHHhCCCCCEEeccCCC
Confidence 3333 445566666664
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=1.2e-09 Score=111.52 Aligned_cols=178 Identities=19% Similarity=0.250 Sum_probs=116.7
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccC-CCc--cccccEEEEeCC---ceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-HDN--VVPLRAFYYSKD---EKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpn--iv~l~~~~~~~~---~~~lv~e~~~~ 425 (654)
+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++......+ ..|+|||+++|
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 347899999999863 56888886533 23467889999998873 333 333444333332 24899999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc----------------------------------------
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS---------------------------------------- 465 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------------------------------------- 465 (654)
..+.+... ..++..++..++.++++.++.||..
T Consensus 101 ~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 101 VPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred eECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 88875432 1266777777888888888887740
Q ss_pred -----------------CCeecCCCCCCcEEECC--CCCeEEeccCCCCCcCCCC------CC---Ccc-------ccc-
Q 036334 466 -----------------GKIVHGNIKASNILLRP--DHDACVSDFGLNPLFGNTT------PP---TRV-------AGY- 509 (654)
Q Consensus 466 -----------------~~ivHrDlk~~NIll~~--~~~~kl~Dfgla~~~~~~~------~~---~~~-------~~y- 509 (654)
..++|+|+++.||++++ ...+.|+||+.+....... .. .+. .+|
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 13799999999999998 4557899999876543211 00 000 002
Q ss_pred -cC-ccccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 036334 510 -RA-PEVVETRKVTFKSDVYSFGVLLLELLTGKAPN 543 (654)
Q Consensus 510 -~a-PE~~~~~~~~~~~DvwslGvil~el~tg~~pf 543 (654)
.. |+... ......+.|+++.++|++.+|..+|
T Consensus 254 ~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 22111 1122368999999999999998664
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.82 E-value=2.5e-09 Score=110.57 Aligned_cols=79 Identities=10% Similarity=0.168 Sum_probs=56.9
Q ss_pred eEEEeecCCCCcc----------c---------cCCcccccC--------CCCccEEEeccCCccCcCCCCCCCcccccc
Q 036334 69 FVYSLRLPGVGLV----------G---------PIPPNTLGK--------LSQLRVLSLRSNRLSGEIPSDFSNLTLLRS 121 (654)
Q Consensus 69 ~v~~L~l~~~~l~----------~---------~~~~~~l~~--------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 121 (654)
+++.|||++|.+. + .||...|.+ +++|+.|+|.+ .++..-+..|.++++|+.
T Consensus 50 ~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~ 128 (329)
T 3sb4_A 50 SLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKI 128 (329)
T ss_dssp TCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCE
T ss_pred cCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccce
Confidence 4777888777765 0 466677888 99999999999 888666668999999999
Q ss_pred ccccccccccccchhhccccccceecc
Q 036334 122 LYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 122 L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
|+|++|.++...+..|.++.++..+.+
T Consensus 129 l~l~~n~i~~i~~~aF~~~~~l~~l~~ 155 (329)
T 3sb4_A 129 CQIRKKTAPNLLPEALADSVTAIFIPL 155 (329)
T ss_dssp EEBCCSSCCEECTTSSCTTTCEEEECT
T ss_pred EEcCCCCccccchhhhcCCCceEEecC
Confidence 999999876454444444444444433
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.62 E-value=8.1e-10 Score=123.79 Aligned_cols=113 Identities=11% Similarity=0.116 Sum_probs=60.2
Q ss_pred cCCCCccEEEeccCCccCcCCCCCCC-cccccccccc----ccccccc-----cchhhccccccceeccccc--cccccC
Q 036334 90 GKLSQLRVLSLRSNRLSGEIPSDFSN-LTLLRSLYLQ----SNQFSGV-----FPASVTRMNRLTRLDLSSN--NFSGKI 157 (654)
Q Consensus 90 ~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~l~~N--~l~~~~ 157 (654)
..+++|++|+|+.|.+++..+..++. +++|+.|+|+ .|++++. ++..+.++++|+.|+|++| .+++..
T Consensus 375 ~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~ 454 (592)
T 3ogk_B 375 QGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG 454 (592)
T ss_dssp HHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHH
T ss_pred hhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHH
Confidence 34566666666666666554444443 5666666664 5556542 3334555666666666532 244333
Q ss_pred CCccc-cccccCccccccccccCC-CCCC--CCCCCCeEEccCCccccc
Q 036334 158 PFDVN-NLTHLTGLFLENNKFSGN-LPSI--NPANLRDFNVSNNNLNGS 202 (654)
Q Consensus 158 p~~~~-~l~~L~~L~l~~N~l~~~-~~~~--~~~~L~~L~l~~N~l~g~ 202 (654)
+..+. .+++|+.|+|++|++++. ++.. .+++|+.|+|++|++++.
T Consensus 455 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 503 (592)
T 3ogk_B 455 LSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSER 503 (592)
T ss_dssp HHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHH
T ss_pred HHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHH
Confidence 33332 255566666666665542 1221 455666666666665533
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.60 E-value=4e-09 Score=118.08 Aligned_cols=137 Identities=10% Similarity=0.070 Sum_probs=84.6
Q ss_pred EEEeecCCCC-ccccCCcccccCCCCccEEEeccCCccCc----CCCCCCCccccccccccccccc----cccchhhccc
Q 036334 70 VYSLRLPGVG-LVGPIPPNTLGKLSQLRVLSLRSNRLSGE----IPSDFSNLTLLRSLYLQSNQFS----GVFPASVTRM 140 (654)
Q Consensus 70 v~~L~l~~~~-l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l 140 (654)
++.|+|+++. +...--+..+..+++|++|+|++|.+++. ++..+.++++|++|+|++|+++ +.++..+.++
T Consensus 140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~ 219 (592)
T 3ogk_B 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219 (592)
T ss_dssp CCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHC
T ss_pred CcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhC
Confidence 7888888775 21111111234678888888888887654 3334456788888888888887 3455556678
Q ss_pred cccceeccccccccccCCCccccccccCccccccccccCC---CC-CC-CCCCCCeEEccCCcccccCccccc
Q 036334 141 NRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGN---LP-SI-NPANLRDFNVSNNNLNGSIPATLS 208 (654)
Q Consensus 141 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~---~~-~~-~~~~L~~L~l~~N~l~g~~p~~~~ 208 (654)
++|+.|+|++|.+.+ +|..+.++++|+.|+++.+..... .. .. .+++|+.|+++++.. +.+|..+.
T Consensus 220 ~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~ 290 (592)
T 3ogk_B 220 RSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFP 290 (592)
T ss_dssp TTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGG
T ss_pred CCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHh
Confidence 888888888888774 556677777777777765322211 11 11 455666666665432 24444443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.59 E-value=1.1e-09 Score=108.56 Aligned_cols=111 Identities=20% Similarity=0.251 Sum_probs=74.1
Q ss_pred cccCCcccccCCCCccE--EEeccCCcc---CcCCCCCCCcccccccccccccccc--ccchhhccccccceeccccccc
Q 036334 81 VGPIPPNTLGKLSQLRV--LSLRSNRLS---GEIPSDFSNLTLLRSLYLQSNQFSG--VFPASVTRMNRLTRLDLSSNNF 153 (654)
Q Consensus 81 ~~~~~~~~l~~l~~L~~--L~Ls~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l 153 (654)
.+.+.-..|...+.|+. ++++.|... +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|
T Consensus 129 ~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i 208 (267)
T 3rw6_A 129 QQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNEL 208 (267)
T ss_dssp TTEEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCC
T ss_pred ccccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCcc
Confidence 33333333555566666 677777433 2222222467788888888888887 4567777888888888888888
Q ss_pred cccCCCcccccc--ccCccccccccccCCCCC--------C-CCCCCCeEE
Q 036334 154 SGKIPFDVNNLT--HLTGLFLENNKFSGNLPS--------I-NPANLRDFN 193 (654)
Q Consensus 154 ~~~~p~~~~~l~--~L~~L~l~~N~l~~~~~~--------~-~~~~L~~L~ 193 (654)
++. ..+..+. +|+.|+|++|.+.+.+|. . .+++|+.||
T Consensus 209 ~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 209 KSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp CSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred CCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 854 3355555 788888888888876663 1 567777775
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.51 E-value=2.9e-09 Score=100.22 Aligned_cols=113 Identities=14% Similarity=0.187 Sum_probs=82.6
Q ss_pred cccCCCCccEEEeccC-CccCc----CCCCCCCccccccccccccccccc----cchhhccccccceecccccccccc--
Q 036334 88 TLGKLSQLRVLSLRSN-RLSGE----IPSDFSNLTLLRSLYLQSNQFSGV----FPASVTRMNRLTRLDLSSNNFSGK-- 156 (654)
Q Consensus 88 ~l~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~-- 156 (654)
.+...++|++|+|++| .|... +...+...++|++|+|++|+|+.. +...+...++|++|+|++|.|+..
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 4667788889999888 77632 334456678889999999988753 344555667899999999988743
Q ss_pred --CCCccccccccCcccc--ccccccCCCC----CC--CCCCCCeEEccCCccc
Q 036334 157 --IPFDVNNLTHLTGLFL--ENNKFSGNLP----SI--NPANLRDFNVSNNNLN 200 (654)
Q Consensus 157 --~p~~~~~l~~L~~L~l--~~N~l~~~~~----~~--~~~~L~~L~l~~N~l~ 200 (654)
+...+...++|+.|+| ++|.|...-. .. ..++|++|+|++|.+.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3455677788999999 7888875321 11 4578999999999885
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.36 E-value=2.1e-08 Score=112.29 Aligned_cols=125 Identities=18% Similarity=0.216 Sum_probs=81.7
Q ss_pred cCCCCccEEEeccCCccCcCCCCCC-Ccccccccccccc-ccccc-cchhhccccccceeccccccccccCCCcc----c
Q 036334 90 GKLSQLRVLSLRSNRLSGEIPSDFS-NLTLLRSLYLQSN-QFSGV-FPASVTRMNRLTRLDLSSNNFSGKIPFDV----N 162 (654)
Q Consensus 90 ~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~----~ 162 (654)
..+++|++|+|++|.+++..+..+. .+++|++|+|++| .+++. ++..+.++++|++|+|++|.+++..+..+ .
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~ 181 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD 181 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence 3567888888888887766655554 5788888888887 55543 44555578888888888888775444333 3
Q ss_pred cccccCcccccccc--ccCC-CCCC--CCCCCCeEEccCC-cccccCcccccCCCCccc
Q 036334 163 NLTHLTGLFLENNK--FSGN-LPSI--NPANLRDFNVSNN-NLNGSIPATLSKFPQSSF 215 (654)
Q Consensus 163 ~l~~L~~L~l~~N~--l~~~-~~~~--~~~~L~~L~l~~N-~l~g~~p~~~~~~~~l~~ 215 (654)
.+++|+.|++++|. ++.. ++.. .+++|+.|+|++| .+. .+|..+.++++|..
T Consensus 182 ~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~ 239 (594)
T 2p1m_B 182 TYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEE 239 (594)
T ss_dssp TCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSE
T ss_pred cCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceE
Confidence 56688888888876 2110 1111 4678888888887 444 36666655555443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=2.8e-06 Score=86.54 Aligned_cols=133 Identities=20% Similarity=0.215 Sum_probs=89.7
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCC---ccccccEEEE-eCCceEEEEEecCCCc
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHD---NVVPLRAFYY-SKDEKLLVYDYMPAGS 427 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp---niv~l~~~~~-~~~~~~lv~e~~~~g~ 427 (654)
+.++.|....||+. |..+++|+-.. ......+.+|.++|+.+.+. .|.+.+.++. ..+..++||||++|..
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 34778888899987 56788888532 22345788999999998653 2455666654 3455789999999988
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc------------------------------------------
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS------------------------------------------ 465 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------------------------ 465 (654)
+.+.... .++..++..++.++++.|+.||+.
T Consensus 100 l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 100 LGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred Cchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 8763211 134444444555555554444421
Q ss_pred -----------------CCeecCCCCCCcEEECC---CCCe-EEeccCCCCC
Q 036334 466 -----------------GKIVHGNIKASNILLRP---DHDA-CVSDFGLNPL 496 (654)
Q Consensus 466 -----------------~~ivHrDlk~~NIll~~---~~~~-kl~Dfgla~~ 496 (654)
..++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 13699999999999997 4554 7999997653
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.31 E-value=7.2e-09 Score=116.04 Aligned_cols=109 Identities=15% Similarity=0.096 Sum_probs=57.1
Q ss_pred CCCccEEEeccCCccCcCCCCCC-Ccccccccccc--c----ccccc-----ccchhhccccccceeccccccccccCCC
Q 036334 92 LSQLRVLSLRSNRLSGEIPSDFS-NLTLLRSLYLQ--S----NQFSG-----VFPASVTRMNRLTRLDLSSNNFSGKIPF 159 (654)
Q Consensus 92 l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~-----~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 159 (654)
+++|++|+++.|.+++.....+. ++++|+.|+|+ + |++++ .++..+..+++|+.|+|++ .+++..+.
T Consensus 371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~ 449 (594)
T 2p1m_B 371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFE 449 (594)
T ss_dssp CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHH
T ss_pred chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHH
Confidence 56666666666666644433343 35666666666 3 44442 1222245556666666655 44433333
Q ss_pred cccc-ccccCccccccccccCCCCCC---CCCCCCeEEccCCcccc
Q 036334 160 DVNN-LTHLTGLFLENNKFSGNLPSI---NPANLRDFNVSNNNLNG 201 (654)
Q Consensus 160 ~~~~-l~~L~~L~l~~N~l~~~~~~~---~~~~L~~L~l~~N~l~g 201 (654)
.+.. +++|+.|+|++|.+++..... .+++|+.|+|++|++++
T Consensus 450 ~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~ 495 (594)
T 2p1m_B 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD 495 (594)
T ss_dssp HHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred HHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence 3333 556666666666654332211 35566666666666643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=3.7e-06 Score=83.87 Aligned_cols=131 Identities=18% Similarity=0.187 Sum_probs=89.6
Q ss_pred ccccCce-eEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccC-CCccccccEEEEeCCceEEEEEecCCCchhh
Q 036334 354 LGKGSVG-TSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDYMPAGSLSA 430 (654)
Q Consensus 354 lg~G~fg-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~ 430 (654)
+..|..| .||+.... ++..+++|+-... ...++.+|...|+.+. +--|-++++++.+.+..++|||++++.++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 4456555 68987754 4667899986543 2456788998888774 3236678888888899999999999988766
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc---------------------------------------------
Q 036334 431 LLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS--------------------------------------------- 465 (654)
Q Consensus 431 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~--------------------------------------------- 465 (654)
..... ......++.+++..|..||..
T Consensus 110 ~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 110 VLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 54311 111223344444444444420
Q ss_pred ----------C--CeecCCCCCCcEEECCCCCeEEeccCCCC
Q 036334 466 ----------G--KIVHGNIKASNILLRPDHDACVSDFGLNP 495 (654)
Q Consensus 466 ----------~--~ivHrDlk~~NIll~~~~~~kl~Dfgla~ 495 (654)
. .++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0 27899999999999987767799998765
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.27 E-value=3.5e-08 Score=92.81 Aligned_cols=110 Identities=16% Similarity=0.176 Sum_probs=85.8
Q ss_pred CeEEEeecCCC-Ccccc----CCcccccCCCCccEEEeccCCccCc----CCCCCCCccccccccccccccccc----cc
Q 036334 68 SFVYSLRLPGV-GLVGP----IPPNTLGKLSQLRVLSLRSNRLSGE----IPSDFSNLTLLRSLYLQSNQFSGV----FP 134 (654)
Q Consensus 68 ~~v~~L~l~~~-~l~~~----~~~~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p 134 (654)
..++.|+|++| .+... +.. .+...++|++|+|++|.|... +...+...++|++|+|++|+|++. +.
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~-~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAE-ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHH-HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHH-HHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 34999999999 87542 222 467788999999999999742 334455668899999999999965 46
Q ss_pred hhhccccccceecc--cccccccc----CCCccccccccCcccccccccc
Q 036334 135 ASVTRMNRLTRLDL--SSNNFSGK----IPFDVNNLTHLTGLFLENNKFS 178 (654)
Q Consensus 135 ~~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 178 (654)
..+...++|++|+| ++|.|... +...+...++|+.|+|++|.|.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 67778889999999 88999843 3344566689999999999985
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.19 E-value=2.9e-06 Score=89.77 Aligned_cols=143 Identities=13% Similarity=0.163 Sum_probs=103.8
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
.++.+.|..+ + ..|+...|.++++|+.|+|.+| ++..-...|.+ .+|+.++| .|.++..-...|.++++|+.+++
T Consensus 204 ~L~~l~lp~~-l-~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l 278 (401)
T 4fdw_A 204 GIEEVLLPVT-L-KEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTT 278 (401)
T ss_dssp CCSEEECCTT-C-CEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEE
T ss_pred ccCEEEeCCc-h-heehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEe
Confidence 3777888754 4 3677778999999999999875 55455556777 78999999 45677566788999999999999
Q ss_pred cccccc-----ccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCC--CCccccCC
Q 036334 149 SSNNFS-----GKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKF--PQSSFTGN 218 (654)
Q Consensus 149 ~~N~l~-----~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~--~~l~~~~n 218 (654)
.+|.+. ...+..|.+|++|+.++|.+ .++...... .+.+|+.|+|.+| ++..-+.+|.++ ..+.+.+|
T Consensus 279 ~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~~L~~l~l~~n 355 (401)
T 4fdw_A 279 YGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNTGIKEVKVEGT 355 (401)
T ss_dssp ESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSSCCCEEEECCS
T ss_pred CCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCCCCCEEEEcCC
Confidence 888775 34566788999999999984 466544443 7789999999655 653334556554 33444444
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=2.8e-06 Score=88.50 Aligned_cols=79 Identities=13% Similarity=0.109 Sum_probs=55.1
Q ss_pred ccc-cccCceeEEEEEec-------CCcEEEEEEecccc---c-CHHHHHHHHHHHhccC-C--CccccccEEEEeC---
Q 036334 352 EVL-GKGSVGTSYKAVLE-------EGTTVVVKRLKEVA---V-GKREFEMQMEVLGKIK-H--DNVVPLRAFYYSK--- 413 (654)
Q Consensus 352 ~~l-g~G~fg~Vy~~~~~-------~g~~vavK~~~~~~---~-~~~~~~~e~~~l~~l~-h--pniv~l~~~~~~~--- 413 (654)
+.| +.|....+|+.... ++..+++|+..... . ....+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999988754 26688999865433 1 2346778888887774 2 3466777777654
Q ss_pred CceEEEEEecCCCchhh
Q 036334 414 DEKLLVYDYMPAGSLSA 430 (654)
Q Consensus 414 ~~~~lv~e~~~~g~L~~ 430 (654)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 34689999998877654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.14 E-value=4.8e-06 Score=88.08 Aligned_cols=87 Identities=10% Similarity=0.038 Sum_probs=36.7
Q ss_pred CCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCcccc
Q 036334 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNN 163 (654)
Q Consensus 84 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 163 (654)
|+...|.+ .+|+.++|.+ .++..-+..|.++++|+.++|++|+++......|. ..+|+.+.|.+| ++..-...|.+
T Consensus 149 I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~ 224 (401)
T 4fdw_A 149 IGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLK 224 (401)
T ss_dssp ECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTT
T ss_pred ECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhC
Confidence 33334444 2345554443 33323333444455555555555444422222222 344444444422 33233334444
Q ss_pred ccccCcccccc
Q 036334 164 LTHLTGLFLEN 174 (654)
Q Consensus 164 l~~L~~L~l~~ 174 (654)
+++|+.+++.+
T Consensus 225 ~~~L~~l~l~~ 235 (401)
T 4fdw_A 225 TSQLKTIEIPE 235 (401)
T ss_dssp CTTCCCEECCT
T ss_pred CCCCCEEecCC
Confidence 44444444443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.11 E-value=2.7e-07 Score=96.14 Aligned_cols=111 Identities=14% Similarity=0.126 Sum_probs=62.4
Q ss_pred cccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhc--cccccceecccc--cccccc-----CC
Q 036334 88 TLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVT--RMNRLTRLDLSS--NNFSGK-----IP 158 (654)
Q Consensus 88 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~l~~--N~l~~~-----~p 158 (654)
.+..+++|+.|+|++|.-. .++. +. +++|+.|+|..|.++...-..+. .+++|+.|+|+. |...+. +.
T Consensus 167 ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~ 243 (362)
T 2ra8_A 167 VLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR 243 (362)
T ss_dssp HHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTG
T ss_pred HHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHH
Confidence 3456677777777776311 2232 32 67777777777776644434443 567777777653 221111 00
Q ss_pred Ccc--ccccccCccccccccccCCCCC-----CCCCCCCeEEccCCcccc
Q 036334 159 FDV--NNLTHLTGLFLENNKFSGNLPS-----INPANLRDFNVSNNNLNG 201 (654)
Q Consensus 159 ~~~--~~l~~L~~L~l~~N~l~~~~~~-----~~~~~L~~L~l~~N~l~g 201 (654)
..+ ..+++|+.|+|++|.+.+..+. ..+++|+.|+|+.|.|++
T Consensus 244 ~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 244 PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp GGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred HHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence 111 2456777777777777642211 145677777777777765
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.08 E-value=8.3e-07 Score=92.40 Aligned_cols=136 Identities=18% Similarity=0.233 Sum_probs=89.5
Q ss_pred CeEEEeecCCCC-ccccCCcccccCCCCccEEEeccCCccCcCCCCCC--Cccccccccccc--cccccc-----cchhh
Q 036334 68 SFVYSLRLPGVG-LVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFS--NLTLLRSLYLQS--NQFSGV-----FPASV 137 (654)
Q Consensus 68 ~~v~~L~l~~~~-l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~~ 137 (654)
++++.|+|+++. + .+++ +. +++|++|+|..|.++...-..+. ++++|+.|+|+. |...+. +...+
T Consensus 172 P~L~~L~L~g~~~l--~l~~--~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l 246 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL--SIGK--KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246 (362)
T ss_dssp TTCCEEEEECCBTC--BCCS--CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred CCCcEEEEeCCCCc--eecc--cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence 458889998773 2 2333 33 78999999998887643333333 678899998863 322211 11122
Q ss_pred --ccccccceeccccccccccCCCcc---ccccccCccccccccccCC----CCCC--CCCCCCeEEccCCcccccCccc
Q 036334 138 --TRMNRLTRLDLSSNNFSGKIPFDV---NNLTHLTGLFLENNKFSGN----LPSI--NPANLRDFNVSNNNLNGSIPAT 206 (654)
Q Consensus 138 --~~l~~L~~L~l~~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~~~----~~~~--~~~~L~~L~l~~N~l~g~~p~~ 206 (654)
..+++|+.|+|++|.+....+..+ ..+++|+.|+|+.|.|.+. ++.. .+++|+.|+|++|.|+...-..
T Consensus 247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~ 326 (362)
T 2ra8_A 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKE 326 (362)
T ss_dssp CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHH
T ss_pred hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHH
Confidence 247899999999998875433223 2578899999999998863 2221 5688999999999887444333
Q ss_pred cc
Q 036334 207 LS 208 (654)
Q Consensus 207 ~~ 208 (654)
|.
T Consensus 327 l~ 328 (362)
T 2ra8_A 327 LQ 328 (362)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=1.8e-05 Score=83.75 Aligned_cols=73 Identities=10% Similarity=0.139 Sum_probs=48.6
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccc--------cCHHHHHHHHHHHhccCC--Cccc-cccEEEEeCCceEEE
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--------VGKREFEMQMEVLGKIKH--DNVV-PLRAFYYSKDEKLLV 419 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~e~~~l~~l~h--pniv-~l~~~~~~~~~~~lv 419 (654)
+.||.|.++.||++... ++..++||...... ....++..|.++++.+.. +..+ +++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999754 46889999865321 123456778888877642 3333 44433 45567899
Q ss_pred EEecCCC
Q 036334 420 YDYMPAG 426 (654)
Q Consensus 420 ~e~~~~g 426 (654)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.89 E-value=6.9e-05 Score=77.15 Aligned_cols=139 Identities=18% Similarity=0.282 Sum_probs=77.8
Q ss_pred cccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccC-----CCcccccc-E--EEEeCCceEEEEEecC
Q 036334 353 VLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-----HDNVVPLR-A--FYYSKDEKLLVYDYMP 424 (654)
Q Consensus 353 ~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----hpniv~l~-~--~~~~~~~~~lv~e~~~ 424 (654)
.|+.|..+.||+....+| .+++|+.... ..++..|+.+++.+. .|.++... | +....+..++||||++
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 466677899999887654 5889998752 234445555554442 34444311 1 1234567899999999
Q ss_pred CCchh--------------hhhccCC-C---C-CC----CCCCHHHHH-------------------------------H
Q 036334 425 AGSLS--------------ALLHGSR-G---S-GR----TPLDWDNRM-------------------------------R 450 (654)
Q Consensus 425 ~g~L~--------------~~l~~~~-~---~-~~----~~l~~~~~~-------------------------------~ 450 (654)
|..+. ..+|... . . .. ..-.|...+ .
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 86542 1112110 0 0 00 012332211 1
Q ss_pred HHHHHHHHHHHhhc------------cCCeecCCCCCCcEEECCCCCeEEeccCCCC
Q 036334 451 IALSAARGLAHLHV------------SGKIVHGNIKASNILLRPDHDACVSDFGLNP 495 (654)
Q Consensus 451 i~~~ia~~l~~LH~------------~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~ 495 (654)
+...+..++++|+. ...++|+|+++.||+++.++.+.|+||+.+.
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11123345566652 2349999999999999888899999998754
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.58 E-value=1.1e-05 Score=74.21 Aligned_cols=82 Identities=10% Similarity=0.171 Sum_probs=47.1
Q ss_pred CccEEEeccCCccCcCCCCCCCccccccccccccc-cccccchhhccc----cccceecccccc-ccccCCCcccccccc
Q 036334 94 QLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQ-FSGVFPASVTRM----NRLTRLDLSSNN-FSGKIPFDVNNLTHL 167 (654)
Q Consensus 94 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~p~~~~~l~~L 167 (654)
+|+.|||+++.|+..--..+.++++|+.|+|+++. +++.--..+..+ ++|++|+|+++. |+..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 57777777776664333345666777777777764 665433344443 357777777653 553222234556666
Q ss_pred Cccccccc
Q 036334 168 TGLFLENN 175 (654)
Q Consensus 168 ~~L~l~~N 175 (654)
+.|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 66666655
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.52 E-value=0.001 Score=67.84 Aligned_cols=74 Identities=15% Similarity=0.102 Sum_probs=49.7
Q ss_pred ccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCC--ccccccEE-----EEeCCceEEEEEecCCC
Q 036334 354 LGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHD--NVVPLRAF-----YYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 354 lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hp--niv~l~~~-----~~~~~~~~lv~e~~~~g 426 (654)
++ |....||+....+|+.+++|+..........+..|..+++.+... .+.+++.. ....+..++||||++|.
T Consensus 34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~ 112 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 112 (328)
T ss_dssp EC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCC
Confidence 55 777899998777777899999875444566777788887766421 23444432 22345568899999875
Q ss_pred ch
Q 036334 427 SL 428 (654)
Q Consensus 427 ~L 428 (654)
.+
T Consensus 113 ~~ 114 (328)
T 1zyl_A 113 QF 114 (328)
T ss_dssp EC
T ss_pred CC
Confidence 43
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00034 Score=70.72 Aligned_cols=70 Identities=9% Similarity=0.020 Sum_probs=42.5
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccc-cccEEEEeCCceEEEEEec-CCCch
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVV-PLRAFYYSKDEKLLVYDYM-PAGSL 428 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv-~l~~~~~~~~~~~lv~e~~-~~g~L 428 (654)
+.|+.|....+|+. ..+++|+.........+..+|+.+++.+....+. +++++ +.+.-++|+||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 45788999999998 5688888764321112235577777666432333 44443 444567999999 55444
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00084 Score=71.31 Aligned_cols=73 Identities=12% Similarity=0.143 Sum_probs=46.3
Q ss_pred CeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCCCCc-----cccccCccccCCC---CCCcchhHHHHHHHHHHHHh
Q 036334 467 KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR-----VAGYRAPEVVETR---KVTFKSDVYSFGVLLLELLT 538 (654)
Q Consensus 467 ~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-----~~~y~aPE~~~~~---~~~~~~DvwslGvil~el~t 538 (654)
.++|+|+++.|||++.++ ++|+||+.+..-........ ...|++|+..... ......++......+|+.+.
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 311 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLFN 311 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHHH
Confidence 499999999999999776 99999998765432111000 1226666654311 11223455677778888776
Q ss_pred CC
Q 036334 539 GK 540 (654)
Q Consensus 539 g~ 540 (654)
++
T Consensus 312 ~~ 313 (420)
T 2pyw_A 312 KR 313 (420)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0019 Score=65.50 Aligned_cols=74 Identities=19% Similarity=0.133 Sum_probs=58.2
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccC---CCccccccEEEEeCCceEEEEEecCCCch
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIK---HDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
+.|+.|.+..+|+.... +..+++|+.... ....+..|.+.|+.+. ...+.++++++...+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 35788999999998764 678889987543 3566888988888773 35677888888877889999999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00073 Score=67.75 Aligned_cols=73 Identities=19% Similarity=0.247 Sum_probs=52.7
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccc-cCHHHHHHHHHHHhccCCC---ccccccEEEEeCCceEEEEEecCCCc
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHD---NVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hp---niv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
+.+|.|..+.||+....+|+.|+||+..... .....|+.|+..|+.+.-. -+.+++++ +..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 4589999999999999999999999875443 2345678899988877422 23344443 23578999998765
Q ss_pred h
Q 036334 428 L 428 (654)
Q Consensus 428 L 428 (654)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.25 E-value=6.1e-05 Score=69.10 Aligned_cols=85 Identities=11% Similarity=0.027 Sum_probs=65.7
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCC-ccCcCCCCCCCc----cccccccccccc-cccccchhhccccc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNR-LSGEIPSDFSNL----TLLRSLYLQSNQ-FSGVFPASVTRMNR 142 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 142 (654)
+++.|||+++.++..--. .+..+++|++|+|++|. |+..--..++.+ ++|++|+|+++. +|+.--..+.++++
T Consensus 62 ~L~~LDLs~~~Itd~GL~-~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFD-HMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CEEEEEEESCCCCGGGGG-GGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred eEeEEeCcCCCccHHHHH-HhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 599999999997654322 47899999999999985 764322235553 479999999974 88765567889999
Q ss_pred cceecccccc-cc
Q 036334 143 LTRLDLSSNN-FS 154 (654)
Q Consensus 143 L~~L~l~~N~-l~ 154 (654)
|++|+|+++. ++
T Consensus 141 L~~L~L~~c~~It 153 (176)
T 3e4g_A 141 LKYLFLSDLPGVK 153 (176)
T ss_dssp CCEEEEESCTTCC
T ss_pred CCEEECCCCCCCC
Confidence 9999999874 44
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0022 Score=65.28 Aligned_cols=142 Identities=11% Similarity=0.176 Sum_probs=75.8
Q ss_pred ccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccC-----CCcccccc-E--EEEeCCceEEEEEec
Q 036334 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-----HDNVVPLR-A--FYYSKDEKLLVYDYM 423 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----hpniv~l~-~--~~~~~~~~~lv~e~~ 423 (654)
+.|+.|....+|+....+| .+++|+.... ....++..|+.+++.+. -|.++... | +....+..+++|+|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 3467788889999887655 6788987652 12345566777766653 23333211 1 112345678999999
Q ss_pred CCCchhh--------------hhccCC-CCCC---CCC---CHHHHHHH------------HHHHHHHHHHhhc------
Q 036334 424 PAGSLSA--------------LLHGSR-GSGR---TPL---DWDNRMRI------------ALSAARGLAHLHV------ 464 (654)
Q Consensus 424 ~~g~L~~--------------~l~~~~-~~~~---~~l---~~~~~~~i------------~~~ia~~l~~LH~------ 464 (654)
+|..+.. .+|... .... ... .|...+.- ...+...+++++.
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 8865321 112110 0000 001 23221110 0113334444431
Q ss_pred cCCeecCCCCCCcEEECCCCCeEEeccCCCC
Q 036334 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNP 495 (654)
Q Consensus 465 ~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~ 495 (654)
...++|+|+++.||+++.++.+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 1149999999999999977656899998654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0019 Score=67.32 Aligned_cols=140 Identities=16% Similarity=0.249 Sum_probs=80.5
Q ss_pred ccccccCceeEEEEEec--------CCcEEEEEEecccccCHHHHHHHHHHHhccCCCc-cccccEEEEeCCceEEEEEe
Q 036334 352 EVLGKGSVGTSYKAVLE--------EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDN-VVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~ 422 (654)
+.|..|-...+|+.... ++..+++|+............+|..+++.+.-.+ ..++++++.+ .+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 34666778889998864 2478999987443334556678988887774222 3456665533 399999
Q ss_pred cCCCchhhh-----------------hccCCCC-CCCCC-CHHHHHHHHHHHHH-------------------HHHHh--
Q 036334 423 MPAGSLSAL-----------------LHGSRGS-GRTPL-DWDNRMRIALSAAR-------------------GLAHL-- 462 (654)
Q Consensus 423 ~~~g~L~~~-----------------l~~~~~~-~~~~l-~~~~~~~i~~~ia~-------------------~l~~L-- 462 (654)
++|..|..- +|...-. ...+. -|.++.++..++.. .+..|
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 988655311 1211110 11111 24455555444321 12222
Q ss_pred --hcc---CCeecCCCCCCcEEECCC----CCeEEeccCCCC
Q 036334 463 --HVS---GKIVHGNIKASNILLRPD----HDACVSDFGLNP 495 (654)
Q Consensus 463 --H~~---~~ivHrDlk~~NIll~~~----~~~kl~Dfgla~ 495 (654)
... ..++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 211 149999999999999876 689999998765
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0011 Score=69.76 Aligned_cols=112 Identities=11% Similarity=0.130 Sum_probs=80.0
Q ss_pred CcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccc
Q 036334 85 PPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNL 164 (654)
Q Consensus 85 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 164 (654)
....|.+..+|+.+.+.++..+ .-...|.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++..-...|.+|
T Consensus 257 ~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C 333 (394)
T 4gt6_A 257 ETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGC 333 (394)
T ss_dssp CTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTC
T ss_pred ccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCC
Confidence 3446778888888888766544 445678888888888886 4566455667888888888888765 554556678888
Q ss_pred cccCccccccccccCCCCCC--CCCCCCeEEccCCccc
Q 036334 165 THLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLN 200 (654)
Q Consensus 165 ~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~ 200 (654)
.+|+.+.|..+ ++..-... ++.+|+.+++.+|...
T Consensus 334 ~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 334 EQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp TTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred CCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence 88888888654 54333322 7888888888877543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.00065 Score=71.50 Aligned_cols=125 Identities=14% Similarity=0.215 Sum_probs=85.0
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 149 (654)
++.+.+..+-. .+....|.+++.|+.+.+. +.++..-...|.++.+|+.++|..| ++..-..+|.++++|+.+.|.
T Consensus 267 L~~i~lp~~~~--~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip 342 (394)
T 4gt6_A 267 LASVKMPDSVV--SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIP 342 (394)
T ss_dssp CCEEECCTTCC--EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEC
T ss_pred ccEEecccccc--eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEEC
Confidence 34444443322 3556678899999999996 5566455568999999999999865 665667789999999999997
Q ss_pred cccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCccc
Q 036334 150 SNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN 200 (654)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~ 200 (654)
.| ++..-...|.+|++|+.+++.+|.... -....+.+|+.|.+..|.+.
T Consensus 343 ~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~-~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 343 SS-VTKIPESAFSNCTALNNIEYSGSRSQW-NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp TT-CCBCCGGGGTTCTTCCEEEESSCHHHH-HTCBCCCCC-----------
T ss_pred cc-cCEEhHhHhhCCCCCCEEEECCceeeh-hhhhccCCCCEEEeCCCCEE
Confidence 65 664556789999999999999886542 11226778888888777653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0043 Score=63.41 Aligned_cols=30 Identities=33% Similarity=0.451 Sum_probs=26.1
Q ss_pred CeecCCCCCCcEEECCC----CCeEEeccCCCCC
Q 036334 467 KIVHGNIKASNILLRPD----HDACVSDFGLNPL 496 (654)
Q Consensus 467 ~ivHrDlk~~NIll~~~----~~~kl~Dfgla~~ 496 (654)
.++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 49999999999999875 6789999998764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.93 E-value=5.3e-05 Score=70.87 Aligned_cols=111 Identities=12% Similarity=0.109 Sum_probs=63.0
Q ss_pred ccCCCCccEEEeccC-CccC----cCCCCCCCcccccccccccccccccc----chhhccccccceecccccccccc---
Q 036334 89 LGKLSQLRVLSLRSN-RLSG----EIPSDFSNLTLLRSLYLQSNQFSGVF----PASVTRMNRLTRLDLSSNNFSGK--- 156 (654)
Q Consensus 89 l~~l~~L~~L~Ls~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~l~~N~l~~~--- 156 (654)
+.+-+.|+.|+|++| .|.. .+-..+..-+.|+.|+|++|+|...- -..+..-+.|+.|+|++|.|...
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 445567788888775 6652 12334455567788888888877442 23344456778888888877632
Q ss_pred -CCCccccccccCccccccc---cccCC----CCCC--CCCCCCeEEccCCcc
Q 036334 157 -IPFDVNNLTHLTGLFLENN---KFSGN----LPSI--NPANLRDFNVSNNNL 199 (654)
Q Consensus 157 -~p~~~~~l~~L~~L~l~~N---~l~~~----~~~~--~~~~L~~L~l~~N~l 199 (654)
+-..+..-+.|+.|+|++| .|... +... .-+.|+.|+|+.|.+
T Consensus 117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 1223333455777777654 22211 1111 335667777766654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0017 Score=67.81 Aligned_cols=122 Identities=11% Similarity=0.136 Sum_probs=68.1
Q ss_pred cccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCcccccccc
Q 036334 88 TLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHL 167 (654)
Q Consensus 88 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 167 (654)
.+....+|+.+.+..+ +...-...|.++..|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-...|.++++|
T Consensus 212 ~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L 288 (379)
T 4h09_A 212 GFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL 288 (379)
T ss_dssp TTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred ccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccc
Confidence 4555666666666544 33234445666667777766655 44344555666666777666543 443334456666777
Q ss_pred CccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCCCc
Q 036334 168 TGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQS 213 (654)
Q Consensus 168 ~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~l 213 (654)
+.+.+.+|.++...... .+.+|+.++|.+| ++..-..+|.++.+|
T Consensus 289 ~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L 335 (379)
T 4h09_A 289 TKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKAL 335 (379)
T ss_dssp CEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred ccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCC
Confidence 77777666665444333 5666777766543 442222345544433
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0031 Score=67.00 Aligned_cols=72 Identities=11% Similarity=0.183 Sum_probs=48.0
Q ss_pred ccccccCceeEEEEEecC--------CcEEEEEEecccccCHHHHHHHHHHHhccCCCcc-ccccEEEEeCCceEEEEEe
Q 036334 352 EVLGKGSVGTSYKAVLEE--------GTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNV-VPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~ 422 (654)
+.|+.|....+|+....+ +..+++|+.... .....+..|..+++.+...++ .++++.+.+ .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 357788889999998653 478999998432 122455678888887753333 456665432 389999
Q ss_pred cCCCch
Q 036334 423 MPAGSL 428 (654)
Q Consensus 423 ~~~g~L 428 (654)
++|-.+
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0022 Score=66.79 Aligned_cols=73 Identities=12% Similarity=0.121 Sum_probs=42.8
Q ss_pred ccccccCceeEEEEEecC---------CcEEEEEEecccccCHHHHHHHHHHHhccCCCcc-ccccEEEEeCCceEEEEE
Q 036334 352 EVLGKGSVGTSYKAVLEE---------GTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNV-VPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e 421 (654)
+.|+.|....+|+....+ +..+++|+.........+...|..+++.+...++ .++++.+ . -++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 347778888999988653 2688888875432211123567777777643333 3565543 2 378999
Q ss_pred ecCCCch
Q 036334 422 YMPAGSL 428 (654)
Q Consensus 422 ~~~~g~L 428 (654)
|++|..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0017 Score=68.32 Aligned_cols=83 Identities=12% Similarity=0.068 Sum_probs=43.2
Q ss_pred CCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC--CCCCC
Q 036334 112 DFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANL 189 (654)
Q Consensus 112 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L 189 (654)
.|..+.+|+.+.+.++ ++..-..+|.++++|+.++|.++ ++..-...|.+|++|+.+++..| ++...... .+.+|
T Consensus 292 ~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L 368 (394)
T 4fs7_A 292 TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINL 368 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTC
T ss_pred cccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCC
Confidence 3455555555555543 44333445566666666666533 44333445666666666666554 43322222 55666
Q ss_pred CeEEccCC
Q 036334 190 RDFNVSNN 197 (654)
Q Consensus 190 ~~L~l~~N 197 (654)
+.++|..|
T Consensus 369 ~~i~lp~~ 376 (394)
T 4fs7_A 369 KKVELPKR 376 (394)
T ss_dssp CEEEEEGG
T ss_pred CEEEECCC
Confidence 66666443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.80 E-value=0.014 Score=54.80 Aligned_cols=101 Identities=13% Similarity=0.088 Sum_probs=66.9
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-ccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCCCCc
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH-VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR 505 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 505 (654)
+|.++|... ..+++++++|.++.|.+++|.-+- .+. -..+=+.|..|++..+|.|.+.+ +.+. ..
T Consensus 34 SL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------~~ 99 (229)
T 2yle_A 34 SLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGAVTLAP-AADD--------AG 99 (229)
T ss_dssp EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhccc-CCceecCCcceEEecCCceeccc-cccc--------cc
Confidence 788888743 468999999999999999987762 111 11233457899999999998874 1111 11
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 036334 506 VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAP 542 (654)
Q Consensus 506 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p 542 (654)
...+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 22377888763 4567889999999999998864433
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0011 Score=57.72 Aligned_cols=56 Identities=23% Similarity=0.300 Sum_probs=32.5
Q ss_pred EeecCCCCcc-ccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccc
Q 036334 72 SLRLPGVGLV-GPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFS 130 (654)
Q Consensus 72 ~L~l~~~~l~-~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 130 (654)
.++.++++|+ ..+|.. + -++|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~-l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTA-F--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSC-C--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCC-C--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4566666664 244432 1 134677777777777544445666666666666666554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.00081 Score=58.61 Aligned_cols=56 Identities=18% Similarity=0.344 Sum_probs=34.0
Q ss_pred EEEeccCCcc-CcCCCCCCCccccccccccccccccccchhhccccccceecccccccc
Q 036334 97 VLSLRSNRLS-GEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFS 154 (654)
Q Consensus 97 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 154 (654)
.++.++++|+ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5677777775 34554332 35666777777776555555666666666666666543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.61 E-value=0.00015 Score=67.86 Aligned_cols=110 Identities=9% Similarity=0.117 Sum_probs=76.4
Q ss_pred CeEEEeecCCC-Ccccc----CCcccccCCCCccEEEeccCCccCcCCCC----CCCccccccccccccccccc----cc
Q 036334 68 SFVYSLRLPGV-GLVGP----IPPNTLGKLSQLRVLSLRSNRLSGEIPSD----FSNLTLLRSLYLQSNQFSGV----FP 134 (654)
Q Consensus 68 ~~v~~L~l~~~-~l~~~----~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~----~p 134 (654)
..++.|+|+++ ++... +- +.|..-+.|+.|+|++|.|...--.. +..-+.|+.|+|++|+|++. +-
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la-~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLI-EAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHH-HHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHH-HHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 44899999986 66421 22 24667789999999999998433333 34457899999999999964 33
Q ss_pred hhhccccccceecccccc---ccc----cCCCccccccccCcccccccccc
Q 036334 135 ASVTRMNRLTRLDLSSNN---FSG----KIPFDVNNLTHLTGLFLENNKFS 178 (654)
Q Consensus 135 ~~~~~l~~L~~L~l~~N~---l~~----~~p~~~~~l~~L~~L~l~~N~l~ 178 (654)
..+..-+.|+.|+|++|. |.. .+-..+..-+.|+.|+++.|.+.
T Consensus 120 ~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 345556789999998763 332 12334555578999999887654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0023 Score=67.22 Aligned_cols=89 Identities=16% Similarity=0.088 Sum_probs=72.6
Q ss_pred CCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCcccc
Q 036334 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNN 163 (654)
Q Consensus 84 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 163 (654)
++...|....+|+.+.+.++ ++..-...|.++++|+.++|.++ ++..-..+|.++++|+.++|..| ++..-...|.+
T Consensus 288 i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~ 364 (394)
T 4fs7_A 288 VPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQG 364 (394)
T ss_dssp ECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTT
T ss_pred eccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhC
Confidence 44456778889999999765 66455668999999999999855 77566788999999999999887 77566678999
Q ss_pred ccccCccccccc
Q 036334 164 LTHLTGLFLENN 175 (654)
Q Consensus 164 l~~L~~L~l~~N 175 (654)
|++|+.+++..|
T Consensus 365 C~~L~~i~lp~~ 376 (394)
T 4fs7_A 365 CINLKKVELPKR 376 (394)
T ss_dssp CTTCCEEEEEGG
T ss_pred CCCCCEEEECCC
Confidence 999999999765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.46 E-value=0.016 Score=61.96 Aligned_cols=73 Identities=10% Similarity=0.107 Sum_probs=46.6
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEecccccCHHHHHHHHHHHhccCCCcc-ccccEEEEeCCceEEEEEecCCCch
Q 036334 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNV-VPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
+.|+.|-...+|+....+ +..+++|+........-+..+|..+++.+...++ .++++++. + .+||||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 357788889999998764 4788899875432111123578888888865555 45666652 2 359999987554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.28 E-value=0.011 Score=61.55 Aligned_cols=111 Identities=13% Similarity=0.097 Sum_probs=77.4
Q ss_pred CCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCcccc
Q 036334 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNN 163 (654)
Q Consensus 84 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 163 (654)
+....+.+...|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-...|.++++|+.+.+.+|.++..-...|.+
T Consensus 231 i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~ 308 (379)
T 4h09_A 231 LGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMD 308 (379)
T ss_dssp ECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTT
T ss_pred EccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcC
Confidence 34445777788888888766 55344557888888888888654 55455567788888888888888887555667888
Q ss_pred ccccCccccccccccCCCCCC--CCCCCCeEEccCC
Q 036334 164 LTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNN 197 (654)
Q Consensus 164 l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N 197 (654)
|.+|+.+.|.++ ++..-... ++.+|+.+.+..|
T Consensus 309 c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 309 CVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred CCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 888888888654 44333322 6778888766443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.89 E-value=0.07 Score=54.54 Aligned_cols=68 Identities=15% Similarity=0.164 Sum_probs=42.9
Q ss_pred cccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccC---CCccccccEE------EEeCCceEEEEEecCC
Q 036334 355 GKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIK---HDNVVPLRAF------YYSKDEKLLVYDYMPA 425 (654)
Q Consensus 355 g~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~---hpniv~l~~~------~~~~~~~~lv~e~~~~ 425 (654)
|.|....||+....+| .+++|+...... ..|+.+++.+. -|++.+.+.. ....+..++||+|++|
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 4444689999987767 899998765432 34555554442 2224444432 2334667999999998
Q ss_pred Cch
Q 036334 426 GSL 428 (654)
Q Consensus 426 g~L 428 (654)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.94 E-value=0.13 Score=54.28 Aligned_cols=72 Identities=7% Similarity=0.099 Sum_probs=45.4
Q ss_pred cccccCceeEEEEEecC--------CcEEEEEEecccccCHHHHHHHHHHHhccCCCc-cccccEEEEeCCceEEEEEec
Q 036334 353 VLGKGSVGTSYKAVLEE--------GTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDN-VVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 353 ~lg~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+..|-...+|+....+ +..+++++........-+.++|..+++.+.-.+ ..++++.+ . -++||||+
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~efI 152 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEFI 152 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEECC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEEe
Confidence 46667778899988653 578999986543222223356777777764223 33455433 2 37899999
Q ss_pred CCCch
Q 036334 424 PAGSL 428 (654)
Q Consensus 424 ~~g~L 428 (654)
+|..|
T Consensus 153 ~G~~l 157 (424)
T 3mes_A 153 DGEPL 157 (424)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 98664
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.07 E-value=0.058 Score=36.35 Aligned_cols=28 Identities=18% Similarity=0.379 Sum_probs=12.8
Q ss_pred eeeeeehhhHHHHHHHHHHHHHHhhccc
Q 036334 260 AIVGIAVGGAVFIVLLLLLLLFCLKKRR 287 (654)
Q Consensus 260 ~ii~~~i~~~~~~~l~~~~~~~~~~~rr 287 (654)
.|++.++|+++++++++++++++.|+|+
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 3444455555544444444444444433
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.78 E-value=0.058 Score=36.26 Aligned_cols=29 Identities=17% Similarity=0.400 Sum_probs=13.6
Q ss_pred ceeeeeehhhHHHHHHHHHHHHHHhhccc
Q 036334 259 AAIVGIAVGGAVFIVLLLLLLLFCLKKRR 287 (654)
Q Consensus 259 ~~ii~~~i~~~~~~~l~~~~~~~~~~~rr 287 (654)
..|++.++|++++++++++.++++.|+|+
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence 34555555555554444444444444433
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=91.68 E-value=0.068 Score=34.87 Aligned_cols=30 Identities=30% Similarity=0.363 Sum_probs=18.6
Q ss_pred CcccceeeeeehhhHHHHHHHHHHHHHHhh
Q 036334 255 KLSTAAIVGIAVGGAVFIVLLLLLLLFCLK 284 (654)
Q Consensus 255 ~~~~~~ii~~~i~~~~~~~l~~~~~~~~~~ 284 (654)
.++.+.+.++++|.++.+.+++++.+|++|
T Consensus 7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~r 36 (38)
T 2k1k_A 7 GLTGGEIVAVIFGLLLGAALLLGILVFRSR 36 (38)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCceeeeehHHHHHHHHHHHHHHHHee
Confidence 455677778887776666655555444443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.30 E-value=0.84 Score=47.56 Aligned_cols=28 Identities=25% Similarity=0.451 Sum_probs=24.0
Q ss_pred eecCCCCCCcEEE------CCCCCeEEeccCCCC
Q 036334 468 IVHGNIKASNILL------RPDHDACVSDFGLNP 495 (654)
Q Consensus 468 ivHrDlk~~NIll------~~~~~~kl~Dfgla~ 495 (654)
++|+|+.+.||++ +++..++++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 445679999998765
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.82 E-value=2 Score=40.20 Aligned_cols=115 Identities=10% Similarity=0.091 Sum_probs=77.5
Q ss_pred CCCccccccEEEEeCCceEEEEEecCCC-chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCc
Q 036334 399 KHDNVVPLRAFYYSKDEKLLVYDYMPAG-SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASN 477 (654)
Q Consensus 399 ~hpniv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~N 477 (654)
.||+.+.. .+-.+.+.+.+.++.-+.+ ++.. ++ .++...+++++.+|+....+++. -+|--+.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik--------~~~~~eKlr~l~ni~~l~~~~~~---r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK--------SFTKNEKLRYLLNIKNLEEVNRT---RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG--------GSCHHHHHHHHHHGGGGGGGGGS---SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH--------hcCHHHHHHHHHHHHHHHHHhcC---ceEEEEecce
Confidence 58888765 4555566666666654322 2222 32 37889999999999988866653 3688899999
Q ss_pred EEECCCCCeEEeccCCCCCcCCCCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 036334 478 ILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQ 544 (654)
Q Consensus 478 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~ 544 (654)
|+++.++.+++.-.|+...+ +|.. .++..=.-.+=+++..+++++..|.
T Consensus 110 L~f~~~~~p~i~~RGik~~l-------------~P~~-----~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV-------------DPLP-----VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTB-------------SCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCC-------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999877764332 2221 1112223347788888999988875
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=88.10 E-value=0.24 Score=33.22 Aligned_cols=7 Identities=43% Similarity=0.800 Sum_probs=3.2
Q ss_pred eeeeehh
Q 036334 261 IVGIAVG 267 (654)
Q Consensus 261 ii~~~i~ 267 (654)
+++.++|
T Consensus 14 Ia~~vVG 20 (44)
T 2jwa_A 14 IISAVVG 20 (44)
T ss_dssp HHHHHHH
T ss_pred hHHHHHH
Confidence 4444444
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.26 E-value=4.1 Score=38.16 Aligned_cols=115 Identities=14% Similarity=0.079 Sum_probs=77.5
Q ss_pred CCCccccccEEEEeCCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH-HhhccCCeecCCCCCCc
Q 036334 399 KHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLA-HLHVSGKIVHGNIKASN 477 (654)
Q Consensus 399 ~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~-~LH~~~~ivHrDlk~~N 477 (654)
.||+. -...-.+++.+.+.++.-+++.=...++ .++...+++++.+|+.... +++. -+|--+.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~---r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR---RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS---SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC---ceeEEEeCce
Confidence 57777 3334456677777777654443333443 2788999999999998887 6653 4688899999
Q ss_pred EEECCCCCeEEeccCCCCCcCCCCCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 036334 478 ILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQ 544 (654)
Q Consensus 478 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~ 544 (654)
|+++.++.+++.-.|+-.. ++|..+ ++.-=.-.+=+++..++.++..|.
T Consensus 115 L~f~~~~~p~i~hRGi~~~-------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKES-------------LPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETTT-------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCccc-------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999987776432 333322 111112246677888888877764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 654 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-58 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-57 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-50 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-47 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-44 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-14 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-09 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 8e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-58
Identities = 69/270 (25%), Positives = 119/270 (44%), Gaps = 26/270 (9%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYY 411
E LG G G + T V VK LK+ ++ F + ++ +++H +V L A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
+++ ++ +YM GSL L G L + + +A A G+A + +H
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE-ERNYIHR 133
Query: 472 NIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA-----GYRAPEVVETRKVTFKSDV 526
+++A+NIL+ ++DFGL L + R + APE + T KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 527 YSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMV 586
+SFG+LL E++T G+ P +Q++ R ++R N EE+
Sbjct: 194 WSFGILLTEIVTHGRIP-----YPGMTNPEVIQNLER--------GYRMVRPDNCPEELY 240
Query: 587 QLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
QL+ C P+ RP + ++E+
Sbjct: 241 QLM---RLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 9e-57
Identities = 70/279 (25%), Positives = 124/279 (44%), Gaps = 32/279 (11%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRA 408
+ +G GS GT YK V VK L A + F+ ++ VL K +H N++
Sbjct: 14 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
+ + + +V + SL LH + + IA A+G+ +LH I
Sbjct: 72 YS-TAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAKS-I 125
Query: 469 VHGNIKASNILLRPDHDACVSDFGLNPLFG---NTTPPTRVAG---YRAPEVVETRK--- 519
+H ++K++NI L D + DFGL + + +++G + APEV+ +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 520 VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579
+F+SDVY+FG++L EL+TG+ P I+ + +V + +
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLP------YSNINNRDQIIFMVGRGYLSPDLS---KVRS 236
Query: 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
N + M +L+ C+ D+RP +++ IE + R
Sbjct: 237 NCPKAMKRLM---AECLKKKRDERPLFPQILASIELLAR 272
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-56
Identities = 59/298 (19%), Positives = 113/298 (37%), Gaps = 36/298 (12%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYY 411
E +GKG G ++ G V VK E ++ ++H+N++ A
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 412 SKDEKL----LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG- 466
+ LV DY GSL L+ R + + +++ALS A GLAHLH+
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 467 ------KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA--------GYRAP 512
I H ++K+ NIL++ + C++D GL + T +A Y AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 513 EVVETR------KVTFKSDVYSFGVLLLELLTGKAPNQASLGEE----GIDLPRWVQSVV 562
EV++ + ++D+Y+ G++ E+ + + + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 563 REEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620
R+ + + E + + +I C R + + + +++ E
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-54
Identities = 59/270 (21%), Positives = 111/270 (41%), Gaps = 26/270 (9%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYY 411
+ +G G G + V +K ++E A+ + +F + EV+ K+ H +V L
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
+ LV+++M G LS L + R + + + L G+A+L ++H
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLR----TQRGLFAAETLLGMCLDVCEGMAYLE-EACVIHR 125
Query: 472 NIKASNILLRPDHDACVSDFGLNPLF--GNTTPPTRVAG---YRAPEVVETRKVTFKSDV 526
++ A N L+ + VSDFG+ T T + +PEV + + KSDV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 527 YSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMV 586
+SFGVL+ E+ + + ++ + + R L + +
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFR-----------LYKPRLASTHVY 232
Query: 587 QLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
Q++ C P+ RPA ++R + +
Sbjct: 233 QIM---NHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-53
Identities = 57/271 (21%), Positives = 107/271 (39%), Gaps = 28/271 (10%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYY 411
+ LG G G V +K +KE ++ + EF + +V+ + H+ +V L
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
+ ++ +YM G L L R + + + +L +H
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQ-FLHR 124
Query: 472 NIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV-----AGYRAPEVVETRKVTFKSDV 526
++ A N L+ VSDFGL+ + + V + PEV+ K + KSD+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 527 YSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585
++FGVL+ E+ + GK P E + + + + L R H E++
Sbjct: 185 WAFGVLMWEIYSLGKMPY------ERFTNSETAEHIAQ--------GLRLYRPHLASEKV 230
Query: 586 VQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
++ C D+RP + ++ I ++
Sbjct: 231 YTIM---YSCWHEKADERPTFKILLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 4e-53
Identities = 64/267 (23%), Positives = 114/267 (42%), Gaps = 24/267 (8%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYY 411
+ +GKG G G V VK +K A + F + V+ +++H N+V L
Sbjct: 13 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 412 SKDEKL-LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVH 470
+ L +V +YM GSL L GR+ L D ++ +L + +L VH
Sbjct: 71 EEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE-GNNFVH 126
Query: 471 GNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV-AGYRAPEVVETRKVTFKSDVYSF 529
++ A N+L+ D+ A VSDFGL +T ++ + APE + +K + KSDV+SF
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSF 186
Query: 530 GVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLL 589
G+LL E+ + + + D+ V+ + + +
Sbjct: 187 GILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKMDAPDGCPP--------------AVY 230
Query: 590 QIAMGCVSTVPDQRPAMQEVVRMIENM 616
++ C RP+ ++ +E++
Sbjct: 231 EVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-50
Identities = 52/291 (17%), Positives = 115/291 (39%), Gaps = 36/291 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLK--EVAVGKREFEMQMEVLGKIKHDNVVPLRA 408
LG G+ G +K G + K + + + +++VL + +V
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
+YS E + ++M GSL +L + +++++ +GL +L KI
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 469 VHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA--GYRAPEVVETRKVTFKSDV 526
+H ++K SNIL+ + + DFG++ ++ + V Y +PE ++ + +SD+
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 186
Query: 527 YSFGVLLLELLTGKAPNQASLGEE------------GIDLPRWVQSVVREEWTAEVFDVE 574
+S G+ L+E+ G+ P +E + P ++ R + +
Sbjct: 187 WSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRP 246
Query: 575 LMRYHNIEEEMV--------------QLLQIAMGCVSTVPDQRPAMQEVVR 611
M + + +V + C+ P +R +++++
Sbjct: 247 PMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 4e-50
Identities = 70/270 (25%), Positives = 113/270 (41%), Gaps = 26/270 (9%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYY 411
LG+G G + T V +K LK + F + +V+ K++H+ +V L A
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 81
Query: 412 SKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHG 471
S++ +V +YM GSL L G G L + +A A G+A++ VH
Sbjct: 82 SEEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMN-YVHR 137
Query: 472 NIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA-----GYRAPEVVETRKVTFKSDV 526
+++A+NIL+ + V+DFGL L + R + APE + T KSDV
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 197
Query: 527 YSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMV 586
+SFG+LL EL T G ++ V+ R E +
Sbjct: 198 WSFGILLTELTTKGRVPYP--GMVNREVLDQVERGYRMPCPPECPE-------------- 241
Query: 587 QLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
L + C P++RP + + +E+
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (438), Expect = 1e-49
Identities = 71/273 (26%), Positives = 117/273 (42%), Gaps = 26/273 (9%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
LG G G Y+ V ++ TV VK LKE + EF + V+ +IKH N+V L
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 411 YSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVH 470
+ ++ ++M G+L L R + + +A + + +L +H
Sbjct: 83 TREPPFYIITEFMTYGNLLDYLR---ECNRQEVSAVVLLYMATQISSAMEYLEKKN-FIH 138
Query: 471 GNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV-----AGYRAPEVVETRKVTFKSD 525
++ A N L+ +H V+DFGL+ L T + APE + K + KSD
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 526 VYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585
V++FGVLL E+ T GIDL + + + + D + R E++
Sbjct: 199 VWAFGVLLWEIATYGMSP-----YPGIDLSQVYELLEK--------DYRMERPEGCPEKV 245
Query: 586 VQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
+L+ C P RP+ E+ + E M +
Sbjct: 246 YELM---RACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 3e-49
Identities = 64/289 (22%), Positives = 116/289 (40%), Gaps = 37/289 (12%)
Query: 341 FDLEDLLRASAEVLGKGSVGTSYKAVL---EEGTTVVVKRLKEVA--VGKREFEMQMEVL 395
++LL A E LG G+ G+ + V ++ V +K LK+ E + +++
Sbjct: 5 LKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 63
Query: 396 GKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSA 455
++ + +V L + +LV + G L L G R + N +
Sbjct: 64 HQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQV 118
Query: 456 ARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN-------TTPPTRVAG 508
+ G+ +L VH ++ A N+LL H A +SDFGL+ G +
Sbjct: 119 SMGMKYLEEKN-FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 509 YRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWT 567
+ APE + RK + +SDV+S+GV + E L+ G+ P + +G ++ +++ R E
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK---KMKGPEVMAFIEQGKRMECP 234
Query: 568 AEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
E +L + C + RP V + +
Sbjct: 235 PECPP--------------ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (434), Expect = 5e-49
Identities = 62/298 (20%), Positives = 116/298 (38%), Gaps = 50/298 (16%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNV 403
+G+G+ G ++A E T V VK LKE A + +F+ + ++ + + N+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGS-------------------GRTPLD 444
V L L+++YM G L+ L G PL
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 445 WDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN----- 499
++ IA A G+A+L K VH ++ N L+ + ++DFGL+ +
Sbjct: 139 CAEQLCIARQVAAGMAYLS-ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 197
Query: 500 -TTPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWV 558
+ PE + + T +SDV+++GV+L E+ + + E ++ +V
Sbjct: 198 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE--EVIYYV 255
Query: 559 QSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
+ E ++L + C S +P RP+ + R+++ M
Sbjct: 256 RDGNILAC--------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 8e-49
Identities = 68/293 (23%), Positives = 114/293 (38%), Gaps = 44/293 (15%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKIK-HDN 402
+ LG G+ G +A + TV VK LK A + +++VL + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 403 VVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGS-------------GRTPLDWDNRM 449
+V L L++ +Y G L L R S LD ++ +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 450 RIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN------TTPP 503
+ A+G+A L S +H ++ A NILL + DFGL N
Sbjct: 149 SFSYQVAKGMAFLA-SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR 563
+ APE + TF+SDV+S+G+ L EL + + G+ + +++
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-----YPGMPVDSKFYKMIK 262
Query: 564 EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
E + R + E ++ I C P +RP +++V++IE
Sbjct: 263 EGF----------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 9e-49
Identities = 63/280 (22%), Positives = 106/280 (37%), Gaps = 36/280 (12%)
Query: 352 EVLGKGSVGTSYKAVLEE----GTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVP 405
EV+G+G G Y L + VK L + +F + ++ H NV+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 406 LRAFYYSKDEK-LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
L + L+V YM G L + + + L A+G+ L
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLAS 148
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN-----TTPPTRVAG---YRAPEVVE 516
VH ++ A N +L V+DFGL + T + A E ++
Sbjct: 149 KK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576
T+K T KSDV+SFGVLL EL+T AP ++ +++ L+
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDITVYLLQGR--------RLL 254
Query: 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
+ + + ++ + C + RP+ E+V I +
Sbjct: 255 QPEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 5e-48
Identities = 67/285 (23%), Positives = 121/285 (42%), Gaps = 37/285 (12%)
Query: 352 EVLGKGSVGTSYKAVLEEG---TTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVP 405
+V+G+G+ G KA +++ +KR+KE A R+F ++EVL K+ H N++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGS-----------RGSGRTPLDWDNRMRIALS 454
L + L +Y P G+L L S S + L + A
Sbjct: 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135
Query: 455 AARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YRA 511
ARG+ +L + +H ++ A NIL+ ++ A ++DFGL+ T + A
Sbjct: 136 VARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 194
Query: 512 PEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571
E + T SDV+S+GVLL E+++ G+ + + +
Sbjct: 195 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-----YCGMTCAELYEKLPQ-------- 241
Query: 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
L + N ++E+ L+ C P +RP+ +++ + M
Sbjct: 242 GYRLEKPLNCDDEVYDLM---RQCWREKPYERPSFAQILVSLNRM 283
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (423), Expect = 2e-47
Identities = 62/283 (21%), Positives = 113/283 (39%), Gaps = 38/283 (13%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVP 405
+V+G G G L + V +K LK +R+F + ++G+ H NV+
Sbjct: 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 91
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
L +++ ++M GSL + L + G + + A G+ +L
Sbjct: 92 LEGVVTKSTPVMIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLADM 147
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA---------GYRAPEVVE 516
VH ++ A NIL+ + VSDFGL+ + T + APE ++
Sbjct: 148 N-YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 206
Query: 517 TRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575
RK T SDV+S+G+++ E+++ G+ P D+ ++ R +
Sbjct: 207 YRKFTSASDVWSYGIVMWEVMSYGERPYW---DMTNQDVINAIEQDYRLPPPMDCPS--- 260
Query: 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
L Q+ + C + RP ++V ++ M R
Sbjct: 261 -----------ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-47
Identities = 64/267 (23%), Positives = 110/267 (41%), Gaps = 31/267 (11%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEMQM----EVLGKIKHDNVVPL 406
LGKG G Y A ++ + +K L + + K E Q+ E+ ++H N++ L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+++ L+ +Y P G++ L D A L++ H S
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCH-SK 125
Query: 467 KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV--AGYRAPEVVETRKVTFKS 524
+++H +IK N+LL + ++DFG + ++ T Y PE++E R K
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 185
Query: 525 DVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584
D++S GVL E L GK P +A+ +E + VE + E
Sbjct: 186 DLWSLGVLCYEFLVGKPPFEANTYQETYK---------------RISRVEFTFPDFVTEG 230
Query: 585 MVQLLQIAMGCVSTVPDQRPAMQEVVR 611
L+ + P QRP ++EV+
Sbjct: 231 ARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-47
Identities = 68/278 (24%), Positives = 111/278 (39%), Gaps = 38/278 (13%)
Query: 353 VLGKGSVGTSYKAVLEE---GTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPL 406
LG G+ GT K + TV VK LK A K E + V+ ++ + +V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+ +LV + G L+ L +R + N + + + G+ +L S
Sbjct: 74 IGICE-AESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN 127
Query: 467 KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA-------GYRAPEVVETRK 519
VH ++ A N+LL H A +SDFGL+ + + APE + K
Sbjct: 128 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 520 VTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578
+ KSDV+SFGVL+ E + G+ P + G +G ++ ++ R A
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYR---GMKGSEVTAMLEKGERMGCPA---------- 233
Query: 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
EM L+ C + + RP V + N
Sbjct: 234 -GCPREMYDLM---NLCWTYDVENRPGFAAVELRLRNY 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-47
Identities = 53/274 (19%), Positives = 105/274 (38%), Gaps = 32/274 (11%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLR 407
+G GS G K +G +V K L ++ K+ ++ +L ++KH N+V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 408 AFYYSKDEKLL--VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH-- 463
+ L V +Y G L++++ R LD + +R+ L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRR 128
Query: 464 --VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV----AGYRAPEVVET 517
++H ++K +N+ L + + DFGL + + T + Y +PE +
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 188
Query: 518 RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577
KSD++S G LL EL P +L ++
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKELAGKIREGKFRRIP---------- 235
Query: 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
+ +E+ +++ ++ RP+++E++
Sbjct: 236 -YRYSDELNEII---TRMLNLKDYHRPSVEEILE 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 9e-47
Identities = 58/268 (21%), Positives = 100/268 (37%), Gaps = 30/268 (11%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKRE----FEMQMEVLGKIKHDNVVPL 406
+G GS G Y A + V +K++ E ++ L K++H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
R Y + LV +Y + L + PL + A +GLA+LH S
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLH-SH 134
Query: 467 KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYRAPEVVET---RKVTFK 523
++H ++KA NILL + DFG + + APEV+ + K
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 524 SDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583
DV+S G+ +EL K P ++ + + + E A + E
Sbjct: 195 VDVWSLGITCIELAERKPPLF------NMNAMSALYHIAQNESPALQSG-------HWSE 241
Query: 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
+ C+ +P RP + +++
Sbjct: 242 YFRNFV---DSCLQKIPQDRPTSEVLLK 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-45
Identities = 57/271 (21%), Positives = 111/271 (40%), Gaps = 31/271 (11%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRL-KEVAVGKREFEMQMEVLGKIKHDNVVPLRAF 409
LG G+ G YKA +E K + + ++ +++++L H N+V L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
+Y ++ ++ ++ G++ A++ PL + L +LH KI+
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLH-DNKII 132
Query: 470 HGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR----VAGYRAPEVV-----ETRKV 520
H ++KA NIL D D ++DFG++ T + APEVV + R
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 192
Query: 521 TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580
+K+DV+S G+ L+E+ + P+ ++ R + + + E L +
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHH------ELNPMRVLLKIAKSEP------PTLAQPSR 240
Query: 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
L+ C+ D R ++++
Sbjct: 241 WSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-45
Identities = 64/293 (21%), Positives = 119/293 (40%), Gaps = 37/293 (12%)
Query: 352 EVLGKGSVGTSYKAVLEEGT-----TVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVV 404
+V+G G G YK +L+ + V +K LK + +F + ++G+ H N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
L +++ +YM G+L L G + + A G+ +L
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLA- 127
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA-------GYRAPEVVET 517
+ VH ++ A NIL+ + VSDFGL+ + + T + APE +
Sbjct: 128 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187
Query: 518 RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577
RK T SDV+SFG+++ E++T L ++ + + R
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAINDGFRLPT----------- 234
Query: 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDDGLRQSSD 630
+ + Q+ M C +RP ++V +++ + R D L+ +D
Sbjct: 235 ---PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR--APDSLKTLAD 282
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-45
Identities = 60/299 (20%), Positives = 111/299 (37%), Gaps = 51/299 (17%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKI-KHDN 402
+VLG G+ G A V VK LKE A + +++++ ++ H+N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 403 VVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRG------------------SGRTPLD 444
+V L L+++Y G L L R L
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 445 WDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPT 504
+++ + A A+G+ L VH ++ A N+L+ + DFGL + +
Sbjct: 163 FEDLLCFAYQVAKGMEFLE-FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 221
Query: 505 RV------AGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRW 557
+ APE + T KSDV+S+G+LL E+ + G P GI +
Sbjct: 222 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY------PGIPVDAN 275
Query: 558 VQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
+++ + ++ + EE+ ++Q C + +RP+ + +
Sbjct: 276 FYKLIQNGF-------KMDQPFYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLGCQ 324
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 162 bits (411), Expect = 3e-45
Identities = 54/265 (20%), Positives = 104/265 (39%), Gaps = 26/265 (9%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRL-KEVAVGKREFEMQMEVLGKIKHDNVVPLRAF 409
E LG G+ G ++ G K + K +++ + ++H +V L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
+ +E +++Y++M G L + + D + +GL H+H V
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMH-ENNYV 146
Query: 470 HGNIKASNILLRPDHDACV--SDFGLNPLFGNTTP---PTRVAGYRAPEVVETRKVTFKS 524
H ++K NI+ + DFGL T A + APEV E + V + +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206
Query: 525 DVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584
D++S GVL LL+G +P G + +++V +W ++ + I E+
Sbjct: 207 DMWSVGVLSYILLSGLSPFG------GENDDETLRNVKSCDWN-----MDDSAFSGISED 255
Query: 585 MVQLLQIAMGCVSTVPDQRPAMQEV 609
++ + P+ R + +
Sbjct: 256 GKDFIR---KLLLADPNTRMTIHQA 277
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-44
Identities = 64/272 (23%), Positives = 111/272 (40%), Gaps = 33/272 (12%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKRE---FEMQMEVLGKIKHDNVVPLR 407
+G+GS T YK + E V L++ + K E F+ + E+L ++H N+V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 408 AFYYS----KDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
+ S K +LV + M +G+L L + + +GL LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 129
Query: 464 VSG-KIVHGNIKASNILLR-PDHDACVSDFGLNPLFGNTTPPTRV--AGYRAPEVVETRK 519
I+H ++K NI + P + D GL L + + + APE+ E K
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-EK 188
Query: 520 VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579
DVY+FG+ +LE+ T + P + R V S V+ +V E+
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSGVKPASFDKVAIPEVK--- 243
Query: 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
+I GC+ D+R ++++++
Sbjct: 244 ----------EIIEGCIRQNKDERYSIKDLLN 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-44
Identities = 61/279 (21%), Positives = 109/279 (39%), Gaps = 38/279 (13%)
Query: 352 EVLGKGSVGTSYKAVLE----EGTTVVVKRLKEVAVGK----REFEMQMEVLGKIKHDNV 403
E LG GS G + + + +V VK LK + + +F ++ + + H N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
+ L + K+ V + P GSL L +G R A+ A G+ +L
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLE 128
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG----NTTPPTRVAG---YRAPEVVE 516
S + +H ++ A N+LL + DFGL + + APE ++
Sbjct: 129 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 517 TRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575
TR + SD + FGV L E+ T G+ P G++ + + + +E
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEP------WIGLNGSQILHKIDKEGE--------- 232
Query: 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIE 614
R E+ + + + C + P+ RP + +
Sbjct: 233 -RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 2e-43
Identities = 58/266 (21%), Positives = 112/266 (42%), Gaps = 28/266 (10%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRL-KEVAVGKREFEMQMEVLGKIKHDNVVPLRAF 409
E +G+G+ GT Y A+ + G V ++++ + K ++ V+ + K+ N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
Y DE +V +Y+ GSL+ ++ T +D + + L LH S +++
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLH-SNQVI 138
Query: 470 HGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA----GYRAPEVVETRKVTFKSD 525
H +IK+ NILL D ++DFG + APEVV + K D
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 526 VYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585
++S G++ +E++ G+ P + R + + EL +
Sbjct: 199 IWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGT------PELQNPEKLSAIF 246
Query: 586 VQLLQIAMGCVSTVPDQRPAMQEVVR 611
L C+ ++R + +E+++
Sbjct: 247 RDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-43
Identities = 55/281 (19%), Positives = 103/281 (36%), Gaps = 34/281 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRL--KEVAVGKREFEMQMEVLGKIKHDNVVPLRA 408
+ LG+G+ G AV V VK + K + ++ + + H+NVV
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
+ + L +Y G L + + + R G+ +LH I
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLH-GIGI 124
Query: 469 VHGNIKASNILLRPDHDACVSDFGLNPLF---GNTTPPTRVAG---YRAPEVVETRKV-T 521
H +IK N+LL + +SDFGL +F ++ G Y APE+++ R+
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 522 FKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581
DV+S G++L +L G+ + + W + + I
Sbjct: 185 EPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWKEKKTYLN-----------PWKKI 232
Query: 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVR---MIENMNRG 619
+ + LL + P R + ++ + + + +G
Sbjct: 233 DSAPLALLH---KILVENPSARITIPDIKKDRWYNKPLKKG 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-43
Identities = 66/297 (22%), Positives = 115/297 (38%), Gaps = 40/297 (13%)
Query: 352 EVLGKGSVGTSYKAVL------EEGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNV 403
LG+GS G Y+ V E T V +K + E A + EF + V+ + +V
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSG-----RTPLDWDNRMRIALSAARG 458
V L L++ + M G L + L R + P +++A A G
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 459 LAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN------TTPPTRVAGYRAP 512
+A+L+ + K VH ++ A N ++ D + DFG+ + +P
Sbjct: 146 MAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204
Query: 513 EVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD 572
E ++ T SDV+SFGV+L E+ T +G+ + ++ V+
Sbjct: 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQGLSNEQVLRFVMEGG------- 252
Query: 573 VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDDGLRQSS 629
+ L ++ C P RP+ E++ I+ E + G R+ S
Sbjct: 253 ----LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK----EEMEPGFREVS 301
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 157 bits (397), Expect = 3e-43
Identities = 58/267 (21%), Positives = 109/267 (40%), Gaps = 26/267 (9%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRL-KEVAVGKREFEMQMEVLGKIKHDNVVPLRAF 409
E LG G+ G ++ V G V K + + K + ++ ++ ++ H ++ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
+ K E +L+ +++ G L + + + A GL H+H IV
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEHS-IV 149
Query: 470 HGNIKASNILLRPDHDA--CVSDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKVTFKS 524
H +IK NI+ + + DFGL + APE+V+ V F +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 525 DVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584
D+++ GVL LL+G +P G D +Q+V R +W FD + + ++ E
Sbjct: 210 DMWAIGVLGYVLLSGLSPFA------GEDDLETLQNVKRCDWE---FDEDA--FSSVSPE 258
Query: 585 MVQLLQIAMGCVSTVPDQRPAMQEVVR 611
++ + P +R + + +
Sbjct: 259 AKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 7e-43
Identities = 56/277 (20%), Positives = 108/277 (38%), Gaps = 35/277 (12%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVP 405
+G+G G ++ + V +K K + +F + + + H ++V
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
L +++ ++ + G L + L + LD + + A + LA+L S
Sbjct: 73 LIG-VITENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLE-S 126
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGLNPLF--GNTTPPTRVAG---YRAPEVVETRKV 520
+ VH +I A N+L+ + + DFGL+ ++ + APE + R+
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 521 TFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579
T SDV+ FGV + E+L G P Q G + D+ +++ R
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQ---GVKNNDVIGRIENGERLPMPP----------- 232
Query: 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
N + L+ C + P +RP E+ + +
Sbjct: 233 NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 7e-42
Identities = 51/266 (19%), Positives = 106/266 (39%), Gaps = 25/266 (9%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
E LG+G G ++ V T + K +K + + ++ +L +H N++ L +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 411 YSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVH 470
S +E +++++++ + ++ S L+ + L LH S I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLH-SHNIGH 125
Query: 471 GNIKASNILLRPDHDACV--SDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKVTFKSD 525
+I+ NI+ + + + +FG + Y APEV + V+ +D
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATD 185
Query: 526 VYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585
++S G L+ LL+G P + +++++ E+T FD E + I E
Sbjct: 186 MWSLGTLVYVLLSGINPFL------AETNQQIIENIMNAEYT---FDEEA--FKEISIEA 234
Query: 586 VQLLQIAMGCVSTVPDQRPAMQEVVR 611
+ + + R E ++
Sbjct: 235 MDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 7e-42
Identities = 70/293 (23%), Positives = 118/293 (40%), Gaps = 45/293 (15%)
Query: 352 EVLGKGSVGTSYKAVL--------EEGTTVVVKRLKEVAVGK--REFEMQMEVLGKI-KH 400
+ LG+G+ G A T V VK LK A K + +ME++ I KH
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 401 DNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSG-----------RTPLDWDNRM 449
N++ L ++ +Y G+L L R G L + +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 450 RIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV--- 506
A ARG+ +L S K +H ++ A N+L+ D+ ++DFGL + +
Sbjct: 139 SCAYQVARGMEYLA-SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 507 ---AGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR 563
+ APE + R T +SDV+SFGVLL E+ T + E +L + ++ R
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--ELFKLLKEGHR 255
Query: 564 EEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
+ + + +L + C VP QRP +++V ++ +
Sbjct: 256 MDKPSNCTN--------------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-41
Identities = 62/281 (22%), Positives = 107/281 (38%), Gaps = 37/281 (13%)
Query: 352 EVLGKGSVGTSYKAVL-----EEGTTVVVKRLKEVAVGK--REFEMQMEVLGKIKHDNVV 404
+VLG G+ GT YK + + V +K L+E K +E + V+ + + +V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
L L+ MP G L + + + + + A+G+ +L
Sbjct: 75 RLL-GICLTSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLED 129
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG------YRAPEVVETR 518
+VH ++ A N+L++ ++DFGL L G G + A E + R
Sbjct: 130 RR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 519 KVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577
T +SDV+S+GV + EL+T G P G ++ ++ R
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGERLPQPPICTI----- 240
Query: 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618
+ I + C D RP +E++ M R
Sbjct: 241 ---------DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-40
Identities = 74/292 (25%), Positives = 114/292 (39%), Gaps = 43/292 (14%)
Query: 352 EVLGKGSVGTSYKAV------LEEGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHD-N 402
+ LG+G+ G +A TV VK LKE A R ++++L I H N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 403 VVPLRAFYYSKDEKL-LVYDYMPAGSLSALLHGSRGS-----------GRTPLDWDNRMR 450
VV L L ++ ++ G+LS L R + L ++ +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 451 IALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVA--- 507
+ A+G+ L S K +H ++ A NILL + + DFGL R
Sbjct: 139 YSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197
Query: 508 ---GYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE 564
+ APE + R T +SDV+SFGVLL E+ + A G+ + ++E
Sbjct: 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKIDEEFCRRLKE 252
Query: 565 EWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616
D EM Q + + C P QRP E+V + N+
Sbjct: 253 GTRMRAPD-------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 9e-40
Identities = 49/277 (17%), Positives = 97/277 (35%), Gaps = 35/277 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKRE----FEMQMEVLGKIKHDNVVPL 406
++LG+GS T A L +K L++ + K + +V+ ++ H V L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+ ++ Y G L + D L +LH
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLH-GK 127
Query: 467 KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTR------VAGYRAPEVVETRKV 520
I+H ++K NILL D ++DFG + + R A Y +PE++ +
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 521 TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580
SD+++ G ++ +L+ G P +A + Q +++ E+
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAG------NEYLIFQKIIKLEYDFP---------EK 232
Query: 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617
+ L++ + +R +E+
Sbjct: 233 FFPKARDLVE---KLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-39
Identities = 57/271 (21%), Positives = 104/271 (38%), Gaps = 28/271 (10%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
+VLG G G + +K L++ +RE E+ + ++V + Y
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRAS---QCPHIVRIVDVY 74
Query: 411 YSKDEK----LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+ L+V + + G L + + G I S + +LH S
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH-SI 130
Query: 467 KIVHGNIKASNILL---RPDHDACVSDFGLNPLFGNTTPPTRV---AGYRAPEVVETRKV 520
I H ++K N+L RP+ ++DFG + T Y APEV+ K
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 190
Query: 521 TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580
D++S GV++ LL G P G+ + +++ +R ++ +
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFY---SNHGLAISPGMKTRIRMGQ----YEFPNPEWSE 243
Query: 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
+ EE+ L++ + T P QR + E +
Sbjct: 244 VSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (363), Expect = 5e-39
Identities = 57/269 (21%), Positives = 109/269 (40%), Gaps = 29/269 (10%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEV--LGKIKHDNVVPLRA 408
+VLG G+ A V +K + + A+ +E M+ E+ L KIKH N+V L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
Y S L+ + G L + + + R+ + +LH I
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIV-----EKGFYTERDASRLIFQVLDAVKYLH-DLGI 128
Query: 469 VHGNIKASNILLR---PDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVVETRKVTF 522
VH ++K N+L D +SDFGL+ + + + G Y APEV+ + +
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 188
Query: 523 KSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582
D +S GV+ LL G P + + + +++ E ++ + + +I
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFY------DENDAKLFEQILKAE-----YEFDSPYWDDIS 237
Query: 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
+ ++ + P++R ++ ++
Sbjct: 238 DSAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 141 bits (356), Expect = 2e-38
Identities = 58/279 (20%), Positives = 104/279 (37%), Gaps = 41/279 (14%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLK----------EVAVGKREFEMQMEVLGKIK- 399
E+LG+G + + VK + EV + ++++L K+
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 400 HDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGL 459
H N++ L+ Y + LV+D M G L L + L +I + +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVI 123
Query: 460 AHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVVE 516
LH IVH ++K NILL D + ++DFG + V G Y APE++E
Sbjct: 124 CALH-KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182
Query: 517 T------RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEV 570
+ D++S GV++ LL G P + + + R + S
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW---HRKQMLMLRMIMS--------GN 231
Query: 571 FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEV 609
+ + + + + L+ + P +R +E
Sbjct: 232 YQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 138 bits (349), Expect = 2e-37
Identities = 57/285 (20%), Positives = 109/285 (38%), Gaps = 37/285 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGK----REFEMQMEVLGKIKHDNVVPL 406
E+LG G + + A L V VK L+ F + + + H +V +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 407 RAFYYSKDEKL----LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
++ +V +Y+ +L ++H P+ + + A + L
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFS 127
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV-------AGYRAPEVV 515
H +G I+H ++K +NI++ + V DFG+ ++ A Y +PE
Sbjct: 128 HQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 516 ETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575
V +SDVYS G +L E+LTG+ P G VRE+
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSVAYQHVREDPIP-----PS 235
Query: 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRP-AMQEVVRMIENMNRG 619
R+ + ++ ++ + ++ P+ R E+ + ++ G
Sbjct: 236 ARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLVRVHNG 277
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (345), Expect = 1e-36
Identities = 43/290 (14%), Positives = 93/290 (32%), Gaps = 33/290 (11%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
+G GS G Y + G V +K V + ++ ++ ++ +P +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 411 YSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVH 470
++ + ++ + SL L + + +A + ++H S +H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIH-SKNFIH 126
Query: 471 GNIKASNILLR---PDHDACVSDFGLNPLFGN-----------TTPPTRVAGYRAPEVVE 516
++K N L+ + + DFGL + + T A Y +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576
+ + + D+ S G +L+ G P Q + ++ +
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQ-------GLKAATKRQKYERISEKKMSTPIEV 239
Query: 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM--NRGETDDG 624
E L C S D +P + ++ N+ +G + D
Sbjct: 240 LCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 286
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 74/284 (26%), Positives = 106/284 (37%), Gaps = 35/284 (12%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFY 410
+V+G GS G Y+A L + G V +K++ + KR +++++ K+ H N+V LR F+
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 411 YSKDEK------LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
YS EK LV DY+P H SR L R LA++H
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ--TLPVIYVKLYMYQLFRSLAYIH- 139
Query: 465 SGKIVHGNIKASNILLRPD-HDACVSDFGLNPLFGNTTPPTRVA---GYRAP-EVVETRK 519
S I H +IK N+LL PD + DFG P YRAP +
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 199
Query: 520 VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEV--------- 570
T DV+S G +L ELL G+ G + + V E E+
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 259
Query: 571 -----FDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEV 609
+ E + L + P R E
Sbjct: 260 PQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEA 300
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 136 bits (343), Expect = 7e-36
Identities = 54/268 (20%), Positives = 102/268 (38%), Gaps = 32/268 (11%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKREFEMQ-------MEVLGKIKHDNV 403
++G+G G Y + G +K L + + ++ E + ++ +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
V + +++ D+ + D M G L L + A GL H+H
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMH 124
Query: 464 VSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV--AGYRAPEVVET-RKV 520
+ +V+ ++K +NILL +SD GL F P V GY APEV++
Sbjct: 125 -NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY 183
Query: 521 TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580
+D +S G +L +LL G +P + ++ ++ R ++ E +
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP------------DS 231
Query: 581 IEEEMVQLLQIAMGCVSTVPDQRPAMQE 608
E+ LL+ G + ++R
Sbjct: 232 FSPELRSLLE---GLLQRDVNRRLGCLG 256
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 132 bits (333), Expect = 4e-35
Identities = 41/293 (13%), Positives = 84/293 (28%), Gaps = 37/293 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVP-LRAF 409
+G+GS G ++ L V +K + + + + +P + F
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIV 469
+LV D + L R A + +H +V
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEKS-LV 123
Query: 470 HGNIKASNILL-----RPDHDACVSDFGLNPLFGNTTPPTRV-----------AGYRAPE 513
+ +IK N L+ + + V DFG+ + + + A Y +
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 514 VVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573
R+ + + D+ + G + + L G P Q + + E+
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA- 242
Query: 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM--NRGETDDG 624
EE + + + D P + + + T+D
Sbjct: 243 ------GFPEEFYKYMHY---ARNLAFDATPDYDYLQGLFSKVLERLNTTEDE 286
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 4e-35
Identities = 57/275 (20%), Positives = 106/275 (38%), Gaps = 35/275 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLK-------EVAVGKREFEMQMEVLGKIKHDNV 403
E LG G K G K +K V + + E ++ +L +I+H NV
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLH 463
+ L Y +K + +L+ + + G L L + L + G+ +LH
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLH 130
Query: 464 VSGKIVHGNIKASNILLRPDHDA----CVSDFGLNPLFGNTTPPTRVAG---YRAPEVVE 516
S +I H ++K NI+L + + DFGL + G + APE+V
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189
Query: 517 TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576
+ ++D++S GV+ LL+G +P +E +A ++ E
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----------TLANVSAVNYEFEDE 238
Query: 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
+ N ++ + P +R +Q+ ++
Sbjct: 239 YFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 131 bits (329), Expect = 9e-35
Identities = 55/282 (19%), Positives = 113/282 (40%), Gaps = 31/282 (10%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRL---KEVAVGKREFEMQMEVLGKIKHDNVVPLRA 408
E +G+G+ G YKA G T +K++ KE ++ +L ++KH N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 409 FYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKI 468
++K +LV++++ L L+ L G+A+ H ++
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDV-----CEGGLESVTAKSFLLQLLNGIAYCH-DRRV 121
Query: 469 VHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPT----RVAGYRAPEVVE-TRKVTFK 523
+H ++K N+L+ + + ++DFGL FG YRAP+V+ ++K +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 524 SDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH---- 579
D++S G + E++ G + + + + V ++ +
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 580 ----------NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
++E + LL + P+QR ++ +
Sbjct: 242 EPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALE 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 8e-34
Identities = 55/279 (19%), Positives = 99/279 (35%), Gaps = 22/279 (7%)
Query: 352 EVLGKGSVGTSYKA--VLEEGTTVVVKRLK-EVAVGKREFEMQMEV-----LGKIKHDNV 403
+G+G+ G +KA + G V +KR++ + EV L +H NV
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 404 VPLRAFYYSKDEKLLVYDYMPAGSLS-ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
V L + + L + + + RGL L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVVETRK 519
H S ++VH ++K NIL+ ++DFGL ++ T V YRAPEV+
Sbjct: 133 H-SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 191
Query: 520 VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579
D++S G + E+ K + S + + V + EE + +H
Sbjct: 192 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH 251
Query: 580 NIEEEMV---------QLLQIAMGCVSTVPDQRPAMQEV 609
+ + + + + C++ P +R +
Sbjct: 252 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-33
Identities = 63/270 (23%), Positives = 107/270 (39%), Gaps = 34/270 (12%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGKRE----FEMQMEVLGK-IKHDNVVP 405
++LGKGS G + A ++ +K LK+ V + ++ VL +H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 406 LRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS 465
+ + +K+ V +Y+ G L + D A GL LH
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 466 GKIVHGNIKASNILLRPDHDACVSDFGL-NPLFGNTTPPTRVAG---YRAPEVVETRKVT 521
G IV+ ++K NILL D ++DFG+ G Y APE++ +K
Sbjct: 123 G-IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 522 FKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581
D +SFGVLL E+L G++P G++ +L ++ +
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIRM------------DNPFYPRWL 226
Query: 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
E+E LL P++R ++ +R
Sbjct: 227 EKEAKDLLV---KLFVREPEKRLGVRGDIR 253
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-32
Identities = 58/286 (20%), Positives = 110/286 (38%), Gaps = 34/286 (11%)
Query: 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEVAVGK------REFEMQMEVLGKIKHDNVV 404
+ LG+G T YKA + V +K++K + R ++++L ++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 405 PLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
L + K LV+D+M + S L + L +GL +LH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLH- 117
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPPTRVAGYRAPEVVETRKV 520
I+H ++K +N+LL + ++DFGL FG+ T YRAPE++ ++
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 521 -TFKSDVYSFGVLLLELLTGKAPNQASLGEEGI-------------DLPRWVQSVVREEW 566
D+++ G +L ELL + + P +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 567 TAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612
+ + ++++ L+Q G P R + ++M
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-32
Identities = 55/281 (19%), Positives = 113/281 (40%), Gaps = 31/281 (11%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLK---EVAVGKREFEMQMEVLGKIKHDNVVPLR 407
E +G+G+ G YKA G V +K+++ E ++ +L ++ H N+V L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
+++++ LV++++ + S T + +GLA H S +
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFM----DASALTGIPLPLIKSYLFQLLQGLAFCH-SHR 122
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPPTRVAGYRAPEVV-ETRKVTF 522
++H ++K N+L+ + ++DFGL FG T YRAPE++ + +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 523 KSDVYSFGVLLLELLTGKAP-----NQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577
D++S G + E++T +A L L + V + + +
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 578 Y---------HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEV 609
+ ++E+ LL + P++R + +
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-32
Identities = 49/274 (17%), Positives = 96/274 (35%), Gaps = 43/274 (15%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLK-------EVAVGKREFEMQMEVLGKIK--HD 401
+LG G G+ Y + + + V +K ++ M++ +L K+
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 402 NVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
V+ L ++ D +L+ + RG L + + H
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRH 125
Query: 462 LHVSGKIVHGNIKASNILLRPD-HDACVSDFGLNPLFGNTTPPTRV--AGYRAPEVVETR 518
H G ++H +IK NIL+ + + + DFG L +T Y PE +
Sbjct: 126 CHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 519 KV-TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577
+ + V+S G+LL +++ G P + E+ ++
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHD---------------------EEIIRGQVFF 223
Query: 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
+ E L++ C++ P RP +E+
Sbjct: 224 RQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 53/291 (18%), Positives = 111/291 (38%), Gaps = 41/291 (14%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRA 408
+G+G+ G A V +K++ + ++++L + +H+N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 409 FYYSKDEKLLVYDYM----PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV 464
+ + + Y+ L LL L D+ RGL ++H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLK------TQHLSNDHICYFLYQILRGLKYIH- 126
Query: 465 SGKIVHGNIKASNILLRPDHDACVSDFGL-------NPLFGNTTPPTRVAGYRAPEVVET 517
S ++H ++K SN+LL D + DFGL + G T YRAPE++
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 518 RKV-TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576
K T D++S G +L E+L+ + + ++ + +E + +++
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 577 RY----------------HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
Y N + + + LL ++ P +R +++ +
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALA 294
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (308), Expect = 2e-31
Identities = 54/260 (20%), Positives = 93/260 (35%), Gaps = 30/260 (11%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGK----REFEMQMEVLGKIKHDNVVPL 406
LG GS G + G +K LK+ V + + +L + H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+ + ++ DY+ G L +LL A L +LH S
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLH-SK 123
Query: 467 KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-TPPTRVAGYRAPEVVETRKVTFKSD 525
I++ ++K NILL + ++DFG + Y APEVV T+ D
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSID 183
Query: 526 VYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEM 585
+SFG+L+ E+L G P + + + ++ E E++
Sbjct: 184 WWSFGILIYEMLAGYTPFY------DSNTMKTYEKILNAELR---------FPPFFNEDV 228
Query: 586 VQLLQIAMGCVSTVPDQRPA 605
LL ++ QR
Sbjct: 229 KDLLS---RLITRDLSQRLG 245
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (294), Expect = 2e-29
Identities = 45/253 (17%), Positives = 92/253 (36%), Gaps = 20/253 (7%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKRE----FEMQMEVLGKIKHDNVVPL 406
+ LG GS G E G +K L + V K + + +L + +V L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+ +V +Y+ G + + L + A +LH S
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 467 KIVHGNIKASNILLRPDHDACVSDFGL-NPLFGNTTPPTRVAGYRAPEVVETRKVTFKSD 525
+++ ++K N+L+ V+DFG + G T APE++ ++ D
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVD 220
Query: 526 VYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM--------R 577
++ GVL+ E+ G P A + + + +++++ D+ R
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKR 280
Query: 578 YHNIEEEMVQLLQ 590
+ N++ + +
Sbjct: 281 FGNLKNGVNDIKN 293
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-29
Identities = 59/286 (20%), Positives = 112/286 (39%), Gaps = 39/286 (13%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGK---REFEMQMEVLGKIKHDNVVPLR 407
+ +G G+ G AV G V +K+L + + ++ +L ++H+NV+ L
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 408 AFYYSKD------EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
+ + + LV +M + H L D + +GL +
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRY 136
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN-TTPPTRVAGYRAPEVV-ETRK 519
+H + I+H ++K N+ + D + + DFGL + T YRAPEV+ +
Sbjct: 137 IH-AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMR 195
Query: 520 VTFKSDVYSFGVLLLELLTGKAPNQAS------------LGEEGIDLPRWVQSVVREEWT 567
T D++S G ++ E++TGK + S G + + +QS + +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 568 AEVFDVELMRYH----NIEEEMVQLLQIAMGCVSTVPDQRPAMQEV 609
+ ++E + N V LL+ + +QR E
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAGEA 298
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 4e-28
Identities = 54/264 (20%), Positives = 94/264 (35%), Gaps = 33/264 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKRE----FEMQMEVLGKIKHDNVVPL 406
++LGKG+ G G +K L++ + ++ + VL +H + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 407 RAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG 466
+ + + D V +Y G L L + L +LH
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 467 KIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRV----AGYRAPEVVETRKVTF 522
+V+ +IK N++L D ++DFGL + + Y APEV+E
Sbjct: 126 -VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 523 KSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582
D + GV++ E++ G+ P D R + ++ E E+ +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPF------YNQDHERLFELILME---------EIRFPRTLS 229
Query: 583 EEMVQLLQIAMGCVSTVPDQRPAM 606
E LL G + P QR
Sbjct: 230 PEAKSLLA---GLLKKDPKQRLGG 250
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-27
Identities = 52/281 (18%), Positives = 110/281 (39%), Gaps = 27/281 (9%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGK---REFEMQMEVLGKIKHDNVVPLR 407
E +G+G+ GT +KA E V +KR++ + ++ +L ++KH N+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 408 AFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
+S + LV+++ + LD + +GL H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRN- 121
Query: 468 IVHGNIKASNILLRPDHDACVSDFGLNPLFGN----TTPPTRVAGYRAPEVVETRKV-TF 522
++H ++K N+L+ + + +++FGL FG + YR P+V+ K+ +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 523 KSDVYSFGVLLLELLTGKAP-NQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581
D++S G + EL P + ++ + + EE + + + + +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 582 EEEMVQLLQIA-----------MGCVSTVPDQRPAMQEVVR 611
L+ + + P QR + +E ++
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-27
Identities = 58/296 (19%), Positives = 107/296 (36%), Gaps = 47/296 (15%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLK---EVAVGKREFEMQMEVLGKIKHDNVVPLR 407
+G+G+ G +KA + G V +K++ E ++++L +KH+NVV L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 408 AFYYSKDEK--------LLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGL 459
+K LV+D+ L G + R+ GL
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHD-----LAGLLSNVLVKFTLSEIKRVMQMLLNGL 130
Query: 460 AHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG-----NTTPPTRVAG---YRA 511
++H KI+H ++KA+N+L+ D ++DFGL F T YR
Sbjct: 131 YYIH-RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 512 PEVVETRK-VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEV 570
PE++ + D++ G ++ E+ T Q + + + L + + E V
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 571 FDVELMRYHNI-----------------EEEMVQLLQIAMGCVSTVPDQRPAMQEV 609
+ EL + + + L+ + P QR +
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID---KLLVLDPAQRIDSDDA 302
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 108 bits (269), Expect = 2e-26
Identities = 49/292 (16%), Positives = 101/292 (34%), Gaps = 50/292 (17%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-HDNVVPLRAF 409
LG+G ++A+ + VVVK LK V K++ + ++++L ++ N++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADI 98
Query: 410 YYSKDEKL--LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGK 467
+ LV++++ L L + + L + H G
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG- 149
Query: 468 IVHGNIKASNILL-RPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEV-VETRKVTF 522
I+H ++K N+++ + D+GL + ++ PE+ V+ + +
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 209
Query: 523 KSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD---------- 572
D++S G +L ++ K P G + D + V+ E + D
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267
Query: 573 ---------------VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEV 609
V H + E + L + R +E
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLD---KLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-25
Identities = 59/272 (21%), Positives = 98/272 (36%), Gaps = 37/272 (13%)
Query: 352 EVLGKGSVGTSYKAVL----EEGTTVVVKRLKEVAVGKRE-----FEMQMEVLGKIKH-D 401
+VLG G+ G + + G +K LK+ + ++ + +VL I+
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 402 NVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
+V L + ++ + L+ DY+ G L L R L H
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEH 144
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN-----TTPPTRVAGYRAPEVVE 516
LH G I++ +IK NILL + ++DFGL+ F Y AP++V
Sbjct: 145 LHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 517 T--RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574
D +S GVL+ ELLTG +P + + E + + E
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-----------SQAEISRRILKSE 252
Query: 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAM 606
+ L+Q + P +R
Sbjct: 253 PPYPQEMSALAKDLIQ---RLLMKDPKKRLGC 281
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (264), Expect = 2e-25
Identities = 40/231 (17%), Positives = 81/231 (35%), Gaps = 19/231 (8%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKH---------- 400
LG G T + A + T V +K ++ V E ++++L ++
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 401 -DNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGL 459
++++ L + K + + LL + + +I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 460 AHLHVSGKIVHGNIKASNILLRP-DHDACVSDFGLNPLFGNTTPPTRVA------GYRAP 512
++H I+H +IK N+L+ D + + L YR+P
Sbjct: 139 DYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP 198
Query: 513 EVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR 563
EV+ +D++S L+ EL+TG + G + ++
Sbjct: 199 EVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 4e-24
Identities = 55/285 (19%), Positives = 106/285 (37%), Gaps = 37/285 (12%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLK---EVAVGKREFEMQMEVLGKIKHDNVVPLR 407
+G G+ G+ A + G V VK+L + + + ++ +L +KH+NV+ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 408 AFYYSKD-----EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHL 462
+ + + ++ L+ ++ L D+ + RGL ++
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK------CQKLTDDHVQFLIYQILRGLKYI 137
Query: 463 HVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-TPPTRVAGYRAPEVV-ETRKV 520
H S I+H ++K SN+ + D + + DFGL + T YRAPE++
Sbjct: 138 H-SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHY 196
Query: 521 TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY-- 578
D++S G ++ ELLTG+ + + + L + E ++ Y
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 579 --------------HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEV 609
V LL+ + D+R +
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 5e-24
Identities = 51/300 (17%), Positives = 104/300 (34%), Gaps = 52/300 (17%)
Query: 352 EVLGKGSVGTSYKAV-LEEGTTVVVKRLKEVAVGK---REFEMQMEVLGKIKHDNVVPLR 407
+ +G G+ G A V +K+L + + ++ ++ + H N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 408 AFYYSKD------EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAH 461
+ + + LV + M A + LD + + G+ H
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKH 134
Query: 462 LHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAG---YRAPEVVETR 518
LH S I+H ++K SNI+++ D + DFGL G + T YRAPEV+
Sbjct: 135 LH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 519 KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGID------------------------- 553
D++S G ++ E++ K + +
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 554 --LPRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611
P++ + + +F + + LL + P +R ++ + ++
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS---KMLVIDPAKRISVDDALQ 310
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 87.4 bits (215), Expect = 4e-19
Identities = 46/186 (24%), Positives = 72/186 (38%), Gaps = 31/186 (16%)
Query: 48 QWNASDSACNWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSG 107
+ + + + + L L G L TL L+ L L L +N++S
Sbjct: 199 LESLIATNNQISDITPLGILTNLDELSLNGNQLKDI---GTLASLTNLTDLDLANNQISN 255
Query: 108 EIPSDFSNLTLLRSLYLQSNQFSGVFP--------------------ASVTRMNRLTRLD 147
P S LT L L L +NQ S + P + ++ + LT L
Sbjct: 256 LAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLT 313
Query: 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPAT 206
L NN S P ++LT L LF NNK S + S+ N N+ + +N ++ P
Sbjct: 314 LYFNNISDISPV--SSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP-- 368
Query: 207 LSKFPQ 212
L+ +
Sbjct: 369 LANLTR 374
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.7 bits (177), Expect = 3e-14
Identities = 36/162 (22%), Positives = 61/162 (37%), Gaps = 27/162 (16%)
Query: 56 CNWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIP----- 110
+ A+ + + L L + P L L++L L L +N++S P
Sbjct: 229 NQLKDIGTLASLTNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISPLAGLT 285
Query: 111 ---------------SDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSG 155
S SNL L L L N S + P V+ + +L RL ++N S
Sbjct: 286 ALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343
Query: 156 KIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNN 197
+ NLT++ L +N+ S P N + +++
Sbjct: 344 --VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.1 bits (165), Expect = 9e-13
Identities = 40/177 (22%), Positives = 66/177 (37%), Gaps = 29/177 (16%)
Query: 56 CNWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSN 115
+ A + + SL + P L+ L LSL N+L ++
Sbjct: 185 NKVSDISVLAKLTNLESLIATNNQISDITPLG---ILTNLDELSLNGNQLKD--IGTLAS 239
Query: 116 LTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFD--------------- 160
LT L L L +NQ S + P ++ + +LT L L +N S P
Sbjct: 240 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL 297
Query: 161 -----VNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQ 212
++NL +LT L L N S P + L+ +NN ++ ++L+
Sbjct: 298 EDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD--VSSLANLTN 352
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 4e-07
Identities = 17/92 (18%), Positives = 35/92 (38%), Gaps = 9/92 (9%)
Query: 83 PIPPNTL---GKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTR 139
P N + L++ L ++ + ++L + +L + V
Sbjct: 9 DTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEY 64
Query: 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLF 171
+N LT+++ S+N + P NLT L +
Sbjct: 65 LNNLTQINFSNNQLTDITPL--KNLTKLVDIL 94
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 19/85 (22%), Positives = 31/85 (36%), Gaps = 4/85 (4%)
Query: 114 SNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLE 173
+ L L + S T ++++T L I V L +LT +
Sbjct: 19 TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFS 74
Query: 174 NNKFSGNLPSINPANLRDFNVSNNN 198
NN+ + P N L D ++NN
Sbjct: 75 NNQLTDITPLKNLTKLVDILMNNNQ 99
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 9e-05
Identities = 15/81 (18%), Positives = 28/81 (34%), Gaps = 6/81 (7%)
Query: 125 QSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI 184
Q + +F + + + L N + + +L +T L + ++ +
Sbjct: 8 QDTPINQIFTDTA--LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGV 62
Query: 185 -NPANLRDFNVSNNNLNGSIP 204
NL N SNN L P
Sbjct: 63 EYLNNLTQINFSNNQLTDITP 83
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (183), Expect = 2e-15
Identities = 40/141 (28%), Positives = 59/141 (41%), Gaps = 2/141 (1%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
+P +T L L L L NR+S F L L L L N+ + V P + + RL
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSIN-PANLRDFNVSNNNLNGS 202
L L +NN S + L L L L +N + + + A L+ F S++ + S
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263
Query: 203 IPATLSKFPQSSFTGNLDLCG 223
+P L+ N DL G
Sbjct: 264 LPQRLAGRDLKRLAAN-DLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (104), Expect = 1e-05
Identities = 35/157 (22%), Positives = 54/157 (34%), Gaps = 13/157 (8%)
Query: 62 ECDANRSFVYSLRLPGVGLV---GPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTL 118
C + P GL IP + + + L NR+S + F
Sbjct: 5 ACVCYNEPKVTTSCPQQGLQAVPVGIPAAS-------QRIFLHGNRISHVPAASFRACRN 57
Query: 119 LRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKI-PFDVNNLTHLTGLFLENNKF 177
L L+L SN + + A+ T + L +LDLS N + P + L L L L+
Sbjct: 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 178 SGNLPSINP--ANLRDFNVSNNNLNGSIPATLSKFPQ 212
P + A L+ + +N L T
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN 154
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 73.6 bits (179), Expect = 7e-15
Identities = 22/83 (26%), Positives = 30/83 (36%), Gaps = 20/83 (24%)
Query: 147 DLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPAT 206
DL +N G +P + L L L + N G +P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN-------------------- 289
Query: 207 LSKFPQSSFTGNLDLCGGPLPPC 229
L +F S++ N LCG PLP C
Sbjct: 290 LQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 69.8 bits (169), Expect = 2e-13
Identities = 48/184 (26%), Positives = 72/184 (39%), Gaps = 31/184 (16%)
Query: 29 QDKQALLAFLSRTPHKNRVQ-WNASDSACN--WVGVECDANRSFVYSLRLPGVGLVGPIP 85
QDKQALL + + W + CN W+GV CD +
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTD------------------- 46
Query: 86 PNTLGKLSQLRVLSLRSNRLSG--EIPSDFSNLTLLRSLYLQSN-QFSGVFPASVTRMNR 142
+ ++ L L L IPS +NL L LY+ G P ++ ++ +
Sbjct: 47 ----TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ 102
Query: 143 LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS--INPANLRDFNVSNNNLN 200
L L ++ N SG IP ++ + L L N SG LP + NL N ++
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162
Query: 201 GSIP 204
G+IP
Sbjct: 163 GAIP 166
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 63.2 bits (152), Expect = 2e-11
Identities = 18/66 (27%), Positives = 26/66 (39%), Gaps = 1/66 (1%)
Query: 93 SQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNN 152
L L LR+NR+ G +P + L L SL + N G P + R ++N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
Query: 153 FSGKIP 158
P
Sbjct: 303 CLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.1 bits (136), Expect = 2e-09
Identities = 18/79 (22%), Positives = 27/79 (34%), Gaps = 2/79 (2%)
Query: 56 CNWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSN 115
+ + L L + G +P L +L L L++ N L GEIP N
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQ-GLTQLKFLHSLNVSFNNLCGEIPQ-GGN 289
Query: 116 LTLLRSLYLQSNQFSGVFP 134
L +N+ P
Sbjct: 290 LQRFDVSAYANNKCLCGSP 308
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 73.1 bits (178), Expect = 1e-14
Identities = 32/184 (17%), Positives = 55/184 (29%), Gaps = 34/184 (18%)
Query: 56 CNWVGVECDANR---------SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLS 106
C+ V+C L L + I L L L L +N++S
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKIS 68
Query: 107 GEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTR--------------------- 145
P F+ L L LYL NQ + + L
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128
Query: 146 --LDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSI 203
L + SG + L+ + + + + +P P +L + ++ N +
Sbjct: 129 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVD 187
Query: 204 PATL 207
A+L
Sbjct: 188 AASL 191
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.9 bits (141), Expect = 5e-10
Identities = 38/198 (19%), Positives = 71/198 (35%), Gaps = 10/198 (5%)
Query: 35 LAFLSRTPHKNRVQWNASDSACNWVGVECDANRSFVYSLRLPGVGLVG-PIPPNTLGKLS 93
L L K + ++ V + + + L L I +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 94 QLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNF 153
+L + + ++ IP L L+L N+ + V AS+ +N L +L LS N+
Sbjct: 151 KLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207
Query: 154 SGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIPAT----LS 208
S + N HL L L NNK + + ++ + NNN++ +I +
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPG 266
Query: 209 KFPQSSFTGNLDLCGGPL 226
+ + + L P+
Sbjct: 267 YNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 25/119 (21%), Positives = 45/119 (37%), Gaps = 9/119 (7%)
Query: 90 GKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149
G L L L N+++ + L L L L N S V S+ L L L+
Sbjct: 168 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227
Query: 150 SNNFSGKIPFDVNNLTHLTGLFLENNK--------FSGNLPSINPANLRDFNVSNNNLN 200
+N K+P + + ++ ++L NN F + A+ ++ +N +
Sbjct: 228 NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 70.2 bits (171), Expect = 2e-14
Identities = 29/202 (14%), Positives = 65/202 (32%), Gaps = 34/202 (16%)
Query: 352 EVLGKGSVGTSYKAVLEEGTTVVVKRLK-----------EVAVGKREFEMQMEVLGKIKH 400
+++G+G + E+ VVK K + G F + + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 401 DNVVPLRAFY----YSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAA 456
+ L+ Y+ + ++ + + A + +N +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKE------------LYRVRVENPDEVLDMIL 113
Query: 457 RGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTPPTRVAGYRAPEVVE 516
+A + IVHG++ N+L+ + + DF + G + R +
Sbjct: 114 EEVAKFY-HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILE--RDVRNII 169
Query: 517 T---RKVTFKSDVYSFGVLLLE 535
T R + D+ S +L+
Sbjct: 170 TYFSRTYRTEKDINSAIDRILQ 191
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.9 bits (138), Expect = 1e-09
Identities = 26/97 (26%), Positives = 39/97 (40%), Gaps = 10/97 (10%)
Query: 100 LRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPF 159
N S EI S L L + +N+ PA R L RL S N+ + ++P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVPE 321
Query: 160 DVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSN 196
NL L +E N P I P ++ D +++
Sbjct: 322 LPQNLKQLH---VEYNPLRE-FPDI-PESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.2 bits (131), Expect = 9e-09
Identities = 16/76 (21%), Positives = 28/76 (36%), Gaps = 9/76 (11%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSN 151
L L++ +N+L E+P+ L L N + V P L +L + N
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAEV-PEL---PQNLKQLHVEYN 334
Query: 152 NFSGKIPFDVNNLTHL 167
+ P ++ L
Sbjct: 335 PLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 4e-08
Identities = 19/89 (21%), Positives = 32/89 (35%), Gaps = 8/89 (8%)
Query: 123 YLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLP 182
N S + L L++S+N ++P L L N + +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVP 320
Query: 183 SINPANLRDFNVSNNNLNG--SIPATLSK 209
+ P NL+ +V N L IP ++
Sbjct: 321 EL-PQNLKQLHVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 2e-05
Identities = 17/61 (27%), Positives = 26/61 (42%), Gaps = 6/61 (9%)
Query: 141 NRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN 200
+ L+L++ S +P HL L N + LP + P +L+ V NNNL
Sbjct: 38 RQAHELELNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPEL-PQSLKSLLVDNNNLK 91
Query: 201 G 201
Sbjct: 92 A 92
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 1e-04
Identities = 14/59 (23%), Positives = 24/59 (40%), Gaps = 8/59 (13%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSS 150
+L L N L+ E+P N L+ L+++ N FP + L ++S
Sbjct: 303 PPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FPDI---PESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.003
Identities = 15/63 (23%), Positives = 21/63 (33%), Gaps = 8/63 (12%)
Query: 93 SQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNN 152
Q L L + LS +P +L SL N + P L L + +NN
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPEL---PQSLKSLLVDNNN 89
Query: 153 FSG 155
Sbjct: 90 LKA 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.7 bits (137), Expect = 3e-09
Identities = 18/99 (18%), Positives = 31/99 (31%), Gaps = 13/99 (13%)
Query: 110 PSDFSNLTLLRSLYLQSNQFSGV----FPASVTRMNRLTRLDLSSNNFSGKIPFDV---- 161
++LR L+L S A++ + L LDLS+N +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 162 -NNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNL 199
L L L + +S + L+ +L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDR----LQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 6e-08
Identities = 12/87 (13%), Positives = 28/87 (32%), Gaps = 5/87 (5%)
Query: 119 LRSLYLQSNQFSGV-FPASVTRMNRLTRLDLSSNNFSGK----IPFDVNNLTHLTGLFLE 173
++SL +Q + S + + + + + L + I + L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 174 NNKFSGNLPSINPANLRDFNVSNNNLN 200
+N+ L+ + L+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLS 90
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 9e-08
Identities = 14/93 (15%), Positives = 29/93 (31%), Gaps = 10/93 (10%)
Query: 95 LRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGV----FPASVTRMNRLTRLDLS 149
++ L ++ LS ++ L + + L + +++ L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 150 SNNFSGKIPFDV-----NNLTHLTGLFLENNKF 177
SN V + L L+N
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 4e-07
Identities = 17/74 (22%), Positives = 27/74 (36%), Gaps = 9/74 (12%)
Query: 89 LGKLSQLRVLSLRSNRLSGE----IPSDFSNLTLLRSLYLQSNQFSGVFPASVTRM---- 140
L L Q +V+ L L+ I S L L L+SN+ V V +
Sbjct: 23 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82
Query: 141 -NRLTRLDLSSNNF 153
++ +L L +
Sbjct: 83 SCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 4e-06
Identities = 17/107 (15%), Positives = 25/107 (23%), Gaps = 8/107 (7%)
Query: 42 PHKNRVQWNASDSACNWVGVECDANRSFVYSLRLPGVGLVGPIP---PNTLGKLSQLRVL 98
D+ + S + L L + TL LR L
Sbjct: 343 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402
Query: 99 SLRSNRLSGEIPSDFS-----NLTLLRSLYLQSNQFSGVFPASVTRM 140
L +N L LL L L +S + +
Sbjct: 403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.2 bits (127), Expect = 3e-09
Identities = 22/106 (20%), Positives = 32/106 (30%), Gaps = 24/106 (22%)
Query: 96 RVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPA-------------------- 135
RVL L L+ + L L+ L L N+ + PA
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 136 -SVTRMNRLTRLDLSSNNF-SGKIPFDVNNLTHLTGLFLENNKFSG 179
V + RL L L +N + + L L L+ N
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.9 bits (113), Expect = 4e-07
Identities = 23/97 (23%), Positives = 38/97 (39%), Gaps = 3/97 (3%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV--FPASVTRMNRLTRL 146
L + VL+ RS+ + + N+ L SL L +N+ + + V + L L
Sbjct: 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96
Query: 147 DLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPS 183
+LS N + D L L+L+ N S
Sbjct: 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 1e-05
Identities = 17/90 (18%), Positives = 31/90 (34%), Gaps = 2/90 (2%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSG--EIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMN 141
+ +L L+L +NRL ++ S L+ L L N+ +
Sbjct: 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL 115
Query: 142 RLTRLDLSSNNFSGKIPFDVNNLTHLTGLF 171
+L L L N+ S ++ + F
Sbjct: 116 KLEELWLDGNSLSDTFRDQSTYISAIRERF 145
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 1e-06
Identities = 8/47 (17%), Positives = 16/47 (34%)
Query: 82 GPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQ 128
+P + S +L + R+ NL LR+ + +
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 2e-04
Identities = 10/45 (22%), Positives = 16/45 (35%), Gaps = 3/45 (6%)
Query: 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI 184
+ LD+S + + NL L N K LP++
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 8/53 (15%), Positives = 19/53 (35%), Gaps = 4/53 (7%)
Query: 107 GEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIP 158
E+P+D F + L + + + + + +L + K+P
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (84), Expect = 0.004
Identities = 11/75 (14%), Positives = 20/75 (26%), Gaps = 18/75 (24%)
Query: 56 CNWVGVECDANRSFVYSLR-LPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFS 114
C+ C ++ + +P +P N L +L FS
Sbjct: 8 CSNRVFLCQESK-----VTEIPS-----DLPRN-------AIELRFVLTKLRVIQKGAFS 50
Query: 115 NLTLLRSLYLQSNQF 129
L + + N
Sbjct: 51 GFGDLEKIEISQNDV 65
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (110), Expect = 1e-06
Identities = 24/127 (18%), Positives = 40/127 (31%), Gaps = 9/127 (7%)
Query: 92 LSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSN 151
+ R L LR ++ I + + L ++ N+ + + RL L +++N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNNN 73
Query: 152 NFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDF------NVSNNNLNGSIPA 205
L LT L L NN A+L+ N
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133
Query: 206 TLSKFPQ 212
+ K PQ
Sbjct: 134 VIYKVPQ 140
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (104), Expect = 6e-06
Identities = 16/82 (19%), Positives = 31/82 (37%), Gaps = 6/82 (7%)
Query: 104 RLSGEI---PSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFD 160
+L+ E+ + ++N R L L+ + V +++ +D S N K+
Sbjct: 2 KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGF 59
Query: 161 VNNLTHLTGLFLENNKFSGNLP 182
L L L + NN+
Sbjct: 60 -PLLRRLKTLLVNNNRICRIGE 80
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 4e-06
Identities = 16/65 (24%), Positives = 29/65 (44%), Gaps = 4/65 (6%)
Query: 110 PSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTG 169
+ +NL+ L +L N+ S + P + + L + L +N S P N ++L
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA--NTSNLFI 221
Query: 170 LFLEN 174
+ L N
Sbjct: 222 VTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 4e-06
Identities = 18/61 (29%), Positives = 31/61 (50%), Gaps = 4/61 (6%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148
L LS+L L N++S P ++L L ++L++NQ S V P + + L + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 149 S 149
+
Sbjct: 225 T 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 5e-06
Identities = 18/86 (20%), Positives = 32/86 (37%), Gaps = 6/86 (6%)
Query: 43 HKNRVQWNASDSACNWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRS 102
S + AN S + +L+ + P L L L + L++
Sbjct: 148 AGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP---LASLPNLIEVHLKN 204
Query: 103 NRLSGEIPSDFSNLTLLRSLYLQSNQ 128
N++S P +N + L + L +NQ
Sbjct: 205 NQISDVSP--LANTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 3e-05
Identities = 17/57 (29%), Positives = 28/57 (49%), Gaps = 2/57 (3%)
Query: 140 MNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSN 196
+++LT L N S P +L +L + L+NN+ S P N +NL ++N
Sbjct: 172 LSKLTTLKADDNKISDISPL--ASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 6e-06
Identities = 13/79 (16%), Positives = 35/79 (44%), Gaps = 3/79 (3%)
Query: 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGE-IPSDFSNLTLLRSLYLQSNQ 128
V + R P + P+ + +++ + L ++ + + S + L++L L+ +
Sbjct: 25 VIAFRCPRSFMDQPLAEH--FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 129 FSGVFPASVTRMNRLTRLD 147
S ++ + + L RL+
Sbjct: 83 LSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 12/89 (13%), Positives = 32/89 (35%), Gaps = 3/89 (3%)
Query: 96 RVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSG 155
+ L L L ++ + ++ + + + R+ +DLS++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEV 60
Query: 156 K-IPFDVNNLTHLTGLFLENNKFSGNLPS 183
+ ++ + L L LE + S + +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVN 89
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 0.001
Identities = 14/94 (14%), Positives = 29/94 (30%), Gaps = 25/94 (26%)
Query: 144 TRLDLSSNNFSGKIP----------------------FDVNNLTHLTGLFLENNKFSGN- 180
LDL+ N + + + + + L N+ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 62
Query: 181 LPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQ 212
L I + L++ ++ L+ I TL+K
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSN 96
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 7e-06
Identities = 13/66 (19%), Positives = 25/66 (37%), Gaps = 3/66 (4%)
Query: 88 TLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147
+ K++ ++ L+ +P D L+L N A++ RLT+L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 148 LSSNNF 153
L
Sbjct: 62 LDRAEL 67
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 7e-06
Identities = 23/121 (19%), Positives = 36/121 (29%), Gaps = 15/121 (12%)
Query: 103 NRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVN 162
N L+ + L L +L LQ N P + L L N P+ N
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN------PWLCN 210
Query: 163 -NLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQSSFTGNLDL 221
+ + +N + NV++ + S KFP + G
Sbjct: 211 CEILYFRRWLQDNAENVYVWKQGVDVKAMTSNVASVQCDNS-----DKFPVYKYPG--KG 263
Query: 222 C 222
C
Sbjct: 264 C 264
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 1e-05
Identities = 15/46 (32%), Positives = 19/46 (41%), Gaps = 1/46 (2%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQF 129
+P L L L L L+ N L IP F LL +L N +
Sbjct: 163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 2e-05
Identities = 17/75 (22%), Positives = 25/75 (33%), Gaps = 1/75 (1%)
Query: 103 NRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVN 162
N L P + L L L +N + + + + L L L N+ IP
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192
Query: 163 NLTHLTGLFLENNKF 177
L FL N +
Sbjct: 193 GSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 13/78 (16%), Positives = 24/78 (30%), Gaps = 3/78 (3%)
Query: 112 DFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLF 171
+ S + + + + P + + T L LS N + T LT L
Sbjct: 5 EVSKVASHLEVNCDKRNLTAL-PPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 172 LENNKFSGNLPSINPANL 189
L+ + + L
Sbjct: 62 LDRAELTKLQVDGTLPVL 79
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 12/46 (26%), Positives = 17/46 (36%), Gaps = 3/46 (6%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQF 129
+PP+ L K +L L N L + T L L L +
Sbjct: 25 LPPD-LPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.0 bits (102), Expect = 1e-05
Identities = 23/94 (24%), Positives = 38/94 (40%), Gaps = 4/94 (4%)
Query: 84 IPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
I L QL+ L+L N++S +P F +L L SL L SN F+ +
Sbjct: 93 ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWL- 151
Query: 144 TRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKF 177
+ L+ P V ++ L +++F
Sbjct: 152 RKKSLNGGAARCGAPSKVRDVQIKD---LPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 1e-04
Identities = 25/101 (24%), Positives = 41/101 (40%), Gaps = 8/101 (7%)
Query: 109 IPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLT 168
F L L++L L NQ S V P S +N LT L+L+SN F+ +L
Sbjct: 94 SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC-----NCHLAWFA 148
Query: 169 GLFLENNKFSGNLPSINPANLRD---FNVSNNNLNGSIPAT 206
+ + G P+ +RD ++ ++ S +
Sbjct: 149 EWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSENS 189
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.9 bits (104), Expect = 2e-05
Identities = 15/106 (14%), Positives = 30/106 (28%), Gaps = 6/106 (5%)
Query: 43 HKNRVQWNASDSACNWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRS 102
N S + + + + L G + + + L+ L L+
Sbjct: 223 QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQY 282
Query: 103 NRLSGEIPSD-----FSNLTLLRSLYLQSNQFSGVFPASVTRMNRL 143
N + + + L L L N+FS V + +
Sbjct: 283 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 12/95 (12%), Positives = 27/95 (28%), Gaps = 9/95 (9%)
Query: 90 GKLSQLRVLSLRSNRLSGE----IPSDFSNLTLLRSLYLQSNQFSG----VFPASVTRMN 141
+ S + SL+ + ++ E + + ++ + L N ++
Sbjct: 1 ARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 59
Query: 142 RLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNK 176
L + S L L L+ K
Sbjct: 60 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPK 94
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 23/182 (12%), Positives = 45/182 (24%), Gaps = 15/182 (8%)
Query: 6 MRLICFLLLSCGGGIGYVNSEPTQDKQALLAFLSRTPHKNRVQWNASDSACNWVGVECDA 65
++ + + + L G+
Sbjct: 156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ 215
Query: 66 NRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSN------LTLL 119
+ L L LR L L LS + + L
Sbjct: 216 ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGL 275
Query: 120 RSLYLQSNQFSG-----VFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLEN 174
++L LQ N+ + +M L L+L+ N FS + + + + +F
Sbjct: 276 QTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE----EDDVVDEIREVFSTR 331
Query: 175 NK 176
+
Sbjct: 332 GR 333
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 5e-04
Identities = 14/74 (18%), Positives = 20/74 (27%), Gaps = 11/74 (14%)
Query: 123 YLQSNQFSGVFPASVTRM------NRLTRLDLSSNNFSGKIPFDV-----NNLTHLTGLF 171
L S A+V L L L N + + L L
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 172 LENNKFSGNLPSIN 185
L N+FS ++
Sbjct: 309 LNGNRFSEEDDVVD 322
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (98), Expect = 3e-05
Identities = 25/133 (18%), Positives = 41/133 (30%), Gaps = 5/133 (3%)
Query: 86 PNTLGKLSQLRVLSLRSNRLSGEIPSD-FSNLTLLRSLYLQSNQFSGVFPASVTRMNRLT 144
+ L L L + + + + L LR+L + + V P + RL+
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83
Query: 145 RLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGN---LPSINPANLRDFNVSNNNLNG 201
RL+LS N + + L L L N + V L
Sbjct: 84 RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQC 142
Query: 202 SIPATLSKFPQSS 214
L+ P +S
Sbjct: 143 HGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 1e-04
Identities = 17/110 (15%), Positives = 32/110 (29%), Gaps = 3/110 (2%)
Query: 93 SQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTR-MNRLTRLDLSSN 151
L + + L LY+++ Q R + L L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 152 NFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLN 200
P + L+ L L N +L++ +S N L+
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 9e-05
Identities = 12/74 (16%), Positives = 27/74 (36%), Gaps = 5/74 (6%)
Query: 107 GEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTH 166
+I SD L+ + + +N + ++ ++++ L +
Sbjct: 15 KQIFSD-DAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ--YLPN 69
Query: 167 LTGLFLENNKFSGN 180
+T LFL NK +
Sbjct: 70 VTKLFLNGNKLTDI 83
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 10/80 (12%), Positives = 29/80 (36%), Gaps = 7/80 (8%)
Query: 83 PIPPNTL---GKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTR 139
P P + ++ +L+ ++ + + L + + ++ V +
Sbjct: 11 PTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQY 66
Query: 140 MNRLTRLDLSSNNFSGKIPF 159
+ +T+L L+ N + P
Sbjct: 67 LPNVTKLFLNGNKLTDIKPL 86
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 6e-04
Identities = 17/87 (19%), Positives = 31/87 (35%), Gaps = 5/87 (5%)
Query: 42 PHKNRVQWNASDSACNWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLR 101
+ Q + N + +R + I P L L++L+ L L
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS 186
Query: 102 SNRLSGEIPSDFSNLTLLRSLYLQSNQ 128
N +S ++ + + L L L L +Q
Sbjct: 187 KNHIS-DLRA-LAGLKNLDVLEL-FSQ 210
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 8e-04
Identities = 12/41 (29%), Positives = 20/41 (48%), Gaps = 2/41 (4%)
Query: 110 PSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSS 150
+ LT L++LYL N S + ++ + L L+L S
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.004
Identities = 8/70 (11%), Positives = 20/70 (28%), Gaps = 4/70 (5%)
Query: 132 VFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRD 191
+F + +L + + + N L + + N+ N+
Sbjct: 17 IFSDDA--FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQYLPNVTK 72
Query: 192 FNVSNNNLNG 201
++ N L
Sbjct: 73 LFLNGNKLTD 82
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.002
Identities = 13/34 (38%), Positives = 18/34 (52%), Gaps = 2/34 (5%)
Query: 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSL 122
L L+ L L + SN++S S + LT L SL
Sbjct: 168 LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 654 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.7 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.69 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.62 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.6 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.58 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.53 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.53 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.48 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.46 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.45 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.43 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.43 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.39 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.35 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.34 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.32 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.31 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.31 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.28 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.24 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.2 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.2 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.14 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.99 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.74 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.72 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.71 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.59 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.54 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.49 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.31 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.3 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.15 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.13 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.06 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.75 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.63 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.49 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.27 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.23 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.71 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.47 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.33 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.12 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=409.73 Aligned_cols=247 Identities=24% Similarity=0.400 Sum_probs=198.8
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchhh
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLSA 430 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~ 430 (654)
.+.||+|+||+||+|.+.+++.||||+++......++|.+|++++++++|||||+++|+|.+++..++||||+++|+|.+
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~ 89 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHH
Confidence 46799999999999999888999999998877778899999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-----CCCc
Q 036334 431 LLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT-----PPTR 505 (654)
Q Consensus 431 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-----~~~~ 505 (654)
++... ...+++..+++++.|||.||+|||+++ |+||||||+|||+++++.+||+|||+++...... ...+
T Consensus 90 ~l~~~----~~~~~~~~~~~i~~qia~gl~~lH~~~-iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~g 164 (263)
T d1sm2a_ 90 YLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEAC-VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF 164 (263)
T ss_dssp HHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCTTCSGGGEEECGGGCEEECSCC------------------
T ss_pred Hhhcc----ccCCCHHHHHHHHHHHHHHHHhhhccc-eeecccchhheeecCCCCeEecccchheeccCCCceeecceec
Confidence 98743 346899999999999999999999998 9999999999999999999999999998764331 2345
Q ss_pred cccccCccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 506 VAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTG-KAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 506 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
+..|+|||++.+..|+.++|||||||++|||+|+ .+||... .....+..+... .. ......+
T Consensus 165 t~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~------~~~~~~~~i~~~-~~----------~~~p~~~ 227 (263)
T d1sm2a_ 165 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR------SNSEVVEDISTG-FR----------LYKPRLA 227 (263)
T ss_dssp CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC------CHHHHHHHHHHT-CC----------CCCCTTS
T ss_pred CcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC------CHHHHHHHHHhc-CC----------CCCcccc
Confidence 6789999999999999999999999999999996 4444321 122222222111 10 0111122
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 585 MVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
..++.+++.+||+.||++||||+||+++|+++.++
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 34677888899999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-51 Score=409.46 Aligned_cols=248 Identities=25% Similarity=0.412 Sum_probs=202.8
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
+.+.||+|+||+||+|.+++++.||||+++......++|.+|++++++++|||||+++|++. ++..++||||+++|+|.
T Consensus 17 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~ 95 (272)
T d1qpca_ 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (272)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred EeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHH
Confidence 45789999999999999988899999999887777889999999999999999999999875 45679999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----CCCC
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-----TPPT 504 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-----~~~~ 504 (654)
+++.... ...+++..+++++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+..... ....
T Consensus 96 ~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~-ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 171 (272)
T d1qpca_ 96 DFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN-YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171 (272)
T ss_dssp HHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCC
T ss_pred HHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCccchhheeeecccceeeccccceEEccCCccccccccC
Confidence 9886432 235899999999999999999999998 999999999999999999999999999876432 2345
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEE 584 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (654)
++..|||||++.++.++.++|||||||++|||+||+.|+.... .....+..+.. ... .......
T Consensus 172 gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-----~~~~~~~~i~~-~~~----------~~~p~~~ 235 (272)
T d1qpca_ 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLER-GYR----------MVRPDNC 235 (272)
T ss_dssp CCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHT-TCC----------CCCCTTC
T ss_pred CcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHh-cCC----------CCCcccC
Confidence 6778999999998899999999999999999999766554321 11222222211 110 0111122
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 585 MVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 585 ~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
..++.+++.+||+.||++||||+||++.|+++-.
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 3457778889999999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-50 Score=406.46 Aligned_cols=251 Identities=26% Similarity=0.383 Sum_probs=207.3
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
+.+.||+|+||+||+|.+. +|+.||||+++......++|.+|+++|++++|||||+++++|.+++..++||||+++|+|
T Consensus 21 ~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l 100 (287)
T d1opja_ 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 100 (287)
T ss_dssp EEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcch
Confidence 3578999999999999975 488999999988777788899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC-----C
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP-----P 503 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----~ 503 (654)
.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....... .
T Consensus 101 ~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~~~-iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~ 176 (287)
T d1opja_ 101 LDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN-FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176 (287)
T ss_dssp HHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTE
T ss_pred HHHhhhc---cccchHHHHHHHHHHHHHHHHHHHHHCC-cccCccccCeEEECCCCcEEEccccceeecCCCCceeeccc
Confidence 9999753 2456999999999999999999999998 99999999999999999999999999987654322 2
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.++..|||||++.++.|+.++|||||||++|||++|+.||..... ... +...+..+... .....
T Consensus 177 ~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~~~-~~~~i~~~~~~----------~~~~~ 240 (287)
T d1opja_ 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQ-VYELLEKDYRM----------ERPEG 240 (287)
T ss_dssp EECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHH-HHHHHHTTCCC----------CCCTT
T ss_pred cccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----HHH-HHHHHhcCCCC----------CCCcc
Confidence 355679999999999999999999999999999998777643221 111 12222222111 11112
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
...++.+|+.+||+.||++|||++||++.|+.+.+..
T Consensus 241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 2345778888999999999999999999999886543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=405.16 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=198.0
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.||+|+||+||+|.++ ..||||+++... ...++|.+|++++++++|||||++++++. .+..++||||+++|
T Consensus 12 ~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g 88 (276)
T d1uwha_ 12 VGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGS 88 (276)
T ss_dssp CCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEE
T ss_pred EEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCC
Confidence 3578999999999999865 369999997543 23467889999999999999999999875 45689999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC------
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT------ 500 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~------ 500 (654)
+|.+++... ...+++..+++++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+|......
T Consensus 89 ~L~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~-ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 89 SLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLHAKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp EHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred CHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHhcCC-EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence 999999743 345999999999999999999999998 999999999999999999999999999776432
Q ss_pred CCCCccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 501 TPPTRVAGYRAPEVVET---RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
....+|+.|||||++.+ ..|+.++|||||||++|||+||+.||..... ...+........... ....
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~------~~~~~~~~~~~~~~p----~~~~ 233 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN------RDQIIFMVGRGYLSP----DLSK 233 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHHHTSCCC----CGGG
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh------HHHHHHHHhcCCCCC----cchh
Confidence 23467888999999864 3589999999999999999999999975322 112222222221111 0000
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
.......++.+++.+||+.||++||||+||++.|+.+.+.-
T Consensus 234 --~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 234 --VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp --SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred --ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 11122346778888999999999999999999999998653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=399.57 Aligned_cols=245 Identities=21% Similarity=0.335 Sum_probs=206.0
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCchh
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
+.+.||+|+||+||+|++++++.||||+++......++|.+|+.++++++||||++++|+|.+++..++||||+++|+|.
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~ 87 (258)
T d1k2pa_ 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87 (258)
T ss_dssp CCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred EeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence 35789999999999999988889999999988778889999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----CCCC
Q 036334 430 ALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-----TPPT 504 (654)
Q Consensus 430 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-----~~~~ 504 (654)
+++... ...+++..+++++.|+++||+|||+++ |+||||||+|||+++++.+||+|||++...... ....
T Consensus 88 ~~~~~~----~~~~~~~~~~~i~~qi~~gl~~LH~~~-iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 162 (258)
T d1k2pa_ 88 NYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQ-FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 162 (258)
T ss_dssp HHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHTT-BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSC
T ss_pred Hhhhcc----ccCCcHHHHHHHHHHHHHHHHHHhhcC-cccccccceeEEEcCCCcEEECcchhheeccCCCceeecccC
Confidence 997643 345899999999999999999999998 999999999999999999999999999765432 2244
Q ss_pred ccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 505 RVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 505 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
++..|+|||.+.+..++.++|||||||++|||+| |+.||...... .....+ ..... ......
T Consensus 163 ~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~~~~~i-~~~~~----------~~~p~~ 225 (258)
T d1k2pa_ 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHI-AQGLR----------LYRPHL 225 (258)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHHH-HTTCC----------CCCCTT
T ss_pred CCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH------HHHHHH-HhCCC----------CCCccc
Confidence 6677999999999999999999999999999998 89999754321 112222 21111 011112
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENM 616 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 616 (654)
...++.+++.+||+.||++||||+|+++.|.++
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 234677888899999999999999999999764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-49 Score=405.26 Aligned_cols=247 Identities=25% Similarity=0.414 Sum_probs=194.2
Q ss_pred hccccccCceeEEEEEecC-C---cEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 351 AEVLGKGSVGTSYKAVLEE-G---TTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~-g---~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
.++||+|+||+||+|.++. | ..||||++..... ..++|.+|+++|++++|||||+++|+|.+++..++||||++
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 4789999999999998652 2 3689998865432 34679999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 501 (654)
+|+|.+++... ...+++.++++++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 111 ~g~L~~~~~~~----~~~l~~~~~~~i~~qia~gl~yLH~~~-iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 185 (299)
T d1jpaa_ 111 NGSLDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLADMN-YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185 (299)
T ss_dssp TEEHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred CCcceeeeccc----cCCCCHHHHHHHHHHHHHHHHHHhhCC-CccCccccceEEECCCCcEEECCcccceEccCCCCcc
Confidence 99999988743 345999999999999999999999998 9999999999999999999999999998764321
Q ss_pred ------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 502 ------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 502 ------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
...+++.|||||++.++.++.++|||||||++|||+| |+.||..... ...+..+....
T Consensus 186 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~------~~~~~~i~~~~--------- 250 (299)
T d1jpaa_ 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN------QDVINAIEQDY--------- 250 (299)
T ss_dssp ----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTC---------
T ss_pred eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCC---------
Confidence 1234667999999999999999999999999999998 8999975322 12222221111
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
+.....+...++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 251 --~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 251 --RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1111222344677888899999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-50 Score=401.14 Aligned_cols=241 Identities=21% Similarity=0.288 Sum_probs=193.4
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.||+|+||+||+|... +|+.||||++.... ...+++.+|++++++++|||||++++++.+++..|+||||+++|
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg 88 (271)
T d1nvra_ 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 88 (271)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCC
Confidence 4578999999999999965 68999999986542 23456899999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC------C
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN------T 500 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~------~ 500 (654)
+|.+++.. ...+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.... .
T Consensus 89 ~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~-IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 89 ELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp EGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred cHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcC-CccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 99999973 346999999999999999999999998 99999999999999999999999999986532 2
Q ss_pred CCCCccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 TPPTRVAGYRAPEVVETRKV-TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....||+.|||||++.+..+ +.++||||+||++|||++|+.||....... .............. ..
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-----~~~~~~~~~~~~~~-------~~- 229 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----QEYSDWKEKKTYLN-------PW- 229 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-----HHHHHHHTTCTTST-------TG-
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-----HHHHHHhcCCCCCC-------cc-
Confidence 34568899999999988776 578999999999999999999997543221 11111111110000 00
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.....++.+++.+||+.||++|||++|+++
T Consensus 230 --~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 230 --KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111234567788999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=402.44 Aligned_cols=240 Identities=23% Similarity=0.359 Sum_probs=198.3
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
..+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|++++++++|||||++++++.+++..|+||||+++|+
T Consensus 24 ~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 103 (293)
T d1yhwa1 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (293)
T ss_dssp SCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCc
Confidence 347799999999999995 469999999987553 456678999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CCC
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TPP 503 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~ 503 (654)
|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|...... ...
T Consensus 104 L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~-iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 176 (293)
T d1yhwa1 104 LTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (293)
T ss_dssp HHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred HHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence 9998863 35899999999999999999999998 999999999999999999999999999876432 345
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.+|+.|||||++.+..|+.++||||+||++|||++|+.||..... ...+..+....... ......
T Consensus 177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~~~---------~~~~~~ 241 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTPE---------LQNPEK 241 (293)
T ss_dssp CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSCC---------CSSGGG
T ss_pred ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCCC---------CCCccc
Confidence 678899999999999999999999999999999999999965321 12222222221110 111111
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
...++.+++.+||+.||++|||++|+++
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2235667888999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=396.42 Aligned_cols=239 Identities=25% Similarity=0.373 Sum_probs=199.4
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV----AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+.+.||+|+||+||+|..+ +|+.||+|++.+. ....+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 9 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~ 88 (263)
T d2j4za1 9 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 88 (263)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeec
Confidence 44678999999999999975 5889999998653 234567889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--C
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--T 501 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--~ 501 (654)
++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|...... .
T Consensus 89 ~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~~~-ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 162 (263)
T d2j4za1 89 PLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKR-VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162 (263)
T ss_dssp TTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred CCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-eeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence 99999999974 345999999999999999999999998 999999999999999999999999999876543 2
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...||+.|||||++.+..++.++|||||||++|||++|+.||.... .......+.+.... .+...
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~~~~---------~p~~~ 227 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETYKRISRVEFT---------FPDFV 227 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTTCCC---------CCTTS
T ss_pred ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC------HHHHHHHHHcCCCC---------CCccC
Confidence 3467889999999999999999999999999999999999996532 22222222222110 11112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..++.+++.+||+.||++|||++|+++
T Consensus 228 ---s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 228 ---TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 235667788999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=399.56 Aligned_cols=243 Identities=24% Similarity=0.368 Sum_probs=197.9
Q ss_pred cccccCceeEEEEEec---CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 353 VLGKGSVGTSYKAVLE---EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 353 ~lg~G~fg~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
.||+|+||+||+|.++ ++..||||+++... ...++|.+|+++|++++|||||+++|+|.+ +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 3999999999999754 35579999997543 234679999999999999999999999864 56899999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-------
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT------- 500 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~------- 500 (654)
|.+++... ...+++..+++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 95 L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~ylH~~~-iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (285)
T d1u59a_ 95 LHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN-FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169 (285)
T ss_dssp HHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred HHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC-eecCcCchhheeeccCCceeeccchhhhcccccccccccc
Confidence 99998643 346999999999999999999999998 999999999999999999999999999866432
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....++..|||||++.++.++.++|||||||++|||+| |+.||..... .+....+ ..+... .
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~------~~~~~~i-~~~~~~----------~ 232 (285)
T d1u59a_ 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------PEVMAFI-EQGKRM----------E 232 (285)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT------HHHHHHH-HTTCCC----------C
T ss_pred cccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH------HHHHHHH-HcCCCC----------C
Confidence 23346678999999998999999999999999999998 8999975422 1222222 111111 1
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
.+.....++.+|+.+||+.||++||||.+|++.|+.+..
T Consensus 233 ~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112233467788889999999999999999999997754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=396.76 Aligned_cols=248 Identities=24% Similarity=0.405 Sum_probs=196.0
Q ss_pred hccccccCceeEEEEEecCC-----cEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 351 AEVLGKGSVGTSYKAVLEEG-----TTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g-----~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.++||+|+||+||+|.++.+ ..||||+++.... ...+|.+|++++++++|||||+++|+|.+.+..++||||+
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 47899999999999986542 3799999975432 2456889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
.+|++.+++... ...+++.++++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~gl~~lH~~~-iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 92 ENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMN-YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp TTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred ccCcchhhhhcc----cccccHHHHHHHHHHHHHhhhhccccc-cccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 999999988643 346999999999999999999999998 999999999999999999999999999875432
Q ss_pred ----CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhh
Q 036334 501 ----TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576 (654)
Q Consensus 501 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (654)
....+|..|||||++.++.++.++|||||||++|||++|+.|+..... ....+.. +..+.
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-----~~~~~~~-i~~~~---------- 230 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----NHEVMKA-INDGF---------- 230 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHH-HHTTC----------
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-----HHHHHHH-HhccC----------
Confidence 123457789999999999999999999999999999997666543211 1111111 11111
Q ss_pred ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
+.....+...++.+|+.+||+.||++||||.||++.|+++.+.
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111222334677888999999999999999999999998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=396.73 Aligned_cols=242 Identities=26% Similarity=0.350 Sum_probs=194.2
Q ss_pred ccccccCceeEEEEEecC---CcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 352 EVLGKGSVGTSYKAVLEE---GTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~---g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.||+|+||+||+|.+++ ++.||||+++.... ..++|.+|+++|++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998643 46899999975432 24678999999999999999999999864 567899999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----- 500 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----- 500 (654)
|+|.+++.. ...+++..+++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 92 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~~~-iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESN-FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHhCC-cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999974 345999999999999999999999998 999999999999999999999999999765432
Q ss_pred --CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 501 --TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
....+++.|||||++.+..++.++|||||||++|||+| |+.||..... .. +...+..+..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~------~~-~~~~i~~~~~---------- 228 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SE-VTAMLEKGER---------- 228 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HH-HHHHHHTTCC----------
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH------HH-HHHHHHcCCC----------
Confidence 22456778999999999999999999999999999998 8999975321 11 1112221111
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
.........++.+|+.+||+.||++||||++|++.|+..-
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1111222346778888999999999999999999998753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=399.43 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=201.3
Q ss_pred HhhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCch
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGSL 428 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 428 (654)
.+.+.||+|+||+||+|.++++..||||+++......++|.+|+.++++++|||||+++|+|. ++..++||||+++|+|
T Consensus 20 ~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l 98 (285)
T d1fmka3 20 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 98 (285)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred EEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCch
Confidence 456789999999999999988889999999887777889999999999999999999999985 4568999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-----CCC
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-----TPP 503 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-----~~~ 503 (654)
.+++.... ...++|.++++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 99 ~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~-ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 174 (285)
T d1fmka3 99 LDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN-YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 174 (285)
T ss_dssp HHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred hhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhh-eecccccceEEEECCCCcEEEcccchhhhccCCCceeeccc
Confidence 99987432 245999999999999999999999998 999999999999999999999999999866432 224
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.++..|+|||++..+.++.++|||||||++|||++|+.|+..... ....+..+.... . ......
T Consensus 175 ~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-----~~~~~~~i~~~~-~----------~~~~~~ 238 (285)
T d1fmka3 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVLDQVERGY-R----------MPCPPE 238 (285)
T ss_dssp -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTTC-C----------CCCCTT
T ss_pred cccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-----HHHHHHHHHhcC-C----------CCCCcc
Confidence 567789999999999999999999999999999997666543221 122222221111 0 111122
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 584 EMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
...++.+++.+||+.||++||||++|+++|++....
T Consensus 239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 234577788899999999999999999999987644
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=400.49 Aligned_cols=243 Identities=21% Similarity=0.339 Sum_probs=198.0
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEeccc-ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV-AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
++.+.||+|+||+||+|... +|+.||||+++.. ....+.+.+|+++|++++|||||++++++.+++..++||||+++|
T Consensus 15 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g 94 (288)
T d2jfla1 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCC
Confidence 34577999999999999965 5889999999754 334567899999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC----CCC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN----TTP 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~----~~~ 502 (654)
+|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|..... ...
T Consensus 95 ~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~~-ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 95 AVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred cHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-EEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 999997642 245999999999999999999999998 99999999999999999999999999876532 235
Q ss_pred CCccccccCccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 503 PTRVAGYRAPEVVE-----TRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 503 ~~~~~~y~aPE~~~-----~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
..+|+.|||||++. +..|+.++|||||||++|||++|+.||...... ..+..+...... .
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~------~~~~~i~~~~~~---------~ 234 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM------RVLLKIAKSEPP---------T 234 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG------GHHHHHHHSCCC---------C
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCC---------C
Confidence 67888999999984 456899999999999999999999999754321 122222222110 0
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.........++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111122345677888999999999999999976
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=393.93 Aligned_cols=244 Identities=21% Similarity=0.309 Sum_probs=187.1
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEe--CCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYS--KDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~ 423 (654)
+.+.||+|+||+||+|... +|+.||||+++..... .+.+.+|++++++++|||||++++++.+ ++..|+||||+
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~ 87 (269)
T d2java1 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 87 (269)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECC
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecC
Confidence 3578999999999999864 6899999999765433 3568899999999999999999999865 45679999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC----CeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG----KIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
++|+|.+++..... ....+++..++.++.|++.||+|||+++ +|+||||||+|||++.++.+||+|||+|.....
T Consensus 88 ~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 166 (269)
T d2java1 88 EGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166 (269)
T ss_dssp TTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred CCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence 99999999864321 2356999999999999999999999764 499999999999999999999999999987643
Q ss_pred C----CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 500 T----TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 500 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
. ....+|+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+....+...... .
T Consensus 167 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~------~~~~~~~i~~~~~~-~------ 233 (269)
T d2java1 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS------QKELAGKIREGKFR-R------ 233 (269)
T ss_dssp ---------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTCCC-C------
T ss_pred CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC------HHHHHHHHHcCCCC-C------
Confidence 3 23567888999999999999999999999999999999999997532 12222222221110 0
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.......++.+++.+||+.||++|||++|+++
T Consensus 234 ----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 01112235677888999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-48 Score=396.29 Aligned_cols=242 Identities=23% Similarity=0.329 Sum_probs=199.0
Q ss_pred HHhhccccccCceeEEEEEec-CCcEEEEEEecccccC----HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 348 RASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG----KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 348 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
+...+.||+|+||+||+|... +|+.||||+++..... .+.+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 444678999999999999854 6889999998765322 34688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCCC
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTTP 502 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 502 (654)
|++|+|..++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|........
T Consensus 97 ~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~-iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (309)
T d1u5ra_ 97 CLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHN-MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 170 (309)
T ss_dssp CSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred cCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCC-EeccCCCcceEEECCCCCEEEeecccccccCCCCc
Confidence 999999877653 346999999999999999999999998 99999999999999999999999999998887777
Q ss_pred CCccccccCccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 503 PTRVAGYRAPEVVET---RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
..||+.|||||++.+ +.|+.++|||||||++|||++|+.||.... ....+..+....... . ..
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~------~~~~~~~i~~~~~~~-~------~~- 236 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNESPA-L------QS- 236 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCCCC-C------SC-
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhCCCCC-C------CC-
Confidence 889999999999864 468999999999999999999999997532 112222222221100 0 01
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.....++.+++.+||+.||++|||++|+++
T Consensus 237 --~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 --GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 112235667788999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=403.03 Aligned_cols=192 Identities=22% Similarity=0.361 Sum_probs=170.2
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.||+|+||+||+|... +|+.||+|+++... ....++.+|+.+|++++|||||+++++|.++++.++||||+++|
T Consensus 10 ~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg 89 (322)
T d1s9ja_ 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89 (322)
T ss_dssp EEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 3578999999999999964 68999999997543 23467889999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC--CCCC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS-GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN--TTPP 503 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~--~~~~ 503 (654)
+|.+++... ..+++..+..++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+|..... ....
T Consensus 90 ~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~~~-IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 163 (322)
T d1s9ja_ 90 SLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163 (322)
T ss_dssp EHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC-CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---
T ss_pred cHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC-EEccccCHHHeeECCCCCEEEeeCCCccccCCCccccc
Confidence 999999743 3589999999999999999999975 6 99999999999999999999999999986532 2345
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASL 547 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 547 (654)
.||..|||||++.+..|+.++||||+||++|||++|+.||....
T Consensus 164 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred cCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 78899999999999999999999999999999999999997643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=401.31 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=198.2
Q ss_pred HhhccccccCceeEEEEEecC------CcEEEEEEeccc--ccCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE------GTTVVVKRLKEV--AVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~~~~~--~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv 419 (654)
.+.++||+|+||+||+|.+.. ...||||++... ......+.+|+.++.++ +|||||+++++|.+.+..++|
T Consensus 40 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 119 (325)
T d1rjba_ 40 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119 (325)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEE
Confidence 356889999999999998643 236999998654 33456788999999998 899999999999999999999
Q ss_pred EEecCCCchhhhhccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEEC
Q 036334 420 YDYMPAGSLSALLHGSRGS------------------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR 481 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~ 481 (654)
|||+++|+|.++++..+.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-IiHRDlKp~Nill~ 198 (325)
T d1rjba_ 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-CVHRDLAARNVLVT 198 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-EEETTCSGGGEEEE
T ss_pred EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCchhccccc
Confidence 9999999999999754321 1235899999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccCCCCCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCCh
Q 036334 482 PDHDACVSDFGLNPLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDL 554 (654)
Q Consensus 482 ~~~~~kl~Dfgla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~ 554 (654)
.++.+||+|||+|+...... ...+|+.|||||++.++.++.++|||||||++|||+| |+.||......
T Consensus 199 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~----- 273 (325)
T d1rjba_ 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD----- 273 (325)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-----
T ss_pred cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH-----
Confidence 99999999999998764332 2345778999999999999999999999999999998 89999753321
Q ss_pred hHHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036334 555 PRWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIEN 615 (654)
Q Consensus 555 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 615 (654)
..+..++...... ........++.+|+.+||+.||++||||+||+++|..
T Consensus 274 -~~~~~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 274 -ANFYKLIQNGFKM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp -HHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHHHhcCCCC----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1122222222111 1111223457778889999999999999999999963
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=388.71 Aligned_cols=239 Identities=24% Similarity=0.393 Sum_probs=190.3
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEe----CCceEEEEEec
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYS----KDEKLLVYDYM 423 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~~ 423 (654)
+.||+|+||+||+|... +++.||+|++..... ..+.+.+|+++|++++|||||+++++|.+ +...++||||+
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 56999999999999965 588999999876533 24568899999999999999999999875 34579999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC-CeecCCCCCCcEEEC-CCCCeEEeccCCCCCcCCC-
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSG-KIVHGNIKASNILLR-PDHDACVSDFGLNPLFGNT- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-~ivHrDlk~~NIll~-~~~~~kl~Dfgla~~~~~~- 500 (654)
++|+|.+++.. ...+++..++.++.||++||+|||+++ +|+||||||+|||++ +++.+||+|||+|+.....
T Consensus 95 ~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~ 169 (270)
T d1t4ha_ 95 TSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169 (270)
T ss_dssp CSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred CCCcHHHHHhc-----cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence 99999999974 345899999999999999999999875 499999999999996 5789999999999865443
Q ss_pred -CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 -TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....||+.|||||++.+ .++.++|||||||++|||++|+.||..... .......+.. ......++ .
T Consensus 170 ~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-----~~~~~~~i~~-~~~~~~~~------~ 236 (270)
T d1t4ha_ 170 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTS-GVKPASFD------K 236 (270)
T ss_dssp BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTT-TCCCGGGG------G
T ss_pred cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-----HHHHHHHHHc-CCCCcccC------c
Confidence 23568889999999865 699999999999999999999999964321 1121222211 11111111 1
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
. ...++.+++.+||+.||++|||++|+++
T Consensus 237 ~---~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 237 V---AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp C---CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c---CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1 1224667888999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=387.24 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=193.9
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEe-CCceEEEEEecCCCch
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYS-KDEKLLVYDYMPAGSL 428 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~~~~g~L 428 (654)
+.+.||+|+||.||+|.++ |+.||||+++.. ...+++.+|++++++++||||++++|+|.+ ++..++||||+++|+|
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88 (262)
T ss_dssp EEEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred EeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence 3578999999999999986 789999999764 345779999999999999999999999865 4568999999999999
Q ss_pred hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-CCCCccc
Q 036334 429 SALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-TPPTRVA 507 (654)
Q Consensus 429 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~~ 507 (654)
.+++.... ...+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++..... ....++.
T Consensus 89 ~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~-ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~~ 164 (262)
T d1byga_ 89 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 164 (262)
T ss_dssp HHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTSCEEECCCCC------------CCT
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCc-eeccccchHhheecCCCCEeecccccceecCCCCccccccc
Confidence 99996431 235899999999999999999999997 999999999999999999999999999876543 3345567
Q ss_pred cccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHHHHH
Q 036334 508 GYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEEEMV 586 (654)
Q Consensus 508 ~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (654)
.|+|||++.+..++.++|||||||++|||+| |+.||...... +.+..+ ..+... ........
T Consensus 165 ~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~------~~~~~i-~~~~~~----------~~~~~~~~ 227 (262)
T d1byga_ 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRV-EKGYKM----------DAPDGCPP 227 (262)
T ss_dssp TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG------GHHHHH-TTTCCC----------CCCTTCCH
T ss_pred cCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH------HHHHHH-HcCCCC----------CCCccCCH
Confidence 8999999999999999999999999999998 67777643221 122222 111111 11112224
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 587 QLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 587 ~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
++.+++.+||+.||++||||.|++++|++++..
T Consensus 228 ~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 228 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 567788899999999999999999999999754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-48 Score=394.86 Aligned_cols=244 Identities=23% Similarity=0.331 Sum_probs=184.7
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
.+.+.||+|+||+||+|... +|+.||||++.... .....+.+|+++|++++|||||++++++.+++..|+||||+++
T Consensus 12 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~g 91 (307)
T d1a06a_ 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSG 91 (307)
T ss_dssp EEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 34578999999999999965 58999999997543 2345678999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEEC---CCCCeEEeccCCCCCcCCC--
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR---PDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~---~~~~~kl~Dfgla~~~~~~-- 500 (654)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|......
T Consensus 92 g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~-iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 92 GELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp CBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred CcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhhce-eeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 999999973 346999999999999999999999998 99999999999995 5789999999999876543
Q ss_pred -CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 -TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....||+.|||||++.+..|+.++|||||||++|||++|+.||..... ......+........ .....
T Consensus 166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~~~~~-----~~~~~ 234 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND------AKLFEQILKAEYEFD-----SPYWD 234 (307)
T ss_dssp -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHTTCCCCC-----TTTTT
T ss_pred eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHhccCCCCC-----Ccccc
Confidence 234678899999999999999999999999999999999999975321 122222222221100 00111
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
....++.+++.+||+.||++|||++|+++.
T Consensus 235 ---~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 235 ---DISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 122356677889999999999999999873
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=393.48 Aligned_cols=259 Identities=22% Similarity=0.324 Sum_probs=198.5
Q ss_pred hccccccCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCC----ceEEEEEecCCC
Q 036334 351 AEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKD----EKLLVYDYMPAG 426 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~----~~~lv~e~~~~g 426 (654)
.+.||+|+||+||+|++. |+.||||+++........++.|+..+.+++|||||+++++|.+.+ ..++||||+++|
T Consensus 8 ~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g 86 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCC
Confidence 467999999999999874 899999999765433333445566667889999999999998754 579999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-------CCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVS-------GKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-------~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
+|.++++. ..++|..+++++.|+|.||+|||+. .+|+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 87 SLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp BHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 99999974 3489999999999999999999963 2499999999999999999999999999876532
Q ss_pred C--------CCCCccccccCccccCCCC------CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCC--------hhHH
Q 036334 500 T--------TPPTRVAGYRAPEVVETRK------VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGID--------LPRW 557 (654)
Q Consensus 500 ~--------~~~~~~~~y~aPE~~~~~~------~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~--------~~~~ 557 (654)
. ....+|+.|||||++.+.. ++.++|||||||+||||+||..||.......... ....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence 2 2345788999999987542 6778999999999999999998876533222110 1111
Q ss_pred HHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 558 VQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
+......+ ..++.+.......+....+.+++.+||+.||++||||.||++.|+++.+.+
T Consensus 241 ~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 241 MRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 22221111 111111111223445667889999999999999999999999999998654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=392.04 Aligned_cols=240 Identities=19% Similarity=0.264 Sum_probs=197.8
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEec
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV----AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
.+.+.||+|+||+||+|... +|+.||||+++.. ....+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus 11 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~ 90 (288)
T d1uu3a_ 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA 90 (288)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEcc
Confidence 34578999999999999964 6899999999753 234467899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
++|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 91 ~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~-iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 91 KNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKG-IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp TTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCCHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHhhcccc-EEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999999873 346999999999999999999999998 999999999999999999999999999876432
Q ss_pred ---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhc
Q 036334 501 ---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMR 577 (654)
Q Consensus 501 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (654)
....||+.|||||++.+..|+.++||||+||++|||++|+.||.... .......+...... .
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~~~~~i~~~~~~---------~ 229 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EYLIFQKIIKLEYD---------F 229 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHTTCCC---------C
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC------HHHHHHHHHcCCCC---------C
Confidence 23468889999999999999999999999999999999999997532 22222222222110 0
Q ss_pred cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 578 YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 578 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
+... ..++.+++.+||+.||++|||++|+++.
T Consensus 230 p~~~---s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 230 PEKF---FPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CTTC---CHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CccC---CHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1111 2346677889999999999999997653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=386.49 Aligned_cols=261 Identities=25% Similarity=0.361 Sum_probs=204.3
Q ss_pred hccccccCceeEEEEEecCC----cEEEEEEecccc--cCHHHHHHHHHHHhccCCCccccccEEEEeC-CceEEEEEec
Q 036334 351 AEVLGKGSVGTSYKAVLEEG----TTVVVKRLKEVA--VGKREFEMQMEVLGKIKHDNVVPLRAFYYSK-DEKLLVYDYM 423 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~~g----~~vavK~~~~~~--~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~-~~~~lv~e~~ 423 (654)
.++||+|+||+||+|.+.++ ..||||+++... ...++|.+|+++|++++|||||+++|++.+. +..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999996532 368999997542 2346799999999999999999999998764 5789999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
++|+|.+++... ...+++..+++++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 112 ~~g~l~~~~~~~----~~~~~~~~~~~i~~qia~gL~~lH~~~-iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKK-FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccc----cccchHHHHHHHHHHHHHhhhhhcccC-cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999998743 345789999999999999999999998 999999999999999999999999999865432
Q ss_pred -----CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 501 -----TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 501 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
....++..|+|||.+.++.++.++||||||+++|||+||+.||...... .+... .+......
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~---~i~~g~~~-------- 253 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITV---YLLQGRRL-------- 253 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH---HHHTTCCC--------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHH---HHHcCCCC--------
Confidence 1234567899999999999999999999999999999988887643221 11222 22111110
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCCCCCCCCCCCCCC
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGETDDGLRQSSDDP 632 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~ 632 (654)
........++.+++.+||+.||++||||.||++.|+++...-..+.....+.++
T Consensus 254 ---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~~~~~~~~ 307 (311)
T d1r0pa_ 254 ---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATY 307 (311)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBCCCCTTT
T ss_pred ---CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhchhccCcc
Confidence 011112235778888999999999999999999999998765555444444433
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=385.59 Aligned_cols=243 Identities=22% Similarity=0.339 Sum_probs=197.8
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc-------cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-------VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVY 420 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 420 (654)
.+.+.||+|+||+||+|... +|+.||||++++.. ...+.+.+|+++|++++|||||+++++|.+++..|+||
T Consensus 13 ~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (293)
T d1jksa_ 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 92 (293)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 44678999999999999964 68999999986542 23567999999999999999999999999999999999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC----CeEEeccCCCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH----DACVSDFGLNPL 496 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~----~~kl~Dfgla~~ 496 (654)
|||++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+|++|||+|..
T Consensus 93 E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~~~-ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 93 ELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhhcc-eeecccccceEEEecCCCcccceEecchhhhhh
Confidence 999999999999742 45999999999999999999999998 99999999999998876 499999999987
Q ss_pred cCCC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 497 FGNT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 497 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
.... ....+++.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+....... ..
T Consensus 167 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~~~~---~~ 237 (293)
T d1jksa_ 167 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVSAVNYEF---ED 237 (293)
T ss_dssp CTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHTTCCCC---CH
T ss_pred cCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH------HHHHHHHHhcCCCC---Cc
Confidence 6433 345677889999999999999999999999999999999999975321 12222222211110 00
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
. .... ...++.+++.+||+.||++|||++|+++
T Consensus 238 ~--~~~~---~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 238 E--YFSN---TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp H--HHTT---SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h--hcCC---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0011 1234667888999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=385.49 Aligned_cols=248 Identities=21% Similarity=0.331 Sum_probs=191.5
Q ss_pred HhhccccccCceeEEEEEecC----CcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE----GTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
.+.+.||+|+||+||+|.+.. +..||||.++.... ..+.+.+|++++++++|||||+++++|. ++..++||||
T Consensus 10 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~ 88 (273)
T d1mp8a_ 10 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL 88 (273)
T ss_dssp EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred EEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEe
Confidence 446789999999999998642 35689999865432 3467899999999999999999999985 5678999999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 500 (654)
+++|+|.+++... ...+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+|+.....
T Consensus 89 ~~~g~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~-iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 89 CTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLESKR-FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp CTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEEETTEEEECC------------
T ss_pred ccCCcHHhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhcccC-eeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 9999999987643 346899999999999999999999998 999999999999999999999999999876432
Q ss_pred ---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhh
Q 036334 501 ---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELM 576 (654)
Q Consensus 501 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (654)
....+++.|+|||++.+..++.++|||||||++|||++ |.+||......+ ....+..... .
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~------~~~~i~~~~~-~-------- 228 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGER-L-------- 228 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCC-C--------
T ss_pred eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCC-C--------
Confidence 23455778999999999999999999999999999998 888887543221 1112211111 0
Q ss_pred ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 577 RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 577 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
........++.+|+.+||+.||++|||++||++.|+++.+.
T Consensus 229 --~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11112234577788899999999999999999999988654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-47 Score=386.93 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=200.7
Q ss_pred hhccccccCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
+.+.||+|+||+||+|.+. +++.||||+++.... ..++|.+|++++++++||||++++++|.+.+..++|||
T Consensus 17 ~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e 96 (301)
T d1lufa_ 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 96 (301)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEE
Confidence 4578999999999999864 357899999976533 24678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC
Q 036334 422 YMPAGSLSALLHGSRG-------------------SGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP 482 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~ 482 (654)
|+++|+|.+++..... .....+++..+++++.|++.||+|||+++ |+||||||+|||++.
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~-ivHrDlKp~NILld~ 175 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-FVHRDLATRNCLVGE 175 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECG
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC-eEeeEEcccceEECC
Confidence 9999999999964321 12335899999999999999999999998 999999999999999
Q ss_pred CCCeEEeccCCCCCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCCCChh
Q 036334 483 DHDACVSDFGLNPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGK-APNQASLGEEGIDLP 555 (654)
Q Consensus 483 ~~~~kl~Dfgla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~-~pf~~~~~~~~~~~~ 555 (654)
++.+||+|||+|...... ....+++.|+|||.+.+..|+.++|||||||++|||++|. +||..... .
T Consensus 176 ~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~------~ 249 (301)
T d1lufa_ 176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH------E 249 (301)
T ss_dssp GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------H
T ss_pred CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH------H
Confidence 999999999998654321 2345667899999999999999999999999999999986 56654321 2
Q ss_pred HHHHHHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 556 RWVQSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
+.+..+ ..+... ........++.+|+.+||+.||++||||.||+++|++|.+
T Consensus 250 e~~~~v-~~~~~~----------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 250 EVIYYV-RDGNIL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HHHHHH-HTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHHH-HcCCCC----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222222 211111 1111223467788999999999999999999999999863
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.6e-47 Score=393.66 Aligned_cols=245 Identities=21% Similarity=0.364 Sum_probs=199.8
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.+.||+|+||+||+|... +|+.||||++.... ...+.+.+|+++|++++|||||++++++.+++..++|||||++|
T Consensus 29 ~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg 108 (350)
T d1koaa2 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 108 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 34678999999999999964 68999999997653 33567889999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC--CCCeEEeccCCCCCcCCCC---
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP--DHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~--~~~~kl~Dfgla~~~~~~~--- 501 (654)
+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++.......
T Consensus 109 ~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~-iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 109 ELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENN-YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp BHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred CHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcC-CeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 999998643 345999999999999999999999998 999999999999964 5789999999998775543
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...+|+.|||||++.+..++.++||||+||++|||++|+.||.+.. ....+..+....+.... . ...
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~~~~~~~---~--~~~-- 250 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN------DDETLRNVKSCDWNMDD---S--AFS-- 250 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCCSCC---G--GGG--
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCCCCc---c--ccc--
Confidence 2467888999999999999999999999999999999999997532 22233333322221100 0 001
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
....++.+++.+||+.||++|||++|+++.
T Consensus 251 -~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 251 -GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112356677889999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-46 Score=392.26 Aligned_cols=245 Identities=23% Similarity=0.371 Sum_probs=199.3
Q ss_pred HhhccccccCceeEEEEEe-cCCcEEEEEEecccc-cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 349 ASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
.+.+.||+|+||+||+|.. .+|+.||||+++... .....+.+|+++|++++|||||+++++|.+++..|+||||+++|
T Consensus 32 ~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg 111 (352)
T d1koba_ 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 111 (352)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 3457899999999999996 469999999987653 34567889999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEEC--CCCCeEEeccCCCCCcCCCC---
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLR--PDHDACVSDFGLNPLFGNTT--- 501 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~--~~~~~kl~Dfgla~~~~~~~--- 501 (654)
+|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|.......
T Consensus 112 ~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~-iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 112 ELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS-IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp BHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred hHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-eeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 999887632 345999999999999999999999998 99999999999998 57899999999998876543
Q ss_pred CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCCh
Q 036334 502 PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNI 581 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (654)
...+++.|||||++.+..++.++||||+||++|||++|+.||..... ...+..+....... . ....
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~~---~-----~~~~ 252 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDWEF---D-----EDAF 252 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCCCC---C-----SSTT
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC---C-----cccc
Confidence 24677889999999999999999999999999999999999975322 22222222221110 0 0001
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 582 EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 582 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.....++.+|+.+||+.||++|||++|+++.
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122356677889999999999999999763
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=388.10 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=196.2
Q ss_pred hhccccccCceeEEEEEec-CCc----EEEEEEeccc--ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGT----TVVVKRLKEV--AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~----~vavK~~~~~--~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 422 (654)
..++||+|+||+||+|.+. +|+ +||+|+++.. ....++|.+|++++++++|||||+++|+|.++ ..++++||
T Consensus 13 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~ 91 (317)
T d1xkka_ 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 91 (317)
T ss_dssp EEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEEC
T ss_pred EeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEe
Confidence 3578999999999999864 343 6899988654 33467899999999999999999999999764 67788999
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC-
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT- 501 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 501 (654)
+.+|+|.+++... ...+++..+++++.|||.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~-iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 92 MPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR-LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp CTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred ccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHHHcC-cccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 9999999988743 356999999999999999999999998 9999999999999999999999999988664321
Q ss_pred -----CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhh
Q 036334 502 -----PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVEL 575 (654)
Q Consensus 502 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (654)
...+|..|||||++.++.++.++|||||||++|||+| |+.||......+ + ...+..+.
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~----~~~i~~~~--------- 230 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGE--------- 230 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---H----HHHHHHTC---------
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHcCC---------
Confidence 2345778999999999999999999999999999999 788886543221 1 11221111
Q ss_pred hccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 576 MRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 576 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
+.........++.+++.+||+.||++|||+.||++.|+.+...
T Consensus 231 -~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 231 -RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 0111122334677888899999999999999999999988643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=382.08 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=199.0
Q ss_pred hhccccccCceeEEEEEecC-Cc--EEEEEEeccc--ccCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLEE-GT--TVVVKRLKEV--AVGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~-g~--~vavK~~~~~--~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.++||+|+||+||+|.+++ |. .||||+++.. ....+++.+|+++|+++ +|||||+++|+|.+++..++||||+
T Consensus 14 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~ 93 (309)
T d1fvra_ 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 93 (309)
T ss_dssp EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEec
Confidence 35789999999999999653 44 4778887543 23456799999999998 7999999999999999999999999
Q ss_pred CCCchhhhhccCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccC
Q 036334 424 PAGSLSALLHGSR-----------GSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFG 492 (654)
Q Consensus 424 ~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfg 492 (654)
++|+|.++++... ......+++..+++++.|||.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~-iiHrDlkp~NIL~~~~~~~kl~DfG 172 (309)
T d1fvra_ 94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-FIHRDLAARNILVGENYVAKIADFG 172 (309)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECGGGCEEECCTT
T ss_pred CCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC-ccccccccceEEEcCCCceEEcccc
Confidence 9999999997431 112356999999999999999999999998 9999999999999999999999999
Q ss_pred CCCCcCCC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 493 LNPLFGNT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKA-PNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 493 la~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
++...... ....++..|+|||.+.++.++.++|||||||++|||++|.. ||... +.......+... ..
T Consensus 173 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~------~~~~~~~~i~~~-~~- 244 (309)
T d1fvra_ 173 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------TCAELYEKLPQG-YR- 244 (309)
T ss_dssp CEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHGGGT-CC-
T ss_pred ccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC------CHHHHHHHHHhc-CC-
Confidence 98765432 23456778999999999999999999999999999999765 56432 222222222221 11
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcCC
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRGE 620 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 620 (654)
.........++.+|+.+||+.||++||||+||++.|+++.+..
T Consensus 245 ---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 245 ---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp ---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1111122345677888999999999999999999999998654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-46 Score=383.61 Aligned_cols=239 Identities=21% Similarity=0.268 Sum_probs=198.9
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV----AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||+||+|+.+ +|+.||||+++.. ....+.+.+|+.++++++|||||++++++.+++..|+||||++
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 87 (316)
T d1fota_ 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 87 (316)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecC
Confidence 4578999999999999964 5899999999754 2345678899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-CCC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-TPP 503 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-~~~ 503 (654)
+|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|...... ...
T Consensus 88 gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~-iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 161 (316)
T d1fota_ 88 GGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKD-IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL 161 (316)
T ss_dssp SCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCC
T ss_pred Cccccccccc-----cccccccHHHHHHHHHHHhhhhhccCc-EEccccCchheeEcCCCCEEEecCccceEeccccccc
Confidence 9999999874 345889999999999999999999998 999999999999999999999999999876543 456
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.||+.|||||++.+..|+.++||||+||++|||++|+.||.... .......+...... .....
T Consensus 162 ~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~~~---------~p~~~-- 224 (316)
T d1fota_ 162 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNAELR---------FPPFF-- 224 (316)
T ss_dssp CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHCCCC---------CCTTS--
T ss_pred cCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC------HHHHHHHHHcCCCC---------CCCCC--
Confidence 78899999999999999999999999999999999999997532 22222232222110 11111
Q ss_pred HHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRP-----AMQEVVRM 612 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 612 (654)
..++.+++.+||..||++|+ |++|+++.
T Consensus 225 -s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 225 -NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 23466777899999999996 89998763
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=377.73 Aligned_cols=246 Identities=23% Similarity=0.353 Sum_probs=190.0
Q ss_pred hhccccccCceeEEEEEecC--C--cEEEEEEecccc----cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLEE--G--TTVVVKRLKEVA----VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~--g--~~vavK~~~~~~----~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
+.+.||+|+||+||+|.+.. + ..||||+++... ...++|.+|+.+|++++|||||+++|+|.+ +..++|||
T Consensus 12 ~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e 90 (273)
T d1u46a_ 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTE 90 (273)
T ss_dssp EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred EEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeee
Confidence 35679999999999998532 2 378999987542 223578999999999999999999999965 46789999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT 501 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 501 (654)
|+++|++.+++... ...+++..+++++.|+|.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 91 ~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~-iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 91 LAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKR-FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp CCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhhCC-EeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 99999999988643 345999999999999999999999998 9999999999999999999999999998764432
Q ss_pred -------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 502 -------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 502 -------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
...++..|+|||++.+..++.++|||||||++|||+| |+.||... +....+..+.+.....
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~------~~~~~~~~i~~~~~~~----- 234 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQILHKIDKEGERL----- 234 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTSCCCC-----
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc------CHHHHHHHHHhCCCCC-----
Confidence 2345567999999999999999999999999999998 89999743 2223333333332211
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMN 617 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 617 (654)
........++.+++.+||+.||++||||+||++.|++.+
T Consensus 235 -----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 235 -----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 111122245778888999999999999999999998763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=384.20 Aligned_cols=238 Identities=22% Similarity=0.272 Sum_probs=197.2
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEeccc----ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEV----AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||+||+|+. .+|+.||||++++. ....+.+.+|+.+|++++||||+++++++.+++..|+||||++
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~ 88 (337)
T d1o6la_ 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccC
Confidence 457899999999999996 46899999999754 2345678899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
+|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 89 gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~~~-iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~ 162 (337)
T d1o6la_ 89 GGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRD-VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp TCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred CCchhhhhhc-----ccCCcHHHHHHHHHHHhhhhhhhhhcC-ccccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence 9999999974 345899999999999999999999998 999999999999999999999999999875432
Q ss_pred CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCC
Q 036334 501 TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHN 580 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (654)
....||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+..... ..+..
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~i~~~~~---------~~p~~ 227 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEEI---------RFPRT 227 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC---------CCCTT
T ss_pred ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH------HHHHHHHhcCCC---------CCCcc
Confidence 235678899999999999999999999999999999999999976432 222222222111 01111
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 036334 581 IEEEMVQLLQIAMGCVSTVPDQRPA-----MQEVVR 611 (654)
Q Consensus 581 ~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 611 (654)
.. .++.+++.+||+.||++||+ ++|+++
T Consensus 228 ~s---~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 228 LS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CC---HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 22 34566778999999999995 788876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=382.95 Aligned_cols=253 Identities=26% Similarity=0.343 Sum_probs=189.9
Q ss_pred HhhccccccCceeEEEEEec------CCcEEEEEEecccc--cCHHHHHHHHHHHhcc-CCCccccccEEEEeCC-ceEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVA--VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKD-EKLL 418 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~-~~~l 418 (654)
.+.+.||+|+||+||+|.+. +++.||||+++... ...+.+.+|+..+.++ +|+||+++++++...+ ..++
T Consensus 16 ~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~i 95 (299)
T d1ywna1 16 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 95 (299)
T ss_dssp EEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEE
T ss_pred EEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEE
Confidence 34678999999999999853 24689999997543 2345677788877776 6899999999887654 6899
Q ss_pred EEEecCCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeE
Q 036334 419 VYDYMPAGSLSALLHGSRGS-----------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDAC 487 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~k 487 (654)
|||||++|+|.++++..+.. ....+++.+++.++.||++||+|||+++ |+||||||+|||+++++.+|
T Consensus 96 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~-ivHrDlKp~NILl~~~~~~K 174 (299)
T d1ywna1 96 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVK 174 (299)
T ss_dssp EEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECGGGCEE
T ss_pred EEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC-CcCCcCCccceeECCCCcEE
Confidence 99999999999999754211 1345899999999999999999999998 99999999999999999999
Q ss_pred EeccCCCCCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCCCChhHHHHH
Q 036334 488 VSDFGLNPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGK-APNQASLGEEGIDLPRWVQS 560 (654)
Q Consensus 488 l~Dfgla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~-~pf~~~~~~~~~~~~~~~~~ 560 (654)
|+|||+|+..... ....+|+.|||||++.++.++.++|||||||++|||++|. .||..... ...+..
T Consensus 175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~------~~~~~~ 248 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------DEEFCR 248 (299)
T ss_dssp ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC------SHHHHH
T ss_pred EccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH------HHHHHH
Confidence 9999999765432 2345778899999999999999999999999999999974 56754322 122222
Q ss_pred HhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 561 VVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
.+..+.... .......++.+++.+||+.||++|||++|++++|+++.+
T Consensus 249 ~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 249 RLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCCC----------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 222222111 111223457788889999999999999999999998864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.6e-46 Score=376.37 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=196.2
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEeccccc----CHHHHHHHHHHHhccCCCccccccEEEEeCCc----eEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAV----GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDE----KLLVY 420 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~----~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~----~~lv~ 420 (654)
+.+.||+|+||+||+|.. .+|+.||||+++.... ....+.+|++++++++|||||++++++...+. .|+||
T Consensus 11 i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvm 90 (277)
T d1o6ya_ 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM 90 (277)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEE
Confidence 457899999999999995 4689999999976532 23468899999999999999999999876543 78999
Q ss_pred EecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC
Q 036334 421 DYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT 500 (654)
Q Consensus 421 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~ 500 (654)
||+++|+|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++..+++|||.+......
T Consensus 91 E~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~-iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 91 EYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNG-IIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp ECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred ECCCCCEehhhhcc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-ccCccccCcccccCccccceeehhhhhhhhccc
Confidence 99999999998873 346999999999999999999999998 999999999999999999999999987654322
Q ss_pred -------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 -------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....+|+.|||||++.+..++.++|||||||++|||+||+.||.... ................
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~~~~---- 234 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIPP---- 234 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCCCG----
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCCCCC----
Confidence 23457888999999999999999999999999999999999997532 2222223332221110
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhhhc
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRP-AMQEVVRMIENMNR 618 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~ 618 (654)
.......+ .++.+++.+||+.||++|| |++++++.|.++..
T Consensus 235 -~~~~~~~s---~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 235 -SARHEGLS---ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp -GGTSSSCC---HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred -chhccCCC---HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 00111122 3566777899999999999 89999999998864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=382.68 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=202.1
Q ss_pred HhhccccccCceeEEEEEec------CCcEEEEEEecccc--cCHHHHHHHHHHHhcc-CCCccccccEEEEeCCceEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVA--VGKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~lv 419 (654)
.+.++||+|+||.||+|.+. +++.||||+++... ....++.+|+.+++++ +|||||+++++|.+++..++|
T Consensus 26 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lv 105 (311)
T d1t46a_ 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI 105 (311)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEE
Confidence 34678999999999999852 35689999997653 2345688999999999 699999999999999999999
Q ss_pred EEecCCCchhhhhccCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCe
Q 036334 420 YDYMPAGSLSALLHGSRGS-------------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDA 486 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~ 486 (654)
|||+++|+|.++++..... ....+++..+++++.||+.||+|||+++ |+||||||+||+++.++.+
T Consensus 106 mE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~-ivHrDLKp~NIl~~~~~~~ 184 (311)
T d1t46a_ 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-CIHRDLAARNILLTHGRIT 184 (311)
T ss_dssp EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEEETTTEE
T ss_pred EEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-eeecccccccccccccCcc
Confidence 9999999999999754321 2346999999999999999999999998 9999999999999999999
Q ss_pred EEeccCCCCCcCCCC------CCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHH
Q 036334 487 CVSDFGLNPLFGNTT------PPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTG-KAPNQASLGEEGIDLPRWVQ 559 (654)
Q Consensus 487 kl~Dfgla~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg-~~pf~~~~~~~~~~~~~~~~ 559 (654)
|++|||+++...... ...+++.|+|||++.++.++.++|||||||++|||+|+ .+||...... ..+.
T Consensus 185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~------~~~~ 258 (311)
T d1t46a_ 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------SKFY 258 (311)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS------HHHH
T ss_pred cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH------HHHH
Confidence 999999998765432 23556789999999999999999999999999999995 4445432211 1122
Q ss_pred HHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 560 SVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
.++..+.. ..........+.+|+.+||+.||++||||++|+++|+++...
T Consensus 259 ~~i~~~~~----------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 259 KMIKEGFR----------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCC----------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 22222211 111122234677888899999999999999999999987544
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=377.43 Aligned_cols=252 Identities=27% Similarity=0.379 Sum_probs=196.5
Q ss_pred HhhccccccCceeEEEEEecC--------CcEEEEEEeccccc--CHHHHHHHHHHHhcc-CCCccccccEEEEeCCceE
Q 036334 349 ASAEVLGKGSVGTSYKAVLEE--------GTTVVVKRLKEVAV--GKREFEMQMEVLGKI-KHDNVVPLRAFYYSKDEKL 417 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~hpniv~l~~~~~~~~~~~ 417 (654)
.+.+.||+|+||.||+|.... +..||||+++.... ...++.+|...+.++ +|||||+++++|.+++..+
T Consensus 16 ~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~ 95 (299)
T d1fgka_ 16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 95 (299)
T ss_dssp EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEE
Confidence 345789999999999998532 34799999976543 346788888888888 7999999999999999999
Q ss_pred EEEEecCCCchhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCe
Q 036334 418 LVYDYMPAGSLSALLHGSRGS-----------GRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDA 486 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~ 486 (654)
+||||+++|+|.+++...+.. ....+++.++++++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 96 ~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~-ivHrDiKp~NiLl~~~~~~ 174 (299)
T d1fgka_ 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-CIHRDLAARNVLVTEDNVM 174 (299)
T ss_dssp EEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCSGGGEEECTTCCE
T ss_pred EEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC-EEeeeecccceeecCCCCe
Confidence 999999999999999754321 2346899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCCCCcCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 036334 487 CVSDFGLNPLFGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLT-GKAPNQASLGEEGIDLPRWVQ 559 (654)
Q Consensus 487 kl~Dfgla~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~~ 559 (654)
||+|||++...... ....+++.|+|||.+.++.|+.++|||||||++|||++ |..||..... .. +.
T Consensus 175 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------~~-~~ 247 (299)
T d1fgka_ 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------EE-LF 247 (299)
T ss_dssp EECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HH-HH
T ss_pred EeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH------HH-HH
Confidence 99999998866432 22456677999999999999999999999999999998 6778764221 11 22
Q ss_pred HHhhhchhhhhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 560 SVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
..+..+... ........++.+|+.+||+.||++|||+.||++.|+++..
T Consensus 248 ~~i~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 248 KLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHTTCCC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCC----------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 222221111 1111122457788889999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-46 Score=381.34 Aligned_cols=244 Identities=20% Similarity=0.317 Sum_probs=199.8
Q ss_pred HhhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCCc
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
.+.+.||+|+||+||+|... +|+.||||+++........+.+|+++|++++|||||++++++.+++..|+|||||++|+
T Consensus 8 ~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~ 87 (321)
T d1tkia_ 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCc
Confidence 34578999999999999965 58899999998776666778899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC--CCeEEeccCCCCCcCCCC---C
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD--HDACVSDFGLNPLFGNTT---P 502 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~--~~~kl~Dfgla~~~~~~~---~ 502 (654)
|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||++....... .
T Consensus 88 L~~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH~~~-iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~ 162 (321)
T d1tkia_ 88 IFERINTS----AFELNEREIVSYVHQVCEALQFLHSHN-IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp HHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC-CCcccccccceeecCCCceEEEEcccchhhccccCCcccc
Confidence 99999743 235999999999999999999999998 9999999999999854 479999999998765432 2
Q ss_pred CCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChH
Q 036334 503 PTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIE 582 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (654)
..+++.|+|||.+.+..|+.++||||+||++|||++|+.||..... ...+..+....... +.. .+...
T Consensus 163 ~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~------~~~~~~i~~~~~~~---~~~--~~~~~- 230 (321)
T d1tkia_ 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEYTF---DEE--AFKEI- 230 (321)
T ss_dssp EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCC---CHH--HHTTS-
T ss_pred cccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC---Chh--hccCC-
Confidence 4567789999999999999999999999999999999999975322 22233333222110 000 00111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 583 EEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 583 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
..++.+++.+||..||++|||++|+++
T Consensus 231 --s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 231 --SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 234667788999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-45 Score=382.58 Aligned_cols=238 Identities=16% Similarity=0.190 Sum_probs=198.3
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV----AVGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
+.+.||+|+||+||+|..+ +|+.||||+++.. ....+.+.+|+++|++++|||||++++++.+.+..++||||+.
T Consensus 45 i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~ 124 (350)
T d1rdqe_ 45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccc
Confidence 4578999999999999964 6999999998653 2334678899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-CCC
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-TPP 503 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-~~~ 503 (654)
+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..... ...
T Consensus 125 ~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~-iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 198 (350)
T d1rdqe_ 125 GGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD-LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL 198 (350)
T ss_dssp TCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCC
T ss_pred ccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-EecCcCCHHHcccCCCCCEEeeeceeeeecccccccc
Confidence 99999999743 45999999999999999999999998 999999999999999999999999999877543 446
Q ss_pred CccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccCChHH
Q 036334 504 TRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYHNIEE 583 (654)
Q Consensus 504 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (654)
.||+.|||||++.+..++.++|||||||++|||++|+.||.... .......+...... .. ..
T Consensus 199 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~~~---------~p---~~ 260 (350)
T d1rdqe_ 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSGKVR---------FP---SH 260 (350)
T ss_dssp EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC---------CC---TT
T ss_pred cCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHhcCCCC---------CC---cc
Confidence 68889999999999999999999999999999999999997532 22222222222110 11 11
Q ss_pred HHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 036334 584 EMVQLLQIAMGCVSTVPDQRP-----AMQEVVR 611 (654)
Q Consensus 584 ~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 611 (654)
...++.+++.+||+.||++|+ |++|+++
T Consensus 261 ~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 223566788899999999994 8999876
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-45 Score=370.45 Aligned_cols=242 Identities=21% Similarity=0.332 Sum_probs=195.3
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccccC----------HHHHHHHHHHHhccC-CCccccccEEEEeCCceE
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVG----------KREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKL 417 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~----------~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~ 417 (654)
+.+.||+|+||+||+|+. .+|+.||||+++..... .+.+.+|+.++++++ ||||+++++++.+++..|
T Consensus 7 ~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 86 (277)
T d1phka_ 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 86 (277)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred EceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceE
Confidence 457899999999999996 46899999998754221 235788999999997 999999999999999999
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 418 LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 87 ivmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~-ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 87 LVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLN-IVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcCCCchHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcC-CcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999973 346999999999999999999999998 999999999999999999999999999876
Q ss_pred CCC---CCCCccccccCccccCC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhh
Q 036334 498 GNT---TPPTRVAGYRAPEVVET------RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTA 568 (654)
Q Consensus 498 ~~~---~~~~~~~~y~aPE~~~~------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 568 (654)
... ....+|..|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+.......
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRMIMSGNYQF 234 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCC
T ss_pred cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------HHHHHHHHhCCCCC
Confidence 543 34567788999998853 3578899999999999999999999975321 12222222222110
Q ss_pred hhhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 569 EVFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.. ........++.+++.+||+.||++|||++||++
T Consensus 235 -----~~---~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 235 -----GS---PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -----CT---TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -----CC---cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00 011112235667888999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=379.33 Aligned_cols=244 Identities=21% Similarity=0.296 Sum_probs=190.3
Q ss_pred hccccccCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHhcc-CCCccccccEEEEe----CCceEEEEEecC
Q 036334 351 AEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVGKREFEMQMEVLGKI-KHDNVVPLRAFYYS----KDEKLLVYDYMP 424 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l-~hpniv~l~~~~~~----~~~~~lv~e~~~ 424 (654)
.++||+|+||+||+|.. .+|+.||||+++. ...+.+|++++.++ +|||||+++++|.+ +...|+|||||+
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 35799999999999996 4689999999864 34677899886554 89999999999875 356899999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC---CCCeEEeccCCCCCcCCC-
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP---DHDACVSDFGLNPLFGNT- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~---~~~~kl~Dfgla~~~~~~- 500 (654)
+|+|.+++... +...+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.....
T Consensus 93 gg~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH~~~-iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~ 168 (335)
T d2ozaa1 93 GGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN-IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168 (335)
T ss_dssp SEEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred CCcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHHHcC-CccccccccccccccccccccccccccceeeeccCCC
Confidence 99999999743 2346999999999999999999999998 999999999999986 457999999999866433
Q ss_pred --CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 501 --TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 501 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
....+|+.|||||++.+..|+.++|||||||++|||+||+.||......+.. ..+....... ..+.. .
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~----~~~~~---~ 238 (335)
T d2ozaa1 169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMG----QYEFP---N 238 (335)
T ss_dssp CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC----SSSCC---T
T ss_pred ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhcC----CCCCC---C
Confidence 3456888999999999999999999999999999999999999764432211 1111100000 00000 0
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
........++.+|+.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0011223457788889999999999999999873
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.5e-45 Score=382.11 Aligned_cols=241 Identities=21% Similarity=0.280 Sum_probs=191.1
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHH---HHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVA----VGKREFEM---QMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~---e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
+.++||+|+||+||+|... +|+.||||++.... .....+.+ ++++++.++|||||+++++|.+++..|+|||
T Consensus 8 i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE 87 (364)
T d1omwa3 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 87 (364)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred eeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEE
Confidence 3578999999999999965 58999999986432 22233444 4667788889999999999999999999999
Q ss_pred ecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC-
Q 036334 422 YMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT- 500 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~- 500 (654)
|+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|......
T Consensus 88 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~~~-iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 88 LMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp CCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred ecCCCcHHHHHHh-----cccccHHHHHHHHHHHHHHHHHHHHCC-ccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 9999999999974 345899999999999999999999998 999999999999999999999999999876543
Q ss_pred -CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhcc
Q 036334 501 -TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRY 578 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (654)
....||+.|||||++.. ..|+.++|||||||++|||+||+.||......+ ........... ....+
T Consensus 162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~~~~~~~---------~~~~~ 229 (364)
T d1omwa3 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLTM---------AVELP 229 (364)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC---HHHHHHHSSSC---------CCCCC
T ss_pred ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcccC---------CCCCC
Confidence 34568899999999964 568999999999999999999999997643322 11111111110 00011
Q ss_pred CChHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 036334 579 HNIEEEMVQLLQIAMGCVSTVPDQRPA-----MQEVVR 611 (654)
Q Consensus 579 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 611 (654)
... ..++.+++.+||+.||++||| ++|+++
T Consensus 230 ~~~---s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 230 DSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSS---CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCC---CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 112 234667778999999999999 678765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=375.25 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=202.5
Q ss_pred hhccccccCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE------EGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYD 421 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 421 (654)
+.+.||+|+||+||+|.+. +++.||||+++.... ....|.+|++++++++|||||+++++|..++..++|||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence 4578999999999999863 357899999975432 23458899999999999999999999999999999999
Q ss_pred ecCCCchhhhhccCC-----CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCC
Q 036334 422 YMPAGSLSALLHGSR-----GSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPL 496 (654)
Q Consensus 422 ~~~~g~L~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~ 496 (654)
|+++|+|.+++...+ ......+++..+.+++.|+|+||.|||+++ |+||||||+|||++.++++||+|||+|+.
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~-ivHrDlk~~NiLld~~~~~Kl~DFGla~~ 182 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRD 182 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT-CBCSCCSGGGEEECTTCCEEECCTTCCCG
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC-eeeceEcCCceeecCCceEEEeeccccee
Confidence 999999999886432 112345799999999999999999999987 99999999999999999999999999986
Q ss_pred cCCC------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCCCChhHHHHHHhhhchhhh
Q 036334 497 FGNT------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGK-APNQASLGEEGIDLPRWVQSVVREEWTAE 569 (654)
Q Consensus 497 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 569 (654)
.... ....+++.|+|||.+.++.++.++|||||||++|||+||. .||... .....+..+..... .
T Consensus 183 ~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------~~~~~~~~i~~~~~-~- 254 (308)
T d1p4oa_ 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQVLRFVMEGGL-L- 254 (308)
T ss_dssp GGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHHHHHHHHHTTCC-C-
T ss_pred ccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHhCCC-C-
Confidence 6432 2234677899999999999999999999999999999985 666542 22233333222211 1
Q ss_pred hhhHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 570 VFDVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
.........+.+++.+||+.+|++||||++|+++|++..+.
T Consensus 255 ---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 255 ---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 11112234678888899999999999999999999887654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=374.32 Aligned_cols=251 Identities=23% Similarity=0.286 Sum_probs=189.2
Q ss_pred ccccccCceeEEEEEec-CCcEEEEEEecccccC------HHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecC
Q 036334 352 EVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG------KREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMP 424 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 424 (654)
++||+|+||+||+|... +|+.||||+++..... .+.+.+|++++++++|||||++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 67999999999999964 5899999998754321 2468899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 500 (654)
++++..+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|......
T Consensus 84 ~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~-iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 84 TDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQHW-ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp EEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred chHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhccc-eecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence 8887777652 345888999999999999999999998 999999999999999999999999999776543
Q ss_pred CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhh-------
Q 036334 501 TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFD------- 572 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 572 (654)
....+|+.|+|||++.+ ..|+.++||||+||++|||++|+.||......+ ....+.............+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhccchh
Confidence 23457788999999864 468999999999999999999999997543211 1111111110000000000
Q ss_pred Hhhhcc-CCh-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 573 VELMRY-HNI-----EEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 573 ~~~~~~-~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
...... ... .....++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000 000 011235777888999999999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=376.89 Aligned_cols=238 Identities=23% Similarity=0.312 Sum_probs=192.9
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHh-ccCCCccccccEEEEeCCceEEEEEec
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEV----AVGKREFEMQMEVLG-KIKHDNVVPLRAFYYSKDEKLLVYDYM 423 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~e~~~l~-~l~hpniv~l~~~~~~~~~~~lv~e~~ 423 (654)
+.+.||+|+||+||+|... +|+.||||++++. ....+.+..|+.++. .++|||||++++++.+++..|+||||+
T Consensus 6 i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~ 85 (320)
T d1xjda_ 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 85 (320)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeec
Confidence 4578999999999999965 5899999999753 233455667777654 689999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC---
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~--- 500 (654)
++|+|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||++......
T Consensus 86 ~~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~~~-iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 86 NGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKG-IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 159 (320)
T ss_dssp TTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT-CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred CCCcHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCcccceeecCCCceeccccchhhhccccccc
Confidence 99999999974 345899999999999999999999998 999999999999999999999999999865432
Q ss_pred -CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHhhhccC
Q 036334 501 -TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVELMRYH 579 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (654)
....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+... ......+..... . .+.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~~-------~--~p~ 224 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRMDNP-------F--YPR 224 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC-------C--CCT
T ss_pred ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC-------C--CCc
Confidence 335678889999999999999999999999999999999999975322 122222211111 0 111
Q ss_pred ChHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 036334 580 NIEEEMVQLLQIAMGCVSTVPDQRPAMQ-EVVR 611 (654)
Q Consensus 580 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 611 (654)
.. ..++.+|+.+||+.||++|||+. |+++
T Consensus 225 ~~---s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 225 WL---EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp TS---CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred cC---CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 12 23466778899999999999995 6753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=366.44 Aligned_cols=232 Identities=21% Similarity=0.380 Sum_probs=188.1
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEeccccc-------CHHHHHHHHHHHhccC--CCccccccEEEEeCCceEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAV-------GKREFEMQMEVLGKIK--HDNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~--hpniv~l~~~~~~~~~~~lv 419 (654)
+.++||+|+||+||+|... +|+.||||+++.... ...++.+|+.++++++ |||||++++++.+++..++|
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv 87 (273)
T d1xwsa_ 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 87 (273)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEE
Confidence 4578999999999999964 689999999875421 1234678999999986 89999999999999999999
Q ss_pred EEecCC-CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCC-CCeEEeccCCCCCc
Q 036334 420 YDYMPA-GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPD-HDACVSDFGLNPLF 497 (654)
Q Consensus 420 ~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~-~~~kl~Dfgla~~~ 497 (654)
|||+.+ +++.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+|...
T Consensus 88 ~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~-iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 88 LERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CccccCcccceEEecCCCeEEECccccceec
Confidence 999976 578888763 345999999999999999999999998 9999999999999854 78999999999865
Q ss_pred CCC--CCCCccccccCccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhHh
Q 036334 498 GNT--TPPTRVAGYRAPEVVETRKV-TFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDVE 574 (654)
Q Consensus 498 ~~~--~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 574 (654)
... ....||+.|||||++.+..+ +.++||||+||++|||++|+.||.... .+.+....
T Consensus 162 ~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~~~------- 222 (273)
T d1xwsa_ 162 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQVF------- 222 (273)
T ss_dssp CSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCCC-------
T ss_pred ccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhcccC-------
Confidence 443 34568889999999987765 577999999999999999999996421 11111110
Q ss_pred hhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 575 LMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 575 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.....+ .++.+++.+||+.||++|||++|+++
T Consensus 223 --~~~~~s---~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 223 --FRQRVS---SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --CSSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCCC---HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111122 34667778999999999999999976
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=367.97 Aligned_cols=252 Identities=19% Similarity=0.265 Sum_probs=189.6
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.+.||+|+||+||+|.. .+|+.||||+++.... ...++.+|++++++++|||||++++++.+++..|+||||+.+
T Consensus 6 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~ 85 (298)
T d1gz8a_ 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 85 (298)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC
Confidence 347899999999999996 5689999999975432 356789999999999999999999999999999999999976
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----C
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----T 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~ 501 (654)
+.+...... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|...... .
T Consensus 86 ~~~~~~~~~----~~~~l~e~~~~~~~~qil~~L~yLH~~~-IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~ 160 (298)
T d1gz8a_ 86 DLKKFMDAS----ALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160 (298)
T ss_dssp EHHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred chhhhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcCC-EEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence 544443332 2345999999999999999999999998 999999999999999999999999998765432 3
Q ss_pred CCCccccccCccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------chhhhhh---
Q 036334 502 PPTRVAGYRAPEVVETRK-VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE------EWTAEVF--- 571 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~--- 571 (654)
...+++.|+|||++.... ++.++||||+||++|||++|+.||...... ..+..+... .......
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~------~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI------DQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH------HHHHHHHHhcCCCchhhcccccccc
Confidence 346778899999877655 578999999999999999999999754221 111111100 0000000
Q ss_pred --hHhhhc--cCCh----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 572 --DVELMR--YHNI----EEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 572 --~~~~~~--~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
...... .... .....++.+++.+||..||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 0000 0112456778889999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.5e-44 Score=362.92 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=192.2
Q ss_pred hhccccccCceeEEEEEecCCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCCC
Q 036334 350 SAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPAG 426 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 426 (654)
+.+.||+|+||+||+|.+++|+.||||+++... ...+++.+|+.+|++++|||||+++++|.+++..+++|||+.++
T Consensus 6 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~ 85 (286)
T d1ob3a_ 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD 85 (286)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEE
T ss_pred eccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhh
Confidence 347899999999999999899999999996543 23467899999999999999999999999999999999999887
Q ss_pred chhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC----CC
Q 036334 427 SLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT----TP 502 (654)
Q Consensus 427 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~ 502 (654)
.+..+... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||.+...... ..
T Consensus 86 ~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~-IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (286)
T d1ob3a_ 86 LKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRR-VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (286)
T ss_dssp HHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred hHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhccCc-EEecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence 77777652 356999999999999999999999988 999999999999999999999999998765433 23
Q ss_pred CCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---h----chh--hh--h
Q 036334 503 PTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR---E----EWT--AE--V 570 (654)
Q Consensus 503 ~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---~----~~~--~~--~ 570 (654)
..+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...... +...++.. . .+. .. .
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~------~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA------DQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH------HHHHHHHHhhCCCChhhccchhhhhh
Confidence 356777999999865 45789999999999999999999999754221 11111110 0 000 00 0
Q ss_pred hhHhhhc------cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 571 FDVELMR------YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 571 ~~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
.+..... ..........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 0001112235667888999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=363.15 Aligned_cols=253 Identities=21% Similarity=0.280 Sum_probs=188.2
Q ss_pred HhhccccccCceeEEEEEec-C-CcEEEEEEeccccc---CHHHHHHHHHHHhcc---CCCccccccEEEEe-----CCc
Q 036334 349 ASAEVLGKGSVGTSYKAVLE-E-GTTVVVKRLKEVAV---GKREFEMQMEVLGKI---KHDNVVPLRAFYYS-----KDE 415 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~---~~~~~~~e~~~l~~l---~hpniv~l~~~~~~-----~~~ 415 (654)
++.+.||+|+||+||+|... + ++.||||+++.... ....+.+|+.+++.+ +||||++++++|.. ...
T Consensus 10 ~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~ 89 (305)
T d1blxa_ 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 89 (305)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCce
Confidence 34578999999999999963 3 66799999875422 233566777777665 79999999999863 235
Q ss_pred eEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCC
Q 036334 416 KLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNP 495 (654)
Q Consensus 416 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~ 495 (654)
.+++|||++++++...... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~~~-ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 90 LTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEEEEEeccCCchhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCC-EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 7999999998877655542 2345899999999999999999999998 9999999999999999999999999987
Q ss_pred CcCCC---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh-------c
Q 036334 496 LFGNT---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE-------E 565 (654)
Q Consensus 496 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-------~ 565 (654)
..... ....+|+.|||||++.+..|+.++||||+||++|||++|+.||...... ..+..+... .
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~------~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV------DQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCCCCGGG
T ss_pred hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH------HHHHHHHHhhCCCchhc
Confidence 65432 4567788999999999999999999999999999999999999754321 111111110 0
Q ss_pred hhhhhh--hHhhh------ccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 566 WTAEVF--DVELM------RYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 566 ~~~~~~--~~~~~------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
+..... ..... ...........+.+|+.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 00000 000001112345667889999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-42 Score=350.84 Aligned_cols=252 Identities=16% Similarity=0.204 Sum_probs=189.2
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccE-EEEeCCceEEEEEecCCCc
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRA-FYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~-~~~~~~~~~lv~e~~~~g~ 427 (654)
+.+.||+|+||+||+|.+ .+|+.||||++.... ...++..|++++++++|+|++..+. ++.+++..++||||+ +++
T Consensus 11 l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~ 88 (299)
T d1ckia_ 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 88 (299)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCc
Confidence 457899999999999986 458999999986543 3346788999999998877666554 556677889999999 556
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC---CCCeEEeccCCCCCcCCC----
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP---DHDACVSDFGLNPLFGNT---- 500 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~---~~~~kl~Dfgla~~~~~~---- 500 (654)
+.+.+... ...+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+|......
T Consensus 89 l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 89 LEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN-FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp HHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT-EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred hhhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHHCC-eeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 66665432 345999999999999999999999998 999999999999864 457999999999865432
Q ss_pred -------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhhhH
Q 036334 501 -------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVFDV 573 (654)
Q Consensus 501 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 573 (654)
....+|+.|||||++.+..++.++|||||||++|||++|+.||............. ........ ...
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~---~~~~~~~~---~~~ 237 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE---RISEKKMS---TPI 237 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH---HHHHHHHH---SCH
T ss_pred ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH---HhhcccCC---CCh
Confidence 23357888999999999999999999999999999999999998654433221111 11000000 000
Q ss_pred hhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036334 574 ELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNR 618 (654)
Q Consensus 574 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 618 (654)
.. ... ....++.+++..||+.+|++||++.++.+.|+++..
T Consensus 238 ~~-~~~---~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 238 EV-LCK---GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HH-HTT---TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hH-hcc---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00 001 122457778889999999999999999999988743
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=356.03 Aligned_cols=254 Identities=20% Similarity=0.261 Sum_probs=186.5
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEecccc---cCHHHHHHHHHHHhccCCCccccccEEEEe--------CCceE
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVA---VGKREFEMQMEVLGKIKHDNVVPLRAFYYS--------KDEKL 417 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~e~~~l~~l~hpniv~l~~~~~~--------~~~~~ 417 (654)
+.+.||+|+||+||+|.. .+|+.||||++.... ....++.+|+++|++++||||+++++++.. +...+
T Consensus 14 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~ 93 (318)
T d3blha1 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 93 (318)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEE
Confidence 457899999999999996 469999999986542 234678899999999999999999999865 34579
Q ss_pred EEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCc
Q 036334 418 LVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLF 497 (654)
Q Consensus 418 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~ 497 (654)
+||||++++.+..... ....++...++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 94 iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~~-ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 94 LVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp EEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhccCC-EEecCcCchheeecCCCcEEeeecceeeec
Confidence 9999998877766554 2345899999999999999999999998 999999999999999999999999999755
Q ss_pred CCC--------CCCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---c
Q 036334 498 GNT--------TPPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE---E 565 (654)
Q Consensus 498 ~~~--------~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~ 565 (654)
... ....+|..|+|||++.+. .++.++||||+||++|||++|+.||......+ ....+...... .
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGSITPE 244 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTT
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH---HHHHHHHhcCCCChh
Confidence 422 224578889999998764 68999999999999999999999997532211 11111111100 0
Q ss_pred hhhhh--------hhHhhhccCChHHH------HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 566 WTAEV--------FDVELMRYHNIEEE------MVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 566 ~~~~~--------~~~~~~~~~~~~~~------~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
..... ............+. ...+.+|+.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000 00000000011111 2245678899999999999999999853
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=359.68 Aligned_cols=256 Identities=26% Similarity=0.328 Sum_probs=188.2
Q ss_pred hccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCCCccccccEEEEeC------CceEEEEEec
Q 036334 351 AEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVVPLRAFYYSK------DEKLLVYDYM 423 (654)
Q Consensus 351 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv~l~~~~~~~------~~~~lv~e~~ 423 (654)
.++||+|+||+||+|+.. +|+.||||+++.... .+.+|+++|++++||||++++++|... .+.++||||+
T Consensus 25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~ 101 (350)
T d1q5ka_ 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred eeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence 478999999999999965 589999999976532 234699999999999999999998643 2468999999
Q ss_pred CCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC-CeEEeccCCCCCcCCC--
Q 036334 424 PAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH-DACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 424 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~-- 500 (654)
+++.+..+....+ ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++......
T Consensus 102 ~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~~-IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 102 PETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp SEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred CCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcC-CcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 8765444433211 2456999999999999999999999998 99999999999999875 8999999999876433
Q ss_pred -CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---hch---hhh---
Q 036334 501 -TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR---EEW---TAE--- 569 (654)
Q Consensus 501 -~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---~~~---~~~--- 569 (654)
....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... +.+..+.. ... ...
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~------~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV------DQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH------HHHHHHHHHHCCCCHHHHHHHCC
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH------HHHHHHHHHhCCChHHhhhhhcc
Confidence 33456778999998765 57899999999999999999999999754321 11111110 000 000
Q ss_pred -hhhHhhhc-------cCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhhc
Q 036334 570 -VFDVELMR-------YHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM--IENMNR 618 (654)
Q Consensus 570 -~~~~~~~~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~ 618 (654)
..+..+.. .........++.+|+.+||..||++|||++|+++. ++++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 00000000 00001122356778889999999999999999864 666654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-41 Score=346.01 Aligned_cols=253 Identities=15% Similarity=0.172 Sum_probs=197.9
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHhccCC-CccccccEEEEeCCceEEEEEecCCCc
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVGKREFEMQMEVLGKIKH-DNVVPLRAFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~~~g~ 427 (654)
+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+|++.++.+.| +|++.+++++..+...++||||+ +++
T Consensus 9 i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~ 86 (293)
T d1csna_ 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 86 (293)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCC
Confidence 4578999999999999965 58999999986543 33457788899988875 89999999999999999999999 689
Q ss_pred hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECC-----CCCeEEeccCCCCCcCCC--
Q 036334 428 LSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRP-----DHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 428 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~-----~~~~kl~Dfgla~~~~~~-- 500 (654)
|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.....
T Consensus 87 l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH~~g-iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 87 LEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKS-LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp HHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTT-EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred HHHHHHhh----ccchhhHHHHHHHHHHHHHHHHHHHCC-ceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 99988743 245899999999999999999999998 999999999999974 578999999999765321
Q ss_pred ---------CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhh
Q 036334 501 ---------TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571 (654)
Q Consensus 501 ---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 571 (654)
....||+.|||||++.+..++.++|||||||++|||++|+.||....... .......+........
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~---~~~~~~~i~~~~~~~~-- 236 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT---NKQKYERIGEKKQSTP-- 236 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC---HHHHHHHHHHHHHHSC--
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh---HHHHHHHHHhccCCCC--
Confidence 23457889999999999999999999999999999999999997643322 1111111111110000
Q ss_pred hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcC
Q 036334 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRMIENMNRG 619 (654)
Q Consensus 572 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 619 (654)
...+ .... ..++.+++..|+..+|++||+++.+.+.|+++.+.
T Consensus 237 ~~~l--~~~~---p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 237 LREL--CAGF---PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HHHH--TTTS---CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred hHHh--cCCC---CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 0001 0111 23567778899999999999999999999987643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=352.62 Aligned_cols=257 Identities=22% Similarity=0.331 Sum_probs=188.0
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeCC------ceEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSKD------EKLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~~------~~~lv 419 (654)
+.+.||+|+||+||+|... +|+.||||+++..... .+.+.+|+++|++++|||||+++++|...+ +.++|
T Consensus 22 ~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 101 (346)
T d1cm8a_ 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 101 (346)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEE
Confidence 4578999999999999964 5999999999765333 346788999999999999999999998654 46999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
|||+ +++|..+++. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+|++|||+|.....
T Consensus 102 ~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~-IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 102 MPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG-IIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp EECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred Eecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCC-CcccccCcchhhcccccccccccccceeccCC
Confidence 9999 6688887752 35999999999999999999999998 99999999999999999999999999987754
Q ss_pred C-CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---c----hhhhh
Q 036334 500 T-TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVRE---E----WTAEV 570 (654)
Q Consensus 500 ~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~----~~~~~ 570 (654)
. ....++..|+|||++.+ ..++.++||||+||++|||++|+.||......+. .......... . .....
T Consensus 174 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH---HHHHHhccCCCcHHHHhhhcchh
Confidence 4 34567888999999876 4578999999999999999999999976432110 0000000000 0 00000
Q ss_pred ---hhHhhhcc------CChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhh
Q 036334 571 ---FDVELMRY------HNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM--IENMN 617 (654)
Q Consensus 571 ---~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 617 (654)
....+... ........++.+|+.+||..||++|||++|+++. ++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00000000 0001112345678889999999999999999985 55554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=351.45 Aligned_cols=253 Identities=18% Similarity=0.269 Sum_probs=185.4
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEeccccc--CHHHHHHHHHHHhccCCCccccccEEEEeCC----ceEEEEEe
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAV--GKREFEMQMEVLGKIKHDNVVPLRAFYYSKD----EKLLVYDY 422 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~----~~~lv~e~ 422 (654)
+.+.||+|+||+||+|.. .+|+.||||++..... ..+.+.+|+++|++++||||+++++++.... ..+++++|
T Consensus 12 ~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~ 91 (345)
T d1pmea_ 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH 91 (345)
T ss_dssp EEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe
Confidence 457899999999999985 5799999999975432 3457889999999999999999999997653 23555667
Q ss_pred cCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCC--
Q 036334 423 MPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNT-- 500 (654)
Q Consensus 423 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 500 (654)
+.+|+|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 92 ~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~~-iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 92 LMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp CCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred ecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC-CcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 779999999963 24899999999999999999999998 999999999999999999999999998765322
Q ss_pred -----CCCCccccccCccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhh------
Q 036334 501 -----TPPTRVAGYRAPEVVET-RKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTA------ 568 (654)
Q Consensus 501 -----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 568 (654)
....+++.|+|||++.. ..++.++||||+||++|||++|+.||......+ ...............
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHTCC
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH---HHHHHhhhccCCChhhhhhhh
Confidence 33456778999999854 567899999999999999999999997543211 000000000000000
Q ss_pred --hhhh--Hhhhc--cCChH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 569 --EVFD--VELMR--YHNIE----EEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 569 --~~~~--~~~~~--~~~~~----~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
...+ ..... ..... ....++.+++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00000 00000 011246778889999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-41 Score=342.13 Aligned_cols=251 Identities=21% Similarity=0.264 Sum_probs=193.0
Q ss_pred hhccccccCceeEEEEEe-cCCcEEEEEEeccccc---CHHHHHHHHHHHhccCCCccccccEEEEeCCceEEEEEecCC
Q 036334 350 SAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAV---GKREFEMQMEVLGKIKHDNVVPLRAFYYSKDEKLLVYDYMPA 425 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~e~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 425 (654)
+.+.||+|+||+||+|+. .+|+.||||+++.... ...++.+|+.++++++||||++++++|.+....++|+|++.+
T Consensus 6 ~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~ 85 (292)
T d1unla_ 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred eeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccc
Confidence 347899999999999996 4688999999975532 246788999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCCCC----
Q 036334 426 GSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGNTT---- 501 (654)
Q Consensus 426 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 501 (654)
++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+.......
T Consensus 86 ~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~~~-IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 86 DLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSRN-VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp EHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred ccccccccc-----ccccchhHHHHHHHHHHHHHHHhhcCC-EeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence 999888873 346899999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCCccccccCccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhch--hhh-------hh
Q 036334 502 PPTRVAGYRAPEVVETRK-VTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEW--TAE-------VF 571 (654)
Q Consensus 502 ~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~-------~~ 571 (654)
...++..|+|||++.... ++.++||||+||++|||++|+.||....+ ..+.+..+..... ... ..
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-----VDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-----HHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC-----HHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 234456699999987654 68999999999999999999999754222 1222222111000 000 00
Q ss_pred --------hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 572 --------DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 572 --------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
................+.+|+.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000011112234667788999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.9e-41 Score=347.37 Aligned_cols=250 Identities=18% Similarity=0.275 Sum_probs=189.0
Q ss_pred HhhccccccCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHhccC-CCccccccEEEEeC--CceEEEEEecC
Q 036334 349 ASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-HDNVVPLRAFYYSK--DEKLLVYDYMP 424 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~--~~~~lv~e~~~ 424 (654)
.+.+.||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|++++ ||||++++++|... ...++||||++
T Consensus 38 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~ 115 (328)
T d3bqca1 38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 115 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecC
Confidence 4567899999999999996 46899999998754 3567889999999995 99999999998754 46899999999
Q ss_pred CCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCC-CeEEeccCCCCCcCCC---
Q 036334 425 AGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDH-DACVSDFGLNPLFGNT--- 500 (654)
Q Consensus 425 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~--- 500 (654)
+|+|..+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|......
T Consensus 116 ~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~g-IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 116 NTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp SCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTT-EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred CCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcc-cccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence 999987643 4899999999999999999999998 99999999999998765 5899999999876543
Q ss_pred CCCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhh---------
Q 036334 501 TPPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEV--------- 570 (654)
Q Consensus 501 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 570 (654)
....+|..|+|||.+.+. .++.++||||+||++|||++|+.||........ ....+............
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~--~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH--HHHHHHHHHCCchhhhhhhhcccccC
Confidence 334567789999998764 579999999999999999999999975432110 01111111100000000
Q ss_pred --hh-----------HhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 571 --FD-----------VELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 571 --~~-----------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
+. ..............++.+|+.+||..||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000000011112245677888999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=349.23 Aligned_cols=243 Identities=23% Similarity=0.285 Sum_probs=191.4
Q ss_pred HhhccccccCceeEEEEEec----CCcEEEEEEecccc-----cCHHHHHHHHHHHhccCC-CccccccEEEEeCCceEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLE----EGTTVVVKRLKEVA-----VGKREFEMQMEVLGKIKH-DNVVPLRAFYYSKDEKLL 418 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h-pniv~l~~~~~~~~~~~l 418 (654)
.+.+.||+|+||+||+|... +|+.||||+++... ...+.+.+|++++++++| |||+++++++.+....++
T Consensus 27 ~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~ 106 (322)
T d1vzoa_ 27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL 106 (322)
T ss_dssp EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred EEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceee
Confidence 34678999999999999842 47899999986542 234668899999999976 899999999999999999
Q ss_pred EEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcC
Q 036334 419 VYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFG 498 (654)
Q Consensus 419 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~ 498 (654)
||||+.+|+|.+++... ..++...+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..+.
T Consensus 107 v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~~~-ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 107 ILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhhcCC-EEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 99999999999999743 34788999999999999999999998 9999999999999999999999999987654
Q ss_pred CC-----CCCCccccccCccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchhhhhh
Q 036334 499 NT-----TPPTRVAGYRAPEVVETR--KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWTAEVF 571 (654)
Q Consensus 499 ~~-----~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 571 (654)
.. ....+++.|+|||.+.+. .++.++||||+||+||||++|+.||......+ ....+.......
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~---~~~~i~~~~~~~------ 251 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKS------ 251 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CHHHHHHHHHHC------
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcccC------
Confidence 32 234566779999998754 46889999999999999999999998654332 111111111000
Q ss_pred hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 036334 572 DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPA-----MQEVVR 611 (654)
Q Consensus 572 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 611 (654)
..........++.+++.+||+.||++||| ++|+++
T Consensus 252 -----~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 -----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 00111123346777888999999999995 788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-40 Score=344.64 Aligned_cols=248 Identities=21% Similarity=0.306 Sum_probs=182.2
Q ss_pred hhccccccCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeC------CceEEE
Q 036334 350 SAEVLGKGSVGTSYKAVLE-EGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSK------DEKLLV 419 (654)
Q Consensus 350 ~~~~lg~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~------~~~~lv 419 (654)
+.++||+|+||+||+|.+. +|+.||||+++..... ..++.+|+.++++++|||||+++++|... .+.|+|
T Consensus 21 i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv 100 (355)
T d2b1pa1 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 100 (355)
T ss_dssp EEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEE
Confidence 4578999999999999965 5999999999765333 34678999999999999999999999643 577999
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
|||+.++.+ +.+. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||++.....
T Consensus 101 ~Ey~~~~l~-~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~g-iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 101 MELMDANLC-QVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp EECCSEEHH-HHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EeccchHHH-Hhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcc-cccccCCccccccccccceeeechhhhhcccc
Confidence 999976554 4443 23899999999999999999999998 99999999999999999999999999876543
Q ss_pred C---CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh-------------
Q 036334 500 T---TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR------------- 563 (654)
Q Consensus 500 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~------------- 563 (654)
. ....+|..|+|||++.+..+++++||||+||++|||++|+.||...... .....+..
T Consensus 172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~------~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI------DQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCCCHHHHTTS
T ss_pred ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH------HHHHHHHHhccCCCHHHHHHh
Confidence 3 3345677899999999999999999999999999999999999754211 11111100
Q ss_pred ---------hchh------hhhhhHhhhccC--ChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 564 ---------EEWT------AEVFDVELMRYH--NIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 564 ---------~~~~------~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
.... ...+........ .......++.+|+.+|+..||++|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 000000000000 112334567889999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-40 Score=343.45 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=186.0
Q ss_pred HhhccccccCceeEEEEEe-cCCcEEEEEEecccccC---HHHHHHHHHHHhccCCCccccccEEEEeC-----CceEEE
Q 036334 349 ASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVG---KREFEMQMEVLGKIKHDNVVPLRAFYYSK-----DEKLLV 419 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~e~~~l~~l~hpniv~l~~~~~~~-----~~~~lv 419 (654)
.+.+.||+|+||+||+|.. .+|+.||||+++....+ .+++.+|+++|++++|||||++++++... ...+++
T Consensus 21 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i 100 (348)
T d2gfsa1 21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 100 (348)
T ss_dssp EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEE
Confidence 3457899999999999995 46999999999765433 34678999999999999999999998643 344677
Q ss_pred EEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEeccCCCCCcCC
Q 036334 420 YDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVSDFGLNPLFGN 499 (654)
Q Consensus 420 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~Dfgla~~~~~ 499 (654)
++|+.+|+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.....
T Consensus 101 ~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~g-iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 101 VTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD-IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp EEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCC-CcccccCCccccccccccccccccchhcccCc
Confidence 888889999999962 35999999999999999999999998 99999999999999999999999999877654
Q ss_pred C-CCCCccccccCccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhchh--hhhh----
Q 036334 500 T-TPPTRVAGYRAPEVVETR-KVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVREEWT--AEVF---- 571 (654)
Q Consensus 500 ~-~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~---- 571 (654)
. ....++..|+|||++.+. .++.++||||+||++|||++|+.||...... .....+...... .+..
T Consensus 174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~------~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI------DQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCCCCHHHHTTCC
T ss_pred ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHHhcCCCChHHhhhcc
Confidence 3 345567779999987664 5689999999999999999999999754221 111111110000 0000
Q ss_pred ----h---Hhhhc--cCCh----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036334 572 ----D---VELMR--YHNI----EEEMVQLLQIAMGCVSTVPDQRPAMQEVVR 611 (654)
Q Consensus 572 ----~---~~~~~--~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 611 (654)
. ..... .... .....++.+|+.+|++.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 00000 0000 011234567888999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-37 Score=322.07 Aligned_cols=261 Identities=20% Similarity=0.263 Sum_probs=188.0
Q ss_pred HhhccccccCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHhccC-----------CCccccccEEEEeC--C
Q 036334 349 ASAEVLGKGSVGTSYKAVL-EEGTTVVVKRLKEVAVGKREFEMQMEVLGKIK-----------HDNVVPLRAFYYSK--D 414 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------hpniv~l~~~~~~~--~ 414 (654)
.+.++||+|+||+||+|+. .+|+.||||+++......+.+++|++++++++ |+||+++++++... .
T Consensus 16 ~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~ 95 (362)
T d1q8ya_ 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN 95 (362)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecccc
Confidence 3458899999999999996 46999999999876555667888998887775 57899999988653 4
Q ss_pred ceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCeecCCCCCCcEEECCCCC------eE
Q 036334 415 EKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHV-SGKIVHGNIKASNILLRPDHD------AC 487 (654)
Q Consensus 415 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~ivHrDlk~~NIll~~~~~------~k 487 (654)
..+++++++..+.......... ....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++. +|
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~~-IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 96 GVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp EEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC-EECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred ceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhcC-cccccCChhHeeeeccCcccccceee
Confidence 5667777765554333322111 34568999999999999999999997 55 999999999999987654 89
Q ss_pred EeccCCCCCcCCC-CCCCccccccCccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---
Q 036334 488 VSDFGLNPLFGNT-TPPTRVAGYRAPEVVETRKVTFKSDVYSFGVLLLELLTGKAPNQASLGEEGIDLPRWVQSVVR--- 563 (654)
Q Consensus 488 l~Dfgla~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~--- 563 (654)
++|||.+...... ....++..|+|||++.+..++.++||||+||+++||++|+.||....................
T Consensus 173 l~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg 252 (362)
T d1q8ya_ 173 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252 (362)
T ss_dssp ECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred EeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhC
Confidence 9999998765433 445678889999999999999999999999999999999999986543322221111111100
Q ss_pred h---c------hhhhhh------------------hHhhhccCChHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036334 564 E---E------WTAEVF------------------DVELMRYHNIEEEMVQLLQIAMGCVSTVPDQRPAMQEVVRM 612 (654)
Q Consensus 564 ~---~------~~~~~~------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 612 (654)
. . .....+ +..............++.+|+.+|+..||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred CCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0 000000 00001222345667788999999999999999999999863
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=4.5e-32 Score=278.35 Aligned_cols=205 Identities=38% Similarity=0.636 Sum_probs=160.8
Q ss_pred CCChhHHHHHHHHHhhCCCCC-CCCccCCCCCCC--ceeeEEcCCC--CeEEEeecCCCCcccc--CCcccccCCCCccE
Q 036334 25 SEPTQDKQALLAFLSRTPHKN-RVQWNASDSACN--WVGVECDANR--SFVYSLRLPGVGLVGP--IPPNTLGKLSQLRV 97 (654)
Q Consensus 25 ~~~~~~~~al~~~~~~~~~~~-~~~W~~~~~~C~--w~gv~C~~~~--~~v~~L~l~~~~l~~~--~~~~~l~~l~~L~~ 97 (654)
.|.++|++||++||+++.++. ..+|..++|||. |.||+|++.. .||+.|+|+++++.|. +|+ .+++|++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~-~l~~L~~L~~ 80 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCCh-HHhcCccccc
Confidence 378999999999999887654 478998889995 9999998643 4799999999999984 666 6999999999
Q ss_pred EEecc-CCccCcCCCCCCCccccccccccccccccccch------------------------hhccccccceecccccc
Q 036334 98 LSLRS-NRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPA------------------------SVTRMNRLTRLDLSSNN 152 (654)
Q Consensus 98 L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~------------------------~~~~l~~L~~L~l~~N~ 152 (654)
|+|++ |+++|.+|..|++|++|++|+|++|++++..|. .+.++++|+.+++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 99997 899999999999999999999999998877554 44455555555555555
Q ss_pred ccccCCC-----------------------------------------------------------------------cc
Q 036334 153 FSGKIPF-----------------------------------------------------------------------DV 161 (654)
Q Consensus 153 l~~~~p~-----------------------------------------------------------------------~~ 161 (654)
++|.+|. .+
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~ 240 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4433221 22
Q ss_pred ccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCccc--ccCCCCccccCCCCCCCCCCCCCC
Q 036334 162 NNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPAT--LSKFPQSSFTGNLDLCGGPLPPCN 230 (654)
Q Consensus 162 ~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~--~~~~~~l~~~~n~~~c~~~~~~C~ 230 (654)
..+++|+.|+|++|+|+|.+|.. .+++|++|+|++|+|+|.+|.. +.++..+.+.||+.+||.|.+.|.
T Consensus 241 ~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c~ 313 (313)
T d1ogqa_ 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313 (313)
T ss_dssp CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred ccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCCC
Confidence 33456777788888888777764 6788888888888888888853 456666778889999998888873
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.2e-23 Score=198.63 Aligned_cols=161 Identities=19% Similarity=0.180 Sum_probs=118.5
Q ss_pred HhhccccccCceeEEEEEecCCcEEEEEEecccccC-------------------HHHHHHHHHHHhccCCCccccccEE
Q 036334 349 ASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKEVAVG-------------------KREFEMQMEVLGKIKHDNVVPLRAF 409 (654)
Q Consensus 349 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-------------------~~~~~~e~~~l~~l~hpniv~l~~~ 409 (654)
++++.||+|+||+||+|...+|+.||||+++..... .....+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 346889999999999999888999999987632110 1234567888999999999887765
Q ss_pred EEeCCceEEEEEecCCCchhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCeecCCCCCCcEEECCCCCeEEe
Q 036334 410 YYSKDEKLLVYDYMPAGSLSALLHGSRGSGRTPLDWDNRMRIALSAARGLAHLHVSGKIVHGNIKASNILLRPDHDACVS 489 (654)
Q Consensus 410 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ivHrDlk~~NIll~~~~~~kl~ 489 (654)
. ..+++|||+++..+.++ +.....+++.|++++++|||+++ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~l------------~~~~~~~i~~ql~~~l~~lH~~g-iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRV------------RVENPDEVLDMILEEVAKFYHRG-IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGGC------------CCSCHHHHHHHHHHHHHHHHHTT-EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccch------------hhHHHHHHHHHHHHHHHHHhhCC-EEEccCChhheeeeCC-CEEEE
Confidence 3 34799999988665432 22335678999999999999998 9999999999999965 58999
Q ss_pred ccCCCCCcCCCCCCCccccccC------ccccCCCCCCcchhHHHHHHH
Q 036334 490 DFGLNPLFGNTTPPTRVAGYRA------PEVVETRKVTFKSDVYSFGVL 532 (654)
Q Consensus 490 Dfgla~~~~~~~~~~~~~~y~a------PE~~~~~~~~~~~DvwslGvi 532 (654)
|||.|......... .|.. .|.+ .+.|+.++|+||..--
T Consensus 145 DFG~a~~~~~~~~~----~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWR----EILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHH----HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcH----HHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 99998765433210 1111 1111 3567889999996543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=2.2e-20 Score=176.13 Aligned_cols=109 Identities=25% Similarity=0.287 Sum_probs=59.0
Q ss_pred CCccEEEeccCCccCcC-CCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccCccc
Q 036334 93 SQLRVLSLRSNRLSGEI-PSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLF 171 (654)
Q Consensus 93 ~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 171 (654)
+++++|+|++|.|++.+ +..|.++++|+.|+|++|++++..+..+..+++|++|+|++|+|++..|..|.++++|++|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 34555555555555433 33445555555555555555555555555555555555555555544444555555555555
Q ss_pred cccccccCCCCCC--CCCCCCeEEccCCcccc
Q 036334 172 LENNKFSGNLPSI--NPANLRDFNVSNNNLNG 201 (654)
Q Consensus 172 l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g 201 (654)
|++|+|++..+.. .+++|++|+|++|++..
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred cCCccccccCHHHhcCCccccccccccccccc
Confidence 5555555555443 45555555555555543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.70 E-value=2.1e-17 Score=155.30 Aligned_cols=171 Identities=22% Similarity=0.294 Sum_probs=146.8
Q ss_pred CCCCceeeEEcCCC---------CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccc
Q 036334 54 SACNWVGVECDANR---------SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYL 124 (654)
Q Consensus 54 ~~C~w~gv~C~~~~---------~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 124 (654)
.-|+|..|.|++.. ..++.|+|++|.|++.+++..|.++++|++|+|++|.+.+..+..|..+++|++|+|
T Consensus 6 C~C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L 85 (192)
T d1w8aa_ 6 CHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85 (192)
T ss_dssp SEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CEEcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeee
Confidence 34789999997542 358899999999998888888999999999999999999999999999999999999
Q ss_pred cccccccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccC
Q 036334 125 QSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSI 203 (654)
Q Consensus 125 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~ 203 (654)
++|+|+...|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....... ....++.+.+..|.++...
T Consensus 86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred ccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCC
Confidence 999999888899999999999999999999888888999999999999999998655433 2234667778889999888
Q ss_pred cccccCCCCccccCCCCCCCC
Q 036334 204 PATLSKFPQSSFTGNLDLCGG 224 (654)
Q Consensus 204 p~~~~~~~~l~~~~n~~~c~~ 224 (654)
|..+.+++-+++..|...|..
T Consensus 166 p~~l~~~~l~~L~~n~l~C~~ 186 (192)
T d1w8aa_ 166 PSKVRDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp STTTTTSBGGGSCTTTCCCCC
T ss_pred ChhhcCCEeeecCHhhCcCCC
Confidence 988887776666666666643
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=2.6e-17 Score=163.22 Aligned_cols=152 Identities=25% Similarity=0.239 Sum_probs=106.8
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
.++.|+|++|.+.+ +++..|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|++++ ++..+.++++|+.|++
T Consensus 32 ~l~~L~Ls~N~i~~-l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 32 DTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDV 107 (266)
T ss_dssp TCCEEECTTSCCSE-EEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCC-cCHHHhhcccccccccccccccc-ccc-cccccccccccccccccccc-cccccccccccccccc
Confidence 47778888888764 55556778888888888888877 444 35667777777777777773 4555666666666666
Q ss_pred ccccc------------------------cccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCccccc
Q 036334 149 SSNNF------------------------SGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGS 202 (654)
Q Consensus 149 ~~N~l------------------------~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~ 202 (654)
++|.+ +...+..+..+++|+.|++++|+|++.++.. .+++|++|+|++|+|+ .
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 55554 4334445566777888888888888777664 6788888888888888 7
Q ss_pred CcccccCCCC---ccccCCCCCCCCC
Q 036334 203 IPATLSKFPQ---SSFTGNLDLCGGP 225 (654)
Q Consensus 203 ~p~~~~~~~~---l~~~~n~~~c~~~ 225 (654)
+|..+..++. +.+.|||+.|+|.
T Consensus 187 lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred cChhHCCCCCCCEEEecCCCCCCCcc
Confidence 8877665544 5567888888643
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=3e-16 Score=157.00 Aligned_cols=156 Identities=24% Similarity=0.289 Sum_probs=130.9
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 149 (654)
+..+....+.-...+++..|.++++|++|+|++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|+|+
T Consensus 82 ~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~ 161 (284)
T d1ozna_ 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLH 161 (284)
T ss_dssp CCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred ccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccc
Confidence 34444433333345666679999999999999999987777788899999999999999998778889999999999999
Q ss_pred cccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCCC---ccccCCCCCCCC
Q 036334 150 SNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQ---SSFTGNLDLCGG 224 (654)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~---l~~~~n~~~c~~ 224 (654)
+|+|++..+..|.++++|+.|++++|++++..|.. .+++|++|++++|.+++..|..|.++.. +.+.+|+..|.+
T Consensus 162 ~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred cCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCc
Confidence 99999888889999999999999999999988865 7899999999999999887777776554 566789988864
Q ss_pred C
Q 036334 225 P 225 (654)
Q Consensus 225 ~ 225 (654)
+
T Consensus 242 ~ 242 (284)
T d1ozna_ 242 R 242 (284)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=8e-16 Score=152.28 Aligned_cols=142 Identities=22% Similarity=0.252 Sum_probs=109.6
Q ss_pred EEcCCCCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhcccc
Q 036334 62 ECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMN 141 (654)
Q Consensus 62 ~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 141 (654)
.|+... ....++.++++|+ .+|++ +. ++|++|+|++|.|++..+..|.++++|++|+|++|+|+ .+| .++.++
T Consensus 5 ~~~~~~-~~~~v~C~~~~L~-~iP~~-lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~ 77 (266)
T d1p9ag_ 5 EVSKVA-SHLEVNCDKRNLT-ALPPD-LP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLP 77 (266)
T ss_dssp EEECST-TCCEEECTTSCCS-SCCSC-CC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCT
T ss_pred EEcccC-CCeEEEccCCCCC-eeCcC-cC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccc
Confidence 455433 2445688888887 47764 43 57999999999999777778999999999999999999 455 467899
Q ss_pred ccceeccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCC
Q 036334 142 RLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFP 211 (654)
Q Consensus 142 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~ 211 (654)
+|++|+|++|+|+ .++..+..+++|+.|++++|.+.+..+.. .+.+++.|++++|.+++..+..+..++
T Consensus 78 ~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~ 148 (266)
T d1p9ag_ 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148 (266)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCT
T ss_pred ccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccc
Confidence 9999999999999 55678889999999999999988766554 666777777777777644444444433
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.58 E-value=2.4e-15 Score=151.86 Aligned_cols=158 Identities=27% Similarity=0.371 Sum_probs=123.2
Q ss_pred CCCCceeeEEcCC---------CCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccc
Q 036334 54 SACNWVGVECDAN---------RSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYL 124 (654)
Q Consensus 54 ~~C~w~gv~C~~~---------~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 124 (654)
+-|.|.+|.|++. ...++.|+|++|.+. .+++..|.++++|++|++++|.+....|..|.++++|++|+|
T Consensus 8 c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 8 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence 3378999999753 234889999999996 577667999999999999999999888889999999999999
Q ss_pred cccccccccchh------------------------------------------------hccccc--------------
Q 036334 125 QSNQFSGVFPAS------------------------------------------------VTRMNR-------------- 142 (654)
Q Consensus 125 s~N~l~~~~p~~------------------------------------------------~~~l~~-------------- 142 (654)
++|+++.. |.. +..+++
T Consensus 87 ~~n~l~~l-~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l 165 (305)
T d1xkua_ 87 SKNQLKEL-PEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI 165 (305)
T ss_dssp CSSCCSBC-CSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC
T ss_pred cCCccCcC-ccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcccc
Confidence 99988733 211 223333
Q ss_pred -------cceeccccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCCCc
Q 036334 143 -------LTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQS 213 (654)
Q Consensus 143 -------L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~l 213 (654)
|+.|++++|.+++..+..+.+++.++.|++++|++++..+.. .+++|+.|+|++|+|+ .+|..|.++++|
T Consensus 166 ~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L 244 (305)
T d1xkua_ 166 PQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 244 (305)
T ss_dssp CSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSC
T ss_pred CcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCC
Confidence 444455555555555667778888999999999999887765 7889999999999998 778887777665
Q ss_pred c
Q 036334 214 S 214 (654)
Q Consensus 214 ~ 214 (654)
.
T Consensus 245 ~ 245 (305)
T d1xkua_ 245 Q 245 (305)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.54 E-value=1.6e-15 Score=153.78 Aligned_cols=121 Identities=29% Similarity=0.497 Sum_probs=113.3
Q ss_pred CCccEEEeccCCccC--cCCCCCCCccccccccccc-cccccccchhhccccccceeccccccccccCCCccccccccCc
Q 036334 93 SQLRVLSLRSNRLSG--EIPSDFSNLTLLRSLYLQS-NQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTG 169 (654)
Q Consensus 93 ~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 169 (654)
.+++.|||++|.++| .+|.+|++|++|++|+|++ |+++|.+|..|++|++|++|+|++|+|.+..+..+..+.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 478999999999998 5889999999999999997 8999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCC--CCCCCCeEEccCCcccccCcccccCCCCc
Q 036334 170 LFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPATLSKFPQS 213 (654)
Q Consensus 170 L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~~~~~~~l 213 (654)
+++++|++.+.+|.. .+++|+.+++++|.++|.+|..+.++..+
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l 175 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT
T ss_pred cccccccccccCchhhccCcccceeecccccccccccccccccccc
Confidence 999999999998865 89999999999999999999998887765
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.53 E-value=5.5e-15 Score=127.71 Aligned_cols=99 Identities=26% Similarity=0.388 Sum_probs=46.2
Q ss_pred EEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccCcccccccc
Q 036334 97 VLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNK 176 (654)
Q Consensus 97 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 176 (654)
+|||++|+|+ .++ .+.++++|++|+|++|+|+ .+|..++.+++|+.|++++|.|+ .+| .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 4455555554 222 2444455555555555554 33444444555555555555554 222 24445555555555555
Q ss_pred ccCCCCC--C-CCCCCCeEEccCCccc
Q 036334 177 FSGNLPS--I-NPANLRDFNVSNNNLN 200 (654)
Q Consensus 177 l~~~~~~--~-~~~~L~~L~l~~N~l~ 200 (654)
|+..... . .+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 5433221 1 4445555555555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.53 E-value=6.6e-15 Score=127.20 Aligned_cols=115 Identities=22% Similarity=0.245 Sum_probs=96.8
Q ss_pred EeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccc
Q 036334 72 SLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSN 151 (654)
Q Consensus 72 ~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 151 (654)
.|+|++|+++ .++ .+..+++|++|||++|.|+ .+|..|+.+++|+.|+|++|+|++ +| .+..+++|++|++++|
T Consensus 2 ~L~Ls~n~l~-~l~--~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLT-VLC--HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCS-SCC--CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred EEEcCCCCCC-CCc--ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 5899999997 454 3899999999999999999 678889999999999999999995 45 5999999999999999
Q ss_pred cccccCC-CccccccccCccccccccccCCCCCC-----CCCCCCeE
Q 036334 152 NFSGKIP-FDVNNLTHLTGLFLENNKFSGNLPSI-----NPANLRDF 192 (654)
Q Consensus 152 ~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~-----~~~~L~~L 192 (654)
+|+.... ..+..+++|+.|++++|+++...... .+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 9994432 46889999999999999998654221 46666665
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=6e-15 Score=147.32 Aligned_cols=136 Identities=24% Similarity=0.301 Sum_probs=124.1
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
.+++.|+|++|++.. ++...+..+++|+.+++++|.|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|+
T Consensus 105 ~~L~~L~l~~n~~~~-~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~ 183 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (284)
T ss_dssp TTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ccCCEEecCCccccc-ccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence 458999999999865 4445689999999999999999977778899999999999999999998899999999999999
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCC--CCCCCCeEEccCCcccccCc
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIP 204 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p 204 (654)
+++|++++..|..|..+++|++|++++|++.+.++.. .+++|++|+|++|++.+..+
T Consensus 184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred hhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 9999999999999999999999999999999888764 88999999999999987655
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=7.6e-15 Score=133.23 Aligned_cols=123 Identities=19% Similarity=0.174 Sum_probs=84.4
Q ss_pred ccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccC
Q 036334 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLT 168 (654)
Q Consensus 89 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 168 (654)
+.+..+|++|||++|+|+ .++..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+|+...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 566677778888888877 45655667777888888888877 343 477777888888888887754444456677888
Q ss_pred ccccccccccCCCC--CC-CCCCCCeEEccCCcccccCcc----cccCCCCccc
Q 036334 169 GLFLENNKFSGNLP--SI-NPANLRDFNVSNNNLNGSIPA----TLSKFPQSSF 215 (654)
Q Consensus 169 ~L~l~~N~l~~~~~--~~-~~~~L~~L~l~~N~l~g~~p~----~~~~~~~l~~ 215 (654)
.|++++|+|+.... .. .+++|++|++++|+++ ..|. .+..+++|.+
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~ 143 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRV 143 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSE
T ss_pred cceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCe
Confidence 88888887765432 22 6777888888888876 4443 3555666553
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.46 E-value=7e-14 Score=132.78 Aligned_cols=135 Identities=27% Similarity=0.395 Sum_probs=83.0
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
+++.|+|++|.+.+ +++ ++.+++|++|+|++|+|++ +| .+.++++|+.|++++|.+.. + ..+..+++|+.+++
T Consensus 69 ~L~~L~L~~n~i~~-l~~--~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 69 NVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (210)
T ss_dssp TCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCEEeCCCccccC-ccc--cccCccccccccccccccc-cc-cccccccccccccccccccc-c-cccccccccccccc
Confidence 36666666666654 332 5666666666666666663 33 46666666666666666652 2 24566666666666
Q ss_pred ccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCCCcc
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQSS 214 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~~l~ 214 (654)
++|.+++. ..+..+++|+.+++++|++++..+-..+++|+.|+|++|+|+ .+| .|.++++|.
T Consensus 142 ~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~ 203 (210)
T d1h6ta2 142 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLD 203 (210)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCS
T ss_pred cccccccc--ccccccccccccccccccccccccccCCCCCCEEECCCCCCC-CCh-hhcCCCCCC
Confidence 66666632 245566777777777777766544336677777777777776 454 355555544
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.45 E-value=6.7e-14 Score=131.77 Aligned_cols=122 Identities=26% Similarity=0.378 Sum_probs=55.5
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 149 (654)
++.|+++++++.. +. .+..+++|++|+|++|+|++..| |+++++|++|++++|.+.. ++ .+.++++|+.|+++
T Consensus 42 l~~L~l~~~~i~~-l~--~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~ 114 (199)
T d2omxa2 42 VTTLQADRLGIKS-ID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLF 114 (199)
T ss_dssp CCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECC
T ss_pred CCEEECCCCCCCC-cc--ccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-cccccccccccccc
Confidence 4445555555432 22 24445555555555555543222 4455555555555555442 22 24444555555555
Q ss_pred cccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCccc
Q 036334 150 SNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN 200 (654)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~ 200 (654)
+|.+.... .+..+++|+.|++++|++.....-..+++|+.|++++|+++
T Consensus 115 ~~~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 115 NNQITDID--PLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp SSCCCCCG--GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCC
T ss_pred cccccccc--ccchhhhhHHhhhhhhhhccccccccccccccccccccccc
Confidence 54444221 24444445555555554443222224444445555555444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.43 E-value=1.3e-13 Score=129.63 Aligned_cols=136 Identities=28% Similarity=0.445 Sum_probs=115.4
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
.+++.|+|++|.+++ +++ ++++++|++|++++|.+. .++ .+.++++|+.|++++|.+... ..+..+++|+.|+
T Consensus 62 ~nL~~L~Ls~N~l~~-~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~ 134 (199)
T d2omxa2 62 NNLTQINFSNNQLTD-ITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLE 134 (199)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred CCcCcCccccccccC-ccc--ccCCcccccccccccccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhh
Confidence 358999999999986 333 899999999999999998 444 488999999999999999854 3588899999999
Q ss_pred cccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCCCcc
Q 036334 148 LSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQSS 214 (654)
Q Consensus 148 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~~l~ 214 (654)
+++|++. .++ .+..+++|+.|++++|++++..+-..+++|+.|+|++|+++ .+| .++++++|.
T Consensus 135 l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~-~i~-~l~~L~~L~ 197 (199)
T d2omxa2 135 LSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVS-DIS-VLAKLTNLE 197 (199)
T ss_dssp CCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-CCG-GGGGCTTCS
T ss_pred hhhhhhc-ccc-cccccccccccccccccccCCccccCCCCCCEEECCCCCCC-CCc-cccCCCCCC
Confidence 9999998 444 58899999999999999998766558999999999999998 455 466776654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=4.2e-14 Score=128.25 Aligned_cols=120 Identities=20% Similarity=0.234 Sum_probs=101.6
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
++..|+|++|+++. ++. .+..+++|++|||++|.|+ .++ .|..+++|++|+|++|+++...+..+..+++|+.|+|
T Consensus 19 ~lr~L~L~~n~I~~-i~~-~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 19 RDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp SCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred cCcEEECCCCCCCc-cCc-cccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 48899999999975 553 5688999999999999999 554 6899999999999999999766666788999999999
Q ss_pred ccccccccCC--CccccccccCccccccccccCCCCC----C-CCCCCCeEE
Q 036334 149 SSNNFSGKIP--FDVNNLTHLTGLFLENNKFSGNLPS----I-NPANLRDFN 193 (654)
Q Consensus 149 ~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~~~----~-~~~~L~~L~ 193 (654)
++|+|+. ++ ..+..+++|++|++++|.++..... . .+++|+.||
T Consensus 95 ~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 95 TNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ccccccc-cccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 9999984 33 3678899999999999999865431 2 678999887
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.39 E-value=2.9e-13 Score=128.44 Aligned_cols=138 Identities=22% Similarity=0.338 Sum_probs=114.5
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 149 (654)
++.|+++++.+.. ++ .+..+++|++|+|++|.|++.. .++++++|++|+|++|++++ +| .+.++++|+.|+++
T Consensus 48 L~~L~l~~~~i~~-l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 48 IDQIIANNSDIKS-VQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp CCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECT
T ss_pred ccEEECcCCCCCC-ch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccccc
Confidence 8899999999875 33 3889999999999999999644 47899999999999999995 55 58999999999999
Q ss_pred cccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccccCCCC---ccccCC
Q 036334 150 SNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATLSKFPQ---SSFTGN 218 (654)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~~~~~~---l~~~~n 218 (654)
+|.+. .++ .+..+++|+.+++++|.+++......+++|+.+++++|++++ ++. +.++++ |.+.+|
T Consensus 121 ~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N 188 (210)
T d1h6ta2 121 HNGIS-DIN-GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKN 188 (210)
T ss_dssp TSCCC-CCG-GGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSS
T ss_pred ccccc-ccc-cccccccccccccccccccccccccccccccccccccccccc-ccc-ccCCCCCCEEECCCC
Confidence 99987 443 688999999999999999976655588999999999999985 442 555544 445444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=3.5e-13 Score=121.17 Aligned_cols=90 Identities=24% Similarity=0.273 Sum_probs=66.8
Q ss_pred cccCCCCccEEEeccC-CccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccc
Q 036334 88 TLGKLSQLRVLSLRSN-RLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTH 166 (654)
Q Consensus 88 ~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 166 (654)
.+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+|+ .+|..+....+
T Consensus 26 ~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~ 104 (156)
T d2ifga3 26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLS 104 (156)
T ss_dssp TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCC
T ss_pred cccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhcccc
Confidence 4777888888888765 477555667888888888888888888777778888888888888888888 45544433345
Q ss_pred cCcccccccccc
Q 036334 167 LTGLFLENNKFS 178 (654)
Q Consensus 167 L~~L~l~~N~l~ 178 (654)
|+.|+|++|.|.
T Consensus 105 l~~L~L~~Np~~ 116 (156)
T d2ifga3 105 LQELVLSGNPLH 116 (156)
T ss_dssp CCEEECCSSCCC
T ss_pred ccccccCCCccc
Confidence 777777776664
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.34 E-value=1.2e-12 Score=131.71 Aligned_cols=131 Identities=24% Similarity=0.312 Sum_probs=94.3
Q ss_pred EEEeecCCCCccc-cCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecc
Q 036334 70 VYSLRLPGVGLVG-PIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDL 148 (654)
Q Consensus 70 v~~L~l~~~~l~~-~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 148 (654)
...++...+.... ......+..+++|+.+++++|.++ .+|..+ +++|+.|++++|.+++..+..|.+++.++.|++
T Consensus 126 ~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~ 202 (305)
T d1xkua_ 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 202 (305)
T ss_dssp CCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEEC
T ss_pred ccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhcccccccccc
Confidence 4445555543221 122335777788888888888877 455443 577888888888888888888888888888888
Q ss_pred ccccccccCCCccccccccCccccccccccCCCCCC-CCCCCCeEEccCCcccccCc
Q 036334 149 SSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI-NPANLRDFNVSNNNLNGSIP 204 (654)
Q Consensus 149 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~g~~p 204 (654)
++|.+++..+..+.++++|++|+|++|+|+..++.+ .+++|+.|+|++|+|+ .++
T Consensus 203 s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~-~i~ 258 (305)
T d1xkua_ 203 SFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIG 258 (305)
T ss_dssp CSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCC-CCC
T ss_pred ccccccccccccccccccceeeecccccccccccccccccCCCEEECCCCccC-ccC
Confidence 888888777777888888888888888887665444 6788888888888887 443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=1.2e-12 Score=126.86 Aligned_cols=98 Identities=19% Similarity=0.274 Sum_probs=81.2
Q ss_pred CCceeeEEcCC---------CCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCC-CCCCCcccccccccc
Q 036334 56 CNWVGVECDAN---------RSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIP-SDFSNLTLLRSLYLQ 125 (654)
Q Consensus 56 C~w~gv~C~~~---------~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls 125 (654)
|.+..|.|... ...++.|+|++|.+. .+++..|.++++|++|+|++|.+...++ ..|.+++++++|++.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 77888999742 135889999999986 5777779999999999999999886554 468889999999876
Q ss_pred -ccccccccchhhccccccceecccccccc
Q 036334 126 -SNQFSGVFPASVTRMNRLTRLDLSSNNFS 154 (654)
Q Consensus 126 -~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 154 (654)
.|++....+..|.++++|+.|++++|++.
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred ccccccccccccccccccccccccchhhhc
Confidence 47788788888899999999999998886
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=1.8e-12 Score=116.48 Aligned_cols=107 Identities=14% Similarity=0.129 Sum_probs=92.3
Q ss_pred CCccEEEeccCCccCcCCCCCCCcccccccccccc-ccccccchhhccccccceeccccccccccCCCccccccccCccc
Q 036334 93 SQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSN-QFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLF 171 (654)
Q Consensus 93 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 171 (654)
...+.++.+++++. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...|..|..+++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34456777777777 66788999999999999766 59977778899999999999999999987788899999999999
Q ss_pred cccccccCCCCCC-CCCCCCeEEccCCccc
Q 036334 172 LENNKFSGNLPSI-NPANLRDFNVSNNNLN 200 (654)
Q Consensus 172 l~~N~l~~~~~~~-~~~~L~~L~l~~N~l~ 200 (654)
|++|+|+...+.. ...+|+.|+|++|++.
T Consensus 87 Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred ccCCCCcccChhhhccccccccccCCCccc
Confidence 9999999777765 5568999999999985
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.31 E-value=1.3e-14 Score=136.26 Aligned_cols=112 Identities=24% Similarity=0.323 Sum_probs=95.6
Q ss_pred cccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCcccccccc
Q 036334 88 TLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHL 167 (654)
Q Consensus 88 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 167 (654)
.|..|++|++|+|++|+|+ .++ .|.++++|+.|+|++|+|+ .+|..+..+++|+.|++++|+|+. ++ .+..+++|
T Consensus 43 sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L 117 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHS
T ss_pred HHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccc
Confidence 5888999999999999999 555 6899999999999999998 667667777899999999999994 43 58899999
Q ss_pred CccccccccccCCCC--CC-CCCCCCeEEccCCcccccCc
Q 036334 168 TGLFLENNKFSGNLP--SI-NPANLRDFNVSNNNLNGSIP 204 (654)
Q Consensus 168 ~~L~l~~N~l~~~~~--~~-~~~~L~~L~l~~N~l~g~~p 204 (654)
+.|+|++|+|+.... .. .+++|+.|+|++|++....+
T Consensus 118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred cccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 999999999986542 22 78999999999999975544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.28 E-value=3.3e-12 Score=122.58 Aligned_cols=39 Identities=26% Similarity=0.342 Sum_probs=19.4
Q ss_pred ccccccCccccccccccCCCCCCCCCCCCeEEccCCccc
Q 036334 162 NNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN 200 (654)
Q Consensus 162 ~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~ 200 (654)
..+++|+.|++++|.+.+..+-..+++|+.|+|++|+++
T Consensus 148 ~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~ 186 (227)
T d1h6ua2 148 AGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS 186 (227)
T ss_dssp GGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred ccccccccccccccccccchhhcccccceecccCCCccC
Confidence 344445555555555544333234455555555555554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.24 E-value=3.9e-12 Score=131.79 Aligned_cols=130 Identities=35% Similarity=0.433 Sum_probs=84.7
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccc-------------
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFP------------- 134 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p------------- 134 (654)
.+++.|++++|.+.. ++ .+..+++|+.|++++|.+++..+ ++.+++|++|++++|++++..+
T Consensus 219 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~ 293 (384)
T d2omza2 219 TNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELN 293 (384)
T ss_dssp TTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred CCCCEEECCCCCCCC-cc--hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCcccccccccccccc
Confidence 457888888888864 33 47888888888888888886543 7778888888888888875432
Q ss_pred -------hhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCc
Q 036334 135 -------ASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIP 204 (654)
Q Consensus 135 -------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p 204 (654)
..+..+++|+.|++++|+|++.. .+..+++|+.|++++|+|++...-..+++|++|+|++|+|++..|
T Consensus 294 ~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l~~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 294 ENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp SSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCBCGG
T ss_pred ccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCChhHcCCCCCCEEECCCCcCCCChh
Confidence 12444555666666666666432 255666666666666666643321256666666666666664433
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.20 E-value=5.2e-12 Score=130.80 Aligned_cols=122 Identities=27% Similarity=0.348 Sum_probs=97.1
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCC--------------------CCCCCccccccccccccc
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIP--------------------SDFSNLTLLRSLYLQSNQ 128 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p--------------------~~~~~l~~L~~L~Ls~N~ 128 (654)
.++.|++++|.+.+.. .+..+++|++|++++|.+++..+ ..+..+++|+.|+|++|+
T Consensus 242 ~L~~L~l~~n~l~~~~---~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~ 318 (384)
T d2omza2 242 NLTDLDLANNQISNLA---PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318 (384)
T ss_dssp TCSEEECCSSCCCCCG---GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSC
T ss_pred ccchhccccCccCCCC---cccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCC
Confidence 3666777777766532 26666777777777766654321 236677889999999999
Q ss_pred cccccchhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCC
Q 036334 129 FSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNN 197 (654)
Q Consensus 129 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N 197 (654)
+++.. .+..+++|+.|+|++|+|++ ++ .+.++++|++|+|++|+|++.+|-..+++|+.|+|++|
T Consensus 319 l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 319 ISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp CSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 99764 38899999999999999994 55 69999999999999999999888668999999999998
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.20 E-value=1.7e-11 Score=117.42 Aligned_cols=138 Identities=24% Similarity=0.363 Sum_probs=93.3
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccc-------------
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFP------------- 134 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p------------- 134 (654)
.+++.|+|++|.+.+.. + +..+++|++|++++|.++ .++ .+.++++|+.|++++|...+..+
T Consensus 63 ~~L~~L~ls~n~i~~~~-~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 63 NNLIGLELKDNQITDLA-P--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137 (227)
T ss_dssp TTCCEEECCSSCCCCCG-G--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCcEeecCCceeeccc-c--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhch
Confidence 34777777777776432 2 677777777777777776 333 46677777777777777664422
Q ss_pred -------hhhccccccceeccccccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCcccccCcccc
Q 036334 135 -------ASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLNGSIPATL 207 (654)
Q Consensus 135 -------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~g~~p~~~ 207 (654)
..+.++++|+.|++++|.++... .+.++++|+.|+|++|++++..+-..+++|++|+|++|+|++ +|. +
T Consensus 138 ~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~N~lt~-i~~-l 213 (227)
T d1h6ua2 138 LNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISD-VSP-L 213 (227)
T ss_dssp SSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCB-CGG-G
T ss_pred hhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCCChhhcCCCCCCEEECcCCcCCC-Ccc-c
Confidence 12455667788888888776433 377888888888888888875443377888888888888874 442 5
Q ss_pred cCCCCcc
Q 036334 208 SKFPQSS 214 (654)
Q Consensus 208 ~~~~~l~ 214 (654)
+++++|.
T Consensus 214 ~~l~~L~ 220 (227)
T d1h6ua2 214 ANTSNLF 220 (227)
T ss_dssp TTCTTCC
T ss_pred ccCCCCC
Confidence 5555543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.14 E-value=2.7e-13 Score=127.12 Aligned_cols=120 Identities=22% Similarity=0.295 Sum_probs=98.3
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceec
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLD 147 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 147 (654)
.+++.|+|++|.+. .++ .|..+++|++|+|++|.|+ .+|..+..+++|++|+|++|+++. + ..+..+++|+.|+
T Consensus 48 ~~L~~L~Ls~n~I~-~i~--~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~ 121 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS--SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVLY 121 (198)
T ss_dssp TTCCEEECSEEEES-CCC--CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEEE
T ss_pred cccceeECcccCCC-Ccc--cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccccccccc
Confidence 34899999999997 454 3899999999999999998 667666667899999999999995 4 3588999999999
Q ss_pred cccccccccCC-CccccccccCccccccccccCCCCCC------------CCCCCCeEE
Q 036334 148 LSSNNFSGKIP-FDVNNLTHLTGLFLENNKFSGNLPSI------------NPANLRDFN 193 (654)
Q Consensus 148 l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~------------~~~~L~~L~ 193 (654)
|++|+|+.... ..+..+++|+.|+|++|.+....+.. .+++|+.||
T Consensus 122 L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 99999984321 35789999999999999998665542 366777765
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.99 E-value=3.9e-10 Score=108.68 Aligned_cols=146 Identities=15% Similarity=0.145 Sum_probs=108.6
Q ss_pred CCceeeEEcCCCCeEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCcccccccccccccccccc-c
Q 036334 56 CNWVGVECDANRSFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVF-P 134 (654)
Q Consensus 56 C~w~gv~C~~~~~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p 134 (654)
|.=.-+.|+.. .++.++.++. .+|++.+ +++++|+|++|.|+...+..|.++++|++|+|++|.+...+ +
T Consensus 1 ~~~~~C~C~~~-----~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~ 71 (242)
T d1xwdc1 1 CHHRICHCSNR-----VFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 71 (242)
T ss_dssp CCCSSEEECSS-----EEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECS
T ss_pred CcCCcCCCcCC-----EEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeec
Confidence 33334778642 3555677776 6776422 57899999999999655567999999999999999998755 4
Q ss_pred hhhccccccceeccc-cccccccCCCccccccccCccccccccccCCCCCC---CCCCCCeEEccCCcccccCcccccCC
Q 036334 135 ASVTRMNRLTRLDLS-SNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSI---NPANLRDFNVSNNNLNGSIPATLSKF 210 (654)
Q Consensus 135 ~~~~~l~~L~~L~l~-~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~---~~~~L~~L~l~~N~l~g~~p~~~~~~ 210 (654)
..|.++++++.|++. .|++....+..|.++++|+.|++++|++....+.. .+..+..+..+++.+...-+..+..+
T Consensus 72 ~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~ 151 (242)
T d1xwdc1 72 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 151 (242)
T ss_dssp SSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccc
Confidence 568899999999986 47888788888999999999999999998665543 34455555667777764444444443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.74 E-value=1.3e-08 Score=102.97 Aligned_cols=114 Identities=26% Similarity=0.353 Sum_probs=88.5
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLS 149 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 149 (654)
++.|||++++|+ .+|+ .+++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .+.|++|+|+
T Consensus 40 l~~LdLs~~~L~-~lp~----~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 40 AHELELNNLGLS-SLPE----LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp CSEEECTTSCCS-CCCS----CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCEEEeCCCCCC-CCCC----CCCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 778999999996 5764 2578999999999999 778665 57888889999988 44421 1469999999
Q ss_pred cccccccCCCccccccccCccccccccccCCCCCCCCCCCCeEEccCCccc
Q 036334 150 SNNFSGKIPFDVNNLTHLTGLFLENNKFSGNLPSINPANLRDFNVSNNNLN 200 (654)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l~~N~l~ 200 (654)
+|.|+ .+|. ++.+++|+.|++++|.+...+.. ...+..+.+.++...
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~--~~~l~~l~~~~~~~~ 153 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDL--PPSLEFIAAGNNQLE 153 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCCS
T ss_pred ccccc-cccc-hhhhccceeeccccccccccccc--cccccchhhcccccc
Confidence 99998 6664 67899999999999998865543 356677777776664
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.72 E-value=3.9e-10 Score=111.62 Aligned_cols=146 Identities=23% Similarity=0.261 Sum_probs=93.5
Q ss_pred eEEEeecCCCCccccCCcccccCCCCccEEEeccCCccCcCCCCCCCccccccccccc-cccccc-cchhhcccccccee
Q 036334 69 FVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQS-NQFSGV-FPASVTRMNRLTRL 146 (654)
Q Consensus 69 ~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~-~p~~~~~l~~L~~L 146 (654)
+++.|||+++.+........+..+++|++|+|++|.+++..+..++++++|++|+|++ +.+++. +...+.++++|++|
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L 126 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccc
Confidence 4888999988876554444578889999999999998877777788889999999988 467643 23334568899999
Q ss_pred ccccc-ccccc-CCCcccc-ccccCccccccc--cccCC-CCCC--CCCCCCeEEccCC-cccccCcccccCCCCcc
Q 036334 147 DLSSN-NFSGK-IPFDVNN-LTHLTGLFLENN--KFSGN-LPSI--NPANLRDFNVSNN-NLNGSIPATLSKFPQSS 214 (654)
Q Consensus 147 ~l~~N-~l~~~-~p~~~~~-l~~L~~L~l~~N--~l~~~-~~~~--~~~~L~~L~l~~N-~l~g~~p~~~~~~~~l~ 214 (654)
+|+++ +++.. +...+.. .++|+.|+++++ .++.. +... .+++|++|+|++| .+++.....+.++++|.
T Consensus 127 ~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~ 203 (284)
T d2astb2 127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203 (284)
T ss_dssp ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred ccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCC
Confidence 99884 44321 1111222 346666666643 23321 1111 4566777777664 45555555555555443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.71 E-value=1.9e-08 Score=101.82 Aligned_cols=95 Identities=26% Similarity=0.267 Sum_probs=43.0
Q ss_pred CccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceeccccccccccCCCccccccccCccccc
Q 036334 94 QLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTHLTGLFLE 173 (654)
Q Consensus 94 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 173 (654)
+|++|||++|.|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++. +. +.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-lp--~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-LP--PLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-CC--TTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-hc--ccccccccc
Confidence 3445555555554 34432 234455555555555 344332 34444555555544 2221 10 235555555
Q ss_pred cccccCCCCCCCCCCCCeEEccCCccc
Q 036334 174 NNKFSGNLPSINPANLRDFNVSNNNLN 200 (654)
Q Consensus 174 ~N~l~~~~~~~~~~~L~~L~l~~N~l~ 200 (654)
+|.|...+....+++|+.|++++|.++
T Consensus 107 ~n~l~~lp~~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 107 NNQLEKLPELQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp SSCCSSCCCCTTCTTCCEEECCSSCCS
T ss_pred ccccccccchhhhccceeecccccccc
Confidence 555543332224455555555555544
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.59 E-value=5.3e-09 Score=93.87 Aligned_cols=118 Identities=18% Similarity=0.180 Sum_probs=73.3
Q ss_pred CccEEEeccCCccCcCCCCCCCccccccccccccccccccchhhccccccceecccccccccc--CCCccccccccCccc
Q 036334 94 QLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGVFPASVTRMNRLTRLDLSSNNFSGK--IPFDVNNLTHLTGLF 171 (654)
Q Consensus 94 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~ 171 (654)
..+.||++++... ..+..+..+..|++.+|... .++..+..+++|++|+|++|+|+.. ++..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3455666554432 23455556666666666554 5555566778888888888888743 234456778888888
Q ss_pred cccccccCCCCCC--CCCCCCeEEccCCcccccCccc-------ccCCCCcccc
Q 036334 172 LENNKFSGNLPSI--NPANLRDFNVSNNNLNGSIPAT-------LSKFPQSSFT 216 (654)
Q Consensus 172 l~~N~l~~~~~~~--~~~~L~~L~l~~N~l~g~~p~~-------~~~~~~l~~~ 216 (654)
|++|+|+...+.. ...+|+.|+|++|+++...... +..+++|...
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~L 151 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEE
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEE
Confidence 8888887654422 4456788888888887544422 4456665543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.54 E-value=1.5e-09 Score=97.52 Aligned_cols=108 Identities=23% Similarity=0.243 Sum_probs=73.0
Q ss_pred ccCCCCccEEEeccCCccCcCCCCCCCccccccccccccccccc--cchhhccccccceeccccccccccCCCccccccc
Q 036334 89 LGKLSQLRVLSLRSNRLSGEIPSDFSNLTLLRSLYLQSNQFSGV--FPASVTRMNRLTRLDLSSNNFSGKIPFDVNNLTH 166 (654)
Q Consensus 89 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 166 (654)
+..+..+..|++.+|.+. .++..+.++++|++|+|++|+|+.. ++..+..+++|+.|+|++|.|+..-+-.+....+
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 445555556666665544 4444456788889999999988854 3456777888999999999988432223334456
Q ss_pred cCccccccccccCCCCCC---------CCCCCCeEEccCCcc
Q 036334 167 LTGLFLENNKFSGNLPSI---------NPANLRDFNVSNNNL 199 (654)
Q Consensus 167 L~~L~l~~N~l~~~~~~~---------~~~~L~~L~l~~N~l 199 (654)
|+.|++++|.+....... .+++|+.|| ++.+
T Consensus 117 L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp CSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred cceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence 888999999888765531 578888775 4444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.49 E-value=5.4e-09 Score=103.17 Aligned_cols=147 Identities=23% Similarity=0.252 Sum_probs=99.0
Q ss_pred CeEEEeecCCCCccccCCcccccCCCCccEEEeccC-CccCc-CCCCCCCcccccccccccc-ccccc-cchhhcc-ccc
Q 036334 68 SFVYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSN-RLSGE-IPSDFSNLTLLRSLYLQSN-QFSGV-FPASVTR-MNR 142 (654)
Q Consensus 68 ~~v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~-l~~ 142 (654)
.+++.|+|+++.+.+.... .++.+++|++|+|+++ .++.. +..-+.++++|++|+|+++ ++++. +...+.. .++
T Consensus 71 ~~L~~L~L~~~~l~~~~~~-~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~ 149 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVN-TLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET 149 (284)
T ss_dssp CCCSEEECTTCBCCHHHHH-HHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred CCcccccccccCCCcHHHH-HHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccc
Confidence 3588999999988766655 5888999999999984 56521 2222456789999999985 45532 2333444 468
Q ss_pred cceeccccc--ccccc-CCCccccccccCccccccc-cccCCCCC-C-CCCCCCeEEccC-CcccccCcccccCCCCccc
Q 036334 143 LTRLDLSSN--NFSGK-IPFDVNNLTHLTGLFLENN-KFSGNLPS-I-NPANLRDFNVSN-NNLNGSIPATLSKFPQSSF 215 (654)
Q Consensus 143 L~~L~l~~N--~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~~~~-~-~~~~L~~L~l~~-N~l~g~~p~~~~~~~~l~~ 215 (654)
|+.|++++. .++.. +...+.++++|+.|++++| .+++.... . .+++|++|+|++ +.+++.....++++++|..
T Consensus 150 L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~ 229 (284)
T d2astb2 150 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 229 (284)
T ss_dssp CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred cchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCE
Confidence 899988864 34422 2223456788999999876 46644332 2 778899999988 5677666666766666543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.31 E-value=1.2e-08 Score=107.16 Aligned_cols=61 Identities=26% Similarity=0.251 Sum_probs=27.9
Q ss_pred EEEeecCCCCccccCCcccccCCCCccEEEeccCCccC----cCCCCCCCccccccccccccccc
Q 036334 70 VYSLRLPGVGLVGPIPPNTLGKLSQLRVLSLRSNRLSG----EIPSDFSNLTLLRSLYLQSNQFS 130 (654)
Q Consensus 70 v~~L~l~~~~l~~~~~~~~l~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 130 (654)
|+.||++++++++.--.+.+..+++|++|+|++|.|+. .+...+..+++|++|||++|+|+
T Consensus 4 l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~ 68 (460)
T d1z7xw1 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68 (460)
T ss_dssp EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred CCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCC
Confidence 55555555555432111123444555555555555541 12223344445555555555544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.30 E-value=1.6e-08 Score=102.57 Aligned_cols=132 Identities=19% Similarity=0.250 Sum_probs=78.5
Q ss_pred eEEEeecCCCCcc--------ccCC----cccccCCCCccEEEeccCCccCc----CCCCCCCccccccccccccccccc
Q 036334 69 FVYSLRLPGVGLV--------GPIP----PNTLGKLSQLRVLSLRSNRLSGE----IPSDFSNLTLLRSLYLQSNQFSGV 132 (654)
Q Consensus 69 ~v~~L~l~~~~l~--------~~~~----~~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ 132 (654)
+++.|+|++|.+. ..+. .......+.|+.|++++|.++.. +...+...+.|+.|+|++|+++..
T Consensus 122 ~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 201 (344)
T d2ca6a1 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201 (344)
T ss_dssp TCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH
T ss_pred cchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccccccccccccc
Confidence 3777888877641 0000 00123456677777777776521 222344556777777777777632
Q ss_pred -----cchhhccccccceecccccccccc----CCCccccccccCccccccccccCCCC--------CCCCCCCCeEEcc
Q 036334 133 -----FPASVTRMNRLTRLDLSSNNFSGK----IPFDVNNLTHLTGLFLENNKFSGNLP--------SINPANLRDFNVS 195 (654)
Q Consensus 133 -----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~--------~~~~~~L~~L~l~ 195 (654)
+...+..+++|+.|+|++|.|+.. +...+..+++|+.|+|++|.|++.-. ......|++|+|+
T Consensus 202 g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls 281 (344)
T d2ca6a1 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQ 281 (344)
T ss_dssp HHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECC
T ss_pred ccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECC
Confidence 233456667777777777776532 33445667777777777777764211 1123567777777
Q ss_pred CCccc
Q 036334 196 NNNLN 200 (654)
Q Consensus 196 ~N~l~ 200 (654)
+|+|+
T Consensus 282 ~N~i~ 286 (344)
T d2ca6a1 282 YNEIE 286 (344)
T ss_dssp SSCCB
T ss_pred CCcCC
Confidence 77775
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.15 E-value=3.8e-08 Score=103.13 Aligned_cols=109 Identities=17% Similarity=0.236 Sum_probs=83.6
Q ss_pred CCccEEEeccCCccCcC-CCCCCCcccccccccccccccc----ccchhhccccccceecccccccccc----CCCccc-
Q 036334 93 SQLRVLSLRSNRLSGEI-PSDFSNLTLLRSLYLQSNQFSG----VFPASVTRMNRLTRLDLSSNNFSGK----IPFDVN- 162 (654)
Q Consensus 93 ~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~- 162 (654)
.+|+.||++.|+|++.. ..-+..+++|++|+|++|.++. .+...+..+++|+.|||++|.|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 36899999999998532 3345678999999999999984 3456678899999999999998621 222222
Q ss_pred cccccCccccccccccCCC----CC-C-CCCCCCeEEccCCcccc
Q 036334 163 NLTHLTGLFLENNKFSGNL----PS-I-NPANLRDFNVSNNNLNG 201 (654)
Q Consensus 163 ~l~~L~~L~l~~N~l~~~~----~~-~-~~~~L~~L~l~~N~l~g 201 (654)
...+|+.|+|++|+|++.. +. . .+++|++|+|++|.++.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 2357999999999997542 22 2 67899999999999874
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.13 E-value=3.5e-08 Score=100.00 Aligned_cols=62 Identities=19% Similarity=0.244 Sum_probs=26.9
Q ss_pred cccccceecccccccccc-----CCCccccccccCccccccccccCC----C-CCC-CCCCCCeEEccCCccc
Q 036334 139 RMNRLTRLDLSSNNFSGK-----IPFDVNNLTHLTGLFLENNKFSGN----L-PSI-NPANLRDFNVSNNNLN 200 (654)
Q Consensus 139 ~l~~L~~L~l~~N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~----~-~~~-~~~~L~~L~l~~N~l~ 200 (654)
..+.|+.|+|++|+|+.. +...+..+++|+.|+|++|.|+.. + ... .+++|++|+|++|.|+
T Consensus 184 ~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred hhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccC
Confidence 344455555555554321 222344444555555555554321 0 011 3444555555555544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.06 E-value=7.9e-06 Score=78.52 Aligned_cols=128 Identities=16% Similarity=0.096 Sum_probs=84.0
Q ss_pred cCceeEEEEEecCCcEEEEEEecccc-cCHHHHHHHHHHHhccC-CCccccccEEEEeCCceEEEEEecCCCchhhhhcc
Q 036334 357 GSVGTSYKAVLEEGTTVVVKRLKEVA-VGKREFEMQMEVLGKIK-HDNVVPLRAFYYSKDEKLLVYDYMPAGSLSALLHG 434 (654)
Q Consensus 357 G~fg~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 434 (654)
++.+.||+.... +..+++|+..... .....+.+|..+++.+. +--+-+++.++.+++..++||+++++..+.+....
T Consensus 25 ~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 334689988654 6677888876542 33445778888877663 33356677888888889999999999887655431
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhhc--------------------------------------------------
Q 036334 435 SRGSGRTPLDWDNRMRIALSAARGLAHLHV-------------------------------------------------- 464 (654)
Q Consensus 435 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-------------------------------------------------- 464 (654)
. .. ...++.++++.++.||+
T Consensus 104 ~-------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (263)
T d1j7la_ 104 E-------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF 173 (263)
T ss_dssp C-------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHH
T ss_pred c-------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHH
Confidence 1 11 11223333333333331
Q ss_pred ---c----C-CeecCCCCCCcEEECCCCCeEEeccCCCC
Q 036334 465 ---S----G-KIVHGNIKASNILLRPDHDACVSDFGLNP 495 (654)
Q Consensus 465 ---~----~-~ivHrDlk~~NIll~~~~~~kl~Dfgla~ 495 (654)
. . .++|+|+.+.||++++++.+-|+||+.+.
T Consensus 174 l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0 0 27899999999999977666799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.75 E-value=7.7e-05 Score=70.90 Aligned_cols=74 Identities=12% Similarity=0.087 Sum_probs=52.6
Q ss_pred ccccCc-eeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCC--CccccccEEEEeCCceEEEEEecCCCchh
Q 036334 354 LGKGSV-GTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKH--DNVVPLRAFYYSKDEKLLVYDYMPAGSLS 429 (654)
Q Consensus 354 lg~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~g~L~ 429 (654)
+..|.. +.||+....++..+++|...... ...+..|+..++.+.. -.+.++++++.+++..++||++++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444543 67899988778889999865543 2346677777766642 23566788878888889999999886653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.63 E-value=0.00014 Score=74.10 Aligned_cols=74 Identities=11% Similarity=0.141 Sum_probs=47.5
Q ss_pred ccccccCceeEEEEEecC-CcEEEEEEeccc--------ccCHHHHHHHHHHHhccC-C--CccccccEEEEeCCceEEE
Q 036334 352 EVLGKGSVGTSYKAVLEE-GTTVVVKRLKEV--------AVGKREFEMQMEVLGKIK-H--DNVVPLRAFYYSKDEKLLV 419 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~-g~~vavK~~~~~--------~~~~~~~~~e~~~l~~l~-h--pniv~l~~~~~~~~~~~lv 419 (654)
+.||.|....||+....+ ++.|+||.-... .....+...|.+.++.+. + ..+.+++. .+++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence 458999999999998654 678999975431 112334556777776652 2 23444443 456677899
Q ss_pred EEecCCCc
Q 036334 420 YDYMPAGS 427 (654)
Q Consensus 420 ~e~~~~g~ 427 (654)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.49 E-value=6.1e-06 Score=73.66 Aligned_cols=109 Identities=14% Similarity=0.113 Sum_probs=60.6
Q ss_pred CCCCccEEEeccC-CccCc----CCCCCCCccccccccccccccccc----cchhhccccccceecccccccccc----C
Q 036334 91 KLSQLRVLSLRSN-RLSGE----IPSDFSNLTLLRSLYLQSNQFSGV----FPASVTRMNRLTRLDLSSNNFSGK----I 157 (654)
Q Consensus 91 ~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~ 157 (654)
+.++|+.|+|+++ .++.. +-..+...++|+.|+|++|.++.. +...+...+.|+.|+|++|.|+.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4466777777653 34421 222344556677777777776633 223344456677777777776632 1
Q ss_pred CCccccccccCccccccccccCCCC-------CC--CCCCCCeEEccCCcc
Q 036334 158 PFDVNNLTHLTGLFLENNKFSGNLP-------SI--NPANLRDFNVSNNNL 199 (654)
Q Consensus 158 p~~~~~l~~L~~L~l~~N~l~~~~~-------~~--~~~~L~~L~l~~N~l 199 (654)
-..+...++|+.|+|++|.+...-. .. ..++|+.|+++.+..
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 1234455667777777776543211 11 346677777766543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.27 E-value=1.2e-05 Score=71.70 Aligned_cols=109 Identities=10% Similarity=0.073 Sum_probs=76.8
Q ss_pred CeEEEeecCCC-Ccccc----CCcccccCCCCccEEEeccCCccCcCCC----CCCCccccccccccccccccc----cc
Q 036334 68 SFVYSLRLPGV-GLVGP----IPPNTLGKLSQLRVLSLRSNRLSGEIPS----DFSNLTLLRSLYLQSNQFSGV----FP 134 (654)
Q Consensus 68 ~~v~~L~l~~~-~l~~~----~~~~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~----~p 134 (654)
..+++|+|+++ .+... +-. .+...++|++|+|++|.+...-.. .+...+.|+.|+|++|.++.. +-
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~-~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIE-AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHH-HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHH-HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 45899999874 45322 222 467778999999999999743222 344568899999999999864 23
Q ss_pred hhhccccccceecccccccccc-------CCCccccccccCccccccccc
Q 036334 135 ASVTRMNRLTRLDLSSNNFSGK-------IPFDVNNLTHLTGLFLENNKF 177 (654)
Q Consensus 135 ~~~~~l~~L~~L~l~~N~l~~~-------~p~~~~~l~~L~~L~l~~N~l 177 (654)
..+...++|++|+|++|.+... +...+...++|+.|+++.+..
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 3466678899999999976522 233445567888898877654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.23 E-value=0.0014 Score=64.57 Aligned_cols=68 Identities=12% Similarity=0.095 Sum_probs=48.2
Q ss_pred eeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHhccCCCc-----ccccc--EEEEeCCceEEEEEecCCCc
Q 036334 360 GTSYKAVLEEGTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDN-----VVPLR--AFYYSKDEKLLVYDYMPAGS 427 (654)
Q Consensus 360 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpn-----iv~l~--~~~~~~~~~~lv~e~~~~g~ 427 (654)
-.||++...+|+.|++|+......+.+++..|.+.+..+.... .+..- ..+...+..+.++++++|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 4799999999999999999877667788888998887764221 11111 12334566789999987643
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.71 E-value=5.6e-05 Score=67.00 Aligned_cols=110 Identities=15% Similarity=0.183 Sum_probs=62.6
Q ss_pred cCCCCccEEEecc-CCccCc----CCCCCCCccccccccccccccccc----cchhhccccccceecccccccccc----
Q 036334 90 GKLSQLRVLSLRS-NRLSGE----IPSDFSNLTLLRSLYLQSNQFSGV----FPASVTRMNRLTRLDLSSNNFSGK---- 156 (654)
Q Consensus 90 ~~l~~L~~L~Ls~-N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~---- 156 (654)
.+.+.|++|+|++ |.++.. +-..+...++|++|+|++|.++.. +-..+...++|+.|++++|.++..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3456777777776 445421 222344566777777777777643 223345567777777777776522
Q ss_pred CCCccccccccCcc--ccccccccCC----CCCC--CCCCCCeEEccCCcc
Q 036334 157 IPFDVNNLTHLTGL--FLENNKFSGN----LPSI--NPANLRDFNVSNNNL 199 (654)
Q Consensus 157 ~p~~~~~l~~L~~L--~l~~N~l~~~----~~~~--~~~~L~~L~l~~N~l 199 (654)
+-..+...++|+.+ ++++|.+... +... ..++|+.|+++.|..
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 22345556667653 4455666431 1111 456778888776654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.47 E-value=0.0054 Score=61.90 Aligned_cols=72 Identities=11% Similarity=0.179 Sum_probs=47.7
Q ss_pred ccccccCceeEEEEEecC--------CcEEEEEEecccccCHHHHHHHHHHHhccCCCccc-cccEEEEeCCceEEEEEe
Q 036334 352 EVLGKGSVGTSYKAVLEE--------GTTVVVKRLKEVAVGKREFEMQMEVLGKIKHDNVV-PLRAFYYSKDEKLLVYDY 422 (654)
Q Consensus 352 ~~lg~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~e~~~l~~l~hpniv-~l~~~~~~~~~~~lv~e~ 422 (654)
+.|+.|-.-.+|+....+ ...|++++... .....+..+|..+++.+.-.++. +++++|. -.+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEE
Confidence 457778888999988653 34677776653 33344566788888877533444 6777663 2689999
Q ss_pred cCCCch
Q 036334 423 MPAGSL 428 (654)
Q Consensus 423 ~~~g~L 428 (654)
+++..+
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.33 E-value=8.8e-05 Score=65.67 Aligned_cols=111 Identities=17% Similarity=0.173 Sum_probs=76.1
Q ss_pred CeEEEeecCCC-CccccCC---cccccCCCCccEEEeccCCccCc----CCCCCCCccccccccccccccccc----cch
Q 036334 68 SFVYSLRLPGV-GLVGPIP---PNTLGKLSQLRVLSLRSNRLSGE----IPSDFSNLTLLRSLYLQSNQFSGV----FPA 135 (654)
Q Consensus 68 ~~v~~L~l~~~-~l~~~~~---~~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~ 135 (654)
..++.|+|+++ .+....- ...+...++|++|+|++|.++.. +-..+...++|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 45888999874 4532210 11356788999999999998743 223455678899999999998754 334
Q ss_pred hhcccccccee--ccccccccc----cCCCccccccccCcccccccccc
Q 036334 136 SVTRMNRLTRL--DLSSNNFSG----KIPFDVNNLTHLTGLFLENNKFS 178 (654)
Q Consensus 136 ~~~~l~~L~~L--~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~ 178 (654)
.+...++|+.+ ++++|.+.. .+...+...++|+.|+++.|...
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 56677888864 456777753 24445667889999999877543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.12 E-value=0.079 Score=50.90 Aligned_cols=29 Identities=17% Similarity=0.314 Sum_probs=25.6
Q ss_pred CeecCCCCCCcEEECCCCCeEEeccCCCC
Q 036334 467 KIVHGNIKASNILLRPDHDACVSDFGLNP 495 (654)
Q Consensus 467 ~ivHrDlk~~NIll~~~~~~kl~Dfgla~ 495 (654)
.+||+|+.+.||+++.+...-|.||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 49999999999999988777899999764
|